PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Takeda, S; Hashimoto, T; Roe, AD; Hori, Y; Spires-Jones, TL; Hyman, BT				Takeda, Shuko; Hashimoto, Tadafumi; Roe, Allyson D.; Hori, Yukiko; Spires-Jones, Tara L.; Hyman, Bradley T.			Brain interstitial oligomeric amyloid beta increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						in vivo microdialysis; apolipoprotein E	A-BETA; APOLIPOPROTEIN-E; SYNAPTIC PLASTICITY; SECRETED OLIGOMERS; PRECURSOR PROTEIN; DEPOSITION; METABOLISM; PLASMA; E4	There is a growing body of evidence that soluble oligomeric forms of amyloid (A) play a critical role in Alzheimer's disease (AD). Despite the importance of soluble A oligomers as a therapeutic target for AD, the dynamic metabolism of these A species in vivo has not been elucidated because of the difficulty in monitoring brain A oligomers in living animals. Here, using a unique large pore-sized membrane microdialysis, we characterized soluble A oligomers in brain interstitial fluid (ISF) of awake, freely moving APP/PS1 transgenic and control WT mice. We could detect high-molecular-weight (HMW) and low-molecular-weight (LMW) A oligomers in the brain ISF of living animals, which increased dramatically in an age-dependent manner (5- to 8-fold increase, 4 vs. 17-18 mo). Notably, HMW A decreased more slowly than other forms of A after acute -secretase inhibition [% decrease from the baseline (HMW vs. LMW) was 36.9 vs. 74.1% (A(40), P<0.05) and 25.4 vs. 88.0% (A(42), P<0.01)], suggesting that HMW A oligomers clear more slowly than other forms from the brain. These data reveal the dynamic metabolism of neurotoxic A oligomers in AD brain and could provide new insights into A-targeted therapies for AD.Takeda, S., Hashimoto, T., Roe, A. D., Hori, Y., Spires-Jones, T. L., and Hyman, B. T. Brain interstitial oligomeric amyloid increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease.	[Takeda, Shuko; Hashimoto, Tadafumi; Roe, Allyson D.; Hori, Yukiko; Spires-Jones, Tara L.; Hyman, Bradley T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Alzheimers Dis Res Lab,Dept Neurol,MassGen Inst N, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Alzheimers Dis Res Lab,Dept Neurol,MassGen Inst N, Bldg 114,16th St, Charlestown, MA 02129 USA.	bhyman@partners.org	Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598; Hashimoto, Tadafumi/0000-0001-5442-4800	U.S. National Institutes of Health [P50AG05134]; Japan Society for the Promotion of Science (JSPS); NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is supported by U.S. National Institutes of Health grant P50AG05134 (B. T. H.). S. T. is supported by a fellowship from the Japan Society for the Promotion of Science (JSPS). The authors also thank Dr. Alberto Serrano-Pozo for valuable discussions. The authors declare no conflicts of interest.	Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cao CH, 2009, J ALZHEIMERS DIS, V17, P681, DOI 10.3233/JAD-2009-1071; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cirrito JR, 2003, J NEUROSCI, V23, P8844; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Klein William L, 2006, Alzheimers Dement, V2, P43, DOI 10.1016/j.jalz.2005.11.003; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 1999, J CLIN INVEST, V104, P1169, DOI 10.1172/JCI8508; Takeda S, 2011, NEUROSCIENCE, V186, P110, DOI 10.1016/j.neuroscience.2011.04.035; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yamada K, 2009, J NEUROSCI, V29, P11393, DOI 10.1523/JNEUROSCI.2021-09.2009	32	47	50	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3239	3248		10.1096/fj.13-229666	http://dx.doi.org/10.1096/fj.13-229666			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23640054	Green Published			2022-12-25	WOS:000329877600029
J	Yamada, K; Hayashi, M; Madokoro, H; Nishida, H; Du, WL; Ohnuma, K; Sakamoto, M; Morimoto, C; Yamada, T				Yamada, Kohji; Hayashi, Mutsumi; Madokoro, Hiroko; Nishida, Hiroko; Du, Wenlin; Ohnuma, Kei; Sakamoto, Michiie; Morimoto, Chikao; Yamada, Taketo			Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; FACTOR RECEPTOR; IN-VITRO; PHASE-I; CANCER; MESOTHELIOMA; TRANSLOCATION; ACCUMULATION; ENDOCYTOSIS; CARCINOMA	CD26 is a type II glycoprotein known as dipeptidyl peptidase IV and has been identified as one of the cell surface markers associated with various types of cancers and a subset of cancer stem cells. Recent studies have suggested that CD26 expression is involved in tumor growth, tumor invasion, and metastasis. The CD26 is shown in an extensive intracellular distribution, ranging from the cell surface to the nucleus. We have previously showed that the humanized anti-CD26 monoclonal antibody (mAb), YS110, exhibits inhibitory effects on various cancers. However, functions of CD26 on cancer cells and molecular mechanisms of impaired tumor growth by YS110 treatment are not well understood. In this study, we demonstrated that the treatment with YS110 induced nuclear translocation of both cell-surface CD26 and YS110 in cancer cells and xenografted tumor. It was shown that the CD26 and YS110 were co-localized in nucleus by immunoelectron microscopic analysis. In response to YS110 treatment, CD26 was translocated into the nucleus via caveolin-dependent endocytosis. It was revealed that the nuclear CD26 interacted with a genomic flanking region of the gene for POLR2A, a subunit of RNA polymerase II, using a chromatin immunoprecipitation assay. This interaction with nuclear CD26 and POLR2A gene consequently led to transcriptional repression of the POLR2A gene, resulting in retarded cell proliferation of cancer cells. Furthermore, the impaired nuclear transport of CD26 by treatment with an endocytosis inhibitor or expressions of deletion mutants of CD26 reversed the POLR2A repression induced by YS110 treatment. These findings reveal that the nuclear CD26 functions in the regulation of gene expression and tumor growth, and provide a novel mechanism of mAb-therapy related to inducible translocation of cell-surface target molecule into the nucleus.	[Yamada, Kohji; Hayashi, Mutsumi; Madokoro, Hiroko; Nishida, Hiroko; Du, Wenlin; Sakamoto, Michiie; Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 160, Japan; [Ohnuma, Kei; Morimoto, Chikao] Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Bunkyo Ku, Tokyo, Japan	Keio University; Juntendo University	Yamada, T (corresponding author), Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 160, Japan.	taketo@a5.keio.jp	Sakamoto, Michiie/N-2917-2015		Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [07-17]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23390086, 22790355]; Ministry of Health, Labor and Welfare [H24-B10-003]	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (07-17 to T.Y. and C.M.), a Grant-in-Aid for Scientific Research (B) (23390086 to T.Y. and 22790355 to M.H.) and Global COE Program "Education and Research Center for Stem Cell Medicine'' (to K.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant-in-Aid for Drug Design Biomarker Research (H24-B10-003 to T.Y. and C.M.) from the Ministry of Health, Labor and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Amatya VJ, 2011, ONCOL REP, V26, P1369, DOI 10.3892/or.2011.1449; Aoe K, 2012, CLIN CANCER RES, V18, P1447, DOI 10.1158/1078-0432.CCR-11-1990; Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Benmerah A, 2004, CURR BIOL, V14, pR314, DOI 10.1016/j.cub.2004.03.053; Calera MR, 2011, BBA-MOL CELL RES, V1813, P1708, DOI 10.1016/j.bbamcr.2011.07.005; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Francis RJ, 2002, BRIT J CANCER, V87, P600, DOI 10.1038/sj.bjc.6600517; Ghani FI, 2011, BIOCHEM BIOPH RES CO, V404, P735, DOI 10.1016/j.bbrc.2010.12.054; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Gordon LI, 2004, CLIN LYMPHOMA, V5, P98, DOI 10.3816/CLM.2004.n.015; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Ho L, 2001, CLIN CANCER RES, V7, P2031; Inamoto T, 2007, CLIN CANCER RES, V13, P4191, DOI 10.1158/1078-0432.CCR-07-0110; Inamoto T, 2006, CLIN CANCER RES, V12, P3470, DOI 10.1158/1078-0432.CCR-06-0361; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; KOTANI T, 1992, INT J EXP PATHOL, V73, P215; Kounnis V, 2011, ONCOTARGETS THER, V4, P27, DOI 10.2147/OTT.S16706; Kreitman RJ, 2001, NEW ENGL J MED, V345, P241, DOI 10.1056/NEJM200107263450402; Lin-Lee YC, 2006, J BIOL CHEM, V281, P18878, DOI 10.1074/jbc.M513315200; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; MARTI U, 1991, HEPATOLOGY, V13, P15, DOI 10.1016/0270-9139(91)90210-M; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miaczynska M, 2010, CURR OPIN CELL BIOL, V22, P535, DOI 10.1016/j.ceb.2010.05.007; Mook ORF, 2009, CANCER GENE THER, V16, P532, DOI 10.1038/cgt.2008.104; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; Ohnuma K, 2002, IMMUNOLOGY, V107, P325, DOI 10.1046/j.1365-2567.2002.01510.x; Ohnuma K, 2007, J BIOL CHEM, V282, P10117, DOI 10.1074/jbc.M609157200; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; RAKOWICZSZULCZYNSKA EM, 1992, AM J PATHOL, V141, P937; RAKOWICZSZULCZYNSKA EM, 1989, ARCH BIOCHEM BIOPHYS, V271, P366, DOI 10.1016/0003-9861(89)90286-5; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Sievers EL, 1999, BLOOD, V93, P3678, DOI 10.1182/blood.V93.11.3678; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057; STEPLEWSKI Z, 1983, SCIENCE, V221, P865, DOI 10.1126/science.6879183; Sudo H, 2010, GENOMICS, V95, P210, DOI 10.1016/j.ygeno.2010.02.002; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Weiner LM, 2012, CELL, V148, P1081, DOI 10.1016/j.cell.2012.02.034; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; WINTZERITH M, 1992, NUCLEIC ACIDS RES, V20, P910, DOI 10.1093/nar/20.4.910; Yamada K, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-17; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62304	10.1371/journal.pone.0062304	http://dx.doi.org/10.1371/journal.pone.0062304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638030	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800036
J	Charlermroj, R; Himananto, O; Seepiban, C; Kumpoosiri, M; Warin, N; Oplatowska, M; Gajanandana, O; Grant, IR; Karoonuthaisiri, N; Elliott, CT				Charlermroj, Ratthaphol; Himananto, Orawan; Seepiban, Channarong; Kumpoosiri, Mallika; Warin, Nuchnard; Oplatowska, Michalina; Gajanandana, Oraprapai; Grant, Irene R.; Karoonuthaisiri, Nitsara; Elliott, Christopher T.			Multiplex Detection of Plant Pathogens Using a Microsphere Immunoassay Technology	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PROTEIN MICROARRAYS; VIRUS; TIME; ELISA; DIAGNOSTICS; PEPPER; ASSAYS; ARRAY	Plant pathogens are a serious problem for seed export, plant disease control and plant quarantine. Rapid and accurate screening tests are urgently required to protect and prevent plant diseases spreading worldwide. A novel multiplex detection method was developed based on microsphere immunoassays to simultaneously detect four important plant pathogens: a fruit blotch bacterium Acidovorax avenae subsp. citrulli (Aac), chilli vein-banding mottle virus (CVbMV, potyvirus), watermelon silver mottle virus (WSMoV, tospovirus serogroup IV) and melon yellow spot virus (MYSV, tospovirus). An antibody for each plant pathogen was linked on a fluorescence-coded magnetic microsphere set which was used to capture corresponding pathogen. The presence of pathogens was detected by R-phycoerythrin (RPE)-labeled antibodies specific to the pathogens. The assay conditions were optimized by identifying appropriate antibody pairs, blocking buffer, concentration of RPE-labeled antibodies and assay time. Once conditions were optimized, the assay was able to detect all four plant pathogens precisely and accurately with substantially higher sensitivity than enzyme-linked immunosorbent assay (ELISA) when spiked in buffer and in healthy watermelon leaf extract. The assay time of the microsphere immunoassay (1 hour) was much shorter than that of ELISA (4 hours). This system was also shown to be capable of detecting the pathogens in naturally infected plant samples and is a major advancement in plant pathogen detection.	[Charlermroj, Ratthaphol; Oplatowska, Michalina; Grant, Irene R.; Karoonuthaisiri, Nitsara; Elliott, Christopher T.] Queens Univ Belfast, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Charlermroj, Ratthaphol; Himananto, Orawan; Seepiban, Channarong; Kumpoosiri, Mallika; Warin, Nuchnard; Gajanandana, Oraprapai; Karoonuthaisiri, Nitsara] Natl Ctr Genet Engn & Biotechnol BIOTEC, NSTDA, Klongluang, Pathum Thani, Thailand	Queens University Belfast; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Charlermroj, R (corresponding author), Queens Univ Belfast, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland.	rcharlermroj01@qub.ac.uk		Grant, Irene/0000-0001-5860-3769	National Science and Technology Development Agency (NSTDA); NSTDA; Marie Curie Fellowship Program	National Science and Technology Development Agency (NSTDA); NSTDA; Marie Curie Fellowship Program(European Commission)	This project was financially supported by National Science and Technology Development Agency (NSTDA). A PhD scholarship was awarded to RC by NSTDA. Dr. NK was supported by the Marie Curie Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ARUNASALAM G, 1989, J PHYTOPATHOL, V126, P160, DOI 10.1111/j.1439-0434.1989.tb01099.x; Baker HN, 2012, JOVE-J VIS EXP, DOI 10.3791/4084; Bergervoet JHW, 2008, J VIROL METHODS, V149, P63, DOI 10.1016/j.jviromet.2008.01.020; Buchwalow I, 2011, SCI REP-UK, V1, DOI 10.1038/srep00028; Charlermroj R, 2012, ANAL BIOCHEM, V421, P26, DOI 10.1016/j.ab.2011.10.005; Charlermroj R, 2011, ANAL LETT, V44, P1085, DOI 10.1080/00032719.2010.511736; Chiemsombat P, 1998, ARCH VIROL, V143, P1855, DOI 10.1007/s007050050425; Chiemsombat P, 2008, ARCH VIROL, V153, P571, DOI 10.1007/s00705-007-0024-3; den Reijer PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053391; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Feng JL, 2008, BIOTECHNIQUES, V44, P901, DOI 10.2144/000112750; Gil-Salas FM, 2007, J VIROL METHODS, V146, P45, DOI 10.1016/j.jviromet.2007.05.032; Himananto O, 2011, PLANT DIS, V95, P1172, DOI 10.1094/PDIS-12-10-0889; Iturria SJ, 2005, J BIOPHARM STAT, V15, P343, DOI 10.1081/BIP-200048798; Karoonuthaisiri N, 2009, BIOSENS BIOELECTRON, V24, P1641, DOI 10.1016/j.bios.2008.08.026; Kato K, 2000, PHYTOPATHOLOGY, V90, P422, DOI 10.1094/PHYTO.2000.90.4.422; Kim Jason S, 2010, Sens Instrum Food Qual Saf, V4, P73, DOI 10.1007/s11694-010-9097-x; Koenig R, 1983, ACT HORT ISHS, V127, P147; Kumpoosiri M., 2007, 6 AS CROP SCI ASS C; Lefeuvre P, 2007, J VIROL METHODS, V144, P165, DOI 10.1016/j.jviromet.2007.03.020; Lievens B, 2005, REC RES DEV MICROBIO, V9, P57; LOMMEL SA, 1982, PHYTOPATHOLOGY, V72, P1018, DOI 10.1094/Phyto-72-1018; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Mushaben EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054426; Nichkova M, 2007, ANAL BIOCHEM, V369, P34, DOI 10.1016/j.ab.2007.06.035; Pickering JW, 2010, CLIN VACCINE IMMUNOL, V17, P185, DOI 10.1128/CVI.00329-09; ROBERTS IM, 1991, J IMMUNOL METHODS, V143, P49, DOI 10.1016/0022-1759(91)90271-G; Saponari M, 2008, J VIROL METHODS, V147, P43, DOI 10.1016/j.jviromet.2007.07.026; Seepiban C, 2011, ARCH VIROL, V156, P263, DOI 10.1007/s00705-010-0856-0; SIRIWONG P, 1995, PLANT PATHOL, V44, P718, DOI 10.1111/j.1365-3059.1995.tb01696.x; Tamborrini M, 2010, CLIN VACCINE IMMUNOL, V17, P1446, DOI 10.1128/CVI.00205-10; Templin MF, 2003, PROTEOMICS, V3, P2155, DOI 10.1002/pmic.200300600; Ward E, 2004, ANN APPL BIOL, V145, P1, DOI 10.1111/j.1744-7348.2004.tb00354.x	33	43	45	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62344	10.1371/journal.pone.0062344	http://dx.doi.org/10.1371/journal.pone.0062344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638044	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700050
J	Li, WH; Shi, YC; Tseng, IL; Liao, VHC				Li, Wen-Hsuan; Shi, Yeu-Ching; Tseng, I-Ling; Liao, Vivian Hsiu-Chuan			Protective Efficacy of Selenite against Lead-Induced Neurotoxicity in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; INDUCED OXIDATIVE STRESS; C-ELEGANS; AFD NEURONS; THIOREDOXIN REDUCTASE; RADICALS; METALS; DAMAGE; DEGENERATION; TOXICITY	Background: Selenium is an essential micronutrient that has a narrow exposure window between its beneficial and toxic effects. This study investigated the protective potential of selenite (IV) against lead (Pb(II))-induced neurotoxicity in Caenorhabditis elegans. Principal Findings: The results showed that Se(IV) (0.01 mu M) pretreatment ameliorated the decline of locomotion behaviors (frequencies of body bends, head thrashes, and reversal) of C. elegans that are damaged by Pb(II) (100 mu M) exposure. The intracellular ROS level of C. elegans induced by Pb(II) exposure was significantly lowered by Se(IV) supplementation prior to Pb(II) exposure. Finally, Se(IV) protects AFD sensory neurons from Pb(II)-induced toxicity. Conclusions: Our study suggests that Se(IV) has protective activities against Pb(II)-induced neurotoxicity through its antioxidant property.	[Li, Wen-Hsuan; Shi, Yeu-Ching; Tseng, I-Ling; Liao, Vivian Hsiu-Chuan] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan	National Taiwan University	Liao, VHC (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	vivianliao@ntu.edu.tw		Liao, Vivian/0000-0002-4676-9953	National Science Council of Taiwan [NSC 100-2313-B-002-013, NSC 101-2313-B-002-041-MY3, NSC 100-2811-B-002-112]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was financially supported in part by grants (NSC 100-2313-B-002-013 and NSC 101-2313-B-002-041-MY3) from the National Science Council of Taiwan to VHC Liao and a postdoctoral fellowship grant (NSC 100-2811-B-002-112) from the National Science Council of Taiwan to YC Shi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battin EE, 2009, CELL BIOCHEM BIOPHYS, V55, P1, DOI 10.1007/s12013-009-9054-7; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; BERNEY B, 1993, MILBANK Q, V71, P3, DOI 10.2307/3350273; BRENNER S, 1974, GENETICS, V77, P71; Brown K M, 2001, Public Health Nutr, V4, P593; Buettner C, 1999, J BIOL CHEM, V274, P21598, DOI 10.1074/jbc.274.31.21598; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; CHIBA CM, 1990, J NEUROBIOL, V21, P543, DOI 10.1002/neu.480210403; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; CORRIGAN FM, 1991, ALCOHOL ALCOHOLISM, V26, P309, DOI 10.1093/oxfordjournals.alcalc.a045116; CROLL N A, 1975, P71, DOI 10.1016/S0065-308X(08)60319-X; Estevez AO, 2012, NEUROTOXICOLOGY, V33, P1021, DOI 10.1016/j.neuro.2012.04.019; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gladyshev VN, 1999, BIOCHEM BIOPH RES CO, V259, P244, DOI 10.1006/bbrc.1999.0765; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; HALL ED, 1987, BRAIN RES, V413, P175, DOI 10.1016/0006-8993(87)90166-1; HALLIWELL B, 1984, LANCET, V1, P1396; Hirano A, 1989, INTOXICATIONS NERV 1, P35; Hobert Oliver, 2005, WormBook, P1; Hsiang J., 2011, CURR NEUROBIOL, V2, P35; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li WH, 2011, FOOD CHEM TOXICOL, V49, P812, DOI 10.1016/j.fct.2010.12.002; Mezes M, 2011, OXID STRESS APPL BAS, P175, DOI 10.1007/978-1-61779-071-3_12; Michalke B, 2009, J ENVIRON MONITOR, V11, P939, DOI 10.1039/b817817h; Morgan KL, 2010, TOXICOL SCI, V118, P530, DOI 10.1093/toxsci/kfq273; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nava-Ruiz C, 2012, J MOL HISTOL; Othman AI, 1998, J BIOCHEM MOL TOXIC, V12, P345, DOI 10.1002/(SICI)1099-0461(1998)12:6<345::AID-JBT4>3.0.CO;2-V; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Roos PM, 2006, EXP BIOL MED, V231, P1481, DOI 10.1177/153537020623100906; ROUSSEAUX C.G., 2002, HDB TOXICOLOGIC PATH; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Smith JV, 2003, J ALZHEIMERS DIS, V5, P287, DOI 10.3233/JAD-2003-5404; Soltaninejad K, 2003, HUM EXP TOXICOL, V22, P417, DOI 10.1191/090327103ht385oa; STADTMAN TC, 1991, J BIOL CHEM, V266, P16257; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Sulston J., 1998, NEMATODE CAENORHABDI, P587; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wallace DC, 1998, NAT GENET, V19, P105, DOI 10.1038/448; Wojewoda M, 2010, BBA-BIOENERGETICS, V1797, P890, DOI 10.1016/j.bbabio.2010.01.035; Wu QL, 2012, J ENVIRON SCI-CHINA, V24, P733, DOI 10.1016/S1001-0742(11)60835-8; Xing XJ, 2009, ENVIRON TOXICOL PHAR, V28, P104, DOI 10.1016/j.etap.2009.03.006; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Yeoman MS, 2001, BIOGERONTOLOGY, V2, P85, DOI 10.1023/A:1011597420036; Yousuf S, 2007, BRAIN RES, V1147, P218, DOI 10.1016/j.brainres.2007.01.143; Zhao BB, 2003, J NEUROSCI, V23, P5319	52	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62387	10.1371/journal.pone.0062387	http://dx.doi.org/10.1371/journal.pone.0062387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638060	gold, Green Published, Green Submitted			2022-12-25	WOS:000318343700053
J	Simonaro, CM; Sachot, S; Ge, Y; He, XX; DeAngelis, VA; Eliyahu, E; Leong, DJ; Sun, HB; Mason, JB; Haskins, ME; Richardson, DW; Schuchman, EH				Simonaro, Calogera M.; Sachot, Sylvain; Ge, Yi; He, Xingxuan; DeAngelis, Victor A.; Eliyahu, Efrat; Leong, Daniel J.; Sun, Hui B.; Mason, Jeffrey B.; Haskins, Mark E.; Richardson, Dean W.; Schuchman, Edward H.			Acid Ceramidase Maintains the Chondrogenic Phenotype of Expanded Primary Chondrocytes and Improves the Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; CARTILAGE REPAIR; SPHINGOSINE-1-PHOSPHATE; IMPLANTATION; EXPRESSION; MUCOPOLYSACCHARIDOSES; IDENTIFICATION; DISEASES; TISSUE; TRIAL	Acid ceramidase is required to maintain the metabolic balance of several important bioactive lipids, including ceramide, sphingosine and sphingosine-1-phosphate. Here we show that addition of recombinant acid ceramidase (rAC) to primary chondrocyte culture media maintained low levels of ceramide and led to elevated sphingosine by 48 hours. Surprisingly, after three weeks of expansion the chondrogenic phenotype of these cells also was markedly improved, as assessed by a combination of histochemical staining (Alcian Blue and Safranin-O), western blotting (e. g., Sox9, aggrecan, collagen 2A1), and/or qPCR. The same effects were evident in rat, equine and human cells, and were observed in monolayer and 3-D cultures. rAC also reduced the number of apoptotic cells in some culture conditions, contributing to overall improved cell quality. In addition to these effects on primary chondrocytes, when rAC was added to freshly harvested rat, equine or feline bone marrow cultures an similar to 2-fold enrichment of mesenchymal stem cells (MSCs) was observed by one week. rAC also improved the chondrogenic differentiation of MSCs, as revealed by histochemical and immunostaining. These latter effects were synergistic with TGF-beta1. Based on these results we propose that rAC could be used to improve the outcome of cell-based cartilage repair by maintaining the quality of the expanded cells, and also might be useful in vivo to induce endogenous cartilage repair in combination with other techniques. The results also suggest that short-term changes in sphingolipid metabolism may lead to longer-term effects on the chondrogenic phenotype.	[Simonaro, Calogera M.; Sachot, Sylvain; Ge, Yi; He, Xingxuan; DeAngelis, Victor A.; Eliyahu, Efrat; Schuchman, Edward H.] Mt Sinai Sch Med, New York, NY 10029 USA; [Leong, Daniel J.; Sun, Hui B.] Orthopaed Surg Albert Einstein Coll Med, Bronx, NY USA; [Leong, Daniel J.; Sun, Hui B.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Mason, Jeffrey B.; Richardson, Dean W.] Univ Penn, New Bolton Ctr, Sch Vet Med, Kennett Sq, PA 19348 USA; [Haskins, Mark E.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; University of Pennsylvania	Schuchman, EH (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.	Edward.schuchman@mssm.edu	Mason, jeffrey B/I-8601-2017	Mason, jeffrey B/0000-0003-2459-1186	NIH [DK087185, DK54830, DK25759, RR02512]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054830, R01DK025759, R01DK087185, R56DK054830] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants DK087185, DK54830, DK25759 and RR02512. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos-Afonso Fernando, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02b03s7; Augello A, 2008, EUR CELLS MATER, V20, P121; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; Bichara DA, 2010, J SURG RES, V163, P331, DOI 10.1016/j.jss.2010.03.070; Breinan HA, 2001, J ORTHOPAED RES, V19, P482, DOI 10.1016/S0736-0266(00)90015-9; Chanda D, 2010, J CELL BIOCHEM, V111, P249, DOI 10.1002/jcb.22701; Ciurtin Coziana, 2006, Rom J Intern Med, V44, P171; Cole BJ, 2011, AM J SPORT MED, V39, P1170, DOI 10.1177/0363546511399382; Ebert JR, 2012, AM J SPORT MED, V40, P1527, DOI 10.1177/0363546512445167; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Fitzpatrick LR, 2011, PHARMACOLOGY, V87, P135, DOI 10.1159/000323911; Frisbie DD, 2008, OSTEOARTHR CARTILAGE, V16, P667, DOI 10.1016/j.joca.2007.09.013; Gilbert SJ, 2008, ARTHRITIS RHEUM-US, V58, P209, DOI 10.1002/art.23172; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; He XX, 2009, J CHROMATOGR B, V877, P983, DOI 10.1016/j.jchromb.2009.02.048; He XX, 1999, ANAL BIOCHEM, V274, P264, DOI 10.1006/abio.1999.4284; Hildner F, 2011, J TISSUE ENG REGEN M, V5, pE36, DOI 10.1002/term.386; KUNIEDA T, 1995, GENOMICS, V29, P582, DOI 10.1006/geno.1995.9962; Lee YH, 2011, GENESIS, V49, P200, DOI 10.1002/dvg.20717; Masuko K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-29; Minas T, 1998, Am J Orthop (Belle Mead NJ), V27, P739; Moon MH, 2012, INT J MOL MED, V30, P1451, DOI 10.3892/ijmm.2012.1135; Mozdziak PE, 2001, J APPL PHYSIOL, V91, P183, DOI 10.1152/jappl.2001.91.1.183; Nadzir MM, 2011, J BIOSCI BIOENG, V112, P395, DOI 10.1016/j.jbiosc.2011.06.005; Novotny JE, 2006, TISSUE ENG, V12, P2755, DOI 10.1089/ten.2006.12.2755; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Sabatini M, 2000, BIOCHEM BIOPH RES CO, V267, P438, DOI 10.1006/bbrc.1999.1983; Schulze-Tanzil G, 2009, ANN ANAT, V191, P325, DOI 10.1016/j.aanat.2009.05.003; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; Umlauf D, 2010, CELL MOL LIFE SCI, V67, P4197, DOI 10.1007/s00018-010-0498-0; Vavken P, 2010, OSTEOARTHR CARTILAGE, V18, P857, DOI 10.1016/j.joca.2010.03.005	32	16	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62715	10.1371/journal.pone.0062715	http://dx.doi.org/10.1371/journal.pone.0062715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638138	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700068
J	Bora, H; Tyagi, RK; Sharma, YD				Bora, Hema; Tyagi, Rupesh Kumar; Sharma, Yagya Dutta			Defining the Erythrocyte Binding Domains of Plasmodium vivax Tryptophan Rich Antigen 33.5	PLOS ONE			English	Article							IMMUNOLOGICAL RESPONSES; RETICULOCYTE-BINDING; MEROZOITE INVASION; FALCIPARUM; PEPTIDES; EXPRESSION; RECEPTOR; PROTEIN; IDENTIFICATION; PURIFICATION	Tryptophan-rich antigens play important role in host-parasite interaction. One of the Plasmodium vivax tryptophan-rich antigens called PvTRAg33.5 had earlier been shown to be predominantly of alpha helical in nature with multidomain structure, induced immune responses in humans, binds to host erythrocytes, and its sequence is highly conserved in the parasite population. In the present study, we divided this protein into three different parts i.e. N-terminal (amino acid position 24-106), middle (amino acid position 107-192), and C-terminal region (amino acid position 185-275) and determined the erythrocyte binding activity of these fragments. This binding activity was retained by the middle and C-terminal fragments covering 107 to 275 amino acid region of the PvTRAg33.5 protein. Eight non-overlapping peptides covering this 107 to 275 amino acid region were then synthesized and tested for their erythrocyte binding activity to further define the binding domains. Only two peptides, peptide P4 (at 171-191 amino acid position) and peptide P8 (at 255-275 amino acid position), were found to contain the erythrocyte binding activity. Competition assay revealed that each peptide recognizes its own erythrocyte receptor. These two peptides were found to be located on two parallel helices at one end of the protein in the modelled structure and could be exposed on its surface to form a suitable site for protein-protein interaction. Natural antibodies present in the sera of the P. vivax exposed individuals or the polyclonal rabbit antibodies against this protein were able to inhibit the erythrocyte binding activity of PvTRAg33.5, its fragments, and these two synthetic peptides P4 and P8. Further studies on receptor-ligand interaction might lead to the development of the therapeutic reagent.	[Bora, Hema; Tyagi, Rupesh Kumar; Sharma, Yagya Dutta] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, YD (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	ydsharma@hotmail.com		Tyagi, Rupesh/0000-0002-5095-8976	Department of Biotechnology of the Government of India [BT/PR9800/MED/29/44/2007]	Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology [BT/PR9800/MED/29/44/2007 to YDS and Senior Research Fellowships to HB and RKT] of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alam MT, 2008, PARASITE IMMUNOL, V30, P379, DOI 10.1111/j.1365-3024.2008.01033.x; Alam MT, 2008, VACCINE, V26, P3787, DOI 10.1016/j.vaccine.2008.05.059; Bora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016294; Burns JM, 2000, MOL BIOCHEM PARASIT, V110, P11, DOI 10.1016/S0166-6851(00)00252-8; Burns JM, 1997, INFECT IMMUN, V65, P3138, DOI 10.1128/IAI.65.8.3138-3145.1997; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Corradin G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001387; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; Curtidor H, 2001, VACCINE, V19, P4496, DOI 10.1016/S0264-410X(01)00202-X; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Espinosa AM, 2003, VACCINE, V21, P1033, DOI 10.1016/S0264-410X(02)00660-6; Garcia LS, 2010, CLIN LAB MED, V30, P93, DOI 10.1016/j.cll.2009.10.001; Garg S, 2008, MICROBES INFECT, V10, P1097, DOI 10.1016/j.micinf.2008.05.008; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Mittra P, 2010, MICROBES INFECT, V12, P1019, DOI 10.1016/j.micinf.2010.07.004; Ntumngia FB, 2005, PARASITOL RES, V96, P347, DOI 10.1007/s00436-005-1398-3; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; Pinzon CG, 2008, VACCINE, V26, P853, DOI 10.1016/j.vaccine.2007.11.086; Puentes A, 2004, VACCINE, V22, P1150, DOI 10.1016/j.vaccine.2003.09.029; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Sahar T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017102; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; Siddiqui AA, 2008, INFECT IMMUN, V76, P2576, DOI 10.1128/IAI.00677-07; Siddiqui AA, 2007, VACCINE, V26, P96, DOI 10.1016/j.vaccine.2007.10.042; Tachibana SI, 2012, NAT GENET, V44, P1051, DOI 10.1038/ng.2375; Tyagi RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050754; Uhlemann AC, 2001, MOL BIOCHEM PARASIT, V118, P41, DOI 10.1016/S0166-6851(01)00370-X; Urquiza M, 1996, PARASITE IMMUNOL, V18, P515, DOI 10.1046/j.1365-3024.1996.d01-15.x; Zeeshan M, 2013, J INFECT DIS, V207, P175, DOI 10.1093/infdis/jis650; Obando-Martinez AZ, 2010, J CELL BIOCHEM, V110, P882, DOI 10.1002/jcb.22600; Obando-Martinez AZ, 2010, J MED CHEM, V53, P3907, DOI 10.1021/jm901474p	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62829	10.1371/journal.pone.0062829	http://dx.doi.org/10.1371/journal.pone.0062829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638151	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400068
J	Staiger, H; Bohm, A; Scheler, M; Berti, L; Machann, J; Schick, F; Machicao, F; Fritsche, A; Stefan, N; Weigert, C; Krook, A; Haring, HU; de Angelis, MH				Staiger, Harald; Boehm, Anja; Scheler, Mika; Berti, Lucia; Machann, Juergen; Schick, Fritz; Machicao, Fausto; Fritsche, Andreas; Stefan, Norbert; Weigert, Cora; Krook, Anna; Haering, Hans-Ulrich; de Angelis, Martin Hrabe			Common Genetic Variation in the Human FNDC5 Locus, Encoding the Novel Muscle-Derived 'Browning' Factor Irisin, Determines Insulin Sensitivity	PLOS ONE			English	Article							FETUIN-A LEVELS; ADIPOSE-TISSUE; SKELETAL-MUSCLE; WHITE FAT; IN-VIVO; GLUCOSE; RESISTANCE; HOMEOSTASIS; EXPRESSION; EXERCISE	Aims/hypothesis: Recently, the novel myokine irisin was described to drive adipose tissue 'browning', to increase energy expenditure, and to improve obesity and insulin resistance in high fat-fed mice. Here, we assessed whether common single nucleotide polymorphisms (SNPs) in the FNDC5 locus, encoding the irisin precursor, contribute to human prediabetic phenotypes (overweight, glucose intolerance, insulin resistance, impaired insulin release). Methods: A population of 1,976 individuals was characterized by oral glucose tolerance tests and genotyped for FNDC5 tagging SNPs. Subgroups underwent hyperinsulinaemic-euglycaemic clamps, magnetic resonance imaging/spectroscopy, and intravenous glucose tolerance tests. From 37 young and 14 elderly participants recruited in two different centres, muscle biopsies were obtained for the preparation of human myotube cultures. Results: After appropriate adjustment and Bonferroni correction for the number of tested variants, SNPs rs16835198 and rs726344 were associated with in vivo measures of insulin sensitivity. Via interrogation of publicly available data from the Meta-Analyses of Glucose and Insulin-related traits Consortium, rs726344's effect on insulin sensitivity was replicated. Moreover, novel data from human myotubes revealed a negative association between FNDC5 expression and appropriately adjusted in vivo measures of insulin sensitivity in young donors. This finding was replicated in myotubes from elderly men. Conclusions/interpretation: This study provides evidence that the FNDC5 gene, encoding the novel myokine irisin, determines insulin sensitivity in humans. Our gene expression data point to an unexpected insulin-desensitizing effect of irisin.	[Staiger, Harald; Boehm, Anja; Fritsche, Andreas; Stefan, Norbert; Weigert, Cora; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany; [Staiger, Harald; Machann, Juergen; Schick, Fritz; Machicao, Fausto; Fritsche, Andreas; Stefan, Norbert; Weigert, Cora; Haering, Hans-Ulrich] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Staiger, Harald; Boehm, Anja; Scheler, Mika; Berti, Lucia; Machann, Juergen; Schick, Fritz; Machicao, Fausto; Fritsche, Andreas; Stefan, Norbert; Weigert, Cora; Haering, Hans-Ulrich; de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Boehm, Anja; Scheler, Mika; Berti, Lucia; Haering, Hans-Ulrich; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Expt Genet, Neuherberg, Germany; [Machann, Juergen; Schick, Fritz] Univ Tubingen, Sect Expt Radiol, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen, Dept Internal Med, Div Nutr & Prevent Med, Tubingen, Germany; [Krook, Anna] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [de Angelis, Martin Hrabe] Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Karolinska Institutet; Technical University of Munich	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de; hrabe@helmholtz-muenchen.de	Krook, Anna/K-1192-2015; Staiger, Harald/N-5871-2014; de Angelis, Martin Hrabe/F-5531-2012	Krook, Anna/0000-0002-0891-0258; de Angelis, Martin Hrabe/0000-0002-7898-2353; Stefan, Norbert/0000-0002-2186-9595; Schick, Fritz/0000-0002-4231-3406; Moller, Anja/0000-0002-5344-8533; Staiger, Harald/0000-0002-9507-5333	German Federal Ministry of Education and Research (BMBF) [01GI0925]; Heisenberg professorship from the Deutsche Forschungsgemeinschaft [STE 1096/3-1]; Swedish Research Council	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Heisenberg professorship from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported in part by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e. V.). Norbert Stefan is supported by a Heisenberg professorship from the Deutsche Forschungsgemeinschaft (STE 1096/3-1), Anna Krook by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Choukem SP, 2008, DIABETES METAB, V34, P664, DOI 10.1016/S1262-3636(08)74602-0; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Febbraio MA, 2005, EXERC SPORT SCI REV, V33, P114, DOI 10.1097/00003677-200507000-00003; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; Hansen J, 2011, ENDOCRINOLOGY, V152, P164, DOI 10.1210/en.2010-0868; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Krutzfeldt J, 2000, DIABETES, V49, P992, DOI 10.2337/diabetes.49.6.992; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Ordelheide AM, 2011, EUR J CLIN INVEST, V41, P1323, DOI 10.1111/j.1365-2362.2011.02547.x; Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105; Peter A, 2010, DIABETES, V59, P3167, DOI 10.2337/db10-0179; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Staiger H, 2004, DIABETES, V53, P2195, DOI 10.2337/diabetes.53.9.2195; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2009, NEW ENGL J MED, V361, P416; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Thamer C, 2004, DIABETES CARE, V27, P2726, DOI 10.2337/diacare.27.11.2726; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Tripathy D, 2004, DIABETES CARE, V27, P2204, DOI 10.2337/diacare.27.9.2204; Tripathy D, 2003, DIABETES CARE, V26, P1395, DOI 10.2337/diacare.26.5.1395; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418	36	74	77	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61903	10.1371/journal.pone.0061903	http://dx.doi.org/10.1371/journal.pone.0061903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637927	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400025
J	Cao, W; Xu, X; Zhang, JL; Duan, YY				Cao, Wei; Xu, Xiang; Zhang, Juliang; Duan, Yunyou			Tumor Angiogenesis after Heated Lipiodol Infusion via the Hepatic Artery in a Rabbit Model of VX2 Liver Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; VASCULAR-PERMEABILITY; VEGF; EMBOLIZATION; HYPERTHERMIA; PROGNOSIS	Objectives: This study aimed to observe the changes in tumor angiogenesis after heated lipiodol (60 degrees C) infusion via the hepatic artery in a rabbit model of VX2 liver cancer. Materials and Methods: Twenty rabbits with VX2 hepatic tumors were randomly divided into 2 groups (10 rabbits in each group). Under anesthesia, a trans-catheter hepatic arterial infusion was performed, and lipiodol (37 degrees C; control group) or heated lipiodol (60 degrees C; treated group) was injected into the hepatic arteries of the animals. Then, changes in tumor angiogenesis were assessed using the following markers and methods. 1. Vascular endothelial growth factor receptor (VEGFR) and vascular endothelial growth factor (VEGF) expression levels in the tumor were assessed using western blotting and real-time quantitative polymerase chain reaction (PCR). 2. Proliferating cell nuclear antigen (PCNA) expression in the tumor was assessed through immunohistochemical staining. 3. The morphological changes in tumor vascular endothelial cells were observed using transmission electron microscopy (TEM). Results: VEGFR and VEGF mRNA and protein expression levels were reduced in the treated group compared to the control group. PCNA protein showed reduced expression levels in the treated group compared to the control group. TEM indicated that the endothelial cell endoplasmic reticulum expanded, the chondriosome was swollen, and the endothelial cell microvilli were decreased after heated lipiodol infusion. Conclusions: The tumor angiogenesis of rabbits with VX2 cancer was inhibited after arterial heated lipiodol infusion compared to lipiodol infusion.	[Cao, Wei] Fourth Mil Med Univ, Tangdu Hosp, Dept Intervent Radiol, Xian 710032, Peoples R China; [Xu, Xiang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pharm, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Juliang] Fourth Mil Med Univ, Xijing Hosp, Dept Vasc & Endocrine Surg, Xian 710032, Peoples R China; [Duan, Yunyou] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasonog, Xian 710032, Peoples R China	Air Force Military Medical University; Zhejiang University; Air Force Military Medical University; Air Force Military Medical University	Cao, W (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Intervent Radiol, Xian 710032, Peoples R China.	cawe-001@163.com; yunyouduan@fmmu.edu.cn			National Natural Science Foundation of China [81170400]; Shaanxi Province Science and Technology Development Projection [2011K13-01-16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province Science and Technology Development Projection	This study was supported in part by the National Natural Science Foundation of China (No. 81170400; http://www.nsfc.gov.cn) and Shaanxi Province Science and Technology Development Projection (No.2011K13-01-16; http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T, 2002, EUR J SURG ONCOL, V28, P37, DOI 10.1053/ejso.2001.1181; Ahrar K, 2004, J VASC INTERV RADIOL, V15, P901, DOI 10.1097/01.RVI.0000136829.36643.ED; Cao W, 2012, EUR J RADIOL, V81, pE209, DOI 10.1016/j.ejrad.2011.01.108; Cao W, 2011, ACAD RADIOL, V18, P1569, DOI 10.1016/j.acra.2011.08.010; Cao W, 2010, EUR J RADIOL, V73, P412, DOI 10.1016/j.ejrad.2008.11.001; DIKOMEY E, 1992, INT J RADIAT BIOL, V61, P221, DOI 10.1080/09553009214550851; DOYON D, 1974, ANN RADIOL, V17, P593; Feldman ED, 2004, J GASTROINTEST SURG, V8, P200, DOI 10.1016/j.gassur.2003.11.005; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; Hsieh MY, 2011, KAOHSIUNG J MED SCI, V27, P314, DOI 10.1016/j.kjms.2011.03.008; Huang JF, 2000, CHINESE MED J-PEKING, V113, P446; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; Moyer HR, 2008, INT J HYPERTHER, V24, P251, DOI 10.1080/02656730701772480; Muraoka A, 2004, HEPATO-GASTROENTEROL, V51, P1662; Murray TG, 1997, INVEST OPHTH VIS SCI, V38, P2516; Nesher E, 2007, ISR MED ASSOC J, V9, P787; Poon RTP, 2000, J SURG ONCOL, V73, P109, DOI 10.1002/(SICI)1096-9098(200002)73:2<109::AID-JSO10>3.3.CO;2-A; Qin LX, 2002, WORLD J GASTROENTERO, V8, P385, DOI 10.3748/wjg.v8.i3.385; Ramirez LH, 1996, CANCER CHEMOTH PHARM, V37, P371, DOI 10.1007/s002800050399; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schuh AC, 1999, P NATL ACAD SCI USA, V96, P2159, DOI 10.1073/pnas.96.5.2159; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Shim JH, 2008, CANCER SCI, V99, P2037, DOI 10.1111/j.1349-7006.2008.00909.x; TAKAYASU K, 1987, RADIOLOGY, V163, P345, DOI 10.1148/radiology.163.2.3031724; Vogl TJ, 2000, RADIOLOGY, V214, P349, DOI 10.1148/radiology.214.2.r00fe06349	28	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61583	10.1371/journal.pone.0061583	http://dx.doi.org/10.1371/journal.pone.0061583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637861	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400031
J	McLamb, BL; Gibson, AJ; Overman, EL; Stahl, C; Moeser, AJ				McLamb, Brittney L.; Gibson, Amelia J.; Overman, Elizabeth L.; Stahl, Chad; Moeser, Adam J.			Early Weaning Stress in Pigs Impairs Innate Mucosal Immune Responses to Enterotoxigenic E. coli Challenge and Exacerbates Intestinal Injury and Clinical Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESCHERICHIA-COLI; MATERNAL SEPARATION; DIARRHEAL DISEASE; BARRIER FUNCTION; ION-TRANSPORT; INFECTION; SEPSIS; MICE; INTERLEUKIN-6	Background and Aims: The clinical onset and severity of intestinal disorders in humans and animals can be profoundly impacted by early life stress. Here we investigated the impact of early weaning stress in pigs on intestinal physiology, clinical disease, and immune response to subsequent challenge with enterotoxigenic F18 E. coli (ETEC). Methodology: Pigs weaned from their dam at 16 d, 18 d, and 20 d of age were given a direct oral challenge of F18 ETEC at 26 d of age. Pigs were monitored from days 0 to 4 post-infection for clinical signs of disease. On Day 4 post-ETEC challenge, ileal barrier function, histopathologic and inflammatory cytokine analysis were performed on ileal mucosa. Results: Early weaned pigs (16 d and 18 d weaning age) exhibited a more rapid onset and severity of diarrhea and reductions in weight gain in response to ETEC challenge compared with late weaned pigs (20 d weaning age). ETEC challenge induced intestinal barrier injury in early weaned pigs, indicated by reductions in ileal transepithelial electrical resistance (TER) and elevated FD4 flux rates, in early weaned pig ileum but not in late weaned pigs. ETEC-induced marked elevations in IL-6 and IL-8, neutrophil recruitment, and mast cell activation in late-weaned pigs; these responses were attenuated in early weaned pigs. TNF levels elevated in ETEC challenged ileal mucosa from early weaned pigs but not in other weaning age groups. Conclusions: These data demonstrate the early weaning stress can profoundly alter subsequent immune and physiology responses and clinical outcomes to subsequent infectious pathogen challenge. Given the link between early life stress and gastrointestinal diseases of animals and humans, a more fundamental understanding of the mechanisms by which early life stress impacts subsequent pathophysiologic intestinal responses has implications for the prevention and management of important GI disorders in humans and animals.	[McLamb, Brittney L.; Gibson, Amelia J.; Overman, Elizabeth L.; Moeser, Adam J.] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Stahl, Chad] N Carolina State Univ, Dept Anim Sci, Lab Dev Nutr, Raleigh, NC 27695 USA; [Moeser, Adam J.] N Carolina State Univ, Coll Vet Med, CCMTR, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Moeser, AJ (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	ajmoeser@ncsu.edu		Moeser, Adam/0000-0003-3068-627X	National Pork Board [09-019]; NIH [K08DK084313]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084313] Funding Source: NIH RePORTER	National Pork Board; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by National Pork Board #09-019, NIH K08DK084313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; AGACE WW, 1995, INFECT IMMUN, V63, P4054, DOI 10.1128/IAI.63.10.4054-4062.1995; Agostini A, 2010, PSYCHOSOMATICS, V51, P208, DOI 10.1176/appi.psy.51.3.208; Agostini A, 2010, PSYCHOSOMATICS, V51, P14, DOI 10.1176/appi.psy.51.1.14; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; ARGENZIO RA, 1990, AM J VET RES, V51, P747; ARGENZIO RA, 1984, GASTROENTEROLOGY, V86, P1501; Bailey MT, 1999, DEV PSYCHOBIOL, V35, P146, DOI 10.1002/(SICI)1098-2302(199909)35:2<146::AID-DEV7>3.0.CO;2-G; Barreau F, 2008, GUT, V57, P582, DOI 10.1136/gut.2007.126680; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Coddens A, 2007, VET MICROBIOL, V122, P332, DOI 10.1016/j.vetmic.2007.02.007; Cutler SA, 2007, ANTIMICROB AGENTS CH, V51, P3830, DOI 10.1128/AAC.00360-07; Dalrymple SA, 1996, INFECT IMMUN, V64, P3231, DOI 10.1128/IAI.64.8.3231-3235.1996; Dapoigny M, 2009, GASTROEN CLIN BIOL, V33, pS3, DOI 10.1016/S0399-8320(09)71519-2; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Frydendahl K, 2003, VET MICROBIOL, V93, P39, DOI 10.1016/S0378-1135(02)00348-6; Gareau MG, 2007, AM J PHYSIOL-GASTR L, V293, pG198, DOI 10.1152/ajpgi.00392.2006; Hill DR, 2010, CURR OPIN INFECT DIS, V23, P481, DOI 10.1097/QCO.0b013e32833dfca5; KO YC, 1993, INFECT IMMUN, V61, P1307, DOI 10.1128/IAI.61.4.1307-1314.1993; Lerebours E, 2007, AM J GASTROENTEROL, V102, P122, DOI 10.1111/j.1572-0241.2006.00931.x; Loos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041041; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; MALAVIYA R, 1994, J CLIN INVEST, V93, P1645, DOI 10.1172/JCI117146; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Moeser AJ, 2007, JAVMA-J AM VET MED A, V231, P56, DOI 10.2460/javma.231.1.56; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naliboff BD, 2011, AM J GASTROENTEROL; O'Mahony SM, 2008, BIOL PSYCHIAT; Peace RM, 2011, J NUTR, V141, P1312, DOI 10.3945/jn.110.136796; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; Qian C, 2012, EUR J IMMUNOL, V42, P1388, DOI 10.1002/eji.201242632; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Sack R.B., 1971, J INFECT DIS, V123, P378, DOI 10.1093/infdis/123.4.378; Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391, DOI 10.1152/ajpgi.1999.277.2.G391; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Sutherland RE, 2008, J IMMUNOL, V181, P5598, DOI 10.4049/jimmunol.181.8.5598; Vaiserman A, 2011, EXP GERONTOL, V46, P189, DOI 10.1016/j.exger.2010.08.031; van der Windt GJW, 2010, INFECT IMMUN, V78, P115, DOI 10.1128/IAI.00949-09; van Enckevort FHJ, 2001, EUR CYTOKINE NETW, V12, P581; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97	47	150	163	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e59838	10.1371/journal.pone.0059838	http://dx.doi.org/10.1371/journal.pone.0059838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637741	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400005
J	Antony, N; Weir, JR; McDougall, ARA; Mantamadiotis, T; Meikle, PJ; Cole, TJ; Bird, AD				Antony, Nisha; Weir, Jacqui R.; McDougall, Annie R. A.; Mantamadiotis, Theo; Meikle, Peter J.; Cole, Timothy J.; Bird, Anthony D.			cAMP Response Element Binding Protein1 Is Essential for Activation of Steroyl Co-Enzyme A Desaturase 1 (Scd1) in Mouse Lung Type II Epithelial Cells	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; FATTY-ACID SYNTHESIS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; PULMONARY SURFACTANT; 3T3-L1 PREADIPOCYTES; C/EBP-ALPHA; CREB; MICE; DIFFERENTIATION	Cyclic AMP Response Element-Binding Protein 1 (Creb1) is a transcription factor that mediates cyclic adenosine 3', 5'-monophosphate (cAMP) signalling in many tissues. Creb1(-/-) mice die at birth due to respiratory failure and previous genome-wide microarray analysis of E17.5 Creb1(-/-) fetal mouse lung identified important Creb1-regulated gene targets during lung development. The lipogenic enzymes stearoyl-CoA desaturase 1 (Scd1) and fatty acid synthase (Fasn) showed highly reduced gene expression in Creb1(-/-) lungs. We therefore hypothesized that Creb1 plays a crucial role in the transcriptional regulation of genes involved in pulmonary lipid biosynthetic pathways during lung development. In this study we confirmed that Scd1 and Fasn mRNA levels were down regulated in the E17.5 Creb1(-/-) mouse lung while the lipogenic-associated transcription factors SrebpF1, C/ebp alpha and Ppar gamma were increased. In vivo studies using germline (Creb1(-/-)) and lung epithelial-specific (Creb1(Epi Delta/Delta)) Creb1 knockout mice showed strongly reduced Scd1, but not Fasn gene expression and protein levels in lung epithelial cells. In vitro studies using mouse MLE-15 epithelial cells showed that forskolin-mediated activation of Creb1 increased both Scd1 gene expression and protein synthesis. Additionally, MLE15 cells transfected with a dominant-negative ACreb vector blocked forskolin-mediated stimulation of Scd1 gene expression. Lipid profiling in MLE15 cells showed that dominant-negative ACreb suppressed forskolin-induced desaturation of ether linked lipids to produce plasmalogens, as well as levels of phosphatidylethanolamine, ceramide and lysophosphatidylcholine. Taken together these results demonstrate that Creb1 is essential for the induction and maintenance of Scd1 in developing fetal mouse lung epithelial cells.	[Antony, Nisha; McDougall, Annie R. A.; Cole, Timothy J.; Bird, Anthony D.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Weir, Jacqui R.; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Weir, Jacqui R.; McDougall, Annie R. A.; Meikle, Peter J.] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Mantamadiotis, Theo] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	Monash University; Baker Heart and Diabetes Institute; Monash University; University of Melbourne	Cole, TJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	tim.cole@monash.edu	Bird, Anthony/AAM-6018-2021; Mantamadiotis, Theo/AAM-1346-2020; Meikle, Peter J/B-4023-2009; Mantamadiotis, Theo/W-9010-2019	Bird, Anthony/0000-0003-3012-7160; Mantamadiotis, Theo/0000-0003-3971-5380; McDougall, Annie/0000-0003-1182-6679; Meikle, Peter/0000-0002-2593-4665	National Health & Research Committee of Australia [606302]	National Health & Research Committee of Australia	This work has been supported by a program grant (number 606302) from the National Health & Research Committee of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Asturias FJ, 2005, NAT STRUCT MOL BIOL, V12, P225, DOI 10.1038/nsmb899; Besnard V, 2009, J BIOL CHEM, V284, P4018, DOI 10.1074/jbc.M805388200; Bird AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017843; Casimir DA, 1996, J BIOL CHEM, V271, P29847, DOI 10.1074/jbc.271.47.29847; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; COCKSHUTT AM, 1991, BIOCHIM BIOPHYS ACTA, V1086, P63, DOI 10.1016/0005-2760(91)90155-B; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Dobrzyn P, 2010, J LIPID RES, V51, P2202, DOI 10.1194/jlr.M003780; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Harding R, 2003, LUNG DEV AGING ENV; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; KING RJ, 1982, J APPL PHYSIOL, V53, P1; Lucki N, 2009, BBA-MOL CELL BIOL L, V1791, P706, DOI 10.1016/j.bbalip.2009.03.005; Mason RJ, 2003, J CLIN INVEST, V112, P244, DOI 10.1172/JCI200316793; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; McGowan SE, 1997, ANNU REV PHYSIOL, V59, P43, DOI 10.1146/annurev.physiol.59.1.43; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Moss TJM, 2006, CLIN EXP PHARMACOL P, V33, P280, DOI 10.1111/j.1440-1681.2006.04359.x; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; RUPPERT S, 1992, EMBO J, V11, P1503, DOI 10.1002/j.1460-2075.1992.tb05195.x; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Sparkman L, 2006, AM J PHYSIOL-LUNG C, V290, pL351, DOI 10.1152/ajplung.00275.2005; Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Westfall PH, 2008, BIOMETRIKA, V95, P709, DOI 10.1093/biomet/asn033; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e59763	10.1371/journal.pone.0059763	http://dx.doi.org/10.1371/journal.pone.0059763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637738	gold, Green Published			2022-12-25	WOS:000317908700004
J	Beaudet, D; Nadimi, M; Iffis, B; Hijri, M				Beaudet, Denis; Nadimi, Maryam; Iffis, Bachir; Hijri, Mohamed			Rapid Mitochondrial Genome Evolution through Invasion of Mobile Elements in Two Closely Related Species of Arbuscular Mycorrhizal Fungi	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; GROUP-I INTRON; GLOMUS-INTRARADICES; DEFENSE RESPONSES; HYPHAL FUSION; LARGE SUBUNIT; DNA; SEQUENCES; PLASMIDS; EXCHANGE	Arbuscular mycorrhizal fungi (AMF) are common and important plant symbionts. They have coenocytic hyphae and form multinucleated spores. The nuclear genome of AMF is polymorphic and its organization is not well understood, which makes the development of reliable molecular markers challenging. In stark contrast, their mitochondrial genome (mtDNA) is homogeneous. To assess the intra- and inter-specific mitochondrial variability in closely related Glomus species, we performed 454 sequencing on total genomic DNA of Glomus sp. isolate DAOM-229456 and we compared its mtDNA with two G. irregulare isolates. We found that the mtDNA of Glomus sp. is homogeneous, identical in gene order and, with respect to the sequences of coding regions, almost identical to G. irregulare. However, certain genomic regions vary substantially, due to insertions/deletions of elements such as introns, mitochondrial plasmid-like DNA polymerase genes and mobile open reading frames. We found no evidence of mitochondrial or cytoplasmic plasmids in Glomus species, and mobile ORFs in Glomus are responsible for the formation of four gene hybrids in atp6, atp9, cox2, and nad3, which are most probably the result of horizontal gene transfer and are expressed at the mRNA level. We found evidence for substantial sequence variation in defined regions of mtDNA, even among closely related isolates with otherwise identical coding gene sequences. This variation makes it possible to design reliable intra- and inter-specific markers.	[Beaudet, Denis; Nadimi, Maryam; Iffis, Bachir; Hijri, Mohamed] Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ H1X 2B2, Canada	Universite de Montreal	Hijri, M (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ H1X 2B2, Canada.	Mohamed.Hijri@Umontreal.ca	Hijri, Mohamed/AAL-5737-2021; Hijri, Mohamed/ABC-5969-2021	Hijri, Mohamed/0000-0001-6112-8372	NSERC Cooperative Research and Development (CRD) [RDPJ 395241-09]; Premier Tech; CRIBIQ; Biopterre centre developpement des bioproduits; CRBM; Natural Sciences and Engineering Research Council of Canada	NSERC Cooperative Research and Development (CRD); Premier Tech; CRIBIQ; Biopterre centre developpement des bioproduits; CRBM; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work is a part of a research project organized and coordinated by Premier Tech. The authors are grateful for financial support from NSERC Cooperative Research and Development (CRD) grant number RDPJ 395241-09, Premier Tech and CRIBIQ. The authors would also like to thank Biopterre centre developpement des bioproduits and CRBM for their support. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare that they have received funds from Premier Tech (a profite company) in a form of a matching funds along with the Natural Sciences and Engineering Research Council of Canada. The authors are not employed nor consultants in Premier Tech and they are not patenting any of the results presented in this manuscript. The authors confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Angelard C, 2011, NEW PHYTOL, V189, P652, DOI 10.1111/j.1469-8137.2010.03602.x; AzconAguilar C, 1996, MYCORRHIZA, V6, P457, DOI 10.1007/s005720050147; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; BELLPEDERSEN D, 1990, NUCLEIC ACIDS RES, V18, P3763, DOI 10.1093/nar/18.13.3763; BERTRAND H, 1989, GENOME, V31, P155, DOI 10.1139/g89-027; Bever JD, 2005, NATURE, V433, pE3, DOI 10.1038/nature03294; BIESSMANN H, 1992, MOL CELL BIOL, V12, P3910, DOI 10.1128/MCB.12.9.3910; Borstler B, 2008, NEW PHYTOL, V180, P452, DOI 10.1111/j.1469-8137.2008.02574.x; Boon E, 2010, J EVOLUTION BIOL, V23, P1519, DOI 10.1111/j.1420-9101.2010.02019.x; Brown R.H., 1995, MOL BIOL PLANT MITOC, P61; Brugger K, 2004, BIOCHEM SOC T, V32, P179, DOI 10.1042/BST0320179; Cahan P, 2005, MOL GENET GENOMICS, V273, P462, DOI 10.1007/s00438-005-1133-x; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Colard A, 2011, APPL ENVIRON MICROB, V77, P6510, DOI 10.1128/AEM.05696-11; Cordier C, 1998, MOL PLANT MICROBE IN, V11, P1017, DOI 10.1094/MPMI.1998.11.10.1017; Corradi N, 2007, APPL ENVIRON MICROB, V73, P366, DOI 10.1128/AEM.01574-06; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; DALGAARD JZ, 1993, P NATL ACAD SCI USA, V90, P5414, DOI 10.1073/pnas.90.12.5414; DATNOFF LE, 1995, BIOL CONTROL, V5, P427, DOI 10.1006/bcon.1995.1051; DUJON B, 1980, CELL, V20, P185, DOI 10.1016/0092-8674(80)90246-9; Eddy S, 1992, THESIS U COLORADO BO; Ferandon C, 2008, FUNGAL GENET BIOL, V45, P292, DOI 10.1016/j.fgb.2007.10.012; Formey D, 2012, NEW PHYTOL, V196, P1217, DOI 10.1111/j.1469-8137.2012.04283.x; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Lang BF, 2009, NEW PHYTOL, V183, P4, DOI 10.1111/j.1469-8137.2009.02885.x; Fricova D, 2010, MICROBIOL-SGM, V156, P2153, DOI 10.1099/mic.0.038646-0; GRIFFITHS AJF, 1995, MOL GEN GENET, V249, P25, DOI 10.1007/BF00290232; Halary Sebastien, 2011, Genome Biol Evol, V3, P950, DOI 10.1093/gbe/evr089; Hausner G, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P329, DOI 10.1007/978-3-642-22380-8_13; Hijri M, 2005, NATURE, V433, P160, DOI 10.1038/nature03069; Ismail Y, 2012, FUNCT PLANT BIOL, V39, P236, DOI 10.1071/FP11218; Ismail Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017990; Kennel JC, 2004, HDB FUNGAL BIOTECHNO, P131; Klassen Roland, 2007, V7, P187, DOI 10.1007/7171_2007_095; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; Lee J, 2009, NEW PHYTOL, V183, P200, DOI 10.1111/j.1469-8137.2009.02834.x; Nadimi M, 2012, MOL BIOL EVOL, V29, P2199, DOI 10.1093/molbev/mss088; PAQUIN B, 1994, P NATL ACAD SCI USA, V91, P11807, DOI 10.1073/pnas.91.25.11807; Pawlowska TE, 2005, NATURE, V433, pE4, DOI 10.1038/nature03295; Pawlowska TE, 2004, NATURE, V427, P733, DOI 10.1038/nature02290; Pelin A, 2012, NEW PHYTOL, V194, P836, DOI 10.1111/j.1469-8137.2012.04072.x; Pozo MJ, 2002, J EXP BOT, V53, P525, DOI 10.1093/jexbot/53.368.525; Raab PA, 2005, MYCOL RES, V109, P1315, DOI 10.1017/S0953756205003977; Robison MM, 2005, CURR GENET, V47, P57, DOI 10.1007/s00294-004-0549-x; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Sanders IR, 2011, CURR BIOL, V21, pR896, DOI 10.1016/j.cub.2011.09.021; Seif E, 2005, NUCLEIC ACIDS RES, V33, P734, DOI 10.1093/nar/gki199; SHARMA M, 1992, P NATL ACAD SCI USA, V89, P6658, DOI 10.1073/pnas.89.14.6658; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; St-Arnaud M, 2007, EFFECTS ARBUSCULAR M; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiery O, 2010, MOL PHYLOGENET EVOL, V55, P599, DOI 10.1016/j.ympev.2010.02.013; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; VanKuren NW, 2013, EVOLUTION, V67, P207, DOI 10.1111/j.1558-5646.2012.01747.x; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6	57	37	39	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e60768	10.1371/journal.pone.0060768	http://dx.doi.org/10.1371/journal.pone.0060768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637766	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700007
J	Lei, T; Jing, D; Xie, KN; Jiang, MG; Li, FJ; Cai, J; Wu, XM; Tang, C; Xu, QL; Liu, J; Guo, W; Shen, GH; Luo, EP				Lei, Tao; Jing, Da; Xie, Kangning; Jiang, Maogang; Li, Feijiang; Cai, Jing; Wu, Xiaoming; Tang, Chi; Xu, Qiaoling; Liu, Juan; Guo, Wei; Shen, Guanghao; Luo, Erping			Therapeutic Effects of 15 Hz Pulsed Electromagnetic Field on Diabetic Peripheral Neuropathy in Streptozotocin-Treated Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STIMULATES AXONAL OUTGROWTH; QUALITY-OF-LIFE; MAGNETIC-FIELDS; NEUROTROPHIC FACTOR; GENE-TRANSFER; PAIN; IMPACT; NERVE; MODEL	Although numerous clinical studies have reported that pulsed electromagnetic fields (PEMF) have a neuroprotective role in patients with diabetic peripheral neuropathy (DPN), the application of PEMF for clinic is still controversial. The present study was designed to investigate whether PEMF has therapeutic potential in relieving peripheral neuropathic symptoms in streptozotocin (STZ)-induced diabetic rats. Adult male Sprague-Dawley rats were randomly divided into three weight-matched groups (eight in each group): the non-diabetic control group (Control), diabetes mellitus with 15 Hz PEMF exposure group (DM+PEMF) which were subjected to daily 8-h PEMF exposure for 7 weeks and diabetes mellitus with sham PEMF exposure group (DM). Signs and symptoms of DPN in STZ-treated rats were investigated by using behavioral assays. Meanwhile, ultrastructural examination and immunohistochemical study for vascular endothelial growth factor (VEGF) of sciatic nerve were also performed. During a 7-week experimental observation, we found that PEMF stimulation did not alter hyperglycemia and weight loss in STZ-treated rats with DPN. However, PEMF stimulation attenuated the development of the abnormalities observed in STZ-treated rats with DPN, which were demonstrated by increased hind paw withdrawal threshold to mechanical and thermal stimuli, slighter demyelination and axon enlargement and less VEGF immunostaining of sciatic nerve compared to those of the DM group. The current study demonstrates that treatment with PEMF might prevent the development of abnormalities observed in animal models for DPN. It is suggested that PEMF might have direct corrective effects on injured nerves and would be a potentially promising non-invasive therapeutic tool for the treatment of DPN.	[Lei, Tao; Jing, Da; Xie, Kangning; Jiang, Maogang; Li, Feijiang; Wu, Xiaoming; Tang, Chi; Liu, Juan; Guo, Wei; Shen, Guanghao; Luo, Erping] Fourth Mil Med Univ, Sch Biomed Engn, Xian 710032, Peoples R China; [Cai, Jing] Fourth Mil Med Univ, Dept Neurol, Xijing Hosp, Xian 710032, Peoples R China; [Xu, Qiaoling] Fourth Mil Med Univ, Sch Nursing, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Shen, GH (corresponding author), Fourth Mil Med Univ, Sch Biomed Engn, Xian 710032, Peoples R China.	ghshen@163.com; erpingluo@hotmail.com	Xie, Kangning/AAQ-1496-2020	Xie, Kangning/0000-0002-6031-8489	National Natural Science Foundation of China [31000491, 51077128, 31000381, 31270889]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Grant no. 31000491, 51077128, 31000381 and 31270889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berti-Mattera LN, 2011, NEUROSCI LETT, V490, P41, DOI 10.1016/j.neulet.2010.12.022; Bril V, 2011, NEUROLOGY, V76, P1758, DOI 10.1212/WNL.0b013e3182166ebe; Calcutt NA, 2004, J NEUROL SCI, V220, P137, DOI 10.1016/j.jns.2004.03.015; Calcutt Nigel A, 2007, Curr Diab Rep, V7, P429, DOI 10.1007/s11892-007-0072-9; Cameron NE, 2001, DIABETOLOGIA, V44, P1161, DOI 10.1007/s001250100626; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen RJ, 2010, CLIN BIOMECH, V25, P409, DOI 10.1016/j.clinbiomech.2010.01.013; Fox A, 1999, PAIN, V81, P307, DOI 10.1016/S0304-3959(99)00024-X; Hoybergs YMJJ, 2008, NEUROSCI LETT, V436, P13, DOI 10.1016/j.neulet.2008.02.051; Imperatore G, 2000, DIABETES, V49, P1049, DOI 10.2337/diabetes.49.6.1049; Jensen Troels S, 2006, Diab Vasc Dis Res, V3, P108, DOI 10.3132/dvdr.2006.013; Jing D, 2011, OSTEOPOROSIS INT, V22, P1885, DOI 10.1007/s00198-010-1447-3; Jing D, 2010, BONE, V46, P487, DOI 10.1016/j.bone.2009.09.021; Jolivalt CG, 2006, DIABETOLOGIA, V49, P2775, DOI 10.1007/s00125-006-0397-y; Kim H, 2003, DIABETES, V52, P2102, DOI 10.2337/diabetes.52.8.2102; Kim S, 2008, J NEUROSCI METH, V174, P91, DOI 10.1016/j.jneumeth.2008.07.005; [李晨 LI Chen], 2008, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V14, P52; Liu GS, 2009, HUM GENE THER, V20, P715, DOI 10.1089/hum.2009.002; Luo E, 2007, BIOELECTROMAGNETICS, V28, P608, DOI 10.1002/bem.20342; Macias MY, 2000, BIOELECTROMAGNETICS, V21, P272, DOI 10.1002/(SICI)1521-186X(200005)21:4<272::AID-BEM4>3.0.CO;2-5; Malcangio M, 1998, PAIN, V76, P151, DOI 10.1016/S0304-3959(98)00037-2; Mert T, 2006, ALTERN THER HEALTH M, V12, P42; Mert T, 2010, BIOELECTROMAGNETICS, V31, P39, DOI 10.1002/bem.20524; Pieber K, 2010, J REHABIL MED, V42, P289, DOI 10.2340/16501977-0554; Price SA, 2006, DIABETES, V55, P1847, DOI 10.2337/db05-1060; RAINE AEG, 1993, DIABETOLOGIA, V36, P1099, DOI 10.1007/BF02374505; Renno Waleed M, 2006, Medicina (Kaunas), V42, P147; Rondon LJ, 2010, J PHYSIOL-LONDON, V588, P4205, DOI 10.1113/jphysiol.2010.197004; Samii A, 1999, NEUROSCI LETT, V262, P159, DOI 10.1016/S0304-3940(99)00064-6; Sator-Katzenschlager SM, 2003, ANESTH ANALG, V97, P791, DOI 10.1213/01.ANE.0000078584.03856.D3; Schmader KE, 2002, CLIN J PAIN, V18, P350, DOI 10.1097/00002508-200211000-00002; Sima AAF, 2006, ANN NY ACAD SCI, V1084, P235, DOI 10.1196/annals.1372.004; Sondell M, 1999, BRAIN RES, V846, P219, DOI 10.1016/S0006-8993(99)02056-9; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Stevens MJ, 2007, J PHARMACOL EXP THER, V320, P458, DOI 10.1124/jpet.106.109702; Stevens MJ, 2000, DIABETES, V49, P1006, DOI 10.2337/diabetes.49.6.1006; Tan AM, 2012, J NEUROSCI, V32, P6795, DOI 10.1523/JNEUROSCI.1017-12.2012; Tasset I, 2012, NEUROSCIENCE, V209, P54, DOI 10.1016/j.neuroscience.2012.02.034; Thomas PK, 1997, DIABETES, V46, pS54, DOI 10.2337/diab.46.2.S54; WALKER JL, 1994, EXP NEUROL, V125, P302, DOI 10.1006/exnr.1994.1033; Wang J, 2001, REV SCI INSTRUM, V20, P6; Wrobel MP, 2008, DIABETES METAB, V34, P349, DOI 10.1016/j.diabet.2008.02.003; Wrobel MP, 2010, ELECTROMAGN BIOL MED, V29, P19, DOI 10.3109/15368371003635376; WUARINBIERMAN L, 1987, DIABETOLOGIA, V30, P653; Yamamoto H, 2009, NEUROPHARMACOLOGY, V57, P403, DOI 10.1016/j.neuropharm.2009.06.037; YU L, 2004, CHIN J CLIN REHABIL, V8, P3590; Ziegler D, 2008, DIABETES CARE, V31, pS255, DOI 10.2337/dc08-s263	48	19	23	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61414	10.1371/journal.pone.0061414	http://dx.doi.org/10.1371/journal.pone.0061414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637830	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700032
J	Zavodna, M; Grueber, CE; Gemmell, NJ				Zavodna, Monika; Grueber, Catherine E.; Gemmell, Neil J.			Parallel Tagged Next-Generation Sequencing on Pooled Samples - A New Approach for Population Genetics in Ecology and Conservation	PLOS ONE			English	Article							ALLELE FREQUENCY; DNA; AMPLIFICATION; TRANSCRIPTOME; DISCOVERY; VARIANTS; SOFTWARE; MARKERS; GENES	Next-generation sequencing (NGS) on pooled samples has already been broadly applied in human medical diagnostics and plant and animal breeding. However, thus far it has been only sparingly employed in ecology and conservation, where it may serve as a useful diagnostic tool for rapid assessment of species genetic diversity and structure at the population level. Here we undertake a comprehensive evaluation of the accuracy, practicality and limitations of parallel tagged amplicon NGS on pooled population samples for estimating species population diversity and structure. We obtained 16S and Cyt b data from 20 populations of Leiopelma hochstetteri, a frog species of conservation concern in New Zealand, using two approaches - parallel tagged NGS on pooled population samples and individual Sanger sequenced samples. Data from each approach were then used to estimate two standard population genetic parameters, nucleotide diversity (pi) and population differentiation (F-ST), that enable population genetic inference in a species conservation context. We found a positive correlation between our two approaches for population genetic estimates, showing that the pooled population NGS approach is a reliable, rapid and appropriate method for population genetic inference in an ecological and conservation context. Our experimental design also allowed us to identify both the strengths and weaknesses of the pooled population NGS approach and outline some guidelines and suggestions that might be considered when planning future projects.	[Zavodna, Monika; Grueber, Catherine E.; Gemmell, Neil J.] Univ Otago, Dept Anat, Ctr Reprod & Genom, Dunedin, New Zealand; [Grueber, Catherine E.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Grueber, Catherine E.; Gemmell, Neil J.] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Zavodna, M (corresponding author), Univ Otago, Dept Anat, Ctr Reprod & Genom, Dunedin, New Zealand.	z_monika@hotmail.com	Gemmell, Neil J/C-6774-2009; Grueber, Catherine E./H-4707-2011	Gemmell, Neil J/0000-0003-0671-3637; Grueber, Catherine E./0000-0002-8179-1822	Landcare Research's OBI 'Sustaining and Restoring Biodiversity' FRST [C09X0503]; Marsden Fund [UOO1009]	Landcare Research's OBI 'Sustaining and Restoring Biodiversity' FRST; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This research was funded by a subcontract to NJG through Landcare Research's OBI 'Sustaining and Restoring Biodiversity' FRST contract no. C09X0503. CEG was supported by the Marsden Fund UOO1009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bordoni R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-464; Cheng CD, 2012, GENETICS, V190, P1417, DOI 10.1534/genetics.111.137794; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fouquet A, 2010, CONSERV GENET, V11, P907, DOI 10.1007/s10592-009-9935-8; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Futschik A, 2010, GENETICS, V186, P207, DOI 10.1534/genetics.110.114397; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Goto H, 2011, GENOME BIOL EVOL, V3, P1096, DOI 10.1093/gbe/evr067; Holyoake A, 2001, ANIM CONSERV, V4, P29, DOI 10.1017/S1367943001001032; Huang YL, 2012, AQUAT BOT, V101, P46, DOI 10.1016/j.aquabot.2012.04.001; HUDSON RR, 1992, GENETICS, V132, P583; Kharabian-Masouleh A, 2011, PLANT BIOTECHNOL J, V9, P1074, DOI 10.1111/j.1467-7652.2011.00629.x; Knaus Brian J., 2011, BMC Ecology, V11, P10, DOI 10.1186/1472-6785-11-10; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marroni F, 2011, PLANT J, V67, P736, DOI 10.1111/j.1365-313X.2011.04627.x; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; R Core Development Team, 2011, R LANG ENV STAT COMP; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Santure AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-283; Schlipf NA, 2011, CLIN GENET, V80, P148, DOI 10.1111/j.1399-0004.2011.01715.x; Sloan DB, 2012, MOL ECOL RESOUR, V12, P333, DOI 10.1111/j.1755-0998.2011.03079.x; Spurgin LG, 2011, MOL ECOL, V20, P5213, DOI 10.1111/j.1365-294X.2011.05367.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wang Tao, 2011, Frontiers in Genetics, V2, P51, DOI 10.3389/fgene.2011.00051; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT S, 1978, P580	36	7	7	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61471	10.1371/journal.pone.0061471	http://dx.doi.org/10.1371/journal.pone.0061471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637841	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700039
J	Vecchiarelli, AG; Havey, JC; Ing, LL; Wong, EOY; Waples, WG; Funnell, BE				Vecchiarelli, Anthony G.; Havey, James C.; Ing, Lori L.; Wong, Erin O. Y.; Waples, William G.; Funnell, Barbara E.			Dissection of the ATPase Active Site of P1 ParA Reveals Multiple Active Forms Essential for Plasmid Partition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC DNA SEGREGATION; ESCHERICHIA-COLI; NONSPECIFIC DNA; BINDING SITE; PROTEIN PARA; F-PLASMID; LOCALIZATION; SYSTEM; SOPA; OSCILLATION	The segregation, or partition, of bacterial plasmids is driven by the action of plasmid-encoded partition ATPases, which work to position plasmids inside the cell. The most common type of partition ATPase, generally called ParA, is represented by the P1 plasmid ParA protein. ParA interacts with P1 ParB (the site-specific DNA binding protein that recognizes the parS partition site), and interacts with the bacterial chromosome via an ATP-dependent nonspecific DNA binding activity. ParA also regulates expression of the par genes by acting as a transcriptional repressor. ParA requires ATP for multiple steps and in different ways during the partition process. Here, we analyze the properties of mutations in P1 ParA that are altered in a key lysine in the Walker A motif of the ATP binding site. Four different residues at this position (Lys, Glu, Gln, Arg) result in four different phenotypes in vivo. We focus particularly on the arginine substitution (K122R) because it results in a worse-than-null and dominant-negative phenotype called ParPD. We show that ParAK122R binds and hydrolyzes ATP, although the latter activity is reduced compared with wild-type. ParAK122R interacts with ParB, but the consequences of the interaction are damaged. The ability of ParB to stimulate the ATPase activity of ParA in vitro and its repressor activity in vivo is defective. The K122R mutation specifically damages the disassembly of ParA-ParB-DNA partition complexes, which we believe explains the ParPD phenotype in vivo.	[Vecchiarelli, Anthony G.; Havey, James C.; Ing, Lori L.; Wong, Erin O. Y.; Waples, William G.; Funnell, Barbara E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto	Funnell, BE (corresponding author), Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	b.funnell@utoronto.ca	Vecchiarelli, Anthony/H-5978-2019	Vecchiarelli, Anthony/0000-0002-6198-3245; Funnell, Barbara/0000-0002-1828-6567	Canadian Institutes of Health Grant [37997]; University of Toronto fellowships	Canadian Institutes of Health Grant(Canadian Institutes of Health Research (CIHR)); University of Toronto fellowships(University of Toronto)	This work was supported by Canadian Institutes of Health Grant 37997 (to B. E. F.) and University of Toronto fellowships (to A. G. V. and J. C. H.).	Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; DAVEY MJ, 1994, J BIOL CHEM, V269, P29908; Davis MA, 1996, MOL MICROBIOL, V21, P1029, DOI 10.1046/j.1365-2958.1996.721423.x; DAVIS MA, 1992, MOL MICROBIOL, V6, P1141, DOI 10.1111/j.1365-2958.1992.tb01552.x; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2004, MOL MICROBIOL, V52, P385, DOI 10.1111/j.1365-2958.2004.04002.x; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; FRIEDMAN SA, 1988, PLASMID, V19, P103, DOI 10.1016/0147-619X(88)90049-2; Fung E, 2001, EMBO J, V20, P4901, DOI 10.1093/emboj/20.17.4901; Funnell BE, 2004, PLASMID BIOLOGY, P81; FUNNELL BE, 1988, J BACTERIOL, V170, P954, DOI 10.1128/JB.170.2.954-960.1988; FUNNELL BE, 1988, P NATL ACAD SCI USA, V85, P6657, DOI 10.1073/pnas.85.18.6657; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Hatano T, 2010, MOL MICROBIOL, V78, P1182, DOI 10.1111/j.1365-2958.2010.07398.x; Havey JC, 2012, NUCLEIC ACIDS RES, V40, P801, DOI 10.1093/nar/gkr747; HAYES F, 1994, MOL MICROBIOL, V11, P249, DOI 10.1111/j.1365-2958.1994.tb00305.x; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; Hwang LC, 2013, EMBO J, V32, P1238, DOI 10.1038/emboj.2013.34; Kaur T, 2011, VIROLOGY, V421, P192, DOI 10.1016/j.virol.2011.09.027; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Libante V, 2001, J MOL BIOL, V314, P387, DOI 10.1006/jmbi.2001.5158; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Lutkenhaus J, 2012, TRENDS MICROBIOL, V20, P411, DOI 10.1016/j.tim.2012.05.002; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; PAL SK, 1986, J MOL BIOL, V192, P275, DOI 10.1016/0022-2836(86)90364-5; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Ringgaard S, 2011, GENE DEV, V25, P1544, DOI 10.1101/gad.2061811; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rodionov O, 2004, MOL MICROBIOL, V52, P1215, DOI 10.1111/j.1365-2958.2004.04055.x; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Silhavy T.J., 1984, EXPT GENE FUSIONS; Slavcev RA, 2005, J BACTERIOL, V187, P1227, DOI 10.1128/JB.187.4.1227-1237.2005; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Vecchiarelli AG, 2012, MOL MICROBIOL, V86, P513, DOI 10.1111/mmi.12017; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Youngren B, 1997, MOL MICROBIOL, V25, P1023, DOI 10.1046/j.1365-2958.1997.4761842.x	47	16	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17823	17831		10.1074/jbc.M113.469981	http://dx.doi.org/10.1074/jbc.M113.469981			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632076	Green Published, hybrid			2022-12-25	WOS:000320380600071
J	Franklin, L; Nobbs, AH; Bricio-Moreno, L; Wright, CJ; Maddocks, SE; Sahota, JS; Ralph, J; O'Connor, M; Jenkinson, HF; Kadioglu, A				Franklin, Linda; Nobbs, Angela H.; Bricio-Moreno, Laura; Wright, Christopher J.; Maddocks, Sarah E.; Sahota, Jaspreet Singh; Ralph, Joe; O'Connor, Matthew; Jenkinson, Howard F.; Kadioglu, Aras			The AgI/II Family Adhesin AspA Is Required for Respiratory Infection by Streptococcus pyogenes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; BIOFILM FORMATION; EPITHELIAL-CELLS; M-PROTEIN; VACCINE DEVELOPMENT; SURFACE PROTEIN; C5A PEPTIDASE; MAC PROTEIN; BINDING; I/II	Streptococcus pyogenes (GAS) is a human pathogen that causes pharyngitis and invasive diseases such as toxic shock syndrome and sepsis. The upper respiratory tract is the primary reservoir from which GAS can infect new hosts and cause disease. The factors involved in colonisation are incompletely known however. Previous evidence in oral streptococci has shown that the AgI/II family proteins are involved. We hypothesized that the AspA member of this family might be involved in GAS colonization. We describe a novel mouse model of GAS colonization of the nasopharynx and lower respiratory tract to elucidate these interactions. We used two clinical M serotypes expressing AspA, and their aspA gene deletant isogenic mutants in experiments using adherence assays to respiratory epithelium, macrophage phagocytosis and neutrophil killing assays and in vivo models of respiratory tract colonisation and infection. We demonstrated the requirement for AspA in colonization of the respiratory tract. AspA mutants were cleared from the respiratory tract and were deficient in adherence to epithelial cells, and susceptible to phagocytosis. Expression of AspA in the surrogate host Lactococcus lactis protected bacteria from phagocytosis. Our results suggest that AspA has an essential role in respiratory infection, and may function as a novel anti-phagocytic factor.	[Franklin, Linda; Sahota, Jaspreet Singh; Ralph, Joe; O'Connor, Matthew; Kadioglu, Aras] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Franklin, Linda; Nobbs, Angela H.; Wright, Christopher J.; Maddocks, Sarah E.; Jenkinson, Howard F.] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [Bricio-Moreno, Laura; Kadioglu, Aras] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of Leicester; University of Bristol; University of Liverpool	Kadioglu, A (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	a.kadioglu@liv.ac.uk	Nobbs, Angela/AAS-3926-2020; Jenkinson, Howard/ABI-1842-2020; Bricio-Moreno, Laura/AAD-2781-2019; Jenkinson, Howard/AAD-9282-2022	Nobbs, Angela/0000-0003-3813-4410; Bricio Moreno, Laura/0000-0002-4956-7142; kadioglu, aras/0000-0003-1137-6321; O'Connor, Matthew/0000-0001-5510-6353; Jenkinson, Howard/0000-0002-9195-7945	Wellcome Trust [081855]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant #081855) awarded to HFJ and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agniswamy J, 2004, J BIOL CHEM, V279, P52789, DOI 10.1074/jbc.M410698200; Areschoug T, 2004, VACCINE, V22, pS9, DOI 10.1016/j.vaccine.2004.08.010; Bangert M, 2012, J INFECT DIS, V205, P1399, DOI 10.1093/infdis/jis223; Berggard K, 2001, MOL MICROBIOL, V42, P539, DOI 10.1046/j.1365-2958.2001.02664.x; Bessen DE, 2005, J BACTERIOL, V187, P4163, DOI 10.1128/JB.187.12.4163-4172.2005; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Cleary PP, 2004, VACCINE, V22, P4332, DOI 10.1016/j.vaccine.2004.04.030; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165; Conley J, 2003, J CLIN MICROBIOL, V41, P4043, DOI 10.1128/JCM.41.9.4043-4048.2003; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Dale JB, 1996, INFECT IMMUN, V64, P1495, DOI 10.1128/IAI.64.5.1495-1501.1996; Eliasson M, 2007, MICROB PATHOGENESIS, V43, P224, DOI 10.1016/j.micpath.2007.06.007; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hollands A, 2010, J INFECT DIS, V202, P11, DOI 10.1086/653124; Hyland KA, 2007, INFECT IMMUN, V75, P3188, DOI 10.1128/IAI.01745-06; Hyland KA, 2009, FEMS IMMUNOL MED MIC, V55, P422, DOI 10.1111/j.1574-695X.2009.00540.x; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Ji YD, 1998, INFECT IMMUN, V66, P5399, DOI 10.1128/IAI.66.11.5399-5405.1998; Johnson DR, 2010, CLIN INFECT DIS, V50, P481, DOI 10.1086/650167; Kadioglu A, 2002, INFECT IMMUN, V70, P2886, DOI 10.1128/IAI.70.6.2886-2890.2002; Kihlberg BM, 1999, INFECT IMMUN, V67, P1708; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kuo CF, 2008, INFECT IMMUN, V76, P1163, DOI 10.1128/IAI.01116-07; Kwinn LA, 2007, FUTURE MICROBIOL, V2, P75, DOI 10.2217/17460913.2.1.75; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; LEE SF, 1989, INFECT IMMUN, V57, P3306, DOI 10.1128/IAI.57.11.3306-3313.1989; Lei BF, 2003, INFECT IMMUN, V71, P2881, DOI 10.1128/IAI.71.5.2881-2884.2003; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Maddocks SE, 2011, MOL MICROBIOL, V81, P1034, DOI 10.1111/j.1365-2958.2011.07749.x; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Mannam P, 2004, INFECT IMMUN, V72, P3444, DOI 10.1128/IAI.72.6.3444-3450.2004; Nobbs AH, 2007, CELL MICROBIOL, V9, P65, DOI 10.1111/j.1462-5822.2006.00768.x; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; POIRIER TP, 1989, INFECT IMMUN, V57, P29, DOI 10.1128/IAI.57.1.29-35.1989; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Romero-Steiner S, 2003, CLIN DIAGN LAB IMMUN, V10, P1019, DOI 10.1128/CDLI.10.6.1019-1024.2003; Sitkiewicz I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-65; Sjogren J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-120; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Tran-Winkler HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002361; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06	52	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62433	10.1371/journal.pone.0062433	http://dx.doi.org/10.1371/journal.pone.0062433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638083	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300057
J	Jin, Q; Yao, Y; Cai, YP; Lin, Y				Jin, Qing; Yao, Yao; Cai, Yongping; Lin, Yi			Molecular Cloning and Sequence Analysis of a Phenylalanine Ammonia-Lyase Gene from Dendrobium	PLOS ONE			English	Article								In this study, a phenylalanine ammonia-lyase (PAL) gene was cloned from Dendrobium candidum using homology cloning and RACE. The full-length sequence and catalytic active sites that appear in PAL proteins of Arabidopsis thaliana and Nicotiana tabacum are also found: PAL cDNA of D. candidum (designated Dc-PAL1, GenBank No. JQ765748) has 2,458 bps and contains a complete open reading frame (ORF) of 2,142 bps, which encodes 713 amino acid residues. The amino acid sequence of DcPAL1 has more than 80% sequence identity with the PAL genes of other plants, as indicated by multiple alignments. The dominant sites and catalytic active sites, which are similar to that showing in PAL proteins of Arabidopsis thaliana and Nicotiana tabacum, are also found in DcPAL1. Phylogenetic tree analysis revealed that DcPAL is more closely related to PALs from orchidaceae plants than to those of other plants. The differential expression patterns of PAL in protocorm-like body, leaf, stem, and root, suggest that the PAL gene performs multiple physiological functions in Dendrobium candidum.	[Jin, Qing; Yao, Yao; Cai, Yongping; Lin, Yi] Anhui Agr Univ, Hefei, Peoples R China	Anhui Agricultural University	Lin, Y (corresponding author), Anhui Agr Univ, Hefei, Peoples R China.	linyi@ahau.edu.cn			Key Project of Anhui Education Department [KJ2011A103, KJ2012A121]; Youth Foundation of Anhui Natural Science Fund [10040606Q22]	Key Project of Anhui Education Department; Youth Foundation of Anhui Natural Science Fund	The study was supported by The Key Project of Anhui Education Department (No. KJ2011A103,KJ2012A121, www.ahedu.gov.cn) and Youth Foundation of Anhui Natural Science Fund (No. 10040606Q22, www.ahkjt.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVAN M, 1989, EMBO J, V8, P1899, DOI 10.1002/j.1460-2075.1989.tb03592.x; Bolwell GP, 1985, EUROPEAN J BIOCH FEB, V149; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaman ME, 2003, J AGR FOOD CHEM, V51, P2227, DOI 10.1021/jf020953b; Dai Y, 2009, CROP PROTECTION, V28; ESTABROOK EM, 1991, PLANT CELL, V3, P299, DOI 10.1105/tpc.3.3.299; Facchini PJ, 1996, PLANT PHYSL, V111; Janas KM, 1993, ACTA BIOCH POLONICA, V40; Jorrin J, 1990, PLANT PHYSL, V92; Li B, 2006, COLLOIDS SURFACES B, V49; Li Y, 2011, PLANTA MED, V77; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOIS R, 1989, EMBO J, V8, P1641, DOI 10.1002/j.1460-2075.1989.tb03554.x; Minami E, 1989, EUROEPAN J BIOCH FEB, V185; Moffitt MC, 2007, BIOCHEMISTRY-US, P46; Ng TB, 2012, APPL MICROBIOLOGY BI, V93; Nugroho LH, 2002, PLANT PHYSL BIOCH, V40; Pellegrini L, 1994, PLANT PHYSL, V106; Reichert AI, 2009, BIOCH J, V424; Sarma AD, 1998, PHYTOCHEMISTRY, V49, P2233, DOI 10.1016/S0031-9422(98)00336-7; Skern R, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-10; Wang Q, 2010, PHYTOMEDICINE, V17, P108, DOI 10.1016/j.phymed.2009.05.010; Wang T, 2010, STUDY CATTLEYA CHINE; Wu KG, 2011, INT J IMMUNOPATHOLOG, V24; Zhang GN, 2005, PHYTOCHEMISTRY, V66, P1113, DOI 10.1016/j.phytochem.2005.04.001	26	32	41	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62352	10.1371/journal.pone.0062352	http://dx.doi.org/10.1371/journal.pone.0062352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638048	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300044
J	Dehle, FC; Mukaro, VR; Jurisevic, C; Moffat, D; Ahern, J; Hodge, G; Jersmann, H; Reynolds, PN; Hodge, S				Dehle, Francis C.; Mukaro, Violet R.; Jurisevic, Craig; Moffat, David; Ahern, Jessica; Hodge, Greg; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra			Defective Lung Macrophage Function in Lung Cancer +/- Chronic Obstructive Pulmonary Disease (COPD/Emphysema)-Mediated by Cancer Cell Production of PGE2?	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; ALVEOLAR MACROPHAGES; EXPRESSION; PHAGOCYTOSIS; RITUXIMAB; RECEPTOR; ABILITY	In chronic obstructive pulmonary disease (COPD/emphysema) we have shown a reduced ability of lung and alveolar (AM) macrophages to phagocytose apoptotic cells (defective 'efferocytosis'), associated with evidence of secondary cellular necrosis and a resultant inflammatory response in the airway. It is unknown whether this defect is present in cancer (no COPD) and if so, whether this results from soluble mediators produced by cancer cells. We investigated efferocytosis in AM (26 controls, 15 healthy smokers, 37 COPD, 20 COPD+ non small cell lung cancer (NSCLC) and 8 patients with NSCLC without COPD) and tumor and tumor-free lung tissue macrophages (21 NSCLC with/13 without COPD). To investigate the effects of soluble mediators produced by lung cancer cells we then treated AM or U937 macrophages with cancer cell line supernatant and assessed their efferocytosis ability. We qualitatively identified Arachidonic Acid (AA) metabolites in cancer cells by LC-ESI-MSMS, and assessed the effects of COX inhibition (using indomethacin) on efferocytosis. Decreased efferocytosis was noted in all cancer/COPD groups in all compartments. Conditioned media from cancer cell cultures decreased the efferocytosis ability of both AM and U937 macrophages with the most pronounced effects occurring with supernatant from SCLC (an aggressive lung cancer type). AA metabolites identified in cancer cells included PGE2. The inhibitory effect of PGE2 on efferocytosis, and the involvement of the COX-2 pathway were shown. Efferocytosis is decreased in COPD/emphysema and lung cancer; the latter at least partially a result of inhibition by soluble mediators produced by cancer cells that include PGE2.	[Dehle, Francis C.; Mukaro, Violet R.; Ahern, Jessica; Hodge, Greg; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra] Hanson Inst, Lung Res Lab, Adelaide, SA, Australia; [Dehle, Francis C.; Mukaro, Violet R.; Ahern, Jessica; Hodge, Greg; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia; [Jurisevic, Craig] Royal Adelaide Hosp, Dept Cardiothorac Surg, Adelaide, SA 5000, Australia; [Moffat, David] SA Pathol, Dept Surg Pathol, Adelaide, SA, Australia; [Hodge, Greg; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia	Hanson Institute; Royal Adelaide Hospital; Royal Adelaide Hospital; SA Pathology; University of Adelaide	Hodge, S (corresponding author), Hanson Inst, Lung Res Lab, Adelaide, SA, Australia.	sandra.hodge@health.sa.gov.au	Jersmann, Hubertus/ABC-5287-2020	Jersmann, Hubertus/0000-0003-1763-2736; Mukaro, Violet/0000-0002-3968-6551	Australian Lung Foundation; National Health and Medical Research Council (NHMRC); NHMRC	Australian Lung Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Lung Foundation (FD), National Health and Medical Research Council (NHMRC) Career Development Award (S. H.), NHMRC Practitioner Fellowship (P.N.R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Access Economics Report for the Australian Lung Foundation, 2008, EC IMP COPD COST EFF; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Cordts F, 2011, LIFE SCI, V89, P806, DOI 10.1016/j.lfs.2011.08.018; Fong KM, 2003, THORAX, V58, P892, DOI 10.1136/thorax.58.10.892; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Hodge S, 2006, EUR RESPIR J, V28, P486, DOI 10.1183/09031936.06.00001506; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hodge S, 2010, AM J RESP CELL MOL, V42, P235, DOI 10.1165/rcmb.2008-0486OC; Hodge SJ, 2004, CYTOM PART B-CLIN CY, V61B, P27, DOI 10.1002/cyto.b.20020; Izzi V, 2009, INT J ONCOL, V34, P543, DOI 10.3892/ijo_00000180; Kempen EC, 2001, ANAL BIOCHEM, V297, P183, DOI 10.1006/abio.2001.5325; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; SKILLRUD D M, 1986, Comprehensive Therapy, V12, P13; Soriano C, 2012, LUNG CANCER, V77, P38, DOI 10.1016/j.lungcan.2012.01.017; Taskinen M, 2007, CLIN CANCER RES, V13, P5784, DOI 10.1158/1078-0432.CCR-07-0778; Travis WD., 2004, TRAVIS WB WHO CLASSI; Tuve S, 2007, CANCER RES, V67, P5929, DOI 10.1158/0008-5472.CAN-06-4296; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Watkins DN, 1999, EUR RESPIR J, V13, P999, DOI 10.1034/j.1399-3003.1999.13e12.x	24	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61573	10.1371/journal.pone.0061573	http://dx.doi.org/10.1371/journal.pone.0061573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637858	gold, Green Published			2022-12-25	WOS:000318343700014
J	Prasad, B; Mah, DJ; Lewis, AR; Plettner, E				Prasad, Brinda; Mah, Derrick J.; Lewis, Andrew R.; Plettner, Erika			Water Oxidation by a Cytochrome P450: Mechanism and Function of the Reaction	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PUTIDAREDOXIN; REDUCTION; CHANNELS; P450CAM; ROUTE; ROLES	P450(cam) (CYP101A1) is a bacterial monooxygenase that is known to catalyze the oxidation of camphor, the first committed step in camphor degradation, with simultaneous reduction of oxygen (O-2). We report that P450(cam) catalysis is controlled by oxygen levels: at high O-2 concentration, P450(cam) catalyzes the known oxidation reaction, whereas at low O-2 concentration the enzyme catalyzes the reduction of camphor to borneol. We confirmed, using O-17 and H-2 NMR, that the hydrogen atom added to camphor comes from water, which is oxidized to hydrogen peroxide (H2O2). This is the first time a cytochrome P450 has been observed to catalyze oxidation of water to H2O2, a difficult reaction to catalyze due to its high barrier. The reduction of camphor and simultaneous oxidation of water are likely catalyzed by the iron-oxo intermediate of P450(cam), and we present a plausible mechanism that accounts for the 1:1 borneol:H2O2 stoichiometry we observed. This reaction has an adaptive value to bacteria that express this camphor catabolism pathway, which requires O-2, for two reasons: 1) the borneol and H2O2 mixture generated is toxic to other bacteria and 2) borneol down-regulates the expression of P450(cam) and its electron transfer partners. Since the reaction described here only occurs under low O-2 conditions, the down-regulation only occurs when O-2 is scarce.	[Prasad, Brinda; Mah, Derrick J.; Lewis, Andrew R.; Plettner, Erika] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Plettner, E (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	plettner@sfu.ca			NSERC [222923]; Simon Fraser University	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Simon Fraser University	This research was supported by NSERC (Discovery Program 222923, to EP) and Simon Fraser University (Graduate Fellowship and Travel Awards to BP). NSERC: http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunom I, 2011, CHEM RES TOXICOL, V24, P1223, DOI 10.1021/tx200080b; Auclair K, 2001, J AM CHEM SOC, V123, P4877, DOI 10.1021/ja0040262; Casny M, 2000, J INORG BIOCHEM, V80, P157, DOI 10.1016/S0162-0134(00)00024-6; CHA Y, 1989, SCIENCE, V243, P1325, DOI 10.1126/science.2646716; Chefson A, 2006, CHEMBIOCHEM, V7, P916, DOI 10.1002/cbic.200600006; Chefson A, 2006, MOL BIOSYST, V2, P462, DOI 10.1039/b607001a; Cho KB, 2008, J PHYS CHEM A, V112, P13128, DOI 10.1021/jp806770y; Cooper HLR, 2011, ARCH BIOCHEM BIOPHYS, V507, P111, DOI 10.1016/j.abb.2010.11.001; Cryle MJ, 2003, AUST J CHEM, V56, P749, DOI 10.1071/CH03040; Dau H, 2010, CHEMCATCHEM, V2, P724, DOI 10.1002/cctc.201000126; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; Glascock MC, 2005, J BIOL CHEM, V280, P42134, DOI 10.1074/jbc.M505426200; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Gunsalus I C, 1978, Methods Enzymol, V52, P166; GUNSALUS IC, 1976, BIOCHIMIE, V58, P143, DOI 10.1016/S0300-9084(76)80364-1; Harada K, 2008, J AM CHEM SOC, V130, P432, DOI 10.1021/ja077902l; Hishiki T, 2000, J BIOCHEM, V128, P965, DOI 10.1093/oxfordjournals.jbchem.a022848; Hlavica P, 2001, EUR J BIOCHEM, V268, P4817, DOI 10.1046/j.1432-1327.2001.02412.x; HUSKEY WP, 1983, J AM CHEM SOC, V105, P5704, DOI 10.1021/ja00355a038; Izgorodin A, 2012, AUST J CHEM, V65, P638, DOI 10.1071/CH12024; Johnson BJ, 2007, J BIOL CHEM, V282, P17767, DOI 10.1074/jbc.M701308200; Kallio JP, 2011, BIOCHEMISTRY-US, V50, P4396, DOI 10.1021/bi200486b; Kaspera R, 2012, BIOCHEM BIOPH RES CO, V418, P464, DOI 10.1016/j.bbrc.2012.01.040; KOPPENOL WH, 1984, J PHYS CHEM-US, V88, P99, DOI 10.1021/j150645a024; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Prasad B, 2011, J CHEM ECOL, V37, P657, DOI 10.1007/s10886-011-9959-7; Prasad B, 2011, ANAL CHEM, V83, P231, DOI 10.1021/ac1022887; Rojubally A, 2007, THESIS S FRASER U; Rojubally A, 2007, BIOCATAL BIOTRANSFOR, V25, P301, DOI 10.1080/10242420701422799; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Song WJ, 2011, P NATL ACAD SCI USA, V108, P14795, DOI 10.1073/pnas.1106514108; TANAKA M, 1974, J BIOL CHEM, V249, P3689; TAYLOR DG, 1986, J BACTERIOL, V165, P489, DOI 10.1128/jb.165.2.489-497.1986; Wade RC, 2004, J INORG BIOCHEM, V98, P1175, DOI 10.1016/j.jinorgbio.2004.02.007; WARDMAN P, 1989, J PHYS CHEM REF DATA, V18, P1637, DOI 10.1063/1.555843; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zhou FL, 2012, ADV ENERGY MATER, V2, P1013, DOI 10.1002/aenm.201100783	40	15	15	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61897	10.1371/journal.pone.0061897	http://dx.doi.org/10.1371/journal.pone.0061897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634216	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400024
J	Kesavan, R; Potunuru, UR; Nastasijevic, B; Avaneesh, T; Joksic, G; Dixit, M				Kesavan, Rushendhiran; Potunuru, Uma Rani; Nastasijevic, Branislav; Avaneesh, T.; Joksic, Gordana; Dixit, Madhulika			Inhibition of Vascular Smooth Muscle Cell Proliferation by Gentiana lutea Root Extracts	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ERK1/2 MAP KINASES; ACTIVATION; MIGRATION; PHOSPHORYLATION; MYELOPEROXIDASE; LYMPHOCYTES; PREVENTION; AUSTRIACA; MECHANISM	Gentiana lutea belonging to the Gentianaceae family of flowering plants are routinely used in traditional Serbian medicine for their beneficial gastro-intestinal and anti-inflammatory properties. The aim of the study was to determine whether aqueous root extracts of Gentiana lutea consisting of gentiopicroside, gentisin, bellidifolin-8-O-glucoside, demethylbellidifolin-8-O-glucoside, isovitexin, swertiamarin and amarogentin prevents proliferation of aortic smooth muscle cells in response to PDGF-BB. Cell proliferation and cell cycle analysis were performed based on alamar blue assay and propidium iodide labeling respectively. In primary cultures of rat aortic smooth muscle cells (RASMCs), PDGF-BB (20 ng/ml) induced a two-fold increase in cell proliferation which was significantly blocked by the root extract (1 mg/ml). The root extract also prevented the S-phase entry of synchronized cells in response to PDGF. Furthermore, PDGF-BB induced ERK1/2 activation and consequent increase in cellular nitric oxide (NO) levels were also blocked by the extract. These effects of extract were due to blockade of PDGF-BB induced expression of iNOS, cyclin D1 and proliferating cell nuclear antigen (PCNA). Docking analysis of the extract components on MEK1, the upstream ERK1/2 activating kinase using AutoDock4, indicated a likely binding of isovitexin to the inhibitor binding site of MEK1. Experiments performed with purified isovitexin demonstrated that it successfully blocks PDGF-induced ERK1/2 activation and proliferation of RASMCs in cell culture. Thus, Gentiana lutea can provide novel candidates for prevention and treatment of atherosclerosis.	[Kesavan, Rushendhiran; Potunuru, Uma Rani; Avaneesh, T.; Dixit, Madhulika] Indian Inst Technol, Dept Biotechnol, Lab Vasc Biol, Chennai 600036, Tamil Nadu, India; [Nastasijevic, Branislav; Joksic, Gordana] Vinca Inst Nucl Sci, Dept Phys Chem, Belgrade, Serbia	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; University of Belgrade	Dixit, M (corresponding author), Indian Inst Technol, Dept Biotechnol, Lab Vasc Biol, Chennai 600036, Tamil Nadu, India.	mdixit@iitm.ac.in	Kesavan, Rushendhiran/AAD-6783-2021; Nastasijevic, Branislav/AAV-1763-2021; Kesavan, Rushendhiran/GLS-9475-2022	Nastasijevic, Branislav/0000-0002-4529-1599; Joksic, Gordana/0000-0002-7186-301X; Kesavan, Rushendhiran/0000-0002-8540-8093	Council of Scientific and Industrial Research (CSIR), Government of India; Department of Biotechnology (DBT), Government of India; Indo-EU 'FUNCFOOD' project;  [BT/IN/EU/17/SN/2009]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Indo-EU 'FUNCFOOD' project; 	Uma Rani Potunuru acknowledges Council of Scientific and Industrial Research (CSIR), Government of India for her Senior Research Fellowship and Madhulika Dixit acknowledges Department of Biotechnology (DBT), Government of India for her 'IYBA Fellowship'.; This was funded by Department of Biotechnology (DBT), Government of India sponsored joint Indo-EU 'FUNCFOOD' project. The grant number for the same is BT/IN/EU/17/SN/2009 and the website address is http://www.gmt.su.se/english/funcfood/main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberham A, 2007, J PHARMACEUT BIOMED, V45, P437, DOI 10.1016/j.jpba.2007.07.001; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akileshwari C, 2012, EXP DIABETES RES, DOI 10.1155/2012/147965; AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; Brahmachari G, 2004, CHEM BIODIVERS, V1, P1627, DOI 10.1002/cbdv.200490123; Brown C, 1999, CIRC RES, V84, P655, DOI 10.1161/01.RES.84.6.655; Calmels S, 1997, CANCER RES, V57, P3365; Cao DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021071; Chang WC, 2008, BRIT J NUTR, V99, P709, DOI 10.1017/S0007114507831734; Chen SY, 2012, FOOD CHEM TOXICOL, V50, P3025, DOI 10.1016/j.fct.2012.06.006; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Chyu KY, 2004, VASC MED, V9, P177, DOI 10.1191/1358863x04vm545oa; Chyu KY, 1999, CIRC RES, V85, P1192; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Dan Q, 2004, LIFE SCI, V76, P445, DOI 10.1016/j.lfs.2004.09.010; Di Pietro N, 2013, ATHEROSCLEROSIS, V226, P88, DOI 10.1016/j.atherosclerosis.2012.10.062; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Geller DA, 1998, CANCER METAST REV, V17, P7, DOI 10.1023/A:1005940202801; Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x; Guo J, 2005, J BIOL CHEM, V280, P35992, DOI 10.1074/jbc.M504583200; Hu YH, 2000, ARTERIOSCL THROM VAS, V20, P18, DOI 10.1161/01.ATV.20.1.18; Hudecova A, 2012, FOOD CHEM TOXICOL, V50, P3352, DOI 10.1016/j.fct.2012.06.017; Jankovic T, 2008, PLANTA MED, V74, P736, DOI 10.1055/s-2008-1074524; Jiang BB, 2001, ARTERIOSCL THROM VAS, V21, P1915, DOI 10.1161/hq1201.099424; Jiang ZL, 2009, WOUND REPAIR REGEN, V17, P224, DOI 10.1111/j.1524-475X.2009.00459.x; Kappert K, 2006, ARTERIOSCL THROM VAS, V26, P2644, DOI 10.1161/01.ATV.0000246777.30819.85; Kreuzer J, 2002, FASEB J, V16, P38, DOI 10.1096/fj.01-1036fje; Lang YS, 2012, J PHARM PHARMACOL, V64, P597, DOI 10.1111/j.2042-7158.2011.01438.x; Leskovac A, 2007, PLANTA MED, V73, P1169, DOI 10.1055/s-2007-981586; Lo HM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-18; Maejima Y, 2005, J MOL CELL CARDIOL, V38, P163, DOI 10.1016/j.yjmcc.2004.10.012; Matsukawa K, 2006, BIOSCI BIOTECH BIOCH, V70, P1046, DOI 10.1271/bbb.70.1046; Menkovic N, 2010, PHYTOTHER RES, V24, P1693, DOI 10.1002/ptr.3225; Miyoshi T, 2006, LIFE SCI, V79, P525, DOI 10.1016/j.lfs.2006.01.043; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Myagmar BE, 2000, PHYTOMEDICINE, V7, P221, DOI 10.1016/S0944-7113(00)80007-0; Myllarniemi M, 1999, CARDIOVASC DRUG THER, V13, P159, DOI 10.1023/A:1007700629728; Nadinic E, 1999, FITOTERAPIA, V70, P166, DOI 10.1016/S0367-326X(99)00020-9; Nastasijevic B, 2012, J PHARMACEUT BIOMED, V66, P191, DOI 10.1016/j.jpba.2012.03.052; Nickel T, 2009, MICROVASC RES, V78, P364, DOI 10.1016/j.mvr.2009.07.008; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Ramana KV, 2002, J BIOL CHEM, V277, P32063, DOI 10.1074/jbc.M202126200; Rojas A, 2000, PLANTA MED, V66, P765, DOI 10.1055/s-2000-9774; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schindhelm RK, 2009, CLIN CHEM, V55, P1462, DOI 10.1373/clinchem.2009.126029; Schmieder A, 2007, ATHEROSCLEROSIS, V194, P317, DOI 10.1016/j.atherosclerosis.2006.10.019; Sezik E, 2005, LIFE SCI, V76, P1223, DOI 10.1016/j.lfs.2004.07.024; Shaul YD, 2009, GENE DEV, V23, P1779, DOI 10.1101/gad.523909; Srivastava S, 2009, CIRC RES, V105, P793, DOI 10.1161/CIRCRESAHA.109.200568; Tammali R, 2010, ENDOCRINOLOGY, V151, P2140, DOI 10.1210/en.2010-0160; Toriumi Y, 2003, CHEM PHARM BULL, V51, P89, DOI 10.1248/cpb.51.89; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Waltenberger J, 1997, CIRCULATION, V96, P4083; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Wu QX, 2006, J ASIAN NAT PROD RES, V8, P391, DOI 10.1080/10286020500172368; Yang JL, 2010, NAT PROD COMMUN, V5, P649	64	37	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61393	10.1371/journal.pone.0061393	http://dx.doi.org/10.1371/journal.pone.0061393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637826	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700029
J	Mai, LY; Yao, AN; Li, J; Wei, Q; Yuchi, M; He, XL; Ding, MY; Zhou, QB				Mai, Liyi; Yao, Anna; Li, Jing; Wei, Qiong; Yuchi, Ming; He, Xiaoling; Ding, Mingyue; Zhou, Qibing			Cyanine 5.5 Conjugated Nanobubbles as a Tumor Selective Contrast Agent for Dual Ultrasound-Fluorescence Imaging in a Mouse Model	PLOS ONE			English	Article							ENHANCED ULTRASOUND; MICROBUBBLES; SURGERY; CANCER; SIZE	Nanobubbles and microbubbles are non-invasive ultrasound imaging contrast agents that may potentially enhance diagnosis of tumors. However, to date, both nanobubbles and microbubbles display poor in vivo tumor-selectivity over non-targeted organs such as liver. We report here cyanine 5.5 conjugated nanobubbles (cy5.5-nanobubbles) of a biocompatible chitosan-vitamin C lipid system as a dual ultrasound-fluorescence contrast agent that achieved tumor-selective imaging in a mouse tumor model. Cy5.5-nanobubble suspension contained single bubble spheres and clusters of bubble spheres with the size ranging between 400-800 nm. In the in vivo mouse study, enhancement of ultrasound signals at tumor site was found to persist over 2 h while tumor-selective fluorescence emission was persistently observed over 24 h with intravenous injection of cy5.5-nanobubbles. In vitro cell study indicated that cy5.5-flurescence dye was able to accumulate in cancer cells due to the unique conjugated nanobubble structure. Further in vivo fluorescence study suggested that cy5.5-nanobubbles were mainly located at tumor site and in the bladder of mice. Subsequent analysis confirmed that accumulation of high fluorescence was present at the intact subcutaneous tumor site and in isolated tumor tissue but not in liver tissue post intravenous injection of cy5.5-nanobubbles. All these results led to the conclusion that cy5.5-nanobubbles with unique crosslinked chitosan-vitamin C lipid system have achieved tumor-selective imaging in vivo.	[Mai, Liyi; Yao, Anna; Wei, Qiong; Zhou, Qibing] Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Dept Nanomed & Biopharmaceut, Wuhan 430074, Hubei, Peoples R China; [Li, Jing; Yuchi, Ming; Ding, Mingyue] Huazhong Univ Sci & Technol, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China; [He, Xiaoling] China Univ Geosci, Univ Hosp, Wuhan 430074, Hubei, Peoples R China; [Zhou, Qibing] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; China University of Geosciences; Virginia Commonwealth University	Zhou, QB (corresponding author), Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Dept Nanomed & Biopharmaceut, Wuhan 430074, Hubei, Peoples R China.	qibingzhou@hust.edu.cn	Yuchi, Ming/AHB-9595-2022	Yuchi, Ming/0000-0003-1506-0631	National Basic Research Program of China [2011CB933100]	National Basic Research Program of China(National Basic Research Program of China)	This work is supported by National Basic Research Program of China (2011CB933100). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja AT., 2005, CANCER IMAGING, V9, P167; Deshpande N, 2011, RADIOLOGY, V258, P804, DOI 10.1148/radiol.10101079; Eichhorn ME, 2010, CANCER BIOL THER, V9, P794; Ferrara KW, 2009, ACCOUNTS CHEM RES, V42, P881, DOI 10.1021/ar8002442; Galie M, 2005, NEOPLASIA, V7, P528, DOI 10.1593/neo.04730; Goertz DE, 2007, ULTRASOUND MED BIOL, V33, P1376, DOI 10.1016/j.ultrasmedbio.2007.03.009; Gray DC, 2012, BIOMED OPT EXPRESS, V3, P1880, DOI 10.1364/BOE.3.001880; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hwang TL, 2011, TOXICOL LETT, V203, P172, DOI 10.1016/j.toxlet.2011.03.022; John R, 2012, MOL IMAGING BIOL, V14, P17, DOI 10.1007/s11307-011-0473-7; Jun HY, 2010, ACAD RADIOL, V17, P54, DOI 10.1016/j.acra.2009.07.017; Ke H, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425105; Kim C, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3302808; Krupka TM, 2010, MOL PHARMACEUT, V7, P49, DOI 10.1021/mp9001816; Kwon IK, 2012, J CONTROL RELEASE, V164, P108, DOI 10.1016/j.jconrel.2012.07.010; Lindner JR, 2004, NAT REV DRUG DISCOV, V3, P527, DOI 10.1038/nrd1417; Liu Z, 2012, CHEM COMMUN, V48, P5142, DOI 10.1039/c2cc18048k; Marxer EEJ, 2011, EUR J PHARM BIOPHARM, V77, P430, DOI 10.1016/j.ejpb.2010.12.007; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Pan TL, 2012, FOOD CHEM TOXICOL, V50, P3892, DOI 10.1016/j.fct.2012.07.005; Pysz MA, 2011, INVEST RADIOL, V46, P187, DOI 10.1097/RLI.0b013e3181f9202d; Qin SP, 2009, PHYS MED BIOL, V54, pR27, DOI 10.1088/0031-9155/54/6/R01; Schutt EG, 2003, ANGEW CHEM INT EDIT, V42, P3218, DOI 10.1002/anie.200200550; Sennoga CA, 2012, ULTRASOUND MED BIOL, V38, P834, DOI 10.1016/j.ultrasmedbio.2012.01.012; Sirsi S, 2010, ULTRASOUND MED BIOL, V36, P935, DOI 10.1016/j.ultrasmedbio.2010.03.015; Stieger SM, 2008, CONTRAST MEDIA MOL I, V3, P9, DOI 10.1002/cmmi.224; Tichauer KM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.066001; Wang Y, 2010, INT J PHARMACEUT, V384, P148, DOI 10.1016/j.ijpharm.2009.09.027; Wang Y, 2012, ULTRASOUND MED BIOL, V38, P1681, DOI 10.1016/j.ultrasmedbio.2012.05.019; Warram JM, 2011, J ULTRAS MED, V30, P921, DOI 10.7863/jum.2011.30.7.921; Wei Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052199; Weller GER, 2005, CANCER RES, V65, P533; Wu X, 2010, J ULTRAS MED, V29, P609, DOI 10.7863/jum.2010.29.4.609; Xing ZW, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145607; Xu JS, 2010, BIOMATERIALS, V31, P1716, DOI 10.1016/j.biomaterials.2009.11.052; Xu RX, 2011, CONTRAST MEDIA MOL I, V6, P401, DOI 10.1002/cmmi.442; Yin TH, 2012, INT J NANOMED, V7, P895, DOI 10.2147/IJN.S28830	37	36	37	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61224	10.1371/journal.pone.0061224	http://dx.doi.org/10.1371/journal.pone.0061224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637799	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700016
J	Lin, HY; Su, YF; Hsieh, MT; Lin, SR; Meng, R; London, D; Lin, C; Tang, HY; Hwang, J; Davis, FB; Mousa, SA; Davis, PJ				Lin, Hung-Yun; Su, Yee-Fun; Hsieh, Meng-Ti; Lin, Sharon; Meng, Ran; London, David; Lin, Cassie; Tang, Heng-Yuan; Hwang, Jaulang; Davis, Faith B.; Mousa, Shaker A.; Davis, Paul J.			Nuclear monomeric integrin alpha v in cancer cells is a coactivator regulated by thyroid hormone	FASEB JOURNAL			English	Article						thyroxine; gene expression; angiogenesis; carcinogenesis	ACTIVATED PROTEIN-KINASE; ESTROGEN-RECEPTOR; GROWTH-FACTOR; SERINE PHOSPHORYLATION; MEMBRANE-RECEPTOR; SURFACE RECEPTOR; EPITHELIAL-CELLS; GLIOMA-CELLS; IN-VITRO; ALPHA-V-BETA-3	Thyroid hormone induces tumor cell and blood vessel cell proliferation via a cell surface receptor on heterodimeric integrin v3. We investigated the role of thyroid hormone-induced internalization of nuclear integrin v monomer. Physiological concentration of thyroxine (free T-4, 10(-10) M), but not 3,5,3-triiodo-l-thyronine (T-3), induced cellular internalization and nuclear translocation of integrin v monomer in human non-small-cell lung cancer (H522) and ovarian carcinoma (OVCAR-3) cells. T-4 did not complex with integrin v monomer during its internalization. The v monomer was phosphorylated by activated ERK1/2 when it heterodimerized with integrin 3 in vitro. Nuclear v complexed with transcriptional coactivator proteins, p300 and STAT1, and with corepressor proteins, NCoR and SMRT. Nuclear v monomer in T-4-exposed cells, but not integrin 3, bound to promoters of specific genes that have important roles in cancer cells, including estrogen receptor-, cyclooxygenase-2, hypoxia-inducible factor-1, and thyroid hormone receptor 1 in chromatin immunoprecipitation assay. In summary, monomeric v is a novel coactivator regulated from the cell surface by thyroid hormone for the expression of genes involved in tumorigenesis and angiogenesis. This study also offers a mechanism for modulation of gene expression by thyroid hormone that is adjunctive to the nuclear hormone receptor (TR)-T-3 pathway.Lin, H.-Y., Su, Y.-F., Hsieh, M.-T., Lin, S., Meng, M., London, D., Lin, C., Tang, H.-Y., Hwang, J., Davis, F. B., Mousa, S. A., and Davis, P. J. Nuclear monomeric integrin v in cancer cells is a coactivator regulated by thyroid hormone.	[Lin, Hung-Yun; Su, Yee-Fun; Hsieh, Meng-Ti] Taipei Med Univ, Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Lin, Sharon; Meng, Ran; London, David; Lin, Cassie; Tang, Heng-Yuan; Davis, Faith B.; Mousa, Shaker A.; Davis, Paul J.] Albany Coll Pharm & Hlth Sci, Pharmaceut Res Inst, Albany, NY USA; [Hwang, Jaulang] Taipei Med Univ, Sch Med, Dept Biochem, Taipei, Taiwan; [Davis, Paul J.] Albany Med Coll, Dept Med, Albany, NY 12208 USA	Taipei Medical University; Albany College of Pharmacy & Health Sciences; Taipei Medical University; Albany Medical College	Lin, HY (corresponding author), Taipei Med Univ, Inst Canc Biol & Drug Discovery, 250 Wu Shin St, Taipei, Taiwan.	linhy@tmu.edu.tw; pdavis.ordwayst@gmail.com	Mousa, Shaker A/A-7151-2017	Mousa, Shaker A/0000-0002-9294-015X	Taipei Medical University	Taipei Medical University	The authors appreciate the support from M. Frank and Margaret D. Rudy for conducting some of the studies described here. This work was also supported, in part, by the startup fund of Taipei Medical University.	Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Beber EH, 2009, CALCIFIED TISSUE INT, V84, P324, DOI 10.1007/s00223-009-9230-1; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cai Weibo, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P407, DOI 10.2174/187152006778226530; CANNISTRA SA, 1995, GYNECOL ONCOL, V58, P216, DOI 10.1006/gyno.1995.1214; Cao HJ, 2009, ENDOCR RES, V34, P31, DOI 10.1080/07435800902911810; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cody V, 2007, STEROIDS, V72, P165, DOI 10.1016/j.steroids.2006.11.008; D'Arezzo S, 2004, ENDOCRINOLOGY, V145, P5694, DOI 10.1210/en.2004-0890; Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365; Davis FB, 2004, CIRC RES, V94, P1500, DOI 10.1161/01.RES.0000130784.90237.4a; Davis PJ, 2011, ANNU REV PHARMACOL, V51, P99, DOI 10.1146/annurev-pharmtox-010510-100512; Davis PJ, 2000, J BIOL CHEM, V275, P38032, DOI 10.1074/jbc.M002560200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dijkgraaf I, 2007, INT J CANCER, V120, P605, DOI 10.1002/ijc.22297; Furuya F, 2007, MOL CELL BIOL, V27, P6116, DOI 10.1128/MCB.00900-07; Glinskii AB, 2009, CELL CYCLE, V8, P3562, DOI 10.4161/cc.8.21.9963; Jang ER, 2010, BIOCHEM BIOPH RES CO, V397, P637, DOI 10.1016/j.bbrc.2010.05.060; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Lazar Mitchell A, 2003, Nucl Recept Signal, V1, pe001; Leonard JL, 1997, THYROID, V7, P147, DOI 10.1089/thy.1997.7.147; Lim JY, 2012, J CELL PHYSIOL, V227, P1081, DOI 10.1002/jcp.22824; Lin HY, 2008, CARCINOGENESIS, V29, P62, DOI 10.1093/carcin/bgm239; Lin HY, 2007, STEROIDS, V72, P180, DOI 10.1016/j.steroids.2006.11.014; Lin HY, 2006, FASEB J, V20, P1742, DOI 10.1096/fj.06-5743fje; Lin HY, 2012, DISCOV MED, V14, P199; Lin HY, 2011, DISCOV MED, V11, P337; Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008; Lin HY, 2009, J STEROID BIOCHEM, V113, P182, DOI 10.1016/j.jsbmb.2008.12.010; Lin HY, 1999, AM J PHYSIOL-CELL PH, V276, pC1014, DOI 10.1152/ajpcell.1999.276.5.C1014; Lin HY, 1998, J IMMUNOL, V161, P843; Meissner JD, 2011, NUCLEIC ACIDS RES, V39, P5907, DOI 10.1093/nar/gkr162; Meng R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027547; Moeller LC, 2005, MOL ENDOCRINOL, V19, P2955, DOI 10.1210/me.2004-0542; Mousa SA, 2006, INT ANGIOL, V25, P407; Mousa SS, 2010, CLIN APPL THROMB-HEM, V16, P288, DOI 10.1177/1076029609348315; Odrljin TM, 2001, AM J RESP CELL MOL, V24, P12, DOI 10.1165/ajrcmb.24.1.3992; Rae MT, 2007, J CLIN ENDOCR METAB, V92, P322, DOI 10.1210/jc.2006-1522; Riis ALD, 2008, J CLIN ENDOCR METAB, V93, P3999, DOI 10.1210/jc.2008-0550; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Shih A, 2001, BIOCHEMISTRY-US, V40, P2870, DOI 10.1021/bi001978b; Tang HY, 2006, MOL CANCER THER, V5, P2034, DOI 10.1158/1535-7163.MCT-06-0216; Tang HY, 2004, ENDOCRINOLOGY, V145, P3265, DOI 10.1210/en.2004-0308; Varlakhanova N, 2011, MOL CELL ENDOCRINOL, V332, P180, DOI 10.1016/j.mce.2010.10.010; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Yalcin M, 2010, J CLIN ENDOCR METAB, V95, P1972, DOI 10.1210/jc.2009-1926; Yonkers MA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-20; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453	53	54	59	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3209	3216		10.1096/fj.12-227132	http://dx.doi.org/10.1096/fj.12-227132			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23640055				2022-12-25	WOS:000329877600026
J	Kline, ER; Shupe, J; Gilbert-Ross, M; Zhou, W; Marcus, AI				Kline, Erik R.; Shupe, John; Gilbert-Ross, Melissa; Zhou, Wei; Marcus, Adam I.			LKB1 Represses Focal Adhesion Kinase (FAK) Signaling via a FAK-LKB1 Complex to Regulate FAK Site Maturation and Directional Persistence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CELL POLARITY; LUNG-CANCER; TYROSINE PHOSPHORYLATION; TUMOR PROGRESSION; PROTEIN-KINASE; METASTASIS; MIGRATION; ACTIVATION; INVASION	Liver kinase beta 1 (LKB1, also known as STK11) is a serine/threonine kinase that has multiple cellular functions including the regulation of cell polarity and motility. Murine proteomic studies show that LKB1 loss causes aberrant adhesion signaling; however, the mechanistic underpinnings of this relationship are unknown. We show that cells stably depleted of LKB1 or its co-activator STRAD alpha have increased phosphorylation of focal adhesion kinase (FAK) at Tyr(397)/Tyr(861) and enhanced adhesion to fibronectin. LKB1 associates in a complex with FAK and LKB1 accumulation at the cellular leading edge is mutually excluded from regions of activated Tyr(397)-FAK. LKB1-compromised cells lack directional persistence compared with wildtype cells, but this is restored through subsequent pharmacological FAK inhibition or depletion, showing that cell directionality is mediated through LKB1-FAK signaling. Live cell confocal imaging reveals that LKB1-compromised cells lack normal FAK site maturation and turnover, suggesting that defects in adhesion and directional persistence are caused by aberrant adhesion dynamics. Furthermore, re-expression of full-length wildtype or the LKB1 N-terminal domain repressed FAK activity, whereas the kinase domain or C-terminal domain alone did not, indicating that FAK suppression is potentially regulated through the LKB1 N-terminal domain. Based upon these results, we conclude that LKB1 serves as a FAK repressor to stabilize focal adhesion sites, and when LKB1 function is compromised, aberrant FAK signaling ensues, resulting in rapid FAK site maturation and poor directional persistence.	[Kline, Erik R.; Shupe, John; Gilbert-Ross, Melissa; Zhou, Wei; Marcus, Adam I.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University	Marcus, AI (corresponding author), 1365-C Clifton Rd,Rm 4092-C, Atlanta, GA 30322 USA.	aimarcu@emory.edu		Gilbert-Ross, Melissa/0000-0002-1960-8302; Shupe, John/0000-0001-6011-557X	National Institutes of Health [1R01CA142858, PO1 Supplement 3PO1CA116676-05S2]; American Cancer Society Research Scholar Grant [RSG-08-035-01-CSM]; American Cancer Society Postdoctoral Training Grant [PF-11-125-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA142858, P01CA116676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); American Cancer Society Postdoctoral Training Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA142858 (to A. I. M.) and PO1 Supplement 3PO1CA116676-05S2 (to A. I. M. and W. Z.), American Cancer Society Research Scholar Grant RSG-08-035-01-CSM (to A. I. M.), and American Cancer Society Postdoctoral Training Grant PF-11-125-01-CSM (to E. R. K.).	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bai XM, 2009, ONCOL REP, V21, P129, DOI 10.3892/or_00000199; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Brenman JE, 2007, CELL CYCLE, V6, P2755, DOI 10.4161/cc.6.22.4927; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Clasper S, 2008, CANCER RES, V68, P7293, DOI 10.1158/0008-5472.CAN-07-6506; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eggers CM, 2012, J BIOL CHEM, V287, P18758, DOI 10.1074/jbc.M111.316422; Engl T, 2006, NEOPLASIA, V8, P290, DOI 10.1593/neo.05694; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Feng Y, 2012, CANCER RES, V72, P6502, DOI 10.1158/0008-5472.CAN-12-1909; Fiorilli P, 2008, LAB INVEST, V88, P1143, DOI 10.1038/labinvest.2008.89; Forcet C, 2005, HUM MOL GENET, V14, P1283, DOI 10.1093/hmg/ddi139; Hamadi A, 2009, CELL MOL LIFE SCI, V66, P324, DOI 10.1007/s00018-008-8424-4; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Lim ST, 2010, J BIOL CHEM, V285, P21526, DOI 10.1074/jbc.M110.129999; Lim YM, 2004, J BIOL CHEM, V279, P29060, DOI 10.1074/jbc.M401183200; Marcus Adam I, 2007, Methods Mol Med, V137, P125, DOI 10.1007/978-1-59745-442-1_9; Marignani PA, 2001, J BIOL CHEM, V276, P32415, DOI 10.1074/jbc.C100207200; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Myers JP, 2012, J CELL SCI, V125, P2918, DOI 10.1242/jcs.100107; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Raveh S, 2009, CANCER LETT, V282, P137, DOI 10.1016/j.canlet.2008.12.021; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schafer-Hales K, 2007, MOL CANCER THER, V6, P1317, DOI 10.1158/1535-7163.MCT-06-0703; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; SCHLAEPFER DD, 1994, NATURE, V372, P786; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xu XJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-77; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559	57	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17663	17674		10.1074/jbc.M112.444620	http://dx.doi.org/10.1074/jbc.M112.444620			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23637231	Green Published, hybrid			2022-12-25	WOS:000320380600057
J	Geng, RQ; Yuan, C; Chen, YL				Geng, Rongqing; Yuan, Chao; Chen, Yulin			Exploring Differentially Expressed Genes by RNA-Seq in Cashmere Goat (Capra hircus) Skin during Hair Follicle Development and Cycling	PLOS ONE			English	Article							DERMAL PAPILLA; SIGNALING PATHWAYS; GROWTH-FACTORS; ADENOSINE; ANAGEN; MORPHOGENESIS; INVOLVEMENT; INSIGHTS; BIOLOGY; PHASE	Cashmere goat (Capra hircus) hair follicle development and cycling can be divided into three stages: anagen, catagen and telogen. To elucidate the genes involved in hair follicle development and cycling in cashmere goats, transcriptome profiling of skin was carried out by analysing samples from three hair follicle developmental stages using RNA-Seq. The RNA-Seq analysis generated 8487344, 8142514 and 7345335 clean reads in anagen, catagen and telogen stages, respectively, which provided abundant data for further analysis. A total of 1332 differentially expressed genes (DEGs) were identified, providing evidence that the development of hair follicles among the three distinct stages changed considerably. A total of 683 genes with significant differential expression were detected between anagen and catagen, 530 DEGs were identified between anagen and telogen, and 119 DEGs were identified between catagen and telogen. A large number of DEGs were predominantly related to cellular process, cell & cell part, binding, biological regulation and metabolic process among the different stages of hair follicle development. In addition, the Wnt, Shh, TGF-beta and Notch signaling pathways may be involved in hair follicle development and the identified DEGs may play important roles in these signaling pathways. These results will expand our understanding of the complex molecular mechanisms of hair follicle development and cycling in cashmere goats and provide a foundation for future studies.	[Geng, Rongqing; Yuan, Chao; Chen, Yulin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Geng, Rongqing] Yancheng Teachers Univ, Coll Life Sci & Technol, Yancheng, Peoples R China	Northwest A&F University - China; Yancheng Teachers University	Chen, YL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China.	myxy11@yahoo.com.cn			National Natural Science Foundation of China [31101684]; Major Projects for New Varieties of Genetically Modified Organisms of China [2011ZX08008-002]; Qing Lan Project of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Projects for New Varieties of Genetically Modified Organisms of China; Qing Lan Project of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (31101684) http://www.nsfc.gov.cn/, the Major Projects for New Varieties of Genetically Modified Organisms of China (2011ZX08008-002) http://www.moa.gov.cn/, and sponsored by Qing Lan Project of Jiangsu Province (http://www.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Ansari-Renani HR, 2011, SMALL RUMINANT RES, V95, P128, DOI 10.1016/j.smallrumres.2010.09.013; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Botchkarev VA, 2005, J INVEST DERM SYMP P, V10, P247, DOI 10.1111/j.1087-0024.2005.10129.x; Botchkarev VA, 2003, J INVEST DERM SYMP P, V8, P46, DOI 10.1046/j.1523-1747.2003.12171.x; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Danilenko DM, 1996, MOL MED TODAY, V2, P460, DOI 10.1016/1357-4310(96)10045-9; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Donet E, 2008, J STEROID BIOCHEM, V108, P8, DOI 10.1016/j.jsbmb.2007.05.033; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Everts HB, 2012, BBA-MOL CELL BIOL L, V1821, P222, DOI 10.1016/j.bbalip.2011.08.017; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fu J, 2013, J INVEST DERMATOL, V133, P890, DOI 10.1038/jid.2012.407; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Geyfman M, 2010, AGING-US, V2, P122, DOI 10.18632/aging.100130; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Huntzicker EG, 2008, J INVEST DERMATOL, V128, P1081, DOI 10.1038/sj.jid.5700957; Hwang KA, 2012, INT J MOL MED, V29, P195, DOI 10.3892/ijmm.2011.817; Iino M, 2007, J INVEST DERMATOL, V127, P1318, DOI 10.1038/sj.jid.5700728; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Li M, 2001, J INVEST DERMATOL, V117, P1594, DOI 10.1046/j.0022-202x.2001.01570.x; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindner G, 2000, FASEB J, V14, P319, DOI 10.1096/fasebj.14.2.319; LITTLE JC, 1994, J INVEST DERMATOL, V103, P715, DOI 10.1111/1523-1747.ep12398584; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McElwee KJ, 2004, J INVEST DERMATOL, V123, P34, DOI 10.1111/j.0022-202X.2004.22712.x; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; NIXON AJ, 1991, J ZOOL, V224, P589, DOI 10.1111/j.1469-7998.1991.tb03787.x; Nuutila K, 2012, WOUND REPAIR REGEN, V20, P830, DOI 10.1111/j.1524-475X.2012.00831.x; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Oura H, 2008, J DERMATOL, V35, P763, DOI 10.1111/j.1346-8138.2008.00564.x; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; RYDER ML, 1966, ANIM PROD, V8, P289, DOI 10.1017/S000335610003467X; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011	52	46	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62704	10.1371/journal.pone.0062704	http://dx.doi.org/10.1371/journal.pone.0062704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638136	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300089
J	Vemula, SV; Ahi, YS; Swaim, AM; Katz, JM; Donis, R; Sambhara, S; Mittal, SK				Vemula, Sai V.; Ahi, Yadvinder S.; Swaim, Anne-Marie; Katz, Jacqueline M.; Donis, Ruben; Sambhara, Suryaprakash; Mittal, Suresh K.			Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness	PLOS ONE			English	Article							H5N1 INFLUENZA; HIV-1 VACCINE; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSES; HEMAGGLUTININ; NUCLEOPROTEIN; EFFICACY; INFECTION; IMMUNOGENICITY	Recurrent outbreaks of H5, H7 and H9 avian influenza viruses in domestic poultry accompanied by their occasional transmission to humans have highlighted the public health threat posed by these viruses. Newer vaccine approaches for pandemic preparedness against these viruses are needed, given the limitations of vaccines currently approved for H5N1 viruses in terms of their production timelines and the ability to induce protective immune responses in the absence of adjuvants. In this study, we evaluated the feasibility of an adenovirus (AdV)-based multivalent vaccine approach for pandemic preparedness against H5, H7 and H9 avian influenza viruses in a mouse model. Replication-defective AdV vectors expressing hemagglutinin (HA) from different subtypes and nucleoprotein (NP) from one subtype induced high levels of humoral and cellular immune responses and conferred protection against virus replication following challenge with H5, H7 and H9 avian influenza virus subtypes. Inclusion of HA from the 2009 H1N1 pandemic virus in the vaccine formulation further broadened the vaccine coverage. Significantly high levels of HA stalk-specific antibodies were observed following immunization with the multivalent vaccine. Inclusion of NP into the multivalent HA vaccine formulation resulted in the induction of CD8 T cell responses. These results suggest that a multivalent vaccine strategy may provide reasonable protection in the event of a pandemic caused by H5, H7, or H9 avian influenza virus before a strain-matched vaccine can be produced.	[Vemula, Sai V.; Ahi, Yadvinder S.; Swaim, Anne-Marie; Mittal, Suresh K.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Vemula, Sai V.; Ahi, Yadvinder S.; Swaim, Anne-Marie; Mittal, Suresh K.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Katz, Jacqueline M.; Donis, Ruben; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centers for Disease Control & Prevention - USA	Sambhara, S (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	ssambhara@cdc.gov; mittal@purdue.edu	Sambhara, Suryaprakash/AAC-4428-2021; Ahi, Yadvinder/H-5580-2019	Ahi, Yadvinder/0000-0001-9331-8349	Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI059374]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059374] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI059374 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi YS, 2011, CURR GENE THER, V11, P307; Atmar RL, 2011, VACCINE, V29, P8066, DOI 10.1016/j.vaccine.2011.08.044; Bangari DS, 2004, VIRUS RES, V105, P127, DOI 10.1016/j.virusres.2004.05.003; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Curlin ME, 2011, AIDS, V25, P153, DOI 10.1097/QAD.0b013e328342115c; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Goji NA, 2008, J INFECT DIS, V198, P635, DOI 10.1086/590916; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoelscher MA, 2007, CLIN PHARMACOL THER, V82, P665, DOI 10.1038/sj.clpt.6100418; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hoelscher MA, 2008, J INFECT DIS, V197, P1185, DOI 10.1086/529522; Hoft DF, 2012, VACCINE, V30, P2098, DOI 10.1016/j.vaccine.2012.01.048; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Katz JM, 2009, POULTRY SCI, V88, P872, DOI 10.3382/ps.2008-00465; Khurana S, 2005, J VIROL, V79, P6791, DOI 10.1128/JVI.79.11.6791-6800.2005; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Ng P, 1999, HUM GENE THER, V10, P2667, DOI 10.1089/10430349950016708; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pandey A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033428; Pappas C, 2007, CLIN VACCINE IMMUNOL, V14, P1425, DOI 10.1128/CVI.00174-07; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Perdue ML, 2005, AVIAN DIS, V49, P317, DOI 10.1637/7390-060305R.1; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; Roy S, 2007, VACCINE, V25, P6845, DOI 10.1016/j.vaccine.2007.07.035; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Sharma A, 2009, VIROLOGY, V386, P44, DOI 10.1016/j.virol.2009.01.008; Singh N, 2008, MOL THER, V16, P965, DOI 10.1038/mt.2008.12; Singh N, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001432; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Stephenson KE, 2012, J INFECT DIS, V205, P1806, DOI 10.1093/infdis/jis285; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; van Olphen AL, 2002, J VIROL, V76, P5882, DOI 10.1128/JVI.76.12.5882-5892.2002; Vemula SV, 2010, EXPERT OPIN BIOL TH, V10, P1469, DOI 10.1517/14712598.2010.519332; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; World Health Organization, CUM NUMB CONF HUM CA; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	58	35	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62496	10.1371/journal.pone.0062496	http://dx.doi.org/10.1371/journal.pone.0062496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638099	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300069
J	Bruneau, E; Dufour, N; Saxe, R				Bruneau, Emile; Dufour, Nicholas; Saxe, Rebecca			How We Know It Hurts: Item Analysis of Written Narratives Reveals Distinct Neural Responses to Others' Physical Pain and Emotional Suffering	PLOS ONE			English	Article							CINGULATE CORTEX; SHARED PAIN; EMPATHY; ACTIVATION; EXPERIENCE; CONFLICT; NETWORKS; PATTERNS; FMRI; FELT	People are often called upon to witness, and to empathize with, the pain and suffering of others. In the current study, we directly compared neural responses to others' physical pain and emotional suffering by presenting participants (n = 41) with 96 verbal stories, each describing a protagonist's physical and/or emotional experience, ranging from neutral to extremely negative. A separate group of participants rated "how much physical pain", and "how much emotional suffering" the protagonist experienced in each story, as well as how "vivid and movie-like" the story was. Although ratings of Pain, Suffering and Vividness were positively correlated with each other across stories, item-analyses revealed that each scale was correlated with activity in distinct brain regions. Even within regions of the "Shared Pain network" identified using a separate data set, responses to others' physical pain and emotional suffering were distinct. More broadly, item analyses with continuous predictors provided a high-powered method for identifying brain regions associated with specific aspects of complex stimuli - like verbal descriptions of physical and emotional events.	[Bruneau, Emile; Dufour, Nicholas; Saxe, Rebecca] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Bruneau, E (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	ebruneau@mit.edu		Bruneau, Emile/0000-0001-7294-8675	Air Force Office of Scientific Research [N000140910845]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Funding for this work was provided by the Air Force Office of Scientific Research, managed through the Office of Naval Research, grant number N000140910845. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; Bedny M, 2007, NEUROIMAGE, V35, P1093, DOI 10.1016/j.neuroimage.2007.01.039; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Bruneau EG, 2012, PHILOS T R SOC B, V367, P717, DOI 10.1098/rstb.2011.0293; Bruneau EG, 2012, NEUROPSYCHOLOGIA, V50, P219, DOI 10.1016/j.neuropsychologia.2011.11.008; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Corradi-Dell'Acqua C, 2011, J NEUROSCI, V31, P17996, DOI 10.1523/JNEUROSCI.2686-11.2011; Dodell-Feder D, 2011, NEUROIMAGE, V55, P705, DOI 10.1016/j.neuroimage.2010.12.040; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fitzgibbon BM, 2010, NEUROSCI BIOBEHAV R, V34, P500, DOI 10.1016/j.neubiorev.2009.10.007; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Han SH, 2009, HUM BRAIN MAPP, V30, P3227, DOI 10.1002/hbm.20742; Hooker CI, 2008, SOC COGN AFFECT NEUR, V3, P204, DOI 10.1093/scan/nsn019; Hooker CI, 2010, BRAIN RES, V1308, P100, DOI 10.1016/j.brainres.2009.10.006; Immordino-Yang MH, 2009, P NATL ACAD SCI USA, V106, P8021, DOI 10.1073/pnas.0810363106; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Masten CL, 2010, NEUROIMAGE; Mathur VA, 2010, NEUROIMAGE, V51, P1468, DOI 10.1016/j.neuroimage.2010.03.025; Morrison I, 2007, NEUROIMAGE, V37, P642, DOI 10.1016/j.neuroimage.2007.03.079; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Rameson L.T., 2011, J COGNITIVE NEUROSCI, V8, P1; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Schnell K, 2010, NEUROIMAGE; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; SHAMAYTSOORY SG, 2008, BRAIN; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; Takahashi H, 2006, NEUROIMAGE, V32, P1299, DOI 10.1016/j.neuroimage.2006.05.049; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009; Yu C, 2010, NEUROIMAGE; Zaki J, 2007, SOC NEUROSCI-UK, V2, P276, DOI 10.1080/17470910701401973	41	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e63085	10.1371/journal.pone.0063085	http://dx.doi.org/10.1371/journal.pone.0063085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638181	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700090
J	Lowe, CF; Katz, K; McGeer, AJ; Muller, MP				Lowe, Christopher F.; Katz, Kevin; McGeer, Allison J.; Muller, Matthew P.		Toronto ESBL Working Grp	Efficacy of Admission Screening for Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae	PLOS ONE			English	Article							MULTIDRUG-RESISTANT ORGANISMS; TO-PATIENT TRANSMISSION; ESCHERICHIA-COLI; OUTBREAK	Objective: We hypothesized that admission screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) reduces the incidence of hospital-acquired ESBL-E clinical isolates. Design: Retrospective cohort study. Setting: 12 hospitals (6 screening and 6 non-screening) in Toronto, Canada. Patients: All adult inpatients with an ESBL-E positive culture collected from 2005-2009. Methods: Cases were defined as hospital-onset (HO) or community-onset (CO) if cultures were positive after or before 72 hours. Efficacy of screening in reducing HO-ESBL-E incidence was assessed with a negative binomial model adjusting for study year and CO-ESBL-E incidence. The accuracy of the HO-ESBL-E definition was assessed by re-classifying HO-ESBL-E cases as confirmed nosocomial (negative admission screen), probable nosocomial (no admission screen) or not nosocomial (positive admission screen) using data from the screening hospitals. Results: There were 2,088 ESBL-E positive patients and incidence of ESBL-E rose from 0.11 to 0.42 per 1,000 inpatient days between 2005 and 2009. CO-ESBL-E incidence was similar at screening and non-screening hospitals but screening hospitals had a lower incidence of HO-ESBL-E in all years. In the negative binomial model, screening was associated with a 49.1% reduction in HO-ESBL-E (p<0.001). A similar reduction was seen in the incidence of HO-ESBL-E bacteremia. When HO-ESBL-E cases were re-classified based on their admission screen result, 46.5% were positive on admission, 32.5% were confirmed as nosocomial and 21.0% were probable nosocomial cases. Conclusions: Admission screening for ESBL-E is associated with a reduced incidence of HO-ESBL-E. Controlled, prospective studies of admission screening for ESBL-E should be a priority.	[Lowe, Christopher F.; Katz, Kevin; McGeer, Allison J.; Muller, Matthew P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Katz, Kevin] North York Gen Hosp, Deparment Infect Prevent & Control, Toronto, ON, Canada; [McGeer, Allison J.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; [Muller, Matthew P.] St Michaels Hosp, Div Infect Dis, Toronto, ON M5B 1W8, Canada; [Muller, Matthew P.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Muller, MP (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	MullerM@smh.ca	McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014	McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137; Lowe, Christopher/0000-0001-9320-4499	Physician's Services Incorporated Foundation	Physician's Services Incorporated Foundation	This work was supported by the Physician's Services Incorporated Foundation (http://www.psifoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2010, J HOSP INFECT, V76, P97, DOI 10.1016/j.jhin.2010.04.027; Ben-David D, 2010, INFECT CONT HOSP EP, V31, P620, DOI 10.1086/652528; Borer A, INFECT CONTROL HOSP, V32, P1158; Carmeli Y, 2010, CLIN MICROBIOL INFEC, V16, P102, DOI 10.1111/j.1469-0691.2009.03115.x; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Gardam MA, 2002, J INFECT DIS, V186, P1754, DOI 10.1086/345921; Goddard S, 2011, AM J INFECT CONTROL, V39, P599, DOI 10.1016/j.ajic.2010.09.018; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Harris AD, 2007, CLIN INFECT DIS, V45, P1347, DOI 10.1086/522657; Harris AD, 2007, AM J INFECT CONTROL, V35, P97, DOI 10.1016/j.ajic.2006.09.011; Laurent C, 2008, INFECT CONT HOSP EP, V29, P517, DOI 10.1086/588004; Lowe C, 2012, AM J INFECT CONTROL, V40, P836, DOI 10.1016/j.ajic.2011.11.008; Lowe CF, 2012, ANTIMICROB AGENTS CH, V56, P3977, DOI 10.1128/AAC.00260-12; Lucet JC, 1999, CLIN INFECT DIS, V29, P1411, DOI 10.1086/313511; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Public Health Agency of Canada, 2010, GUID INF PREV CONTR; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Weintrob AC, 2010, INFECT CONT HOSP EP, V31, P330, DOI 10.1086/651304	20	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62678	10.1371/journal.pone.0062678	http://dx.doi.org/10.1371/journal.pone.0062678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638132	gold, Green Published, Green Submitted			2022-12-25	WOS:000318343700065
J	Arooj, M; Kim, S; Sakkiah, S; Cao, GP; Lee, Y; Lee, KW				Arooj, Mahreen; Kim, Songmi; Sakkiah, Sugunadevi; Cao, Guang Ping; Lee, Yuno; Lee, Keun Woo			Molecular Modeling Study for Inhibition Mechanism of Human Chymase and Its Application in Inhibitor Design	PLOS ONE			English	Article							MAST-CELL CHYMASE; ANGIOTENSIN-II; DERIVATIVES; DISEASE; IDENTIFICATION; GROWTH; POTENT; MOTION	Human chymase catalyzes the hydrolysis of peptide bonds. Three chymase inhibitors with very similar chemical structures but highly different inhibitory profiles towards the hydrolase function of chymase were selected with the aim of elucidating the origin of disparities in their biological activities. As a substrate (angiotensin-I) bound crystal structure is not available, molecular docking was performed to dock the substrate into the active site. Molecular dynamics simulations of chymase complexes with inhibitors and substrate were performed to calculate the binding orientation of inhibitors and substrate as well as to characterize conformational changes in the active site. The results elucidate details of the 3D chymase structure as well as the importance of K40 in hydrolase function. Binding mode analysis showed that substitution of a heavier Cl atom at the phenyl ring of most active inhibitor produced a great deal of variation in its orientation causing the phosphinate group to interact strongly with residue K40. Dynamics simulations revealed the conformational variation in region of V36-F41 upon substrate and inhibitor binding induced a shift in the location of K40 thus changing its interactions with them. Chymase complexes with the most activecompound and substrate were used for development of a hybrid pharmacophore model which was applied in databases screening. Finally, hits which bound well at the active site, exhibited key interactions and favorable electronic properties were identified as possible inhibitors for chymase. This study not only elucidates inhibitory mechanism of chymase inhibitors but also provides key structural insights which will aid in the rational design of novel potent inhibitors of the enzyme. In general, the strategy applied in the current study could be a promising computational approach and may be generally applicable to drug design for other enzymes.	[Arooj, Mahreen; Kim, Songmi; Sakkiah, Sugunadevi; Cao, Guang Ping; Lee, Yuno; Lee, Keun Woo] Gyeongsang Natl Univ, Res Inst Nat Sci, Plant Mol Biol & Biotechnol Res Ctr,Program BK21, Syst & Synthet Agrobiotech Ctr,Div Appl Life Sci, Jinju, South Korea	Gyeongsang National University	Lee, KW (corresponding author), Gyeongsang Natl Univ, Res Inst Nat Sci, Plant Mol Biol & Biotechnol Res Ctr,Program BK21, Syst & Synthet Agrobiotech Ctr,Div Appl Life Sci, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020	Arooj, Mahreen/0000-0003-1975-5289; Sakkiah, Suguna Devi/0000-0002-8337-9348	Basic Science Research Program [2012R1A1A4A01013657]; Pioneer Research Center Program [2009-0081539]; National Research Foundation of Korea (NRF) [2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Rural Development Administration (RDA) of Republic of Korea [PJ008038]	Basic Science Research Program; Pioneer Research Center Program; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA) of Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ008038) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano N, 2009, LASER MED SCI, V24, P223, DOI 10.1007/s10103-008-0558-y; Amir RE, 2008, GENET MED, V10, P593, DOI [10.1097/GIM.0b013e3181804b9c, 10.1097GIM.0b013e3181804b9c]; [Anonymous], 2009, GAUSS 09 RB; Aoyama Y, 2000, BIOORG MED CHEM LETT, V10, P2397, DOI 10.1016/S0960-894X(00)00488-1; Aoyama Y, 2001, BIOORG MED CHEM LETT, V11, P1695, DOI 10.1016/S0960-894X(01)00265-7; Arooj M, 2012, CHEM BIOL DRUG DESIG; Arooj M, 2011, INT J MOL SCI, V12, P9236, DOI 10.3390/ijms12129236; BASTOS M, 1995, P NATL ACAD SCI USA, V92, P6738, DOI 10.1073/pnas.92.15.6738; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; CHOU KC, 1988, BIOPOLYMERS, V27, P1795, DOI 10.1002/bip.360271109; CHOU KC, 1994, BIOPOLYMERS, V34, P143, DOI 10.1002/bip.360340114; de Garavilla L, 2005, J BIOL CHEM, V280, P18001, DOI 10.1074/jbc.M501302200; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Greco MN, 2007, J MED CHEM, V50, P1727, DOI 10.1021/jm0700619; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Hayashi Y, 2000, BIOORG MED CHEM LETT, V10, P199, DOI 10.1016/S0960-894X(99)00659-9; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Kelly D, 2007, EUR HEART J, V28, P711, DOI 10.1093/eurheartj/ehm003; Kervinen J, 2010, BIOCHEM PHARMACOL, V80, P1033, DOI 10.1016/j.bcp.2010.06.014; Koide Y, 2003, BIOORG MED CHEM LETT, V13, P25, DOI 10.1016/S0960-894X(02)00853-3; Lipinski CA, 2012, ADV DRUG DELIVERY RE; Lorenz JN, 2010, AM J PHYSIOL-RENAL, V298, pF35, DOI 10.1152/ajprenal.00641.2009; Masaki H, 2003, BIOORG MED CHEM LETT, V13, P4085, DOI 10.1016/j.bmcl.2003.08.040; McGrath ME, 1997, BIOCHEMISTRY-US, V36, P14318, DOI 10.1021/bi971403n; Muilenburg DJ, 2002, BBA-PROTEIN STRUCT M, V1596, P346, DOI 10.1016/S0167-4838(02)00224-8; Omoto Y, 2006, J IMMUNOL, V177, P8315, DOI 10.4049/jimmunol.177.12.8315; Oyamada S, 2010, BASIC RES CARDIOL, V105, P513, DOI 10.1007/s00395-010-0093-4; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Takai S, 2005, LETT DRUG DES DISCOV, V2, P19, DOI 10.2174/1570180053398433; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Yamamoto D, 1998, BIOCHEM BIOPH RES CO, V242, P158, DOI 10.1006/bbrc.1997.7875	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62740	10.1371/journal.pone.0062740	http://dx.doi.org/10.1371/journal.pone.0062740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638140	Green Published, gold			2022-12-25	WOS:000318341400065
J	Reis-Santos, B; Locatelli, R; Horta, BL; Faerstein, E; Sanchez, MN; Riley, LW; Maciel, EL				Reis-Santos, Barbara; Locatelli, Rodrigo; Horta, Bernardo L.; Faerstein, Eduardo; Sanchez, Mauro N.; Riley, Lee W.; Maciel, Ethel Leonor			Socio-Demographic and Clinical Differences in Subjects with Tuberculosis with and without Diabetes Mellitus in Brazil - A Multivariate Analysis	PLOS ONE			English	Article							TREATMENT OUTCOMES; RISK-FACTORS; PREVALENCE; PREDICTORS; FAILURE; IMPACT	Background: Several studies have evaluated the relationship between diabetes mellitus (DM) and tuberculosis (TB), but the nature of this relationship is not fully understood. TB incidence may be influenced by immunosuppression from DM, but this association may be confounded by other clinical and socioeconomic factors. We aimed to assess socio-demographic and clinical differences in TB patients with and without DM. Methods: Using the Brazilian national surveillance system (SINAN), we compared 1,797 subjects with TB and DM with 29,275 subjects diagnosed with TB only in 2009. We performed multivariate analysis to identify factors associated with the presence of DM among TB patients. Results: Subjects with TB - DM were older; have initial positive sputum smear test (OR = 1.42, 95% CI 1.26-1.60), and were more likely to die from TB (OR = 1.44, 95% CI 1.03-2.01). They were less likely to have been institutionalized [ in prison, shelter, orphanage, psychiatric hospital (OR = 0.74, 95% CI 0.60-0.93)]; developed extra pulmonary TB (OR = 0.62, 95% CI 0.51-0.75) and to return to TB treatment after abandonment (OR = 0.66, 95% CI 0.51-0.86). Conclusions: Prevalence of NCD continues to rise in developing countries, especially with the rise of elderly population, the prevention and treatment of infectious diseases will be urgent. DM and TB represent a critical intersection between communicable and non-communicable diseases in these countries and the effect of DM on TB incidence and outcomes provide numerous opportunities for collaboration and management of these complex diseases in the national public health programs.	[Reis-Santos, Barbara; Locatelli, Rodrigo; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Lab Epi UFES, Vitoria, ES, Brazil; [Horta, Bernardo L.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, RS, Brazil; [Faerstein, Eduardo] Univ Estado Rio de Janeiro, Inst Social Med, Postgrad Programme Saude Colet, Rio De Janeiro, Brazil; [Sanchez, Mauro N.] Univ Brasilia, Fac Ciencies Saude, Dept Saude Colet, Brasilia, DF, Brazil; [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA	Universidade Federal do Espirito Santo; Universidade Federal de Pelotas; Universidade do Estado do Rio de Janeiro; Universidade de Brasilia; University of California System; University of California Berkeley	Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Lab Epi UFES, Vitoria, ES, Brazil.	ethel.maciel@gmail.com	Maciel, Ethel Leonor LN/G-1027-2012; Reis-Santos, Barbara/A-3149-2014; Sanchez, Mauro/AAU-2404-2020; Horta, Bernardo/A-7604-2008	Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos, Barbara/0000-0001-6952-0352; Sanchez, Mauro/0000-0002-0472-1804; Horta, Bernardo/0000-0001-9843-412X	CNPq/Brazil; United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health and Human Services [NO1-AI95383, HHSN266200700022C/NO1-AI-70022];  [ICOHRTA 5 U2R TW006883-02]; FOGARTY INTERNATIONAL CENTER [U2RTW006885, U2RTW006883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383] Funding Source: NIH RePORTER	CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Human Genome Research Institute (NHGRI)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by CNPq/Brazil edital Doencas negligenciadas-2006 and Universal-2009. The United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health and Human Services, under contract NO1-AI95383 and HHSN266200700022C/NO1-AI-70022 and was also supported by ICOHRTA 5 U2R TW006883-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Banerjee D, 2011, ADV CLIN CHEM, V53, P139, DOI 10.1016/S0065-2423(11)53006-9; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Belo MTCT, 2011, INT J TUBERC LUNG D, V15, P978, DOI 10.5588/ijtld.10.0706; Brasil, 2004, SIST INF AGR NOT; Brasil MdS, 2008, MAN NAC VIG LAB TUB; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dyck RF, 2007, CAN J PUBLIC HEALTH, V98, P55, DOI 10.1007/BF03405386; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Faurholt-Jepsen D, 2012, INT J TUBERC LUNG D, V16, P1680, DOI 10.5588/ijtld.12.0360; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; Gupta Soham, 2011, J Infect Public Health, V4, P140, DOI 10.1016/j.jiph.2011.03.005; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jimenez-Corona ME, 2012, THORAX; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Laguardia J, 2004, EPIDEMIOL SERV SAUDE, V13, P135; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Machado A, 2009, INT J TUBERC LUNG D, V13, P719; Malhao TA, 2010, EPIDEMIOL SERV SAUDE, V19, P245; Medeiros D, 2012, CAD SAUDE COLET RIO, V20, P146; Moreira Cláudia Maria Marques, 2008, J. bras. pneumol., V34, P225, DOI 10.1590/S1806-37132008000400007; MUGUSI F, 1990, TUBERCLE, V71, P271, DOI 10.1016/0041-3879(90)90040-F; Maciel ELN, 2009, J BRAS PNEUMOL, V35, P884, DOI 10.1590/S1806-37132009000900010; Orofino RD, 2012, J BRAS PNEUMOL, V38, P88, DOI 10.1590/S1806-37132012000100013; Pajankar Sumant, 2008, Oman Med J, V23, P263; Perez-Guzman C, 2011, LUNG INDIA, V28, P191, DOI 10.4103/0970-2113.83976; de Albuquerque MDPM, 2007, CAD SAUDE PUBLICA, V23, P1573, DOI 10.1590/S0102-311X2007000700008; Pinheiro RS, 2011, MELHORIA QUALIDADE S; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Selig L, 2010, REV SAUDE PUBL, V44, P1072, DOI 10.1590/S0034-89102010000600012; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SILWER H, 1958, Acta Med Scand Suppl, V335, P1; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Stop TB Patnership World Health Organization, 2006, STOP TB STRAT BUILD; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291; Wang C.-H., 1999, Tubercle and Lung Disease, V79, P235, DOI 10.1054/tuld.1998.0167; Wang JY, 2009, RESPIROLOGY, V14, P1012, DOI 10.1111/j.1440-1843.2009.01598.x; World Health Organization, 2011, WHO FRAM TARG TUB DI; World Health Organization, 2011, TUB DIAB COLL FRAM C	54	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62604	10.1371/journal.pone.0062604	http://dx.doi.org/10.1371/journal.pone.0062604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638123	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400117
J	Schneider, KA; Kim, Y				Schneider, Kristan A.; Kim, Yuseob			Genetic Hitchhiking under Heterogeneous Spatial Selection Pressures	PLOS ONE			English	Article							POSITIVE SELECTION; GLYPHOSATE-RESISTANT; EVOLUTION; POLYMORPHISM; ADAPTATION; SIMULATION; MUTATIONS; MODELS; SWEEP; DHPS	During adaptive evolutionary processes substantial heterogeneity in selective pressure might act across local habitats in sympatry. Examples are selection for drug resistance in malaria or herbicide resistance in weeds. In such setups standard population-genetic assumptions (homogeneous constant selection pressures, random mating etc.) are likely to be violated. To avoid misinferences on the strength and pattern of natural selection it is therefore necessary to adjust population-genetic theory to meet the specifics driving adaptive processes in particular organisms. We introduce a deterministic model in which selection acts heterogeneously on a population of haploid individuals across different patches over which the population randomly disperses every generation. A fixed proportion of individuals mates exclusively within patches, whereas the rest mates randomly across all patches. We study how the allele frequencies at neutral markers are affected by the spread of a beneficial mutation at a closely linked locus (genetic hitchhiking). We provide an analytical solution for the frequency change and the expected heterozygosity at the neutral locus after a single copy of a beneficial mutation became fixed. We furthermore provide approximations of these solutions which allow for more obvious interpretations. In addition, we validate the results by stochastic simulations. Our results show that the application of standard population-genetic theory is accurate as long as differences across selective environments are moderate. However, if selective differences are substantial, as for drug resistance in malaria, herbicide resistance in weeds, or insecticide resistance in agriculture, it is necessary to adapt available theory to the specifics of particular organisms.	[Schneider, Kristan A.] Univ Appl Sci Mittweida, Dept Fak Math Nat Wissensch Informat, Mittweida, Germany; [Schneider, Kristan A.] Univ Vienna, Dept Math, Vienna, Austria; [Kim, Yuseob] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Kim, Yuseob] Ewha Womans Univ, Div EcoSci, Seoul, South Korea	University of Vienna; Ewha Womans University; Ewha Womans University	Schneider, KA (corresponding author), Univ Appl Sci Mittweida, Dept Fak Math Nat Wissensch Informat, Mittweida, Germany.	kristan.schneider@hs-mittweida.de		Schneider, Kristan/0000-0003-4138-1180	National Research Foundation of Korea; Korean government (MEST) [2011-0001575, 2012R1A1A2004932]; WTZ project [KR 05/2011]; U.S. National Institutes of Health [R01GM084320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); WTZ project; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Research Foundation of Korea grants funded by the Korean government (MEST) (Grant number: 2011-0001575 and 2012R1A1A2004932) to YK, the WTZ project KR 05/2011 to KS and YK, and partly by the grant R01GM084320 from the U.S. National Institutes of Health to Ananias Escalante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Amos JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030888; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Booth W, 2012, J MED ENTOMOL, V49, P535, DOI 10.1603/ME11256; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Chevin LM, 2008, GENETICS, V180, P1645, DOI 10.1534/genetics.108.093351; Etheridge A, 2006, ANN APPL PROBAB, V16, P685, DOI 10.1214/105051606000000114; Heitman J, 2010, CELL HOST MICROBE, V8, P86, DOI 10.1016/j.chom.2010.06.011; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Innan H, 2008, GENETICS, V179, P1713, DOI 10.1534/genetics.108.086835; Jones SC, 2012, J ECON ENTOMOL, V105, P957, DOI 10.1603/EC12037; KAPLAN NL, 1989, GENETICS, V123, P887; Kim Y, 2011, GENETICS, V189, P213, DOI 10.1534/genetics.111.130203; Kim Y, 2010, GENETICS, V184, P571, DOI 10.1534/genetics.109.109447; Kim Y, 2009, BRIEF BIOINFORM, V10, P84, DOI 10.1093/bib/bbn048; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77; NAGYLAKI T, 1992, BIOMATHEMATICS, V21; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; Neve P, 2008, PEST MANAG SCI, V64, P392, DOI 10.1002/ps.1495; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Powles SB, 2010, P NATL ACAD SCI USA, V107, P955, DOI 10.1073/pnas.0913433107; Schneider KA, 2011, J MATH BIOL, V62, P789, DOI 10.1007/s00285-010-0353-9; Schneider KA, 2010, THEOR POPUL BIOL, V78, P93, DOI 10.1016/j.tpb.2010.06.005; Slatkin M, 1998, GENET RES, V71, P155, DOI 10.1017/S001667239800319X; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Stephan W, 2010, MOL ECOL RESOUR, V10, P863, DOI 10.1111/j.1755-0998.2010.02869.x; Teshima KM, 2006, GENETICS, V172, P713, DOI 10.1534/genetics.105.044065; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967	37	4	4	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61742	10.1371/journal.pone.0061742	http://dx.doi.org/10.1371/journal.pone.0061742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637897	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400045
J	Tong, NT; Zhang, ZZ; Zhang, W; Qiu, YT; Gong, YY; Yin, LL; Qiu, QH; Wu, XW				Tong, Nianting; Zhang, Zhenzhen; Zhang, Wei; Qiu, Yating; Gong, Yuanyuan; Yin, Lili; Qiu, Qinghua; Wu, Xingwei			Diosmin Alleviates Retinal Edema by Protecting the Blood-Retinal Barrier and Reducing Retinal Vascular Permeability during Ischemia/Reperfusion Injury	PLOS ONE			English	Article							EPITHELIUM-DERIVED-FACTOR; CHRONIC VENOUS INSUFFICIENCY; DAFLON 500 MG; DIABETIC-RETINOPATHY; ENDOTHELIAL-CELLS; FACTOR RATIO; IN-VIVO; EXPRESSION; VEGF; HYPERPERMEABILITY	Background and Purpose: Retinal swelling, leading to irreversible visual impairment, is an important early complication in retinal ischemia/reperfusion (I/R) injury. Diosmin, a naturally occurring flavonoid glycoside, has been shown to have antioxidative and anti-inflammatory effects against I/R injury. The present study was performed to evaluate the retinal microvascular protective effect of diosmin in a model of I/R injury. Methods: Unilateral retinal I/R was induced by increasing intraocular pressure to 110 mm Hg for 60 min followed by reperfusion. Diosmin (100 mg/kg) or vehicle solution was administered intragastrically 30 min before the onset of ischemia and then daily after I/R injury until the animals were sacrificed. Rats were evaluated for retinal functional injury by electroretinogram (ERG) just before sacrifice. Retinas were harvested for HE staining, immunohistochemistry assay, ELISA, and western blotting analysis. Evans blue (EB) extravasation was determined to assess blood-retinal barrier (BRB) disruption and the structure of tight junctions (TJ) was examined by transmission electron microscopy. Results: Diosmin significantly ameliorated the reduction of b-wave, a-wave, and b/a ratio in ERG, alleviated retinal edema, protected the TJ structure, and reduced EB extravasation. All of these effects of diosmin were associated with increased zonular occluden-1 (ZO-1) and occludin protein expression and decreased VEGF/PEDF ratio. Conclusions: Maintenance of TJ integrity and reduced permeability of capillaries as well as improvements in retinal edema were observed with diosmin treatment, which may contribute to preservation of retinal function. This protective effect of diosmin may be at least partly attributed to its ability to regulate the VEGF/PEDF ratio.	[Tong, Nianting; Zhang, Zhenzhen; Zhang, Wei; Qiu, Yating; Gong, Yuanyuan; Yin, Lili; Qiu, Qinghua; Wu, Xingwei] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wu, XW (corresponding author), Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China.	eyewxw@gmail.com	Tong, Nianting/J-5860-2017		Key Program of the National Administration of Traditional Chinese Medicine, Shanghai, China [20062001]; Opening Project of Shanghai Key Laboratory of Fundus Diseases [07Z22911]	Key Program of the National Administration of Traditional Chinese Medicine, Shanghai, China; Opening Project of Shanghai Key Laboratory of Fundus Diseases	This work was supported by the Key Program of the National Administration of Traditional Chinese Medicine, Shanghai, China (Grant No. 20062001), and Opening Project of Shanghai Key Laboratory of Fundus Diseases (Grant No. 07Z22911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergan JJ, 2001, ANGIOLOGY, V52, pS43, DOI 10.1177/0003319701052001S06; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Fan W, 2011, DIFFERENTIATION, V81, P181, DOI 10.1016/j.diff.2010.12.003; FAVA RA, 1994, J EXP MED, V180, P341, DOI 10.1084/jem.180.1.341; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Kaur C, 2007, J PATHOL, V212, P429, DOI 10.1002/path.2195; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; LABRID C, 1994, ANGIOLOGY, V45, P524, DOI 10.1177/000331979404500605; Le Devehat C, 1997, INT J MICROCIRC, V17, P27, DOI 10.1159/000179264; Liu K, 2012, J MOL NEUROSCI; Lu M, 1999, INVEST OPHTH VIS SCI, V40, P1808; Manthey JA, 2000, MICROCIRCULATION, V7, pS29; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pons M, 2011, INVEST OPHTH VIS SCI, V52, P3842, DOI 10.1167/iovs.10-6254; Ramelet AA, 2000, ANGIOLOGY, V51, P19, DOI 10.1177/000331970005100105; Ramelet AA, 2001, ANGIOLOGY, V52, pS49, DOI 10.1177/0003319701052001S07; Sheikpranbabu S, 2010, VASC PHARMACOL, V52, P84, DOI 10.1016/j.vph.2009.12.002; Silambarasan T, 2012, EUR J PHARMACOL, V679, P81, DOI 10.1016/j.ejphar.2011.12.040; Smith C, 1999, J VASC RES, V36, P24, DOI 10.1159/000054071; Spoerri PE, 2006, MOL VIS, V12, P32; Tong NT, 2012, J OCUL PHARMACOL TH, V28, P459, DOI 10.1089/jop.2011.0218; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Yamagishi S, 2007, J INT MED RES, V35, P896, DOI 10.1177/147323000703500619; Yang JL, 2010, INVEST OPHTH VIS SCI, V51, P3273, DOI 10.1167/iovs.08-2878; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zheng BQ, 2011, AM J OPHTHALMOL, V152, P1039, DOI 10.1016/j.ajo.2011.05.022; Zheng Z, 2009, DIABETES, V58, P954, DOI 10.2337/db07-1524; Zhong YS, 2008, J OCUL PHARMACOL TH, V24, P453, DOI 10.1089/jop.2008.0021	32	40	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61794	10.1371/journal.pone.0061794	http://dx.doi.org/10.1371/journal.pone.0061794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637907	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400051
J	van der Kant, A; Deregnaucourt, S; Gahr, M; Van der Linden, A; Poirier, C				van der Kant, Anne; Deregnaucourt, Sebastien; Gahr, Manfred; Van der Linden, Annemie; Poirier, Colline			Representation of Early Sensory Experience in the Adult Auditory Midbrain: Implications for Vocal Learning	PLOS ONE			English	Article							GANGLIA-FOREBRAIN CIRCUIT; ZEBRA FINCH BRAIN; SONG SYSTEM; NEURAL REPRESENTATION; BIRDSONG; MECHANISMS; SELECTIVITY; MODULATION; NEURONS; SLEEP	Vocal learning in songbirds and humans occurs by imitation of adult vocalizations. In both groups, vocal learning includes a perceptual phase during which juveniles birds and infants memorize adult vocalizations. Despite intensive research, the neural mechanisms supporting this auditory memory are still poorly understood. The present functional MRI study demonstrates that in adult zebra finches, the right auditory midbrain nucleus responds selectively to the copied vocalizations. The selective signal is distinct from selectivity for the bird's own song and does not simply reflect acoustic differences between the stimuli. Furthermore, the amplitude of the selective signal is positively correlated with the strength of vocal learning, measured by the amount of song that experimental birds copied from the adult model. These results indicate that early sensory experience can generate a long-lasting memory trace in the auditory midbrain of songbirds that may support song learning.	[van der Kant, Anne; Van der Linden, Annemie; Poirier, Colline] Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium; [Deregnaucourt, Sebastien; Gahr, Manfred] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany	University of Antwerp; Max Planck Society	Van der Linden, A (corresponding author), Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium.	Annemie.VanDerLinden@ua.ac.be	Van der Linden, Annemie/L-7855-2017	Van der Linden, Annemie/0000-0003-2941-6520; Poirier, Colline/0000-0001-9793-4907	Research Foundation - Flanders (FWO) [G.0420.02]; University of Antwerp; EC FP6 project DiMI [LSHB-CT-2005-512146]; EC FP6 project EMIL [LSHC-CT-2004-503569]; Max Planck Society	Research Foundation - Flanders (FWO)(FWO); University of Antwerp; EC FP6 project DiMI; EC FP6 project EMIL; Max Planck Society(Max Planck Society)	This research was supported by grants from the Research Foundation - Flanders (FWO, www.fwo.be, project Nr G.0420.02), Concerted Research Actions (GOA funding) from the University of Antwerp (www.ua.ac.be), and partly sponsored by EC FP6 project DiMI, LSHB-CT-2005-512146, EC FP6 project EMIL LSHC-CT-2004-503569 and the Max Planck Society (www.mpg.de). C. P. is a Postdoctoral Fellow of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Boumans T, 2007, EUR J NEUROSCI, V26, P2613, DOI 10.1111/j.1460-9568.2007.05865.x; Brainard MS, 2004, ANN NY ACAD SCI, V1016, P377, DOI 10.1196/annals.1298.042; Cardin JA, 2004, J NEUROPHYSIOL, V91, P2148, DOI 10.1152/jn.00918.2003; Chandrasekaran B, 2012, J NEUROPHYSIOL, V107, P1325, DOI 10.1152/jn.00923.2011; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Gobes SM, 2010, P BIOL SCI, V277, P343; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Lei HM, 2010, NEURON, V65, P122, DOI 10.1016/j.neuron.2009.12.008; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; Margoliash D, 2010, BRAIN LANG, V115, P45, DOI 10.1016/j.bandl.2009.09.005; Moorman S, 2012, P NATL ACAD SCI USA, V109, P12782, DOI 10.1073/pnas.1207207109; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Phan ML, 2010, P NATL ACAD SCI USA, V107, P2301, DOI 10.1073/pnas.0900091107; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pinaud R, 2006, J NEUROBIOL, V66, P182, DOI 10.1002/neu.20211; Poirier C, 2008, NEUROIMAGE, V41, P1, DOI 10.1016/j.neuroimage.2008.01.069; Poirier C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020131; Poirier C, 2010, NMR BIOMED, V23, P1027, DOI 10.1002/nbm.1525; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; Prather JF, 2004, CURR OPIN NEUROBIOL, V14, P496, DOI 10.1016/j.conb.2004.06.004; Pytte CL, 2010, BEHAV BRAIN RES, V211, P141, DOI 10.1016/j.bbr.2010.03.029; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schneider DM, 2010, J NEUROPHYSIOL, V103, P3248, DOI 10.1152/jn.01131.2009; Schumacher JW, 2011, J NEUROPHYSIOL, V106, P500, DOI 10.1152/jn.01072.2010; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; Solis MM, 2000, NEURON, V25, P109, DOI 10.1016/S0896-6273(00)80875-2; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Song JH, 2012, CEREB CORTEX, V22, P1180, DOI 10.1093/cercor/bhr196; Stripling R, 1997, J NEUROSCI, V17, P3883; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P222, DOI 10.1196/annals.1298.023; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Van der Linden A, 2009, TRENDS NEUROSCI, V32, P257, DOI 10.1016/j.tins.2009.01.005; Wilbrecht L, 2003, MENT RETARD DEV D R, V9, P135, DOI 10.1002/mrdd.10073; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; Woolley SMN, 2012, DEV PSYCHOBIOL, V54, P612, DOI 10.1002/dev.21014; Woolley SMN, 2010, DEV NEUROBIOL, V70, P235, DOI 10.1002/dneu.20783; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Xiong Y, 2009, NEUROSCI BIOBEHAV R, V33, P1178, DOI 10.1016/j.neubiorev.2008.10.006; Yazaki-Sugiyama Y, 2004, J NEUROPHYSIOL, V92, P2771, DOI 10.1152/jn.00467.2004	53	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61764	10.1371/journal.pone.0061764	http://dx.doi.org/10.1371/journal.pone.0061764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637903	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400048
J	Baez, JC; Gimeno, L; Gomez-Gesteira, M; Ferri-Yanez, F; Real, R				Baez, Jose C.; Gimeno, Luis; Gomez-Gesteira, Moncho; Ferri-Yanez, Francisco; Real, Raimundo			Combined Effects of the North Atlantic Oscillation and the Arctic Oscillation on Sea Surface Temperature in the Alboran Sea	PLOS ONE			English	Article							ANCHOVY ENGRAULIS-ENCRASICOLUS; DATA ASSIMILATION ANALYSIS; UPPER OCEAN 1950-95; CUTOFF LOW SYSTEMS; PART II; VARIABILITY; PRECIPITATION; LANDINGS; CIRCULATION; ABUNDANCE	We explored the possible effects of the North Atlantic Oscillation (NAO) and Arctic Oscillation (AO) on interannual sea surface temperature (SST) variations in the Alboran Sea, both separately and combined. The probability of observing mean annual SST values higher than average was related to NAO and AO values of the previous year. The effect of NAO on SST was negative, while that of AO was positive. The pure effects of NAO and AO on SST are obscuring each other, due to the positive correlation between them. When decomposing SST, NAO and AO in seasonal values, we found that variation in mean annual SST and mean winter SST was significantly related to the mean autumn NAO of the previous year, while mean summer SST was related to mean autumn AO of the previous year. The one year delay in the effect of the NAO and AO on the SST could be partially related to the amount of accumulated snow, as we found a significant correlation between the total snow in the North Alboran watershed for a year with the annual average SST of the subsequent year. A positive AO implies a colder atmosphere in the Polar Regions, which could favour occasional cold waves over the Iberian Peninsula which, when coupled with precipitations favoured by a negative NAO, may result in snow precipitation. This snow may be accumulated in the high peaks and melt down in spring-summer of the following year, which consequently increases the runoff of freshwater to the sea, which in turn causes a diminution of sea surface salinity and density, and blocks the local upwelling of colder water, resulting in a higher SST.	[Baez, Jose C.; Real, Raimundo] Univ Malaga, Dept Biol Anim, E-29071 Malaga, Spain; [Baez, Jose C.] Ctr Oceanog Malaga, Inst Espanol Oceanog, Malaga, Spain; [Gimeno, Luis; Gomez-Gesteira, Moncho] Univ Vigo, Fac Ciencias Ourense, Orense, Spain; [Ferri-Yanez, Francisco] CSIC, Museo Ciencias Nat, Madrid, Spain	Universidad de Malaga; Spanish Institute of Oceanography; Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); Museu de Ciencies Naturals de Barcelona	Baez, JC (corresponding author), Univ Malaga, Dept Biol Anim, E-29071 Malaga, Spain.	granbaez_29@hotmail.com	Real, Raimundo/E-6559-2010; GIMENO, LUIS/B-8137-2008; Gesteira, Moncho Gomez/R-9431-2019; Baez, Jose C/I-2644-2013	Real, Raimundo/0000-0002-6642-1284; Gesteira, Moncho Gomez/0000-0002-0661-9731; Baez, Jose C/0000-0003-2049-0409; Ferri Yanez, Francisco/0000-0001-7433-3404; GIMENO, LUIS/0000-0002-0778-3605	Ministerio de Ciencia e Innovacion, Spain [CGL2009-11316]; FEDER	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission)	This study was partially supported by the projects CGL2009-11316 (Ministerio de Ciencia e Innovacion, Spain, and FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Ambaum MHP, 2001, J CLIMATE, V14, P3495, DOI 10.1175/1520-0442(2001)014<3495:AOONAO>2.0.CO;2; Baez JC, 2011, J APPL ICHTHYOL, V27, P1356, DOI 10.1111/j.1439-0426.2011.01799.x; Baez JC, 2011, J APPL ICHTHYOL, V27, P1232, DOI 10.1111/j.1439-0426.2011.01796.x; Baez JC, 2011, SCI MAR, V75, P571, DOI 10.3989/scimar.2011.75n3571; Baldwin MP, 2007, SCIENCE, V316, P1576, DOI 10.1126/science.1144303; Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; Barcena S, 2004, BIODIVERS CONSERV, V13, P1997, DOI 10.1023/B:BIOC.0000040000.23854.b9; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Bjerknes J., 1964, ADV GEOPHYS, V10, P1, DOI [10.1016/S0065-2687(08)60005-9, DOI 10.1016/S0065-2687(08)60005-9]; Bojariu R, 2003, EARTH-SCI REV, V63, P145, DOI 10.1016/S0012-8252(03)00036-9; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP, 2002, MULTIMODEL INFERENCE; Carton JA, 2000, J PHYS OCEANOGR, V30, P311, DOI [10.1175/1520-0485(2000)030<0311:ASODAA>2.0.CO;2, 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2]; Cartron JLE, 2000, OIKOS, V90, P381, DOI 10.1034/j.1600-0706.2000.900219.x; Christiansen B, 2007, GEOPHYS RES ABS, V9, P1607; Clement A, 2011, J CLIMATE, V24, P4056, DOI 10.1175/2011JCLI3973.1; Delibes-Mateos M., 2010, ENVIRON CONSERV, V37, P1; DIAMOND GA, 1992, J CLIN EPIDEMIOL, V45, P85, DOI 10.1016/0895-4356(92)90192-P; Douville H, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039334; Drinkwater K.F., 2003, GEOPHYS MONOGR SER, V134, P211; Frias T, 2005, GEOPHYS RES ABS, V7; Gamiz-Fortis SR, 2010, J HYDROL, V385, P143, DOI 10.1016/j.jhydrol.2010.02.010; Ganzedo U, 2009, ICES J MAR SCI, V66, P1595, DOI 10.1093/icesjms/fsp050; Gimeno L, 2007, METEOROL ATMOS PHYS, V96, P1, DOI 10.1007/s00703-006-0216-5; Goni N, 2005, ICES J MAR SCI, V62, P1475, DOI 10.1016/j.icesjms.2005.05.014; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Kotroni V, 2006, J APPL METEOROL CLIM, V45, P576, DOI 10.1175/JAM2347.1; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Levitus S, 1982, 13 NOAA US DEP COMM; Lloret J, 2004, FISH OCEANOGR, V13, P102, DOI 10.1046/j.1365-2419.2003.00279.x; Lloret J, 2001, FISH OCEANOGR, V10, P33, DOI 10.1046/j.1365-2419.2001.00151.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lohmann G, 2005, CLIMATE PAST DISCUSS, V1, P17, DOI [10.5194/cpd-1-17-2005, DOI 10.5194/CPD-1-17-2005]; Luo JJ, 2011, NATURE, V477, P544, DOI 10.1038/477544a; Mercado JM, 2005, SCI MAR, V69, P451, DOI 10.3989/scimar.2005.69n4451; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Nieto R, 2007, METEOROL ATMOS PHYS, V96, P103, DOI 10.1007/s00703-006-0223-6; Nieto R, 2005, J CLIMATE, V18, P3085, DOI 10.1175/JCLI3386.1; Nieto R, 2008, ANN NY ACAD SCI, V1146, P256, DOI 10.1196/annals.1446.016; Overland JE, 2010, J MARINE SYST, V79, P305, DOI 10.1016/j.jmarsys.2008.12.009; PARRILLA G, 1987, Boletin Instituto Espanol de Oceanografia, V4, P133; Peng SL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014043; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Porcu F, 2007, METEOROL ATMOS PHYS, V96, P121, DOI 10.1007/s00703-006-0224-5; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Rodriguez J, 1982, OCEANOGRAFIA MAR MED; Sarhan T, 2000, J MARINE SYST, V23, P317, DOI 10.1016/S0924-7963(99)00068-8; Sims DW, 2001, P ROY SOC B-BIOL SCI, V268, P2607, DOI 10.1098/rspb.2001.1847; Cabrillo RS, 2011, OCEAN DYNAM, V61, P1215, DOI 10.1007/s10236-011-0407-6; Straile D, 2007, CLIM RES, V34, P259, DOI 10.3354/cr00702; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Trigo RM, 2002, CLIMATE RES, V20, P9, DOI 10.3354/cr020009; Trigo RM, 2004, INT J CLIMATOL, V24, P925, DOI 10.1002/joc.1048; Vargas-Yanez M, 2009, FISH RES, V99, P159, DOI 10.1016/j.fishres.2009.05.013; Vicente-Serrano SM, 2011, CLIM RES, V46, P51, DOI 10.3354/cr00977; Visbeck, 2003, GEOPHYS MONOGR SER, V134, P1, DOI [DOI 10.1029/134GM01, 10.1029/134GM01]; Visbeck M, 2003, GEOPHYS MONOGR, V134, P113, DOI DOI 10.1029/134GM06; Visbeck MH, 2001, P NATL ACAD SCI USA, V98, P12876, DOI 10.1073/pnas.231391598; Walker G T, 1932, MEM R METEOROL SOC, V4, P53; Wang JJ, 2003, ICES J MAR SCI, V60, P1149, DOI 10.1016/S1054-3139(03)00118-8; Zhang XD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035607; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	70	30	31	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62201	10.1371/journal.pone.0062201	http://dx.doi.org/10.1371/journal.pone.0062201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23638005	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700081
J	Campos-Bermudez, VA; Fauguel, CM; Tronconi, MA; Casati, P; Presello, DA; Andreo, CS				Campos-Bermudez, Valeria A.; Fauguel, Carolina M.; Tronconi, Marcos A.; Casati, Paula; Presello, Daniel A.; Andreo, Carlos S.			Transcriptional and Metabolic Changes Associated to the Infection by Fusarium verticillioides in Maize Inbreds with Contrasting Ear Rot Resistance	PLOS ONE			English	Article							FUMONISIN CONTAMINATION; EXPRESSION DATA; MALIC ENZYME; PLANT; PROTEASOME; MYCOTOXINS; GIBBERELLA; SEVERITY; SYMPTOMS; GRAINS	Fusarium verticillioides causes ear rot and grain mycotoxins in maize (Zea mays L.), which are harmful to human and animal health. Breeding and growing less susceptible plant genotypes is one alternative to reduce these detrimental effects. A better understanding of the resistance mechanisms would facilitate the implementation of strategic molecular agriculture to breeding of resistant germplasm. Our aim was to identify genes and metabolites that may be related to the Fusarium reaction in a resistant (L4637) and a susceptible (L4674) inbred. Gene expression data were obtained from microarray hybridizations in inoculated and non-inoculated kernels from both inbreds. Fungal inoculation did not produce considerable changes in gene expression and metabolites in L4637. Defense-related genes changed in L4674 kernels, responding specifically to the pathogen infection. These results indicate that L4637 resistance may be mainly due to constitutive defense mechanisms preventing fungal infection. These mechanisms seem to be poorly expressed in L4674; and despite the inoculation activate a defense response; this is not enough to prevent the disease progress in this susceptible line. Through this study, a global view of differential genes expressed and metabolites accumulated during resistance and susceptibility to F. verticillioides inoculation has been obtained, giving additional information about the mechanisms and pathways conferring resistance to this important disease in maize.	[Campos-Bermudez, Valeria A.; Tronconi, Marcos A.; Casati, Paula; Andreo, Carlos S.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Ctr Estudios Fotosintet & Bioquim, RA-2000 Rosario, Santa Fe, Argentina; [Fauguel, Carolina M.; Presello, Daniel A.] Inst Nacl Tecnol Agr, Pergamino, Argentina	National University of Rosario; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Andreo, CS (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Ctr Estudios Fotosintet & Bioquim, RA-2000 Rosario, Santa Fe, Argentina.	andreo@cefobi-conicet.gov.ar		Campos Bermudez, Valeria/0000-0003-0135-6482; Tronconi, Marcos/0000-0001-9568-7818	Agencia Nacional para la Promocion Cientifica y Tecnologica, ANPCyT (PICT) [358]; Secretaria de Ciencia y Tecnica de la Provincia de Santa Fe, SecTei [2010-110-11]; Instituto Nacional de Tecnologia Agropecuaria, INTA	Agencia Nacional para la Promocion Cientifica y Tecnologica, ANPCyT (PICT); Secretaria de Ciencia y Tecnica de la Provincia de Santa Fe, SecTei; Instituto Nacional de Tecnologia Agropecuaria, INTA	This work was supported by grants from Agencia Nacional para la Promocion Cientifica y Tecnologica, ANPCyT (PICT No. 358); Secretaria de Ciencia y Tecnica de la Provincia de Santa Fe, SecTei (Project No. 2010-110-11), and Instituto Nacional de Tecnologia Agropecuaria, INTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandra L, 2010, J PLANT PHYSIOL, V167, P1398, DOI 10.1016/j.jplph.2010.05.015; Bush BJ, 2004, PHYTOPATHOLOGY, V94, P88, DOI 10.1094/PHYTO.2004.94.1.88; CAHAGNIER B, 1993, LETT APPL MICROBIOL, V17, P7, DOI 10.1111/j.1472-765X.1993.tb01423.x; Campo S, 2004, PROTEOMICS, V4, P383, DOI 10.1002/pmic.200300657; Chulze SN, 1996, J AGR FOOD CHEM, V44, P2797, DOI 10.1021/jf950381d; Clements MJ, 2003, PLANT DIS, V87, P147, DOI 10.1094/PDIS.2003.87.2.147; Desjardins AE, 1998, PLANT DIS, V82, P953, DOI 10.1094/PDIS.1998.82.8.953; DOMBRINKKURTZMAN MA, 1993, CEREAL CHEM, V70, P105; Dulermo T, 2009, PLANT SIGNAL BEHAV, V4, P859, DOI 10.4161/psb.4.9.9397; Eller M, 2008, TOXIN REV, V27, P371, DOI 10.1080/15569540802450326; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Gardiner DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-289; Gaudet DA, 2010, MOL PLANT MICROBE IN, V23, P1619, DOI 10.1094/MPMI-11-09-0271; Gibson G., 2004, GENETIC ANAL COMPLEX, P251; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; HEADRICK JM, 1990, PHYTOPATHOLOGY, V80, P487, DOI 10.1094/Phyto-80-487; HOJ PB, 1995, PLANT J, V7, P367, DOI 10.1046/j.1365-313X.1995.7030367.x; Iglesias J, 2010, J PLANT PATHOL, V92, P205; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Koehler B, 1942, J AGRIC RES, V64, P0421; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kurepa J, 2008, BIOCHIMIE, V90, P324, DOI 10.1016/j.biochi.2007.07.019; Lanubile A, 2012, PHYSIOL MOL PLANT P, V77, P52, DOI 10.1016/j.pmpp.2011.12.002; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; MARASAS WFO, 1988, ONDERSTEPOORT J VET, V55, P197; Maurino VG, 2001, PLANT MOL BIOL, V45, P409, DOI 10.1023/A:1010665910095; Miller JD, 2008, FOOD ADDIT CONTAM A, V25, P219, DOI 10.1080/02652030701744520; Munkvold GP, 2003, ANNU REV PHYTOPATHOL, V41, P99, DOI 10.1146/annurev.phyto.41.052002.095510; Munkvold GP, 1997, PLANT DIS, V81, P556, DOI 10.1094/PDIS.1997.81.6.556; Murillo I, 1997, PLANT CELL, V9, P145, DOI 10.1105/tpc.9.2.145; Odjakova Mariela, 2001, Bulgarian Journal of Plant Physiology, V27, P101; Prelusky D. B., 1994, P359; Presello DA, 2008, CROP PROT, V27, P572, DOI 10.1016/j.cropro.2007.08.015; Presello DA, 2004, MAYDICA, V49, P73; Presello DA, 2007, CROP PROT, V26, P852, DOI 10.1016/j.cropro.2006.08.004; Presello DA, 2006, EUPHYTICA, V147, P403, DOI 10.1007/s10681-005-9037-8; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Saigo M, 2004, PLANT MOL BIOL, V55, P97, DOI 10.1007/s11103-004-0472-z; Sampietro DA, 2013, EUR J PLANT PATHOL, V135, P105, DOI 10.1007/s10658-012-0069-3; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Vigier B, 2001, CAN J PLANT PATHOL, V23, P99, DOI 10.1080/07060660109506915; Voegele RT, 2005, PLANT PHYSIOL, V137, P190, DOI 10.1104/pp.104.051839; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yuan GS, 2012, PLANT OMICS, V5, P471	50	41	48	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61580	10.1371/journal.pone.0061580	http://dx.doi.org/10.1371/journal.pone.0061580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637860	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700046
J	Higgins, J; Hagman, J; Pan, ZX; MacLean, P				Higgins, Janine; Hagman, Jennifer; Pan, Zhaoxing; MacLean, Paul			Increased Physical Activity Not Decreased Energy Intake Is Associated with Inpatient Medical Treatment for Anorexia Nervosa in Adolescent Females	PLOS ONE			English	Article							EATING DISORDERS; MACRONUTRIENT; WOMEN; FOOD; EXERCISE; WEIGHT; EXPENDITURE; VALIDATION; ACCURACY; EFFICACY	There is a dearth of data regarding changes in dietary intake and physical activity over time that lead to inpatient medical treatment for anorexia nervosa (AN). Without such data, more effective nutritional therapies for patients cannot be devised. This study was undertaken to describe changes in diet and physical activity that precede inpatient medical hospitalization for AN in female adolescents. This data can be used to understand factors contributing to medical instability in AN, and may advance rodent models of AN to investigate novel weight restoration strategies. It was hypothesized that hospitalization for AN would be associated with progressive energy restriction and increased physical activity over time. 20 females, 11-19 years (14.3 +/- 1.8 years), with restricting type AN, completed retrospective, self-report questionnaires to assess dietary intake and physical activity over the 6 month period prior to inpatient admission (food frequency questionnaire, Pediatric physical activity recall) and 1 week prior (24 hour food recall, modifiable activity questionnaire). Physical activity increased acutely prior to inpatient admission without any change in energy or macronutrient intake. However, there were significant changes in reported micronutrient intake causing inadequate intake of Vitamin A, Vitamin D, and pantothenic acid at 1 week versus high, potentially harmful, intake of Vitamin A over 6 months prior to admission. Subject report of significantly increased physical activity, not decreased energy intake, were associated with medical hospitalization for AN. Physical activity and Vitamin A and D intake should be carefully monitored following initial AN diagnosis, as markers of disease progression as to potentially minimize the risk of medical instability.	[Higgins, Janine] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Hagman, Jennifer] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA; [Pan, Zhaoxing] Childrens Hosp Colorado, Res Inst, Aurora, CO USA; [MacLean, Paul] Univ Colorado, Sch Med, Div Endocrinol Diabet & Metab, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Higgins, J (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Anschutz Med Campus, Aurora, CO USA.	janine.higgins@childrenscolorado.org	Hagman, Jennifer/R-8240-2017; Zamora, Cristina Cuesta/E-2864-2016; MacLean, Paul/A-7887-2008	Hagman, Jennifer/0000-0002-7770-3092; Zamora, Cristina Cuesta/0000-0003-1121-9561; MacLean, Paul/0000-0002-1123-6612; Higgins, Janine/0000-0002-4273-194X	National Institutes of Health/National Center for Research Resources (NIH/NCRR) Colorado CTSI Grant [UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Research Resources (NIH/NCRR) Colorado CTSI Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/National Center for Research Resources (NIH/NCRR) Colorado CTSI Grant UL1 RR025780 (Independent Investigator Pilot and Feasibility Award). Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARON DJ, 1995, AM J EPIDEMIOL, V142, P191, DOI 10.1093/oxfordjournals.aje.a117618; Affenito SG, 2002, J PEDIATR-US, V141, P701, DOI 10.1067/mpd.2002.129840; American Association of Psychiatrists, 2000, DIAGN STAT MAN MENT; [Anonymous], DRI TABL; ARAVICH PF, 1994, APPETITE, V23, P196, DOI 10.1006/appe.1994.1049; Baxter SD, 2009, EUR J CLIN NUTR, V63, pS19, DOI 10.1038/ejcn.2008.61; Beasley J, 2005, NUTRITION, V21, P672, DOI 10.1016/j.nut.2004.11.006; BENDICH A, 1989, AM J CLIN NUTR, V49, P358, DOI 10.1093/ajcn/49.2.358; BENEKE WM, 1995, PHYSIOL BEHAV, V58, P451, DOI 10.1016/0031-9384(95)00083-U; CASPER RC, 1991, AM J CLIN NUTR, V53, P1143, DOI 10.1093/ajcn/53.5.1143; Davis C, 1997, COMPR PSYCHIAT, V38, P321, DOI 10.1016/S0010-440X(97)90927-5; DAVIS C, 1990, J PSYCHOSOM RES, V34, P563, DOI 10.1016/0022-3999(90)90031-X; Dellava JE, 2011, INT J EAT DISORDER, V44, P376, DOI 10.1002/eat.20865; Dixon DP, 2003, PHYSIOL BEHAV, V80, P273, DOI 10.1016/j.physbeh.2003.08.008; FERNSTROM MH, 1994, BIOL PSYCHIAT, V36, P696, DOI 10.1016/0006-3223(94)91179-7; FRENCH SA, 1994, J ADOLESCENT HEALTH, V15, P286, DOI 10.1016/1054-139X(94)90601-7; Gardner RM, 1996, J CLIN PSYCHOL, V52, P3, DOI 10.1002/(SICI)1097-4679(199601)52:1<3::AID-JCLP1>3.0.CO;2-X; Gentile MG, 2008, EAT WEIGHT DISORD-ST, V13, P191; GWIRTSMAN HE, 1989, J AM DIET ASSOC, V89, P54; Hadigan CM, 2000, INT J EAT DISORDER, V28, P284, DOI 10.1002/1098-108X(200011)28:3&lt;284::AID-EAT5&gt;3.0.CO;2-G; Halmi Katherine A, 2009, Dialogues Clin Neurosci, V11, P100; Hechler T, 2008, ADAPT PHYS ACT Q, V25, P159, DOI 10.1123/apaq.25.2.159; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; KRON L, 1978, COMPR PSYCHIAT, V19, P433, DOI 10.1016/0010-440X(78)90072-X; Misra M, 2006, AM J CLIN NUTR, V84, P698, DOI 10.1093/ajcn/84.4.698; Neumarker KJ, 1997, INT J EAT DISORDER, V21, P205, DOI 10.1002/(SICI)1098-108X(199704)21:3<205::AID-EAT1>3.0.CO;2-O; Nogal P, 2009, NEUROENDOCRINOL LETT, V30, P32; Nova E, 2001, EUR J CLIN NUTR, V55, P547, DOI 10.1038/sj.ejcn.1601181; PIRKE KM, 1991, BIOL PSYCHIAT, V30, P711, DOI 10.1016/0006-3223(91)90016-F; Rockett HRH, 1997, PREV MED, V26, P808, DOI 10.1006/pmed.1997.0200; Schebendach JE, 2012, INT J EAT DISORDER, V45, P570, DOI 10.1002/eat.20973; Schwartz BI, 2008, J ADOLESCENT HEALTH, V43, P425, DOI 10.1016/j.jadohealth.2008.04.010; Soh NLW, 2008, EUR EAT DISORD REV, V16, P427, DOI 10.1002/erv.876; United States Department of Agriculture FaNIC, 2007, NAT HLTH NUTR EX SUR; WALLIN GV, 1995, J AM COLL NUTR, V14, P271; Weston AT, 1997, MED SCI SPORT EXER, V29, P138, DOI 10.1097/00005768-199701000-00020	37	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61559	10.1371/journal.pone.0061559	http://dx.doi.org/10.1371/journal.pone.0061559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130IU	23637854	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700045
J	Kieffer, A; Paboriboune, P; Crepey, P; Flaissier, B; Souvong, V; Steenkeste, N; Salez, N; Babin, FX; Longuet, C; Carrat, F; Flahault, A; de Lamballerie, X				Kieffer, Alexia; Paboriboune, Phimpha; Crepey, Pascal; Flaissier, Bruno; Souvong, Vimalay; Steenkeste, Nicolas; Salez, Nicolas; Babin, Francois-Xavier; Longuet, Christophe; Carrat, Fabrice; Flahault, Antoine; de lamballerie, Xavier			2009 A(H1N1) Seroconversion Rates and Risk Factors among the General Population in Vientiane Capital, Laos	PLOS ONE			English	Article							PANDEMIC H1N1 INFLUENZA; SPATIAL-DISTRIBUTION; VIRUS; INFECTION; SEROPREVALENCE; TRANSMISSION; PREVALENCE; IMMUNITY; SEASON; EAST	Objective: To assess 2009 A(H1N1) seroconversion rates and their determinants within an unvaccinated population in Vientiane Capital, Laos. Methods: CoPanFlu Laos, a general population cohort of 807 households and 4,072 participants was established in March 2010. Sociodemographic data, epidemiological data, and capillary blood samples were collected from all the household members in March, and again in October 2010, in order to assess the level of antibodies to 2009 A(H1N1) with the haemagglutination inhibition assay. 2009 A(H1N1) seroconversion was defined as a fourfold or greater increase in titre between inclusion and follow-up. Determinants for pandemic influenza infection were studied using the generalized estimating equations model, taking household clustering into account. Results: Between March and November 2010, 3,524 paired sera were tested. Prior to the pandemic, our cohort was almost completely vaccine-naive for seasonal influenza. The overall seroconversion rate among nonvaccinated individuals (n = 2,810) was 14.3% (95% CI [13.0, 15.6]), with the highest rate for participants under 20 yo (19.8%, 95% CI [17.4, 22.4]) and the lowest rate for participants over 60 yo (6.5%, 95% CI [3.7, 10.4]). Participants with lower baseline titres had significantly higher infection rates, with a dose-effect relationship. Odds ratios (ORs) ranged from 76.5 (95% CI [27.1, 215.8]), for those with a titre at inclusion of 1: 10, to 8.1 (95% CI [3.3, 20.4]), for those with a titre of 1: 40. Having another household member with a titre >= 1: 80 was associated with a higher likelihood of immunity (OR = 3.3, 95% CI [2.8, 3.9]). Conclusion: The determinants and age distribution for seroconversion within a vaccine-naive population were similar to those found in developed countries. This pandemic was characterized by strong epidemiological determinants, regardless of geographical zone and level of development. Moreover, we detected pre-existing cross-reacting antibodies in participants over 60 yo, which could not have originated from former multiple vaccination as has been suggested elsewhere.	[Kieffer, Alexia; Crepey, Pascal; Salez, Nicolas; de lamballerie, Xavier] Aix Marseille Univ, UMR 190, IRD, EHESP, Marseille, France; [Paboriboune, Phimpha; Souvong, Vimalay] Ctr Infectiol Christophe Merieux Laos, Vientiane Capital, Laos; [Kieffer, Alexia; Crepey, Pascal; Flaissier, Bruno; Flahault, Antoine] EHESP Rennes, Sorbonne Paris Cite, Paris, France; [Steenkeste, Nicolas; Babin, Francois-Xavier; Longuet, Christophe] Fdn Merieux, Lyon, France; [Carrat, Fabrice] UPMC, INSERM, UMR S 707, Paris, France	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Kieffer, A (corresponding author), Aix Marseille Univ, UMR 190, IRD, EHESP, Marseille, France.	alexia.kieffer@gmail.com	Carrat, Fabrice/AAU-8480-2020; Crépey, Pascal/G-5422-2011	Carrat, Fabrice/0000-0002-8672-7918; Crépey, Pascal/0000-0003-1852-0752	EHESP (Ecole des hautes etudes en sante publique); INSERM/IMMI (Institut de Microbiologie et des Maladies Infectieuses); Fondation Merieux; IRD (Institut de Recherche pour le Developpement)	EHESP (Ecole des hautes etudes en sante publique); INSERM/IMMI (Institut de Microbiologie et des Maladies Infectieuses); Fondation Merieux; IRD (Institut de Recherche pour le Developpement)	This study was supported by funds from EHESP (Ecole des hautes etudes en sante publique), INSERM/IMMI (Institut de Microbiologie et des Maladies Infectieuses), Fondation Merieux and IRD (Institut de Recherche pour le Developpement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achonu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026427; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Broberg E, 2011, CLIN VACCINE IMMUNOL, V18, P1205, DOI 10.1128/CVI.05072-11; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chang SC, 2010, CLIN INFECT DIS, V51, P1465, DOI 10.1086/657406; Chao DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014555; Chen H, 2009, EMERG INFECT DIS, V15, P3; Chen MC, 2010, INT J COMPUT INTEG M, V23, P1, DOI 10.1080/09511920903030353; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Delangue J, 2012, CLIN MICROBIOL INFEC, V18, P177, DOI 10.1111/j.1469-0691.2011.03545.x; Dellagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025738; Dowse GK, 2011, MED J AUSTRALIA, V194, P68, DOI 10.5694/j.1326-5377.2011.tb04170.x; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanvoravongchai P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-322; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Huang DTN, 2011, EMERG INFECT DIS, V17, P76, DOI 10.3201/eid1701.100014; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Koita OA, 2012, CLIN MICROBIOL INFEC, V18, P976, DOI 10.1111/j.1469-0691.2011.03725.x; Kok J, 2011, LANCET INFECT DIS, V11, P423, DOI 10.1016/S1473-3099(11)70120-7; Kok J, 2011, JAIDS-J ACQ IMM DEF, V56, P91, DOI 10.1097/QAI.0b013e318204a1c3; Lapidus N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-417; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; Maltezou HC, 2011, VACCINE, V29, P6664, DOI 10.1016/j.vaccine.2011.06.098; McCullers JA, 2010, CLIN INFECT DIS, V50, P1487, DOI 10.1086/652441; McVernon J, 2010, EUROSURVEILLANCE, V15; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Nauta JJP, 2006, BIOLOGICALS, V34, P183, DOI 10.1016/j.biologicals.2005.09.001; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Smith K, 2011, J ENVIRON PUBLIC HEA, V2011, DOI 10.1155/2011/407505; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Tang JW, 2010, EMERG INFECT DIS, V16, P2009; Vallee J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000909; Vallee J, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-6; Vallee J, 2009, TROP MED INT HEALTH, V14, P1134, DOI 10.1111/j.1365-3156.2009.02319.x; Vongphrachanh P, 2010, INFLUENZA OTHER RESP, V4, P47, DOI 10.1111/j.1750-2659.2009.00120.x; Waalen K, 2010, EUROSURVEILLANCE, V15, P2; WHO, 2010, INFL UPD PERSP WHO L; WHO, 2009, HUM INF INFL A H1N1; WOOD JM, 1994, VACCINE, V12, P167, DOI 10.1016/0264-410X(94)90056-6; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Xu C, 2011, J NANOMATER, V2011, DOI 10.1155/2011/201834; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang P, 2012, INFLUENZA OTHER RESP, V6, P381, DOI 10.1111/j.1750-2659.2011.00326.x; Yee BWK, 1997, SOCIAL CULTURAL CONT; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	57	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61909	10.1371/journal.pone.0061909	http://dx.doi.org/10.1371/journal.pone.0061909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637928	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700064
J	Singer, J; Trollor, JN; Crawford, J; O'Rourke, MF; Baune, BT; Brodaty, H; Samaras, K; Kochan, NA; Campbell, L; Sachdev, PS; Smith, E				Singer, Joel; Trollor, Julian N.; Crawford, John; O'Rourke, Michael F.; Baune, Bernhard T.; Brodaty, Henry; Samaras, Katherine; Kochan, Nicole A.; Campbell, Lesley; Sachdev, Perminder S.; Smith, Evelyn			The Association between Pulse Wave Velocity and Cognitive Function: The Sydney Memory and Ageing Study	PLOS ONE			English	Article							ARTERIAL STIFFNESS; ALZHEIMERS-DISEASE; OLDER; IMPAIRMENT; DECLINE; PRESSURE; DEMENTIA; RISK	Objectives: Pulse wave velocity (PWV) is a measure of arterial stiffness and its increase with ageing has been associated with damage to cerebral microvessels and cognitive impairment. This study examined the relationship between carotid-femoral PWV and specific domains of cognitive function in a non-demented elderly sample. Method: Data were drawn from the Sydney Memory and Ageing Study, a cohort study of non-demented community-dwelling individuals aged 70-90 years, assessed in successive waves two years apart. In Wave 2, PWV and cognitive function were measured in 319 participants. Linear regression was used to analyse the cross-sectional relationship between arterial stiffness and cognitive function in the whole sample, and separately for men and women. Analysis of covariance was used to assess potential differences in cognition between subjects with PWV measurements in the top and bottom tertiles of the cohort. Covariates were age, education, body mass index, pulse rate, systolic blood pressure, cholesterol, depression, alcohol, smoking, hormone replacement therapy, apolipoprotein E epsilon 4 genotype, use of anti-hypertensive medications, history of stroke, transient ischemic attack, myocardial infarction, angina, diabetes, and also sex for the whole sample analyses. Results: There was no association between PWV and cognition after Bonferroni correction for multiple testing. When examining this association for males and females separately, an association was found in males, with higher PWV being associated with lower global cognition and memory, however, a significant difference between PWV and cognition between males and females was not found. Conclusion: A higher level of PWV was not associated with lower cognitive function in the whole sample.	[Singer, Joel; Trollor, Julian N.; Crawford, John; Brodaty, Henry; Kochan, Nicole A.; Sachdev, Perminder S.; Smith, Evelyn] Univ New S Wales, Sch Psychiat, Brain & Aging Res Program, Sydney, NSW, Australia; [Singer, Joel; Trollor, Julian N.; Smith, Evelyn] Univ New S Wales, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia; [O'Rourke, Michael F.; Samaras, Katherine; Campbell, Lesley] St Vincents Hosp, Darlinghurst, NSW 2010, Australia; [O'Rourke, Michael F.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Samaras, Katherine; Campbell, Lesley] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Baune, Bernhard T.] Univ Adelaide, Discipline Psychiat, Sch Med, Adelaide, SA, Australia; [Baune, Bernhard T.; Kochan, Nicole A.; Sachdev, Perminder S.] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Brodaty, Henry] Univ New S Wales, Dementia Collaborat Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; Victor Chang Cardiac Research Institute; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Adelaide; University of New South Wales Sydney	Smith, E (corresponding author), Univ New S Wales, Sch Psychiat, Brain & Aging Res Program, Sydney, NSW, Australia.	evelyn.smith@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220; Trollor, Julian/0000-0002-7685-2977; Smith, Evelyn/0000-0002-9142-986X	Australian National Health and Medical Research Council [510124]; Australian National Health and Medical Research Council Program Grant [350833]; Australian National Health and Medical Research Council Enabling Grant [401184]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council Enabling Grant(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a Dementia Research Grant from the Australian National Health and Medical Research Council (Grant ID 510124). The Sydney Memory and Ageing Study is supported by an Australian National Health and Medical Research Council Program Grant (Grant ID 350833). DNA was extracted by Genetic Repositories Australia, which is supported by an Australian National Health and Medical Research Council Enabling Grant (Grant ID 401184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Benetos A, 2012, J AM MED DIR ASSOC, V13, P239, DOI 10.1016/j.jamda.2010.08.014; Benton A.L., 1967, CORTEX, V3, P32, DOI [10.1016/s0010-9452(67)80005-4, DOI 10.1016/S0010-9452(67)80005-4, 10.1016/S0010-9452(67)80005-4]; Benton Sivan AB, 1996, BENTON TEST; Brodaty H, 2012, ALZHEIMERS DEMENTIA; Elias MF, 2009, HYPERTENSION, V53, P668, DOI 10.1161/HYPERTENSIONAHA.108.126342; Fastenau PS, 1998, J CLIN EXP NEUROPSYC, V20, P828, DOI 10.1076/jcen.20.6.828.1105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujiwara Y, 2005, J GERONTOL A-BIOL, V60, P607, DOI 10.1093/gerona/60.5.607; Fukuhara M, 2006, CIRC J, V70, P756, DOI 10.1253/circj.70.756; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hanon O, 2005, STROKE, V36, P2193, DOI 10.1161/01.STR.0000181771.82518.1c; Henry-Feugeas MC, 2009, CURR ALZHEIMER RES, V6, P488, DOI 10.2174/156720509790147124; Kaplan E, 2001, BOSTON NAMING TEST; Lacolley P, 2009, CARDIOVASC RES, V81, P637, DOI 10.1093/cvr/cvn353; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Narkiewicz K, 2006, BLOOD PRESSURE, V15, P68, DOI 10.1080/08037050600750165; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Pase MP, 2010, J HYPERTENS, V28, P1724, DOI 10.1097/HJH.0b013e32833b1ee7; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Poels MMF, 2007, STROKE, V38, P888, DOI 10.1161/01.STR.0000257998.33768.87; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Rey A, 1964, LEXAMEN CLINIQUE PSY; Ronnlund M, 2011, J GENET PSYCHOL, V172, P266, DOI 10.1080/00221325.2010.538450; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schiepers OJG, 2012, MOL PSYCHIATR, V17, P315, DOI 10.1038/mp.2010.137; Scuteri A, 2005, J HYPERTENS, V23, P1211, DOI 10.1097/01.hjh.0000170384.38708.b7; Scuteri A, 2007, J HYPERTENS, V25, P1035, DOI 10.1097/HJH.0b013e3280895b55; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spreen O., 1969, NEUROSENSORY CTR COM; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Watson NL, 2011, J GERONTOL A-BIOL, V66, P1336, DOI 10.1093/gerona/glr119; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd	38	31	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61855	10.1371/journal.pone.0061855	http://dx.doi.org/10.1371/journal.pone.0061855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23637918	gold, Green Submitted, Green Published			2022-12-25	WOS:000319077300018
J	Scheiter, S; Higgins, SI				Scheiter, Simon; Higgins, Steven I.			Intermediate Coupling between Aboveground and Belowground Biomass Maximises the Persistence of Grasslands	PLOS ONE			English	Article							SHOOT; MODEL; ROOT; MANAGEMENT; COMPETITION; STABILITY; GROWTH; CARBON; FIRE; VARIABILITY	Aboveground and belowground biomass compartments of vegetation fulfil different functions and they are coupled by complex interactions. These compartments exchange water, carbon and nutrients and the belowground biomass compartment has the capacity to buffer vegetation dynamics when aboveground biomass is removed by disturbances such as herbivory or fire. However, despite their importance, root-shoot interactions are often ignored in more heuristic vegetation models. Here, we present a simple two-compartment grassland model that couples aboveground and belowground biomass. In this model, the growth of belowground biomass is influenced by aboveground biomass and the growth of aboveground biomass is influenced by belowground biomass. We used the model to explore how the dynamics of a grassland ecosystem are influenced by fire and grazing. We show that the grassland system is most persistent at intermediate levels of aboveground-belowground coupling. In this situation, the system can sustain more extreme fire or grazing regimes than in the case of strong coupling. In contrast, the productivity of the system is maximised at high levels of coupling. Our analysis suggests that the yield of a grassland ecosystem is maximised when coupling is strong, however, the intensity of disturbance that can be sustained increases dramatically when coupling is intermediate. Hence, the model predicts that intermediate coupling should be selected for as it maximises the chances of persistence in disturbance driven ecosystems.	[Scheiter, Simon] Senckenberg Gesell Nat Forsch, Biodivers & Klima Forschungszentrum LOEWE BiK F, Frankfurt, Germany; [Higgins, Steven I.] Goethe Univ Frankfurt, Inst Phys Geog, D-60054 Frankfurt, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Scheiter, S (corresponding author), Senckenberg Gesell Nat Forsch, Biodivers & Klima Forschungszentrum LOEWE BiK F, Frankfurt, Germany.	scheiter@em.uni-frankfurt.de	Higgins, Steven I/A-5138-2012; Scheiter, Simon/G-5048-2012	Higgins, Steven I/0000-0001-5695-9665; Scheiter, Simon/0000-0002-5449-841X	Deutsche Forschungsgemeinschaft (DFG); Robert Bosch Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Robert Bosch Foundation	Financial support was provided by the Deutsche Forschungsgemeinschaft (DFG) and by the Robert Bosch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderies JM, 2002, ECOSYSTEMS, V5, P23, DOI 10.1007/s10021-001-0053-9; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Borner J, 2007, AGR ECON-BLACKWELL, V37, P189, DOI 10.1111/j.1574-0862.2007.00265.x; Casagrandi R, 1999, AM NAT, V153, P527, DOI 10.1086/303194; Case T. J, 2000, ILLUSTRATED GUIDE TH; Crider FJ, 1955, USDA TECHNICAL B, V1102, P2; DAVIDSON RL, 1969, ANN BOT-LONDON, V33, P561, DOI 10.1093/oxfordjournals.aob.a084308; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Higgins SI, 2008, INT J WILDLAND FIRE, V17, P595, DOI 10.1071/WF06037; Higgins SI, 2007, ECOL ECON, V62, P102, DOI 10.1016/j.ecolecon.2006.05.019; Higgins SI, 2012, J BIOGEOGR, V39, P2132, DOI 10.1111/j.1365-2699.2012.02752.x; Higgins SI, 2010, ECOLOGY, V91, P1682, DOI 10.1890/08-1368.1; Ives AR, 2000, ECOLOGY, V81, P3330, DOI 10.2307/177497; Janssen MA, 2004, J ENVIRON ECON MANAG, V47, P140, DOI 10.1016/S0095-0696(03)00069-X; JOHNSON IR, 1987, ANN BOT-LONDON, V60, P133, DOI 10.1093/oxfordjournals.aob.a087429; Law BE, 1999, GLOBAL CHANGE BIOL, V5, P169, DOI 10.1046/j.1365-2486.1999.00214.x; LAW R, 1987, J ECOL, V75, P871, DOI 10.2307/2260211; MAKELA AA, 1987, ANN BOT-LONDON, V59, P129; MCMURTRIE R, 1983, ANN BOT-LONDON, V52, P437, DOI 10.1093/oxfordjournals.aob.a086599; NOYMEIR I, 1978, J THEOR BIOL, V71, P347, DOI 10.1016/0022-5193(78)90165-0; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; Quaas MF, 2007, ECOL ECON, V62, P251, DOI 10.1016/j.ecolecon.2006.03.028; Rees M, 1997, J THEOR BIOL, V184, P353, DOI 10.1006/jtbi.1996.0297; REYNOLDS JF, 1982, ANN BOT-LONDON, V49, P585, DOI 10.1093/oxfordjournals.aob.a086286; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scheiter S, 2007, AM NAT, V170, P587, DOI 10.1086/521317; Scheiter S, 2009, GLOBAL CHANGE BIOL, V15, P2224, DOI 10.1111/j.1365-2486.2008.01838.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Schroter D, 2004, BASIC APPL ECOL, V5, P515, DOI 10.1016/j.baae.2004.09.006; THORNLEY JH, 1972, ANN BOT-LONDON, V36, P419, DOI 10.1093/oxfordjournals.aob.a084601; THORNLEY JH, 1972, ANN BOT-LONDON, V36, P431, DOI 10.1093/oxfordjournals.aob.a084602; TILMAN D, 1988; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; WOLFSON M, 1999, VELD MANAGEMENT S AF, P91; WOODWARD SJR, 1997, AGR SYSTEMS MODELING, P419; Xu CL, 2005, J MATH BIOL, V50, P663, DOI 10.1007/s00285-004-0303-5; Yang ZJ, 2005, ECOL MODEL, V181, P59, DOI 10.1016/j.ecolmodel.2004.06.023	39	6	6	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61149	10.1371/journal.pone.0061149	http://dx.doi.org/10.1371/journal.pone.0061149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637792	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800006
J	Colli, LM; Saggioro, F; Serafini, LN; Camargo, RC; Machado, HR; Moreira, AC; Antonini, SR; de Castro, M				Colli, Leandro Machado; Saggioro, Fabiano; Serafini, Luciano Neder; Camargo, Renata Costa; Machado, Helio Rubens; Moreira, Ayrton Custodio; Antonini, Sonir R.; de Castro, Margaret			Components of the Canonical and Non-Canonical Wnt Pathways Are Not Mis-Expressed in Pituitary Tumors	PLOS ONE			English	Article							BETA-CATENIN; SIGNALING PATHWAY; CELL-MIGRATION; ADAMANTINOMATOUS CRANIOPHARYNGIOMAS; DIFFERENTIAL EXPRESSION; CCN5/WISP-2 EXPRESSION; THERAPEUTIC TARGET; COLORECTAL-CANCER; MUTATIONS; GENE	Introduction: Canonical and non-canonical Wnt pathways are involved in the genesis of multiple tumors; however, their role in pituitary tumorigenesis is mostly unknown. Objective: This study evaluated gene and protein expression of Wnt pathways in pituitary tumors and whether these expression correlate to clinical outcome. Materials and Methods: Genes of the Wnt canonical pathway: activating ligands (WNT11, WNT4, WNT5A), binding inhibitors (DKK3, sFRP1), beta-catenin (CTNNB1), beta-catenin degradation complex (APC, AXIN1, GSK3 beta), inhibitor of beta-catenin degradation complex (AKT1), sequester of beta-catenin (CDH1), pathway effectors (TCF7, MAPK8, NFAT5), pathway mediators (DVL-1, DVL-2, DVL-3, PRICKLE, VANGL1), target genes (MYB, MYC, WISP2, SPRY1, TP53, CCND1); calcium dependent pathway (PLCB1, CAMK2A, PRKCA, CHP); and planar cell polarity pathway (PTK7, DAAM1, RHOA) were evaluated by QPCR, in 19 GH-, 18 ACTH-secreting, 21 non-secreting (NS) pituitary tumors, and 5 normal pituitaries. Also, the main effectors of canonical (beta-catenin), planar cell polarity (JNK), and calcium dependent (NFAT5) Wnt pathways were evaluated by immunohistochemistry. Results: There are no differences in gene expression of canonical and non-canonical Wnt pathways between all studied subtypes of pituitary tumors and normal pituitaries, except for WISP2, which was over-expressed in ACTH-secreting tumors compared to normal pituitaries (4.8x; p = 0.02), NS pituitary tumors (7.7x; p = 0.004) and GH-secreting tumors (5.0x; p = 0.05). beta-catenin, NFAT5 and JNK proteins showed no expression in normal pituitaries and in any of the pituitary tumor subtypes. Furthermore, no association of the studied gene or protein expression was observed with tumor size, recurrence, and progressive disease. The hierarchical clustering showed a regular pattern of genes of the canonical and non-canonical Wnt pathways randomly distributed throughout the dendrogram. Conclusions: Our data reinforce previous reports suggesting no activation of canonical Wnt pathway in pituitary tumorigenesis. Moreover, we describe, for the first time, evidence that non-canonical Wnt pathways are also not misexpressed in the pituitary tumors.	[Colli, Leandro Machado; Camargo, Renata Costa; Moreira, Ayrton Custodio; de Castro, Margaret] Univ Sao Paulo, Dept Internal Med, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Saggioro, Fabiano; Serafini, Luciano Neder] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, Sao Paulo, Brazil; [Machado, Helio Rubens] Univ Sao Paulo, Dept Surg, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Antonini, Sonir R.] Univ Sao Paulo, Dept Pediat, Sch Med Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	de Castro, M (corresponding author), Univ Sao Paulo, Dept Internal Med, Sch Med Ribeirao Preto, Sao Paulo, Brazil.	castrom@fmrp.usp.br	Colli, Leandro/A-3445-2009; de Castro, Margaret/A-4918-2009; Antonini, Sonir RR/J-5264-2015; Machado, Helio R/I-6602-2012	Colli, Leandro/0000-0001-6928-1195; de Castro, Margaret/0000-0003-4932-4623; Machado, Helio/0000-0002-1069-7804; Antonini, Sonir/0000-0003-4778-8803	Sao Paulo Research Foundation (FAPESP) [2010/01286-7, 2007/58365-3]; Brazilian National Council for Research and Development (CNPq) [2008/3003867]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo Research Foundation (FAPESP grant numbers 2010/01286-7 and 2007/58365-3) and Brazilian National Council for Research and Development (CNPq grant number 2008/3003867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Buslei R, 2005, ACTA NEUROPATHOL, V109, P589, DOI 10.1007/s00401-005-1004-x; Campanini ML, 2010, HORMONES CANC; Castinetti F, 2011, ENDOCR REV, V32, P453, DOI 10.1210/er.2010-0011; Chen X, 2008, ACTA BIOCH BIOPH SIN, V40, P577, DOI 10.1111/j.1745-7270.2008.00440.x; Davies SR, 2010, INT J ONCOL, V36, P1129, DOI 10.3892/ijo_00000595; Duong MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002538; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Ferrand N, 2012, BIOCHEM J, V447, P71, DOI 10.1042/BJ20120311; Gaston-Massuet C, 2011, P NATL ACAD SCI USA, V108, P11482, DOI 10.1073/pnas.1101553108; Gueorguiev M, 2011, NAT REV ENDOCRINOL, V7, P71, DOI 10.1038/nrendo.2010.233; Gueorguiev M, 2009, PITUITARY, V12, P245, DOI 10.1007/s11102-008-0147-x; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Holsken A, 2010, ACTA NEUROPATHOL, V119, P631, DOI 10.1007/s00401-010-0642-9; Howng SL, 2002, CANCER LETT, V183, P95, DOI 10.1016/S0304-3835(02)00085-X; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Kaltsas GA, 2002, CLIN ENDOCRINOL, V57, P443, DOI 10.1046/j.1365-2265.2002.01643.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katoh M, 2005, ONCOL REP, V14, P1583; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Leal LF, 2011, J CLIN ENDOCR METAB, V96, P3106, DOI 10.1210/jc.2011-0363; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Miyakoshi T, 2008, ENDOCR PATHOL, V19, P261, DOI 10.1007/s12022-008-9048-9; Miyata N, 2012, PANCREAS; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Ruebel KH, 2001, ENDOCR PATHOL, V12, P125, DOI 10.1385/EP:12:2:125; Sekine S, 2002, AM J PATHOL, V161, P1997, DOI 10.1016/S0002-9440(10)64477-X; Semba S, 2001, CANCER, V91, P42, DOI 10.1002/1097-0142(20010101)91:1<42::AID-CNCR6>3.0.CO;2-7; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Sun CL, 2005, J NEURO-ONCOL, V73, P131, DOI 10.1007/s11060-004-4597-3; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Yagyu R, 2002, INT J ONCOL, V20, P1173; Zhuang ZP, 1997, CANCER RES, V57, P5446; Zieglschmid V, 2007, ANTICANCER RES, V27, P1769	45	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62424	10.1371/journal.pone.0062424	http://dx.doi.org/10.1371/journal.pone.0062424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638078	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700054
J	Berrou, J; Fougeray, S; Venot, M; Chardiny, V; Gautier, JF; Dulphy, N; Toubert, A; Peraldi, MN				Berrou, Jeannig; Fougeray, Sophie; Venot, Marion; Chardiny, Victor; Gautier, Jean-Francois; Dulphy, Nicolas; Toubert, Antoine; Peraldi, Marie-Noelle			Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 Diabetes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CYTOKINE PRODUCTION; OXIDATIVE STRESS; NK CELLS; IN-VIVO; RECEPTOR; EXPRESSION; NKG2D; HYPERGLYCEMIA; ACTIVATION	Patients with Type 2 diabetes (T2D) are highly susceptible to infection and have an increased incidence of some tumors, possibly due to immune system dysfunction. In the innate cellular immune system, Natural Killer (NK) lymphocytes are important effectors responsible for controlling infections and combating tumor development. We analyzed NK cell subsets in 51 patients with long-standing T2D. Compared with healthy blood donors, diabetic patients showed a profound decrease in both NKG2D-positive NK cells (44% vs. 55.5%, P<0.01) and NKp46-positive cells (26% vs. 50%, P<0.01). Decreased expression of these receptors was associated with functional defects, such as reduced NK degranulation capacity when challenged with the tumor target cell line K562 (10.3 vs. 15.8%, P<0.05). This defect could be restored in vitro by stimulating NK cells from T2D patients with IL-15 (P<0.05). NKG2D expression was found to be negatively correlated with HBA1c level (r = 20.50; P = 0.009), suggesting that sustained hyperglycemia could directly influence NK cell defects. We demonstrated that endoplasmic reticulum (ER) stress, an important mediator in diabetes-associated complications, was inducible in vitro in normal NK cells and that tunicamycin treatment resulted in a significant decrease in NKG2D expression (P<0.05). Furthermore, markers of the Unfolded Protein Response (UPR) BiP, PDI and sXBP1 mRNAs were significantly increased in NK cells from T2D patients (P<0.05, P<0.01, P<0.05, respectively), indicating that ER stress is activated in vivo through both PERK and IRE1 sensors. These results demonstate for the first time defects in NK cell-activating receptors NKG2D and NKp46 in T2D patients, and implicate the UPR pathway as a potential mechanism. These defects may contribute to susceptibility to infections and malignancies and could be targetted therapeutically.	[Berrou, Jeannig; Venot, Marion; Chardiny, Victor; Dulphy, Nicolas; Toubert, Antoine; Peraldi, Marie-Noelle] INSERM, UMR 90, Paris, France; [Berrou, Jeannig; Dulphy, Nicolas; Toubert, Antoine] Hop St Louis, AP HP, Ctr Invest Biomed H O G, Paris, France; [Fougeray, Sophie] Ctr Univ St Peres, INSERM U775, Paris, France; [Fougeray, Sophie] Univ Paris 05, Paris, France; [Gautier, Jean-Francois] Hop St Louis, AP HP, Dept Endocrinol & Diabet, Paris, France; [Gautier, Jean-Francois; Dulphy, Nicolas; Toubert, Antoine; Peraldi, Marie-Noelle] Univ Paris 07, Paris, France; [Dulphy, Nicolas; Toubert, Antoine] Univ Paris Diderot, Inst Univ Hematol, Paris, France; [Peraldi, Marie-Noelle] Hop St Louis, AP HP, Nephrol & Transplantat Dept, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Peraldi, MN (corresponding author), INSERM, UMR 90, Paris, France.	mnperaldi@gmail.com	Dulphy, Nicolas/J-5960-2017; Toubert, Antoine/Q-3404-2017; Fougeray, Sophie/M-2310-2015	Dulphy, Nicolas/0000-0002-1243-6456; Toubert, Antoine/0000-0002-7308-7317; Fougeray, Sophie/0000-0002-5745-3831	INSERM (French public research)	INSERM (French public research)	This work was supported by INSERM (French public research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson C, 2010, CLIN EXP IMMUNOL, V161, P48, DOI 10.1111/j.1365-2249.2010.04114.x; Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; American Diabetes Association, 2009, DIABETES CARE, V32, P13; Basha B, 2012, EXP DIABETES RES, V48, P1; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Claus M, 2009, J IMMUNOL METHODS, V341, P154, DOI 10.1016/j.jim.2008.11.006; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Fischer L, 2006, EXP HEMATOL, V34, P753, DOI 10.1016/j.exphem.2006.02.015; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Hand WL, 2007, DIABETES RES CLIN PR, V76, P44, DOI 10.1016/j.diabres.2006.07.015; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kuznetsov G, 1996, P NATL ACAD SCI USA, V93, P8584, DOI 10.1073/pnas.93.16.8584; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Morgan CL, 2010, DIABETIC MED, V27, P673, DOI [10.1111/j.1464-5491.2010.02912.x, 10.1111/j.1464-5491.2009.02912.x]; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Peraldi MN, 2009, J IMMUNOL, V182, P1696, DOI 10.4049/jimmunol.182.3.1696; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rodacki M, 2007, DIABETES, V56, P177, DOI 10.2337/db06-0493; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Stegenga ME, 2008, DIABETIC MED, V25, P157, DOI 10.1111/j.1464-5491.2007.02348.x; Stegenga ME, 2008, BLOOD, V112, P82, DOI 10.1182/blood-2007-11-121723; Stevens LA, 2010, NEPHROL DIAL TRANSPL, V25, P449, DOI 10.1093/ndt/gfp510; Tang C, 2012, DIABETOLOGIA, V55, P1366, DOI 10.1007/s00125-012-2474-8; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Veiga-Fernandes H, 2010, J EXP MED, V207, P269, DOI 10.1084/jem.20100105; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Xia MC, 2011, CIRCULATION, V124, P2933, DOI 10.1161/CIRCULATIONAHA.111.034850; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhong YM, 2012, DIABETES, V61, P492, DOI 10.2337/db11-0315; Zwirner NW, 1999, HUM IMMUNOL, V60, P323, DOI 10.1016/S0198-8859(98)00128-1	43	76	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62418	10.1371/journal.pone.0062418	http://dx.doi.org/10.1371/journal.pone.0062418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638076	Green Submitted, gold, Green Published			2022-12-25	WOS:000318341400054
J	Freeman, D; Cedillos, R; Choyke, S; Lukic, Z; McGuire, K; Marvin, S; Burrage, AM; Sudholt, S; Rana, A; O'Connor, C; Wiethoff, CM; Campbell, EM				Freeman, David; Cedillos, Rudy; Choyke, Samantha; Lukic, Zana; McGuire, Kathleen; Marvin, Shauna; Burrage, Andrew M.; Sudholt, Stacey; Rana, Ajay; O'Connor, Christopher; Wiethoff, Christopher M.; Campbell, Edward M.			Alpha-Synuclein Induces Lysosomal Rupture and Cathepsin Dependent Reactive Oxygen Species Following Endocytosis	PLOS ONE			English	Article							FLUORESCENT PROTEIN INDICATORS; TO-CELL TRANSMISSION; PARKINSONS-DISEASE; VESICLE PERMEABILIZATION; NALP3 INFLAMMASOME; DEATH; NEUROINFLAMMATION; MECHANISMS; INCLUSIONS; INDUCTION	alpha-synuclein dysregulation is a critical aspect of Parkinson's disease pathology. Recent studies have observed that alpha-synuclein aggregates are cytotoxic to cells in culture and that this toxicity can be spread between cells. However, the molecular mechanisms governing this cytotoxicity and spread are poorly characterized. Recent studies of viruses and bacteria, which achieve their cytoplasmic entry by rupturing intracellular vesicles, have utilized the redistribution of galectin proteins as a tool to measure vesicle rupture by these organisms. Using this approach, we demonstrate that alpha-synuclein aggregates can induce the rupture of lysosomes following their endocytosis in neuronal cell lines. This rupture can be induced by the addition of alpha-synuclein aggregates directly into cells as well as by cell-to-cell transfer of alpha-synuclein. We also observe that lysosomal rupture by alpha-synuclein induces a cathepsin B dependent increase in reactive oxygen species (ROS) in target cells. Finally, we observe that alpha-synuclein aggregates can induce inflammasome activation in THP-1 cells. Lysosomal rupture is known to induce mitochondrial dysfunction and inflammation, both of which are well established aspects of Parkinson's disease, thus connecting these aspects of Parkinson's disease to the propagation of alpha-synuclein pathology in cells.	[Freeman, David; Cedillos, Rudy; Choyke, Samantha; Lukic, Zana] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA; [McGuire, Kathleen; Marvin, Shauna; Burrage, Andrew M.; Wiethoff, Christopher M.; Campbell, Edward M.] Loyola Univ Chicago, Dept Microbiol & Immunol, Stritch Sch Med, Maywood, IL USA; [Rana, Ajay] Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL USA; [Sudholt, Stacey] Missouri Sch Med, Columbia, MO USA; [O'Connor, Christopher] North Cent Coll, Dept Biol Sci, Naperville, IL USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Campbell, EM (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA.	ecampbell@lumc.edu	Rana, Ajay/ABE-3739-2020	Rana, Ajay/0000-0003-0951-2566	NIAID NIH HHS [T32 AI007508] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007508] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Barlan AU, 2011, VIROLOGY, V412, P306, DOI 10.1016/j.virol.2011.01.019; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Cesen MH, 2012, EXP CELL RES, V318, P1245, DOI 10.1016/j.yexcr.2012.03.005; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jensen MB, 2011, J BIOL CHEM, V286, P42603, DOI 10.1074/jbc.M111.271130; Kaul S, 2005, MOL BRAIN RES, V139, P137, DOI 10.1016/j.molbrainres.2005.05.022; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2012, METHODS MOL BIOL, V849, P347, DOI 10.1007/978-1-61779-551-0_23; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maier O, 2012, J VIROL, V86, P10821, DOI 10.1128/JVI.01428-12; Maier O, 2010, VIROLOGY, V402, P11, DOI 10.1016/j.virol.2010.03.043; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; McGuire KA, 2011, J VIROL, V85, P10806, DOI 10.1128/JVI.00675-11; Miyazawa N, 2001, J VIROL, V75, P1387, DOI 10.1128/JVI.75.3.1387-1400.2001; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Mogi M, 2000, J NEURAL TRANSM, V107, P335, DOI 10.1007/s007020050028; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Ray K, 2010, CELL MICROBIOL, V12, P545, DOI 10.1111/j.1462-5822.2010.01428.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shayakhmetov DM, 2003, J VIROL, V77, P3712, DOI 10.1128/JVI.77.6.3712-3723.2003; Steiner JA, 2011, CELL DEATH DIFFER, V18, P1425, DOI 10.1038/cdd.2011.53; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	51	154	155	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62143	10.1371/journal.pone.0062143	http://dx.doi.org/10.1371/journal.pone.0062143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634225	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400036
J	Wong, VWS; Tse, CH; Lam, TTY; Wong, GLH; Chim, AML; Chu, WCW; Yeung, DKW; Law, PTW; Kwan, HS; Yu, J; Sung, JJY; Chan, HLY				Wong, Vincent Wai-Sun; Tse, Chi-Hang; Lam, Tommy Tsan-Yuk; Wong, Grace Lai-Hung; Chim, Angel Mei-Ling; Chu, Winnie Chiu-Wing; Yeung, David Ka-Wai; Law, Patrick Tik-Wan; Kwan, Hoi-Shan; Yu, Jun; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen			Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis - A Longitudinal Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INDUCED HEPATIC STEATOSIS; GUT MICROBIOTA; ADVANCED FIBROSIS; ASSOCIATION; PROBIOTICS; SIGNATURES; ENDOTOXIN; INFERENCE; OBESITY	Background: The human gut microbiota has profound influence on host metabolism and immunity. This study characterized the fecal microbiota in patients with nonalcoholic steatohepatitis (NASH). The relationship between microbiota changes and changes in hepatic steatosis was also studied. Methods: Fecal microbiota of histology-proven NASH patients and healthy controls was analyzed by 16S ribosomal RNA pyrosequencing. NASH patients were from a previously reported randomized trial on probiotic treatment. Proton-magnetic resonance spectroscopy was performed to monitor changes in intrahepatic triglyceride content (IHTG). Results: A total of 420,344 16S sequences with acceptable quality were obtained from 16 NASH patients and 22 controls. NASH patients had lower fecal abundance of Faecalibacterium and Anaerosporobacter but higher abundance of Parabacteroides and Allisonella. Partial least-square discriminant analysis yielded a model of 10 genera that discriminated NASH patients from controls. At month 6, 6 of 7 patients in the probiotic group and 4 of 9 patients in the usual care group had improvement in IHTG (P = 0.15). Improvement in IHTG was associated with a reduction in the abundance of Firmicutes (R-2 = 0.4820, P = 0.0028) and increase in Bacteroidetes (R-2 = 0.4366, P = 0.0053). This was accompanied by corresponding changes at the class, order and genus levels. In contrast, bacterial biodiversity did not differ between NASH patients and controls, and did not change with probiotic treatment. Conclusions: NASH patients have fecal dysbiosis, and changes in microbiota correlate with improvement in hepatic steatosis. Further studies are required to investigate the mechanism underlying the interaction between gut microbes and the liver.	[Wong, Vincent Wai-Sun; Tse, Chi-Hang; Wong, Grace Lai-Hung; Chim, Angel Mei-Ling; Yu, Jun; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Wong, Vincent Wai-Sun; Tse, Chi-Hang; Wong, Grace Lai-Hung; Chim, Angel Mei-Ling; Yu, Jun; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Lam, Tommy Tsan-Yuk] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Chu, Winnie Chiu-Wing] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Yeung, David Ka-Wai] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Law, Patrick Tik-Wan; Kwan, Hoi-Shan] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Oxford; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, VWS (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	wongv@cuhk.edu.hk	Yu, Jun/D-8569-2015; Sung, Joseph J. Y./R-3203-2018; Chan, Henry Lik-Yuen/B-9636-2008; Kwan, Hoi Shan/GOV-6863-2022; Chu, Winnie CW/F-8449-2014; Wong, Vincent WS/K-3864-2014; Lam, Tsan Yuk/D-4837-2012	Yu, Jun/0000-0001-5008-2153; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Chu, Winnie CW/0000-0003-4962-4132; Wong, Vincent WS/0000-0003-2215-9410; Kwan, Hoi Shan/0000-0002-7943-2513; Wong, Grace Lai-Hung/0000-0002-2863-9389; Lam, Tsan Yuk/0000-0002-9769-1527	Chinese University of Hong Kong [2010.1.042]; Roche; Novartis; Abbott Diagnostics; Echosens; Otsuka; Abbott; Bristol-Myers Squibb; Gilead; Glaxo-Smith-Kline; Merck	Chinese University of Hong Kong(Chinese University of Hong Kong); Roche(Roche Holding); Novartis(Novartis); Abbott Diagnostics(Abbott Laboratories); Echosens; Otsuka(Otsuka Pharmaceutical); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Glaxo-Smith-Kline(GlaxoSmithKline); Merck(Merck & Company)	The work described in this paper was partially supported by the Direct Grant of The Chinese University of Hong Kong (Reference no. 2010.1.042). The additional part of the funding of our study came from the authors' own team. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Vincent Wai-Sun Wong has been an advisory board member of Roche, Novartis, Gilead and Otsuka, and received paid lecture fees from Roche, Novartis, Abbott Diagnostics and Echosens. Grace Lai-Hung Wong has been an advisory board member of Otsuka, and received paid lecture fees from Echosens and Otsuka. Henry Lik-Yuen Chan has been consultant for Abbott, Bristol-Myers Squibb, Merck, Novartis and Roche, and received paid lecture fees from Abbott, Bristol-Myers Squibb, Echosens, Gilead, Glaxo-Smith-Kline, Merck, Novartis and Roche. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aller R, 2011, EUR REV MED PHARMACO, V15, P1090; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Wit N, 2012, AM J PHYSIOL-GASTR L, V303, pG589, DOI 10.1152/ajpgi.00488.2011; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Malaguarnera M, 2012, DIGEST DIS SCI, V57, P545, DOI 10.1007/s10620-011-1887-4; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Nardone G, 2010, AM J PHYSIOL-GASTR L, V299, pG669, DOI 10.1152/ajpgi.00188.2010; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Verdam FJ, 2011, J CLIN GASTROENTEROL, V45, P149, DOI 10.1097/MCG.0b013e3181e12c24; Wagnerberger S, 2012, BRIT J NUTR, V107, P1727, DOI 10.1017/S0007114511004983; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wong VWS, 2013, ANN HEPATOL, V12, P256, DOI 10.1016/S1665-2681(19)31364-X; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Wong VWS, 2011, GUT, V60, P1721, DOI 10.1136/gut.2011.242016; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	44	212	220	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62885	10.1371/journal.pone.0062885	http://dx.doi.org/10.1371/journal.pone.0062885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638162	Green Published, gold			2022-12-25	WOS:000318341400073
J	Feng, JY; Guo, H; Li, S; Lu, T				Feng, Jianyu; Guo, Hong; Li, Sen; Lu, Tun			A Study of the Mechanism of the Chaperone-like Function of an scFv of Human Creatine Kinase by Computer Simulation	PLOS ONE			English	Article							C-TERMINAL DOMAIN; PHAGE DISPLAY; MOLECULAR CHAPERONES; COMPUTATIONAL DESIGN; HUMAN-ANTIBODIES; PROTEIN-DOCKING; LINKER; SPECIFICITY; STABILITY; SELECTION	A new application of antibodies is to use them as macromolecular chaperones. Protein antigens usually have multiple epitopes, thus, there may be a plurality of antibodies binding to one antigen. However, not all antibodies that bind to one antigen could act as a chaperone. Experiments show that some screened anti-human creatine kinase single chain antibodies (scFV) could assist in the folding and stabilizing of the enzyme, while others could not. We built the model of the single chain antibody (scFv-A4) that increased the stability of human creatine kinase (HCK) by the homology modeling method. Epitopes of human creatine kinase were predicted by computer and then the binding of scFv-A4 and HCK was modeled with computer. The calculation results were further combined with the peptide array membrane experiment results to obtain reliable models for the scFv-A4-HCK complex. Based on the above study we gave an explanation about how scFv-A4 could act as a macromolecular chaperone assisting the folding of HCK. This study provides an approach for predicting antigen-antibody binding mode and also a useful theoretical guidance for the study of antibodies' chaperone-like function.	[Feng, Jianyu; Lu, Tun] Fuzhou Univ, Coll Biol Sci & Engn, Fuzhou 350002, Peoples R China; [Guo, Hong] Fuzhou Univ, Coll Math & Comp Sci, Fuzhou 350002, Peoples R China; [Li, Sen] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Genet Engn Drugs & Biotechnol, Beijing 100875, Peoples R China	Fuzhou University; Fuzhou University; Beijing Normal University	Li, S (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Genet Engn Drugs & Biotechnol, Beijing 100875, Peoples R China.	lisen@bnu.edu.cn; lvtun@yahoo.com			National Natural Science Foundation of China [30800188, 51139005]; Fundamental Research Funds for the Central Universities [105564GK]; cooperation project of Industry, Education and Academy; Fuzhou Science and Technology Bureau [2012-G106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); cooperation project of Industry, Education and Academy; Fuzhou Science and Technology Bureau	This work is financially supported by the National Natural Science Foundation of China (No.30800188 and No.51139005), Fundamental Research Funds for the Central Universities (No.105564GK), and the cooperation project of Industry, Education and Academy sponsored by Fuzhou Science and Technology Bureau (No.2012-G106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Burklen TS, 2006, J BIOMEDICINE BIOTEC, V2006; Cattaneo A, 1999, TRENDS BIOTECHNOL, V17, P115, DOI 10.1016/S0167-7799(98)01268-2; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen Z, 2012, BIOPHYS J, V103, P558, DOI 10.1016/j.bpj.2012.07.002; Chiari M, 2005, PROTEOMICS, V5, P3600, DOI 10.1002/pmic.200401216; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; Ermolenko DN, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1233, DOI 10.1007/s10541-005-0069-4; ESWAR N, 2007, CURR PROTOC PROTEIN, V2, P15; Feng S, 2007, INT J BIOCHEM CELL B, V39, P392, DOI 10.1016/j.biocel.2006.09.004; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; GROSS M, 1994, PROTEIN SCI, V3, P1058, DOI 10.1002/pro.5560030708; Grover A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S30; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; He HW, 2007, INT J BIOCHEM CELL B, V39, P1816, DOI 10.1016/j.biocel.2007.04.028; He HW, 2005, BIOPHYS J, V89, P2650, DOI 10.1529/biophysj.105.066142; Heller Kira, 2010, PLoS Biol, V8, pe1000290, DOI 10.1371/journal.pbio.1000290; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Kabat EA, 1991, SEQUENCES PROTEINS I; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li S, 2013, SCFV ANTIBO IN PRESS; Liu YM, 2009, INT J BIOL MACROMOL, V44, P271, DOI 10.1016/j.ijbiomac.2008.12.016; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; McCully ME, 2010, BIOPHYS J, V99, P1628, DOI 10.1016/j.bpj.2010.06.040; MORRIS GE, 1990, BIOCHIM BIOPHYS ACTA, V1039, P318, DOI 10.1016/0167-4838(90)90265-H; Neckers Len, 2007, V2, P231; Nilsson F, 2000, ADV DRUG DELIVER REV, V43, P165, DOI 10.1016/S0169-409X(00)00068-5; Nosaka K, 2002, SCAND J MED SCI SPOR, V12, P337, DOI 10.1034/j.1600-0838.2002.10178.x; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; Sammond DW, 2010, PROTEINS, V78, P1055, DOI 10.1002/prot.22631; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2002, BBA-GENE STRUCT EXPR, V1579, P124, DOI 10.1016/S0167-4781(02)00530-4; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Webb T, 1997, BIOCHEM J, V321, P83, DOI 10.1042/bj3210083; Yokota S, 2000, CELL STRESS CHAPERON, V5, P337, DOI 10.1379/1466-1268(2000)005<0337:AACCIH>2.0.CO;2; Yu R, 2009, J BIOMOL SCREEN, V14, P991, DOI 10.1177/1087057109343206	46	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62147	10.1371/journal.pone.0062147	http://dx.doi.org/10.1371/journal.pone.0062147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637984	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400077
J	Newton, C; Bracken, MES; McConville, M; Rodrigue, K; Thornber, CS				Newton, Christine; Bracken, Matthew E. S.; McConville, Megan; Rodrigue, Katherine; Thornber, Carol S.			Invasion of the Red Seaweed Heterosiphonia japonica Spans Biogeographic Provinces in the Western North Atlantic Ocean	PLOS ONE			English	Article							CLIMATE-CHANGE; ALGA; RHODOPHYTA; CERAMIALES; BIODIVERSITY; REPRODUCTION; DASYACEAE; IMPACTS	The recent invasion of the red alga Heterosiphonia japonica in the western North Atlantic Ocean has provided a unique opportunity to study invasion dynamics across a biogeographical barrier. Native to the western North Pacific Ocean, initial collections in 2007 and 2009 restricted the western North Atlantic range of this invader to Rhode Island, USA. However, through subtidal community surveys, we document the presence of Heterosiphonia in coastal waters from Maine to New York, USA, a distance of more than 700 km. This geographical distribution spans a well-known biogeographical barrier at Cape Cod, Massachusetts. Despite significant differences in subtidal community structure north and south of Cape Cod, Heterosiphonia was found at all but two sites surveyed in both biogeographic provinces, suggesting that this invader is capable of rapid expansion over broad geographic ranges. Across all sites surveyed, Heterosiphonia comprised 14% of the subtidal benthic community. However, average abundances of nearly 80% were found at some locations. As a drifting macrophyte, Heterosiphonia was found as intertidal wrack in abundances of up to 65% of the biomass washed up along beaches surveyed. Our surveys suggest that the high abundance of Heterosiphonia has already led to marked changes in subtidal community structure; we found significantly lower species richness in recipient communities with higher Heterosiphona abundances. Based on temperature and salinity tolerances of the European populations, we believe Heterosiphonia has the potential to invade and alter subtidal communities from Florida to Newfoundland in the western North Atlantic.	[Newton, Christine; Bracken, Matthew E. S.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [McConville, Megan; Rodrigue, Katherine; Thornber, Carol S.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	Northeastern University; University of Rhode Island	Newton, C (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	newton.c@husky.neu.edu	Thornber, Carol/B-5786-2014; Bracken, Matthew E S/B-1259-2008; Bracken, Matthew E.S./I-9359-2019	Thornber, Carol/0000-0003-0034-1035; Bracken, Matthew E S/0000-0002-0068-7485; Bracken, Matthew E.S./0000-0002-0068-7485	Woods Hole Sea Grant [A100923]	Woods Hole Sea Grant	This work was funded by Woods Hole Sea Grant (Subaward A100923 to M. E. S. B and C. S. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Bjaerke MR, 2004, BOT MAR, V47, P373, DOI 10.1515/BOT.2004.055; Choi CG, 2009, J FAC AGR KYUSHU U, V54, P339; Humm H. J., 1968, PHYCOLOGIA, V7, P43, DOI DOI 10.2216/I0031-8884-7-1-43.1; Husa V, 2004, SARSIA, V89, P211, DOI 10.1080/00364820410006600; Husa V, 2008, MAR BIOL RES, V4, P414, DOI 10.1080/17451000802232874; Husa V, 2006, BOT MAR, V49, P191, DOI 10.1515/BOT.2006.024; Jones E, 2010, MAR ECOL PROG SER, V400, P87, DOI 10.3354/meps08391; Kang CK, 2008, MAR BIOL, V153, P1181, DOI 10.1007/s00227-007-0890-y; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Savoie A. M., 2013, BioInvasions Records, V2, P27; Schneider CW, 2010, J PHYCOL, V46, P653, DOI 10.1111/j.1529-8817.2010.00866.x; Sjotun K., 2008, Aquatic Invasions, V3, P377, DOI 10.3391/ai.2008.3.4.3; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Thomsen MS, 2009, J PHYCOL, V45, P812, DOI 10.1111/j.1529-8817.2009.00709.x; Underwood AJ, 1997, EXPT ECOLOGY; Wethey DS, 2002, INTEGR COMP BIOL, V42, P872, DOI 10.1093/icb/42.4.872; Williams SL, 2007, ANNU REV ECOL EVOL S, V38, P327, DOI 10.1146/annurev.ecolsys.38.091206.095543	23	14	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62261	10.1371/journal.pone.0062261	http://dx.doi.org/10.1371/journal.pone.0062261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638018	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400089
J	Svensson, M; Dahlberg, A; Ranius, T; Thor, G				Svensson, Mans; Dahlberg, Anders; Ranius, Thomas; Thor, Goran			Occurrence Patterns of Lichens on Stumps in Young Managed Forests	PLOS ONE			English	Article							DEAD WOOD; SPECIES-DIVERSITY; BOREAL FORESTS; DYNAMICS; BIODIVERSITY; BRYOPHYTES; FIRES	The increasing demand for forest-derived bio-fuel may decrease the amount of dead wood and hence also the amount of available substrate for saproxylic (= dead-wood dependent) organisms. Cut stumps constitute a large portion of dead wood in managed boreal forests. The lichen flora of such stumps has received little interest. Therefore, we investigated which lichens that occur on stumps in young (4-19 years), managed forests and analyzed how species richness and occurrence of individual species were related to stump and stand characteristics. We performed lichen inventories of 576 Norway spruce stumps in 48 forest stands in two study areas in Central Sweden, recording in total 77 lichen species. Of these, 14 were obligately lignicolous, while the remaining were generalists that also grow on bark, soil or rocks. We tested the effect of characteristics reflecting successional stage, microclimate, substrate patch size, and the species pool in the surrounding area on (1) total lichen species richness, (2) species richness of obligately lignicolous lichens and (3) the occurrence of four obligately lignicolous lichen species. The most important variables were stump age, with more species on old stumps, and study area, with similar total species richness but differences in occupancy for individual species. Responses for total lichen species richness and species richness of obligately lignicolous lichens were overall similar, indicating similar ecological requirements of these two groups. Our results indicate that species richness measurements serve as poor proxies for the responses of individual, obligately lignicolous lichen species.	[Svensson, Mans; Ranius, Thomas; Thor, Goran] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Dahlberg, Anders] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Svensson, M (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	mans.svensson@slu.se			Swedish Energy Agency [30651-1]; Future Forests; Foundation for Strategic Environmental Research (MISTRA); Swedish Forestry Industry; Swedish University of Agricultural Sciences (SLU); Umea University; Forestry Research Institute of Sweden	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Future Forests; Foundation for Strategic Environmental Research (MISTRA); Swedish Forestry Industry; Swedish University of Agricultural Sciences (SLU); Umea University; Forestry Research Institute of Sweden	This study was supported by the Swedish Energy Agency (grant nr 30651-1) and by Future Forests, a multidisciplinary research programme supported by the Foundation for Strategic Environmental Research (MISTRA), the Swedish Forestry Industry, the Swedish University of Agricultural Sciences (SLU), Umea University, and the Forestry Research Institute of Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K., 2010, **DATA OBJECT**; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bjorheden R, 2006, BIOMASS BIOENERG, V30, P289, DOI 10.1016/j.biombioe.2005.07.005; Bogomazova K, 2012, ECOLOGY CLADONIA BOT; Bouget C, 2012, CAN J FOREST RES, V42, P1421, DOI [10.1139/X2012-078, 10.1139/x2012-078]; Brassard BW, 2006, CRIT REV PLANT SCI, V25, P115, DOI 10.1080/07352680500348857; Bunnell FL, 2008, CAN J FOREST RES, V38, P1033, DOI 10.1139/X07-206; Burnham K.P., 2010, MODEL SELECTION MULT; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; Caruso A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027936; Caruso A, 2009, BRYOLOGIST, V112, P520, DOI 10.1639/0007-2745-112.3.520; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Egnell G, 2007, MILJOKONSEKVENSER ST, V40; Erajaa S, 2010, SILVA FENN, V44, P203, DOI 10.14214/sf.150; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Fridman J, 2000, FOREST ECOL MANAG, V131, P23, DOI 10.1016/S0378-1127(99)00208-X; Gardenfors U., 2010, RED LIST SWEDISH SPE; Gelman A, 2009, ARM DATA ANAL USING; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hautala H, 2011, RESTOR ECOL, V19, P418, DOI 10.1111/j.1526-100X.2009.00545.x; Hottola J, 2008, BIODIVERS CONSERV, V17, P2559, DOI 10.1007/s10531-008-9317-4; Hyvarinen E, 2009, INSECT CONSERV DIVER, V2, P93, DOI 10.1111/j.1752-4598.2009.00048.x; Johansson V, 2012, ECOLOGY, V93, P235, DOI 10.1890/11-0760.1; Jonsson BG, 2005, SILVA FENN, V39, P289, DOI 10.14214/sf.390; Melin Y, 2009, FOREST ECOL MANAG, V257, P1445, DOI 10.1016/j.foreco.2008.12.020; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nascimbene J, 2008, BIODIVERS CONSERV, V17, P2661, DOI 10.1007/s10531-008-9344-1; Niklasson M, 2000, ECOLOGY, V81, P1484, DOI 10.1890/0012-9658(2000)081[1484:NASOFL]2.0.CO;2; Nordin A, 2012, SANTESSONS CHECKLIST; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranius T, 2000, BIOL CONSERV, V95, P85, DOI 10.1016/S0006-3207(00)00007-0; Riffell S, 2011, FOREST ECOL MANAG, V261, P878, DOI 10.1016/j.foreco.2010.12.021; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Sju┬rs H., 1999, ACTA PHYTOGEOGRAPHIC, V84, P5; SODERSTROM L, 1988, NORD J BOT, V8, P89, DOI 10.1111/j.1756-1051.1988.tb01709.x; Spribille T, 2008, ECOGRAPHY, V31, P741, DOI 10.1111/j.1600-0587.2008.05503.x; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Walmsley JD, 2010, FORESTRY, V83, P17, DOI 10.1093/forestry/cpp028	40	24	24	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62825	10.1371/journal.pone.0062825	http://dx.doi.org/10.1371/journal.pone.0062825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638150	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400127
J	von Helversen, B; Schooler, LJ; Czienskowski, U				von Helversen, Bettina; Schooler, Lael J.; Czienskowski, Uwe			Are Stripes Beneficial? Dazzle Camouflage Influences Perceived Speed and Hit Rates	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; COLOR PATTERN; GARTER SNAKE; MOVING-OBJECTS; PERCEPTION; SELECTION; FLICKER; MOTION	In the animal kingdom, camouflage refers to patterns that help potential prey avoid detection. Mostly camouflage is thought of as helping prey blend in with their background. In contrast, disruptive or dazzle patterns protect moving targets and have been suggested as an evolutionary force in shaping the dorsal patterns of animals. Dazzle patterns, such as stripes and zigzags, are thought to reduce the probability with which moving prey will be captured by impairing predators' perception of speed. We investigated how different patterns of stripes (longitudinal-i.e., parallel to movement direction- and vertical-i.e., perpendicular to movement direction) affect the probability with which humans can hit moving objects and if differences in hitting probability are caused by a misperception of speed. A first experiment showed that longitudinally striped objects were hit more often than unicolored objects. However, vertically striped objects did not differ from unicolored objects. A second study examining the link between perceived speed and hitting probability showed that longitudinally and vertically striped objects were both perceived as moving faster and were hit more often than unicolored objects. In sum, our results provide evidence that striped patterns disrupt the perception of speed, which in turn influences how often objects are hit. However, the magnitude and the direction of the effects depend on additional factors such as speed and the task setup.	[von Helversen, Bettina; Schooler, Lael J.; Czienskowski, Uwe] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [von Helversen, Bettina] Univ Basel, Dept Psychol, Basel, Switzerland	Max Planck Society; University of Basel	von Helversen, B (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	Bettina.vonhelversen@unibas.ch		von Helversen, Bettina/0000-0003-2004-6922	Max Planck Institute for Human Development	Max Planck Institute for Human Development	The research was funded by the Max Planck Institute for Human Development (http://www.mpib-berlin.mpg.de/de.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstis S, 2003, NEURAL NETWORKS, V16, P933, DOI 10.1016/S0893-6080(03)00111-4; Blakemore MR, 2000, VISION RES, V40, P629, DOI 10.1016/S0042-6989(99)00214-X; BRODIE ED, 1993, ANIM BEHAV, V45, P851, DOI 10.1006/anbe.1993.1106; BRODIE ED, 1992, EVOLUTION, V46, P1284, DOI 10.1111/j.1558-5646.1992.tb01124.x; BRODIE ED, 1989, NATURE, V342, P542, DOI 10.1038/342542a0; Brouwer AM, 2000, EXP BRAIN RES, V133, P242, DOI 10.1007/s002210000371; Brouwer AM, 2004, J VISION, V4, P575, DOI 10.1167/4.7.5; Brouwer AM, 2002, EXP BRAIN RES, V143, P198, DOI 10.1007/s00221-001-0980-x; Brown JF, 1931, PSYCHOL FORSCH, V14, P199, DOI 10.1007/BF00403873; Carretero MA, 2006, CAN J ZOOL, V84, P1594, DOI 10.1139/Z06-154; Creem SH, 2001, J EXP PSYCHOL HUMAN, V27, P218, DOI 10.1037/0096-1523.27.1.218; Creer DA, 2005, ETHOLOGY, V111, P287, DOI 10.1111/j.1439-0310.2004.01062.x; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Georges S, 2002, VISION RES, V42, P2757, DOI 10.1016/S0042-6989(02)00303-6; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; JACKSON JF, 1976, AM NAT, V110, P1029, DOI 10.1086/283125; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Lindell LE, 1996, CAN J ZOOL, V74, P2254, DOI 10.1139/z96-256; POUGH FH, 1976, COPEIA, P834, DOI 10.2307/1443481; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Scott-Samuel NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020233; SMEETS JBJ, 1995, J EXP PSYCHOL HUMAN, V21, P19, DOI 10.1037/0096-1523.21.1.19; Srygley RB, 1999, EVOL ECOL, V13, P691, DOI 10.1023/A:1011046202928; Stevens M, 2008, P ROY SOC B-BIOL SCI, V275, P2639, DOI 10.1098/rspb.2008.0877; Stevens M, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-81; STONE LS, 1992, VISION RES, V32, P1535, DOI 10.1016/0042-6989(92)90209-2; Taya S, 2007, PERCEPTION, V36, P3, DOI 10.1068/p5597; Thompson B, 2008, J VISION, V8, DOI 10.1167/8.4.22; Thompson P, 1997, VISION RES, V37, P1255, DOI 10.1016/S0042-6989(96)00302-1; Williams D., 2001, NAVAL CAMOUFLAGE 191	30	33	33	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61173	10.1371/journal.pone.0061173	http://dx.doi.org/10.1371/journal.pone.0061173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637795	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000318340400013
J	Brocqueville, G; Ndour, PA; Ouk, TS; Le Goff, A; De Witte, C; Mougel, A; Coll, J; Fafeur, V; Le Bourhis, X; Adriaenssens, E				Brocqueville, Guillaume; Ndour, Papa Alioune; Ouk, Tan-Sothea; Le Goff, Arnaud; De Witte, Caroline; Mougel, Alexandra; Coll, Jean; Fafeur, Veronique; Le Bourhis, Xuefen; Adriaenssens, Eric			LMP1-Induced Cell Death May Contribute to the Emergency of Its Oncogenic Property	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; NF-KAPPA-B; METASTATIC NASOPHARYNGEAL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; II LATENCY; 1 LMP1; ACTIVATION; APOPTOSIS	Background and Objectives: Epstein-Barr Virus (EBV) Latent Membrane Protein 1 (LMP1) is linked to a variety of malignancies including Hodgkin's disease, lymphomas, nasopharyngeal and gastric carcinoma. LMP1 exerts its transforming or oncogenic activity mainly through the recruitment of intracellular adapters via LMP1 C-terminal Transformation Effector Sites (TES) 1 and 2. However, LMP1 is also reported to elicit significant cytotoxic effects in some other cell types. This cytotoxic effect is quite intriguing for an oncogenic protein, and it is unclear whether both functional aspects of the protein are related or mutually exclusive. Methodology and Principal Findings: Using different ectopic expression systems in both Madin-Darby canine kidney (MDCK) epithelial cells and human embryonic kidney HEK-293 cells, we observe that LMP1 ectopic expression massively induces cell death. Furthermore, we show that LMP1-induced cytotoxicity mainly implies LMP1 C-terminal transformation effector sites and TRADD recruitment. However, stable expression of LMP1 in the same cells, is found to be associated with an increase of cell survival and an acquisition of epithelial mesenchymal transition phenotype as evidenced by morphological modifications, increased cell mobility, increased expression of MMP9 and decreased expression of E-cadherin. Our results demonstrate for the first time that the cytotoxic and oncogenic effects of LMP1 are not mutually exclusive but may operate sequentially. We suggest that in a total cell population, cells resistant to LMP1-induced cytotoxicity are those that could take advantage of LMP1 oncogenic activity by integrating LMP1 signaling into the preexistent signaling network. Our findings thus reconcile the apparent opposite apoptotic and oncogenic effects described for LMP1 and might reflect what actually happens on LMP1-induced cell transformation after EBV infection in patients.	[Brocqueville, Guillaume; Ndour, Papa Alioune; Le Goff, Arnaud; De Witte, Caroline; Mougel, Alexandra; Coll, Jean; Fafeur, Veronique; Adriaenssens, Eric] Univ Lille Nord France, Inst Pasteur Lille, CNRS, Inst Biol Lille,IFR 142,UMR8161, Lille, France; [Ouk, Tan-Sothea] Univ Limoges, Lab Chim Subst Nat, SFR GEIST 145, Limoges, France; [Le Bourhis, Xuefen] Univ Lille 1, INSERM, U908, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Adriaenssens, E (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, CNRS, Inst Biol Lille,IFR 142,UMR8161, Lille, France.	eric.adriaenssens@ibl.fr	Le+Bourhis, Xuefen/AAL-5141-2021; OUK, Tan Sothea/P-5874-2018; Fafeur, Veronique/L-9072-2018; Ndour, Papa Alioune/N-8448-2013	OUK, Tan Sothea/0000-0001-8576-5106; Ndour, Papa Alioune/0000-0001-7203-9754; De Witte, Caroline/0000-0001-8625-0825; Brocqueville, Guillaume/0000-0001-9904-6970	Ligue Regionale Contre le Cancer" (Aisne committee)	Ligue Regionale Contre le Cancer" (Aisne committee)	This work was supported by a grant from the "Ligue Regionale Contre le Cancer" (Aisne committee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens E, 2004, ONCOGENE, V23, P2681, DOI 10.1038/sj.onc.1207432; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Dawson CW, 2008, J VIROL, V82, P3654, DOI 10.1128/JVI.01888-07; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Eliopoulos AG, 1998, ONCOGENE, V16, P1731, DOI 10.1038/sj.onc.1201694; Everly DN, 2004, J VIROL, V78, P13470, DOI 10.1128/JVI.78.24.13470-13478.2004; Gires O, 1997, EMBO J, V16, P6131, DOI 10.1093/emboj/16.20.6131; Goormachtigh G, 2006, J VIROL, V80, P7382, DOI 10.1128/JVI.02052-05; Groux H, 1997, BLOOD, V89, P4521, DOI 10.1182/blood.V89.12.4521; HAMMERSCHMIDT W, 1989, J VIROL, V63, P2469, DOI 10.1128/JVI.63.6.2469-2475.1989; Horikawa T, 2011, BRIT J CANCER, V104, P1160, DOI 10.1038/bjc.2011.38; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kaykas A, 2000, ONCOGENE, V19, P1400, DOI 10.1038/sj.onc.1203365; Kim KR, 2000, ONCOGENE, V19, P1764, DOI 10.1038/sj.onc.1203502; Le Clorennec C, 2006, BLOOD, V107, P2070, DOI 10.1182/blood-2005-05-2053; Le Clorennec C, 2008, J VIROL, V82, P6721, DOI 10.1128/JVI.02250-07; Li LQ, 2002, BLOOD, V99, P3725, DOI 10.1182/blood.V99.10.3725; Lu JJY, 1996, J GEN VIROL, V77, P1883, DOI 10.1099/0022-1317-77-8-1883; Masy E, 2002, J VIROL, V76, P6460, DOI 10.1128/JVI.76.13.6460-6472.2002; Ndour PA, 2012, J VIROL, V86, P3934, DOI 10.1128/JVI.05747-11; Ndour PA, 2010, CELL SIGNAL, V22, P303, DOI 10.1016/j.cellsig.2009.09.037; Nitta T, 2003, CELL SIGNAL, V15, P423, DOI 10.1016/S0898-6568(02)00141-9; PAINE E, 1995, J VIROL, V69, P4572, DOI 10.1128/JVI.69.7.4572-4576.1995; Rickinson AB, 2007, FIELDS VIROLOGY, V5, P2655; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; Shair KHY, 2008, CANCER RES, V68, P6997, DOI 10.1158/0008-5472.CAN-08-1178; Zeng Q, 1998, ANAL BIOCHEM, V259, P187, DOI 10.1006/abio.1998.2645; Zhang XN, 2007, BIOCHEM BIOPH RES CO, V360, P263, DOI 10.1016/j.bbrc.2007.06.043; Zhang XN, 2002, VIROLOGY, V304, P330, DOI 10.1006/viro.2002.1640; Zou P, 2007, J VIROL, V81, P10029, DOI 10.1128/JVI.02241-06	33	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60743	10.1371/journal.pone.0060743	http://dx.doi.org/10.1371/journal.pone.0060743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637765	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400011
J	Huang, QY; Zhang, R; Zou, LY; Cao, X; Chu, XF				Huang, Qiaoying; Zhang, Rui; Zou, Liang Yu; Cao, Xu; Chu, Xiaofan			Cell Death Pathways in Astrocytes with a Modified Model of Oxygen-Glucose Deprivation	PLOS ONE			English	Article							ONCOSIS; APOPTOSIS; NEURONS; NECROSIS; STROKE; ISCHEMIA	Traditional oxygen-glucose deprivation (OGD) models do not produce sufficiently stable and continuous deprivation to induce cell death in the ischemic core. Therefore, we modified the OGD model to mimic the observed damage in the ischemic core following stroke and utilized this new model to study cell death pathways in astrocytes. The PO2 and pH levels in the astrocyte culture medium were compared between a physical OGD group, a chemical OGD group and a mixed OGD group. The mixed OGD group was able to maintain anaerobic conditions in astrocyte culture medium for 6 h, while the physical and the chemical groups failed to maintain such conditions. Astrocyte viability decreased and LDH release into in the medium increased as a function of exposure to OGD. Compared to the control group, the expression of active caspase-3 in the mixed OGD group increased within 2 h after OGD, but decreased after 2 h of OGD. Additionally, porimin mRNA levels did not significantly increase during the first 2 h of OGD, while bcl-2 mRNA levels decreased at 1 h. However, both porimin and bcl-2 mRNA levels increased after 2 h of OGD; interestingly, they both suddenly decreased at 4 h of OGD. Taken together, these results indicate that apoptosis and oncosis are the two cell death pathways responsible for astrocyte death in the ischemic core. However, the main death pathway varies depending on the OGD period.	[Huang, Qiaoying; Zhang, Rui; Zou, Liang Yu; Cao, Xu; Chu, Xiaofan] Jinan Univ, Clin Coll 2, Peoples Hosp Shenzhen City, Dept Neurol, Shenzhen, Peoples R China; [Huang, Qiaoying; Zhang, Rui] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Res Ctr Neural Engn, Shenzhen, Peoples R China	Jinan University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Chu, XF (corresponding author), Jinan Univ, Clin Coll 2, Peoples Hosp Shenzhen City, Dept Neurol, Shenzhen, Peoples R China.	chuxiaofan@hotmail.com			National Natural Science Foundation of China [30971024, 30870845]; Guangdong Provincial Natural Science Foundation [91510515000009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (grant number: 30971024, 30870845), Guangdong Provincial Natural Science Foundation (91510515000009) (all foundations awards granted to Xiaofan Chu). The funders had an important role in study design, analysis and decision to publish the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; AW TY, 1989, AM J PHYSIOL, V257, pC435, DOI 10.1152/ajpcell.1989.257.3.C435; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Cao X, 2010, NEUROSCI LETT, V479, P118, DOI 10.1016/j.neulet.2010.05.040; Chu XF, 2007, BRAIN RES, V1149, P157, DOI 10.1016/j.brainres.2007.02.061; Ciccarelli R, 2004, EUR J NEUROSCI, V20, P1514, DOI 10.1111/j.1460-9568.2004.03613.x; CLARK D., 2006, ENCY CHEM TECHNOLOGY; CUMMINS TR, 1993, J NEUROSCI METH, V46, P183, DOI 10.1016/0165-0270(93)90065-Y; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Donnan GA, 2007, ISCHEMIC PENUBRA OVE; DUCHEN MR, 1990, J PHYSIOL-LONDON, V424, P387, DOI 10.1113/jphysiol.1990.sp018073; Eguchi Y, 1997, CANCER RES, V57, P1835; Endres M, 2008, CEREBROVASC DIS, V25, P268, DOI 10.1159/000118039; Fisher M, 1996, NEUROLOGY, V47, P884, DOI 10.1212/WNL.47.4.884; Gabryel B, 2001, NEUROTOX RES, V3, P205, DOI 10.1007/BF03033192; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; JUURLINK BHJ, 1992, NEUROREPORT, V3, P1135, DOI 10.1097/00001756-199212000-00026; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Kuwada SK, 2004, INT J CANCER, V109, P291, DOI 10.1002/ijc.11686; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Ma FR, 2001, P NATL ACAD SCI USA, V98, P9778, DOI 10.1073/pnas.171322898; Machaalani R, 2008, BRAIN, V131, P218, DOI 10.1093/brain/awm290; MAJNO G, 1995, AM J PATHOL, V146, P3; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sun LM, 2011, CANCER CHEMOTH PHARM, V67, P813, DOI 10.1007/s00280-010-1387-9; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; Ye RD, 2009, NEUROSCI RES, V64, P306, DOI 10.1016/j.neures.2009.03.016	28	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61345	10.1371/journal.pone.0061345	http://dx.doi.org/10.1371/journal.pone.0061345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637816	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400037
J	Yang, L; Price, ET; Chang, CW; Li, Y; Huang, Y; Guo, LW; Guo, YL; Kaput, J; Shi, LM; Ning, BT				Yang, Lun; Price, Elvin T.; Chang, Ching-Wei; Li, Yan; Huang, Ying; Guo, Li-Wu; Guo, Yongli; Kaput, Jim; Shi, Leming; Ning, Baitang			Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters	PLOS ONE			English	Article							HUMAN LIVER; CYTOCHROME-P450 ENZYMES; HUMAN HEPATOCYTES; POLYMORPHISMS; BIOTRANSFORMATION; PHARMACOGENETICS; HEPATOTOXICITY; RECEPTORS; NETWORKS	Interindividual variability in the expression of drug-metabolizing enzymes and transporters (DMETs) in human liver may contribute to interindividual differences in drug efficacy and adverse reactions. Published studies that analyzed variability in the expression of DMET genes were limited by sample sizes and the number of genes profiled. We systematically analyzed the expression of 374 DMETs from a microarray data set consisting of gene expression profiles derived from 427 human liver samples. The standard deviation of interindividual expression for DMET genes was much higher than that for non-DMET genes. The 20 DMET genes with the largest variability in the expression provided examples of the interindividual variation. Gene expression data were also analyzed using network analysis methods, which delineates the similarities of biological functionalities and regulation mechanisms for these highly variable DMET genes. Expression variability of human hepatic DMET genes may affect drug-gene interactions and disease susceptibility, with concomitant clinical implications.	[Yang, Lun; Chang, Ching-Wei; Li, Yan; Guo, Li-Wu; Guo, Yongli; Kaput, Jim; Shi, Leming; Ning, Baitang] US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Price, Elvin T.] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Huang, Ying] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA USA	US Food & Drug Administration (FDA); University of Arkansas System; University of Arkansas Medical Sciences; Western University of Health Sciences	Shi, LM (corresponding author), US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR USA.	leming.shi@fda.hhs.gov; baitang.ning@fda.hhs.gov	Shi, Leming/B-3150-2010; Kaput, Jim/GSD-5978-2022; Kaput, Jim/AAJ-1386-2020	Shi, Leming/0000-0002-7143-2033; Ning, Baitang/0000-0003-0798-0331	Postgraduate Research Program at the National Center for Toxicological Research	Postgraduate Research Program at the National Center for Toxicological Research	LY, YL and LG were supported by appointments to the Postgraduate Research Program at the National Center for Toxicological Research administered by Oak Ridge Institute for Science Education through an interagency agreement between the United States Department of Energy and the Federal Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Burk O, 2005, BIOL CHEM, V386, P503, DOI 10.1515/BC.2005.060; Chrostek L, 2003, J CLIN LAB ANAL, V17, P93, DOI 10.1002/jcla.10076; Constable S, 2006, EXPERT REV MOL DIAGN, V6, P193, DOI 10.1586/14737159.6.2.193; Daniel WC, 1996, AM J CARDIOL, V78, P288, DOI 10.1016/S0002-9149(96)00279-2; Garcia-Martin E, 2002, CLIN PHARMACOL THER, V71, P196, DOI 10.1067/mcp.2002.121371; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Guo L, 2011, DRUG METAB DISPOS, V39, P528, DOI 10.1124/dmd.110.035873; Hagenbuch B, 2010, CLIN PHARMACOL THER, V87, P39, DOI 10.1038/clpt.2009.235; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Ieiri I, 2009, EXPERT OPIN DRUG MET, V5, P703, DOI 10.1517/17425250902976854; Kajinami K, 2004, AM J CARDIOL, V93, P104, DOI 10.1016/j.amjcard.2003.08.078; Kroetz DL, 2010, CLIN PHARMACOL THER, V87, P109, DOI 10.1038/clpt.2009.226; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Li DS, 2011, ECOTOXICOLOGY, V20, P1018, DOI 10.1007/s10646-011-0693-2; Liguori MJ, 2005, HEPATOLOGY, V41, P177, DOI 10.1002/hep.20514; Ma MK, 2002, AM J HEALTH-SYST PH, V59, P2061, DOI 10.1093/ajhp/59.21.2061; Ning BT, 2008, J BIOMOL SCREEN, V13, P194, DOI 10.1177/1087057108315513; Ning BT, 2005, PHARMACOGENET GENOM, V15, P465, DOI 10.1097/01.fpc.0000166823.74378.79; Ning BT, 2004, PHARMACOGENETICS, V14, P35, DOI 10.1097/00008571-200401000-00004; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Omiecinski CJ, 2011, TOXICOL SCI, V120, pS49, DOI 10.1093/toxsci/kfq338; Owens IS, 2005, METHOD ENZYMOL, V400, P1, DOI 10.1016/S0076-6879(05)00001-7; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Pirmohamed M, 2001, TRENDS PHARMACOL SCI, V22, P298, DOI 10.1016/S0165-6147(00)01717-X; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rodriguez-Antona C, 2001, ARCH BIOCHEM BIOPHYS, V393, P308, DOI 10.1006/abbi.2001.2499; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shay NF, 2005, ANNU REV NUTR, V25, P297, DOI 10.1146/annurev.nutr.25.050304.092639; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tirona RG, 2005, J PHARM SCI-US, V94, P1169, DOI 10.1002/jps.20324; Tolson AH, 2010, ADV DRUG DELIVER REV, V62, P1238, DOI 10.1016/j.addr.2010.08.006; Tomalik-Scharte D, 2008, PHARMACOGENOMICS J, V8, P4, DOI 10.1038/sj.tpj.6500462; Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yang L, 2012, J DRUG METAB TOXICOL, V3, P1, DOI DOI 10.4172/2157-7609.1000119; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zanger UM, 2013, PHARM THER; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	43	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60368	10.1371/journal.pone.0060368	http://dx.doi.org/10.1371/journal.pone.0060368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637747	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400004
J	Liu, YM; Dalal, K; Stollenwerk, B				Liu, Yanmei; Dalal, Koustuv; Stollenwerk, Bjoern			The Association between Health System Development and the Burden of Cardiovascular Disease: An Analysis of WHO Country Profiles	PLOS ONE			English	Article							COST-EFFECTIVENESS; CARE; MORTALITY; DISABILITY; ALCOHOL; INFANT	Background: Several risk factors for cardiovascular disease (CVD) have been identified in recent decades. However, the association between the health system and the burden of CVD has not yet been sufficiently researched. The objective of this study was to analyse the association between health system development and the burden of CVD, in particular CVD-related disability-adjusted life-years (DALYs). Methods: Univariate and multivariate generalized linear mixed models were applied to country-level data collected by the World Bank and World Health Organization. Response variables were the age-standardized CVD mortality and age-standardized CVD DALY rates. Results: The amount of available health system resources, indicated by total health expenditures per capita, physician density, nurse density, dentistry density, pharmaceutical density and the density of hospital beds, was associated with reduced CVD DALY rates and CVD mortality. However, in the multivariate models, the density of nurses and midwives was positively associated with CVD. High out-of-pocket costs were associated with increased CVD mortality in both univariate and multivariate analyses. Conclusion: A highly developed health system with a low level of out-of-pocket costs seems to be the most appropriate to reduce the burden of CVD. Furthermore, an efficient balance between human health resources and health technologies is essential.	[Liu, Yanmei; Stollenwerk, Bjoern] Helmholtz Zentrum Munchen GmbH, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Liu, Yanmei] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Dalal, Koustuv] Univ Orebro, Sch Hlth & Med Sci, Dept Publ Hlth Sci, Orebro, Sweden	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet; Orebro University	Dalal, K (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Dept Publ Hlth Sci, Orebro, Sweden.	Koustuv.dalal@oru.se	Stollenwerk, Björn/G-5408-2013; Dalal, Koustuv/O-6737-2017	Dalal, Koustuv/0000-0001-7393-796X; Stollenwerk, Bjorn/0000-0002-3189-409X	Karolinska Institutet, Sweden; Helmholtz Zentrum Munchen, German Research Center for Environmental Health	Karolinska Institutet, Sweden(Karolinska Institutet); Helmholtz Zentrum Munchen, German Research Center for Environmental Health(Helmholtz Association)	Financial support for this study was provided by Karolinska Institutet, Sweden, and by Helmholtz Zentrum Munchen, German Research Center for Environmental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alexander GC, 2004, J GEN INTERN MED, V19, P856, DOI 10.1111/j.1525-1497.2004.30249.x; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], WHO STAT INF SYST WH; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; De Longueville F, 2010, SCI TOTAL ENVIRON, V409, P1, DOI 10.1016/j.scitotenv.2010.09.025; Deaton C, 2011, J CARDIOVASC NURS, V26, pS5, DOI 10.1097/JCN.0b013e318213efcf; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; ELOLA J, 1995, AM J PUBLIC HEALTH, V85, P1397, DOI 10.2105/AJPH.85.10.1397; Falkingham J, 2004, SOC SCI MED, V58, P247, DOI 10.1016/S0277-9536(03)00008-X; Gaziano TA, 2008, HEART, V94, P140, DOI 10.1136/hrt.2007.128785; Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; Gruber EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051312; HOLM S, 1979, SCAND J STAT, V6, P65; Hunger M, 2012, QUAL LIFE RES, V21, P1205, DOI 10.1007/s11136-011-0024-3; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; MARMOT M, 1991, BMJ-BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Mbewu A, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P305; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P481; Murray RP, 2002, AM J EPIDEMIOL, V155, P242, DOI 10.1093/aje/155.3.242; Musgrove P, 2002, B WORLD HEALTH ORGAN, V80, P134; ROBEY B, 1993, OUTLOOK AGR, V22, P221, DOI 10.1177/003072709302200403; Sauer Maria Teresa Nardin, 2003, Cad. Saúde Pública, V19, P1519, DOI 10.1590/S0102-311X2003000500030; Shenoy AU, 2012, EUR J VASC ENDOVASC, V44, P505, DOI 10.1016/j.ejvs.2012.08.010; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Steinman MA, 2001, J GEN INTERN MED, V16, P793, DOI 10.1046/j.1525-1497.2001.10412.x; Stock S, 2010, HEALTH POLICY, V96, P51, DOI 10.1016/j.healthpol.2009.12.015; Stollenwerk B, 2013, EUR J HLTH EC; Stollenwerk B, 2009, MED DECIS MAKING, V29, P619, DOI 10.1177/0272989X09331810; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World Health Organisation, 2007, STRENGTH HLTH SYST I; World Health Organization, 2011, GLOB HLTH OBS DAT RE; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2011, IND MEAS REG VERS 1; Zechmeister I, 2012, J PUBLIC HEALTH-HEID, V20, P31, DOI 10.1007/s10389-011-0440-4; Zindel S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-192	41	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61718	10.1371/journal.pone.0061718	http://dx.doi.org/10.1371/journal.pone.0061718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130IU	23637891	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700055
J	Shkryl, VM; Blatter, LA				Shkryl, Vyacheslav M.; Blatter, Lothar A.			Ca2+ Release Events in Cardiac Myocytes Up Close: Insights from Fast Confocal Imaging	PLOS ONE			English	Article							RYANODINE RECEPTOR CLUSTERS; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; ATRIAL MYOCYTES; RAT; SPARKS; SKELETAL; CHANNELS; HEART; ALTERNANS	The spatio-temporal properties of Ca2+ transients during excitation-contraction coupling and elementary Ca2+ release events (Ca2+ sparks) were studied in atrial and ventricular myocytes with ultra-fast confocal microscopy using a Zeiss LSM 5 LIVE system that allows sampling rates of up to 60 kHz. Ca2+ sparks which originated from subsarcolemmal junctional sarcoplasmic reticulum (j-SR) release sites in atrial myocytes were anisotropic and elongated in the longitudinal direction of the cell. Ca2+ sparks in atrial cells originating from non-junctional SR and in ventricular myocytes were symmetrical. Ca2+ spark recording in line scan mode at 40,000 lines/s uncovered step-like increases of [Ca2+](i). 2-D imaging of Ca2+ transients revealed an asynchronous activation of release sites and allowed the sequential recording of Ca2+ entry through surface membrane Ca2+ channels and subsequent activation of Ca2+-induced Ca2+ release. With a latency of 2.5 ms after application of an electrical stimulus, Ca2+ entry could be detected that was followed by SR Ca2+ release after an additional 3 ms delay. Maximum Ca2+ release was observed 4 ms after the beginning of release. The timing of Ca2+ entry and release was confirmed by simultaneous [Ca2+](i) and membrane current measurements using the whole cell voltage-clamp technique. In atrial cells activation of discrete individual release sites of the j-SR led to spatially restricted Ca2+ release events that fused into a peripheral ring of elevated [Ca2+](i) that subsequently propagated in a wave-like fashion towards the center of the cell. In ventricular myocytes asynchronous Ca2+ release signals from discrete sites with no preferential subcellular location preceded the whole-cell Ca2+ transient. In summary, ultra-fast confocal imaging allows investigation of Ca2+ signals with a time resolution similar to patch clamp technique, however in a less invasive fashion.	[Shkryl, Vyacheslav M.] AA Bogomoletz Inst Physiol, Dept Gen Physiol Nervous Syst, Kiev, Ukraine; [Blatter, Lothar A.] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; Rush University	Blatter, LA (corresponding author), Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA.	Lothar_Blatter@rush.edu	Blatter, Lothar/AAC-8431-2020		National Institutes of Health [HL62231, HL80101, HL101235]; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062231, P01HL080101, R01HL101235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grants HL62231, HL80101 and HL101235, and the Leducq Foundation (to LAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asghari P, 2012, PROTOPLASMA, V249, pS31, DOI 10.1007/s00709-011-0347-5; Baddeley D, 2009, P NATL ACAD SCI USA, V106, P22275, DOI 10.1073/pnas.0908971106; BERLIN JR, 1995, AM J PHYSIOL-HEART C, V269, pH1165, DOI 10.1152/ajpheart.1995.269.3.H1165; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blatter LA, 2003, J PHYSIOL-LONDON, V546, P19, DOI 10.1113/jphysiol.2002.025239; Blatter LA, 1997, P NATL ACAD SCI USA, V94, P4176, DOI 10.1073/pnas.94.8.4176; Bootman MD, 2006, J CELL SCI, V119, P3915, DOI 10.1242/jcs.03223; Bootman MD, 2011, BBA-MOL CELL RES, V1813, P922, DOI 10.1016/j.bbamcr.2011.01.030; Bridge JHB, 1999, J PHYSIOL-LONDON, V518, P469, DOI 10.1111/j.1469-7793.1999.0469p.x; Brochet DX, 2010, CIRC RES; Brochet DXP, 2005, P NATL ACAD SCI USA, V102, P3099, DOI 10.1073/pnas.0500059102; Bruton JD, 2012, ADV EXP MED BIOL, V740, P27, DOI 10.1007/978-94-007-2888-2_2; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; Chen-Izu Y, 2006, BIOPHYS J, V91, P1, DOI 10.1529/biophysj.105.077180; CHENG H, 1994, PFLUG ARCH EUR J PHY, V428, P415, DOI 10.1007/BF00724526; CHENG H, 1995, CIRC RES, V76, P236, DOI 10.1161/01.RES.76.2.236; Cheng H, 1996, CELL CALCIUM, V20, P129, DOI 10.1016/S0143-4160(96)90102-5; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Cheng HP, 2002, FRONT BIOSCI, V7, pD1867, DOI 10.2741/cheng; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; Das T, 2012, J MOL CELLULAR CARDI; Domeier TL, 2009, J PHYSIOL-LONDON, V587, P5197, DOI 10.1113/jphysiol.2009.177576; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; Gillespie D, 2013, J MOL CELLULAR CARDI; Hayashi H, 2007, BIOPHYS J, V92, P448, DOI 10.1529/biophysj.106.091009; Hayashi T, 2009, J CELL SCI, V122, P1005, DOI 10.1242/jcs.028175; Heinzel FR, 2002, CIRC RES, V91, P1023, DOI 10.1161/01.RES.0000045940.67060.DD; Heinzel FR, 2008, CIRC RES, V102, P338, DOI 10.1161/CIRCRESAHA.107.160085; Huser J, 1996, J PHYSIOL-LONDON, V494, P641; Izu LT, 2001, BIOPHYS J, V80, P88, DOI 10.1016/S0006-3495(01)75997-8; Jayasinghe ID, 2012, BIOPHYS J, V102, pL9, DOI 10.1016/j.bpj.2012.01.034; Keizer J, 1998, BIOPHYS J, V75, P595, DOI 10.1016/S0006-3495(98)77550-2; Kettlun C, 2003, J GEN PHYSIOL, V122, P407, DOI 10.1085/jgp.200308843; Kockskamper J, 2002, J PHYSIOL-LONDON, V545, P65, DOI 10.1113/jphysiol.2002.025502; Kockskamper J, 2001, BIOPHYS J, V81, P2590, DOI 10.1016/S0006-3495(01)75903-6; Lipp P, 1998, J PHYSIOL-LONDON, V508, P801, DOI 10.1111/j.1469-7793.1998.801bp.x; Lipp P, 1996, J PHYSIOL-LONDON, V492, P31, DOI 10.1113/jphysiol.1996.sp021286; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; Mackenzie L, 2001, J PHYSIOL-LONDON, V530, P417, DOI 10.1111/j.1469-7793.2001.0417k.x; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; MCNUTT NS, 1969, J CELL BIOL, V42, P46, DOI 10.1083/jcb.42.1.46; MEISSNER G, 1987, J BIOL CHEM, V262, P3065; Porta M, 2012, AM J PHYSIOL-CELL PH, V303, pC682, DOI 10.1152/ajpcell.00150.2012; RUBENSTEIN DS, 1995, CIRCULATION, V91, P201, DOI 10.1161/01.CIR.91.1.201; Santiago DJ, 2010, BIOPHYS J, V98, P2111, DOI 10.1016/j.bpj.2010.01.042; Scriven DRL, 2010, BIOPHYS J, V99, P3923, DOI 10.1016/j.bpj.2010.11.008; Sheehan KA, 2003, J PHYSIOL-LONDON, V546, P119, DOI 10.1113/jphysiol.2002.026963; Sheehan KA, 2006, J PHYSIOL-LONDON, V572, P799, DOI 10.1113/jphysiol.2005.103267; Shkryl VM, 2012, J GEN PHYSIOL, V139, P189, DOI 10.1085/jgp.201110709; SIPIDO KR, 1991, J PHYSIOL-LONDON, V435, P605, DOI 10.1113/jphysiol.1991.sp018528; Smyrnias I, 2010, CELL CALCIUM, V47, P210, DOI 10.1016/j.ceca.2009.10.001; Sobie EA, 2002, BIOPHYS J, V83, P59, DOI 10.1016/S0006-3495(02)75149-7; Soeller C, 2002, BIOPHYS J, V82, P2396, DOI 10.1016/S0006-3495(02)75584-7; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Soeller C, 2012, J MOL CELLULAR CARDI; Soeller C, 2007, P NATL ACAD SCI USA, V104, P14958, DOI 10.1073/pnas.0703016104; Stern MD, 1999, J GEN PHYSIOL, V113, P469, DOI 10.1085/jgp.113.3.469; Wang SQ, 2004, P NATL ACAD SCI USA, V101, P3979, DOI 10.1073/pnas.0306157101; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Woo SH, 2005, J PHYSIOL-LONDON, V567, P905, DOI 10.1113/jphysiol.2005.092270; Woo SH, 2003, CIRC RES, V92, pE1, DOI 10.1161/01.RES.0000051887.97625.07; Woo SH, 2002, J PHYSIOL-LONDON, V543, P439, DOI 10.1113/jphysiol.2002.024190; WU JY, 1991, CIRC RES, V68, P1059, DOI 10.1161/01.RES.68.4.1059; Zahradnikova A, 2010, J GEN PHYSIOL, V136, P101, DOI 10.1085/jgp.200910380	69	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61525	10.1371/journal.pone.0061525	http://dx.doi.org/10.1371/journal.pone.0061525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637847	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700042
J	Tugues, S; Honjo, S; Konig, C; Padhan, N; Kroon, J; Gualandi, L; Li, XJ; Barkefors, I; Thijssen, VL; Griffioen, AW; Claesson-Welsh, L				Tugues, Sonia; Honjo, Satoshi; Konig, Christian; Padhan, Narendra; Kroon, Jeffrey; Gualandi, Laura; Li, Xiujuan; Barkefors, Irmeli; Thijssen, Victor L.; Griffioen, Arjan W.; Claesson-Welsh, Lena			Tetraspanin CD63 Promotes Vascular Endothelial Growth Factor Receptor 2-beta 1 Integrin Complex Formation, Thereby Regulating Activation and Downstream Signaling in Endothelial Cells in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; ENRICHED MICRODOMAINS; HUMAN-MELANOMA; ANGIOGENESIS; PROTEINS; SURFACE; SRC; MECHANISMS; MIGRATION	CD63 is a member of the transmembrane-4 glycoprotein superfamily (tetraspanins) implicated in the regulation of membrane protein trafficking, leukocyte recruitment, and adhesion processes. We have investigated the involvement of CD63 in endothelial cell (EC) signaling downstream of beta 1 integrin and VEGF. We report that silencing of CD63 in primary ECs arrested capillary sprouting and tube formation in vitro because of impaired adhesion and migration of ECs. Mechanistically, CD63 associated with both beta 1 integrin and the main VEGF receptor on ECs, VEGFR2. Our data suggest that CD63 serves to bridge between beta 1 integrin and VEGFR2 because CD63 silencing disrupted VEGFR2-beta 1 integrin complex formation identified using proximity ligation assays. Signaling downstream of beta 1 integrin and VEGFR2 was attenuated in CD63-silenced cells, although their cell surface expression levels remained unaffected. CD63 was furthermore required for efficient internalization of VEGFR2 in response to VEGF. Importantly, systemic delivery of VEGF failed to potently induce VEGFR2 phosphorylation and downstream signaling in CD63-deficient mouse lungs. Taken together, our findings demonstrate a previously unrecognized role for CD63 in coordinated integrin and receptor tyrosine kinase signaling in vitro and in vivo.	[Tugues, Sonia; Honjo, Satoshi; Konig, Christian; Padhan, Narendra; Kroon, Jeffrey; Gualandi, Laura; Li, Xiujuan; Claesson-Welsh, Lena] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; [Barkefors, Irmeli] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, S-75123 Uppsala, Sweden; [Thijssen, Victor L.; Griffioen, Arjan W.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Angiogenesis Lab, NL-1007 MB Amsterdam, Netherlands	Uppsala University; Uppsala University; Vrije Universiteit Amsterdam	Tugues, S (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland.	tugues@immunology.uzh.ch	Kroon, Jeffrey/AAL-2588-2021; König, Christian/G-1895-2015; Thijssen, Victor LJL/B-2792-2009; li, xiu/GXV-1745-2022	Kroon, Jeffrey/0000-0001-9983-6614; König, Christian/0000-0001-7671-231X; Thijssen, Victor LJL/0000-0002-6146-1842; 	Swedish Cancer Foundation; Swedish Science Council; Knut and Alice Wallenberg Foundation; Spanish Ministry of Science and Education; Spanish Association of Liver Diseases; Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of Science	Swedish Cancer Foundation; Swedish Science Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Spanish Ministry of Science and Education(Spanish Government); Spanish Association of Liver Diseases; Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Swedish Cancer Foundation, the Swedish Science Council, and the Knut and Alice Wallenberg Foundation (to L. C.-W.).; Supported by a postdoctoral grant from the Spanish Ministry of Science and Education and the Spanish Association of Liver Diseases. To whom correspondence should be addressed. Present address: Inst. of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland. Tel.: 41-44-6353709; Fax: 41-44-6356883; E-mail: tugues@immunology.uzh.ch.; Supported by a postdoctoral grant from Manpei Suzuki Diabetes Foundation and the Japan Society for the Promotion of Science.	Bailey RL, 2011, BIOCHEM SOC T, V39, P1667, DOI 10.1042/BST20110745; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; Berditchevski F, 2001, J CELL SCI, V114, P4143; BERDITCHEVSKI F, 1995, J BIOL CHEM, V270, P17784, DOI 10.1074/jbc.270.30.17784; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; Heijnen HFG, 2003, J THROMB HAEMOST, V1, P1161, DOI 10.1046/j.1538-7836.2003.00316.x; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; HOTTA H, 1988, CANCER RES, V48, P2955; Hupalowska A, 2012, TRAFFIC, V13, P9, DOI 10.1111/j.1600-0854.2011.01249.x; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Israels SJ, 2001, THROMB HAEMOSTASIS, V85, P134; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kamisasanuki T, 2011, BIOCHEM BIOPH RES CO, V413, P128, DOI 10.1016/j.bbrc.2011.08.068; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Koyama Y, 1998, BIOCHEM BIOPH RES CO, V246, P841, DOI 10.1006/bbrc.1998.8725; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Lee M, 2005, J BIOL CHEM, V280, P125, DOI 10.1074/jbc.M408858200; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mannion BA, 1996, J IMMUNOL, V157, P2039; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Radford KJ, 1996, BIOCHEM BIOPH RES CO, V222, P13, DOI 10.1006/bbrc.1996.0690; Radford KJ, 1997, J IMMUNOL, V158, P3353; Ramjaun AR, 2009, INT J BIOCHEM CELL B, V41, P521, DOI 10.1016/j.biocel.2008.05.030; Ross RS, 2004, CARDIOVASC RES, V63, P381, DOI 10.1016/j.cardiores.2004.04.027; Schroder J, 2009, MOL CELL BIOL, V29, P1083, DOI 10.1128/MCB.01163-08; Skubitz KM, 1996, J IMMUNOL, V157, P3617; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; TOOTHILL VJ, 1990, J IMMUNOL, V145, P283; VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X; Zhang XF, 2005, J CELL PHYSIOL, V202, P205, DOI 10.1002/jcp.20106	51	37	40	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19060	19071		10.1074/jbc.M113.468199	http://dx.doi.org/10.1074/jbc.M113.468199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23632027	Green Published, hybrid			2022-12-25	WOS:000321335800041
J	Zhou, Z; Jing, C; Zhang, LY; Takeo, F; Kim, H; Huang, Y; Liu, ZH; Wan, Y				Zhou, Zhuan; Jing, Chao; Zhang, Liyong; Takeo, Fujita; Kim, Hyun; Huang, Yi; Liu, Zhihua; Wan, Yong			Regulation of Rad17 Protein Turnover Unveils an Impact of Rad17-APC Cascade in Breast Carcinogenesis and Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; GENOMIC INSTABILITY; ANTICANCER BARRIER; REPLICATION STRESS; GENOTOXIC STRESS; CHECKPOINT GENE; CANCER; REPAIR; HRAD17	Aberrant regulation of DNA damage checkpoint function leads to genome instability that in turn can predispose cellular tissues to become cancerous. Previous works from us and others demonstrated the role of Rad17 in either activation or termination of DNA damage checkpoint function. In the current study, we have revealed the unexpected accumulation of Rad17 in various types of breast cancer cell lines as well as human breast cancer tissues. We observed that Rad17 protein turnover rate in breast epithelial cells is much faster than in breast cancer cells, where the turnover of Rad17 is regulated by the Cdh1/APC pathway. We further observed that Rad17-mediated checkpoint function is modulated by proteolysis. Stabilization of Rad17 disrupts cellular response to chemotherapeutic drug-induced DNA damage and enhances cellular transformation. In addition, manipulation of Rad17 by RNA interference or stabilization of Rad17 significantly sensitize breast cancer cell to various chemotherapeutic drugs. Our present results indicate the manipulation of Rad17 proteolysis could be a valuable approach to sensitize breast cancer cell to the chemotherapeutic treatment despite of the critical role in governing DNA damage response and cellular recovery from genotoxic stress.	[Zhou, Zhuan; Zhang, Liyong; Takeo, Fujita; Kim, Hyun; Wan, Yong] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15213 USA; [Zhou, Zhuan; Zhang, Liyong; Takeo, Fujita; Kim, Hyun; Wan, Yong] Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Jing, Chao; Liu, Zhihua] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China; [Jing, Chao; Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Takeo, Fujita] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2770882, Japan; [Huang, Yi] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Cancer Center - Japan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, ZH (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn; yow4@pitt.edu	Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X; Zhang, Liyong/0000-0002-6952-7463	National Institutes of Health [R01CA154695]; Pittsburgh Woman Cancer Fund; Breast Cancer Research Foundation grant; National Nature Science Foundation of China [30928029]; NATIONAL CANCER INSTITUTE [R01CA154695] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Woman Cancer Fund; Breast Cancer Research Foundation grant; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institutes of Health Grant R01CA154695, a Pittsburgh Woman Cancer Fund and Breast Cancer Research Foundation grant, and National Nature Science Foundation of China Grant 30928029.	Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bao SD, 1999, CANCER RES, V59, P2023; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Budzowska M, 2004, EMBO J, V23, P3548, DOI 10.1038/sj.emboj.7600353; Chini CCS, 2004, DNA REPAIR, V3, P1033, DOI 10.1016/j.dnarep.2004.03.001; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Dean FB, 1998, GENOMICS, V54, P424, DOI 10.1006/geno.1998.5587; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hopkins KM, 2003, CANCER RES, V63, P5291; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kataoka A, 2001, CLIN CANCER RES, V7, P2815; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Kobayashi M, 2004, GENES CELLS, V9, P291, DOI 10.1111/j.1356-9597.2004.00728.x; Li L, 1999, ONCOGENE, V18, P1689, DOI 10.1038/sj.onc.1202469; Ma CX, 2013, BREAST CANCER RES TR, V137, P483, DOI 10.1007/s10549-012-2378-9; Nouspikel T, 2008, DNA REPAIR, V7, P1155, DOI 10.1016/j.dnarep.2008.03.015; Paulovich AG, 1997, GENETICS, V145, P45; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Sasaki H, 2001, LUNG CANCER, V34, P47, DOI 10.1016/S0169-5002(01)00223-9; Shinohara M, 2003, GENETICS, V164, P855; Siede W, 1996, NUCLEIC ACIDS RES, V24, P1669, DOI 10.1093/nar/24.9.1669; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Wang X, 2001, CANCER RES, V61, P7417; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	39	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18134	18145		10.1074/jbc.M113.456962	http://dx.doi.org/10.1074/jbc.M113.456962			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23637229	Green Published, hybrid			2022-12-25	WOS:000320721900019
J	Shaltiel-Karyo, R; Frenkel-Pinter, M; Rockenstein, E; Patrick, C; Levy-Sakin, M; Schiller, A; Egoz-Matia, N; Masliah, E; Segal, D; Gazit, E				Shaltiel-Karyo, Ronit; Frenkel-Pinter, Moran; Rockenstein, Edward; Patrick, Christina; Levy-Sakin, Michal; Schiller, Abigail; Egoz-Matia, Nirit; Masliah, Eliezer; Segal, Daniel; Gazit, Ehud			A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent alpha-Synuclein (alpha-syn) Aggregation Inhibitor A NOVEL DUAL MECHANISM OF MANNITOL FOR THE TREATMENT OF PARKINSON DISEASE (PD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA MODEL; CHAPERONES; PATHWAYS; PROTEINS; DYNAMICS; SYSTEM; ROLES; BETA	The development of disease-modifying therapy for Parkinson disease has been a main drug development challenge, including the need to deliver the therapeutic agents to the brain. Here, we examined the ability of mannitol to interfere with the aggregation process of alpha-synuclein in vitro and in vivo in addition to its blood-brain barrier-disrupting properties. Using in vitro studies, we demonstrated the effect of mannitol on alpha-synuclein aggregation. Although low concentration of mannitol inhibited the formation of fibrils, high concentration significantly decreased the formation of tetramers and high molecular weight oligomers and shifted the secondary structure of alpha-synuclein from alpha-helical to a different structure, suggesting alternative potential pathways for aggregation. When administered to a Parkinson Drosophila model, mannitol dramatically corrected its behavioral defects and reduced the amount of alpha-synuclein aggregates in the brains of treated flies. In the mThy1-human alpha-synuclein transgenic mouse model, a decrease in alpha-synuclein accumulation was detected in several brain regions following treatment, suggesting that mannitol promotes alpha-synuclein clearance in the cell bodies. It appears that mannitol has a general neuroprotective effect in the transgenic treated mice, which includes the dopaminergic system. We therefore suggest mannitol as a basis for a dual mechanism therapeutic agent for the treatment of Parkinson disease.	[Shaltiel-Karyo, Ronit; Frenkel-Pinter, Moran; Levy-Sakin, Michal; Schiller, Abigail; Egoz-Matia, Nirit; Segal, Daniel; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Segal, Daniel] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Rockenstein, Edward; Patrick, Christina; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	Tel Aviv University; Tel Aviv University; University of California System; University of California San Diego	Segal, D (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	dsegal@post.tau.ac.il; ehudg@post.tau.ac.il	Gazit, Ehud/C-3715-2011; Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Lipton, Stuart/0000-0002-3490-1259; Segal, Daniel/0000-0002-6777-505X	Parkinson's Disease Foundation; Lord Alliance Family Trust; National Institutes of Health [AG18440, AG022074, NS057096]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG018440, P01AG022074, R37AG018440] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; Lord Alliance Family Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Parkinson's Disease Foundation and the Lord Alliance Family Trust (to D. S.) and by National Institutes of Health Grants AG18440, AG022074, and NS057096 (to E. M.).	Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Butler Tracy, 2007, Brain, V130, pe78, DOI 10.1093/brain/awm119; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; Elbaz A, 2002, J CLIN EPIDEMIOL, V55, P25, DOI 10.1016/S0895-4356(01)00425-5; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fleming SM, 2006, NEUROSCIENCE, V142, P1245, DOI 10.1016/j.neuroscience.2006.07.005; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Hashimoto M, 2004, J MOL NEUROSCI, V24, P343, DOI 10.1385/JMN:24:3:343; Holthauzen LMF, 2007, PROTEIN SCI, V16, P293, DOI 10.1110/ps.062610407; Ikeda M, 2002, BIOCHEM BIOPH RES CO, V291, P669, DOI 10.1006/bbrc.2002.6495; Leong SL, 2009, NEUROCHEM RES, V34, P1838, DOI 10.1007/s11064-009-9986-8; Liu XR, 2005, CURR OPIN DRUG DISC, V8, P505; Lu DN, 2006, BIOPHYS J, V90, P3224, DOI 10.1529/biophysj.105.071761; Malek AM, 1998, STROKE, V29, P2631, DOI 10.1161/01.STR.29.12.2631; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Pan GY, 2000, ACTA PHARMACOL SIN, V21, P613; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Rajan RS, 2011, CURR MED CHEM, V18, P1; Richmon JD, 1995, NEUROSCI LETT, V202, P1, DOI 10.1016/0304-3940(95)12208-7; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Ruijter GJG, 2003, EUKARYOT CELL, V2, P690, DOI 10.1128/EC.2.4.690-698.2003; Samiotakis A, 2009, INT J MOL SCI, V10, P572, DOI 10.3390/ijms10020572; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Shaltiel-Karyo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013863; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SUZUKI J, 1985, STROKE, V16, P695, DOI 10.1161/01.STR.16.4.695; Tofaris GK, 2005, MOVEMENT DISORD, V20, pS37, DOI 10.1002/mds.20538; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; WETZEL R, 1994, TRENDS BIOTECHNOL, V12, P193, DOI 10.1016/0167-7799(94)90082-5	41	68	69	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17579	17588		10.1074/jbc.M112.434787	http://dx.doi.org/10.1074/jbc.M112.434787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23637226	hybrid, Green Published			2022-12-25	WOS:000320380600049
J	Boulineau, S; Tostevin, F; Kiviet, DJ; ten Wolde, PR; Nghe, P; Tans, SJ				Boulineau, Sarah; Tostevin, Filipe; Kiviet, Daniel J.; ten Wolde, Pieter Rein; Nghe, Philippe; Tans, Sander J.			Single-Cell Dynamics Reveals Sustained Growth during Diauxic Shifts	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; RIBONUCLEIC-ACID; GLUCOSE; BISTABILITY; INDUCTION; NETWORK; NOISE	Stochasticity in gene regulation has been characterized extensively, but how it affects cellular growth and fitness is less clear. We study the growth of E. coli cells as they shift from glucose to lactose metabolism, which is characterized by an obligatory growth arrest in bulk experiments that is termed the lag phase. Here, we follow the growth dynamics of individual cells at minute-resolution using a single-cell assay in a microfluidic device during this shift, while also monitoring lac expression. Mirroring the bulk results, the majority of cells displays a growth arrest upon glucose exhaustion, and resume when triggered by stochastic lac expression events. However, a significant fraction of cells maintains a high rate of elongation and displays no detectable growth lag during the shift. This ability to suppress the growth lag should provide important selective advantages when nutrients are scarce. Trajectories of individual cells display a highly non-linear relation between lac expression and growth, with only a fraction of fully induced levels being sufficient for achieving near maximal growth. A stochastic molecular model together with measured dependencies between nutrient concentration, lac expression level, and growth accurately reproduces the observed switching distributions. The results show that a growth arrest is not obligatory in the classic diauxic shift, and underscore that regulatory stochasticity ought to be considered in terms of its impact on growth and survival.	[Boulineau, Sarah; Tostevin, Filipe; Kiviet, Daniel J.; ten Wolde, Pieter Rein; Nghe, Philippe; Tans, Sander J.] FOM Inst AMOLF, Amsterdam, Netherlands	AMOLF	Tans, SJ (corresponding author), FOM Inst AMOLF, Amsterdam, Netherlands.	tans@amolf.nl	Nghe, Philippe/AAB-3575-2019; Tans, Sander/AAS-2901-2020; Wolde, Pieter Rein Ten/U-4433-2019; Nghe, Philippe/M-3065-2015	Nghe, Philippe/0000-0003-3690-4610; Wolde, Pieter Rein Ten/0000-0001-9933-4016; Nghe, Philippe/0000-0003-3690-4610; Tostevin, Filipe/0000-0002-2263-2135	Netherlands Institute for Systems Biology (NISB)	Netherlands Institute for Systems Biology (NISB)	This work is part of the research program of the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organization for Scientific Research (NWO). S.B. was supported by Netherlands Institute for Systems Biology (NISB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; BRUNSCHEDE H, 1977, J BACTERIOL, V129, P1020, DOI 10.1128/JB.129.2.1020-1033.1977; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong IG, 2011, BIOESSAYS, V33, P215, DOI 10.1002/bies.201000127; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dreisigmeyer DW, 2008, IET SYST BIOL, V2, P293, DOI 10.1049/iet-syb:20080095; Ducret A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007282; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fischer D, 1998, J BACTERIOL, V180, P6203; Hermsen R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002265; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JOHNSEN K, 1977, J BACTERIOL, V131, P18, DOI 10.1128/JB.131.1.18-29.1977; Kalisky T, 2007, PHYS BIOL, V4, P229, DOI 10.1088/1478-3975/4/4/001; Kartal O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.76; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; KJELDGAARD NO, 1958, J GEN MICROBIOL, V19, P607, DOI 10.1099/00221287-19-3-607; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Kremling A, 2001, METAB ENG, V3, P362, DOI 10.1006/mben.2001.0199; KUBITSCHEK HE, 1990, J BACTERIOL, V172, P94, DOI 10.1128/JB.172.1.94-101.1990; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; LOOMIS WF, 1967, J BACTERIOL, V93, P1397, DOI 10.1128/JB.93.4.1397-1401.1967; MAGASANIK B, 1961, COLD SPRING HARB SYM, V26, P249, DOI 10.1101/SQB.1961.026.01.031; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; MARR AG, 1991, MICROBIOL REV, V55, P316, DOI 10.1128/MMBR.55.2.316-333.1991; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; MOLIN S, 1977, J BACTERIOL, V131, P7, DOI 10.1128/JB.131.1.7-17.1977; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; NAZAR RN, 1969, J BACTERIOL, V100, P956, DOI 10.1128/JB.100.2.956-961.1969; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; SHEHATA T, 1971, J BACTERIOL, V107, P210, DOI 10.1128/JB.107.1.210-216.1971; SLOAN JB, 1976, J BACTERIOL, V128, P302, DOI 10.1128/JB.128.1.302-308.1976; Tanase-Nicola S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000125; van Hoek MJA, 2006, BIOPHYS J, V91, P2833, DOI [10.1529/biophysj.105.077420, 10.1529/biophysj.106.077420]; WINSLOW RM, 1971, J BIOL CHEM, V246, P4872; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	49	64	64	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61686	10.1371/journal.pone.0061686	http://dx.doi.org/10.1371/journal.pone.0061686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23637881	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300013
J	Joh, DY; Sun, L; Stangl, M; Al Zaki, A; Murty, S; Santoiemma, PP; Davis, JJ; Baumann, BC; Alonso-Basanta, M; Bhang, D; Kao, GD; Tsourkas, A; Dorsey, JF				Joh, Daniel Y.; Sun, Lova; Stangl, Melissa; Al Zaki, Ajlan; Murty, Surya; Santoiemma, Phillip P.; Davis, James J.; Baumann, Brian C.; Alonso-Basanta, Michelle; Bhang, Dongha; Kao, Gary D.; Tsourkas, Andrew; Dorsey, Jay F.			Selective Targeting of Brain Tumors with Gold Nanoparticle-Induced Radiosensitization	PLOS ONE			English	Article							RAY COMPUTED-TOMOGRAPHY; CONTRAST AGENT; BARRIER; ENHANCEMENT; CANCER; SIZE; BIODISTRIBUTION; EXPRESSION; ENERGY; CELLS	Successful treatment of brain tumors such as glioblastoma multiforme (GBM) is limited in large part by the cumulative dose of Radiation Therapy (RT) that can be safely given and the blood-brain barrier (BBB), which limits the delivery of systemic anticancer agents into tumor tissue. Consequently, the overall prognosis remains grim. Herein, we report our pilot studies in cell culture experiments and in an animal model of GBM in which RT is complemented by PEGylated-gold nanoparticles (GNPs). GNPs significantly increased cellular DNA damage inflicted by ionizing radiation in human GBM-derived cell lines and resulted in reduced clonogenic survival (with dose-enhancement ratio of similar to 1.3). Intriguingly, combined GNP and RT also resulted in markedly increased DNA damage to brain blood vessels. Follow-up in vitro experiments confirmed that the combination of GNP and RT resulted in considerably increased DNA damage in brain-derived endothelial cells. Finally, the combination of GNP and RT increased survival of mice with orthotopic GBM tumors. Prior treatment of mice with brain tumors resulted in increased extravasation and in-tumor deposition of GNP, suggesting that RT-induced BBB disruption can be leveraged to improve the tumor-tissue targeting of GNP and thus further optimize the radiosensitization of brain tumors by GNP. These exciting results together suggest that GNP may be usefully integrated into the RT treatment of brain tumors, with potential benefits resulting from increased tumor cell radiosensitization to preferential targeting of tumor-associated vasculature.	[Joh, Daniel Y.; Sun, Lova; Stangl, Melissa; Murty, Surya; Santoiemma, Phillip P.; Davis, James J.; Baumann, Brian C.; Alonso-Basanta, Michelle; Kao, Gary D.; Dorsey, Jay F.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Al Zaki, Ajlan; Tsourkas, Andrew] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Bhang, Dongha] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Dorsey, JF (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	JayD@uphs.upenn.edu	Tsourkas, Andrew/A-1074-2007; Tsourkas, Andrew/AAM-8252-2020	Tsourkas, Andrew/0000-0001-7758-1753; Tsourkas, Andrew/0000-0001-7758-1753; Baumann, Brian/0000-0002-7482-1413	University of Pennsylvania Nano/Bio Interface Center (NBIC); Abramson Cancer Center (NCI) [5-P30-CA-016520-36]; NIH/NINDS [RC1 CA145075, K08 NS076548]; NIH/NIBIB [R21 EB013754]; Burroughs Wellcome Career Award for Medical Scientists [1006792]; NATIONAL CANCER INSTITUTE [P30CA016520, RC1CA145075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB013754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS076548] Funding Source: NIH RePORTER	University of Pennsylvania Nano/Bio Interface Center (NBIC); Abramson Cancer Center (NCI); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the University of Pennsylvania Nano/Bio Interface Center (NBIC), the Abramson Cancer Center (NCI-sponsored pilot grant, 5-P30-CA-016520-36), IH/NINDS (RC1 CA145075 and K08 NS076548), NIH/NIBIB (R21 EB013754) and the Burroughs Wellcome Career Award for Medical Scientists (1006792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Balasubramanian SK, 2010, BIOMATERIALS, V31, P2034, DOI 10.1016/j.biomaterials.2009.11.079; Baumann BC, 2012, JOVE-J VIS EXP, DOI 10.3791/4089; Baumann BC, 2013, ONCOTARGET, V4, P64, DOI 10.18632/oncotarget.777; Baumann BC, 2012, TRANSL ONCOL, V5, P230, DOI 10.1593/tlo.12136; Berbeco RI, 2011, INT J RADIAT ONCOL, V81, P270, DOI 10.1016/j.ijrobp.2010.10.022; Black Keith L, 2004, Cancer Control, V11, P165; Butterworth KT, 2012, NANOSCALE, V4, P4830, DOI 10.1039/c2nr31227a; Cai QY, 2007, INVEST RADIOL, V42, P797, DOI 10.1097/RLI.0b013e31811ecdcd; Cao Y, 2005, J CLIN ONCOL, V23, P4127, DOI 10.1200/JCO.2005.07.144; Chattopadhyay N, 2010, MOL PHARMACEUT, V7, P2194, DOI 10.1021/mp100207t; Chithrani DB, 2010, RADIAT RES, V173, P719, DOI 10.1667/RR1984.1; Cho WS, 2010, TOXICOL APPL PHARM, V245, P116, DOI 10.1016/j.taap.2010.02.013; Cloughesy TF, 1995, J NEURO-ONCOL, V26, P125, DOI 10.1007/BF01060218; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; Fricker S. P., 1996, GOLD BULL, V29, P53, DOI DOI 10.1007/BF03215464; Gibson JD, 2007, J AM CHEM SOC, V129, P11653, DOI 10.1021/ja075181k; Goel R, 2009, NANOMEDICINE-UK, V4, P401, DOI [10.2217/nnm.09.21, 10.2217/NNM.09.21]; Hainfeld JF, 2010, PHYS MED BIOL, V55, P3045, DOI 10.1088/0031-9155/55/11/004; Hainfeld JF, 2006, BRIT J RADIOL, V79, P248, DOI 10.1259/bjr/13169882; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; Hou YN, 2009, RADIAT RES, V171, P360, DOI 10.1667/RR1349.1; Huo SD, 2013, CANCER RES, V73, P319, DOI 10.1158/0008-5472.CAN-12-2071; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Jain S, 2012, BRIT J RADIOL, V85, P101, DOI 10.1259/bjr/59448833; Jain S, 2011, INT J RADIAT ONCOL, V79, P531, DOI 10.1016/j.ijrobp.2010.08.044; James WD, 2007, J RADIOANAL NUCL CH, V271, P455, DOI 10.1007/s10967-007-0230-1; Jin YD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1042; Kim D, 2007, J AM CHEM SOC, V129, P7661, DOI 10.1021/ja071471p; Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w; Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Lasagna-Reeves C, 2010, BIOCHEM BIOPH RES CO, V393, P649, DOI 10.1016/j.bbrc.2010.02.046; Lechtman E, 2011, PHYS MED BIOL, V56, P4631, DOI 10.1088/0031-9155/56/15/001; Libutti SK, 2010, CLIN CANCER RES, V16, P6139, DOI 10.1158/1078-0432.CCR-10-0978; Liu CJ, 2010, PHYS MED BIOL, V55, P931, DOI 10.1088/0031-9155/55/4/002; Liu CJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295104; Machein MR, 2000, J NEURO-ONCOL, V50, P109, DOI 10.1023/A:1006416003964; McMahon SJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00018; Ngwa W, 2012, PHYS MED BIOL, V57, P6371, DOI 10.1088/0031-9155/57/20/6371; Ngwa W, 2010, PHYS MED BIOL, V55, P6533, DOI 10.1088/0031-9155/55/21/013; Ozawa Tomoko, 2010, J Vis Exp, DOI 10.3791/1986; Papadopoulos MC, 2001, NEUROPATH APPL NEURO, V27, P384, DOI 10.1046/j.0305-1846.2001.00341.x; Park JA, 2008, BIOORG MED CHEM LETT, V18, P6135, DOI 10.1016/j.bmcl.2008.10.017; Popovtzer R, 2008, NANO LETT, V8, P4593, DOI 10.1021/nl8029114; Radaelli E, 2009, HISTOL HISTOPATHOL, V24, P879, DOI 10.14670/HH-24.879; Rahman WN, 2009, NANOMED-NANOTECHNOL, V5, P136, DOI 10.1016/j.nano.2009.01.014; Sadauskas E, 2009, NANOMED-NANOTECHNOL, V5, P162, DOI 10.1016/j.nano.2008.11.002; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Zhang XD, 2012, BIOMATERIALS, V33, P6408, DOI 10.1016/j.biomaterials.2012.05.047; Zhang XD, 2011, INT J NANOMED, V6, P2071, DOI 10.2147/IJN.S21657	58	164	172	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62425	10.1371/journal.pone.0062425	http://dx.doi.org/10.1371/journal.pone.0062425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638079	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300056
J	Perng, W; Mora-Plazas, M; Marin, C; Rozek, LS; Baylin, A; Villamor, E				Perng, Wei; Mora-Plazas, Mercedes; Marin, Constanza; Rozek, Laura S.; Baylin, Ana; Villamor, Eduardo			A Prospective Study of LINE-1DNA Methylation and Development of Adiposity in School-Age Children	PLOS ONE			English	Article							GENOMIC DNA METHYLATION; WAIST CIRCUMFERENCE; PRENATAL EXPOSURE; FAT; DISEASE; OBESITY; FAMINE; GROWTH; MASS; CHOLESTEROL	Background: Repetitive element DNA methylation is related to prominent obesity-related chronic diseases including cancer and cardiovascular disease; yet, little is known of its relation with weight status. We examined associations of LINE-1 DNA methylation with changes in adiposity and linear growth in a longitudinal study of school-age children from Bogota, Colombia. Methods: We quantified methylation of LINE-1 elements from peripheral leukocytes of 553 children aged 5-12 years at baseline using pyrosequencing technology. Anthropometric characteristics were measured periodically for a median of 30 months. We estimated mean change in three age-and sex-standardized indicators of adiposity: body mass index (BMI)-for-age Z-score, waist circumference Z-score, and subscapular-to-triceps skinfold thickness ratio Z-score according to quartiles of LINE-1 methylation using mixed effects regression models. We also examined associations with height-for-age Z-score. Results: There were non-linear, inverse relations of LINE-1 methylation with BMI-for-age Z-score and the skinfold thickness ratio Z-score. After adjustment for baseline age and socioeconomic status, boys in the lowest quartile of LINE-1 methylation experienced annual gains in BMI-for-age Z-score and skinfold thickness ratio Z-score that were 0.06 Z/year (P = 0.04) and 0.07 Z/year (P = 0.03), respectively, higher than those in the upper three quartiles. The relation of LINE-1 methylation and annual change in waist circumference followed a decreasing monotonic trend across the four quartiles (P trend = 0.02). DNA methylation was not related to any of the adiposity indicators in girls. There were no associations between LINE-1 methylation and linear growth in either sex. Conclusions: Lower LINE-1 DNA methylation is related to development of adiposity in boys.	[Perng, Wei; Baylin, Ana; Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Mora-Plazas, Mercedes; Marin, Constanza] FINUSAD, Fdn Invest Nutr & Salud, Bogota, Colombia; [Rozek, Laura S.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Perng, W (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	perngwei@umich.edu		Mora, Mercedes/0000-0001-5396-8726; Marin, Constanza/0000-0002-7324-1302	Robert Wood Johnson Foundation; ASISA Research Fund at the University of Michigan; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); ASISA Research Fund at the University of Michigan; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the Robert Wood Johnson Foundation Research Project Awards. The Bogota School Children Cohort Study is currently sponsored by the ASISA Research Fund at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; [Anonymous], 1994, Vital Health Stat 1, P1; Arsenault JE, 2009, J NUTR, V139, P1744, DOI 10.3945/jn.109.108662; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Baccarelli A, 2010, EPIGENETICS-US, V5; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Boeke CE, 2012, EPIGENETICS-US, V7, P253, DOI 10.4161/epi.7.3.19082; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Cash HL, 2011, EPIGENETICS, V6; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; Fryer Anthony A, 2009, Epigenetics, V4, P394; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Juonala M, 2011, J CLIN ENDOCR METAB, V96, pE1542, DOI 10.1210/jc.2011-1243; Kim KY, 2010, ENVIRON HEALTH PERSP, V118, P370, DOI 10.1289/ehp.0901131; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Metzger D, 2005, PROSTAG LEUKOTR ESS, V73, P51, DOI 10.1016/j.plefa.2005.04.007; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Office of the Mayor of Bogota, 2006, EST SECT ED BOG 2005; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Perng W, 2012, EPIGENETICS, V7; Relton CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031821; Schmidt MD, 2011, INT J OBESITY, V35, P38, DOI 10.1038/ijo.2010.205; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tanner J., 1990, FETUS MAN; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Tresaco B, 2009, OBESITY, V17, P1086, DOI 10.1038/oby.2008.626; Wang J, INT J OBES LOND; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wen XZ, 2011, J DEV ORIG HLTH DIS, V2, pS122; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Wu HC, 2011, EPIGENETICS-US, V6, P29, DOI 10.4161/epi.6.1.13393; Yang HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009355; Zhang FF, 2011, J NUTR, V141, P1165, DOI 10.3945/jn.110.134536; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378; Zhao J, 2011, DIABETES; Zhu ZZ, 2010, INT J EPIDEMIOL	56	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62587	10.1371/journal.pone.0062587	http://dx.doi.org/10.1371/journal.pone.0062587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638120	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300079
J	Weyd, H; Abeler-Dorner, L; Linke, B; Mahr, A; Jahndel, V; Pfrang, S; Schnolzer, M; Falk, CS; Krammer, PH				Weyd, Heiko; Abeler-Doerner, Lucie; Linke, Bjoern; Mahr, Andrea; Jahndel, Veronika; Pfrang, Sandra; Schnoelzer, Martina; Falk, Christine S.; Krammer, Peter H.			Annexin A1 on the Surface of Early Apoptotic Cells Suppresses CD8(+) T Cell Immunity	PLOS ONE			English	Article							DENDRITIC CELLS; DYING CELLS; TOLERANCE; ACTIVATION; ANTIGEN; RESPONSES; SIGNALS; MECHANISMS; ENGULFMENT; MATURATION	Prevention of an immune response against self-antigens derived from apoptotic cells is essential to preclude autoimmune and chronic inflammatory diseases. Here, we describe apoptosis induced externalization of endogenous cytosolic annexin 1 initiating an anti-inflammatory effector mechanism that suppresses the immune response against antigens of apoptotic cells. Cytosolic annexin 1 rapidly translocated to the apoptotic cell surface and inhibited dendritic cell (DC) activation induced by Toll like receptors (TLR). Annexin 1-inhibited DC showed strongly reduced secretion of pro-inflammatory cytokines (e.g. TNF and IL-12) and costimulatory surface molecules (e.g. CD40 and CD86), while anti-inflammatory mediators like PD-L1 remained unchanged. T cells stimulated by such DC lacked secretion of interferon-gamma (IFN-gamma) and TNF but retained IL-10 secretion. In mice, annexin 1 prevented the development of inflammatory DC and suppressed the cellular immune response against the model antigen ovalbumin (OVA) expressed in apoptotic cells. Furthermore, annexin 1 on apoptotic cells compromised OVA-specific tumor vaccination and impaired rejection of an OVA-expressing tumor. Thus, our results provide a molecular mechanism for the suppressive activity of apoptotic cells on the immune response towards apoptotic cell-derived self-antigens. This process may play an important role in prevention of autoimmune diseases and of the immune response against cancer.	[Weyd, Heiko; Abeler-Doerner, Lucie; Linke, Bjoern; Mahr, Andrea; Jahndel, Veronika; Pfrang, Sandra; Krammer, Peter H.] German Canc Res Ctr, Tumor Immunol Program, Heidelberg, Germany; [Schnoelzer, Martina] German Canc Res Ctr, Heidelberg, Germany; [Falk, Christine S.] Hannover Med Sch, Inst Transplant Immunol, Hannover, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School	Krammer, PH (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Heidelberg, Germany.	p.krammer@dkfz.de	Falk, Christine/Q-4143-2016	Falk, Christine/0000-0003-1376-7318	Deutsche Krebshilfe; Helmholtz Alliance on Immunotherapy of Cancer; Deutsche Forschungsgemeinschaft [TRR77 Projekt A3]	Deutsche Krebshilfe(Deutsche Krebshilfe); Helmholtz Alliance on Immunotherapy of Cancer; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Krebshilfe, the Helmholtz Alliance on Immunotherapy of Cancer and the Deutsche Forschungsgemeinschaft (TRR77 Projekt A3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Blume KE, 2009, J IMMUNOL, V183, P8138, DOI 10.4049/jimmunol.0902250; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Cohen PL, 2004, RHEUM DIS CLIN N AM, V30, P473, DOI 10.1016/j.rdc.2004.04.003; D'Acquisto F, 2007, BLOOD, V109, P1095, DOI 10.1182/blood-2006-05-022798; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GONZALEZ N, 2009, IMMUNITY, V31, P245, DOI DOI 10.1016/J.IMMUNI.2009.06.018; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Jordan KR, 2008, J IMMUNOL, V180, P188, DOI 10.4049/jimmunol.180.1.188; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li XR, 2010, EUR J IMMUNOL, V40, P3325, DOI 10.1002/eji.201041093; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Lutz MB, 2009, EUR J IMMUNOL, V39, P2325, DOI 10.1002/eji.200939548; MAJNO G, 1995, AM J PATHOL, V146, P3; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Natarajan S, 2010, IMMUNOBIOLOGY, V215, P698, DOI 10.1016/j.imbio.2010.05.024; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Pupjalis D, 2011, EMBO MOL MED, V3, P102, DOI 10.1002/emmm.201000113; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rondepierre F, 2009, BBA-PROTEINS PROTEOM, V1794, P61, DOI 10.1016/j.bbapap.2008.09.014; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Skurkovich S, 2005, ANN NY ACAD SCI, V1051, P684, DOI 10.1196/annals.1361.113; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Tomimori Y, 2000, IMMUNOL LETT, V71, P49, DOI 10.1016/S0165-2478(99)00163-7; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang YH, 1999, ARTHRITIS RHEUM, V42, P1538, DOI 10.1002/1529-0131(199907)42:7<1538::AID-ANR29>3.0.CO;2-3; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	56	50	53	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62449	10.1371/journal.pone.0062449	http://dx.doi.org/10.1371/journal.pone.0062449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638088	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300061
J	Talavera, D; Robertson, DL; Lovell, SC				Talavera, David; Robertson, David L.; Lovell, Simon C.			The Role of Protein Interactions in Mediating Essentiality and Synthetic Lethality	PLOS ONE			English	Article							GENETIC INTERACTION NETWORKS; SACCHAROMYCES-CEREVISIAE GENOME; DUPLICATE GENES; YEAST INTERACTOME; INTERACTIONS REVEAL; MAP; EVOLUTION; MOUSE; TECHNOLOGIES; ORGANIZATION	Genes are characterized as essential if their knockout is associated with a lethal phenotype, and these "essential genes'' play a central role in biological function. In addition, some genes are only essential when deleted in pairs, a phenomenon known as synthetic lethality. Here we consider genes displaying synthetic lethality as "essential pairs'' of genes, and analyze the properties of yeast essential genes and synthetic lethal pairs together. As gene duplication initially produces an identical pair or sets of genes, it is often invoked as an explanation for synthetic lethality. However, we find that duplication explains only a minority of cases of synthetic lethality. Similarly, disruption of metabolic pathways leads to relatively few examples of synthetic lethality. By contrast, the vast majority of synthetic lethal gene pairs code for proteins with related functions that share interaction partners. We also find that essential genes and synthetic lethal pairs cluster in the protein-protein interaction network. These results suggest that synthetic lethality is strongly dependent on the formation of protein-protein interactions. Compensation by duplicates does not usually occur mainly because the genes involved are recent duplicates, but is more commonly due to functional similarity that permits preservation of essential protein complexes. This unified view, combining genes that are individually essential with those that form essential pairs, suggests that essentiality is a feature of physical interactions between proteins protein-protein interactions, rather than being inherent in gene and protein products themselves.	[Talavera, David; Robertson, David L.; Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lovell, SC (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	simon.lovell@manchester.ac.uk	Talavera, David/AAD-2088-2021	Lovell, Simon/0000-0002-4092-8458; Talavera, David/0000-0002-8820-3931	Biotechnology and Biological Sciences Research Council [BB/F013337/1]; BBSRC [BB/F013337/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk), grant number BB/F013337/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Collins SR, 2010, METHOD ENZYMOL, V470, P205, DOI 10.1016/S0076-6879(10)70009-4; Conant GC, 2004, P ROY SOC B-BIOL SCI, V271, P89, DOI 10.1098/rspb.2003.2560; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Coulomb S, 2005, P ROY SOC B-BIOL SCI, V272, P1721, DOI 10.1098/rspb.2005.3128; D'Elia MA, 2009, TRENDS MICROBIOL, V17, P433, DOI 10.1016/j.tim.2009.08.005; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Doyle MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-222; Feiglin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039662; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guan HT, 2008, ADV BIOCHEM ENG BIOT, V110, P1, DOI 10.1007/10_2007_092; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Hakes L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r209; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hollunder J, 2005, PROTEOMICS, V5, P2082, DOI 10.1002/pmic.200401121; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Le Meur N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r135; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Li JJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001187; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liang H, 2009, TRENDS GENET, V25, P441, DOI 10.1016/j.tig.2009.08.001; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Michaut M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001092; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Pereira-Leal JB, 2005, MOL BIOL EVOL, V22, P421, DOI 10.1093/molbev/msi024; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stuart GR, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp140; Su ZX, 2008, J MOL EVOL, V67, P705, DOI 10.1007/s00239-008-9170-9; Suter B, 2008, CURR OPIN BIOTECH, V19, P316, DOI 10.1016/j.copbio.2008.06.005; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Valente AXCN, 2009, P NATL ACAD SCI USA, V106, P1490, DOI 10.1073/pnas.0808624106; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Wagner A., 2005, BIOESSAYS; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	61	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62866	10.1371/journal.pone.0062866	http://dx.doi.org/10.1371/journal.pone.0062866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638160	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000321662800066
J	Veringa, SJE; Biesmans, D; van Vuurden, DG; Jansen, MHA; Wedekind, LE; Horsman, I; Wesseling, P; Vandertop, WP; Noske, DP; Kaspers, GJL; Hulleman, E				Veringa, Susanna J. E.; Biesmans, Dennis; van Vuurden, Dannis G.; Jansen, Marc H. A.; Wedekind, Laurine E.; Horsman, Ilona; Wesseling, Pieter; Vandertop, William Peter; Noske, David P.; Kaspers, GertJan J. L.; Hulleman, Esther			In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma	PLOS ONE			English	Article							CHILDRENS ONCOLOGY GROUP; REFRACTORY SOLID TUMORS; HUMAN-MALIGNANT GLIOMA; GROWTH-FACTOR RECEPTOR; BRAIN-STEM GLIOMA; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; PHASE-I; CLINICAL-TRIALS; CANCER CELLS	Pediatric high-grade gliomas (pHGG), including diffuse intrinsic pontine gliomas (DIPG), are the leading cause of cancer-related death in children. While it is clear that surgery (if possible), and radiotherapy are beneficial for treatment, the role of chemotherapy for these tumors is still unclear. Therefore, we performed an in vitro drug screen on primary glioma cells, including three DIPG cultures, to determine drug sensitivity of these tumours, without the possible confounding effect of insufficient drug delivery. This screen revealed a high in vitro cytotoxicity for melphalan, doxorubicine, mitoxantrone, and BCNU, and for the novel, targeted agents vandetanib and bortezomib in pHGG and DIPG cells. We subsequently determined the expression of the drug efflux transporters P-gp, BCRP1, and MRP1 in glioma cultures and their corresponding tumor tissues. Results indicate the presence of P-gp, MRP1 and BCRP1 in the tumor vasculature, and expression of MRP1 in the glioma cells themselves. Our results show that pediatric glioma and DIPG tumors per se are not resistant to chemotherapy. Treatment failure observed in clinical trials, may rather be contributed to the presence of drug efflux transporters that constitute a first line of drug resistance located at the blood-brain barrier or other resistance mechanism. As such, we suggest that alternative ways of drug delivery may offer new possibilities for the treatment of pediatric high-grade glioma patients, and DIPG in particular.	[Veringa, Susanna J. E.; Biesmans, Dennis; van Vuurden, Dannis G.; Jansen, Marc H. A.; Kaspers, GertJan J. L.; Hulleman, Esther] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands; [Veringa, Susanna J. E.; Biesmans, Dennis; van Vuurden, Dannis G.; Wedekind, Laurine E.; Noske, David P.; Hulleman, Esther] Vrije Univ Amsterdam, Med Ctr, Dept Neurooncol Res Grp, Amsterdam, Netherlands; [Horsman, Ilona] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Wesseling, Pieter] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Wedekind, Laurine E.; Vandertop, William Peter; Noske, David P.] Vrije Univ Amsterdam, Med Ctr, Dept Neurosurg, Amsterdam, Netherlands; [Wesseling, Pieter] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen	Hulleman, E (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands.	e.hulleman@vumc.nl	Hulleman, Esther/AAD-7073-2021; van Vuurden, Dannis/ACA-6952-2022; Kaspers, Gertjan/ABC-5334-2020; Vandertop, William P./K-9288-2018; Wesseling, P./H-8114-2014	Kaspers, Gertjan/0000-0001-7716-8475; Wesseling, P./0000-0001-5453-5201; Noske, David/0000-0001-5992-4468; Van Vuurden, Dannis/0000-0002-1364-9007; Vandertop, William/0000-0001-5417-0265; Hulleman, Esther/0000-0001-9256-947X	KiKa "Stichting Kinderen Kankervrij'' - Dutch Children Cancer-free foundation	KiKa "Stichting Kinderen Kankervrij'' - Dutch Children Cancer-free foundation	This work was supported by KiKa "Stichting Kinderen Kankervrij'' - Dutch Children Cancer-free foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2008, MOL THER, V16, P487, DOI 10.1038/sj.mt.6300400; Azzariti A, 2010, CANCER CHEMOTH PHARM, V65, P335, DOI 10.1007/s00280-009-1039-0; Bahr O, 2003, BRAIN PATHOL, V13, P482; Bredel M, 2002, LANCET ONCOL, V3, P397, DOI 10.1016/S1470-2045(02)00786-6; Bredel M, 2001, BRAIN RES REV, V35, P161, DOI 10.1016/S0165-0173(01)00045-5; Broniscer A, 2006, CANCER INVEST, V24, P77, DOI 10.1080/07357900500449702; Broniscer A, 2004, ONCOLOGIST, V9, P197, DOI 10.1634/theoncologist.9-2-197; Cohen KJ, 2011, NEURO-ONCOLOGY, V13, P410, DOI 10.1093/neuonc/noq205; Cohen KJ, 2011, NEURO-ONCOLOGY, V13, P317, DOI 10.1093/neuonc/noq191; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Daood M, 2008, NEUROPEDIATRICS, V39, P211, DOI 10.1055/s-0028-1103272; Decleves X, 2006, CURR CANCER DRUG TAR, V6, P433, DOI 10.2174/156800906777723930; Dixit S, 2011, BRIT J NEUROSURG, V25, P459, DOI 10.3109/02688697.2010.550342; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Doz F, 2001, BRIT J CANCER, V84, P604, DOI 10.1054/bjoc.2000.1637; Estlin EJ, 1998, BRIT J CANCER, V78, P652, DOI 10.1038/bjc.1998.555; Fruehauf JP, 2006, CLIN CANCER RES, V12, P4523, DOI 10.1158/1078-0432.CCR-05-1830; Geoerger B, 2001, CANCER RES, V61, P1527; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Hart MG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007294.pub2; Hempel G, 2002, CANCER CHEMOTH PHARM, V49, P133, DOI 10.1007/s00280-001-0392-4; HENSON JW, 1992, J NEURO-ONCOL, V14, P37; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Homsi J, 2009, MELANOMA RES, V19, P167, DOI 10.1097/CMR.0b013e328304974c; Hooijberg JH, 2003, BIOCHEM PHARMACOL, V65, P765, DOI 10.1016/S0006-2952(02)01615-5; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Jane EP, 2006, J PHARMACOL EXP THER, V319, P1070, DOI 10.1124/jpet.106.108621; Jansen MHA, 2012, CANCER TREAT REV, V38, P27, DOI 10.1016/j.ctrv.2011.06.007; Jiang XY, 2011, INT J PHARMACEUT, V420, P385, DOI 10.1016/j.ijpharm.2011.08.052; Kato Y, 2003, PEDIATR INT, V45, P74, DOI 10.1046/j.1442-200X.2003.01675.x; Kirches E, 1997, CLIN NEUROPATHOL, V16, P34; KLETZEL M, 1992, BONE MARROW TRANSPL, V10, P171; KupczykSubotkowska L, 1997, J MED CHEM, V40, P1726, DOI 10.1021/jm960592p; Litman T, 2002, BBA-BIOMEMBRANES, V1565, P6, DOI 10.1016/S0005-2736(02)00492-3; Marquez-Rivas J, 2010, J PEDIAT HEMATOL ONC, V32, pE202, DOI 10.1097/MPH.0b013e3181e0d16b; Mi YJ, 2010, CANCER RES, V70, P7981, DOI 10.1158/0008-5472.CAN-10-0111; Moore AS, 2011, J PAEDIATR CHILD H, V47, P875, DOI 10.1111/j.1440-1754.2011.02103.x; Ng WH, 2007, J CLIN NEUROSCI, V14, P261, DOI 10.1016/j.jocn.2005.11.010; Ni ZL, 2010, CURR DRUG METAB, V11, P603, DOI 10.2174/138920010792927325; Nies AT, 2007, CANCER LETT, V254, P11, DOI 10.1016/j.canlet.2006.12.023; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Phuphanich S, 2010, J NEURO-ONCOL, V100, P95, DOI 10.1007/s11060-010-0143-7; Premkumar D. R., 2010, J CARCINOG, V9; Qu HQ, 2010, NEURO-ONCOLOGY, V12, P153, DOI 10.1093/neuonc/nop001; RICCARDI R, 1994, CANCER CHEMOTH PHARM, V33, P477, DOI 10.1007/s002800050086; Rich JN, 2005, CLIN CANCER RES, V11, P8145, DOI 10.1158/1078-0432.CCR-05-0319; Sankar A, 1999, ANTI-CANCER DRUG, V10, P179, DOI 10.1097/00001813-199902000-00006; Sawada T, 1999, Brain Tumor Pathol, V16, P23, DOI 10.1007/BF02478898; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205; Souid AK, 2003, CLIN CANCER RES, V9, P703; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Styczynski J, 2006, ANTICANCER RES, V26, P4499; Suri V, 2009, NEURO-ONCOLOGY, V11, P274, DOI 10.1215/15228517-2008-092; Tamber Mandeep S, 2003, Neurosurg Focus, V14, pe1; Ueno M, 2010, CURR MED CHEM, V17, P1125, DOI 10.2174/092986710790827816; van Vuurden D.G., 2011, ONCOTARGET; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; WHELAN RDH, 1992, INT J CANCER, V52, P241, DOI 10.1002/ijc.2910520215; Wolff J, 2011, PEDIAT BLOOD CANC; Wolff JEA, 1999, J CANCER RES CLIN, V125, P481, DOI 10.1007/s004320050305; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	64	72	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61512	10.1371/journal.pone.0061512	http://dx.doi.org/10.1371/journal.pone.0061512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637844	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800008
J	Weissman, DH; Carp, J				Weissman, Daniel H.; Carp, Joshua			The Congruency Effect in the Posterior Medial Frontal Cortex Is More Consistent with Time on Task than with Response Conflict	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; ERROR; TRIAL; INTERFERENCE; PERFORMANCE; FREQUENCY; SEQUENCE; THETA; FMRI	The posterior medial frontal cortex (pMFC) is thought to play a pivotal role in enabling the control of attention during periods of distraction. In line with this view, pMFC activity is ubiquitously greater in incongruent trials of response-interference (e.g., Stroop) tasks than in congruent trials. Nonetheless, the process underlying this congruency effect remains highly controversial. We therefore sought to distinguish between two competing accounts of the congruency effect. The conflict monitoring account posits the effect indexes a process that detects conflict between competing response alternatives, which is indexed by trial-specific reaction time (RT). The time on task account posits the effect indexes a process whose recruitment increases with time on task independent of response conflict (e.g., sustained attention, arousal, effort, etc.). To distinguish between these accounts, we used functional MRI to record brain activity in twenty-four healthy adults while they performed two tasks: a response-interference task and a simple RT task with only one possible response. We reasoned that demands on a process that detects response conflict should increase with RT in the response-interference task but not in the simple RT task. In contrast, demands on a process whose recruitment increases with time on task independent of response conflict should increase with RT in both tasks. Trial-by-trial analyses revealed that pMFC activity increased with RT in both tasks. Moreover, pMFC activity increased with RT in the simple RT task enough to fully account for the congruency effect in the response-interference task. These findings appear more consistent with the time on task account of the congruency effect than with the conflict monitoring account.	[Weissman, Daniel H.; Carp, Joshua] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Weissman, DH (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	danweiss@umich.edu			National Science Foundation; National Defense Science and Engineering Graduate Fellowship; University of Michigan startup funds	National Science Foundation(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship; University of Michigan startup funds(University of Michigan System)	This research was supported by National Science Foundation and National Defense Science and Engineering Graduate Fellowships awarded to Joshua Carp and by University of Michigan startup funds awarded to Daniel Weissman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Burle B, 2008, J COGNITIVE NEUROSCI, V20, P1637, DOI 10.1162/jocn.2008.20110; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Carp J, 2012, NEUROIMAGE, V59, P853, DOI 10.1016/j.neuroimage.2011.07.064; Carp J, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00231; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chee MWL, 2008, J NEUROSCI, V28, P5519, DOI 10.1523/JNEUROSCI.0733-08.2008; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Feredoes E, 2006, P NATL ACAD SCI USA, V103, P19530, DOI 10.1073/pnas.0604509103; Grinband J, 2011, NEUROIMAGE, V57, P303, DOI 10.1016/j.neuroimage.2010.12.027; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nee DE, 2011, NEUROIMAGE, V54, P528, DOI 10.1016/j.neuroimage.2010.08.027; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Orr JM, 2009, CEREB CORTEX, V19, P703, DOI 10.1093/cercor/bhn119; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Posner MI, 1998, ATTENTIVE BRAIN, P401; Prado J, 2011, NEUROIMAGE, V56, P2276, DOI 10.1016/j.neuroimage.2011.03.048; Prado J, 2011, NEUROIMAGE, V54, P541, DOI 10.1016/j.neuroimage.2010.08.022; Schmidt JR, 2013, PSYCHON B REV; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Spunt RP, 2012, J COGNITIVE NEUROSCI, V24, P1753, DOI 10.1162/jocn_a_00242; Szmalec A, 2008, NEUROSCI LETT, V435, P158, DOI 10.1016/j.neulet.2008.02.023; van Driel J, 2012, J NEUROSCI, V32, P16795, DOI 10.1523/JNEUROSCI.0802-12.2012; Van Essen DC, 2001, J AM MED INFORM ASS; van Maanen L, 2011, J NEUROSCI, V31, P17488, DOI 10.1523/JNEUROSCI.2924-11.2011; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yeung N, 2011, NEUROIMAGE, V57, P316, DOI 10.1016/j.neuroimage.2011.04.029	42	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62405	10.1371/journal.pone.0062405	http://dx.doi.org/10.1371/journal.pone.0062405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638070	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800040
J	Cline, TJ; Bennington, V; Kitchell, JF				Cline, Timothy J.; Bennington, Val; Kitchell, James F.			Climate Change Expands the Spatial Extent and Duration of Preferred Thermal Habitat for Lake Superior Fishes	PLOS ONE			English	Article							LAURENTIAN GREAT-LAKES; BIOENERGETICS MODEL; TEMPERATURE; TROUT; POPULATIONS; COMMUNITY; ABUNDANCE; RESPONSES; MICHIGAN; SYSTEMS	Climate change is expected to alter species distributions and habitat suitability across the globe. Understanding these shifting distributions is critical for adaptive resource management. The role of temperature in fish habitat and energetics is well established and can be used to evaluate climate change effects on habitat distributions and food web interactions. Lake Superior water temperatures are rising rapidly in response to climate change and this is likely influencing species distributions and interactions. We use a three-dimensional hydrodynamic model that captures temperature changes in Lake Superior over the last 3 decades to investigate shifts in habitat size and duration of preferred temperatures for four different fishes. We evaluated habitat changes in two native lake trout (Salvelinus namaycush) ecotypes, siscowet and lean lake trout, Chinook salmon (Oncorhynchus tshawytscha), and walleye (Sander vitreus). Between 1979 and 2006, days with available preferred thermal habitat increased at a mean rate of 6, 7, and 5 days per decade for lean lake trout, Chinook salmon, and walleye, respectively. Siscowet lake trout lost 3 days per decade. Consequently, preferred habitat spatial extents increased at a rate of 579, 495 and 419 km(2) per year for the lean lake trout, Chinook salmon, and walleye while siscowet lost 161 km(2) per year during the modeled period. Habitat increases could lead to increased growth and production for three of the four fishes. Consequently, greater habitat overlap may intensify interguild competition and food web interactions. Loss of cold-water habitat for siscowet, having the coldest thermal preference, could forecast potential changes from continued warming. Additionally, continued warming may render more suitable conditions for some invasive species.	[Cline, Timothy J.; Bennington, Val; Kitchell, James F.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Bennington, Val] Univ Wisconsin, Ctr Climat Res, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Cline, TJ (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	tjcline@uw.edu; benesh@wisc.edu			Wisconsin Sea Grant; National Science Foundation	Wisconsin Sea Grant; National Science Foundation(National Science Foundation (NSF))	This work was funded by grants to JFK from the Wisconsin Sea Grant (www.seagrant.wisc.edu/) and a National Science Foundation Graduate Research Fellowship Program fellowship to TJC (www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Assel R.A., 2003, ELECT ATLAS GREAT LA; Assel RA, 2005, J CLIMATE, V18, P4895, DOI 10.1175/JCLI3571.1; Austin J, 2008, LIMNOL OCEANOGR, V53, P2724, DOI 10.4319/lo.2008.53.6.2724; Austin JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029021; Bennington V, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006261; Bronte CR, 2008, T AM FISH SOC, V137, P916, DOI 10.1577/T07-096.1; Bronte CR, 2003, CAN J FISH AQUAT SCI, V60, P1552, DOI 10.1139/F03-136; Burkett DP, 1995, GREAT LAKES FISHERY; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Casselman JM, 2002, AM FISH S S, V32, P39; CHRISTIE GC, 1988, CAN J FISH AQUAT SCI, V45, P301, DOI 10.1139/f88-036; Ebener MP, 2007, GREAT LAKES FISHERIE, P07; Gorman O. T., 2010, GREAT LAKES FISHERY; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hansen MJ, 1995, J GREAT LAKES RES, V21, P152, DOI 10.1016/S0380-1330(95)71088-7; Holeck KT, 2004, BIOSCIENCE, V54, P919, DOI 10.1641/0006-3568(2004)054[0919:BTWBIT]2.0.CO;2; IPCC, 2001, ADV CLIM CHANG RES; Kitchell J. F., INVASIVE SPECIES GLO; Kitchell J. F., 2008, ECOLOGICAL HIST WISC, P157; KITCHELL JF, 1980, CAN J FISH AQUAT SCI, V37, P2159, DOI 10.1139/f80-258; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; Kitchell JF, 2000, ECOSYSTEMS, V3, P545, DOI 10.1007/s100210000048; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Lester NP, 2004, T AM FISH SOC, V133, P588, DOI 10.1577/T02-111.1; Madenjian CP, 1999, T AM FISH SOC, V128, P802, DOI 10.1577/1548-8659(1999)128&lt;0802:LEOALT&gt;2.0.CO;2; Magnuson JJ, 2010, J FISH BIOL, V77, P1731, DOI 10.1111/j.1095-8649.2010.02781.x; MAGNUSON JJ, 1990, T AM FISH SOC, V119, P254, DOI 10.1577/1548-8659(1990)119<0254:PCITTH>2.3.CO;2; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5733, DOI 10.1029/96JC02776; Mattes W. P., 2004, DEPTH TEMPERATURE DI; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Moody EK, 2011, J GREAT LAKES RES, V37, P343, DOI 10.1016/j.jglr.2011.01.007; Negus MT, 2008, N AM J FISH MANAGE, V28, P1649, DOI 10.1577/M07-176.1; Olsen RA, 1988, T AM FISH SOC, V117, P552; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Schwab D. J., 1996, COMPUTERIZED BATHYME; Sharma S, 2007, GLOBAL CHANGE BIOL, V13, P2052, DOI 10.1111/j.1365-2486.2007.01426.x; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, 10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2]; STEWART DJ, 1991, CAN J FISH AQUAT SCI, V48, P909, DOI 10.1139/f91-107; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weiler RR, 1978, J GREAT LAKES RES, V4, P370, DOI DOI 10.1016/S0380-1330(78)72207-0	47	50	50	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62279	10.1371/journal.pone.0062279	http://dx.doi.org/10.1371/journal.pone.0062279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638023	Green Published, gold			2022-12-25	WOS:000318343700045
J	Di Cesare, A; Luna, GM; Vignaroli, C; Pasquaroli, S; Tota, S; Paroncini, P; Biavasco, F				Di Cesare, Andrea; Luna, Gian Marco; Vignaroli, Carla; Pasquaroli, Sonia; Tota, Sara; Paroncini, Paolo; Biavasco, Francesca			Aquaculture Can Promote the Presence and Spread of Antibiotic-Resistant Enterococci in Marine Sediments	PLOS ONE			English	Article							ANTIMICROBIAL-RESISTANCE; ESCHERICHIA-COLI; SPECIES DISTRIBUTION; GENES; PCR; ERYTHROMYCIN; VIRULENCE; FAECIUM; HEALTH; BEACH	Aquaculture is an expanding activity worldwide. However its rapid growth can affect the aquatic environment through release of large amounts of chemicals, including antibiotics. Moreover, the presence of organic matter and bacteria of different origin can favor gene transfer and recombination. Whereas the consequences of such activities on environmental microbiota are well explored, little is known of their effects on allochthonous and potentially pathogenic bacteria, such as enterococci. Sediments from three sampling stations (two inside and one outside) collected in a fish farm in the Adriatic Sea were examined for enterococcal abundance and antibiotic resistance traits using the membrane filter technique and an improved quantitative PCR. Strains were tested for susceptibility to tetracycline, erythromycin, ampicillin and gentamicin; samples were directly screened for selected tetracycline [tet(M), tet(L), tet(O)] and macrolide [erm(A), erm(B) and mef] resistance genes by newly-developed multiplex PCRs. The abundance of benthic enterococci was higher inside than outside the farm. All isolates were susceptible to the four antimicrobials tested, although direct PCR evidenced tet(M) and tet(L) in sediment samples from all stations. Direct multiplex PCR of sediment samples cultured in rich broth supplemented with antibiotic (tetracycline, erythromycin, ampicillin or gentamicin) highlighted changes in resistance gene profiles, with amplification of previously undetected tet(O), erm(B) and mef genes and an increase in benthic enterococcal abundance after incubation in the presence of ampicillin and gentamicin. Despite being limited to a single farm, these data indicate that aquaculture may influence the abundance and spread of benthic enterococci and that farm sediments can be reservoirs of dormant antibiotic-resistant bacteria, including enterococci, which can rapidly revive in presence of new inputs of organic matter. This reservoir may constitute an underestimated health risk and deserves further investigation.	[Di Cesare, Andrea; Vignaroli, Carla; Pasquaroli, Sonia; Tota, Sara; Paroncini, Paolo; Biavasco, Francesca] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy; [Luna, Gian Marco] CNR, Inst Marine Sci, Venice, Italy	Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Di Cesare, A (corresponding author), Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy.	andrix.di.cesare@alice.it	Vignaroli, Carla/K-5745-2016; Biavasco, Francesca/AAB-4118-2019; Di Cesare, Andrea/P-5157-2016; Luna, Gian Marco/AAY-5262-2020; CNR, Ismar/P-1247-2014	Vignaroli, Carla/0000-0002-0993-5967; Biavasco, Francesca/0000-0002-8582-2227; CNR, Ismar/0000-0001-5351-1486; Di Cesare, Andrea/0000-0002-5481-6182; LUNA, GIAN MARCO/0000-0002-8303-3400	Italian Ministry of Research and Education [PRIN 2008-I31J10000050001FYXAXL_003]	Italian Ministry of Research and Education(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of Research and Education (contract PRIN 2008-I31J10000050001FYXAXL_003) (http://www.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x; Badgley BD, 2010, WATER RES, V44, P5857, DOI 10.1016/j.watres.2010.07.005; Barros J, 2011, MAR POLLUT BULL, V62, P1245, DOI 10.1016/j.marpolbul.2011.03.021; Bergeron P, 2011, INT J HYG ENVIR HEAL, V214, P478, DOI 10.1016/j.ijheh.2011.07.013; Brenciani A, 2004, J ANTIMICROB CHEMOTH, V54, P991, DOI 10.1093/jac/dkh481; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cao Y, 2012, J APPL MICROBIOL, V113, P66, DOI 10.1111/j.1365-2672.2012.05305.x; Cattaneo C, 2010, SCAND J INFECT DIS, V42, P324, DOI 10.3109/00365540903496569; Champagne J, 2011, APPL ENVIRON MICROB, V77, P2625, DOI 10.1128/AEM.00263-11; Clinical and Laboratory Standards Institute, 2009, M07A8 CLIN LAB STAND, V29; Di Cesare A, 2012, MICROB DRUG RESIST, V18, P502, DOI 10.1089/mdr.2011.0204; Ferretti JA, 2011, MAR POLLUT BULL, V62, P1066, DOI 10.1016/j.marpolbul.2011.02.018; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Garofalo C, 2007, INT J FOOD MICROBIOL, V113, P75, DOI 10.1016/j.ijfoodmicro.2006.07.015; Gomez JAL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016720; Heaney CD, 2009, AM J EPIDEMIOL, V170, P164, DOI 10.1093/aje/kwp152; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; HYNES WL, 1992, FEMS MICROBIOL LETT, V94, P139; Jeng HWC, 2005, J ENVIRON SCI HEAL A, V40, P779, DOI 10.1081/ESE-200048264; Kao SJ, 2000, ANTIMICROB AGENTS CH, V44, P2876, DOI 10.1128/AAC.44.10.2876-2879.2000; Korajkic A, 2011, J APPL MICROBIOL, V110, P174, DOI 10.1111/j.1365-2672.2010.04869.x; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Lata P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-140; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Luna GM, 2010, APPL ENVIRON MICROB, V76, P5659, DOI 10.1128/AEM.03138-09; Luna GM, 2012, J BIOTECHNOL, V157, P446, DOI 10.1016/j.jbiotec.2011.07.033; Manolopoulou E, 2003, INT J FOOD MICROBIOL, V82, P153, DOI 10.1016/S0168-1605(02)00258-1; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Moore DF, 2008, J APPL MICROBIOL, V105, P1017, DOI 10.1111/j.1365-2672.2008.03828.x; Pallecchi L, 2008, EXPERT REV ANTI-INFE, V6, P725, DOI 10.1586/14787210.6.5.725; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Petersen A, 2003, ENVIRON MICROBIOL, V5, P395, DOI 10.1046/j.1462-2920.2003.00430.x; Pianetti A, 2004, J APPL MICROBIOL, V97, P682, DOI 10.1111/j.1365-2672.2004.02352.x; Pusceddu A, 2007, ECOL APPL, V17, P1366, DOI 10.1890/06-2028.1; Radhouani H, 2011, J ENVIRON MONITOR, V13, P2227, DOI 10.1039/c0em00682c; Seyfried EE, 2010, MICROB ECOL, V59, P799, DOI 10.1007/s00248-009-9624-7; Srinivasan S, 2011, WATER RES, V45, P2561, DOI 10.1016/j.watres.2011.02.010; Stachowiak M, 2010, WATER AIR SOIL POLL, V211, P251, DOI 10.1007/s11270-009-0296-1; Sundsfjord A, 2010, CLIN MICROBIOL INFEC, V16, P525, DOI 10.1111/j.1469-0691.2010.03215.x; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Tamminen M, 2011, ENVIRON SCI TECHNOL, V45, P386, DOI 10.1021/es102725n; Vignaroli C, 2012, APPL ENVIRON MICROB, V78, P3916, DOI 10.1128/AEM.07820-11; Vignaroli C, 2011, CURR MICROBIOL, V62, P1438, DOI 10.1007/s00284-011-9880-x; Wright ME, 2011, WATER SCI TECHNOL, V63, P542, DOI 10.2166/wst.2011.255; Yu DJ, 2012, CHEMOSPHERE, V89, P70, DOI 10.1016/j.chemosphere.2012.04.014	48	100	103	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62838	10.1371/journal.pone.0062838	http://dx.doi.org/10.1371/journal.pone.0062838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638152	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700076
J	Higgins, HM; Ferguson, E; Smith, RF; Green, MJ				Higgins, Helen M.; Ferguson, Eamonn; Smith, Robert F.; Green, Martin J.			Using Hormones to Manage Dairy Cow Fertility: The Clinical and Ethical Beliefs of Veterinary Practitioners	PLOS ONE			English	Article							CATTLE; ROTATION; UK	In the face of a steady decline in dairy cow fertility over several decades, using hormones to assist reproduction has become common. In the European Union, hormones are prescription-only medicines, giving veterinary practitioners a central role in their deployment. This study explored the clinical and ethical beliefs of practitioners, and provides data on their current prescribing practices. During 2011, 93 practitioners working in England completed a questionnaire (95% response rate). Of the 714 non-organic farms they attended, only 4 farms (0.6%) never used hormones to assist the insemination of lactating dairy cows. Practitioners agreed (>80%) that hormones improve fertility and farm businesses profitability. They also agreed (>80%) that if farmers are able to tackle management issues contributing to poor oestrus expression, then over a five year period these outcomes would both improve, relative to using hormones instead. If management issues are addressed instead of prescribing hormones, practitioners envisaged a less favourable outcome for veterinary practices profitability (p < 0.01), but an improvement in genetic selection for fertility (p < 0.01) and overall cow welfare (p < 0.01). On farms making no efforts to address underlying management problems, long-term routine use at the start of breeding for timing artificial insemination or inducing oestrus was judged "unacceptable" by 69% and 48% of practitioners, respectively. In contrast, practitioners agreed (>= 90%) that both these types of use are acceptable, provided a period of time has been allowed to elapse during which the cow is observed for natural oestrus. Issues discussed include: weighing quality versus length of cow life, fiscal factors, legal obligations, and balancing the interests of all stakeholders, including the increasing societal demand for food. This research fosters debate and critical appraisal, contributes to veterinary ethics, and encourages the pro-active development of professional codes of conduct.	[Higgins, Helen M.; Green, Martin J.] Univ Nottingham, Sch Vet Med & Sci, Populat Hlth & Welf Grp, Loughborough, England; [Ferguson, Eamonn] Univ Nottingham, Sch Psychol, Personal Social Psychol & Hlth Res Grp, Nottingham NG7 2RD, England; [Smith, Robert F.] Univ Liverpool, Sch Vet Sci, Div Livestock Hlth & Welf, Neston, England	University of Nottingham; University of Nottingham; University of Liverpool	Higgins, HM (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Populat Hlth & Welf Grp, Loughborough, England.	helen.higgins@nottingham.ac.uk	Green, Martin/F-7066-2011	Green, Martin/0000-0002-6408-6443; Ferguson, Eamonn/0000-0002-7678-1451; Smith, Robert/0000-0003-0944-310X	Wellcome Trust [087797/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Wellcome Trust[087797/Z/08/Z], www.wellcome.ac.uk. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; [Anonymous], 2011, FUT FOOD FARM EX SUM; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Directorate Veterinary Medicines, 2009, DET WITHDR PER; Dobson H, 2008, ANIMAL, V2, P1104, DOI 10.1017/S175173110800236X; Dyer F, 2012, VET REC, V170, P640, DOI 10.1136/vr.e4195; Goldstein Harvey, 2010, MULTILEVEL STAT MODE; Green M, 2012, DAIRY HERD HEALTH, P1, DOI 10.1079/9781845939977.0000; HENDRICKSON AE, 1964, BRIT J STATIST PSYCH, V17, P65, DOI 10.1111/j.2044-8317.1964.tb00244.x; Hobson-West P, 2007, SOCIOL HEALTH ILL, V29, P198, DOI 10.1111/j.1467-9566.2007.00544.x; Hoey R, 2007, LANCET, V370, P643, DOI 10.1016/S0140-6736(07)61321-X; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johnson R., 2010, US EU BEEF HORMONE D; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kalton G., 1987, INTRO SURVEY SAMPLIN; Kim J.-O., 1978, FACTOR ANAL STAT MET; Kline P., 1994, EASY GUIDE FACTOR AN; Legood G, 2000, INTRO VET ETHICS; Longworth L, 2011, INT J TECHNOL ASSESS, V27, P180, DOI 10.1017/S0266462311000043; Moore K, 2006, J DAIRY SCI, V89, P1254, DOI 10.3168/jds.S0022-0302(06)72194-4; Nunnally J., 1978, PSYCHOMETRIC THEORY; Orpin PG, 2010, CATTLE PRACT, V18, P163; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasbash J, 2011, MLWIN VERSION 2 24; RCVS, 2012, GUID PROF COND; RCVS, 2022, COD PROF COND VET SU; Rollin B., 2006, INTRO VET MED ETHICS, V2nd ed.; Royal MD, 2000, ANIM SCI, V70, P487, DOI 10.1017/S1357729800051845; THATCHER WW, 1993, ANIM REPROD SCI, V33, P27, DOI 10.1016/0378-4320(93)90105-Z; Thompson B, 2004, EXPLORATORY CONFIRMA; Thompson PB, 2007, INT LIBR ENVIRON AGR, V10, P1, DOI 10.1007/1-4020-5791-1; van Arendonk JAM, 2003, THERIOGENOLOGY, V59, P563, DOI 10.1016/S0093-691X(02)01240-2; Veterinary Medicines Directorate, 2009, AV VET RES FOOD MAIN; Veterinary Medicines Directorate, 2011, CONTR VET MED; Veterinary Medicines Directorate, 2011, GUID RET; Veterinary Medicines Directorate, 2012, WORK VMD	36	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62993	10.1371/journal.pone.0062993	http://dx.doi.org/10.1371/journal.pone.0062993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638174	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700083
J	Portwine, C; Mitchell, D; Johnston, D; Gillmeister, B; Ethier, MC; Yanofsky, R; Dix, D; Cellot, S; Lewis, V; Price, V; Silva, M; Zelcer, S; Bowes, L; Michon, B; Stobart, K; Brossard, J; Beyene, J; Sung, L				Portwine, Carol; Mitchell, David; Johnston, Donna; Gillmeister, Biljana; Ethier, Marie-Chantal; Yanofsky, Rochelle; Dix, David; Cellot, Sonia; Lewis, Victor; Price, Victoria; Silva, Mariana; Zelcer, Shayna; Bowes, Lynette; Michon, Bruno; Stobart, Kent; Brossard, Josee; Beyene, Joseph; Sung, Lillian			Infectious Events Prior to Chemotherapy Initiation in Children with Acute Myeloid Leukemia	PLOS ONE			English	Article							RISK-FACTORS; ANTIMICROBIAL AGENTS; NEUTROPENIC PATIENTS; CANCER; MORTALITY	Background: The primary objective was to describe infectious complications in children with acute myeloid leukemia from presentation to the healthcare system to initiation of chemotherapy and to describe how these infections differ depending on neutropenia. Methods: We conducted a retrospective, population-based cohort study that included children and adolescents with acute myeloid leukemia diagnosed and treated at 15 Canadian centers. We evaluated infections that occurred between presentation to the healthcare system (for symptoms that led to the diagnosis of acute myeloid leukemia) until initiation of chemotherapy. Results: Among 328 children, 92 (28.0%) were neutropenic at presentation. Eleven (3.4%) had sterile-site microbiologically documented infection and four had bacteremia (only one Gram negative). Infection rate was not influenced by neutropenia. No child died from an infectious cause prior to chemotherapy initiation. Conclusion: It may be reasonable to withhold empiric antibiotics in febrile non-neutropenic children with newly diagnosed acute myeloid leukemia until initiation of chemotherapy as long as they appear well without a clinical focus of infection. Future work could examine biomarkers or a clinical score to identify children presenting with leukemia and fever who are more likely to have an invasive infection.	[Portwine, Carol] McMaster Childrens Hosp Hamilton Hlth Sci, Hamilton, ON, Canada; [Mitchell, David] Montreal Childrens Hosp, Quebec City, PQ, Canada; [Johnston, Donna] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Gillmeister, Biljana; Ethier, Marie-Chantal; Beyene, Joseph; Sung, Lillian] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Yanofsky, Rochelle] Cancercare Manitoba, Winnipeg, MB, Canada; [Dix, David] British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada; [Cellot, Sonia] Hosp Sainte Justine, Quebec City, PQ, Canada; [Lewis, Victor] Alberta Childrens Prov Gen Hosp, Hematol Oncol Transplant Program, Calgary, AB, Canada; [Price, Victoria] IWK Hlth Ctr, Halifax, NS, Canada; [Silva, Mariana] Canc Ctr Southeastern Ontario Kingston, Kingston, ON, Canada; [Zelcer, Shayna] London Hlth Sci, London, ON, Canada; [Bowes, Lynette] Janeway Child Hlth Ctr, St John, NF, Canada; [Michon, Bruno] Hosp Univ Quebec Ctr, Pediat Hematol Oncol Ctr, Quebec City, PQ, Canada; [Stobart, Kent] Univ Alberta Hosp, Stollery Childrens Hosp, ECHA, Edmonton, AB T6G 2B7, Canada; [Brossard, Josee] Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada; [Beyene, Joseph] McMaster Univ, Dept Clin Epidemiol & Biostat, Populat Genom Program, Hamilton, ON, Canada; [Sung, Lillian] Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada	McMaster University; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); CancerCare Manitoba Foundation; BC Childrens Hospital; University of British Columbia; Alberta Childrens Hospital; University of Calgary; Dalhousie University; London Health Sciences Centre; Memorial University Newfoundland; Stollery Children's Hospital; University of Alberta; University of Sherbrooke; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Sung, L (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	lillian.sung@sickkids.ca	Portwine, Carol/AAS-4083-2021	Portwine, Carol/0000-0002-1314-8691; Dix, David/0000-0002-1498-5555	Canadian Cancer Society [019468]; C17 Research Network; Canadian Institutes of Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); C17 Research Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Cancer Society (grant number 019468) and the C17 Research Network. LS is supported by a New Investigator Award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almyroudis NG, 2011, INFECT CONT HOSP EP, V32, P490, DOI 10.1086/659408; Dix D, 2012, CLIN INFECT IN PRESS; Fadoo Z, 2012, J PAK MED ASSOC, V62, P125; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; GARNER JS, 1996, APIC INFECT CONTROL; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hann I, 1997, BRIT J HAEMATOL, V99, P580, DOI 10.1046/j.1365-2141.1997.4453255.x; Hu R, 2012, NEOPLASMA, V59, P669, DOI 10.4149/neo_2012_085; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Lange BJ, 2005, JAMA-J AM MED ASSOC, V293, P203, DOI 10.1001/jama.293.2.203; Lehrnbecher T, 2012, J CLIN ONCO IN PRESS; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Rangaraj G, 2010, CANCER-AM CANCER SOC, V116, P967, DOI 10.1002/cncr.24812; Santolaya ME, 2001, J CLIN ONCOL, V19, P3415, DOI 10.1200/JCO.2001.19.14.3415; Sung LL, 2007, PAED CHILD HEALT-CAN, V12, P19, DOI 10.1093/pch/12.1.19; Sung LL, 2007, BLOOD, V110, P3532, DOI 10.1182/blood-2007-05-091942	16	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61899	10.1371/journal.pone.0061899	http://dx.doi.org/10.1371/journal.pone.0061899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637925	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700023
J	Alam, FM; Turner, CE; Smith, K; Wiles, S; Sriskandan, S				Alam, Faraz M.; Turner, Claire E.; Smith, Ken; Wiles, Siouxsie; Sriskandan, Shiranee			Inactivation of the CovR/S Virulence Regulator Impairs Infection in an Improved Murine Model of Streptococcus pyogenes Naso-Pharyngeal Infection	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; LYMPHOID-TISSUE; MICE; SUSCEPTIBILITY; MICROBIOLOGY; EXPRESSION; SYSTEM; STRAIN; CELLS	Streptococcus pyogenes is a leading cause of pharyngeal infection, with an estimated 616 million cases per year. The human nasopharynx represents the major reservoir for all S. pyogenes infection, including severe invasive disease. To investigate bacterial and host factors that influence S. pyogenes infection, we have devised an improved murine model of nasopharyngeal colonization, with an optimized dosing volume to avoid fulminant infections and a sensitive host strain. In addition we have utilized a refined technique for longitudinal monitoring of bacterial burden that is non-invasive thereby reducing the numbers of animals required. The model was used to demonstrate that the two component regulatory system, CovR/S, is required for optimum infection and transmission from the nasopharynx. There is a fitness cost conferred by covR/S mutation that is specific to the nasopharynx. This may explain why S. pyogenes with altered covR/S have not become prevalent in community infections despite possessing a selective advantage in invasive infection.	[Alam, Faraz M.; Turner, Claire E.; Wiles, Siouxsie; Sriskandan, Shiranee] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Infect Dis & Immun, London, England; [Smith, Ken] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London, Herts, England; [Wiles, Siouxsie] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand	Imperial College London; University of London; University of London Royal Veterinary College; University of Auckland	Sriskandan, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Infect Dis & Immun, London, England.	s.sriskandan@imperial.ac.uk	Wiles, Siouxsie/E-1690-2011; Turner, Claire/H-8142-2019	Wiles, Siouxsie/0000-0002-0467-0015; Turner, Claire/0000-0002-4458-9748; Alam, Faraz/0000-0003-3738-0409; Sriskandan, Shiranee/0000-0002-5214-4941	Biotechnology and Biological Sciences Research Council via the Centre for Integrative Mammalian Physiology and Pharmacology [DDDH.PS0618]; National Centres for Replacement, Refinement and Reduction of Animals in Research; BBSRC [BB/E52708X/1] Funding Source: UKRI; MRC [G0800777] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: researchfish; Medical Research Council [G0800777] Funding Source: researchfish; National Centre for the Replacement [G0800720/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council via the Centre for Integrative Mammalian Physiology and Pharmacology(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centres for Replacement, Refinement and Reduction of Animals in Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	This work was supported by the Biotechnology and Biological Sciences Research Council via the Centre for Integrative Mammalian Physiology and Pharmacology [DDDH.PS0618] and the National Centres for Replacement, Refinement and Reduction of Animals in Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRONZE MS, 1988, J IMMUNOL, V141, P2767; Brook Itzhak, 2011, Proc Am Thorac Soc, V8, P90, DOI 10.1513/pats.201006-038RN; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Eyles JE, 2001, J PHARM PHARMACOL, V53, P601, DOI 10.1211/0022357011775929; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Grewal IS, 1997, IMMUNOLOGY, V90, P165, DOI 10.1046/j.1365-2567.1997.00190.x; HILLENIUS WJ, 1992, PALEOBIOLOGY, V18, P17, DOI 10.1017/S0094837300012197; Hollands A, 2010, J INFECT DIS, V202, P11, DOI 10.1086/653124; HOOK EW, 1960, AM J HYG, V72, P111, DOI 10.1093/oxfordjournals.aje.a120127; Husmann LK, 1996, MICROB PATHOGENESIS, V20, P213, DOI 10.1006/mpat.1996.0020; JORDAN RT, 1958, CANCER RES, V18, P47; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Mannam P, 2004, INFECT IMMUN, V72, P3444, DOI 10.1128/IAI.72.6.3444-3450.2004; Medina E, 2001, J INFECT DIS, V184, P846, DOI 10.1086/323292; Ozcan M, 2002, RHINOLOGY, V40, P24; Park HS, 2003, J IMMUNOL, V171, P2532, DOI 10.4049/jimmunol.171.5.2532; RABIN BS, 1987, J NEUROIMMUNOL, V17, P11, DOI 10.1016/0165-5728(87)90027-0; SHANKS N, 1994, PHARMACOL BIOCHEM BE, V47, P497, DOI 10.1016/0091-3057(94)90150-3; SLIPKA J, 1988, ACTA OTO-LARYNGOL, P18; Sriskandan S, 1999, MOL MICROBIOL, V33, P778, DOI 10.1046/j.1365-2958.1999.01525.x; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Turner CE, 2009, J INFECT DIS, V200, P555, DOI 10.1086/603541; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wiles S, 2006, NAT REV MICROBIOL, V4, P307, DOI 10.1038/nrmicro1386; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; WILLOUGHBY DS, 1964, J BACTERIOL, V87, P1457, DOI 10.1128/JB.87.6.1457-1461.1964; Wu HY, 1997, SCAND J IMMUNOL, V46, P506, DOI 10.1046/j.1365-3083.1997.d01-159.x; Yung DL, 1999, INFECT IMMUN, V67, P6691	30	49	49	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61655	10.1371/journal.pone.0061655	http://dx.doi.org/10.1371/journal.pone.0061655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637876	Green Submitted, gold, Green Published			2022-12-25	WOS:000318341400018
J	Cozen, ML; Ryan, JC; Shen, H; Lerrigo, R; Yee, RM; Sheen, E; Wu, R; Monto, A				Cozen, Myrna L.; Ryan, James C.; Shen, Hui; Lerrigo, Robert; Yee, Russell M.; Sheen, Edward; Wu, Richard; Monto, Alexander			Nonresponse to Interferon-alpha Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis	PLOS ONE			English	Article							UNITED-STATES; FIBROSIS PROGRESSION; SUSTAINED RESPONSE; ANTIVIRAL THERAPY; PROPENSITY SCORE; VIRUS-INFECTION; LIVER FIBROSIS; RIBAVIRIN; PEGINTERFERON; VETERANS	Background: The long-term consequences of unsuccessful interferon-alpha based hepatitis C treatment on liver disease progression and survival have not been fully explored. Methods and Findings: We performed retrospective analyses to assess long-term clinical outcomes among treated and untreated patients with hepatitis C virus in two independent cohorts from a United States Veterans Affairs Medical Center and a University Teaching Hospital. Eligible patients underwent liver biopsy during consideration for interferon-alpha based treatment between 1992 and 2007. They were assessed for the probability of developing cirrhosis and of dying during follow-up using Cox proportional hazards models, stratified by pretreatment liver fibrosis stage and adjusted for known risk factors for cirrhosis and characteristics affecting treatment selection. The major predictor was a time-dependent covariate for treatment outcome among four patient groups: 1) patients with sustained virological response to treatment; 2) treatment relapsers; 3) treatment nonresponders; and 4) never treated patients. Treatment nonresponders in both cohorts had a statistically significantly increased hazard of cirrhosis compared to never treated patients, as stratified by pretreatment liver fibrosis stage and adjusted for clinical and psychosocial risk factors that disproportionately affect patients who were ineligible for treatment (Veterans Affairs HR = 2.35, CI 1.18-4.69, mean follow-up 10 years, and University Hospital HR = 5.90, CI 1.50-23.24, mean follow-up 7.7 years). Despite their increased risk for liver disease progression, the overall survival of nonresponders in both cohorts was not significantly different from that of never treated patients. Conclusion: These unexpected findings suggest that patients who receive interferon-alpha based therapies but fail to clear the hepatitis C virus may have an increased hazard of cirrhosis compared to untreated patients.	[Cozen, Myrna L.; Ryan, James C.; Shen, Hui; Lerrigo, Robert; Wu, Richard; Monto, Alexander] Dept Med Vet Affairs Med Ctr, San Francisco, CA USA; [Yee, Russell M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Sheen, Edward] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Columbia University; Stanford University	Cozen, ML (corresponding author), Dept Med Vet Affairs Med Ctr, San Francisco, CA USA.	Myrna.Cozen@va.gov			National Institutes of Health (NIH) [RO1 AI 083113-01, U19 AI 088790, P30 DK026743]; Veterans Affairs Merit Award Program; Veterans Affairs Hepatitis C Resource Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083113, U19AI088790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award Program(US Department of Veterans Affairs); Veterans Affairs Hepatitis C Resource Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health (NIH) RO1 AI 083113-01; NIH U19 AI 088790; NIH P30 DK026743 (University of California San Francisco Liver Center); Veterans Affairs Merit Award Program and the Veterans Affairs Hepatitis C Resource Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1995, SURVIVAL ANAL USING; [Anonymous], 1965, WHO CHRON, V19, P31; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bialek Stephanie R, 2006, Clin Liver Dis, V10, P697, DOI 10.1016/j.cld.2006.08.003; Bini EJ, 2005, AM J GASTROENTEROL, V100, P1772, DOI 10.1111/j.1572-0241.2005.41860.x; Bosco JLF, 2010, J CLIN EPIDEMIOL, V63, P64, DOI 10.1016/j.jclinepi.2009.03.001; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; Butt AA, 2009, HEPATOLOGY, V50, P387, DOI 10.1002/hep.23000; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Coverdale SA, 2004, AM J GASTROENTEROL, V99, P636, DOI 10.1111/j.1572-0241.2004.04085.x; Di Bisceglie AM, 2011, HEPATOLOGY, V53, P1100, DOI 10.1002/hep.24169; Dienstag JL, 2011, HEPATOLOGY, V54, P396, DOI 10.1002/hep.24370; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; Etzioni R, 1999, MED DECIS MAKING, V19, P242, DOI 10.1177/0272989X9901900303; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goodman ZD, 2009, HEPATOLOGY, V50, P1738, DOI 10.1002/hep.23211; Harris DR, 2001, ANN INTERN MED, V134, P120, DOI 10.7326/0003-4819-134-2-200101160-00012; Heathcote EJ, 2000, NEW ENGL J MED, V343, P1673, DOI 10.1056/NEJM200012073432302; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kamal SM, 2004, HEPATOLOGY, V39, P1721, DOI 10.1002/hep.20266; Kayali Z, 2007, J VIRAL HEPATITIS, V14, P11, DOI 10.1111/j.1365-2893.2006.00764.x; Koretz RL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003617.pub2; Luo Zhehui, 2010, Med Care Res Rev, V67, P528, DOI 10.1177/1077558710361486; MALLAT A, 1995, HEPATOLOGY, V21, P1003, DOI 10.1016/0270-9139(95)90247-3; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Pawlotsky Jean-Michel, 2011, Gastroenterology, V140, P746, DOI 10.1053/j.gastro.2011.01.028; Pockros PJ, 2010, HEPATOLOGY, V52, P1193, DOI 10.1002/hep.23809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Poynard T, 2012, J HEPATOL; Poynard T, 2013, J HEPATOL, V58, P452, DOI 10.1016/j.jhep.2012.11.001; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; Shiffman ML, 1999, GASTROENTEROLOGY, V117, P1164, DOI 10.1016/S0016-5085(99)70402-6; Shiffman ML, 1997, HEPATOLOGY, V26, P780, DOI 10.1002/hep.510260335; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Singal AG, 2010, ALIMENT PHARM THER, V32, P969, DOI 10.1111/j.1365-2036.2010.04427.x; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Sofair AN, 2010, J CLIN GASTROENTEROL, V44, P301, DOI 10.1097/MCG.0b013e3181b3f760; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Tam RC, 1999, J HEPATOL, V30, P376, DOI 10.1016/S0168-8278(99)80093-2; Terrault NA, 2008, CLIN GASTROENTEROL H, V6, P1403, DOI 10.1016/j.cgh.2008.08.006; Thomas H, 2003, J HEPATOL, V39, pS93, DOI 10.1016/S0168-8278(03)00207-1; Veldt BJ, 2007, ANN INTERN MED, V147, P677; Yee HS, 2012, AM J GASTROENTEROL, V107, P669, DOI 10.1038/ajg.2012.48; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785	54	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61568	10.1371/journal.pone.0061568	http://dx.doi.org/10.1371/journal.pone.0061568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637856	gold, Green Published, Green Submitted			2022-12-25	WOS:000318341400014
J	Forconi, M; Canapa, A; Barucca, M; Biscotti, MA; Capriglione, T; Buonocore, F; Fausto, AM; Makapedua, DM; Pallavicini, A; Gerdol, M; De Moro, G; Scapigliati, G; Olmo, E; Schartl, M				Forconi, Mariko; Canapa, Adriana; Barucca, Marco; Biscotti, Maria A.; Capriglione, Teresa; Buonocore, Francesco; Fausto, Anna M.; Makapedua, Daisy M.; Pallavicini, Alberto; Gerdol, Marco; De Moro, Gianluca; Scapigliati, Giuseppe; Olmo, Ettore; Schartl, Manfred			Characterization of Sex Determination and Sex Differentiation Genes in Latimeria	PLOS ONE			English	Article							MULLERIAN HORMONE AMH; DM-DOMAIN GENE; DIMORPHIC EXPRESSION; GENOMIC ORGANIZATION; MEDAKA; EVOLUTION; ESTROGEN; REVERSAL; GONADS; DMRT1	Genes involved in sex determination and differentiation have been identified in mice, humans, chickens, reptiles, amphibians and teleost fishes. However, little is known of their functional conservation, and it is unclear whether there is a common set of genes shared by all vertebrates. Coelacanths, basal Sarcopterygians and unique "living fossils", could help establish an inventory of the ancestral genes involved in these important developmental processes and provide insights into their components. In this study 33 genes from the genome of Latimeria chalumnae and from the liver and testis transcriptomes of Latimeria menadoensis, implicated in sex determination and differentiation, were identified and characterized and their expression levels measured. Interesting findings were obtained for GSDF, previously identified only in teleosts and now characterized for the first time in the sarcopterygian lineage; FGF9, which is not found in teleosts; and DMRT1, whose expression in adult gonads has recently been related to maintenance of sexual identity. The gene repertoire and testis-specific gene expression documented in coelacanths demonstrate a greater similarity to modern fishes and point to unexpected changes in the gene regulatory network governing sexual development.	[Forconi, Mariko; Canapa, Adriana; Barucca, Marco; Biscotti, Maria A.; Olmo, Ettore] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Capriglione, Teresa] Univ Naples Federico II, Dipartimento Biol Strutturale & Funzionale, Naples, Italy; [Buonocore, Francesco; Fausto, Anna M.; Scapigliati, Giuseppe] Univ Tuscia, Dipartimento Innovaz Sistemi Biol Agroaliment & F, Viterbo, Italy; [Makapedua, Daisy M.] Univ Sam Ratulangi, Fac Fisheries & Marine Sci, Manado, Indonesia; [Pallavicini, Alberto; Gerdol, Marco; De Moro, Gianluca] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Schartl, Manfred] Univ Wurzburg, Bioctr, Wurzburg, Germany	Marche Polytechnic University; University of Naples Federico II; Tuscia University; Universitas Sam Ratulangi; University of Trieste; University of Wurzburg	Canapa, A (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	a.canapa@univpm.it	Fausto, Anna Maria/AAB-6778-2020; Buonocore, Francesco/AAA-5236-2020; Gerdol, Marco/D-2115-2013; Pallavicini, Alberto/J-4158-2012; Pallavicini, Alberto/H-9281-2019; Makapedua, Daisy Monica/GOK-2761-2022	Gerdol, Marco/0000-0001-6411-0813; Pallavicini, Alberto/0000-0001-7174-4603; Pallavicini, Alberto/0000-0001-7174-4603; Makapedua, Daisy Monica/0000-0003-4334-6020; De Moro, Gianluca/0000-0002-5542-0278; Schartl, Manfred/0000-0001-9882-5948; scapigliati, giuseppe/0000-0001-9730-9394; FAUSTO, Anna Maria/0000-0001-5800-7473; Buonocore, Francesco/0000-0001-8045-5651				Abinawanto, 1996, GEN COMP ENDOCR, V102, P241, DOI 10.1006/gcen.1996.0065; Akazome Y, 1999, J REPROD FERTIL, V115, P9, DOI 10.1530/jrf.0.1150009; Amemiya CT, 2013, NATURE IN PRESS; Anand A, 2008, GENE, V425, P56, DOI 10.1016/j.gene.2008.08.005; Angelopoulou R, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-13; BAKER PJ, 1993, J ANAT, V182, P267; Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Beau C, 2000, MOL REPROD DEV, V56, P124, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;124::AID-MRD2&gt;3.0.CO;2-J; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Biason-Lauber A, 2010, BEST PRACT RES CL EN, V24, P163, DOI 10.1016/j.beem.2009.12.002; BOGART JP, 1994, J HERED, V85, P322, DOI 10.1093/oxfordjournals.jhered.a111470; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Bratus A, 2009, CYTOGENET GENOME RES, V126, P180, DOI 10.1159/000245918; Brunner B, 2001, GENOMICS, V77, P8, DOI 10.1006/geno.2001.6615; Canapa A, 2012, J EXP ZOOL PART B, V318B, P404, DOI 10.1002/jez.b.22455; Chardard D, 2003, J EXP ZOOL PART A, V296A, P46, DOI 10.1002/jez.a.10240; Chue J, 2011, FEBS J, V278, P1027, DOI 10.1111/j.1742-4658.2011.08032.x; Clinton M, 2012, CHROMOSOME RES, V20, P177, DOI 10.1007/s10577-011-9257-9; Coveney D, 2001, BIOL REPROD, V65, P613, DOI 10.1095/biolreprod65.2.613; Craves JAM, 2008, ANNU REV GENET, V42, P565, DOI 10.1146/annurev.genet.42.110807.091714; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; El-Mogharbel N, 2007, GENOMICS, V89, P10, DOI 10.1016/j.ygeno.2006.07.017; Fadem BH, 2000, HORM BEHAV, V37, P79, DOI 10.1006/hbeh.1999.1561; Gautier A, 2011, BIOL REPROD, V85, P1240, DOI 10.1095/biolreprod.111.091892; Gautier A, 2011, GENE, V472, P7, DOI 10.1016/j.gene.2010.10.014; GNESSI L, 1995, J CELL BIOL, V131, P1105, DOI 10.1083/jcb.131.4.1105; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graves JAM, 1995, PHILOS T R SOC B, V350, P305, DOI 10.1098/rstb.1995.0166; Graves JAM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-205; Guiguen Y, 1999, MOL REPROD DEV, V54, P154, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;154::AID-MRD7&gt;3.0.CO;2-5; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Halm S, 2007, GENE, V388, P148, DOI 10.1016/j.gene.2006.10.018; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Hayes TB, 1998, J EXP ZOOL, V281, P373, DOI 10.1002/(SICI)1097-010X(19980801)281:5<373::AID-JEZ4>3.0.CO;2-L; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-99; Herpin A, 2011, FEBS J, V278, P1010, DOI 10.1111/j.1742-4658.2011.08030.x; Herpin A, 2011, CURR BIOL, V21, pR656, DOI 10.1016/j.cub.2011.07.026; Higasa K, 2012, GENE, V505, P324, DOI 10.1016/j.gene.2012.05.047; Hornung U, 2007, SEX DEV, V1, P197, DOI 10.1159/000102108; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Itoh N, 2007, ZEBRAFISH, V4, P179, DOI 10.1089/zeb.2007.0509; Johnsen H, 2012, GENE, V505, P221, DOI 10.1016/j.gene.2012.06.021; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kapoor BG, 2004, ICHTHYOLOGY HDB, P487; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kim SS, 2003, GENE EXPR PATTERNS, V3, P77, DOI 10.1016/S1567-133X(02)00071-6; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kluver N, 2007, DEV DYNAM, V236, P271, DOI 10.1002/dvdy.20997; Kobayashi T, 2003, CYTOGENET GENOME RES, V101, P289, DOI 10.1159/000074351; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MacKenzie CA, 2003, ENVIRON TOXICOL CHEM, V22, P2466, DOI 10.1897/02-173; Makapedua DM, 2011, MAR GENOM, V4, P167, DOI 10.1016/j.margen.2011.04.001; Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; McClelland K, 2012, ASIAN J ANDROL, V14, P164, DOI 10.1038/aja.2011.169; Mittwoch U, 1998, J EXP ZOOL, V281, P466, DOI 10.1002/(SICI)1097-010X(19980801)281:5&lt;466::AID-JEZ11&gt;3.0.CO;2-7; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Nakamura S, 2012, DEVELOPMENT, V139, P2283, DOI 10.1242/dev.076307; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029982; Nakatani M, 2008, FASEB J, V22, P477, DOI 10.1096/fj.07-8673com; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; NEI M, 1986, MOL BIOL EVOL, V3, P418; ODonnell L, 1996, ENDOCRINOLOGY, V137, P2703, DOI 10.1210/en.137.7.2703; Ooe H, 2012, J CELL PHYSIOL, V227, P2363, DOI 10.1002/jcp.22971; Pala I, 2008, GENE, V410, P249, DOI 10.1016/j.gene.2007.12.018; Pallavicini A, 2013, ANAL TRANSCRIPTOME I; Pieau C, 2004, J ENDOCRINOL, V181, P367, DOI 10.1677/joe.0.1810367; Ramsey M, 2009, SEMIN CELL DEV BIOL, V20, P283, DOI 10.1016/j.semcdb.2008.10.004; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Renfree MB, 2001, REPROD FERT DEVELOP, V13, P231, DOI 10.1071/RD00123; Rey R, 2003, MOL CELL ENDOCRINOL, V211, P21, DOI 10.1016/j.mce.2003.09.007; Rhen T, 2010, SEX DEV, V4, P16, DOI 10.1159/000282495; Schartl M, 2004, CURR OPIN GENET DEV, V14, P634, DOI 10.1016/j.gde.2004.09.005; SHAW G, 1988, DEVELOPMENT, V104, P689; Shibata Y, 2010, GENE EXPR PATTERNS, V10, P283, DOI 10.1016/j.gep.2010.06.005; Shinomiya A, 2004, ZOOL SCI, V21, P613, DOI 10.2108/zsj.21.613; Smith CA, 2005, DEV BIOL, V284, P337, DOI 10.1016/j.ydbio.2005.05.030; Smith Craig A., 2002, Gene Expression Patterns, V2, P69, DOI 10.1016/S0925-4773(02)00360-X; Sun YL, 2012, FISH PHYSIOL BIOCHEM, V38, P1427, DOI 10.1007/s10695-012-9630-4; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Uller T, 2011, Q REV BIOL, V86, P163, DOI 10.1086/661118; Winkler C, 2004, MECH DEVELOP, V121, P997, DOI 10.1016/j.mod.2004.03.018; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; ZACCANTI F, 1994, COMP BIOCHEM PHYS A, V107, P171, DOI 10.1016/0300-9629(94)90290-9; Zarkower David, 2006, WormBook, P1; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhao Y, 2007, DEV GENES EVOL, V217, P119, DOI 10.1007/s00427-006-0117-0	95	52	56	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e56006	10.1371/journal.pone.0056006	http://dx.doi.org/10.1371/journal.pone.0056006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634199	gold, Green Submitted, Green Published			2022-12-25	WOS:000318341400001
J	Gu, JY; Gui, YS; Chen, LR; Yuan, G; Lu, HZ; Xu, XJ				Gu, Jiangyong; Gui, Yuanshen; Chen, Lirong; Yuan, Gu; Lu, Hui-Zhe; Xu, Xiaojie			Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; DATABASE; SPACE; EXPLORATION; DIVERSITY; ORIGIN; BEAUTY; CANCER	Background: Natural products have been an important source of lead compounds for drug discovery. How to find and evaluate bioactive natural products is critical to the achievement of drug/lead discovery from natural products. Methodology: We collected 19,7201 natural products structures, reported biological activities and virtual screening results. Principal component analysis was employed to explore the chemical space, and we found that there was a large portion of overlap between natural products and FDA-approved drugs in the chemical space, which indicated that natural products had large quantity of potential lead compounds. We also explored the network properties of natural product-target networks and found that polypharmacology was greatly enriched to those compounds with large degree and high betweenness centrality. In order to make up for a lack of experimental data, high throughput virtual screening was employed. All natural products were docked to 332 target proteins of FDA-approved drugs. The most potential natural products for drug discovery and their indications were predicted based on a docking score-weighted prediction model. Conclusions: Analysis of molecular descriptors, distribution in chemical space and biological activities of natural products was conducted in this article. Natural products have vast chemical diversity, good drug-like properties and can interact with multiple cellular target proteins.	[Gu, Jiangyong; Gui, Yuanshen; Chen, Lirong; Yuan, Gu; Lu, Hui-Zhe; Xu, Xiaojie] Peking Univ, Coll Chem & Mol Engn, State Key Lab Rare Earth Mat Chem & Applicat, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Gui, Yuanshen; Lu, Hui-Zhe] China Agr Univ, Inst Sci & Technol, Beijing 100094, Peoples R China	Chinese Academy of Sciences; Peking University; China Agricultural University	Chen, LR (corresponding author), Peking Univ, Coll Chem & Mol Engn, State Key Lab Rare Earth Mat Chem & Applicat, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.	lirongc@pku.edu.cn; xiaojxu@pku.edu.cn			Major Scientific and Technological Special Project for 'Significant New Drugs Formulation' [2012ZX09501001, 012ZX09301002-001]	Major Scientific and Technological Special Project for 'Significant New Drugs Formulation'	The present work was supported by the Major Scientific and Technological Special Project for 'Significant New Drugs Formulation' number 2012ZX09501001; 012ZX09301002-001 (http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bade R, 2010, EUR J MED CHEM, V45, P5646, DOI 10.1016/j.ejmech.2010.09.018; Basso LA, 2005, MEM I OSWALDO CRUZ, V100, P575, DOI 10.1590/S0074-02762005000600001; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/NCHEM.1243, 10.1038/nchem.1243]; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Faller B, 2011, DRUG DISCOV TODAY, V16, P976, DOI 10.1016/j.drudis.2011.07.003; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Firn RD, 2003, NAT PROD REP, V20, P382, DOI 10.1039/b208815k; Gani OABSM, 2010, NAT PROD REP, V27, P489, DOI 10.1039/b923848b; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gibellini L, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq053; Grabowski K, 2007, CURR CHEM BIOL, V1, P115, DOI DOI 10.2174/187231307779814066; Grabowski K, 2008, NAT PROD REP, V25, P892, DOI 10.1039/b715668p; Gu JY, 2011, COMPUT BIOL CHEM, V35, P293, DOI 10.1016/j.compbiolchem.2011.07.003; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; He M, 2001, J CHEM INF COMP SCI, V41, P273, DOI 10.1021/ci0003101; Henkel T, 1999, ANGEW CHEM INT EDIT, V38, P643, DOI 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G; Hoeng J, 2012, DRUG DISCOV TODAY, V17, P413, DOI 10.1016/j.drudis.2011.11.008; Hong JY, 2011, CURR OPIN CHEM BIOL, V15, P350, DOI 10.1016/j.cbpa.2011.03.004; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Ji HF, 2009, EMBO REP, V10, P194, DOI 10.1038/embor.2009.12; Jiang XH, 2008, CHEM CENTRAL J, P2; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-219; Kingston DGI, 2011, J NAT PROD, V74, P496, DOI 10.1021/np100550t; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lagunin A, 2010, CURR PHARM DESIGN, V16, P1703, DOI 10.2174/138161210791164063; Lee ML, 2001, J COMB CHEM, V3, P284, DOI 10.1021/cc000097l; Leeson P, 2012, NATURE, V481, P455, DOI 10.1038/481455a; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Li QA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014774; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Lopez-Vallejo F, 2012, DRUG DISCOV TODAY, V17, P718, DOI 10.1016/j.drudis.2012.04.001; Mirza A, 2009, EUR J MED CHEM, V44, P5006, DOI 10.1016/j.ejmech.2009.08.014; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; O'Boyle N. M., 2011, J CHEMINFORMATICS, P3, DOI [DOI 10.1186/1758-2946-3-33, 10.1186/1758-2946-3-33]; OMURA S, 1977, J ANTIBIOT, V30, P275, DOI 10.7164/antibiotics.30.275; Qiao XB, 2002, J CHEM INF COMP SCI, V42, P481, DOI 10.1021/ci010113h; Quinn RJ, 2008, J NAT PROD, V71, P464, DOI 10.1021/np070526y; Rosen J, 2009, J MED CHEM, V52, P1953, DOI 10.1021/jm801514w; Shen JH, 2003, CURR MED CHEM, V10, P2327, DOI 10.2174/0929867033456729; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Verschoyle RD, 2007, NUTR CANCER, V59, P152, DOI 10.1080/01635580701458186; Vogt I, 2010, MOL INFORM, V29, P10, DOI 10.1002/minf.200900069; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wang YF, 2008, J CLIN PHARMACOL, V48, P763, DOI 10.1177/0091270008318006; Wu LL, 2007, ACTA PHARMACOL SIN, V28, P404, DOI 10.1111/j.1745-7254.2007.00510.x; Yang K, 2007, PLOS COMPUT BIOL, V3, P523, DOI 10.1371/journal.pcbi.0030055; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yongye AB, 2012, CHEM BIOL DRUG DES, V80, P717, DOI 10.1111/cbdd.12011; Yu YB, 2007, ARCH PHARM RES, V30, P820, DOI 10.1007/BF02978831; Zhang ML, 2010, MOL NETWORK ANAL APP, P251; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	62	204	216	6	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62839	10.1371/journal.pone.0062839	http://dx.doi.org/10.1371/journal.pone.0062839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638153	gold, Green Published, Green Submitted			2022-12-25	WOS:000318341400069
J	Khann, S; Mao, ET; Rajendra, YP; Satyanarayana, S; Nagaraja, SB; Kumar, AMV				Khann, Sokhan; Mao, Eang Tan; Prasad Rajendra, Yadav; Satyanarayana, Srinath; Nagaraja, Sharath Burugina; Kumar, Ajay M. V.			Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR-TB) Patients to Diagnostic and Treatment Services in Cambodia	PLOS ONE			English	Article								Setting: National Tuberculosis Programme, Cambodia. Objective: In a cohort of TB patients, to ascertain the proportion of patients who fulfil the criteria for presumptive MDR-TB, assess whether they underwent investigation for MDR-TB, and the results of the culture and drug susceptibility testing (DST). Methods: A cross sectional record review of TB patients registered for treatment between July-December 2011. Results: Of 19,236 TB patients registered, 409 (2%) fulfilled the criteria of presumptive MDR-TB; of these, 187 (46%) were examined for culture. This proportion was higher among relapse, failure, return after default (RAD) and non-converters at 3 months of new smear positive TB patients (>60%) as compared to non-converters at 2 months of new TB cases (<20%). Nearly two thirds (n = 113) of the samples were culture positive; of these, three-fourth (n = 85) grew Mycobacterium tuberculosis complex (MTBc) and one-fourth (n = 28) grew non-tuberculous Mycobacteria. DST results were available for 96% of the MTBc isolates. Overall, 21 patients were diagnosed as MDR-TB (all diagnosed among retreatment TB cases and none from non-converters) and all of them were initiated on MDR-TB treatment. Conclusion: There is a need to strengthen mechanisms for linking patients with presumptive MDR-TB to culture centers. The policy of testing non-converters for culture and DST needs to be reviewed.	[Khann, Sokhan; Prasad Rajendra, Yadav] WHO, Stop TB Dept, Phnom Penh, Cambodia; [Mao, Eang Tan] Minist Hlth, Natl TB Control Program, Phnom Penh, Cambodia; [Satyanarayana, Srinath; Kumar, Ajay M. V.] Int Union TB & Lung Dis Union, South East Asia Off, New Delhi, India; [Nagaraja, Sharath Burugina] WHO, New Delhi, India	World Health Organization; World Health Organization	Khann, S (corresponding author), WHO, Stop TB Dept, Phnom Penh, Cambodia.	khannsokhan@yahoo.com	Nagaraja, Sharath Burugina/ABD-7748-2021; Nagaraja, Sharath Burugina/ABD-7238-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Satyanarayana, Srinath/0000-0002-5420-2551; Yadav, Rajendra Prasad/0000-0002-0398-1313; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	WPRO of WHO; Department for International Development, UK; The Union South-East Asia Office, New Delhi, India; Operational Research Unit, Medecins sans Frontieres, Brussels Operational Center, Luxembourg	WPRO of WHO; Department for International Development, UK; The Union South-East Asia Office, New Delhi, India; Operational Research Unit, Medecins sans Frontieres, Brussels Operational Center, Luxembourg	The study was mainly supported by WPRO of WHO and WHO Cambodia for national ethical clearance, data collection, data analysis, wrote manuscript, dissemination, and follow up. Funding for the operational research training course came from an anonymous donor and the Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported through: 1. An operational research course, which was jointly developed and run by the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease; The Union South-East Asia Office, New Delhi, India; the Operational Research Unit, Medecins sans Frontieres, Brussels Operational Center, Luxembourg. 2. Dr Keo Sokonth, Dr Kloeng Phally, Dr Tan Kundara, Dr Narith Ratha, and MOH staff working for TB controls Program in Cambodia for data collection. 3. MSF-France working in Cambodia who giving me the opportunity to access data from Kampong Cham culture laboratory.	[Anonymous], 2011, TUBERCULOSIS; Chadha SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026659; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Steingart KR, 2013, XPERT MTB RIF ASSAY; Wang HX, 2010, CHINESE MED J-PEKING, V123, P184, DOI 10.3760/cma.j.issn.0366-6999.2010.02.011; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2011, WHOHTMTB20116	7	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e59903	10.1371/journal.pone.0059903	http://dx.doi.org/10.1371/journal.pone.0059903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634202	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400004
J	Mulay, V; Wood, P; Manetsch, M; Darabi, M; Cairns, R; Hoque, M; Chan, KC; Reverter, M; Alvarez-Guaita, A; Rye, KA; Rentero, C; Heeren, J; Enrich, C; Grewal, T				Mulay, Vishwaroop; Wood, Peta; Manetsch, Melanie; Darabi, Masoud; Cairns, Rose; Hoque, Monira; Chan, Karen Cecilia; Reverter, Meritxell; Alvarez-Guaita, Anna; Rye, Kerry-Anne; Rentero, Carles; Heeren, Joerg; Enrich, Carlos; Grewal, Thomas			Inhibition of Mitogen-Activated Protein Kinase Erk1/2 Promotes Protein Degradation of ATP Binding Cassette Transporters A1 and G1 in CHO and HuH7 Cells	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; X-RECEPTOR-ALPHA; B TYPE-I; SCAVENGER RECEPTOR; CHOLESTEROL EFFLUX; GENE-EXPRESSION; PPAR-ALPHA; PEST SEQUENCE; ABCA1; PHOSPHORYLATION	Signal transduction modulates expression and activity of cholesterol transporters. We recently demonstrated that the Ras/mitogen-activated protein kinase (MAPK) signaling cascade regulates protein stability of Scavenger Receptor BI (SR-BI) through Proliferator Activator Receptor (PPAR alpha) -dependent degradation pathways. In addition, MAPK (Mek/Erk 1/2) inhibition has been shown to influence liver X receptor (LXR) -inducible ATP Binding Cassette (ABC) transporter ABCA1 expression in macrophages. Here we investigated if Ras/MAPK signaling could alter expression and activity of ABCA1 and ABCG1 in steroidogenic and hepatic cell lines. We demonstrate that in Chinese Hamster Ovary (CHO) cells and human hepatic HuH7 cells, extracellular signal-regulated kinase 1/2 (Erk1/2) inhibition reduces PPAR alpha-inducible ABCA1 protein levels, while ectopic expression of constitutively active H-Ras, K-Ras and MAPK/Erk kinase 1 (Mek1) increases ABCA1 protein expression, respectively. Furthermore, Mek1/2 inhibitors reduce ABCG1 protein levels in ABCG1 overexpressing CHO cells (CHO-ABCG1) and human embryonic kidney 293 (HEK293) cells treated with LXR agonist. This correlates with Mek1/2 inhibition reducing ABCG1 cell surface expression and decreasing cholesterol efflux onto High Density Lipoproteins (HDL). Real Time reverse transcriptase polymerase chain reaction (RT-PCR) and protein turnover studies reveal that Mek1/2 inhibitors do not target transcriptional regulation of ABCA1 and ABCG1, but promote ABCA1 and ABCG1 protein degradation in HuH7 and CHO cells, respectively. In line with published data from mouse macrophages, blocking Mek1/2 activity upregulates ABCA1 and ABCG1 protein levels in human THP1 macrophages, indicating opposite roles for the Ras/MAPK pathway in the regulation of ABC transporter activity in macrophages compared to steroidogenic and hepatic cell types. In summary, this study suggests that Ras/MAPK signaling modulates PPAR alpha- and LXR-dependent protein degradation pathways in a cell-specific manner to regulate the expression levels of ABCA1 and ABCG1 transporters.	[Mulay, Vishwaroop; Wood, Peta; Manetsch, Melanie; Darabi, Masoud; Cairns, Rose; Hoque, Monira; Chan, Karen Cecilia; Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Reverter, Meritxell; Alvarez-Guaita, Anna; Rentero, Carles; Enrich, Carlos] Univ Barcelona, Fac Med, Inst Invest Biomediques August Pi & Sunyer IDIBAP, Dept Biol Cellular Immunol & Neurociencies, Barcelona 7, Spain; [Rye, Kerry-Anne] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia; [Rye, Kerry-Anne] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, Hamburg, Germany	University of Sydney; University of Barcelona; University of Sydney; Heart Research Institute; University of Sydney; University of Hamburg; University Medical Center Hamburg-Eppendorf	Grewal, T (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	thomas.grewal@sydney.edu.au	Hoque, Monira/AAN-5715-2020; Rentero Alfonso, Carles/L-4430-2017; Darabi, Masoud/B-3525-2008	Rentero Alfonso, Carles/0000-0003-4684-0278; Darabi, Masoud/0000-0001-6380-272X; Cairns, Rose/0000-0002-8946-5079; Alvarez-Guaita, Anna/0000-0002-9248-2275; Grewal, Thomas/0000-0002-7937-8887; Enrich, Carlos/0000-0003-0382-2993	National Health and Medical Research Council of Australia [510294, 101867]; University of Sydney [2010-02681]; Ministerio de Innovacion, Ciencia y Tecnologia [CSD2009-00016]; Fundacio Marato TV3 (Barcelona, Spain) [PI040236]; NHF/NHMRC postgraduate scholarship; Tabriz University of Medical Sciences (Iran);  [BFU2009-10335]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); Ministerio de Innovacion, Ciencia y Tecnologia; Fundacio Marato TV3 (Barcelona, Spain); NHF/NHMRC postgraduate scholarship; Tabriz University of Medical Sciences (Iran); 	This study was supported by grants to T.G. from the National Health and Medical Research Council of Australia (510294, 101867) and the University of Sydney (2010-02681). C.E. is supported by BFU2009-10335, Consolider-Ingenio (CSD2009-00016) from the Ministerio de Innovacion, Ciencia y Tecnologia and PI040236 from the Fundacio Marato TV3 (Barcelona, Spain). P.W. is a recipient of an NHF/NHMRC postgraduate scholarship. M.D. is thankful for a travel and research scholarship from the Tabriz University of Medical Sciences (Iran). The funders had no rle in study design, data collection and analysis, decision to publsih, or preparation of the manuscript.	Agassandian M, 2007, BIOCHEM J, V403, P409, DOI 10.1042/BJ20061364; Al-Jarallah A, 2010, BBA-MOL CELL BIOL L, V1801, P1239, DOI 10.1016/j.bbalip.2010.08.006; Allen LF, 2003, SEMIN ONCOL, V30, P105, DOI 10.1053/j.seminoncol.2003.08.012; Anderson SP, 2004, J BIOL CHEM, V279, P52390, DOI 10.1074/jbc.M409347200; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Cariello NF, 2005, TOXICOL SCI, V88, P250, DOI 10.1093/toxsci/kfi273; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen MY, 2006, FEBS LETT, V580, P4835, DOI 10.1016/j.febslet.2006.07.074; Chinetti G, 2006, BIOCHEM SOC T, V34, P1128, DOI 10.1042/BST0341128; Deeg MA, 1997, ARTERIOSCL THROM VAS, V17, P1667, DOI 10.1161/01.ATV.17.9.1667; Dou Q Ping, 2003, Prog Cell Cycle Res, V5, P441; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gelissen IC, 2010, ATHEROSCLEROSIS, V208, P75, DOI 10.1016/j.atherosclerosis.2009.06.028; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; George J, 2004, ARTERIOSCL THROM VAS, V24, P363, DOI 10.1161/01.ATV.0000112021.98971.f0; George J, 2002, CIRCULATION, V105, P2416, DOI 10.1161/01.CIR.0000016065.90068.96; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Haidar B, 2002, J LIPID RES, V43, P2087, DOI 10.1194/jlr.M200235-JLR200; Haidar B, 2006, J BIOL CHEM, V281, P39971, DOI 10.1074/jbc.M605095200; Han JH, 2002, J BIOL CHEM, V277, P23582, DOI 10.1074/jbc.M200685200; Hanriot D, 2008, THROMB HAEMOSTASIS, V99, P558, DOI 10.1160/TH07-06-0410; Hori N, 2011, ATHEROSCLEROSIS, V215, P383, DOI 10.1016/j.atherosclerosis.2010.12.033; Ishii N, 2010, ARTERIOSCL THROM VAS, V30, P1598, DOI 10.1161/ATVBAHA.109.202309; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Leiva A, 2011, ATHEROSCLEROSIS, V217, P299, DOI 10.1016/j.atherosclerosis.2011.05.036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macoritto M, 2008, J BIOL CHEM, V283, P4943, DOI 10.1074/jbc.M707517200; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; Mizuno T, 2011, HEPATOLOGY, V54, P631, DOI 10.1002/hep.24387; Moffit JS, 2007, TOXICOL APPL PHARM, V222, P169, DOI 10.1016/j.taap.2007.04.008; Mogilenko DA, 2010, BIOCHEM BIOPH RES CO, V402, P477, DOI 10.1016/j.bbrc.2010.10.053; Mulay V, 2012, CURR PHARM BIOTECHNO, V13, P352, DOI 10.2174/138920112799095356; Nagelin MH, 2008, ARTERIOSCL THROM VAS, V28, P1811, DOI 10.1161/ATVBAHA.108.167908; Nagelin MH, 2009, J BIOL CHEM, V284, P31303, DOI 10.1074/jbc.M109.028910; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Nofer JR, 2001, THROMB HAEMOSTASIS, V85, P730; Ogura M, 2011, ARTERIOSCL THROM VAS, V31, P1980, DOI 10.1161/ATVBAHA.111.228478; Pourcet B, 2010, J BIOL CHEM, V285, P5983, DOI 10.1074/jbc.M109.078311; Rentero C, 2006, CELL SIGNAL, V18, P1006, DOI 10.1016/j.cellsig.2005.08.008; Roosbeek S, 2004, J BIOL CHEM, V279, P37779, DOI 10.1074/jbc.M401821200; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; RYE KA, 1990, BIOCHIM BIOPHYS ACTA, V1042, P227, DOI 10.1016/0005-2760(90)90013-N; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Taketa K, 2008, J BIOL CHEM, V283, P9852, DOI 10.1074/jbc.M703318200; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang YT, 2007, J LIPID RES, V48, P1062, DOI 10.1194/jlr.M600437-JLR200; Wood P, 2011, J BIOL CHEM, V286, P23077, DOI 10.1074/jbc.M111.236398; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Ye D, 2011, CURR DRUG TARGETS, V12, P647, DOI 10.2174/138945011795378522; Yokoyama S, 2012, BBA-MOL CELL BIOL L, V1821, P547, DOI 10.1016/j.bbalip.2011.07.017; Zanotti I, 2012, CURR PHARM BIOTECHNO, V13, P292, DOI 10.2174/138920112799095383; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhao GJ, 2012, MOL MED, V18, P149, DOI 10.2119/molmed.2011.00183; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601; Zitzer H, 2006, ENDOCRINOLOGY, V147, P3898, DOI 10.1210/en.2005-1483	64	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62667	10.1371/journal.pone.0062667	http://dx.doi.org/10.1371/journal.pone.0062667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634230	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400064
J	Nakanishi, Y; Kondo, S; Wakisaka, N; Tsuji, A; Endo, K; Murono, S; Ito, M; Kitamura, K; Muramatsu, M; Yoshizaki, T				Nakanishi, Yosuke; Kondo, Satoru; Wakisaka, Naohiro; Tsuji, Akira; Endo, Kazuhira; Murono, Shigeyuki; Ito, Makoto; Kitamura, Kouichi; Muramatsu, Masamichi; Yoshizaki, Tomokazu			Role of Activation-Induced Cytidine Deaminase in the Development of Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN-PAPILLOMAVIRUS; EXPRESSION; AID; HYPERMUTATION; CANCER; INFLAMMATION; INDUCTION; PROTEIN; LINKS	Purpose: In humans, activation-induced cytidine deaminase (AID) expression results due to inflammation and this deaminase activity is also involved in carcinogenesis. The aim of this study is to investigate the correlation between AID expression and the clinical classification of oral cancer tissues. Experimental Design: The current study investigated the correlation between AID expression and the clinical classification of oral cancer tissues from 27 patients who underwent surgical resection using immunohistochemistry. Specific AID expression and its induction by cytokine stimulation were investigated in cultured HSC oral cancer cell lines by reverse transcriptase PCR. Results: AID expression was detected in 10 of 27 specimens (37.0%). AID expression was more frequently detected in early-stage cancer, especially in early stage T, than in late-stage cancer (T1/T2 vs. T3/4; P = 0.0493, N0 vs. N1/2/3; P = 0.0793). HSC-2, a nonmetastatic oral cancer cell line, abundantly expressed endogenous AID, whereas no such expression was observed in HSC-3, a metastatic oral cancer cell line. Moreover, AID expression was substantially induced in HSC-2 cells by stimulation of an inflammation-related cytokine, TNF-alpha. Conclusions: Aberrant AID expression in the oral epithelium would contribute to the initiation of oral squamous cell carcinoma. Avoiding persistent AID inducible condition such as frequent cleaning of oral cavity would play an important role for the prevention of developing oral cancer.	[Nakanishi, Yosuke; Kondo, Satoru; Wakisaka, Naohiro; Tsuji, Akira; Endo, Kazuhira; Murono, Shigeyuki; Ito, Makoto; Yoshizaki, Tomokazu] Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa, Japan; [Kitamura, Kouichi; Muramatsu, Masamichi] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Yoshizaki, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa, Japan.	tomoy@med.kanazawa-u.ac.jp	Muramatsu, Masamichi/C-4339-2015; Kitamura, Kouichi/L-3654-2015	Muramatsu, Masamichi/0000-0002-0153-3533; Kitamura, Kouichi/0000-0001-9692-8724	Grants-in-Aid for Scientific Research [25670713] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bello IO, 2010, ORAL ONCOL, V46, P630, DOI 10.1016/j.oraloncology.2010.06.006; Cascalho M, 2004, J IMMUNOL, V172, P6513, DOI 10.4049/jimmunol.172.11.6513; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Endo K, 2006, HUM PATHOL, V37, P1111, DOI 10.1016/j.humpath.2006.03.020; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Goto A, 2011, VIRCHOWS ARCH, V458, P717, DOI 10.1007/s00428-011-1086-x; Gourzi P, 2007, J EXP MED, V204, P259, DOI 10.1084/jem.20061801; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kinoshita K, 2006, INT J HEMATOL, V83, P201, DOI 10.1532/IJH97.06011; Komori J, 2008, HEPATOLOGY, V47, P888, DOI 10.1002/hep.22125; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Morita S, 2011, CARCINOGENESIS, V32, P1706, DOI 10.1093/carcin/bgr194; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NELSON WG, 1984, CANCER RES, V44, P1600; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Pauklin S, 2009, J EXP MED, V206, P99, DOI 10.1084/jem.20080521; Petti S, 2009, ORAL ONCOL, V45, P340, DOI 10.1016/j.oraloncology.2008.05.018; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rhodus NL, 2005, MOL CARCINOGEN, V44, P77, DOI 10.1002/mc.20113; Rhodus NL, 2004, CANCER DETECT PREV, V29, P42, DOI 10.1016/j.cdp.2004.10.003; Sobin LH, 2010, PHARYNX INT UNION CA, P30; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Yoshizaki T, 1997, CANCER, V79, P139, DOI 10.1002/(SICI)1097-0142(19970101)79:1<139::AID-CNCR20>3.0.CO;2-4; Yoshizaki T, 2001, INT J CANCER, V95, P44, DOI 10.1002/1097-0215(20010120)95:1<44::AID-IJC1008>3.3.CO;2-D	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62066	10.1371/journal.pone.0062066	http://dx.doi.org/10.1371/journal.pone.0062066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634222	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400033
J	Sanchez-Buso, L; Coscolla, M; Pinto-Carbo, M; Catalan, V; Gonzalez-Candelas, F				Sanchez-Buso, Leonor; Coscolla, Mireia; Pinto-Carbo, Marta; Catalan, Vicente; Gonzalez-Candelas, Fernando			Genetic Characterization of Legionella pneumophila Isolated from a Common Watershed in Comunidad Valenciana, Spain	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FALSE DISCOVERY RATE; LEGIONNAIRES-DISEASE; POPULATION-STRUCTURE; ESCHERICHIA-COLI; MOSAIC STRUCTURE; DNA-SEQUENCES; DIVERSITY; RECOMBINATION; SPP.	Legionella pneumophila infects humans to produce legionellosis and Pontiac fever only from environmental sources. In order to establish control measures and study the sources of outbreaks it is essential to know extent and distribution of strain variants of this bacterium in the environment. Sporadic and outbreak-related cases of legionellosis have been historically frequent in the Comunidad Valenciana region (CV, Spain), with a high prevalence in its Southeastern-most part (BV). Environmental investigations for the detection of Legionella pneumophila are performed in this area routinely. We present a population genetics study of 87 L. pneumophila strains isolated in 13 different localities of the BV area irrigated from the same watershed and compare them to a dataset of 46 strains isolated in different points of the whole CV. Our goal was to compare environmental genetic variation at two different geographic scales, at county and regional levels. Genetic diversity, recombination and population structure were analyzed with Sequence-Based Typing data and three intergenic regions. The results obtained reveal a low, but detectable, level of genetic differentiation between both datasets, mainly, but not only, attributed to the occurrence of unusual variants of the neuA locus present in the BV populations. This differentiation is still detectable when the 10 loci considered are analyzed independently, despite the relatively high incidence of the most common genetic variant in this species, sequence type 1 (ST-1). However, when the genetic data are considered without their associated geographic information, four major groups could be inferred at the genetic level which did not show any correlation with sampling locations. The overall results indicate that the population structure of these environmental samples results from the joint action of a global, widespread ST-1 along with genetic differentiation at shorter geographic distances, which in this case are related to the common watershed for the BV localities.	[Sanchez-Buso, Leonor; Pinto-Carbo, Marta; Gonzalez-Candelas, Fernando] Univ Valencia, Cavanilles Inst, Genom & Hlth Joint Unit CSISP FISABIO, Valencia, Spain; [Sanchez-Buso, Leonor; Gonzalez-Candelas, Fernando] CIBER Epidemiol & Publ Hlth, Valencia, Spain; [Coscolla, Mireia] Swiss Trop & Publ Hlth Inst, TB Res Unit, Basel, Switzerland; [Catalan, Vicente] Labaqua SA, Alicante, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Basel; Swiss Tropical & Public Health Institute	Gonzalez-Candelas, F (corresponding author), Univ Valencia, Cavanilles Inst, Genom & Hlth Joint Unit CSISP FISABIO, Valencia, Spain.	fernando.gonzalez@uv.es	Coscolla, Mireia/ABD-7942-2021; Sánchez-Busó, Leonor/E-1023-2013; Candelas, Fernando Gonzalez/G-5681-2010	Sánchez-Busó, Leonor/0000-0002-4162-0228; Candelas, Fernando Gonzalez/0000-0002-0879-5798; Coscolla, Mireia/0000-0003-0752-0538	Conselleria de Sanidad; Generalitat Valencia; Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-03000/BMC]; Ministerio de Economia y Competitividad (MINECO), Spanish Government [BFU2011-24112]	Conselleria de Sanidad; Generalitat Valencia; Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad (MINECO), Spanish Government(Spanish Government)	This work has been supported by Conselleria de Sanidad, Generalitat Valencia and projects BFU2008-03000/BMC from Ministerio de Ciencia e Innovacion (MICINN) and BFU2011-24112 from Ministerio de Economia y Competitividad (MINECO), Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bartlett CLR, 1984, LEGIONELLA, P237; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bozue JA, 1996, INFECT IMMUN, V64, P668, DOI 10.1128/IAI.64.2.668-673.1996; Carvalho FRS, 2007, CURR MICROBIOL, V55, P288, DOI 10.1007/s00284-006-0589-1; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cazalet C, 2008, GENOME RES, V18, P431, DOI 10.1101/gr.7229808; Chen B, 2011, APPL ENVIRON MICROB, V77, P148, DOI 10.1128/AEM.01676-10; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Coscolla M, 2007, ENVIRON MICROBIOL, V9, P643, DOI 10.1111/j.1462-2920.2006.01184.x; Coscolla M, 2006, ENVIRON MICROBIOL, V8, P1056, DOI 10.1111/j.1462-2920.2006.00997.x; Coscolla M, 2011, MOL BIOL EVOL, V28, P985, DOI 10.1093/molbev/msq278; Coscolla M, 2009, INFECT GENET EVOL, V9, P882, DOI 10.1016/j.meegid.2009.05.013; Costa J, 2005, APPL ENVIRON MICROB, V71, P663, DOI 10.1128/AEM.71.2.663-671.2005; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Declerck P, 2007, WATER RES, V41, P3159, DOI 10.1016/j.watres.2007.04.011; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Farhat C, 2011, J CLIN MICROBIOL, V49, P4052, DOI 10.1128/JCM.00687-11; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; FLIERMANS CB, 1979, APPL ENVIRON MICROB, V37, P1239, DOI 10.1128/AEM.37.6.1239-1242.1979; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Gaia V, 2003, J CLIN MICROBIOL, V41, P2932, DOI 10.1128/JCM.41.7.2932-2939.2003; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; GLICK TH, 1978, AM J EPIDEMIOL, V107, P149, DOI 10.1093/oxfordjournals.aje.a112517; Gomez-Valero L, 2009, INFECT GENET EVOL, V9, P727, DOI 10.1016/j.meegid.2009.05.004; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Goto DK, 2011, APPL ENVIRON MICROB, V77, P3988, DOI 10.1128/AEM.02140-10; GRIST NR, 1979, ANN INTERN MED, V90, P563, DOI 10.7326/0003-4819-90-4-563; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; Lyautey E, 2010, APPL ENVIRON MICROB, V76, P1486, DOI 10.1128/AEM.02288-09; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Nei M., 1987, MOL EVOLUTIONARY GEN; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Parthuisot N, 2010, APPL ENVIRON MICROB, V76, P8201, DOI 10.1128/AEM.00188-10; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Sheehan KB, 2005, APPL ENVIRON MICROB, V71, P507, DOI 10.1128/AEM.71.1.507-511.2005; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SMITH JM, 1992, J MOL EVOL, V34, P126; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinert M, 2007, INT J MED MICROBIOL, V297, P577, DOI 10.1016/j.ijmm.2007.03.009; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; TAJIMA F, 1993, MOL BIOL EVOL, V10, P677; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wullings BA, 2006, APPL ENVIRON MICROB, V72, P157, DOI 10.1128/AEM.72.1.157-166.2006; Wullings BA, 2011, APPL ENVIRON MICROB, V77, P634, DOI 10.1128/AEM.01215-10	70	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61564	10.1371/journal.pone.0061564	http://dx.doi.org/10.1371/journal.pone.0061564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634210	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000318341400013
J	Yoo, J; Choi, S; Medina-Franco, JL				Yoo, Jakyung; Choi, Sun; Medina-Franco, Jose L.			Molecular Modeling Studies of the Novel Inhibitors of DNA Methyltransferases SGI-1027 and CBC12: Implications for the Mechanism of Inhibition of DNMTs	PLOS ONE			English	Article							CXXC DOMAIN; METHYLATION; DISCOVERY; CANCER; PROCAINAMIDE; DERIVATIVES; DECITABINE	DNA methylation is an epigenetic modification that regulates gene expression by DNA methyltransferases (DNMTs). Inhibition of DNMTs is a promising approach for cancer therapy. Recently, novel classes of the quinolone-based compound, SGI-1027, and RG108-procainamide conjugates, CBC12, have been identified as potent DNMT inhibitors. In this work, we report comprehensive studies using induced-fit docking of SGI-1027 and CBC12 with human DNMT1 and DNMT3A. The docking was performed in the C-terminal MTase catalytic domain, which contains the substrate and cofactor binding sites, in the presence and absence of other domains. Induced-fit docking predicts possible binding modes of the ligands through the appropriate structural changes in the receptor. This work suggests a hypothesis of the inhibitory mechanisms of the new inhibitors which is in agreement with the reported autoinhibitory mechanism. The insights obtained in this work can be used to design DNMT inhibitors with novel scaffolds.	[Yoo, Jakyung; Choi, Sun] Ewha Womans Univ, Div Life & Pharmaceut Sci, Coll Pharm, Natl Leading Res Lab Mol Modeling & Drug Design, Seoul, South Korea; [Yoo, Jakyung; Choi, Sun] Ewha Womans Univ, Global Res Program Top5, Seoul, South Korea; [Medina-Franco, Jose L.] Univ Nacl Autonoma Mexico, Inst Quim, Mexico City 04510, DF, Mexico	Ewha Womans University; Ewha Womans University; Universidad Nacional Autonoma de Mexico	Choi, S (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Coll Pharm, Natl Leading Res Lab Mol Modeling & Drug Design, Seoul, South Korea.	sunchoi@ewha.ac.kr; jose.medina.franco@gmail.com	Choi, Sun/AAQ-9407-2020; Medina-Franco, Jose/AAJ-1633-2020	Medina-Franco, Jose/0000-0003-4940-1107; Choi, Sun/0000-0002-7669-7954	National Leading Research Lab program [2011-0028885]; Ministry of Education, Science and Technology; National Research Foundation of Korea; RP-Grant of Ewha Womans University; PAPIIT [IA200413]	National Leading Research Lab program; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); RP-Grant of Ewha Womans University; PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was supported by the grant from the National Leading Research Lab program (2011-0028885) funded by the Ministry of Education, Science and Technology and the National Research Foundation of Korea (to SC) and by RP-Grant 2012 of Ewha Womans University (to SC and JY). This work was also supported in part by PAPIIT grant IA200413 (to JLM-F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Castellano S, 2011, J MED CHEM, V54, P7663, DOI 10.1021/jm2010404; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Godley LA, 2011, SCIENCE, V331, P1017, DOI 10.1126/science.1202090; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Halby L, 2012, CHEMBIOCHEM, V13, P157, DOI 10.1002/cbic.201100522; Issa JPJ, 2005, NAT REV DRUG DISCOV, V4, P275, DOI 10.1038/nrd1698; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kuck D, 2010, BIOORGAN MED CHEM, V18, P822, DOI 10.1016/j.bmc.2009.11.050; Lan J, 2010, ACTA BIOCH BIOPH SIN, V42, P243, DOI 10.1093/abbs/gmq015; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Martinet N, 2012, MEDCHEMCOMM, V3, P263, DOI 10.1039/c1md00194a; Medina-Franco JL, 2013, CURR PHARM DESIGN, V19, P2138; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Rius M, 2012, ONCOGENE, V31, P4257, DOI 10.1038/onc.2011.601; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Schrodinger LLC, 2011, PRIM VERS 3 0; Schrodinger Suite, 2011, SCHROD SUIT IND FIT; Schrump DS, 2006, CLIN CANCER RES, V12, P5777, DOI 10.1158/1078-0432.CCR-06-0669; Siedlecki P, 2006, J MED CHEM, V49, P678, DOI 10.1021/jm050844z; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Yoo J, 2012, CURR MED CHEM, V19, P3475, DOI 10.2174/092986712801323289; Yoo J, 2011, COMPUT MOL BIOSCI, V1, P7; Yoo J, 2011, DRUG DEVELOPMENT - A CASE STUDY BASED INSIGHT INTO MODERN STRATEGIES, P3; Yoo J, 2012, CURR COMPUT-AID DRUG, V8, P317, DOI 10.2174/157340912803519606; Yoo J, 2012, ADV PROTEIN CHEM STR, V87, P219, DOI 10.1016/B978-0-12-398312-1.00008-1; Yoo J, 2012, J MOL MODEL, V18, P1583, DOI 10.1007/s00894-011-1191-4; Yoo J, 2011, J COMPUT AID MOL DES, V25, P555, DOI 10.1007/s10822-011-9441-1	36	45	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62152	10.1371/journal.pone.0062152	http://dx.doi.org/10.1371/journal.pone.0062152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637988	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400040
J	Carrillo-Sepulveda, MA; Ceravolo, GS; Furstenau, CR; Monteiro, PD; Bruno-Fortes, Z; Carvalho, MH; Laurindo, FR; Tostes, RC; Webb, RC; Barreto-Chaves, MLM				Carrillo-Sepulveda, Maria Alicia; Ceravolo, Graziela S.; Furstenau, Cristina R.; Monteiro, Priscilla de Souza; Bruno-Fortes, Zuleica; Carvalho, Maria Helena; Laurindo, Francisco R.; Tostes, Rita C.; Webb, R. Clinton; Barreto-Chaves, Maria Luiza M.			Emerging Role of Angiotensin Type 2 Receptor (AT2R)/Akt/NO Pathway in Vascular Smooth Muscle Cell in the Hyperthyroidism	PLOS ONE			English	Article							PROTEIN-KINASE-B; THYROID-HORMONE; AT(2) RECEPTOR; NITRIC-OXIDE; CARDIOVASCULAR-SYSTEM; STIMULATION INCREASES; CARDIAC-HYPERTROPHY; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; CONSCIOUS RATS	Hyperthyroidism is characterized by increased vascular relaxation and decreased vascular contraction and is associated with augmented levels of triiodothyronine (T3) that contribute to the diminished systemic vascular resistance found in this condition. T3 leads to augmented NO production via PI3K/Akt signaling pathway, which in turn causes vascular smooth muscle cell (VSMC) relaxation; however, the underlying mechanisms involved remain largely unknown. Evidence from human and animal studies demonstrates that the renin-angiotensin system (RAS) plays a crucial role in vascular function and also mediates some of cardiovascular effects found during hyperthyroidism. Thus, in this study, we hypothesized that type 2 angiotensin II receptor (AT2R), a key component of RAS vasodilatory actions, mediates T3 induced-decreased vascular contraction. Marked induction of AT2R expression was observed in aortas from T3-induced hyperthyroid rats (Hyper). These vessels showed decreased protein levels of the contractile apparatus: a-actin, calponin and phosphorylated myosin light chain (p-MLC). Vascular reactivity studies showed that denuded aortic rings from Hyper rats exhibited decreased maximal contractile response to angiotensin II (AngII), which was attenuated in aortic rings pre-incubated with an AT2R blocker. Further study showed that cultured VSMC stimulated with T3 (0.1 mu mol/L) for 24 hours had increased AT2R gene and protein expression. Augmented NO levels and decreased p-MLC levels were found in VSMC stimulated with T3, both of which were reversed by a PI3K/Akt inhibitor and AT2R blocker. These findings indicate for the first time that the AT2R/Akt/NO pathway contributes to decreased contractile responses in rat aorta, promoted by T3, and this mechanism is independent from the endothelium.	[Carrillo-Sepulveda, Maria Alicia; Furstenau, Cristina R.; Monteiro, Priscilla de Souza; Barreto-Chaves, Maria Luiza M.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Lab Cell Biol & Funct Anat, Sao Paulo, Brazil; [Ceravolo, Graziela S.; Bruno-Fortes, Zuleica; Carvalho, Maria Helena; Tostes, Rita C.] Univ Sao Paulo, Inst Biomed Sci, Lab Hypertens, Sao Paulo, Brazil; [Laurindo, Francisco R.] Univ Sao Paulo, Inst Heart, Vasc Biol Lab, Sao Paulo, Brazil; [Tostes, Rita C.; Webb, R. Clinton] Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University System of Georgia; Augusta University	Barreto-Chaves, MLM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Lab Cell Biol & Funct Anat, Sao Paulo, Brazil.	mchaves@usp.br	Ceravolo, Graziela/P-3046-2014; Ceravolo, Graziela Scalianti/AAQ-8452-2020; Carvalho, Maria Helena C/C-8539-2013; Laurindo, Francisco R/J-6575-2015; Barreto-Chaves, Maria Luiza/C-4459-2012; Tostes, Rita C/C-1025-2012; Barreto-Chaves, Maria Luiza/Y-9264-2019	Ceravolo, Graziela/0000-0001-7558-6294; Ceravolo, Graziela Scalianti/0000-0001-7558-6294; Barreto-Chaves, Maria Luiza/0000-0001-5514-7921; Tostes, Rita C/0000-0002-9446-0707; Barreto-Chaves, Maria Luiza/0000-0001-5514-7921	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo) [06/61523-7, 06/54064-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo; grants 06/61523-7 and 06/54064-6) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadir PM, 2003, HYPERTENSION, V42, P600, DOI 10.1161/01.HYP.0000090323.58122.5C; Abe A, 1998, BIOCHEM BIOPH RES CO, V245, P226, DOI 10.1006/bbrc.1998.8411; Akishita M, 2000, PHYSIOL GENOMICS, V2, P13; Alves GM, 2002, PEDIATR NEPHROL, V17, P856, DOI 10.1007/s00467-002-0941-z; Barreto-Chaves ML, 2011, CURR OPIN ENDOCRINOL, V18, P300, DOI 10.1097/MED.0b013e32834a785c; Barreto-Chaves MLM, 2010, VASC PHARMACOL, V52, P166, DOI 10.1016/j.vph.2009.10.009; Batenburg WW, 2004, CIRCULATION, V109, P2296, DOI 10.1161/01.CIR.0000128696.12245.57; Biondi B, 2002, J CLIN ENDOCR METAB, V87, P968, DOI 10.1210/jc.87.3.968; Boerth SR, 1996, CARDIOVASC RES, V31, pE145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Carey RM, 2005, HYPERTENSION, V45, P840, DOI 10.1161/01.HYP.0000159192.93968.8f; Carneiro-Ramos MS, 2010, BASIC RES CARDIOL, V105, P325, DOI 10.1007/s00395-010-0089-0; Carrillo-Sepulveda MA, 2010, MOL CELL BIOCHEM, V341, P279, DOI 10.1007/s11010-010-0459-9; Carrillo-Sepulveda MA, 2010, CARDIOVASC RES, V85, P560, DOI 10.1093/cvr/cvp304; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Danzi S, 2004, Minerva Endocrinol, V29, P139; Dimitropoulou C, 2001, HYPERTENSION, V37, P301, DOI 10.1161/01.HYP.37.2.301; Diniz GP, 2009, BASIC RES CARDIOL, V104, P653, DOI 10.1007/s00395-009-0043-1; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Fukada SY, 2005, J CARDIOVASC PHARM, V45, P136, DOI 10.1097/01.fjc.0000151929.34896.c3; Fukuyama K, 2003, HYPERTENSION, V41, P598, DOI 10.1161/01.HYP.0000056524.35294.80; Gloss B, 2001, ENDOCRINOLOGY, V142, P544, DOI 10.1210/en.142.2.544; Gohlke P, 1998, HYPERTENSION, V31, P349, DOI 10.1161/01.HYP.31.1.349; Hannan RE, 2003, BRIT J PHARMACOL, V140, P987, DOI 10.1038/sj.bjp.0705484; Hashimoto T, 2006, ARTERIOSCL THROM VAS, V26, P1267, DOI 10.1161/01.ATV.0000218841.39828.91; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Horiuchi M, 1999, HYPERTENSION, V33, P613, DOI 10.1161/01.HYP.33.2.613; Hu LW, 2003, AM J PHYSIOL-REG I, V285, pR1473, DOI 10.1152/ajpregu.00269.2003; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; Kilian P, 2008, ENDOCRINOLOGY, V149, P2923, DOI 10.1210/en.2007-0313; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Lee JH, 2008, AM J PHYSIOL-REG I, V295, pR144, DOI 10.1152/ajpregu.00191.2008; MACARI D, 1994, EUR J PHARMACOL, V259, P27, DOI 10.1016/0014-2999(94)90153-8; McAllister RM, 2005, J ENDOCRINOL, V185, P111, DOI 10.1677/joe.1.06022; Mizuma H, 2001, CIRC RES, V88, P313, DOI 10.1161/01.RES.88.3.313; MURPHY TJ, 1992, AM J HYPERTENS, V5, pS236, DOI 10.1093/ajh/5.12.236S; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Ojamaa K, 2000, ENDOCRINOLOGY, V141, P2139, DOI 10.1210/en.141.6.2139; OWENS GK, 1986, J CELL BIOL, V102, P343, DOI 10.1083/jcb.102.2.343; Rodriguez-Gomez I, 2003, HYPERTENSION, V42, P220, DOI 10.1161/01.HYP.0000081944.47230.69; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Siragy HM, 2007, AM J PHYSIOL-REG I, V293, pR1461, DOI 10.1152/ajpregu.00014.2007; Siragy HM, 1996, J CLIN INVEST, V97, P1978, DOI 10.1172/JCI118630; Siragy HM, 1997, J CLIN INVEST, V100, P264, DOI 10.1172/JCI119531; SKALLI O, 1986, J SUBMICR CYTOL PATH, V18, P481; Takahashi T, 1999, AM J PHYSIOL-HEART C, V276, pH1927, DOI 10.1152/ajpheart.1999.276.6.H1927; Tsutsumi Y, 1999, J CLIN INVEST, V104, P925, DOI 10.1172/JCI7886; Vargas F, 2006, EUR J ENDOCRINOL, V154, P197, DOI 10.1530/eje.1.02093; Watanabe M, 2006, BRIT J PHARMACOL, V149, P355, DOI 10.1038/sj.bjp.0706883; Widdop RE, 2003, BRIT J PHARMACOL, V140, P809, DOI 10.1038/sj.bjp.0705448; You D, 2005, CIRCULATION, V111, P1006, DOI 10.1161/01.CIR.0000156503.62815.48	54	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61982	10.1371/journal.pone.0061982	http://dx.doi.org/10.1371/journal.pone.0061982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637941	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400063
J	Chang, HY; Lee, PH; Lei, CC; Tung, CW; Hsu, YC; Huang, TJ; Lu, LC; Lin, CL				Chang, Hung-Yu; Lee, Pei-Hsien; Lei, Chen-Chou; Tung, Chun-Wu; Hsu, Yung-Chien; Huang, Tung-Jung; Lu, Long-chuan; Lin, Chun-Liang			Hyperuricemia Is an Independent Risk Factor for New Onset Micro-Albuminuria in a Middle-Aged and Elderly Population: A Prospective Cohort Study in Taiwan	PLOS ONE			English	Article							SERUM URIC-ACID; CHRONIC KIDNEY-DISEASE; MUSCLE-CELL-PROLIFERATION; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; DIABETES-MELLITUS; RENAL-DISEASE; ALL-CAUSE; PROGRESSION; ALBUMINURIA	Background: Hyperuricemia is now regarded as a risk factor for cardiovascular disease. Micro-albuminuria is associated with increased risk for cardiovascular disease and chronic kidney disease. We hypothesized that elevated serum uric acid (UA) is associated with development of micro-albuminuria in the general population. Methodology/Principal Findings: We conducted a community-based prospective cohort study. A total of 1862 subjects from southern Taiwan, all older than 40 years, were screened and 993 of these participants without micro-albuminuria were followed for 4 years. Urinary albumin-to-creatinine ratio was measured two times per year. A multiple linear regression model indicated that serum UA was independently associated with ln(ACR) after adjustment for 8 factors (age, sex, and 6 metabolic metrics) (beta = 0.194, p<0.01). Logistic regression analysis indicated that each 1 mg/dL increase of UA was associated with a 1.42-fold increased risk of micro-albuminuria after adjustment for the same 8 factors (OR = 1.42, 95% CI: 1.27-1.59, p<0.01). A Cox regression model using subjects with serum UA less than 5 mg/dL as reference group indicated higher hazard ratios (HRs) only found in subjects with serum UA more than 7 mg/dL (HR = 3.54, 95% CI: 2.11-5.93, p<0.01) and not in subjects with serum UA of 5 to 7 mg/dL (HR = 1.30, 95% CI: 0.82-2.07, p = 0.15). Conclusion: Hyperuricemia is significantly associated with micro-albuminuria in middle-aged and elderly males and females from a general population in Taiwan. Elevated serum UA is an independent predictor for development of micro-albuminuria in this population.	[Chang, Hung-Yu; Lee, Pei-Hsien; Lei, Chen-Chou; Tung, Chun-Wu; Hsu, Yung-Chien; Lin, Chun-Liang] Chang Gung Mem Hosp, Dept Nephrol, Chiayi, Taiwan; [Lin, Chun-Liang] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Tao Yuan, Taiwan; [Tung, Chun-Wu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Huang, Tung-Jung] Chang Gung Mem Hosp, Dept Pulm Med, Yunlin, Taiwan; [Lu, Long-chuan] Natl Chung Cheng Univ, Coll Management, Grad Sch Mkt Management, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; National Chung Cheng University	Lin, CL (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Chiayi, Taiwan.	linchunliang@adm.cgmh.org.tw			Chang Gung Memorial Hospital [CMRP670081.82.83.84]; Chiayi County Health Bureau	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chiayi County Health Bureau	This study was supported by Chang Gung Memorial Hospital grant CMRP670081.82.83.84. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Chiayi County Health Bureau for its support.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; BRAND FN, 1985, AM J EPIDEMIOL, V121, P11, DOI 10.1093/oxfordjournals.aje.a113972; Chang HY, 2010, AM J MED SCI, V339, P509, DOI 10.1097/MAJ.0b013e3181db6e16; Chang HY, 2001, J RHEUMATOL, V28, P1640; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Cravedi P, 2012, NAT REV NEPHROL, V8, P301, DOI 10.1038/nrneph.2012.42; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hovind P, 2011, J RENAL NUTR, V21, P124, DOI 10.1053/j.jrn.2010.10.024; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kaplan Norman M., 1998, Keio Journal of Medicine, V47, P99; Kohagura K, 2013, HYPERTENS RES, V36, P43, DOI 10.1038/hr.2012.135; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Lee JE, 2006, HYPERTENSION, V47, P962, DOI 10.1161/01.HYP.0000210550.97398.c2; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Molitch ME, 2003, DIABETES CARE, V26, P2702, DOI 10.2337/diacare.26.9.2702; Nakagawa T, 2003, AM J NEPHROL, V23, P2, DOI 10.1159/000066303; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; RAO GN, 1991, J BIOL CHEM, V266, P8604; Resl M, 2012, DIABETIC MED, V29, P721, DOI 10.1111/j.1464-5491.2011.03515.x; Rodrigues SL, 2012, ARQ BRAS CARDIOL, V98, P13, DOI 10.1590/S0066-782X2011005000116; Sanchez-Lozada LG, 2002, AM J PHYSIOL-RENAL, V283, pF1105, DOI 10.1152/ajprenal.00170.2002; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Tseng CH, 2005, KIDNEY INT, V68, P796, DOI 10.1111/j.1523-1755.2005.00459.x; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Yamada T, 2011, AM J MED SCI, V342, P461, DOI 10.1097/MAJ.0b013e318218bd89; Yuyun MF, 2004, INT J EPIDEMIOL, V33, P189, DOI 10.1093/ije/dyh008	40	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61450	10.1371/journal.pone.0061450	http://dx.doi.org/10.1371/journal.pone.0061450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637835	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400022
J	Cheung, VCK; DeBoer, C; Hanson, E; Tunesi, M; D'Onofrio, M; Arisi, I; Brandi, R; Cattaneo, A; Goosens, KA				Cheung, Vincent C. K.; DeBoer, Caroline; Hanson, Elizabeth; Tunesi, Marta; D'Onofrio, Mara; Arisi, Ivan; Brandi, Rossella; Cattaneo, Antonino; Goosens, Ki A.			Gene Expression Changes in the Motor Cortex Mediating Motor Skill Learning	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR; PLASTICITY; PROTEINS; DIFFERENTIATION; SYNAPTOGENESIS; REORGANIZATION; REPRESENTATION; PERFORMANCE; MORPHOLOGY; MOLECULES	The primary motor cortex (M1) supports motor skill learning, yet little is known about the genes that contribute to motor cortical plasticity. Such knowledge could identify candidate molecules whose targeting might enable a new understanding of motor cortical functions, and provide new drug targets for the treatment of diseases which impair motor function, such as ischemic stroke. Here, we assess changes in the motor-cortical transcriptome across different stages of motor skill acquisition. Adult rats were trained on a gradually acquired appetitive reach and grasp task that required different strategies for successful pellet retrieval, or a sham version of the task in which the rats received pellet reward without needing to develop the reach and grasp skill. Tissue was harvested from the forelimb motor-cortical area either before training commenced, prior to the initial rise in task performance, or at peak performance. Differential classes of gene expression were observed at the time point immediately preceding motor task improvement. Functional clustering revealed that gene expression changes were related to the synapse, development, intracellular signaling, and the fibroblast growth factor (FGF) family, with many modulated genes known to regulate synaptic plasticity, synaptogenesis, and cytoskeletal dynamics. The modulated expression of synaptic genes likely reflects ongoing network reorganization from commencement of training till the point of task improvement, suggesting that motor performance improves only after sufficient modifications in the cortical circuitry have accumulated. The regulated FGF-related genes may together contribute to M1 remodeling through their roles in synaptic growth and maturation.	[Cheung, Vincent C. K.; DeBoer, Caroline; Hanson, Elizabeth; Goosens, Ki A.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cheung, Vincent C. K.; DeBoer, Caroline; Hanson, Elizabeth; Goosens, Ki A.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Tunesi, Marta] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20133 Milan, Italy; [D'Onofrio, Mara; Arisi, Ivan; Brandi, Rossella; Cattaneo, Antonino] European Brain Res Inst Rita Levi Montalcini, Rome, Italy	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Polytechnic University of Milan	Cheung, VCK (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ckcheung@mit.edu; kgoosens@mit.edu	Goosens, Ki/ABI-6743-2020; Arisi, Ivan/AAM-1152-2021; Cheung, Vincent C. K./AAL-5807-2020; Cattaneo, Antonino/AAA-7252-2019; Tunesi, Marta/G-4420-2018; CATTANEO, ANTONINO/K-4471-2016	Arisi, Ivan/0000-0002-0536-2508; Cheung, Vincent C. K./0000-0002-6031-7320; Tunesi, Marta/0000-0003-2507-6186; Goosens, Ki/0000-0002-5246-2261; Hanson, Elizabeth/0000-0002-5150-8926; CATTANEO, ANTONINO/0000-0002-6975-8923	National Institutes of Health (NIH) [1-RC1-NS068103-01]; MIT McGovern Institute for Brain Research; NIH [R01-MH084966]; Roberto Rocca Doctoral Fellowship; MIT Undergraduate Research Opportunities Program; Italian Ministry of University and Scientific Research (MIUR) [RBIN04H5AS, RBLA03FLJC]; Italian Institute of Technology; Fondazione Roma; FIRB [RBAP10L8TY]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT McGovern Institute for Brain Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roberto Rocca Doctoral Fellowship; MIT Undergraduate Research Opportunities Program; Italian Ministry of University and Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Fondazione Roma(Fondazione RomaEuropean Commission); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health (NIH) grant 1-RC1-NS068103-01 and funds from the MIT McGovern Institute for Brain Research to Emilio Bizzi; NIH grant R01-MH084966 to KAG; the Roberto Rocca Doctoral Fellowship to MT; fellowships from the MIT Undergraduate Research Opportunities Program to CD and EH; the Italian Ministry of University and Scientific Research (MIUR) grants RBIN04H5AS, RBLA03FLJC, and FIRB n. RBAP10L8TY to the European Brain Research Institute (EBRI); and funds from the Italian Institute of Technology and Fondazione Roma to EBRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOYAGI A, 1994, BRAIN RES, V661, P117, DOI 10.1016/0006-8993(94)91188-6; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bartolini F, 2005, J CELL SCI, V118, P1197, DOI 10.1242/jcs.01719; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Comeau WL, 2007, BEHAV BRAIN RES, V180, P18, DOI 10.1016/j.bbr.2007.02.026; DAI ZS, 1995, J NEUROSCI, V15, P5466; Dum RP, 1996, HDB PHYSIOL 12, P217; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011; Gentner R, 2010, CURR BIOL, V20, P1869, DOI 10.1016/j.cub.2010.09.045; Gharbawie OA, 2005, BEHAV BRAIN RES, V156, P125, DOI 10.1016/j.bbr.2004.05.015; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; Harms KJ, 2008, J NEUROSCI, V28, P5686, DOI 10.1523/JNEUROSCI.0584-08.2008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones S, 2008, J NEUROCHEM, V105, P46, DOI 10.1111/j.1471-4159.2007.05089.x; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kayser MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017417; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Leibowitz N, 2010, J MATH PSYCHOL, V54, P338, DOI 10.1016/j.jmp.2010.01.006; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Franco DL, 2010, MOL CELL NEUROSCI, V44, P154, DOI 10.1016/j.mcn.2010.03.004; Lyckman AW, 2008, P NATL ACAD SCI USA, V105, P9409, DOI 10.1073/pnas.0710172105; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Metz GA, 2005, BEHAV BRAIN RES, V162, P71, DOI 10.1016/j.bbr.2005.03.002; Muto A, 2007, DEV DYNAM, V236, P214, DOI 10.1002/dvdy.21009; Nelissen K, 2010, J NEUROSCI METH, V187, P78, DOI 10.1016/j.jneumeth.2009.12.018; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Ohtaka-Maruyama C, 2007, J COMP NEUROL, V502, P1098, DOI 10.1002/cne.21350; Okado H, 2009, DEV BIOL, V331, P140, DOI 10.1016/j.ydbio.2009.04.030; Olveczky BP, 2011, CURR OPI NEUROBIOL, V21, P1; Park SS, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-63; Phillips GR, 2004, J NEUROSCI RES, V78, P38, DOI 10.1002/jnr.20224; Porter K, 2005, EUR J NEUROSCI, V21, P351, DOI 10.1111/j.1460-9568.2005.03874.x; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; VandenBerg PM, 2002, BRAIN RES BULL, V59, P197, DOI 10.1016/S0361-9230(02)00865-1; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zechel S, 2010, NEUROSCIENTIST, V16, P357, DOI 10.1177/1073858410371513	55	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61496	10.1371/journal.pone.0061496	http://dx.doi.org/10.1371/journal.pone.0061496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637843	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400025
J	Chunara, R; Bouton, L; Ayers, JW; Brownstein, JS				Chunara, Rumi; Bouton, Lindsay; Ayers, John W.; Brownstein, John S.			Assessing the Online Social Environment for Surveillance of Obesity Prevalence	PLOS ONE			English	Article							ASSOCIATIONS; RISK; RELIABILITY; OVERWEIGHT; CHILDREN; NETWORK; WEIGHT; ADULTS; NORMS	Background: Understanding the social environmental around obesity has been limited by available data. One promising approach used to bridge similar gaps elsewhere is to use passively generated digital data. Purpose: This article explores the relationship between online social environment via web-based social networks and population obesity prevalence. Methods: We performed a cross-sectional study using linear regression and cross validation to measure the relationship and predictive performance of user interests on the online social network Facebook to obesity prevalence in metros across the United States of America (USA) and neighborhoods within New York City (NYC). The outcomes, proportion of obese and/or overweight population in USA metros and NYC neighborhoods, were obtained via the Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance and NYC EpiQuery systems. Predictors were geographically specific proportion of users with activity-related and sedentary-related interests on Facebook. Results: Higher proportion of the population with activity-related interests on Facebook was associated with a significant 12.0% (95% Confidence Interval (CI) 11.9 to 12.1) lower predicted prevalence of obese and/or overweight people across USA metros and 7.2% (95% CI: 6.8 to 7.7) across NYC neighborhoods. Conversely, greater proportion of the population with interest in television was associated with higher prevalence of obese and/or overweight people of 3.9% (95% CI: 3.7 to 4.0) (USA) and 27.5% (95% CI: 27.1 to 27.9, significant) (NYC). For activity-interests and national obesity outcomes, the average root mean square prediction error from 10-fold cross validation was comparable to the average root mean square error of a model developed using the entire data set. Conclusions: Activity-related interests across the USA and sedentary-related interests across NYC were significantly associated with obesity prevalence. Further research is needed to understand how the online social environment relates to health outcomes and how it can be used to identify or target interventions.	[Chunara, Rumi; Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Chunara, Rumi; Brownstein, John S.] Boston Childrens Hosp, Div Emergency Med, Childrens Hosp Informat Program, Boston, MA USA; [Bouton, Lindsay] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ayers, John W.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; California State University System; San Diego State University	Chunara, R (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.	rumi@alum.mit.edu			National Library of Medicine [G08 LM009776]; National Institutes of Health [R01 LM010812]; NATIONAL LIBRARY OF MEDICINE [R01LM010812, G08LM009776] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants from the National Library of Medicine (G08 LM009776) and National Institutes of Health (R01 LM010812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An RP, 2012, AM J PREV MED, V42, P129, DOI 10.1016/j.amepre.2011.10.012; Ayers JW, 2010, J SCI STUD RELIG, V49, P536, DOI 10.1111/j.1468-5906.2010.01527.x; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Chang VW, 2003, AM J PREV MED, V24, P332, DOI 10.1016/S0749-3797(03)00020-5; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cohen DA, 2006, SOC SCI MED, V62, P769, DOI 10.1016/j.socscimed.2005.06.033; DeJong W, 2006, J STUD ALCOHOL, V67, P868, DOI 10.15288/jsa.2006.67.868; Dekkers JC, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-69; eBiz MBA, 2012, TOP 15 MOST POP SOC; Elbel B, 2012, NEW ENGL J MED, V23, P23; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glass TA, 2006, AM J PREV MED, V31, P455, DOI 10.1016/j.amepre.2006.07.028; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Imai K, 2007, IS LEAST SEQUARES RE; Kim S, 2000, AM J CLIN NUTR, V71, P44; KING G, 2000, AM J POLIT SCI, V0044; Moreno MA, 2012, J BEHAV HEALTH SER R, V39, P295, DOI 10.1007/s11414-011-9258-7; Napolitano MA, 2012, USING FACEBOOK TEXT; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; Neter J., 1996, APPL LINEAR REGRESSI; New York City Department of Health and Mental Hygiene, 2010, COMM HLTH SURV; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Olson DL, 2008, ADV DATA MINING TECH, DOI DOI 10.1007/978-3-540-76917-0; Pettee KK, 2009, OBESITY, V17, P487, DOI 10.1038/oby.2008.554; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Sallis JF, 2009, SOC SCI MED, V68, P1285, DOI 10.1016/j.socscimed.2009.01.017; Signorini A, 2010, USING TWITTER ESTIMA; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; The Centers for Disease Control, 2010, SMART BRFSS CIT COUN; The Centers for Disease Control, 2010, 2010 SMART BRFSS CIT; The Centers for Disease Control and Prevention, MART BRFSS CIT COUNT; Van Dyck D, 2012, SOC SCI MED, V74, P1375, DOI 10.1016/j.socscimed.2012.01.018	40	41	44	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61373	10.1371/journal.pone.0061373	http://dx.doi.org/10.1371/journal.pone.0061373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136DE	23637820	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400017
J	Essoh, C; Blouin, Y; Loukou, G; Cablanmian, A; Lathro, S; Kutter, E; Thien, HV; Vergnaud, G; Pourcel, C				Essoh, Christiane; Blouin, Yann; Loukou, Guillaume; Cablanmian, Arsher; Lathro, Serge; Kutter, Elizabeth; Hoang Vu Thien; Vergnaud, Gilles; Pourcel, Christine			The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages	PLOS ONE			English	Article							PROVIDES ACQUIRED-RESISTANCE; PHAGE THERAPY; HOST-RANGE; CRISPR; EVOLUTION; GENOME; SYSTEM; DNA; IDENTIFICATION; PATHOGENICITY	Phage therapy may become a complement to antibiotics in the treatment of chronic Pseudomonas aeruginosa infection. To design efficient therapeutic cocktails, the genetic diversity of the species and the spectrum of susceptibility to bacteriophages must be investigated. Bacterial strains showing high levels of phage resistance need to be identified in order to decipher the underlying mechanisms. Here we have selected genetically diverse P. aeruginosa strains from cystic fibrosis patients and tested their susceptibility to a large collection of phages. Based on plaque morphology and restriction profiles, six different phages were purified from "pyophage", a commercial cocktail directed against five different bacterial species, including P. aeruginosa. Characterization of these phages by electron microscopy and sequencing of genome fragments showed that they belong to 4 different genera. Among 47 P. aeruginosa strains, 13 were not lysed by any of the isolated phages individually or by pyophage. We isolated two new phages that could lyse some of these strains, and their genomes were sequenced. The presence/absence of a CRISPR-Cas system (Clustered Regularly Interspaced Short Palindromic Repeats and Crisper associated genes) was investigated to evaluate the role of the system in phage resistance. Altogether, the results show that some P. aeruginosa strains cannot support the growth of any of the tested phages belonging to 5 different genera, and suggest that the CRISPR-Cas system is not a major defence mechanism against these lytic phages.	[Essoh, Christiane; Blouin, Yann; Vergnaud, Gilles; Pourcel, Christine] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Essoh, Christiane; Blouin, Yann; Vergnaud, Gilles; Pourcel, Christine] CNRS, F-91405 Orsay, France; [Loukou, Guillaume; Cablanmian, Arsher; Lathro, Serge] Lab Natl Sante Publ, Abidjan, Cote Ivoire; [Kutter, Elizabeth] Evergreen State Coll, Olympia, WA 98505 USA; [Hoang Vu Thien] Hop Armand Trousseau, APHP, Paris, France; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Pourcel, C (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	christine.pourcel@u-psud.fr	Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/P-1304-2015; Vergnaud, Gilles/AAC-1162-2020	Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X	association Vaincre La Mucoviscidose [2010/IC1020]; Agence Universitaire de la Francophonie	association Vaincre La Mucoviscidose; Agence Universitaire de la Francophonie	This study was performed with the financial support of the association Vaincre La Mucoviscidose (Grant No 2010/IC1020). The development of tools for the surveillance of bacterial pathogens is supported by the French Direction Generale de l'Armement (DGA). CE holds a fellowship of Agence Universitaire de la Francophonie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon Stephen T, 2011, Bacteriophage, V1, P66; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Brussow H, 2012, MBIO, V3, DOI 10.1128/mBio.00061-12; Cady KC, 2011, MICROBIOL-SGM, V157, P430, DOI 10.1099/mic.0.045732-0; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Ceyssens PJ, 2008, VIROLOGY, V377, P233, DOI 10.1016/j.virol.2008.04.038; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI 10.2217/FMB.10.66; Chan BK, 2012, ADV APPL MICROBIOL, V78, P1, DOI 10.1016/B978-0-12-394805-2.00001-4; Chanishvili N, 2012, ADV VIRUS RES, V83, P3, DOI 10.1016/B978-0-12-394438-2.00001-3; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P8287, DOI 10.1128/JB.186.24.8287-8294.2004; Davies JC, 2009, RESP CARE, V54, P628, DOI 10.4187/aarc0492; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Edgell DR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-290; Garbe J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-102; Gimble FS, 2000, FEMS MICROBIOL LETT, V185, P99; Glukhov AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051163; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; HOLLOWAY BW, 1969, BACTERIOL REV, V33, P419, DOI 10.1128/MMBR.33.3.419-443.1969; Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Karumidze N, 2012, APPL MICROBIOL BIOT, V94, P1609, DOI 10.1007/s00253-012-4119-8; Koskella B, 2012, P ROY SOC B-BIOL SCI, V279, P1896, DOI 10.1098/rspb.2011.2259; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Krylov V, 2003, RES MICROBIOL, V154, P269, DOI 10.1016/S0923-2508(03)00070-6; Kutateladze M, 2008, MED MALADIES INFECT, V38, P426, DOI 10.1016/j.medmal.2008.06.023; Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Larche J, 2012, ANTIMICROB AGENTS CH; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Miedzybrodzki R, 2012, ADV VIRUS RES, V83, P73, DOI 10.1016/B978-0-12-394438-2.00003-7; MILLER RV, 1984, J CLIN MICROBIOL, V19, P717, DOI 10.1128/JCM.19.5.717-719.1984; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Pirnay JP, 2011, PHARM RES-DORDR, V28, P934, DOI 10.1007/s11095-010-0313-5; Pleteneva E A, 2008, Genetika, V44, P185; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; SHARMA M, 1992, P NATL ACAD SCI USA, V89, P6658, DOI 10.1073/pnas.89.14.6658; Sobral D, 2012, EUR J CLIN MICROBIOL, V31, P2247, DOI 10.1007/s10096-012-1562-5; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Tan YL, 2007, CELL MICROBIOL, V9, P479, DOI 10.1111/j.1462-5822.2006.00804.x; TEJEDOR C, 1982, INFECT IMMUN, V36, P440, DOI 10.1128/IAI.36.1.440-441.1982; Thomas JA, 2008, VIROLOGY, V376, P330, DOI 10.1016/j.virol.2008.04.004; Vieira A, 2012, EUR J CLIN MICROBIOL, V31, P3241, DOI 10.1007/s10096-012-1691-x; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Whichard JM, 2010, VIRUSES-BASEL, V2, P710, DOI 10.3390/v2030710; Yuzenkova J, 2003, J MOL BIOL, V330, P735, DOI 10.1016/S0022-2836(03)00634-X; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	62	56	56	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e60575	10.1371/journal.pone.0060575	http://dx.doi.org/10.1371/journal.pone.0060575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637754	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400007
J	Luo, LX; Lin, HT; Chen, WR; Wang, CX; Zhang, XY; Tang, XC; Liu, JP; Congdon, N; Chen, JJ; Lin, ZL; Liu, YZ				Luo, Lixia; Lin, Haotian; Chen, Weirong; Wang, Chunxiao; Zhang, Xinyu; Tang, Xiangchen; Liu, Jianping; Congdon, Nathan; Chen, Jingjing; Lin, Zhuoling; Liu, Yizhi			In-the-Bag Intraocular Lens Placement via Secondary Capsulorhexis with Radiofrequency Diathermy in Pediatric Aphakic Eyes	PLOS ONE			English	Article							ULTRASOUND BIOMICROSCOPIC ANALYSIS; ANTERIOR CAPSULOTOMY; CATARACT-SURGERY; IMPLANTATION; ENDODIATHERMY; RING; MANAGEMENT; CHILDREN; REMOVAL; UPDATE	Pediatric ophthalmologists increasingly recognize that the ideal site for intraocular lens (IOL) implantation is in the bag for aphakic eyes, but it is always very difficult via conventional technique. We conducted a prospective case series study to investigate the success rate and clinical outcomes of capsular bag reestablishment and in-the-bag IOL implantation via secondary capsulorhexis with radiofrequency diathermy (RFD) in pediatric aphakic eyes, in which twenty-two consecutive aphakic pediatric patients (43 aphakic eyes) enrolled in the Childhood Cataract Program of the Chinese Ministry of Health were included. The included children underwent either our novel technique for secondary IOL implantation (with RFD) or the conventional technique (with a bent needle or forceps), depending on the type of preoperative proliferative capsular bag present. In total, secondary capsulorhexis with RFD was successfully applied in 32 eyes (32/43, 74.4%, age 5.6+/-2.3 years), of which capsular bag reestablishment and in-the-bag IOL implantation were both achieved in 30 eyes (30/43, 70.0%), but in the remaining 2 eyes (2/32, 6.2%) the IOLs were implanted in the sulcus with a capsular bag that was too small. Secondary capsulorhexis with conventional technique was applied in the other 11 eyes (11/43, 25.6%, age 6.9+/-2.3 years), of which capsular bag reestablishment and in-the-bag IOL implantation were both achieved only in 3 eyes(3/43, 7.0%), and the IOLs were implanted in the sulcus in the remaining 8 eyes. A doughnut-like proliferative capsular bag with an extensive Soemmering ring (32/43, 74.4%) was the main success factor for secondary capsulorhexis with RFD, and a sufficient capsular bag size (33/43, 76.7%) was an additional factor in successful in-the-bag IOL implantation. In conclusion, RFD secondary capsulorhexis technique has 70% success rate in the capsular bag reestablishment and in-the-bag IOL implantation in pediatric aphakic eyes, particularly effective in cases with a doughnut-like, extensively proliferative Soemmering ring.	[Luo, Lixia; Lin, Haotian; Chen, Weirong; Wang, Chunxiao; Zhang, Xinyu; Tang, Xiangchen; Liu, Jianping; Congdon, Nathan; Chen, Jingjing; Lin, Zhuoling; Liu, Yizhi] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	yizhi_liu@yahoo.cn	Chen, Wei/GZK-7348-2022; liu, yi/GXE-9662-2022		Ministry of Health of China [175]	Ministry of Health of China	This study was funded by the Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China in 2010-2012 (Project No. 175 in Document 439 of the Planning and Finance Secretary of Ministry of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonuma H, 1997, JPN J OPHTHALMOL, V41, P98, DOI 10.1016/S0021-5155(97)00005-1; Basti Surendra, 1995, Indian Journal of Ophthalmology, V43, P159; Butcher JM, 1994, EUR J IMPLANT REFRAC, V6, P344; Chee KYH, 2009, J CATARACT REFR SURG, V35, P720, DOI 10.1016/j.jcrs.2008.12.012; Chen PF, 2009, JPN J OPHTHALMOL, V53, P275, DOI 10.1007/s10384-008-0647-2; Comer RM, 1997, J CATARACT REFR SURG, V23, P641, DOI 10.1016/S0886-3350(97)80047-8; DeVaro JM, 1997, AM J OPHTHALMOL, V123, P24, DOI 10.1016/S0002-9394(14)70988-2; Findl O, 1998, J CATARACT REFR SURG, V24, P870, DOI 10.1016/S0886-3350(98)80147-8; Forbes BJ, 2006, J PEDIATR OPHTHALMOL, V43, P165; Forbes BJ, 2006, J PEDIAT OPHTH STRAB, V43, P143, DOI 10.3928/01913913-20060301-01; GASSMANN F, 1988, J CATARACT REFR SURG, V14, P673, DOI 10.1016/S0886-3350(88)80040-3; Gimbel HV, 2008, J CATARACT REFR SURG, V34, P1246, DOI 10.1016/j.jcrs.2008.03.046; Grewal DS, 2012, J CATARACT REFR SURG, V38, P739, DOI 10.1016/j.jcrs.2012.02.023; HAUSMANN N, 1991, INVEST OPHTH VIS SCI, V32, P2155; Kim KH, 2010, OPHTHALMOLOGY, V117, P2278, DOI 10.1016/j.ophtha.2010.03.053; KLOTI R, 1984, KLIN MONATSBL AUGENH, V184, P442, DOI 10.1055/s-2008-1054517; Kobayashi H, 2000, BRIT J OPHTHALMOL, V84, P1142, DOI 10.1136/bjo.84.10.1142; Lin AA, 2010, CURR OPIN OPHTHALMOL, V21, P55, DOI 10.1097/ICU.0b013e32833383cb; Lin HT, 2012, OPHTHALMOLOGY, V119, P2463, DOI 10.1016/j.ophtha.2012.06.046; Lin HT, 2013, OPHTHALMOLO IN PRESS; LUCK J, 1994, BRIT J OPHTHALMOL, V78, P392, DOI 10.1136/bjo.78.5.392; Magli A, 2012, GRAEFES ARCH CLIN EX, P14; Mura JJ, 2010, AM J OPHTHALMOL, V149, P245, DOI 10.1016/j.ajo.2009.08.022; Vasavada AR, 2010, J CATARACT REFR SURG, V36, P771, DOI 10.1016/j.jcrs.2009.11.027; Wagoner MD, 2003, OPHTHALMOLOGY, V110, P840, DOI 10.1016/S0161-6420(02)02000-6; Wang Yu-lin, 2011, Zhonghua Yan Ke Za Zhi, V47, P298; Wilson ME, 1999, J AAPOS, V3, P350, DOI 10.1016/S1091-8531(99)70044-3	27	10	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62381	10.1371/journal.pone.0062381	http://dx.doi.org/10.1371/journal.pone.0062381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638058	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400102
J	Xiao, H; Liu, HN; Gao, LD; Huang, CR; Li, Z; Lin, XL; Chen, BY; Tian, HY				Xiao, Hong; Liu, Hai-Ning; Gao, Li-Dong; Huang, Cun-Rui; Li, Zhou; Lin, Xiao-Ling; Chen, Bi-Yun; Tian, Huai-Yu			Investigating the Effects of Food Available and Climatic Variables on the Animal Host Density of Hemorrhagic Fever with Renal Syndrome in Changsha, China	PLOS ONE			English	Article							NEPHROPATHIA-EPIDEMICA; TEMPORAL DYNAMICS; BANK VOLES; HANTAVIRUS; INFECTION; RODENTS; VIRUS	Background: The transmission of hemorrhagic fever with renal syndrome (HFRS) is influenced by population dynamics of its main host, rodents. It is therefore important to better understand rodents' characteristic in epidemic areas. Methodology/Principal Findings: We examined the potential impact of food available and climatic variability on HFRS rodent host and developed forecasting models. Monthly rodent density of HFRS host and climate data in Changsha from January 2004 to December 2011 were obtained. Monthly normalized difference vegetation index (NDVI) and temperature vegetation dryness index (TVDI) for rice paddies were extracted from MODIS data. Cross-correlation analysis were carried out to explore correlation between climatic variables and food available with monthly rodent data. We used auto-regressive integrated moving average model with explanatory variables to examine the independent contribution of climatic variables and food supply to rodent density. The results indicated that relative rodent density of HFRS host was significantly correlated with monthly mean temperatures, monthly accumulative precipitation, TVDI and NDVI with lags of 1-6 months. Conclusions/Significance: Food available plays a significant role in population fluctuations of HFRS host in Changsha. The model developed in this study has implications for HFRS control and prevention.	[Xiao, Hong; Liu, Hai-Ning; Lin, Xiao-Ling; Tian, Huai-Yu] Hunan Normal Univ, Coll Resources & Environm Sci, Changsha, Hunan, Peoples R China; [Gao, Li-Dong; Chen, Bi-Yun] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Huang, Cun-Rui] Griffith Univ, Sch Environm, Ctr Environm & Populat Hlth, Brisbane, Qld 4111, Australia; [Li, Zhou] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China; [Li, Zhou] Beijing Energy Conservat & Environm Protect Ctr, Beijing, Peoples R China	Hunan Normal University; Griffith University; Beijing Normal University	Xiao, H (corresponding author), Hunan Normal Univ, Coll Resources & Environm Sci, Changsha, Hunan, Peoples R China.	xiaohong.hnnu@gmail.com; tianhuaiyu@gmail.com	Huang, Cunrui/ABI-3312-2020; Tian, Huaiyu/G-1934-2016	Tian, Huaiyu/0000-0002-4466-0858	Key Discipline Construction Project in Hunan Province [2008001]; Scientific Research Fund of the Hunan Provincial Education Department [11K037]; Hunan Provincial Natural Science Foundation of China [11JJ3119]; Science and Technology Planning Project of Hunan Province, China [2010SK3007]; Key Subject Construction Project of Hunan Normal University (geographic information systems)	Key Discipline Construction Project in Hunan Province; Scientific Research Fund of the Hunan Provincial Education Department(Hunan Provincial Education Department); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Science and Technology Planning Project of Hunan Province, China; Key Subject Construction Project of Hunan Normal University (geographic information systems)	This work was supported by the Key Discipline Construction Project in Hunan Province (2008001), Scientific Research Fund of the Hunan Provincial Education Department (11K037), Hunan Provincial Natural Science Foundation of China (11JJ3119), Science and Technology Planning Project of Hunan Province, China (2010SK3007), and Key Subject Construction Project of Hunan Normal University (geographic information systems). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1976, TIME SERIES ANAL; Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; Clement J, 2012, EUR J CLIN MICROBIOL, V31, P1, DOI 10.1007/s10096-011-1456-y; Ernest SKM, 2000, OIKOS, V88, P470, DOI 10.1034/j.1600-0706.2000.880302.x; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Haredasht SA, 2011, BIOSYST ENG, V109, P77, DOI 10.1016/j.biosystemseng.2011.02.004; Huang XX, 2012, WEST PAC SURVEILL RE, V3, P12, DOI [10.5365/wpsar.2011.2.2.007, 10.5365/WPSAR.2011.2.2.007]; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; LEE PW, 1981, INFECT IMMUN, V31, P334, DOI 10.1128/IAI.31.1.334-338.1981; Luo CW, 2003, CHINESE J VECTOR BIO, V14, P451; Mills JA, 2008, J ANIM ECOL, V77, P1129, DOI 10.1111/j.1365-2656.2008.01383.x; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; Olsson GE, 2005, VECTOR-BORNE ZOONOT, V5, P315, DOI 10.1089/vbz.2005.5.315; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; Qin CM, 2007, DIS SURVEILLANCE, V22, P162; Sandholt I, 2002, REMOTE SENS ENVIRON, V79, P213, DOI 10.1016/S0034-4257(01)00274-7; Sauvage F, 2007, EPIDEMIOL INFECT, V135, P46, DOI 10.1017/S0950268806006595; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; 付家荣, 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P751	25	17	19	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61536	10.1371/journal.pone.0061536	http://dx.doi.org/10.1371/journal.pone.0061536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637849	Green Published, gold			2022-12-25	WOS:000318340400026
J	Xiao, XM; Cheng, ZH; Meng, HW; Liu, LH; Li, HZ; Dong, YX				Xiao, Xuemei; Cheng, Zhihui; Meng, Huanwen; Liu, Lihong; Li, Hezi; Dong, Yinxin			Intercropping of Green Garlic (Allium sativum L.) Induces Nutrient Concentration Changes in the Soil and Plants in Continuously Cropped Cucumber (Cucumis sativus L.) in a Plastic Tunnel	PLOS ONE			English	Article							NITROGEN TRANSFER; ENZYME-ACTIVITIES; FUSARIUM-WILT; WHITE LUPIN; PHOSPHORUS; MAIZE; NUTRITION; WHEAT; RHIZOSPHERE; MAGNESIUM	A pot-based experiment was conducted to investigate nutrient concentrations in cucumber plants intercropped with various amounts of green garlic. In addition, the soil nutrient contents were studied over two consecutive growing seasons. The results revealed that the accumulation of biomass and the nutritional elements nitrogen (N), phosphorus (P), potassium (K), calcium (Ca) and manganese (Mn) in cucumber plants were significantly increased for intercropping treatments during the two growing seasons compared to monoculture. Conversely, magnesium (Mg) concentrations were decreased in the cucumber plants. Shoot iron (Fe) concentrations decreased whereas root Fe concentrations increased in the intercropping system. Shoot and root zinc (Zn) concentrations decreased during the fall of 2011 but increased during the spring of 2012. Soil organic matter and available N, P and K were significantly increased as the proportion of intercropped green garlic increasing. Medium levels of intercropping green garlic improved cucumber nutrient concentrations the most. The regression analysis showed that the concentrations of most elements were significantly related to the amounts of garlic bulbs, especially the microelements in the spring 2011. The available soil N and organic matter were linearly related to the amounts of garlic bulbs. The results indicate that the nutritional status of the soil and plants of continuously cropped cucumber could be improved by intercropping with green garlic.	[Xiao, Xuemei; Cheng, Zhihui; Meng, Huanwen; Liu, Lihong; Li, Hezi; Dong, Yinxin] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Cheng, ZH (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	chengzh@nwsuaf.edu.cn			project of the State Natural Science Foundation [31171949]; project of the State Commonwealth (Agriculture) Scientific Research [200903018]	project of the State Natural Science Foundation; project of the State Commonwealth (Agriculture) Scientific Research	This research was supported by the project of the State Natural Science Foundation (No. 31171949) and the project of the State Commonwealth (Agriculture) Scientific Research (No. 200903018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2007, APPL SOIL ECOL, V35, P35, DOI 10.1016/j.apsoil.2006.05.012; Adu-Gyamfi JJ, 2007, PLANT SOIL, V295, P127, DOI 10.1007/s11104-007-9270-0; AE N, 1990, SCIENCE, V248, P477, DOI 10.1126/science.248.4954.477; Bremner JM, 1965, METHODS SOIL ANAL 2, V9, P1324, DOI DOI 10.2134/AGRONMONOGR9.2.C37; Cheng ZH, 2011, AFR J BIOTECHNOL, V10, P15514, DOI 10.5897/AJB10.2171; Ding Y, 2006, ANN APPL BIOL, V149, P111, DOI 10.1111/j.1744-7348.2006.00080.x; GARDNER WK, 1983, PLANT SOIL, V70, P391, DOI 10.1007/BF02374894; HORST WJ, 1987, Z PFLANZ BODENKUNDE, V150, P1, DOI 10.1002/jpln.19871500102; Huang HC, 2006, ALLELOPATHY J, V18, P1; Inal A, 2007, PLANT PHYSIOL BIOCH, V45, P350, DOI 10.1016/j.plaphy.2007.03.016; Jensen ES, 1996, SOIL BIOL BIOCHEM, V28, P159, DOI 10.1016/0038-0717(95)00134-4; Keeney D.R, 1982, AGRON MONOGR, P643; Lai RQ, 2011, AGRON J, V103, P856, DOI 10.2134/agronj2010.0404; Lalande R, 2000, CAN J SOIL SCI, V80, P263, DOI 10.4141/S99-064; LATIF MA, 1992, PLANT SOIL, V140, P15, DOI 10.1007/BF00012802; Li L, 1999, PLANT SOIL, V212, P105, DOI 10.1023/A:1004656205144; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Li L, 2004, PLANT SOIL, V261, P29, DOI 10.1023/B:PLSO.0000035579.39823.16; Li YF, 2009, PLANT SOIL, V315, P285, DOI 10.1007/s11104-008-9751-9; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; Lin S., 2002, WATER WISE RICE PROD, P187; Marschener H, 1998, FIELD CROP RES, V56, P203, DOI 10.1016/S0378-4290(97)00131-7; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MARTIN RC, 1991, PLANT SOIL, V132, P53, DOI 10.1007/BF00011012; Mogahed MI, 2003, INDIAN J AGR SCI, V73, P546; Mueller S, 1998, PESQUI AGROPECU BRAS, V33, P1361; Nishio M., 1975, Soil Science and Plant Nutrition, V21, P391, DOI 10.1080/00380768.1975.10432654; NISHIZAWA T, 1971, P KANTO TOSAN PLANT, V18, P121; OHNO T, 1985, SOIL SCI SOC AM J, V49, P685, DOI 10.2136/sssaj1985.03615995004900030032x; Olasantan FO, 1996, AGR ECOSYST ENVIRON, V57, P149, DOI 10.1016/0167-8809(96)01019-5; Olsen S., 1954, ESTIMATION AVAILABLE; Ren LX, 2008, SOIL BIOL BIOCHEM, V40, P834, DOI 10.1016/j.soilbio.2007.11.003; Romheld V., 1986, Advances in Plant Nutrition, V2, P155; SHANMUGHAM K, 1988, CURR SCI INDIA, V57, P1128; Sivaraman K, 1996, J SPICES AROMATIC CR, V5, P49; Ventura W., 1984, IRRI Research Paper Series; Wang ChunHui, 2009, Journal of Northwest A & F University - Natural Science Edition, V37, P103; WARNOCK RE, 1970, SOIL SCI SOC AM PRO, V34, P765, DOI 10.2136/sssaj1970.03615995003400050028x; Wasaki J, 2003, PLANT SOIL, V248, P129, DOI 10.1023/A:1022332320384; Xiao XM, 2012, ACTA AGR SCAND B-S P, V62, P696, DOI 10.1080/09064710.2012.697571; Yao HY, 2006, PLANT SOIL, V284, P195, DOI 10.1007/s11104-006-0023-2; Ye SF, 2004, PLANT SOIL, V263, P143, DOI 10.1023/B:PLSO.0000047721.78555.dc; YU JQ, 1994, J CHEM ECOL, V20, P21, DOI 10.1007/BF02065988; Yu JQ, 2000, PLANT SOIL, V223, P149, DOI 10.1023/A:1004829512147; Zheng Y, 2003, J PLANT NUTR, V26, P2425, DOI 10.1081/PLN-120025470; Zhou XG, 2011, EUR J SOIL BIOL, V47, P279, DOI 10.1016/j.ejsobi.2011.07.001; Zhu YG, 2002, AUST J AGR RES, V53, P211, DOI 10.1071/AR01085; Zuo YM, 2003, J PLANT NUTR, V26, P2093, DOI 10.1081/PLN-120024267	48	51	58	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62173	10.1371/journal.pone.0062173	http://dx.doi.org/10.1371/journal.pone.0062173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637994	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400080
J	Lledo, JIL; Caceres, M				Lucas Lledo, Jose Ignacio; Caceres, Mario			On the Power and the Systematic Biases of the Detection of Chromosomal Inversions by Paired-End Genome Sequencing	PLOS ONE			English	Article							STRUCTURAL VARIATION; COMBINATORIAL ALGORITHMS; COPY NUMBER; SHORT-READ; IDENTIFICATION; INSERTION; VARIANTS	One of the most used techniques to study structural variation at a genome level is paired-end mapping (PEM). PEM has the advantage of being able to detect balanced events, such as inversions and translocations. However, inversions are still quite difficult to predict reliably, especially from high-throughput sequencing data. We simulated realistic PEM experiments with different combinations of read and library fragment lengths, including sequencing errors and meaningful base-qualities, to quantify and track down the origin of false positives and negatives along sequencing, mapping, and downstream analysis. We show that PEM is very appropriate to detect a wide range of inversions, even with low coverage data. However, >= 80% of inversions located between segmental duplications are expected to go undetected by the most common sequencing strategies. In general, longer DNA libraries improve the detectability of inversions far better than increments of the coverage depth or the read length. Finally, we review the performance of three algorithms to detect inversions -SVDetect, GRIAL, and VariationHunter-, identify common pitfalls, and reveal important differences in their breakpoint precisions. These results stress the importance of the sequencing strategy for the detection of structural variants, especially inversions, and offer guidelines for the design of future genome sequencing projects.	[Lucas Lledo, Jose Ignacio; Caceres, Mario] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Caceres, Mario] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Autonomous University of Barcelona; ICREA	Caceres, M (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	mcaceres@icrea.cat	Cáceres, Mario/A-6379-2009; Lucas Lledó, José Ignacio/L-3112-2014; Lledó, José Ignacio Lucas/AAA-5392-2019	Cáceres, Mario/0000-0002-7736-3251; Lucas Lledó, José Ignacio/0000-0001-6254-8942; Lledó, José Ignacio Lucas/0000-0001-6254-8942	European Research Council (INVFEST) under the European Union Seventh Research Framework Programme (FP7) [243212]; Beatriu de Pinos Postdoctoral fellowship from the Generalitat de Catalunya; ICREA Funding Source: Custom	European Research Council (INVFEST) under the European Union Seventh Research Framework Programme (FP7); Beatriu de Pinos Postdoctoral fellowship from the Generalitat de Catalunya; ICREA(ICREA)	This work was supported by the European Research Council Starting Grant 243212 (INVFEST) under the European Union Seventh Research Framework Programme (FP7) to MC and a Beatriu de Pinos Postdoctoral fellowship from the Generalitat de Catalunya to JILL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 1992, DROSOPHILA INVERSION; Bashir A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-385; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Feuk L, 2010, GENOME MED, V2, DOI 10.1186/gm132; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hormozdiari F, 2010, BIOINFORMATICS, V26, pi350, DOI 10.1093/bioinformatics/btq216; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jiang Y, 2012, BIOINFORMATICS, V28, P2576, DOI 10.1093/bioinformatics/bts484; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manly KF, 2004, GENOME RES, V14, P997, DOI 10.1101/gr.2156804; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Onishi-Seebacher M, 2011, BIOESSAYS, V33, P840, DOI 10.1002/bies.201100075; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sindi SS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r22; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Suzuki S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S7; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xi RB, 2010, BRIEF FUNCT GENOMICS, V9, P405, DOI 10.1093/bfgp/elq025; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; Zhang ZDD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-375	38	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61292	10.1371/journal.pone.0061292	http://dx.doi.org/10.1371/journal.pone.0061292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637806	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400033
J	Tolf, C; Latorre-Margalef, N; Wille, M; Bengtsson, D; Gunnarsson, G; Grosbois, V; Hasselquist, D; Olsen, B; Elmberg, J; Waldenstrom, J				Tolf, Conny; Latorre-Margalef, Neus; Wille, Michelle; Bengtsson, Daniel; Gunnarsson, Gunnar; Grosbois, Vladimir; Hasselquist, Dennis; Olsen, Bjorn; Elmberg, Johan; Waldenstrom, Jonas			Individual Variation in Influenza A Virus Infection Histories and Long-Term Immune Responses in Mallards	PLOS ONE			English	Article							DUCK ANAS-PLATYRHYNCHOS; AVIAN INFLUENZA; TRADE-OFFS; SURVEILLANCE; IMMUNOLOGY; BIRDS; IGY; CIRCULATION; WATERFOWL; DYNAMICS	Wild dabbling ducks (genus Anas) are the main reservoir for influenza A virus (IAV) in the Northern Hemisphere. Current understanding of disease dynamics and epidemiology in this virus-host system has primarily been based on population-level surveillance studies and infection experiments conducted in laboratory settings. Using a combined experimental-natural approach with wild-strain captive mallards (Anas platyrhynchos), we monitored individual IAV infection histories and immunological responses of 10 birds over the course of 15 months. This is the first detailed study to track natural IAV infection histories over several seasons amongst the same individuals growing from juvenile to adults. The general trends in the infection histories of the monitored birds reflected seasonal variation in prevalence at the population level. However, within the study group there were significant differences between individuals in infection frequency as well as in short and long term anti-IAV antibody response. Further observations included individual variation in the number of infecting virus subtypes, and a strong tendency for long-lasting hemagglutinin-related homosubtypic immunity. Specifically, all infections in the second autumn, except one, were of different subtypes compared to the first autumn. The variation among birds concerning these epidemiologically important traits illustrates the necessity for IAV studies to move from the level of populations to examine individuals in order to further our understanding of IAV disease and epidemiology.	[Tolf, Conny; Latorre-Margalef, Neus; Wille, Michelle; Bengtsson, Daniel; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden; [Gunnarsson, Gunnar; Elmberg, Johan] Kristianstad Univ, Div Nat Sci, Kristianstad, Sweden; [Grosbois, Vladimir] Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France; [Hasselquist, Dennis] Lund Univ, Dept Biol, Lund, Sweden; [Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Linnaeus University; Kristianstad University; CIRAD; Lund University; Uppsala University	Waldenstrom, J (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden.	jonas.waldenstrom@lnu.se	Elmberg, Johan/H-1868-2014; Waldenström, Jonas/E-4460-2013; Hasselquist, Dennis/M-5223-2014; Gunnarsson, Gunnar/G-8458-2014; Wille, Michelle/F-4819-2013	Waldenström, Jonas/0000-0002-1152-4235; Hasselquist, Dennis/0000-0002-0056-6616; Gunnarsson, Gunnar/0000-0003-2345-3953; Wille, Michelle/0000-0002-5629-0196; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council VR [2010-3067, 2010-5399, 2011-3568]; Swedish Research Council FORMAS [2009-1220]; EC FP6 program NewFlubird	Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); EC FP6 program NewFlubird	Funding for this project came from the Swedish Research Councils VR (2010-3067, 2010-5399, 2011-3568), FORMAS (2009-1220), and the EC FP6 program NewFlubird. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; ARENAS A, 1990, AVIAN PATHOL, V19, P539, DOI 10.1080/03079459008418706; Arsnoe DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022633; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Costa TP, 2010, AVIAN DIS, V54, P1286, DOI 10.1637/9480-072210-Reg.1; De Marco MA, 2004, VET MICROBIOL, V98, P197, DOI 10.1016/j.vetmic.2003.10.018; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; Demas G, 2012, ECOIMMUNOLGY; Ellstrom P, 2008, VACCINE, V26, P4414, DOI 10.1016/j.vaccine.2008.06.027; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Fuller T, 2012, ECOHEALTH, V9, P80, DOI 10.1007/s10393-012-0750-1; Globig A, 2013, TRANSBOUND EMERG DIS, V60, P395, DOI 10.1111/j.1865-1682.2012.01357.x; Guillemain M, 2005, IBIS, V147, P688, DOI 10.1111/j.1474-919X.2005.00446.x; Hanssen SA, 2004, P ROY SOC B-BIOL SCI, V271, P925, DOI 10.1098/rspb.2004.2678; Hasselquist D, 1999, BEHAV ECOL SOCIOBIOL, V45, P167, DOI 10.1007/s002650050550; Hasselquist D, 2012, ANIM BEHAV, V83, P1303, DOI 10.1016/j.anbehav.2012.03.025; HIGGINS DA, 1987, IMMUNOLOGY, V62, P499; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; KIDA H, 1980, INFECT IMMUN, V30, P547; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Magor KE, 2011, DEV COMP IMMUNOL, V35, P1008, DOI 10.1016/j.dci.2011.02.011; Magor KE, 1998, EUR J IMMUNOL, V28, P1063, DOI 10.1002/(SICI)1521-4141(199803)28:03&lt;1063::AID-IMMU1063&gt;3.0.CO;2-O; MAGOR KE, 1994, J IMMUNOL, V153, P5549; MAGOR KE, 1992, J IMMUNOL, V149, P2627; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owen-Ashley NT, 2004, AM NAT, V164, P490, DOI 10.1086/423714; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; Verhulst S, 2005, J AVIAN BIOL, V36, P22, DOI 10.1111/j.0908-8857.2005.03342.x; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Wobeser G.A, 2006, ESSENTIALS DIS WILD	41	48	48	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61201	10.1371/journal.pone.0061201	http://dx.doi.org/10.1371/journal.pone.0061201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637797	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400029
J	Andersson, A; Jurgensone, I; Rowe, OF; Simonelli, P; Bignert, A; Lundberg, E; Karlsson, J				Andersson, Agneta; Jurgensone, Iveta; Rowe, Owen F.; Simonelli, Paolo; Bignert, Anders; Lundberg, Erik; Karlsson, Jan			Can Humic Water Discharge Counteract Eutrophication in Coastal Waters?	PLOS ONE			English	Article							BACTERIAL PRODUCTION; ZOOPLANKTON; PLANKTON; BALANCE; GROWTH; CARBON; FRESH; LAKES; FISH	A common and established view is that increased inputs of nutrients to the sea, for example via river flooding, will cause eutrophication and phytoplankton blooms in coastal areas. We here show that this concept may be questioned in certain scenarios. Climate change has been predicted to cause increased inflow of freshwater to coastal areas in northern Europe. River waters in these areas are often brown from the presence of high concentrations of allochthonous dissolved organic carbon ( humic carbon), in addition to nitrogen and phosphorus. In this study we investigated whether increased inputs of humic carbon can change the structure and production of the pelagic food web in the recipient seawater. In a mesocosm experiment unfiltered seawater from the northern Baltic Sea was fertilized with inorganic nutrients and humic carbon (CNP), and only with inorganic nutrients (NP). The system responded differently to the humic carbon addition. In NP treatments bacterial, phytoplankton and zooplankton production increased and the systems turned net autotrophic, whereas the CNP-treatment only bacterial and zooplankton production increased driving the system to net heterotrophy. The size-structure of the food web showed large variations in the different treatments. In the enriched NP treatments the phytoplankton community was dominated by filamentous >20 mu m algae, while in the CNP treatments the phytoplankton was dominated by picocyanobacteria <5 mu m. Our results suggest that climate change scenarios, resulting in increased humic-rich river inflow, may counteract eutrophication in coastal waters, leading to a promotion of the microbial food web and other heterotrophic organisms, driving the recipient coastal waters to net-heterotrophy.	[Andersson, Agneta; Rowe, Owen F.; Karlsson, Jan] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Jurgensone, Iveta] Latvian Inst Aquat Ecol, Marine Monitoring Ctr, Riga, Latvia; [Simonelli, Paolo] Univ Bergen, Dept Biol, Bergen, Norway; [Bignert, Anders] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden; [Andersson, Agneta; Lundberg, Erik] Umea Univ, Umea Marine Sci Ctr, Hornefors, Sweden	Umea University; University of Bergen; Swedish Museum of Natural History; Umea University	Andersson, A (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	agneta.andersson@emg.umu.se		Jurgensone, Iveta/0000-0002-0811-1747	Swedish Research Council Formas [21.0/2004-0376]; European Social Fund within the project "Support for Doctoral Studies at University of Latvia"	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); European Social Fund within the project "Support for Doctoral Studies at University of Latvia"	This study was supported by grants from the Swedish Research Council Formas to A. Andersson (21.0/2004-0376) and to the strategic research programme ECOCHANGE, and by the European Social Fund within the project "Support for Doctoral Studies at University of Latvia". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund J, 2007, LIMNOL OCEANOGR, V52, P121, DOI 10.4319/lo.2007.52.1.0121; Bignert A., 2007, PIA STAT APPL DEV US; Blackburn N, 1998, APPL ENVIRON MICROB, V64, P3246; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Dahlgren K, 2011, AQUAT ECOL, V45, P307, DOI 10.1007/s10452-011-9355-y; DELGIORGIO PA, 1993, CAN J FISH AQUAT SCI, V50, P282, DOI 10.1139/f93-032; DELGIORGIO PA, 1994, LIMNOL OCEANOGR, V39, P772, DOI 10.4319/lo.1994.39.4.0772; Eiane K, 1999, LIMNOL OCEANOGR, V44, P1352, DOI 10.4319/lo.1999.44.5.1352; Findlay S., 2003, AQUATIC ECOSYSTEMS I; Gargas E., 1975, BALTIC MARINE BIOL P, V2; Grasshoff K., 1999, METHODS SEAWATER ANA; Hansson D, 2011, INT J CLIMATOL, V31, P696, DOI 10.1002/joc.2097; Haraldsson M, 2012, MAR ECOL PROG SER, V471, P73, DOI 10.3354/meps10036; HELCOM, 2005, MAN MAR MON COMB PRO; Hernroth L., 1985, MESOZOOPLANKTON BIOM, V10; Karlsson J, 2001, MICROB ECOL, V42, P372, DOI 10.1007/s00248-001-0009-9; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; KIRK KL, 1992, ECOLOGY, V73, P2208, DOI 10.2307/1941468; LARSSON U, 1982, MAR BIOL, V67, P57, DOI 10.1007/BF00397095; LEGENDRE L, 1995, OPHELIA, V41, P153, DOI 10.1080/00785236.1995.10422042; Meier HEM, 2006, CLIM DYNAM, V27, P39, DOI 10.1007/s003S2-006-0124-x; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MULLIN MM, 1969, PAC SCI, V23, P438; Nixon SW, 2009, HYDROBIOLOGIA, V629, P5, DOI 10.1007/s10750-009-9759-z; Norland S., 1993, HDB METHODS AQUATIC, P303, DOI DOI 10.1201/9780203752746-36; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Paoli A, 2008, FEMS MICROBIOL ECOL, V64, P219, DOI 10.1111/j.1574-6941.2008.00459.x; Pettersson C, 1992, THESIS LINKOPING U S; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19; Sommer U, 2002, ECOL RES, V17, P161, DOI 10.1046/j.1440-1703.2002.00476.x; SPJOTVOLL E, 1973, J AM STAT ASSOC, V68, P975, DOI 10.2307/2284534; Straile D, 1997, LIMNOL OCEANOGR, V42, P1375, DOI 10.4319/lo.1997.42.6.1375; Thingstad TF, 2008, NATURE, V455, P387, DOI 10.1038/nature07235; Utermohl H., 1958, INT VER THEOR ANGEW, V9, P1, DOI [10.1080/05384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Valiela I, 1995, MARINE ECOLOGICAL PR; Wiklund AKE, 2009, MAR ECOL PROG SER, V396, P13, DOI 10.3354/meps08290; Wikner J, 2012, GLOBAL CHANGE BIOL, V18, P2509, DOI 10.1111/j.1365-2486.2012.02718.x	41	23	23	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61293	10.1371/journal.pone.0061293	http://dx.doi.org/10.1371/journal.pone.0061293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637807	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700020
J	Leistritz, L; Weiss, T; Bar, KJ; De VicoFallani, F; Babiloni, F; Witte, H; Lehmann, T				Leistritz, Lutz; Weiss, Thomas; Baer, Karl-Juergen; De VicoFallani, Fabrizio; Babiloni, Fabio; Witte, Herbert; Lehmann, Thomas			Network Redundancy Analysis of Effective Brain Networks; a Comparison of Healthy Controls and Patients with Major Depression	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; ANTERIOR CINGULATE; GAMMA OSCILLATIONS; GRANGER CAUSALITY; PAIN PERCEPTION; ACTIVATION; STIMULI; MODEL; POTENTIALS; DYNAMICS	This study investigated electroencephalographic correlates in chronically depressed patients compared to healthy controls using intracutaneously applied electrical pain stimulus, to better understand the interaction between pain processing and depression. A close interaction between pain and depression is generally recognized although the precise mechanisms are not yet fully understood. The present study focuses on the hypothesis that effective brain connectivity in major depression patients is altered. Multifunctional interactions between brain regions represent a robust index of effective interactions within the brain, and can be quantified by network redundancy. Thus, structural network differences between 18 normal controls and 18 major depression patients before as well as during the processing of moderately painful intracutaneous electrical stimuli were investigated on the basis of network redundancy differences. In our sample, both patients and control subjects exhibit comparable network redundancies before stimulus application. Caused by the stimulus, there is a global increase of network redundancy in both groups. This increase is diminished in the group of major depression patients. We found clear differences between patients and controls during the stimulus processing, where the network redundancy in normal controls is larger in comparison to patients. The differences might be explained by the fact that major depression patients are more restricted to the affective component of the processing. The well-established biasing to affective processing might suppress the somatosensory processing resulting in a lower number of connections within the considered network. This might then lead to a reduction in network redundancy during stimulus processing.	[Leistritz, Lutz; Witte, Herbert; Lehmann, Thomas] Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Jena, Germany; [Weiss, Thomas] Univ Jena, Dept Biol & Clin Psychol, Jena, Germany; [Baer, Karl-Juergen] Univ Jena, Jena Univ Hosp, Dept Psychiat & Psychotherapy, Jena, Germany; [De VicoFallani, Fabrizio; Babiloni, Fabio] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [De VicoFallani, Fabrizio] IRCCS Fdn Santa Lucia, Neuroeletr Imaging & Brain Comp Interface Lab, Rome, Italy; [De VicoFallani, Fabrizio] Hop La Pitie Salpetriere, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, Paris, France	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Sapienza University Rome; IRCCS Santa Lucia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Leistritz, L (corresponding author), Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Jena, Germany.	Lutz.Leistritz@mti.uni-jena.de	Babiloni, Fabio/E-5169-2015	Babiloni, Fabio/0000-0002-4962-176X	German Research Foundation [Wi 1166/9-2]	German Research Foundation(German Research Foundation (DFG))	This research was supported by a grant of the German Research Foundation (Wi 1166/9-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2007, J PSYCHIATR RES, V41, P511, DOI 10.1016/j.jpsychires.2006.07.020; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baccala LA, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P163, DOI 10.1109/ICDSP.2007.4288544; Bar KJ, 2007, BIOL PSYCHIAT, V62, P1281, DOI 10.1016/j.biopsych.2007.02.011; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BROMM B, 1984, METHOD FIND EXP CLIN, V6, P405; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Fallani FDV, 2008, NEUROINFORMATICS, V6, P23, DOI 10.1007/s12021-007-9006-6; Fallani FD, 2011, BRAIN TOPOGR, V23, P344, DOI 10.1007/s10548-010-0152-z; First M. B., 1997, STRUCTURED CLIN INTE; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Gross J, 2007, PLOS BIOL, V5, P1168, DOI 10.1371/journal.pbio.0050133; HOLM S, 1979, SCAND J STAT, V6, P65; Hu L, 2012, NEUROIMAGE, V62, P217, DOI 10.1016/j.neuroimage.2012.03.094; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leistritz L, 2010, METHOD INFORM MED, V49, P484, DOI 10.3414/ME09-02-0038; Liitkepohl H, 2007, NEW INTRO MULTIPLE T; Ohara S, 2004, J NEUROPHYSIOL, V91, P2734, DOI 10.1152/jn.00912.2003; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rossini PM, 2000, ANN NEUROL, V48, P128, DOI 10.1002/1531-8249(200007)48:1<128::AID-ANA25>3.3.CO;2-0; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sato JR, 2009, HUM BRAIN MAPP, V30, P452, DOI 10.1002/hbm.20513; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schelter B, 2006, J NEUROSCI METH, V152, P210, DOI 10.1016/j.jneumeth.2005.09.001; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Schulz E, 2012, J NEUROPHYSIOL, V108, P1025, DOI 10.1152/jn.00186.2012; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stahl SM, 2002, J CLIN PSYCHIAT, V63, P273, DOI 10.4088/JCP.v63n0401; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Straube T, 2009, HUM BRAIN MAPP, V30, P689, DOI 10.1002/hbm.20536; Straube T, 2009, NEUROIMAGE, V44, P975, DOI 10.1016/j.neuroimage.2008.10.022; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiss T, 1997, NEUROSCI LETT, V227, P95, DOI 10.1016/S0304-3940(97)00320-0; Weiss T, 2008, J NEUROPHYSIOL, V99, P2220, DOI 10.1152/jn.00912.2007; Zhang ZG, 2012, J NEUROSCI, V32, P7429, DOI 10.1523/JNEUROSCI.5877-11.2012	45	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e60956	10.1371/journal.pone.0060956	http://dx.doi.org/10.1371/journal.pone.0060956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637778	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700011
J	Li, Z; Wang, S; Gui, XL; Chang, XB; Gong, ZH				Li, Zheng; Wang, Shu; Gui, Xiao-Ling; Chang, Xiao-Bei; Gong, Zhen-Hui			A Further Analysis of the Relationship between Yellow Ripe-Fruit Color and the Capsanthin-Capsorubin Synthase Gene in Pepper (Capsicum sp.) Indicated a New Mutant Variant in C. annuum and a Tandem Repeat Structure in Promoter Region	PLOS ONE			English	Article							CANDIDATE GENE; CAROTENOID ACCUMULATION; Y LOCUS; PIGMENTATION; SUGGESTS; DELETION; TOMATO	Mature pepper (Capsicum sp.) fruits come in a variety of colors, including red, orange, yellow, brown, and white. To better understand the genetic and regulatory relationships between the yellow fruit phenotype and the capsanthin-capsorubin synthase gene (Ccs), we examined 156 Capsicum varieties, most of which were collected from Northwest Chinese landraces. A new ccs variant was identified in the yellow fruit cultivar CK7. Cluster analysis revealed that CK7, which belongs to the C. annuum species, has low genetic similarity to other yellow C. annuum varieties. In the coding sequence of this ccs allele, we detected a premature stop codon derived from a C to G change, as well as a downstream frame-shift caused by a 1-bp nucleotide deletion. In addition, the expression of the gene was detected in mature CK7 fruit. Furthermore, the promoter sequences of Ccs from some pepper varieties were examined, and we detected a 176-bp tandem repeat sequence in the promoter region. In all C. annuum varieties examined in this study, the repeat number was three, compared with four in two C. chinense accessions. The sequence similarity ranged from 84.8% to 97.7% among the four types of repeats, and some putative cis-elements were also found in every repeat. This suggests that the transcriptional regulation of Ccs expression is complex. Based on the analysis of the novel C. annuum mutation reported here, along with the studies of three mutation types in yellow C. annuum and C. chinense accessions, we suggest that the mechanism leading to the production of yellow color fruit may be not as complex as that leading to orange fruit production.	[Li, Zheng; Gui, Xiao-Ling; Chang, Xiao-Bei; Gong, Zhen-Hui] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Wang, Shu] Southwest Forest Univ, Coll Hort & Landscape Architecture, Kunming, Yunnan, Peoples R China	Northwest A&F University - China	Gong, ZH (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	gzhh168@yahoo.com.cn			National Natural Science Foundation of China [31101540, 31272163]; Research Fund for the Doctoral Program of Higher Education of China [20110204120004]; Basic Scientific Research Fund from Northwest AF University [QN2012010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Basic Scientific Research Fund from Northwest AF University	This work was supported by National Natural Science Foundation of China (No. 31101540 and No. 31272163), Research Fund for the Doctoral Program of Higher Education of China (No. 20110204120004), and Basic Scientific Research Fund from Northwest A&F University (No. QN2012010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLEY GE, 1995, PLANT CELL, V7, P1027, DOI 10.1105/tpc.7.7.1027; Borovsky Y, 2008, THEOR APPL GENET, V117, P235, DOI 10.1007/s00122-008-0768-5; Eshbaugh W. H., 1993, New crops., P132; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Guzman I, 2010, PLANT SCI, V179, P49, DOI 10.1016/j.plantsci.2010.04.014; Ha SH, 2007, J EXP BOT, V58, P3135, DOI 10.1093/jxb/erm132; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huh JH, 2001, THEOR APPL GENET, V102, P524, DOI 10.1007/s001220051677; HURTADOHERNANDEZ H, 1985, J HERED, V76, P211, DOI 10.1093/oxfordjournals.jhered.a110070; Joy N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-42; KORMOS J., 1960, ACTA BOT ACAD SCI HUNGARICAE, V6, P305; Kuntz M, 1998, PLANT J, V13, P351, DOI 10.1046/j.1365-313X.1998.00032.x; Lang YQ, 2004, BREEDING SCI, V54, P33, DOI 10.1270/jsbbs.54.33; Lefebvre V, 1998, PLANT MOL BIOL, V36, P785, DOI 10.1023/A:1005966313415; Li Z, 2008, THEOR APPL GENET, V117, P1253, DOI 10.1007/s00122-008-0859-3; Li Z, 2012, J EXP BOT, V63, P4475, DOI 10.1093/jxb/ers123; Li Z, 2009, GENETICS, V182, P1381, DOI 10.1534/genetics.109.104737; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Popovsky S, 2000, THEOR APPL GENET, V101, P86, DOI 10.1007/s001220051453; Portis E, 2006, CROP SCI, V46, P2517, DOI 10.2135/cropsci2006.04.0216; Rodriguez-Uribe L, 2012, J EXP BOT, V63, P517, DOI 10.1093/jxb/err302; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Tam SM, 2005, THEOR APPL GENET, V110, P819, DOI 10.1007/s00122-004-1837-z; Thorup TA, 2000, P NATL ACAD SCI USA, V97, P11192, DOI 10.1073/pnas.97.21.11192; Thul ST, 2012, MOL BIOTECHNOL, V51, P137, DOI 10.1007/s12033-011-9446-y; Toquica SP, 2003, GENET RESOUR CROP EV, V50, P639, DOI 10.1023/A:1024429320771	27	26	30	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61996	10.1371/journal.pone.0061996	http://dx.doi.org/10.1371/journal.pone.0061996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637942	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700071
J	Ljung, R; Drefahl, S; Andersson, G; Lagergren, J				Ljung, Rickard; Drefahl, Sven; Andersson, Gunnar; Lagergren, Jesper			Socio-Demographic and Geographical Factors in Esophageal and Gastric Cancer Mortality in Sweden	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HELICOBACTER-PYLORI; OCCUPATIONAL EXPOSURES; HEALTH RESEARCH; RISK; SURVIVAL; INEQUALITIES; ADENOCARCINOMA; ETIOLOGY; ALCOHOL	Background: Socio-demographic factors and area of residence might influence the development of esophageal and gastric cancer. Large-scale population-based research can determine the role of such factors. Methods: This population-based cohort study included all Swedish residents aged 30-84 years in 1990-2007. Educational level, marital status, place of birth, and place of residence were evaluated with regard to mortality from esophageal or gastric cancer. Cox regression yielded hazard ratios (HR) with 95% confidence intervals (CI), adjusted for potential confounding. Results: Among 84 920 565 person-years, 5125 and 12 230 deaths occurred from esophageal cancer and gastric cancer, respectively. Higher educational level decreased the HR of esophageal cancer (HR = 0.61, 95%CI 0.42-0.90 in women, HR = 0.71, 95%CI 0.60-0.84 in men) and gastric cancer (HR = 0.80, 95%CI 0.63-1.03 in women, HR = 0.73, 95%CI 0.64-0.83 in men). Being unmarried increased HR of esophageal cancer (HR = 1.64, 95%CI 1.35-1.99 in women, HR = 1.64, 95%CI 1.50-1.80 in men), but not of gastric cancer. Being born in low density populated areas increased HR of gastric cancer (HR = 1.23, 95%CI 1.10-1.38 in women, HR = 1.37, 95%CI 1.25-1.50 in men), while no strong association was found with esophageal cancer. Living in densely populated areas increased HR of esophageal cancer (HR = 1.31, 95%CI 1.14-1.50 in women, HR = 1.40, 95%CI 1.29-1.51 in men), but not of gastric cancer. Conclusion: These socio-demographic inequalities in cancer mortality warrant efforts to investigate possible preventable mechanisms and to promote and support healthier lifestyles among deprived groups.	[Ljung, Rickard; Lagergren, Jesper] Karolinska Inst, Dept Mol Med & Surg, Unit Upper Gastrointestinal Res, Stockholm, Sweden; [Drefahl, Sven; Andersson, Gunnar] Stockholm Univ, Dept Sociol, SIMSAM Node Demog Res, S-10691 Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Karolinska Institutet; Stockholm University; University of London; King's College London	Ljung, R (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Unit Upper Gastrointestinal Res, Stockholm, Sweden.	rickard.ljung@ki.se	Ljung, Rickard/E-6752-2011	Ljung, Rickard/0000-0002-0654-4530; Drefahl, Sven/0000-0003-4533-7558; Andersson, Gunnar/0000-0001-8900-8903; Lagergren, Jesper/0000-0002-5143-5448	Swedish Research Council through the Swedish Initiative for research on Microdata in the Social and Medical Sciences (SIMSAM)	Swedish Research Council through the Swedish Initiative for research on Microdata in the Social and Medical Sciences (SIMSAM)	The study was supported by grants from the Swedish Research Council through the Swedish Initiative for research on Microdata in the Social and Medical Sciences (SIMSAM). The study sponsor had no involvement in the analysis or the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baastrup R, 2008, EUR J CANCER, V44, P1962, DOI 10.1016/j.ejca.2008.06.013; Carr D, 2010, J MARRIAGE FAM, V72, P743, DOI 10.1111/j.1741-3737.2010.00728.x; Cooper SC, 2009, CANCER CAUSE CONTROL, V20, P1459, DOI 10.1007/s10552-009-9372-5; FERRARONI M, 1989, INT J EPIDEMIOL, V18, P556, DOI 10.1093/ije/18.3.556; HANSSON LE, 1993, GASTROENTEROLOGY, V105, P1098, DOI 10.1016/0016-5085(93)90954-B; Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195; Jansson C, 2006, OCCUP ENVIRON MED, V63, P107, DOI 10.1136/oem.2005.022467; Jansson C, 2005, CANCER EPIDEM BIOMAR, V14, P1754, DOI 10.1158/1055-9965.EPI-05-0140; Jansson C, 2005, CANCER CAUSE CONTROL, V16, P755, DOI 10.1007/s10552-005-1723-2; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Lagergren J, 2000, INT J CANCER, V85, P340; Lagergren J, 2011, EUR J CANCER, V47, P1446, DOI 10.1016/j.ejca.2011.04.017; Lagergren J, 2011, INT J CANCER, V129, P513, DOI 10.1002/ijc.25701; Lambe M, 2011, ACTA ONCOL, V50, P1220, DOI 10.3109/0284186X.2011.599338; Malaty HM, 1998, AM J EPIDEMIOL, V148, P793, DOI 10.1093/oxfordjournals.aje.a009700; Menvielle G, 2008, EUR J CANCER, V44, P1933, DOI 10.1016/j.ejca.2008.06.034; Menvielle G, 2007, AM J PUBLIC HEALTH, V97, P2082, DOI 10.2105/AJPH.2005.073429; Nagel G, 2007, INT J EPIDEMIOL, V36, P66, DOI 10.1093/ije/dyl275; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PUKKALA E, 1986, PREV MED, V15, P127, DOI 10.1016/0091-7435(86)90083-6; Rendall MS, 2011, DEMOGRAPHY, V48, P481, DOI 10.1007/s13524-011-0032-5; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1080/140349401753683444; Socialstyrelsen (The National Board of Health and Welfare Sweden), 2011, CAUS DEATH SWED 2009; Spadea T, 2009, EUR J CANCER PREV, V18, P169, DOI 10.1097/CEJ.0b013e3283265bc9; Statistics Sweden, 2007, MAIN OUTL ORG POP ST; Thjodleifsson B, 2007, SCAND J INFECT DIS, V39, P683, DOI 10.1080/00365540701225736; van Loon AJM, 1998, J EPIDEMIOL COMMUN H, V52, P166, DOI 10.1136/jech.52.3.166; Whiteman DC, 2010, GASTROENTEROLOGY, V139, P73, DOI 10.1053/j.gastro.2010.04.009	31	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62067	10.1371/journal.pone.0062067	http://dx.doi.org/10.1371/journal.pone.0062067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130IU	23637965	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700074
J	Welinder, C; Baldetorp, B; Blixt, O; Grabau, D; Jansson, B				Welinder, Charlotte; Baldetorp, Bo; Blixt, Ola; Grabau, Dorthe; Jansson, Bo			Primary Breast Cancer Tumours Contain High Amounts of IgA1 Immunoglobulin: An Immunohistochemical Analysis of a Possible Carrier of the Tumour-Associated Tn Antigen	PLOS ONE			English	Article							LECTIN-BINDING; HEAVY-CHAIN; SERUM IGA1; EXPRESSION; RECEPTOR; CELLS; IDENTIFICATION; GLYCOSYLATION; ANTIBODY; REGION	The Tn antigen (GalNAc alpha-O-Ser/Thr) as defined by the binding of the lectin, helix pomatia agglutinin (HPA) or anti-Tn monoclonal antibodies, is known to be exposed in a majority of cancers, and it has also been shown to correlate positively with the metastatic capacity in breast carcinoma. The short O-glycan that forms the antigen is carried by a number of different proteins. One potential carrier of the Tn antigen is immunoglobulin A1 (IgA1), which we surprisingly found in tumour cells of the invasive parts of primary breast carcinoma. Conventional immunohistochemical analysis of paraffin-embedded sections from primary breast cancers showed IgA1 to be present in the cytoplasm and plasma membrane of 35 out of 36 individual primary tumours. The immunohistochemical staining of HPA and anti-Tn antibody (GOD3-2C4) did to some extent overlap with the presence of IgA1 in the tumours, but differences were seen in the percentage of stained cells and in the staining pattern in the different breast cancers analysed. Anti-Tn antibody and HPA were also shown to specifically bind to a number of possible constellations of the Tn antigen in the hinge region of IgA1. Both reagents could also detect the presence of Tn positive IgA in serum. On average 51% of the tumour cells in the individual breast cancer tumour sections showed staining for IgA1. The overall amount of staining in the invasive part of the tumour with the anti Tn antibody was 67%, and 93% with HPA. The intra-expression or uptake of IgA1 in breast cancer makes it a new potential carrier of the tumour associated and immunogenic Tn antigen.	[Welinder, Charlotte; Baldetorp, Bo; Jansson, Bo] Lund Univ, Dept Oncol, Lund, Sweden; [Blixt, Ola] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Copenhagen, Denmark; [Grabau, Dorthe] Skane Univ Hosp, Dept Pathol, Lund, Sweden	Lund University; University of Copenhagen; Lund University; Skane University Hospital	Jansson, B (corresponding author), Lund Univ, Dept Oncol, Lund, Sweden.	bo.jansson@med.lu.se	Baldetorp, Bo/HDM-9924-2022; Welinder, Charlotte/G-1144-2014	Welinder, Charlotte/0000-0001-9626-0576; Blixt, Ola/0000-0003-4143-6276	Mrs. Berta Kamprad Foundation; Gunnar Nilsson Cancer Foundation; Danish Agency for Science Technology and Innovation (FTP); EU FP7/2007-2013-EuroGlycoArrays [215536]; EU FP7-GlycoBioM	Mrs. Berta Kamprad Foundation; Gunnar Nilsson Cancer Foundation; Danish Agency for Science Technology and Innovation (FTP); EU FP7/2007-2013-EuroGlycoArrays; EU FP7-GlycoBioM	This study was supported by grants from the Mrs. Berta Kamprad Foundation and the Gunnar Nilsson Cancer Foundation and The Danish Agency for Science Technology and Innovation (FTP), EU FP7/2007-2013-EuroGlycoArrays 215536 and EU FP7-GlycoBioM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2008, BIOL PHARM BULL, V31, P1739, DOI 10.1248/bpb.31.1739; Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Brooks SA, 2001, BRIT J CANCER, V85, P1014, DOI 10.1054/bjoc.2001.2028; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chen ZS, 2009, AM J PATHOL, V174, P1139, DOI 10.2353/ajpath.2009.080879; Dwek MV, 2001, INT J CANCER, V95, P79, DOI 10.1002/1097-0215(20010320)95:2<79::AID-IJC1014>3.0.CO;2-E; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; FARRIS MA, 1985, VOX SANG, V48, P116, DOI 10.1111/j.1423-0410.1985.tb00155.x; Freire T, 2003, ONCOL REP, V10, P1577; Geng LY, 2007, WORLD J GASTROENTERO, V13, P2305, DOI 10.3748/wjg.v13.i16.2305; Gomes MM, 2010, BIOCHEMISTRY-US, V49, P5671, DOI 10.1021/bi9019498; Hansen MH, 2001, P NATL ACAD SCI USA, V98, P12659, DOI 10.1073/pnas.171460798; Hoja-Lukowicz D, 2009, CANCER IMMUNOL IMMUN, V58, P1471, DOI 10.1007/s00262-009-0705-8; Hubert P, 2011, CANCER RES, V71, P5134, DOI 10.1158/0008-5472.CAN-10-4222; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; LEATHEM AJ, 1987, LANCET, V1, P1054; Li M, 2012, CELL MOL IMMUNOL, V9, P54, DOI 10.1038/cmi.2011.40; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; Moura IC, 2001, J EXP MED, V194, P417, DOI 10.1084/jem.194.4.417; Qiu XY, 2003, CANCER RES, V63, P6488; ROBERTS MM, 1975, CANCER, V36, P221, DOI 10.1002/1097-0142(197507)36:1<221::AID-CNCR2820360124>3.0.CO;2-P; Streets AJ, 1996, CLIN CHIM ACTA, V254, P47, DOI 10.1016/0009-8981(96)06363-2; Stuchlova' Horynova JM, 2012, CELL MOL LIFE SCI; SYRE G, 1981, VIRCHOWS ARCH A, V393, P315, DOI 10.1007/BF00430831; Takahashi K, 2012, J PROTEOME RES, V11, P692, DOI 10.1021/pr200608q; Welinder C, 2011, GLYCOBIOLOGY, V21, P1097, DOI 10.1093/glycob/cwr048; Zheng H, 2007, MOL IMMUNOL, V44, P2221, DOI 10.1016/j.molimm.2006.11.010	31	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61749	10.1371/journal.pone.0061749	http://dx.doi.org/10.1371/journal.pone.0061749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637900	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700058
J	Chugunov, AO; Koromyslova, AD; Berkut, AA; Peigneur, S; Tytgat, J; Polyansky, AA; Pentkovsky, VM; Vassilevski, AA; Grishin, EV; Efremov, RG				Chugunov, Anton O.; Koromyslova, Anna D.; Berkut, Antonina A.; Peigneur, Steve; Tytgat, Jan; Polyansky, Anton A.; Pentkovsky, Vladimir M.; Vassilevski, Alexander A.; Grishin, Eugene V.; Efremov, Roman G.			Modular Organization of alpha-Toxins from Scorpion Venom Mirrors Domain Structure of Their Targets, Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-BASIS; RECEPTOR-SITE; SPATIAL STRUCTURE; BUTHUS-EUPEUS; NEUROTOXIN M9; RAT-BRAIN; PURIFICATION; PEPTIDE; INSECT	To gain success in the evolutionary "arms race," venomous animals such as scorpions produce diverse neurotoxins selected to hit targets in the nervous system of prey. Scorpion alpha-toxins affect insect and/or mammalian voltage-gated sodium channels (Na(v)s) and thereby modify the excitability of muscle and nerve cells. Although more than 100 alpha-toxins are known and a number of them have been studied into detail, the molecular mechanism of their interaction with Na(v)s is still poorly understood. Here, we employ extensive molecular dynamics simulations and spatial mapping of hydrophobic/hydrophilic properties distributed over the molecular surface of alpha-toxins. It is revealed that despite the small size and relatively rigid structure, these toxins possess modular organization from structural, functional, and evolutionary perspectives. The more conserved and rigid " core module" is supplemented with the " specificity module" (SM) that is comparatively flexible and variable and determines the taxon (mammal versus insect) specificity of alpha-toxin activity. We further show that SMs in mammal toxins are more flexible and hydrophilic than in insect toxins. Concomitant sequence-based analysis of the extracellular loops of Na(v)s suggests that alpha-toxins recognize the channels using both modules. We propose that the core module binds to the voltage-sensing domain IV, whereas the more versatile SM interacts with the pore domain in repeat I of Na(v)s. These findings corroborate and expand the hypothesis on different functional epitopes of toxins that has been reported previously. In effect, we propose that the modular structure in toxins evolved to match the domain architecture of Na(v)s.	[Chugunov, Anton O.; Koromyslova, Anna D.; Berkut, Antonina A.; Polyansky, Anton A.; Vassilevski, Alexander A.; Grishin, Eugene V.; Efremov, Roman G.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Koromyslova, Anna D.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Berkut, Antonina A.; Pentkovsky, Vladimir M.; Efremov, Roman G.] State Univ, Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Russia; [Peigneur, Steve; Tytgat, Jan] Univ Louvain, Lab Toxicol & Pharmacol, B-3000 Louvain, Belgium; [Polyansky, Anton A.] Max F Perutz Labs GmbH, Lab Computat Biophys, AT-1030 Vienna, Austria	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Chugunov, AO (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia.	batch2k@yandex.ru; avas@ibch.ru	Polyansky, Anton A/J-2145-2018; Vassilevski, Alexander/S-3824-2016; Chugunov, Anton O/D-1058-2009; Koromyslova, Anna/AAU-8672-2020; Berkut, Antonina/AAE-4247-2019; Roman, Efremov/A-7460-2014	Polyansky, Anton A/0000-0002-1011-2706; Vassilevski, Alexander/0000-0002-1359-0076; Chugunov, Anton O/0000-0003-1331-3949; Roman, Efremov/0000-0002-5474-4721; Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702	Ministry of Education and Science of the Russian Federation [P818, 07.514.11.4127, 8794]; Russian Foundation for Basic Research [11-04-01606, 10-04-01217]; Russian Academy of Sciences; Russian Federation; F.W.O. Vlaanderen Grants [G.0433.12, G.A071.10N, G.0257.08]; Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy [IUAP7/10]; KU Leuven Grant [OT/12/081]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); F.W.O. Vlaanderen Grants; Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); KU Leuven Grant	This work was supported by the Ministry of Education and Science of the Russian Federation (Contracts P818, 07.514.11.4127, and 8794), by the Russian Foundation for Basic Research (Grants 11-04-01606 and 10-04-01217), and by the "Basic Fundamental Research for Nanotechnologies and Nanomaterials" and "Molecular and Cell Biology" programs of the Russian Academy of Sciences.; Recipient of the Stipend of the President of the Russian Federation.; Supported by F.W.O. Vlaanderen Grants G.0433.12, G.A071.10N, and G.0257.08; IUAP7/10 (Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy), and KU Leuven Grant OT/12/081.	Andavan GSB, 2011, CURR MED CHEM, V18, P377; Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Arnon T, 2005, INSECT BIOCHEM MOLEC, V35, P187, DOI 10.1016/j.ibmb.2004.11.005; Ben-Shimon A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002288; Benkhadir K, 2004, PEPTIDES, V25, P151, DOI 10.1016/j.peptides.2004.01.009; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Borchani L, 1997, TOXICON, V35, P365, DOI 10.1016/S0041-0101(96)00173-0; Bosmans F, 2007, TOXICON, V49, P142, DOI 10.1016/j.toxicon.2006.09.023; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cao ZY, 2004, J PEPT RES, V64, P33, DOI 10.1111/j.1399-3011.2004.00164.x; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; del Rio-Portilla F, 2004, EUR J BIOCHEM, V271, P2504, DOI 10.1111/j.1432-1033.2004.04181.x; DeLano WL, 2002, PYMOL USERS MANUAL; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Dong XL, 2011, CURR COMPUT-AID DRUG, V7, P181, DOI 10.2174/157340911796504332; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; EFREMOV RG, 1992, J PROTEIN CHEM, V11, P665, DOI 10.1007/BF01024968; Efremov RG, 2007, CURR MED CHEM, V14, P393, DOI 10.2174/092986707779941050; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Gordon D, 1996, J BIOL CHEM, V271, P8034, DOI 10.1074/jbc.271.14.8034; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Guan RJ, 2004, J MOL BIOL, V341, P1189, DOI 10.1016/j.jmb.2004.06.067; Gur M, 2011, J BIOL CHEM, V286, P35209, DOI 10.1074/jbc.M111.259507; Gurevitz M, 2001, FASEB J, V15, P1201, DOI 10.1096/fj.00-0571hyp; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; Hamon A, 2002, EUR J BIOCHEM, V269, P3920, DOI 10.1046/j.1432-1033.2002.03065.x; Hasegawa K, 2012, BIOORGAN MED CHEM, V20, P5410, DOI 10.1016/j.bmc.2012.03.041; He XL, 1999, J MOL BIOL, V292, P125, DOI 10.1006/jmbi.1999.3036; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hille B, 2001, ION CHANNELS EXCITAB, P1; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Krimm I, 1999, J MOL BIOL, V285, P1749, DOI 10.1006/jmbi.1998.2418; Landon C, 1996, EUR J BIOCHEM, V236, P395, DOI 10.1111/j.1432-1033.1996.00395.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li HM, 1999, ACTA CRYSTALLOGR D, V55, P341, DOI 10.1107/S0907444998006593; Little MJ, 1998, FEBS LETT, V439, P246, DOI 10.1016/S0014-5793(98)01378-7; Liu LH, 2005, FASEB J, V19, P594, DOI 10.1096/fj.04-2485fje; Lopreato GF, 2001, P NATL ACAD SCI USA, V98, P7588, DOI 10.1073/pnas.131171798; Luo MJ, 1997, TOXICON, V35, P723, DOI 10.1016/S0041-0101(96)00146-8; MARTIN MF, 1984, TOXICON, V22, P279, DOI 10.1016/0041-0101(84)90028-X; NOREL R, 1995, J MOL BIOL, V252, P263, DOI 10.1006/jmbi.1995.0493; NOREL R, 1994, PROTEIN ENG, V7, P39, DOI 10.1093/protein/7.1.39; PASHKOV VS, 1988, BIOPHYS CHEM, V31, P121, DOI 10.1016/0301-4622(88)80016-4; PASHKOV VS, 1986, BIOORG KHIM+, V12, P1306; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Petrov D, 2011, J AM CHEM SOC, V133, P7016, DOI 10.1021/ja110577e; Polanski J, 2000, COMPUT CHEM, V24, P615, DOI 10.1016/S0097-8485(00)00064-4; Polyansky AA, 2012, J PHYS CHEM LETT, V3, P973, DOI 10.1021/jz300103p; Pyrkov TV, 2008, SAR QSAR ENVIRON RES, V19, P91, DOI 10.1080/10629360701844092; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; Snyder J. P., 1993, FLATTENING EARTH 200, P112; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Sun YM, 2003, J BIOL CHEM, V278, P24125, DOI 10.1074/jbc.M211931200; Tanrikulu Y, 2008, NAT REV DRUG DISCOV, V7, P667, DOI 10.1038/nrd2615; Tugarinov V, 1997, BIOCHEMISTRY-US, V36, P2414, DOI 10.1021/bi961497l; VOLKOVA TM, 1984, BIOORG KHIM+, V10, P979; VOLKOVA TM, 1985, BIOORG KHIM+, V11, P1445; Wang CG, 2003, BIOCHEMISTRY-US, V42, P4699, DOI 10.1021/bi0270438; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; Wu HM, 1999, PURE APPL CHEM, V71, P1157, DOI 10.1351/pac199971061157; Ye X, 2005, J MOL BIOL, V353, P788, DOI 10.1016/j.jmb.2005.08.068; Zhang JZ, 2011, J BIOL CHEM, V286, P33641, DOI 10.1074/jbc.M111.282509; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhu SY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012054; Zhu SY, 2004, J MOL EVOL, V58, P145, DOI 10.1007/s00239-003-2534-2; Zilberberg N, 1997, J BIOL CHEM, V272, P14810, DOI 10.1074/jbc.272.23.14810	81	26	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19014	19027		10.1074/jbc.M112.431650	http://dx.doi.org/10.1074/jbc.M112.431650			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23637230	hybrid, Green Published			2022-12-25	WOS:000321335800037
J	Menyhard, DK; Kiss-Szeman, A; Tichy-Racs, E; Hornung, B; Radi, K; Szeltner, Z; Domokos, K; Szamosi, I; Naray-Szabo, G; Polgar, L; Harmat, V				Menyhard, Dora K.; Kiss-Szeman, Anna; Tichy-Racs, Eva; Hornung, Balazs; Radi, Krisztina; Szeltner, Zoltan; Domokos, Klarissza; Szamosi, Ilona; Naray-Szabo, Gabor; Polgar, Laszlo; Harmat, Veronika			A Self-compartmentalizing Hexamer Serine Protease from Pyrococcus Horikoshii SUBSTRATE SELECTION ACHIEVED THROUGH MULTIMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-IV; BETA-PROPELLER DOMAIN; AEROPYRUM-PERNIX K1; CRYSTAL-STRUCTURE; PROLYL OLIGOPEPTIDASE; ACYLPEPTIDE HYDROLASE; HALOALKANE DEHALOGENASE; ACYLAMINOACYL PEPTIDASE; ALPHA/BETA-HYDROLASE; MOLECULAR-DYNAMICS	Oligopeptidases impose a size limitation on their substrates, the mechanism of which has long been under debate. Here we present the structure of a hexameric serine protease, an oligopeptidase from Pyrococcus horikoshii (PhAAP), revealing a complex, self-compartmentalized inner space, where substrates may access the monomer active sites passing through a double-gated "check-in" system, first passing through a pore on the hexamer surface and then turning to enter through an even smaller opening at the monomers' domain interface. This substrate screening strategy is unique within the family. We found that among oligopeptidases, a residue of the catalytic apparatus is positioned near an amylogenic beta-edge, which needs to be protected to prevent aggregation, and we found that different oligopeptidases use different strategies to achieve such an end. We propose that self-assembly within the family results in characteristically different substrate selection mechanisms coupled to different multimerization states.	[Harmat, Veronika] Eotvos Lorand Univ, Hungarian Acad Sci, Prot Modeling Res Grp, H-1117 Budapest, Hungary; [Kiss-Szeman, Anna; Tichy-Racs, Eva; Hornung, Balazs; Radi, Krisztina; Naray-Szabo, Gabor; Harmat, Veronika] Eotvos Lorand Univ, Inst Chem, Lab Struct Chem & Biol, H-1117 Budapest, Hungary; [Szeltner, Zoltan; Domokos, Klarissza; Szamosi, Ilona; Polgar, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1113 Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Harmat, V (corresponding author), Eotvos Lorand Univ, Inst Chem, Pazmany Peter Setany 1-A, H-1117 Budapest, Hungary.	veronika@chem.elte.hu	Menyhárd, Dóra K./AAE-4527-2021; Harmat, Veronika/B-8033-2016	Menyhárd, Dóra K./0000-0002-0095-5531; Harmat, Veronika/0000-0002-1866-9904	Hungarian Scientific Research Fund (OTKA) [PD101095, NK101072, NK67800]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian Scientific Research Fund (OTKA) Grants PD101095, NK101072, and NK67800.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biswal BK, 2008, J MOL BIOL, V381, P897, DOI 10.1016/j.jmb.2008.06.030; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bosch J, 2007, ACTA CRYSTALLOGR D, V63, P179, DOI 10.1107/S0907444906045471; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clark LA, 2005, PROTEIN SCI, V14, P653, DOI 10.1110/ps.041017305; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Duysen EG, 2001, J PHARMACOL EXP THER, V299, P528; Eldrup AB, 2010, BIOORG MED CHEM LETT, V20, P571, DOI 10.1016/j.bmcl.2009.11.091; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel M, 2006, J MOL BIOL, V355, P768, DOI 10.1016/j.jmb.2005.11.014; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; ERLANDSSON R, 1991, ONCOGENE, V6, P1293; FRANKEN SM, 1991, EMBO J, V10, P1297, DOI 10.1002/j.1460-2075.1991.tb07647.x; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Fuxreiter M, 2005, PROTEINS, V60, P504, DOI 10.1002/prot.20508; Goettig P, 2002, EMBO J, V21, P5343, DOI 10.1093/emboj/cdf552; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hiramatsu H, 2003, BIOCHEM BIOPH RES CO, V302, P849, DOI 10.1016/S0006-291X(03)00258-4; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; Juhasz R, 2007, PROTEINS, V69, P633, DOI 10.1002/prot.21522; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JS, 2002, J MOL BIOL, V324, P1041, DOI 10.1016/S0022-2836(02)01153-1; Kim KK, 1997, STRUCTURE, V5, P1571, DOI 10.1016/S0969-2126(97)00306-7; Kiss AL, 2008, J STRUCT BIOL, V162, P312, DOI 10.1016/j.jsb.2008.01.012; Kiss AL, 2007, J MOL BIOL, V368, P509, DOI 10.1016/j.jmb.2007.02.025; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McLuskey K, 2010, J BIOL CHEM, V285, P39249, DOI 10.1074/jbc.M110.156679; Medrano FJ, 1998, EMBO J, V17, P1, DOI 10.1093/emboj/17.1.1; Monincova M, 2007, APPL ENVIRON MICROB, V73, P2005, DOI 10.1128/AEM.02416-06; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAYLOR SL, 1989, GENOMICS, V4, P355, DOI 10.1016/0888-7543(89)90342-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; PATHAK D, 1990, J MOL BIOL, V214, P497, DOI 10.1016/0022-2836(90)90196-S; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Prokop Z, 2010, ANGEW CHEM INT EDIT, V49, P6111, DOI 10.1002/anie.201001753; Richards PG, 2000, MOL PHARMACOL, V58, P577, DOI 10.1124/mol.58.3.577; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; ROULD MA, 1991, NATURE, V352, P213, DOI 10.1038/352213a0; SCALONI A, 1992, J LAB CLIN MED, V120, P546; Schmidt A, 2008, J BIOL CHEM, V283, P21827, DOI 10.1074/jbc.M801056200; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soldi G, 2005, BIOPHYS J, V89, P4234, DOI 10.1529/biophysj.105.067538; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Szeltner Z, 2002, J BIOL CHEM, V277, P42613, DOI 10.1074/jbc.M208043200; Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96; Szeltner Z, 2009, BBA-PROTEINS PROTEOM, V1794, P1204, DOI 10.1016/j.bbapap.2009.03.004; Thoms S, 2011, J STRUCT BIOL, V175, P362, DOI 10.1016/j.jsb.2011.06.008; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Zhang ZM, 2008, BBA-PROTEINS PROTEOM, V1784, P1176, DOI 10.1016/j.bbapap.2008.05.011	63	15	15	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17884	17894		10.1074/jbc.M113.451534	http://dx.doi.org/10.1074/jbc.M113.451534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632025	hybrid, Green Published			2022-12-25	WOS:000320380600076
J	Luca, F; Maranville, JC; Richards, AL; Witonsky, DB; Stephens, M; Di Rienzo, A				Luca, Francesca; Maranville, Joseph C.; Richards, Allison L.; Witonsky, David B.; Stephens, Matthew; Di Rienzo, Anna			Genetic, Functional and Molecular Features of Glucocorticoid Receptor Binding	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION-FACTOR-BINDING; EXPRESSION; ENHANCER; DETERMINANTS; ACTIVATION; REPRESSION; CROSSTALK; TARGET	Glucocorticoids (GCs) are key mediators of stress response and are widely used as pharmacological agents to treat immune diseases, such as asthma and inflammatory bowel disease, and certain types of cancer. GCs act mainly by activating the GC receptor (GR), which interacts with other transcription factors to regulate gene expression. Here, we combined different functional genomics approaches to gain molecular insights into the mechanisms of action of GC. By profiling the transcriptional response to GC over time in 4 Yoruba (YRI) and 4 Tuscans (TSI) lymphoblastoid cell lines (LCLs), we suggest that the transcriptional response to GC is variable not only in time, but also in direction (positive or negative) depending on the presence of specific interacting transcription factors. Accordingly, when we performed ChIP-seq for GR and NF-kappa B in two YRI LCLs treated with GC or with vehicle control, we observed that features of GR binding sites differ for up- and down-regulated genes. Finally, we show that eQTLs that affect expression patterns only in the presence of GC are 1.9-fold more likely to occur in GR binding sites, compared to eQTLs that affect expression only in its absence. Our results indicate that genetic variation at GR and interacting transcription factors binding sites influences variability in gene expression, and attest to the power of combining different functional genomic approaches.	[Luca, Francesca; Maranville, Joseph C.; Richards, Allison L.; Witonsky, David B.; Stephens, Matthew; Di Rienzo, Anna] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Di Rienzo, A (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	dirienzo@bsd.uchicago.edu	Luca, Francesca/B-4850-2019	Luca, Francesca/0000-0001-8252-9052; Di Rienzo, Anna/0000-0002-8982-9098; Maranville, Joseph/0000-0002-1688-1573	NIH [R01DK056670, R01DK056670-S1]; AHA [11POST5390005, 11PRE4960001]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056670] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by NIH R01DK056670, NIH R01DK056670-S1, AHA 11POST5390005 & AHA 11PRE4960001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp381; Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7; Barnes Neil C, 2007, Prim Care Respir J, V16, P149, DOI 10.3132/pcrj.2007.00038; Barnes PJ, 1997, INT J BIOCHEM CELL B, V29, P867, DOI 10.1016/S1357-2725(96)00159-8; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hillier SG, 2007, J ENDOCRINOL, V195, P1, DOI 10.1677/JOE-07-0309; ISRAEL A, 1989, EMBO J, V8, P3793, DOI 10.1002/j.1460-2075.1989.tb08556.x; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Karczewski KJ, 2011, P NATL ACAD SCI USA, V108, P13353, DOI 10.1073/pnas.1103105108; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Keith BD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-84; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Luca F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000489; Maranville JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002162; Maynard ND, 2008, NAT METHODS, V5, P307, DOI [10.1038/NMETH.1194, 10.1038/nmeth.1194]; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PAN D, 2011, CANC RES; Ploner C, 2005, J STEROID BIOCHEM, V93, P153, DOI 10.1016/j.jsbmb.2004.12.017; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; REDDY TE, 2012, GENOME RES; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reily MM, 2006, EMBO J, V25, P108, DOI 10.1038/sj.emboj.7600919; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; WETH O, 2011, BIOCH CELL BIOL; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	41	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61654	10.1371/journal.pone.0061654	http://dx.doi.org/10.1371/journal.pone.0061654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23637875	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300012
J	Sun, EW; Wagner, ML; Maize, A; Kemler, D; Garland-Kuntz, E; Xu, L; Luo, ZQ; Hollenbeck, PJ				Sun, Elizabeth Wen; Wagner, Monica L.; Maize, Amanda; Kemler, Doris; Garland-Kuntz, Elisabeth; Xu, Li; Luo, Zhao-Qing; Hollenbeck, Peter J.			Legionella pneumophila Infection of Drosophila S2 Cells Induces Only Minor Changes in Mitochondrial Dynamics	PLOS ONE			English	Article							WIDE RNAI SCREEN; PHAGOSOME; GROWTH; PATHOGENESIS; MODULATION; PROTEINS; FUSION	During infection of cells by Legionella pneumophila, the bacterium secretes a large number of effector proteins into the host cell cytoplasm, allowing it to alter many cellular processes and make the vacuole and the host cell into more hospitable environments for bacterial replication. One major change induced by infection is the recruitment of ER-derived vesicles to the surface of the vacuole, where they fuse with the vacuole membrane and prevent it from becoming an acidified, degradative compartment. However, the recruitment of mitochondria to the region of the vacuole has also been suggested by ultrastructural studies. In order to test this idea in a controlled and quantitative experimental system, and to lay the groundwork for a genome-wide screen for factors involved in mitochondrial recruitment, we examined the behavior of mitochondria during the early stages of Legionella pneumophila infection of Drosophila S2 cells. We found that the density of mitochondria near vacuoles formed by infection with wild type Legionella was not different from that found in dotA(-) mutant-infected cells during the first 4 hours after infection. We then examined 4 parameters of mitochondrial motility in infected cells: velocity of movement, duty cycle of movement, directional persistence and net direction. In the 4 hours following infection, most of these measures were indistinguishable between wild type and dotA(-) infection. However, wild type Legionella did induce a modest shift in the velocity distribution toward faster movement compared dotA(-) infection, and a small downward shift in the duty cycle distribution. In addition, wild type infection produced mitochondrial movement that was biased in the direction of the bacterial vacuole relative to dotA-, although not enough to cause a significant accumulation within 10 um of the vacuole. We conclude that in this host cell, mitochondria are not strongly recruited to the vacuole, nor is their motility dramatically affected.	[Sun, Elizabeth Wen; Wagner, Monica L.; Maize, Amanda; Kemler, Doris; Garland-Kuntz, Elisabeth; Xu, Li; Luo, Zhao-Qing; Hollenbeck, Peter J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hollenbeck, PJ (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	phollenb@purdue.edu		Luo, Zhao-Qing/0000-0001-8890-6621; Wagner, Monica/0000-0002-8776-8033	NIH [K02 A2085403, R21 A2092043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI085403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants to ZQL (K02 A2085403 and R21 A2092043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AbuKwaik Y, 1996, APPL ENVIRON MICROB, V62, P2022, DOI 10.1128/AEM.62.6.2022-2028.1996; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Ayres JS, 2006, TRENDS MICROBIOL, V14, P101, DOI 10.1016/j.tim.2006.01.008; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Chong A, 2009, INFECT IMMUN, V77, P4724, DOI 10.1128/IAI.00150-09; Coers J, 1999, NAT CELL BIOL, V1, P451, DOI 10.1038/15687; Degtyar E, 2009, CELL MICROBIOL, V11, P1219, DOI 10.1111/j.1462-5822.2009.01328.x; Dolezal P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002459; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Francione L, 2009, DIS MODEL MECH, V2, P479, DOI 10.1242/dmm.003319; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Jain P, 2011, P NATL ACAD SCI USA, V108, P16032, DOI 10.1073/pnas.1105175108; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; Luo ZQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00036; MUDER RR, 1986, ARCH INTERN MED, V146, P1607, DOI 10.1001/archinte.146.8.1607; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Segal G, 1999, INFECT IMMUN, V67, P2117, DOI 10.1128/IAI.67.5.2117-2124.1999; Shin S, 2008, CELL MICROBIOL, V10, P1209, DOI 10.1111/j.1462-5822.2008.01145.x; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tilney LG, 2001, J CELL SCI, V114, P4637; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	37	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62972	10.1371/journal.pone.0062972	http://dx.doi.org/10.1371/journal.pone.0062972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638172	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300119
J	Ma, WP; Sun, XD; Song, YY; Tao, FF; Feng, W; He, Y; Zhao, NQ; Yuan, ZA				Ma, Weiping; Sun, Xiaodong; Song, Yanyan; Tao, Fangfang; Feng, Wei; He, Yi; Zhao, Naiqing; Yuan, Zhengan			Applied Mixed Generalized Additive Model to Assess the Effect of Temperature on the Incidence of Bacillary Dysentery and Its Forecast	PLOS ONE			English	Article							TIME-SERIES; CLIMATE VARIATIONS; AIR-POLLUTION; CHINA; MORTALITY; DISEASE; REGRESSION; DIARRHEA; NORTHERN; CITIES	Background: Association between bacillary dysentery (BD) disease and temperature has been reported in some studies applying Poisson regression model, however the effect estimation might be biased due to the data autocorrelation. Furthermore the temperature effect distributed in the time of different lags has not been studied either. The purpose of this work was to obtaining the association between the BD counts and the climatic factors such as temperature in the form of the weighted averages, concerning the autocorrelation pattern of the model residuals, and to make short term predictions using the model. The data was collected in the city of Shanghai from 2004 to 2008. Methods: We used mixed generalized additive model (MGAM) to analyze data on bacillary dysentery, temperature and other covariates with autoregressive random effect. Short term predictions were made using MGAM with the moving average of the BD counts. Main Results: Our results showed that temperature was significant linearly associated with the logarithm of BD count for temperature in the range from 12 degrees C to 22 degrees C. Optimal weights in the temperature effect have been obtained, in which the one of 1-day-lag was close to 0, and the one of 2-days-lag was the maximum (p-value of the difference was less than 0.05). The predictive model was showing good fitness on the internal data with R 2 value 0.875, and the good short term prediction effect on the external data with correlation coefficient to be 0.859. Conclusion: According to the model estimation, corresponding Risk Ratio to affect BD was close to 1.1 when temperature effect goes up for 1 degrees C in the range from 12 degrees C to 22 degrees C. And the 1-day incubation period could be inferred from the model estimation. Good prediction has been made using the predictive MGAM.	[Ma, Weiping; Zhao, Naiqing] Fudan Univ, Sch Publ Hlth, Dept Biostat & Social Med, Shanghai 200433, Peoples R China; [Sun, Xiaodong; Tao, Fangfang; Feng, Wei; He, Yi; Yuan, Zhengan] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Song, Yanyan] Jiao Tong Univ, Coll Basic Med Sci, Dept Biostat, Shanghai 200030, Peoples R China	Fudan University; Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University	Zhao, NQ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Biostat & Social Med, Shanghai 200433, Peoples R China.	nqzhao@fudan.edu.cn; zayuan@scdc.sh.cn			National Natural Science Foundation of China [30972551, 81273187]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the projects 30972551 and 81273187 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin MA, 2003, J AM STAT ASSOC, V98, P214, DOI 10.1198/016214503388619238; Bettaieb J, 2010, Arch Inst Pasteur Tunis, V87, P25; Carson C, 2006, AM J EPIDEMIOL, V164, P77, DOI 10.1093/aje/kwj147; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Cheng YX, 2012, J EPIDEMIOL, V22, P28, DOI 10.2188/jea.JE20110049; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Guan P, 2008, JPN J INFECT DIS, V61, P356; Hall GV, 2002, MED J AUSTRALIA, V177, P614, DOI 10.5694/j.1326-5377.2002.tb04984.x; Hastie TJ, 1990, GEN ADDITIVE MODELS, P308; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; Kumar Rajesh, 2010, Indian J Public Health, V54, P98, DOI 10.4103/0019-557X.73278; Lama JR, 2004, J HEALTH POPUL NUTR, V22, P399; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Niyogi SK, 2005, J MICROBIOL, V43, P133; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Tong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037500; Yang L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-165; Zhang Jin-Yan, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P139; Zhang Y, 2008, PUBLIC HEALTH REP, V123, P61, DOI 10.1177/003335490812300109; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002; Zhang Y, 2012, J ENVIRON MONITOR, V14, P510, DOI 10.1039/c1em10391a; Zhao QG, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-2	23	35	37	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62122	10.1371/journal.pone.0062122	http://dx.doi.org/10.1371/journal.pone.0062122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637978	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800026
J	Zhou, HL; Chen, M; Zhao, DW				Zhou, Heling; Chen, Min; Zhao, Dawen			Longitudinal MRI Evaluation of Intracranial Development and Vascular Characteristics of Breast Cancer Brain Metastases in a Mouse Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR BARRIER PERMEABILITY; CEREBRAL BLOOD-VOLUME; IN-VIVO; CONTRAST; GLIOMAS; NEOPLASMS; DELIVERY; GRADE; STEPS	Longitudinal MRI was applied to monitor intracranial initiation and development of brain metastases and assess tumor vascular volume and permeability in a mouse model of breast cancer brain metastases. Using a 9.4T system, high resolution anatomic MRI and dynamic susceptibility contrast (DSC) perfusion MRI were acquired at different time points after an intracardiac injection of brain-tropic breast cancer MDA-MB231BR-EGFP cells. Three weeks post injection, multifocal brain metastases were first observed with hyperintensity on T-2-weighted images, but isointensity on T-1-weighted post contrast images, indicating that blood-tumor-barrier (BTB) at early stage of brain metastases was impermeable. Follow-up MRI revealed intracranial tumor growth and increased number of metastases that distributed throughout the whole brain. At the last scan on week 5, T-1-weighted post contrast images detected BTB disruption in 160 (34%) of a total of 464 brain metastases. Enhancement in some of the metastases was only seen in partial regions of the tumor, suggesting intratumoral heterogeneity of BTB disruption. DSC MRI measurements of relative cerebral blood volume (rCBV) showed that rCBV of brain metastases was significantly lower (mean = 0.89 +/- 0.03) than that of contralateral normal brain (mean = 1.00 +/- 0.03; p, 0.005). Intriguingly, longitudinal measurements revealed that rCBV of individual metastases at early stage was similar to, but became significantly lower than that of contralateral normal brain with tumor growth (p < 0.05). The rCBV data were concordant with histological analysis of microvascular density (MVD). Moreover, comprehensive analysis suggested no significant correlation among tumor size, rCBV and BTB permeability. In conclusion, longitudinal MRI provides non-invasive in vivo assessments of spatial and temporal development of brain metastases and their vascular volume and permeability. The characteristic rCBV of brain metastases may have a diagnostic value.	[Zhou, Heling; Zhao, Dawen] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Chen, Min] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhao, DW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.	Dawen.Zhao@UTSouthwestern.edu		Chen, Min/0000-0002-0676-3143	DOD IDEA Award [W81XWH-08-1-0583, W81XWH-12-1-0317]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584, S10RR025648] Funding Source: NIH RePORTER	DOD IDEA Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the DOD IDEA Awards W81XWH-08-1-0583 and W81XWH-12-1-0317. MRI experiments were performed in the Advanced Imaging Research Center, an NIH BTRP # P41-RR02584 facility, and ultrasound-guided intracardiac injection was performed with VisualSonics Vevo 770 under 1S10RR02564801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Bendell JC, 2003, CANCER-AM CANCER SOC, V97, P2972, DOI 10.1002/cncr.11436; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Cha S, 2003, MAGNET RESON MED, V49, P848, DOI 10.1002/mrm.10446; Danchaivijitr N, 2008, RADIOLOGY, V247, P170, DOI 10.1148/radiol.2471062089; Doolittle ND, 2005, CLIN CANCER RES, V11, P421; Eichler AF, 2011, NAT REV CLIN ONCOL; Fidler IJ, 2002, LANCET ONCOL, V3, P53, DOI 10.1016/S1470-2045(01)00622-2; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson G, 2004, MAGN RESON MED, V51, P961, DOI 10.1002/mrm.20049; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Knopp EA, 1999, RADIOLOGY, V211, P791, DOI 10.1148/radiology.211.3.r99jn46791; Kosaka N, 2007, INVEST RADIOL, V42, P629, DOI 10.1097/RLI.0b013e318059ae69; Kusters B, 2002, CANCER RES, V62, P341; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Melisko ME, 2008, J NEURO-ONCOL, V88, P359, DOI 10.1007/s11060-008-9578-5; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Peereboom DM, 2005, NEUROSURGERY, V57, P54, DOI 10.1227/01.NEU.0000182740.39014.9A; Percy DB, 2011, INVEST RADIOL, V46, P718, DOI 10.1097/RLI.0b013e318226c427; ROSEN BR, 1991, MAGNET RESON MED, V22, P293, DOI 10.1002/mrm.1910220227; Schouten LJ, 2002, CANCER, V94, P2698, DOI 10.1002/cncr.10541; Song HT, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-88; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Subramanian A, 2002, LANCET ONCOL, V3, P498, DOI 10.1016/S1470-2045(02)00819-7; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; VILLRINGER A, 1988, MAGNET RESON MED, V6, P164, DOI 10.1002/mrm.1910060205; Wong EC, 1998, MAGNET RESON MED, V40, P348, DOI 10.1002/mrm.1910400303; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; ZHANG RD, 1992, AM J PATHOL, V141, P1115	35	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62238	10.1371/journal.pone.0062238	http://dx.doi.org/10.1371/journal.pone.0062238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638013	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800032
J	Chang, TJ; Qi, C; Meng, J; Zhang, N; Bing, T; Yang, XD; Cao, ZH; Shangguan, D				Chang, Tianjun; Qi, Cui; Meng, Jie; Zhang, Nan; Bing, Tao; Yang, Xianda; Cao, Zehui; Shangguan, Dihua			General Cell-Binding Activity of Intramolecular G-Quadruplexes with Parallel Structure	PLOS ONE			English	Article							ANTIPROLIFERATIVE ACTIVITY; NUCLEASE RESISTANCE; PROMOTER REGION; FORMING REGION; DNA; NUCLEOLIN; APTAMERS; SURFACE; IDENTIFICATION; RECOGNITION	G-quadruplexes (G4s) are four-stranded nucleic acid structures adopted by some repetitive guanine-rich sequences. Putative G-quadruplex-forming sequences (PQSs) are highly prevalent in human genome. Recently some G4s have been reported to have cancer-selective antiproliferative activity. A G4 DNA, AS1411, is currently in phase II clinical trials as an anticancer agent, which is reported to bind tumor cells by targeting surface nucleolin. AS1411 also has been extensively investigated as a target-recognition element for cancer cell specific drug delivery or cancer cell imaging. Here we show that, in addition to AS1411, intramolecular G4s with parallel structure (including PQSs in genes) have general binding activity to many cell lines with different affinity. The binding of these G4s compete with each other, and their targets are certain cellular surface proteins. The tested G4s exhibit enhanced cellular uptake than non-G4 sequences. This uptake may be through the endosome/lysosome pathway, but it is independent of cellular binding of the G4s. The tested G4s also show selective antiproliferative activity that is independent of their cellular binding. Our findings provide new insight into the molecular recognition of G4s by cells; offer new clues for understanding the functions of G4s in vivo, and may extend the potential applications of G4s.	[Chang, Tianjun; Qi, Cui; Zhang, Nan; Bing, Tao; Cao, Zehui; Shangguan, Dihua] Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing Natl Lab Mol Sci, Beijing 100080, Peoples R China; [Meng, Jie; Yang, Xianda] Natl Ctr Nanosci & Technol, Beijing, Peoples R China; [Yang, Xianda] Chinese Acad Sci, Inst Basic Med Sci, Beijing 100080, Peoples R China; [Yang, Xianda] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shangguan, D (corresponding author), Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing Natl Lab Mol Sci, Beijing 100080, Peoples R China.	sgdh@iccas.ac.cn	Bing, Tao/F-3476-2017; Shangguan, Dihua/G-4530-2011; Bing, Tao/AAM-6162-2020; Chang, Tianjun/F-4460-2016	Bing, Tao/0000-0002-5121-053X; Shangguan, Dihua/0000-0002-5746-803X; Bing, Tao/0000-0002-5121-053X; Chang, Tianjun/0000-0003-2030-9868	Grant 973 Program [2011CB935800, 2011CB911000]; National Natural Science Foundation of China [21075124]	Grant 973 Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Grant 973 Program [2011CB935800, 2011CB911000]; and the National Natural Science Foundation of China [21075124]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Bing T, 2011, BIOORGAN MED CHEM, V19, P4211, DOI 10.1016/j.bmc.2011.05.061; Bishop JS, 1996, J BIOL CHEM, V271, P5698, DOI 10.1074/jbc.271.10.5698; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cao ZH, 2009, ANGEW CHEM INT EDIT, V48, P6494, DOI 10.1002/anie.200901452; Cao ZH, 2006, ANAL CHEM, V78, P1478, DOI 10.1021/ac0517601; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; Cheng XH, 2009, BIOCHEMISTRY-US, V48, P7817, DOI 10.1021/bi9006786; Cheng XH, 2009, BIOPOLYMERS, V91, P874, DOI 10.1002/bip.21272; Choi EW, 2010, NUCLEIC ACIDS RES, V38, P1623, DOI 10.1093/nar/gkp1088; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Dapic V, 2003, NUCLEIC ACIDS RES, V31, P2097, DOI 10.1093/nar/gkg316; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Hwang DW, 2010, J NUCL MED, V51, P98, DOI 10.2967/jnumed.109.069880; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lee JY, 2008, BIOCHEMISTRY-US, V47, P3389, DOI 10.1021/bi702013d; Li YF, 1996, BIOCHEMISTRY-US, V35, P6911, DOI 10.1021/bi960038h; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Miller MC, 2011, ORG BIOMOL CHEM, V9, P7633, DOI 10.1039/c1ob05891f; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Raddatz MSL, 2008, ANGEW CHEM INT EDIT, V47, P5190, DOI 10.1002/anie.200800216; Reyes-Reyes EM, 2008, EXP CELL RES, V314, P2212, DOI 10.1016/j.yexcr.2008.03.016; Reyes-Reyes EM, 2010, CANCER RES, V70, P8617, DOI 10.1158/0008-5472.CAN-10-0920; Shangguan DH, 2007, CLIN CHEM, V53, P1153, DOI 10.1373/clinchem.2006.083246; Shangguan D, 2007, CHEMBIOCHEM, V8, P603, DOI 10.1002/cbic.200600532; Shieh YA, 2010, ACS NANO, V4, P1433, DOI 10.1021/nn901374b; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Yu ZB, 2009, J AM CHEM SOC, V131, P1876, DOI 10.1021/ja806782s; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k	46	28	32	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62348	10.1371/journal.pone.0062348	http://dx.doi.org/10.1371/journal.pone.0062348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638046	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700051
J	Hwang, JH; Hsu, CJ; Yu, WH; Liu, TC; Yang, WS				Hwang, Juen-Haur; Hsu, Chuan-Jen; Yu, Wei-Hsuan; Liu, Tien-Chen; Yang, Wei-Shiung			Diet-Induced Obesity Exacerbates Auditory Degeneration via Hypoxia, Inflammation, and Apoptosis Signaling Pathways in CD/1 Mice	PLOS ONE			English	Article							BODY-MASS INDEX; HEARING IMPAIRMENT; CELL-DEATH; MODEL; RISK; ASSOCIATION; GENE; DYSFUNCTION; MECHANISMS; MOUSE	The aim of this study was to investigate the mechanisms of diet-induced obesity on hearing degeneration in CD/1 mice. Sixty 4-week-old male CD/1 mice were randomly and equally divided into 2 groups. For 16 weeks, the diet-induced obesity (DIO) group was fed a high fat diet and the control group was fed a standard diet of 13.43 % kcal fat. The morphometry, biochemistry, auditory brainstem response thresholds, omental fat, and histopathology of the cochlea were compared between the beginning and end of the study (4 vs. 20 weeks old). The results show that the body weight, fasting plasma triglyceride concentrations, and omental fat weight were higher in the DIO group than in the control group at the end of experiment. The auditory brainstem response thresholds at high frequencies were significantly elevated in the DIO group compared to those of the control group. Histology studies showed that, compared to the control group, the DIO group had blood vessels with smaller diameters and thicker walls in the stria vascularis at the middle and basal turns of the cochlea. The cell densities in the spiral ganglion and spiral ligament at the basal turn of the cochlea were significantly lower in the DIO group. Immunohistochemical staining showed that hypoxia-induced factor 1 (HIF-1), tumor necrosis factor alpha (TNF-alpha), nuclear factor kappa B (NF-kappa B), caspase 3, poly(ADP-ribose) polymerase-1, and apoptosis inducing factor were all significantly more dense in the spiral ganglion and spiral ligament at the basal turn of cochlea in the DIO group. Our results suggest that diet-induced obesity exacerbates hearing degeneration via increased hypoxia, inflammatory responses, and cell loss in the spiral ganglion and spiral ligament and is associated with the activation of both caspase-dependent and - independent apoptosis signaling pathways in CD/1 mice.	[Hwang, Juen-Haur; Yang, Wei-Shiung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Hwang, Juen-Haur] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Hwang, Juen-Haur] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hsu, Chuan-Jen; Liu, Tien-Chen] Natl Taiwan Univ, Dept Otolaryngol, Hosp Taipei, Taipei 10764, Taiwan; [Yu, Wei-Hsuan] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10764, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Dept Internal Med, Hosp Taipei, Taipei 10764, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	National Taiwan University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; National Taiwan University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University; Taipei Medical University Hospital; National Taiwan University	Liu, TC (corresponding author), Natl Taiwan Univ, Dept Otolaryngol, Hosp Taipei, Taipei 10764, Taiwan.	liuent@ntu.edu.tw; wsyang@ntu.edu.tw	Yu, Wei Hsuan/AAF-7129-2021	YANG, WEI-SHIUNG/0000-0001-5087-373X; YU, WEI-HSUAN/0000-0002-1782-3738	Buddhist Dalin Tzu Chi General Hospital [DTCRD-98 (2)-03]	Buddhist Dalin Tzu Chi General Hospital	This project was supported by grant DTCRD-98 (2)-03 from the Buddhist Dalin Tzu Chi General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho BB, 2008, J INVEST SURG, V21, P141, DOI 10.1080/08941930802029945; Chou CL, 2010, TZU CHI MED J, V22, P11, DOI 10.1016/S1016-3190(10)60029-8; Chung SH, 2011, NEUROBIOL DIS, V41, P445, DOI 10.1016/j.nbd.2010.10.016; COHEN AH, 1975, AM J PATHOL, V81, P117; Cottet S, 2009, CURR MOL MED, V9, P375, DOI 10.2174/156652409787847155; Engel T, 2010, J NEUROCHEM, V115, P92, DOI 10.1111/j.1471-4159.2010.06909.x; Evans MB, 2006, OTOL NEUROTOL, V27, P609, DOI 10.1097/01.mao.0000226286.19295.34; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Friedland DR, 2009, LARYNGOSCOPE, V119, P473, DOI 10.1002/lary.20130; Frisina ST, 2006, HEARING RES, V211, P103, DOI 10.1016/j.heares.2005.09.002; Hidaka T, 1997, Nihon Jibiinkoka Gakkai Kaiho, V100, P900; Hwang JH, 2011, AUDIOLOGY NEUROTOL E, V1, P1, DOI 10.1159/000329795; Hwang JH, 2011, CLIN ENDOCRINOL, V75, P614, DOI 10.1111/j.1365-2265.2011.04090.x; Hwang JH, 2011, OTOLARYNG HEAD NECK, V144, P114, DOI 10.1177/0194599810390859; Hwang JH, 2009, OBESITY, V17, P1796, DOI 10.1038/oby.2009.66; Jackson AW, 2010, OBESITY, V18, P1988, DOI 10.1038/oby.2009.422; Kabrhel C, 2009, OBESITY, V17, P2040, DOI 10.1038/oby.2009.92; Lee HS, 2008, CLIN EXP OTORHINOLAR, V1, P211, DOI 10.3342/ceo.2008.1.4.211; Lin YH, 2011, LARYNGOSCOPE, V121, P1303, DOI 10.1002/lary.21771; Lin YS, 2011, J CLIN INVEST, V121, P1519, DOI 10.1172/JCI43220; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Madsen AN, 2010, J ENDOCRINOL, V206, P287, DOI 10.1677/JOE-10-0004; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; McQueen CT, 1999, J LARYNGOL OTOL, V113, P13, DOI 10.1017/S0022215100143051; Mittra S, 2008, DRUG DISCOV TODAY, V13, P211, DOI 10.1016/j.drudis.2008.01.006; Mizukoshi S, 2010, EXP EYE RES, V91, P353, DOI 10.1016/j.exer.2010.06.004; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Park SY, 2010, CELL MOL BIOL LETT, V15, P1, DOI 10.2478/s11658-009-0030-4; Reynolds K, 2007, AM J KIDNEY DIS, V50, P754, DOI 10.1053/j.ajkd.2007.08.011; Riva C, 2007, EXP GERONTOL, V42, P327, DOI 10.1016/j.exger.2006.10.014; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schulz JB, 2006, J NEURAL TRANSM-SUPP, P467; SHONE G, 1991, HEARING RES, V57, P153, DOI 10.1016/0378-5955(91)90084-M; SIKORA MA, 1986, ACTA OTO-LARYNGOL, V102, P372, DOI 10.3109/00016488609119420; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Vasilyeva ON, 2009, HEARING RES, V249, P44, DOI 10.1016/j.heares.2009.01.007; Wu T, 2003, JARO-J ASSOC RES OTO, V4, P353, DOI 10.1007/s10162-002-3026-6; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	39	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e60730	10.1371/journal.pone.0060730	http://dx.doi.org/10.1371/journal.pone.0060730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637762	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700006
J	Suarez, ALP; Lorenzetti, MA; Lucano, RG; Cohen, M; Gass, H; Vazquez, PM; Gonzalez, P; Preciado, MV; Chabay, P				Pereira Suarez, Ana Laura; Alejandro Lorenzetti, Mario; Gonzalez Lucano, Rene; Cohen, Melina; Gass, Hugo; Martinez Vazquez, Paula; Gonzalez, Pedro; Preciado, Maria V.; Chabay, Paola			Presence of Human Papilloma Virus in a Series of Breast Carcinoma from Argentina	PLOS ONE			English	Article							NO EVIDENCE; CANCER; HPV; DNA; PREVALENCE; ASSOCIATION; E6; INFECTIONS; SEQUENCES; PRECANCER	Background: The etiology and the molecular mechanisms related to breast carcinogenesis remain poorly understood. Some recent reports have examined the role of Human Papillomavirus (HPV) in this disease. The purpose of this study was to determine the prevalence of HPV in breast cancer. Methods: Sixty one fresh frozen breast cancers samples were analyzed. Samples were tested for HPV by PCR, and products were automatically sequenced. Findings were correlated with clinical and pathological characteristics. Results: The HPV DNA prevalence in the breast cancer samples was 26% (16/61). Clinical parameters were not statistically associated with HPV presence (p>0.05 chi(2) test). Sequence analysis in a subgroup of cases indicates the prevalence of low risk HPV11, followed by high risk HPV16. We found no HPV transcriptional activity. Conclusion: The present study demonstrated for the first time in Argentina the presence of HPV in a proportion of the malignant breast tissues. This finding suggests that HPV may have a biological significance in breast carcinogenesis.	[Pereira Suarez, Ana Laura; Gonzalez Lucano, Rene] Univ Guadalajara, Univ Ctr Hlth Sci, Dept Physiol, Guadalajara 44430, Jalisco, Mexico; [Alejandro Lorenzetti, Mario; Cohen, Melina; Preciado, Maria V.; Chabay, Paola] Ricardo Gutierrez Children Hosp, Div Pathol, Mol Biol Lab, Buenos Aires, DF, Argentina; [Gass, Hugo; Martinez Vazquez, Paula] Magdalena Villegas Martinez Hosp, Ginecol Div, Tigre, Buenos Aires, Argentina; [Gonzalez, Pedro] Magdalena Villegas Martinez Hosp, Div Pathol, Tigre, Buenos Aires, Argentina	Universidad de Guadalajara; Hospital de Ninos Doctor Ricardo Gutierrez	Chabay, P (corresponding author), Ricardo Gutierrez Children Hosp, Div Pathol, Mol Biol Lab, Buenos Aires, DF, Argentina.	paola_chabay@yahoo.com.ar	Lorenzetti, Mario Alejandro/O-8976-2019	Lorenzetti, Mario Alejandro/0000-0002-9434-399X; Gonzalez Lucano, Luis Renee/0000-0002-9435-7283; Preciado, Maria Victoria/0000-0003-4082-0698; Pereira, Ana Laura/0000-0002-6310-3715	National Agency for Science and Technology Promotion (PICT) [1071]; National Ministry of Science - Conacty [Mex 0717]	National Agency for Science and Technology Promotion (PICT)(ANPCyT); National Ministry of Science - Conacty	This study was supported in part by a grant from National Agency for Science and Technology Promotion (PICT 2007 no1071), and a grant from National Ministry of Science - Conacty (Mex 0717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo F, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-7; Amarante MK, 2009, J CANCER RES CLIN, V135, P329, DOI 10.1007/s00432-008-0511-2; [Anonymous], 2000, SIST UN INF VIG EP D; Antonsson A, 2011, J MED VIROL, V83, P2157, DOI 10.1002/jmv.22223; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Broccolo F, 2013, J MED VIROL, V85, P472, DOI 10.1002/jmv.23487; de Leon DC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-26; Ciapponi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025493; Damin APS, 2004, BREAST CANCER RES TR, V84, P131, DOI 10.1023/B:BREA.0000018411.89667.0d; de Villiers EM, 2005, BREAST CANCER RES, V7, pR1, DOI 10.1186/bcr940; Frega A, 2012, EUR J GYNAECOL ONCOL, V33, P164; Gao G, 2013, INT J CANCER, V132, P882, DOI 10.1002/ijc.27739; Glenn WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048788; Hachana M, 2010, BREAST, V19, P541, DOI 10.1016/j.breast.2010.05.007; Hansen BT, 2012, BRIT J CANCER, V107, P1451, DOI 10.1038/bjc.2012.438; Hedau S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-27; Heng B, 2009, BRIT J CANCER, V101, P1345, DOI 10.1038/sj.bjc.6605282; Herrera-Goepfert R, 2011, BREAST, V20, P184, DOI 10.1016/j.breast.2010.11.006; Kan CY, 2005, BRIT J CANCER, V93, P946, DOI 10.1038/sj.bjc.6602778; Khan NA, 2008, BRIT J CANCER, V99, P408, DOI 10.1038/sj.bjc.6604502; Kroupis C, 2006, CLIN BIOCHEM, V39, P727, DOI 10.1016/j.clinbiochem.2006.03.005; Lawson JS, 2009, BRIT J CANCER, V101, P1351, DOI 10.1038/sj.bjc.6605328; Li N, 2011, BREAST CANCER RES TR, V126, P515, DOI 10.1007/s10549-010-1128-0; Lorenzetti MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013603; Maria Viniegra, 2010, CANC MAMA ARGENTINA, P141; Mendizabal-Ruiz AP, 2009, BREAST CANCER RES TR, V114, P189, DOI 10.1007/s10549-008-9989-1; Mou X, 2011, J INT MED RES, V39, P1636, DOI 10.1177/147323001103900506; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Sigaroodi A, 2012, SCI WORLD J, P1, DOI 10.1100/2012/837191; Silva RG, 2011, BREAST CANCER RES TR, V125, P261, DOI 10.1007/s10549-010-1129-z; Simoes PW, 2012, INT J GYNECOL CANCER, V22, P343, DOI 10.1097/IGC.0b013e31823c712e; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]; Tinelli A, 2009, CURR PHARM BIOTECHNO, V10, P767, DOI 10.2174/138920109789978739; WAZER DE, 1995, P NATL ACAD SCI USA, V92, P3687, DOI 10.1073/pnas.92.9.3687; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61613	10.1371/journal.pone.0061613	http://dx.doi.org/10.1371/journal.pone.0061613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637866	Green Submitted, gold, Green Published			2022-12-25	WOS:000318341400017
J	Rathnayake, N; Akerman, S; Klinge, B; Lundegren, N; Jansson, H; Tryselius, Y; Sorsa, T; Gustafsson, A				Rathnayake, Nilminie; Akerman, Sigvard; Klinge, Bjorn; Lundegren, Nina; Jansson, Henrik; Tryselius, Ylva; Sorsa, Timo; Gustafsson, Anders			Salivary Biomarkers for Detection of Systemic Diseases	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-8 CONCENTRATIONS; PERIODONTAL-DISEASE; ORAL-HEALTH; DIABETES-MELLITUS; ADULT-POPULATION; MMP-8; ATHEROSCLEROSIS; EXPRESSION; MARKERS; SERUM	Background and Objective: Analysis of inflammatory biomarkers in saliva could offer an attractive opportunity for the diagnosis of different systemic conditions specifically in epidemiological surveys. The aim of this study was to investigate if certain salivary biomarkers could be used for detection of common systemic diseases. Materials and Methods: A randomly selected sample of 1000 adults living in Skane, a county in the southern part of Sweden, was invited to participate in a clinical study of oral health. 451 individuals were enrolled in this investigation, 51% women. All participants were asked to fill out a questionnaire, history was taken, a clinical examination was made and stimulated saliva samples were collected. Salivary concentrations of IL-1 beta, -6, -8, TNF-alpha, lysozyme, MMP-8 and TIMP-1 were determined using ELISA, IFMA or Luminex assays. Results: Salivary IL-8 concentration was found to be twice as high in subjects who had experience of tumour diseases. In addition, IL-8 levels were also elevated in patients with bowel disease. MMP-8 levels were elevated in saliva from patients after cardiac surgery or suffering from diabetes, and muscle and joint diseases. The levels of IL-1 beta, IL-8 and MMP-8, as well as the MMP-8/TIMP-1 ratio were higher in subjects with muscle and joint diseases. Conclusion: Biomarkers in saliva have the potential to be used for screening purposes in epidemiological studies. The relatively unspecific inflammatory markers used in this study can not be used for diagnosis of specific diseases but can be seen as markers for increased systemic inflammation.	[Rathnayake, Nilminie; Klinge, Bjorn; Tryselius, Ylva; Gustafsson, Anders] Karolinska Inst, Div Periodontol, Dept Dent Med, Stockholm, Sweden; [Akerman, Sigvard; Lundegren, Nina] Malmo Univ, Fac Odontol, Dept Oral Diagnost, Malmo, Sweden; [Klinge, Bjorn; Jansson, Henrik] Malmo Univ, Fac Odontol, Dept Periodontol, Malmo, Sweden; [Sorsa, Timo] Univ Helsinki, Helsinki Univ Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland	Karolinska Institutet; Malmo University; Malmo University; University of Helsinki; Helsinki University Central Hospital	Rathnayake, N (corresponding author), Karolinska Inst, Div Periodontol, Dept Dent Med, Stockholm, Sweden.	Nilminie.Rathnayake@ki.se	Klinge, Bjorn/ABA-7045-2021	Klinge, Bjorn/0000-0003-2100-2446	Regional Board of Dental Public Health in the county of Skane, Sweden; Swedish National Graduate School in Odontological Science; Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Stockholm, Sweden; Academy of Finland; Helsinki University Central Hospital Research Foundation	Regional Board of Dental Public Health in the county of Skane, Sweden; Swedish National Graduate School in Odontological Science; Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Stockholm, Sweden; Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Foundation	The study was initiated and financially supported by the Regional Board of Dental Public Health in the county of Skane, Sweden. The study was also supported by the Swedish National Graduate School in Odontological Science, the Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Stockholm, Sweden, and Academy of Finland and Helsinki University Central Hospital Research Foundation. Timo Sorsa is inventor of US-Patents 5652227, 5866432 and 6143476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Berg G, 2011, CLIN CHIM ACTA, V412, P1731, DOI 10.1016/j.cca.2011.06.013; BEUTLER B, 1990, HOSP PRACT, V25, P45; BOYLE JO, 1994, AM J SURG, V168, P429, DOI 10.1016/S0002-9610(05)80092-3; Cavusoglu E, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.029; Djuric T, 2010, J CLIN LAB ANAL, V24, P246, DOI 10.1002/jcla.20393; Dowd F J, 1999, Dent Clin North Am, V43, P579; FOX PC, 1993, ANN NY ACAD SCI, V694, P234, DOI 10.1111/j.1749-6632.1993.tb18356.x; Gursoy UK, 2011, DIS MARKERS, V30, P299, DOI [10.3233/DMA-2011-0788, 10.1155/2011/621484]; Gursoy UK, 2010, J CLIN PERIODONTOL, V37, P487, DOI 10.1111/j.1600-051X.2010.01563.x; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hardy DC, 2012, J CLIN PERIODONTOL, V39, P249, DOI 10.1111/j.1600-051X.2011.01788.x; Hojo Y, 2001, JPN CIRC J, V65, P71, DOI 10.1253/jcj.65.71; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Kardesler L, 2010, ORAL DIS, V16, P476, DOI 10.1111/j.1601-0825.2010.01659.x; Kato R, 2005, CIRC J, V69, P1035, DOI 10.1253/circj.69.1035; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kaufman E, 2000, J CLIN PERIODONTOL, V27, P453, DOI 10.1034/j.1600-051x.2000.027007453.x; Kaushik R, 2011, J PERIODONTOL, V82, P1353, DOI 10.1902/jop.2011.100472; Kinney JS, 2011, J DENT RES, V90, P752, DOI 10.1177/0022034511399908; Kozak KR, 2005, PROTEOMICS, V5, P4589, DOI 10.1002/pmic.200500093; Lee KD, 2011, ANTICANCER RES, V31, P1161; Lee YH, 2009, AM J DENT, V22, P241; Lundegren N, 2012, ACTA ODONTOL SCAND, V70, P511, DOI 10.3109/00016357.2011.640279; Lundegren N, 2011, SWED DENT J, V35, P89; Chavarry NGM, 2009, ORAL HLTH PREV DENT, V7, P107; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Mirrielees J, 2010, J CLIN PERIODONTOL, V37, P1068, DOI 10.1111/j.1600-051X.2010.01625.x; Nibali L, 2012, ORAL DIS, V18, P236, DOI 10.1111/j.1601-0825.2011.01867.x; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Pradhan-Palikhe P, 2010, SCAND J IMMUNOL, V72, P150, DOI 10.1111/j.1365-3083.2010.02418.x; Punyani SR, 2012, CLIN ORAL INVESTIG; Pussinen PJ, 2013, INT J CARDIOL, V167, P362, DOI 10.1016/j.ijcard.2011.12.095; Qvarnstrom M, 2008, J DENT RES, V87, P480, DOI 10.1177/154405910808700507; Qvarnstrom M, 2010, J CLIN PERIODONTOL, V37, P805, DOI 10.1111/j.1600-051X.2010.01605.x; Rao PV, 2009, J PROTEOME RES, V8, P239, DOI 10.1021/pr8003776; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Seymour GJ, 2001, ACTA ODONTOL SCAND, V59, P167, DOI 10.1080/000163501750266765; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sodek J, 1992, Matrix Suppl, V1, P352; Sorsa T, 2010, ORAL DIS, V16, P39, DOI 10.1111/j.1601-0825.2009.01603.x; Sorsa T, 2011, PHARMACOL RES, V63, P108, DOI 10.1016/j.phrs.2010.10.005; Tchetverikov I, 2004, ANN RHEUM DIS, V63, P881, DOI 10.1136/ard.2003.013243; Tonetti MS, 2009, J CLIN PERIODONTOL, V36, P15, DOI 10.1111/j.1600-051X.2009.01417.x; Tuomainen AM, 2007, ARTERIOSCL THROM VAS, V27, P2722, DOI 10.1161/ATVBAHA.107.154831; UDALL JN, 1984, BIOL NEONATE, V45, P289, DOI 10.1159/000242019; Virkler K, 2009, FORENSIC SCI INT, V188, P1, DOI 10.1016/j.forsciint.2009.02.013; Wagsater D, 2011, INT J MOL MED, V28, P247, DOI 10.3892/ijmm.2011.693; Wei F, 2009, CLIN CANCER RES, V15, P4446, DOI 10.1158/1078-0432.CCR-09-0050; Wong DT, 2006, J AM DENT ASSOC, V137, P313, DOI 10.14219/jada.archive.2006.0180; Yoon AJ, 2012, J CLIN PERIODONTOL, V39, P434, DOI 10.1111/j.1600-051X.2012.01866.x; Zhang L, 2010, PLOS ONE, V5, P1	54	96	102	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61356	10.1371/journal.pone.0061356	http://dx.doi.org/10.1371/journal.pone.0061356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637817	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400016
J	Vergetaki, A; Jeschke, U; Vrekoussis, T; Taliouri, E; Sabatini, L; Papakonstanti, EA; Makrigiannakis, A				Vergetaki, Aikaterini; Jeschke, Udo; Vrekoussis, Thomas; Taliouri, Eirini; Sabatini, Luca; Papakonstanti, Evangelia A.; Makrigiannakis, Antonis			Differential Expression of CRH, UCN, CRHR1 and CRHR2 in Eutopic and Ectopic Endometrium of Women with Endometriosis	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; UROCORTIN MESSENGER-RNA; IN-VITRO; STROMAL CELLS; RECEPTOR; IMPLANTATION; DECIDUALIZATION; PROGESTERONE; MECHANISMS; APOPTOSIS	Endometriosis is considered as a benign aseptic inflammatory disease, characterised by the presence of ectopic endometrium-like tissue. Its symptoms (mostly pain and infertility) are reported as constant stressors. Corticotropin releasing hormone (CRH) and urocortin (UCN) are neuropeptides, strongly related to stress and inflammation. The effects of CRH and UCN are mediated through CRHR1 and CRHR2 receptors which are implicated in several reproductive functions acting as inflammatory components. However, the involvement of these molecules to endometriosis remains unknown. The aim of this study was to examine the expression of CRHR1 and CRHR2 in endometriotic sites and to compare the expression of CRHR1 and CRHR2 in eutopic endometrium of endometriotic women to that of healthy women. We further compared the expression of CRH, UCN, CRHR1 and CRHR2 in ectopic endometrium to that in eutopic endometrium of women with endometriosis. Endometrial biopsy specimens were taken from healthy women (10 patients) and endometrial and endometriotic biopsy specimens were taken from women with endometriosis (16 patients). The expression of CRH, UCN, CRHR1, and CRHR2 was tested via RT-PCR, immunohistochemistry and Western blotting. This study shows for the first time that CRH and UCN receptor subtypes CRHR1 beta and CRHR2 alpha are expressed in endometriotic sites and that they are more strongly expressed (p<0.01) in eutopic endometrium of women with endometriosis compared to healthy women endometrium at the mRNA and protein level. CRH, UCN, CRHR1 and CRHR2 mRNA were also more highly expressed in ectopic rather than eutopic endometrium (CRH, UCN, CRHR2 alpha: p<0.01, CRHR1 beta: p<0.05) and protein (CRH and UCN: p<0.05, CRHR1 and CRHR2: p<0.01) in women with endometriosis. These data indicate that CRH and UCN might play an immunoregulatory role in endometriotic sites by affecting reproductive functions such as decidualization and implantation of women with endometriosis.	[Vergetaki, Aikaterini; Taliouri, Eirini; Makrigiannakis, Antonis] Univ Crete, Sch Med, Dept Obstet & Gynecol, Iraklion, Greece; [Jeschke, Udo; Vrekoussis, Thomas] Univ Munich, Dept Obstet & Gynecol, Munich, Germany; [Sabatini, Luca] St Bartholomews Hosp, Ctr Reprod Med, London, England; [Papakonstanti, Evangelia A.] Univ Crete, Sch Med, Dept Biochem, Iraklion, Greece	University of Crete; University of Munich; University of London; Queen Mary University London; University of Crete	Makrigiannakis, A (corresponding author), Univ Crete, Sch Med, Dept Obstet & Gynecol, Iraklion, Greece.	makrigia@med.uoc.gr	Jeschke, Udo/A-6643-2009	Jeschke, Udo/0000-0003-2623-3235; Makrigiannakis, Antonis/0000-0002-8475-1500; Papakonstanti, Evangelia/0000-0002-7119-6026	University Laboratory of Human Reproduction [KA 2920]; Research Committee of the University of Crete [KA 3001]	University Laboratory of Human Reproduction; Research Committee of the University of Crete	This work was supported by funding from the University Laboratory of Human Reproduction (KA 2920) (in the laboratory of A. M.) and by the Research Committee of the University of Crete (KA 3001) (in the laboratory of E. A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanassakis I, 1999, J ENDOCRINOL, V163, P221, DOI 10.1677/joe.0.1630221; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chrousos George P., 1998, Annals of Internal Medicine, V129, P229; Chrousos GP, 1999, AM J OBSTET GYNECOL, V180, pS249, DOI 10.1016/S0002-9378(99)70710-6; DiBlasio AM, 1997, J CLIN ENDOCR METAB, V82, P1594, DOI 10.1210/jc.82.5.1594; FERRARI A, 1995, J STEROID BIOCHEM, V54, P251, DOI 10.1016/0960-0760(95)00142-M; Florio P, 2002, J ENDOCRINOL, V173, pR9, DOI 10.1677/joe.0.173R009; Garcia-Velasco JA, 2002, FERTIL STERIL, V78, P855, DOI 10.1016/S0015-0282(02)03320-4; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Gravanis Achille, 2002, Hormones (Athens), V1, P139; Harada T, 2001, FERTIL STERIL, V76, P1, DOI 10.1016/S0015-0282(01)01816-7; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Kalantaridou SN, 2007, CRIT REV CL LAB SCI, V44, P461, DOI 10.1080/10408360701548468; KARALIS K, 1991, SCIENCE, V254, P421, DOI 10.1126/science.1925600; Karteris E, 2003, J CLIN ENDOCR METAB, V88, P363, DOI 10.1210/jc.2002-020375; Kempuraj D, 2004, AM J REPROD IMMUNOL, V52, P267, DOI 10.1111/j.1600-0897.2004.00224.x; Lima AP, 2006, BRAZ J MED BIOL RES, V39, P1121, DOI 10.1590/S0100-879X2006000800015; Makrigiannakis A, 1997, ANN NY ACAD SCI, V816, P116, DOI 10.1111/j.1749-6632.1997.tb52135.x; Makrigiannakis A, 2001, NAT IMMUNOL, V2, P1018, DOI 10.1038/ni719; MAKRIGIANNAKIS A, 1995, J CLIN ENDOCR METAB, V80, P185, DOI 10.1210/jc.80.1.185; Makrigiannakis A, 2003, BIOCHEM PHARMACOL, V65, P917, DOI 10.1016/S0006-2952(02)01547-2; MAKRIGIANNAKIS A, 1995, LIFE SCI, V57, P1869, DOI 10.1016/0024-3205(95)02167-H; Makrigiannakis A, 1996, NEUROENDOCRINOLOGY, V64, P85, DOI 10.1159/000127103; Makrigiannakis A, 1999, NEUROENDOCRINOLOGY, V70, P451, DOI 10.1159/000054507; Makrigiannakis A, 1999, MOL HUM REPROD, V5, P789, DOI 10.1093/molehr/5.9.789; Makrigiannakis A, 2006, TRENDS ENDOCRIN MET, V17, P178, DOI 10.1016/j.tem.2006.05.001; Mastorakos G, 1996, J CLIN ENDOCR METAB, V81, P1046, DOI 10.1210/jc.81.3.1046; Minas V, 2007, MOL HUM REPROD, V13, P663, DOI 10.1093/molehr/gam054; Minici F, 2007, GYNECOL ENDOCRINOL, V23, P574, DOI 10.1080/09513590701581721; Novembri R, 2011, J CLIN ENDOCR METAB, V96, P1145, DOI 10.1210/jc.2010-2263; PETRAGLIA F, 1992, J CLIN ENDOCR METAB, V74, P1427, DOI 10.1210/jc.74.6.1427; Pozzoli G, 1996, ENDOCRINOLOGY, V137, P65, DOI 10.1210/en.137.1.65; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Tariverdian N, 2010, J MOL MED, V88, P267, DOI 10.1007/s00109-009-0559-8; Torricelli M, 2007, HUM REPROD, V22, P92, DOI 10.1093/humrep/del331; Warren BN, 2001, FERTIL STERIL, V76, P223; Webster EL, 1996, ENDOCRINOLOGY, V137, P5747, DOI 10.1210/en.137.12.5747; Zoumakis E, 2000, MOL HUM REPROD, V6, P344, DOI 10.1093/molehr/6.4.344; Zoumakis E, 2010, EUR J ENDOCRINOL, V155, P58	40	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62313	10.1371/journal.pone.0062313	http://dx.doi.org/10.1371/journal.pone.0062313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638035	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400094
J	Dortel, E; Massiot-Granier, F; Rivot, E; Million, J; Hallier, JP; Morize, E; Munaron, JM; Bousquet, N; Chassot, E				Dortel, Emmanuelle; Massiot-Granier, Felix; Rivot, Etienne; Million, Julien; Hallier, Jean-Pierre; Morize, Eric; Munaron, Jean-Marie; Bousquet, Nicolas; Chassot, Emmanuel			Accounting for Age Uncertainty in Growth Modeling, the Case Study of Yellowfin Tuna (Thunnus albacares) of the Indian Ocean	PLOS ONE			English	Article							STOCK ASSESSMENT; OTOLITH MICROSTRUCTURE; INCREMENT FORMATION; TAG-RECAPTURE; HAKE; VALIDATION; MERLUCCIUS; CONSEQUENCES; LARVAL; RATES	Age estimates, typically determined by counting periodic growth increments in calcified structures of vertebrates, are the basis of population dynamics models used for managing exploited or threatened species. In fisheries research, the use of otolith growth rings as an indicator of fish age has increased considerably in recent decades. However, otolith readings include various sources of uncertainty. Current ageing methods, which converts an average count of rings into age, only provide periodic age estimates in which the range of uncertainty is fully ignored. In this study, we describe a hierarchical model for estimating individual ages from repeated otolith readings. The model was developed within a Bayesian framework to explicitly represent the sources of uncertainty associated with age estimation, to allow for individual variations and to include knowledge on parameters from expertise. The performance of the proposed model was examined through simulations, and then it was coupled to a two-stanza somatic growth model to evaluate the impact of the age estimation method on the age composition of commercial fisheries catches. We illustrate our approach using the saggital otoliths of yellowfin tuna of the Indian Ocean collected through large-scale mark-recapture experiments. The simulation performance suggested that the ageing error model was able to estimate the ageing biases and provide accurate age estimates, regardless of the age of the fish. Coupled with the growth model, this approach appeared suitable for modeling the growth of Indian Ocean yellowfin and is consistent with findings of previous studies. The simulations showed that the choice of the ageing method can strongly affect growth estimates with subsequent implications for age-structured data used as inputs for population models. Finally, our modeling approach revealed particularly useful to reflect uncertainty around age estimates into the process of growth estimation and it can be applied to any study relying on age estimation.	[Dortel, Emmanuelle; Hallier, Jean-Pierre; Chassot, Emmanuel] Inst Rech Dev, Unite Mixte Rech Ecosyst Marins Exploites 212, Sete, France; [Massiot-Granier, Felix; Rivot, Etienne] Univ Europeenne Bretagne, Unite Mixte Rech Ecol & Sante Ecosyst 985, Rennes, France; [Million, Julien] Indian Ocean Tuna Commiss, Victoria, Seychelles; [Morize, Eric; Munaron, Jean-Marie] Inst Rech Dev, Unite Mixte Rech 6539, Lab Sci Environm Marin, Plouzane, France; [Bousquet, Nicolas] Elect France, Dept Ind Risk Management, Chatou, France	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Electricite de France (EDF)	Dortel, E (corresponding author), Inst Rech Dev, Unite Mixte Rech Ecosyst Marins Exploites 212, Sete, France.	emmanuelle.dortel@ird.fr	martel, celine/O-6651-2016; Munaron, Jean-Marie/B-8282-2015	martel, celine/0000-0002-1800-4558; CHASSOT, Emmanuel/0000-0002-6779-4955; Rivot, Etienne/0000-0002-5442-121X; Bousquet, Nicolas/0000-0003-0170-0503	Agence Nationale de la Recherche EMOTION; ORTHONGEL; French Ministry of Agriculture and Fisheries; Institut de Recherche pour le Developement	Agence Nationale de la Recherche EMOTION(French National Research Agency (ANR)); ORTHONGEL; French Ministry of Agriculture and Fisheries; Institut de Recherche pour le Developement	This study was supported by the Agence Nationale de la Recherche EMOTION project through a grant from ORTHONGEL, the French Ministry of Agriculture and Fisheries and the Institut de Recherche pour le Developement. (http://www.umr-eme.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R.C., 1988, TWS88 COU IPTP, P28; Bertignac M, 2007, ICES J MAR SCI, V64, P981, DOI 10.1093/icesjms/fsm039; Bertolero A, 2005, AMPHIBIA-REPTILIA, V26, P17, DOI 10.1163/1568538053693198; Booth AJ, 2011, FISH B-NOAA, V109, P101; Borchani A, 2010, 10009 ESSEC BUS SCH; Buratti CC, 2010, FISH RES, V106, P2, DOI 10.1016/j.fishres.2010.05.007; Caillart B., 1989, Aquatic Living Resources, V2, P255, DOI 10.1051/alr:1989030; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; Chen Y, 2003, FISH FISH, V4, P105, DOI 10.1046/j.1467-2979.2003.00111.x; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Cotter AJR, 2004, FISH FISH, V5, P235, DOI 10.1111/j.1467-2679.2004.00157.x; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; de Pontual H, 2006, ICES J MAR SCI, V63, P1674, DOI 10.1016/j.icesjms.2006.07.007; Eveson J, 2008, IOTC WORKING PARTY T, V7; Eveson JP, 2004, CAN J FISH AQUAT SCI, V61, P292, DOI 10.1139/F03-163; Firoozi A, 1992, IPTP COLLECTIVE VOLU, V8, P95; Gascuel D, 1992, AQUAT LIVING RESOUR, V5, P155, DOI 10.1051/alr:1992016; Gelman A., 2004, CHAPMAN HALL CRC TEX; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Hallier J, 2008, 10 IOTCWPTDA; Hayes EJ, 1999, PHYSIOL ENTOMOL, V24, P1, DOI 10.1046/j.1365-3032.1999.00104.x; Helser TE, 2004, ECOL MODEL, V178, P399, DOI 10.1016/j.ecolmodel.2004.02.013; Herrera M, 2010, 3 IOTCWPTT; Hilborn Ray, 1997, V28; HOSKING JRM, 1985, J R STAT SOC C-APPL, V34, P301; Ishimura G., 2010, FAO FISH AQUAC TECH; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Langley A, 2010, 23 IOTCWPTT; Laslett GM, 2002, CAN J FISH AQUAT SCI, V59, P976, DOI 10.1139/F02-069; LEGUEN JC, 1973, FISH B-NOAA, V71, P175; Lehodey P, 1999, 12 M SCTB, P1; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Marriott RJ, 2006, CAN J FISH AQUAT SCI, V63, P2259, DOI 10.1139/F06-109; Marsac F., 1985, IPTP COLLECTIVE VOLU; Marsac F, 1991, IPTP COLLECTIVE VOLU, V6, P35; McAllister MK, 2001, CAN J FISH AQUAT SCI, V58, P1871, DOI 10.1139/cjfas-58-9-1871; Meyer R, 1999, CAN J FISH AQUAT SCI, V56, P1078, DOI 10.1139/cjfas-56-6-1078; MITCHELL ND, 1993, CORAL REEFS, V12, P65, DOI 10.1007/BF00302103; Miyake M.P., 2004, 467 FAO; Morgado C., 2000, GUIDELINES TOOLS AGE; MUGIYA Y, 1992, NIPPON SUISAN GAKK, V58, P845; Natanson LJ, 2006, ENVIRON BIOL FISH, V77, P367, DOI 10.1007/s10641-006-9127-z; Neilson John D., 1992, Canadian Special Publication of Fisheries and Aquatic Sciences, V117, P115; Nootmorn P., 2005, REPROD BIOL YELLOWFI, V14, P379; Norbis W, 1999, FISH RES, V44, P129, DOI 10.1016/S0165-7836(99)00059-4; Olivier L, 2002, IOTC P, V5, P316; Panfili J., 2002, MANUEL SCLEROCHRONOL; Panfili J, 2009, REV-METHODS TECHNOL, V11, P212, DOI 10.1007/978-1-4020-5775-5_7; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; Punt AE, 1997, REV FISH BIOL FISHER, V7, P35, DOI 10.1023/A:1018419207494; Punt AE, 2008, CAN J FISH AQUAT SCI, V65, P1991, DOI 10.1139/F08-111; Radtke R, 1996, J FISH BIOL, V48, P1238, DOI 10.1111/j.1095-8649.1996.tb01818.x; Rivot E, 2004, ECOL MODEL, V179, P463, DOI 10.1016/j.ecolmodel.2004.05.011; Romanov E, 1988, FAO IPTP COLLECTION, V3, P68; SAETHER SA, 1994, CONDOR, V96, P959, DOI 10.2307/1369105; Secor D.H., 1991, MANUAL OTOLITH REMOV; Spiegelhalter D., 2011, OPENBUGS VERSION 3 2; Stequert B, 2004, CYBIUM, V28, P163; Stequert B, 1996, FISH B-NOAA, V94, P124; Stequert B., 1995, DOCUMENT TECHNIQUE C, V76, P1; Stequert B, 2000, IOTC P, V1, P249; UCHIYAMA JH, 1981, FISH B-NOAA, V79, P151; Viera A, 2005, 32 IOTCWPTT; WILD A, 1995, B MAR SCI, V57, P555; Wild A., 1980, INT AM TROPIC TUNA C, V17, P507; Wild A., 1986, B INTERAMERICAN TROP, V18, P423; Yamaguchi K., 1990, INT C SPOKEN LANGUAG, P1; YOUNG JZ, 1960, PROC R SOC SER B-BIO, V152, P3, DOI 10.1098/rspb.1960.0019; Zhu Guoping, 2008, Journal of Ocean University of China, V7, P327, DOI 10.1007/s11802-008-0327-3	70	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60886	10.1371/journal.pone.0060886	http://dx.doi.org/10.1371/journal.pone.0060886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637773	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400018
J	Busch, H; Boerries, M; Bao, J; Hanke, ST; Hiss, M; Tiko, T; Rensing, SA				Busch, Hauke; Boerries, Melanie; Bao, Jie; Hanke, Sebastian T.; Hiss, Manuel; Tiko, Theodhor; Rensing, Stefan A.			Network Theory Inspired Analysis of Time-Resolved Expression Data Reveals Key Players Guiding P. patens Stem Cell Development	PLOS ONE			English	Article							PHYSCOMITRELLA-PATENS; LAND; GENES; PROTEINS; PATTERNS; GROWTH; CLOCK	Transcription factors (TFs) often trigger developmental decisions, yet, their transcripts are often only moderately regulated and thus not easily detected by conventional statistics on expression data. Here we present a method that allows to determine such genes based on trajectory analysis of time-resolved transcriptome data. As a proof of principle, we have analysed apical stem cells of filamentous moss (P. patens) protonemata that develop from leaflets upon their detachment from the plant. By our novel correlation analysis of the post detachment transcriptome kinetics we predict five out of 1,058 TFs to be involved in the signaling leading to the establishment of pluripotency. Among the predicted regulators is the basic helix loop helix TF PpRSL1, which we show to be involved in the establishment of apical stem cells in P. patens. Our methodology is expected to aid analysis of key players of developmental decisions in complex plant and animal systems.	[Busch, Hauke; Boerries, Melanie; Bao, Jie; Rensing, Stefan A.] Univ Freiburg, ZBSA Ctr Biol Syst Anal, D-79106 Freiburg, Germany; [Busch, Hauke; Hanke, Sebastian T.; Hiss, Manuel; Rensing, Stefan A.] Univ Freiburg, FRISYS Freiburg Initiat Syst Biol, D-79106 Freiburg, Germany; [Busch, Hauke; Boerries, Melanie; Bao, Jie] Univ Freiburg, FRIAS Freiburg Inst Adv Studies, D-79106 Freiburg, Germany; [Busch, Hauke; Boerries, Melanie] Univ Freiburg, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; [Busch, Hauke; Boerries, Melanie] German Canc Consortium DKTK, Freiburg, Germany; [Busch, Hauke; Boerries, Melanie] German Canc Res Ctr, Heidelberg, Germany; [Hanke, Sebastian T.; Hiss, Manuel; Tiko, Theodhor; Rensing, Stefan A.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Hanke, Sebastian T.; Hiss, Manuel; Rensing, Stefan A.] Univ Marburg, Fac Biol, Marburg, Germany; [Rensing, Stefan A.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Philipps University Marburg; University of Freiburg	Busch, H (corresponding author), Univ Freiburg, ZBSA Ctr Biol Syst Anal, Hugstetter Str 55, D-79106 Freiburg, Germany.	h.busch@dkfz.de; stefan.rensing@biologie.uni-marburg.de	Boerries, Melanie/AAM-2602-2021; Busch, Hauke/R-6452-2016	Busch, Hauke/0000-0003-4763-4521; Hiss, Manuel/0000-0002-7876-783X	Excellence Initiative of the German Federal and State Governments (FRIAS LifeNet); Excellence Initiative of the German Federal and State Governments [EXC 294]; German Federal Ministry of Education and Research (Freiburg Initiative for Systems Biology) [0313921]; German Federal Ministry of Education and Research (Medical Systems Biology, LungSys); German Research Foundation (DFG); Albert Ludwigs University Freiburg	Excellence Initiative of the German Federal and State Governments (FRIAS LifeNet); Excellence Initiative of the German Federal and State Governments; German Federal Ministry of Education and Research (Freiburg Initiative for Systems Biology); German Federal Ministry of Education and Research (Medical Systems Biology, LungSys); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This study was supported by the Excellence Initiative of the German Federal and State Governments (FRIAS LifeNet to H.B. and M. B.; EXC 294 to S.A.R.) and by the German Federal Ministry of Education and Research (Freiburg Initiative for Systems Biology, 0313921, to S.A.R.; Medical Systems Biology, LungSys, to J.B.). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2004, PLANT CELL PHYSIOL, V45, P68, DOI 10.1093/pcp/pch006; Azzalini A, 2003, J R STAT SOC B, V65, P367, DOI 10.1111/1467-9868.00391; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; HAKEN H, 1987, ADV SYNERGETICS; Harrison C.J., 2009, CURR BIOL, V18, P18; Holm K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-109; Ichikawa K, 2008, FEBS LETT, V582, P405, DOI 10.1016/j.febslet.2007.12.034; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jang G, 2011, DEVELOPMENT, V138, P2273, DOI 10.1242/dev.060582; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Lang D, 2010, GENOME BIOL EVOL, V2, P488, DOI 10.1093/gbe/evq032; Li WT, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-64; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Maiwald T, 2010, FEBS J, V277, P4741, DOI 10.1111/j.1742-4658.2010.07880.x; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Mar JC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000626; Marko NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020826; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Mosquna A, 2009, DEVELOPMENT, V136, P2433, DOI 10.1242/dev.035048; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Okada R, 2009, PLANT J, V16, P16; Okada R, 2009, GENES GENET SYST, V84, P379, DOI 10.1266/ggs.84.379; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Satbhai SB, 2011, BIOSCI BIOTECH BIOCH, V2011, P22; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Shimizu M, 2004, BIOCHEM BIOPH RES CO, V324, P1296, DOI 10.1016/j.bbrc.2004.09.194; Strickert M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-165; Tsuchiya M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012116; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Wolf L, 2010, PLANT PHYSIOL, V153, P1123, DOI 10.1104/pp.110.154658; Xiao LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035961; Yi K, 2010, NAT GENET, V42, P264, DOI 10.1038/ng.529	39	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e60494	10.1371/journal.pone.0060494	http://dx.doi.org/10.1371/journal.pone.0060494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637751	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700005
J	Hiemstra, M; Engels, RCME; Barker, ED; van Schayck, OCP; Otten, R				Hiemstra, Marieke; Engels, Rutger C. M. E.; Barker, Edward D.; van Schayck, Onno C. P.; Otten, Roy			Smoking-Specific Parenting and Smoking Onset in Adolescence: The Role of Genes from the Dopaminergic System (DRD2, DRD4, DAT1 Genotypes)	PLOS ONE			English	Article							TRANSPORTER GENE; CIGARETTE-SMOKING; ALCOHOL-USE; ANTISMOKING SOCIALIZATION; ENVIRONMENT INTERACTIONS; VNTR POLYMORPHISM; ASSOCIATION; BEHAVIOR; COMMUNICATION; TOBACCO	Although only few studies have shown direct links between dopaminergic system genes and smoking onset, this does not rule out the effect of a gene-environment interaction on smoking onset. Therefore, the aim of this study was to examine the associations between smoking-specific parenting (i.e., frequency and quality of communication and house rules) and smoking onset while considering the potential moderating role of dopaminergic system genes (i.e., DRD2, DRD4, and DAT1 genotypes). Data from five annual waves of the 'Family and Health' project were used. At time 1, the sample comprised 365 non-smoking adolescents (200 younger adolescents, mean age = 13.31, SD = .48; 165 older adolescents, mean age = 15.19, SD = .57). Advanced longitudinal analyses were used (i.e., logistic regression analyses, (dual) latent growth curves, and cross-lagged path models). The results showed a direct effect of quality of communication on smoking onset. No direct effects were found for frequency of communication and house rules. Furthermore, no direct and moderating effects of the DRD2, DRD4, or DAT1 genotypes were found. In conclusion, the findings indicated that the effects of smoking-specific parenting on smoking are similar for adolescent carriers and non-carriers of the dopaminergic system genes.	[Hiemstra, Marieke; Engels, Rutger C. M. E.; Otten, Roy] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Barker, Edward D.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [van Schayck, Onno C. P.] Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Maastricht, Netherlands	Radboud University Nijmegen; University of London; King's College London; Maastricht University	Hiemstra, M (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	m.hiemstra@bsi.ru.nl		Engels, Rutger/0000-0003-1944-9126; Barker, Edward/0000-0002-9914-8958	Dutch Cancer Society [KWF: 2006-3464]; Dutch Organization of Scientific Research [NWO: 016-005-029, 400-05-051]	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO))	The 'Family and Health' project was granted by the Dutch Cancer Society (KWF: 2006-3464) and the Dutch Organization of Scientific Research (NWO: 016-005-029; 400-05-051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ROKEN HARDE FEITEN J; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Babic M, 2012, NEUROSCI LETT, V520, P67, DOI 10.1016/j.neulet.2012.05.032; Beaver KM, 2012, PSYCHIAT QUART, V83, P29, DOI 10.1007/s11126-011-9180-4; Chassin L, 2000, HEALTH PSYCHOL, V19, P223, DOI 10.1037//0278-6133.19.3.223; Chassin L, 2005, J PEDIATR PSYCHOL, V30, P333, DOI 10.1093/jpepsy/jsi028; Chen NH, 2000, EUR J PHARMACOL, V405, P329, DOI 10.1016/S0014-2999(00)00563-X; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; Das D, 2011, AM J MED GENET B, V156B, P346, DOI 10.1002/ajmg.b.31169; de Leeuw R, 2010, PSYCHOL HEALTH, V25, P999, DOI 10.1080/08870440903477204; Dick DM, 2007, TWIN RES HUM GENET, V10, P315, DOI 10.1375/twin.10.2.315; Dolcini MM, 2003, NICOTINE TOB RES, V5, P473, DOI 10.1080/1462220031000118586; Emory K, 2010, TOB CONTROL, V19, P495, DOI 10.1136/tc.2010.035998; Engels RCME, 2004, HEALTH EDUC RES, V19, P227, DOI 10.1093/her/cyg042; Ennet ST, 2001, J MARRIAGE FAM, V63, P48, DOI 10.1111/j.1741-3737.2001.00048.x; HAHN G, 1990, ADDICT BEHAV, V15, P439, DOI 10.1016/0306-4603(90)90030-2; Harakeh Z, 2005, ADDICTION, V100, P862, DOI 10.1111/j.1360-0443.2005.01067.x; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; HEATH AC, 1995, BEHAV GENET, V25, P103, DOI 10.1007/BF02196921; Ho MK, 2007, PHARMACOGENOMICS J, V7, P81, DOI 10.1038/sj.tpj.6500436; Huang SW, 2005, PHARMACOGENET GENOM, V15, P839, DOI 10.1097/01213011-200512000-00002; Hutchison KE, 2002, J ABNORM PSYCHOL, V111, P134, DOI 10.1037//0021-843X.111.1.134; Jackson C, 1997, ADDICT BEHAV, V22, P107, DOI 10.1016/0306-4603(95)00108-5; Jorm AF, 2000, AM J MED GENET, V96, P331, DOI 10.1002/1096-8628(20000612)96:3<331::AID-AJMG19>3.0.CO;2-0; Koopmans JR, 1999, BEHAV GENET, V29, P383, DOI 10.1023/A:1021618719735; Kremers SPJ, 2001, PREV MED, V33, P392, DOI 10.1006/pmed.2001.0904; Laucht M, 2005, J AM ACAD CHILD PSY, V44, P477, DOI 10.1097/01.chi.0000155980.01792.7f; Laucht M, 2008, J AM ACAD CHILD PSY, V47, P673, DOI 10.1097/CHI.0b013e31816bff77; Lerman C, 1999, HEALTH PSYCHOL, V18, P14, DOI 10.1037/0278-6133.18.1.14; Li MD, 2004, CLIN GENET, V66, P382, DOI 10.1111/j.1399-0004.2004.00302.x; Ling DJ, 2004, J HUM GENET, V49, P35, DOI 10.1007/s10038-003-0104-5; Mayhew Kathryn P., 2000, Drug and Alcohol Dependence, V59, pS61; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x; Munafo M., 2004, NICOTINE TOB RES, V6, P1; Munafo MR, 2008, ADDICT BIOL, V13, P435, DOI 10.1111/j.1369-1600.2008.00098.x; Munafo MR, 2009, NICOTINE TOB RES, V11, P64, DOI 10.1093/ntr/ntn012; Muthen BO, 1997, PSYCHOL METHODS, V2, P371, DOI 10.1037/1082-989X.2.4.371; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; O'Connor TG, 1998, DEV PSYCHOL, V24, P735; Otten R, 2007, PSYCHOL ADDICT BEHAV, V21, P1, DOI 10.1037/0893-164X.21.1.1; Otten R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049432; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Pieters S, 2012, ALCOHOL ALCOHOLISM, V47, P663, DOI 10.1093/alcalc/ags075; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Sabol SZ, 1999, HEALTH PSYCHOL, V18, P7, DOI 10.1037/0278-6133.18.1.7; Schmid B, 2009, ADDICT BIOL, V14, P489, DOI 10.1111/j.1369-1600.2009.00171.x; Shields PG, 1998, CANCER EPIDEM BIOMAR, V7, P453; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Timberlake DS, 2006, HEALTH PSYCHOL, V25, P190, DOI 10.1037/0278-6133.25.2.190; van der Zwaluw CS, 2010, MOL PSYCHIATR, V15, P727, DOI 10.1038/mp.2009.4; van der Zwaluw CS, 2009, ADDICTION, V104, P907, DOI 10.1111/j.1360-0443.2009.02563.x; Vandenbergh David J, 2002, Nicotine Tob Res, V4, P333, DOI 10.1080/14622200210142689; Vet R, 2007, GEBRUIK ALCOHOL DOOR, V51; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; White VM, 2003, ADDICTION, V98, P1087, DOI 10.1046/j.1360-0443.2003.00427.x; World Health Organization, 2019, WHO REPORT GLOBAL TO	58	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61673	10.1371/journal.pone.0061673	http://dx.doi.org/10.1371/journal.pone.0061673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637880	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700050
J	Michaud, DS; Siddiq, A; Cox, DG; Backes, DM; Calboli, FCF; Sughrue, ME; Gaziano, JM; Ma, J; Stampfer, M; Tworoger, SS; Hunter, DJ; Camargo, CA; Parsa, AT				Michaud, Dominique S.; Siddiq, Afshan; Cox, David G.; Backes, Danielle M.; Calboli, Federico C. F.; Sughrue, Michael E.; Gaziano, J. Michael; Ma, Jing; Stampfer, Meir; Tworoger, Shelley S.; Hunter, David J.; Camargo, Carlos A., Jr.; Parsa, Andrew T.			Mannose-Binding Lectin 2 Gene and Risk of Adult Glioma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN-PAPILLOMAVIRUS INFECTION; CANCER RISK; FUNCTIONAL POLYMORPHISMS; UNRELATED INDIVIDUALS; BREAST-CANCER; MBL2; WOMEN; SUSCEPTIBILITY; POPULATION	Background and Aims: The immune system is likely to play a key role in the etiology of gliomas. Genetic polymorphisms in the mannose-binding lectin gene, a key activator in the lectin complement pathway, have been associated with risk of several cancers. Methods: To examine the role of the lectin complement pathway, we combined data from prospectively collected cohorts with available DNA specimens. Using a nested case-control design, we genotyped 85 single nucleotide polymorphisms (SNPs) in 9 genes in the lectin complement pathway and 3 additional SNPs in MBL2 were tested post hoc). Initial SNPs were selected using tagging SNPs for haplotypes; the second group of SNPs for MBL2 was selected based on functional SNPs related to phenotype. Associations were examined using logistic regression analysis. All statistical tests were two-sided. Nominal p-values are presented and are not corrected for multiple comparisons. Results: A total of 143 glioma cases and 419 controls were available for this analysis. Statistically significant associations were observed for two SNPs in the mannose-binding lectin 2 (ML2) gene and risk of glioma (rs1982266 and rs1800450, test for trend p = 0.003 and p = 0.04, respectively, using the additive model). One of these SNPs, rs1800450, was associated with a 58% increase in glioma risk among those carrying one or two mutated alleles (odds ratio = 1.58, 95% confidence interval = 0.99-2.54), compared to those homozygous for the wild type allele. Conclusions: Overall, our findings suggest that MBL may play a role in the etiology of glioma. Future studies are needed to confirm these findings which may be due to chance, and if reproduced, to determine mechanisms that link glioma pathogenesis with the MBL complement pathway.	[Michaud, Dominique S.; Backes, Danielle M.] Brown Univ, Brown Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Michaud, Dominique S.; Siddiq, Afshan; Cox, David G.; Calboli, Federico C. F.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, London, England; [Cox, David G.] UCBL1, CNRS UMR 5286, INSERM U1052, Lyon Canc Res Ctr, Lyon, France; [Sughrue, Michael E.] Univ Oklahoma, Dept Neurol Surg, Norma, OK USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Ma, Jing; Stampfer, Meir; Tworoger, Shelley S.; Hunter, David J.; Camargo, Carlos A., Jr.] Brigham & Womens Hosp, Dept Med, Channing Div, Med Network, Boston, MA 02115 USA; [Ma, Jing; Stampfer, Meir; Tworoger, Shelley S.; Hunter, David J.; Camargo, Carlos A., Jr.] Harvard Univ, Sch Med, Boston, MA USA; [Stampfer, Meir; Tworoger, Shelley S.; Hunter, David J.; Camargo, Carlos A., Jr.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Stampfer, Meir; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Parsa, Andrew T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	Brown University; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	Michaud, DS (corresponding author), Brown Univ, Brown Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA.	Dominique_Michaud@brown.edu	Cox, David G/A-2023-2009; Cox, David/ABA-7454-2020; Camargo, Carlos A./C-2145-2008; Michaud, Dominique S/I-5231-2014	Cox, David G/0000-0002-2152-9259; Camargo, Carlos A./0000-0002-5071-7654; Siddiq, Afshan/0000-0002-9110-1434; Cox, David/0000-0003-2047-4687; Tworoger, Shelley/0000-0002-6986-7046	National Institutes of Health [R01 CA114205, P01 CA097193, P01 CA087969, P01 CA055075-]; NATIONAL CANCER INSTITUTE [R01CA097193, P01CA055075, R01CA114205, P01CA087969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA114205; P01 CA097193; P01 CA087969; P01 CA055075-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2006, INT J CANCER, V119, P1970, DOI 10.1002/ijc.22075; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; Bernig T, 2007, CARCINOGENESIS, V28, P828, DOI 10.1093/carcin/bgl198; Brown EE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-57; Calboli FCF, 2011, J NATL CANCER I, V103, P1588, DOI 10.1093/jnci/djr361; CBTRUS, 2010, STAT REP PRIM BRAIN; Comar M, 2011, HUM IMMUNOL, V72, P663, DOI 10.1016/j.humimm.2011.04.002; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Guimaraes V, 2008, HUM IMMUNOL, V69, P273, DOI 10.1016/j.humimm.2008.03.002; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Pine SR, 2007, J NATL CANCER I, V99, P1401, DOI 10.1093/jnci/djm128; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1991, LANCET, V338, P1073; Rutkowski MJ, 2010, MOL CANCER RES, V8, P1453, DOI 10.1158/1541-7786.MCR-10-0225; Sanson M, 2011, HUM MOL GENET, V20, P2897, DOI 10.1093/hmg/ddr192; Segat L, 2009, HUM IMMUNOL, V70, P436, DOI 10.1016/j.humimm.2009.03.006; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; STAMPFER MJ, 1985, STAT MED, V4, P111, DOI 10.1002/sim.4780040202; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Stuart LM, 2005, J IMMUNOL, V174, P3220, DOI 10.4049/jimmunol.174.6.3220; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Wang FY, 2008, DIGEST DIS SCI, V53, P2904, DOI 10.1007/s10620-008-0249-3; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Ytting H, 2011, SCAND J IMMUNOL, V73, P122, DOI 10.1111/j.1365-3083.2010.02480.x; Zanetti KA, 2012, CANCER RES, V72, P1467, DOI 10.1158/0008-5472.CAN-11-3073; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61117	10.1371/journal.pone.0061117	http://dx.doi.org/10.1371/journal.pone.0061117			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637788	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700014
J	Park, HY; Man, SFP; Tashkin, D; Wise, RA; Connett, JE; Anthonisen, NA; Sin, DD				Park, Hye Yun; Man, S. F. Paul; Tashkin, Donald; Wise, Robert A.; Connett, John E.; Anthonisen, Nicholas A.; Sin, Don D.			The Relation of Serum Myeloperoxidase to Disease Progression and Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD)	PLOS ONE			English	Article							INDUCED SPUTUM; BRONCHIAL LAVAGE; GLOBAL BURDEN; INFLAMMATION; RISK; MEDIATORS; INTERVENTION; SMOKING; MARKERS; ASTHMA	Myeloperoxidase is a strong oxidant stored in primary granules of neutrophils with potent antibacterial and proatherogenic properties. Myeloperoxidase has been implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, the relationship of myeloperoxidase to health outcomes in COPD is not well known. We measured serum myeloperoxidase levels from 4,677 subjects with mild to moderate airflow limitation in the Lung Health Study. Using a Cox proportional hazards model, we determined the relationship of serum myeloperoxidase concentration to the risk of all-cause and disease specific causes of mortality. We found that serum myeloperoxidase concentrations were significantly related to accelerated decline in forced expiratory volume in 1 second (FEV1) over 11 years of follow-up (p<0.0001), and this association persisted after adjustments for age, sex, race, baseline FEV1, and smoking status (p = 0.048). Serum myeloperoxidase concentrations were also associated with increased risk of cardiovascular mortality (p = 0.036). Individuals in the highest quintile of myeloperoxidase had a hazard ratio of cardiovascular mortality of 1.90 (95% confidence interval 1.00-3.58; p = 0.049) compared with those in the lowest quintile, which was particularly notable in patients who continued to smoke (adjusted p-value of 0.0396). However, serum myeloperoxidase concentration was not related to total mortality, respiratory mortality, or deaths from malignancies. In conclusion, increased serum myeloperoxidase levels are associated with rapid lung function decline and poor cardiovascular outcomes in COPD patients, which support the emerging role of myeloperoxidase in the pathogenesis of COPD progression and cardiovascular disease.	[Park, Hye Yun; Man, S. F. Paul; Sin, Don D.] St Pauls Hosp, UBC James Hogg Res Ctr, Vancouver, BC V6Z 1Y6, Canada; [Park, Hye Yun; Man, S. F. Paul; Sin, Don D.] St Pauls Hosp, Inst Heart, Vancouver, BC V6Z 1Y6, Canada; [Park, Hye Yun; Man, S. F. Paul; Sin, Don D.] St Pauls Hosp, Lung Inst, Vancouver, BC V6Z 1Y6, Canada; [Man, S. F. Paul; Sin, Don D.] Univ British Columbia, Dept Med, Div Pulm, Vancouver, BC, Canada; [Park, Hye Yun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Tashkin, Donald] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Wise, Robert A.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA; [Connett, John E.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Anthonisen, Nicholas A.] Univ Manitoba, Dept Med, Winnipeg, MB, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Sungkyunkwan University (SKKU); Samsung Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of Manitoba	Sin, DD (corresponding author), St Pauls Hosp, UBC James Hogg Res Ctr, Vancouver, BC V6Z 1Y6, Canada.	don.sin@hli.ubc.ca	Sin, Don/AAC-2219-2021; park, hy/O-5934-2014	Wise, Robert/0000-0002-8353-2349	Canadian Institutes of Health Research; GlaxoSmithKline; GlaxoSmithKline (GSK)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline (GSK)(GlaxoSmithKline)	The study was funded by the Canadian Institutes of Health Research and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by GlaxoSmithKline (GSK). Dr. Park is employed by the Samsung Medical Center. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aaron SD, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-41; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Casanova C, 2011, AM J RESP CRIT CARE, V184, P1015, DOI 10.1164/rccm.201105-0831OC; Churg A, 2012, AM J RESP CRIT CARE, V185, P34, DOI 10.1164/rccm.201103-0468OC; Cockayne DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038629; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P449, DOI 10.1164/ajrccm.155.2.9032177; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; Man SFP, 2008, EUR RESPIR J, V32, P1451, DOI 10.1183/09031936.00153207; Man SFP, 2012, CAN J CARDIOL, V28, P653, DOI 10.1016/j.cjca.2012.06.013; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nishimura M, 2012, AM J RESP CRIT CARE, V185, P44, DOI 10.1164/rccm.201106-0992OC; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; Parr DG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-136; Pesci A, 1998, EUR RESPIR J, V12, P380, DOI 10.1183/09031936.98.12020380; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; RIISE GC, 1995, THORAX, V50, P360, DOI 10.1136/thx.50.4.360; Sethi JM, 2000, CLIN CHEST MED, V21, P67, DOI 10.1016/S0272-5231(05)70008-3; Sin DD, 2011, AM J RESP CRIT CARE, V183, P1187, DOI 10.1164/rccm.201008-1220OC; Tang WHW, 2009, AM J CARDIOL, V103, P1269, DOI 10.1016/j.amjcard.2009.01.026; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482	29	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61315	10.1371/journal.pone.0061315	http://dx.doi.org/10.1371/journal.pone.0061315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637811	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700023
J	van den Hengel, LG; Hellingman, AA; Nossent, AY; van Oeveren-Rietdijk, AM; de Vries, MR; Spek, CA; van Zonneveld, AJ; Reitsma, PH; Hamming, JF; de Boer, HC; Versteeg, HH; Quax, PHA				van den Hengel, Lisa G.; Hellingman, Alwine A.; Nossent, Anne Yael; van Oeveren-Rietdijk, Annemarie M.; de Vries, Margreet R.; Spek, C. Arnold; van Zonneveld, Anton Jan; Reitsma, Pieter H.; Hamming, Jaap F.; de Boer, Hetty C.; Versteeg, Henri H.; Quax, Paul H. A.			Protease-Activated Receptor (PAR)2, but Not PAR1, Is Involved in Collateral Formation and Anti-Inflammatory Monocyte Polarization in a Mouse Hind Limb Ischemia Model	PLOS ONE			English	Article							THROMBIN RECEPTOR; ARTERY GROWTH; KAPPA-B; CELLS; ARTERIOGENESIS; ANGIOGENESIS; REVASCULARIZATION; EXTRAVASATION; INFLAMMATION; CIRCULATION	Aims: In collateral development (i.e. arteriogenesis), mononuclear cells are important and exist as a heterogeneous population consisting of pro-inflammatory and anti-inflammatory/repair-associated cells. Protease-activated receptor (PAR) 1 and PAR2 are G-protein-coupled receptors that are both expressed by mononuclear cells and are involved in pro-inflammatory reactions, while PAR2 also plays a role in repair-associated responses. Here, we investigated the physiological role of PAR1 and PAR2 in arteriogenesis in a murine hind limb ischemia model. Methods and Results: PAR1-deficient (PAR1-/-), PAR2-deficient (PAR2-/-) and wild-type (WT) mice underwent femoral artery ligation. Laser Doppler measurements revealed reduced post-ischemic blood flow recovery in PAR2-/- hind limbs when compared to WT, while PAR1-/- mice were not affected. Upon ischemia, reduced numbers of smooth muscle actin (SMA)-positive collaterals and CD31-positive capillaries were found in PAR2-/- mice when compared to WT mice, whereas these parameters in PAR1-/- mice did not differ from WT mice. The pool of circulating repair-associated (Ly6C-low) monocytes and the number of repair-associated (CD206-positive) macrophages surrounding collaterals in the hind limbs were increased in WT and PAR1-/- mice, but unaffected in PAR2-/- mice. The number of repair-associated macrophages in PAR2-/- hind limbs correlated with CD11b- and CD115-expression on the circulating monocytes in these animals, suggesting that monocyte extravasation and M-CSF-dependent differentiation into repair-associated cells are hampered. Conclusion: PAR2, but not PAR1, is involved in arteriogenesis and promotes the repair-associated response in ischemic tissues. Therefore, PAR2 potentially forms a new pro-arteriogenic target in coronary artery disease (CAD) patients.	[van den Hengel, Lisa G.; Hellingman, Alwine A.; Nossent, Anne Yael; van Oeveren-Rietdijk, Annemarie M.; de Vries, Margreet R.; van Zonneveld, Anton Jan; Reitsma, Pieter H.; de Boer, Hetty C.; Versteeg, Henri H.; Quax, Paul H. A.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Hellingman, Alwine A.; Nossent, Anne Yael; de Vries, Margreet R.; Hamming, Jaap F.; Quax, Paul H. A.] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands; [van Oeveren-Rietdijk, Annemarie M.; van Zonneveld, Anton Jan; de Boer, Hetty C.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Spek, C. Arnold] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Versteeg, HH (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	h.h.versteeg@lumc.nl	Versteeg, Henri/G-1783-2018; de Vries, Margreet/Z-5653-2019; Spek, Arnold/AAC-5866-2019; Quax, Paul/W-8520-2019; van Zonneveld, Anton Jan/D-8060-2018; Quax, Paul/ABD-5294-2020	Versteeg, Henri/0000-0003-4294-175X; Spek, Arnold/0000-0002-2149-4068; van Zonneveld, Anton Jan/0000-0002-1676-7738; Quax, Paul/0000-0002-6853-5760; Nossent, Anne Yael/0000-0002-2155-4286	Smart-Mix Translational excellence in Regenerative Medicine (TeRM) program; Kassenaar Fund; Leducq Initiative Against Thrombosis (LINAT) [0630/09/KB]; NWO VIDI [17.106.329]	Smart-Mix Translational excellence in Regenerative Medicine (TeRM) program; Kassenaar Fund; Leducq Initiative Against Thrombosis (LINAT); NWO VIDI(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Smart-Mix Translational excellence in Regenerative Medicine (TeRM) program to A. A. H.; the Kassenaar Fund and the Leducq Initiative Against Thrombosis (LINAT) [0630/09/KB to H. H. V.]. H. H. V. is the recipient of a NWO VIDI award (17.106.329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Bono F, 1997, BIOCHEM BIOPH RES CO, V241, P762, DOI 10.1006/bbrc.1997.7847; Buschmann I, 2000, J PATHOL, V190, P338, DOI 10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7; Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Cochain C, 2010, CARDIOVASC RES, V88, P186, DOI 10.1093/cvr/cvq153; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Dutra-Oliveira A, 2012, BIOCHEM BIOPH RES CO, V421, P221, DOI 10.1016/j.bbrc.2012.03.140; Fan CL, 2006, CLIN EXP PHARMACOL P, V33, P617, DOI 10.1111/j.1440-1681.2006.04416.x; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Katsanos K, 2009, J VASC SURG, V49, P1000, DOI 10.1016/j.jvs.2008.11.004; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Meisner JK, 2010, MICROCIRCULATION, V17, P583, DOI 10.1111/j.1549-8719.2010.00051.x; Milia AF, 2002, CIRC RES, V91, P346, DOI 10.1161/01.RES.0000031958.92781.9E; Mirza H, 1996, J CLIN INVEST, V97, P1705, DOI 10.1172/JCI118597; Nhu QM, 2012, INNATE IMMUN-LONDON, V18, P193, DOI 10.1177/1753425910395044; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rasmussen JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046087; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Stone OA, 2009, ARTERIOSCL THROM VAS, V29, P657, DOI 10.1161/ATVBAHA.108.182139; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Uusitalo-Jarvinen H, 2007, ARTERIOSCL THROM VAS, V27, P1456, DOI 10.1161/ATVBAHA.107.142539; van den Hengel Lisa G, 2011, Front Biosci (Schol Ed), V3, P1500; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P2310, DOI 10.1161/ATVBAHA.107.151407; van Weel V, 2006, ARTERIOSCL THROM VAS, V26, P1383, DOI 10.1161/01.ATV.0000219234.78165.85; Vergnolle N, 2004, J CLIN INVEST, V114, P1444, DOI 10.1172/JCI200421689; Vergnolle N, 1999, J IMMUNOL, V163, P5064; Wang SL, 2010, CIRC RES, V107, P558, DOI 10.1161/CIRCRESAHA.110.224634; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; ZIMMERMAN BJ, 1994, AM J PHYSIOL, V267, pH1049, DOI 10.1152/ajpheart.1994.267.3.H1049	40	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61923	10.1371/journal.pone.0061923	http://dx.doi.org/10.1371/journal.pone.0061923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637930	gold, Green Published, Green Submitted			2022-12-25	WOS:000317908700065
J	Duan, AG; Zhang, JG; Zhang, XQ; He, CY				Duan, Ai-guo; Zhang, Jian-guo; Zhang, Xiong-qing; He, Cai-yun			Stand Diameter Distribution Modelling and Prediction Based on Richards Function	PLOS ONE			English	Article							ACCURACY; YIELD	The objective of this study was to introduce application of the Richards equation on modelling and prediction of stand diameter distribution. The long-term repeated measurement data sets, consisted of 309 diameter frequency distributions from Chinese fir (Cunninghamia lanceolata) plantations in the southern China, were used. Also, 150 stands were used as fitting data, the other 159 stands were used for testing. Nonlinear regression method (NRM) or maximum likelihood estimates method (MLEM) were applied to estimate the parameters of models, and the parameter prediction method (PPM) and parameter recovery method (PRM) were used to predict the diameter distributions of unknown stands. Four main conclusions were obtained: (1) R distribution presented a more accurate simulation than three-parametric Weibull function; (2) the parameters p, q and r of R distribution proved to be its scale, location and shape parameters, and have a deep relationship with stand characteristics, which means the parameters of R distribution have good theoretical interpretation; (3) the ordinate of inflection point of R distribution has significant relativity with its skewness and kurtosis, and the fitted main distribution range for the cumulative diameter distribution of Chinese fir plantations was 0.4 similar to 0.6; (4) the goodness-of-fit test showed diameter distributions of unknown stands can be well estimated by applying R distribution based on PRM or the combination of PPM and PRM under the condition that only quadratic mean DBH or plus stand age are known, and the non-rejection rates were near 80%, which are higher than the 72.33% non-rejection rate of three-parametric Weibull function based on the combination of PPM and PRM.	[Duan, Ai-guo; Zhang, Jian-guo; He, Cai-yun] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Duan, Ai-guo; Zhang, Jian-guo; Zhang, Xiong-qing; He, Cai-yun] Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat, State Forestry Adm, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Zhang, JG (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	Zhangjg@caf.ac.cn	Zhang, Xiongqing/AAW-6171-2020	Zhang, Xiongqing/0000-0001-5592-6730	national scientific and technological task for the 12th five-year plan in China [2012BAD01B02, 2011AA100203]	national scientific and technological task for the 12th five-year plan in China	The authors acknowledge the financial assistance provided by the national scientific and technological task for the 12th five-year plan in China (No. 2012BAD01B02, 2011AA100203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiguo Duan, 2011, 2011 International Conference on Remote Sensing, Environment and Transportation Engineering, P7313; BAILEY RL, 1973, FOREST SCI, V19, P97; BORDERS BE, 1987, FOREST SCI, V33, P570; Brooks J. R., 1992, Southern Journal of Applied Forestry, V16, P130; Burgess D, 2005, FOREST ECOL MANAG, V209, P117, DOI 10.1016/j.foreco.2005.01.006; Burkhart HE, 1974, GROWTH MODELS TREE S, P128; Burr IW, 1942, ANN MATH STAT, V13, P215, DOI 10.1214/aoms/1177731607; Chen WJ, 2004, FOREST SCI, V50, P436; Clutter JL, 1983, TIMBER MANAGEMENT QU; Duan AG, 2003, SCI SIL SIN, V16, P423; Duan AiGuo, 2006, Journal of Beijing Forestry University, V28, P86; Duan AiGuo, 2004, Scientia Silvae Sinicae, V40, P32; DUBEY SD, 1967, TECHNOMETRICS, V9, P119, DOI 10.2307/1266322; Gadow K. V., 1998, MODELING FOREST DEV; Gove JH, 1998, FOREST SCI, V44, P285; Haara A, 1997, SCAND J FOREST RES, V12, P200, DOI 10.1080/02827589709355401; HAFLEY WL, 1977, CAN J FOREST RES, V7, P481, DOI 10.1139/x77-062; HYINK DM, 1983, FOREST SCI, V29, P85; Ishikawa Y, 1998, J PLANN, V31, P15; Kilkki P., 1986, Silva Fennica, V20, P149; KNOEBEL BR, 1986, FOREST SCI MONOGR, V32, P1; Lee YJ, 2001, J KOREAN FOREST SOC, V90, P176; LITTLE SN, 1983, CAN J FOREST RES, V13, P85, DOI 10.1139/x83-012; Liu CM, 2004, CAN J FOREST RES, V34, P2424, DOI [10.1139/x04-117, 10.1139/X04-117]; Liu CM, 2002, FOREST SCI, V48, P653; Maltamo M, 1998, CAN J FOREST RES, V28, P1107, DOI 10.1139/cjfr-28-8-1107; Maltamo M, 2000, FOREST ECOL MANAG, V133, P263, DOI 10.1016/S0378-1127(99)00239-X; Maltamo Matti, 1997, Silva Fennica, V31, P53; Monness E, 2011, CAN J FOREST RES, V41, P707, DOI [10.1139/x10-246, 10.1139/X10-246]; Newton PF, 2005, FOREST ECOL MANAG, V209, P181, DOI 10.1016/j.foreco.2005.01.020; Newton PF, 2004, FOREST CHRON, V80, P349, DOI 10.5558/tfc80349-3; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; SAS I, 1991, SAS STAT US GUID VER; SCHREUDER H T, 1974, Canadian Journal of Forest Research, V4, P518, DOI 10.1139/x74-075; Tokola T, 1996, INT J REMOTE SENS, V17, P2333, DOI 10.1080/01431169608948776; Wang M, 2007, CAN J FOREST RES, V37, P2052, DOI 10.1139/X07-023; Weibull W, 1939, HANDLINGAR; ZEIDE B, 1989, CAN J FOREST RES, V19, P1283, DOI 10.1139/x89-195; ZEIDE B, 1993, FOREST SCI, V39, P594, DOI 10.1093/forestscience/39.3.594; Zhang J., 2004, STUDY THEORETICAL GR; Zhang JianGuo, 2003, Scientia Silvae Sinicae, V39, P55; Zhang XQ, 2010, FOREST SCI, V56, P552	42	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62605	10.1371/journal.pone.0062605	http://dx.doi.org/10.1371/journal.pone.0062605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638124	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300082
J	Tokuda, M; Jikumaru, Y; Matsukura, K; Takebayashi, Y; Kumashiro, S; Matsumura, M; Kamiya, Y				Tokuda, Makoto; Jikumaru, Yusuke; Matsukura, Keiichiro; Takebayashi, Yumiko; Kumashiro, Shun; Matsumura, Masaya; Kamiya, Yuji			Phytohormones Related to Host Plant Manipulation by a Gall-Inducing Leafhopper	PLOS ONE			English	Article							BIPUNCTATA MELICHAR HOMOPTERA; MAIZE ORANGE LEAFHOPPER; WALLABY EAR DISEASE; INSECT; INDUCTION; TOBACCO; VIRUS; IAA	The maize orange leafhopper Cicadulina bipunctata (Hemiptera: Cicadellidae) induces galls characterized by growth stunting and severe swelling of leaf veins on various plants of Poaceae. Previous studies revealed that galls are induced not on feeding site but on distant, newly extended leaves during the feeding, and strongly suggested that some chemicals injected by the leafhopper affect at the leaf primordia. To approach the mechanism underlying gall induction by C. bipunctata, we examined physiological response of plants to feeding by the leafhopper. We performed high-throughput and comprehensive plant hormone analyses using LC-ESI-MS/MS. Galled maize leaves contained higher contents of abscisic acid (ABA) and trans-Zeatin (tZ) and lower contents of gibberellins (GA(1) and GA(4)) than ungalled maize leaves. Leafhopper treatment significantly increased ABA and tZ contents and decreased GA(1) and GA(4) contents in extending leaves. After the removal of leafhoppers, contents of tZ and gibberellins in extending leaves soon became similar to the control values. ABA content was gradually decreased after the removal of leafhoppers. Such hormonal changes were not observed in leafhopper treatment on leaves of resistant maize variety. Water contents of galled leaves were significantly lower than control leaves, suggesting water stress of galled leaves and possible reason of the increase in ABA content. These results imply that ABA, tZ, and gibberellins are related to gall induction by the leafhopper on susceptible variety of maize.	[Tokuda, Makoto] Saga Univ, Fac Agr, Lab Syst Ecol, Saga 840, Japan; [Tokuda, Makoto; Jikumaru, Yusuke; Takebayashi, Yumiko; Kamiya, Yuji] RIKEN Plant Sci Ctr, Growth Regulat Res Grp, Yokohama, Kanagawa, Japan; [Matsukura, Keiichiro; Matsumura, Masaya] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Agroenvironm Res Div, Kumamoto, Japan; [Kumashiro, Shun] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan	Saga University; RIKEN; National Agriculture & Food Research Organization - Japan; Kagoshima University	Tokuda, M (corresponding author), Saga Univ, Fac Agr, Lab Syst Ecol, Saga 840, Japan.	tokudam@cc.saga-u.ac.jp	Kamiya, Yuji/F-9420-2010; Takebayashi, Yumiko/C-8190-2017	Kamiya, Yuji/0000-0003-4415-520X; Takebayashi, Yumiko/0000-0003-4207-297X; Tokuda, Makoto/0000-0001-7162-0715	Special Postdoctral Researchers Program of RIKEN; MEXT, Japan [21200066];  [24. 2812]	Special Postdoctral Researchers Program of RIKEN; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was supported partly by the Special Postdoctral Researchers Program of RIKEN to MT, a Grant-in-Aid for Scientific Research on Innovative Areas (21200066) from MEXT, Japan to MT, and Grants-in-Aid for JSPS fellows (24. 2812) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati JA, 1949, PHILIPP J AGR, V14, P31; Beiderbeck Rolf, 2005, P731; BOCCARDO G, 1980, VIROLOGY, V100, P300, DOI 10.1016/0042-6822(80)90521-8; Doss RP, 2000, P NATL ACAD SCI USA, V97, P6218, DOI 10.1073/pnas.110054697; GRYLLS NE, 1975, ANN APPL BIOL, V79, P283, DOI 10.1111/j.1744-7348.1975.tb01584.x; GUISCAFREARRILLAGA J, 1949, PHYTOPATHOLOGY, V39, P489; Hamner KC, 1936, BOT GAZ, V98, P735; Harris MO, 2003, ANNU REV ENTOMOL, V48, P549, DOI 10.1146/annurev.ento.48.091801.112559; Hopp HH, 1955, WEINBAU WISSENSCHAFT, V9, P9; Hori K., 1992, P157; HORI K, 1977, J INSECT PHYSIOL, V23, P1075, DOI 10.1016/0022-1910(77)90136-6; ISHIKAWA K, 1988, PLANT CELL PHYSIOL, V29, P461; JENSEN PB, 1948, PHYSIOL PLANTARUM, V1, P95, DOI 10.1111/j.1399-3054.1948.tb07113.x; Jikumaru Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1461, DOI 10.1271/bbb.68.1461; Kaiser W, 2010, P ROY SOC B-BIOL SCI, V277, P2311, DOI 10.1098/rspb.2010.0214; Kawano S, 1994, B OKINAWA AGR EXP ST, V15, P51; Kumashiro S, 2011, NATURWISSENSCHAFTEN, V98, P983, DOI 10.1007/s00114-011-0846-4; LEATHERDALE D, 1955, NATURE, V175, P553, DOI 10.1038/175553a0; Li XiaoZhen, 2004, Journal of Maize Sciences, V12, P89; LINK GEORGE K. K., 1940, BOT GAZ, V101, P928, DOI 10.1086/334925; Mapes CC, 2001, NEW PHYTOL, V151, P195, DOI 10.1046/j.1469-8137.2001.00161.x; MARAMOROSCH KARL, 1961, ENT EXPTL ET APPL, V4, P86, DOI 10.1007/BF00334032; Martin JP, 1942, SCIENCE, V96, P39, DOI 10.1126/science.96.2480.39; Matsukura K., 2009, Kyushu Plant Protection Research, V55, P105; Matsukura K, 2012, EVOL BIOL, V39, P341, DOI 10.1007/s11692-011-9150-7; Matsukura K, 2010, CROP PROT, V29, P1401, DOI 10.1016/j.cropro.2010.07.022; Matsukura Keiichiro, 2010, Communicative & Integrative Biology, V3, P388; Matsukura K, 2009, NATURWISSENSCHAFTEN, V96, P1059, DOI 10.1007/s00114-009-0566-1; Matsukura K, 2009, APPL ENTOMOL ZOOL, V44, P207, DOI 10.1303/aez.2009.207; Matsumura Masaya, 2005, Kyushu Byogaichu Kenkyukaiho, V51, P36; Matsumura M, 2006, GALLING ARTHROPODS AND THEIR ASSOCIATES: ECOLOGY AND EVOLUTION, P149, DOI 10.1007/4-431-32185-3_12; Matsumura Masaya, 2004, Kyushu Byogaichu Kenkyukaiho, V50, P35; MAXWELL FG, 1962, J ECON ENTOMOL, V55, P57, DOI 10.1093/jee/55.1.57; MCCALLA DR, 1962, PLANT PHYSIOL, V37, P98, DOI 10.1104/pp.37.1.98; OFORI FA, 1983, ANN APPL BIOL, V103, P185, DOI 10.1111/j.1744-7348.1983.tb02755.x; Ohata Shinichi, 1993, Journal of Japanese Society of Grassland Science, V39, P120; PRICE PW, 1987, ENVIRON ENTOMOL, V16, P15, DOI 10.1093/ee/16.1.15; REDDY DVR, 1976, VIROLOGY, V73, P36, DOI 10.1016/0042-6822(76)90058-1; Schaller G., 1968, Zoologische Jahrbuecher (Allgemeine Zoologie), V74, P54; Schultz JC, 2001, TRENDS PLANT SCI, V6, P406, DOI 10.1016/S1360-1385(01)02041-6; SITBON F, 1991, PLANT PHYSIOL, V95, P480, DOI 10.1104/pp.95.2.480; Sopow SL, 2003, ECOL LETT, V6, P102, DOI 10.1046/j.1461-0248.2003.00410.x; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Straka JR, 2010, J PLANT INTERACT, V5, P197, DOI 10.1080/17429145.2010.484552; Tokuda M, 2005, APPL ENTOMOL ZOOL, V40, P213, DOI 10.1303/aez.2005.213; Tokuda M, 2012, ENTOMOL SCI, V15, P361, DOI 10.1111/j.1479-8298.2012.00539.x; Tooker JF, 2011, ARTHROPOD-PLANT INTE, V5, P115, DOI 10.1007/s11829-010-9120-5; WYNDAELE R, 1985, PLANT CELL PHYSIOL, V26, P1147, DOI 10.1093/oxfordjournals.pcp.a077010; Yamaguchi H, 2012, NEW PHYTOL, V196, P586, DOI 10.1111/j.1469-8137.2012.04264.x; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635	50	39	40	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62350	10.1371/journal.pone.0062350	http://dx.doi.org/10.1371/journal.pone.0062350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638047	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300043
J	Smith, SA; Wood, C; West, JT				Smith, S. Abigail; Wood, Charles; West, John T.			HIV-1 Env C2-V4 Diversification in a Slow-Progressor Infant Reveals a Flat but Rugged Fitness Landscape	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG-TERM NONPROGRESSORS; DRUG-RESISTANT HIV-1; T-CELL RESPONSES; DISEASE PROGRESSION; REVERSE-TRANSCRIPTASE; NEUTRALIZING ANTIBODIES; REPLICATIVE FITNESS; TYPE-1 INFECTION; SUBTYPE-C	Human immunodeficiency virus type-1 (HIV-1) fitness has been associated with virus entry, a process mediated by the envelope glycoprotein (Env). We previously described Env genetic diversification in a Zambian, subtype C infected, slow-progressor child (1157i) in parallel with an evolving neutralizing antibody response. Because of the role the Variable-3 loop (V3) plays in transmission, cell tropism, neutralization sensitivity, and fitness, longitudinally isolated 1157i C2-V4 alleles were cloned into HIV-1(NL4-3)-eGFP and -DsRed2 infectious molecular clones. The fluorescent reporters allowed for dual-infection competitions between all patient-derived C2-V4 chimeras to quantify the effect of V3 diversification and selection on fitness. 'Winners' and 'losers' were readily discriminated among the C2-V4 alleles. Exceptional sensitivity for detection of subtle fitness differences was revealed through analysis of two alleles differing in a single synonymous amino acid. However, when the outcomes of N = 33 competitions were averaged for each chimera, the aggregate analysis showed that despite increasing diversification and divergence with time, natural selection of C2-V4 sequences in this individual did not appear to be producing a 'survival of the fittest' evolutionary pattern. Rather, we detected a relatively flat fitness landscape consistent with mutational robustness. Fitness outcomes were then correlated with individual components of the entry process. Env incorporation into particles correlated best with fitness, suggesting a role for Env avidity, as opposed to receptor/coreceptor affinity, in defining fitness. Nevertheless, biochemical analyses did not identify any step in HIV-1 entry as a dominant determinant of fitness. Our results lead us to conclude that multiple aspects of entry contribute to maintaining adequate HIV-1 fitness, and there is no surrogate analysis for determining fitness. The capacity for subtle polymorphisms in Env to nevertheless significantly impact viral fitness suggests fitness is best defined by head-to-head competition.	[Smith, S. Abigail; West, John T.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Wood, Charles] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Wood, Charles] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	West, JT (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	john-west@ouhsc.edu	Wood, Charles/AAH-4536-2021	Wood, Charles/0000-0002-4256-1530	Junior Investigator award under Oklahoma INBRE [8P20GM103447, 1R01AI090672, 5T32AI007633]; NATIONAL CANCER INSTITUTE [R01CA075903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090672, T32AI007633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER	Junior Investigator award under Oklahoma INBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported, in part, by a Junior Investigator award under the Oklahoma INBRE 8P20GM103447, and by 1R01AI090672 to J.W. Miss Smith (A.S.) was partially supported by a training award 5T32AI007633. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha Awet, 2005, Methods Mol Biol, V304, P355; ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Anastassopoulou CG, 2007, PLOS PATHOG, V3, P720, DOI 10.1371/journal.ppat.0030079; Anderson RM, 1996, AIDS, V10, P1663, DOI 10.1097/00002030-199612000-00011; ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Batorsky R, 2011, P NATL ACAD SCI USA, V108, P5661, DOI 10.1073/pnas.1102036108; Biesinger Tasha, 2008, Virology (Auckl), V2008, P49; Bjorndal A, 1997, J VIROL, V71, P7478; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BOSCH ML, 1989, SCIENCE, V244, P694, DOI 10.1126/science.2541505; Bunnik EM, 2010, VIROLOGY, V397, P224, DOI 10.1016/j.virol.2009.11.009; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chopera DR, 2011, J VIROL, V85, P7070, DOI 10.1128/JVI.02543-10; CLARKE DK, 1994, P NATL ACAD SCI USA, V91, P4821, DOI 10.1073/pnas.91.11.4821; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; Corzana F, 2007, J AM CHEM SOC, V129, P9458, DOI 10.1021/ja072181b; Croteau G, 1997, J VIROL, V71, P1089, DOI 10.1128/JVI.71.2.1089-1096.1997; DEBYSER Z, 1993, MOL PHARMACOL, V43, P521; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Fryer HR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001196; GAUSE G. F., 1934, SCIENCE, V79, P16, DOI 10.1126/science.79.2036.16-a; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOLLAND JJ, 1991, J VIROL, V65, P2960, DOI 10.1128/JVI.65.6.2960-2967.1991; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kimata JT, 2006, CURR HIV RES, V4, P65, DOI 10.2174/157016206775197628; Kong XH, 2008, J VIROL, V82, P11609, DOI 10.1128/JVI.00952-08; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Lobritz MA, 2007, J VIROL, V81, P8258, DOI 10.1128/JVI.02739-06; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Lucas GM, 2005, J ANTIMICROB CHEMOTH, V55, P413, DOI 10.1093/jac/dki042; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Marozsan AJ, 2005, J VIROL, V79, P7121, DOI 10.1128/JVI.79.11.7121-7134.2005; MCKEATING JA, 1989, AIDS, V3, P777, DOI 10.1097/00002030-198912000-00001; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Miura T, 2009, J VIROL; NARA PL, 1990, J VIROL, V64, P3779, DOI 10.1128/JVI.64.8.3779-3791.1990; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Rangel HR, 2003, J VIROL, V77, P9069, DOI 10.1128/JVI.77.16.9069-9073.2003; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Saen-oon S, 2007, J MOL GRAPH MODEL, V26, P720, DOI 10.1016/j.jmgm.2007.04.009; Sardanyes J, 2008, J THEOR BIOL, V250, P560, DOI 10.1016/j.jtbi.2007.10.027; Sather DN, 2012, J VIROL, V86, P12676, DOI 10.1128/JVI.01893-12; Schlub TE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000766; Sharma PL, 1997, J VIROL, V71, P8846, DOI 10.1128/JVI.71.11.8846-8851.1997; Sole RV, 1999, J THEOR BIOL, V198, P47, DOI 10.1006/jtbi.1999.0901; Song HS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-89; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Sterjovski J, 2011, VIROLOGY, V410, P418, DOI 10.1016/j.virol.2010.12.010; Tebit DM, 2007, AIDS REV, V9, P75; Thenin S, 2012, VIROLOGY, V426, P12, DOI 10.1016/j.virol.2012.01.017; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Tso FY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032827; Tso FY, 2009, AIDS, V23, P1817, DOI 10.1097/QAD.0b013e32832f3da6; van Gils MJ, 2010, J VIROL, V84, P3576, DOI 10.1128/JVI.02622-09; Wang CY, 1999, P NATL ACAD SCI USA, V96, P10367, DOI 10.1073/pnas.96.18.10367; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Weber J, 2003, J GEN VIROL, V84, P2217, DOI 10.1099/vir.0.19123-0; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X; Zhang H, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-67; Zhang H, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-73	96	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63094	10.1371/journal.pone.0063094	http://dx.doi.org/10.1371/journal.pone.0063094			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638182	Green Published, gold			2022-12-25	WOS:000321662800075
J	Huang, SH; Wang, L; Chi, F; Wu, CH; Cao, H; Zhang, AM; Jong, A				Huang, Sheng-He; Wang, Lin; Chi, Feng; Wu, Chun-Hua; Cao, Hong; Zhang, Aimin; Jong, Ambrose			Circulating Brain Microvascular Endothelial Cells (cBMECs) as Potential Biomarkers of the Blood-Brain Barrier Disorders Caused by Microbial and Non-Microbial Factors	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CRYPTOCOCCUS-NEOFORMANS BINDING; ESCHERICHIA-COLI INVASION; TERMINAL HYDROLASE L1; PROGENITOR CELLS; BACTERIAL-MENINGITIS; OXIDATIVE STRESS; UP-REGULATION; IN-VIVO; HIV-1	Despite aggressive research, central nervous system (CNS) disorders, including blood-brain barrier (BBB) injury caused by microbial infection, stroke, abused drugs [e. g., methamphetamine (METH) and nicotine], and other pathogenic insults, remain the world's leading cause of disabilities. In our previous work, we found that dysfunction of brain microvascular endothelial cells (BMECs), which are a major component of the BBB, could be caused by nicotine, meningitic pathogens and microbial factors, including HIV-1 virulence factors gp41 and gp120. One of the most challenging issues in this area is that there are no available cell-based biomarkers in peripheral blood for BBB disorders caused by microbial and non-microbial insults. To identify such cellular biomarkers for BBB injuries, our studies have shown that mice treated with nicotine, METH and gp120 resulted in increased blood levels of CD146+(endothelial marker)/S100B+ (brain marker) circulating BMECs (cBMECs) and CD133+[progenitor cell (PC) marker]/CD146+ endothelial PCs (EPCs), along with enhanced Evans blue and albumin extravasation into the brain. Nicotine and gp120 were able to significantly increase the serum levels of ubiquitin C-terminal hydrolase 1 (UCHL1) (a new BBB marker) as well as S100B in mice, which are correlated with the changes in cBMECs and EPCs. Nicotine-and meningitic E. coli K1-induced enhancement of cBMEC levels, leukocyte migration across the BBB and albumin extravasation into the brain were significantly reduced in alpha7 nAChR knockout mice, suggesting that this inflammatory regulator plays an important role in CNS inflammation and BBB disorders caused by microbial and non-microbial factors. These results demonstrated that cBMECs as well as EPCs may be used as potential cell-based biomarkers for indexing of BBB injury.	[Huang, Sheng-He; Wang, Lin; Chi, Feng; Wu, Chun-Hua; Zhang, Aimin; Jong, Ambrose] Univ Calif Los Angeles, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90024 USA; [Huang, Sheng-He; Cao, Hong] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Wang, Lin] Wuhan Univ, Sch Basic Med Sci, Dept Histol & Embryol, Wuhan 430072, Peoples R China; [Zhang, Aimin] 302 Hosp, Ctr Diag & Treatment Liver Failure, Beijing, Peoples R China	Children's Hospital Los Angeles; University of California System; University of California Los Angeles; Southern Medical University - China; Wuhan University; Fifth Medical Center of Chinese PLA General Hospital	Huang, SH (corresponding author), Univ Calif Los Angeles, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90024 USA.	shhuang@hsc.usc.edu	Chi, Feng/H-5895-2012		Public Health Service [R03-DA034515, R01-NS047599]; Saban Research Institute Research Career Development Fellowship (RCDF); China Natural Science Foundation [81070514, 81171644]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA034515] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Saban Research Institute Research Career Development Fellowship (RCDF); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was financially supported by Public Health Service grants R03-DA034515 (SHH) and R01-NS047599 (AJ), a Saban Research Institute Research Career Development Fellowship (RCDF) (FC), China Natural Science Foundation grants No. 81070514 (LW) and No. 81171644 (HC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester LY, 2012, J BIOL CHEM, V287, P3079, DOI 10.1074/jbc.M111.262543; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Begley D.J., 2006, ENHANCEMENT DRUG DEL, P575; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Bogoslovsky T, 2010, NEUROLOGY, V75, P2059, DOI 10.1212/WNL.0b013e318200d741; Che XJ, 2011, BRAIN PATHOL, V21, P389, DOI 10.1111/j.1750-3639.2010.00463.x; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chen YH, 2002, CELL MICROBIOL, V4, P503, DOI 10.1046/j.1462-5822.2002.00209.x; Chi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035862; Chi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025016; Chi F, 2011, FUTURE MICROBIOL, V6, P953, DOI 10.2217/FMB.11.65; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Esteve-Rudd J, 2010, BRAIN RES, V1352, P70, DOI 10.1016/j.brainres.2010.07.019; Fink K, 2010, CRIT CARE, V14, DOI 10.1186/cc9050; FLEMING JO, 1983, J NEUROIMMUNOL, V4, P129, DOI 10.1016/0165-5728(83)90017-6; Foster W, 2009, RHEUMATOLOGY, V48, P285, DOI 10.1093/rheumatology/ken486; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Fritzsch FSO, 2012, ANNU REV CHEM BIOMOL, V3, P129, DOI 10.1146/annurev-chembioeng-062011-081056; Goon PKY, 2006, NEOPLASIA, V8, P79, DOI 10.1593/neo.05592; Haubitz M, 2009, AUTOIMMUNITY, V42, P605, DOI 10.1080/08916930903002503; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Huang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048570; Huang SH, 2011, BIOCHEM J, V438, P457, DOI 10.1042/BJ20110218; JACKSON CJ, 1990, J CELL SCI, V96, P257; Jong A, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/375620; Jong AY, 2007, BIOCHEM BIOPH RES CO, V356, P899, DOI 10.1016/j.bbrc.2007.03.100; Jung KH, 2008, J CLIN NEUROL, V4, P139, DOI 10.3988/jcn.2008.4.4.139; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kraan J, 2012, DRUG DISCOV TODAY, V17, P710, DOI 10.1016/j.drudis.2012.01.011; Lamers SL, 2011, INFECT GENET EVOL, V11, P31, DOI 10.1016/j.meegid.2010.10.016; Lee JD, 2006, ACTA TROP, V97, P204, DOI 10.1016/j.actatropica.2005.11.003; Lelyveld VS, 2010, INT J IMAG SYST TECH, V20, P71, DOI 10.1002/ima.20221; LESLIE M, 2011, SCIENCE, V331, P24; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Loram LC, 2010, BRAIN BEHAV IMMUN, V24, P959, DOI 10.1016/j.bbi.2010.03.008; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Martinez LR, 2009, J INFECT DIS, V200, P131, DOI 10.1086/599328; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Miric D, 2010, CLIN BIOCHEM, V43, P246, DOI 10.1016/j.clinbiochem.2009.09.023; Mitra S, 2011, AM J RESP CRIT CARE, V184, P1030, DOI 10.1164/rccm.201103-0447OC; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Northrop NA, 2011, J PHARMACOL EXP THER, V336, P900, DOI 10.1124/jpet.110.177287; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; Olsen AL, 2007, ANTIVIR RES, V75, P104, DOI 10.1016/j.antiviral.2006.11.013; Patel MM, 2009, CNS DRUGS, V23, P35, DOI 10.2165/0023210-200923010-00003; Pendyala G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037604; Porto I, 2011, ATHEROSCLEROSIS, V216, P355, DOI 10.1016/j.atherosclerosis.2011.02.014; Rouhl RPW, 2009, CURR NEUROVASC RES, V6, P32, DOI 10.2174/156720209787466082; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Slominski A, 2010, AM J PHYSIOL-CELL PH, V299, pC885, DOI 10.1152/ajpcell.00324.2010; Stahlberg A, 2011, EXPERT REV MOL DIAGN, V11, P735, DOI [10.1586/erm.11.60, 10.1586/ERM.11.60]; Stastny F, 1997, MOL CHEM NEUROPATHOL, V32, P143, DOI 10.1007/BF02815173; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Stins MF, 2001, J NEUROVIROL, V7, P125; Strazza M, 2011, BRAIN RES, V1399, P96, DOI 10.1016/j.brainres.2011.05.015; Strijbos MH, 2008, BRIT J CANCER, V98, P1731, DOI 10.1038/sj.bjc.6604383; Takami Y, 2007, ARTERIOSCL THROM VAS, V27, P2184, DOI 10.1161/ATVBAHA.107.142505; Tsoporis JN, 2012, J MOL CELL CARDIOL, V52, P464, DOI 10.1016/j.yjmcc.2011.08.015; Zhang XH, 2007, J CEREBR BLOOD F MET, V27, P534, DOI 10.1038/sj.jcbfm.9600368; Zhang YL, 2012, BRAIN RES, V1458, P1, DOI 10.1016/j.brainres.2012.04.001; Zhong JL, 2012, INT J MOL MED, V30, P430, DOI 10.3892/ijmm.2012.1012; Zhong JF, 2008, LAB CHIP, V8, P68, DOI 10.1039/b712116d	69	19	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62164	10.1371/journal.pone.0062164	http://dx.doi.org/10.1371/journal.pone.0062164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637989	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700037
J	Le Pichon, CE; Dominguez, SL; Solanoy, H; Ngu, H; Lewin-Koh, N; Chen, M; Eastham-Anderson, J; Watts, R; Scearce-Levie, K				Le Pichon, Claire E.; Dominguez, Sara L.; Solanoy, Hilda; Ngu, Hai; Lewin-Koh, Nicholas; Chen, Mark; Eastham-Anderson, Jeffrey; Watts, Ryan; Scearce-Levie, Kimberly			EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALS	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; SPINAL-CORD; BRAIN-STEM; RECEPTOR; MICE; ACTIVATION	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive paralysis due to motor neuron death. Several lines of published evidence suggested that inhibition of epidermal growth factor receptor (EGFR) signaling might protect neurons from degeneration. To test this hypothesis in vivo, we treated the SOD1 transgenic mouse model of ALS with erlotinib, an EGFR inhibitor clinically approved for oncology indications. Although erlotinib failed to extend ALS mouse survival it did provide a modest but significant delay in the onset of multiple behavioral measures of disease progression. However, given the lack of protection of motor neuron synapses and the lack of survival extension, the small benefits observed after erlotinib treatment appear purely symptomatic, with no modification of disease course.	[Le Pichon, Claire E.; Dominguez, Sara L.; Solanoy, Hilda; Chen, Mark; Watts, Ryan; Scearce-Levie, Kimberly] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Ngu, Hai; Eastham-Anderson, Jeffrey] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Lewin-Koh, Nicholas] Genentech Inc, Dept Nonclin Biostat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Scearce-Levie, K (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	scearcelevie.kimberly@gene.com	Le Pichon, Claire/ABB-9829-2020	Le Pichon, Claire/0000-0002-9274-3615	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Genentech, Inc. funded this research. The study was funded by Genentech, Inc. through the employment (at the time of the study) of the authors. These authors contributed to all aspects of the study. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Angenstein F, 2004, NEUROREPORT, V15, P2271, DOI 10.1097/00001756-200410050-00026; Bates D, 2012, LINEAR MIXED EFFECTS; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Canton T, 1998, NEUROREPORT, V9, P775, DOI 10.1097/00001756-199803300-00001; Carlsson T, 2011, J NEUROCHEM, V117, P1066, DOI 10.1111/j.1471-4159.2011.07284.x; CHIU AY, 1995, MOL CELL NEUROSCI, V6, P349, DOI 10.1006/mcne.1995.1027; Derave W, 2003, NEUROBIOL DIS, V13, P264, DOI 10.1016/S0969-9961(03)00041-X; Erschbamer M, 2007, J NEUROSCI, V27, P6428, DOI 10.1523/JNEUROSCI.1037-07.2007; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Frey D, 2000, J NEUROSCI, V20, P2534; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; Hossaini M, 2011, J NEUROPATH EXP NEUR, V70, P662, DOI 10.1097/NEN.0b013e31822581ac; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kennedy HS, 2011, LAB ANIMAL, V40, P53, DOI 10.1038/laban0211-53; Kraus D., 2008, SURV2SAMPLE 2 SAMPLE; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; Offen D, 2009, J MOL NEUROSCI, V38, P85, DOI 10.1007/s12031-007-9004-z; Pollack VA, 1999, J PHARMACOL EXP THER, V291, P739; Schlatterer SD, 2011, J ALZHEIMERS DIS, V25, P119, DOI 10.3233/JAD-2011-102025; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zang DW, 2004, EUR J NEUROSCI, V20, P1745, DOI 10.1111/j.1460-9568.2004.03648.x	31	30	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62342	10.1371/journal.pone.0062342	http://dx.doi.org/10.1371/journal.pone.0062342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638043	Green Submitted, gold, Green Published			2022-12-25	WOS:000318343700049
J	Salgueiro, P; Moreno, M; Simard, F; O'Brochta, D; Pinto, J				Salgueiro, Patricia; Moreno, Marta; Simard, Frederic; O'Brochta, David; Pinto, Joao			New Insights into the Population Structure of Anopheles gambiae s.s. in the Gulf of Guinea Islands Revealed by Herves Transposable Elements	PLOS ONE			English	Article							TOME-AND-PRINCIPE; SAO-TOME; MALARIA VECTOR; GENETIC DIFFERENTIATION; INSERTION POLYMORPHISM; BIOKO ISLAND; F-STATISTICS; WEST-AFRICA; CULICIDAE; DYNAMICS	Transposable elements (TEs) are mobile portions of DNA that are able to replicate and spread in the genome of many organisms. TEs can be used as a means to insert transgenes in insects, being stably inherited throughout generations. Anopheles gambiae is the main vector of human malaria in Sub-Saharan Africa. Given the extraordinary burden this disease imposes, the mosquito became a choice target for genetic control approaches with the purpose of reducing malaria transmission. In this study, we investigated the abundance and distribution of Herves TE in An. gambiae s.s. from Cameroon and four islands in the Gulf of Guinea, in order to determine their genetic structure. We have detected a population subdivision between Equatorial Guinea islands and the islands of Sao Tome, Principe and mainland. This partitioning associates more with political rather than geographic boundaries, possibly reflecting different mainland source populations colonizing the islands.	[Salgueiro, Patricia; Pinto, Joao] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais UEI Parasi, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Moreno, Marta] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Simard, Frederic] UM2, Inst Rech Dev, UM1, UMR IRD224,CNRS5290, Montpellier, France; [O'Brochta, David] Univ Maryland, Dept Entomol, Rockville, MD USA; [O'Brochta, David] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Salgueiro, P (corresponding author), Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais UEI Parasi, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.	psalgueiro@ihmt.unl.pt	SIMARD, Frederic/J-9489-2016; Moreno, Marta/AAW-8848-2020; Salgueiro, Patrícia/B-6410-2012; Frederic, SIMARD/AFV-5001-2022; Pinto, Joao/C-2208-2012; J., Pinto/H-6177-2019	SIMARD, Frederic/0000-0002-2871-5329; Moreno, Marta/0000-0002-9091-5612; Salgueiro, Patrícia/0000-0001-8628-3651; Frederic, SIMARD/0000-0002-2871-5329; Pinto, Joao/0000-0001-8572-7708; J., Pinto/0000-0001-8572-7708	UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) [A50239]; CMDT/IHMT Plurianual Program funds; US National Institutes of Health [GM48102]; Fundacao para a Ciencia e Tecnologia (FCT) through the European Program FEDER [SFRH/BPD/72532/2010]	UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR); CMDT/IHMT Plurianual Program funds; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia (FCT) through the European Program FEDER	This work received financial support from the UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR, A50239) and CMDT/IHMT Plurianual Program funds, as well as the US National Institutes of Health grant GM48102. PS was funded by a post-doc fellowship (SFRH/BPD/72532/2010) from Fundacao para a Ciencia e Tecnologia (FCT) through the European Program FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Antao T, 2011, BIOINFORMATICS; Arensburger P, 2005, GENETICS, V169, P697, DOI 10.1534/genetics.104.036145; Barnes MJ, 2005, INSECT MOL BIOL, V14, P353, DOI 10.1111/j.1365-2583.2005.00566.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Belkhir K, 1996, GENETIX 4 05 COMPUTE; Berzosa PJ, 2002, J VECTOR ECOL, V27, P102; Boulesteix M, 2007, MOL ECOL, V16, P441, DOI 10.1111/j.1365-294X.2006.03150.x; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Craig NL., 2002, MOBILE DNA-UK; Deceliere G, 2005, GENETICS, V169, P467, DOI 10.1534/genetics.104.032243; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Donnelly MJ, 1999, HEREDITY, V83, P408, DOI 10.1038/sj.hdy.6885930; Esnault C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001968; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Fernandez-Medina RD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-260; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Fraser MJ, 2012, ANNU REV ENTOMOL, V57, P267, DOI 10.1146/annurev.ento.54.110807.090545; Handler AM, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P90, DOI 10.1016/B978-0-12-384747-8.10004-2; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Holsinger KE, 2005, HICKORY PACKAGE ANAL; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; JONES PJ, 1994, BIODIVERS CONSERV, V3, P772, DOI 10.1007/BF00129657; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Lanzaro GC, 2006, WAG UR FRON, V11, P157, DOI 10.1007/1-4020-3799-6_14; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Lehmann T, 1998, MOL BIOL EVOL, V15, P264, DOI 10.1093/oxfordjournals.molbev.a025923; Lepetit D, 2002, MOL ECOL, V11, P347, DOI 10.1046/j.1365-294X.2002.01470.x; Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020; Marshall JC, 2008, EVOL APPL, V1, P631, DOI 10.1111/j.1752-4571.2008.00048.x; Mateu E, 1997, ANN HUM GENET, V61, P507, DOI 10.1017/S0003480097006544; MILLER LH, 1987, SCIENCE, V237, P779, DOI 10.1126/science.3039658; MOLINA R, 1993, J MED ENTOMOL, V30, P622, DOI 10.1093/jmedent/30.3.622; Moreno M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-137; O'Brochta DA, 2006, GENETICA, V127, P185, DOI 10.1007/s10709-005-3535-4; Pardo G, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-10; Pinto J, 2003, HEREDITY, V91, P407, DOI 10.1038/sj.hdy.6800348; Pinto J, 2002, MOL ECOL, V11, P2183, DOI 10.1046/j.1365-294X.2002.01587.x; Pinto J, 2000, ACTA TROP, V76, P185, DOI 10.1016/S0001-706X(00)00100-5; Reimer LJ, 2005, INSECT MOL BIOL, V14, P683, DOI 10.1111/j.1365-2583.2005.00599.x; Ribeiro H., 1990, GARCIA ORTA Z, V15, P135; RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P10, DOI 10.1093/jmedent/31.1.10; Rousset F, 1997, GENETICS, V145, P1219; Simard F, 2000, INSECT MOL BIOL, V9, P467, DOI 10.1046/j.1365-2583.2000.00210.x; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Struchiner CJ, 2009, EVOLUTION, V63, P3136, DOI 10.1111/j.1558-5646.2009.00788.x; Subramanian RA, 2007, GENETICS, V176, P2477, DOI 10.1534/genetics.107.071811; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2009, PROGR PROSP US GEN M; Wright SI, 2001, GENETICS, V158, P1279	56	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62964	10.1371/journal.pone.0062964	http://dx.doi.org/10.1371/journal.pone.0062964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638171	gold, Green Published, Green Submitted			2022-12-25	WOS:000318343700082
J	Dyer, LA; Richards, LA; Short, SA; Dodson, CD				Dyer, Lee A.; Richards, Lora A.; Short, Stephanie A.; Dodson, Craig D.			Effects of CO2 and Temperature on Tritrophic Interactions	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; ELEVATED ATMOSPHERIC CO2; CLIMATE-CHANGE; SPECIES INTERACTIONS; CARBON-DIOXIDE; GLOBAL CHANGE; HERBIVORE INTERACTIONS; BIOTIC INTERACTIONS; TROPHIC CASCADES; CHANGE IMPACTS	There has been a significant increase in studies of how global change parameters affect interacting species or entire communities, yet the combined or interactive effects of increased atmospheric CO2 and associated increases in global mean temperatures on chemically mediated trophic interactions are mostly unknown. Thus, predictions of climate-induced changes on plant-insect interactions are still based primarily on studies of individual species, individual global change parameters, pairwise interactions, or parameters that summarize communities. A clear understanding of community response to global change will only emerge from studies that examine effects of multiple variables on biotic interactions. We examined the effects of increased CO2 and temperature on simple laboratory communities of interacting alfalfa, chemical defense, armyworm caterpillars, and parasitoid wasps. Higher temperatures and CO2 caused decreased plant quality, decreased caterpillar development times, developmental asynchrony between caterpillars and wasps, and complete wasp mortality. The effects measured here, along with other effects of global change on natural enemies suggest that biological control and other top-down effects of insect predators will decline over the coming decades.	[Dyer, Lee A.; Richards, Lora A.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Short, Stephanie A.] Lewis & Clark Law Sch, Portland, OR USA; [Dodson, Craig D.] Univ Nevada, Desert Res Inst, Reno, NV 89506 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Nevada Reno	Dyer, LA (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	nolaclimber@gmail.com		Richards, Lora/0000-0002-8052-4378	Earthwatch Institute; University of Nevada Reno; Department of Energy (National Institute for Global Environmental Change); National Science Foundation [DEB1020509, DEB0849361]; Department of Energy (National Institute for Climatic Change Research)	Earthwatch Institute; University of Nevada Reno; Department of Energy (National Institute for Global Environmental Change)(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Department of Energy (National Institute for Climatic Change Research)(United States Department of Energy (DOE))	This work was supported by: Earthwatch Institute (www.Earthwatch.org), University of Nevada Reno (www.unr.edu), Department of Energy (National Institute for Global Environmental Change and National Institute for Climatic Change Research, http://niccr.nau.edu/), and National Science Foundation (nsf.gov) grants - DEB1020509 and DEB0849361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrell J, 2004, J CHEM ECOL, V30, P2309, DOI 10.1023/B:JOEC.0000048791.74017.93; ALI A, 1990, ANN ENTOMOL SOC AM, V83, P725, DOI 10.1093/aesa/83.4.725; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bannerman JA, 2011, ECOL ENTOMOL, V36, P490, DOI 10.1111/j.1365-2311.2011.01292.x; Barbosa HA, 2004, VEGETATION DYNAMICS; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Berggren A, 2009, OIKOS, V118, P1121, DOI 10.1111/j.1600-0706.2009.17558.x; Bezemer TM, 1998, OECOLOGIA, V116, P128, DOI 10.1007/s004420050571; Bezemer TM, 1998, OIKOS, V82, P212, DOI 10.2307/3546961; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Binzer A, 2012, PHILOS T R SOC B, V367, P2935, DOI 10.1098/rstb.2012.0230; Brose U, 2012, PHILOS T R SOC B, V367, P2903, DOI 10.1098/rstb.2012.0232; Butler CD, 2010, BIOCONTROL SCI TECHN, V20, P391, DOI 10.1080/09583150903551587; Cotrufo MF, 1998, GLOBAL CHANGE BIOL, V4, P43, DOI 10.1046/j.1365-2486.1998.00101.x; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; de Sassi C, 2012, PHILOS T R SOC B, V367, P3033, DOI 10.1098/rstb.2012.0233; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; de Sassi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040557; Dyer LA, 2004, ECOLOGY, V85, P2795, DOI 10.1890/03-0233; Dyer LA, 2003, BASIC APPL ECOL, V4, P423, DOI 10.1078/1439-1791-00191; Gillespie DR, 2012, OIKOS, V121, P149, DOI 10.1111/j.1600-0706.2011.19512.x; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; HAGGSTROM H, 1995, OECOLOGIA, V104, P308, DOI 10.1007/BF00328366; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harmon JP, 2009, SCIENCE, V323, P1347, DOI 10.1126/science.1167396; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Harvey JA, 1999, J INSECT PHYSIOL, V45, P173, DOI 10.1016/S0022-1910(98)00113-9; Harvey JA, 2005, J CHEM ECOL, V31, P287, DOI 10.1007/s10886-005-1341-1; Harvey JA, 2010, J INSECT PHYSIOL, V56, P1178, DOI 10.1016/j.jinsphys.2010.03.018; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hoekman D, 2010, ECOLOGY, V91, P2819, DOI 10.1890/10-0260.1; Hoover JK, 2004, GLOBAL CHANGE BIOL, V10, P1197, DOI 10.1111/j.1529-8817.2003.00796.x; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hulme M, 1998, CLIMATIC CHANGE, V39, P145, DOI 10.1023/A:1005376007729; Klapwijk MJ, 2010, GLOBAL CHANGE BIOL, V16, P102, DOI 10.1111/j.1365-2486.2009.01918.x; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Kratina P, 2012, ECOLOGY, V93, P1421, DOI 10.1890/11-1595.1; Kursar TA, 2009, P NATL ACAD SCI USA, V106, P18073, DOI 10.1073/pnas.0904786106; Lampert EC, 2011, J CHEM ECOL, V37, P1063, DOI 10.1007/s10886-011-0018-1; Li S. Y., 1996, ACTA BOT SIN, V38, P83; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; Logan JD, 2006, ECOL MODEL, V196, P471, DOI 10.1016/j.ecolmodel.2006.02.034; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Lurgi M, 2012, PHILOS T R SOC B, V367, P3050, DOI 10.1098/rstb.2012.0239; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Merrill RM, 2008, J ANIM ECOL, V77, P145, DOI 10.1111/j.1365-2656.2007.01303.x; Mironidis GK, 2009, BIOL CONTROL, V49, P58, DOI 10.1016/j.biocontrol.2008.12.006; Newman JA, 2004, GLOBAL CHANGE BIOL, V10, P5, DOI 10.1111/j.1365-2486.2003.00709.x; O'Connor MI, 2011, AM NAT, V178, P626, DOI 10.1086/662171; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson CV, 2008, ENVIRON ENTOMOL, V37, P947, DOI 10.1603/0046-225X(2008)37[947:DCIAFF]2.0.CO;2; Pecetti L, 2006, EUR J AGRON, V25, P187, DOI 10.1016/j.eja.2006.04.013; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petchey OL, 2010, PHILOS T R SOC B, V365, P2081, DOI 10.1098/rstb.2010.0011; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; Putnam DH, 2000, IMP W ALF PROD P 200; Roth S, 1998, GLOBAL CHANGE BIOL, V4, P419, DOI 10.1046/j.1365-2486.1998.00164.x; Sallas L, 2003, TREE PHYSIOL, V23, P97, DOI 10.1093/treephys/23.2.97; Schadler M, 2007, GLOBAL CHANGE BIOL, V13, P1005, DOI 10.1111/j.1365-2486.2007.01319.x; Shurin JB, 2012, PHILOS T R SOC B, V367, P3008, DOI 10.1098/rstb.2012.0243; Smilanich Angela M., 2012, Insects, V3, P616, DOI 10.3390/insects3030616; Stacey DA, 2003, INT J PEST MANAGE, V49, P205, DOI 10.1080/0967087031000085042; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022; Traill LW, 2010, J ANIM ECOL, V79, P937, DOI 10.1111/j.1365-2656.2010.01695.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Voigt W, 2007, GLOBAL CHANGE BIOL, V13, P1710, DOI 10.1111/j.1365-2486.2007.01398.x; Williams RS, 2003, OECOLOGIA, V137, P114, DOI 10.1007/s00442-003-1327-z; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x	72	57	58	1	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62528	10.1371/journal.pone.0062528	http://dx.doi.org/10.1371/journal.pone.0062528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638105	gold, Green Published, Green Submitted			2022-12-25	WOS:000318341400056
J	Yu, L; Li, Y; Zhao, K; Tang, YF; Cheng, Z; Chen, J; Zang, Y; Wu, JW; Kong, L; Liu, SA; Lei, W; Wu, ZX				Yu, Long; Li, Yang; Zhao, Kang; Tang, Yufei; Cheng, Zhe; Chen, Jun; Zang, Yuan; Wu, Jianwei; Kong, Liang; Liu, Shuai; Lei, Wei; Wu, Zixiang			A Novel Injectable Calcium Phosphate Cement-Bioactive Glass Composite for Bone Regeneration	PLOS ONE			English	Article							BETA-TRICALCIUM PHOSPHATE; CELL-PROLIFERATION; DIFFERENTIATION; SCAFFOLDS; RAT; BIOMATERIAL; DEGRADATION; STRENGTH; ADHESION; COLLAGEN	Background: Calcium phosphate cement (CPC) can be molded or injected to form a scaffold in situ, which intimately conforms to complex bone defects. Bioactive glass (BG) is known for its unique ability to bond to living bone and promote bone growth. However, it was not until recently that literature was available regarding CPC-BG applied as an injectable graft. In this paper, we reported a novel injectable CPC-BG composite with improved properties caused by the incorporation of BG into CPC. Materials and Methods: The novel injectable bioactive cement was evaluated to determine its composition, microstructure, setting time, injectability, compressive strength and behavior in a simulated body fluid (SBF). The in vitro cellular responses of osteoblasts and in vivo tissue responses after the implantation of CPC-BG in femoral condyle defects of rabbits were also investigated. Results: CPC-BG possessed a retarded setting time and markedly better injectability and mechanical properties than CPC. Moreover, a new Ca-deficient apatite layer was deposited on the composite surface after immersing immersion in SBF for 7 days. CPC-BG samples showed significantly improved degradability and bioactivity compared to CPC in simulated body fluid (SBF). In addition, the degrees of cell attachment, proliferation and differentiation on CPC-BG were higher than those on CPC. Macroscopic evaluation, histological evaluation, and micro-computed tomography (micro-CT) analysis showed that CPC-BG enhanced the efficiency of new bone formation in comparison with CPC. Conclusions: A novel CPC-BG composite has been synthesized with improved properties exhibiting promising prospects for bone regeneration.	[Yu, Long; Li, Yang; Chen, Jun; Zang, Yuan; Wu, Jianwei; Liu, Shuai; Lei, Wei; Wu, Zixiang] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped, Xian 710032, Shaanxi Provinc, Peoples R China; [Zhao, Kang; Tang, Yufei; Cheng, Zhe] Xian Univ Technol, Sch Mat & Engn, Xian, Shaanxi Provinc, Peoples R China; [Kong, Liang] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Xi'an University of Technology; Air Force Military Medical University	Lei, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped, Xian 710032, Shaanxi Provinc, Peoples R China.	leiwei@fmmu.edu.cn; wuzixiang@fmmu.edu.cn	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Lei, Wei/0000-0002-7346-6915	National Science Foundation of China [31170913]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (No. 31170913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodde EWH, 2008, J BIOMED MATER RES A, V87A, P780, DOI 10.1002/jbm.a.31830; Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059; Brown WE., 1986, CEMENTS RES PROGR, P352; Chen QZ, 2008, J BIOMED MATER RES A, V84A, P1049, DOI 10.1002/jbm.a.31512; Chen ZG, 2011, J BIOMED MATER RES A, V99A, P554, DOI 10.1002/jbm.a.33212; Chou SY, 2009, BIOMATERIALS, V30, P3136, DOI 10.1016/j.biomaterials.2009.02.037; Christodoulou I, 2005, J BIOMED MATER RES B, V74B, P529, DOI 10.1002/jbm.b.30249; Combes C, 2010, ACTA BIOMATER, V6, P920, DOI 10.1016/j.actbio.2009.08.032; Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0; Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018; He Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042525; Heikkila JT, 1995, BIOCERAMICS, V8, P35; Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014; Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; Hu GF, 2010, J MATER SCI-MATER M, V21, P627, DOI 10.1007/s10856-009-3885-z; Huan ZG, 2009, ACTA BIOMATER, V5, P1253, DOI 10.1016/j.actbio.2008.10.006; Huan ZG, 2009, J MATER SCI-MATER M, V20, P833, DOI 10.1007/s10856-008-3641-9; Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542; Julien M, 2007, BIOMATERIALS, V28, P956, DOI 10.1016/j.biomaterials.2006.10.018; Kobayashi M, 1999, J BIOMED MATER RES, V46, P447, DOI 10.1002/(SICI)1097-4636(19990915)46:4<447::AID-JBM2>3.3.CO;2-G; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031; Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19; Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033; Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029; Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003; Lin Q, 2010, J MATER SCI-MATER M, V21, P3065, DOI 10.1007/s10856-010-4160-z; Link DP, 2008, BIOMATERIALS, V29, P675, DOI 10.1016/j.biomaterials.2007.10.029; Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015; Lu JX, 2011, J MATER SCI-MATER M, V22, P607, DOI 10.1007/s10856-011-4228-4; Manitha B, 2009, J MATER SCI-MATER M, V20, pS251; Miguel BS, 2010, J BIOMED MATER RES A, V94A, P1023, DOI 10.1002/jbm.a.32773; Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022; Pamula E, 2011, ANN BIOMED ENG, V39, P2114, DOI 10.1007/s10439-011-0307-4; Radin S, 2005, J BIOMED MATER RES A, V73A, P21, DOI 10.1002/jbm.a.30241; Reilly GC, 2007, BIOMATERIALS, V28, P4091, DOI 10.1016/j.biomaterials.2007.05.038; Renno ACM, 2013, ACTA BIOMATER, V9, P5728, DOI 10.1016/j.actbio.2012.11.009; Saboori A, 2009, MAT SCI ENG C-BIO S, V29, P335, DOI 10.1016/j.msec.2008.07.004; Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019; van de Watering FCJ, 2012, CLIN ORAL IMPLAN RES, V23, P151, DOI 10.1111/j.1600-0501.2011.02218.x; Wada Y, 1998, BONE, V22, P479, DOI 10.1016/S8756-3282(98)00039-8; Wu C, 2009, BIOMATERIALS, V30, P2199, DOI 10.1016/j.biomaterials.2009.01.029; Wu F, 2008, ACTA BIOMATER, V4, P1873, DOI 10.1016/j.actbio.2008.06.020; Xu HHK, 2010, TISSUE ENG PT A, V16, P2743, DOI [10.1089/ten.tea.2009.0757, 10.1089/ten.TEA.2009.0757]; Yao J, 2005, J BIOMED MATER RES A, V75A, P794, DOI 10.1002/jbm.a.30494; Zhang JT, 2011, MAT SCI ENG C-MATER, V31, P740, DOI 10.1016/j.msec.2010.10.014	46	45	45	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62570	10.1371/journal.pone.0062570	http://dx.doi.org/10.1371/journal.pone.0062570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638115	Green Submitted, gold, Green Published			2022-12-25	WOS:000318341400060
J	Chung, YM; Goyette, J; Tedla, N; Hsu, K; Geczy, CL				Chung, Yuen Ming; Goyette, Jesse; Tedla, Nicodemus; Hsu, Kenneth; Geczy, Carolyn L.			S100A12 Suppresses Pro-inflammatory, but Not Pro-Thrombotic Functions of Serum Amyloid A	PLOS ONE			English	Article							ACUTE-PHASE PROTEIN; HIGH-DENSITY-LIPOPROTEIN; NECROSIS-FACTOR-ALPHA; FORMYL PEPTIDE RECEPTOR-LIKE-1; C-REACTIVE PROTEIN; FACTOR-KAPPA-B; A-PROTEIN; EN-RAGE; LUNG INFLAMMATION; MESSENGER-RNA	S100A12 is elevated in the circulation in patients with chronic inflammatory diseases and recent studies indicate pleiotropic functions. Serum amyloid A induces monocyte cytokines and tissue factor. S100A12 did not stimulate IL-6, IL-8, IL-1 beta or TNF-alpha production by human peripheral blood mononuclear cells but low amounts consistently reduced cytokine mRNA and protein levels induced by serum amyloid A, by similar to 49% and similar to 46%, respectively. However, S100A12 did not affect serum amyloid A-induced monocyte tissue factor. In marked contrast, LPS-induced cytokines or tissue factor were not suppressed by S100A12. S100A12 did not alter cytokine mRNA stability or the cytokine secretory pathway. S100A12 and serum amyloid A did not appear to form complexes and although they may have common receptors, suppression was unlikely via receptor competition. Serum amyloid A induces cytokines via activation of NF-kappa B and the MAPK pathways. S100A12 reduced serum amyloid A-, but not LPS-induced ERK1/2 phosphorylation to baseline. It did not affect JNK or p38 phosphorylation or the NF-kappa B pathway. Reduction in ERK1/2 phosphorylation by S100A12 was unlikely due to changes in intracellular reactive oxygen species, Ca2+ flux or to recruitment of phosphatases. We suggest that S100A12 may modulate sterile inflammation by blunting pro-inflammatory properties of lipid-poor serum amyloid A deposited in chronic lesions where both proteins are elevated as a consequence of macrophage activation.	[Chung, Yuen Ming; Goyette, Jesse; Tedla, Nicodemus; Hsu, Kenneth; Geczy, Carolyn L.] Univ New S Wales, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	Geczy, CL (corresponding author), Univ New S Wales, Inflammat & Infect Res Ctr, Sydney, NSW, Australia.	c.geczy@unsw.edu.au	Hsu, Kenneth/ABA-4079-2020; Goyette, Jesse/AAW-4701-2021	Goyette, Jesse/0000-0002-1008-1890	National Health and Medical Research Council of Australia [630647]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by grant #630647 from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2003, ANAL BIOCHEM, V318, P132, DOI 10.1016/S0003-2697(03)00192-1; Andrassy M, 2006, AM J PATHOL, V169, P1223, DOI 10.2353/ajpath.2006.050713; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bjorkman L, 2008, J LEUKOCYTE BIOL, V83, P245, DOI 10.1189/jlb.0607-408; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bowman MAH, 2011, CLIN EXP ALLERGY, V41, P878, DOI 10.1111/j.1365-2222.2011.03714.x; Bowman MAH, 2011, ARTERIOSCL THROM VAS, V31, P337, DOI 10.1161/ATVBAHA.110.217745; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Cai H, 2007, J IMMUNOL, V178, P1852, DOI 10.4049/jimmunol.178.3.1852; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cerioni L, 2003, FEBS LETT, V547, P92, DOI 10.1016/S0014-5793(03)00675-6; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Chung TF, 2000, AMYLOID, V7, P105, DOI 10.3109/13506120009146246; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Cunnane G, 2000, J RHEUMATOL, V27, P58; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Dong Z, 2011, MOL MED, V17, P1357, DOI 10.2119/molmed.2011.00186; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; ERIKSEN N, 1980, P NATL ACAD SCI-BIOL, V77, P6860, DOI 10.1073/pnas.77.11.6860; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2003, GUT, V52, P847, DOI 10.1136/gut.52.6.847; Foell D, 2003, LANCET, V361, P1270, DOI 10.1016/S0140-6736(03)12986-8; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Garner B, 1997, FREE RADICAL RES, V27, P487, DOI 10.3109/10715769709065788; Gatt ME, 1998, J LAB CLIN MED, V132, P414, DOI 10.1016/S0022-2143(98)90112-3; GECZY CL, 1994, INT REV CYTOL, V152, P49, DOI 10.1016/S0074-7696(08)62554-1; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Goyette J, 2009, J IMMUNOL, V183, P593, DOI 10.4049/jimmunol.0900373; Guignard F, 1996, EUR J BIOCHEM, V241, P265, DOI 10.1111/j.1432-1033.1996.0265t.x; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hasegawa T, 2003, ATHEROSCLEROSIS, V171, P211, DOI 10.1016/j.atherosclerosis.2003.08.021; Hatanaka E, 2003, FEMS IMMUNOL MED MIC, V38, P81, DOI 10.1016/S0928-8244(03)00112-3; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; HOFFMAN JS, 1982, J BIOL CHEM, V257, P518; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hoppmann S, 2010, INT J BIOCHEM CELL B, V42, P651, DOI 10.1016/j.biocel.2009.12.010; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Jang SY, 2012, GLIA, V60, P1619, DOI 10.1002/glia.22382; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; KUMON Y, 1994, CLIN BIOCHEM, V27, P469, DOI 10.1016/0009-9120(94)00044-V; Leach ST, 2007, SCAND J GASTROENTERO, V42, P1321, DOI 10.1080/00365520701416709; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; Lee HY, 2006, MOL PHARMACOL, V70, P241, DOI 10.1124/mol.105.022103; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Mishra JP, 2005, J BIOL CHEM, V280, P26825, DOI 10.1074/jbc.M500244200; MIWATA H, 1993, ARCH DIS CHILD, V68, P210, DOI 10.1136/adc.68.2.210; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; Ohta S, 2009, CHEM PHYS LIPIDS, V162, P62, DOI 10.1016/j.chemphyslip.2009.07.008; Okamoto H, 2008, J RHEUMATOL, V35, P752; Olsson N, 1999, BIOCHEM BIOPH RES CO, V254, P143, DOI 10.1006/bbrc.1998.9911; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; Song CJ, 2009, ATHEROSCLEROSIS, V202, P596, DOI 10.1016/j.atherosclerosis.2008.04.049; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tolle M, 2012, CARDIOVASC RES, V94, P154, DOI 10.1093/cvr/cvs089; Traore K, 2008, J CELL PHYSIOL, V216, P276, DOI 10.1002/jcp.21403; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; van Lent PL, 2010, ARTHRITIS RHEUM-US, V62, P3353, DOI 10.1002/art.27654; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; WALSH JD, 1991, THROMB HAEMOSTASIS, V66, P552; Wang LM, 2007, BIOCHEMISTRY-US, V46, P5562, DOI 10.1021/bi602629y; Wang XW, 2008, AM J PHYSIOL-HEART C, V295, pH2399, DOI 10.1152/ajpheart.00238.2008; Witting PK, 2011, FREE RADICAL BIO MED, V51, P1390, DOI 10.1016/j.freeradbiomed.2011.06.031; Yamada T, 2000, SCAND J IMMUNOL, V52, P7; Yan WX, 2008, J BIOL CHEM, V283, P13035, DOI 10.1074/jbc.M710388200; Yang Z, 2001, J LEUKOCYTE BIOL, V69, P986; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021; Yavin EJ, 2000, FEBS LETT, V472, P259, DOI 10.1016/S0014-5793(00)01470-8; Zhao Y, 2007, ARTERIOSCL THROM VAS, V27, P1645, DOI 10.1161/ATVBAHA.106.137455	101	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62372	10.1371/journal.pone.0062372	http://dx.doi.org/10.1371/journal.pone.0062372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638054	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400100
J	Chen, M; Hombrebueno, JR; Luo, C; Penalva, R; Zhao, JW; Colhoun, L; Pandi, SPS; Forrester, JV; Xu, HP				Chen, Mei; Hombrebueno, Jose R.; Luo, Chang; Penalva, Rosana; Zhao, Jiawu; Colhoun, Liza; Pandi, Sudha Pirya Soundara; Forrester, John V.; Xu, Heping			Age- and Light-Dependent Development of Localised Retinal Atrophy in CCL2(-/-)CX3CR1(GFP/GFP) Mice	PLOS ONE			English	Article							SUBRETINAL DRUSENOID DEPOSITS; MACULAR DEGENERATION AMD; FACTOR-H POLYMORPHISM; RETICULAR PSEUDODRUSEN; FRACTALKINE RECEPTOR; SUNLIGHT EXPOSURE; PARA-INFLAMMATION; ANIMAL-MODEL; RISK; GENE	Previous studies have shown that CCL2/CX3CR1 deficient mice on C57BL/6N background (with rd8 mutation) have an early onset (6 weeks) of spontaneous retinal degeneration. In this study, we generated CCL2(-/-)CX3CR1(GFP/GFP) mice on the C57BL/6J background. Retinal degeneration was not detected in CCL2(-/-)CX3CR1(GFP/GFP) mice younger than 6 months. Patches of whitish/yellowish fundus lesions were observed in 17 similar to 60% of 12-month, and 30 similar to 100% of 18-month CCL2(-/-)CX3CR1(GFP/GFP) mice. Fluorescein angiography revealed no choroidal neovascularisation in these mice. Patches of retinal pigment epithelium (RPE) and photoreceptor damage were detected in 30% and 50% of 12- and 18-month CCL2(-/-)CX3CR1(GFP/GFP) mice respectively, but not in wild-type mice. All CCL2(-/-)CX3CR1(GFP/GFP) mice exposed to extra-light (similar to 800lux, 6 h/day, 6 months) developed patches of retinal atrophy, and only 20-25% of WT mice which underwent the same light treatment developed atrophic lesions. In addition, synaptophysin expression was detected in the outer nucler layer (ONL) of area related to photoreceptor loss in CCL2(-/-)CX3CR1(GFP/GFP) mice. Markedly increased rhodopsin but reduced cone arrestin expression was observed in retinal outer layers in aged CCL2(-/-)CX3CR1(GFP/GFP) mice. GABA expression was reduced in the inner retina of aged CCL2(-/-)CX3CR1(GFP/GFP) mice. Significantly increased Muller glial and microglial activation was observed in CCL2(-/-)CX3CR1(GFP/GFP) mice compared to age-matched WT mice. Macrophages from CCL2(-/-)CX3CR1(GFP/GFP) mice were less phagocytic, but expressed higher levels of iNOS, IL-1 beta, IL-12 and TNF-alpha under hypoxia conditions. Our results suggest that the deletions of CCL2 and CX3CR1 predispose mice to age- and light-mediated retinal damage. The CCL2/CX3CR1 deficient mouse may thus serve as a model for age-related atrophic degeneration of the RPE, including the dry type of macular degeneration, geographic atrophy.	[Chen, Mei; Hombrebueno, Jose R.; Luo, Chang; Penalva, Rosana; Zhao, Jiawu; Colhoun, Liza; Pandi, Sudha Pirya Soundara; Xu, Heping] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland; [Forrester, John V.] Univ Aberdeen, Sch Med & Dent, Sect Immunol & Infect, Ocular Immunol Grp, Aberdeen, Scotland	Queens University Belfast; University of Aberdeen	Xu, HP (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland.	heping.xu@qub.ac.uk	Xu, Heping/A-4430-2008	Xu, Heping/0000-0003-4000-931X; Romero Hombrebueno, Jose/0000-0003-1094-2977; Soundara Pandi, Sudha Priya/0000-0002-0308-0742	Fight for Sight [1362]; Age UK - Research into Ageing [322]; Fight for Sight [1361/62] Funding Source: researchfish	Fight for Sight; Age UK - Research into Ageing; Fight for Sight	The project is funded by Fight for Sight (1362) and Age UK - Research into Ageing (322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chan CC, 2005, HISTOL HISTOPATHOL, V20, P857, DOI 10.14670/HH-20.857; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen M, 2011, MOL VIS; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Chen M, 2013, INVEST OPHTH VIS SCI, V54, P682, DOI 10.1167/iovs.12-10888; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022818; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DeAngelis MM, 2011, SEMIN OPHTHALMOL, V26, P77, DOI 10.3109/08820538.2011.577129; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fletcher AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P1396, DOI 10.1001/archopht.126.10.1396; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hirakawa M, 2008, BRIT J OPHTHALMOL, V92, P630, DOI 10.1136/bjo.2007.130575; Johnson LV, 2002, AM J OPHTHALMOL; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Luhmann UF, 2013, EXP EYE RES, P10780; Luhmann UFO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035551; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Nussenblatt RB, 2010, RETINA-J RET VIT DIS, V30, P1579, DOI 10.1097/IAE.0b013e3181e7978e; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Telander DG, 2011, SEMIN OPHTHALMOL, V26, P192, DOI 10.3109/08820538.2011.570849; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Vessey KA, 2012, INVEST OPHTH VIS SCI, V53, P7833, DOI 10.1167/iovs.12-10650; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2007, INVEST OPHTH VIS SCI, V48, P2162, DOI 10.1167/iovs.06-0783; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang X, 2010, BRIT J OPHTHALMOL, V94, P1211, DOI 10.1136/bjo.2009.165811; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154; Zerbib J, 2011, EXP EYE RES, V93, P382, DOI 10.1016/j.exer.2011.05.005; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	54	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61381	10.1371/journal.pone.0061381	http://dx.doi.org/10.1371/journal.pone.0061381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637822	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700028
J	Huang, HL; Wu, WQ; Zhang, L; Liu, XY				Huang, Hongling; Wu, Wenqing; Zhang, Lei; Liu, Xin-Yuan			Drosophila Ste-20 Family Protein Kinase, Hippo, Modulates Fat Cell Proliferation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CURRENT STRATEGIES; SIGNALING PATHWAY; TEAD/TEF FAMILY; APOPTOSIS; PROMOTES; ENCODES; OBESITY; GROWTH; AUTOPHAGY	Background: Evolutionarily conserved Hippo (Hpo) pathway plays a pivotal role in the control of organ size. Although the Hpo pathway regulates proliferation of a variety of epidermal cells, its function in non-ectoderm-derived cells is largely unknown. Methodology/Principal Findings: Through methods including fat quantification assays, starvation assays, in vivo labeling assays, we show that overexpression of Hpo in Drosophila melanogaster fat body restricts Drosophila body growth and reduces fat storage through regulation of adipocyte proliferation rather than through influencing the size of fat cells and lipid metabolism, whereas compromising Hpo activity results in weight gain and greater fat storage. Furthermore, we provide evidence that Yorkie (Yki, a transcriptional coactivator that functions in the Hpo pathway) antagonizes Hpo to modulate fat storage in Drosophila. Conclusions/Significance: Our findings specify a role of Hpo in controlling mesoderm-derived cell proliferation. The observed anti-obesity effects of Hpo may indicate great potential for its utilization in anti-obesity therapeutics.	[Huang, Hongling; Wu, Wenqing; Zhang, Lei; Liu, Xin-Yuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Liu, Xin-Yuan] Zhejiang Sci Tech Univ, Coll Biol Sci, Xinyuan Inst Med & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Sci-Tech University	Zhang, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China.	rayzhang@sibs.ac.cn; xyliu@sibs.ac.cn	Liu, Xinyuan/HDM-5505-2022		National Basic Research Program of China (973 Program) [2010CB529901, 2011CB510104, 2010CB912101, 2012CB945001]; National Natural Science Foundation of China [30623003, 81172449, 31171394, 30971646]; National Key Basic Research and Development Program of China [2011CB915502]; New Innovation Program [2009-ZX-09102-246]; Zhejiang Sci-Tech University [1016834-Y]; 28 "Strategic Priority Research Program'' of the Chinese Academy of Sciences [XDA01010406]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); New Innovation Program; Zhejiang Sci-Tech University(Zhejiang Sci-Tech University); 28 "Strategic Priority Research Program'' of the Chinese Academy of Sciences	This research was supported by grants from the National Basic Research Program of China (973 Program 2010CB529901 (X. L.), 2011CB510104 (X. L.), 2010CB912101 (L.Z.), 2012CB945001 (L.Z.), from National Natural Science Foundation of China 30623003 (X. L.), 81172449 (X. L.), 31171394 (L.Z.), 30971646 (L.Z.), from National Key Basic Research and Development Program of China (2011CB915502 (L.Z.), from New Innovation Program (2009-ZX-09102-246)(X. L.), and Zhejiang Sci-Tech University grant (1016834-Y) (X. L.) and also supported by the 28 "Strategic Priority Research Program'' of the Chinese Academy of Sciences Grant No. XDA01010406 (L.Z.). L.Z. is the scholar of the Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bao YJ, 2011, J BIOCHEM, V149, P361, DOI 10.1093/jb/mvr021; Bjorntorp P, 1974, Horm Metab Res, VSuppl 4, P77; Chen J, 2012, CURR BIOL, V22, P1582, DOI 10.1016/j.cub.2012.06.074; Cooke D, 2006, NAT REV DRUG DISCOV, V5, P919, DOI 10.1038/nrd2136; Delaney JR, 2006, EMBO J, V25, P3068, DOI 10.1038/sj.emboj.7601182; Elangbam CS, 2009, VET PATHOL, V46, P10, DOI 10.1354/vp.46-1-10; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hirsch J, 1975, Curr Concepts Nutr, V3, P15; HOSHIZAKI DK, 1994, DEVELOPMENT, V120, P2489; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Jin Y, 2012, J BIOL CHEM; Juhasz G, 2005, EUR J CELL BIOL, V84, P491, DOI 10.1016/j.ejcb.2004.11.010; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Marsh JL, 2003, HUM MOL GENET, V12, pR187, DOI 10.1093/hmg/ddg271; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Nelliot A, 2006, GENESIS, V44, P396, DOI 10.1002/dvg.20229; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Poernbacher I, 2012, CURR BIOL, V22, P389, DOI 10.1016/j.cub.2012.01.019; Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Suh JM, 2007, CELL METAB, V6, P195, DOI 10.1016/j.cmet.2007.08.001; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Yue T, 2012, DEV CELL; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang Y, 2012, BIOCHEM BIOPH RES CO, V417, P1, DOI 10.1016/j.bbrc.2011.11.158; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	46	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61740	10.1371/journal.pone.0061740	http://dx.doi.org/10.1371/journal.pone.0061740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637896	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700057
J	Kang, HJ; Seo, HA; Go, Y; Oh, CJ; Jeoung, NH; Park, KG; Lee, IK				Kang, Hyeon-Ji; Seo, Hyun-Ae; Go, Younghoon; Oh, Chang Joo; Jeoung, Nam Ho; Park, Keun-Gyu; Lee, In-Kyu			Dimethylfumarate Suppresses Adipogenic Differentiation in 3T3-L1 Preadipocytes through Inhibition of STAT3 Activity	PLOS ONE			English	Article							PLACEBO-CONTROLLED PHASE-3; FUMARIC-ACID ESTERS; ADIPOCYTE DIFFERENTIATION; MULTIPLE-SCLEROSIS; ADIPOSE-TISSUE; DOUBLE-BLIND; ORAL BG-12; ACTIVATION; BINDING; TRANSCRIPTION	The excessive accumulation of adipocytes contributes to the development of obesity and obesity-related diseases. The interactions of several transcription factors, such as C/EBP beta, PPAR gamma, C/EBP alpha, Nrf2, and STAT3, are required for adipogenic differentiation. Dimethylfumarate (DMF), an immune modulator and antioxidant, may function as an inhibitor of STAT3 and an activator of Nrf2. This study examined whether DMF inhibits adipogenic differentiation of 3T3-L1 preadipocytes by inhibiting STAT3 or activating Nrf2. DMF suppressed 3T3-L1 preadipocyte differentiation to mature adipocytes in a dose-dependent manner as determined by Oil Red O staining. The mRNA and protein levels of adipogenic genes, including C/EBP beta, C/EBP alpha, PPAR gamma, SREBP-1c, FAS, and aP2, were significantly lower in DMF-treated 3T3-L1 preadipocytes. Suppression of adipogenic differentiation by DMF treatment resulted primarily from inhibition of the early stages of differentiation. DMF inhibits clonal expansion during adipogenic differentiation through induction of a G1 cell cycle arrest. Additionally, DMF regulates cell cycle-related proteins, such as p21, pRb, and cyclin D. DMF treatment markedly inhibited differentiation medium-induced STAT3 phosphorylation and inhibited STAT3 transcriptional activation of a reporter construct composed of four synthetic STAT3-response elements. Moreover, inhibition of endogenous Nrf2 activity using a dominant negative Nrf2 did not abolish the DMF-induced inhibition of adipogenic differentiation of 3T3-L1 preadipocytes. In summary, DMF is a negative regulator of adipogenic differentiation based on its regulation of adipogenic transcription factors and cell cycle proteins. This negative regulation by DMF is mediated by STAT3 inhibition, but is unlikely to involve Nrf2 activation.	[Kang, Hyeon-Ji] Kyungpook Natl Univ, Grad Sch, Dept Biomed Sci, Taegu, South Korea; [Seo, Hyun-Ae; Go, Younghoon; Oh, Chang Joo; Park, Keun-Gyu; Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, WCU Program, Dept Internal Med,Res Inst Aging & Metab, Taegu, South Korea; [Seo, Hyun-Ae] Daegu Fatima Hosp, Dept Internal Med, Taegu, South Korea; [Jeoung, Nam Ho] Catholic Univ Daegu, Dept Fundamental Med & Pharmaceut Sci, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Daegu Fatima Hospital; Catholic University of Daegu	Park, KG (corresponding author), Kyungpook Natl Univ, Sch Med, WCU Program, Dept Internal Med,Res Inst Aging & Metab, Taegu, South Korea.	kpark@knu.ac.kr; leei@knu.ac.kr	Lee, In-Kyu/AAR-6374-2021	Jeoung, Nam Ho/0000-0002-7584-3761	National Research Foundation [2012R1A2A1A03670452, 2012R1A2A2A01043867, R32-10064]; Future-based Technology Development program [Bio Field 2010-0019514]; Ministry of Education, Science, and Technology; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111345]	National Research Foundation; Future-based Technology Development program; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by grants from the National Research Foundation (2012R1A2A1A03670452, 2012R1A2A2A01043867, WCU program R32-10064) and the Future-based Technology Development program (Bio Field 2010-0019514) funded by the Ministry of Education, Science, and Technology and a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMEYER PJ, 1994, J AM ACAD DERMATOL, V30, P977, DOI 10.1016/S0190-9622(94)70121-0; Brun RP, 1996, CURR OPIN CELL BIOL, V8, P826, DOI 10.1016/S0955-0674(96)80084-6; Chartoumpekis DV, 2011, INT J MOL MED, V28, P823, DOI 10.3892/ijmm.2011.761; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; CHUI DHK, 1995, BIOCHEM BIOPH RES CO, V209, P40, DOI 10.1006/bbrc.1995.1467; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Deng JB, 2000, ENDOCRINOLOGY, V141, P2370, DOI 10.1210/en.141.7.2370; Ellrichmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016172; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Mrowietz U, 1999, BRIT J DERMATOL, V141, P424; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Seidel P, 2010, SWISS MED WEEKLY, V140; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Wang DM, 2010, BIOL CELL, V102, P1, DOI 10.1042/BC20090070; Wehinger J, 1996, FEBS LETT, V394, P365, DOI 10.1016/0014-5793(96)00990-8; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Zhang KM, 2011, J CELL BIOCHEM, V112, P488, DOI 10.1002/jcb.22936	39	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61411	10.1371/journal.pone.0061411	http://dx.doi.org/10.1371/journal.pone.0061411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637829	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700031
J	Mileva-Seitz, V; Steiner, M; Atkinson, L; Meaney, MJ; Levitan, R; Kennedy, JL; Sokolowski, MB; Fleming, AS				Mileva-Seitz, Viara; Steiner, Meir; Atkinson, Leslie; Meaney, Michael J.; Levitan, Robert; Kennedy, James L.; Sokolowski, Marla B.; Fleming, Alison S.			Interaction between Oxytocin Genotypes and Early Experience Predicts Quality of Mothering and Postpartum Mood	PLOS ONE			English	Article							PARENTAL BONDING INSTRUMENT; SCALE CES-D; MATERNAL-BEHAVIOR; RECEPTOR GENE; INTERGENERATIONAL TRANSMISSION; PSYCHOMETRIC PROPERTIES; DIRECTED SPEECH; INFANT; DEPRESSION; ASSOCIATION	Individual differences in maternal behavior are affected by both early life experiences and oxytocin, but little is known about genetic variation in oxytocin genes and its effects on mothering. We examined two polymorphisms in the oxytocin peptide gene OXT (rs2740210 and rs4813627) and one polymorphism in the oxytocin receptor gene OXTR (rs237885) in 187 Caucasian mothers at six months postpartum. For OXT, both rs2740210 and rs4813627 significantly associated with maternal vocalizing to the infant. These polymorphisms also interacted with the quality of care mothers experienced in early life, to predict variation in maternal instrumental care and postpartum depression. However, postpartum depression did not mediate the gene-environment effects of the OXT SNPs on instrumental care. In contrast, the OXTR SNP rs237885 did not associate with maternal behavior, but it did associate with pre-natal (but not post-natal) depression score. The findings illustrate the importance of variation in oxytocin genes, both alone and in interaction with early environment, as predictors of individual differences in human mothering. Furthermore, depression does not appear to have a causal role on the variation we report in instrumental care. This suggests that variation in instrumental care varies in association with a gene-early environment effect regardless of current depressive symptomatology. Finally, our findings highlight the importance of examining multiple dimensions of human maternal behavior in studies of genetic associations.	[Mileva-Seitz, Viara] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Mileva-Seitz, Viara; Fleming, Alison S.] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Steiner, Meir] St Josephs Healthcare, Womens Hlth Concerns Clin, Hamilton, ON, Canada; [Steiner, Meir] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Atkinson, Leslie] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Meaney, Michael J.] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Meaney, Michael J.] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Levitan, Robert; Kennedy, James L.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Levitan, Robert; Kennedy, James L.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Sokolowski, Marla B.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Sokolowski, Marla B.; Fleming, Alison S.] Univ Toronto, Fraser Mustard Inst Human Dev, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Mississauga; McMaster University; Toronto Metropolitan University; McGill University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto	Fleming, AS (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	alison.fleming@utoronto.ca	Meaney, Michael/N-5931-2019; Kennedy, James Lowery/AAZ-6947-2020; Steiner, Meir/B-2121-2016	Kennedy, James Lowery/0000-0002-8733-3806; Atkinson, Leslie/0000-0003-1265-3298; Sokolowski, Marla/0000-0002-7462-8007; Steiner, Meir/0000-0001-7838-2246; Levitan, Robert/0000-0003-1306-3847	Canadian Institutes of Health Research (CIHR); University of Toronto Connaught Global Challenge Grant; Canadian Institutes for Advanced Research Grant; Natural Sciences and Engineering Research Council Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Toronto Connaught Global Challenge Grant; Canadian Institutes for Advanced Research Grant; Natural Sciences and Engineering Research Council Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca/e/193.html) trajectory grant for the MAVAN, principal investigators (PIs) M.J.M. and S. G. M., by CIHR grants to A. S. F. and J.L.K., by a University of Toronto Connaught Global Challenge Grant to A. S. F. and M. B. S., by a Canadian Institutes for Advanced Research Grant to M.J.M. and M. B. S., and by a Natural Sciences and Engineering Research Council Canada (NSERC; http://www.nserc-crsng.gc.ca/index_eng.asp) PhD scholarship to V.M.-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M.D.S., 1974, INTEGRATION CHILD SO, P99; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bakermans-Kranenburg MJ, 2012, SOC COGN AFFECT NEUR, V7, P951, DOI 10.1093/scan/nsr067; Bales Karen L, 2011, Front Psychiatry, V2, P24, DOI 10.3389/fpsyt.2011.00024; Barrett J, 2011, J CHILD PSYCHOL PSYC, V52, P368, DOI 10.1111/j.1469-7610.2010.02306.x; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Belsky J, 2009, DEV PSYCHOL, V45, P1201, DOI 10.1037/a0016245; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bisceglia R, 2012, GENES BRAIN BEHAV, V11, P262, DOI 10.1111/j.1601-183X.2012.00769.x; Bloom L, 1996, CHILD DEV, V67, P3154, DOI 10.1111/j.1467-8624.1996.tb01907.x; BORNSTEIN MH, 1992, DEV PSYCHOL, V28, P593, DOI 10.1037/0012-1649.28.4.593; Bryant GA, 2007, PSYCHOL SCI, V18, P746, DOI 10.1111/j.1467-9280.2007.01970.x; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Caspi A, 1996, AID MPR156 3 3 CO 2; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Champagne F, 2001, Prog Brain Res, V133, P287; Chung A.L., 2002, EARLY PREDICTION PRE, P217; Chung EK, 2004, PEDIATRICS, V113, pE523, DOI 10.1542/peds.113.6.e523; Costa B, 2009, PSYCHONEUROENDOCRINO, V34, P1506, DOI 10.1016/j.psyneuen.2009.05.006; Dwyer CM, 2008, J NEUROENDOCRINOL, V20, P526, DOI 10.1111/j.1365-2826.2008.01657.x; Edwards JR, 2007, PSYCHOL METHODS, V12, P1, DOI 10.1037/1082-989X.12.1.1; Febo M, 2005, J NEUROSCI, V25, P11637, DOI 10.1523/JNEUROSCI.3604-05.2005; Feldman R, 2007, DEV PSYCHOBIOL, V49, P290, DOI 10.1002/dev.20220; Feldman R, 2012, BIOL PSYCHIAT, V72, P175, DOI 10.1016/j.biopsych.2011.12.025; Feldman R, 2010, PSYCHONEUROENDOCRINO, V35, P1133, DOI 10.1016/j.psyneuen.2010.01.013; Field T, 2006, DEV REV, V26, P15, DOI 10.1016/j.dr.2005.04.001; FIELD T, 1992, DEV PSYCHOPATHOL, V4, P49, DOI 10.1017/S0954579400005551; FLEMING AS, 1988, DEV PSYCHOL, V24, P71, DOI 10.1037/0012-1649.24.1.71; Francis DD, 2008, PHARMACOL BIOCHEM BE, V90, P497, DOI 10.1016/j.pbb.2008.04.012; Francis DD, 2000, J NEUROENDOCRINOL, V12, P1145, DOI 10.1046/j.1365-2826.2000.00599.x; Galbally M, 2011, HARVARD REV PSYCHIAT, V19, P1, DOI 10.3109/10673229.2011.549771; Gonzalez A, 2001, DEV PSYCHOBIOL, V38, P11, DOI 10.1002/1098-2302(2001)38:1<11::AID-DEV2>3.0.CO;2-B; Gordon I, 2010, PHYSIOL BEHAV, V101, P679, DOI 10.1016/j.physbeh.2010.08.008; GOTLIB IH, 1988, BRIT J PSYCHIAT, V152, P24, DOI 10.1192/bjp.152.1.24; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; Heim C, 2009, MOL PSYCHIATR, V14, P954, DOI 10.1038/mp.2008.112; Herrera E, 2004, J AFFECT DISORDERS, V81, P29, DOI 10.1016/j.jad.2003.07.001; Huston AC, 2005, CHILD DEV, V76, P467, DOI 10.1111/j.1467-8624.2005.00857.x; Inoue H, 2010, BIOL PSYCHIAT, V68, P1066, DOI 10.1016/j.biopsych.2010.07.019; INSEL TR, 1992, ANN NY ACAD SCI, V652, P122, DOI 10.1111/j.1749-6632.1992.tb34350.x; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Karevold E, 2009, DEV PSYCHOL, V45, P1051, DOI 10.1037/a0016123; KENDRICK KM, 1987, NEUROENDOCRINOLOGY, V46, P56, DOI 10.1159/000124796; KEVERNE EB, 1988, PSYCHOPHARMACOLOGY, V96, pS30; Keverne EB, 1996, J PSYCHOPHARMACOL, V10, P16, DOI 10.1177/026988119601000104; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Knight RG, 1997, BEHAV RES THER, V35, P373, DOI 10.1016/S0005-7967(96)00107-6; Krpan KM, 2005, HORM BEHAV, V47, P112, DOI 10.1016/j.yhbeh.2004.08.006; Langeland W., 1995, CHILD ABUSE REV, V4, P4, DOI [10.1002/car.2380040104, DOI 10.1002/CAR.2380040104]; Leuine A, 2007, PEPTIDES, V28, P1162, DOI 10.1016/j.peptides.2007.04.016; Maestripieri D, 2005, P NATL ACAD SCI USA, V102, P9726, DOI 10.1073/pnas.0504122102; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; Mileva-Seitz V, 2012, GENES BRAIN BEHAV, V11, P684, DOI 10.1111/j.1601-183X.2012.00804.x; Mileva-Seitz V, 2011, GENES BRAIN BEHAV, V10, P325, DOI 10.1111/j.1601-183X.2010.00671.x; Milgrom J, 2004, INFANT BEHAV DEV, V27, P443, DOI 10.1016/j.infbeh.2004.03.003; Moehler E, 2007, AM J ORTHOPSYCHIAT, V77, P624, DOI 10.1037/0002-9432.77.4.624; Morin AJS, 2011, REV EPIDEMIOL SANTE, V59, P327, DOI 10.1016/j.respe.2011.03.061; Numan M, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1921; Numan M, 2007, DEV PSYCHOBIOL, V49, P12, DOI 10.1002/dev.20198; PARKER G, 1990, SOC PSYCH PSYCH EPID, V25, P281, DOI 10.1007/BF00782881; Pedersen CA, 2006, GENES BRAIN BEHAV, V5, P274, DOI 10.1111/j.1601-183X.2005.00162.x; PEDERSEN CA, 1994, BEHAV NEUROSCI, V108, P1163, DOI 10.1037/0735-7044.108.6.1163; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rees SL, 2008, DEV PSYCHOBIOL, V50, P315, DOI 10.1002/dev.20292; Righetti-Veltema M, 2002, J AFFECT DISORDERS, V70, P291, DOI 10.1016/S0165-0327(01)00367-6; Saphire-Bernstein S, 2011, P NATL ACAD SCI USA, V108, P15118, DOI 10.1073/pnas.1113137108; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Shahrokh DK, 2010, ENDOCRINOLOGY, V151, P2276, DOI 10.1210/en.2009-1271; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; Souza RP, 2010, INT J NEUROPSYCHOPH, V13, P793, DOI 10.1017/S1461145710000167; Stivers J A, 1988, Peptides, V9 Suppl 1, P223, DOI 10.1016/0196-9781(88)90248-3; Strauss JS, 2010, PSYCHONEUROENDOCRINO, V35, P1422, DOI 10.1016/j.psyneuen.2010.04.008; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Thompson RJ, 2011, PSYCHONEUROENDOCRINO, V36, P144, DOI 10.1016/j.psyneuen.2010.07.003; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Tost H, 2011, BIOL PSYCHIAT, V70, pE37, DOI 10.1016/j.biopsych.2011.06.034; van Ijzendoorn MH, 2008, GENES BRAIN BEHAV, V7, P403, DOI 10.1111/j.1601-183X.2007.00362.x; Wilhelm K, 2005, PSYCHOL MED, V35, P387, DOI 10.1017/S0033291704003538; Winslow JT, 2003, NEUROPSYCHOPHARMACOL, V28, P910, DOI 10.1038/sj.npp.1300128	81	91	91	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61443	10.1371/journal.pone.0061443	http://dx.doi.org/10.1371/journal.pone.0061443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130IU	23637833	gold, Green Published			2022-12-25	WOS:000317908700034
J	Allende, ML; Sipe, LM; Tuymetova, G; Wilson-Henjum, KL; Chen, WP; Proia, RL				Allende, Maria L.; Sipe, Laura M.; Tuymetova, Galina; Wilson-Henjum, Kelsey L.; Chen, Weiping; Proia, Richard L.			Sphingosine-1-phosphate Phosphatase 1 Regulates Keratinocyte Differentiation and Epidermal Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY BARRIER; CELL-DEATH; IN-VITRO; SKIN; PHOSPHOHYDROLASE; SPHINGOLIPIDS; CERAMIDE; METABOLISM; EXPRESSION; RECEPTOR	Sphingosine 1-phosphate (S1P) is a bioactive lipid whose levels are tightly regulated by its synthesis and degradation. Intracellularly, S1P is dephosphorylated by the actions of two S1P-specific phosphatases, sphingosine-1-phosphate phosphatases 1 and 2. To identify the physiological functions of S1P phosphatase 1, we have studied mice with its gene, Sgpp1, deleted. Sgpp1(-/-) mice appeared normal at birth, but during the 1st week of life they exhibited stunted growth and suffered desquamation, with most dying before weaning. Both Sgpp1(-/-) pups and surviving adults exhibited multiple epidermal abnormalities. Interestingly, the epidermal permeability barrier developed normally during embryogenesis in Sgpp1(-/-) mice. Keratinocytes isolated from the skin of Sgpp1(-/-) pups had increased intracellular S1P levels and displayed a gene expression profile that indicated overexpression of genes associated with keratinocyte differentiation. The results reveal S1P metabolism as a regulator of keratinocyte differentiation and epidermal homeostasis.	[Allende, Maria L.; Sipe, Laura M.; Tuymetova, Galina; Wilson-Henjum, Kelsey L.; Chen, Weiping; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, Bldg 10,Rm 9D-06,10 Ctr Dr MSC 1821, Bethesda, MD 20892 USA.	rp36y@nih.gov	Chen, Weiping/C-9550-2011; Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270	National Institutes of Health from NIDDK [P30 CA138313, P20 RR017677]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056018, ZIADK056014] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grants from NIDDK, Grant P30 CA138313 (to Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina), and Grant P20 RR017677 (to Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE).	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Celli A, 2012, J INVEST DERMATOL, V132, P1188, DOI 10.1038/jid.2011.447; Denda M, 2000, BIOCHEM BIOPH RES CO, V272, P134, DOI 10.1006/bbrc.2000.2739; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; ELIAS PM, 1991, ADV LIPID RES, V24, P1; ELIAS PM, 1992, SEMIN DERMATOL, V11, P176; Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Harris IR, 1997, J INVEST DERMATOL, V109, P783, DOI 10.1111/1523-1747.ep12340962; Herzinger T, 2007, AM J CLIN DERMATOL, V8, P329, DOI 10.2165/00128071-200708060-00002; Holleran WM, 2006, FEBS LETT, V580, P5456, DOI 10.1016/j.febslet.2006.08.039; HOLLERAN WM, 1991, J CLIN INVEST, V88, P1338, DOI 10.1172/JCI115439; Hong JH, 2008, J INVEST DERMATOL, V128, P2166, DOI 10.1038/jid.2008.66; Hwang J, 2011, P NATL ACAD SCI USA, V108, P11566, DOI 10.1073/pnas.1019658108; Kim DS, 2004, CELL SIGNAL, V16, P89, DOI 10.1016/S0898-6568(03)00114-1; Kwon YB, 2007, J LIPID RES, V48, P1936, DOI 10.1194/jlr.M700185-JLR200; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Le Stunff H, 2002, BBA-MOL CELL BIOL L, V1582, P8, DOI 10.1016/S1388-1981(02)00132-4; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Lepine S, 2011, J BIOL CHEM, V286, P44380, DOI 10.1074/jbc.M111.257519; LI LW, 1995, J CELL PHYSIOL, V163, P105, DOI 10.1002/jcp.1041630112; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; MANSBRIDGE JN, 1987, J INVEST DERMATOL, V89, P253, DOI 10.1111/1523-1747.ep12471216; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; OLIVERA A, 2013, BIOCHIM BIOPHYS ACTA, V183, P193; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Saitoh M, 2007, NEUROSCI LETT, V417, P165, DOI 10.1016/j.neulet.2007.01.083; Schmitz EI, 2012, MOL CELL BIOCHEM, V371, P165, DOI 10.1007/s11010-012-1433-5; Schuette CG, 2001, GLYCOBIOLOGY, V11, p81R, DOI 10.1093/glycob/11.6.81R; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Vogler R, 2003, J INVEST DERMATOL, V120, P693, DOI 10.1046/j.1523-1747.2003.12096.x; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; ZUHERINGDORF DM, 2004, J CELL BIOCHEM, V92, P937	63	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18381	18391		10.1074/jbc.M113.478420	http://dx.doi.org/10.1074/jbc.M113.478420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23637227	hybrid, Green Published			2022-12-25	WOS:000320721900041
J	Thirkettle, S; Decock, J; Arnold, H; Pennington, CJ; Jaworski, DM; Edwards, DR				Thirkettle, Sally; Decock, Julie; Arnold, Hugh; Pennington, Caroline J.; Jaworski, Diane M.; Edwards, Dylan R.			Matrix Metalloproteinase 8 (Collagenase 2) Induces the Expression of Interleukins 6 and 8 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-2; ESTROGEN-RECEPTOR; IL-8 EXPRESSION; STEM-CELLS; MICE; INVASION; MMP-8; TUMORIGENESIS; INFLAMMATION; METASTASIS	Matrix metalloproteinase 8 (MMP-8) is a tumor-suppressive protease that cleaves numerous substrates, including matrix proteins and chemokines. In particular, MMP-8 proteolytically activates IL-8 and, thereby, regulates neutrophil chemotaxis in vivo. We explored the effects of expression of either a WT or catalytically inactive (E198A) mutant version of MMP-8 in human breast cancer cell lines. Analysis of serum-free conditioned media from three breast cancer cell lines (MCF-7, SKBR- 3, and MDA-MB-231) expressing WT MMP-8 revealed elevated levels of IL-6 and IL-8. This increase was mirrored at the mRNA level and was dependent on MMP-8 catalytic activity. However, sustained expression of WT MMP-8 by breast cancer cells was non-permissive for long-term growth, as shown by reduced colony formation compared with cells expressing either control vector or E198A mutantMMP-8. In long-term culture of transfected MDA-MB-231 cells, expression of WT but not E198A mutant MMP-8 was lost, with IL-6 and IL-8 levels returning to base line. Rare clonal isolates ofMDA-MB-231cells expressing WT MMP-8 were generated, and these showed constitutively high levels of IL-6 and IL-8, although production of the interleukins was no longer dependent upon MMP-8 activity. These studies support a causal connection between MMP-8 activity and the IL-6/IL-8 network, with an acute response to MMP-8 involving induction of the proinflammatory mediators, which may in part serve to compensate for the deleterious effects of MMP-8 on breast cancer cell growth. This axis may be relevant to the recognized ability of MMP-8 to orchestrate the innate immune system in inflammation in vivo.	[Thirkettle, Sally; Decock, Julie; Arnold, Hugh; Pennington, Caroline J.; Edwards, Dylan R.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Jaworski, Diane M.] Univ Vermont Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA	University of East Anglia; University of Vermont	Edwards, DR (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	dylan.edwards@uea.ac.uk	Edwards, Dylan R/B-4734-2009; Decock, Julie/A-1453-2010	Edwards, Dylan R/0000-0002-3292-2064; Decock, Julie/0000-0002-4409-100X	Big C PhD studentship; Breast Cancer Campaign, Cancer Research-UK; European Union	Big C PhD studentship; Breast Cancer Campaign, Cancer Research-UK(Cancer Research UK); European Union(European Commission)	This work was supported by a Big C PhD studentship (to S.T.); by the Breast Cancer Campaign, Cancer Research-UK; and by European Union FP6 (Cancerdegradome) and FP7 (SaveMe) projects.	Agarwal D, 2003, DIFFERENTIATION, V71, P114, DOI 10.1046/j.1432-0436.2003.710202.x; Albaiceta GM, 2010, AM J RESP CELL MOL, V43, P555, DOI 10.1165/rcmb.2009-0034OC; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Chernov AV, 2010, J BIOL CHEM, V285, P19647, DOI 10.1074/jbc.M109.088153; Decock J, 2007, CANCER RES, V67, P10214, DOI 10.1158/0008-5472.CAN-07-1683; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Folgueras AR, 2008, J BIOL CHEM, V283, P9465, DOI 10.1074/jbc.M709522200; Freund A, 2004, ONCOGENE, V23, P6105, DOI 10.1038/sj.onc.1207815; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hartman ZC, 2011, CANCER RES, V71, P4380, DOI 10.1158/0008-5472.CAN-11-0308; HASTY KA, 1990, J BIOL CHEM, V265, P11421; Hernandez M, 2011, J PERIODONTAL RES, V46, P58, DOI 10.1111/j.1600-0765.2010.01310.x; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Howells GL, 1997, J CELL SCI, V110, P881; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kees T, 2011, J MAMMARY GLAND BIOL, V16, P189, DOI 10.1007/s10911-011-9224-2; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Korpi JT, 2008, BRIT J CANCER, V98, P766, DOI 10.1038/sj.bjc.6604239; Kuula H, 2009, INFECT IMMUN, V77, P850, DOI 10.1128/IAI.00873-08; Lin M, 2008, AM J PATHOL, V173, P144, DOI 10.2353/ajpath.2008.080081; Lin Y, 2004, INT J CANCER, V109, P507, DOI 10.1002/ijc.11724; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Montel V, 2004, CANCER RES, V64, P1687, DOI 10.1158/0008-5472.CAN-03-2047; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Rallabhandi P, 2008, J BIOL CHEM, V283, P24314, DOI 10.1074/jbc.M804800200; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Shpacovitch VM, 2004, J LEUKOCYTE BIOL, V76, P388, DOI 10.1189/jlb.0503221; Stadlmann S, 2003, EUR J CANCER, V39, P2499, DOI 10.1016/j.ejca.2003.08.011; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V377, P622, DOI 10.1016/j.bbrc.2008.10.018; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843	49	39	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16282	16294		10.1074/jbc.M113.464230	http://dx.doi.org/10.1074/jbc.M113.464230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23632023	hybrid, Green Published			2022-12-25	WOS:000320378900008
J	Prady, SL; Pickett, KE; Croudace, T; Fairley, L; Bloor, K; Gilbody, S; Kiernan, KE; Wright, J				Prady, Stephanie L.; Pickett, Kate E.; Croudace, Tim; Fairley, Lesley; Bloor, Karen; Gilbody, Simon; Kiernan, Kathleen E.; Wright, John			Psychological Distress during Pregnancy in a Multi-Ethnic Community: Findings from the Born in Bradford Cohort Study	PLOS ONE			English	Article							GENERAL HEALTH QUESTIONNAIRE; COMMON MENTAL-DISORDERS; RISK-FACTORS; POSTPARTUM DEPRESSION; POSTNATAL DEPRESSION; PAKISTANI ORIGIN; MATERNAL ANXIETY; ETHNIC DENSITY; SOCIAL STRESS; LOW-INCOME	Purpose: Antenatal anxiety and depression are predictive of future mental distress, which has negative effects on children. Ethnic minority women are more likely to have a lower socio-economic status (SES) but it is unclear whether SES is an independent risk factor for mental health in pregnancy. We described the association between maternal mental distress and socio-demographic factors in a multi-ethnic cohort located in an economically deprived city in the UK. Methods: We defined eight distinct ethno-language groups (total N = 8,454) and classified a threshold of distress as the 75th centile of within-group GHQ-28 scores, which we used as the outcome for univariate and multivariate logistic regression for each ethnic group and for the sample overall. Results: Financial concerns were strongly and independently associated with worse mental health for six out of the eight ethnic groups, and for the cohort overall. In some groups, factors such as working status, education and family structure were associated with worse mental health, but for others these factors were of little importance. Conclusions: The diversity between and within ethnic groups in this sample underlines the need to take into consideration individual social, migration and economic circumstances and their potential effect on mental health in ethnically diverse areas.	[Prady, Stephanie L.; Pickett, Kate E.; Croudace, Tim; Bloor, Karen; Gilbody, Simon] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Croudace, Tim; Gilbody, Simon] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Fairley, Lesley; Wright, John] Bradford Teaching Hosp NHS Fdn Trust, Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Kiernan, Kathleen E.] Univ York, Dept Social Policy & Social Work, York YO10 5DD, N Yorkshire, England	University of York - UK; University of Hull; University of York - UK; University of York - UK	Prady, SL (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	stephanie.prady@york.ac.uk	Gilbody, Simon/AAY-3720-2021; Wright, John/H-1624-2012; Croudace, Tim/ABC-9681-2021	Gilbody, Simon/0000-0002-8236-6983; Wright, John/0000-0001-9572-7293; Smith, Lesley/0000-0002-4280-6323; Croudace, Tim/0000-0001-8346-7463; Bloor, Karen/0000-0003-4852-9854	National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) implementation grant [KRD/012/001/006]; NIHR [RP-PG-0407-10044]; Economic and Social Research Council (ESRC) research grant [RES-177-25-0016]; MRC [MR/K006665/1, MR/J013501/1] Funding Source: UKRI; Medical Research Council [MR/K006665/1, MR/J013501/1, MC_PC_13042] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10044, CSA/03/07/014] Funding Source: researchfish	National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) implementation grant; NIHR(National Institute for Health Research (NIHR)); Economic and Social Research Council (ESRC) research grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) implementation grant (KRD/012/001/006), an NIHR applied programme grant (RP-PG-0407-10044) and an Economic and Social Research Council (ESRC) research grant (RES-177-25-0016). This paper presents independent research commissioned by the NIHR under the CLAHRC programme. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERIBIGBE YA, 1992, SOC PSYCH PSYCH EPID, V27, P280; Alegria M, 2003, J HEALTH SOC BEHAV, V44, P257, DOI 10.2307/1519778; Barker ED, 2011, DEPRESS ANXIETY, V28, P696, DOI 10.1002/da.20856; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Bhugra D, 2005, ACTA PSYCHIAT SCAND, V111, P84, DOI 10.1111/j.1600-0447.2004.00454.x; Bhui K, 2000, SOC PSYCH PSYCH EPID, V35, P248, DOI 10.1007/s001270050235; Bhui K, 2001, PSYCHOL MED, V31, P815, DOI 10.1017/S0033291701003853; Bhui Kamaldeep, 2004, Transcult Psychiatry, V41, P307, DOI 10.1177/1363461504045642; Coll CG, 1996, CHILD DEV, V67, P1891, DOI 10.2307/1131600; Das-Munshi J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5367; Field T, 2010, INFANT BEHAV DEV, V33, P23, DOI 10.1016/j.infbeh.2009.10.004; Gater R, 2009, SOC PSYCH PSYCH EPID, V44, P198, DOI 10.1007/s00127-008-0426-x; Gausia K, 2009, PSYCHOL MED, V39, P999, DOI 10.1017/S0033291708004455; GL Assessment, FREQ ASK QUEST GEN H; Glasheen C, 2010, ARCH WOMEN MENT HLTH, V13, P61, DOI 10.1007/s00737-009-0109-y; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Halpern D, 2000, INT J SOC PSYCHIATR, V46, P34, DOI 10.1177/002076400004600105; Hamamy H, 2011, GENET MED, V13, P841, DOI 10.1097/GIM.0b013e318217477f; Hanna L, 2006, J EPIDEMIOL COMMUN H, V60, P1034, DOI 10.1136/jech.2005.043877; Hunt SM, 2004, J EPIDEMIOL COMMUN H, V58, P618, DOI 10.1136/jech.2003.010074; Husain N, 1997, BRIT J PSYCHIAT, V171, P434, DOI 10.1192/bjp.171.5.434; Husain N, 2012, J AFFECT DISORDERS, V140, P268, DOI 10.1016/j.jad.2012.02.009; Hussain Feryad, 2004, Transcult Psychiatry, V41, P253, DOI 10.1177/1363461504043567; Jayaweera H, 2010, SOC SCI MED, V71, P1002, DOI 10.1016/j.socscimed.2010.05.039; Ji SA, 2011, J PSYCHIATR RES, V45, P213, DOI 10.1016/j.jpsychires.2010.05.017; Karlsen S, 2002, AM J PUBLIC HEALTH, V92, P624, DOI 10.2105/AJPH.92.4.624; Karmaliani R, 2009, INT J SOC PSYCHIATR, V55, P414, DOI 10.1177/0020764008094645; Koleva H, 2011, ARCH WOMEN MENT HLTH, V14, P99, DOI 10.1007/s00737-010-0184-0; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Mangalore R, 2012, SOC PSYCH PSYCH EPID, V47, P351, DOI 10.1007/s00127-011-0345-0; Matthey S, 2012, J AFFECT DISORDERS, V141, P213, DOI 10.1016/j.jad.2012.02.037; Matthey S, 2011, J AFFECT DISORDERS, V133, P546, DOI 10.1016/j.jad.2011.05.004; Matthey S, 2010, J AFFECT DISORDERS, V120, P263, DOI 10.1016/j.jad.2009.05.004; McIntyre L, 2003, AFFILIA J WOM SOC WO, V18, P316, DOI 10.1177/0886109903254581; Melhuish E. C., 2008, INVESTIGATION RELATI; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Murray L, 2011, J AM ACAD CHILD PSY, V50, P460, DOI 10.1016/j.jaac.2011.02.001; Nazroo JY, 1997, ETHNICITY MENTAL HLT; Nazroo JY., 2001, ETHNICITY CLASS HLTH; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; Onozawa K, 2003, Arch Womens Ment Health, V6 Suppl 2, pS51, DOI 10.1007/s00737-003-0006-8; Pickett KE, 2008, ETHNIC HEALTH, V13, P321, DOI 10.1080/13557850701882928; Prady SL, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-55; Raynor P, 2012, INT J EPIDEMIOL, V42, P1; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Rubin DB, 2004, MULTIPLE IMPUTATION; Shah SMA, 2011, J PAK MED ASSOC, V61, P242; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Weich S, 2004, PSYCHOL MED, V34, P1543, DOI 10.1017/S0033291704002715; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Williams P, 2006, USERS GUIDE GEN HLTH; Williams R, 1997, ETHN HLTH; Willmott SA, 2004, SOC PSYCH PSYCH EPID, V39, P613, DOI 10.1007/s00127-004-0801-1	57	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e60693	10.1371/journal.pone.0060693	http://dx.doi.org/10.1371/journal.pone.0060693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146GG	23637759	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300001
J	Xing, H; Wang, X; Liao, LJ; Ma, YL; Su, B; Fu, JH; He, JM; Chen, L; Pan, XH; Dong, YH; Liu, W; Hsi, JH; Yang, LT; Ruan, YH; Shao, YM				Xing, Hui; Wang, Xia; Liao, Lingjie; Ma, Yanling; Su, Bin; Fu, Jihua; He, Jianmei; Chen, Lin; Pan, Xiaohong; Dong, Yonghui; Liu, Wei; Hsi, Jenny H.; Yang, Liting; Ruan, Yuhua; Shao, Yiming			Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment	PLOS ONE			English	Article							THERAPY; ADULTS; PREVALENCE; MORTALITY; SURVIVAL; COHORT	Background: A critical indicator of the future success of highly active antiretroviral therapy (HAART) is the incidence of HIV drug resistance, which has not been studied in China on the national scale. Methods: HIV drug resistance baseline survey was conducted in the eight provinces with the largest numbers of patients on HAART in 2009, and a prospective cohort study with 12-month follow-up was completed in 2010. Patients completed an interviewer-administrated questionnaire and provided blood for CD4+ T-lymphocyte count (CD4 count), HIV viral load (VL), and HIV drug resistance genotyping. Factors associated with incidence of HIVDR were identified by Cox regression analysis. Results: The overall prevalence of HIV RNA >= 1000 copies/ml and HIVDR at baseline was 12.4% and 5.6%, respectively. Incidence of HIVDR in the one year follow-up was 3.5 per 100 person years. Independently associated factors were started treatment with a didanosine-based regimen, received care at township hospital or village clinic, low baseline CD4 counts, and high baseline VL. Conclusions: The incidence of HIVDR in China was higher than that of some developed countries. China urgently needs to provide comprehensive education and training to doctors at village clinics and township hospitals to improve quality community-based care and treatment.	[Xing, Hui; Wang, Xia; Liao, Lingjie; Hsi, Jenny H.; Yang, Liting; Ruan, Yuhua; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xing, Hui; Wang, Xia; Liao, Lingjie; Hsi, Jenny H.; Yang, Liting; Ruan, Yuhua; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Ma, Yanling] Yunnan Ctr Dis Control & Prevent, Kunming, Peoples R China; [Su, Bin] Anhui Ctr Dis Control & Prevent, Hefei, Peoples R China; [Fu, Jihua] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [He, Jianmei] Hunan Ctr Dis Control & Prevent, Changcha, Peoples R China; [Chen, Lin] Shenzheng Ctr Dis Control & Prevent, Shenzheng, Peoples R China; [Pan, Xiaohong] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Dong, Yonghui] Xinjiang Ctr Dis Control & Prevent, Urumqi, Peoples R China; [Liu, Wei] Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao08@gmail.com	MA, YAN/HHN-2912-2022; Wang, Xia/C-3298-2018	Wang, Xia/0000-0002-1684-7076	Ministry of Science and Technology of China [2012ZX10001-002, 2009DFB30420]; International Development Research Center of Canada [104519-010]; Chinese State Key Laboratory for Infectious Disease Develop Grant [2012SKLID103]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); International Development Research Center of Canada; Chinese State Key Laboratory for Infectious Disease Develop Grant	This work was supported by grants from the Ministry of Science and Technology of China (2012ZX10001-002 and 2009DFB30420) and the International Development Research Center of Canada (#104519-010), and Chinese State Key Laboratory for Infectious Disease Develop Grant (2012SKLID103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audelin AM, 2009, ANTIVIR THER, V14, P995, DOI 10.3851/IMP1412; Chang HM, 2012, JPN J INFECT DIS, V65, P61; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Gong Jian, 2011, Virologica Sinica, V26, P386, DOI 10.1007/s12250-011-3210-0; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Johannessen A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-108; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Ruan YH, 2010, TROP MED INT HEALTH, V15, P1357, DOI 10.1111/j.1365-3156.2010.02621.x; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Vercauteren J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-12; Wang Hui, 2010, Zhonghua Yi Xue Za Zhi, V90, P584; WANG X, 2012, J ANTIVIRALS ANTIRET, V4, P5; *WORLD HE ORG, 2011, ANT THER HIV INF AD; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054917; Yuan Yuan, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P619; Zhang Y, 2012, JAIDS-J ACQ IMM DEF, V60, P59, DOI 10.1097/QAI.0b013e31824c3d9f; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	26	24	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62408	10.1371/journal.pone.0062408	http://dx.doi.org/10.1371/journal.pone.0062408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638072	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300053
J	Donohue, SE; Appelbaum, LG; Park, CJ; Roberts, KC; Woldorff, MG				Donohue, Sarah E.; Appelbaum, Lawrence G.; Park, Christina J.; Roberts, Kenneth C.; Woldorff, Marty G.			Cross-Modal Stimulus Conflict: The Behavioral Effects of Stimulus Input Timing in a Visual-Auditory Stroop Task	PLOS ONE			English	Article							TIME-COURSE; INTERFERENCE; WORD; INTEGRATION; ATTENTION; FACILITATION; INFORMATION; COMPETITION; MECHANISMS; RESOLUTION	Cross-modal processing depends strongly on the compatibility between different sensory inputs, the relative timing of their arrival to brain processing components, and on how attention is allocated. In this behavioral study, we employed a cross-modal audio-visual Stroop task in which we manipulated the within-trial stimulus-onset-asynchronies (SOAs) of the stimulus-component inputs, the grouping of the SOAs (blocked vs. random), the attended modality (auditory or visual), and the congruency of the Stroop color-word stimuli (congruent, incongruent, neutral) to assess how these factors interact within a multisensory context. One main result was that visual distractors produced larger incongruency effects on auditory targets than vice versa. Moreover, as revealed by both overall shorter response times (RTs) and relative shifts in the psychometric incongruency-effect functions, visual-information processing was faster and produced stronger and longer-lasting incongruency effects than did auditory. When attending to either modality, stimulus incongruency from the other modality interacted with SOA, yielding larger effects when the irrelevant distractor occurred prior to the attended target, but no interaction with SOA grouping. Finally, relative to neutral-stimuli, and across the wide range of the SOAs employed, congruency led to substantially more behavioral facilitation than did incongruency to interference, in contrast to findings that within-modality stimulus-compatibility effects tend to be more evenly split between facilitation and interference. In sum, the present findings reveal several key characteristics of how we process the stimulus compatibility of cross-modal sensory inputs, reflecting stimulus processing patterns that are critical for successfully navigating our complex multisensory world.	[Donohue, Sarah E.; Appelbaum, Lawrence G.; Park, Christina J.; Roberts, Kenneth C.; Woldorff, Marty G.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27710 USA; [Donohue, Sarah E.; Woldorff, Marty G.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Donohue, Sarah E.; Woldorff, Marty G.] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; [Donohue, Sarah E.; Woldorff, Marty G.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Park, Christina J.] Smith Coll, Northampton, MA 01063 USA; [Appelbaum, Lawrence G.; Woldorff, Marty G.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Woldorff, Marty G.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Duke University; Duke University; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Smith College; Duke University; Duke University	Donohue, SE (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27710 USA.	donohue.sarah.e@gmail.com		Woldorff, Marty/0000-0002-2683-4551; Appelbaum, Lawrence/0000-0002-3184-6725	National Institutes of Health [R01-NS051048]; National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an National Institutes of Health RO1 grant (R01-NS051048) to M.G.W. and a National Science Foundation graduate student fellowship award to S.E.D. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Appelbaum LG, 2012, J COGNITIVE NEUROSCI, V24, P1834, DOI 10.1162/jocn_a_00209; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Beierholm UR, 2009, J VISION, V9, DOI 10.1167/9.5.23; BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Brown TL, 1998, BRAIN LANG, V63, P122, DOI 10.1006/brln.1997.1940; Brown TL, 2011, J EXP PSYCHOL HUMAN, V37, P85, DOI 10.1037/a0019252; Chen YC, 2011, J EXP PSYCHOL HUMAN, V37, P1554, DOI 10.1037/a0024329; Chen YC, 2010, COGNITION, V114, P389, DOI 10.1016/j.cognition.2009.10.012; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Coderre E, 2011, BRAIN RES, V1413, P51, DOI 10.1016/j.brainres.2011.07.017; COLAVITA FB, 1974, PERCEPT PSYCHOPHYS, V16, P409, DOI 10.3758/BF03203962; Correa A, 2006, BRAIN RES, V1070, P202, DOI 10.1016/j.brainres.2005.11.094; De Gelder B, 2004, TRENDS COGN SCI, V8, P7, DOI 10.1016/j.tics.2003.11.005; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Donohue SE, 2010, ATTEN PERCEPT PSYCHO, V72, P1120, DOI 10.3758/APP.72.4.1120; DYER FN, 1971, PSYCHON SCI, V25, P229; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Fiebelkorn IC, 2010, CEREB CORTEX, V20, P109, DOI 10.1093/cercor/bhp083; GIELEN SCAM, 1983, PERCEPT PSYCHOPHYS, V34, P161, DOI 10.3758/BF03211343; GLASER MO, 1982, J EXP PSYCHOL HUMAN, V8, P875, DOI 10.1037/0096-1523.8.6.875; GLASER WR, 1984, J EXP PSYCHOL HUMAN, V10, P640, DOI 10.1037/0096-1523.10.5.640; Lu CH, 2001, Q J EXP PSYCHOL-A, V54, P95, DOI 10.1080/02724980042000048; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MacLeod CM, 1998, MEM COGNITION, V26, P201, DOI 10.3758/BF03201133; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Mondor TA, 1998, J EXP PSYCHOL HUMAN, V24, P745, DOI 10.1037/0096-1523.24.3.745; Moore CM, 1996, PSYCHON B REV, V3, P360, DOI 10.3758/BF03210761; Roelofs A, 2005, MEM COGNITION, V33, P1325, DOI 10.3758/BF03193365; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; SHIMADA H, 1990, PERCEPT MOTOR SKILL, V70, P1155, DOI 10.2466/PMS.70.4.1155-1161; Shore DI, 2006, NEUROSCI LETT, V392, P96, DOI 10.1016/j.neulet.2005.09.001; Shore DI, 2005, EXP BRAIN RES, V166, P509, DOI 10.1007/s00221-005-2391-x; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; Sinnett S, 2008, ACTA PSYCHOL, V128, P153, DOI 10.1016/j.actpsy.2007.12.002; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUART DM, 1993, AM J PSYCHOL, V106, P383, DOI 10.2307/1423183; SUGG MJ, 1994, J EXP PSYCHOL HUMAN, V20, P647, DOI 10.1037/0096-1523.20.3.647; Szucs D, 2010, BRAIN RES, V1325, P63, DOI 10.1016/j.brainres.2010.02.011; TAYLOR DA, 1977, J EXP PSYCHOL GEN, V106, P404, DOI 10.1037/0096-3445.106.4.404; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Vatakis A, 2008, J VISION, V8, DOI 10.1167/8.9.14; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; Yuval-Greenberg S, 2007, J NEUROSCI, V27, P1090, DOI 10.1523/JNEUROSCI.4828-06.2007; Yuval-Greenberg S, 2009, EXP BRAIN RES, V193, P603, DOI 10.1007/s00221-008-1664-6; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2005, NEUROSCI LETT, V381, P217, DOI 10.1016/j.neulet.2005.01.085; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	56	19	20	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62802	10.1371/journal.pone.0062802	http://dx.doi.org/10.1371/journal.pone.0062802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	181JC	23638149	gold, Green Published			2022-12-25	WOS:000321662800063
J	Liu, XM; Wang, XM; Li, LX; Wang, HY; Jiao, XL				Liu, Xiumei; Wang, Xueming; Li, Lixia; Wang, Haiyan; Jiao, Xiaoling			Influence of Mesenchymal Stem Cell Transplantation on Stereotypic Behavior and Dopamine Levels in Rats with Tourette Syndrome	PLOS ONE			English	Article							MODEL	Context: Tourette syndrome (TS) is a heterogeneous neuropsychiatric disorder. Chronic motor and phonic tics are central symptoms in TS patients. For some patients, tics are intractable to any traditional treatment and cause lifelong impairment and life-threatening symptoms. New therapies should be developed to address symptoms and overt manifestations of TS. Transplantation of neurogenic stem cells might be a viable approach in TS treatment. Objective: We used mesenchymal stem cell (MSC) transplantation to treat TS. We discuss the mechanism of action, as well as the efficiency of this approach, in treating TS. Settings and Design: An autoimmune TS animal model was adopted in the present study. Forty-eight Wistar rats were randomly allocated to the control group and the 2 experimental groups, namely, TS rats+vehicle and TS rats+MSC. MSCs were co-cultured with 5-bromodeoxyuridine (BrdU) for 24 h for labeling prior to grafting. Methods: Stereotypic behaviors were recorded at 1, 7, 14, and 28 days after transplantation. Dopamine (DA) content in the striatum of rats in the 3 groups was measured using a high-performance liquid chromatography column equipped with an electrochemical detector (HPLC-ECD) on day 28 after transplantation. Statistical analysis: Statistical analysis was performed by repeated measurements analysis of variance to evaluate stereotypic behavior counts at different time points. Results: TS rats exhibited higher stereotypic behavioral counts compared with the control group. One week after transplantation, TS rats with MSC grafts exhibited significantly decreased stereotypic behavior. Rats with MSC grafts also showed reduced levels of DA in the striatum when compared with TS rats, which were exposed only to the vehicle. Conclusions: Intrastriatal transplantation of MSCs can provide relief from the stereotypic behavior of TS. Our results indicate that this approach may have potential for developing therapies against TS. The mechanism(s) of the observed effect may be related to the suppression of DA system by decreasing the content of DA in TS rats.	[Liu, Xiumei; Wang, Xueming; Li, Lixia; Wang, Haiyan; Jiao, Xiaoling] Qingdao Univ, Yuhuangding Hosp, Dept Pediat, Yantai, Shandong, Peoples R China	Qingdao University	Li, LX (corresponding author), Qingdao Univ, Yuhuangding Hosp, Dept Pediat, Yantai, Shandong, Peoples R China.	dr_llx@sina.com			National Natural Science Foundation [81101017]; Department of Science and Technology of Shandong Province [BS2010F030]; Yantai Science and Technology Development project [2010148-24]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Shandong Province; Yantai Science and Technology Development project	This study was supported by National Natural Science Foundation (81101017), Department of Science and Technology of Shandong Province (BS2010F030), and Yantai Science and Technology Development project (2010148-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; Arbouw MEL, 2012, EUR J CLIN PHARMACOL, V68, P83, DOI 10.1007/s00228-011-1084-6; Cheung MYC, 2007, MOVEMENT DISORD, V22, P1743, DOI 10.1002/mds.21599; Cortese S, 2008, MED HYPOTHESES, V70, P1128, DOI 10.1016/j.mehy.2007.10.013; Davila G, 2010, J CLIN PSYCHIAT, V71, P1401, DOI 10.4088/JCP.09l05669blu; Hallett JJ, 2000, J NEUROIMMUNOL, V111, P195, DOI 10.1016/S0165-5728(00)00320-9; Hassan N, 2012, FUNCT NEUROL, V27, P23; Herzberg I, 2010, PSYCHIAT GENET, V20, P179, DOI 10.1097/YPG.0b013e32833a215a; Idris Z, 2010, J CLIN NEUROSCI, V17, P1343, DOI 10.1016/j.jocn.2010.01.054; Knight T, 2012, PEDIATR NEUROL, V47, P77, DOI 10.1016/j.pediatrneurol.2012.05.002; Li JJ, 2010, NEUROL INDIA, V58, P523, DOI 10.4103/0028-3886.68663; Li Z, 2011, CYTOTHERAPY, V13, P69, DOI 10.3109/14653249.2010.510502; Liu XM, 2010, NEURAL REGEN RES, V5, P1285, DOI 10.3969/j.issn.1673-5374.2010.17.001; Liu XM, 2008, BEHAV BRAIN RES, V186, P84, DOI 10.1016/j.bbr.2007.07.040; Nemoda Z, 2011, NEUROSCI BIOBEHAV R, V35, P1665, DOI 10.1016/j.neubiorev.2011.04.002; Neuner Irene, 2010, Biol Psychiatry, V68, pe19, DOI 10.1016/j.biopsych.2010.03.001; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Palminteri S, 2011, BRAIN, V134, P2287, DOI 10.1093/brain/awr147; Rickards H, 2012, EUR J PAEDIATR NEURO, V16, P361, DOI 10.1016/j.ejpn.2011.12.001; Tang HL, 2011, CHINESE MED J-PEKING, V124, P1848, DOI 10.3760/cma.j.issn.0366-6999.2011.12.016; Taylor JL, 2010, BRAIN RES, V1322, P92, DOI 10.1016/j.brainres.2010.01.052; Taylor JR, 2002, AM J PSYCHIAT, V159, P657, DOI 10.1176/appi.ajp.159.4.657; Wang ZS, 2011, AM J PSYCHIAT, V168, P1326, DOI 10.1176/appi.ajp.2011.09111692; Yoon DY, 2007, J NEUROL SCI, V255, P50, DOI 10.1016/j.jns.2007.01.069	24	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62198	10.1371/journal.pone.0062198	http://dx.doi.org/10.1371/journal.pone.0062198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638003	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700039
J	Zhang, J; Li, L; Peng, LY; Sun, YX; Li, J				Zhang, Jie; Li, Li; Peng, Luying; Sun, Yingxian; Li, Jue			An Efficient Weighted Graph Strategy to Identify Differentiation Associated Genes in Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; INTERACTION NETWORK; PROTEIN; EXPRESSION; PREDICTION; NANOG; PLURIPOTENCY; REPLICATION; METHYLATION; INDUCTION	In the past few decades, embryonic stem cells (ESCs) were of great interest as a model system for studying early developmental processes and because of their potential therapeutic applications in regenerative medicine. However, the underlying mechanisms of ESC differentiation remain unclear, which limits our exploration of the therapeutic potential of stem cells. Fortunately, the increasing quantity and diversity of biological datasets can provide us with opportunities to explore the biological secrets. However, taking advantage of diverse biological information to facilitate the advancement of ESC research still remains a challenge. Here, we propose a scalable, efficient and flexible function prediction framework that integrates diverse biological information using a simple weighted strategy, for uncovering the genetic determinants of mouse ESC differentiation. The advantage of this approach is that it can make predictions based on dynamic information fusion, owing to the simple weighted strategy. With this approach, we identified 30 genes that had been reported to be associated with differentiation of stem cells, which we regard to be associated with differentiation or pluripotency in embryonic stem cells. We also predicted 70 genes as candidates for contributing to differentiation, which requires further confirmation. As a whole, our results showed that this strategy could be applied as a useful tool for ESC research.	[Zhang, Jie; Li, Jue] Tongji Univ, Sch Med, Dept Prevent, Shanghai 200092, Peoples R China; [Li, Li; Peng, Luying] Tongji Univ, Sch Med, Key Lab Arrhythmias, Minist Educ, Shanghai 200092, Peoples R China; [Sun, Yingxian] China Med Univ, Hosp 1, Dept Cardiol, Shenyang, Peoples R China	Tongji University; Tongji University; China Medical University	Zhang, J (corresponding author), Tongji Univ, Sch Med, Dept Prevent, Shanghai 200092, Peoples R China.	jiezhang@tongji.edu.cn; jueli@tongji.edu.cn			Young Talents Scheme of Tongji University, China [1500219046]; Shanghai Municipal Health Bureau Project [z0124y166]; National Natural Science Foundation of China [30971621, 81270231, 31170791]; International Science & Technology Cooperation Program of China [2011DFB30010]	Young Talents Scheme of Tongji University, China; Shanghai Municipal Health Bureau Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	Research was supported by the Young Talents Scheme of Tongji University, China (To Zhang Jie, 1500219046); Shanghai Municipal Health Bureau Project (To Zhang Jie, z0124y166); National Natural Science Foundation of China (30971621, 81270231 and 31170791); and International Science & Technology Cooperation Program of China (2011DFB30010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bar-On O, 2010, CELL CYCLE, V9, P1986, DOI 10.4161/cc.9.10.11727; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; BLAU HM, 1989, TRENDS GENET, V5, P268, DOI 10.1016/0168-9525(89)90100-5; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Casson SA, 2009, PLANT J, V57, P857, DOI 10.1111/j.1365-313X.2008.03738.x; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Chung KC, 1998, NEUROSCI LETT, V255, P155, DOI 10.1016/S0304-3940(98)00733-2; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dupont Edmond, 1997, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V191, P95; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Gu B, BIOCH BIOPHYS RES CO, V394, P418; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jane Grossman MG, 1980, 1 SYSTEMS WEIGHTED D; Katoh M, 2007, INT J MOL MED, V20, P405; Kele J, 2012, STEM CELLS, V30, P865, DOI 10.1002/stem.1049; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Leeb M, GENES DEV, V24, P265; Li L, 2010, STEM CELLS, V28, P247, DOI 10.1002/stem.289; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Mea Langaas, 2005, STAT HYPOTHESIS TEST; Mouillet-Richard S, 1999, MICROBES INFECT, V1, P969, DOI 10.1016/S1286-4579(99)80514-0; Murali TM, 2006, NAT BIOTECHNOL, V24, P1474, DOI 10.1038/nbt1206-1474; Nakajima M, 2006, CELL BIOL INT, V30, P239, DOI 10.1016/j.cellbi.2005.11.003; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ochsner SA, 2007, STEM CELLS, V25, P2476, DOI 10.1634/stemcells.2007-0101; Pavlidis P, 2003, BIOINFORMATICS, V19, P1620, DOI 10.1093/bioinformatics/btg227; Perry P, 2004, CELL CYCLE, V3, P1645; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Richie ER, 2002, ONCOGENE, V21, P299, DOI 10.1038/sj.onc.1205051; Rubin R, 2007, J CELL PHYSIOL, V213, P445, DOI 10.1002/jcp.21185; Salehi H, 2011, INT J DEV BIOL, V55, P321, DOI 10.1387/ijdb.103185hs; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Schrenk-Siemens K, 2008, STEM CELLS, V26, P2153, DOI 10.1634/stemcells.2008-0010; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Shaw L, IN VITRO CELL DEV BI, V46, P155; Sugaya K, 2007, CURR ALZHEIMER RES, V4, P370, DOI 10.2174/156720507781788936; Suh HN, J CELL PHYSL; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Traister A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037802; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ura H, 2011, EMBO J, V30, P2190, DOI 10.1038/emboj.2011.126; Veeraraghavalu K, 2010, J NEUROSCI, V30, P6903, DOI 10.1523/JNEUROSCI.0527-10.2010; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Wice BM, 1998, J BIOL CHEM, V273, P25310, DOI 10.1074/jbc.273.39.25310; Wu HW, 2005, NUCLEIC ACIDS RES, V33, P2822, DOI 10.1093/nar/gki573; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Xie Y, 2005, BIOINFORMATICS, V21, P4280, DOI 10.1093/bioinformatics/bti685; Yao WL, 2010, NEUROREPORT, V21, P39, DOI 10.1097/WNR.0b013e32833312fe; Zhang J, 2005, LECT NOTES ARTIF INT, V3614, P852; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200	70	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62716	10.1371/journal.pone.0062716	http://dx.doi.org/10.1371/journal.pone.0062716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638139	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700069
J	Taronna, A; Mazzoni, E; Corallini, A; Bononi, I; Pietrobon, S; Guerra, G; Palmonari, C; Borgna-Pignatti, C; Comar, M; Bovenzi, M; Casali, F; Marci, R; Rezza, G; Barbanti-Brodano, G; Tognon, M; Martini, F				Taronna, Angelo; Mazzoni, Elisa; Corallini, Alfredo; Bononi, Ilaria; Pietrobon, Silvia; Guerra, Giovanni; Palmonari, Caterina; Borgna-Pignatti, Caterina; Comar, Manola; Bovenzi, Massimo; Casali, Ferruccio; Marci, Roberto; Rezza, Giovanni; Barbanti-Brodano, Giuseppe; Tognon, Mauro; Martini, Fernanda			Serological Evidence of an Early Seroconversion to Simian Virus 40 in Healthy Children and Adolescents	PLOS ONE			English	Article							CAPSID PROTEIN MIMOTOPES; HUMAN MESOTHELIAL CELLS; PERIPHERAL-BLOOD CELLS; LARGE T-ANTIGEN; POLYOMAVIRUS SV40; BK VIRUS; HOSPITALIZED CHILDREN; SV40-LIKE SEQUENCES; SERUM ANTIBODIES; CHOROID-PLEXUS	At present Simian virus 40 (SV40) infection in humans appears to be transmitted independently from early contaminated vaccines. In order to test the spread of SV40 infection in children, an immunologic assay employing specific SV40 synthetic peptides corresponding to its viral protein (VP) antigens was employed to estimate the seroprevalence of this polyomavirus in Italian infants and adolescents. Serum samples from 328 children and adolescents, up to 17 years, were investigated. Serum antibodies against SV40 VPs were detected by indirect enzyme-linked immunosorbent assays. The seroprevalence of this polyomavirus was calculated after stratifying the subjects by age. Anti-viral capsid protein 1-2-3 SV40 IgG antibodies were detected in 16% of the study participants. The prevalence of antibodies against SV40 VPs tended to increase with age in children, up to 10 year old (21%). Then, in the cohort of individuals aged 11-17 years, the prevalence decreased (16%). A higher prevalence rate (23%) of SV40 VP antibodies was detected in the cohorts of 1-3 year and 7-10 year old children, than in children and adolescents of the other age groups. This age corresponds to children starting nursery and primary school, respectively, in Italy. IgM antibodies against SV40 VP mimotopes were detected in 6-8 month old children suggesting that SV40 seroconversion can occur early in life. SV40 VP antibodies are present at low prevalence in Italian children (16%), suggesting that SV40 infection, although acquired early in life, probably through different routes, is not widespread. The low SV40 seroprevalence suggests that SV40 is less transmissible than other common polyomaviruses, such as BKV and JCV. Alternatively, our immunologic data could be due to another, as yet undiscovered, human polyomavirus closely related to SV40.	[Taronna, Angelo; Corallini, Alfredo; Barbanti-Brodano, Giuseppe] Univ Ferrara, Microbiol Sect, I-44100 Ferrara, Italy; [Mazzoni, Elisa; Bononi, Ilaria; Pietrobon, Silvia; Tognon, Mauro; Martini, Fernanda] Univ Ferrara, Sect Cell Biol & Mol Genet, I-44100 Ferrara, Italy; [Guerra, Giovanni] Ferrara City Hosp, Ferrara, Italy; [Palmonari, Caterina] Cty Hosp Delta, Lagosanto, Italy; [Borgna-Pignatti, Caterina] Univ Ferrara, Sect Pediat, I-44100 Ferrara, Italy; [Comar, Manola] Univ Trieste, Ist Ric & Cura Carattere Sci Burlo Garofolo Tries, Inst Maternal & Child Hlth, Trieste, Italy; [Bovenzi, Massimo] Univ Trieste, Dept Med Sci, Clin Unit Occupat Med, Trieste, Italy; [Casali, Ferruccio] San Marino State Hosp, Borgo Maggiore, San Marino; [Marci, Roberto] Univ Ferrara, Dept Obstet & Genecol, I-44100 Ferrara, Italy; [Rezza, Giovanni] Ist Super Sanita, Dept Infect Dis, I-00161 Rome, Italy	University of Ferrara; University of Ferrara; University of Ferrara; University of Trieste; University of Trieste; University of Ferrara; Istituto Superiore di Sanita (ISS)	Tognon, M (corresponding author), Univ Ferrara, Sect Cell Biol & Mol Genet, I-44100 Ferrara, Italy.	tgm@unife.it; mrf@unife.it	Marci, Roberto/G-6927-2012; rezza, giovanni/D-4393-2016; Comar, Manola/K-4613-2016; Mazzoni, Elisa/K-6313-2016; COMAR, Manola/K-4613-2016	Marci, Roberto/0000-0002-9230-6685; rezza, giovanni/0000-0003-0268-6790; Comar, Manola/0000-0001-6310-3320; BOVENZI, MASSIMO/0000-0002-6001-5218; Mazzoni, Elisa/0000-0001-6829-8569; Bononi, Ilaria/0000-0002-5286-5845; COMAR, Manola/0000-0002-9487-861X	Fondazione Buzzi UNICEM, Casale Monferrato; A.S.L.E.M., Repubblica di San Marino; Regione Emilia-Romagna, Bologna; I.S.S, Roma; Fondazione Cassa di Risparmio di Cento, Cento; University Hospital of Ferrara, Ferrara; University of Ferrara, FAR projects, Ferrara, Italy	Fondazione Buzzi UNICEM, Casale Monferrato; A.S.L.E.M., Repubblica di San Marino; Regione Emilia-Romagna, Bologna(Regione Emilia Romagna); I.S.S, Roma; Fondazione Cassa di Risparmio di Cento, Cento; University Hospital of Ferrara, Ferrara; University of Ferrara, FAR projects, Ferrara, Italy	Dr. Elisa Mazzoni is a post doctoral fellow of the Fondazione Veronesi, Milan, Italy. This project was supported, in part, by grants from Fondazione Buzzi UNICEM, Casale Monferrato; A.S.L.E.M., Repubblica di San Marino; Regione Emilia-Romagna, Bologna; I.S.S, Roma; Fondazione Cassa di Risparmio di Cento, Cento; University Hospital of Ferrara, Ferrara; University of Ferrara, FAR projects, Ferrara, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbanti-Brodano G, 2004, JNCI-J NATL CANCER I, V96, P803, DOI 10.1093/jnci/djh151; Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004; BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504; Bocchetta M, 2000, P NATL ACAD SCI USA, V97, P10214, DOI 10.1073/pnas.170207097; Bouvard V, 2012, LANCET ONCOL, V13, P339, DOI 10.1016/S1470-2045(12)70125-0; Butel JS, 2012, CURR OPIN VIROL, V2, P508, DOI 10.1016/j.coviro.2012.06.004; Butel JS, 2012, CURR CANCER RES, P377, DOI 10.1007/978-1-4614-0016-5_15; Butel JS, 1999, J INFECT DIS, V180, P884, DOI 10.1086/314915; Butel JS, 1999, HUM PATHOL, V30, P1496, DOI 10.1016/S0046-8177(99)90173-9; Cacciotti P, 2001, P NATL ACAD SCI USA, V98, P12032, DOI 10.1073/pnas.211026798; Carbone M, 1996, ONCOGENE, V13, P527; Carter JJ, 2003, JNCI-J NATL CANCER I, V95, P1522, DOI 10.1093/jnci/djg074; Corallini A, 2012, HUM IMMUNOL, V73, P502, DOI 10.1016/j.humimm.2012.02.009; Dolcetti R, 2003, J VIROL, V77, P1595, DOI 10.1128/JVI.77.2.1595-1597.2003; Gamberi G, 2000, GENE CHROMOSOME CANC, V28, P23, DOI 10.1002/(SICI)1098-2264(200005)28:1<23::AID-GCC3>3.0.CO;2-W; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Jafar S, 1998, J MED VIROL, V54, P276, DOI 10.1002/(SICI)1096-9071(199804)54:4<276::AID-JMV7>3.0.CO;2-1; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Lednicky JA, 1997, INT J CANCER, V72, P791; LEDNICKY JA, 1995, VIROLOGY, V212, P710, DOI 10.1006/viro.1995.1529; Lundstig A, 2005, J GEN VIROL, V86, P1703, DOI 10.1099/vir.0.80783-0; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Martini F, 1996, CANCER RES, V56, P4820; Martini F, 2002, CANCER-AM CANCER SOC, V94, P1037, DOI 10.1002/cncr.10272; Martini F, 1998, INT J CANCER, V78, P669, DOI 10.1002/(SICI)1097-0215(19981209)78:6<669::AID-IJC1>3.0.CO;2-B; Martini Fernanda, 2007, Infect Agent Cancer, V2, P13, DOI 10.1186/1750-9378-2-13; Mazzoni E, 2012, P NATL ACAD SCI USA, V109, P18066, DOI 10.1073/pnas.1213238109; Mazzoni E, 2012, EXP HEMATOL, V40, P466, DOI 10.1016/j.exphem.2012.02.008; Morelli C, 2004, MOL MED, V10, P112, DOI 10.2119/2004-00037.Morelli; Nicol JT, 2013, CLIN VACCINE IMMUNOL; Pancaldi C, 2009, J INFECTION, V58, P53, DOI 10.1016/j.jinf.2008.10.014; Patel NC, 2008, J CLIN VIROL, V43, P66, DOI 10.1016/j.jcv.2008.04.011; Randhawa P, 2008, CLIN VACCINE IMMUNOL, V15, P1564, DOI 10.1128/CVI.00206-08; Ribeiro T, 2010, NEUROL SCI, V31, P517, DOI 10.1007/s10072-010-0353-y; Stratton K, 2003, IMMUNIZATION SAFETY; Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076; Vanchiere JA, 2005, J MED VIROL, V75, P447, DOI 10.1002/jmv.20287; Viscidi RP, 2003, CLIN DIAGN LAB IMMUN, V10, P278, DOI 10.1128/CDLI.10.2.278-285.2003; Yamamoto H, 2000, BRIT J CANCER, V82, P1677	39	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61182	10.1371/journal.pone.0061182	http://dx.doi.org/10.1371/journal.pone.0061182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634207	gold, Green Published, Green Submitted			2022-12-25	WOS:000318341400010
J	Joussain, P; Thevenet, M; Rouby, C; Bensafi, M				Joussain, Pauline; Thevenet, Marc; Rouby, Catherine; Bensafi, Moustafa			Effect of Aging on Hedonic Appreciation of Pleasant and Unpleasant Odors	PLOS ONE			English	Article							RAT OLFACTORY-BULB; HUMAN AMYGDALA; PIRIFORM CORTEX; HUMAN BRAIN; REPRESENTATIONS; PERCEPTION; ODORANTS; HUMANS; ACTIVATION; QUALITY	Does hedonic appreciation evolve differently for pleasant odors and unpleasant odors during normal aging? To answer this question we combined psychophysics and electro-encephalographic recordings in young and old adults. A first study showed that pleasant odorants (but not unpleasant ones) were rated as less pleasant by old adults. A second study validated this decrease in hedonic appreciation for agreeable odors and further showed that smelling these odorants decreased beta event-related synchronization in aged participants. In conclusion, the study offers new insights into the evolution of odor hedonic perception during normal aging, highlighting for the first time a change in processing pleasant odors.	[Joussain, Pauline; Thevenet, Marc; Rouby, Catherine; Bensafi, Moustafa] Univ Lyon, Lyon Neurosci Res Ctr, INSERM, CNRS,UMR5292,U1028, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Joussain, P (corresponding author), Univ Lyon, Lyon Neurosci Res Ctr, INSERM, CNRS,UMR5292,U1028, Lyon, France.	pauline.joussain@olfac.univ-lyon1.fr; bensafi@olfac.univ-lyon1.fr	Bensafi, Moustafa/H-6618-2017	Bensafi, Moustafa/0000-0002-2991-3036; Rouby, Catherine/0000-0002-5683-5491	Fondation Roudnitska; Region Rhone-Alpes (CMIRA Explora' doc); French National Research Agency (ANR); French National Research Agency (EMCO); French National Research Agency (ICEO)	Fondation Roudnitska; Region Rhone-Alpes (CMIRA Explora' doc)(Region Auvergne-Rhone-Alpes); French National Research Agency (ANR)(French National Research Agency (ANR)); French National Research Agency (EMCO)(French National Research Agency (ANR)); French National Research Agency (ICEO)(French National Research Agency (ANR))	This work was funded by the Fondation Roudnitska, the Region Rhone-Alpes (CMIRA Explora' doc 2011) and the French National Research Agency (ANR, EMCO Program, ICEO project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Bensafi M, 2002, NEUROPHYSIOL CLIN, V32, P326, DOI 10.1016/S0987-7053(02)00339-8; Bensafi M, 2002, NEUROSCI LETT, V328, P309, DOI 10.1016/S0304-3940(02)00548-7; Bensafi M, 2003, BRAIN COGNITION, V51, P270, DOI 10.1016/S0278-2626(03)00019-8; Bensafi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038358; Boyle JA, 2009, CEREB CORTEX, V19, P66, DOI 10.1093/cercor/bhn058; Cerf-Ducastel B, 2003, BRAIN RES, V986, P39, DOI 10.1016/S0006-8993(03)03168-8; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delplanque S, 2008, CHEM SENSES, V33, P469, DOI 10.1093/chemse/bjn014; Djordjevic J, 2005, NEUROIMAGE, V24, P791, DOI 10.1016/j.neuroimage.2004.09.035; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Farahbod H, 2006, J COMP NEUROL, V497, P350, DOI 10.1002/cne.20982; Ferdenzi C, 2013, CHEM SENSES, V38, P175, DOI 10.1093/chemse/bjs083; Frank RA, 2003, PHYSIOL BEHAV, V78, P195, DOI 10.1016/S0031-9384(02)00965-4; Frasnelli J, 2011, HUM BRAIN MAPP, V32, P450, DOI 10.1002/hbm.21035; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; Huart C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033221; Hudry J, 2003, BRAIN, V126, P1851, DOI 10.1093/brain/awg192; Hudry J, 2001, CEREB CORTEX, V11, P619, DOI 10.1093/cercor/11.7.619; Hummel T, 2007, BEHAV BRAIN RES, V180, P133, DOI 10.1016/j.bbr.2007.02.040; Jacob TJC, 2006, PHYSIOL BEHAV, V87, P500, DOI 10.1016/j.physbeh.2005.11.018; Johnson BA, 2005, J COMP NEUROL, V483, P192, DOI 10.1002/cne.20415; Johnson BN, 2006, CHEM SENSES, V31, P795, DOI 10.1093/chemse/bjl021; Joussain Pauline, 2011, Commun Integr Biol, V4, P563, DOI 10.4161/cib.4.5.15811; Jung J, 2006, CEREB CORTEX, V16, P1, DOI 10.1093/cercor/bhi090; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kermen F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00206; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Kline JP, 2000, BIOL PSYCHOL, V52, P241, DOI 10.1016/S0301-0511(99)00046-0; Kline JP, 2000, CONSCIOUS COGN, V9, P50, DOI 10.1006/ccog.1999.0422; Konstantinidis I, 2006, ARCH CLIN NEUROPSYCH, V21, P615, DOI 10.1016/j.acn.2006.05.006; Lapid H, 2011, NAT NEUROSCI, V14, P1455, DOI 10.1038/nn.2926; Mandairon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004209; Markovic K, 2007, J GERONTOL A-BIOL, V62, P1287, DOI 10.1093/gerona/62.11.1287; Martin GN, 1998, INT J PSYCHOPHYSIOL, V30, P287, DOI 10.1016/S0167-8760(98)00025-7; Meisami E, 1998, ANN NY ACAD SCI, V855, P708, DOI 10.1111/j.1749-6632.1998.tb10649.x; Nagashima A, 2010, J NEUROSCI, V30, P16391, DOI 10.1523/JNEUROSCI.2527-10.2010; Pause BM, 2000, INT J PSYCHOPHYSIOL, V36, P105, DOI 10.1016/S0167-8760(99)00105-1; Poncelet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013878; Poncelet J, 2010, BEHAV BRAIN RES, V208, P458, DOI 10.1016/j.bbr.2009.12.011; Pouliot S, 2008, CHEMOSENS PERCEPT, V1, P43, DOI 10.1007/s12078-007-9001-1; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Rouby C, 2009, ANN NY ACAD SCI, V1170, P333, DOI 10.1111/j.1749-6632.2009.03915.x; Rouby C, 2009, FOOD QUAL PREFER, V20, P545, DOI 10.1016/j.foodqual.2009.05.004; Savic I, 2002, HUM BRAIN MAPP, V17, P17, DOI 10.1002/hbm.10045; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; SCHIFFMAN SS, 1974, SCIENCE, V185, P112, DOI 10.1126/science.185.4146.112; Wang J, 2005, J GERONTOL A-BIOL, V60, P510, DOI 10.1093/gerona/60.4.510; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zelano C, 2007, J NEUROPHYSIOL, V97, P1969, DOI 10.1152/jn.01122.2006	53	33	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61376	10.1371/journal.pone.0061376	http://dx.doi.org/10.1371/journal.pone.0061376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637821	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400018
J	Samkange-Zeeb, F; Pottgen, S; Zeeb, H				Samkange-Zeeb, Florence; Poettgen, Saskia; Zeeb, Hajo			Higher Risk Perception of HIV than of Chlamydia and HPV among Secondary School Students in Two German Cities	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; ADOLESCENT KNOWLEDGE; VACCINE ACCEPTANCE; OPTIMISTIC BIAS; YOUNG-PEOPLE; AWARENESS; EPIDEMIOLOGY; GONORRHEA; PARENTS	Background: Chlamydia and genital human papillomavirus (HPV) are the two most common sexually transmitted infections (STIs) among teens and young adults in industrialised countries. The majority of adolescents, however, have limited or no knowledge of these infections. Within the context of a cross-sectional survey on awareness and knowledge of sexually transmitted infections, secondary school students attending the 8th grade and above in Bremen and Bremerhaven, two cities in northern Germany, were asked to rate the risk of peers to get infected with HIV, HPV or chlamydia. Methods: Between October and December 2011, students aged 12-20 years completed an anonymous, self-administered questionnaire at their school. In addition to answering questions on awareness and knowledge of sexually transmitted infections, all students were also asked to rate the risk of peers to get infected with HIV, HPV or chlamydia. Furthermore, those reporting ever having sexual intercourse were asked to rate their own risk of getting infected with each of the three infections. Results: 1,148 students, 55% female, completed the questionnaire. 27% of the students reported having had sexual intercourse. 68% of all students rated the risk of same-aged students to get infected with HIV/AIDS as high/medium. The corresponding proportions for HPV and chlamydia were 19 and 25% respectively. Those reporting ever having sexual intercourse generally perceived their own risk of getting infected with HIV, chlamydia or HPV as lower than that of their peers. Conclusion: Generally, the risk of getting infected with HIV was perceived as being higher than that of getting infected with HPV or chlamydia, most likely due to the fact that the students were more aware of HIV than of the other two infections. Efforts should be made to improve awareness and knowledge of HPV and chlamydia among school going adolescents, and to make them realize that these are common infections that are preventable.	[Samkange-Zeeb, Florence; Poettgen, Saskia; Zeeb, Hajo] Leibniz Inst Prevent Res & Epidemiol, Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS)	Samkange-Zeeb, F (corresponding author), Leibniz Inst Prevent Res & Epidemiol, Bremen, Germany.	samkange@bips.uni-bremen.de	Zeeb, Hajo/I-2701-2019	Zeeb, Hajo/0000-0001-7509-242X; Muellmann, Saskia/0000-0002-8650-8395				Adler MW, 2006, EUROHEALTH, V12, P3; [Anonymous], [No title captured]; Berglund T, 2001, SEX TRANSM DIS, V28, P111, DOI 10.1097/00007435-200102000-00009; Blodt S, 2012, EUR J PUBLIC HEALTH, V22, P808, DOI 10.1093/eurpub/ckr188; Bobrova N, 2005, PERSPECT SEX REPRO H, V37, P174, DOI 10.1363/3717405; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Bundeszentrale fur gesundheitliche Aufklarung, 2006, COUNTR PAP YOUTH SEX; Busen Nancy H, 2006, J Pediatr Health Care, V20, P393, DOI 10.1016/j.pedhc.2006.03.003; BVSDE, VIRT LIB SUST DEV EN; Centres for Disease Control and Prevention, 2012, SEX TRANSM DIS STDS; Clark LR, 2002, SEX TRANSM DIS, V29, P436, DOI 10.1097/00007435-200208000-00002; Das A, 2010, VACCINE, V28, P1440, DOI 10.1016/j.vaccine.2009.11.041; Department of Statistics M, 2012, HUM PAP GREEN BOOK, P1; Editorial team, 2005, EURO SURVEILL, V10; FORD N, 1992, J ADOLESCENCE, V15, P393, DOI 10.1016/0140-1971(92)90071-C; Forhan SE, 2009, PEDIATRICS, V124, P1505, DOI 10.1542/peds.2009-0674; Forster AS, 2012, VACCINE, V30, P4505, DOI 10.1016/j.vaccine.2012.04.066; Garside R, 2001, INT J STD AIDS, V12, P582, DOI 10.1258/0956462011923750; Gerrard M, 1996, PSYCHOL BULL, V119, P390, DOI 10.1037/0033-2909.119.3.390; Gilbert S, 2011, NATL CHLAMYDIA COALI, V3; Gille G, 2005, DTSCH ARZTEBLATT, V28-29, P2021; Gottvall M, 2009, EUR J CONTRACEP REPR, V14, P399, DOI 10.3109/13625180903229605; Harris PR, 2008, J PERS SOC PSYCHOL, V95, P1225, DOI 10.1037/a0013315; Hayden J, 2009, INTRO HLTH BEHAV THE, P31; Health protection Surveillance Centre, 2005, SURV STI REP SEX TRA; Klein CTF, 2002, PSYCHOL HEALTH, V17, P437, DOI 10.1080/0887044022000004920; Lengen C, 2010, SOC SCI MED, V70, P1789, DOI 10.1016/j.socscimed.2010.01.048; Leval A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020624; Lister-Sharp D, 1999, HLTH TECHNOLOGY ASSE, V3, P1, DOI DOI 10.3310/HTA3220; MacDonald NE, 1997, CANADIAN J HUMAN SEX, V6; Nicoll A, 2002, BMJ-BRIT MED J, V324, P1324, DOI 10.1136/bmj.324.7349.1324; Panchaud C, 2000, FAM PLANN PERSPECT, V32, P24, DOI 10.2307/2648145; Pelucchi C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-378; Rosengard C, 2004, SEX TRANSM INFECT, V80, P130, DOI 10.1136/sti.2003.006056; Sachsenweger M, 2011, GESUNDHEITSWESEN, V73, P54, DOI 10.1055/s-0029-1246200; Samkange-Zeeb F, 2012, J COMMUN HEALTH, V37, P1151, DOI 10.1007/s10900-012-9589-1; Samkange-Zeeb F, 2013, J COMMUN HEALTH, V38, P293, DOI 10.1007/s10900-012-9614-4; Samkange-Zeeb FN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-727; Simms I, 2000, SEX TRANSM INFECT, V76, P80, DOI 10.1136/sti.76.2.80; Stephenson JM, 2004, LANCET, V364, P338, DOI 10.1016/S0140-6736(04)16722-6; Stocker P, 2012, HUM VACC IMMUNOTHER, V9, P1; Tucker JS, 2007, EUR J PUBLIC HEALTH, V17, P33, DOI 10.1093/eurpub/ckl044; Twisselmann B, 2002, EURO SURVEILL, V6; UNAIDS, 2008, N AM W CENTR EUR AID; van der Pligt J, 1998, BRIT J HEALTH PSYCH, V3, P1; Warner LM, 2007, Z GESUNDHEITSPSYCHOL, V15, P109; Wight D, 2002, BMJ-BRIT MED J, V324, P435; Woodhall SC, 2007, J ADOLESCENT HEALTH, V40, P466, DOI 10.1016/j.jadohealth.2007.01.005	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61636	10.1371/journal.pone.0061636	http://dx.doi.org/10.1371/journal.pone.0061636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136DE	23637872	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400037
J	Sun, Y; Zhu, Y; Wang, LX; Mao, XF; Peng, X; Peng, YZ				Sun, Yong; Zhu, Yun; Wang, Liangxi; Mao, Xuefei; Peng, Xi; Peng, Yizhi			Recombinant Adenovirus-Mediated Intestinal Trefoil Factor Gene Therapy for Burn-Induced Intestinal Mucosal Injury	PLOS ONE			English	Article							GROWTH-FACTOR; CELL-MIGRATION; IDENTIFICATION; CHEMOTHERAPY; EXPRESSION; RECEPTOR; CATENIN; FAMILY; CANCER; MODEL	Intestinal trefoil factor (ITF) is a small polypeptide with potential medical values whose main pharmacological effects are to alleviate gastrointestinal mucosal injury caused by various injury factors and promote the repair of damaged mucosa. However, its low yield limits its application. The purpose of our study was to construct a recombinant adenoviral vector containing the hITF gene and observe the therapeutic effect of burn-induced intestinal mucosal injury using in vitro and in vivo analysis. First, a recombinant shuttle plasmid was constructed by ligating a pAdTrack-CMV vector with a full-length hITF gene containing a signal peptide and the mature peptide, followed by the recombinant Ad-hITF adenovirus vector after linearization and homologous recombination with the backbone plasmid in the competent BJ5183 strain. Second, the hITF expression level was detected using reverse transcription polymerase chain reaction and western blotting after Ad-hITF infection of colon cancer HT-29 cells. The recombinant adenovirus significantly promoted cell migration in an in vitro wounding model. Finally, we confirmed that the recombinant adenovirus could significantly expedite the healing of intestinal mucosal injury after establishing a mouse model in which severe burns were stimulated and the recombinant adenovirus was delivered by intragastric injection. In summary, we constructed a recombinant adenoviral vector containing the hITF gene and confirmed its role in promoting repair of the intestinal mucosa. Our study provides a novel way to treat burn-induced intestinal mucosal injury.	[Sun, Yong; Wang, Liangxi; Mao, Xuefei] 97 Hosp PLA, Plast Surg Ctr, Dept Burn Surg, Xuzhou, Peoples R China; [Zhu, Yun] 97 Hosp PLA, Dept Gastroenterol, Xuzhou, Peoples R China; [Peng, Xi; Peng, Yizhi] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Sun, Y (corresponding author), 97 Hosp PLA, Plast Surg Ctr, Dept Burn Surg, Xuzhou, Peoples R China.	sunyong_97@163.com; yizhipen@sina.com			National Natural Science Foundation of China [81100252]; Scientific Research Funds of Nanjing Military Command [09Z007, 12Z10]; National Key New Drug Creation Project [2009ZX09103-647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059376] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Funds of Nanjing Military Command; National Key New Drug Creation Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Natural Science Foundation of China (Grant 81100252), the Scientific Research Funds of Nanjing Military Command (09Z007, 12Z10) and the National Key New Drug Creation Project (2009ZX09103-647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auman JT, 2010, CURR OPIN MOL THER, V12, P637; Beck PL, 2004, GASTROENTEROLOGY, V126, P796, DOI 10.1053/j.gastro.2003.12.004; Efstathiou JA, 1998, P NATL ACAD SCI USA, V95, P3122, DOI 10.1073/pnas.95.6.3122; HAUSER F, 1993, P NATL ACAD SCI USA, V90, P6961, DOI 10.1073/pnas.90.15.6961; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jiang YB, 2009, J ANIM PHYSIOL AN N, V93, P754, DOI 10.1111/j.1439-0396.2008.00864.x; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; KAUR P, 1986, CELL TISSUE KINET, V19, P611, DOI 10.1111/j.1365-2184.1986.tb00762.x; Liu D, 1997, LAB INVEST, V77, P557; Lombardi JV, 2001, J SURG RES, V99, P377, DOI 10.1006/jsre.2001.6209; Millar AD, 1996, GUT, V39, P407, DOI 10.1136/gut.39.3.407; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Nomura S, 2006, BIOCHEM BIOPH RES CO, V349, P136, DOI 10.1016/j.bbrc.2006.08.032; Patricia MK, 2001, CIRC RES, V88, P659, DOI 10.1161/hh0701.088838; Peterson DE, 2009, J CLIN ONCOL, V27, P4333, DOI 10.1200/JCO.2008.21.2381; PODOLSKY DK, 1993, J BIOL CHEM, V268, P6694; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Sun Y, 2008, J TRAUMA, V65, P163, DOI 10.1097/TA.0b013e318076b49f; Tan XD, 1997, BIOCHEM BIOPH RES CO, V237, P673, DOI 10.1006/bbrc.1997.7144; Tangney Mark, 2010, Bioeng Bugs, V1, P284, DOI 10.4161/bbug.1.4.11725; THIM L, 1989, FEBS LETT, V250, P85, DOI 10.1016/0014-5793(89)80690-8; Wang JY, 1996, AM J PHYSIOL-GASTR L, V270, pG355, DOI 10.1152/ajpgi.1996.270.2.G355; Zhang XX, 2010, PROTEIN CELL, V1, P107, DOI 10.1007/s13238-010-0026-x	23	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62429	10.1371/journal.pone.0062429	http://dx.doi.org/10.1371/journal.pone.0062429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638081	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400108
J	Tran, SD; Liu, YN; Xia, DS; Maria, OM; Khalili, S; Wang, RWJ; Quan, VH; Hu, S; Seuntjens, J				Tran, Simon D.; Liu, Younan; Xia, Dengsheng; Maria, Ola M.; Khalili, Saeed; Wang, Renee Wan-Jou; Quan, Vu-Hung; Hu, Shen; Seuntjens, Jan			Paracrine Effects of Bone Marrow Soup Restore Organ Function, Regeneration, and Repair in Salivary Glands Damaged by Irradiation	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; GENE-TRANSFER; GROWTH-FACTOR; THERAPY; DYSFUNCTION; PROTECTION; TISSUES; HEAD; TRANSDIFFERENTIATION; HYPOFUNCTION	Background: There are reports that bone marrow cell (BM) transplants repaired irradiated salivary glands (SGs) and re-established saliva secretion. However, the mechanisms of action behind these reports have not been elucidated. Methods: To test if a paracrine mechanism was the main effect behind this reported improvement in salivary organ function, whole BM cells were lysed and its soluble intracellular contents (termed as "BM Soup'') injected into mice with irradiation-injured SGs. The hypothesis was that BM Soup would protect salivary cells, increase tissue neovascularization, function, and regeneration. Two minor aims were also tested a) comparing two routes of delivering BM Soup, intravenous (I.V.) versus intra-glandular injections, and b) comparing the age of the BM Soup's donors. The treatment-comparison group consisted of irradiated mice receiving injections of living whole BM cells. Control mice received irradiation and injections of saline or sham-irradiation. All mice were followed for 8 weeks post-irradiation. Results: BM Soup restored salivary flow rates to normal levels, protected salivary acinar, ductal, myoepithelial, and progenitor cells, increased cell proliferation and blood vessels, and up-regulated expression of tissue remodeling/repair/regenerative genes (MMP2, CyclinD1, BMP7, EGF, NGF). BM Soup was as an efficient therapeutic agent as injections of live BM cells. Both intra-glandular or I.V. injections of BM Soup, and from both young and older mouse donors were as effective in repairing irradiated SGs. The intra-glandular route reduced injection frequency/dosage by four-fold. Conclusion: BM Soup, which contains only the cell by-products, can be advantageously used to repair irradiation-damaged SGs rather than transplanting whole live BM cells which carry the risk of differentiating into unwanted/tumorigenic cell types in SGs.	[Tran, Simon D.; Liu, Younan; Xia, Dengsheng; Maria, Ola M.; Khalili, Saeed; Wang, Renee Wan-Jou] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Quan, Vu-Hung] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Hu, Shen] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Seuntjens, Jan] McGill Univ, Dept Oncol, Med Phys Unit, Montreal, PQ, Canada	McGill University; Universite de Montreal; University of California System; University of California Los Angeles; McGill University	Tran, SD (corresponding author), McGill Univ, Fac Dent, Montreal, PQ, Canada.	simon.tran@mcgill.ca	Hu, Steve/B-3799-2011	Seuntjens, Jan/0000-0003-2222-5924	Canadian Institutes of Health Research (CIHR) Institute Musculoskeletal Health and Arthritis (IMHA); Canada Research Chairs (CRC)	Canadian Institutes of Health Research (CIHR) Institute Musculoskeletal Health and Arthritis (IMHA)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs (CRC)(Canada Research Chairs)	This study was supported in part by the Canadian Institutes of Health Research (CIHR) Institute Musculoskeletal Health and Arthritis (IMHA), and the Canada Research Chairs (CRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aframian DJ, 2008, TISSUE ENG PART B-RE, V14, P187, DOI 10.1089/ten.teb.2008.0044; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Angeli FS, 2012, OPEN CARDIOVASC MED, V6, P38, DOI 10.2174/1874192401206010038; Bahary N, 2001, SCIENCE, V294, P530, DOI 10.1126/science.1066282; Barnett ML, 1996, J DENT RES, V75, P1721, DOI 10.1177/00220345960750100201; Baum BJ, 2006, PERIODONTOL 2000, V41, P218, DOI 10.1111/j.1600-0757.2006.00160.x; Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; Baum BJ, 2010, METHODS MOL BIOL, V666, P3, DOI 10.1007/978-1-60761-820-1_1; Bhide SA, 2009, CLIN ONCOL-UK, V21, P737, DOI 10.1016/j.clon.2009.09.002; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cotrim AP, 2007, MOL THER, V15, P2101, DOI 10.1038/sj.mt.6300296; Cotrim AP, 2007, CLIN CANCER RES, V13, P4928, DOI 10.1158/1078-0432.CCR-07-0662; Ellies M, 2003, J ORAL MAXIL SURG, V61, P454, DOI 10.1053/joms.2003.50086; Feng JL, 2009, RADIOTHER ONCOL, V92, P466, DOI 10.1016/j.radonc.2009.06.023; Gago N, 2009, STEM CELLS, V27, P1164, DOI 10.1002/stem.27; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Huang GL, 2012, CELL REPROGRAM, V14, P377, DOI 10.1089/cell.2011.0096; Khalili S, 2010, INT J BIOCHEM CELL B, V42, P1893, DOI 10.1016/j.biocel.2010.08.008; Koch M, 2008, ANN OTO RHINOL LARYN, V117, P271, DOI 10.1177/000348940811700406; Kojima T, 2011, LARYNGOSCOPE, V121, P1870, DOI 10.1002/lary.21873; Kuriki Y, 2011, JOVE-J VIS EXP, DOI 10.3791/3074; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Lim JY, 2012, ORAL ONCOL; Limesand KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004663; Lin CY, 2011, J DENT RES, V90, P341, DOI 10.1177/0022034510386374; Lombaert IMA, 2006, CLIN CANCER RES, V12, P1804, DOI 10.1158/1078-0432.CCR-05-2381; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lombaert IMA, 2008, STEM CELLS, V26, P2595, DOI 10.1634/stemcells.2007-1034; Lombaert IMA, 2008, CLIN CANCER RES, V14, P7741, DOI 10.1158/1078-0432.CCR-08-1449; Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x; Maria OM, 2011, STEM CELLS DEV, V20, P959, DOI 10.1089/scd.2010.0214; Nanduri LSY, 2011, RADIOTHER ONCOL, V99, P367, DOI 10.1016/j.radonc.2011.05.085; Neumann Y, 2012, TISSUE ENG PART C-ME, V18, P710, DOI [10.1089/ten.tec.2012.0013, 10.1089/ten.TEC.2012.0013]; Obokata H, 2011, TISSUE ENG PT A, V17, P607, DOI [10.1089/ten.tea.2010.0385, 10.1089/ten.TEA.2010.0385]; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Redman RS, 2009, BIOTECH HISTOCHEM, V84, P253, DOI 10.3109/10520290903081377; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Souza LN, 2011, ORAL DIS, V17, P484, DOI 10.1111/j.1601-0825.2010.01779.x; Sugito T, 2004, CELL TRANSPLANT, V13, P691, DOI 10.3727/000000004783983567; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI 10.1016/j.biocel.2010.09.023; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Tran SD, 2011, BIOL BLOOD MARROW TR, V17, P429, DOI 10.1016/j.bbmt.2010.09.021; Tran SD, 2011, INT J BIOCHEM CELL B, V43, P5, DOI 10.1016/j.biocel.2010.10.010; Tyndall A, 2009, CURR OPIN HEMATOL, V16, P285, DOI 10.1097/MOH.0b013e32832aacb3; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wang JH, 2006, HUM GENE THER, V17, P455, DOI 10.1089/hum.2006.17.455; Wang X, 2011, J TISSUE SCI ENG, VS3; Westerman KA, 2010, EXP CELL RES, V316, P1966, DOI 10.1016/j.yexcr.2010.03.022; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Xu JJ, 2010, INT J RADIAT ONCOL, V78, P897, DOI 10.1016/j.ijrobp.2010.05.048; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; Zheng C, 2011, ORAL DIS, V17, P77, DOI 10.1111/j.1601-0825.2010.01707.x; Zheng CY, 2011, CLIN CANCER RES, V17, P2842, DOI 10.1158/1078-0432.CCR-10-2982; Ziment I, 2006, LANCET, V368, P646, DOI 10.1016/S0140-6736(06)69246-5	61	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61632	10.1371/journal.pone.0061632	http://dx.doi.org/10.1371/journal.pone.0061632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637870	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400035
J	Tsang, SY; Zhong, SF; Mei, LL; Chen, JH; Ng, SK; Pun, FW; Zhao, CY; Jing, BY; Chark, R; Guo, JH; Tan, YL; Li, LJ; Wang, CY; Chew, SH; Xue, H				Tsang, Shui Ying; Zhong, Songfa; Mei, Lingling; Chen, Jianhuan; Ng, Siu-Kin; Pun, Frank W.; Zhao, Cunyou; Jing, Bingyi; Chark, Robin; Guo, Jianhua; Tan, Yunlong; Li, Lijun; Wang, Chuanyue; Chew, Soo Hong; Xue, Hong			Social Cognitive Role of Schizophrenia Candidate Gene GABRB2	PLOS ONE			English	Article							RECEPTOR BETA(2) SUBUNIT; PSYCHOTIC SYMPTOMS; ASSOCIATION; POLYMORPHISM; HAPLOTYPE; POPULATION; EXPRESSION; ALTRUISM; ISOFORMS; DISEASE	The occurrence of positive selection in schizophrenia-associated GABRB2 suggests a broader impact of the gene product on population fitness. The present study considered the possibility of cognition-related GABRB2 involvement by examining the association of GABRB2 with psychosis and altruism, respectively representing psychiatric and psychological facets of social cognition. Four single nucleotide polymorphisms (SNPs) were genotyped for quantitative trait analyses and population-based association studies. Psychosis was measured by either the Positive and Negative Syndrome Scale (PANSS) or antipsychotics dosage, and altruism was based on a self-report altruism scale. The minor alleles of SNPs rs6556547, rs1816071 and rs187269 in GABRB2 were correlated with high PANSS score for positive symptoms in a Han Chinese schizophrenic cohort, whereas those of rs1816071 and rs1816072 were associated with high antipsychotics dosage in a US Caucasian schizophrenic cohort. Moreover, strongly significant GABRB2-disease associations were found among schizophrenics with severe psychosis based on high PANSS positive score, but no significant association was observed for schizophrenics with only mild psychosis. Interestingly, in addition to association with psychosis in schizophrenics, rs187269 was also associated with altruism in healthy Han Chinese. Furthermore, parallel to correlation with severe psychosis, its minor allele was correlated with high altruism scores. These findings revealed that GABRB2 is associated with psychosis, the core symptom and an endophenotype of schizophrenia. Importantly, the association was found across the breadth of the psychiatric (psychosis) to psychological (altruism) spectrum of social cognition suggesting GABRB2 involvement in human cognition.	[Tsang, Shui Ying; Mei, Lingling; Chen, Jianhuan; Ng, Siu-Kin; Pun, Frank W.; Zhao, Cunyou; Xue, Hong] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Tsang, Shui Ying; Mei, Lingling; Chen, Jianhuan; Ng, Siu-Kin; Pun, Frank W.; Zhao, Cunyou; Xue, Hong] Hong Kong Univ Sci & Technol, Appl Genom Lab, Hong Kong, Hong Kong, Peoples R China; [Zhong, Songfa; Chew, Soo Hong] Hong Kong Univ Sci & Technol, Dept Econ, Hong Kong, Hong Kong, Peoples R China; [Zhong, Songfa; Chew, Soo Hong] Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore; [Pun, Frank W.; Jing, Bingyi; Xue, Hong] Hong Kong Univ Sci & Technol, Ctr Stat Sci, Hong Kong, Hong Kong, Peoples R China; [Jing, Bingyi] Hong Kong Univ Sci & Technol, Dept Math, Hong Kong, Hong Kong, Peoples R China; [Chark, Robin] Natl Univ Singapore, Dept Mkt, Singapore 117548, Singapore; [Guo, Jianhua] NE Normal Univ, Sch Math & Stat, Changchun, Peoples R China; [Tan, Yunlong] Beijing Huilongguan Hosp, Beijing, Peoples R China; [Li, Lijun; Wang, Chuanyue] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Xue, Hong] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; National University of Singapore; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; National University of Singapore; Northeast Normal University - China; Capital Medical University; Hong Kong University of Science & Technology	Xue, H (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	hxue@ust.hk	Zhong, Songfa Z/I-4718-2016; Wang, Chuan-Yue/C-9369-2015; ZHAO, Cunyou/Q-5076-2016; Chen, Jian-Huan/L-7188-2017; Chen, Jian-Huan/ABB-9660-2021	Wang, Chuan-Yue/0000-0001-6549-3713; ZHAO, Cunyou/0000-0001-6116-4584; Chen, Jian-Huan/0000-0001-8714-2543; Chen, Jian-Huan/0000-0001-8714-2543; Jing, Bing-yi/0000-0002-8876-1570; Chew, Soo Hong/0000-0003-1245-0909; Xue, Hong/0000-0002-8133-9828	Fok Ying Tung Group; Research Grants Council of Hong Kong (RGC) [662811]; National Basic Research Program of China [2012CB517902]	Fok Ying Tung Group; Research Grants Council of Hong Kong (RGC)(Hong Kong Research Grants Council); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Fok Ying Tung Group, the Research Grants Council of Hong Kong (RGC grant no. 662811) and the National Basic Research Program of China (Project no. 2012CB517902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Angelucci F, 2009, J ALZHEIMERS DIS, V17, P203, DOI 10.3233/JAD-2009-1031; Benedetti F, 2010, J AFFECT DISORDERS, V125, P341, DOI 10.1016/j.jad.2010.01.005; Borroni B, 2004, NEUROSCI LETT, V370, P127, DOI 10.1016/j.neulet.2004.08.006; Breuer R, 2011, MOL PSYCHIATR, V16, P587, DOI 10.1038/mp.2010.67; Brune M, 2004, NEUROSCI BIOBEHAV R, V28, P41, DOI 10.1016/j.neubiorev.2003.10.002; Chen JH, 2009, BIOCHEM SOC T, V37, P1415, DOI 10.1042/BST0371415; Crespi B, 2008, BIOL REV, V83, P441, DOI 10.1111/j.1469-185X.2008.00050.x; Di Maria E, 2009, J ALZHEIMERS DIS, V18, P953, DOI 10.3233/JAD-2009-1194; Domschke K, 2011, J PSYCHIATR RES, V45, P588, DOI 10.1016/j.jpsychires.2010.09.014; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; EYSENCK HJ, 1992, PERS INDIV DIFFER, V13, P757, DOI 10.1016/0191-8869(92)90050-Y; Goes Fernando S, 2008, Curr Psychiatry Rep, V10, P178, DOI 10.1007/s11920-008-0030-5; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Kang JI, 2010, NEUROPHARMACOLOGY, V58, P1109, DOI 10.1016/j.neuropharm.2010.02.001; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kishimoto M, 2008, BIOL PSYCHIAT, V63, P191, DOI 10.1016/j.biopsych.2007.03.019; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; La Salvia E, 2011, HARVARD REV PSYCHIAT, V19, P190, DOI 10.3109/10673229.2011.599184; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JX, 2005, BIOCHEM BIOPH RES CO, V334, P817, DOI 10.1016/j.bbrc.2005.06.167; Lo WS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000462; Lo WS, 2007, BIOL PSYCHIAT, V61, P653, DOI 10.1016/j.biopsych.2006.05.003; Lo WS, 2004, MOL PSYCHIATR, V9, P603, DOI 10.1038/sj.mp.4001461; Mancuso F, 2011, SCHIZOPHR RES, V125, P143, DOI 10.1016/j.schres.2010.11.007; Molero P, 2007, PHARMACOGENOMICS J, V7, P418, DOI 10.1038/sj.tpj.6500441; Ng SK, 2010, PLOS ONE, V5, pA18, DOI 10.1371/journal.pone.0009547; Owen MJ, 2004, PSYCHIAT GENETICS GE; Pagliaro LA, 1998, PSYCHOL PSYCHOTROPIC, P234; Petryshen TL, 2005, MOL PSYCHIATR, V10, P1074, DOI 10.1038/sj.mp.4001739; Pun FW, 2011, MOL PSYCHIATR, V16, P557, DOI 10.1038/mp.2010.47; Reichenberg Abraham, 2005, Dialogues Clin Neurosci, V7, P31; Reuter M, 2011, SOC COGN AFFECT NEUR, V6, P662, DOI 10.1093/scan/nsq083; Roussos P, 2008, NEUROPSYCHOLOGIA, V46, P757, DOI 10.1016/j.neuropsychologia.2007.10.009; RUSHTON JP, 1981, PERS INDIV DIFFER, V2, P293; Rushton JP, 2004, P ROY SOC B-BIOL SCI, V271, P2583, DOI 10.1098/rspb.2004.2941; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Szeszko PR, 2008, BIOL PSYCHOL, V79, P103, DOI 10.1016/j.biopsycho.2007.10.011; Tosato S, 2005, SCHIZOPHRENIA BULL, V31, P613, DOI 10.1093/schbul/sbi043; Yu ZL, 2006, CLIN BIOCHEM, V39, P210, DOI 10.1016/j.clinbiochem.2006.01.009; Zhao C, 2006, MOL PSYCHIATR, V11, P1092, DOI 10.1038/sj.mp.4001899; Zhao CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006977; Zhong SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013765; Zhong SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008516	49	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62322	10.1371/journal.pone.0062322	http://dx.doi.org/10.1371/journal.pone.0062322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638040	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400096
J	Xu, Y; Lee, A; Wu, WL; Liu, X; Birkholz, P				Xu, Yi; Lee, Albert; Wu, Wing-Li; Liu, Xuan; Birkholz, Peter			Human Vocal Attractiveness as Signaled by Body Size Projection	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; MASCULINITY PREFERENCES; SEXUAL SELECTION; HUMAN FACES; BREATHINESS; FEMALE; PERCEPTION; FREQUENCY; PREDICT; VOICES	Voice, as a secondary sexual characteristic, is known to affect the perceived attractiveness of human individuals. But the underlying mechanism of vocal attractiveness has remained unclear. Here, we presented human listeners with acoustically altered natural sentences and fully synthetic sentences with systematically manipulated pitch, formants and voice quality based on a principle of body size projection reported for animal calls and emotional human vocal expressions. The results show that male listeners preferred a female voice that signals a small body size, with relatively high pitch, wide formant dispersion and breathy voice, while female listeners preferred a male voice that signals a large body size with low pitch and narrow formant dispersion. Interestingly, however, male vocal attractiveness was also enhanced by breathiness, which presumably softened the aggressiveness associated with a large body size. These results, together with the additional finding that the same vocal dimensions also affect emotion judgment, indicate that humans still employ a vocal interaction strategy used in animal calls despite the development of complex language.	[Xu, Yi; Lee, Albert; Wu, Wing-Li; Liu, Xuan] UCL, Dept Speech Hearing & Phonet Sci, Div Psychol & Language Sci, London, England; [Birkholz, Peter] Univ Hosp Aachen, Clin Phoniatr Pedaudiol & Commun Disorders, Aachen, Germany; [Birkholz, Peter] Rhein Westfal TH Aachen, Aachen, Germany	University of London; University College London; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University	Xu, Y (corresponding author), UCL, Dept Speech Hearing & Phonet Sci, Div Psychol & Language Sci, London, England.	yi.xu@ucl.ac.uk	Lee, Albert/F-6710-2012; Xu, Yi/M-9738-2019; Xu, Yi/C-4013-2008; /B-4740-2014	Lee, Albert/0000-0002-3224-5788; Xu, Yi/0000-0002-8541-2658; Xu, Yi/0000-0002-8541-2658; /0000-0003-2883-4333	UCL Overseas Research Scholarship	UCL Overseas Research Scholarship	AL is in part supported by the UCL Overseas Research Scholarship (http://www.ucl.ac.uk/prospective-students/scholarships/graduate/overs-res/ors). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2011, INTERSPEECH 2011; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; BERSCHEID E, 1971, J EXP SOC PSYCHOL, V7, P173, DOI 10.1016/0022-1031(71)90065-5; Birkhoz P, 2007, IEEE T AUDIO SPEECH, V15, P1218, DOI 10.1109/TASL.2006.889731; Boersma P., 2013, PRAAT DOING PHONETIC; Bruckert L, 2006, P ROY SOC B-BIOL SCI, V273, P83, DOI 10.1098/rspb.2005.3265; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Chuenwattanapranithi S, 2008, PHONETICA, V65, P210, DOI 10.1159/000192793; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; CROSS JF, 1971, DEV PSYCHOL, V5, P433, DOI 10.1037/h0031591; Dacakis G., 2002, CURR OPIN OTOLARYNGO, V10, P173, DOI [DOI 10.1097/01.M00.0000014709.20032.9B, 10.1097/00020840-200206000-00003, DOI 10.1097/00020840-200206000-00003]; Fant CarlGunnarMichael., 1960, ACOUSTIC THEORY SPEE; Feinberg DR, 2012, BEHAV ECOL SOCIOBIOL, V66, P413, DOI 10.1007/s00265-011-1287-y; Feinberg DR, 2008, EVOL ANTHROPOL, V17, P112, DOI 10.1002/evan.20166; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Fraccaro P.J., 2011, J EVOLUTIONARY PSYCH, V9, P57, DOI [10.1556/JEP.9.2011.33.1, DOI 10.1556/JEP.9.2011.33.1]; Hanson HM, 2001, J PHONETICS, V29, P451, DOI 10.1006/jpho.2001.0146; Hanson HM, 1997, J ACOUST SOC AM, V101, P466, DOI 10.1121/1.417991; HENTON CG, 1985, LANG COMMUN, V5, P221, DOI 10.1016/0271-5309(85)90012-6; Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; LINVILLE SE, 1992, J SPEECH HEAR RES, V35, P1209, DOI 10.1044/jshr.3506.1209; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Noble L., 2011, P 17 INT C PHON SCI, P1502; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Puts DA, 2012, J SEX RES, V49, P227, DOI 10.1080/00224499.2012.658924; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Riding D, 2006, J NONVERBAL BEHAV, V30, P55, DOI 10.1007/s10919-006-0005-3; SARASON BR, 1985, J PERS SOC PSYCHOL, V49, P469; SODERSTEN M, 1990, J SPEECH HEAR RES, V33, P601, DOI 10.1044/jshr.3303.601; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Surendran D, 2008, INT CONF ACOUST SPEE, P4177, DOI 10.1109/ICASSP.2008.4518575; Van Borsel J, 2009, J VOICE, V23, P291, DOI 10.1016/j.jvoice.2007.08.002; Xu Y, 2010, P 5 INT C SPEECH PRO; Xu Y, 2010, PENTATRAINER; ZUCKERMAN M, 1990, J NONVERBAL BEHAV, V14, P97, DOI 10.1007/BF01670437; ZUCKERMAN M, 1989, J NONVERBAL BEHAV, V13, P67	43	34	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62397	10.1371/journal.pone.0062397	http://dx.doi.org/10.1371/journal.pone.0062397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136DE	23638065	Green Submitted, gold, Green Published			2022-12-25	WOS:000318340400105
J	Chemes, LB; Noval, MG; Sanchez, IE; de Prat-Gay, G				Chemes, Lucia B.; Noval, Maria G.; Sanchez, Ignacio E.; de Prat-Gay, Gonzalo			Folding of a Cyclin Box LINKING MULTITARGET BINDING TO MARGINAL STABILITY, OLIGOMERIZATION, AND AGGREGATION OF THE RETINOBLASTOMA TUMOR SUPPRESSOR AB POCKET DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 CORE DOMAIN; DIFFERENTIAL SCANNING CALORIMETRY; DNA-BINDING; MUTANT P53; CELL-CYCLE; THERMODYNAMIC STABILITY; FAMILIAL RETINOBLASTOMA; INCOMPLETE PENETRANCE; MOLTEN GLOBULE; WILD-TYPE	The retinoblastoma tumor suppressor (Rb) controls the proliferation, differentiation, and survival of cells in most eukaryotes with a role in the fate of stem cells. Its inactivation by mutation or oncogenic viruses is required for cellular transformation and eventually carcinogenesis. The high conservation of the Rb cyclin fold prompted us to investigate the link between conformational stability and ligand binding properties of the RbAB pocket domain. RbAB unfolding presents a three-state transition involving cooperative secondary and tertiary structure changes and a partially folded intermediate that can oligomerize. The first transition corresponds to unfolding of the metastable B subdomain containing the binding site for the LXCXE motif present in cellular and viral targets, and the second transition corresponds to the stable A subdomain. The low thermodynamic stability of RbAB translates into a propensity to rapidly oligomerize and aggregate at 37 degrees C (T-50 = 28 min) that is suppressed by human papillomavirus E7 and E2F peptide ligands, suggesting that Rb is likely stabilized in vivo through binding to target proteins. We propose that marginal stability and associated oligomerization may be conserved for function as a "hub" protein, allowing the formation of multiprotein complexes, which could constitute a robust mechanism to retain its cell cycle regulatory role throughout evolution. Decreased stability and oligomerization are shared with the p53 tumor suppressor, suggesting a link between folding and function in these two essential cell regulators that are inactivated in most cancers and operate within multitarget signaling pathways.	[Chemes, Lucia B.; Noval, Maria G.; de Prat-Gay, Gonzalo] Fdn Inst Leloir, Prot Struct Funct & Engn Lab, RA-1405 Buenos Aires, DF, Argentina; [Chemes, Lucia B.; Noval, Maria G.; de Prat-Gay, Gonzalo] Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Chemes, Lucia B.; Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Prot Physiol Lab, Buenos Aires, DF, Argentina; [Chemes, Lucia B.; Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Inst Quim Biol, Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	de Prat-Gay, G (corresponding author), Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Ave Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.	gpg@leloir.org.ar	Noval, Maria Gabriela/GLV-0239-2022	Chemes, Lucia Beatriz/0000-0003-0192-9906; Prat Gay, Gonzalo/0000-0001-5748-6863; Sanchez, Ignacio Enrique/0000-0003-4284-9013	Instituto Nacional de Cancer (Ministerio de Salud de la Nacion, Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CONICET	Instituto Nacional de Cancer (Ministerio de Salud de la Nacion, Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by a grant for basic research from the Instituto Nacional de Cancer (Ministerio de Salud de la Nacion, Argentina).; Holds a postdoctoral fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET).; Holds a graduate fellowship from CONICET.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Butler JS, 2006, PROTEIN SCI, V15, P2457, DOI 10.1110/ps.062324206; Butler JS, 2005, J MOL BIOL, V350, P906, DOI 10.1016/j.jmb.2005.05.060; Cao LH, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-55; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Coschi C. H., 2010, GENES DEV; Cremades N, 2006, TRENDS BIOCHEM SCI, V31, P494, DOI 10.1016/j.tibs.2006.07.001; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; de Souza RF, 2010, BBA-GENE REGUL MECH, V1799, P302, DOI 10.1016/j.bbagrm.2009.10.006; DeGregori J, 2004, J CELL SCI, V117, P3411, DOI 10.1242/jcs.01189; Dick FA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-26; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gast K, 2005, PROTEIN FOLDING HANDBOOK, P673, DOI 10.1002/9783527619498.ch19; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P946, DOI 10.1093/nar/22.6.946; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Grossmann JG, 2001, BIOCHEMISTRY-US, V40, P6267, DOI 10.1021/bi0028946; Gunbin KV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-224; Gutzat R, 2012, TRENDS PLANT SCI, V17, P139, DOI 10.1016/j.tplants.2011.12.001; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; Hayashi F, 1998, BIOCHEMISTRY-US, V37, P7941, DOI 10.1021/bi9801098; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Ishimaru D, 2003, J MOL BIOL, V333, P443, DOI 10.1016/j.jmb.2003.08.026; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Khoo KH, 2009, J BIOL CHEM, V284, P30974, DOI 10.1074/jbc.M109.033183; Kim HY, 1997, NAT STRUCT BIOL, V4, P390, DOI 10.1038/nsb0597-390; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; KRATZKE RA, 1994, ONCOGENE, V9, P1321; Lamber EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058463; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; LEPOCK JR, 1992, BIOCHEMISTRY-US, V31, P12706, DOI 10.1021/bi00165a023; Lohmann DR, 1999, HUM MUTAT, V14, P283, DOI 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Natan E, 2011, J MOL BIOL, V409, P358, DOI 10.1016/j.jmb.2011.03.047; Nichols NM, 2002, BIOCHEMISTRY-US, V41, P170, DOI 10.1021/bi011736r; Noble MEM, 1997, TRENDS BIOCHEM SCI, V22, P482, DOI 10.1016/S0968-0004(97)01144-4; Otterson GA, 1999, AM J HUM GENET, V65, P1040, DOI 10.1086/302581; Park Y, 2008, CELL CYCLE, V7, P2384, DOI 10.4161/cc.6363; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sage J, 2012, GENE DEV, V26, P1409, DOI 10.1101/gad.193730.112; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Sastre-Garau X, 2011, PATHOL BIOL, V59, P127, DOI 10.1016/j.patbio.2010.07.007; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Silva JL, 2006, BBA-PROTEINS PROTEOM, V1764, P443, DOI 10.1016/j.bbapap.2005.11.012; Singh M, 2005, J BIOL CHEM, V280, P37868, DOI 10.1074/jbc.M504877200; Smal C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036457; Tang KS, 1999, J MOL BIOL, V285, P1869, DOI 10.1006/jmbi.1998.2420; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Valverde JR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-53; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Xiao SF, 2010, J MOL BIOL, V401, P274, DOI 10.1016/j.jmb.2010.05.070; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a	73	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18923	18938		10.1074/jbc.M113.467316	http://dx.doi.org/10.1074/jbc.M113.467316			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23632018	Green Published, hybrid			2022-12-25	WOS:000321335800030
J	Wang, YJ; Shankar, SR; Kher, D; Ling, BMT; Taneja, R				Wang, Yaju; Shankar, Shilpa Rani; Kher, Devaki; Ling, Belinda Mei Tze; Taneja, Reshma			Sumoylation of the Basic Helix-Loop-Helix Transcription Factor Sharp-1 Regulates Recruitment of the Histone Methyltransferase G9a and Function in Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; SUMO MODIFICATION; EXPRESSION; REPRESSION; PROTEINS; INHIBITION; UBIQUITIN; DEC2	Sumoylation is an important post-translational modification that alters the activity of many transcription factors. However, the mechanisms that link sumoylation to alterations in chromatin structure, which culminate in tissue specific gene expression, are not fully understood. In this study, we demonstrate that SUMO modification of the transcription factor Sharp-1 is required for its full transcriptional repression activity and function as an inhibitor of skeletal muscle differentiation. Sharp-1 is modified by sumoylation at two conserved lysine residues 240 and 255. Mutation of these SUMO acceptor sites in Sharp-1 does not impact its subcellular localization but attenuates its ability to act as a transcriptional repressor and inhibit myogenic differentiation. Consistently, co-expression of the SUMO protease SENP1 with wild type Sharp-1 abrogates Sharp-1-dependent inhibition of myogenesis. Interestingly, sumoylation acts as a signal for recruitment of the co-repressor G9a. Thus, enrichment of G9a, and histone H3 lysine 9 dimethylation (H3K9me2), a signature of G9a activity, is dramatically reduced at muscle promoters in cells expressing sumoylation-defective Sharp-1. Our findings demonstrate how sumoylation of Sharp-1 exerts an impact on chromatin structure and transcriptional repression of muscle gene expression through recruitment of G9a.	[Wang, Yaju; Shankar, Shilpa Rani; Kher, Devaki; Ling, Belinda Mei Tze; Taneja, Reshma] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore	National University of Singapore	Taneja, R (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.	phsrt@nus.edu.sg	Taneja, Reshma/F-9658-2014	Taneja, Reshma/0000-0002-2151-2094; Reshma, Taneja/0000-0001-6214-6177	Singapore Ministry of Health National Medical Research Council Exploratory/Development grant	Singapore Ministry of Health National Medical Research Council Exploratory/Development grant	This work was supported by the Singapore Ministry of Health National Medical Research Council Exploratory/Development grant (to R.T.). Both authors contributed equally to this work.	Azmi S, 2004, J BIOL CHEM, V279, P52643, DOI 10.1074/jbc.M409188200; Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Azmi S, 2002, MECH DEVELOP, V114, P181, DOI 10.1016/S0925-4773(02)00049-7; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Fujimoto K, 2001, BIOCHEM BIOPH RES CO, V280, P164, DOI 10.1006/bbrc.2000.4133; Fujimoto K, 2007, INT J MOL MED, V19, P925; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; Gupta V, 2006, BIOCHEM BIOPH RES CO, V345, P74, DOI 10.1016/j.bbrc.2006.03.232; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Ling BMT, 2012, MOL BIOL CELL, V23, P4778, DOI 10.1091/mbc.E12-04-0311; Ling BMT, 2012, P NATL ACAD SCI USA, V109, P841, DOI 10.1073/pnas.1111628109; Luan ZD, 2013, CELL MOL LIFE SCI, V70, P1793, DOI 10.1007/s00018-012-1220-1; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Riquelme C, 2006, J CELL MOL MED, V10, P132, DOI 10.1111/j.1582-4934.2006.tb00295.x; Riquelme C, 2006, EXP CELL RES, V312, P2132, DOI 10.1016/j.yexcr.2006.03.016; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sun Hong, 2007, Transl Oncogenomics, V2, P107; Wang JP, 2012, INT J NUMER ANAL MOD, V9, P1; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043137; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	32	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17654	17662		10.1074/jbc.M113.463257	http://dx.doi.org/10.1074/jbc.M113.463257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23637228	Green Published, hybrid			2022-12-25	WOS:000320380600056
J	Osmundson, TW; Robert, VA; Schoch, CL; Baker, LJ; Smith, A; Robich, G; Mizzan, L; Garbelotto, MM				Osmundson, Todd W.; Robert, Vincent A.; Schoch, Conrad L.; Baker, Lydia J.; Smith, Amy; Robich, Giovanni; Mizzan, Luca; Garbelotto, Matteo M.			Filling Gaps in Biodiversity Knowledge for Macrofungi: Contributions and Assessment of an Herbarium Collection DNA Barcode Sequencing Project	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR-IDENTIFICATION; MYCORRHIZAL FUNGI; TAXONOMY; DATABASES; ECOLOGY; NUCLEAR; FUTURE; UNITE	Despite recent advances spearheaded by molecular approaches and novel technologies, species description and DNA sequence information are significantly lagging for fungi compared to many other groups of organisms. Large scale sequencing of vouchered herbarium material can aid in closing this gap. Here, we describe an effort to obtain broad ITS sequence coverage of the approximately 6000 macrofungal-species-rich herbarium of the Museum of Natural History in Venice, Italy. Our goals were to investigate issues related to large sequencing projects, develop heuristic methods for assessing the overall performance of such a project, and evaluate the prospects of such efforts to reduce the current gap in fungal biodiversity knowledge. The effort generated 1107 sequences submitted to GenBank, including 416 previously unrepresented taxa and 398 sequences exhibiting a best BLAST match to an unidentified environmental sequence. Specimen age and taxon affected sequencing success, and subsequent work on failed specimens showed that an ITS1 mini-barcode greatly increased sequencing success without greatly reducing the discriminating power of the barcode. Similarity comparisons and nonmetric multidimensional scaling ordinations based on pairwise distance matrices proved to be useful heuristic tools for validating the overall accuracy of specimen identifications, flagging potential misidentifications, and identifying taxa in need of additional species-level revision. Comparison of within- and among-species nucleotide variation showed a strong increase in species discriminating power at 1-2% dissimilarity, and identified potential barcoding issues (same sequence for different species and vice-versa). All sequences are linked to a vouchered specimen, and results from this study have already prompted revisions of species-sequence assignments in several taxa.	[Osmundson, Todd W.; Baker, Lydia J.; Smith, Amy; Garbelotto, Matteo M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Forest Pathol & Mycol Lab, Berkeley, CA 94720 USA; [Robert, Vincent A.] CBS KNAW Fungal Biodivers Ctr, Cent Bur Schimmelcultures, Utrecht, Netherlands; [Schoch, Conrad L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Robich, Giovanni; Mizzan, Luca] Venice Museum Nat Hist, Venice, Italy	University of California System; University of California Berkeley; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Garbelotto, MM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Forest Pathol & Mycol Lab, Berkeley, CA 94720 USA.	matteog@berkeley.edu	Schoch, Conrad/HCH-2412-2022; Schoch, Conrad L./J-4825-2012	Schoch, Conrad/0000-0003-1839-5322; Schoch, Conrad L./0000-0003-1839-5322; Baker, Lydia/0000-0002-1453-421X	Intramural Research Program of the NIH, National Library of Medicine; Gordon and Betty Moore Foundation	Intramural Research Program of the NIH, National Library of Medicine; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	CLS was supported in part by the Intramural Research Program of the NIH, National Library of Medicine. Funding by the Gordon and Betty Moore Foundation to MG for the Moorea BIOCODE project generated much-needed synergy with the Venice herbarium project. Sequencing was performed in house thanks to equipment purchased through a grant by the Gordon and Betty Moore Foundation to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Agresti A., 2006, INTRO CATEGORICAL DA, DOI [10.1002/0470114754, DOI 10.1002/0470114754]; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Brock PM, 2009, NEW PHYTOL, V181, P719, DOI 10.1111/j.1469-8137.2008.02703.x; Dentinger BTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025081; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Dickie IA, 2007, MYCORRHIZA, V17, P259, DOI 10.1007/s00572-007-0129-2; GARDES M, 1991, CAN J BOT, V69, P180, DOI 10.1139/b91-026; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Ivors KL, 2004, MYCOL RES, V108, P378, DOI 10.1017/S0953756204009827; Kirk PM, 2008, AINSWORTH BISBYS DIC; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lucking R, 2008, ARCH SCI, V61, P75; MacDonald PL, 2000, EDUC PSYCHOL MEAS, V60, P735, DOI 10.1177/00131640021970871; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2006, MYCOL RES, V110, P1426, DOI 10.1016/j.mycres.2006.09.017; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Nilsson RH, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-1; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nilsson RH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-178; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Osmundson TW, 2007, MYCORRHIZA, V17, P217, DOI 10.1007/s00572-006-0098-x; Peay KG, 2008, BIOSCIENCE, V58, P799, DOI 10.1641/B580907; Puillandre N, 2012, MOL ECOL RESOUR, V12, P396, DOI 10.1111/j.1755-0998.2011.03105.x; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Schmit JP, 2007, BIODIVERS CONSERV, V16, P99, DOI 10.1007/s10531-006-9129-3; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	36	163	175	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62419	10.1371/journal.pone.0062419	http://dx.doi.org/10.1371/journal.pone.0062419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638077	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300055
J	Huang, ZR; Zhao, L; Chen, DD; Liang, MX; Liu, ZP; Shao, HB; Long, XH				Huang, Zengrong; Zhao, Long; Chen, Dandan; Liang, Mingxiang; Liu, Zhaopu; Shao, Hongbo; Long, Xiaohua			Salt Stress Encourages Proline Accumulation by Regulating Proline Biosynthesis and Degradation in Jerusalem Artichoke Plantlets	PLOS ONE			English	Article							ORNITHINE-DELTA-AMINOTRANSFERASE; HIGH-YIELDING GENOTYPES; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; DROUGHT STRESS; METABOLISM; DEHYDROGENASE; TOLERANCE; TOBACCO; GROWTH	Proline accumulation is an important mechanism for osmotic regulation under salt stress. In this study, we evaluated proline accumulation profiles in roots, stems and leaves of Jerusalem artichoke (Helianthus tuberosus L.) plantlets under NaCl stress. We also examined HtP5CS, HtOAT and HtPDH enzyme activities and gene expression patterns of putative HtP5CS1, HtP5CS2, HtOAT, HtPDH1, and HtPDH2 genes. The objective of our study was to characterize the proline regulation mechanisms of Jerusalem artichoke, a moderately salt tolerant species, under NaCl stress. Jerusalem artichoke plantlets were observed to accumulate proline in roots, stems and leaves during salt stress. HtP5CS enzyme activities were increased under NaCl stress, while HtOAT and HtPDH activities generally repressed. Transcript levels of HtP5CS2 increased while transcript levels of HtOAT, HtPDH1 and HtPDH2 generally decreased in response to NaCl stress. Our results supports that for Jerusalem artichoke, proline synthesis under salt stress is mainly through the Glu pathway, and HtP5CS2 is predominant in this process while HtOAT plays a less important role. Both HtPDH genes may function in proline degradation.	[Huang, Zengrong; Zhao, Long; Chen, Dandan; Liang, Mingxiang; Liu, Zhaopu; Shao, Hongbo; Long, Xiaohua] Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China; [Huang, Zengrong; Shao, Hongbo] Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Biol & Bioesources Utilizat, Yantai, Peoples R China; [Shao, Hongbo] Qingdao Univ Sci & Technol, Inst Life Sci, Qingdao, Peoples R China	Nanjing Agricultural University; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Qingdao University of Science & Technology	Liang, MX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China.	liangmx@njau.edu.cn; sea@njau.edu.cn; shaohongbochu@126.com	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Liang, Mingxiang/0000-0002-8530-9714	National Natural Science Foundation of China [31201842, 31201692, 41171216]; National Key Technology R&D Program of the Ministry of Science and Technology [2011BAD13B09]; State Key Laboratory of Crop Genetics and Germplasm Enhancement [ZW2010004]; Doctoral Program of Higher Education of China [20120097120015]; Fundamental Research Funds for the Central Universities [KYZ201206]; National High Technology Research and Development Program ("863'' Program) [2011AA100209]; Priority Academic Program Development of Jiangsu Higher Education Institutions (RAPD program) [809001]; Scientific & Technological Innovation Foundation for Young Scientists of Nanjing Agricultural University [Y201058]; Jiangsu Agricultural Science and Technology Independent Innovation Fund Project [CX(12)1005-1, CX(12)1005-3]; Ministry of Science and Technology of Jiangsu Province [BE2011368]; One-Hundred-Talent Plan of Chinese Academy of Sciences CAS); CAS/SAFEA International Partnership Program for Creative Research Teams; Science & Technology Development Plan of Shandong Province [2010GSF10208]; Science & Technology Development Plan of Yantai City [2011016, 20102450]; Yantai Double-hundred High-end Talent Plan [XY-003-02]; 135 Development Plan of YIC-CAS; Scientific Research Foundation of the State Human Resource Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program); State Key Laboratory of Crop Genetics and Germplasm Enhancement; Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National High Technology Research and Development Program ("863'' Program)(National High Technology Research and Development Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions (RAPD program); Scientific & Technological Innovation Foundation for Young Scientists of Nanjing Agricultural University; Jiangsu Agricultural Science and Technology Independent Innovation Fund Project; Ministry of Science and Technology of Jiangsu Province; One-Hundred-Talent Plan of Chinese Academy of Sciences CAS)(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Science & Technology Development Plan of Shandong Province; Science & Technology Development Plan of Yantai City; Yantai Double-hundred High-end Talent Plan; 135 Development Plan of YIC-CAS(Chinese Academy of Sciences); Scientific Research Foundation of the State Human Resource Ministry	The research is supported by grants from National Natural Science Foundation of China (31201842; 31201692; 41171216), National Key Technology R&D Program of the Ministry of Science and Technology (2011BAD13B09), the State Key Laboratory of Crop Genetics and Germplasm Enhancement (ZW2010004), the Doctoral Program of Higher Education of China (20120097120015), Fundamental Research Funds for the Central Universities (KYZ201206), the National High Technology Research and Development Program ("863'' Program, 2011AA100209), the Priority Academic Program Development of Jiangsu Higher Education Institutions (RAPD program, 809001), the Scientific Research Foundation of the State Human Resource Ministry and Scientific & Technological Innovation Foundation for Young Scientists of Nanjing Agricultural University (Y201058), Jiangsu Agricultural Science and Technology Independent Innovation Fund Project [ No. CX(12)1005-1 and 3], the Ministry of Science and Technology of Jiangsu Province (No. BE2011368), One-Hundred-Talent Plan of Chinese Academy of Sciences CAS), the CAS/SAFEA International Partnership Program for Creative Research Teams, the Science & Technology Development Plan of Shandong Province (2010GSF10208), the Science & Technology Development Plan of Yantai City (2011016; 20102450), Yantai Double-hundred High-end Talent Plan (XY-003-02), and 135 Development Plan of YIC-CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	da Rocha IMA, 2012, J PLANT PHYSIOL, V169, P41, DOI 10.1016/j.jplph.2011.08.001; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Deuschle K, 2004, PLANT CELL, V16, P3413, DOI 10.1105/tpc.104.023622; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Funck D, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-40; Funck D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-70; Vendruscolo ECG, 2007, J PLANT PHYSIOL, V164, P1367, DOI 10.1016/j.jplph.2007.05.001; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; HAYZER DJ, 1980, J GEN MICROBIOL, V118, P287; Hoagland D. R., 1950, CALIFORNIA AGR EXPT, P347; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Huang ZR, 2012, PROCESS BIOCHEM, V47, P591, DOI 10.1016/j.procbio.2011.12.016; KIM HR, 1994, ANAL BIOCHEM, V223, P205, DOI 10.1006/abio.1994.1574; Kimura T, 2001, BIOSCI BIOTECH BIOCH, V65, P1275, DOI 10.1271/bbb.65.1275; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kiyosue T, 1996, PLANT CELL, V8, P1323, DOI 10.1105/tpc.8.8.1323; KOSARIC N, 1984, BIOMASS, V5, P1, DOI 10.1016/0144-4565(84)90066-0; Kumar V, 2010, PLANT BIOTECHNOL REP, V4, P37, DOI 10.1007/s11816-009-0118-3; Liang M, 2012, PLANTA, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutts S, 1999, PHYSIOL PLANTARUM, V105, P450, DOI 10.1034/j.1399-3054.1999.105309.x; Miller G, 2005, PLANTA, V222, P70, DOI 10.1007/s00425-005-1518-4; Misra N, 2005, PLANT SCI, V169, P331, DOI 10.1016/j.plantsci.2005.02.013; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NEWTON PJ, 1991, IRRIGATION SCI, V12, P213, DOI 10.1007/BF00190526; Ribarits A, 2007, PLANTA, V225, P1313, DOI 10.1007/s00425-006-0429-3; Roosens NHCJ, 1998, PLANT PHYSIOL, V117, P263, DOI 10.1104/pp.117.1.263; ROY D, 1992, BIOL PLANTARUM, V34, P159, DOI 10.1007/BF02925814; Saadia M, 2012, MOLECULES, V17, P5803, DOI 10.3390/molecules17055803; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shahbaz M, 2011, ACTA PHYSIOL PLANT, V33, P1113, DOI 10.1007/s11738-010-0639-y; Shannon MC, 1999, SCI HORTIC-AMSTERDAM, V78, P5, DOI 10.1016/S0304-4238(98)00189-7; Silva-Ortega CO, 2008, PLANT PHYSIOL BIOCH, V46, P82, DOI 10.1016/j.plaphy.2007.10.011; Su M, 2011, PLANT SCI, V181, P652, DOI 10.1016/j.plantsci.2011.03.002; Surabhi GK, 2008, ENVIRON EXP BOT, V64, P171, DOI 10.1016/j.envexpbot.2008.04.006; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Walton EF, 1998, PHYSIOL PLANTARUM, V102, P171, DOI 10.1034/j.1399-3054.1998.1020203.x; Wang K, 2011, AFR J BIOTECHNOL, V10, P2886; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Xue XN, 2009, BMB REP, V42, P28, DOI 10.5483/BMBRep.2009.42.1.028; Yamchi A, 2007, J PLANT BIOCHEM BIOT, V16, P9, DOI 10.1007/BF03321922; YOSHIBA Y, 1995, PLANT J, V7, P751, DOI 10.1046/j.1365-313X.1995.07050751.x; You J, 2012, PLANT SCI, V197, P59, DOI 10.1016/j.plantsci.2012.09.002	46	100	102	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62085	10.1371/journal.pone.0062085	http://dx.doi.org/10.1371/journal.pone.0062085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637970	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800024
J	Ruangsri, J; Kitani, Y; Kiron, V; Lokesh, J; Brinchmann, MF; Karlsen, BO; Fernandes, JMO				Ruangsri, Jareeporn; Kitani, Yoichiro; Kiron, Viswanath; Lokesh, Jep; Brinchmann, Monica F.; Karlsen, Bard Ove; Fernandes, Jorge M. O.			A Novel Beta-Defensin Antimicrobial Peptide in Atlantic Cod with Stimulatory Effect on Phagocytic Activity	PLOS ONE			English	Article							RAINBOW-TROUT; EXPRESSION; SEQUENCE; PISCIDIN	A novel defensin antimicrobial peptide gene was identified in Atlantic cod, Gadus morhua. This three exon/two intron defensin gene codes for a peptide precursor consisting of two domains: a signal peptide of 26 amino acids and a mature peptide of 40 residues. The mature cod defensin has six conserved cysteine residues that form 1-5, 2-4 and 3-6 disulphide bridges. This pattern is typical of beta-defensins and this gene was therefore named cod beta-defensin (defb). The tertiary structure of Defb exhibits an alpha/beta fold with one alpha helix and beta(1)beta(2)beta(3) sheets. RT-PCR analysis indicated that defb transcripts were present mainly in the swim bladder and peritoneum wall but could also be detected at moderate to low levels in skin, head-and excretory kidneys. In situ hybridisation revealed that defb was specifically expressed by cells located in the swim bladder submucosa and the oocytes. During embryonic development, defb gene transcripts were detectable from the golden eye stage onwards and their expression was restricted to the swim bladder and retina. Defb was differentially expressed in several tissues following antigenic challenge with Vibrio anguillarum, being up-regulated up to 25-fold in head kidney. Recombinant Defb displayed antibacterial activity, with a minimal inhibitory concentration of 0.4-0.8 mu M and 25-50 mu M against the Gram-(+) bacteria Planococcus citreus and Micrococcus luteus, respectively. In addition, Defb stimulated phagocytic activity of cod head kidney leucocytes in vitro. These findings imply that beta-defensins may play an important role in the innate immune response of Atlantic cod.	[Ruangsri, Jareeporn; Kitani, Yoichiro; Kiron, Viswanath; Lokesh, Jep; Brinchmann, Monica F.; Karlsen, Bard Ove; Fernandes, Jorge M. O.] Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway	Nord University	Fernandes, JMO (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway.	Jorge.fernandes@uin.no	Brinchmann, Monica Fengsrud/C-2916-2012; Fernandes, Jorge/AAC-4632-2022; Jep, Lokesh/ABB-9946-2021; Fernandes, Jorge MO/A-3526-2013	Brinchmann, Monica Fengsrud/0000-0002-1222-0743; Fernandes, Jorge/0000-0002-2550-1640; Fernandes, Jorge MO/0000-0002-2550-1640; Viswanath, Kiron/0000-0003-4640-1910	Research Council of Norway (NFR) [184703, 176528]; Yggdrasil grant from NFR [211233/F11]; Prince of Songkla University, (Thailand)	Research Council of Norway (NFR)(Research Council of Norway); Yggdrasil grant from NFR; Prince of Songkla University, (Thailand)	This study was undertaken as part of the project 'Mucosal Immune System of Atlantic Cod - Creating a Knowledge Base' (184703), funded by the Research Council of Norway (NFR, www.forskningsradet.no). The pathogen challenge study was a component of another NFR project 'Preventive Health Care of Farmed Fish (ref. 176528). YK was supported by an Yggdrasil grant from the NFR (ref. 211233/F11). JR would like to express her gratitude to the Prince of Songkla University, (Thailand) for granting the PhD scholarship that enabled her to do research at the University of Nordland, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarbiou J, 2002, ANN MED, V34, P96, DOI 10.1080/07853890252953482; Adzhubei AA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-209; Casadei E, 2009, MOL IMMUNOL, V46, P3358, DOI 10.1016/j.molimm.2009.07.018; Cuesta A, 2011, MOL IMMUNOL, V48, P1432, DOI 10.1016/j.molimm.2011.03.022; Falco A, 2008, MOL IMMUNOL, V45, P757, DOI 10.1016/j.molimm.2007.06.358; Fernandes JMO, 2003, BIOCHEM J, V373, P621, DOI 10.1042/BJ20030259; Fernandes JMO, 2002, BIOCHEM BIOPH RES CO, V296, P167, DOI 10.1016/S0006-291X(02)00837-9; Fernandes JMO, 2004, FISH SHELLFISH IMMUN, V16, P1, DOI 10.1016/S1050-4648(03)00027-5; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Fernandes JMO, 2006, COMP BIOCHEM PHYS D, V1, P35, DOI 10.1016/j.cbd.2005.09.003; Fernandes JMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009501; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Jin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012883; Jin Y, 2005, ANTIMICROB AGENTS CH, V49, P4957, DOI 10.1128/AAC.49.12.4957-4964.2005; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lokesh J, 2012, FISH SHELLFISH IMMUN, V33, P626, DOI 10.1016/j.fsi.2012.06.017; Lund V, 2006, DEV COMP IMMUNOL, V30, P1145, DOI 10.1016/j.dci.2006.02.004; McDermott AM, 2009, OPHTHALMIC RES, V41, P60, DOI 10.1159/000187622; Meng Z, 2003, DEV COMP IMMUNOL, V27, P313, DOI 10.1016/S0145-305X(02)00104-0; Mikkelsen H, 2011, FISH SHELLFISH IMMUN, V30, P330, DOI 10.1016/j.fsi.2010.11.007; MOLNAR K, 1993, DIS AQUAT ORGAN, V15, P41, DOI 10.3354/dao015041; Nam BH, 2010, FISH SHELLFISH IMMUN, V28, P267, DOI 10.1016/j.fsi.2009.11.004; Nicastro G, 2003, EUR J BIOCHEM, V270, P1969, DOI 10.1046/j.1432-1033.2003.03563.x; Nilsson S, 2009, ACTA HISTOCHEM, V111, P176, DOI 10.1016/j.acthis.2008.11.016; Noga EJ, 2011, COMP BIOCHEM PHYS D, V6, P44, DOI 10.1016/j.cbd.2010.06.001; Oehlers SH, 2011, DEV COMP IMMUNOL, V35, P385, DOI 10.1016/j.dci.2010.11.008; Overbye A, 2007, AUTOPHAGY, V3, P300, DOI 10.4161/auto.3910; Rajanbabu V, 2011, PEPTIDES, V32, P415, DOI 10.1016/j.peptides.2010.11.005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruangsri J, 2012, FISH SHELLFISH IMMUN, V32, P396, DOI 10.1016/j.fsi.2011.11.022; Ruangsri J, 2010, FISH SHELLFISH IMMUN, V28, P879, DOI 10.1016/j.fsi.2010.02.006; Shestakova T., 2008, Experimental Oncology, V30, P153; Shimizu M, 2008, POULTRY SCI, V87, P2653, DOI 10.3382/ps.2008-00210; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stotz HU, 2009, PLANT SIGNAL BEHAV, V4, P1010, DOI 10.4161/psb.4.11.9755; Taylor K, 2008, BIOPOLYMERS, V90, P1, DOI 10.1002/bip.20900; Taylor K, 2009, EUR J IMMUNOL, V39, P1353, DOI 10.1002/eji.200838566; Thisse C, 2002, SCIENCE, V295, P457, DOI 10.1126/science.1063654; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GL, 2012, FISH SHELLFISH IMMUN, V33, P522, DOI 10.1016/j.fsi.2012.06.003; Zhao JG, 2009, DEV COMP IMMUNOL, V33, P624, DOI 10.1016/j.dci.2008.11.006; Zou J, 2007, MOL IMMUNOL, V44, P638, DOI 10.1016/j.molimm.2006.01.012	44	43	46	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62302	10.1371/journal.pone.0062302	http://dx.doi.org/10.1371/journal.pone.0062302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638029	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400047
J	Yang, KL; Wang, YS; Chang, CC; Huang, SC; Huang, YC; Chi, MS; Chi, KH				Yang, Kai-Lin; Wang, Yu-Shan; Chang, Chao-Chun; Huang, Su-Chen; Huang, Yi-Chun; Chi, Mau-Shin; Chi, Kwan-Hwa			Reciprocal Complementation of the Tumoricidal Effects of Radiation and Natural Killer Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; NEOADJUVANT IMMUNOTHERAPY; MELANOMA-CELLS; CYTOCHROME-C; IMMUNE CELLS; CANCER CELLS; TGF-BETA; TUMOR; RADIOTHERAPY; APOPTOSIS	The tumor microenvironment is a key determinant for radio-responsiveness. Immune cells play an important role in shaping tumor microenvironments; however, there is limited understanding of how natural killer (NK) cells can enhance radiation effects. This study aimed to assess the mechanism of reciprocal complementation of radiation and NK cells on tumor killing. Various tumor cell lines were co-cultured with human primary NK cells or NK cell line (NK-92) for short periods and then exposed to irradiation. Cell proliferation, apoptosis and transwell assays were performed to assess apoptotic efficacy and cell viability. Western blot analysis and immunoprecipitation methods were used to determine XIAP (X-linked inhibitor of apoptosis protein) and Smac (second mitochondria-derived activator of caspase) expression and interaction in tumor cells. Co-culture did not induce apoptosis in tumor cells, but a time-and dose-dependent enhancing effect was found when co-cultured cells were irradiated. A key role for caspase activation via perforin/granzyme B (Grz B) after cell-cell contact was determined, as the primary radiation enhancing effect. The efficacy of NK cell killing was attenuated by upregulation of XIAP to bind caspase-3 in tumor cells to escape apoptosis. Knockdown of XIAP effectively potentiated NK cell-mediated apoptosis. Radiation induced Smac released from mitochondria and neutralized XIAP and therefore increased the NK killing. Our findings suggest NK cells in tumor microenvironment have direct radiosensitization effect through Grz B injection while radiation enhances NK cytotoxicity through triggering Smac release.	[Yang, Kai-Lin; Wang, Yu-Shan; Chang, Chao-Chun; Huang, Su-Chen; Huang, Yi-Chun; Chi, Mau-Shin; Chi, Kwan-Hwa] Shin Kong Wu Ho Su Mem Hosp, Dept Radiat Therapy & Oncol, Taipei, Taiwan; [Chi, Kwan-Hwa] Natl Yang Ming Univ, Inst Radiat Sci, Taipei 112, Taiwan; [Chi, Kwan-Hwa] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chi, KH (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Radiat Therapy & Oncol, Taipei, Taiwan.	M006565@ms.skh.org.tw	Yang, Kai-Lin/AAG-2047-2020	Multhoff, Gabriele/0000-0002-2616-3137	National Science Council, Taiwan [NSC 97-2320-B-341-001-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council, Taiwan (NSC 97-2320-B-341-001-MY2, http://web1.nsc.gov.tw/). The National Science Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2009, CELL CYCLE, V8, P970, DOI 10.4161/cc.8.7.8075; Ames E, 2009, CLIN EXP IMMUNOL, V155, P504, DOI 10.1111/j.1365-2249.2008.03818.x; Campoli M, 2008, TISSUE ANTIGENS, V72, P321, DOI 10.1111/j.1399-0039.2008.01106.x; Cha E, 2011, J CLIN ONCOL, V29, P3677, DOI 10.1200/JCO.2010.34.5025; Chi CH, 2010, CANCER BIOTHER RADIO, V25, P39, DOI 10.1089/cbr.2009.0699; Chi KH, 2012, CANCER BIOTHER RADIO, V27, P6, DOI 10.1089/cbr.2011.1048; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; Dahlin AM, 2011, MODERN PATHOL, V24, P671, DOI 10.1038/modpathol.2010.234; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dietrich PY, 2010, CURR OPIN ONCOL, V22, P604, DOI 10.1097/CCO.0b013e32833dead8; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Farooque A, 2011, EXPERT REV ANTICANC, V11, P791, DOI [10.1586/ERA.10.217, 10.1586/era.10.217]; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Grabenbauer GG, 2006, CLIN CANCER RES, V12, P3355, DOI 10.1158/1078-0432.CCR-05-2434; Gulley JL, 2005, CLIN CANCER RES, V11, P3353, DOI 10.1158/1078-0432.CCR-04-2062; Hersey P, 2001, NAT REV CANCER, V1, P142, DOI 10.1038/35101078; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Owens TW, 2010, J BIOL CHEM, V285, P1081, DOI 10.1074/jbc.M109.072322; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Rudner J, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-108; Seeger JM, 2010, CANCER RES, V70, P1825, DOI 10.1158/0008-5472.CAN-09-3175; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Sommariva M, 2011, CANCER RES, V71, P6382, DOI 10.1158/0008-5472.CAN-11-1285; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Timar J, 2003, LARYNGOSCOPE, V113, P2206; Timar J, 2005, J CLIN ONCOL, V23, P3421, DOI 10.1200/JCO.2005.06.005; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang YS, 2008, CANCER LETT, V266, P275, DOI 10.1016/j.canlet.2008.02.063; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Westwood JA, 2010, EXPERT OPIN BIOL TH, V10, P531, DOI 10.1517/14712591003610622; Wilczynski JR, 2008, FRONT BIOSCI-LANDMRK, V13, P2266, DOI 10.2741/2840; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Yasuda K, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-49; Zhou LL, 2005, APOPTOSIS, V10, P289, DOI 10.1007/s10495-005-0803-9; Zitvogel L, 2004, ADV IMMUNOL, V84, P131, DOI 10.1016/S0065-2776(04)84004-5	42	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61797	10.1371/journal.pone.0061797	http://dx.doi.org/10.1371/journal.pone.0061797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634213	Green Submitted, Green Published, gold			2022-12-25	WOS:000318341400021
J	Cuenca, A; Petersen, G; Seberg, O				Cuenca, Argelia; Petersen, Gitte; Seberg, Ole			The Complete Sequence of the Mitochondrial Genome of Butomus umbellatus - A Member of an Early Branching Lineage of Monocotyledons	PLOS ONE			English	Article							SUBSTITUTION RATES; MULTIGENE ANALYSES; EXTENSIVE LOSS; GENE-TRANSFER; DNA-SEQUENCE; TRNASCAN-SE; RNA; CHLOROPLAST; EVOLUTION; PHYLOGENY	In order to study the evolution of mitochondrial genomes in the early branching lineages of the monocotyledons, i.e., the Acorales and Alismatales, we are sequencing complete genomes from a suite of key taxa. As a starting point the present paper describes the mitochondrial genome of Butomus umbellatus (Butomaceae) based on next-generation sequencing data. The genome was assembled into a circular molecule, 450,826 bp in length. Coding sequences cover only 8.2% of the genome and include 28 protein coding genes, four rRNA genes, and 12 tRNA genes. Some of the tRNA genes and a 16S rRNA gene are transferred from the plastid genome. However, the total amount of recognized plastid sequences in the mitochondrial genome is only 1.5% and the amount of DNA transferred from the nucleus is also low. RNA editing is abundant and a total of 557 edited sites are predicted in the protein coding genes. Compared to the 40 angiosperm mitochondrial genomes sequenced to date, the GC content of the Butomus genome is uniquely high (49.1%). The overall similarity between the mitochondrial genomes of Butomus and Spirodela (Araceae), the closest relative yet sequenced, is low (less than 20%), and the two genomes differ in size by a factor 2. Gene order is also largely unconserved. However, based on its phylogenetic position within the core alismatids Butomus will serve as a good reference point for subsequent studies in the early branching lineages of the monocotyledons.	[Cuenca, Argelia; Petersen, Gitte; Seberg, Ole] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark	University of Copenhagen	Cuenca, A (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark.	acuenca@snm.ku.dk; gittep@snm.ku.dk; oles@snm.ku.dk	Cuenca, Argelia/AAK-9053-2021; Seberg, Ole/A-5111-2013; Petersen, Gitte/H-1903-2011	Cuenca, Argelia/0000-0001-8596-1086; Seberg, Ole/0000-0001-9675-4090; Petersen, Gitte/0000-0002-2325-0059	Danish Council for Independent Research \ Natural Sciences (FNU) [272-06-0436]	Danish Council for Independent Research \ Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council)	The research was supported by the Danish Council for Independent Research vertical bar Natural Sciences (FNU; http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research/scientific-research-councils/natural-sciences) grant no. 272-06-0436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Adams KL, 2001, GENETICS, V158, P1289; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; ATLAN A, 1993, GENETICS, V135, P213; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chase Mark W., 2006, Aliso, V22, P63; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Cochella L, 2004, NAT STRUCT MOL BIOL, V11, P1160, DOI 10.1038/nsmb1204-1160; Cuenca A, 2012, J MOL EVOL, V74, P158, DOI 10.1007/s00239-012-9496-1; Cuenca A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-349; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Kocyan A, 2007, MOL PHYLOGENET EVOL, V44, P553, DOI 10.1016/j.ympev.2006.12.022; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malek O, 1996, EMBO J, V15, P1403, DOI 10.1002/j.1460-2075.1996.tb00482.x; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Martin W, 2005, HEREDITY, V94, P565, DOI 10.1038/sj.hdy.6800659; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Mower JP, 2006, MOL GENET GENOMICS, V276, P285, DOI 10.1007/s00438-006-0139-3; Mower JP, 2012, GENOME BIOL EVOL, V4, P670, DOI 10.1093/gbe/evs042; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Mower JP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-96; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Parkinson CL, 1999, CURR BIOL, V9, P1485, DOI 10.1016/S0960-9822(00)80119-0; Parkinson CL, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-73; Petersen G, 2006, TAXON, V55, P871, DOI 10.2307/25065682; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Richardson AO, 2007, J EXP BOT, V58, P1, DOI 10.1093/jxb/erl148; Rodriguez-Moreno L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-424; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Sloan DB, 2010, GENETICS, V185, P1369, DOI 10.1534/genetics.110.118000; STERN DB, 1982, NATURE, V299, P698, DOI 10.1038/299698a0; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Triboush SO, 1998, PLANT MOL BIOL REP, V16, P183, DOI 10.1023/A:1007487806583; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wang WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046747; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yukawa M, 2008, P NATL ACAD SCI USA, V105, P19550, DOI 10.1073/pnas.0809240105; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531	59	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61552	10.1371/journal.pone.0061552	http://dx.doi.org/10.1371/journal.pone.0061552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637852	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400027
J	Iwaki, A; Ohnuki, S; Suga, Y; Izawa, S; Ohya, Y				Iwaki, Aya; Ohnuki, Shinsuke; Suga, Yohei; Izawa, Shingo; Ohya, Yoshikazu			Vanillin Inhibits Translation and Induces Messenger Ribonucleoprotein (mRNP) Granule Formation in Saccharomyces cerevisiae: Application and Validation of High-Content, Image-Based Profiling	PLOS ONE			English	Article							P-BODIES; BIOETHANOL FERMENTATION; ALCOHOL-DEHYDROGENASE; POTENTIAL INHIBITOR; STRESS GRANULES; BAKERS-YEAST; PATHWAYS; ETHANOL; GENES; RNA	Vanillin, generated by acid hydrolysis of lignocellulose, acts as a potent inhibitor of the growth of the yeast Saccharomyces cerevisiae. Here, we investigated the cellular processes affected by vanillin using high-content, image-based profiling. Among 4,718 non-essential yeast deletion mutants, the morphology of those defective in the large ribosomal subunit showed significant similarity to that of vanillin-treated cells. The defects in these mutants were clustered in three domains of the ribosome: the mRNA tunnel entrance, exit and backbone required for small subunit attachment. To confirm that vanillin inhibited ribosomal function, we assessed polysome and messenger ribonucleoprotein granule formation after treatment with vanillin. Analysis of polysome profiles showed disassembly of the polysomes in the presence of vanillin. Processing bodies and stress granules, which are composed of non-translating mRNAs and various proteins, were formed after treatment with vanillin. These results suggest that vanillin represses translation in yeast cells.	[Iwaki, Aya; Izawa, Shingo] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Appl Biol, Matsugasaki, Kyoto, Japan; [Ohnuki, Shinsuke; Suga, Yohei; Ohya, Yoshikazu] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	Kyoto Institute of Technology; University of Tokyo	Ohya, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	ohya@k.u-tokyo.ac.jp	Ohya, Yoshikazu/AAW-2200-2021	Ohya, Yoshikazu/0000-0003-0837-1239; Izawa, Shingo/0000-0002-4920-2450; Ohnuki, Shinsuke/0000-0001-6254-081X	New Energy and Industrial Technology Development Organization; Ministry of Education, Culture, Sports, Science and Technology, Japan [24370002, 23580113]; Grants-in-Aid for Scientific Research [19057002] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the New Energy and Industrial Technology Development Organization (Y.O.) and by grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (24370002 to Y.O. and 23580113 to S. I.). S.O. was a research fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Azad MA, 2012, BIOORGAN MED CHEM, V20, P1929, DOI 10.1016/j.bmc.2011.10.088; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brochado AR, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-84; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Durant S, 2003, NUCLEIC ACIDS RES, V31, P5501, DOI 10.1093/nar/gkg753; Endo A, 2009, FEMS MICROBIOL LETT, V299, P95, DOI 10.1111/j.1574-6968.2009.01733.x; Endo A, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-3; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Fitzgerald DJ, 2003, INT J FOOD MICROBIOL, V86, P113, DOI 10.1016/S0168-1605(03)00059-X; Gray KA, 2006, CURR OPIN CHEM BIOL, V10, P141, DOI 10.1016/j.cbpa.2006.02.035; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hansen EH, 2009, APPL ENVIRON MICROB, V75, P2765, DOI 10.1128/AEM.02681-08; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwaki A, 2012, BIOCHEM J, V446, P225, DOI 10.1042/BJ20120583; Izawa S, 2007, BIOSCI BIOTECH BIOCH, V71, P2800, DOI 10.1271/bbb.70417; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kato K, 2011, YEAST, V28, P339, DOI 10.1002/yea.1842; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Larroy C, 2002, EUR J BIOCHEM, V269, P5738, DOI 10.1046/j.1432-1033.2002.03296.x; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; Ohnuki S, 2012, FEMS YEAST RES, V12, P293, DOI 10.1111/j.1567-1364.2011.00770.x; Ohnuki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010177; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Parawira W, 2011, CRIT REV BIOTECHNOL, V31, P20, DOI 10.3109/07388551003757816; Pereira FB, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-57; Saito TL, 2004, NUCLEIC ACIDS RES, V32, pD319, DOI 10.1093/nar/gkh113; Stolc V, 1997, GENE DEV, V11, P2926, DOI 10.1101/gad.11.21.2926; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549	37	55	60	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61748	10.1371/journal.pone.0061748	http://dx.doi.org/10.1371/journal.pone.0061748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637899	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400046
J	Kuhn, S; Gallinat, J				Kuehn, Simone; Gallinat, Juergen			Does Taste Matter? How Anticipation of Cola Brands Influences Gustatory Processing in the Brain	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; ORBITOFRONTAL CORTEX; RESPONSES; REWARD; INTENSITY; VALUATION; STRIATUM; VALUES	Brands surround us everywhere in daily life. Here we investigate the influences of brand cues on gustatory processing of the same beverage. Participants were led to believe that the brand that announced the administration of a Cola mixture provided correct information about the drink to come. We found stronger fMRI signal in right mOFC during weak compared to strong brand cues in a contrast of parametric modulation with subjective liking. When directly comparing the two strong brands cues, more activation in the right amygdala was found for Coca Cola cues compared with Pepsi Cola cues. During the taste phase the same beverage elicited stronger activation in left ventral striatum when it was previously announced by a strong compared with a weak brand. This effect was stronger in participants who drink Cola infrequently and might therefore point to a stronger reliance on brand cues in less experienced consumers. The present results reveal strong effects of brand labels on neural responses signalling reward.	[Kuehn, Simone; Gallinat, Juergen] Charite, Clin Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Kuehn, Simone] Max Planck Inst Human Dev & Educ, Ctr Lifespan Psychol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Kuhn, S (corresponding author), Charite, Clin Psychiat & Psychotherapy, D-13353 Berlin, Germany.	kuehn@mpib-berlin.mpg.de	Kuehn, Simone/P-6145-2014	Kuhn, Simone/0000-0001-6823-7969				Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bennett P.B, 1988, DICT MARKETING TERMS; BRANTHWAITE A, 1981, BRIT MED J, V282, P1576, DOI 10.1136/bmj.282.6276.1576; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Brown G., 1992, PEOPLE BRANDS ADVERT; Calder AJ, 2001, REV NEUROSCIENCE; Cauda F, 2011, J COGNITIVE NEUROSCI, V23, P2864, DOI 10.1162/jocn.2011.21624; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Grabenhorst F, 2008, CEREBRAL CORTEX; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Hamann S, 2002, NEUROREPORT, V13, P15, DOI 10.1097/00001756-200201210-00008; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hassani OK, 2001, INFLUENCE EXPECTATIO; Heinz A, 2009, BIOL PSYCHIAT, V65, P101, DOI 10.1016/j.biopsych.2008.11.003; Hommer DW, 2003, ANN NY ACAD SCI, V985, P476; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Linder NS, 2010, NEUROIMAGE, V53, P215, DOI 10.1016/j.neuroimage.2010.05.077; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Pecina S, 2006, NEUROSCIENTIST, V12, P500, DOI 10.1177/1073858406293154; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Smith K., 2010, PLEASURES BRAIN, P1; Torres-Moreno M, 2012, APPETITE, V58, P665, DOI 10.1016/j.appet.2011.12.005; Tusche A, 2010, J NEUROSCI, V30, P8024, DOI 10.1523/JNEUROSCI.0064-10.2010; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	34	24	24	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61569	10.1371/journal.pone.0061569	http://dx.doi.org/10.1371/journal.pone.0061569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637857	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400030
J	Paschaki, M; Schneider, C; Rhinn, M; Thibault-Carpentier, C; Dembele, D; Niederreither, K; Dolle, P				Paschaki, Marie; Schneider, Carole; Rhinn, Muriel; Thibault-Carpentier, Christelle; Dembele, Doulaye; Niederreither, Karen; Dolle, Pascal			Transcriptomic Analysis of Murine Embryos Lacking Endogenous Retinoic Acid Signaling	PLOS ONE			English	Article							NEURAL STEM-CELLS; MOTIF OVER-REPRESENTATION; NUCLEAR RECEPTOR TLX; VERTEBRATE BODY AXIS; NERVOUS-SYSTEM; POSTIMPLANTATION DEVELOPMENT; RETINALDEHYDE DEHYDROGENASE; NEURONAL DIFFERENTIATION; MOUSE DEVELOPMENT; RESPONSE ELEMENT	Retinoic acid (RA), an active derivative of the liposoluble vitamin A (retinol), acts as an important signaling molecule during embryonic development, regulating phenomenons as diverse as anterior-posterior axial patterning, forebrain and optic vesicle development, specification of hindbrain rhombomeres, pharyngeal arches and second heart field, somitogenesis, and differentiation of spinal cord neurons. This small molecule directly triggers gene activation by binding to nuclear receptors (RARs), switching them from potential repressors to transcriptional activators. The repertoire of RA-regulated genes in embryonic tissues is poorly characterized. We performed a comparative analysis of the transcriptomes of murine wild-type and Retinaldehyde Dehydrogenase 2 null-mutant (Raldh2(-/-)) embryos - unable to synthesize RA from maternally-derived retinol - using Affymetrix DNA microarrays. Transcriptomic changes were analyzed in two embryonic regions: anterior tissues including forebrain and optic vesicle, and posterior (trunk) tissues, at early stages preceding the appearance of overt phenotypic abnormalities. Several genes expected to be downregulated under RA deficiency appeared in the transcriptome data (e. g. Emx2, Foxg1 anteriorly, Cdx1, Hoxa1, Rarb posteriorly), whereas reverse-transcriptase-PCR and in situ hybridization performed for additional selected genes validated the changes identified through microarray analysis. Altogether, the affected genes belonged to numerous molecular pathways and cellular/organismal functions, demonstrating the pleiotropic nature of RA-dependent events. In both tissue samples, genes upregulated were more numerous than those downregulated, probably due to feedback regulatory loops. Bioinformatic analyses highlighted groups (clusters) of genes displaying similar behaviors in mutant tissues, and biological functions most significantly affected (e. g. mTOR, VEGF, ILK signaling in forebrain tissues; pyrimidine and purine metabolism, calcium signaling, one carbon metabolism in posterior tissues). Overall, these data give an overview of the gene expression changes resulting from embryonic RA deficiency, and provide new candidate genes and pathways that may help understanding retinoid-dependent molecular events.	[Paschaki, Marie; Schneider, Carole; Rhinn, Muriel; Niederreither, Karen; Dolle, Pascal] Univ Strasbourg, Ctr Natl Rech Sci, IGBMC,Unite Mixte Rech 7104,U964, Inst Natl Sante & Rech Med,Dev Biol & Stem Cells, Illkirch Graffenstaden, France; [Thibault-Carpentier, Christelle; Dembele, Doulaye] Univ Strasbourg, Ctr Natl Rech Sci, IGBMC,U964, Inst Natl Sante & Rech Med,Unite Mixte Rech 7104, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dolle, P (corresponding author), Univ Strasbourg, Ctr Natl Rech Sci, IGBMC,Unite Mixte Rech 7104,U964, Inst Natl Sante & Rech Med,Dev Biol & Stem Cells, Illkirch Graffenstaden, France.	dolle@igbmc.fr	Dolle, Pascal/A-8037-2010; Dembélé, Doulaye/O-6513-2017	Dolle, Pascal/0000-0002-9294-9090; Dembélé, Doulaye/0000-0003-3879-6940; Paschaki, Marie/0000-0002-9490-8997; Thibault-Carpentier, Christelle/0000-0003-1562-1451; Rhinn, Muriel/0000-0002-1918-0246	Agence Nationale de la Recherche; Fondation pour la Recherche Medicale (Equipe FRM); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from the Agence Nationale de la Recherche (ANR Neurosciences 2007, ANR Blanc 2011) and the Fondation pour la Recherche Medicale (Equipe FRM 2007), and by institutional funds from the Centre National de la Recherche Scientifique (CNRS) and Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma Hiromi, 2012, Frontiers in Genetics, V3, P141, DOI 10.3389/fgene.2012.00141; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Burgess R, 1996, NATURE, V384, P570, DOI 10.1038/384570a0; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Chotteau-Lelievre Anne, 2006, Methods Mol Biol, V326, P61; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Di W, 1998, J INVEST DERMATOL, V111, P1109, DOI 10.1046/j.1523-1747.1998.00455.x; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; DiRocco G, 1997, EMBO J, V16, P3644, DOI 10.1093/emboj/16.12.3644; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Elkouris M, 2011, STEM CELLS, V29, P89, DOI 10.1002/stem.554; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Finley KR, 2003, GENE EXPR PATTERNS, V3, P681, DOI 10.1016/S1567-133X(03)00091-7; Gavalas A, 2002, TRENDS NEUROSCI, V25, P61, DOI 10.1016/S0166-2236(02)02067-2; Glaser T, 2005, TRENDS NEUROSCI, V28, P397, DOI 10.1016/j.tins.2005.05.008; Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201; Houle M, 2003, DEVELOPMENT, V130, P6555, DOI 10.1242/dev.00889; Hunter C, 2005, MOL BIOL REP, V32, P67, DOI 10.1007/s11033-004-7657-z; Jung S, 2010, STEM CELLS DEV, V19, P831, DOI 10.1089/scd.2009.0093; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kim M, 2009, DEV BIOL, V328, P456, DOI 10.1016/j.ydbio.2009.02.001; Kobayashi M, 2000, MOL CELL BIOL, V20, P8731, DOI 10.1128/MCB.20.23.8731-8739.2000; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lee HS, 2010, J CELL SCI, V123, P1959, DOI 10.1242/jcs.063784; Li HX, 2000, MECH DEVELOP, V95, P283, DOI 10.1016/S0925-4773(00)00352-X; Luque JM, 2003, DEV BRAIN RES, V140, P195, DOI 10.1016/S0165-3806(02)00604-1; Maden M, 1998, DEVELOPMENT, V125, P4133; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; McCaffery P, 2000, CYTOKINE GROWTH F R, V11, P233, DOI 10.1016/S1359-6101(00)00002-2; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Mic FA, 2000, MECH DEVELOP, V97, P227, DOI 10.1016/S0925-4773(00)00434-2; Mic FA, 2002, DEVELOPMENT, V129, P2271; Mic FA, 2004, DEV DYNAM, V231, P270, DOI 10.1002/dvdy.20128; Mochida Y, 2006, J BIOL CHEM, V281, P36044, DOI 10.1074/jbc.M604787200; Molotkova N, 2005, MECH DEVELOP, V122, P145, DOI 10.1016/j.mod.2004.10.008; Moutier E, 2012, J BIOL CHEM, V287, P26328, DOI 10.1074/jbc.M112.361790; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2003, DEVELOPMENT, V130, P2525, DOI 10.1242/dev.00463; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Paschaki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032447; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Ribes V, 2008, DEV BIOL, V321, P470, DOI 10.1016/j.ydbio.2008.06.003; Ribes V, 2009, DEVELOPMENT, V136, P665, DOI 10.1242/dev.016204; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Ryckebusch L, 2008, P NATL ACAD SCI USA, V105, P2913, DOI 10.1073/pnas.0712344105; Sapin V, 1997, DEV DYNAM, V208, P199, DOI 10.1002/(SICI)1097-0177(199702)208:2<199::AID-AJA7>3.0.CO;2-D; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Seo KW, 2006, DEV BIOL, V290, P200, DOI 10.1016/j.ydbio.2005.11.027; Serpente P, 2005, DEVELOPMENT, V132, P503, DOI 10.1242/dev.01593; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Sirbu IO, 2008, DEV DYNAM, V237, P1627, DOI 10.1002/dvdy.21570; Soyer J, 2010, DEVELOPMENT, V137, P203, DOI 10.1242/dev.041673; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Thomas MA, 2006, J CELL BIOCHEM, V99, P1409, DOI 10.1002/jcb.21020; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; von Lintig J, 2005, BBA-MOL BASIS DIS, V1740, P122, DOI 10.1016/j.bbadis.2004.11.010; Wagner E, 2000, DEV BIOL, V222, P460, DOI 10.1006/dbio.2000.9719; Ward SJ, 1997, BIOL REPROD, V57, P751, DOI 10.1095/biolreprod57.4.751; Williams ME, 2006, NAT NEUROSCI, V9, P996, DOI 10.1038/nn1736; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430	83	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62274	10.1371/journal.pone.0062274	http://dx.doi.org/10.1371/journal.pone.0062274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638021	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400091
J	Shin, MH; Park, R; Nojima, H; Kim, HC; Kim, YK; Chung, JH				Shin, Mi Hee; Park, Raeeun; Nojima, Hideo; Kim, Hyung-Chel; Kim, Yeon Kyung; Chung, Jin Ho			Atomic Hydrogen Surrounded by Water Molecules, H(H2O)(m), Modulates Basal and UV-Induced Gene Expressions in Human Skin In Vivo	PLOS ONE			English	Article							AGED HUMAN SKIN; TRANSCRIPTION FACTOR AP-1; HUMAN DERMAL FIBROBLASTS; ULTRAVIOLET-LIGHT; OXIDATIVE STRESS; MATRIX METALLOPROTEINASE-1; HUMAN KERATINOCYTES; PYRIMIDINE DIMERS; INFLAMMATION; IRRADIATION	Recently, there has been much effort to find effective ingredients which can prevent or retard cutaneous skin aging after topical or systemic use. Here, we investigated the effects of the atomic hydrogen surrounded by water molecules, H(H2O)(m), on acute UV-induced responses and as well as skin aging. Interestingly, we observed that H(H2O)(m) application to human skin prevented UV-induced erythema and DNA damage. And H(H2O)(m) significantly prevented UV-induced MMP-1, COX-2, IL-6 and IL-1 beta mRNA expressions in human skin in vivo. We found that H(H2O)(m) prevented UV-induced ROS generation and inhibited UV-induced MMP-1, COX-2 and IL-6 expressions, and UV-induced JNK and c-Jun phosphorylation in HaCaT cells. Next, we investigated the effects of H(H2O)(m) on intrinsically aged or photoaged skin of elderly subjects. In intrinsically aged skin, H(H2O)(m) application significantly reduced constitutive expressions of MMP-1, IL-6, and IL-1b mRNA. Additionally, H(H2O)(m) significantly increased procollagen mRNA and also decreased MMP-1 and IL-6 mRNA expressions in photoaged facial skin. These results demonstrated that local application of H(H2O)(m) may prevent UV-induced skin inflammation and can modulate intrinsic skin aging and photoaging processes. Therefore, we suggest that modifying the atmospheric gas environment within a room may be a new way to regulate skin functions or skin aging.	[Shin, Mi Hee; Kim, Yeon Kyung; Chung, Jin Ho] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Shin, Mi Hee; Kim, Yeon Kyung; Chung, Jin Ho] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Cutaneous Aging Res, Seoul 110744, South Korea; [Shin, Mi Hee; Kim, Yeon Kyung; Chung, Jin Ho] Seoul Natl Univ, Med Res Ctr, Inst Human Environm Interface Biol, Seoul, South Korea; [Park, Raeeun; Nojima, Hideo; Kim, Hyung-Chel] Samsung Elect CO LTD, R&D Team, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Samsung; Samsung Electronics	Chung, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea.	jhchung@snu.ac.kr	Chung, Jin Ho/C-3604-2011		National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0029819]; Samsung Electronics CO., LTD.	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Samsung Electronics CO., LTD.(Samsung)	This study was supported by a grant from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0029819), and research agreement with Samsung Electronics CO., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber LA, 1998, J BIOL CHEM, V273, P18891, DOI 10.1074/jbc.273.30.18891; Berneburg M, 2000, PHOTODERMATOL PHOTO, V16, P239, DOI 10.1034/j.1600-0781.2000.160601.x; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Briganti S, 2003, J EUR ACAD DERMATOL, V17, P663, DOI 10.1046/j.1468-3083.2003.00751.x; Burren R, 1998, INT J CANCER, V76, P201, DOI 10.1002/(SICI)1097-0215(19980413)76:2<201::AID-IJC6>3.0.CO;2-0; Chung JH, 2000, J INVEST DERMATOL, V115, P177, DOI 10.1046/j.1523-1747.2000.00009.x; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; DELICONSTANTINOS G, 1995, BRIT J PHARMACOL, V114, P1257, DOI 10.1111/j.1476-5381.1995.tb13341.x; Fisher G J, 1998, J Investig Dermatol Symp Proc, V3, P61; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fontanari P, 2000, EUR J APPL PHYSIOL, V81, P325, DOI 10.1007/s004210050050; Hideo N, 2007, J PHYS D, V40, P501; Huang CS, 2010, FREE RADICAL RES, V44, P971, DOI 10.3109/10715762.2010.500328; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Kang S, 2003, J INVEST DERMATOL, V120, P835, DOI 10.1046/j.1523-1747.2003.12122.x; Katiyar SK, 2000, CLIN CANCER RES, V6, P3864; Katiyar SK, 2005, INT J ONCOL, V26, P169; Kawaguchi Y, 1996, ARCH DERMATOL RES, V288, P39, DOI 10.1007/BF02505041; Kawamura T, 2010, TRANSPLANTATION, V90, P1344, DOI 10.1097/TP.0b013e3181fe1357; Kim HH, 2005, J LIPID RES, V46, P1712, DOI 10.1194/jlr.M500105-JLR200; Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5; Kim MK, 2010, EXP GERONTOL, V45, P419, DOI 10.1016/j.exger.2010.03.005; KIRNBAUER R, 1991, J INVEST DERMATOL, V96, P484, DOI 10.1111/1523-1747.ep12470181; Kitazawa M, 1997, PHOTOCHEM PHOTOBIOL, V65, P355, DOI 10.1111/j.1751-1097.1997.tb08571.x; KONNIKOV N, 1989, J INVEST DERMATOL, V92, P235, DOI 10.1111/1523-1747.ep12276763; Kuhn M, 2006, ARCH DERMATOL RES, V297, P477, DOI 10.1007/s00403-006-0648-2; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Lee Y, 2009, J INVEST DERMATOL, V129, P460, DOI 10.1038/jid.2008.261; Lekic T, 2011, ACTA NEUROCHIR SUPPL, V111, P237, DOI 10.1007/978-3-7091-0693-8_40; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MASAKI H, 1995, BIOCHEM BIOPH RES CO, V206, P474, DOI 10.1006/bbrc.1995.1067; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Portugal-Cohen M, 2011, EXP DERMATOL, V20, P749, DOI 10.1111/j.1600-0625.2011.01317.x; Quan TH, 2010, J INVEST DERMATOL, V130, P1697, DOI 10.1038/jid.2010.29; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Quan TH, 2005, J BIOL CHEM, V280, P8079, DOI 10.1074/jbc.M409647200; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Rundhaug JE, 2008, PHOTOCHEM PHOTOBIOL, V84, P322, DOI 10.1111/j.1751-1097.2007.00261.x; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Seo JY, 2003, MECH AGEING DEV, V124, P903, DOI 10.1016/S0047-6374(03)00150-7; Shih TS, 2009, AM J IND MED, V52, P654, DOI 10.1002/ajim.20709; Shin MH, 2005, J INVEST DERMATOL, V125, P221, DOI 10.1111/j.0022-202X.2005.23823.x; SMITH WL, 1994, ANN NY ACAD SCI, V714, P136, DOI 10.1111/j.1749-6632.1994.tb12037.x; Varani J, 2000, J INVEST DERMATOL, V114, P480, DOI 10.1046/j.1523-1747.2000.00902.x; Wang SM, 2006, J HAZARD MATER, V138, P518, DOI 10.1016/j.jhazmat.2006.05.072; Wang XY, 2006, CHINESE MED J-PEKING, V119, P827, DOI 10.1097/00029330-200605020-00006; Wenk J, 2001, CURR PROBL DERMATOL, V29, P83; WLASCHEK M, 1994, PHOTOCHEM PHOTOBIOL, V59, P550, DOI 10.1111/j.1751-1097.1994.tb02982.x; Xie KL, 2010, SHOCK, V34, P495, DOI 10.1097/SHK.0b013e3181def9aa; Yang B, 2009, INT J MOL MED, V23, P555, DOI 10.3892/ijmm_00000164; Yasui H, 2000, BIOCHEM BIOPH RES CO, V269, P131, DOI 10.1006/bbrc.2000.2254	56	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61696	10.1371/journal.pone.0061696	http://dx.doi.org/10.1371/journal.pone.0061696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637886	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400042
J	Deschemin, JC; Vaulont, S				Deschemin, Jean-Christophe; Vaulont, Sophie			Role of Hepcidin in the Setting of Hypoferremia during Acute Inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; IRON-ABSORPTION; DIETARY IRON; MICE; TRANSPORTER; FERROPORTIN; HEMOJUVELIN; PROTEINS; LIVER	The anemia of chronic disease (also called anemia of inflammation) is an acquired disorder of iron homeostasis associated with infection, malignancy, organ failure, trauma, or other causes of inflammation. It is now widely accepted that induction of hepcidin expression in response to inflammation might explain the characteristic hypoferremia associated with this condition. To determine the role of hepcidin in acute inflammation and the regulation of its receptor, the iron exporter, ferroportin, wild-type, heterozygote and hepcidin knockout mice (Hepc-/-) were challenged with sublethal doses of lipopolysaccharide (LPS). Six hours after injection, ferroportin mRNA and protein levels were assessed in the duodenum and the spleen and plasma iron was determined. Our results demonstrate that hepcidin is crucial, though not the sole mediator of LPS-mediated acute hypoferremia, and also that hepcidin major contribution relies on decreased ferroportin protein levels found in the spleen. Furthermore, we establish that LPS-mediated repression of the membrane iron transporter DMT1 and oxidoreductase Dcytb in the duodenum is independent of hepcidin. Finally, our results in the hepc+/- mice indicate that elevated hepcidin gene expression is not a prerequisite for the setting of hypoferremia during early inflammatory response, and they highlight the intimate crosstalk between inflammatory and iron-responsive pathways for the control of hepcidin.	[Deschemin, Jean-Christophe; Vaulont, Sophie] Inst Natl Sante & Rech Med, U1016, Inst Cochin, Fac Med Cochin Port Royal, Paris, France; [Deschemin, Jean-Christophe; Vaulont, Sophie] CNRS, UMR8104, Paris, France; [Deschemin, Jean-Christophe; Vaulont, Sophie] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Vaulont, S (corresponding author), Inst Natl Sante & Rech Med, U1016, Inst Cochin, Fac Med Cochin Port Royal, Paris, France.	sophie.vaulont@inserm.fr	Vaulont, Sophie/O-6732-2017	Deschemin, Jean-Christophe/0000-0002-1256-8459	Institut National de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Institut National de la Sante et de la Recherche Medicale and Agence Nationale de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2002, BIOCHEM SOC T, V30, P724, DOI 10.1042/bst0300724; Badial PR, 2011, VET IMMUNOL IMMUNOP, V141, P157, DOI 10.1016/j.vetimm.2011.02.009; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Constante M, 2007, AM J PATHOL, V170, P497, DOI 10.2353/ajpath.2007.060437; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Krijt J, 2006, FOLIA BIOL-PRAGUE, V52, P1; Krijt J, 2004, BLOOD, V104, P4308, DOI 10.1182/blood-2004-06-2422; Laftah AH, 2006, BIOCHEM J, V397, P61, DOI 10.1042/BJ20060215; Lawless MW, 2012, CYTOKINE, V59, P195, DOI 10.1016/j.cyto.2012.04.003; Layoun A, 2012, AM J PATHOL, V180, P2340, DOI 10.1016/j.ajpath.2012.01.046; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Lou DQ, 2005, HEPATOLOGY, V41, P1056, DOI 10.1002/hep.20663; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Rodrigues PN, 2011, IMMUNOBIOLOGY, V216, P1127, DOI 10.1016/j.imbio.2011.04.004; Salama MF, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-83; Schubert TEO, 2012, MOL MED REP, V6, P838, DOI 10.3892/mmr.2012.1004; Srinivasan G, 2012, J IMMUNOL, V189, P1911, DOI 10.4049/jimmunol.1200892; Viatte L, 2005, BLOOD, V105, P4861, DOI 10.1182/blood-2004-12-4608; Villarroel P, 2012, BIOL TRACE ELEM RES; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200; Yeh KY, 2004, AM J PHYSIOL-GASTR L, V286, pG385, DOI 10.1152/ajpgi.00246.2003; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	31	65	67	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61050	10.1371/journal.pone.0061050	http://dx.doi.org/10.1371/journal.pone.0061050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637785	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400023
J	Chiang, PY; Shen, YF; Su, YL; Kao, CH; Lin, NY; Hsu, PH; Tsai, MD; Wang, SC; Chang, GD; Lee, SC; Chang, CJ				Chiang, Pei-Yu; Shen, Yu-Fang; Su, Yu-Lun; Kao, Ching-Han; Lin, Nien-Yi; Hsu, Pang-Hung; Tsai, Ming-Daw; Wang, Shun-Chang; Chang, Geen-Dong; Lee, Sheng-Chung; Chang, Ching-Jin			Phosphorylation of mRNA Decapping Protein Dcp1a by the ERK Signaling Pathway during Early Differentiation of 3T3-L1 Preadipocytes	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; FHA DOMAIN; P-BODIES; ACTIVATION; YEAST; DECAY; TRISTETRAPROLIN; RECOGNITION; COMPLEX; KINASE	Background: Turnover of mRNA is a critical step in the regulation of gene expression, and an important step in mRNA decay is removal of the 5' cap. We previously demonstrated that the expression of some immediate early gene mRNAs is controlled by RNA stability during early differentiation of 3T3-L1 preadipocytes. Methodology/Principal Findings: Here we show that the mouse decapping protein Dcp1a is phosphorylated via the ERK signaling pathway during early differentiation of preadipocytes. Mass spectrometry analysis and site-directed mutagenesis combined with a kinase assay identified ERK pathway-mediated dual phosphorylation at Ser 315 and Ser 319 of Dcp1a. To understand the functional effects of Dcp1a phosphorylation, we examined protein-protein interactions between Dcp1a and other decapping components with co-immunoprecipitation. Dcp1a interacted with Ddx6 and Edc3 through its proline-rich C-terminal extension, whereas the conserved EVH1 (enabled vasodilator-stimulated protein homology 1) domain in the N terminus of Dcp1a showed a stronger interaction with Dcp2. Once ERK signaling was activated, the interaction between Dcp1a and Ddx6, Edc3, or Edc4 was not affected by Dcp1a phosphorylation. Phosphorylated Dcp1a did, however, enhanced interaction with Dcp2. Protein complexes immunoprecipitated with the recombinant phosphomimetic Dcp1a(S315D/S319D) mutant contained more Dcp2 than did those immunoprecipitated with the nonphosphorylated Dcp1a(S315A/S319A) mutant. In addition, Dcp1a associated with AU-rich element (ARE)-containing mRNAs such as MAPK phosphatase-1 (MKP-1), whose mRNA stability was analyzed under the overexpression of Dcp1a constructs in the Dcp1a knockdown 3T3-L1 cells. Conclusions/Significance: Our findings suggest that ERK-phosphorylated Dcp1a enhances its interaction with the decapping enzyme Dcp2 during early differentiation of 3T3-L1 cells.	[Chiang, Pei-Yu; Shen, Yu-Fang; Su, Yu-Lun; Kao, Ching-Han; Tsai, Ming-Daw; Chang, Geen-Dong; Chang, Ching-Jin] Natl Taiwan Univ, Grad Inst Biochem Sci, Coll Life Sci, Taipei 10764, Taiwan; [Lin, Nien-Yi; Tsai, Ming-Daw; Wang, Shun-Chang; Lee, Sheng-Chung; Chang, Ching-Jin] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Dept Life Sci, Keelung, Taiwan; [Tsai, Ming-Daw] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lee, Sheng-Chung] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan Ocean University; Academia Sinica - Taiwan; National Taiwan University	Chang, CJ (corresponding author), Natl Taiwan Univ, Grad Inst Biochem Sci, Coll Life Sci, Taipei 10764, Taiwan.	chingjin@gate.sinica.edu.tw	Hsu, Pang-Hung/C-5587-2018; Tsai, Ming-Daw/G-4689-2019; Chang, Ching-Jin/G-4511-2019	Hsu, Pang-Hung/0000-0001-6873-6434; Tsai, Ming-Daw/0000-0003-1374-0414; Chang, Ching-Jin/0000-0001-7129-8092	Academia Sinica; National Taiwan University [98R0066-32]; National Science Council [NSC97-2311-B-001-019-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Taiwan University(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica and National Taiwan University (98R0066-32 to G.-D. Chang) and National Science Council (NSC97-2311-B-001-019-MY3 to C.-J. Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049783; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BENITO M, 1991, SCIENCE, V253, P565, DOI 10.1126/science.1857988; Blumenthal J, 2009, FEBS LETT, V583, P197, DOI 10.1016/j.febslet.2008.12.002; Borja MS, 2011, RNA, V17, P278, DOI 10.1261/rna.2382011; Byeon IJL, 2005, NAT STRUCT MOL BIOL, V12, P987, DOI 10.1038/nsmb1008; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Deshmukh MV, 2008, MOL CELL, V29, P324, DOI 10.1016/j.molcel.2007.11.027; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Floor SN, 2010, NAT STRUCT MOL BIOL, V17, P1096, DOI 10.1038/nsmb.1879; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Larance M, 2010, MOL CELL PROTEOMICS, V9, P682, DOI 10.1074/mcp.M900435-MCP200; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Lin NY, 2008, BIOCHEM BIOPH RES CO, V365, P69, DOI 10.1016/j.bbrc.2007.10.119; Lin NY, 2007, FEBS J, V274, P867, DOI 10.1111/j.1742-4658.2007.05632.x; Lin NY, 2012, INT J BIOL SCI, V8, P761, DOI 10.7150/ijbs.4036; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Ma J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105312; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PORRAS A, 1992, J BIOL CHEM, V267, P21124; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Renfranz PJ, 2002, CURR OPIN CELL BIOL, V14, P88, DOI 10.1016/S0955-0674(01)00299-X; Rzeczkowski K, 2011, J CELL BIOL, V194, P581, DOI 10.1083/jcb.201006089; Sakuno T, 2004, J BIOCHEM, V136, P805, DOI 10.1093/jb/mvh190; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; She MP, 2006, NAT STRUCT MOL BIOL, V13, P63, DOI 10.1038/nsmb1033; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tritschler F, 2009, P NATL ACAD SCI USA, V106, P21591, DOI 10.1073/pnas.0909871106; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Xu H, 2010, J PROTEOME RES, V9, P3384, DOI 10.1021/pr100369y; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019; Yu JH, 2005, RNA, V11, P1795, DOI 10.1261/rna.2142405	46	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61697	10.1371/journal.pone.0061697	http://dx.doi.org/10.1371/journal.pone.0061697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637887	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700052
J	De Laporte, L; Rice, JJ; Tortelli, F; Hubbell, JA				De Laporte, Laura; Rice, Jeffrey J.; Tortelli, Federico; Hubbell, Jeffrey A.			Tenascin C Promiscuously Binds Growth Factors via Its Fifth Fibronectin Type III-Like Domain	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; BIOMIMETIC MATERIALS; CELL-MIGRATION; HEPARIN; EXPRESSION; FUSION; SRC	Tenascin C (TNC) is an extracellular matrix protein that is upregulated during development as well as tissue remodeling. TNC is comprised of multiple independent folding domains, including 15 fibronectin type III-like (TNCIII) domains. The fifth TNCIII domain (TNCIII5) has previously been shown to bind heparin. Our group has shown that the heparin-binding fibronectin type III domains of fibronectin (FNIII), specifically FNIII12-14, possess affinity towards a large number of growth factors. Here, we show that TNCIII5 binds growth factors promiscuously and with high affinity. We produced recombinant fragments of TNC representing the first five TNCIII repeats (TNCIII1-5), as well as subdomains, including TNCIII5, to study interactions with various growth factors. Multiple growth factors of the platelet-derived growth factor (PDGF) family, the fibroblast growth factor (FGF) family, the transforming growth factor beta (TGF-beta) superfamily, the insulin-like growth factor binding proteins (IGF-BPs), and neurotrophins were found to bind with high affinity to this region of TNC, specifically to TNCIII5. Surface plasmon resonance was performed to analyze the kinetics of binding of TNCIII1-5 with TGF-beta 1, PDGF-BB, NT-3, and FGF-2. The promiscuous yet high affinity of TNC for a wide array of growth factors, mediated mainly by TNCIII5, may play a role in multiple physiological and pathological processes involving TNC.	[De Laporte, Laura; Rice, Jeffrey J.; Tortelli, Federico; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [De Laporte, Laura; Rice, Jeffrey J.; Tortelli, Federico; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland; [Rice, Jeffrey J.] Tennessee Technol Univ, Dept Chem Engn, Cookeville, TN 38505 USA; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Tennessee Technological University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch	De Laporte, Laura/B-9980-2014; Hubbell, Jeffrey A/A-9266-2008	De Laporte, Laura/0000-0002-9438-0977; Hubbell, Jeffrey A/0000-0003-0276-5456	European Community's Seventh Framework Programme in the project Angioscaff [NMP-LA-2008-214402]; Whitaker International Scholarship program; Swiss National Science Foundation [31003A_138307]	European Community's Seventh Framework Programme in the project Angioscaff; Whitaker International Scholarship program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded in part by the European Community's Seventh Framework Programme in the project Angioscaff (NMP-LA-2008-214402), the Whitaker International Scholarship program, and the Swiss National Science Foundation (grant 31003A_138307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUKHIL I, 1993, J BIOL CHEM, V268, P2542; BARKALOW FJB, 1991, J BIOL CHEM, V266, P7812; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P986, DOI 10.1016/j.biocel.2003.12.002; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; ERICKSON HP, 1993, J CELL BIOL, V120, P1079, DOI 10.1083/jcb.120.5.1079; Golledge J, 2011, CARDIOVASC RES, V92, P19, DOI 10.1093/cvr/cvr183; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Imanaka-Yoshida K, 2001, VIRCHOWS ARCH, V439, P185, DOI 10.1007/s004280000390; Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614; Iso Y, 2005, CIRC J, V69, P481, DOI 10.1253/circj.69.481; Joester A, 2001, MATRIX BIOL, V20, P13, DOI 10.1016/S0945-053X(00)00136-0; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035; LAVALLIE ER, 1995, CURR OPIN BIOTECH, V6, P501, DOI 10.1016/0958-1669(95)80083-2; Mackie EJ, 1999, J CELL SCI, V112, P3847; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; MARTON LS, 1989, J BIOL CHEM, V264, P13145; Matei I, 2011, CANCER CELL, V20, P139, DOI 10.1016/j.ccr.2011.08.004; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; Morgan JM, 2011, J CELL BIOCHEM, V112, P3354, DOI 10.1002/jcb.23265; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4; Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Smith EM, 2009, P NATL ACAD SCI USA, V106, P21683, DOI 10.1073/pnas.0902510106; Tanaka S, 2010, MOL VIS, V16, P1194; Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020; Trebaul A, 2007, BIOCHEM SOC T, V35, P695, DOI 10.1042/BST0350695; Udalova IA, 2011, CRIT REV IMMUNOL, V31, P115, DOI 10.1615/CritRevImmunol.v31.i2.30; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; WEBER P, 1995, J BIOL CHEM, V270, P4619, DOI 10.1074/jbc.270.9.4619; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79	41	82	84	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62076	10.1371/journal.pone.0062076	http://dx.doi.org/10.1371/journal.pone.0062076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637968	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700075
J	Gansen, A; Hieb, AR; Bohm, V; Toth, K; Langowski, J				Gansen, Alexander; Hieb, Aaron R.; Boehm, Vera; Toth, Katalin; Langowski, Joerg			Closing the Gap between Single Molecule and Bulk FRET Analysis of Nucleosomes	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; HISTONE OCTAMER; DNA INTERACTIONS; DYNAMICS; STABILITY; CHROMATIN; PROTEIN; EXCITATION; ACCESSIBILITY; ACETYLATION	Nucleosome structure and stability affect genetic accessibility by altering the local chromatin morphology. Recent FRET experiments on nucleosomes have given valuable insight into the structural transformations they can adopt. Yet, even if performed under seemingly identical conditions, experiments performed in bulk and at the single molecule level have given mixed answers due to the limitations of each technique. To compare such experiments, however, they must be performed under identical conditions. Here we develop an experimental framework that overcomes the conventional limitations of each method: single molecule FRET experiments are carried out at bulk concentrations by adding unlabeled nucleosomes, while bulk FRET experiments are performed in microplates at concentrations near those used for single molecule detection. Additionally, the microplate can probe many conditions simultaneously before expending valuable instrument time for single molecule experiments. We highlight this experimental strategy by exploring the role of selective acetylation of histone H3 on nucleosome structure and stability; in bulk, H3-acetylated nucleosomes were significantly less stable than non-acetylated nucleosomes. Single molecule FRET analysis further revealed that acetylation of histone H3 promoted the formation of an additional conformational state, which is suppressed at higher nucleosome concentrations and which could be an important structural intermediate in nucleosome regulation.	[Gansen, Alexander; Boehm, Vera; Toth, Katalin; Langowski, Joerg] DKFZ, Dept Biophys Macromol, Heidelberg, Germany; [Gansen, Alexander] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Hieb, Aaron R.] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Washington; University of Washington Seattle; Colorado State University; Howard Hughes Medical Institute	Gansen, A (corresponding author), DKFZ, Dept Biophys Macromol, Heidelberg, Germany.	alexander.gansen@gmail.com	Langowski, Jörg/A-1843-2011; Toth, Katalin/AAC-2064-2020	Langowski, Jörg/0000-0001-8600-0666; Toth, Katalin/0000-0002-0081-4720	DFG [La 500/18-1, La 500/18-2]	DFG(German Research Foundation (DFG))	This work was funded by DFG grants La 500/18-1 and La 500/18-2 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Buning R, 2010, BIOCHIMIE, V92, P1729, DOI 10.1016/j.biochi.2010.08.010; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Cisse I, 2007, P NATL ACAD SCI USA, V104, P12646, DOI 10.1073/pnas.0610673104; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gansen A, 2009, J PHYS CHEM B, V113, P2604, DOI 10.1021/jp7114737; Gansen A, 2007, ANAL BIOCHEM, V368, P193, DOI 10.1016/j.ab.2007.04.047; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Gottesfeld JM, 2001, BIOCHEMISTRY-US, V40, P10927, DOI 10.1021/bi0109966; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Hoch DA, 2007, J MOL BIOL, V371, P971, DOI 10.1016/j.jmb.2007.05.075; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kelbauskas L, 2009, BIOCHEM CELL BIOL, V87, P323, DOI 10.1139/O08-126; Kelbauskas L, 2008, BIOCHEMISTRY-US, V47, P9627, DOI 10.1021/bi8000775; Kimura H, 2005, DNA REPAIR, V4, P939, DOI 10.1016/j.dnarep.2005.04.012; Koopmans WJA, 2007, J FLUORESC, V17, P785, DOI 10.1007/s10895-007-0218-9; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lymperopoulos K, 2010, ANGEW CHEM INT EDIT, V49, P1316, DOI 10.1002/anie.200904597; MARUSHIGE K, 1976, P NATL ACAD SCI USA, V73, P3937, DOI 10.1073/pnas.73.11.3937; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; OLINS AL, 1974, SCIENCE, V183, P330, DOI 10.1126/science.183.4122.330; Olins DE, 2003, NAT REV MOL CELL BIO, V4, P809, DOI 10.1038/nrm1225; OOHARA I, 1987, J MOL BIOL, V196, P399, DOI 10.1016/0022-2836(87)90700-5; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Reiner JE, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2219977; Santoso Y, 2009, ANAL CHEM, V81, P9561, DOI 10.1021/ac901423e; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Srisa-Art M, 2010, J PHYS CHEM B, V114, P15766, DOI 10.1021/jp105749t; Thastrom A, 2004, BIOCHEMISTRY-US, V43, P736, DOI 10.1021/bi0302043; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Toth K, 2006, BIOCHEMISTRY-US, V45, P1591, DOI 10.1021/bi052110u; Toth K, 2001, BIOCHEMISTRY-US, V40, P6921, DOI 10.1021/bi002695m; van Holde KE., 1989, SPRINGER SERIES MOL; Wolffe A., 1995, CHROMATIN STRUCTURE; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170	44	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e57018	10.1371/journal.pone.0057018	http://dx.doi.org/10.1371/journal.pone.0057018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637734	gold, Green Published, Green Submitted			2022-12-25	WOS:000317908700003
J	d'Almeida, KW; Pateron, D; Kierzek, G; Renaud, B; Semaille, C; de Truchis, P; Simon, F; Leblanc, J; Lert, F; Le Vu, S; Cremieux, AC				d'Almeida, Kayigan Wilson; Pateron, Dominique; Kierzek, Gerald; Renaud, Bertrand; Semaille, Caroline; de Truchis, Pierre; Simon, Francois; Leblanc, Judith; Lert, France; Le Vu, Stephane; Cremieux, Anne-Claude			Understanding Providers' Offering and Patients' Acceptance of HIV Screening in Emergency Departments: A Multilevel Analysis. ANRS 95008, Paris, France	PLOS ONE			English	Article							CLINICAL PREVENTIVE SERVICES; PUBLIC-HEALTH; CARE; MEDICINE; FEASIBILITY; INFECTION; BARRIERS; OUTCOMES; PROGRAM; MODELS	Objective: We assessed the EDs' characteristics associated with the offer and acceptance rates of a nontargeted HIV rapid-test screening in 29 Emergency Departments (EDs) in the metropolitan Paris region (11.7 million inhabitants), where half of France's new HIV cases are diagnosed annually. Methods: EDs nurses offered testing to all patients 18-64-year-old, able to provide consent, either with or without supplemental staff (hybrid staff model or indigenous staff model). The EDS' characteristics collected included structural characteristics (location, type, size), daily workload (patients' number and severity, length of stay in hours), staff's participation (training, support to the intervention, leadership), type of week day (weekends vs weekdays) and time (in days). Associations between these variables and the staff model, the offer and acceptance rates were studied using multilevel modeling. Results: Indigenous staff model was more frequent in EDs with a lower daily patient flow and a higher staff support score to the intervention. In indigenous-model EDs, the offer rate was associated with the patient flow (OR = 0.838, 95% CI = 0.773-0.908), was lower during weekends (OR = 0.623, 95% CI = 0.581-0.667) and decreased over time (OR = 0.978, 95% CI = 0.975-0.981). Similar results were found in hybrid-model EDs. Acceptance was poorly associated with EDs characteristics in indigenous-model EDs while in hybrid-model EDs it was lower during weekends (OR = 0.713, 95% CI = 0.623-0.816) and increased after the first positive test (OR = 1.526, 95% CI = 1.142-2.038). The EDs' characteristics explained respectively 38.5% and 15% of the total variance in the offer rate across indigenous model-EDs and hybrid model-EDs vs 12% and 1% for the acceptance rate. Conclusion: Our findings suggest the need for taking into account EDs' characteristics while considering the implementation of an ED-based HIV screening program. Strategies allowing the optimization of human resources' utilization such as HIV targeted screening in the EDs might be privileged.	[d'Almeida, Kayigan Wilson; Leblanc, Judith; Lert, France] INSERM, Ctr Rech Epidemiol & Sante Populat, U1018, Villejuif, France; [d'Almeida, Kayigan Wilson; Lert, France; Cremieux, Anne-Claude] Univ Versailles St Quentin, Fac Med Paris Ile de France Ouest, EA 4499, Paris, France; [Kierzek, Gerald] AP HP, Hotel Dieu Cochin, Serv Accueil & Traitement Urgences, Paris, France; [de Truchis, Pierre; Cremieux, Anne-Claude] Hop Raymond Poincare, AP HP, Dept Med Aigue Specialisee, Garches, France; [Semaille, Caroline; Le Vu, Stephane] Inst Veille Sanit, St Maurice, France; [Pateron, Dominique] Hop St Antoine, AP HP, Serv Accueil & Traitement Urgences, F-75571 Paris, France; [Renaud, Bertrand] Hop Henri Mondor, AP HP, Serv Accueil & Traitement Urgences, F-94010 Creteil, France; [Simon, Francois] Hop St Louis, AP HP, Serv Bacteriol Virol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	d'Almeida, KW (corresponding author), INSERM, Ctr Rech Epidemiol & Sante Populat, U1018, Villejuif, France.	kayigan.wilson@inserm.fr	Crémieux, A/AAP-9147-2020	Le Vu, Stephane/0000-0002-1303-8281; LEBLANC, Judith/0000-0002-0323-6671	ANRS (Agence Nationale de Recherche sur le Sida et les Hepatites Virales); Sidaction, Paris, France	ANRS (Agence Nationale de Recherche sur le Sida et les Hepatites Virales)(ANRSFrench National Research Agency (ANR)); Sidaction, Paris, France	The study was funded by grants from ANRS (Agence Nationale de Recherche sur le Sida et les Hepatites Virales) and Sidaction, Paris, France. Rapid tests were provided free of charge by Orasure Technologies Inc., Bethlehem, Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, B WORLD HEALTH ORGAN, V84, P835, DOI 10.2471/BLT.05.028548; Arbelaez C, 2012, J EMERG MED, V42, P7, DOI 10.1016/j.jemermed.2009.07.038; Beltzer nathalie, 2010, CONNAISSANCE ATTITUD; Bernstein SL, 2008, ACAD EMERG MED, V15, P190, DOI 10.1111/j.1553-2712.2008.00055.x; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2008, PUBLIC HEALTH REP, V123, P21, DOI 10.1177/00333549081230S304; Casalino E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046437; Cazein F., 2011, Bulletin Epidemiologique Hebdomadaire, P446; Christopoulos KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-3; Christopoulos KA, 2010, JAIDS-J ACQ IMM DEF, V53, P420, DOI 10.1097/QAI.0b013e3181b7220f; d'Almeida KW, 2012, ARCH INTERN MED, V172, P12, DOI 10.1001/archinternmed.2011.535; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Direction de la Recherche des Etudes de l'Evaluation et des Statistiques, 2006, ETUDES RESULTATS, P1; Ersel M, 2010, EUR J EMERG MED, V17, P73, DOI 10.1097/MEJ.0b013e32832e67d6; George PM, 2005, DIABETIC MED, V22, P1766, DOI 10.1111/j.1464-5491.2005.01674.x; Haukoos JS, 2012, ARCH INTERN MED, V172, P20, DOI 10.1001/archinternmed.2011.538; Haukoos JS, 2011, ANN EMERG MED, V58, pS96, DOI 10.1016/j.annemergmed.2011.03.017; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Hsieh YH, 2011, ANN EMERG MED, V58, pS133, DOI 10.1016/j.annemergmed.2011.03.037; Hungerford DW, 2003, ACAD EMERG MED, V10, P79, DOI 10.1197/aemj.10.1.79; Hutchinson AB, 2011, AIDS EDUC PREV, V23, P58, DOI 10.1521/aeap.2011.23.3_supp.58; Irvin CB, 2000, ACAD EMERG MED, V7, P1042; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Mitchell L, 2011, INT J STD AIDS, V22, P753, DOI 10.1258/ijsa.2009.009244; Mumma BE, 2011, ANN EMERG MED, V58, pS44, DOI 10.1016/j.annemergmed.2011.03.022; Pisculli ML, 2011, AIDS BEHAV, V15, P734, DOI 10.1007/s10461-010-9837-2; PITTS SR, 2008, NATL HLTH STAT REPOR, V7, P1; Rhodes KV, 2000, ACAD EMERG MED, V7, P1036, DOI 10.1111/j.1553-2712.2000.tb02097.x; Rothman RE, 2011, ANN EMERG MED, V58, pS3, DOI 10.1016/j.annemergmed.2011.03.016; Schoenfeld EM, 2010, J EMERG MED, V38, P542, DOI [10.1016/j.jemermed.2008.11.021, 10.1016/j.jemermed.2008.09.036]; Scott RL, 2011, J AM ACAD NURSE PRAC, V23, P493, DOI 10.1111/j.1745-7599.2011.00636.x; Torres GW, 2011, ANN EMERG MED, V58, pS104, DOI 10.1016/j.annemergmed.2011.03.034; Torres M, 2010, EMERG MED CLIN N AM, V28, P369, DOI 10.1016/j.emc.2010.01.008; Trautman DE, 2007, ANN EMERG MED, V49, P526, DOI 10.1016/j.annemergmed.2006.11.022; Van Gerven R, 2001, Eur J Emerg Med, V8, P3, DOI 10.1097/00063110-200103000-00002; Walensky RP, 2011, ANN EMERG MED, V58, pS126, DOI 10.1016/j.annemergmed.2011.03.023; Zuckerbrot RA, 2007, PEDIATRICS, V119, P101, DOI 10.1542/peds.2005-2965	37	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62686	10.1371/journal.pone.0062686	http://dx.doi.org/10.1371/journal.pone.0062686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638133	Green Published, gold			2022-12-25	WOS:000321662800055
J	Nagel, S; Ehrentraut, S; Tomasch, J; Quentmeier, H; Meyer, C; Kaufmann, M; Drexler, HG; MacLeod, RAF				Nagel, Stefan; Ehrentraut, Stefan; Tomasch, Juergen; Quentmeier, Hilmar; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.			Ectopic Expression of Homeobox Gene NKX2-1 in Diffuse Large B-Cell Lymphoma Is Mediated by Aberrant Chromatin Modifications	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; HODGKIN LYMPHOMA; LUNG-CANCER; HISTONE METHYLTRANSFERASE; TUMOR-SUPPRESSOR; LINES; PROTEIN; DIFFERENTIATION	Homeobox genes encode transcription factors ubiquitously involved in basic developmental processes, deregulation of which promotes cell transformation in multiple cancers including hematopoietic malignancies. In particular, NKL-family homeobox genes TLX1, TLX3 and NKX2-5 are ectopically activated by chromosomal rearrangements in T-cell neoplasias. Here, using transcriptional microarray profiling and RQ-PCR we identified ectopic expression of NKL-family member NKX2-1, in a diffuse large B-cell lymphoma (DLBCL) cell line SU-DHL-5. Moreover, in silico analysis demonstrated NKX2-1 overexpression in 5% of examined DLBCL patient samples. NKX2-1 is physiologically expressed in lung and thyroid tissues where it regulates differentiation. Chromosomal and genomic analyses excluded rearrangements at the NKX2-1 locus in SU-DHL-5, implying alternative activation. Comparative expression profiling implicated several candidate genes in NKX2-1 regulation, variously encoding transcription factors, chromatin modifiers and signaling components. Accordingly, siRNA-mediated knockdown and overexpression studies confirmed involvement of transcription factor HEY1, histone methyltransferase MLL and ubiquitinated histone H2B in NKX2-1 deregulation. Chromosomal aberrations targeting MLL at 11q23 and the histone gene cluster HIST1 at 6p22 which we observed in SU-DHL-5 may, therefore, represent fundamental mutations mediating an aberrant chromatin structure at NKX2-1. Taken together, we identified ectopic expression of NKX2-1 in DLBCL cells, representing the central player in an oncogenic regulative network compromising B-cell differentiation. Thus, our data extend the paradigm of NKL homeobox gene deregulation in lymphoid malignancies.	[Nagel, Stefan; Ehrentraut, Stefan; Quentmeier, Hilmar; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.] DSMZ German Collect Microorganisms & Cell Culture, Leibniz Inst, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Tomasch, Juergen] Helmholtz Ctr Infect Res, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Helmholtz Association; Helmholtz-Center for Infection Research	Nagel, S (corresponding author), DSMZ German Collect Microorganisms & Cell Culture, Leibniz Inst, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de		Tomasch, Jurgen/0000-0002-3914-2781				Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Chan WC, 2010, INT J HEMATOL, V92, P219, DOI 10.1007/s12185-010-0602-0; Chen Y, 2007, INT J CANCER, V121, P1021, DOI 10.1002/ijc.22753; Deisch J, 2009, ARCH PATHOL LAB MED, V133, P1477, DOI 10.1043/1543-2165-133.9.1477; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Fagman H, 2011, J MOL ENDOCRINOL, V46, pR33, DOI 10.1677/JME-10-0084; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Graux C, 2006, LEUKEMIA, V20, P1496, DOI 10.1038/sj.leu.2404302; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Homminga I, 2012, LEUKEMIA, V26, P572, DOI 10.1038/leu.2011.330; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kee HJ, 2007, J BIOL CHEM, V282, P7700, DOI 10.1074/jbc.M611198200; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kochert K, 2011, ONCOGENE, V30, P1831, DOI 10.1038/onc.2010.544; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Li CG, 2002, J BIOL CHEM, V277, P38399, DOI 10.1074/jbc.M203188200; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; MacLeod RAF, 2011, METHODS MOL BIOL, V731, P57, DOI 10.1007/978-1-61779-080-5_6; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marschalek R, 2011, BRIT J HAEMATOL, V152, P141, DOI 10.1111/j.1365-2141.2010.08459.x; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Nagel S, 2007, BLOOD, V109, P3015, DOI 10.1182/blood-2006-08-044347; Nagel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040747; Nagel S, 2012, LEUKEMIA RES, V36, P646, DOI 10.1016/j.leukres.2011.10.019; Nagel S, 2011, GENE CHROMOSOME CANC, V50, P996, DOI 10.1002/gcc.20920; Nagel S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-151; Nagel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-371; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Ponticos M, 2010, ADVANCES IN VASCULAR MEDICINE, P113, DOI 10.1007/978-1-84882-637-3_7; Quentmeier H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-19; Rao V, 2012, J BIOL CHEM, V287, P36331, DOI 10.1074/jbc.M112.352823; Sanchez-Beato M, 2004, J PATHOL, V204, P528, DOI 10.1002/path.1661; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Wang JY, 2012, BLOOD, V119, P1151, DOI 10.1182/blood-2011-06-362079; Watanabe H, 2013, GENE DEV, V27, P197, DOI 10.1101/gad.203208.112; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003	61	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61447	10.1371/journal.pone.0061447	http://dx.doi.org/10.1371/journal.pone.0061447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637834	Green Submitted, Green Published, gold			2022-12-25	WOS:000321662800007
J	Caperchione, CM; Kolt, GS; Mummery, WK				Caperchione, Cristina M.; Kolt, Gregory S.; Mummery, W. Kerry			Examining Physical Activity Service Provision to Culturally and Linguistically Diverse (CALD) Communities in Australia: A Qualitative Evaluation	PLOS ONE			English	Article							HEALTH-CARE; HEART-DISEASE; BARRIERS; WOMEN; ACCESS; INTERVENTIONS; DISPARITIES; PREVENTION; PROGRAMS; EXERCISE	Strong evidence exists for the role of physical activity in preventing and managing a range of chronic health conditions. A particular challenge in promoting physical activity as a health strategy exists in culturally and linguistically diverse (CALD) groups, as such groups demonstrate high risk for a range of non-communicable diseases. The aim of this research was to examine the perspective of multicultural health service providers for CALD groups with respect to the physical activity services/initiatives on offer, access barriers to these services, and ideas for future service delivery in this area. Semi-structured interviews were conducted with 15 multicultural health service providers across the capital cities of the three most populous states in Australia (New South Wales, Queensland, and Victoria), and thematic content analysis was used to examine the data. Findings indicated that the majority of physical activity initiatives were associated with organizations offering other social services for CALD communities but were greatly restrained by resources. As well, it was found that most services were not designed by taking into account specific cultural requirements for CALD communities or their cultural expectations. Common barriers identified to service uptake were classified as socio-cultural (e. g., gender, language, context of health) and environmental (e. g., transportation) in nature. These findings should be utilized when planning future physical activity and health promotion initiatives for increasing CALD participation. In particular, programs need to be culturally tailored to the specific expectations of CALD groups, addressing cultural safety and sensitivity, and should be in partnership with other organizations to extend the reach and capacity.	[Caperchione, Cristina M.] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Kolt, Gregory S.] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia; [Mummery, W. Kerry] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada	University of British Columbia; Western Sydney University; University of Alberta	Caperchione, CM (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.	cristina.caperchione@ubc.ca	Kolt, Gregory/W-1342-2019	Kolt, Gregory/0000-0002-9223-3324; Caperchione, Cristina M./0000-0003-2290-5946	Central Queensland University in Rockhmapton, Australia	Central Queensland University in Rockhmapton, Australia	This research was funded by an Internal University Research Grant from Central Queensland University in Rockhmapton, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adily Armita, 2005, Health Promot J Austr, V16, P207; Anderson LM, 2003, AM J PREV MED, V24, P68, DOI 10.1016/S0749-3797(02)00657-8; [Anonymous], NAT HLTH MED RES COU; [Anonymous], J HLTH ED; Asanin J, 2008, SOC SCI MED, V66, P1271, DOI 10.1016/j.socscimed.2007.11.043; Australian Bureau of Statistics, 2006, MIGR PART SPORT PHYS; Babakus WS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-150; Barnes M., 2005, HLTH ACTION ZONES PA; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; Belza Basia, 2004, Prev Chronic Dis, V1, pA09; Brach C, 2000, MED CARE RES REV, V57, P181, DOI 10.1177/107755800773743655; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; Caperchione CM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-26; Caperchione CM, 2009, SPORTS MED, V39, P167, DOI 10.2165/00007256-200939030-00001; Comino EJ, 2001, FAM PRACT, V18, P71, DOI 10.1093/fampra/18.1.71; Cortis N., 2007, PARTICIPATION SPORT; Davidson Patricia M, 2003, Contemp Nurse, V16, P62; Dumont JC, 2005, 25 OECD SOCIAL EMPLO, V25; Fennelly Katherine, 2007, Minn Med, V90, P51; Fuller J, 2000, Aust J Rural Health, V8, P189, DOI 10.1046/j.1440-1584.2000.00270.x; Gettleman L, 2000, J COMMUN HEALTH, V25, P439, DOI 10.1023/A:1005155329922; Guerin Pauline B, 2007, J Immigr Minor Health, V9, P191, DOI 10.1007/s10903-006-9030-x; Guerin PB, 2003, WOMEN HEALTH, V38, P83, DOI 10.1300/J013v38n01_06; Guest G., 2012, APPL THEMATIC ANAL V, DOI 10.4135/9781483384436; Henderson S, 2011, HEALTH SOC CARE COMM, V19, P225, DOI 10.1111/j.1365-2524.2010.00972.x; Horne M, 2012, PREV MED, V55, P276, DOI 10.1016/j.ypmed.2012.07.016; Jepson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045333; Johnson PA, 2002, WOMEN HEALTH ISS, V12, P252, DOI 10.1016/S1049-3867(02)00148-2; Khan N, 1994, HLTH SERVICES MULTIC; Kolt GS, 2006, AUSTRALAS J AGEING, V25, P119, DOI 10.1111/j.1741-6612.2006.00157.x; Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021; Lawton J, 2006, HEALTH EDUC RES, V21, P43, DOI 10.1093/her/cyh042; Lee J, 2009, NATURALIZATIONS US 2; [刘继春 Liu Jichun], 2012, [厦门大学学报. 自然科学版, Journal of Xiamen University. Natural Science], V51, P1; Majumdar B, 2004, J NURS SCHOLARSHIP, V36, P161, DOI 10.1111/j.1547-5069.2004.04029.x; Marquez DX, 2006, ANN BEHAV MED, V31, P138, DOI 10.1207/s15324796abm3102_5; Marshall SJ, 2007, MED SCI SPORT EXER, V39, P44, DOI 10.1249/01.mss.0000239401.16381.37; MPND, 2006, POPULATION HOUSING C; Oliffe J. L., 2009, Critical Public Health, V19, P383, DOI 10.1080/09581590902951605; Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148; Queensland Health, 2010, ENG CULT LING DIV CA; Ramsden I, 1990, N Z Nurs J, V83, P18; Rao DV, 2006, AUSTRALAS J AGEING, V25, P174, DOI 10.1111/j.1741-6612.2006.00181.x; Roussos ST, 2000, ANNU REV PUBL HEALTH, V21, P369, DOI 10.1146/annurev.publhealth.21.1.369; Sole-Auro A, 2009, RESULTS SURVEY HLTH; SOMERVILLE W., 2009, IMMIGRATION UK RECES; Statistics Canada, 2006, 2006 CENS IMM CAN PO; Sundquist J, 2001, J EPIDEMIOL COMMUN H, V55, P691, DOI 10.1136/jech.55.10.691; Torpy Janet M, 2003, JAMA, V290, P980, DOI 10.1001/jama.290.7.980; Van Duyn Mary Ann S., 2007, PREV CHRONIC DIS, V4, P1; Walseth K., 2003, International Review for the Sociology of Sport, V38, P45, DOI 10.1177/10126902030381003; Warburton J, 2009, AUST SOC WORK, V62, P168, DOI 10.1080/03124070902748886; Ward B, 2005, AUSTR J PRIMARY HLTH, V11, P147; Wynaden D, 2005, INT J MENT HEALTH NU, V14, P88, DOI 10.1111/j.1440-0979.2005.00364.x; Yancey AK, 2006, AM J PREV MED, V31, pS82, DOI 10.1016/j.amepre.2006.06.020	55	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62777	10.1371/journal.pone.0062777	http://dx.doi.org/10.1371/journal.pone.0062777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136EF	23638145	gold, Green Published, Green Submitted			2022-12-25	WOS:000318343700074
J	Huang, XM; Liew, K; Natalang, O; Siau, A; Zhang, N; Preiser, PR				Huang, Ximei; Liew, Kingsley; Natalang, Onguma; Siau, Anthony; Zhang, Neng; Preiser, Peter Rainer			The Role of Serine-Type Serine Repeat Antigen in Plasmodium yoelii Blood Stage Development	PLOS ONE			English	Article							MALARIA PARASITE; FALCIPARUM MEROZOITES; HOST ERYTHROCYTE; CELL INVASION; PROTEASES; SERA; PROTEIN; EXPRESSION; EGRESS; IDENTIFICATION	A key step for the survival of the malaria parasite is the release from and subsequent invasion of erythrocytes by the merozoite. Differences in the efficiency of these two linked processes have a direct impact on overall parasite burden in the host and thereby virulence. A number of parasite proteases have recently been shown to play important roles during both merozoite egress as well as merozoite invasion. The rodent malaria parasite Plasmodium yoelii has been extensively used to investigate the mechanisms of parasite virulence in vivo and a number of important proteins have been identified as being key contributors to pathology. Here we have utilized transcriptional comparisons to identify two protease-like SERAs as playing a potential role in virulence. We show that both SERAs are non-essential for blood stage development of the parasite though they provide a subtle but important growth advantage in vivo. In particular SERA2 appears to be an important factor in enabling the parasite to fully utilize the whole age repertoire of circulating erythrocytes. This work for the first time demonstrates the subtle contributions different protease-like SERAs make to provide the parasite with a maximal capacity to successfully maintain an infection in the host.	[Huang, Ximei; Liew, Kingsley; Natalang, Onguma; Siau, Anthony; Zhang, Neng; Preiser, Peter Rainer] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Preiser, PR (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	prpreiser@ntu.edu.sg	Preiser, Peter R/A-2201-2011	, Peter/0000-0003-4331-7000	Singapore Ministry of Health's National Medical Research Council [NMRC/1168/2008]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This project is supported by the Singapore Ministry of Health's National Medical Research Council under its Individual Research Grant (NMRC/1168/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Arisue N, 2007, J MOL EVOL, V65, P82, DOI 10.1007/s00239-006-0253-1; Arisue N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017775; Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; DELPLACE P, 1988, BIOL CELL, V64, P215, DOI 10.1016/0248-4900(88)90080-9; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Gelhaus C, 2005, BIOL CHEM, V386, P499, DOI 10.1515/BC.2005.059; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Iyer JK, 2007, MOL MICROBIOL, V65, P333, DOI 10.1111/j.1365-2958.2007.05786.x; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jongco AM, 2006, MOL BIOCHEM PARASIT, V146, P242, DOI 10.1016/j.molbiopara.2006.01.001; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Lantos PM, 2009, PARASITOLOGY, V136, P1, DOI 10.1017/S0031182008005167; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Okech RN, 2006, AM J TROP MED HYG, V74, P191, DOI 10.4269/ajtmh.2006.74.191; Pang XL, 1999, INFECT IMMUN, V67, P1821; PERKINS ME, 1994, INFECT IMMUN, V62, P1207, DOI 10.1128/IAI.62.4.1207-1212.1994; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Robert H, 2006, ANIMAL MODELS TOXICO, P787; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Sato D, 2005, PARASITOL INT, V54, P261, DOI 10.1016/j.parint.2005.06.006; Shi QF, 2005, INFECT IMMUN, V73, P6363, DOI 10.1128/IAI.73.10.6363-6371.2005; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; STOCCHI V, 1987, MECH AGEING DEV, V39, P29, DOI 10.1016/0047-6374(87)90084-4; Uzureau P, 2004, CELL MICROBIOL, V6, P65, DOI 10.1046/j.1462-5822.2003.00343.x; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Withers-Martinez C, 2004, MOL MICROBIOL, V53, P55, DOI 10.1111/j.1365-2958.2004.04144.x; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	34	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e60723	10.1371/journal.pone.0060723	http://dx.doi.org/10.1371/journal.pone.0060723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634205	gold, Green Published			2022-12-25	WOS:000318341400007
J	Lee, GKY; Wang, HHX; Liu, KQL; Cheung, Y; Morisky, DE; Wong, MCS				Lee, Gabrielle K. Y.; Wang, Harry H. X.; Liu, Kirin Q. L.; Cheung, Yu; Morisky, Donald E.; Wong, Martin C. S.			Determinants of Medication Adherence to Antihypertensive Medications among a Chinese Population Using Morisky Medication Adherence Scale	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; DRUG ADHERENCE; PERSISTENCE; THERAPY; HYPERTENSION; RISK; DISCONTINUATION; NONCOMPLIANCE; OUTCOMES; PATIENT	Background and Objectives: Poor adherence to medications is one of the major public health challenges. Only one-third of the population reported successful control of blood pressure, mostly caused by poor drug adherence. However, there are relatively few reports studying the adherence levels and their associated factors among Chinese patients. This study aimed to study the adherence profiles and the factors associated with antihypertensive drug adherence among Chinese patients. Methods: A cross-sectional study was conducted in an outpatient clinic located in the New Territories Region of Hong Kong. Adult patients who were currently taking at least one antihypertensive drug were invited to complete a self-administered questionnaire, consisting of basic socio-demographic profile, self-perceived health status, and self-reported medication adherence. The outcome measure was the Morisky Medication Adherence Scale (MMAS-8). Good adherence was defined as MMAS scores greater than 6 points (out of a total score of 8 points). Results: From 1114 patients, 725 (65.1%) had good adherence to antihypertensive agents. Binary logistic regression analysis was conducted. Younger age, shorter duration of antihypertensive agents used, job status being employed, and poor or very poor self-perceived health status were negatively associated with drug adherence. Conclusion: This study reported a high proportion of poor medication adherence among hypertensive subjects. Patients with factors associated with poor adherence should be more closely monitored to optimize their drug taking behavior.	[Lee, Gabrielle K. Y.; Wang, Harry H. X.; Liu, Kirin Q. L.; Wong, Martin C. S.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Cheung, Yu] Hosp Author, Hong Kong, Hong Kong, Peoples R China; [Morisky, Donald E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90024 USA	Chinese University of Hong Kong; University of California System; University of California Los Angeles	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Morisky, Donald/AAU-4679-2021; Wong, Martin/L-4568-2014; Wang, Harry H.X./E-9027-2015	Wong, Martin/0000-0001-7706-9370; Wang, Harry H.X./0000-0002-0361-6527	Direct Grant of the Research Committee, The Chinese University of Hong Kong	Direct Grant of the Research Committee, The Chinese University of Hong Kong	The funding source is the Direct Grant of the Research Committee, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billups SJ, 2000, PHARMACOTHERAPY, V20, P941, DOI 10.1592/phco.20.11.941.35266; Black HR, 2001, HYPERTENSION, V37, P12, DOI 10.1161/01.HYP.37.1.12; Burnier M, 2006, AM J HYPERTENS, V19, P1190, DOI 10.1016/j.amjhyper.2006.04.006; Carter BL, 2007, COMPREHENSIVE HYPERT, P1119; Champion V L, 1984, ANS Adv Nurs Sci, V6, P73; Cushman William C, 2002, J Clin Hypertens (Greenwich), V4, P393; Elliott WJ, 2007, J AM BOARD FAM MED, V20, P72, DOI 10.3122/jabfm.2007.01.060094; Esposti ED, 2002, J HUM HYPERTENS, V16, P439, DOI 10.1038/sj/jhh/1001418; Esposti LD, 2011, CLINICOECONOMIC OUTC, V3, P47, DOI 10.2147/CEOR.S15619; Friedman O, 2010, AM J MED, V123, P173, DOI 10.1016/j.amjmed.2009.08.008; Gerth WC, 2002, CURR HYPERTENS REP, V4, P424, DOI 10.1007/s11906-002-0021-6; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; HAYNES RB, 1976, COMPLIANCE THERAPEUT; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Hyre Amanda D, 2007, J Clin Hypertens (Greenwich), V9, P179, DOI 10.1111/j.1524-6175.2007.06372.x; Inkster ME, 2006, J HUM HYPERTENS, V20, P295, DOI 10.1038/sj.jhh.1001981; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Krousel-Wood MA, 2009, MED CLIN N AM, V93, P753, DOI 10.1016/j.mcna.2009.02.007; Lam P. W., 2007, Hong Kong Medical Journal, V13, P284; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Levy G, 2000, CLIN PHARMACOL THER, V68, P586, DOI 10.1067/mcp.2000.110976; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; McDonnell PJ, 2002, ANN PHARMACOTHER, V36, P1331, DOI 10.1345/aph.1A333; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Morisky DE, 2011, J CLIN EPIDEMIOL, V64, P255, DOI 10.1016/j.jclinepi.2010.09.002; Morris AB, 2006, PHARMACOTHERAPY, V26, P483, DOI 10.1592/phco.26.4.483; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Organization WHOWH, 2002, WORLD HLTH REP 2002; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Sabate E, 2003, ADHERENCE LONG TERM, Vxv; Sabate E., 2003, ADHERENCE LONG TERM; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; Turnbull F, 2003, LANCET, V362, P1527; Wang PS, 2002, J GEN INTERN MED, V17, P504, DOI 10.1046/j.1525-1497.2002.00406.x; Wetzels GEC, 2004, J HYPERTENS, V22, P1849, DOI 10.1097/00004872-200410000-00002; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wong MCS, 2011, J CLIN PHARM THER, V36, P179, DOI 10.1111/j.1365-2710.2010.01174.x; Wong MCS, 2010, J EPIDEMIOL COMMUN H, V64, P895, DOI 10.1136/jech.2009.091603; Wong MCS, 2010, J CLIN PHARMACOL, V50, P598, DOI 10.1177/0091270009346058; Wong MCS, 2009, CLIN THER, V31, P2170, DOI 10.1016/j.clinthera.2009.10.004; Wong MCS, 2009, AM J HYPERTENS, V22, P904, DOI 10.1038/ajh.2009.95; Yiannakopoulou EC, 2005, EUR J CARDIOV PREV R, V12, P243, DOI 10.1097/01.hjr.0000160601.41762.44; Zhang SY., 2010, CHIN J ANTITUBERCULO, V32, P527; Zyczynski T M, 2000, Curr Hypertens Rep, V2, P510, DOI 10.1007/s11906-996-0034-7	48	134	137	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62775	10.1371/journal.pone.0062775	http://dx.doi.org/10.1371/journal.pone.0062775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638143	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000318341400066
J	Wu, S; Lv, ZJ; Wang, Y; Sun, L; Jiang, ZM; Xu, CJ; Zhao, J; Sun, XJ; Li, XX; Hu, LJ; Tang, AF; Gui, YT; Zhou, FJ; Cai, ZM; Wang, RF				Wu, Song; Lv, Zhaojie; Wang, Yong; Sun, Liang; Jiang, Zhimao; Xu, Congjie; Zhao, Jun; Sun, Xiaojuan; Li, Xianxin; Hu, Lijun; Tang, Aifa; Gui, Yaoting; Zhou, Fangjian; Cai, Zhiming; Wang, Rongfu			Increased Expression of Pregnancy Up-Regulated Non-Ubiquitous Calmodulin Kinase Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							CANCER; PNCK; LOCALIZATION; SURVIVAL; GROWTH	Purpose: The aims of this study were to evaluate the clinical significance and potential prognostic value of pregnancy up-regulated non-ubiquitous calmodulin kinase (PNCK) in clear cell renal cell carcinoma (ccRCC) patients. Materials and Methods: The expression of PNCK mRNA was determined in 24 paired samples of ccRCCs and adjacent normal tissues using real-time RT-PCR. The expression of PNCK was determined in 248 samples of ccRCCs and 92 paired samples of adjacent normal tissues by immunohistochemical analysis. Statistical analysis was performed to define the relationship between PNCK expression and the clinical features of ccRCC. Results: The mRNA level of PNCK was significantly higher in tumorous tissues than in the adjacent non-tumorous tissues (p<0.001). An immunohistochemical analysis of 92 paired tissue specimens showed that PNCK expression was higher in tumorous tissues than in the adjacent non-tumorous tissues (p<0.001). Moreover, there was a significant correlation between the PNCK expression and various clinicopathological parameters such as Fuhrman grade (p = 0.011), tumor size (p<0.001), T stage (p<0.001) and N stage (p = 0.015). Patients with higher PNCK expression had shorter overall survival time than those with lower PNCK expression (p<0.001). Multivariate analysis indicated that PNCK expression was an independent predictor for poor survival of ccRCC patients. Conclusions: To our knowledge, this is the first study that determines the relationship between PNCK and prognosis in ccRCC. We found that increased PNCK expression is associated with poor prognosis in ccRCC. PNCK may represent a novel prognostic marker for ccRCC.	[Wu, Song; Hu, Lijun; Wang, Rongfu] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Song; Lv, Zhaojie; Wang, Yong; Sun, Liang; Jiang, Zhimao; Xu, Congjie; Zhao, Jun; Li, Xianxin; Tang, Aifa; Gui, Yaoting; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen, Guangdong, Peoples R China; [Lv, Zhaojie] Anhui Med Univ, Clin Med Coll 1, Hefei, Anhui, Peoples R China; [Sun, Xiaojuan] Shenzhen PKU HKUST Med Ctr, Inst Urol, Shenzhen, Guangdong, Peoples R China; [Wu, Song; Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Shenzhen University; Anhui Medical University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Sun Yat Sen University	Cai, ZM (corresponding author), Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen, Guangdong, Peoples R China.	caizhiming2000@yahoo.com.cn; rfwang888@hotmail.com	gui, yaoting/GLT-3684-2022					Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Cheng L, 2009, HUM PATHOL, V40, P10, DOI 10.1016/j.humpath.2008.09.009; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Deb TB, 2008, AM J PHYSIOL-CELL PH, V295, pC365, DOI 10.1152/ajpcell.00449.2007; Deb TB, 2011, AM J PHYSIOL-CELL PH, V300, pC1139, DOI 10.1152/ajpcell.00167.2010; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1016/S0022-5347(05)64153-5; Gardner HP, 2000, GENOMICS, V63, P279, DOI 10.1006/geno.1999.6091; Gardner HP, 2000, CANCER RES, V60, P5571; Green FL, 2003, ANN ONCOL, V14, P345, DOI DOI 10.1093/ANN0NC/MDG077; Grignon DJ, 2005, CLIN LAB MED, V25, P305, DOI 10.1016/j.cll.2005.01.012; Gudbjartsson T, 2005, EUR UROL, V48, P593, DOI 10.1016/j.eururo.2005.04.016; Iliopoulos O, 2006, J CLIN ONCOL, V24, P5593, DOI 10.1200/JCO.2006.08.8948; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Loseth OP, 2000, BRAIN RES, V869, P137, DOI 10.1016/S0006-8993(00)02359-3; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Mulders P F A, 2008, Ned Tijdschr Geneeskd, V152, P376; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rina-Susilowati, 2001, BRAIN RES, V911, P1; Sabatino M, 2009, J CLIN ONCOL, V27, P2645, DOI 10.1200/JCO.2008.19.1106; Shaheen Philip E, 2005, Expert Opin Emerg Drugs, V10, P773, DOI 10.1517/14728214.10.4.773; Sorbellini M, 2005, J UROLOGY, V173, P48, DOI 10.1097/01.ju.0000148261.19532.2c; Ueda T, 1999, J NEUROCHEM, V73, P2119; Wei C, 2013, ONCOL LETT, V5, P473, DOI 10.3892/ol.2012.1032; Wood Laura S, 2010, Urol Nurs, V30, P40; Wu S, 2012, CELL RES, V22, P1712, DOI 10.1038/cr.2012.149; Wu S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-413; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	31	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e59936	10.1371/journal.pone.0059936	http://dx.doi.org/10.1371/journal.pone.0059936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634203	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400005
J	Hudson, LO; Murphy, CR; Spratt, BG; Enright, MC; Elkins, K; Nguyen, C; Terpstra, L; Gombosev, A; Kim, D; Hannah, P; Mikhail, L; Alexander, R; Moore, DF; Huang, SS				Hudson, Lyndsey O.; Murphy, Courtney R.; Spratt, Brian G.; Enright, Mark C.; Elkins, Kristen; Nguyen, Christopher; Terpstra, Leah; Gombosev, Adrijana; Kim, Diane; Hannah, Paul; Mikhail, Lydia; Alexander, Richard; Moore, Douglas F.; Huang, Susan S.			Diversity of Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Isolated from Inpatients of 30 Hospitals in Orange County, California	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; FIELD GEL-ELECTROPHORESIS; CARE-ASSOCIATED INFECTION; SOFT-TISSUE INFECTIONS; HEALTH-CARE; UNITED-STATES; NOSOCOMIAL TRANSMISSION; MOLECULAR EPIDEMIOLOGY; EMERGENCY-DEPARTMENT; TYPING METHODS	There is a need for a regional assessment of the frequency and diversity of MRSA to determine major circulating clones and the extent to which community and healthcare MRSA reservoirs have mixed. We conducted a prospective cohort study of inpatients in Orange County, California, systematically collecting clinical MRSA isolates from 30 hospitals, to assess MRSA diversity and distribution. All isolates were characterized by spa typing, with selective PFGE and MLST to relate spa types with major MRSA clones. We collected 2,246 MRSA isolates from hospital inpatients. This translated to 91/10,000 inpatients with MRSA and an Orange County population estimate of MRSA inpatient clinical cultures of 86/100,000 people. spa type genetic diversity was heterogeneous between hospitals, and relatively high overall (72%). USA300 (t008/ST8), USA100 (t002/ST5) and a previously reported USA100 variant (t242/ST5) were the dominant clones across all Orange County hospitals, representing 83% of isolates. Fifteen hospitals isolated more t008 (USA300) isolates than t002/242 (USA100) isolates, and 12 hospitals isolated more t242 isolates than t002 isolates. The majority of isolates were imported into hospitals. Community-based infection control strategies may still be helpful in stemming the influx of traditionally community-associated strains, particularly USA300, into the healthcare setting.	[Hudson, Lyndsey O.; Spratt, Brian G.; Enright, Mark C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Murphy, Courtney R.] Univ Calif Irvine, Sch Social Ecol, Sch Med, Irvine, CA 92717 USA; [Murphy, Courtney R.; Elkins, Kristen; Nguyen, Christopher; Terpstra, Leah; Gombosev, Adrijana; Kim, Diane; Huang, Susan S.] Univ Calif Irvine, Sch Med, Div Infect Dis, Irvine, CA 92717 USA; [Elkins, Kristen; Nguyen, Christopher; Terpstra, Leah; Gombosev, Adrijana; Kim, Diane; Huang, Susan S.] Univ Calif Irvine, Sch Med, Hlth Policy Res Inst, Irvine, CA 92717 USA; [Hannah, Paul; Mikhail, Lydia; Alexander, Richard; Moore, Douglas F.] Orange Cty Hlth Care Agcy, Santa Ana, CA USA	Imperial College London; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Spratt, BG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	b.spratt@imperial.ac.uk		Enright, Mark/0000-0001-5273-8750	University of California Irvine, Biotechnology and Biological Sciences Research Council [BB/D52637X/1]; Wellcome Trust [089472/Z/09/Z]; National Institute for Health Research [NF-SI-0507-10336] Funding Source: researchfish	University of California Irvine, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the University of California Irvine, Biotechnology and Biological Sciences Research Council [grant number BB/D52637X/1] and The Wellcome Trust [grant number 089472/Z/09/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit SR, 2008, EMERG INFECT DIS, V14, P1216, DOI 10.3201/eid1408.071183; Boyce JM, 2008, CLIN INFECT DIS, V46, P795, DOI 10.1086/528717; Chung M, 2004, J CLIN MICROBIOL, V42, P542, DOI 10.1128/JCM.42.2.542-547.2004; Cookson BD, 2007, J CLIN MICROBIOL, V45, P1830, DOI 10.1128/JCM.02402-06; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; David MD, 2006, J HOSP INFECT, V64, P244, DOI 10.1016/j.jhin.2006.06.022; David MZ, 2013, J CLIN MICROBIOL, V51, P814, DOI 10.1128/JCM.02429-12; Davis SL, 2006, INFECT CONT HOSP EP, V27, P1025, DOI 10.1086/507918; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Gould IM, 2009, EPIDEMIOL INFECT, V137, P1242, DOI 10.1017/S0950268809002234; Graber CJ, 2007, EMERG INFECT DIS, V13, P491, DOI 10.3201/eid1303.060960; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Huang H, 2006, J CLIN MICROBIOL, V44, P2423, DOI 10.1128/JCM.00254-06; Huang SS, 2007, J INFECT DIS, V195, P330, DOI 10.1086/510622; Hudson LO, 2012, J CLIN MICROBIOL, V50, P573, DOI 10.1128/JCM.05336-11; Johnson JK, 2007, EMERG INFECT DIS, V13, P1195, DOI 10.3201/eid1308.061575; Kardas-Sloma L, 2011, ANTIMICROB AGENTS CH, V55, P4888, DOI 10.1128/AAC.01626-10; Kinnevey P, 2010, 20 EUR C CLIN MICR I; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Lee SS, 2010, J CLIN MICROBIOL, V48, P311, DOI 10.1128/JCM.00297-09; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Lucet JC, 2009, ARCH INTERN MED, V169, P1372, DOI 10.1001/archinternmed.2009.217; Malachowa N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005; McDougal LK, 2010, ANTIMICROB AGENTS CH, V54, P3804, DOI 10.1128/AAC.00351-10; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Moellering RC, 2006, ANN INTERN MED, V144, P368, DOI 10.7326/0003-4819-144-5-200603070-00014; Mollaghan AM, 2010, EPIDEMIOL INFECT, V138, P673, DOI 10.1017/S0950268810000191; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Moore CL, 2009, INT J ANTIMICROB AG, V34, P148, DOI 10.1016/j.ijantimicag.2009.03.004; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Murphy CR, 2013, INFECT CONT IN PRESS; O'Hara FP, 2012, MICROB DRUG RESIST, V18, P555, DOI 10.1089/mdr.2012.0056; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028; Otter JA, 2009, EUR J CLIN MICROBIOL, V28, P835, DOI 10.1007/s10096-008-0698-9; Otter JA, 2006, LANCET INFECT DIS, V6, P753, DOI 10.1016/S1473-3099(06)70636-3; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Parlato C, 2009, 19 EUR C CLIN MICR I; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Regev-Yochay G, 2005, EMERG INFECT DIS, V11, P453, DOI 10.3201/eid1103.040470; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shurland S, 2007, INFECT CONT HOSP EP, V28, P273, DOI 10.1086/512627; Skov RL, 2009, J HOSP INFECT, V73, P364, DOI 10.1016/j.jhin.2009.07.004; Tacconelli E, 2004, J ANTIMICROB CHEMOTH, V53, P474, DOI 10.1093/jac/dkh107; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Wallin TR, 2008, EMERG MED CLIN N AM, V26, P431, DOI 10.1016/j.emc.2008.01.010; Wang SH, 2012, EMERG INFECT DIS, V18, P1557, DOI 10.3201/eid1810.120468; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x	59	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62117	10.1371/journal.pone.0062117	http://dx.doi.org/10.1371/journal.pone.0062117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637976	gold, Green Published, Green Accepted			2022-12-25	WOS:000318340400075
J	Raschke, S; Eckardt, K; Holven, KB; Jensen, J; Eckel, J				Raschke, Silja; Eckardt, Kristin; Holven, Kirsten Bjorklund; Jensen, Jorgen; Eckel, Juergen			Identification and Validation of Novel Contraction-Regulated Myokines Released from Primary Human Skeletal Muscle Cells	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; I MESSENGER-RNA; GROWTH FACTOR-C; INSULIN-RESISTANCE; ACUTE EXERCISE; NEUROTROPHIC FACTOR; PROTEOMIC ANALYSIS; SECRETED PROTEINS	Proteins secreted by skeletal muscle, so called myokines, have been shown to affect muscle physiology and additionally exert systemic effects on other tissues and organs. Although recent profiling studies have identified numerous myokines, the amount of overlap from these studies indicates that the secretome of skeletal muscle is still incompletely characterized. One limitation of the models used is the lack of contraction, a central characteristic of muscle cells. Here we aimed to characterize the secretome of primary human myotubes by cytokine antibody arrays and to identify myokines regulated by contraction, which was induced by electrical pulse stimulation (EPS). In this study, we validated the regulation and release of two selected myokines, namely pigment epithelium derived factor (PEDF) and dipeptidyl peptidase 4 (DPP4), which were recently described as adipokines. This study reveals that both factors, DPP4 and PEDF, are secreted by primary human myotubes. PEDF is a contraction-regulated myokine, although PEDF serum levels from healthy young men decrease after 60 min cycling at VO(2)max of 70%. Most interestingly, we identified 52 novel myokines which have not been described before to be secreted by skeletal muscle cells. For 48 myokines we show that their release is regulated by contractile activity. This profiling study of the human skeletal muscle secretome expands the number of myokines, identifies novel contraction-regulated myokines and underlines the overlap between proteins which are adipokines as well as myokines.	[Raschke, Silja; Eckardt, Kristin; Eckel, Juergen] German Diabet Ctr, Paul Langerhans Grp Integrat Physiol, Dusseldorf, Germany; [Holven, Kirsten Bjorklund] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Jensen, Jorgen] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway	Deutsches Diabetes-Zentrum (DDZ); University of Oslo; Norwegian School of Sport Sciences	Eckel, J (corresponding author), German Diabet Ctr, Paul Langerhans Grp Integrat Physiol, Dusseldorf, Germany.	eckel@uni-duesseldorf.de	Jensen, Jørgen/O-2245-2013	Eckel, Juergen/0000-0003-3645-5288	Ministerium fur Wissenschaft und Forschung des Landes Nordrhein-Westfalen (Ministry of Science and Research of the State of North Rhine-Westphalia); Bundesministerium fur Gesundheit (Federal Ministry of Health); Commission of the European Communities (Collaborative Project ADAPT) [HEALTH-F2-2008-201100]; Deutsche Forschungsgemeinschaft [EC 440/1-1]	Ministerium fur Wissenschaft und Forschung des Landes Nordrhein-Westfalen (Ministry of Science and Research of the State of North Rhine-Westphalia); Bundesministerium fur Gesundheit (Federal Ministry of Health); Commission of the European Communities (Collaborative Project ADAPT); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Ministerium fur Wissenschaft und Forschung des Landes Nordrhein-Westfalen (Ministry of Science and Research of the State of North Rhine-Westphalia), the Bundesministerium fur Gesundheit (Federal Ministry of Health), the Commission of the European Communities (Collaborative Project ADAPT, contract number HEALTH-F2-2008-201100), and the Deutsche Forschungsgemeinschaft (EC 440/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2002, CANCER LETT, V175, P181, DOI 10.1016/S0304-3835(01)00717-0; Baetta R, 2011, DRUGS, V71, P1441, DOI 10.2165/11591400-000000000-00000; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; BARTOCCIONI E, 1994, IMMUNOL LETT, V42, P135, DOI 10.1016/0165-2478(94)90076-0; Becerra SP, 1997, ADV EXP MED BIOL, V425, P223; Birzniece V, 2011, TRENDS ENDOCRIN MET, V22, P171, DOI 10.1016/j.tem.2011.02.005; Bolton K, 2008, INT J OBESITY, V32, P1113, DOI 10.1038/ijo.2008.41; Borge BAS, 2009, AM J PHYSIOL-HEART C, V296, pH735, DOI 10.1152/ajpheart.01309.2008; Bortoluzzi S, 2006, PROTEINS, V62, P776, DOI 10.1002/prot.20803; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Broholm C, 2008, J PHYSIOL-LONDON, V586, P2195, DOI 10.1113/jphysiol.2007.149781; Broholm C, 2011, J APPL PHYSIOL, V111, P251, DOI 10.1152/japplphysiol.01399.2010; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Canto C, 2007, DIABETES, V56, P2185, DOI 10.2337/db06-1726; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Chan CYX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004804; Chan XCY, 2007, J PROTEOME RES, V6, P698, DOI 10.1021/pr060448k; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Chevrel G, 2003, J NEUROIMMUNOL, V137, P125, DOI 10.1016/S0165-5728(03)00032-8; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Crown AL, 2000, J ENDOCRINOL, V167, P403, DOI 10.1677/joe.0.1670403; De Rossi M, 2000, INT IMMUNOL, V12, P1329, DOI 10.1093/intimm/12.9.1329; Dietze D, 2004, INT J OBESITY, V28, P985, DOI 10.1038/sj.ijo.0802701; Dietze D, 2002, DIABETES, V51, P2369, DOI 10.2337/diabetes.51.8.2369; Famulla S, 2011, INT J OBESITY, V35, P762, DOI 10.1038/ijo.2010.212; Fernyhough P, 1998, DIABETOLOGIA, V41, P300, DOI 10.1007/s001250050907; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Frost RA, 2002, ENDOCRINOLOGY, V143, P492, DOI 10.1210/en.143.2.492; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; Garg M K, 2012, Indian J Endocrinol Metab, V16, P116, DOI 10.4103/2230-8210.91206; Gattu AK, 2012, ACTA DIABETOL, V49, pS161, DOI 10.1007/s00592-012-0397-y; Ge X, 2012, J ANIM SCI, V90, P1126, DOI 10.2527/jas.2011-4358; Haugen F, 2010, AM J PHYSIOL-CELL PH, V298, pC807, DOI 10.1152/ajpcell.00094.2009; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hiscock N, 2004, FASEB J, V18, P992, DOI 10.1096/fj.03-1259fje; Hittel DS, 2010, MED SCI SPORT EXER, V42, P2023, DOI 10.1249/MSS.0b013e3181e0b9a8; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Hoier B, 2012, J PHYSIOL-LONDON, V590, P595, DOI 10.1113/jphysiol.2011.216135; Hoier B, 2010, AM J PHYSIOL-HEART C, V299, pH857, DOI 10.1152/ajpheart.00082.2010; Hojman P, 2011, AM J PHYSIOL-ENDOC M, V301, pE504, DOI 10.1152/ajpendo.00520.2010; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Hubal MJ, 2008, AM J PHYSIOL-REG I, V294, pR1628, DOI 10.1152/ajpregu.00853.2007; Jenkins Alicia, 2008, Diabetes Res Clin Pract, V82, pe5, DOI 10.1016/j.diabres.2008.06.019; Jensen L., 2004, Angiogenesis, V7, P255, DOI 10.1007/s10456-004-4184-4; Joory K. D., 2006, Lymphatic Research and Biology, V4, P73, DOI 10.1089/lrb.2006.4.73; Garcia JJ, 2011, J PHYSIOL BIOCHEM, V67, P87, DOI 10.1007/s13105-010-0052-4; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Kivela R, 2007, HISTOCHEM CELL BIOL, V127, P31, DOI 10.1007/s00418-006-0226-x; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lambernd S, 2012, DIABETOLOGIA, V55, P1128, DOI 10.1007/s00125-012-2454-z; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lappas M, 2005, J ENDOCRINOL, V186, P457, DOI 10.1677/joe.1.06227; Lehr S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010504; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; Matthews VB, 2012, DIABETOLOGIA, V55, P864, DOI 10.1007/s00125-011-2406-z; Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Nagaraju K, 1998, CLIN EXP IMMUNOL, V113, P407; Nielsen AR, 2007, J PHYSIOL-LONDON, V584, P305, DOI 10.1113/jphysiol.2007.139618; Nikolic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033203; Norheim F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1013, DOI 10.1152/ajpendo.00326.2011; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Ohlendieck K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-6; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Papanicolaou DA, 1996, AM J PHYSIOL-ENDOC M, V271, pE601; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Perez-Ilzarbe M, 2008, EUR J HEART FAIL, V10, P1065, DOI 10.1016/j.ejheart.2008.08.002; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Peterson JM, 2009, J APPL PHYSIOL, V106, P130, DOI 10.1152/japplphysiol.90584.2008; Piva SJ, 2013, INFLAMMATION, V36, P226, DOI 10.1007/s10753-012-9538-2; Porter JD, 2003, NEUROMUSCULAR DISORD, V13, P223, DOI 10.1016/S0960-8966(02)00242-0; Qin SX, 1996, EUR J IMMUNOL, V26, P640, DOI 10.1002/eji.1830260320; Ross A, 2001, SPORTS MED, V31, P1063, DOI 10.2165/00007256-200131150-00003; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Sabater M, 2010, J CLIN ENDOCR METAB, V95, P4720, DOI 10.1210/jc.2010-0630; SEJERSEN T, 1986, P NATL ACAD SCI USA, V83, P6844, DOI 10.1073/pnas.83.18.6844; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Sell H, 2007, CURR OPIN LIPIDOL, V18, P258, DOI 10.1097/MOL.0b013e3281338546; Sell Henrike, 2006, Archives of Physiology and Biochemistry, V112, P105, DOI 10.1080/13813450600711540; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Solberg R, 2005, J CELL BIOCHEM, V96, P89, DOI 10.1002/jcb.20521; Sotiropoulos A, 2006, P NATL ACAD SCI USA, V103, P7315, DOI 10.1073/pnas.0510033103; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Steensberg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1272, DOI 10.1152/ajpendo.00255.2002; Stelzer I, 2012, TRANSL RES, V159, P118, DOI 10.1016/j.trsl.2011.10.001; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Uaesoontrachoon K, 2008, INT J BIOCHEM CELL B, V40, P2303, DOI 10.1016/j.biocel.2008.03.020; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Vianney JM, 2011, BRAIN RES, V1390, P1, DOI 10.1016/j.brainres.2011.03.030; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Yang SJ, 2011, CLIN ENDOCRINOL, V75, P464, DOI 10.1111/j.1365-2265.2011.04078.x; Yoon JH, 2011, J PROTEOME RES, V10, P5315, DOI 10.1021/pr200573b; Yoon JH, 2009, PROTEOMICS, V9, P51, DOI 10.1002/pmic.200800187; Yu HC, 2010, J BONE MINER RES, V25, P1128, DOI 10.1002/jbmr.9; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	105	136	141	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62008	10.1371/journal.pone.0062008	http://dx.doi.org/10.1371/journal.pone.0062008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637948	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000318340400067
J	Andreu-Ballester, JC; Garcia-Ballesteros, C; Amigo, V; Ballester, F; Gil-Borras, R; Catalan-Serra, I; Magnet, A; Fenoy, S; del Aguila, C; Ferrando-Marco, J; Cuellar, C				Andreu-Ballester, Juan C.; Garcia-Ballesteros, Carlos; Amigo, Victoria; Ballester, Ferran; Gil-Borras, Rafael; Catalan-Serra, Ignacio; Magnet, Angela; Fenoy, Soledad; del Aguila, Carmen; Ferrando-Marco, Jose; Cuellar, Carmen			Microsporidia and Its Relation to Crohn's Disease. A Retrospective Study	PLOS ONE			English	Article							ENCEPHALITOZOON-CUNICULI INFECTION; ENTEROCYTOZOON-BIENEUSI; INTRAEPITHELIAL LYMPHOCYTES; INTESTINAL MICROSPORIDIOSIS; HIV-1-INFECTED INDIVIDUALS; SACCHAROMYCES-CEREVISIAE; IMMUNOCOMPETENT SUBJECTS; IMMUNE-RESPONSE; SEROPREVALENCE; PREVALENCE	Background: The cause of Crohn's Disease (CD) remains unknown. Recently a decrease in the global lymphocyte population in the peripheral blood of CD patients has been reported. This decrease was more evident in gamma delta T lymphocytes, especially gamma delta CD8+T subsets. Furthermore, a decrease of IL-7 was also observed in these patients. We propose the hypothesis that microsporidia, an obligate intracellular opportunistic parasite recently related to fungi, in CD patients can take advantage of the lymphocytes and IL-7 deficits to proliferate and to contribute to the pathophysiology of this disease. Methods and Findings: In this case-control study, serum samples were collected from 36 CD patients and from 36 healthy individuals (controls), IgE and IgG anti-Encephalitozoon antibodies were determined by ELISA; and forty-four intestinal tissue samples were analyzed through real time Polymerase Chain Reaction (PCR), twenty CD patients, nine with others diseases and 15 healthy subjects. We observed that IgE anti-Encephalitozoon levels were significantly higher in patients with CD: 0.386(+/- 0.256) vs control group, 0.201(+/- 0.147), P<0.001. However, IgG anti-Encephalitozoon values were significantly lower in CD patients: 0.361(+/- 0.256) vs control group, 0.876(+/- 0.380), P<0.001. In the group of CD patients, 6/20 (30%) were positive by real time PCR for microsporidia and, all the patients of the control group were negative by real time PCR. Conclusions: These results suggest that CD patients are a group at risk for microsporidiasis and, moreover that microsporidia may be involved as a possible etiologic factor of CD.	[Andreu-Ballester, Juan C.; Garcia-Ballesteros, Carlos] Arnau de Vilanova Hosp, Res Dept, Valencia, Spain; [Garcia-Ballesteros, Carlos; Amigo, Victoria] Arnau de Vilanova Hosp, Dept Hematol, Valencia, Spain; [Ballester, Ferran] Univ Valencia, Spanish Consortium Res Epidemiol & Publ Hlth, Ctr Res Publ Hlth, Valencia, Spain; [Gil-Borras, Rafael; Catalan-Serra, Ignacio] Arnau de Vilanova Hosp, Digest Dept, Valencia, Spain; [Magnet, Angela; Fenoy, Soledad; del Aguila, Carmen] San Pablo Ctr Estudios Univ Univ, Parasitol Lab, Madrid, Spain; [Ferrando-Marco, Jose] Arnau de Vilanova Hosp, Dept Anat Pathol, Valencia, Spain; [Cuellar, Carmen] Univ Complutense, Fac Pharm, Dept Parasitol, E-28040 Madrid, Spain	University of Valencia; Complutense University of Madrid	Andreu-Ballester, JC (corresponding author), Arnau de Vilanova Hosp, Res Dept, Valencia, Spain.	jcandreu@ono.com	Magnet, Angela/G-5325-2013; Fenoy, Soledad/A-9633-2016; Cuellar, Carmen/H-1669-2015; del Aguila, Carmen/A-6063-2016; García, Carlos/GNM-5627-2022; Andreu-Ballester, Juan Carlos/GPF-7094-2022	Magnet, Angela/0000-0002-8642-4343; Fenoy, Soledad/0000-0002-5218-6308; Cuellar, Carmen/0000-0001-7948-9889; del Aguila, Carmen/0000-0003-0063-7899; Andreu-Ballester, Juan Carlos/0000-0003-3790-3054				Andreu-Ballester JC, 2013, INFLAMM BOWEL DIS, V19, pE30, DOI 10.1002/ibd.22914; BLANSHARD C, 1991, LANCET, V337, P1488, DOI 10.1016/0140-6736(91)93187-E; BONNEVILLE M, 1988, NATURE, V336, P479, DOI 10.1038/336479a0; Andreu-Ballester JC, 2011, DIGEST DIS SCI, V56, P2613, DOI 10.1007/s10620-011-1636-8; Daschner A, 2002, PARASITE IMMUNOL, V24, P243, DOI 10.1046/j.1365-3024.2002.00458.x; Del Aguila C, 2001, J EUKARYOT MICROBIOL, p75S; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Enriquez FJ, 1998, CLIN INFECT DIS, V26, P1227, DOI 10.1086/520278; Furuya K, 2008, HYBRIDOMA, V27, P153, DOI 10.1089/hyb.2007.0564; Galvan AL, 2011, J CLIN MICROBIOL, V49, P1301, DOI 10.1128/JCM.01833-10; Ghosh K, 2012, FEMS MICROBIOL REV, V36, P748, DOI 10.1111/j.1574-6976.2011.00318.x; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; Greer C E, 1991, PCR Methods Appl, V1, P46; Gutierrez R, 2002, J HELMINTHOL, V76, P131, DOI 10.1079/JOH2001104; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Khan IA, 1999, J IMMUNOL, V162, P6086; Lanternier F, 2009, TRANSPL INFECT DIS, V11, P83, DOI 10.1111/j.1399-3062.2008.00347.x; Lee SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010539; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; MAIN J, 1988, BRIT MED J, V297, P1105, DOI 10.1136/bmj.297.6656.1105; Miranda-Saavedra D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-309; Moretto M, 2004, J IMMUNOL, V172, P4402, DOI 10.4049/jimmunol.172.7.4402; Moretto M, 2001, J IMMUNOL, V166, P7389, DOI 10.4049/jimmunol.166.12.7389; Pavie J, 2012, INT J INFECT DIS, V16, pE677, DOI 10.1016/j.ijid.2012.05.1022; Polley SD, 2011, J MED MICROBIOL, V60, P459, DOI 10.1099/jmm.0.026781-0; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; SCHATTENKERK JKME, 1991, LANCET, V337, P895, DOI 10.1016/0140-6736(91)90215-B; SCHMIDT EC, 1984, J IMMUNOL, V133, P2712; vanGool T, 1997, J INFECT DIS, V175, P1020, DOI 10.1086/513963; Velasquez JN, 2005, ENFERM INFEC MICR CL, V23, P218, DOI 10.1157/13073148; WEBER R, 1992, NEW ENGL J MED, V326, P161, DOI 10.1056/NEJM199201163260304; Weber R, 1997, NEW ENGL J MED, V336, P474, DOI 10.1056/NEJM199702133360704	33	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62107	10.1371/journal.pone.0062107	http://dx.doi.org/10.1371/journal.pone.0062107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637975	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700077
J	Lombardo, E; Sabellico, C; Hajek, J; Stankova, V; Filipsky, T; Balducci, V; De Vito, P; Leone, S; Bavavea, EI; Silvestri, IP; Righi, G; Luly, P; Saso, L; Bovicelli, P; Pedersen, JZ; Incerpi, S				Lombardo, Emanuele; Sabellico, Cristian; Hajek, Jan; Stankova, Veronika; Filipsky, Tomas; Balducci, Valentina; De Vito, Paolo; Leone, Stefano; Bavavea, Eugenia I.; Silvestri, Ilaria Proietti; Righi, Giuliana; Luly, Paolo; Saso, Luciano; Bovicelli, Paolo; Pedersen, Jens Z.; Incerpi, Sandra			Protection of Cells against Oxidative Stress by Nanomolar Levels of Hydroxyflavones Indicates a New Type of Intracellular Antioxidant Mechanism	PLOS ONE			English	Article							BAICALEIN; SCUTELLARIA; FLAVONOIDS; APOPTOSIS; PROLIFERATION; ACTIVATION; 2'-HYDROXYCHALCONES; INHIBITION; MIGRATION; WOGONIN	Natural polyphenol compounds are often good antioxidants, but they also cause damage to cells through more or less specific interactions with proteins. To distinguish antioxidant activity from cytotoxic effects we have tested four structurally related hydroxyflavones (baicalein, mosloflavone, negletein, and 5,6-dihydroxyflavone) at very low and physiologically relevant levels, using two different cell lines, L-6 myoblasts and THP-1 monocytes. Measurements using intracellular fluorescent probes and electron paramagnetic resonance spectroscopy in combination with cytotoxicity assays showed strong antioxidant activities for baicalein and 5,6-dihydroxyflavone at picomolar concentrations, while 10 nM partially protected monocytes against the strong oxidative stress induced by 200 mu M cumene hydroperoxide. Wide range dose-dependence curves were introduced to characterize and distinguish the mechanism and targets of different flavone antioxidants, and identify cytotoxic effects which only became detectable at micromolar concentrations. Analysis of these dose-dependence curves made it possible to exclude a protein-mediated antioxidant response, as well as a mechanism based on the simple stoichiometric scavenging of radicals. The results demonstrate that these flavones do not act on the same radicals as the flavonol quercetin. Considering the normal concentrations of all the endogenous antioxidants in cells, the addition of picomolar or nanomolar levels of these flavones should not be expected to produce any detectable increase in the total cellular antioxidant capacity. The significant intracellular antioxidant activity observed with 1 pM baicalein means that it must be scavenging radicals that for some reason are not eliminated by the endogenous antioxidants. The strong antioxidant effects found suggest these flavones, as well as quercetin and similar polyphenolic antioxidants, at physiologically relevant concentrations act as redox mediators to enable endogenous antioxidants to reach and scavenge different pools of otherwise inaccessible radicals.	[Lombardo, Emanuele; Sabellico, Cristian; Balducci, Valentina; Leone, Stefano; Incerpi, Sandra] Univ Roma Tre, Dept Sci, Rome, Italy; [Hajek, Jan; Stankova, Veronika] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem Sci, Prague, Czech Republic; [Filipsky, Tomas] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Pharmacol & Toxicol, Prague, Czech Republic; [De Vito, Paolo; Luly, Paolo; Pedersen, Jens Z.] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Bavavea, Eugenia I.] Univ Athens, Fac Pharm, Dept Med Chem, GR-10679 Athens, Greece; [Silvestri, Ilaria Proietti] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy; [Righi, Giuliana; Bovicelli, Paolo] CNR, Inst Biomol Chem, Rome, Italy; [Saso, Luciano] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy	Italfarmaco; Roma Tre University; Charles University Prague; Charles University Prague; University of Rome Tor Vergata; National & Kapodistrian University of Athens; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	Incerpi, S (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	sandra.incerpi@uniroma3.it	saso, luciano/F-6306-2012	saso, luciano/0000-0003-4530-8706; Leone, Stefano/0000-0001-6339-6397	Italian Ministry for Education, University and Research, General Management for International Research	Italian Ministry for Education, University and Research, General Management for International Research(Ministry of Education, Universities and Research (MIUR))	The financial support from the Italian Ministry for Education, University and Research, General Management for International Research, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2009, EXP DERMATOL, V18, P939, DOI 10.1111/j.1600-0625.2009.00874.x; Armstrong JS, 2008, ANTIOXID REDOX SIGN, V10, P575, DOI 10.1089/ars.2007.1929; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Barzegar A, 2011, BIOCHIMIE, V93, P1880, DOI 10.1016/j.biochi.2011.07.019; Chiu YW, 2011, TOXICOL APPL PHARM, V255, P316, DOI 10.1016/j.taap.2011.07.008; Choi JH, 2010, EXP MOL MED, V42, P811, DOI 10.3858/emm.2010.42.12.084; Chou DS, 2009, FREE RADICAL BIO MED, V46, P1197, DOI 10.1016/j.freeradbiomed.2009.01.024; Clifford MN, 2004, PLANTA MED, V70, P1103, DOI 10.1055/s-2004-835835; D'Arezzo S, 2004, ENDOCRINOLOGY, V145, P5694, DOI 10.1210/en.2004-0890; Deschamps JD, 2006, BIOORGAN MED CHEM, V14, P4295, DOI 10.1016/j.bmc.2006.01.057; Gao ZH, 1999, BBA-GEN SUBJECTS, V1472, P643, DOI 10.1016/S0304-4165(99)00152-X; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Hajieva P, 2009, J NEUROCHEM, V110, P118, DOI 10.1111/j.1471-4159.2009.06114.x; Halliwell B, 2007, CARDIOVASC RES, V73, P341, DOI 10.1016/j.cardiores.2006.10.004; Halliwell B, 2009, FREE RADICAL BIO MED, V46, P531, DOI 10.1016/j.freeradbiomed.2008.11.008; HAMADA H, 1993, ARCH BIOCHEM BIOPHYS, V306, P261, DOI 10.1006/abbi.1993.1509; Himeji M, 2007, CANCER LETT, V245, P269, DOI 10.1016/j.canlet.2006.01.011; Khanna S, 2010, J NEUROCHEM, V112, P1249, DOI 10.1111/j.1471-4159.2009.06550.x; Leone S, 2008, MOL CARCINOGEN, V47, P587, DOI 10.1002/mc.20416; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Liu BM, 2012, FREE RADICAL BIO MED, V53, P183, DOI 10.1016/j.freeradbiomed.2012.04.015; Ma Z, 2005, BLOOD, V105, P3312, DOI 10.1182/blood-2004-10-3915; MARUYAMA K, 1989, TETRAHEDRON LETT, V30, P4145, DOI 10.1016/S0040-4039(00)99344-4; Mladenka P, 2011, J INORG BIOCHEM, V105, P693, DOI 10.1016/j.jinorgbio.2011.02.003; Morabito G, 2010, BIOCHIMIE, V92, P1101, DOI 10.1016/j.biochi.2010.04.017; Pallottini V, 2005, MECH AGEING DEV, V126, P845, DOI 10.1016/j.mad.2005.02.009; Pedersen JZ, 2007, J PHARM PHARMACOL, V59, P1721, DOI 10.1211/jpp.59.12.0015; Perez CA, 2009, J INORG BIOCHEM, V103, P326, DOI 10.1016/j.jinorgbio.2008.11.003; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; RiceEvans CA, 1996, BIOCHEM SOC T, V24, P790, DOI 10.1042/bst0240790; Righi G, 2010, TETRAHEDRON, V66, P1294, DOI 10.1016/j.tet.2009.12.021; SANICANIN Z, 1986, TETRAHEDRON LETT, V27, P407, DOI 10.1016/S0040-4039(00)84031-9; Shao ZH, 2002, AM J PHYSIOL-HEART C, V282, pH999, DOI 10.1152/ajpheart.00163.2001; Shi HL, 2001, METHOD ENZYMOL, V335, P157; Shieh DE, 2000, ANTICANCER RES, V20, P2861; Suk K, 2003, J PHARMACOL EXP THER, V305, P638, DOI 10.1124/jpet.102.047373; Tofani D, 2010, J AGR FOOD CHEM, V58, P5292, DOI 10.1021/jf1000716; Van Kiem P, 2005, ARCH PHARM RES, V28, P1345, DOI 10.1007/BF02977900; Wagsater D, 2009, ATHEROSCLEROSIS, V202, P415, DOI 10.1016/j.atherosclerosis.2008.04.050; Walle UK, 2007, DRUG METAB DISPOS, V35, P1985, DOI 10.1124/dmd.107.016782; YANO H, 1994, CANCER RES, V54, P448; Yoon SY, 2011, EUR J PHARMACOL, V659, P155, DOI 10.1016/j.ejphar.2011.03.012; Zhao ZS, 1998, BIOCHEM PHARMACOL, V56, P825, DOI 10.1016/S0006-2952(98)00222-6	44	23	24	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e60796	10.1371/journal.pone.0060796	http://dx.doi.org/10.1371/journal.pone.0060796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637768	Green Submitted, gold, Green Published			2022-12-25	WOS:000317908700008
J	Anderson, MJ; Naiche, LA; Wilson, CP; Elder, C; Swing, DA; Lewandoski, M				Anderson, Matthew J.; Naiche, L. A.; Wilson, Catherine P.; Elder, Cindy; Swing, Deborah A.; Lewandoski, Mark			TCreERT2, a Transgenic Mouse Line for Temporal Control of Cre-Mediated Recombination in Lineages Emerging from the Primitive Streak or Tail Bud	PLOS ONE			English	Article							SEGMENTATION CLOCK; NERVOUS-SYSTEM; GENE; MESODERM; MICE; FGF8; INACTIVATION; EXPRESSION; BRACHYURY; KIDNEY	The study of axis extension and somitogenesis has been greatly advanced through the use of genetic tools such as the TCre mouse line. In this line, Cre is controlled by a fragment of the T (Brachyury) promoter that is active in progenitor cells that reside within the primitive streak and tail bud and which give rise to lineages emerging from these tissues as the embryonic axis extends. However, because TCre-mediated recombination occurs early in development, gene inactivation can result in an axis truncation that precludes the study of gene function in later or more posterior tissues. To address this limitation, we have generated an inducible TCre transgenic mouse line, called TCreERT2, that provides temporal control, through tamoxifen administration, in all cells emerging from the primitive streak or tail bud throughout development. TCreERT2 activity is mostly silent in the absence of tamoxifen and, in its presence, results in near complete recombination of emerging mesoderm from E7.5 through E13.5. We demonstrate the utility of the TCreERT2 line for determining rate of posterior axis extension and somite formation, thus providing the first in vivo tool for such measurements. To test the usefulness of TCreERT2 for genetic manipulation, we demonstrate that an early deletion of beta-Catenin via TCreERT2 induction phenocopies the TCre-mediated deletion of beta-Catenin defect, whereas a later induction bypasses this early phenotype and produces a similar defect in more caudal tissues. TCreERT2 provides a useful and novel tool for the control of gene expression of emerging embryonic lineages throughout development.	[Anderson, Matthew J.; Naiche, L. A.; Wilson, Catherine P.; Elder, Cindy; Lewandoski, Mark] NCI, Inst Canc & Dev Biol, Frederick, MD 21701 USA; [Swing, Deborah A.] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lewandoski, M (corresponding author), NCI, Inst Canc & Dev Biol, Frederick, MD 21701 USA.	Lewandom@mail.nih.gov		Anderson, Matthew/0000-0001-9387-5743; Naiche, L. A./0000-0002-5031-4804; Lewandoski, Mark/0000-0002-1066-3735	Intramural Research Program of the National Institutes of Health, National Cancer Institute and Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010338, ZICBC010903] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal VS, 2010, DEV BIOL, V344, P669, DOI 10.1016/j.ydbio.2010.05.496; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brault V, 2001, DEVELOPMENT, V128, P1253; Braunstein EM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-31; Cambray N, 2002, DEVELOPMENT, V129, P4855; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Clements D, 1996, MECH DEVELOP, V56, P139, DOI 10.1016/0925-4773(96)00520-5; Correia KM, 2000, MECH DEVELOP, V91, P19, DOI 10.1016/S0925-4773(99)00260-9; Di-Poi N, 2010, DEV BIOL, V341, P488, DOI 10.1016/j.ydbio.2010.03.006; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jukkola T, 2005, GENESIS, V43, P148, DOI 10.1002/gene.20163; Kitagaki J, 2011, DEVELOPMENT, V138, P5369, DOI 10.1242/dev.051888; Kumar A, 2008, DEV DYNAM, V237, P3591, DOI 10.1002/dvdy.21665; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lewandoski M, 2007, Handb Exp Pharmacol, P235; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; MacDonald ST, 2008, CARDIOVASC RES, V79, P448, DOI 10.1093/cvr/cvn101; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Neidhardt LM, 1997, DEV GENES EVOL, V207, P330, DOI 10.1007/s004270050120; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Peter Lopez T, 2011, GENESIS; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tam PP, 1981, J EMBRYOL EXP MORP S, P103; Tzchori I, 2009, DEVELOPMENT, V136, P1375, DOI 10.1242/dev.026476; Verheyden JM, 2005, DEVELOPMENT, V132, P4235, DOI 10.1242/dev.02001; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Wehn AK, 2009, GENESIS, V47, P309, DOI 10.1002/dvg.20503; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yi L, 2009, DEV DYNAM, V238, P123, DOI 10.1002/dvdy.21831; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zhang Z, 2011, DEV BIOL, V351, P254, DOI 10.1016/j.ydbio.2011.01.005	43	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62479	10.1371/journal.pone.0062479	http://dx.doi.org/10.1371/journal.pone.0062479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638095	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300064
J	Mischo, A; Ohlenschlager, O; Hortschansky, P; Ramachandran, R; Gorlach, M				Mischo, Andre; Ohlenschlaeger, Oliver; Hortschansky, Peter; Ramachandran, Ramadurai; Goerlach, Matthias			Structural Insights into a Wildtype Domain of the Oncoprotein E6 and Its Interaction with a PDZ Domain	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; RISK HUMAN-PAPILLOMAVIRUS; GRADE CERVICAL LESIONS; LARGE TUMOR-SUPPRESSOR; BINDING PARTNERS; P53 DEGRADATION; COMMON TARGETS; HUMAN HOMOLOG; CELL-CYCLE; PROTEIN	The high-risk human papilloma virus (HPV) oncoproteins E6 and E7 interact with key cellular regulators and are etiological agents for tumorigenesis and tumor maintenance in cervical cancer and other malignant conditions. E6 induces degradation of the tumor suppressor p53, activates telomerase and deregulates cell polarity. Analysis of E6 derived from a number of high risk HPV finally yielded the first structure of a wild-type HPV E6 domain (PDB 2M3L) representing the second zinc-binding domain of HPV 51 E6 (termed 51Z2) determined by NMR spectroscopy. The 51Z2 structure provides clues about HPV-type specific structural differences between E6 proteins. The observed temperature sensitivity of the well-folded wild-type E6 domain implies a significant malleability of the oncoprotein in vivo. Hence, the structural differences between individual E6 and their malleability appear, together with HPV type-specific surface exposed side-chains, to provide the structural basis for the different interaction networks reported for individual E6 proteins. Furthermore, the interaction of 51Z2 with a PDZ domain of hDlg was analyzed. Human Dlg constitutes a prototypic representative of the large family of PDZ proteins regulating cell polarity, which are common targets of high-risk HPV E6. Nine C-terminal residues of 51Z2 interact with the second PDZ domain of hDlg2. Surface plasmon resonance in conjunction with the NMR spectroscopy derived complex structure (PDB 2M3M) indicate that E6 residues N-terminal to the canonical PDZ-BM of E6 significantly contribute to this interaction and increase affinity. The structure of the complex reveals how residues outside of the classical PDZ-BM enhance the affinity of E6 towards PDZ domains. Such mechanism facilitates successful competition of E6 with cellular PDZ-binding proteins and may apply to PDZ-binding proteins of other viruses as well.	[Mischo, Andre; Ohlenschlaeger, Oliver; Ramachandran, Ramadurai; Goerlach, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Biomol NMR Spect, Jena, Germany; [Hortschansky, Peter] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Hans Knoll Institute (HKI)	Gorlach, M (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Biomol NMR Spect, Jena, Germany.	mago@fli-leibniz.de		Ohlenschlaeger, Oliver/0000-0002-6428-4423	Fritz Lipmann Institute (FLI); Hans Knoll Institute (HKI); Federal Government of Germany; State of Thuringia; FLI by the Leibniz Graduate School on Ageing (LGSA)	Fritz Lipmann Institute (FLI); Hans Knoll Institute (HKI); Federal Government of Germany; State of Thuringia; FLI by the Leibniz Graduate School on Ageing (LGSA)	This work was funded by the Fritz Lipmann Institute (FLI) and the Hans Knoll Institute (HKI). FLI and HKI are members of the Science Association 'Gottfried Wilhelm Leibniz' (WGL) and are financially supported by the Federal Government of Germany and the State of Thuringia. AM was funded through FLI by the Leibniz Graduate School on Ageing (LGSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari T, 2012, J VIROL, V86, P11386, DOI 10.1128/JVI.01236-12; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Charbonnier S, 2011, J MOL BIOL, V406, P745, DOI 10.1016/j.jmb.2011.01.015; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; DOWHANICK JJ, 1995, J VIROL, V69, P7791, DOI 10.1128/JVI.69.12.7791-7799.1995; DURST M, 1987, ONCOGENE, V1, P251; Facciuto F, 2012, FEBS J, V279, P3538, DOI 10.1111/j.1742-4658.2012.08699.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freund C., 2008, V186, P407, DOI 10.1007/978-3-540-72843-6_17; Fu L., 2010, PLOS ONE, P5; Gaiffe E, 2012, PLOS ONE, P7; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hiller T, 2006, CANCER EPIDEM BIOMAR, V15, P1262, DOI 10.1158/1055-9965.EPI-05-0778; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; HUDSON JB, 1990, J VIROL, V64, P519, DOI 10.1128/JVI.64.2.519-526.1990; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HWANG ES, 1993, J VIROL, V67, P3720, DOI 10.1128/JVI.67.7.3720-3729.1993; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents, 2012, IARC MON EV CARC RIS, V100; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Javier RT, 2008, ONCOGENE, V27, P7031, DOI 10.1038/onc.2008.352; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Krishna Subbaiah V, 2012, PLOS PATHOG, V8; Laprise P, 2004, J BIOL CHEM, V279, P10157, DOI 10.1074/jbc.M309843200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CH, 2004, J VIROL, V78, P12366, DOI 10.1128/JVI.78.22.12366-12377.2004; Lee C, 2007, VIROLOGY, V358, P201, DOI 10.1016/j.virol.2006.08.028; Liu XF, 2009, P NATL ACAD SCI USA, V106, P18780, DOI 10.1073/pnas.0906357106; Liu Y, 1999, J VIROL, V73, P7297, DOI 10.1128/JVI.73.9.7297-7307.1999; Liu Y, 2007, BIOCHEMISTRY-US, V46, P10864, DOI 10.1021/bi700879k; Liu YQ, 2009, J MOL BIOL, V386, P1123, DOI 10.1016/j.jmb.2009.01.018; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Lue RA, 1996, J CELL BIOL, V135, P1125, DOI 10.1083/jcb.135.4.1125; Magaldi TG, 2012, VIROLOGY, V422, P114, DOI 10.1016/j.virol.2011.10.012; Massimi P, 2008, ONCOGENE, V27, P1800, DOI 10.1038/sj.onc.1210810; Massimi P, 2012, PLOS ONE, P7; McCann JJ, 2011, STRUCTURE, V19, P810, DOI 10.1016/j.str.2011.02.017; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mesplede T, 2012, J VIROL, V86, P94, DOI 10.1128/JVI.00751-11; Mischo A, 2012, BIOMOL NMR ASSIGN; Mischo A, 2012, CHEMBIOCHEM, V13, P1421, DOI 10.1002/cbic.201200178; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Muench P, 2009, VIROLOGY, V387, P380, DOI 10.1016/j.virol.2009.02.018; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; MUNGER K, 1989, J VIROL, V63, P4417; Neveu G, 2012, METHODS, V58, P349, DOI 10.1016/j.ymeth.2012.07.029; Nicolaides L, 2011, VIROLOGY, V414, P137, DOI 10.1016/j.virol.2011.03.017; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Nomine Y, 2005, J BIOMOL NMR, V31, P129, DOI 10.1007/s10858-004-7802-y; Nomine Y, 2001, PROTEIN EXPRES PURIF, V23, P22, DOI 10.1006/prep.2001.1451; Parish JL, 2006, J VIROL, V80, P4580, DOI 10.1128/JVI.80.9.4580-4590.2006; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; POPLE JA, 1956, J CHEM PHYS, V24, P1111, DOI 10.1063/1.1742701; Prehaud C, 2010, SCI SIGNAL, P3; Ristriani T, 2009, ONCOGENE, V28, P762, DOI 10.1038/onc.2008.422; Roberts S, 2012, FEBS J, V279, P3549, DOI 10.1111/j.1742-4658.2012.08729.x; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shai A, 2007, CANCER RES, V67, P1626, DOI 10.1158/0008-5472.CAN-06-3344; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Song S, 2000, VIROLOGY, V267, P141, DOI 10.1006/viro.1999.0106; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Tomaic V, 2009, VIROLOGY, V393, P7, DOI 10.1016/j.virol.2009.07.029; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; Van Doorslaer K, 2012, VIROLOGY, V433, P216, DOI 10.1016/j.virol.2012.08.006; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; White EA, 2012, J VIROL, V86, P13174, DOI 10.1128/JVI.02172-12; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zhang Y, 2007, J VIROL, V81, P3618, DOI 10.1128/JVI.02044-06; Zhang Zhipeng, 2011, PORT WATERWAY ENG, P6	91	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62584	10.1371/journal.pone.0062584	http://dx.doi.org/10.1371/journal.pone.0062584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638119	gold, Green Published			2022-12-25	WOS:000319077300078
J	Schmeing, JB; Kehyayan, A; Kessler, H; Do Lam, ATA; Fell, J; Schmidt, AC; Axmacher, N				Schmeing, Jo-Birger; Kehyayan, Aram; Kessler, Henrik; Do Lam, Anne T. A.; Fell, Juergen; Schmidt, Anna-Christine; Axmacher, Nikolai			Can the Neural Basis of Repression Be Studied in the MRI Scanner? New Insights from Two Free Association Paradigms	PLOS ONE			English	Article							DECLARATIVE MEMORY; STRESS; EVENTS; SUPPRESSION; MECHANISMS; RETRIEVAL; VALENCE; SYSTEMS; TRAUMA; MODEL	Background: The psychodynamic theory of repression suggests that experiences which are related to internal conflicts become unconscious. Previous attempts to investigate repression experimentally were based on voluntary, intentional suppression of stimulus material. Unconscious repression of conflict-related material is arguably due to different processes, but has never been studied with neuroimaging methods. Methods: We used functional magnetic resonance imaging (fMRI) in addition with skin conductance recordings during two free association paradigms to identify the neural mechanisms underlying forgetting of freely associated words according to repression theory. Results: In the first experiment, free association to subsequently forgotten words was accompanied by increases in skin conductance responses (SCRs) and reaction times (RTs), indicating autonomic arousal, and by activation of the anterior cingulate cortex. These findings are consistent with the hypothesis that these associations were repressed because they elicited internal conflicts. To test this idea more directly, we conducted a second experiment in which participants freely associated to conflict-related sentences. Indeed, these associations were more likely to be forgotten than associations to not conflict-related sentences and were accompanied by increases in SCRs and RTs. Furthermore, we observed enhanced activation of the anterior cingulate cortex and deactivation of hippocampus and parahippocampal cortex during association to conflict-related sentences. Conclusions: These two experiments demonstrate that high autonomic arousal during free association predicts subsequent memory failure, accompanied by increased activation of conflict-related and deactivation of memory-related brain regions. These results are consistent with the hypothesis that during repression, explicit memory systems are down-regulated by the anterior cingulate cortex.	[Schmeing, Jo-Birger; Kehyayan, Aram; Do Lam, Anne T. A.; Fell, Juergen; Axmacher, Nikolai] Univ Bonn, Dept Epileptol, Bonn, Germany; [Kessler, Henrik] Univ Bonn, Dept Med Psychol, Bonn, Germany; [Schmidt, Anna-Christine; Axmacher, Nikolai] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Kessler, Henrik] Univ Ulm, Dept Med Psychol, D-89069 Ulm, Germany	University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Ulm University	Axmacher, N (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.	nikolai.axmacher@ukb.uni-bonn.de		Kehyayan, Aram/0000-0002-1087-5631; Axmacher, Nikolai/0000-0002-0475-6492	Deutsche Forschungsgemeinschaft (DFG) [FE 366/5-1]; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	ATAD was supported by the Deutsche Forschungsgemeinschaft (DFG) grant FE 366/5-1. NA received an Emmy Noether grant from the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Axmacher N, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00211; Axmacher N, 2009, BEHAV BRAIN RES, V200, P1, DOI 10.1016/j.bbr.2009.01.028; Beblo T, 2006, PSYCHOL MED, V36, P845, DOI 10.1017/S0033291706007227; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Brewin CR, 2007, MEMORY, V15, P227, DOI 10.1080/09658210701256423; Cahill L, 2000, PROG BRAIN RES, V126, P29; Chiew KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017635; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Dudukovic NM, 2007, NEUROPSYCHOLOGIA, V45, P2608, DOI 10.1016/j.neuropsychologia.2007.02.025; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Freud S, 1915, STANDARD EDITION COM, V14, P143; Freud S, STANDARD EDITION COM, V12, P121; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; HEUER F, 1990, MEM COGNITION, V18, P496, DOI 10.3758/BF03198482; Howard MW, 2002, J MEM LANG, V46, P85, DOI 10.1006/jmla.2001.2798; JONES BP, 1993, J AM PSYCHOANAL ASS, V41, P63, DOI 10.1177/000306519304100103; Jung C. G., 1918, STUDIES WORD ASS, P8; Jung CG, 1979, GESAMMELTE WERKE, V2, P20; Kaplan-Solms K., 2000, CLIN STUDIES NEURO P; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kessler H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015712; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; Kohler T, 1999, PSYCHOTHER PSYCHOSOM; Kolb P, 2008, KONVENS 2008 ERGANZU; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lang PJ, 1995, INT AFFECTIVE PICTUR; LEVINGER G, 1961, J ABNORM SOC PSYCH, V62, P99, DOI 10.1037/h0044271; Lupien SJ, 1997, J CLIN ENDOCR METAB, V82, P2070, DOI 10.1210/jc.82.7.2070; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Northoff Georg, 2011, NEUROPSYCHOANALYSIS; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; OPD Task Force, 2008, OP PSYCH DIAGN OPD 2; Panksepp J, 2012, TRENDS COGN SCI, V16, P6, DOI 10.1016/j.tics.2011.11.005; Person E. S., 2005, AM PSYCHIAT PUBLISHI; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; ROSSMANN P, 1984, PSYCHOL RES-PSYCH FO, V45, P377, DOI 10.1007/BF00309713; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Schauenburg H, 2007, PSYCHOL PSYCHOTHER-T, V80, P355, DOI 10.1348/147608306X146068; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Vuilleumier P, 2005, PROG BRAIN RES, V150, P309, DOI 10.1016/S0079-6123(05)50023-2; Wittfoth M, 2010, CEREB CORTEX, V20, P383, DOI 10.1093/cercor/bhp106; Woller W, 2010, TIEFENPSYCHOLOGISCH; Wylie GR, 2008, CEREB CORTEX, V18, P670, DOI 10.1093/cercor/bhm101	58	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62358	10.1371/journal.pone.0062358	http://dx.doi.org/10.1371/journal.pone.0062358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638050	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300045
J	Grinwald, M; Ron, EZ				Grinwald, Maya; Ron, Eliora Z.			The Escherichia coli Translation-Associated Heat Shock Protein YbeY Is Involved in rRNA Transcription Antitermination	PLOS ONE			English	Article							AQUIFEX-AEOLICUS; GENE-PRODUCT; RRNB OPERON; LEADER; REGION; TERMINATION; POLYMERASE; MATURATION; SEQUENCES; SUBUNITS	A new group of translation-associated heat shock genes has been recently identified. One of these novel genes is ybeY which is highly conserved in bacteria. In Escherichia coli the YbeY protein is important for efficient translation at all temperatures and is essential at high temperatures. Deletion mutants of ybeY are defective in protein translation, due to impaired 30 S ribosomal subunits. Here we provide evidence which tie YbeY to the transcription antitermination process. Thus, in ybeY deletion mutants transcription is significantly inhibited when the "nut like'' sequences required for transcriptional antitermination are present, while if these sequences are removed transcription is not affected by the mutation.	[Grinwald, Maya; Ron, Eliora Z.] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Ron, EZ (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	eliora@post.tau.ac.il						AKSOY S, 1984, J BACTERIOL, V159, P260, DOI 10.1128/JB.159.1.260-264.1984; BERG KL, 1989, J MOL BIOL, V209, P345, DOI 10.1016/0022-2836(89)90002-8; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; CECCARELLI A, 1978, FEBS LETT, V93, P348, DOI 10.1016/0014-5793(78)81137-5; Cohen-Or I, 2010, RES MICROBIOL, V161, P694, DOI [10.1016/j.resmic.2010.06.009, 10.1016/J.resmic.2010.06.009]; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; DAS A, 1992, J BACTERIOL, V174, P6711, DOI 10.1128/JB.174.21.6711-6716.1992; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies BW, 2010, MOL MICROBIOL, V78, P506, DOI 10.1111/j.1365-2958.2010.07351.x; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Greive SJ, 2005, J BIOL CHEM, V280, P36397, DOI 10.1074/jbc.M507146200; HAYES F, 1976, EUR J BIOCHEM, V61, P433, DOI 10.1111/j.1432-1033.1976.tb10037.x; Jacob AI, 2012, MOL CELL; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; KINGSTON RE, 1981, CELL, V27, P523, DOI 10.1016/0092-8674(81)90394-9; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; LEWICKI BTU, 1993, J MOL BIOL, V231, P581, DOI 10.1006/jmbi.1993.1311; LI SC, 1984, CELL, V38, P851, DOI 10.1016/0092-8674(84)90280-0; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; MORGAN EA, 1986, J BACTERIOL, V168, P1; Oganesyan V, 2003, ACTA CRYSTALLOGR D, V59, P1219, DOI 10.1107/S0907444903011028; PARDON B, 1995, NUCLEIC ACIDS RES, V23, P932, DOI 10.1093/nar/23.6.932; Quan S, 2005, J BACTERIOL, V187, P1632, DOI 10.1128/JB.187.5.1632-1638.2005; Rasouly A, 2010, J BACTERIOL, V192, P4592, DOI 10.1128/JB.00448-10; Rasouly A, 2009, J BACTERIOL, V191, P2649, DOI 10.1128/JB.01663-08; Schaferkordt J, 2001, NUCLEIC ACIDS RES, V29, P3394, DOI 10.1093/nar/29.16.3394; SQUIRES CL, 1993, P NATL ACAD SCI USA, V90, P970, DOI 10.1073/pnas.90.3.970; THEISSEN G, 1990, MOL MICROBIOL, V4, P1667, DOI 10.1111/j.1365-2958.1990.tb00544.x; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843; Yeh DC, 2005, PROTEIN SCI, V14, P424, DOI 10.1110/ps.041096705; ZACHARIAS M, 1987, NUCLEIC ACIDS RES, V15, P8235, DOI 10.1093/nar/15.20.8235; Zhan CY, 2005, ACTA CRYSTALLOGR F, V61, P959, DOI 10.1107/S1744309105031131	34	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62297	10.1371/journal.pone.0062297	http://dx.doi.org/10.1371/journal.pone.0062297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638028	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800035
J	Siddall, HK; Yellon, DM; Ong, SB; Mukherjee, UA; Burke, N; Hall, AR; Angelova, PR; Ludtmann, MHR; Deas, E; Davidson, SM; Mocanu, MM; Hausenloy, DJ				Siddall, Hilary K.; Yellon, Derek M.; Ong, Sang-Bing; Mukherjee, Uma A.; Burke, Niall; Hall, Andrew R.; Angelova, Plamena R.; Ludtmann, Marthe H. R.; Deas, Emma; Davidson, Sean M.; Mocanu, Mihaela M.; Hausenloy, Derek J.			Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PARKINSONS-DISEASE; PTEN; PORE; DROSOPHILA-PINK1; MUTATIONS; PROTECTS; MUTANTS; RELEASE; DEATH	Objectives: Mutations in PTEN inducible kinase-1 (PINK1) induce mitochondrial dysfunction in dopaminergic neurons resulting in an inherited form of Parkinson's disease. Although PINK1 is present in the heart its exact role there is unclear. We hypothesized that PINK1 protects the heart against acute ischemia reperfusion injury (IRI) by preventing mitochondrial dysfunction. Methods and Results: Over-expressing PINK1 in HL-1 cardiac cells reduced cell death following simulated IRI (29.2 +/- 5.2% PINK1 versus 49.0 +/- 2.4% control; N = 320 cells/group P < 0.05), and delayed the onset of mitochondrial permeability transition pore (MPTP) opening (by 1.3 fold; P < 0.05). Hearts excised from PINK1+/+, PINK1+/- and PINK1-/- mice were subjected to 35 minutes regional ischemia followed by 30 minutes reperfusion. Interestingly, myocardial infarct size was increased in PINK1-/- hearts compared to PINK1+/+ hearts with an intermediate infarct size in PINK1+/- hearts (25.162.0% PINK1+/+, 38.963.4% PINK1+/- versus 51.564.3% PINK1-/- hearts; N. 5 animals/group; P < 0.05). Cardiomyocytes isolated from PINK1-/- hearts had a lower resting mitochondrial membrane potential, had inhibited mitochondrial respiration, generated more oxidative stress during simulated IRI, and underwent rigor contracture more rapidly in response to an uncoupler when compared to PINK1+/+ cells suggesting mitochondrial dysfunction in hearts deficient in PINK1. Conclusions: We show that the loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injury. This may be due, in part, to increased mitochondrial dysfunction. These findings implicate PINK1 as a novel target for cardioprotection.	[Siddall, Hilary K.; Yellon, Derek M.; Mukherjee, Uma A.; Burke, Niall; Hall, Andrew R.; Davidson, Sean M.; Mocanu, Mihaela M.; Hausenloy, Derek J.] UCL, Hatter Cardiovasc Inst, London, England; [Ong, Sang-Bing] Univ Teknol Malaysia, Fac Biosci & Med Engn, Dept Clin Sci, Johor Baharu, Malaysia; [Angelova, Plamena R.; Ludtmann, Marthe H. R.; Deas, Emma] UCL, Inst Neurol, Dept Mol Neurosci, London, England	University of London; University College London; Universiti Teknologi Malaysia; University of London; University College London	Hausenloy, DJ (corresponding author), UCL, Hatter Cardiovasc Inst, London, England.	d.hausenloy@ucl.ac.uk	Yellon, Derek M/ABD-5110-2021; ONG, SANG-BING/B-7786-2014; Ludtmann, Marthe H.R./A-1446-2013; Stroh, Plamena/K-4444-2013; Davidson, Sean M/F-5275-2010; Deas, Emma/A-6755-2010	ONG, SANG-BING/0000-0001-7421-2610; Ludtmann, Marthe H.R./0000-0003-1051-6425; Stroh, Plamena/0000-0003-4596-9117; Davidson, Sean M/0000-0001-5182-4980; Yellon, Derek/0000-0001-7791-9320; Hausenloy, Derek/0000-0003-0729-4956	British Heart Foundation [FS/06/023]; MRC [MR/J003530/1] Funding Source: UKRI; British Heart Foundation [RG/08/015/26411] Funding Source: researchfish; Medical Research Council [MR/J003530/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10164] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Heart Foundation grant number FS/06/023 and supported by researchers at the National Institute for Health Research University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108; Bueler H, 2010, APOPTOSIS, V15, P1336, DOI 10.1007/s10495-010-0465-0; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dagda R. K., 2009, J BIOL CHEM; Davidson Sean M, 2007, Methods Mol Biol, V372, P421, DOI 10.1007/978-1-59745-365-3_30; Davidson SM, 2006, INT J BIOCHEM CELL B, V38, P414, DOI 10.1016/j.biocel.2005.09.017; Di Lisa F, 2011, BBA-MOL CELL RES, V1813, P1316, DOI 10.1016/j.bbamcr.2011.01.031; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Ganote CE, 2003, J MOL CELL CARDIOL, V35, P749, DOI 10.1016/S0022-2828(03)00114-7; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; Hausenloy DJ, 2004, AM J PHYSIOL-HEART C, V287, pH841, DOI 10.1152/ajpheart.00678.2003; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; KAMINISHI K, 1989, CAN J CARDIOL, V5, P168; LI Q, 1989, AM J PHYSIOL, V257, pC427, DOI 10.1152/ajpcell.1989.257.3.C427; Lim SY, 2008, J CELL MOL MED, V12, P1395, DOI 10.1111/j.1582-4934.2008.00332.x; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shan YX, 2009, J NEUROCHEM, V111, P1149, DOI 10.1111/j.1471-4159.2009.06398.x; Siddall HK, 2008, CARDIOVASC DRUG THER, V22, P507, DOI 10.1007/s10557-008-6136-5; Siddall HK, 2008, BASIC RES CARDIOL, V103, P560, DOI 10.1007/s00395-008-0735-y; Simpkin JC, 2007, CARDIOVASC DRUG THER, V21, P409, DOI 10.1007/s10557-007-6054-y; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Wang HL, 2007, NEUROBIOL DIS, V28, P216, DOI 10.1016/j.nbd.2007.07.010; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	40	93	99	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62400	10.1371/journal.pone.0062400	http://dx.doi.org/10.1371/journal.pone.0062400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638067	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800038
J	Duan, L; Wu, R; Ye, LW; Wang, HY; Yang, X; Zhang, YY; Chen, X; Zuo, GW; Zhang, Y; Weng, YG; Luo, JY; Tang, M; Shi, Q; He, TC; Zhou, L				Duan, Liang; Wu, Rui; Ye, Liwei; Wang, Haiyan; Yang, Xia; Zhang, Yunyuan; Chen, Xian; Zuo, Guowei; Zhang, Yan; Weng, Yaguang; Luo, Jinyong; Tang, Min; Shi, Qiong; He, Tongchuan; Zhou, Lan			S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/beta-Catenin Pathway	PLOS ONE			English	Article							PSORIASIN S100A7; GENE-EXPRESSION; TUMOR-CELLS; CROSS-TALK; CANCER; PROTEINS; RAGE; RECEPTOR; BINDING; WNT	Background and Objective: S100A8 and S100A9, two members of the S100 protein family, have been reported in association with the tumor cell differentiation and tumor progression. Previous study has showed that their expression in stromal cells of colorectal carcinoma (CRC) is associated with tumor size. Here, we investigated the clinical significances of S100A8 and S100A9 in tumor cells of CRC and their underlying molecular mechanisms. Methods: Expression of S100A8 and S100A9 in colorectal carcinoma and matching distal normal tissues were measured by reverse transcriptase polymerase chain reaction (RT-PCR), immunohistochemistry and western blot. CRC cell lines treated with the recombinant S100A8 and S100A9 proteins were used to analyze the roles and molecular mechanisms of the two proteins in CRC in vitro. Results: S100A8 and S100A9 were elevated in more than 50% of CRC tissues and their expression in tumor cells was associated with differentiation, Dukes stage and lymph node metastasis. The CRC cell lines treatment with recombinant S100A8 and S100A9 proteins promoted the viability and migration of CRC cells. Furthermore, the two recombinant proteins also resulted in the increased levels of beta-catenin and its target genes c-myc and MMP7. beta-catenin over-expression in CRC cells by Ad beta-catenin increased cell viability and migration. beta-catenin knock-down by Adsi beta-catenin reduced cell viability and migration. Furthermore, beta-catenin knockdown also partially abolished the promotive effects of recombinant S100A8 and S100A9 proteins on the viability and migration of CRC cells. Conclusions: Our work demonstrated that S100A8 and S100A9 are linked to the CRC progression, and one of the underlying molecular mechanisms is that extracellular S100A8 and S100A9 proteins contribute to colorectal carcinoma cell survival and migration via Wnt/beta-catenin pathway.	[Duan, Liang; Wu, Rui; Ye, Liwei; Wang, Haiyan; Yang, Xia; Zhang, Yunyuan; Chen, Xian; Zuo, Guowei; Zhang, Yan; Weng, Yaguang; Luo, Jinyong; Tang, Min; Shi, Qiong; Zhou, Lan] Chongqing Med Univ, Key Lab Diagnost Med Designated Chinese, Minist Educ, Chongqing, Peoples R China; [He, Tongchuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA	Chongqing Medical University; University of Chicago; University of Chicago Medical Center	Zhou, L (corresponding author), Chongqing Med Univ, Key Lab Diagnost Med Designated Chinese, Minist Educ, Chongqing, Peoples R China.	zhoulan0111@foxmail.com		Duan, Liang/0000-0002-3882-7527	Natural Science Foundation of China [30772548]; Foundation from Excellent Master Dissertation of College of Laboratory Medicine at Chongqing Medical University [201202]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation from Excellent Master Dissertation of College of Laboratory Medicine at Chongqing Medical University	This work was supported in part by research grants from the Natural Science Foundation of China (#30772548 to Dr. Luo), and Foundation from Excellent Master Dissertation of College of Laboratory Medicine at Chongqing Medical University (#201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2010, CARCINOGENESIS, V31, P1541, DOI 10.1093/carcin/bgq137; Arai K, 2000, MED ONCOL, V17, P183, DOI 10.1007/BF02780526; Arai K, 2001, ONCOL REP, V8, P591; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; Atallah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029333; Baryawno N, 2010, CANCER RES, V70, P266, DOI 10.1158/0008-5472.CAN-09-0578; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Carlsson H, 2005, INT J ONCOL, V27, P1473; Caverzasio J, 2007, ENDOCRINOLOGY, V148, P5323, DOI 10.1210/en.2007-0520; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; Deol YS, 2011, J BIOL CHEM, V286, P44845, DOI 10.1074/jbc.M111.225466; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Du Qiang, 2010, For Immunopathol Dis Therap, V1, P155; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; El-Rifai W, 2002, CANCER RES, V62, P6823; Elzagheid A, 2008, WORLD J GASTROENTERO, V14, P3866, DOI 10.3748/wjg.14.3866; Filipek A, 2006, CHEMOTHERAPY, V52, P32, DOI 10.1159/000090240; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Ghavami S, 2009, EUR J PHARMACOL, V625, P73, DOI 10.1016/j.ejphar.2009.08.044; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Han JJ, 2012, MED SCI MONITOR, V18, pBR273, DOI 10.12659/MSM.883205; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352; Hermani Alexander, 2006, Exp Cell Res, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hsieh HL, 2003, BIOCHEM BIOPH RES CO, V307, P375, DOI 10.1016/S0006-291X(03)01190-2; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Ito Y, 2009, ANTICANCER RES, V29, P4157; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kallberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034207; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Li CY, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/248574; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Nakatani Y, 2005, MEDIAT INFLAMM, P280, DOI 10.1155/MI.2005.280; Ning XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030185; Qin FJ, 2010, PATHOL ONCOL RES, V16, P353, DOI 10.1007/s12253-009-9225-2; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Sack U, 2009, GEN PHYSIOL BIOPHYS, V28, pF55; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; Seth A, 2003, ANTICANCER RES, V23, P2043; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Stulik J, 1999, ELECTROPHORESIS, V20, P1047, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<1047::AID-ELPS1047>3.0.CO;2-E; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wanitsuwan W, 2008, WORLD J GASTROENTERO, V14, P6052, DOI 10.3748/wjg.14.6052; Wu K, 2012, INT J ONCOL, V41, P292, DOI 10.3892/ijo.2012.1423; Wu R, 2013, INT J ONCOL, V42, P1001, DOI 10.3892/ijo.2013.1796; Xiong F, 2011, J BIOL CHEM, V286, P35061, DOI 10.1074/jbc.M111.261073; [游莉 YOU Li], 2011, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V32, P253; Yui S, 2002, MEDIAT INFLAMM, V11, P165, DOI 10.1080/09622935020138208; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025	75	68	74	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62092	10.1371/journal.pone.0062092	http://dx.doi.org/10.1371/journal.pone.0062092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637971	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700032
J	Latiano, A; Palmieri, O; Pastorelli, L; Vecchi, M; Pizarro, TT; Bossa, F; Merla, G; Augello, B; Latiano, T; Corritore, G; Settesoldi, A; Valvano, MR; D'Inca, R; Stronati, L; Annese, V; Andriulli, A				Latiano, Anna; Palmieri, Orazio; Pastorelli, Luca; Vecchi, Maurizio; Pizarro, Theresa T.; Bossa, Fabrizio; Merla, Giuseppe; Augello, Bartolomeo; Latiano, Tiziana; Corritore, Giuseppe; Settesoldi, Alessia; Valvano, Maria Rosa; D'Inca, Renata; Stronati, Laura; Annese, Vito; Andriulli, Angelo			Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALLERGIC AIRWAY INFLAMMATION; CROHNS-DISEASE; ULCERATIVE-COLITIS; SUSCEPTIBILITY LOCI; INTERLEUKIN-18 GENE; SEQUENCE VARIANTS; COMMON VARIANTS; CELIAC-DISEASE; MAST-CELLS	Background: Recent evidence suggests that the IL-33/IL1RL1 axis plays a critical role in several autoimmune and inflammatory disorders; however, its mechanistic role in inflammatory bowel disease (IBD) has not been clearly defined. We investigated the contribution of IL-33 and IL1RL1 polymorphisms to IBD risk, and possible correlations with phenotype in an Italian cohort of adult and pediatric patients. Methods: We evaluated the association of six SNPs in IL-33 and IL1RL1 genes, in 805 Crohn's disease (CD), 816 ulcerative colitis (UC), and 752 controls, using Taqman. IL-33 and IL1RL1 mRNA expression was also analyzed. Results: Significant allele and genotype associations with IL-33 rs3939286 were found in CD (P = 0.004; P = 0.035) and UC patients (P = 0.002; P = 0.038). After stratifying the cohort for age at diagnosis, the differences remained significant only in the IBD adult-onset. Significant associations were also obtained in CD patients with two IL1RL1 polymorphisms (rs13015714 and rs2058660, P < 0.015). By combining homo-and heterozygous carriers of the rs13015714 risk allele, differences were still significant for both CD adult-and pediatric-onset. Upon genotype-phenotype evaluation, an increased frequency of extensive colitis in adult UC (P = 0.019) and in steroid-responsive pediatric patients (P = 0.024) carrying the IL-33 rs3939286 risk genotype, was observed. mRNA expression of IL-33 and IL1RL1 in inflamed IBD biopsy samples was significantly increased. Conclusions: Common IL-33 and IL1RL1 polymorphisms contribute to the risk of IBD in an Italian cohort of adult and pediatric patients, with some influence on sub-phenotypes.	[Latiano, Anna; Palmieri, Orazio; Bossa, Fabrizio; Latiano, Tiziana; Corritore, Giuseppe; Valvano, Maria Rosa; Andriulli, Angelo] IRCCS Casa Sollievo Sofferenza, Div Gastroenterol, San Giovanni Rotondo, Italy; [Pastorelli, Luca; Vecchi, Maurizio] IRCCS Policlin San Donato, Gastroenterol & Gastrointestinal Endoscopy Unit, San Donato Milanese, Italy; [Pizarro, Theresa T.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Merla, Giuseppe; Augello, Bartolomeo] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Settesoldi, Alessia] AOU Careggi Hosp, Gastroenterol Unit, Florence, Italy; [D'Inca, Renata] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy; [Stronati, Laura] Italian Natl Agcy New Technol,Energy & Sustainabl, Dept Radiobiol & Human Hlth, Rome, Italy; [Pastorelli, Luca; Vecchi, Maurizio] Univ Milan, Dept Med & Surg Sci, Milan, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Policlinico San Donato; Case Western Reserve University; IRCCS Casa Sollievo Della Sofferenza; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Padua; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Milan	Latiano, A (corresponding author), IRCCS Casa Sollievo Sofferenza, Div Gastroenterol, San Giovanni Rotondo, Italy.	a.latiano@operapadrepio.it	Andriulli, Angelo/B-5027-2017; Augello, Bartolomeo/B-1927-2017; Pastorelli, Luca/K-5513-2016; Annese, Vito/AGW-4200-2022; Bossa, Fabrizio/B-3078-2017; merla, giuseppe/K-4627-2012; Palmieri, Orazio/J-7697-2012; Latiano, Anna/R-1965-2016; Vecchi, Maurizio/AAB-7383-2019; Valvano, Maria/B-5118-2017	Andriulli, Angelo/0000-0001-8862-7083; Augello, Bartolomeo/0000-0001-7475-6976; Pastorelli, Luca/0000-0002-2810-9951; Annese, Vito/0000-0002-0082-892X; Bossa, Fabrizio/0000-0002-4518-9949; merla, giuseppe/0000-0001-5078-928X; Palmieri, Orazio/0000-0002-0019-7929; Latiano, Anna/0000-0003-3719-2061; Valvano, Maria/0000-0003-4704-8354; Stronati, Laura/0000-0001-5222-9497	Italian Ministry of the Health [RC1102GA33, RC1102GA34, RC1202GA38, GR-2008-1144485]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222] Funding Source: NIH RePORTER	Italian Ministry of the Health(Ministry of Health, Italy); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Italian Ministry of the Health grants: RC1102GA33, RC1102GA34, RC1202GA38 and GR-2008-1144485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2005, TISSUE ANTIGENS, V65, P88, DOI 10.1111/j.1399-0039.2005.00336.x; Andersen V, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-82; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Bosse Y, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-98; Buysschaert ID, 2010, ALLERGY, V65, P616, DOI 10.1111/j.1398-9995.2009.02227.x; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Castano R, 2009, AMJ RHINOL ALLERGY, V23, P377, DOI 10.2500/ajra.2009.23.3303; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chapuis J, 2009, MOL PSYCHIATR, V14, P1004, DOI 10.1038/mp.2009.10; Cominelli F, 2004, NEW ENGL J MED, V351, P2045, DOI 10.1056/NEJMp048253; Cucchiara S, 2007, J PEDIATR GASTR NUTR, V44, P171, DOI 10.1097/MPG.0b013e31802c41f3; Duan L, 2012, MOL MED, V12; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas J, 2005, INFLAMM BOWEL DIS, V11, P1031, DOI 10.1097/01.MIB.0000187574.41290.b1; Grob P, 2012, INFLAMM BOWEL DIS; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Imaeda H, 2011, INT J MOL MED, V28, P573, DOI 10.3892/ijmm.2011.718; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; International HapMap Project, DAT GEN ASS HUM DIS; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kim SW, 2011, GUT, V60, P1527, DOI 10.1136/gut.2011.238477; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Koskinen LLE, 2009, HUM MOL GENET, V18, P1148, DOI 10.1093/hmg/ddn438; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Li MC, 2012, J NEUROIMMUNOL, V247, P25, DOI 10.1016/j.jneuroim.2012.03.016; Luzina IG, 2012, J IMMUNOL, V189, P403, DOI 10.4049/jimmunol.1200259; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; Nemetz A, 1999, IMMUNOGENETICS, V49, P527, DOI 10.1007/s002510050530; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oshikawa K, 2002, CLIN EXP ALLERGY, V32, P1520, DOI 10.1046/j.1365-2745.2002.01494.x; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Palmieri O, 2010, AM J GASTROENTEROL, V105, P1586, DOI 10.1038/ajg.2010.4; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pastorelli Luca, 2011, Therap Adv Gastroenterol, V4, P311, DOI 10.1177/1756283X11410770; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Plaza-Izurieta L, 2011, J MED GENET, V48, P493, DOI 10.1136/jmg.2011.089714; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Seldin MF, 2009, GENES IMMUN, V10, P1, DOI 10.1038/gene.2008.92; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sponheim J, 2010, AM J PATHOL, V177, P2804, DOI 10.2353/ajpath.2010.100378; Stokkers PCF, 1998, GUT, V43, P33, DOI 10.1136/gut.43.1.33; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Tamura K, 2002, J GASTROENTEROL, V37, P111, DOI 10.1007/BF03326428; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Volarevic V, 2012, J HEPATOL, V56, P26, DOI 10.1016/j.jhep.2011.03.022; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	66	69	77	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62144	10.1371/journal.pone.0062144	http://dx.doi.org/10.1371/journal.pone.0062144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634226	gold, Green Published, Green Submitted			2022-12-25	WOS:000318341400037
J	Morgan, JK; Luzio, GA; Ammar, ED; Hunter, WB; Hall, DG; Shatters, RG				Morgan, J. Kent; Luzio, Gary A.; Ammar, El-Desouky; Hunter, Wayne B.; Hall, David G.; Shatters, Robert G., Jr.			Formation of Stylet Sheaths in aere (in air) from Eight Species of Phytophagous Hemipterans from Six Families (Suborders: Auchenorrhyncha and Sternorrhyncha)	PLOS ONE			English	Article							FASCIATUS DALL HETEROPTERA; PLANT-SUCKING BUG; ELECTRICAL PENETRATION GRAPHS; GLASSY-WINGED SHARPSHOOTER; SALIVARY SECRETIONS; XYLELLA-FASTIDIOSA; FINE-STRUCTURE; APHID SALIVA; HOST PLANTS; CITRUS	Stylet sheath formation is a common feature among phytophagous hemipterans. These sheaths are considered essential to promote a successful feeding event. Stylet sheath compositions are largely unknown and their mode of solidification remains to be elucidated. This report demonstrates the formation and solidification of in aere (in air) produced stylet sheaths by six hemipteran families: Diaphorina citri (Psyllidae, Asian citrus psyllid), Aphis nerii (Aphididae, oleander/milkweed aphid), Toxoptera citricida (Aphididae, brown citrus aphid), Aphis gossypii (Aphididae, cotton melon aphid), Bemisia tabaci biotype B (Aleyrodidae, whitefly), Homalodisca vitripennis (Cicadellidae, glassy-winged sharpshooter), Ferrisia virgata (Pseudococcidae, striped mealybug), and Protopulvinaria pyriformis (Coccidae, pyriform scale). Examination of in aere produced stylet sheaths by confocal and scanning electron microscopy shows a common morphology of an initial flange laid down on the surface of the membrane followed by continuous hollow core structures with sequentially stacked hardened bulbous droplets. Single and multi-branched sheaths were common, whereas mealybug and scale insects typically produced multi-branched sheaths. Micrographs of the in aere formed flanges indicate flange sealing upon stylet bundle extraction in D. citri and the aphids, while the B. tabaci whitefly and H. vitripennis glassy-winged sharpshooter flanges remain unsealed. Structural similarity of in aere sheaths are apparent in stylet sheaths formed in planta, in artificial diets, or in water. The use of 'Solvy', a dissolvable membrane, for intact stylet sheath isolation is reported. These observations illustrate for the first time this mode of stylet sheath synthesis adding to the understanding of stylet sheath formation in phytophagous hemipterans and providing tools for future use in structural and compositional analysis.	[Morgan, J. Kent; Luzio, Gary A.; Ammar, El-Desouky; Hunter, Wayne B.; Hall, David G.; Shatters, Robert G., Jr.] USDA ARS, United States Hort Res Lab, Ft Pierce, FL USA	United States Department of Agriculture (USDA)	Shatters, RG (corresponding author), USDA ARS, United States Hort Res Lab, Ft Pierce, FL USA.	robert.shatters@ars.usda.gov	hunter, wayne/AAB-9096-2020	hunter, wayne/0000-0001-8603-3337; Shatters, Robert/0000-0002-3903-772X	Citrus Research and Development Foundation (CRDF) [330]	Citrus Research and Development Foundation (CRDF)	Funding for this work was provided by a Citrus Research and Development Foundation (CRDF) grant, CRDF Project # 330. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaddad H, 2011, ANN ENTOMOL SOC AM, V104, P543, DOI 10.1603/AN10137; Ammar ED, 2012, ANN ENTOMOL SOC AM, V105, P731, DOI 10.1603/AN12056; Ammar E, 2011, FLA ENTOMOL, V94, P340, DOI 10.1653/024.094.0229; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Brennan EB, 2001, BIOTECH HISTOCHEM, V76, P59, DOI 10.1080/714028130; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; Dejean A, 2000, CR ACAD SCI III-VIE, V323, P447, DOI 10.1016/S0764-4469(00)00156-6; Forero D, 2008, REV COLOMB ENTOMOL, V34, P1; Freeman TP, 2001, ANN ENTOMOL SOC AM, V94, P761, DOI 10.1603/0013-8746(2001)094[0761:SPBBAH]2.0.CO;2; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Gullan P. J., 2009, ENCY INSECTS, P957, DOI DOI 10.1016/B978-0-12-374144-8.00253-8; Hall DG, 2010, ANN ENTOMOL SOC AM, V103, P611, DOI 10.1603/AN10004; Howard F.W., 2001, INSECTS PALMS, V131, DOI [10.1079/9780851993263.0000, DOI 10.1079/9780851993263.0000]; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Lapointe SL, 2004, AGR FOREST ENTOMOL, V6, P251, DOI 10.1111/j.1461-9555.2004.00230.x; Leopold RA, 2003, ARTHROPOD STRUCT DEV, V32, P189, DOI 10.1016/S1467-8039(03)00047-1; LLOYD M, 1987, OHIO J SCI, V87, P50; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; MILES P. W., 1965, J INSECT PHYSIOL, V11, P1261, DOI 10.1016/0022-1910(65)90119-8; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MILES PW, 1960, J INSECT PHYSIOL, V4, P271, DOI 10.1016/0022-1910(60)90054-8; MILES PW, 1959, J INSECT PHYSIOL, V3, P243, DOI 10.1016/0022-1910(59)90004-6; MILES PW, 1960, J INSECT PHYSIOL, V4, P209, DOI 10.1016/0022-1910(60)90028-7; MILES PW, 1991, ENTOMOL EXP APPL, V59, P123, DOI 10.1007/BF00351957; Miranda MP, 2009, ENTOMOL EXP APPL, V130, P35, DOI 10.1111/j.1570-7458.2008.00794.x; Moreno A, 2011, ENTOMOL EXP APPL, V139, P145, DOI 10.1111/j.1570-7458.2011.01117.x; NEAL JW, 1994, ANN ENTOMOL SOC AM, V87, P609, DOI 10.1093/aesa/87.5.609; Nelson DR, 2000, COMP BIOCHEM PHYS B, V125, P265, DOI 10.1016/S0305-0491(99)00177-7; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Urbanska A, 2010, ELECT J POLISH AGR U, V13; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Wang YC, 2008, ENTOMOL EXP APPL, V129, P295, DOI 10.1111/j.1570-7458.2008.00785.x; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Will T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046903	39	22	24	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62444	10.1371/journal.pone.0062444	http://dx.doi.org/10.1371/journal.pone.0062444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638086	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400109
J	Patterson, RA; Juarez, MT; Hermann, A; Sasik, R; Hardiman, G; McGinnis, W				Patterson, Rachel A.; Juarez, Michelle T.; Hermann, Anita; Sasik, Roman; Hardiman, Gary; McGinnis, William			Serine Proteolytic Pathway Activation Reveals an Expanded Ensemble of Wound Response Genes in Drosophila	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; NERVE GROWTH-FACTOR; GRAINY-HEAD; EPIDERMAL BARRIER; HOST-DEFENSE; SIGNALING PATHWAYS; HORSESHOE-CRAB; DORSAL CLOSURE; C-JUN; MELANOGASTER	After injury to the animal epidermis, a variety of genes are transcriptionally activated in nearby cells to regenerate the missing cells and facilitate barrier repair. The range and types of diffusible wound signals that are produced by damaged epidermis and function to activate repair genes during epidermal regeneration remains a subject of very active study in many animals. In Drosophila embryos, we have discovered that serine protease function is locally activated around wound sites, and is also required for localized activation of epidermal repair genes. The serine protease trypsin is sufficient to induce a striking global epidermal wound response without inflicting cell death or compromising the integrity of the epithelial barrier. We developed a trypsin wounding treatment as an amplification tool to more fully understand the changes in the Drosophila transcriptome that occur after epidermal injury. By comparing our array results with similar results on mammalian skin wounding we can see which evolutionarily conserved pathways are activated after epidermal wounding in very diverse animals. Our innovative serine protease-mediated wounding protocol allowed us to identify 8 additional genes that are activated in epidermal cells in the immediate vicinity of puncture wounds, and the functions of many of these genes suggest novel genetic pathways that may control epidermal wound repair. Additionally, our data augments the evidence that clean puncture wounding can mount a powerful innate immune transcriptional response, with different innate immune genes being activated in an interesting variety of ways. These include puncture-induced activation only in epidermal cells in the immediate vicinity of wounds, or in all epidermal cells, or specifically in the fat body, or in multiple tissues.	[Patterson, Rachel A.; Hermann, Anita; McGinnis, William] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Juarez, Michelle T.] CUNY, Sophie Davis Sch Biomed Educ, New York, NY 10021 USA; [Sasik, Roman; Hardiman, Gary] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education; University of California System; University of California San Diego	McGinnis, W (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	wmcginnis@ucsd.edu		Hardiman, Gary/0000-0003-4558-0400; Juarez, Michelle/0000-0002-6910-0881	NIH [R01 GM07797, R01 HD28315]; Stern Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028315] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stern Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	NIH R01 GM07797; NIH R01 HD28315; Stern Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Belacortu Y, 2011, DEV DYNAM, V240, P2379, DOI 10.1002/dvdy.22753; Bergner A, 1997, BIOL CHEM, V378, P283, DOI 10.1515/bchm.1997.378.3-4.283; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; Bernard JJ, 2011, CELL MOL LIFE SCI; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brock AR, 2012, J CELL SCI; Campos I, 2010, GENETICS, V184, P129, DOI 10.1534/genetics.109.110288; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; Cole J, 2001, WOUND REPAIR REGEN, V9, P360, DOI 10.1046/j.1524-475x.2001.00360.x; Colwell AS, 2008, WOUND REPAIR REGEN, V16, P450, DOI 10.1111/j.1524-475X.2008.00383.x; Cooper L, 2005, GENOME BIOL, V6; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Esfahani SS, 2011, DEV COMP IMMUNOL, V35, P263, DOI 10.1016/j.dci.2010.11.002; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Gabius HJ, 1997, EUR J BIOCHEM, V243, P543, DOI 10.1111/j.1432-1033.1997.t01-1-00543.x; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Geiger JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028349; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Han JF, 2000, P NATL ACAD SCI USA, V97, P9093, DOI 10.1073/pnas.97.16.9093; Harden N, 2005, SCIENCE, V308, P364, DOI 10.1126/science.1112050; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; IWANAGA S, 1992, THROMB RES, V68, P1, DOI 10.1016/0049-3848(92)90124-S; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Juarez MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002424; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kim M, 2011, P NATL ACAD SCI USA, V108, P650, DOI 10.1073/pnas.1016386108; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lanier LL, 1998, ADV EXP MED BIOL, V452, P13; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lesch C, 2010, GENETICS, V186, P943, DOI 10.1534/genetics.110.121822; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Li HM, 2008, INSECT MOL BIOL, V17, P325, DOI 10.1111/j.1365-2583.2008.00808.x; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Migeon JC, 1999, MOL BIOL CELL, V10, P1733, DOI 10.1091/mbc.10.6.1733; Moreira S, 2010, CURR BIOL, V20, P464, DOI 10.1016/j.cub.2010.01.047; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Osaki T, 2004, CELL MOL LIFE SCI, V61, P1257, DOI 10.1007/s00018-004-3396-5; Overmeyer JH, 2008, MOL CANCER RES, V6, P965, DOI 10.1158/1541-7786.MCR-07-2036; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; Pearson JC, 2009, P NATL ACAD SCI USA, V106, P2224, DOI 10.1073/pnas.0810219106; Radyuk SN, 2010, BBA-GEN SUBJECTS, V1800, P1153, DOI 10.1016/j.bbagen.2010.06.010; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; Razzell W, 2011, DIS MODEL MECH, V4, P569, DOI 10.1242/dmm.006825; Rose NL, 2003, TRANSPLANTATION, V75, P462, DOI 10.1097/01.TP.0000046537.47139.CE; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Sano Y, 2005, MOL BIOL CELL, V16, P2934, DOI 10.1091/mbc.E04-11-1008; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; SMITH CL, 1994, NATURE, V368, P548, DOI 10.1038/368548a0; SMITH CL, 1992, PROTEIN SCI, V1, P1225, DOI 10.1002/pro.5560010915; STEIN D, 1992, CELL, V68, P429, DOI 10.1016/0092-8674(92)90181-B; Stramer B, 2005, CURR BIOL, V15, pR425, DOI 10.1016/j.cub.2005.05.034; Stramer B, 2008, EMBO REP, V9, P465, DOI 10.1038/embor.2008.34; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Tingvall TO, 2001, P NATL ACAD SCI USA, V98, P3884, DOI 10.1073/pnas.061230198; Tingvall TO, 2001, EMBO REP, V2, P239; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wang SQ, 2009, NAT CELL BIOL, V11, P890, DOI 10.1038/ncb1898; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Wright TRF, 1996, J HERED, V87, P175, DOI 10.1093/oxfordjournals.jhered.a022983; Wu YJ, 2009, CURR BIOL, V19, P1473, DOI 10.1016/j.cub.2009.07.019	79	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61773	10.1371/journal.pone.0061773	http://dx.doi.org/10.1371/journal.pone.0061773			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637905	Green Published, gold			2022-12-25	WOS:000318340400049
J	Wu, SJ; Chiang, CJ; Lin, CT; Tien, HF; Lai, MS				Wu, Shang-Ju; Chiang, Chun-Ju; Lin, Chien-Ting; Tien, Hwei-Fang; Lai, Mei-Shu			Improving but Inferior Survival in Patients with Chronic Lymphocytic Leukemia in Taiwan: A Population-Based Study, 1990-2004	PLOS ONE			English	Article							PERIOD-COHORT ANALYSIS; BIM; LYMPHOMA; CANCER; AGE; EPIDEMIOLOGY; RESISTANCE; CLASSIFICATION; DIFFERENCE; TRENDS	Background: Chronic lymphocytic leukemia (CLL) is much less prevalent in Asian countries. Whether there are differences in survival outcomes between the East and West, however, remain unclear. Methods: The survival data for CLL patients identified in the Taiwan Cancer Registry database between 1990 and 2004, together with corresponding data in the US Surveillance, Epidemiology, and End Results database, were retrieved. The relative survivals (RS, adjusted for the expected survival in the general population) were estimated in patients diagnosed in three 5-year periods of time. Results: CLL drastically shortened patients' life expectancy; more importantly, this negative impact in Taiwan was much larger than that in the US: the 5-year RS in Taiwan and US were 59% and 76%, and the 10-year RS, 45% and 56%, respectively. Nevertheless, survival in Taiwan was better in the periods after 1995 (5-year RS, from 53.0% to 60.6%), a time period corresponding to the introduction of the Taiwan National Health Insurance scheme. Such improvement was largely due to decreased mortality in patients younger than 65 (5-year RS, from 53.5% to 69.1%). Despite the improvement, patients' RS in Taiwan in recent periods remain steadily 15 similar to 20% inferior to that in the US in both younger and older patient groups. Conclusions: The improved RS in Taiwan implies that therapeutic advances are changing the prognosis of CLL. The stable RS gap between Taiwanese and the US patients suggests the existence of an ethnic difference in CLL patients' outcomes.	[Wu, Shang-Ju; Lin, Chien-Ting; Tien, Hwei-Fang] Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan; [Wu, Shang-Ju] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chiang, Chun-Ju; Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chiang, Chun-Ju; Lai, Mei-Shu] Taiwan Canc Registry, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Tien, HF (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan.	hftien@ntu.edu.tw; mslai@ntu.edu.tw		TIEN, HWEI-FANG/0000-0002-1384-5593; WU, SHANG-JU/0000-0002-0772-869X; CHIANG, CHUN-JU/0000-0002-1330-5319; Lai, Mei-shu/0000-0001-6130-3468	National Science Council [NSC 99-2314-B-002-026-MY2]; Department of Medical Research, National Taiwan University Hospital Taiwan, Republic of China [NTUH 100-P04, 100-M1692, 101-N2014]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Medical Research, National Taiwan University Hospital Taiwan, Republic of China	This work was supported by grants from the National Science Council (NSC 99-2314-B-002-026-MY2), and Department of Medical Research, National Taiwan University Hospital (NTUH 100-P04, 100-M1692, and 101-N2014), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrisqueta P, 2009, BLOOD, V114, P2044, DOI 10.1182/blood-2009-04-214346; Anderson JR, 1998, ANN ONCOL, V9, P717, DOI 10.1023/A:1008265532487; [Anonymous], 1999, Am J Epidemiol, V150, P223; Brenner H, 2008, BLOOD, V111, P4916, DOI 10.1182/blood-2007-12-129379; CATOVSKY D, 1989, BRIT J HAEMATOL, V72, P141, DOI 10.1111/j.1365-2141.1989.tb07674.x; Chan WC, 1997, BLOOD, V89, P3909; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Chuang SS, 2000, CANCER, V89, P1586, DOI 10.1002/1097-0142(20001001)89:7&lt;1586::AID-CNCR24&gt;3.0.CO;2-1; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; Danese MD, 2011, BLOOD, V117, P3505, DOI 10.1182/blood-2010-08-301929; Dores GAM, 2007, BRIT J HAEMATOL, V139, P809, DOI 10.1111/j.1365-2141.2007.06856.x; Ederer F, 1959, INSTRUCTIONS IBM 650; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Goldin Lynn R, 2007, Hematology Am Soc Hematol Educ Program, P339; Gribben JG, 2008, J CLIN ONCOL, V26, P4864, DOI 10.1200/JCO.2008.17.7733; Gribben John G, 2008, Clin Adv Hematol Oncol, V6, P409; Gribben JG, 2009, BIOL BLOOD MARROW TR, V15, P53, DOI 10.1016/j.bbmt.2008.10.022; Gunawardana C, 2008, BRIT J HAEMATOL, V142, P606, DOI 10.1111/j.1365-2141.2008.07226.x; Hakulinen T, 2011, EUR J CANCER, V47, P2202, DOI 10.1016/j.ejca.2011.03.011; Hsu C, 2006, CANCER EPIDEM BIOMAR, V15, P856, DOI 10.1158/1055-9965.EPI-05-0821; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Lang HC, 2004, J FORMOS MED ASSOC, V103, P280; Lang HC, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-261; Li Z, 2007, CELL DEATH DIFFER, V14, P318, DOI 10.1038/sj.cdd.4401983; Lin MC, 2009, J FORMOS MED ASSOC, V108, P849, DOI 10.1016/S0929-6646(09)60416-2; Lin TS, 2005, J CLIN ONCOL, V23, P4009, DOI 10.1200/JCO.2005.08.964; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Parkin D., 2002, IARC PUBL, V8; Richter-Larrea JA, 2010, BLOOD, V116, P2531, DOI 10.1182/blood-2010-02-268003; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Wang J, 2011, J BIOL CHEM, V286, P22384, DOI 10.1074/jbc.M111.239566; Wu SJ, 2010, BLOOD, V116, P4430, DOI 10.1182/blood-2010-05-285221; Wu SJ, ANN HEMATOL IN PRESS; Zantl N, 2007, ONCOGENE, V26, P7038, DOI 10.1038/sj.onc.1210510	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62930	10.1371/journal.pone.0062930	http://dx.doi.org/10.1371/journal.pone.0062930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638168	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400132
J	Plata, KB; Riosa, S; Singh, CR; Rosato, RR; Rosato, AE				Plata, Konrad B.; Riosa, Sarah; Singh, Christopher R.; Rosato, Roberto R.; Rosato, Adriana E.			Targeting of PBP1 by beta-lactams Determines recA/SOS Response Activation in Heterogeneous MRSA Clinical Strains	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PENICILLIN-BINDING-PROTEINS; GALLERIA-MELLONELLA; SOS RESPONSE; VIRULENCE FACTORS; CELL-DIVISION; IN-VITRO; DAPTOMYCIN; EXPRESSION; OXACILLIN	The SOS response, a conserved regulatory network in bacteria that is induced in response to DNA damage, has been shown to be associated with the emergence of resistance to antibiotics. Previously, we demonstrated that heterogeneous (HeR) MRSA strains, when exposed to sub-inhibitory concentrations of oxacillin, were able to express a homogeneous high level of resistance (HoR). Moreover, we showed that oxacillin appeared to be the triggering factor of a beta-lactam-mediated SOS response through lexA/recA regulators, responsible for an increased mutation rate and selection of a HoR derivative. In this work, we demonstrated, by selectively exposing to beta-lactam and non-beta-lactam cell wall inhibitors, that PBP1 plays a critical role in SOS-mediated recA activation and HeR-HoR selection. Functional analysis of PBP1 using an inducible PBP1-specific antisense construct showed that PBP1 depletion abolished both beta-lactam-induced recA expression/activation and increased mutation rates during HeR/HoR selection. Furthermore, based on the observation that HeR/HoR selection is accompanied by compensatory increases in the expression of PBP1,-2, -2a, and -4, our study provides evidence that a combination of agents simultaneously targeting PBP1 and either PBP2 or PBP2a showed both in-vitro and in-vivo efficacy, thereby representing a therapeutic option for the treatment of highly resistant HoR-MRSA strains. The information gathered from these studies contributes to our understanding of beta-lactam-mediated HeR/HoR selection and provides new insights, based on beta-lactam synergistic combinations, that mitigate drug resistance for the treatment of MRSA infections.	[Plata, Konrad B.; Riosa, Sarah; Singh, Christopher R.; Rosato, Roberto R.; Rosato, Adriana E.] Methodist Hosp, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Plata, Konrad B.; Riosa, Sarah; Singh, Christopher R.; Rosato, Roberto R.; Rosato, Adriana E.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Rosato, AE (corresponding author), Methodist Hosp, Dept Pathol & Genom Med, 6535 Fannin, Houston, TX 77030 USA.	aerosato@tmhs.org		Rosato, Adriana E./0000-0001-6115-6955	United States National Institutes of Health [5R01AI080688-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080688] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by United States National Institutes of Health grant 5R01AI080688-03 (to A. E. Rosato, principal investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RL, 2001, ANTIMICROB AGENTS CH, V45, P454, DOI 10.1128/AAC.45.2.454-459.2001; Aubry-Damon H, 1998, ANTIMICROB AGENTS CH, V42, P2590, DOI 10.1128/AAC.42.10.2590; Bisognano C, 2004, J BIOL CHEM, V279, P9064, DOI 10.1074/jbc.M309836200; BOTTA GA, 1981, J BACTERIOL, V145, P333, DOI 10.1128/JB.145.1.333-340.1981; BRUCKNER R, 1993, J BACTERIOL, V175, P851; Cirz RT, 2006, ANTIMICROB AGENTS CH, V50, P220, DOI 10.1128/AAC.50.1.220-225.2006; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Costa T, 2008, MOL MICROBIOL, V70, P634, DOI 10.1111/j.1365-2958.2008.06432.x; Cuirolo A, 2009, J ANTIMICROB CHEMOTH, V64, P37, DOI 10.1093/jac/dkp164; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DELPORTILLO FG, 1987, J BACTERIOL, V169, P2410, DOI 10.1128/jb.169.6.2410-2416.1987; Desbois AP, 2011, J ANTIMICROB CHEMOTH, V66, P1785, DOI 10.1093/jac/dkr198; Dumitrescu O, 2011, ANTIMICROB AGENTS CH, V55, P3261, DOI 10.1128/AAC.01401-10; Finan JE, 2002, ANTIMICROB AGENTS CH, V46, P24, DOI 10.1128/AAC.46.1.24-30.2002; Forbes BA, 2008, DIAGN MICR INFEC DIS, V61, P387, DOI 10.1016/j.diagmicrobio.2008.04.003; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; GEORGOPAPADAKOU NH, 1982, ANTIMICROB AGENTS CH, V22, P172, DOI 10.1128/AAC.22.1.172; Goldstein F, 2007, ANTIMICROB AGENTS CH, V51, P2514, DOI 10.1128/AAC.00040-07; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hocquet D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002778; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Julian K, 2007, ANTIMICROB AGENTS CH, V51, P3445, DOI 10.1128/AAC.00559-07; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luong TT, 2006, MICROBIOL-SGM, V152, P3123, DOI 10.1099/mic.0.29177-0; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Miller C, 2003, J BACTERIOL, V185, P6025, DOI 10.1128/JB.185.20.6025-6031.2003; National Committee for Clinical Laboratory Standards, 2007, M2A8 NAT COMM CLIN L; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Olsen RJ, 2011, VIRULENCE, V2, P111, DOI 10.4161/viru.2.2.14338; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Pereira SFF, 2007, J BACTERIOL, V189, P3525, DOI 10.1128/JB.00044-07; Pereira SFF, 2009, MOL MICROBIOL, V72, P895, DOI 10.1111/j.1365-2958.2009.06687.x; Perez-Capilla T, 2005, J BACTERIOL, V187, P1515, DOI 10.1128/JB.187.4.1515-1518.2005; Pillai SK, 2007, ANTIMICROB AGENTS CH, V51, P2223, DOI 10.1128/AAC.00202-07; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; Pinho MG, 1997, MICROB DRUG RESIST, V3, P409, DOI 10.1089/mdr.1997.3.409; Plata KB, 2011, ANTIMICROB AGENTS CH, V55, P3176, DOI 10.1128/AAC.01119-09; Rosato A, 1998, ANTIMICROB AGENTS CH, V42, P1392, DOI 10.1128/AAC.42.6.1392; Rosato AE, 2003, J BACTERIOL, V185, P3446, DOI 10.1128/JB.185.11.3446-3452.2003; Rose WE, 2007, J ANTIMICROB CHEMOTH, V60, P334, DOI 10.1093/jac/dkm170; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Thanbichler M, 2010, COLD SPRING HARB PER, V2, P2; TOMASZ A, 1991, ANTIMICROB AGENTS CH, V35, P124, DOI 10.1128/AAC.35.1.124; Trong HNG, 2005, ANTIMICROB AGENTS CH, V49, P2098, DOI 10.1128/AAC.49.5.2098-2101.2005; Ubeda C, 2005, MOL MICROBIOL, V56, P836, DOI 10.1111/j.1365-2958.2005.04584.x; Wada A, 1998, J BACTERIOL, V180, P2759, DOI 10.1128/JB.180.10.2759-2765.1998; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Xiong YQ, 1999, ANTIMICROB AGENTS CH, V43, P1737, DOI 10.1128/AAC.43.7.1737; YANG YJ, 1995, J ANTIMICROB CHEMOTH, V35, P75, DOI 10.1093/jac/35.1.75	55	19	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61083	10.1371/journal.pone.0061083	http://dx.doi.org/10.1371/journal.pone.0061083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637786	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400024
J	Abdelhady, HG; Lin, YL; Sun, HP; ElSayed, MEH				Abdelhady, Hosam G.; Lin, Yen-Ling; Sun, Haiping; ElSayed, Mohamed E. H.			Visualizing the Attack of RNase Enzymes on Dendriplexes and Naked RNA Using Atomic Force Microscopy	PLOS ONE			English	Article							GENE DELIVERY; POLYAMIDOAMINE DENDRIMERS; STARBURST DENDRIMERS; DNA CONDENSATION; MAMMALIAN-CELLS; PLASMID DNA; IN-VITRO; SIRNA; INTERFERENCE; COMPLEXES	Cationic polymers such as poly(amidoamine), PAMAM, dendrimers have been used to electrostatically complex siRNA molecules forming dendriplexes for enhancing the cytoplasmic delivery of the encapsulated cargo. However, excess PAMAM dendrimers is typically used to protect the loaded siRNA against enzymatic attack, which results in systemic toxicity that hinders the in vivo use of these particles. In this paper, we evaluate the ability of G4 (flexible) and G5 (rigid) dendrimers to complex model siRNA molecules at low +/- ratio of 2/1 upon incubation for 20 minutes and 24 hours. We examine the ability of the formed G4 and G5 dendriplexes to shield the loaded siRNA molecules and protect them from degradation by RNase V1 enzymes using atomic force microscopy (AFM). Results show that G4 and G5 dendrimers form similar hexagonal complexes upon incubation with siRNA molecules for 20 minutes with average full width of 43 +/- 19.3 nm and 62 +/- 8.3 at half the maximum height, respectively. AFM images show that these G4 and G5 dendriplexes were attacked by RNase V1 enzyme leading to degradation of the exposed RNA molecules that increased with the increase in incubation time. In comparison, incubating G4 and G5 dendrimers with siRNA for 24 hours led to the formation of large particles with average full width of 263 +/- 60 nm and 48.3 +/- 2.5 nm at half the maximum height, respectively. Both G4 and G5 dendriplexes had a dense central core that proved to shield the loaded RNA molecules from enzymatic attack for up to 60 minutes. These results show the feasibility of formulating G4 and G5 dendriplexes at a low N/P (+/-) ratio that can resist degradation by RNase enzymes, which reduces the risk of inducing non-specific toxicity when used in vivo.	[Abdelhady, Hosam G.] Taibah Univ, Coll Pharm, Al Madinah Al Munawwarah, Saudi Arabia; [Abdelhady, Hosam G.] Natl Org Drug Control & Res, Cairo, Egypt; [Abdelhady, Hosam G.; Lin, Yen-Ling; ElSayed, Mohamed E. H.] Univ Michigan, Cellular Engn & Nanotherapeut Lab, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Sun, Haiping] Univ Michigan, Electron Microbeam Anal Lab, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [ElSayed, Mohamed E. H.] Univ Michigan, Macromol Sci & Engn Program, Ann Arbor, MI 48109 USA	Taibah University; National Organization for Drug Control & Research (NODCAR); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	ElSayed, MEH (corresponding author), Univ Michigan, Cellular Engn & Nanotherapeut Lab, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	melsayed@umich.edu		Gharib Abdelhady, Hosam/0000-0001-6653-3705	Science and Technology Unit at Taibah University; King Abdulaziz City for Science and Technology (KACST); National Science, Technology and Innovation Plan	Science and Technology Unit at Taibah University; King Abdulaziz City for Science and Technology (KACST); National Science, Technology and Innovation Plan	Hosam G. Abdelhady acknowledges the Science and Technology Unit at Taibah University, King Abdulaziz City for Science and Technology (KACST), and its National Science, Technology and Innovation Plan for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhady HG, 2005, NANOTECHNOLOGY, V16, P966, DOI 10.1088/0957-4484/16/6/058; Abdelhady HG, 2003, NUCLEIC ACIDS RES, V31, P4001, DOI 10.1093/nar/gkg462; BEZANILLA M, 1994, BIOPHYS J, V67, P2454, DOI 10.1016/S0006-3495(94)80733-7; Bielinska AU, 1997, BBA-GENE STRUCT EXPR, V1353, P180, DOI 10.1016/S0167-4781(97)00069-9; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Boeckle S, 2004, J GENE MED, V6, P1102, DOI 10.1002/jgm.598; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Eccleston A, 2004, NATURE, V431, P337, DOI 10.1038/431337a; El-Sayed MEH, 2005, EXPERT OPIN BIOL TH, V5, P23, DOI 10.1517/14712598.5.1.23; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ellis JS, 2004, J MICROSC-OXFORD, V215, P297, DOI 10.1111/j.0022-2720.2004.01379.x; FATTAL E, 1994, BIOCHEMISTRY-US, V33, P6721, DOI 10.1021/bi00187a044; Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g; FRECHET JMJ, 1994, SCIENCE, V263, P1710, DOI 10.1126/science.8134834; Funhoff AM, 2005, J CONTROL RELEASE, V101, P233, DOI 10.1016/j.jconrel.2004.06.023; Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021; HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012; Hansma HG, 1996, BIOPHYS J, V70, P1933, DOI 10.1016/S0006-3495(96)79757-6; Hansma HG, 1998, NUCLEIC ACIDS RES, V26, P2481, DOI 10.1093/nar/26.10.2481; HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795; Hassan Ali, 2006, Recent Pat Cardiovasc Drug Discov, V1, P141, DOI 10.2174/157489006777442540; Henderson RM, 2000, AM J PHYSIOL-RENAL, V278, pF689, DOI 10.1152/ajprenal.2000.278.5.F689; HOH JH, 1991, SCIENCE, V253, P1405, DOI 10.1126/science.1910206; Hori K, 1998, EUR BIOPHYS J BIOPHY, V27, P63, DOI 10.1007/s002490050111; Jensen LB, 2011, INT J PHARMACEUT, V416, P410, DOI 10.1016/j.ijpharm.2011.03.015; Jensen LB, 2010, BIOMACROMOLECULES, V11, P3571, DOI 10.1021/bm101033g; Karatasos K, 2012, MACROMOL BIOSCI, V12, P225, DOI 10.1002/mabi.201100276; Koutsilieri E, 2007, J NEURAL TRANSM-SUPP, P43; Kukowska-Latallo JF, 2000, HUM GENE THER, V11, P1385, DOI 10.1089/10430340050057468; KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897; Lee H, 2001, J CONTROL RELEASE, V76, P183, DOI 10.1016/S0168-3659(01)00426-6; Merkel OM, 2010, MOL PHARMACEUT, V7, P969, DOI 10.1021/mp100101s; NAYLOR AM, 1989, J AM CHEM SOC, V111, P2339, DOI 10.1021/ja00188a079; Neish CS, 2002, BRIT J PHARMACOL, V135, P1943, DOI 10.1038/sj.bjp.0704660; Ottaviani MF, 1996, J PHYS CHEM-US, V100, P13675, DOI 10.1021/jp960291r; Pavan GM, 2010, BIOMACROMOLECULES, V11, P721, DOI 10.1021/bm901298t; Perez AP, 2009, INT J PHARMACEUT, V380, P189, DOI 10.1016/j.ijpharm.2009.06.035; PUTMAN CAJ, 1994, APPL PHYS LETT, V64, P2454, DOI 10.1063/1.111597; Riddihough G, 2005, SCIENCE, V309, P1816; Shim MS, 2010, MICROSC RES TECHNIQ, V73, P845, DOI 10.1002/jemt.20856; Spagnou S, 2004, BIOCHEMISTRY-US, V43, P13348, DOI 10.1021/bi048950a; Wagner E, 2006, ADV POLYM SCI, V192, P135, DOI 10.1007/12_023; Yessine MA, 2004, ADV DRUG DELIVER REV, V56, P999, DOI 10.1016/j.addr.2003.10.039; Zeng FW, 1997, CHEM REV, V97, P1681, DOI 10.1021/cr9603892; Zhang J, 2007, MOL BIOTECHNOL, V37, P225, DOI 10.1007/s12033-007-9000-0	46	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61710	10.1371/journal.pone.0061710	http://dx.doi.org/10.1371/journal.pone.0061710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637890	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700054
J	Ding, GL; Chopp, M; Poulsen, DJ; Li, L; Qu, CS; Li, QJ; Nejad-Davarani, SP; Budaj, JS; Wu, HT; Mahmood, A; Jiang, Q				Ding, Guang Liang; Chopp, Michael; Poulsen, David J.; Li, Lian; Qu, Changsheng; Li, Qingjiang; Nejad-Davarani, Siamak P.; Budaj, John S.; Wu, Hongtao; Mahmood, Asim; Jiang, Quan			MRI of Neuronal Recovery after Low-Dose Methamphetamine Treatment of Traumatic Brain Injury in Rats	PLOS ONE			English	Article							MARROW STROMAL CELL; DIFFUSE AXONAL INJURY; WHITE-MATTER INJURY; CEREBRAL-ISCHEMIA; EMBOLIC STROKE; ATROPHY; TRANSPLANTATION; SUBPOPULATION; ARCHITECTURE; EXPRESSION	We assessed the effects of low dose methamphetamine treatment of traumatic brain injury (TBI) in rats by employing MRI, immunohistology, and neurological functional tests. Young male Wistar rats were subjected to TBI using the controlled cortical impact model. The treated rats (n = 10) received an intravenous (iv) bolus dose of 0.42 mg/kg of methamphetamine at eight hours after the TBI followed by continuous iv infusion for 24 hrs. The control rats (n = 10) received the same volume of saline using the same protocol. MRI scans, including T2-weighted imaging (T2WI) and diffusion tensor imaging (DTI), were performed one day prior to TBI, and at 1 and 3 days post TBI, and then weekly for 6 weeks. The lesion volumes of TBI damaged cerebral tissue were demarcated by elevated values in T-2 maps and were histologically identified by hematoxylin and eosin (H&E) staining. The fractional anisotropy (FA) values within regions-of-interest (ROI) were measured in FA maps deduced from DTI, and were directly compared with Bielschowsky's silver and Luxol fast blue (BLFB) immunohistological staining. No therapeutic effect on lesion volumes was detected during 6 weeks after TBI. However, treatment significantly increased FA values in the recovery ROI compared with the control group at 5 and 6 weeks after TBI. Myelinated axons histologically measured using BLFB were significantly increased (p<0.001) in the treated group (25.84 +/- 1.41%) compared with the control group (17.05 +/- 2.95%). Significant correlations were detected between FA and BLFB measures in the recovery ROI (R = 0.54, p<0.02). Methamphetamine treatment significantly reduced modified neurological severity scores from 2 to 6 weeks (p<0.05) and foot-fault errors from 3 days to 6 weeks (p<0.05) after TBI. Thus, the FA data suggest that methamphetamine treatment improves white matter reorganization from 5 to 6 weeks after TBI in rats compared with saline treatment, which may contribute to the observed functional recovery.	[Ding, Guang Liang; Chopp, Michael; Li, Lian; Li, Qingjiang; Nejad-Davarani, Siamak P.; Budaj, John S.; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Poulsen, David J.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Qu, Changsheng; Wu, Hongtao; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; University of Montana System; University of Montana; Henry Ford Health System; Henry Ford Hospital; Oakland University	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021	Ding, Guangliang/0000-0003-1286-5901; Li, Lian/0000-0003-0097-1184; Nejad-Davarani, Siamak/0000-0002-2415-6689	Department of Defense [CDMRP DR080702 (W81XWH-11-2-0026)]; National Institutes of Health [RO1 NS064134]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was financially supported by Department of Defense Grant CDMRP DR080702 (W81XWH-11-2-0026) and National Institutes of Health RO1 NS064134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Braun AA, 2011, NEUROSCIENCE, V184, P164, DOI 10.1016/j.neuroscience.2011.03.045; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Ding GL, 2011, STROKE, V42, P3537, DOI 10.1161/STROKEAHA.111.622092; Ding GL, 2010, J NEUROSCI RES, V88, P3206, DOI 10.1002/jnr.22470; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DZIABIS MD, 1958, STAIN TECHNOL, V33, P96; GOTTRON F, 1995, NEUROSCI LETT, V194, P1, DOI 10.1016/0304-3940(95)11698-V; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; KALCHEVA N, 1995, P NATL ACAD SCI USA, V92, P10894, DOI 10.1073/pnas.92.24.10894; Lazar M, 2008, MAGN RESON MED, V60, P774, DOI 10.1002/mrm.21725; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Llewellyn BD, 2009, BIOTECH HISTOCHEM, V84, P159, DOI 10.1080/10520290903052899; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McIntosh A, 2006, NEUROLOGY, V67, P2259, DOI 10.1212/01.wnl.0000249180.61312.d3; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; PECK DJ, 1992, MAGNET RESON MED, V26, P259, DOI 10.1002/mrm.1910260207; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tanaka K, 2003, BRAIN RES, V989, P172, DOI 10.1016/S0006-8993(03)03317-1; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]	54	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61241	10.1371/journal.pone.0061241	http://dx.doi.org/10.1371/journal.pone.0061241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637800	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700017
J	Paul, CPL; Schoorl, T; Zuiderbaan, HA; Doulabi, BZ; van der Veen, AJ; van de Ven, PM; Smit, TH; van Royen, BJ; Helder, MN; Mullender, MG				Paul, Cornelis P. L.; Schoorl, Tom; Zuiderbaan, Hendrik A.; Doulabi, Behrouz Zandieh; van der Veen, Albert J.; van de Ven, Peter M.; Smit, Theo H.; van Royen, Barend J.; Helder, Marco N.; Mullender, Margriet G.			Dynamic and Static Overloading Induce Early Degenerative Processes in Caprine Lumbar Intervertebral Discs	PLOS ONE			English	Article							NUCLEUS PULPOSUS TISSUE; IN-VITRO; EXTRACELLULAR-MATRIX; ANNULUS FIBROSUS; GENE-EXPRESSION; END-PLATES; BACK-PAIN; COMPRESSION; MODEL; CELLS	Mechanical overloading of the spine is associated with low back pain and intervertebral disc (IVD) degeneration. How excessive loading elicits degenerative changes in the IVD is poorly understood. Comprehensive knowledge of the interaction between mechanical loading, cell responses and changes in the extracellular matrix of the disc is needed in order to successfully intervene in this process. The purpose of the current study was to investigate whether dynamic and static overloading affect caprine lumbar discs differently and what mechanisms lead to mechanically induced IVD degeneration. Lumbar caprine IVDs (n = 175) were cultured 7, 14 and 21 days under simulated-physiological loading (control), high dynamic or high static loading. Axial deformation and stiffness were continuously measured. Cell viability, cell density, and gene expression were assessed in the nucleus, inner- and outer annulus. The extracellular matrix (ECM) was analyzed for water, glycosaminoglycan and collagen content. IVD height loss and changes in axial deformation were gradual with dynamic and acute with static overloading. Dynamic overloading caused cell death in all IVD regions, whereas static overloading mostly affected the outer annulus. IVDs expression of catabolic and inflammation-related genes was upregulated directly, whereas loss of water and glycosaminoglycan were significant only after 21 days. Static and dynamic overloading both induced pathological changes to caprine lumbar IVDs within 21 days. The mechanism by which they inflict biomechanical, cellular, and extracellular changes to the nucleus and annulus differed. The described cascades provide leads for the development of new pharmacological and rehabilitative therapies to halt the progression of DDD.	[Paul, Cornelis P. L.; Schoorl, Tom; Zuiderbaan, Hendrik A.; van der Veen, Albert J.; Smit, Theo H.; van Royen, Barend J.; Helder, Marco N.; Mullender, Margriet G.] Vrije Univ Amsterdam Med Ctr, Dept Orthopaed Surg, Amsterdam, Netherlands; [Paul, Cornelis P. L.; Smit, Theo H.; van Royen, Barend J.; Helder, Marco N.; Mullender, Margriet G.] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands; [van der Veen, Albert J.; Smit, Theo H.; van Royen, Barend J.; Helder, Marco N.] Vrije Univ Amsterdam Med Ctr, Skeletal Tissue Engn Grp Amsterdam, Amsterdam, Netherlands; [Doulabi, Behrouz Zandieh] Acad Ctr Dent Amsterdam, Dept Oral Cell Biol, NL-1066 EA Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Mullender, Margriet G.] Vrije Univ Amsterdam Med Ctr, Dept Plast Reconstruct & Hand Surg, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Mullender, MG (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Orthopaed Surg, Amsterdam, Netherlands.	m.mullender@vumc.nl	Paul/O-8870-2017; van Royen, Barend/W-4864-2019; Smit, Theo/N-7534-2019; Smit, Theodoor/AAX-6657-2020	van Royen, Barend/0000-0002-6548-7214; Smit, Theo/0000-0002-8906-7433; Zandieh Doulabi, Behrouz/0000-0002-0290-3241	Dutch Government ZonMw Program "Alternatives for life animal testing" [11400090]; government led consortium for the development of BioMedical Materials, BMM [P2.01 IDiDAS]	Dutch Government ZonMw Program "Alternatives for life animal testing"; government led consortium for the development of BioMedical Materials, BMM	This work is supported by the Dutch Government ZonMw Program "Alternatives for life animal testing" (grant number 11400090). The development of the LDCS is supported by the government led consortium for the development of BioMedical Materials, BMM (grant number P2.01 IDiDAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Barbir A, 2010, J BIOMECH, V43, P1067, DOI 10.1016/j.jbiomech.2009.12.005; Battie MC, 2009, SPINE J, V9, P47, DOI 10.1016/j.spinee.2008.11.011; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Chen J, 2004, MATRIX BIOL, V22, P573, DOI 10.1016/j.matbio.2003.11.008; Cheung KMC, 2010, SPINE J, V10, P958, DOI 10.1016/j.spinee.2010.09.011; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Ching CTS, 2004, MED ENG PHYS, V26, P587, DOI 10.1016/j.medengphy.2004.03.006; Creemers LB, 1997, BIOTECHNIQUES, V22, P656, DOI 10.2144/97224bm19; Dormans K. W., 2004, P 14 EUR SOC BIOM ES, P224; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Fosang AJ, 2010, METHODS MOL BIOL, V622, P305, DOI 10.1007/978-1-60327-299-5_19; Gilbert HTJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3229; Gilbert HTJ, 2010, ARTHRITIS RHEUM-US, V62, P3385, DOI 10.1002/art.27643; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290; Hancock MJ, 2010, SPINE, V35, P1925, DOI 10.1097/BRS.0b013e3181d60598; Hoogendoorn R, 2009, THESIS; Hoogendoorn R. J. W., 2005, EUR CELLS MAT S3, V10, P59; Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468; Iatridis JC, 1999, J ORTHOP RES, V17, P732, DOI 10.1002/jor.1100170517; Iatridis JC, 2004, J BIOMECH, V37, P1165, DOI 10.1016/j.jbiomech.2003.12.026; Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009; Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019; Kauppila LI, 2009, EUR J VASC ENDOVASC, V37, P661, DOI 10.1016/j.ejvs.2009.02.006; KOELLER W, 1984, BIORHEOLOGY, V21, P675; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Lakes R. S., 1998, VISCOELASTIC SOLIDS, P15; Lotz JC, 2002, BIOCHEM SOC T, V30, P853, DOI 10.1042/bst0300853; MacLean JL, 2004, J ORTHOP RES, V22, P1193, DOI 10.1016/j.orthres.2004.04.004; NACHEMSON AL, 1995, J NEUROSURG, V82, P1095; Neidlinger-Wilke C, 2006, EUR SPINE J, V15, pS372, DOI 10.1007/s00586-006-0112-1; Neidlinger-Wilke C, 2012, J ORTHOP RES, V30, P112, DOI 10.1002/jor.21481; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Rogerson FM, 2008, ARTHRITIS RHEUM-US, V58, P1664, DOI 10.1002/art.23458; Rutges JPHJ, 2008, J PATHOL, V214, P523, DOI 10.1002/path.2317; Schmidt H, 2009, MED ENG PHYS, V31, P642, DOI 10.1016/j.medengphy.2008.12.004; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Seguin CA, 2008, SPINE, V33, P356, DOI 10.1097/BRS.0b013e3181642a5e; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Seki S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2851; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346; Sowa GA, 2011, SPINE J, V11, P36, DOI 10.1016/j.spinee.2010.09.019; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Studer RK, 2011, SPINE, V36, P593, DOI 10.1097/BRS.0b013e3181da38d5; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; van der Veen AJ, 2007, J BIOMECH, V40, P2230, DOI 10.1016/j.jbiomech.2006.10.018; van der Veen AJ, 2008, J BIOMECH, V41, P1260, DOI 10.1016/j.jbiomech.2008.01.010; Vernon-Roberts B, 2008, SPINE, V33, P2767, DOI 10.1097/BRS.0b013e31817bb989; Vonk LA, 2010, BIOCHEM CELL BIOL, V88, P539, DOI [10.1139/O09-174, 10.1139/o09-174]; Vonk LA, 2010, MATRIX BIOL, V29, P209, DOI 10.1016/j.matbio.2009.12.001; Walsh AJL, 2004, J BIOMECH, V37, P329, DOI 10.1016/S0021-9290(03)00290-2; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; Wang DL, 2007, SPINE, V32, P2521, DOI 10.1097/BRS.0b013e318158cb61; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867; Yao J, 2006, BIOMATERIALS, V27, P377, DOI 10.1016/j.biomaterials.2005.06.036	60	74	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62411	10.1371/journal.pone.0062411	http://dx.doi.org/10.1371/journal.pone.0062411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638074	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300054
J	Larsson, E; Wahlstrand, B; Hedblad, B; Hedner, T; Kjeldsen, SE; Melander, O; Lindahl, P				Larsson, Erik; Wahlstrand, Bjorn; Hedblad, Bo; Hedner, Thomas; Kjeldsen, Sverre E.; Melander, Olle; Lindahl, Per			Hypertension and Genetic Variation in Endothelial-Specific Genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; QUANTITATIVE TRAITS; RISK; LOCI; POLYMORPHISM; CHOLESTEROL; POPULATIONS; MORTALITY; APOPTOSIS	Genome-wide association (GWA) studies usually detect common genetic variants with low-to-medium effect sizes. Many contributing variants are not revealed, since they fail to reach significance after strong correction for multiple comparisons. The WTCCC study for hypertension, for example, failed to identify genome-wide significant associations. We hypothesized that genetic variation in genes expressed specifically in the endothelium may be important for hypertension development. Results from the WTCCC study were combined with previously published gene expression data from mice to specifically investigate SNPs located within endothelial-specific genes, bypassing the requirement for genome-wide significance. Six SNPs from the WTCCC study were selected for independent replication in 5205 hypertensive patients and 5320 population-based controls, and successively in a cohort of 16537 individuals. A common variant (rs10860812) in the DRAM (damage-regulated autophagy modulator) locus showed association with hypertension (P = 0.008) in the replication study. The minor allele (A) had a protective effect (OR = 0.93; 95% CI 0.88-0.98 per A-allele), which replicates the association in the WTCCC GWA study. However, a second follow-up, in the larger cohort, failed to reveal an association with blood pressure. We further tested the endothelial-specific genes for co-localization with a panel of newly discovered SNPs from large meta-GWAS on hypertension or blood pressure. There was no significant overlap between those genes and hypertension or blood pressure loci. The result does not support the hypothesis that genetic variation in genes expressed in endothelium plays an important role for hypertension development. Moreover, the discordant association of rs10860812 with blood pressure in the case control study versus the larger Malmo "Preventive Project-study highlights the importance of rigorous replication in multiple large independent studies.	[Larsson, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Wahlstrand, Bjorn; Hedner, Thomas] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Hedblad, Bo; Melander, Olle] Malmo Univ Hosp, CRC, Malmo, Sweden; [Kjeldsen, Sverre E.] Ullevaal Univ Hosp, Dept Cardiol, Cardiovasc & Renal Res Ctr, Oslo, Norway; [Lindahl, Per] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Lund University; Skane University Hospital; University of Oslo; University of Gothenburg	Larsson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	erik.larsson@gu.se; per.lindahl@wlab.gu.se	Larsson Lekholm, Erik/AHE-0932-2022; Larsson Lekholm, Erik/HDM-8032-2022	Larsson Lekholm, Erik/0000-0003-1400-0119; Larsson Lekholm, Erik/0000-0003-1400-0119; Melander, Olle/0000-0002-2581-484X	Sahlgrenska Academy; Swedish Medical Research Council; Swedish Heart and Lung Foundation; Swedish Cancer Foundation; Polysackaridforskning AB; European Union [LSHG-CT-2004-503573]; Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Wallenberg Foundation; Lennart Hansson Memorial Fund; InGenious HyperCare (European Union, Network of Excellence) [037093]; Sahlgrenska Academy (ALF-LUA); Wellcome Trust [076113]	Sahlgrenska Academy; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Cancer Foundation; Polysackaridforskning AB(HOGANAS ABStatisticon AB); European Union(European Commission); Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Wallenberg Foundation(European Commission); Lennart Hansson Memorial Fund; InGenious HyperCare (European Union, Network of Excellence); Sahlgrenska Academy (ALF-LUA); Wellcome Trust(Wellcome Trust)	EL and PL were supported by the Sahlgrenska Academy, the Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Swedish Cancer Foundation, Polysackaridforskning AB and the European Union (Lymphangiogenomics, LSHG-CT-2004-503573). OM was supported by grants from the Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, Malmo University Hospital, the Albert Pahlsson Research Foundation, the Crafoord foundation, the Ernhold Lundstroms Research Foundation, the Region Skane, the Hulda and Conrad Mossfelt Foundation and the King Gustaf V and Queen Victoria Foundation. OM, TH, and BW were supported by the Wallenberg Foundation, the Lennart Hansson Memorial Fund and InGenious HyperCare (European Union, Network of Excellence, project number 037093). TH and BW were supported by the Sahlgrenska Academy (ALF-LUA). This study makes use of data generated by the Wellcome Trust Case-Control Consortium. Funding for the project was provided by the Wellcome Trust under award 076113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Arnett DK, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-43; Asai T, 2001, HYPERTENSION, V38, P1321, DOI 10.1161/hy1101.095333; Berglund G, 1996, J INTERN MED, V239, P489, DOI 10.1046/j.1365-2796.1996.483819000.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Glenn CL, 1999, HYPERTENSION, V33, P927, DOI 10.1161/01.HYP.33.4.927; Guo YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031489; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hedblad B, 2001, CIRCULATION, V103, P1721, DOI 10.1161/01.CIR.103.13.1721; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim SJ, 2012, CIRC J, V76, P907, DOI 10.1253/circj.CJ-11-0713; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rutherford S, 2001, HUM GENET, V109, P408, DOI 10.1007/s004390100565; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Tiret L, 1999, HYPERTENSION, V33, P1169, DOI 10.1161/01.HYP.33.5.1169; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961	37	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62035	10.1371/journal.pone.0062035	http://dx.doi.org/10.1371/journal.pone.0062035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637959	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800021
J	Barisani-Asenbauer, T; Inic-Kanada, A; Belij, S; Marinkovic, E; Stojicevic, I; Montanaro, J; Stein, E; Bintner, N; Stojanovic, M				Barisani-Asenbauer, Talin; Inic-Kanada, Aleksandra; Belij, Sandra; Marinkovic, Emilija; Stojicevic, Ivana; Montanaro, Jacqueline; Stein, Elisabeth; Bintner, Nora; Stojanovic, Marijana			The Ocular Conjunctiva as a Mucosal Immunization Route: A Profile of the Immune Response to the Model Antigen Tetanus Toxoid	PLOS ONE			English	Article							LYMPHOID-TISSUE; BORDETELLA-PERTUSSIS; TRICHOSURUS-VULPECULA; VACCINE; DIPHTHERIA; INFECTION	Background: In a quest for a needle-free vaccine administration strategy, we evaluated the ocular conjunctiva as an alternative mucosal immunization route by profiling and comparing the local and systemic immune responses to the subcutaneous or conjunctival administration of tetanus toxoid (TTd), a model antigen. Materials and methods: BALB/c and C57BL/6 mice were immunized either subcutaneously with TTd alone or via the conjunctiva with TTd alone, TTd mixed with 2% glycerol or TTd with merthiolate-inactivated whole-cell B. pertussis (wBP) as adjuvants. Mice were immunized on days 0, 7 and 14 via both routes, and an evaluation of the local and systemic immune responses was performed two weeks after the last immunization. Four weeks after the last immunization, the mice were challenged with a lethal dose (2 x LD50) of tetanus toxin. Results: The conjunctival application of TTd in BALB/c mice induced TTd-specific secretory IgA production and skewed the TTd-specific immune response toward a Th1/Th17 profile, as determined by the stimulation of IFN gamma and IL-17A secretion and/or the concurrent pronounced reduction of IL-4 secretion, irrespective of the adjuvant. In conjunctivaly immunized C57BL/6 mice, only TTd administered with wBP promoted the establishment of a mixed Th1/Th17 TTd-specific immune response, whereas TTd alone or TTd in conjunction with glycerol initiated a dominant Th1 response against TTd. Immunization via the conjunctiva with TTd plus wBP adjuvant resulted in a 33% survival rate of challenged mice compared to a 0% survival rate in non-immunized animals (p<0.05). Conclusion: Conjunctival immunization with TTd alone or with various adjuvants induced TTd-specific local and systemic immune responses, predominantly of the Th1 type. The strongest immune responses developed in mice that received TTd together with wBP, which implies that this alternative route might tailor the immune response to fight intracellular bacteria or viruses more effectively.	[Barisani-Asenbauer, Talin; Inic-Kanada, Aleksandra; Belij, Sandra; Montanaro, Jacqueline; Stein, Elisabeth; Bintner, Nora] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, OCUVAC Ctr Ocular Inflammat & Infect,Laura Bassi, Vienna, Austria; [Marinkovic, Emilija; Stojicevic, Ivana; Stojanovic, Marijana] Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia	Medical University of Vienna	Barisani-Asenbauer, T (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, OCUVAC Ctr Ocular Inflammat & Infect,Laura Bassi, Vienna, Austria.	talin.barisani@meduniwien.ac.at	Belij-Rammerstorfer, Sandra/B-8243-2018	Stein, Elisabeth/0000-0002-1240-506X; Stojanovic, Marijana/0000-0002-8204-4183; Inic-Kanada, Aleksandra/0000-0001-7854-3812; Lukic, Ivana/0000-0002-6330-471X; Belij-Rammerstorfer, Sandra/0000-0002-8637-3785; Barisani-Asenbauer, Talin/0000-0002-8661-9183	Laura Bassi Centers of Expertise (FFG) [822768]; Republic of Austria; Ministry of Education, Science, and Technological Development of the Republic of Serbia [172049]	Laura Bassi Centers of Expertise (FFG); Republic of Austria; Ministry of Education, Science, and Technological Development of the Republic of Serbia	This research was funded by the Laura Bassi Centers of Expertise (FFG Project Number: 822768, http://www.ffg.at/en) and the Republic of Austria and was partly supported by the Ministry of Education, Science, and Technological Development of the Republic of Serbia (Grant Number 172049, http://www.mpn.gov.rs/sajt/index.php?page=1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerbeck H, 1996, VACCINE, V14, P1265, DOI 10.1016/S0264-410X(96)00092-8; Corner LAL, 2005, NEW ZEAL VET J, V53, P133, DOI 10.1080/00480169.2005.36490; Corner LAL, 2003, VET J, V166, P177, DOI 10.1016/S1090-0233(02)00311-8; Martins RD, 2012, J CONTROL RELEASE, V162, P553, DOI 10.1016/j.jconrel.2012.07.030; Daniel Nelson J, 2010, CORNEA, P25; Egan RM, 2000, J IMMUNOL, V164, P4543, DOI 10.4049/jimmunol.164.9.4543; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; FENSTERBANK R, 1985, ANN RECH VET, V16, P351; Fujkuyama Y, 2012, EXPERT REV VACCINES, V11, P367, DOI [10.1586/erv.11.196, 10.1586/ERV.11.196]; Garin-Bastuji B, 1998, VET RES, V29, P255; Gebril A, 2012, EXPERT REV VACCINES, V11, P1139, DOI [10.1586/ERV.12.81, 10.1586/erv.12.81]; Gore TC, 2006, VET THER, V7, P213; Grangett C, 2001, INFECT IMMUN, V69, P1547, DOI 10.1128/IAI.69.3.1547-1553.2001; Gukasyan HJ, 2008, IN VITRO, P310; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Kageyama M, 2006, ARCH HISTOL CYTOL, V69, P311, DOI 10.1679/aohc.69.311; Knop E, 2005, J ANAT, V206, P271, DOI 10.1111/j.1469-7580.2005.00394.x; Knop E, 2003, OPHTHALMOLOGE, V100, P929, DOI 10.1007/s00347-003-0936-6; Lavigne MV, 2004, MICROBES INFECT, V6, P481, DOI 10.1016/j.micinf.2004.01.004; Lavigne MV, 2002, MICROBES INFECT, V4, P815, DOI 10.1016/S1286-4579(02)01601-5; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Men Y, 1999, VACCINE, V17, P1047, DOI 10.1016/S0264-410X(98)00321-1; Mishra KP, 2010, IMMUNOPHARM IMMUNOT, V32, P141, DOI [10.3109/08923970903218874, 10.3109/08923970903503668]; Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; Osorio JE, 2004, J DRUG TARGET, V11, P463, DOI 10.1080/10611860410001670062; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; Pepose JS, 2006, AM J OPHTHALMOL, V141, P547, DOI 10.1016/j.ajo.2005.10.008; Rowe J, 2005, INFECT IMMUN, V73, P8130, DOI 10.1128/IAI.73.12.8130-8135.2005; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Steven P, 2009, OPHTHAL RES, V42, P2, DOI 10.1159/000219678; Terpstra C, 1996, VACCINE, V14, P570, DOI 10.1016/0264-410X(96)83467-0; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214	35	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e60682	10.1371/journal.pone.0060682	http://dx.doi.org/10.1371/journal.pone.0060682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637758	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700005
J	Okiro, EA; Kazembe, LN; Kabaria, CW; Ligomeka, J; Noor, AM; Ali, D; Snow, RW				Okiro, Emelda A.; Kazembe, Lawrence N.; Kabaria, Caroline W.; Ligomeka, Jeffrey; Noor, Abdisalan M.; Ali, Doreen; Snow, Robert W.			Childhood Malaria Admission Rates to Four Hospitals in Malawi between 2000 and 2010	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; SCALE-UP; PEDIATRIC MALARIA; FEBRILE ILLNESS; MORBIDITY; MORTALITY; CHILDREN; BURDEN; TRENDS; IMPACT	Introduction: The last few years have witnessed rapid scaling-up of key malaria interventions in several African countries following increases in development assistance. However, there is only limited country-specific information on the health impact of expanded coverage of these interventions. Methods: Paediatric admission data were assembled from 4 hospitals in Malawi reflecting different malaria ecologies. Trends in monthly clinical malaria admissions between January 2000 and December 2010 were analysed using time-series models controlling for covariates related to climate and service use to establish whether changes in admissions can be related to expanded coverage of interventions aimed at reducing malaria infection. Results: In 3 of 4 sites there was an increase in clinical malaria admission rates. Results from time series models indicate a significant month-to-month increase in the mean clinical malaria admission rates at two hospitals (trend P<0.05). At these hospitals clinical malaria admissions had increased from 2000 by 41% to 100%. Comparison of changes in malaria risk and ITN coverage appear to correspond to a lack of disease declines over the period. Changes in intervention coverage within hospital catchments showed minimal increases in ITN coverage from <6% across all sites in 2000 to maximum of 33% at one hospital site by 2010. Additionally, malaria transmission intensity remained unchanged between 2000-2010 across all sites. Discussion: Despite modest increases in coverage of measures to reduce infection there has been minimal changes in paediatric clinical malaria cases in four hospitals in Malawi. Studies across Africa are increasingly showing a mixed set of impact results and it is important to assemble more data from more sites to understand the wider implications of malaria funding investment. We also caution that impact surveillance should continue in areas where intervention coverage is increasing with time, for example Malawi, as decline may become evident within a period when coverage reaches optimal levels.	[Okiro, Emelda A.; Kabaria, Caroline W.; Noor, Abdisalan M.; Snow, Robert W.] Kenya Med Res Inst Wellcome Trust Univ Oxford Col, Malaria Publ Hlth Dept, Nairobi, Kenya; [Okiro, Emelda A.; Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Kazembe, Lawrence N.] Univ Malawi, Chancellor Coll, Dept Math Sci, Zomba, Malawi; [Kazembe, Lawrence N.] Univ Namibia, Dept Stat, Windhoek, Namibia; [Ligomeka, Jeffrey] Zomba Cent Hosp, Records Dept, Zomba, Malawi; [Ali, Doreen] Minist Hlth, Natl Malaria Control Programme, Lilongwe, Malawi	Kenya Medical Research Institute; University of Oxford; University of Malawi; University of Namibia	Okiro, EA (corresponding author), Kenya Med Res Inst Wellcome Trust Univ Oxford Col, Malaria Publ Hlth Dept, Nairobi, Kenya.	eokiro@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; Okiro, Emelda/0000-0001-9543-8360; Kabaria, Caroline/0000-0002-5641-5243	Wellcome Trust, UK; Kenyan Medical Research Institute; Wellcome Trust [086166, 079080]; Novartis; Pfizer	Wellcome Trust, UK(Wellcome Trust); Kenyan Medical Research Institute; Wellcome Trust(Wellcome TrustEuropean Commission); Novartis(Novartis); Pfizer(Pfizer)	This study received financial support from The Wellcome Trust, UK and The Kenyan Medical Research Institute. EAO is supported by the Wellcome Trust as a Research Training Fellow (#086166). RWS is supported by the Wellcome Trust as Principal Research Fellow (#079080) that also supports CWK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors' have read the journal's policy and have the following conflicts: RWS has received funding from Novartis for chairing meetings of national control programmes in Africa and EAO has received honoraria from Novartis at their regional best practice workshops. RWS has received a research grant from Pfizer. All other authors have no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], TIME SERIES ANAL FOR; [Anonymous], ACC PROGR HLTH REL M; [Anonymous], NAT MAL CONTR PROGR; Arcury TA, 2005, HEALTH SERV RES, V40, P135, DOI 10.1111/j.1475-6773.2005.00346.x; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bennett A, AM J TROPIC IN PRESS; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Gething PW, 2004, ACTA TROP, V91, P227, DOI 10.1016/j.actatropica.2004.05.002; GILL CA, 1938, SEASONAL PERIODICITY; Graves PM, 2008, TROP MED INT HEALTH, V13, P218, DOI 10.1111/j.1365-3156.2007.01993.x; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; KLOOS H, 1990, SOC SCI MED, V31, P101, DOI 10.1016/0277-9536(90)90052-T; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; Linard Catherine, 2010, Int J Health Geogr, V9, P45, DOI 10.1186/1476-072X-9-45; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mabiala-Babela JR, 2003, ARCH PEDIATRIE, V10, P650, DOI 10.1016/S0929-693X(03)00290-2; Maegga B T A, 2005, Tanzan Health Res Bull, V7, P125; Malawi National Malaria Control Programme, 2010, MAL NAT MAL IND SURV; Measure-DHS, 2004, MAL DEM HLTH SURV; Measure-DHS, 2000, MAL DEM HLTH SURV; Measure-DHS, 2010, MAL DEM HLTH SURV; Mufunda J, 2007, SAMJ S AFR MED J, V97, P46; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; Munier A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-270; National Statistical Office, 2008, 2008 POP HOUS CENS; Ndymugyenyi R, 2004, ANN TROP MED PARASIT, V98, P315, DOI 10.1179/000349804225003433; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okiro EA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-37; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; President's Malaria Initiative, 2009, MAL MAL OP PLAN FY 2; President's Malaria Initiative, 2007, MAL MAL OP PLAN FY 2; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Roca-Feltrer A, 2012, EMERG INFECT DIS, V18, P272, DOI 10.3201/eid1802.111008; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Roll Back Malaria, 2010, SAV LIV MAL CONTR CO; Roll Back Malaria Partnership, 2012, FOC SWAZ PROGR IMP S; Rose-Wood A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-319; Sarrassat S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-215; Sievers AC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-167; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Tanser F, 2001, TROP MED INT HEALTH, V6, P826, DOI 10.1046/j.1365-3156.2001.00794.x; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; UNDP, 2012, UNDP HUM DEV REP; USGS, 2006, SHUTTL RAD TOP MISS	73	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62214	10.1371/journal.pone.0062214	http://dx.doi.org/10.1371/journal.pone.0062214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638008	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700040
J	Lang, JM; Darling, AE; Eisen, JA				Lang, Jenna Morgan; Darling, Aaron E.; Eisen, Jonathan A.			Phylogeny of Bacterial and Archaeal Genomes Using Conserved Genes: Supertrees and Supermatrices	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIUM; MATRIX REPRESENTATION; SP-NOV.; HORIZONTAL TRANSFER; MAXIMUM-LIKELIHOOD; SPECIES TREES; DATA SETS; EVOLUTION; LIFE; RECONSTRUCTION	Over 3000 microbial (bacterial and archaeal) genomes have been made publically available to date, providing an unprecedented opportunity to examine evolutionary genomic trends and offering valuable reference data for a variety of other studies such as metagenomics. The utility of these genome sequences is greatly enhanced when we have an understanding of how they are phylogenetically related to each other. Therefore, we here describe our efforts to reconstruct the phylogeny of all available bacterial and archaeal genomes. We identified 24, single-copy, ubiquitous genes suitable for this phylogenetic analysis. We used two approaches to combine the data for the 24 genes. First, we concatenated alignments of all genes into a single alignment from which a Maximum Likelihood (ML) tree was inferred using RAxML. Second, we used a relatively new approach to combining gene data, Bayesian Concordance Analysis (BCA), as implemented in the BUCKy software, in which the results of 24 single-gene phylogenetic analyses are used to generate a "primary concordance'' tree. A comparison of the concatenated ML tree and the primary concordance (BUCKy) tree reveals that the two approaches give similar results, relative to a phylogenetic tree inferred from the 16S rRNA gene. After comparing the results and the methods used, we conclude that the current best approach for generating a single phylogenetic tree, suitable for use as a reference phylogeny for comparative analyses, is to perform a maximum likelihood analysis of a concatenated alignment of conserved, single-copy genes.	[Lang, Jenna Morgan; Darling, Aaron E.; Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Lang, Jenna Morgan; Darling, Aaron E.; Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Lang, Jenna Morgan; Eisen, Jonathan A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Eisen, JA (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	jaeisen@ucdavis.edu	Darling, Aaron/G-8119-2017; Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Darling, Aaron/0000-0003-2397-7925; Lang, Jenna/0000-0002-4871-4497	US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Gordon and Betty Moore Foundation [1660]; Department of Homeland Security [201118313]	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Homeland Security(United States Department of Homeland Security (DHS))	This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231. Funding was also provided by Gordon and Betty Moore Foundation Grant 1660 (www.moore.org) and Department of Homeland Security contract #201118313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Alexe G, 2004, DISCRETE APPL MATH, V145, P11, DOI 10.1016/j.dam.2003.09.004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Beiko RG, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-34; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bininda-Emonds ORP, 2001, SYST BIOL, V50, P565, DOI 10.1080/106351501750435112; Bouchard-Cote A, 2012, SYSTEMATIC BIOL; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Chang W-C, MAXIMAL BICLIQUE ENU; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Darwin C., 1859, ORIGIN SPECIES MEANS; Daubin V, 2001, Genome Inform, V12, P155; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eddy Sean R, 2009, Genome Inform, V23, P205; Eisen JA, 1995, J MOL EVOL, V41, P1105; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Gatesy J, 2005, SYST BIOL, V54, P483, DOI 10.1080/10635150590945368; Hao W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-235; HENRY EA, 1994, ARCH MICROBIOL, V161, P62, DOI 10.1007/BF00248894; HILARIO E, 1993, BIOSYSTEMS, V31, P111, DOI 10.1016/0303-2647(93)90038-E; Holland B, 2007, SYST BIOL, V56, P57, DOI 10.1080/10635150601167013; Huntemann M, 2011, STAND GENOMIC SCI, V4, P303, DOI 10.4056/sigs.1814460; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Keim PS, 2009, NAT REV MICROBIOL, V7, P813, DOI 10.1038/nrmicro2219; Kembel SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023214; Klein M, 2001, J BACTERIOL, V183, P6028, DOI 10.1128/JB.183.20.6028-6035.2001; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kuck P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036593; Kupczok A, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-37; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leigh JW, 2011, MOL BIOL EVOL, V28, P2773, DOI 10.1093/molbev/msr110; Levasseur C, 2006, EVOL BIOINFORM, V2, P1; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; McDonald D., 2012, ISME J; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Messick JB, 2011, J BACTERIOL, V193, P2068, DOI 10.1128/JB.00133-11; Miroshnichenko ML, 1999, INT J SYST BACTERIOL, V49, P1033, DOI 10.1099/00207713-49-3-1033; Mori K, 2003, EXTREMOPHILES, V7, P283, DOI 10.1007/s00792-003-0320-0; Moussard H, 2004, INT J SYST EVOL MICR, V54, P227, DOI 10.1099/ijs.0.02669-0; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nishida H, 2011, GENOMICS, V98, P370, DOI 10.1016/j.ygeno.2011.08.001; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; Ocana KACS, 2011, EVOL BIOINFORM, V7, P107, DOI 10.4137/EBO.S6861; Pisani D, 2002, SYST BIOL, V51, P151, DOI 10.1080/106351502753475925; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Ren FR, 2009, GENE, V441, P119, DOI 10.1016/j.gene.2008.04.002; Retief J D, 2000, Methods Mol Biol, V132, P243; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Ronquist F., 2012, SYST BIOL; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan Jack, 1997, Journal of Mammalian Evolution, V4, P77, DOI 10.1023/A:1027314112438; Thao ML, 2001, CURR MICROBIOL, V42, P419, DOI 10.1007/s002840010240; Van Leuven JT, 2012, GENOME BIOL EVOL; Vila R, 2011, P ROY SOC B-BIOL SCI, V278, P2737, DOI 10.1098/rspb.2010.2213; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Wiens JJ, 2008, J SYST EVOL, V46, P307, DOI 10.3724/SP.J.1002.2008.08040; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Yang J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S4; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972	85	93	93	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62510	10.1371/journal.pone.0062510	http://dx.doi.org/10.1371/journal.pone.0062510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638103	Green Submitted, gold, Green Published			2022-12-25	WOS:000318341400055
J	Pfaller, JB; Bjorndal, KA; Chaloupka, M; Williams, KL; Frick, MG; Bolten, AB				Pfaller, Joseph B.; Bjorndal, Karen A.; Chaloupka, Milani; Williams, Kristina L.; Frick, Michael G.; Bolten, Alan B.			Accounting for Imperfect Detection Is Critical for Inferring Marine Turtle Nesting Population Trends	PLOS ONE			English	Article							TEMPORARY EMIGRATION; SURVIVAL; MODELS; CONSERVATION; TIME	Assessments of population trends based on time-series counts of individuals are complicated by imperfect detection, which can lead to serious misinterpretations of data. Population trends of threatened marine turtles worldwide are usually based on counts of nests or nesting females. We analyze 39 years of nest-count, female-count, and capture-mark-recapture (CMR) data for nesting loggerhead turtles (Caretta caretta) on Wassaw Island, Georgia, USA. Annual counts of nests and females, not corrected for imperfect detection, yield significant, positive trends in abundance. However, multistate open robust design modeling of CMR data that accounts for changes in imperfect detection reveals that the annual abundance of nesting females has remained essentially constant over the 39-year period. The dichotomy could result from improvements in surveys or increased within-season nest-site fidelity in females, either of which would increase detection probability. For the first time in a marine turtle population, we compare results of population trend analyses that do and do not account for imperfect detection and demonstrate the potential for erroneous conclusions. Past assessments of marine turtle population trends based exclusively on count data should be interpreted with caution and re-evaluated when possible. These concerns apply equally to population assessments of all species with imperfect detection.	[Pfaller, Joseph B.; Williams, Kristina L.] Caretta Res Project, Savannah, GA USA; [Pfaller, Joseph B.; Bjorndal, Karen A.; Frick, Michael G.; Bolten, Alan B.] Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL USA; [Pfaller, Joseph B.; Bjorndal, Karen A.; Frick, Michael G.; Bolten, Alan B.] Univ Florida, Dept Biol, Gainesville, FL USA; [Chaloupka, Milani] Univ Queensland, Ecol Modeling Serv PL, St Lucia, Qld, Australia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Queensland	Pfaller, JB (corresponding author), Caretta Res Project, Savannah, GA USA.	jpfaller@ufl.edu		Bjorndal, Karen/0000-0002-6286-1901; Bolten, Alan/0000-0002-4834-2742	Georgia Ports Authority; Shared Earth Foundation; Anderson-Rogers Foundation; Imlay Foundation, Inc.; Sweetwater Foundation; Georgia Department of Natural Resources; U.S. Fish and Wildlife Service/Savannah Coastal Refuges; Wassaw Island LLC.	Georgia Ports Authority; Shared Earth Foundation; Anderson-Rogers Foundation; Imlay Foundation, Inc.; Sweetwater Foundation; Georgia Department of Natural Resources; U.S. Fish and Wildlife Service/Savannah Coastal Refuges; Wassaw Island LLC.	General operating expenses for the Caretta Research Project on Wassaw Island were funded by the Georgia Ports Authority (www.gaports.com), the Shared Earth Foundation (www.sharedearth.org), the Anderson-Rogers Foundation (foundationcenter.org/grantmaker/arfdn), the Imlay Foundation, Inc. (theimlayfoundation.org), and the Sweetwater Foundation (sweetwaterfoundation.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the assistants, volunteers and supporters of the Caretta Research Project. We appreciate the support provided by the Georgia Department of Natural Resources, U.S. Fish and Wildlife Service/Savannah Coastal Refuges, and Wassaw Island LLC.	Bjorndal KA, 1999, CONSERV BIOL, V13, P126, DOI 10.1046/j.1523-1739.1999.97329.x; Bjorndal KA, 2005, ECOL APPL, V15, P304, DOI 10.1890/04-0059; Bjorndal KA, 2011, SCIENCE, V331, P537, DOI 10.1126/science.1199935; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Chaloupka MY, 2002, MAR BIOL, V140, P267, DOI 10.1007/s002270100697; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Converse SJ, 2009, AUK, V126, P77, DOI 10.1525/auk.2009.07189; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Heppell SS, 2003, CRC MAR BIOL SER, P275; Heppell SS, 1999, AM FISH S S, V23, P137; Holmberg Jason, 2009, Endangered Species Research, V7, P39, DOI 10.3354/esr00186; IUCN, 2022, IUCN RED LIST THREAT; Kendall W. L., 2004, Animal Biodiversity and Conservation, V27, P97; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kendall WL, 2001, BIOMETRICS, V57, P1113, DOI 10.1111/j.0006-341X.2001.01113.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; McClenachan L, 2012, CONSERV LETT, V5, P349, DOI 10.1111/j.1755-263X.2012.00253.x; Miller Jeffrey D., 1997, P51; National Research Council, 2010, ASS SEA TURTL STAT T; NMFS USFWS (National Marine Fisheries Service US Fish and Wildlife Service), 2008, REC PLAN NW ATL POP; Pilcher N, 2013, ENDANGER SPECIES RES, V20, P49, DOI 10.3354/esr00480; Prince RIT, 2012, MAR BIOL, V159, P355, DOI 10.1007/s00227-011-1813-5; Rivalan P, 2006, MAR ECOL PROG SER, V317, P285, DOI 10.3354/meps317285; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Schwarz CJ, 1997, BIOMETRICS, V53, P178, DOI 10.2307/2533106; TEWG [Turtle Expert Working Group], 2009, ASS LOGG TURTL POP W; White GC, 2006, J WILDLIFE MANAGE, V70, P1521, DOI 10.2193/0022-541X(2006)70[1521:MSMATE]2.0.CO;2; Williams KL, 2008, SOUTHEAST NAT, V7, P165, DOI 10.1656/1528-7092(2008)7[165:TRFLTF]2.0.CO;2	30	44	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62326	10.1371/journal.pone.0062326	http://dx.doi.org/10.1371/journal.pone.0062326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638041	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400097
J	Rehan, M; Hong, KS				Rehan, Muhammad; Hong, Keum-Shik			Modeling and Automatic Feedback Control of Tremor: Adaptive Estimation of Deep Brain Stimulation	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; FULL-ORDER; DYNAMICS; SYNCHRONIZATION; FREQUENCY; AMPLITUDE	This paper discusses modeling and automatic feedback control of ( postural and rest) tremor for adaptive-controlmethodology- based estimation of deep brain stimulation (DBS) parameters. The simplest linear oscillator-based tremor model, between stimulation amplitude and tremor, is investigated by utilizing input-output knowledge. Further, a nonlinear generalization of the oscillator-based tremor model, useful for derivation of a control strategy involving incorporation of parametric-bound knowledge, is provided. Using the Lyapunov method, a robust adaptive output feedback control law, based on measurement of the tremor signal from the fingers of a patient, is formulated to estimate the stimulation amplitude required to control the tremor. By means of the proposed control strategy, an algorithm is developed for estimation of DBS parameters such as amplitude, frequency and pulse width, which provides a framework for development of an automatic clinical device for control of motor symptoms. The DBS parameter estimation results for the proposed control scheme are verified through numerical simulations.	[Rehan, Muhammad] Pakistan Inst Engn & Appl Sci, Dept Elect Engn, Islamabad, Pakistan; [Hong, Keum-Shik] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan, South Korea; [Hong, Keum-Shik] Pusan Natl Univ, Sch Mech Engn, Pusan, South Korea	Pakistan Institute of Engineering & Applied Science; Pusan National University; Pusan National University	Rehan, M (corresponding author), Pakistan Inst Engn & Appl Sci, Dept Elect Engn, Islamabad, Pakistan.	rehanqau@gmail.com	Hong, Keum-Shik/B-9911-2013; Rehan, Muhammad/ABG-5590-2020	Hong, Keum-Shik/0000-0002-8528-4457; Rehan, Muhammad/0000-0002-9908-3971	Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-20004, MEST-2012-R1A2A2A01046411]	Ministry of Education, Science and Technology through the National Research Foundation of Korea	The second author was supported by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (grant no. R31-20004 and MEST-2012-R1A2A2A01046411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszadeh M, 2012, AUTOMATICA, V48, P894, DOI 10.1016/j.automatica.2012.02.033; Aguilar-Lopez R, 2008, CHAOS SOLITON FRACT, V37, P539, DOI 10.1016/j.chaos.2006.09.029; Aqil M, 2012, NEUROIMAGE, V63, P553, DOI 10.1016/j.neuroimage.2012.07.006; Bartolic A, 2010, MED HYPOTHESES, V74, P362, DOI 10.1016/j.mehy.2009.06.057; Behrend CE, 2009, J NEUROSCI METH, V180, P278, DOI 10.1016/j.jneumeth.2009.04.001; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Beuter A, 2003, BRAIN COGNITION, V53, P190, DOI 10.1016/S0278-2626(03)00107-6; Donnell P, 2009, J THEOR BIOL, V261, P120, DOI 10.1016/j.jtbi.2009.07.012; Earhart GM, 2007, EXP NEUROL, V208, P257, DOI 10.1016/j.expneurol.2007.08.014; Frankemolle AMM, 2010, BRAIN, V133, P746, DOI 10.1093/brain/awp315; Haeri M, 2005, J THEOR BIOL, V236, P311, DOI 10.1016/j.jtbi.2005.03.014; Jobst B, 2010, EPILEPSY RES, V89, P154, DOI 10.1016/j.eplepsyres.2009.08.017; Khalil HK, 2002, NONLINEAR SYSTEMS, V3; Limousin P, 2008, NEUROTHERAPEUTICS, V5, P309, DOI 10.1016/j.nurt.2008.01.006; Lin W, 2008, PHYS LETT A, V372, P3195, DOI 10.1016/j.physleta.2008.01.038; Lu GP, 2006, IEEE T CIRCUITS-II, V53, P563, DOI 10.1109/TCSII.2006.875332; Melzer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047617; Mera T, 2011, J NEUROSCI METH, V198, P280, DOI 10.1016/j.jneumeth.2011.03.019; Modolo J, 2009, MED ENG PHYS, V31, P615, DOI 10.1016/j.medengphy.2009.01.005; Ostrem JL, 2008, NEUROTHERAPEUTICS, V5, P320, DOI 10.1016/j.nurt.2008.01.002; Perozzo P, 2001, J NEUROL SCI, V192, P9, DOI 10.1016/S0022-510X(01)00575-5; Rehan M, 2011, PHYS LETT A, V375, P1666, DOI 10.1016/j.physleta.2011.03.012; Rehan M, 2011, NONLINEAR ANAL-REAL, V12, P1786, DOI 10.1016/j.nonrwa.2010.11.011; Rehan M, 2010, J CHIN INST ENG, V33, P397, DOI 10.1080/02533839.2010.9671628; Santaniello S, 2011, IEEE T NEUR SYS REH, V19, P15, DOI 10.1109/TNSRE.2010.2081377; Thompson CJ, 1999, CHAOS SOLITON FRACT, V10, P1825, DOI 10.1016/S0960-0779(98)00131-3; Titcombe MS, 2001, CHAOS, V11, P766, DOI 10.1063/1.1408257; Ushe M, 2004, MOVEMENT DISORD, V19, P1163, DOI 10.1002/mds.20231; Wojtecki L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024589; Zhang DG, 2011, CONTROL ENG PRACT, V19, P74, DOI 10.1016/j.conengprac.2010.08.009	30	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62888	10.1371/journal.pone.0062888	http://dx.doi.org/10.1371/journal.pone.0062888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638163	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400131
J	Sukhotinsky, I; Chan, AM; Ahmed, OJ; Rao, VR; Gradinaru, V; Ramakrishnan, C; Deisseroth, K; Majewska, AK; Cash, SS				Sukhotinsky, Inna; Chan, Alexander M.; Ahmed, Omar J.; Rao, Vikram R.; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl; Majewska, Ania K.; Cash, Sydney S.			Optogenetic Delay of Status Epilepticus Onset in an In Vivo Rodent Epilepsy Model	PLOS ONE			English	Article							OPTICAL CONTROL; PILOCARPINE; SEIZURES; LITHIUM; PATHOGENESIS; CELLS; GENE	Epilepsy is a devastating disease, currently treated with medications, surgery or electrical stimulation. None of these approaches is totally effective and our ability to control seizures remains limited and complicated by frequent side effects. The emerging revolutionary technique of optogenetics enables manipulation of the activity of specific neuronal populations in vivo with exquisite spatiotemporal resolution using light. We used optogenetic approaches to test the role of hippocampal excitatory neurons in the lithium-pilocarpine model of acute elicited seizures in awake behaving rats. Hippocampal pyramidal neurons were transduced in vivo with a virus carrying an enhanced halorhodopsin (eNpHR), a yellow light activated chloride pump, and acute seizure progression was then monitored behaviorally and electrophysiologically in the presence and absence of illumination delivered via an optical fiber. Inhibition of those neurons with illumination prior to seizure onset significantly delayed electrographic and behavioral initiation of status epilepticus, and altered the dynamics of ictal activity development. These results reveal an essential role of hippocampal excitatory neurons in this model of ictogenesis and illustrate the power of optogenetic approaches for elucidation of seizure mechanisms. This early success in controlling seizures also suggests future therapeutic avenues.	[Sukhotinsky, Inna; Chan, Alexander M.; Ahmed, Omar J.; Rao, Vikram R.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sukhotinsky, Inna; Chan, Alexander M.; Ahmed, Omar J.; Rao, Vikram R.; Cash, Sydney S.] Harvard Univ, Sch Med, Boston, MA USA; [Chan, Alexander M.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Majewska, Ania K.] Univ Rochester, Ctr Visual Sci, Dept Neurobiol & Anat, Rochester, NY 14627 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Stanford University; University of Rochester	Cash, SS (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	scash@partners.org	Core, Vector/CAF-4832-2022	Ramakrishnan, Charu/0000-0002-3474-6332; Majewska, Ania/0000-0002-2167-6849	DOD [W81xWH-09-1-0480]	DOD(United States Department of Defense)	DOD grant # W81xWH-09-1-0480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Bittencourt S, 2010, SEIZURE-EUR J EPILEP, V19, P242, DOI 10.1016/j.seizure.2010.02.010; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CLIFFORD DB, 1987, NEUROSCIENCE, V23, P953, DOI 10.1016/0306-4522(87)90171-0; Cramer JA, 2010, EXPERT REV NEUROTHER, V10, P885, DOI 10.1586/ERN.10.71; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dichter MA, 2009, ARCH NEUROL-CHICAGO, V66, P443, DOI 10.1001/archneurol.2009.10; Esteller R, 2001, P ANN INT IEEE EMBS, V23, P1707, DOI 10.1109/IEMBS.2001.1020545; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Guo L, 2010, J NEUROSCI METH, V191, P101, DOI 10.1016/j.jneumeth.2010.05.020; Hill DS, 2010, EXPERT REV NEUROTHER, V10, P943, DOI 10.1586/ERN.10.57; HONCHAR MP, 1983, SCIENCE, V220, P323, DOI 10.1126/science.6301005; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; JOPE RS, 1986, EXP NEUROL, V91, P471, DOI 10.1016/0014-4886(86)90045-2; KERANEN T, 1989, EPILEPSIA, V30, P413, DOI 10.1111/j.1528-1157.1989.tb05320.x; KERANEN T, 1988, EPILEPSIA, V29, P1, DOI 10.1111/j.1528-1157.1988.tb05089.x; Kokaia M, 2011, EPILEPSIA, V52, P16, DOI 10.1111/j.1528-1167.2011.03226.x; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Lillis KP, 2012, NEUROBIOL DIS, V47, P358, DOI 10.1016/j.nbd.2012.05.016; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Omori Y, 2004, ARZNEIMITTELFORSCH, V54, P171; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; PERSINGER MA, 1988, PHYSIOL BEHAV, V44, P27, DOI 10.1016/0031-9384(88)90342-3; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raol YH, 2001, MENT RETARD DEV D R, V7, P254, DOI 10.1002/mrdd.1035; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stafstrom CE, 2006, J CEREBR BLOOD F MET, V26, P983, DOI 10.1038/sj.jcbfm.9600265; Stead M, 2010, BRAIN, V133, P2789, DOI 10.1093/brain/awq190; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tanzer JM, 1995, J DENT RES, V74, P1845, DOI 10.1177/00220345950740120701; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Truccolo W, 2011, NAT NEUROSCI; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190; Yang XF, 2012, ANN NEUROL, V71, P68, DOI 10.1002/ana.22596; Zarrelli MM, 1999, EPILEPSIA, V40, P1708, DOI 10.1111/j.1528-1157.1999.tb01587.x; Zhan RZ, 2010, J NEUROPHYSIOL, V104, P3293, DOI 10.1152/jn.00663.2010; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	43	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62013	10.1371/journal.pone.0062013	http://dx.doi.org/10.1371/journal.pone.0062013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637949	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000318340400068
J	Hinrichs, S; Patten, NL; Feng, M; Strickland, D; Waite, AM				Hinrichs, Saskia; Patten, Nicole L.; Feng, Ming; Strickland, Daniel; Waite, Anya M.			Which Environmental Factors Predict Seasonal Variation in the Coral Health of Acropora digitifera and Acropora spicifera at Ningaloo Reef?	PLOS ONE			English	Article							2 SCLERACTINIAN CORALS; SKELETAL GROWTH; CLIMATE-CHANGE; INTERANNUAL VARIATIONS; MONTASTREA-CAVERNOSA; MADRACIS-MIRABILIS; METABOLIC-ACTIVITY; RNA/DNA RATIOS; LONG-TERM; ZOOPLANKTON	The impact of physico-chemical factors on percent coral cover and coral health was examined on a spatial basis for two dominant Acropora species, A. digitifera and A. spicifera, at Ningaloo Reef (north-western Australia) in the southeast Indian Ocean. Coral health was investigated by measuring metabolic indices (RNA/DNA ratio and protein concentration), energy levels (lipid ratio) and autotrophic indices (chlorophyll a (chl a) and zooxanthellae density) at six stations during typical seasons (austral autumn 2010 (March and April), austral winter 2010 (August)) and during an extreme La Nina event in summer 2011 (February). These indices were correlated with 15 physico-chemical factors (measured immediately following coral sampling) to identify predictors for health indices. Variations in metabolic indices (protein concentration and RNA/DNA ratio) for A. spicifera were mainly explained by nitrogen, temperature and zooplankton concentrations under typical conditions, while for A. digitifera, light as well as phytoplankton, in particular picoeukaryotes, were important, possibly due to higher energy requirement for lipid synthesis and storage in A. digitifera. Optimum metabolic values occurred for both Acropora species at 26-28 degrees C when autotrophic indices (chl a and zooxanthellae density) were lowest. The extreme temperature during the La Nina event resulted in a shift of feeding modes, with an increased importance of water column plankton concentrations for metabolic rates of A. digitifera and light and plankton for A. spicifera. Our results suggest that impacts of high sea surface temperatures during extreme events such as La Nina may be mitigated via reduction on metabolic rates in coral host. The high water column plankton concentrations and associated low light levels resulted in a shift towards high symbiont densities, with lower metabolic rates and energy levels than the seasonal norm for the coral host.	[Hinrichs, Saskia] Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia; Univ Western Australia, Oceans Inst M470, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Hinrichs, S (corresponding author), Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia.	saskia-hinrichs@gmx.de	Feng, Ming/F-5411-2010; Waite, Anya M/A-5492-2015	Feng, Ming/0000-0002-2855-7092; Waite, Anya M/0000-0003-2965-0296	Australian Research Council; Australian Government; Western Australian Marine Science Institute	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR); Western Australian Marine Science Institute	Funding was provided by a Discovery Grant to A. M. Waite from the Australian Research Council. Funding was provided by the Endeavour International Postgraduate Research (IPRS) Scholarship from the Australian Government and a top-up scholarship from the Western Australian Marine Science Institute (Node 2) to S. Hinrichs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON A, 1993, LIMNOL OCEANOGR, V38, P1116, DOI 10.4319/lo.1993.38.6.1116; ACHITUV Y, 1990, ECOSYSTEMS WORLD, V25, P1; ALMOGHRABI S, 1995, J COMP PHYSIOL B, V165, P183; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Anthony KRN, 2004, OECOLOGIA, V141, P373, DOI 10.1007/s00442-004-1647-7; Anthony KRN, 1999, J EXP MAR BIOL ECOL, V232, P85, DOI 10.1016/S0022-0981(98)00099-9; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Anthony KRN, 2012, MARINE CLIMATE CHANG; Atkinson M. J., 1994, Pacific Science, V48, P296; Barott KL, 2012, TRENDS MICROBIOL, V20, P621, DOI 10.1016/j.tim.2012.08.004; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Buckley BA, 2004, MAR ECOL PROG SER, V282, P143, DOI 10.3354/meps282143; Buddemeier R., 2004, CORAL REEFS GLOBAL C, V15, P17789; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; CLAYTON WS, 1984, BIOL BULL, V167, P590, DOI 10.2307/1541412; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; D Elia C. F, 1977, Proceedings int Coral Reef Symp, V3, P325; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; Davy SK, 2001, MAR BIOL, V139, P999; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; DREW E A, 1972, Journal of Experimental Marine Biology and Ecology, V9, P71, DOI 10.1016/0022-0981(72)90008-1; DUBINSKY Z, 1990, PROC R SOC SER B-BIO, V239, P231, DOI 10.1098/rspb.1990.0015; Dubinsky Z., 1994, Pacific Science, V48, P313; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Feng M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001763; Feng M., 2009, MARINE CLIMATE CHANG; Ferrier-Pages C, 2003, CORAL REEFS, V22, P229, DOI 10.1007/s00338-003-0312-7; Fitt WK, 2001, J EXP MAR BIOL ECOL, V256, P15, DOI 10.1016/S0022-0981(00)00302-6; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2011, CORAL REEFS, V30, P687, DOI 10.1007/s00338-011-0756-0; Grover R, 2008, J EXP BIOL, V211, P860, DOI 10.1242/jeb.012807; Harris R.P., 2000, ZOOPLANKTON METHODOL; Heidelberg KB, 2004, CORAL REEFS, V23, P263, DOI 10.1007/s00338-004-0375-0; Hinrichs S, CORAL REEFS; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, MAR ECOL PROG SER, V57, P173, DOI 10.3354/meps057173; Holbrook NJ, 2009, NINOSOUTHERN OSCILLA; Hoogenboom MO, 2008, ECOLOGY, V89, P1144, DOI 10.1890/07-1272.1; Houlbreque F, 2004, MAR ECOL PROG SER, V282, P151, DOI 10.3354/meps282151; Houlbreque F, 2004, J EXP BIOL, V207, P1461, DOI 10.1242/jeb.00911; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Howe SA, 2001, J EXP MAR BIOL ECOL, V259, P231, DOI 10.1016/S0022-0981(01)00230-1; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Humphrey C, 2009, CHANGES RNA DNA RATI; Instruments L, 2000, QUIKCHEM FIA AUT ION; Jeffrey SW, 1975, BIOCH PHYSL PFLANZ, V167, P1; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Lough JM, 1998, CORAL REEFS, V17, P351, DOI 10.1007/s003380050139; Lowe RJ, 2008, HYDRODYNAMICS FRINGI; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meesters EH, 2002, MAR ECOL PROG SER, V227, P233, DOI 10.3354/meps227233; Mills MM, 2004, MAR BIOL, V145, P1097, DOI 10.1007/s00227-004-1398-3; Muko S, 2000, B MAR SCI, V66, P225; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Muscatine, 1990, CORAL REEFS, V25, P1; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Oku H, 2003, CORAL REEFS, V22, P83, DOI 10.1007/s00338-003-0279-4; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Patten NL, 2011, CORAL REEFS, V30, P555, DOI 10.1007/s00338-011-0777-8; Pearce AF, 2012, J MARINE SY IN PRESS; Reidenbach MA, 2006, LIMNOL OCEANOGR, V51, P1956, DOI 10.4319/lo.2006.51.5.1956; Ribes M, 2007, CORAL REEFS, V26, P413, DOI 10.1007/s00338-007-0211-4; Ribes M, 2003, MAR ECOL PROG SER, V257, P13, DOI 10.3354/meps257013; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rohwer F, 2001, CORAL REEFS, V20, P85; Rousseaux CSG, 2012, CONT SHELF RES, V32, P22, DOI 10.1016/j.csr.2011.10.010; Saunders SM, 2005, ENVIRON CHEM, V2, P331, DOI 10.1071/EN05043; Sebens KP, 1998, MAR BIOL, V131, P347, DOI 10.1007/s002270050328; Sebens KP, 1996, MAR BIOL, V127, P303, DOI 10.1007/BF00942116; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; SOROKIN YI, 1973, LIMNOL OCEANOGR, V18, P380, DOI 10.4319/lo.1973.18.3.0380; Staehr PA, 2009, HYDROBIOLOGIA, V620, P191, DOI 10.1007/s10750-008-9628-1; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; STIMSON JS, 1987, B MAR SCI, V41, P889; Taebi S, 2011, J GEOPHYS RES, V116, P1200; Taebi S, 2012, OCEAN DYNAM, P1; Titlyanov E.A., 2002, RUSS J MAR BIOL, V28, P16; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Watson RJ, 2004, J ENVIRON MONITOR, V7, P37; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Weller E, 2012, J CLIMATE, V25, P5587, DOI 10.1175/JCLI-D-11-00324.1; Wilkinson CR, 2008, CORAL REEFS CLIMATE; Wyatt ASJ, 2012, LIMNOL OCEANOGR, V57, P401, DOI 10.4319/lo.2012.57.2.0401; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508; Yahel R, 2005, CORAL REEFS, V24, P75, DOI 10.1007/s00338-004-0449-z; YAMAGUCHI M, 1974, PAC SCI, V28, P139	102	10	10	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60830	10.1371/journal.pone.0060830	http://dx.doi.org/10.1371/journal.pone.0060830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637770	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400015
J	Segui, N; Pineda, M; Guino, E; Borras, E; Navarro, M; Bellido, F; Moreno, V; Lazaro, C; Blanco, I; Capella, G; Valle, L				Segui, Nuria; Pineda, Marta; Guino, Elisabet; Borras, Ester; Navarro, Matilde; Bellido, Fernando; Moreno, Victor; Lazaro, Conxi; Blanco, Ignacio; Capella, Gabriel; Valle, Laura			Telomere Length and Genetic Anticipation in Lynch Syndrome	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; PERIPHERAL-BLOOD CELLS; DYSKERATOSIS-CONGENITA; NORMAL INDIVIDUALS; INSTABILITY; HETEROGENEITY; GERMLINE; AGE; ASSOCIATION; DEFICIENCY	Telomere length variation has been associated with increased risk of several types of tumors, and telomere shortening, with genetic anticipation in a number of genetic diseases including hereditary cancer syndromes. No conclusive studies have been performed for Lynch syndrome, a hereditary colorectal cancer syndrome caused by germline mutations in the DNA mismatch repair genes. Here we evaluate telomere length in Lynch syndrome, both as a cancer risk factor and as a mechanism associated with anticipation in the age of cancer onset observed in successive generations of Lynch syndrome families. Leukocyte telomere length was measured in 244 mismatch repair gene mutation carriers from 96 Lynch syndrome families and in 234 controls using a monochrome multiplex quantitative PCR method. Cancer-affected mutation carriers showed significantly shorter telomeres than cancer-free mutation carriers. In addition, cancer-affected carriers showed the most pronounced shortening of telomere length with age, compared with unaffected carriers. The anticipation in the age of cancer onset observed in successive generations was not associated with telomere shortening, although, interestingly, all mother-son pairs showed telomere shortening. In conclusion, cancer-affected mismatch repair gene mutation carriers have distinct telomere-length pattern and dynamics. However, anticipation in the age of onset is not explained by telomere shortening. Pending further study, our findings suggest that telomere attrition might explain the previously reported dependence of cancer risk on the parent-of-origin of mismatch repair gene mutations.	[Segui, Nuria; Pineda, Marta; Borras, Ester; Navarro, Matilde; Bellido, Fernando; Lazaro, Conxi; Blanco, Ignacio; Capella, Gabriel; Valle, Laura] Hosp Llobregat, IDIBELL, Catalan Inst Oncol, Hereditary Canc Program, Barcelona, Spain; [Guino, Elisabet; Moreno, Victor] Hosp Llobregat, IDIBELL, Catalan Inst Oncol, Unit Biomarkers & Susceptibil, Barcelona, Spain; [Guino, Elisabet; Moreno, Victor] Hosp Llobregat, CIBERESP, Barcelona, Spain; [Moreno, Victor] Univ Barcelona, Fac Med, Hosp Llobregat, Dept Clin Sci, Barcelona 7, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; University of Barcelona	Valle, L (corresponding author), Hosp Llobregat, IDIBELL, Catalan Inst Oncol, Hereditary Canc Program, Barcelona, Spain.	lvalle@iconcologia.net	Capella, Gabriel/I-1879-2015; Blanco, Ignacio/AAN-5426-2021; Valle, Laura/H-8118-2012; Moreno, Victor/A-1697-2010; Riu, Marta Pineda/I-1497-2015; Blanco, Ignacio/D-2565-2013; GARCIA, CONXI LAZARO/Q-2410-2016	Capella, Gabriel/0000-0002-4669-7320; Blanco, Ignacio/0000-0002-7414-7481; Valle, Laura/0000-0003-0371-0844; Moreno, Victor/0000-0002-2818-5487; Riu, Marta Pineda/0000-0002-5403-5845; Blanco, Ignacio/0000-0002-7414-7481; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Guino, Elisabet/0000-0003-0093-2652	Spanish Ministry of Economy (State Secretariat for Research, Development and Innovation) [BFU2009-10281]; Carlos III Health Institute [FIS PI08/1635, FIS PI08/1359, RETIC RD06/0020/1050, RD06/0020/1051]; Scientific Foundation Asociacion Espanola Contra el Cancer; Catalan Government [2009SGR290]; CIBERESP [CB07/02/2005]; Carlos III Health Institute; contract "Ramon y Cajal"	Spanish Ministry of Economy (State Secretariat for Research, Development and Innovation); Carlos III Health Institute(Instituto de Salud Carlos III); Scientific Foundation Asociacion Espanola Contra el Cancer; Catalan Government; CIBERESP; Carlos III Health Institute(Instituto de Salud Carlos III); contract "Ramon y Cajal"	This work was funded by the Spanish Ministry of Economy (State Secretariat for Research, Development and Innovation) (BFU2009-10281), Carlos III Health Institute (FIS PI08/1635, FIS PI08/1359 and RETIC RD06/0020/1050 and RD06/0020/1051), the Scientific Foundation Asociacion Espanola Contra el Cancer, the Catalan Government (2009SGR290), and CIBERESP (CB07/02/2005). Nuria Segui is supported by a fellowship from the Carlos III Health Institute and Laura Valle holds a contract "Ramon y Cajal." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Bellido F, 2012, EUR J HUM GENET; Bender HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046195; Boonstra PS, 2011, BIOMETRICS, V67, P1627, DOI 10.1111/j.1541-0420.2011.01607.x; Boonstra PS, 2010, GENET EPIDEMIOL, V34, P756, DOI 10.1002/gepi.20534; Bozzao C, 2011, CANCER-AM CANCER SOC, V117, P4325, DOI 10.1002/cncr.26022; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Coolbaugh-Murphy MI, 2010, HUM MUTAT, V31, P317, DOI 10.1002/humu.21190; Cui Y, 2012, CANCER EPIDEM BIOMAR, V21, P1807, DOI 10.1158/1055-9965.EPI-12-0657; Gramatges MM, 2010, CANCER EPIDEM BIOMAR, V19, P605, DOI 10.1158/1055-9965.EPI-09-0896; Gruber SB, 2009, J CLIN ONCOL, V27, P326, DOI 10.1200/JCO.2008.19.1445; Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Larsen K, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1424; Londono-Vallejo JA, 2004, CANCER LETT, V212, P135, DOI 10.1016/j.canlet.2004.05.008; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Marrone A, 2005, CURR OPIN GENET DEV, V15, P249, DOI 10.1016/j.gde.2005.04.004; Martinez P, 2009, AGING CELL, V8, P2, DOI 10.1111/j.1474-9726.2008.00441.x; Martinez-Delgado B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002182; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; Mendez-Bermudez A, 2011, HUM MUTAT, V32, P939, DOI 10.1002/humu.21522; Mendez-Bermudez A, 2009, NUCLEIC ACIDS RES, V37, P6225, DOI 10.1093/nar/gkp629; Nilbert M, 2009, J CLIN ONCOL, V27, P360, DOI 10.1200/JCO.2008.16.1281; Pickett HA, 2004, ONCOGENE, V23, P3434, DOI 10.1038/sj.onc.1207477; Prescott J, 2012, MUTAT RES-FUND MOL M, V730, P75, DOI 10.1016/j.mrfmmm.2011.06.009; Rampazzo E, 2010, BRIT J CANCER, V102, P1300, DOI 10.1038/sj.bjc.6605644; RodriguezBigas MA, 1996, DIS COLON RECTUM, V39, P649, DOI 10.1007/BF02056944; Scott RJ, 2001, AM J HUM GENET, V68, P118, DOI 10.1086/316942; Stella A, 2007, CLIN GENET, V71, P130, DOI 10.1111/j.1399-0004.2007.00745.x; Tabori U, 2007, CANCER RES, V67, P1415, DOI 10.1158/0008-5472.CAN-06-3682; Trkova M, 2007, CANCER, V110, P694, DOI 10.1002/cncr.22834; van Vliet CM, 2011, HUM MUTAT, V32, P207, DOI 10.1002/humu.21408; VASEN HFA, 1994, GUT, V35, P1262, DOI 10.1136/gut.35.9.1262; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Westphalen AA, 2005, HUM GENET, V116, P461, DOI 10.1007/s00439-005-1272-5	37	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61286	10.1371/journal.pone.0061286	http://dx.doi.org/10.1371/journal.pone.0061286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637804	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400032
J	Vriend, HJ; Bogaards, JA; van der Klis, FRM; Scherpenisse, M; Boot, HJ; King, AJ; van der Sande, MAB				Vriend, Henrike J.; Bogaards, Johannes A.; van der Klis, Fiona R. M.; Scherpenisse, Mirte; Boot, Hein J.; King, Audrey J.; van der Sande, Marianne A. B.		Municipal Hlth Serv	Patterns of Human Papillomavirus DNA and Antibody Positivity in Young Males and Females, Suggesting a Site-Specific Natural Course of Infection	PLOS ONE			English	Article							HPV TYPES; UNITED-STATES; WOMEN; SEROPREVALENCE; TYPE-16; MEN; VACCINATION; IMPACT; CANCER; AUSTRALIA	Background: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in the Netherlands, we started an ongoing study in sexually transmitted infection (STI) clinics in 2009. Here, we analyze baseline type-specific HPV DNA and HPV-specific antibody positivity rates. Methods: We enrolled 3569 men and women, 16-24 years of age, from 14 STI clinics, and estimated genital and anal HPV DNA and antibody positivity rates of 7 main carcinogenic HPV types. Generalized estimating equations regression analyses were applied to determine risk factors for, and associations between, type-specific HPV DNA and antibody positivity. Results: Genital HPV DNA positivity rates were higher in women than in men; anal HPV DNA was especially high in men who have sex with men (MSM). HPV antibody seropositivity rates were also highest in women and MSM. High-risk sexual behavior was predictive of both HPV DNA and antibody positivity. Despite a strong correlation in serological profiles for multiple HPV types, seropositivity was independently associated with homologous HPV DNA detection. Conclusions: HPV DNA and antibody positivity rates are higher in women and MSM than in heterosexual men, but their association is similar across gender. This suggests a site-specific natural course of infection.	[Vriend, Henrike J.; Bogaards, Johannes A.; van der Klis, Fiona R. M.; Scherpenisse, Mirte; Boot, Hein J.; King, Audrey J.; van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Vriend, Henrike J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Internal Med,Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Bogaards, Johannes A.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr, Julius Ctr, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center	Vriend, HJ (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	rianne.vriend@rivm.nl	Rossen, John W/G-7564-2011	Rossen, John W/0000-0002-7167-8623; Bogaards, Johannes/0000-0002-3389-5141; Wolffs, Petra/0000-0002-5326-3985; Hoebe, Christian/0000-0003-1815-0974; van der Sande, Marianne AB/0000-0002-4778-6739; Gotz, Hannelore Martha/0000-0002-1236-6224	Ministry of Health, Welfare and Sport, the Netherlands	Ministry of Health, Welfare and Sport, the Netherlands	This work was supported by the Ministry of Health, Welfare and Sport, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2004, APPL LONGITUDINAL AN; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brisson M, 2011, SEX TRANSM INFECT, V87, P41, DOI 10.1136/sti.2010.044412; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; Carter JJ, 2001, CANCER RES, V61, P1934; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; De Carvalho N, 2010, VACCINE, V28, P6247, DOI 10.1016/j.vaccine.2010.07.007; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Donovan Basil, 2011, Evid Based Med, V16, P157, DOI 10.1136/ebm1405; Durham DP, 2012, J INFECT DIS, V206, P1291, DOI 10.1093/infdis/jis494; Edelstein ZR, 2011, J INFECT DIS, V204, P209, DOI 10.1093/infdis/jir242; Ho GYF, 2004, CANCER EPIDEM BIOMAR, V13, P110, DOI 10.1158/1055-9965.EPI-03-0191; Lu BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160; Markowitz LE, 2009, J INFECT DIS, V200, P1059, DOI 10.1086/604729; Molijn A, 2005, J CLIN VIROL, V32, pS43, DOI 10.1016/j.jcv.2004.12.004; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Newall AT, 2008, CLIN INFECT DIS, V46, P1647, DOI 10.1086/587895; Nielsen A, 2008, SEX TRANSM DIS, V35, P276, DOI 10.1097/OLQ.0b013e31815ac5c7; Nielson CM, 2007, J INFECT DIS, V196, P1137, DOI 10.1086/521632; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Scherpenisse M, 2012, VACCINE IN PRESS; Shikary T, 2009, J CLIN VIROL, V46, P107, DOI 10.1016/j.jcv.2009.07.006; Smith MA, 2011, VACCINE, V29, P9112, DOI 10.1016/j.vaccine.2011.02.091; Steele J, 2008, CLIN VACCINE IMMUNOL, V15, P1387, DOI 10.1128/CVI.00013-08; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Vonka V, 1999, INT J CANCER, V80, P365, DOI 10.1002/(SICI)1097-0215(19990129)80:3&lt;365::AID-IJC5&gt;3.0.CO;2-C; Vriend HJ, 2012, SEX TRANSM DIS, V39, P72, DOI 10.1097/OLQ.0b013e318235b3b0; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546	31	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60696	10.1371/journal.pone.0060696	http://dx.doi.org/10.1371/journal.pone.0060696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637760	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400010
J	Silva, CC; Hayden, H; Sawbridge, T; Mele, P; De Paula, SO; Silva, LCF; Vidigal, PMP; Vicentini, R; Sousa, MP; Torres, APR; Santiago, VMJ; Oliveira, VM				Silva, Cynthia C.; Hayden, Helen; Sawbridge, Tim; Mele, Pauline; De Paula, Sergio O.; Silva, Livia C. F.; Vidigal, Pedro M. P.; Vicentini, Renato; Sousa, Maira P.; Torres, Ana Paula R.; Santiago, Vania M. J.; Oliveira, Valeria M.			Identification of Genes and Pathways Related to Phenol Degradation in Metagenomic Libraries from Petroleum Refinery Wastewater	PLOS ONE			English	Article							COMAMONAS-TESTOSTERONI TA441; CATECHOL 1,2-DIOXYGENASE; MEMBRANE BIOREACTOR; NUCLEOTIDE-SEQUENCE; RESISTANT BACTERIUM; FUNCTIONAL-ANALYSIS; CATABOLIC PATHWAY; SP-NOV; HYDROXYLASE; ORGANIZATION	Two fosmid libraries, totaling 13,200 clones, were obtained from bioreactor sludge of petroleum refinery wastewater treatment system. The library screening based on PCR and biological activity assays revealed more than 400 positive clones for phenol degradation. From these, 100 clones were randomly selected for pyrosequencing in order to evaluate the genetic potential of the microorganisms present in wastewater treatment plant for biodegradation, focusing mainly on novel genes and pathways of phenol and aromatic compound degradation. The sequence analysis of selected clones yielded 129,635 reads at an estimated 17-fold coverage. The phylogenetic analysis showed Burkholderiales and Rhodocyclales as the most abundant orders among the selected fosmid clones. The MG-RAST analysis revealed a broad metabolic profile with important functions for wastewater treatment, including metabolism of aromatic compounds, nitrogen, sulphur and phosphorus. The predicted 2,276 proteins included phenol hydroxylases and cathecol 2,3-dioxygenases, involved in the catabolism of aromatic compounds, such as phenol, byphenol, benzoate and phenylpropanoid. The sequencing of one fosmid insert of 33 kb unraveled the gene that permitted the host, Escherichia coli EPI300, to grow in the presence of aromatic compounds. Additionally, the comparison of the whole fosmid sequence against bacterial genomes deposited in GenBank showed that about 90% of sequence showed no identity to known sequences of Proteobacteria deposited in the NCBI database. This study surveyed the functional potential of fosmid clones for aromatic compound degradation and contributed to our knowledge of the biodegradative capacity and pathways of microbial assemblages present in refinery wastewater treatment system.	[Silva, Cynthia C.; Oliveira, Valeria M.] Univ Estadual Campinas, Res Ctr Chem Biol & Agr, Microbial Resources Div, Campinas, SP, Brazil; [Hayden, Helen; Sawbridge, Tim; Mele, Pauline] Dept Primary Ind, BioSci Res Div, Melbourne, Vic, Australia; [De Paula, Sergio O.; Silva, Livia C. F.] Univ Fed Vicosa, Dept Gen Biol, Lab Mol Immunovirol, Vicosa, MG, Brazil; [Vidigal, Pedro M. P.] Univ Fed Vicosa, Inst Appl Biotechnol Agr, Bioinformat Lab, Vicosa, MG, Brazil; [Vicentini, Renato] Univ Estadual Campinas, Genet Engn & Mol Biol Ctr CBMEG, Campinas, SP, Brazil; [Sousa, Maira P.; Torres, Ana Paula R.; Santiago, Vania M. J.] CENPES, PETROBRAS R&D Ctr, Rio De Janeiro, Brazil	Universidade Estadual de Campinas; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Estadual de Campinas; Petrobras	Silva, CC (corresponding author), Univ Estadual Campinas, Res Ctr Chem Biol & Agr, Microbial Resources Div, Campinas, SP, Brazil.	ccanedosilva@yahoo.com.br	Vidigal, Pedro Marcus/G-3100-2011; Vicentini, Renato/C-5967-2012; De Paula, Sergio/N-2609-2018; Oliveira, Valéria Maia/L-2422-2014	Vidigal, Pedro Marcus/0000-0002-5116-9856; De Paula, Sergio/0000-0002-2275-5768; Oliveira, Valéria Maia/0000-0001-8817-4758; Vicentini, Renato/0000-0002-0527-1083; Hayden, Helen L./0000-0002-5443-538X	Petrobras; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful to Petrobras for technical and financial support. CCS was supported by grants from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1998, MICROBIOL-UK, V144, P2895, DOI 10.1099/00221287-144-10-2895; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrios-Martinez A, 2006, J MEMBRANE SCI, V281, P288, DOI 10.1016/j.memsci.2006.03.048; Bicalho B, 2003, Z NATURFORSCH C, V58, P746; Breinig S, 2000, J BACTERIOL, V182, P5849, DOI 10.1128/JB.182.20.5849-5863.2000; Bushnell LD, 1941, J BACTERIOL, V41, P653, DOI 10.1128/JB.41.5.653-673.1941; Caposio P, 2002, RES MICROBIOL, V153, P69, DOI 10.1016/S0923-2508(01)01290-6; Chou JH, 2007, INT J SYST EVOL MICR, V57, P887, DOI 10.1099/ijs.0.64551-0; Cordova-Rosa SM, 2009, J HAZARD MATER, V164, P61, DOI 10.1016/j.jhazmat.2008.07.120; de Vasconcellos SP, 2009, ORG GEOCHEM, V40, P574, DOI 10.1016/j.orggeochem.2009.02.006; Dong XJ, 2008, INT BIODETER BIODEGR, V62, P257, DOI 10.1016/j.ibiod.2008.01.011; EHRT S, 1995, MOL MICROBIOL, V18, P13, DOI 10.1111/j.1365-2958.1995.mmi_18010013.x; El-Sayed WS, 2003, BIOSCI BIOTECH BIOCH, V67, P2026, DOI 10.1271/bbb.67.2026; Futamata H, 2001, APPL ENVIRON MICROB, V67, P4671, DOI 10.1128/AEM.67.10.4671-4677.2001; Gaillard M, 2008, P NATL ACAD SCI USA, V105, P7058, DOI 10.1073/pnas.0801269105; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Gul Mustafa, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P317, DOI 10.1556/AMicr.54.2007.3.6; Gumaelius L, 2001, INT J SYST EVOL MICR, V51, P999, DOI 10.1099/00207713-51-3-999; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P4421, DOI 10.1128/AEM.69.8.4421-4430.2003; Jiang Y, 2006, BIOCHEM ENG J, V29, P227, DOI 10.1016/j.bej.2005.12.002; Johnsen AR, 2002, APPL ENVIRON MICROB, V68, P2683, DOI 10.1128/AEM.68.6.2683-2689.2002; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; McFall SM, 1998, GENE, V223, P257, DOI 10.1016/S0378-1119(98)00366-7; Merimaa M, 2006, ARCH MICROBIOL, V186, P287, DOI 10.1007/s00203-006-0143-3; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mrozik A, 2011, J APPL MICROBIOL, V111, P1357, DOI 10.1111/j.1365-2672.2011.05140.x; Nair IC, 2007, BIORESOURCE TECHNOL, V98, P714, DOI 10.1016/j.biortech.2006.02.034; Oosterkamp MJ, 2011, J BACTERIOL, V193, P5028, DOI 10.1128/JB.00365-11; Peters M, 1997, APPL ENVIRON MICROB, V63, P4899, DOI 10.1128/AEM.63.12.4899-4906.1997; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Ryan MP, 2011, J IND MICROBIOL BIOT, V38, P1613, DOI 10.1007/s10295-011-1011-y; SHINGLER V, 1992, J BACTERIOL, V174, P711, DOI 10.1128/jb.174.3.711-724.1992; Silva CC, 2010, J MICROBIOL BIOTECHN, V20, P447, DOI 10.4014/jmb.0906.06052; Silva CC, 2010, J MICROBIOL BIOTECHN, V20, P21, DOI 10.4014/jmb.0906.06001; Spormann AM, 2000, BIODEGRADATION, V11, P85, DOI 10.1023/A:1011122631799; Suenaga H, 2007, ENVIRON MICROBIOL, V9, P2289, DOI 10.1111/j.1462-2920.2007.01342.x; Sueoka K, 2009, FEMS MICROBIOL LETT, V291, P169, DOI 10.1111/j.1574-6968.2008.01448.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valle A, 2004, ENVIRON MICROBIOL, V6, P424, DOI 10.1111/j.1462-2920.2004.00581.x; Viero AF, 2008, J MEMBRANE SCI, V319, P223, DOI 10.1016/j.memsci.2008.03.038; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wohlbrand L, 2007, PROTEOMICS, V7, P2222, DOI 10.1002/pmic.200600987; Wu JF, 2006, APPL ENVIRON MICROB, V72, P1759, DOI 10.1128/AEM.72.3.1759-1765.2006; Xiong JB, 2011, RES MICROBIOL, V162, P671, DOI 10.1016/j.resmic.2011.06.002; Zhan YH, 2011, RES MICROBI IN PRESS; Zhan YH, 2008, CURR MICROBIOL, V57, P609, DOI 10.1007/s00284-008-9251-4	48	37	41	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61811	10.1371/journal.pone.0061811	http://dx.doi.org/10.1371/journal.pone.0061811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637911	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700061
J	Zhong, WL; Zhang, WG; Wang, SY; Qin, JH				Zhong, Weiliang; Zhang, Weiguo; Wang, Shouyu; Qin, Jianhua			Regulation of Fibrochondrogenesis of Mesenchymal Stem Cells in an Integrated Microfluidic Platform Embedded with Biomimetic Nanofibrous Scaffolds	PLOS ONE			English	Article							GENE-EXPRESSION; CHONDROGENIC DIFFERENTIATION; FOCAL ADHESION; NUCLEAR SHAPE; FATE; MICROENVIRONMENT; MODULATION; PATHWAY; REGENERATION; CHONDROCYTES	In native fibrocartilage, mechanotransduction allows the cells to perceive the physical microenvironment not only through topographical cues from the extracellular matrix, but also through mechanical cues, such as interstitial flow. To create a microenvironment that simultaneously integrates nanotopography and flow stimulus, we developed a biomimetic microfluidic device embedded with aligned nanofibers to contain microchambers of different angles, which enabled the flow direction to form different angles with the fibers. Using this device, we investigated the effects of microfluidic and nanotopographical environment on the morphology and fibrochondrogenesis of mesenchymal stem cells (MSCs) and the involvement of RhoA/ROCK pathway and Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ). The results showed that the flow direction perpendicular to aligned nanofibers was conducive to fibrochondrogenesis of MSCs. In addition, ROCK inhibitor and knockdown of YAP/TAZ disrupted fibrochondrogenic differentiation of MSCs. In conclusion, our data suggest the crucial role of mechanotransduction in regulating fibrochondrogenic differentiation of MSCs, which may be mediated by RhoA/ROCK pathway and YAP/TAZ.	[Zhong, Weiliang; Zhang, Weiguo; Wang, Shouyu] Dalian Med Univ, Affiliated Hosp 1, Dept Orthopaed, Dalian, Peoples R China; [Qin, Jianhua] Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, Dalian, Peoples R China	Dalian Medical University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Zhang, WG (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Orthopaed, Dalian, Peoples R China.	weiguozhang63@gmail.com; wlzhong@hotmail.com			National Nature Science Foundation of China [81171464]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No. 81171464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172; Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004; Baker BM, 2011, TISSUE ENG PT A, V17, P1445, DOI [10.1089/ten.TEA.2010.0535, 10.1089/ten.tea.2010.0535]; Baker BM, 2010, BIOMATERIALS, V31, P6190, DOI 10.1016/j.biomaterials.2010.04.036; Ballyns JJ, 2011, J BIOMECH, V44, P509, DOI 10.1016/j.jbiomech.2010.09.017; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chung BG, 2012, LAB CHIP, V12, P45, DOI 10.1039/c1lc20859d; Driscoll TP, 2011, J MECH BEHAV BIOMED, V4, P1627, DOI 10.1016/j.jmbbm.2011.03.022; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Ghafar-Zadeh E, 2011, LAB CHIP, V11, P3031, DOI 10.1039/c1lc20284g; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grassel S, 2007, FRONT BIOSCI, V12, P4946, DOI 10.2741/2440; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gunja NJ, 2010, J BIOMED MATER RES A, V92A, P896, DOI 10.1002/jbm.a.32451; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Haudenschild DR, 2010, ARTHRITIS RHEUM-US, V62, P191, DOI 10.1002/art.25051; Heo SJ, 2011, ANN BIOMED ENG, V39, P2780, DOI 10.1007/s10439-011-0365-7; Hoben GM, 2008, STEM CELLS, V26, P422, DOI 10.1634/stemcells.2007-0641; Hoben GM, 2009, STEM CELLS DEV, V18, P283, DOI 10.1089/scd.2008.0024; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Kim H. N., 2012, ADV DRUG DELIV REV; Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Moraes C, 2011, INTEGR BIOL-UK, V3, P959, DOI 10.1039/c1ib00056j; Morgan JT, 2012, BIOMATERIALS, V33, P4126, DOI 10.1016/j.biomaterials.2012.02.047; Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007; Nerurkar NL, 2011, BIOMATERIALS, V32, P461, DOI 10.1016/j.biomaterials.2010.09.015; Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077; Shao JB, 2009, LAB CHIP, V9, P3118, DOI 10.1039/b909312e; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Yang Y, 2011, LAB CHIP, V11, P1638, DOI 10.1039/c0lc00736f; Yao YF, 2007, ADV MATER, V19, P3707, DOI 10.1002/adma.200701212; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	51	30	33	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61283	10.1371/journal.pone.0061283	http://dx.doi.org/10.1371/journal.pone.0061283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637803	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700019
J	da Silva, JD; de Oliveira, HC; Marcos, CM; da Silva, RAM; da Costa, TA; Calich, VLG; Almeida, AMF; Mendes-Giannini, MJS				da Silva, Julhiany de Fatima; de Oliveira, Haroldo Cesar; Marcos, Caroline Maria; Moraes da Silva, Rosangela Aparecida; da Costa, Tania Alves; Garcia Calich, Vera Lucia; Fusco Almeida, Ana Marisa; Soares Mendes-Giannini, Maria Jose			Paracoccidoides brasiliensis 30 kDa Adhesin: Identification as a 14-3-3 Protein, Cloning and Subcellular Localization in Infection Models	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; PARACOCCIDIOIDES-BRASILIENSIS; HISTOPLASMA-CAPSULATUM; CANDIDA-ALBICANS; PULMONARY PARACOCCIDIOIDOMYCOSIS; TRANSCRIPTIONAL RESPONSE; HOST-CELLS; VIRULENCE; BINDING; GENES	Paracoccidoides brasiliensis adhesion to lung epithelial cells is considered an essential event for the establishment of infection and different proteins participate in this process. One of these proteins is a 30 kDa adhesin, pl 4.9 that was described as a laminin ligand in previous studies, and it was more highly expressed in more virulent P. brasiliensis isolates. This protein may contribute to the virulence of this important fungal pathogen. Using Edman degradation and mass spectrometry analysis, this 30 kDa adhesin was identified as a 14-3-3 protein. These proteins are a conserved group of small acidic proteins involved in a variety of processes in eukaryotic organisms. However, the exact function of these proteins in some processes remains unknown. Thus, the goal of the present study was to characterize the role of this protein during the interaction between the fungus and its host. To achieve this goal, we cloned, expressed the 14-3-3 protein in a heterologous system and determined its subcellular localization in in vitro and in vivo infection models. Immunocytochemical analysis revealed the ubiquitous distribution of this protein in the yeast form of P. brasiliensis, with some concentration in the cytoplasm. Additionally, this 14-3-3 protein was also present in P. brasiliensis cells at the sites of infection in C57BL/6 mice intratracheally infected with P. brasiliensis yeast cells for 72 h (acute infections) and 30 days (chronic infection). An apparent increase in the levels of the 14-3-3 protein in the cell wall of the fungus was also noted during the interaction between P. brasiliensis and A549 cells, suggesting that this protein may be involved in host-parasite interactions, since inhibition assays with the protein and this antibody decreased P. brasiliensis adhesion to A549 epithelial cells. Our data may lead to a better understanding of P. brasiliensis interactions with host tissues and paracoccidioidomycosis pathogenesis.	[da Silva, Julhiany de Fatima; de Oliveira, Haroldo Cesar; Marcos, Caroline Maria; Moraes da Silva, Rosangela Aparecida; Fusco Almeida, Ana Marisa; Soares Mendes-Giannini, Maria Jose] Univ Estadual Paulista Araraquara, Sao Paulo State Univ, Fac Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil; [da Costa, Tania Alves; Garcia Calich, Vera Lucia] Univ Sao Paulo, Inst Biomed, Dept Immunol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo	Mendes-Giannini, MJS (corresponding author), Univ Estadual Paulista Araraquara, Sao Paulo State Univ, Fac Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil.	giannini@fcfar.unesp.br	Calich, Vera/G-8367-2011; FUSCO-ALMEIDA, ANA/G-1507-2013; Marcos, Caroline Maria/N-9884-2015; Giannini, Maria José Soares Mendes/C-5387-2012; de Fátima da Silva, Julhiany F/F-8706-2012; de Oliveira, Haroldo Cesar/G-1769-2012	Calich, Vera/0000-0002-2170-5099; FUSCO-ALMEIDA, ANA/0000-0002-5399-8527; Marcos, Caroline Maria/0000-0001-9306-7404; Giannini, Maria José Soares Mendes/0000-0002-8059-0826; de Fátima da Silva, Julhiany F/0000-0002-9675-088X; de Oliveira, Haroldo Cesar/0000-0001-5760-4209	FAPESP [2011/18038-9]; National Council for Scientific and Technological Development [473119/2010-2]; PADCFCF-Sao Paulo State University; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PADCFCF-Sao Paulo State University; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This investigation was financially supported by the Brazilian Organizations: FAPESP (Process Number 2011/18038-9), National Council for Scientific and Technological Development (Process number 473119/2010-2), PADCFCF-Sao Paulo State University and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JFS has a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andre DC, 2004, MICROBES INFECT, V6, P549, DOI 10.1016/j.micinf.2004.02.010; Andreotti P., 2005, INTERACAO PARACOCCID; Andreotti PF, 2005, MICROBES INFECT, V7, P875, DOI 10.1016/j.micinf.2005.02.005; ASSIS B, 2003, AY4621241 GENBANK; Bailao AM, 2006, MICROBES INFECT, V8, P2686, DOI 10.1016/j.micinf.2006.07.019; Barbosa MS, 2006, INFECT IMMUN, V74, P382, DOI 10.1128/IAI.74.1.382-389.2006; Bhavsar AP, 2010, FUTURE MICROBIOL, V5, P253, DOI 10.2217/FMB.09.114; Borges CL, 2011, MYCOPATHOLOGIA, V171, P1, DOI 10.1007/s11046-010-9349-7; BRUMMER E, 1990, MYCOPATHOLOGIA, V109, P13, DOI 10.1007/BF00437001; CANO LE, 1995, INFECT IMMUN, V63, P1777, DOI 10.1128/IAI.63.5.1777-1783.1995; CASTANEDA E, 1987, J MED VET MYCOL, V25, P377; Castro NDS, 2008, YEAST, V25, P141, DOI 10.1002/yea.1574; Cheng SJ, 2005, INFECT IMMUN, V73, P7190, DOI 10.1128/IAI.73.11.7190-7197.2005; da Fonseca CA, 2001, MICROBES INFECT, V3, P535, DOI 10.1016/S1286-4579(01)01409-5; Cruz AHD, 2011, FEBS J, V278, P2318, DOI 10.1111/j.1742-4658.2011.08150.x; da Silva MF, 2011, IMMUNOBIOLOGY, V216, P821, DOI 10.1016/j.imbio.2010.12.002; Neto BRD, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-272; de Wouw APV, 2011, MOL PLANT PATHOL, V12, P507, DOI 10.1111/j.1364-3703.2010.00680.x; Del Vecchio A, 2009, MEM I OSWALDO CRUZ, V104, P749, DOI 10.1590/S0074-02762009000500015; Donofrio FC, 2009, J MED MICROBIOL, V58, P706, DOI 10.1099/jmm.0.003830-0; Tavares AHFP, 2007, MICROBES INFECT, V9, P583, DOI 10.1016/j.micinf.2007.01.024; FA VA NETTO Celeste., 1961, Revista do Instituto Adolfo Lutz, V21, P99; Felipe MSS, 2003, YEAST, V20, P263, DOI 10.1002/yea.964; Fernandes L, 2008, FEMS YEAST RES, V8, P300, DOI 10.1111/j.1567-1364.2007.00317.x; Franco M, 1993, Curr Top Med Mycol, V5, P115; FRANCO M, 1987, J MED VET MYCOL, V25, P5; Frases S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00207; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Garcia Blanco S, 2011, FUNGAL GENET BIOL; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Gonzalez A, 2005, MED MYCOL, V43, P637, DOI 10.1080/13693780500064599; Gonzalez A, 2005, INFECT IMMUN, V73, P2486, DOI 10.1128/IAI.73.4.2486-2495.2005; Gonzalez A, 2005, MICROBES INFECT, V7, P666, DOI 10.1016/j.micinf.2005.01.004; Grosso DD, 2003, INFECT IMMUN, V71, P6534, DOI 10.1128/IAI.71.11.6534-6542.2003; Hanna SA, 2000, MICROBES INFECT, V2, P877, DOI 10.1016/S1286-4579(00)00390-7; Hernandez O, 2011, YEAST; Hernandez O., 2011, MED MYCOL; Hernandez O, 2010, INFECT IMMUN, V78, P5280, DOI 10.1128/IAI.00692-10; Hwang L, 2003, MOL BIOL CELL, V14, P2314, DOI 10.1091/mbc.E03-01-0027; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Kraus PR, 2002, FEMS MICROBIOL LETT, V210, P61, DOI 10.1111/j.1574-6968.2002.tb11160.x; Kurokawa Cilmery Suemi, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P125, DOI 10.1590/S0036-46651998000300001; Kwon-Chung KJ, 1998, CURR OPIN MICROBIOL, V1, P381, DOI 10.1016/S1369-5274(98)80053-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Marcos CM, 2012, FEMS YEAST RES; Marion CL, 2006, MOL MICROBIOL, V62, P970, DOI 10.1111/j.1365-2958.2006.05436.x; Mendes-Giannini MJS, 2000, MED MYCOL, V38, P113, DOI 10.1080/mmy.38.s1.113.123; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Montijn RC, 1997, MICROBIOL-SGM, V143, P1673, DOI 10.1099/00221287-143-5-1673; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nittler MP, 2005, MOL BIOL CELL, V16, P4792, DOI 10.1091/mbc.E05-05-0434; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; Odds FC, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-3-reviews1009; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Patel A, 2006, CELL MICROBIOL, V8, P55, DOI 10.1111/j.1462-5822.2005.00600.x; PATTI JM, 1994, CURR OPIN CELL BIOL, V6, P752, DOI 10.1016/0955-0674(94)90104-X; Pearson W R, 2000, Methods Mol Biol, V132, P185; Pereira LA, 2007, FEMS YEAST RES, V7, P1381, DOI 10.1111/j.1567-1364.2007.00292.x; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; Rappleye CA, 2006, ANNU REV MICROBIOL, V60, P281, DOI 10.1146/annurev.micro.59.030804.121055; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; San-Blas G, 2008, MYCOPATHOLOGIA, V165, P183, DOI 10.1007/s11046-007-9040-9; Mendes-Giannini MJS, 2006, MICROBES INFECT, V8, P1550, DOI 10.1016/j.micinf.2006.01.012; Sohn K, 2006, FEMS YEAST RES, V6, P1085, DOI 10.1111/j.1567-1364.2006.00130.x; Sullivan DJ, 2004, FEMS YEAST RES, V4, P369, DOI 10.1016/S1567-1356(03)00240-X; Taborda CP, 2008, MYCOPATHOLOGIA, V165, P331, DOI 10.1007/s11046-007-9061-4; Troyanovsky Sergey M, 2009, Front Biosci (Schol Ed), V1, P61, DOI 10.2741/s7; Troyanovsky SM, 1999, CURR OPIN CELL BIOL, V11, P561, DOI 10.1016/S0955-0674(99)00021-6; Vaejo MC, 2012, J PROTEOME RES, V11, P1676, DOI 10.1021/pr200872s; Vallejo MC, 2011, EUKARYOT CELL, V10, P343, DOI 10.1128/EC.00227-10; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; Verstrepen KJ, 2009, ANNU REV GENET, V43, P1, DOI 10.1146/annurev-genet-102108-134156; VICENTINI AP, 1994, INFECT IMMUN, V62, P1465, DOI 10.1128/IAI.62.4.1465-1469.1994; Zambuzzi-Carvalho PF, 2009, MED MYCOL, V47, P734, DOI 10.3109/13693780802609620	79	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62533	10.1371/journal.pone.0062533	http://dx.doi.org/10.1371/journal.pone.0062533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638109	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300073
J	Wang, C; Yao, CF; Li, YR; Cai, WL; Bao, XM; Girton, J; Johansen, J; Johansen, KM				Wang, Chao; Yao, Changfu; Li, Yeran; Cai, Weili; Bao, Xiaomin; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.			Evidence against a Role for the JIL-1 Kinase in H3S28 Phosphorylation and 14-3-3 Recruitment to Active Genes in Drosophila	PLOS ONE			English	Article							HISTONE H3 PHOSPHORYLATION; PUTATIVE SPINDLE MATRIX; H3S10 PHOSPHORYLATION; CHROMATIN-STRUCTURE; LOCALIZES; PROTEIN; MITOSIS; TRANSCRIPTION; INTERACTS; MEGATOR	JIL-1 is the major kinase controlling phosphorylation of histone H3S10 and has been demonstrated to function to counteract heterochromatization and gene silencing. However, an alternative model has been proposed in which JIL-1 is required for transcription to occur, additionally phosphorylates H3S28, and recruits 14-3-3 to active genes. Since these findings are incompatible with our previous demonstration that there are robust levels of transcription in the complete absence of JIL-1 and that JIL-1 is not present at developmental or heat shock-induced polytene chromosome puffs, we have reexamined JIL-1's possible role in H3S28 phosphorylation and 14-3-3 recruitment. Using two different H3S28ph antibodies we show by immunocytochemistry and immunoblotting that in Drosophila the H3S28ph mark is not present at detectable levels above background on polytene chromosomes at interphase but only on chromosomes at pro-, meta-, and anaphase during cell division in S2 cells and third instar larval neuroblasts. Moreover, this mitotic H3S28ph signal is also present in a JIL-1 null mutant background at undiminished levels suggesting that JIL-1 is not the mitotic H3S28ph kinase. We also demonstrate that H3S28ph is not enriched at heat shock puffs. Using two different pan-specific 14-3-3 antibodies as well as an enhancer trap 14-3-3 epsilon-GFP line we show that 14-3-3, while present in salivary gland nuclei, does not localize to chromosomes but only to the nuclear matrix surrounding the chromosomes. In our hands 14-3-3 is not recruited to developmental or heat shock puffs. Furthermore, using a lacO repeat tethering system to target LacI-JIL-1 to ectopic sites on polytene chromosomes we show that only H3S10ph is present and upregulated at such sites, not H3S28ph or 14-3-3. Thus, our results argue strongly against a model where JIL-1 is required for H3S28 phosphorylation and 14-3-3 recruitment at active genes.	[Wang, Chao; Yao, Changfu; Li, Yeran; Cai, Weili; Bao, Xiaomin; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Johansen, J (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	jorgen@iastate.edu; kristen@iastate.edu	Wang, Chao/C-4214-2013; Cai, Weili/B-7691-2013	Bao, Xiaomin/0000-0002-8845-5012	National Institutes of Health [GM62916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Johansen laboratory is supported by a grant from the National Institutes of Health [GM62916]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XM, 2008, J BIOL CHEM, V283, P32741, DOI 10.1074/jbc.M806227200; Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Cai W, 2011, MOL BIOL CELL, V22; Cai WL, 2008, DEVELOPMENT, V135, P2917, DOI 10.1242/dev.024927; Cai Weili, 2010, J Vis Exp, DOI 10.3791/1748; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; Deng HA, 2010, GENETICS, V185, P1183, DOI 10.1534/genetics.110.117150; Ding Y, 2009, DEV BIOL, V334, P253, DOI 10.1016/j.ydbio.2009.07.027; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Karam CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000975; Kellner WA, 2012, GENOME RES, V22, P1081, DOI 10.1101/gr.136929.111; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Qi HY, 2009, DEV DYNAM, V238, P3248, DOI 10.1002/dvdy.22150; Qi HY, 2005, J CELL BIOCHEM, V95, P1284, DOI 10.1002/jcb.20495; Qi HY, 2004, MOL BIOL CELL, V15, P4854, DOI 10.1091/mbc.E04-07-0579; Regnard C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001327; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Sambrook J, 2001, MOL CLONING LAB MANU; Su TT, 2001, J CELL SCI, V114, P3445; Wang C, 2012, FLY, V6, P93, DOI 10.4161/fly.20029; Wang C, 2011, J CELL SCI, V124, P4309, DOI 10.1242/jcs.092585; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Yano M, 2006, MOL BIOL CELL, V17, P4769, DOI 10.1091/mbc.E06-03-0229; Yao CF, 2012, MOL BIOL CELL, V23, P3532, DOI 10.1091/mbc.E12-06-0429; Yao CF, 2012, CHROMOSOMA, V121, P209, DOI 10.1007/s00412-011-0355-4; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhang WG, 2003, GENETICS, V165, P1341	35	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62484	10.1371/journal.pone.0062484	http://dx.doi.org/10.1371/journal.pone.0062484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638096	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300065
J	Yang, BF; Wang, XJ; Jiang, J; Cheng, XX				Yang, Bingfen; Wang, Xinjing; Jiang, Jing; Cheng, Xiaoxing			Involvement of CD244 in Regulating CD4(+) T Cell Immunity in Patients with Active Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR-BASIS; EXPRESSION; RESPONSES; MICE; RECEPTORS; INFECTION; INNATE; MEMORY; GAMMA	CD244 (2B4) is a member of the signaling lymphocyte activation molecule (SLAM) family of immune cell receptors and it plays an important role in modulating NK cell and CD8(+) T cell immunity. In this study, we investigated the expression and function of CD244/2B4 on CD4(+) T cells from active TB patients and latent infection individuals. Active TB patients had significantly elevated CD244/2B4 expression on M. tuberculosis antigen-specific CD4(+) T cells compared with latent infection individuals. The frequencies of CD244/2B4-expressing antigen-specific CD4(+) T cells were significantly higher in retreatment active TB patients than in new active TB patients. Compared with CD244/2B4-dull and -middle CD4(+) T cells, CD244/2B4bright CD4(+) T cell subset had significantly reduced expression of IFN-gamma, suggesting that CD244/2B4 expression may modulate IFN-c production in M. tuberculosis antigen-responsive CD4(+) T cells. Activation of CD244/2B4 signaling by crosslinking led to significantly decreased production of IFN-gamma. Blockage of CD244/2B4 signaling pathway of T cells from patients with active TB resulted in significantly increased production of IFN-gamma, compared with isotype antibody control. In conclusion, CD244/2B4 signaling pathway has an inhibitory role on M. tuberculosis antigen-specific CD4(+) T cell function.	[Yang, Bingfen; Wang, Xinjing; Jiang, Jing; Cheng, Xiaoxing] 309 Hosp, Inst TB, Div Res, Beijing, Peoples R China		Cheng, XX (corresponding author), 309 Hosp, Inst TB, Div Res, Beijing, Peoples R China.	xcheng2@139.com			National Natural Science Foundation of China [81061120518, 81071318, 81071319]; Ministry of Health and Ministry of Science and Technology, China [2013ZX10003006-003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health and Ministry of Science and Technology, China	The study was supported by grants from National Natural Science Foundation of China (81061120518, 81071318 and 81071319) (http://www.nsfc.gov.cn), by grant for infectious diseases from Ministry of Health and Ministry of Science and Technology, China to XC (2013ZX10003006-003-001) (http://www.moh.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR; Avgustin B, 2005, CLIN DIAGN LAB IMMUN, V12, P101, DOI 10.1128/CDLI.12.1.101-106.2005; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chlewicki LK, 2008, J IMMUNOL, V180, P8159, DOI 10.4049/jimmunol.180.12.8159; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Enose-Akahata Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000682; GARNIWAGNER BA, 1993, J IMMUNOL, V151, P60; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023700; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Romero X, 2004, TISSUE ANTIGENS, V64, P132, DOI 10.1111/j.1399-0039.2004.00247.x; Salgame P, 2005, CURR OPIN IMMUNOL, V17, P374, DOI 10.1016/j.coi.2005.06.006; Schlaphoff V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002045; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Tangye SG, 2000, MOL IMMUNOL, V37, P493, DOI 10.1016/S0161-5890(00)00076-6; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; VALIANTE NM, 1993, J EXP MED, V178, P1397, DOI 10.1084/jem.178.4.1397; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; Wang XJ, 2011, J INFECTION, V62, P292, DOI 10.1016/j.jinf.2011.02.013; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30	37	20	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63261	10.1371/journal.pone.0063261	http://dx.doi.org/10.1371/journal.pone.0063261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638187	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300162
J	Schuwald, AM; Noldner, M; Wilmes, T; Klugbauer, N; Leuner, K; Muller, WE				Schuwald, Anita M.; Noeldner, Michael; Wilmes, Thomas; Klugbauer, Norbert; Leuner, Kristina; Mueller, Walter E.			Lavender Oil-Potent Anxiolytic Properties via Modulating Voltage Dependent Calcium Channels	PLOS ONE			English	Article							ANXIETY DISORDERS; IDENTIFICATION; PREGABALIN; LINALOOL; RELEASE; SILEXAN; NEURONS; BRAIN; GABAPENTIN; INHIBITION	Recent clinical data support the clinical use of oral lavender oil in patients suffering from subsyndromal anxiety. We identified the molecular mechanism of action that will alter the perception of lavender oil as a nonspecific ingredient of aromatherapy to a potent anxiolytic inhibiting voltage dependent calcium channels (VOCCs) as highly selective drug target. In contrast to previous publications where exorbitant high concentrations were used, the effects of lavender oil in behavioral, biochemical, and electrophysiological experiments were investigated in physiological concentrations in the nanomolar range, which correlate to a single dosage of 80 mg/d in humans that was used in clinical trials. We show for the first time that lavender oil bears some similarities with the established anxiolytic pregabalin. Lavender oil inhibits VOCCs in synaptosomes, primary hippocampal neurons and stably overexpressing cell lines in the same range such as pregabalin. Interestingly, Silexan does not primarily bind to P/Q type calcium channels such as pregabalin and does not interact with the binding site of pregabalin, the alpha 2 delta subunit of VOCCs. Lavender oil reduces non-selectively the calcium influx through several different types of VOCCs such as the N-type, P/Q-type and T-type VOCCs. In the hippocampus, one brain region important for anxiety disorders, we show that inhibition by lavender oil is mainly mediated via N-type and P/Q-type VOCCs. Taken together, we provide a pharmacological and molecular rationale for the clinical use of the oral application of lavender oil in patients suffering from anxiety.	[Schuwald, Anita M.; Mueller, Walter E.] Goethe Univ Frankfurt, Dept Pharmacol, Bioctr, D-60054 Frankfurt, Germany; [Noeldner, Michael] Dr Willmar Schwabe Pharmaceut, Karlsruhe, Germany; [Wilmes, Thomas; Klugbauer, Norbert] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79106 Freiburg, Germany; [Leuner, Kristina] Univ Erlangen Nurnberg, Dept Mol & Clin Pharm, D-91054 Erlangen, Germany	Goethe University Frankfurt; Dr. Willmar Schwabe GmbH & Co. KG; University of Freiburg; University of Erlangen Nuremberg	Leuner, K (corresponding author), Univ Erlangen Nurnberg, Dept Mol & Clin Pharm, D-91054 Erlangen, Germany.	Leuner@pharmtech.uni-erlangen.de	; Friedland, Kristina/G-4651-2015	Muller, Werner E.G./0000-0002-8223-3689; Friedland, Kristina/0000-0001-8603-5957	Dr. Willmar Schwabe Pharmaceuticals	Dr. Willmar Schwabe Pharmaceuticals	This study was supported by a research grant of Dr. Willmar Schwabe Pharmaceuticals to K. Leuner and W. E. Muller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: M. Noldner is a full time employee of Dr. Willmar Schwabe Pharmaceuticals. K. Leuner received research support by Dr. Willmar Schwabe Pharmaceuticals. W. E. Muller received research support as well as speaker and scientific advisor honorarium by Dr. Willmar Schwabe Pharmaceuticals. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Axelrod J, 1998, NEUROCHEM RES, V23, P575, DOI 10.1023/A:1022418217479; Batista PA, 2008, NEUROSCI LETT, V440, P299, DOI 10.1016/j.neulet.2008.05.092; Bradley BF, 2007, J ETHNOPHARMACOL, V111, P517, DOI 10.1016/j.jep.2006.12.021; Bradley BF, 2009, HUM PSYCHOPHARM CLIN, V24, P319, DOI 10.1002/hup.1016; Brum LFS, 2001, PHYTOTHER RES, V15, P422, DOI 10.1002/ptr.973; Dooley DJ, 2007, TRENDS PHARMACOL SCI, V28, P75, DOI 10.1016/j.tips.2006.12.006; Dooley DJ, 2002, SYNAPSE, V45, P171, DOI 10.1002/syn.10094; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Fink K, 2002, NEUROPHARMACOLOGY, V42, P229, DOI 10.1016/S0028-3908(01)00172-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Huang LP, 2009, J PHARM PHARMACOL, V61, P267; Kalk NJ, 2011, J PSYCHOPHARMACOL, V25, P3, DOI 10.1177/0269881110367448; Kasper S, 2010, PLANTA MED, V76, P1184; Kasper S, 2010, WIEN MED WOCHENSCHR, V160, P547, DOI 10.1007/s10354-010-0845-7; Kasper S, 2010, INT CLIN PSYCHOPHARM, V25, P277, DOI 10.1097/YIC.0b013e32833b3242; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; Leal-Cardoso JH, 2010, EUR J PHARMACOL, V645, P86, DOI 10.1016/j.ejphar.2010.07.014; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Leuner K, 2010, MOL PHARMACOL, V77, P368, DOI 10.1124/mol.109.057513; Leuner K, 2013, HIPPOCAMPUS, V23, P40, DOI 10.1002/hipo.22052; Li Z, 2011, EUR J PHARMACOL, V667, P80, DOI 10.1016/j.ejphar.2011.05.054; Linck VD, 2009, PHYTOMEDICINE, V16, P303, DOI 10.1016/j.phymed.2008.08.001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meder W, 1999, J PHARMACOL EXP THER, V290, P1126; Moss M, 2003, INT J NEUROSCI, V113, P15, DOI 10.1080/00207450390161903; Musazzi L, 2011, NEUROCHEM INT, V59, P138, DOI 10.1016/j.neuint.2011.05.002; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Re L, 2000, PHARMACOL RES, V42, P177, DOI 10.1006/phrs.2000.0671; Ryff CD, 2008, J HAPPINESS STUD, V9, P13, DOI 10.1007/s10902-006-9019-0; Ryff CD, 1996, PSYCHOTHER PSYCHOSOM, V65, P14, DOI 10.1159/000289026; Shaw D, 2007, PHYTOMEDICINE, V14, P613, DOI 10.1016/j.phymed.2007.03.007; SUMANCHAUHAN N, 1993, EUR J PHARM-MOLEC PH, V244, P293, DOI 10.1016/0922-4106(93)90155-3; Treiber K, 2005, BRIT J PHARMACOL, V145, P75, DOI 10.1038/sj.bjp.0706155; Twitchell W, 1997, J NEUROPHYSIOL, V78, P43, DOI 10.1152/jn.1997.78.1.43; Uehleke B, 2012, PHYTOMEDICINE, V19, P665, DOI 10.1016/j.phymed.2012.02.020; Umezu T, 2006, PHARMACOL BIOCHEM BE, V85, P713, DOI 10.1016/j.pbb.2006.10.026; Woelk H, 2010, PHYTOMEDICINE, V17, P94, DOI 10.1016/j.phymed.2009.10.006; Xu YR, 1996, INFECT IMMUN, V64, P593, DOI 10.1128/IAI.64.2.593-599.1996	40	63	64	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e59998	10.1371/journal.pone.0059998	http://dx.doi.org/10.1371/journal.pone.0059998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637742	Green Published, gold			2022-12-25	WOS:000321662800003
J	Lee, S; Hasegawa, T				Lee, Sean; Hasegawa, Toshikazu			Evolution of the Ainu Language in Space and Time	PLOS ONE			English	Article							MITOCHONDRIAL-DNA ANALYSIS; POPULATION HISTORY; OKHOTSK PEOPLE; Y-CHROMOSOMES; ANCIENT DNA; HOKKAIDO; ORIGINS; PHYLOGENIES; EXPANSION; LINEAGES	Languages evolve over space and time. Illuminating the evolutionary history of language is important because it provides a unique opportunity to shed light on the population history of the speakers. Spatial and temporal aspects of language evolution are particularly crucial for understanding demographic history, as they allow us to identify when and where the languages originated, as well as how they spread across the globe. Here we apply Bayesian phylogeographic methods to reconstruct spatiotemporal evolution of the Ainu language: an endangered language spoken by an indigenous group that once thrived in northern Japan. The conventional dual-structure model has long argued that modern Ainu are direct descendants of a single, Pleistocene human lineage from Southeast Asia, namely the Jomon people. In contrast, recent evidence from archaeological, anthropological and genetic evidence suggest that the Ainu are an outcome of significant genetic and cultural contributions from Siberian hunter-gatherers, the Okhotsk, who migrated into northern Hokkaido around 900-1600 years ago. Estimating from 19 Ainu language varieties preserved five decades ago, our analysis shows that they are descendants of a common ancestor who spread from northern Hokkaido around 1300 years ago. In addition to several lines of emerging evidence, our phylogeographic analysis strongly supports the hypothesis that recent expansion of the Okhotsk to northern Hokkaido had a profound impact on the origins of the Ainu people and their culture, and hence calls for a refinement to the dual-structure model.	[Lee, Sean; Hasegawa, Toshikazu] Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Tokyo, Japan	University of Tokyo	Lee, S (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Tokyo, Japan.	seanlee@darwin.c.u-tokyo.ac.jp			 [248973]		This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (248973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2011, AM J PHYS ANTHROPOL, V146, P346, DOI 10.1002/ajpa.21561; Alekseyenko AV, 2008, SYST BIOL, V57, P772, DOI 10.1080/10635150802434394; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Crowley T., 2009, INTRO HIST LINGUISTI; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; Darwin Charles, 1871, DESCENT MAN; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Dodo Y, 2002, ANTHROPOL SCI, V110, P1, DOI 10.1537/ase.110.1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Embleton S. M., 1986, STAT HIST LINGUISTIC; Forster P, 2011, SCIENCE, V333, P1390, DOI 10.1126/science.1205331; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Gray Russell D., 2007, Biological Theory, V2, P360, DOI 10.1162/biot.2007.2.4.360; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Hanihara T, 2010, AM J HUM BIOL, V22, P163, DOI 10.1002/ajhb.20969; Hanihara T, 2009, AM J PHYS ANTHROPOL, V139, P311, DOI 10.1002/ajpa.20985; Hattori S, 2011, JAPANESE J ETHNOLOGY, V24, P31; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; Holland BR, 2002, MOL BIOL EVOL, V19, P2051, DOI 10.1093/oxfordjournals.molbev.a004030; Hudson MJ, 2004, J ANTHROPOL ARCHAEOL, V23, P290, DOI 10.1016/j.jaa.2004.05.002; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; ISHIDA H, 1991, J ANTHROPOL SOC NIP, V99, P23; Ishida H, 2009, ANTHROPOL SCI, V117, P147, DOI 10.1537/ase.081219; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; Lee S, 2011, P ROY SOC B-BIOL SCI, V278, P3662, DOI 10.1098/rspb.2011.0518; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Mace R, 2011, PHILOS T R SOC B, V366, P402, DOI 10.1098/rstb.2010.0238; Masuda R, 2001, ZOOL SCI, V18, P741, DOI 10.2108/zsj.18.741; OHYI H, 1985, B I STUDY N EURASIAN, V17, P165; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Pagel M, 2004, NATURE, V428, P275, DOI 10.1038/428275a; Pagel M, 2009, NAT REV GENET, V10, P405, DOI 10.1038/nrg2560; Paradis E, 2002, ECOL MODEL, V151, P279, DOI 10.1016/S0304-3800(01)00487-2; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; RENFREW C, 1989, T PHILOL SOC, V87, P103, DOI 10.1111/j.1467-968X.1989.tb00622.x; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Sato T, 2007, J HUM GENET, V52, P618, DOI 10.1007/s10038-007-0164-z; Sato T, 2009, ANTHROPOL SCI, V117, P171, DOI 10.1537/ase.081202; Swadesh Morris, 1971, ORIGIN DIVERSIFICATI; Tajima A, 2004, J HUM GENET, V49, P187, DOI 10.1007/s10038-004-0131-x; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; TURNER CG, 1986, SCIENCE, V232, P1140, DOI 10.1126/science.232.4754.1140; Vovin A., 1993, RECONSTRUCTION PROTO; Walker RS, 2011, P ROY SOC B-BIOL SCI, V278, P2562, DOI 10.1098/rspb.2010.2579; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; [No title captured]	57	17	17	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62243	10.1371/journal.pone.0062243	http://dx.doi.org/10.1371/journal.pone.0062243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136EF	23638014	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700042
J	Bartels, MD; Boye, K; Oliveira, DC; Worning, P; Goering, R; Westh, H				Bartels, Mette D.; Boye, Kit; Oliveira, Duarte C.; Worning, Peder; Goering, Richard; Westh, Henrik			Associations between dru Types and SCCmec Cassettes	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MEC HYPERVARIABLE REGION; METHICILLIN-RESISTANT; RAPID IDENTIFICATION; MULTIPLEX PCR; CLONAL GROUP; POLYMORPHISMS; STRAINS; STRATEGY; FINLAND	Molecular typing is an important tool in the investigation of methicillin resistant Staphylococcus aureus (MRSA) outbreaks and in following the evolution of MRSA. The staphylococcal cassette chromosome mec (SCCmec) contains a hypervariable region with a variable number of 40 bp repeats named direct repeat units (dru). The dru region has been suggested as a supplementary typing method for MRSA and an international nomenclature exists. The purpose of this study was to investigate the diversity and variability of the dru region in a diverse collection of MRSA. We studied 302 MRSA isolates harbouring SCCmec types I to VI. The isolates represented a broad genetic background based on Staphylococcal protein A (spa) typing and multilocus sequence typing (MLST) and included 68 isolates (68 patients) from an outbreak with t024-ST8-IVa and 26 isolates from the same patient. Sequencing identified 53 dru types (dt) in 283 isolates, while eighteen isolates contained no dru repeats and one isolate resisted sequencing. The most common dru type, dt10a, was present in 53% of the sequenced isolates and was found in all SCCmec types, except type II. Seven (10%) of the 68 epidemiologically related patients had isolates with dru type variants indicating that dru typing is not useful as a first line epidemiological typing tool. However, MRSA isolates cultured from a single patient over a three year period exhibited a single dru type. The finding of dt10a in most SCCmec types suggests that dru and mecA originate from the same Staphylococcus species.	[Bartels, Mette D.; Boye, Kit; Worning, Peder; Westh, Henrik] Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark; [Westh, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Oliveira, Duarte C.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Caparica, Portugal; [Oliveira, Duarte C.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Goering, Richard] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA	University of Copenhagen; University of Copenhagen; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Creighton University	Bartels, MD (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark.	mette.damkjaer@dadlnet.dk	Bartels, Mette Damkjær/AAY-5809-2020	Bartels, Mette Damkjær/0000-0002-8187-3684; Goering, Richard/0000-0001-7502-7185; Westh, Henrik/0000-0001-5681-647X; Oliveira, Duarte/0000-0002-9591-1039				Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Bartels MD, 2007, EMERG INFECT DIS, V13, P1533, DOI 10.3201/eid1310.070503; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; Boye K, 2011, FEMS MICROBIOL LETT, V314, P101, DOI 10.1111/j.1574-6968.2010.02151.x; Creamer E, 2012, EUR J CLIN MICROBIOL; Damborg P, 2011, ANTIMICROB AGENTS CH, V55, P3932, DOI 10.1128/AAC.00012-11; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Ghaznavi-Rad E, 2011, EUR J CLIN MICROBIOL, V30, P1365, DOI 10.1007/s10096-011-1230-1; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Kahl BC, 2005, J CLIN MICROBIOL, V43, P502, DOI 10.1128/JCM.43.1.502-505.2005; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Lim KT, 2012, DIAGN MICROBIOL INFE; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nahvi MD, 2001, MICROB DRUG RESIST, V7, P1, DOI 10.1089/107662901750152684; Nishi J, 2002, INFECT CONT HOSP EP, V23, P506, DOI 10.1086/502097; NISHI JI, 1995, J LAB CLIN MED, V126, P29; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Oliveira DC, 2000, ANTIMICROB AGENTS CH, V44, P1906, DOI 10.1128/AAC.44.7.1906-1910.2000; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2006, J ANTIMICROB CHEMOTH, V58, P23, DOI 10.1093/jac/dkl208; RYFFEL C, 1991, J BACTERIOL, V173, P7416, DOI 10.1128/jb.173.23.7416-7422.1991; Salmenlinna S, 2002, EMERG INFECT DIS, V8, P602, DOI 10.3201/eid0806.010313; Salmenlinna S, 2001, J CLIN MICROBIOL, V39, P2243, DOI 10.1128/JCM.39.6.2243-2247.2001; Schmitz FJ, 1998, J MED MICROBIOL, V47, P341, DOI 10.1099/00222615-47-4-341; Senna JPM, 2002, J CLIN MICROBIOL, V40, P2254, DOI 10.1128/JCM.40.6.2254-2256.2002; Shore AC, 2010, J CLIN MICROBIOL, V48, P1839, DOI 10.1128/JCM.02155-09; Smyth DS, 2011, INFECT GENET EVOL, V11, P446, DOI 10.1016/j.meegid.2010.12.005; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Stefani S, 2012, INT J ANTIMICROB AGE; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Witte W, 2001, INT J MED MICROBIOL, V291, P57, DOI 10.1078/1438-4221-00116	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61860	10.1371/journal.pone.0061860	http://dx.doi.org/10.1371/journal.pone.0061860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634214	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400022
J	He, L; Xu, XL; Li, Y; Li, CF; Zhu, YJ; Yan, HX; Sun, ZY; Sun, C; Song, JY; Bi, Y; Shen, J; Cheng, RY; Wang, ZZ; Xiao, W; Chen, SL				He, Liu; Xu, Xiaolan; Li, Ying; Li, Chunfang; Zhu, Yingjie; Yan, Haixia; Sun, Zhiying; Sun, Chao; Song, Jingyuan; Bi, Yu'an; Shen, Juan; Cheng, Ruiyang; Wang, Zhenzhong; Xiao, Wei; Chen, Shilin			Transcriptome Analysis of Buds and Leaves Using 454 Pyrosequencing to Discover Genes Associated with the Biosynthesis of Active Ingredients in Lonicera japonica Thunb	PLOS ONE			English	Article							QUINATE HYDROXYCINNAMOYL TRANSFERASE; CHLOROGENIC ACID; FLOS-LONICERAE; UDP-GLUCOSE; 7-O-GLUCOSYLTRANSFERASE ACTIVITY; REGULATORY NETWORKS; CITRUS-PARADISI; ARABIDOPSIS; PURIFICATION; CONSTITUENTS	Background: Lonicera japonica Thunb. is a plant used in traditional Chinese medicine known for its anti-inflammatory, antioxidative, anti-carcinogenic, and antiviral pharmacological properties. The major active secondary metabolites of this plant are chlorogenic acid (CGA) and luteoloside. While the biosynthetic pathways of these metabolites are relatively well known, the genetic information available for this species, especially the biosynthetic pathways of its active ingredients, is limited. Methodology/Principal Findings: We obtained one million reads (average length of 400 bp) in a whole sequence run using a Roche/454 GS FLX titanium platform. Altogether, 85.69% of the unigenes covering the entire life cycle of the plant were annotated and 325 unigenes were assigned to secondary metabolic pathways. Moreover, 2039 unigenes were predicted as transcription factors. Nearly all of the possible enzymes involved in the biosynthesis of CGA and luteoloside were discovered in L. japonica. Three hydroxycinnamoyl transferase genes, including two hydroxycinnamoyl-CoA quinate hydroxycinnamoyl transferase genes and one hydroxycinnamoyl-CoA shikimate/quinate hydroxycinnamoyl transferase (HCT) gene featuring high similarity to known genes from other species, were cloned. The HCT gene was discovered for the first time in L. japonica. In addition, 188 candidate cytochrome P450 unigenes and 245 glycosyltransferase unigenes were found in the expressed sequence tag (EST) dataset. Conclusion: This study provides a high quality EST database for L. japonica by 454 pyrosequencing. Based on the EST annotation, a set of putative genes involved in CGA and luteoloside biosynthetic pathways were discovered. The database serves as an important source of public information on genetic markers, gene expression, genomics, and functional genomics in L. japonica.	[He, Liu; Xu, Xiaolan; Li, Ying; Li, Chunfang; Zhu, Yingjie; Yan, Haixia; Sun, Zhiying; Sun, Chao; Song, Jingyuan; Chen, Shilin] Chinese Acad Med Sci, Inst Med Plant Dev IMPLAD, Beijing 100730, Peoples R China; [He, Liu; Xu, Xiaolan; Li, Ying; Li, Chunfang; Zhu, Yingjie; Yan, Haixia; Sun, Zhiying; Sun, Chao; Song, Jingyuan; Chen, Shilin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Bi, Yu'an; Shen, Juan; Wang, Zhenzhong; Xiao, Wei] Jiangsu Kanion Pharmaceut Co LTD, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Peoples R China; [Cheng, Ruiyang] Beijing Univ Chinese Med, Beijing, Peoples R China; [Chen, Shilin] Chinese Acad Med Sci, Inst Chinese Materia Med, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing University of Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College	Xiao, W (corresponding author), Jiangsu Kanion Pharmaceut Co LTD, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Peoples R China.	wzhzh-nj@tom.com; slchen@implad.ac.cn	Zhu, Yingjie/W-3315-2017	Zhu, Yingjie/0000-0003-1849-6019; He, Liu/0000-0003-3951-4132	Key National Natural Science Foundation of China [81130069]; National Basic Research Program of China [2010CB735604]; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [IRT1150]	Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China	This work was supported by the Key National Natural Science Foundation of China (Grant no. 81130069), the National Basic Research Program of China (Grant no.2010CB735604), and the Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (Grant no. IRT1150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandyopadhyay G, 2004, BLOOD, V104, P2514, DOI 10.1182/blood-2003-11-4065; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; BRADFIELD AE, 1952, NATURE, V170, P168, DOI 10.1038/170168b0; Caniard A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-119; Cao Y, 2009, SHANDONG FORESTRY SC, V3, P29; Chai XY, 2005, J CHROMATOGR A, V1070, P43, DOI 10.1016/j.chroma.2005.02.031; CHANG WC, 1992, PROSTAG LEUKOTR ESS, V45, P307, DOI 10.1016/0952-3278(92)90088-Z; Chen J, 2005, J SEP SCI, V28, P365, DOI 10.1002/jssc.200400024; Choi CW, 2007, ARCH PHARM RES, V30, P1, DOI 10.1007/BF02977770; Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1118::AID-JSFA570&gt;3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9]; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Comino C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-30; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; DICKINSON D, 1954, J SCI FOOD AGR, V5, P525, DOI 10.1002/jsfa.2740051104; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; Franke R, 2002, PLANT J, V30, P33, DOI 10.1046/j.1365-313X.2002.01266.x; Hirotani M, 2000, PLANTA, V210, P1006, DOI 10.1007/s004250050710; INAGAKI I, 1974, YAKUGAKU ZASSHI, V94, P524, DOI 10.1248/yakushi1947.94.4_524; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kishimoto Noriaki, 2005, Biocontrol Science, V10, P155; Kitada C, 2001, PLANT CELL PHYSIOL, V42, P1338, DOI 10.1093/pcp/pce169; KOJIMA M, 1972, PLANT CELL PHYSIOL, V13, P311, DOI 10.1093/oxfordjournals.pcp.a074741; Kumar N, 2005, PHYTOCHEMISTRY, V66, P2740, DOI 10.1016/j.phytochem.2005.10.002; Kurata R, 2007, J AGR FOOD CHEM, V55, P185, DOI 10.1021/jf0620259; Kwak WJ, 2003, CHEM PHARM BULL, V51, P333, DOI 10.1248/cpb.51.333; Lan W, 2007, DRUG DEV IND PHARM, V33, P841, DOI 10.1080/03639040701378019; LEE SJ, 1995, ARCH PHARM RES, V18, P133, DOI 10.1007/BF02979147; Lepelley M, 2007, PLANT SCI, V172, P978, DOI 10.1016/j.plantsci.2007.02.004; Li Huijun, 2002, Zhong Yao Cai, V25, P476; Li Q, 2012, PLANT OMICS, V5, P1; Lin LM, 2008, J ASIAN NAT PROD RES, V10, P925, DOI 10.1080/10286020802217366; Liu BaoChen, 2011, Medicinal Plant, V2, P35; Liu ZL, 2009, J HAZARD MATER, V169, P170, DOI 10.1016/j.jhazmat.2009.03.090; Lu HT, 2004, J CHROMATOGR A, V1026, P185, DOI 10.1016/j.chroma.2003.11.004; MCINTOSH CA, 1990, PHYTOCHEMISTRY, V29, P1533, DOI 10.1016/0031-9422(90)80115-W; MCINTOSH CA, 1990, ARCH BIOCHEM BIOPHYS, V282, P50, DOI 10.1016/0003-9861(90)90085-D; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; MORI H, 1986, CANCER LETT, V30, P49, DOI 10.1016/0304-3835(86)90131-X; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nicolai M, 2012, GENET MOL RES, V11, P2295, DOI 10.4238/2012.August.13.3; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OSBORNE TB, 1897, J AM CHEM SOC, V19, P487; Peng XX, 2010, PLANTA MED, V76, P1921, DOI 10.1055/s-0030-1250020; Qian ZM, 2007, BIOMED CHROMATOGR, V21, P649, DOI 10.1002/bmc.803; Qiu F, 2013, BIOMED CHROMATOGR, V27, P311, DOI 10.1002/bmc.2793; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schierenbeck KA, 2004, CRIT REV PLANT SCI, V23, P391, DOI 10.1080/07352680490505141; Schlotzhauer WS, 1996, J AGR FOOD CHEM, V44, P206, DOI 10.1021/jf950275b; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; SCHULZ M, 1988, PHYTOCHEMISTRY, V27, P1261, DOI 10.1016/0031-9422(88)80175-4; Sonnante G, 2010, PLANT PHYSIOL, V153, P1224, DOI 10.1104/pp.109.150144; St-Pierre B, 2000, RECENT ADV PHYTOCHEM, V34, P285, DOI 10.1016/S0079-9920(00)80010-6; Stich K, 1997, Z NATURFORSCH C, V52, P153; STOCKIGT J, 1974, FEBS LETT, V42, P131, DOI 10.1016/0014-5793(74)80769-6; STRACK D, 1990, PLANT PHYSIOL, V92, P41, DOI 10.1104/pp.92.1.41; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA T, 1990, BASIC LIFE SCI, V52, P429; TANAKA T, 1993, CARCINOGENESIS, V14, P1321, DOI 10.1093/carcin/14.7.1321; Tang D, 2008, J SEP SCI, V31, P3519, DOI 10.1002/jssc.200800173; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765; ULBRICH B, 1979, PHYTOCHEMISTRY, V18, P929, DOI 10.1016/S0031-9422(00)91451-1; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; VELLEKOOP P, 1993, FEBS LETT, V330, P36, DOI 10.1016/0014-5793(93)80914-G; VILLEGAS RJA, 1986, J BIOL CHEM, V261, P8729; Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002; Wang LM, 2009, J SCI FOOD AGR, V89, P953, DOI 10.1002/jsfa.3537; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15; Xing J, 1999, Zhong Yao Cai, V22, P366; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Yuan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-195; ZUCKER M, 1959, PLANT PHYSIOL, V34, P108, DOI 10.1104/pp.34.2.108	81	38	50	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62922	10.1371/journal.pone.0062922	http://dx.doi.org/10.1371/journal.pone.0062922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638167	Green Submitted, Green Published, gold			2022-12-25	WOS:000318341400075
J	Lin, J; Shou, XL; Mao, XB; Dong, JC; Mohabeer, N; Kushwaha, KK; Wang, L; Su, YS; Fang, HC; Li, DZ				Lin, Jing; Shou, Xiling; Mao, Xiaobo; Dong, Jiangchuan; Mohabeer, Nilesh; Kushwaha, Kishan Kumar; Wang, Lei; Su, Yousu; Fang, Hongcheng; Li, Dazhu			Oxidized Low Density Lipoprotein Induced Caspase-1 Mediated Pyroptotic Cell Death in Macrophages: Implication in Lesion Instability?	PLOS ONE			English	Article							NALP3 INFLAMMASOME; T-CELLS; ATHEROSCLEROSIS; ACTIVATION; PLAQUE; APOPTOSIS; PART	Background: Macrophage death in advanced lesion has been confirmed to play an important role in plaque instability. However, the mechanism underlying lesion macrophage death still remains largely unknown. Methods and Results: Immunohistochemistry showed that caspase-1 activated in advanced lesion and co-located with macrophages and TUNEL positive reaction. In in-vitro experiments showed that ox-LDL induced caspase-1 activation and this activation was required for ox-LDL induced macrophages lysis, IL-1 beta and IL-18 production as well as DNA fragmentation. Mechanism experiments showed that CD36 and NLRP3/caspase-1/pathway involved in ox-LDL induced macrophage pyroptosis. Conclusion: Our study here identified a novel cell death, pyroptosis in ox-LDL induced human macrophage, which may be implicated in lesion macrophages death and play an important role in lesion instability.	[Lin, Jing; Shou, Xiling] Shaanxi Prov Peoples Hosp, Dept Cardiovasc Med, Xian, Peoples R China; [Mao, Xiaobo; Dong, Jiangchuan; Mohabeer, Nilesh; Kushwaha, Kishan Kumar; Li, Dazhu] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol,Inst Cardiovasc Dis, Wuhan 430074, Peoples R China; [Wang, Lei; Su, Yousu; Fang, Hongcheng] Huazhong Univ Sci & Technol, Union Shenzhen Hosp, Shenzhen Peoples Hosp 6, Nanshan Hosp,Dept Cardiol, Shenzhen, Peoples R China	Xi'an Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, DZ (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol,Inst Cardiovasc Dis, Wuhan 430074, Peoples R China.	lidazhuhp@sohu.com			National Natural Science Foundation of China [81170258]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China to Dr. Dazhu Li (NO. 81170258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmis R, 2003, CIRC RES, V92, pE20, DOI 10.1161/01.RES.0000051886.43510.90; BALL RY, 1995, ATHEROSCLEROSIS, V114, P45, DOI 10.1016/0021-9150(94)05463-S; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Crisby M, 1997, ATHEROSCLEROSIS, V130, P17, DOI 10.1016/S0021-9150(96)06037-6; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Kolodgie FD, 2000, AM J PATHOL, V157, P1259, DOI 10.1016/S0002-9440(10)64641-X; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Li M, 2010, CELL PHYSIOL BIOCHEM, V25, P649, DOI 10.1159/000315084; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Lin J, 2010, J LIPID RES, V51, P1208, DOI 10.1194/jlr.D000497; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Merched AJ, 2003, ARTERIOSCL THROM VAS, V23, P1608, DOI 10.1161/01.ATV.0000084825.88022.53; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Monack DM, 2001, CELL MICROBIOL, V3, P825, DOI 10.1046/j.1462-5822.2001.00162.x; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Netea MG, 2001, EUR J IMMUNOL, V31, P2529, DOI 10.1002/1521-4141(200109)31:9<2529::AID-IMMU2529>3.0.CO;2-B; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shibata N, 2009, J LIPID RES, V50, pS277, DOI 10.1194/jlr.R800063-JLR200; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675	34	45	55	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62148	10.1371/journal.pone.0062148	http://dx.doi.org/10.1371/journal.pone.0062148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637985	gold, Green Published, Green Submitted			2022-12-25	WOS:000318341400038
J	Arnal, M; Herrero, J; de la Fe, C; Revilla, M; Prada, C; Martinez-Duran, D; Gomez-Martin, A; Fernandez-Arberas, O; Amores, J; Contreras, A; Garcia-Serrano, A; de Luco, DF				Arnal, MariaCruz; Herrero, Juan; de la Fe, Christian; Revilla, Miguel; Prada, Carlos; Martinez-Duran, David; Gomez-Martin, Angel; Fernandez-Arberas, Olatz; Amores, Joaquin; Contreras, Antonio; Garcia-Serrano, Alicia; Fernandez de Luco, Daniel			Dynamics of an Infectious Keratoconjunctivitis Outbreak by Mycoplasma conjunctivae on Pyrenean Chamois Rupicapra p. pyrenaica	PLOS ONE			English	Article							IBEX CAPRA-PYRENAICA; ALPINE CHAMOIS; R.-RUPICAPRA; WILD CAPRINAE; NATIONAL-PARK; MULE DEER; SHEEP; SWITZERLAND; POPULATION; SPAIN	Between 2006 and 2008, an outbreak of Infectious Keratoconjunctivitis (IKC) affected Pyrenean chamois Rupicapra p. pyrenaica, an endemic subspecies of mountain ungulate that lives in the Pyrenees. The study focused on 14 mountain massifs (180,000 ha) where the species' population is stable. Cases of IKC were detected in ten of the massifs and, in five of them, mortality was substantial. The outbreak spread quickly from the first location detected, with two peaks in mortality that affected one (2007) and three (2008) massifs. In the latter, the peak was seasonal (spring to autumn) and, in the former, the outbreak persisted through winter. To identify the outbreak's aetiology, we examined 105 Pyrenean chamois clinically affected with IKC. TaqMan rt-PCR identified Mycoplasma conjunctivae in 93 (88.5%) of the chamois. Another rt-PCR detected Chlamydophila spp. in 14 of chamois, and 12 of those had mixed infections with mycoplasmas. In the period 2000-2007, the chamois population increased slightly (lambda 1.026) but decreased significantly during the IKC outbreak (lambda 0.8, 2007-2008; lambda 0.85, 2008-2009) before increasing significantly after the outbreak (lambda 1.1, 2009-2010). Sex-biased mortality shifted the adult sex ratio toward males (from 0.6 to 0.7 males per female) and reduced productivity slightly. Hunting was practically banned in the massifs where chamois experienced significant mortality and allowed again after the outbreak ended. Long-term monitoring of wild populations provides a basis for understanding the impacts of disease outbreaks and improves management decisions, particularly when species are subject to extractive exploitation.	[Arnal, MariaCruz; Revilla, Miguel; Martinez-Duran, David; Fernandez de Luco, Daniel] Univ Zaragoza, Fac Vet, Dept Patol Anim, Zaragoza, Spain; [Herrero, Juan] Univ Zaragoza, Escuela Politecn Super Huesca, Dept Ciencias Agr & Medio Nat, Area Ecol, Huesca, Spain; [de la Fe, Christian; Gomez-Martin, Angel; Amores, Joaquin; Contreras, Antonio] Univ Murcia, Dept Sanidad Anim, Fac Vet, Murcia, Spain; [Prada, Carlos; Fernandez-Arberas, Olatz; Garcia-Serrano, Alicia] Ega Wildlife Consultants, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; University of Murcia	Arnal, M (corresponding author), Univ Zaragoza, Fac Vet, Dept Patol Anim, Zaragoza, Spain.	maricruz@unizar.es	De la Fe, Christian/F-3373-2016; Arnal, Maria Cruz MCA/D-5931-2017	De la Fe, Christian/0000-0002-4354-1689; Arnal, Maria Cruz/0000-0002-6770-3400; Joaquin, Amores-Iniesta/0000-0002-4125-2250; Contreras de Vera, Antonio/0000-0002-4455-8730; Fernandez de Luco Martinez, Daniel/0000-0003-3289-4267	Departamento de Agricultura, Ganaderia y Medio Ambiente, Gobierno de Aragon; Departamento de Desarrollo Rural, Medio Ambiente y Administracion Local, Gobierno de Navarra	Departamento de Agricultura, Ganaderia y Medio Ambiente, Gobierno de Aragon; Departamento de Desarrollo Rural, Medio Ambiente y Administracion Local, Gobierno de Navarra	The study was funded by Departamento de Agricultura, Ganaderia y Medio Ambiente, Gobierno de Aragon and Departamento de Desarrollo Rural, Medio Ambiente y Administracion Local, Gobierno de Navarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal MC, 2004, PYRENEAN CHAMOIS RUP, P125; Balbo T, 1985, BIOL MANAGEMENT MOUN; Bassano B, 1994, IBEX, V2, P17; Belda A. S., 1985, Atti del Simposio internazionale sulla cheratocongiuntivite infettiva del camoscio, Vercelli-Varallo Sesia, 30 novembre-2 dicembre 1982, P73; Berducou C., 1985, P166; Berducou C, 1982, ACTA BIOL MONTANA, V1, P153; Blanco A, 1982, INIA SERIE GANADERA, V17, P79; Cugnasse J. M., 1997, Gibier Faune Sauvage, V14, P569; Daniel M. J., 1963, Schweizer Archiv fur Tierheilkunde, V105, P399; Degiorgis MP, 2000, SCHWEIZ ARCH TIERH, V142, P520; DOMENECH JM, 2005, REGRESION LOGISTICA; Dubay SA, 2000, J WILDLIFE DIS, V36, P241, DOI 10.7589/0090-3558-36.2.241; Egwu G. O., 1991, Veterinary Bulletin, V61, P547; EGWU GO, 1989, VET REC, V125, P253, DOI 10.1136/vr.125.10.253; Garcia-Gonzalez R, 1992, ONGULESUNGULATES, V91, P321; Gauthier D, 1991, THESIS U LYON LYON; Giacometti M, 1998, VET MICROBIOL, V61, P279, DOI 10.1016/S0378-1135(98)00186-2; Giacometti M, 2002, J WILDLIFE DIS, V38, P297, DOI 10.7589/0090-3558-38.2.297; Giacometti M, 2002, REV SCI TECH OIE, V21, P335, DOI 10.20506/rst.21.2.1338; Gonzalez-Candela M, 2007, VET REC, V161, P167, DOI 10.1136/vr.161.5.167; Gortazar C, 2000, MAMMALIA, V64, P411, DOI 10.1515/mamm.2000.64.4.411; Grattarola C, 1999, VET REC, V145, P588, DOI 10.1136/vr.145.20.588; Herrero J, 1996, FOREST ECOL MANAG, V88, P25, DOI 10.1016/S0378-1127(96)03806-6; Herrero J., 2002, Pirineos, V157, P89; Herrero J, 2004, PYRENEAN CHAMOIS RUP, P69; Herrero J, 2010, ORYX, V44, P529, DOI 10.1017/S0030605310000761; Holzwarth N, 2011, J VET DIAGN INVEST, V23, P333, DOI 10.1177/104063871102300223; Hosie B. D., 2000, Diseases of sheep, P301; Hotzel H, 1996, VET MICROBIOL, V49, P31, DOI 10.1016/0378-1135(95)00176-X; Janovsky M, 2001, VET MICROBIOL, V83, P11, DOI 10.1016/S0378-1135(01)00407-2; Jansen BD, 1996, J WILDLIFE DIS, V42, P407; KLEINBAUM DG, 1988, DUXBURY SERIES STAT; Loison A, 1996, J WILDLIFE MANAGE, V60, P517, DOI 10.2307/3802069; Marco I, 1992, VET PRAXIS, V6, P57; Marco I, 2009, J WILDLIFE DIS, V45, P238, DOI 10.7589/0090-3558-45.1.238; Marco J, 2011, REV ECOLOGIA MONTANA, V166, P135; Marenda MS, 2005, MICROBIOL-SGM, V151, P475, DOI 10.1099/mic.0.27590-0; Mavrot F, 2012, J WILDLIFE DIS, V48, P619, DOI 10.7589/0090-3558-48.3.619; Mayer D, 1997, J WILDLIFE DIS, V33, P413, DOI 10.7589/0090-3558-33.3.413; MEAGHER M, 1992, J WILDLIFE DIS, V28, P171, DOI 10.7589/0090-3558-28.2.171; Naglic T, 2000, VET REC, V147, P72, DOI 10.1136/vr.147.3.72; Polkinghorne A, 2009, VET MICROBIOL, V135, P142, DOI 10.1016/j.vetmic.2008.09.034; R Development Core Team, 2012, R LANG ENV STAT COMP; Taylor SK, 1996, J WILDLIFE DIS, V32, P326, DOI 10.7589/0090-3558-32.2.326; Tschopp R, 2005, VET REC, V157, P13, DOI 10.1136/vr.157.1.13; VANKUPPEVELD FJM, 1994, APPL ENVIRON MICROB, V60, P149, DOI 10.1128/AEM.60.1.149-152.1994; Verbisck-Bucker G, 2008, J WILDLIFE DIS, V44, P369, DOI 10.7589/0090-3558-44.2.369; Vilei EM, 2007, J MICROBIOL METH, V70, P384, DOI 10.1016/j.mimet.2007.05.007; Zimmermann L, 2008, WILDLIFE BIOL, V14, P118, DOI 10.2981/0909-6396(2008)14[118:SOMCSF]2.0.CO;2	49	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61887	10.1371/journal.pone.0061887	http://dx.doi.org/10.1371/journal.pone.0061887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637923	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400056
J	Chai, R; Qiu, CW; Liu, DR; Qi, YC; Gao, YQ; Shen, JW; Qiu, LY				Chai, Ran; Qiu, Cuiwei; Liu, Dongren; Qi, Yuancheng; Gao, Yuqian; Shen, Jinwen; Qiu, Liyou			beta-Glucan Synthase Gene Overexpression and beta-Glucans Overproduction in Pleurotus ostreatus Using Promoter Swapping	PLOS ONE			English	Article							HYGROMYCIN-B RESISTANCE; CELL-WALL; TRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; EXPRESSION SYSTEMS; MEDICINAL MUSHROOM; OVERLAP EXTENSION; ESCHERICHIA-COLI; TOUCHDOWN PCR; POLYSACCHARIDES	Mushroom beta-glucans are potent immunological stimulators in medicine, but their productivities are very low. In this study, we successfully improved its production by promoter engineering in Pleurotus ostreatus. The promoter for beta-1,3-glucan synthase gene (GLS) was replaced by the promoter of glyceraldehyde-3-phosphate dehydrogenase gene of Aspergillus nidulans. The homologous recombination fragment for swapping GLS promoter comprised five segments, which were fused by two rounds of combined touchdown PCR and overlap extension PCR (TD-OE PCR), and was introduced into P. ostreatus through PEG/CaCl2-mediated protoplast transformation. The transformants exhibited one to three fold higher transcription of GLS gene and produced 32% to 131% higher yield of beta-glucans than the wild type. The polysaccharide yields had a significant positive correlation to the GLS gene expression. The infrared spectra of the polysaccharides all displayed the typical absorption peaks of beta-glucans. This is the first report of successful swapping of promoters in filamentous fungi.	[Chai, Ran; Qiu, Cuiwei; Liu, Dongren; Qi, Yuancheng; Gao, Yuqian; Shen, Jinwen; Qiu, Liyou] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Chai, Ran; Qiu, Cuiwei; Liu, Dongren; Qi, Yuancheng; Gao, Yuqian; Shen, Jinwen; Qiu, Liyou] Minist Agr, Key Lab Enzyme Engn Agr Microbiol, Zhengzhou, Peoples R China	Henan Agricultural University; Ministry of Agriculture & Rural Affairs	Qiu, LY (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China.	qliyou@henau.edu.cn			Natural Science Foundation of Henan Province; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Natural Science Foundation of Henan Province; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was funded by a grant from the Natural Science Foundation of Henan Province (http://www.hnkjt.gov.cn/new/index.eiip). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. C.A.M.J.J. van den Hondel for providing plasmid pAN7-1. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Blazeck J, 2013, BIOTECHNOL J, V8, P46, DOI 10.1002/biot.201200120; Borchers AT, 2004, EXP BIOL MED, V229, P393, DOI 10.1177/153537020422900507; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; De Silva DD, 2012, FUNGAL DIVERS, V55, P1, DOI 10.1007/s13225-012-0151-3; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Dong XY, 2012, INT J MED MUSHROOMS, V14, P21, DOI 10.1615/IntJMedMushr.v14.i1.20; Fleissner A, 2010, APPL MICROBIOL BIOT, V87, P1255, DOI 10.1007/s00253-010-2672-6; Ge Y, 2009, CARBOHYD POLYM, V77, P188, DOI 10.1016/j.carbpol.2008.12.020; GIOVANNOZZISERMANNI G, 1991, AGROCHIMICA, V35, P174; Gu PF, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-30; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hammel KE, 2002, ENZYME MICROB TECH, V30, P445, DOI 10.1016/S0141-0229(02)00011-X; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; JENSEN DF, 2003, HDB FUNGAL BIOTECHNO, P441; KARACSONYI S, 1994, CARBOHYD POLYM, V24, P107, DOI 10.1016/0144-8617(94)90019-1; KIHO T, 1991, CHEM PHARM BULL, V39, P798, DOI 10.1248/cpb.39.798; KOCHERT G, 1978, P95; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; McCleary WR, 2009, APPL MICROBIOL BIOT, V84, P641, DOI 10.1007/s00253-009-2137-y; Popov I, 1999, METHOD ENZYMOL, V300, P437; PUNT PJ, 1991, J BIOTECHNOL, V17, P19, DOI 10.1016/0168-1656(91)90024-P; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Qiu LY, 2010, FUNGAL BIOL-UK, V114, P507, DOI 10.1016/j.funbio.2010.04.001; Reverberi M, 2004, APPL MICROBIOL BIOT, V66, P217, DOI 10.1007/s00253-004-1662-y; Robledo-Briones M, 2012, CURR MICROBIOL, V65, P85, DOI 10.1007/s00284-012-0129-0; Rop O, 2009, NUTR REV, V67, P624, DOI 10.1111/j.1753-4887.2009.00230.x; SCHULTZ TP, 1990, PHYTOCHEMISTRY, V29, P1501, DOI 10.1016/0031-9422(90)80109-T; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Silva S, 2012, J SCI FOOD AGR, V92, P1826, DOI 10.1002/jsfa.5560; Smits GJ, 2001, MICROBIOL-SGM, V147, P781, DOI 10.1099/00221287-147-4-781; STAUB A. M., 1965, METHOD CARBOHYD CHEM, V5, P5; Tang YJ, 2007, FOOD TECHNOL BIOTECH, V45, P221; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Wang LQ, 2011, HORTTECHNOLOGY, V21, P82, DOI 10.21273/HORTTECH.21.1.82; Wasser SP, 2010, INT J MED MUSHROOMS, V12, P1, DOI 10.1615/IntJMedMushr.v12.i1.10; Waterham HR, 1997, GENE, V186, P37, DOI 10.1016/S0378-1119(96)00675-0; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Zhao GH, 2005, CARBOHYD POLYM, V61, P125, DOI 10.1016/j.carbpol.2005.04.020	44	19	22	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61693	10.1371/journal.pone.0061693	http://dx.doi.org/10.1371/journal.pone.0061693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637884	gold, Green Submitted, Green Published			2022-12-25	WOS:000318340400040
J	Clond, MA; Lee, BS; Yu, JJ; Singer, MB; Amano, T; Lamb, AW; Drazin, D; Kateb, B; Ley, EJ; Yu, JS				Clond, Morgan A.; Lee, Bong-Seop; Yu, Jeffrey J.; Singer, Matthew B.; Amano, Takayuki; Lamb, Alexander W.; Drazin, Doniel; Kateb, Babak; Ley, Eric J.; Yu, John S.			Reactive Oxygen Species-Activated Nanoprodrug of Ibuprofen for Targeting Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; VITAMIN-E; NEURODEGENERATIVE DISEASES; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; UNITED-STATES; CARE-UNIT	Traumatic brain injury (TBI) is an enormous public health problem, with 1.7 million new cases of TBI recorded annually by the Centers for Disease Control. However, TBI has proven to be an extremely challenging condition to treat. Here, we apply a nanoprodrug strategy in a mouse model of TBI. The novel nanoprodrug contains a derivative of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen in an emulsion with the antioxidant a-tocopherol. The ibuprofen derivative, Ibu(2)TEG, contains a tetra ethylene glycol (TEG) spacer consisting of biodegradable ester bonds. The biodegradable ester bonds ensure that the prodrug molecules break down hydrolytically or enzymatically. The drug is labeled with the fluorescent reporter Cy5.5 using nonbiodegradable bonds to 1-octadecanethiol, allowing us to reliably track its accumulation in the brain after TBI. We delivered a moderate injury using a highly reproducible mouse model of closed-skull controlled cortical impact to the parietal region of the cortex, followed by an injection of the nanoprodrug at a dose of 0.2 mg per mouse. The blood brain barrier is known to exhibit increased permeability at the site of injury. We tested for accumulation of the fluorescent drug particles at the site of injury using confocal and bioluminescence imaging of whole brains and brain slices 36 hours after administration. We demonstrated that the drug does accumulate preferentially in the region of injured tissue, likely due to an enhanced permeability and retention (EPR) phenomenon. The use of a nanoprodrug approach to deliver therapeutics in TBI represents a promising potential therapeutic modality.	[Clond, Morgan A.; Singer, Matthew B.; Lamb, Alexander W.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Lee, Bong-Seop; Yu, Jeffrey J.; Amano, Takayuki; Drazin, Doniel; Kateb, Babak; Yu, John S.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Yu, JS (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA.	John.Yu@cshs.org		Yu, John/0000-0003-1230-8494; Clond, Morgan/0000-0002-3036-4193; Kateb, Babak/0000-0001-7546-7543	American Association for the Surgery of Trauma; Department of Health Services Division of Trauma Research	American Association for the Surgery of Trauma; Department of Health Services Division of Trauma Research	This study was sponsored by grants from the American Association for the Surgery of Trauma and the Department of Health Services Division of Trauma Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Afshari D, 2012, CLIN NEUROLOGY NEURO; [Anonymous], 1999, WISQARS YEARS POT LI; Bernardi A, 2012, INT J NANOMED, V7, P4927, DOI 10.2147/IJN.S35333; Bonina FP, 2001, EUR J PHARM SCI, V14, P123, DOI 10.1016/S0928-0987(01)00163-4; Botteri M, 2008, CRIT CARE MED, V36, P3089, DOI 10.1097/CCM.0b013e31818bd7df; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; BURTON GW, 1982, LANCET, V2, P327; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chassidim Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-9; Chung ES, 2012, BRAIN RES, V1451, P110, DOI 10.1016/j.brainres.2012.02.058; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Cote S, 2012, ALZHEIMERS DEMENT, V8, P219, DOI 10.1016/j.jalz.2011.03.012; Dannhardt G, 2001, EUR J MED CHEM, V36, P109, DOI 10.1016/S0223-5234(01)01197-7; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; HALLIWELL B, 1989, ACTA NEUROL SCAND, V80, P23, DOI 10.1111/j.1600-0404.1989.tb01779.x; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Iadecola C, 2005, STROKE, V36, P182, DOI 10.1161/01.STR.0000153797.33611.d8; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Langham J., 2003, COCHRANE DATABASE SY; Lee BS, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/980720; Lee BS, 2009, INT J PHARMACEUT, V372, P112, DOI 10.1016/j.ijpharm.2008.12.037; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin Y, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/16/165101; LINDGREN S, 1966, RADIAT ENVIRON BIOPH, V3, P174, DOI DOI 10.1007/BF01191611; Liu ML, 2012, NEUROSCI LETT, V508, P31, DOI 10.1016/j.neulet.2011.12.010; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu WY, 1997, NEUROSURGERY, V41, P416, DOI 10.1097/00006123-199708000-00017; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Muehlschlegel S, 2009, NEUROCRIT CARE, V10, P103, DOI 10.1007/s12028-008-9133-4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niki E, 2004, ACCOUNTS CHEM RES, V37, P45, DOI 10.1021/ar030069m; Nogawa S, 1997, J NEUROSCI, V17, P2746; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Siskou IC, 2007, BIOORGAN MED CHEM, V15, P951, DOI 10.1016/j.bmc.2006.10.056; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; TAMMARA VK, 1993, PHARM RES-DORDR, V10, P1191, DOI 10.1023/A:1018976520391; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman DJ, 2001, EPIDEMIOLOGY EC HEAD, P1193; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Viscomi MT, 2008, CEREBELLUM, V7, P401, DOI 10.1007/s12311-008-0042-z; Wallenquist U, 2012, RESTOR NEUROL NEUROS, V30, P9, DOI 10.3233/RNN-2011-0606; Warden SJ, 2010, PHYSICIAN SPORTSMED, V38, P132, DOI 10.3810/psm.2010.04.1770; Xu J, NATL VITAL STAT REPO, V58, P19; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	75	24	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61819	10.1371/journal.pone.0061819	http://dx.doi.org/10.1371/journal.pone.0061819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637912	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400053
J	Nicholson, TB; Singh, AK; Su, H; Hevi, S; Wang, J; Bajko, J; Li, M; Valdez, R; Goetschkes, M; Capodieci, P; Loureiro, J; Cheng, XD; Li, E; Kinzel, B; Labow, M; Chen, TP				Nicholson, Thomas B.; Singh, Anup K.; Su, Hui; Hevi, Sarah; Wang, Jing; Bajko, Jeff; Li, Mei; Valdez, Reginald; Goetschkes, Margaret; Capodieci, Paola; Loureiro, Joseph; Cheng, Xiaodong; Li, En; Kinzel, Bernd; Labow, Mark; Chen, Taiping			A Hypomorphic Lsd1 Allele Results in Heart Development Defects in Mice	PLOS ONE			English	Article							HISTONE DEMETHYLASE LSD1; CATENIN/E-CADHERIN COMPLEX; CELL-ADHESION; CARDIAC DIFFERENTIATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BETA-CATENIN; MOUSE HEART; TRANSCRIPTION; EXPRESSION	Lysine-specific demethylase 1 (Lsd1/Aof2/Kdm1a), the first enzyme with specific lysine demethylase activity to be described, demethylates histone and non-histone proteins and is essential for mouse embryogenesis. Lsd1 interacts with numerous proteins through several different domains, most notably the tower domain, an extended helical structure that protrudes from the core of the protein. While there is evidence that Lsd1-interacting proteins regulate the activity and specificity of Lsd1, the significance and roles of such interactions in developmental processes remain largely unknown. Here we describe a hypomorphic Lsd1 allele that contains two point mutations in the tower domain, resulting in a protein with reduced interaction with known binding partners and decreased enzymatic activity. Mice homozygous for this allele die perinatally due to heart defects, with the majority of animals suffering from ventricular septal defects. Molecular analyses revealed hyperphosphorylation of E-cadherin in the hearts of mutant animals. These results identify a previously unknown role for Lsd1 in heart development, perhaps partly through the control of E-cadherin phosphorylation.	[Nicholson, Thomas B.; Su, Hui; Hevi, Sarah; Li, Mei; Valdez, Reginald; Goetschkes, Margaret; Capodieci, Paola; Loureiro, Joseph; Labow, Mark; Chen, Taiping] Novartis Inst BioMed Res, Cambridge, MA USA; [Nicholson, Thomas B.; Su, Hui; Hevi, Sarah; Wang, Jing; Bajko, Jeff; Li, En; Chen, Taiping] Novartis Inst BioMed Res, Epigenet Program, Cambridge, MA USA; [Singh, Anup K.; Chen, Taiping] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Cheng, Xiaodong] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Kinzel, Bernd] Novartis Inst BioMed Res, Basel, Switzerland	Novartis; Novartis; University of Texas System; UTMD Anderson Cancer Center; Emory University; Novartis	Chen, TP (corresponding author), Novartis Inst BioMed Res, Cambridge, MA USA.	tchen2@mdanderson.org			Novartis Institutes for BioMedical Research	Novartis Institutes for BioMedical Research	This research was funded by the Novartis Institutes for BioMedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Banck MS, 2009, EPIGENETICS-US, V4, P100, DOI 10.4161/epi.4.2.7953; Bao Y, 2009, GENE EXPR PATTERNS, V9, P273, DOI 10.1016/j.gep.2009.03.004; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Bruneau B.G, 2002, TRENDS GENET, V18, pS15, DOI [10.1016/S0168-9525(02)02686-0, DOI 10.1016/S0168-9525(02)02686-0]; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; BURROUGHS CL, 1991, J MOL CELL CARDIOL, V23, P1411, DOI 10.1016/0022-2828(91)90187-Q; Chen Y, 2006, P NATL ACAD SCI USA, V103, P13956, DOI 10.1073/pnas.0606381103; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Hakim ZS, 2007, MOL CELL BIOL, V27, P5352, DOI 10.1128/MCB.00068-07; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Imanaka-Yoshida K, 2003, DIFFERENTIATION, V71, P291, DOI 10.1046/j.1432-0436.2003.7104506.x; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Li XJ, 2009, AM J PHYSIOL-HEART C, V296, pH159, DOI 10.1152/ajpheart.00375.2008; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Lohmann F, 2010, STEM CELLS, V28, P201, DOI 10.1002/stem.278; Luo Y, 2001, DEVELOPMENT, V128, P459; Mailander J, 2001, FEBS LETT, V507, P331, DOI 10.1016/S0014-5793(01)02986-6; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Nguyen AT, 2011, GENE DEV, V25, P263, DOI 10.1101/gad.2018511; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Serres M, 2000, EXP CELL RES, V257, P255, DOI 10.1006/excr.2000.4895; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Suikki HE, 2010, PROSTATE, V70, P889, DOI 10.1002/pros.21123; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Thienpont B, 2010, AM J HUM GENET, V86, P839, DOI 10.1016/j.ajhg.2010.04.011; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Zaun HC, 2008, J BIOL CHEM, V283, P12456, DOI 10.1074/jbc.M800267200; Zhang YZ, 2010, NEUROSCI RES, V68, P66, DOI 10.1016/j.neures.2010.06.002; Zibetti C, 2010, J NEUROSCI, V30, P2521, DOI 10.1523/JNEUROSCI.5500-09.2010	67	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e60913	10.1371/journal.pone.0060913	http://dx.doi.org/10.1371/journal.pone.0060913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637775	Green Published, gold			2022-12-25	WOS:000318340400010
J	Schulte, BM; Kers-Rebel, ED; Prosser, AC; Galama, JMD; van Kuppeveld, FJM; Adema, GJ				Schulte, Barbara M.; Kers-Rebel, Esther D.; Prosser, Amy C.; Galama, Jochem M. D.; van Kuppeveld, Frank J. M.; Adema, Gosse J.			Differential Susceptibility and Response of Primary Human Myeloid BDCA1(+) Dendritic Cells to Infection with Different Enteroviruses	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; HUMAN PANCREATIC-ISLETS; EXPRESSION; SUBSETS; RNA; PHAGOCYTOSIS; RECOGNITION; RECEPTORS; VIRUSES; GAMMA	Coxsackie B viruses (CVBs) and echoviruses (EVs) form the Human Enterovirus-B (HEV-B) species within the family Picornaviridae. HEV-B infections are widespread and generally cause mild disease; however, severe infections occur and HEV-B are associated with various chronic diseases such as cardiomyopathy and type 1 diabetes. Dendritic cells (DCs) are the professional antigen-presenting cells of our immune system and initiate and control immune responses to invading pathogens, yet also maintain tolerance to self-antigens. We previously reported that EVs, but not CVBs, can productively infect in vitro generated monocyte-derived DCs. The interactions between HEV-B and human myeloid DCs (mDCs) freshly isolated from blood, however, remain unknown. Here, we studied the susceptibility and responses of BDCA1(+) mDC to HEV-B species and found that these mDC are susceptible to EV, but not CVB infection. Productive EV7 infection resulted in massive, rapid cell death without DC activation. Contrary, EV1 infection, which resulted in lower virus input at the same MOI, resulted in DC activation as observed by production of type I interferon-stimulated genes (ISGs), upregulation of co-stimulatory and co-inhibitory molecules (CD80, CD86, PDL1) and production of IL-6 and TNF-alpha, with a relative moderate decrease in cell viability. EV1-induced ISG expression depended on virus replication. CVB infection did not affect DC viability and resulted in poor induction of ISGs and CD80 induction in part of the donors. These data show for the first time the interaction between HEV-B species and BDCA1+ mDCs isolated freshly from blood. Our data indicate that different HEV-B species can influence DC homeostasis in various ways, possibly contributing to HEV-B associated pathology.	[Schulte, Barbara M.; Kers-Rebel, Esther D.; Prosser, Amy C.; Adema, Gosse J.] Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands; [Schulte, Barbara M.; Kers-Rebel, Esther D.; Prosser, Amy C.; Galama, Jochem M. D.; van Kuppeveld, Frank J. M.; Adema, Gosse J.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Galama, Jochem M. D.; van Kuppeveld, Frank J. M.] Nijmegen Ctr Mol Life Sci, Dept Med Microbiol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Adema, GJ (corresponding author), Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands.	g.adema@ncmls.ru.nl	Kers-Rebel, Esther/F-2312-2016; Adema, G.J./H-8007-2014	van Kuppeveld, Frank/0000-0001-5800-749X; Prosser, Amy/0000-0003-3540-5203	Juvenile Diabetes Research Foundation; Dutch Diabetes Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Dutch Diabetes Research Foundation	This work was supported by a grant from the Juvenile Diabetes Research Foundation (to G.J.A. and F.J.M.v.K.), and a Ruby grant from the Dutch Diabetes Research Foundation to B. M. S and G.J.A.). No potential conflicts of interest relevant to this article were reported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althof N, 2013, J VIROL, V87, P2823, DOI 10.1128/JVI.03004-12; Arrode G, 2003, CURR TOP MICROBIOL, V276, P277; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goodfellow IG, 2005, J VIROL, V79, P12016, DOI 10.1128/JVI.79.18.12016-12024.2005; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hober D, 2001, J INFECT DIS, V184, P1098, DOI 10.1086/323801; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kassianos AJ, 2012, EUR J IMMUNOL, V42, P1512, DOI 10.1002/eji.201142098; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kemball CC, 2012, VIROLOGY, V429, P74, DOI 10.1016/j.virol.2012.04.005; Killip MJ, 2012, J GEN VIROL, V93, P299, DOI 10.1099/vir.0.037531-0; Kramer M, 2008, J VIROL, V82, P2930, DOI 10.1128/JVI.02376-07; Kramer M, 2007, CELL MICROBIOL, V9, P1507, DOI 10.1111/j.1462-5822.2007.00888.x; Kramer M, 2010, J INNATE IMMUN, V2, P360, DOI 10.1159/000300568; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Moutaftsi M, 2002, BLOOD, V99, P2913, DOI 10.1182/blood.V99.8.2913; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Osugi Y, 2002, BLOOD, V100, P2858, DOI 10.1182/blood.V100.8.2858; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; ROSENFELD SI, 1987, J IMMUNOL, V138, P2869; Ruedl C, 2002, EUR J IMMUNOL, V32, P818, DOI 10.1002/1521-4141(200203)32:3<818::AID-IMMU818>3.0.CO;2-U; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Schulte BM, 2012, DIABETES, V61, P2030, DOI 10.2337/db11-1547; Schulte BM, 2010, DIABETES, V59, P1182, DOI 10.2337/db09-1071; Schulte BM, 2010, VIRAL IMMUNOL, V23, P99, DOI 10.1089/vim.2009.0072; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Skog O, 2011, J MED VIROL, V83, P658, DOI 10.1002/jmv.21924; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Tel J, 2012, CANC IMMUNOL IMMUNOT; Varela-Calvino R, 2003, DIABETES-METAB RES, V19, P431, DOI 10.1002/dmrr.407; Wahid R, 2005, J VIROL, V79, P401, DOI 10.1128/JVI.79.1.401-409.2005; Wang JP, 2007, J IMMUNOL, V178, P3363, DOI 10.4049/jimmunol.178.6.3363; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; Whitton JL, 2002, SPRINGER SEMIN IMMUN, V24, P201, DOI 10.1007/s00281-002-0100-4; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62502	10.1371/journal.pone.0062502	http://dx.doi.org/10.1371/journal.pone.0062502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638101	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400112
J	Yang, X; Yang, J; Chu, YW; Wang, JC; Guan, M; Zhu, XX; Xue, Y; Zou, HJ				Yang, Xue; Yang, Ji; Chu, Yiwei; Wang, Jiucun; Guan, Ming; Zhu, Xiaoxia; Xue, Yu; Zou, Hejian			T Follicular Helper Cells Mediate Expansion of Regulatory B Cells via IL-21 in Lupus-Prone MRL/lpr Mice	PLOS ONE			English	Article							B10 CELLS; SYSTEMIC AUTOIMMUNITY; IMMUNE-RESPONSES; T(H)17 CELLS; MURINE LUPUS; ERYTHEMATOSUS; DISEASE; IL-10; INTERLEUKIN-21; GENERATION	T follicular helper (Tfh) cells can mediate humoral immune responses and augment autoimmunity, whereas the role of Tfh cells on regulatory B (B10) cells in autoimmunity diseases is not clear. Here, we investigated the percentages of Tfh cells and B10 cells in lupus-prone MRL/Mp-lpr/lpr (MRL/lpr) mice and examined the effects and mechanism of Tfh cell-derived interleukin-21 (IL-21) on IL-10 production during the differentiation of B10 cells. Both Tfh cells and B10 cells were expanded in spleens of MRL/lpr mice. In addition, a positive correlation between the proportions of Tfh cells and B10 cells was observed. Tfh cell- derived IL-21 from MRL/lpr mice could promote IL-10 production during the differentiation of B10 cells. Importantly, neutralization of IL-21 inhibited IL-10 production and expansion of B10 cells both in vitro and in vivo. IL-21 induced IL-10 production via activation of phosphorylated signal transduction and activator of transcription 3 (p-STAT3). Inhibition of p-STAT3 effectively blocked IL-10 production during the differentiation of B10 cells. Moreover, IL-21-induced IL-10 exerted a regulatory function by inhibiting the proliferation of T cells. These data suggest that Tfh cells not only mediate humoral immune responses and augment autoimmunity but also play a broader role in immune regulatory actions via the induction of IL-10 production.	[Yang, Xue; Zhu, Xiaoxia; Xue, Yu; Zou, Hejian] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200433, Peoples R China; [Yang, Xue; Zhu, Xiaoxia; Xue, Yu; Zou, Hejian] Fudan Univ, Inst Rheumatol Immunol & Allergy, Shanghai 200433, Peoples R China; [Yang, Ji] Fudan Univ, Zhongshan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Chu, Yiwei] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200433, Peoples R China; [Wang, Jiucun] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Guan, Ming] Fudan Univ, Huashan Hosp, Dept Lab Med, Cent Lab, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Zou, HJ (corresponding author), Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200433, Peoples R China.	hejianzou@gmail.com	Wang, Jiucun/J-8744-2012	Wang, Jiucun/0000-0003-2765-0620	National Natural Science Foundation of China [81072463, 81000693]; Program of Shanghai Subject Chief Scientist [11XD1401100]; Medical Postgraduate "Mingdao Project'' of Fudan University [10111220016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Medical Postgraduate "Mingdao Project'' of Fudan University	This work was supported by grants from National Natural Science Foundation of China (No. 81072463; 81000693), Program of Shanghai Subject Chief Scientist (No. 11XD1401100), and Medical Postgraduate "Mingdao Project'' of Fudan University (No. 10111220016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; D'Alfonso S, 2000, ARTHRITIS RHEUM, V43, P120, DOI 10.1002/1529-0131(200001)43:1<120::AID-ANR15>3.0.CO;2-3; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Dong WJ, 2011, AUTOIMMUN REV, V10, P299, DOI 10.1016/j.autrev.2010.11.004; Ettinger R, 2008, ANN RHEUM DIS, V67, P83, DOI 10.1136/ard.2008.098400; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Hamel KM, 2012, AUTOIMMUNITY; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lauwerys BR, 2000, ARTHRITIS RHEUM, V43, P1976, DOI 10.1002/1529-0131(200009)43:9<1976::AID-ANR8>3.0.CO;2-V; Li J, 2011, MOL BIOL REP, V38, P4077, DOI 10.1007/s11033-010-0527-y; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Teichmann LL, 2012, J IMMUNOL, V188, P678, DOI 10.4049/jimmunol.1102456; Tomita M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-22; Nguyen V, 2012, J IMMUNOL, V189, P1081, DOI 10.4049/jimmunol.1200318; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yang J, 2011, RHEUMATOLOGY, V50, P1366, DOI 10.1093/rheumatology/ker116; Yang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017164; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang M, 2010, J IMMUNOL, V184, P3321, DOI 10.4049/jimmunol.0902551; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Yu B, 2011, ARTHRITIS RHEUM-US, V63, P3487, DOI 10.1002/art.30595; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	52	33	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62855	10.1371/journal.pone.0062855	http://dx.doi.org/10.1371/journal.pone.0062855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638156	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400129
J	Ortega, FB; Konstabel, K; Pasquali, E; Ruiz, JR; Hurtig-Wennlof, A; Maestu, J; Lof, M; Harro, J; Bellocco, R; Labayen, I; Veidebaum, T; Sjostrom, M				Ortega, Francisco B.; Konstabel, Kenn; Pasquali, Elena; Ruiz, Jonatan R.; Hurtig-Wennlof, Anita; Maeestu, Jarek; Lof, Marie; Harro, Jaanus; Bellocco, Rino; Labayen, Idoia; Veidebaum, Toomas; Sjostrom, Michael			Objectively Measured Physical Activity and Sedentary Time during Childhood, Adolescence and Young Adulthood: A Cohort Study	PLOS ONE			English	Article							TELEVISION VIEWING TIME; CARDIOVASCULAR-DISEASE; UNITED-STATES; RISK-FACTORS; SELF-REPORT; LIFE-STYLE; CHILDREN; BEHAVIOR; ASSOCIATIONS; INACTIVITY	Background: To know how moderate-to-vigorous physical activity (MVPA) and sedentary time change across lifespan periods is needed for designing successful lifestyle interventions. We aimed to study changes in objectively measured (accelerometry) MVPA and sedentary time from childhood to adolescence and from adolescence to young adulthood. Methods: Estonian and Swedish participants from the European Youth Heart Study aged 9 and 15 years at baseline (N = 2312) were asked to participate in a second examination 6 (Sweden) to 9/10 (Estonia) years later. 1800 participants with valid accelerometer data were analyzed. Results: MVPA decreased from childhood to adolescence (-1 to -2.5 min/d per year of follow-up, P = 0.01 and <0.001, for girls and boys respectively) and also from adolescence to young adulthood (-0.8 to -2.2 min/d per year, P = 0.02 and <0.001 for girls and boys, respectively). Sedentary time increased from childhood to adolescence (+ 15 and + 20 min/d per year, for girls and boys respectively, P<0.001), with no substantial change from adolescence to young adulthood. Changes in both MVPA and sedentary time were greater in Swedish than in Estonian participants and in boys than in girls. The magnitude of the change observed in sedentary time was 3-6 time larger than the change observed in MVPA. Conclusions: The decline in MVPA (overall change = 30 min/d) and increase sedentary time (overall change = 2: 45 h/d) observed from childhood to adolescence are of concern and might increase the risk of developing obesity and other chronic diseases later in life. These findings substantially contribute to understand how key health-related behaviors (physical activity and sedentary) change across important periods of life.	[Ortega, Francisco B.; Ruiz, Jonatan R.] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sports, PROmoting FITness & Hlth Phys Act Res Grp, Granada, Spain; [Ortega, Francisco B.; Ruiz, Jonatan R.; Lof, Marie; Sjostrom, Michael] Karolinska Inst, Novum, Dept Biosci & Nutr, Stockholm, Sweden; [Konstabel, Kenn] Natl Inst Hlth Dev, Ctr Behav & Hlth Sci, Dept Chron Dis, Tallinn, Estonia; [Konstabel, Kenn; Harro, Jaanus] Univ Tartu, Estonian Ctr Behav & Hlth Sci, Dept Psychol, EE-50090 Tartu, Estonia; [Pasquali, Elena] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Hurtig-Wennlof, Anita] Univ Orebro, Sch Hlth & Med Sci Clin Med, Orebro, Sweden; [Maeestu, Jarek] Univ Tartu, Ctr Behav & Hlth Sci, Fac Exercise & Sport Sci, Dept Coaching Sci, EE-50090 Tartu, Estonia; [Bellocco, Rino] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bellocco, Rino] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy; [Labayen, Idoia] European Humanities Univ, Univ Pais Vasco, Univ Basque Country, Dept Nutr & Food Sci, Vitoria, Spain; [Veidebaum, Toomas] Natl Inst Hlth Dev, Ctr Behav & Hlth Sci, Tallinn, Estonia	University of Granada; Karolinska Institutet; National Institute for Health Development - Estonia; University of Tartu; IRCCS European Institute of Oncology (IEO); Orebro University; University of Tartu; Karolinska Institutet; University of Milano-Bicocca; University of Basque Country; National Institute for Health Development - Estonia	Ortega, FB (corresponding author), Univ Granada, Sch Sport Sci, Dept Phys Educ & Sports, PROmoting FITness & Hlth Phys Act Res Grp, Granada, Spain.	ortegaf@ugr.es	RUIZ, JONATAN R/M-1338-2015; Konstabel, Kenn/E-9919-2016; LABAYEN, IDOIA/C-7661-2009; Harro, Jaanus/W-4939-2017; Bellocco, Rino/E-7674-2018; Ortega, Francisco B/B-4002-2010; , jarek/AAG-5620-2021; Löf, Marie/ABB-2697-2020; Löf, Marie/AAW-3323-2020; Ortega, Francisco B./AAG-5195-2021	RUIZ, JONATAN R/0000-0002-7548-7138; Konstabel, Kenn/0000-0002-9673-8469; LABAYEN, IDOIA/0000-0002-4334-3287; Harro, Jaanus/0000-0002-4484-2096; Ortega, Francisco B/0000-0003-2001-1121; Löf, Marie/0000-0002-2273-4430; Ortega, Francisco B./0000-0003-2001-1121	Estonian Ministry of Education and Science [0180027, 0942706]; Estonian Science Foundation [6932, 6788]; Stockholm County Council; Spanish Ministry of Economy and Competitiveness [RYC-2010-05957, RYC-2011-09011]	Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Estonian Science Foundation; Stockholm County Council(Stockholm County Council); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was also supported by grants from the Estonian Ministry of Education and Science (No 0180027 and 0942706) and the Estonian Science Foundation (No 6932 and 6788). The study was supported by grants from the Stockholm County Council. This study is also being supported by grants from Spanish Ministry of Economy and Competitiveness (RYC-2010-05957; RYC-2011-09011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; BARANOWSKI T, 1984, RES Q EXERCISE SPORT, V55, P309, DOI 10.1080/02701367.1984.10608408; Basterfield L, 2011, PEDIATRICS, V127, pE24, DOI 10.1542/peds.2010-1935; Cleland VJ, 2009, AM J EPIDEMIOL, V170, P1069, DOI 10.1093/aje/kwp271; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Ekelund U, 2004, AM J CLIN NUTR, V80, P584; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Gnavi R, 2000, EUR J EPIDEMIOL, V16, P797, DOI 10.1023/A:1007645703292; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Harro J, 2009, BIOL PSYCHOL, V81, P9, DOI 10.1016/j.biopsycho.2009.01.001; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Jauregui A, 2011, SALUD PUBLICA MEXICO, V53, P228; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Labayen I, 2010, DIABETES CARE, V33, P894, DOI 10.2337/dc09-1878; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mitchell JA, 2013, INT J OBESITY, V37, P54, DOI 10.1038/ijo.2012.41; Mitchell JA, 2012, MED SCI SPORT EXER, V44, P1081, DOI 10.1249/MSS.0b013e3182446c65; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nguyen HHDT, 2012, MED SCI SPORT EXER, V44, P1481, DOI 10.1249/MSS.0b013e31824e50dc; Nilsson A, 2009, SCAND J MED SCI SPOR, V19, P10, DOI 10.1111/j.1600-0838.2007.00762.x; Ortega FB, 2011, MED SCI SPORT EXER, V43, P1891, DOI 10.1249/MSS.0b013e3182190d71; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Riddoch CJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4544; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Ruiz JR, 2006, AM J CLIN NUTR, V84, P299; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; SALLIS JF, 1991, J SCHOOL HEALTH, V61, P215, DOI 10.1111/j.1746-1561.1991.tb06017.x; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Steele RM, 2009, AM J CLIN NUTR, V90, P1185, DOI 10.3945/ajcn.2009.28153; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Taylor RW, 2009, MED SCI SPORT EXER, V41, P96, DOI 10.1249/MSS.0b013e3181849d81; Trang NHHD, 2013, AM J PREV MED, V44, P223, DOI 10.1016/j.amepre.2012.10.021; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Wennlof AH, 2003, PUBLIC HEALTH NUTR, V6, P291, DOI 10.1079/PHN2002425; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105	45	205	207	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60871	10.1371/journal.pone.0060871	http://dx.doi.org/10.1371/journal.pone.0060871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131QH	23637772	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400017
J	Alvarez-Fischer, D; Noelker, C; Vulinovic, F; Grunewald, A; Chevarin, C; Klein, C; Oertel, WH; Hirsch, EC; Michel, PP; Hartmann, A				Alvarez-Fischer, Daniel; Noelker, Carmen; Vulinovic, Franca; Gruenewald, Anne; Chevarin, Caroline; Klein, Christine; Oertel, Wolfgang H.; Hirsch, Etienne C.; Michel, Patrick P.; Hartmann, Andreas			Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model	PLOS ONE			English	Article							DOPAMINERGIC MIDBRAIN NEURONS; SMALL-CONDUCTANCE; CHANNEL; MECHANISMS; MPTP; SK3; INFLAMMATION; EXPRESSION; CELLS; MICE	Bee venom has recently been suggested to possess beneficial effects in the treatment of Parkinson disease (PD). For instance, it has been observed that bilateral acupoint stimulation of lower hind limbs with bee venom was protective in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. In particular, a specific component of bee venom, apamin, has previously been shown to have protective effects on dopaminergic neurons in vitro. However, no information regarding a potential protective action of apamin in animal models of PD is available to date. The specific goals of the present study were to (i) establish that the protective effect of bee venom for dopaminergic neurons is not restricted to acupoint stimulation, but can also be observed using a more conventional mode of administration and to (ii) demonstrate that apamin can mimic the protective effects of a bee venom treatment on dopaminergic neurons. Using the chronic mouse model of MPTP/probenecid, we show that bee venom provides sustained protection in an animal model that mimics the chronic degenerative process of PD. Apamin, however, reproduced these protective effects only partially, suggesting that other components of bee venom enhance the protective action of the peptide.	[Alvarez-Fischer, Daniel; Noelker, Carmen; Hirsch, Etienne C.; Michel, Patrick P.; Hartmann, Andreas] Univ Paris 06, UMR S 975, UMR Therapeut Expt Neurodegenerescence 7725, ICM,Ctr Rech Neurosci, Paris, France; [Alvarez-Fischer, Daniel; Noelker, Carmen; Hirsch, Etienne C.; Michel, Patrick P.; Hartmann, Andreas] INSERM, Therapeut Expt Neurodegenerescence U975, Ctr Rech Neurosci, ICM, Paris, France; [Alvarez-Fischer, Daniel; Noelker, Carmen; Hirsch, Etienne C.; Michel, Patrick P.; Hartmann, Andreas] CNRS, UMR Therapeut Expt Neurodegenerescence 7225, Ctr Rech Neurosci, ICM, Paris, France; [Alvarez-Fischer, Daniel; Noelker, Carmen; Hirsch, Etienne C.; Michel, Patrick P.; Hartmann, Andreas] ICM, Paris, France; [Alvarez-Fischer, Daniel; Noelker, Carmen; Oertel, Wolfgang H.] Univ Marburg, Dept Neurol, Marburg, Germany; [Chevarin, Caroline] Univ Paris 06, Unite Mixte Rech S677, Paris, France; [Hartmann, Andreas] Hop La Pitie Salpetriere, Dept Neurol, Paris, France; [Alvarez-Fischer, Daniel; Vulinovic, Franca; Gruenewald, Anne; Klein, Christine] Med Univ Lubeck, Inst Neurogenet, D-23538 Lubeck, Germany; [Alvarez-Fischer, Daniel] Med Univ Lubeck, Dept Psychiat, D-23538 Lubeck, Germany	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Philipps University Marburg; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Lubeck; University of Lubeck	Hartmann, A (corresponding author), Univ Paris 06, UMR S 975, UMR Therapeut Expt Neurodegenerescence 7725, ICM,Ctr Rech Neurosci, Paris, France.	andreas.hartmann@psl.aphp.fr	Alvarez-Fischer, Daniel/AAJ-7572-2021; Chevarin, Caroline/M-1438-2015; Michel, Patrick Pierre/J-5248-2019; Hirsch, Etienne/AAC-7655-2019; Grünewald, Anne/ABD-1255-2021; Klein, Christine/AGK-8003-2022	Alvarez-Fischer, Daniel/0000-0001-7655-9589; Michel, Patrick Pierre/0000-0001-5607-3119; Hirsch, Etienne/0000-0003-4823-276X; Grünewald, Anne/0000-0002-4179-2994; Klein, Christine/0000-0003-2102-3431	Michael J. Fox Foundation; Deutsche Forschungsgemeinschaft (DFG); University Medical Center Giessen and Marburg (UKGM); program "Investissements d'avenir'' [ANR-10-IAIHU-06]	Michael J. Fox Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University Medical Center Giessen and Marburg (UKGM); program "Investissements d'avenir''(French National Research Agency (ANR))	This study was funded by the Michael J. Fox Foundation. CN was supported by a postdoctoral grant from the Deutsche Forschungsgemeinschaft (DFG). DAF was funded by a grant from the University Medical Center Giessen and Marburg (UKGM). ECH is an investigator at the Centre National pour la Recherche Scientifique (CNRS). PPM and AH were supported by program "Investissements d'avenir'' ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fischer D, 2008, J NEUROCHEM, V107, P701, DOI 10.1111/j.1471-4159.2008.05651.x; Alvarez-Fischer D, 2008, EXP NEUROL, V210, P182, DOI 10.1016/j.expneurol.2007.10.012; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Chen YN, 2006, NEUROSCIENCE, V138, P631, DOI 10.1016/j.neuroscience.2005.11.022; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davanlou M, 2004, IMAGE ANAL STEREOL, P1; Deignan J, 2012, NEUROSCIENCE, V217, P67, DOI 10.1016/j.neuroscience.2012.04.053; Doo AR, 2012, BRAIN RES, V1429, P106, DOI 10.1016/j.brainres.2011.10.003; Doo AR, 2010, NEUROL RES, V32, pS88, DOI 10.1179/016164109X12537002794282; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Garcia-Amado M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038692; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; Han SM, 2007, J ETHNOPHARMACOL, V111, P176, DOI 10.1016/j.jep.2006.11.008; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Kim JI, 2011, INT J NEUROSCI, V121, P209, DOI 10.3109/00207454.2010.548613; Kwon YB, 2006, NEUROSCI RES, V55, P197, DOI 10.1016/j.neures.2006.03.003; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; Luchtman DW, 2009, PHYSIOL BEHAV, V98, P130, DOI 10.1016/j.physbeh.2009.04.021; Meredith GE, 2008, PARKINSONISM RELA S2, V14, P112, DOI DOI 10.1016/J.PARKRELDIS.2008.04.012; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Michel PP, 2007, J NEUROCHEM, V101, P289, DOI 10.1111/j.1471-4159.2006.04424.x; Nagayama T, 1997, EUR J PHARMACOL, V327, P135, DOI 10.1016/S0014-2999(97)89652-5; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Rascol O, 2011, MOVEMENT DISORD, V26, P1072, DOI 10.1002/mds.23714; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Schlichter LC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-4; Toulorge D, 2011, FASEB J, V25, P2563, DOI 10.1096/fj.11-182824; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; WEMMER D, 1983, BIOCHEMISTRY-US, V22, P1901; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Yalcin M, 2009, PROSTAG LEUKOTR ESS, V81, P341, DOI 10.1016/j.plefa.2009.10.001; Yang EJ, 2011, MELITTIN RESTORES PR, P1; Yang S, 1997, ACTA PHARMACOL SIN, V18, P3	36	73	74	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61700	10.1371/journal.pone.0061700	http://dx.doi.org/10.1371/journal.pone.0061700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637888	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700053
J	Yu, LZ; Jiang, C; Na, J; Li, N; Diao, WL; Gu, Y; Zhao, L; Zou, Y; Chen, Y; Liu, L; Mu, HJ; Liu, YY; Yu, LY; Yang, XL; Pan, GW				Yu, Lianzheng; Jiang, Chao; Na, Jun; Li, Ning; Diao, Wenli; Gu, Yuan; Zhao, Li; Zou, Yan; Chen, Ying; Liu, Li; Mu, Huijuan; Liu, Yunyong; Yu, Liya; Yang, Xiaoli; Pan, Guowei			Elevated 12-Month and Lifetime Prevalence and Comorbidity Rates of Mood, Anxiety, and Alcohol Use Disorders in Chinese Men Who Have Sex with Men	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; SUBSTANCE USE; GAY; HEALTH; INDIVIDUALS; POPULATIONS; ORIENTATION; BEHAVIOR; SUICIDE; RISK	Background: This study aimed to assess whether Chinese men who have sex with men (MSM) had a significantly elevated prevalence of psychiatric disorders compared to urban males in China. Methods: 807 MSM were recruited using a respondent-driven sampling (RDS) method in urban area of northeast China. Psychiatric disorders were assessed employing the Composite International Diagnostic Interview (CIDI. Version 1.0) according to the criteria of the DSM-III-R. Results: Chinese MSM had a significantly elevated standardized prevalence ratios (SPR) for lifetime prevalence of any disorder (SPR = 2.8; 95%CI: 2.5-3.2), mood disorder (SPR = 3.0; 95%CI: 2.3-3.7), anxiety disorder (SPR = 5.5; 95%CI: 4.6-6.5), alcohol use disorder (SPR = 2.4, 95%CI: 2.0-2.8), and combination of disorders (SPR = 4.2; 95%CI: 3.4-5.1). Conclusions: Chinese MSM had significantly elevated prevalence and comorbidity of psychiatric disorders. RDS is a suitable sampling method for psychiatric epidemiological survey in MSM population.	[Yu, Lianzheng; Na, Jun; Li, Ning; Diao, Wenli; Liu, Li; Mu, Huijuan] Liaoning Prov Ctr Dis Control & Prevent, Dept Chron Dis, Shenyang, Peoples R China; [Jiang, Chao] Dalian Med Univ, Dept Epidemiol, Dalian, Peoples R China; [Gu, Yuan] Shenyang Municipal Ctr Dis Control & Prevent, Dept AIDS, Shenyang, Peoples R China; [Zhao, Li] Anshan Municipal Ctr Dis Control & Prevent, Dept AIDS, Anshan, Peoples R China; [Zou, Yan] Dandong Municipal Ctr Dis Control & Prevent, Dept AIDS, Dandong, Peoples R China; [Chen, Ying] Benxi Municipal Ctr Dis Control & Prevent, Dept AIDS, Benxi, Peoples R China; [Liu, Yunyong; Yu, Liya; Yang, Xiaoli; Pan, Guowei] Shenyang Med Coll, Dept Mental Hlth, Shenyang, Peoples R China	Dalian Medical University; Shenyang Medical College	Pan, GW (corresponding author), Shenyang Med Coll, Dept Mental Hlth, Shenyang, Peoples R China.	panpgw@yahoo.com.cn			Liaoning Provincial Science-Technology Department [2008225001]	Liaoning Provincial Science-Technology Department	This study was supported by Liaoning Provincial Science-Technology Department grant 2008225001 to Dr. PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Bostwick WB, 2010, AM J PUBLIC HEALTH, V100, P468, DOI 10.2105/AJPH.2008.152942; BOYD JH, 1984, ARCH GEN PSYCHIAT, V41, P983; Chen Q., 2010, J MED PHILOS, V31, P56; Cochran S.D., 2005, SEXUAL ORIENTATION M, P143; Cochran SD, 2000, AM J EPIDEMIOL, V151, P516; Cochran SD, 2003, J CONSULT CLIN PSYCH, V71, P53, DOI 10.1037/0022-006X.71.1.53; Cochran SD, 2007, J CONSULT CLIN PSYCH, V75, P785, DOI 10.1037/0022-006X.75.5.785; Cochran SD, 2009, J ABNORM PSYCHOL, V118, P647, DOI 10.1037/a0016501; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS98, DOI 10.1097/QAI.0b013e3181c7df71; GABBARD GO, 1992, B MENNINGER CLIN, V56, pA3; Gershon Elliot S., 1990, MANIC DEPRESSIVE ILL, P373; Gilman SE, 2001, AM J PUBLIC HEALTH, V91, P933, DOI 10.2105/AJPH.91.6.933; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; [黄悦勤 HUANY Yue-Qin], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P21; Johnston LG, 2010, METHODOLOGICAL INNOV, DOI [10.4256/mio.5(2)38-48, DOI 10.4256/MIO.5(2)38-48]; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Liu DL, 2005, STUDY HOMOSEXUAL CHI; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Meyer IH, 2008, AM J PUBLIC HEALTH, V98, P1004, DOI 10.2105/AJPH.2006.096826; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2008, 2007 UPD HIV AIDS EP; Pan G., 2006, CHIN J PUBLIC HLTH, V22, P1505; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Rosario M, 2004, ADDICT BEHAV, V29, P1623, DOI 10.1016/j.addbeh.2004.02.032; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Sandfort TGM, 2001, ARCH GEN PSYCHIAT, V58, P85, DOI 10.1001/archpsyc.58.1.85; Shu L, 1993, CHIN MENT HLTH J, V7, P208; Tao L., 2000, CHIN J HUMAN SEXUALI, V9, P20; World Health Organization, 1991, RES MAN INT MAN COMP; Zhang Bing, 2002, Computer Integrated Manufacturing Systems, V8, P197	38	35	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e50762	10.1371/journal.pone.0050762	http://dx.doi.org/10.1371/journal.pone.0050762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130IU	23637731	Green Submitted, gold, Green Published			2022-12-25	WOS:000317908700001
J	Sowa, JP; Heider, D; Bechmann, LP; Gerken, G; Hoffmann, D; Canbay, A				Sowa, Jan-Peter; Heider, Dominik; Bechmann, Lars Peter; Gerken, Guido; Hoffmann, Daniel; Canbay, Ali			Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SCORING SYSTEM; APOPTOSIS; STEATOHEPATITIS; MARKERS; BIOPSY; VALIDATION; DIAGNOSIS; PANEL; ACID	Introduction: Various conditions of liver disease and the downsides of liver biopsy call for a non-invasive option to assess liver fibrosis. A non-invasive score would be especially useful to identify patients with slow advancing fibrotic processes, as in Non-Alcoholic Fatty Liver Disease (NAFLD), which should undergo histological examination for fibrosis. Patients/Methods: Classic liver serum parameters, hyaluronic acid (HA) and cell death markers of 126 patients undergoing bariatric surgery for morbid obesity were analyzed by machine learning techniques (logistic regression, k-nearest neighbors, linear support vector machines, rule-based systems, decision trees and random forest (RF)). Specificity, sensitivity and accuracy of the evaluated datasets to predict fibrosis were assessed. Results: None of the single parameters (ALT, AST, M30, M60, HA) did differ significantly between patients with a fibrosis score 1 or 2. However, combining these parameters using RFs reached 79% accuracy in fibrosis prediction with a sensitivity of more than 60% and specificity of 77%. Moreover, RFs identified the cell death markers M30 and M65 as more important for the decision than the classic liver parameters. Conclusion: On the basis of serum parameters the generation of a fibrosis scoring system seems feasible, even when only marginally fibrotic tissue is available. Prospective evaluation of novel markers, i.e. cell death parameters, should be performed to identify an optimal set of fibrosis predictors.	[Sowa, Jan-Peter; Bechmann, Lars Peter; Gerken, Guido; Canbay, Ali] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Heider, Dominik; Hoffmann, Daniel] Univ Duisburg Essen, Ctr Med Biotechnol, Dept Bioinformat, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Canbay, A (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany.	ali.canbay@uni-due.de	Hoffmann, Daniel/P-5624-2019; Heider, Dominik/F-8545-2010; Sowa, Jan-Peter/AAQ-6318-2020; Bechmann, Lars/AAZ-7141-2020; Canbay, Ali/AAL-9620-2020; Hoffmann, Daniel/B-1314-2018	Hoffmann, Daniel/0000-0003-2973-7869; Heider, Dominik/0000-0002-3108-8311; Hoffmann, Daniel/0000-0003-2973-7869; Gerken, Guido/0000-0001-6734-5001; Canbay, Ali/0000-0001-6069-7899; Bechmann, Lars/0000-0003-3487-9810; Sowa, Jan-Peter/0000-0003-2943-0015	Deutsche Forschungsgemeinschaft [CA267/4-1, CA267/8-1]; Wilhelm Laupitz Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Laupitz Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/, grant CA267/4-1 and CA267/8-1) and the Wilhelm Laupitz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Bacchetti P, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1139; Bechmann LP, 2010, LIVER INT, V30, P850, DOI 10.1111/j.1478-3231.2010.02248.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cales P, 2009, J HEPATOL, V50, P165, DOI 10.1016/j.jhep.2008.07.035; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Canbay A, 2005, Z GASTROENTEROL, V43, P211, DOI 10.1055/s-2004-813744; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Cawley GC, 2004, NEURAL NETWORKS, V17, P1467, DOI 10.1016/j.neunet.2004.07.002; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Fitzpatrick E, 2010, J PEDIATR GASTR NUTR, V51, P500, DOI 10.1097/MPG.0b013e3181e376be; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; Gieseler RK, 2011, J VIRAL HEPATITIS, V18, P760, DOI 10.1111/j.1365-2893.2010.01362.x; Gronbaek K, 2002, J VIRAL HEPATITIS, V9, P443, DOI 10.1046/j.1365-2893.2002.00389.x; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Kalsch J, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/369168; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lydatakis H, 2006, LIVER INT, V26, P864, DOI 10.1111/j.1478-3231.2006.01312.x; Malik R, 2009, J GASTROEN HEPATOL, V24, P564, DOI 10.1111/j.1440-1746.2008.05731.x; McHutchison JG, 2000, J GASTROEN HEPATOL, V15, P945, DOI 10.1046/j.1440-1746.2000.02233.x; Nobili V, 2010, TRANSL RES, V156, P229, DOI 10.1016/j.trsl.2010.05.008; RAMADORI G, 1991, EUR J CLIN INVEST, V21, P323, DOI 10.1111/j.1365-2362.1991.tb01377.x; Ratziu V, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-6; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Sajda P, 2006, ANNU REV BIOMED ENG, V8, P537, DOI 10.1146/annurev.bioeng.8.061505.095802; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tomeno W, 2012, HEPATOL RES; Vizzutti F, 2009, ANN HEPATOL, V8, P89; Younossi ZM, 2011, OBES SURG, V21, P431, DOI 10.1007/s11695-010-0204-1	36	43	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62439	10.1371/journal.pone.0062439	http://dx.doi.org/10.1371/journal.pone.0062439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638085	gold, Green Submitted, Green Published			2022-12-25	WOS:000319077300059
J	Zhao, BH; Yu, XL; Wang, CX; Teng, Z; Wang, C; Shen, JR; Gao, Y; Zhu, ZK; Wang, JY; Yuan, ZB; Wu, F; Zhang, X; Ghildyal, R				Zhao, Baihui; Yu, Xuelian; Wang, Chuanxian; Teng, Zheng; Wang, Chun; Shen, Jiaren; Gao, Ye; Zhu, Zhaokui; Wang, Jiayu; Yuan, Zhengan; Wu, Fan; Zhang, Xi; Ghildyal, Reena			High Human Bocavirus Viral Load Is Associated with Disease Severity in Children under Five Years of Age	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; INFECTION; PREVALENCE	Human bocavirus (HBoV) is a parvovirus and detected worldwide in lower respiratory tract infections (LRTIs), but its pathogenic role in respiratory illness is still debatable due to high incidence of co-infection with other respiratory viruses. To determine the prevalence of HBoV infection in patients with LRTI in Shanghai and its correlation with disease severity, we performed a 3-year prospective study of HBoV in healthy controls, outpatients and inpatients under five years of age with X-ray diagnosed LRTIs. Nasopharyngeal aspirates were tested by PCR for common respiratory viruses and by real time PCR for HBoV subtypes 1-4. Nasopharyngeal swabs from healthy controls and serum samples and stools from inpatients were also tested for HBoV1-4 by real time PCR. Viral loads were determined by quantitative real time PCR in all HBoV positive samples. HBoV1 was detected in 7.0% of inpatients, with annual rates of 5.1%, 8.0% and 4.8% in 2010, 2011 and 2012, respectively. Respiratory syncytial virus (RSV) subtype A was the most frequent co-infection detected; HBoV1 and RSVA appeared to co-circulate with similar seasonal variations. High HBoV viral loads (>10(6) copies/ml) were significantly more frequent in inpatients and outpatients than in healthy controls. There was a direct correlation of high viral load with increasing disease severity in patients co-infected with HBoV1 and at least one other respiratory virus. In summary, our data suggest that HBoV1 can cause LRTIs, but symptomatic HBoV infection is only observed in the context of high viral load.	[Zhao, Baihui; Yu, Xuelian; Teng, Zheng; Shen, Jiaren; Gao, Ye; Zhu, Zhaokui; Wang, Jiayu; Yuan, Zhengan; Wu, Fan; Zhang, Xi] Shanghai Municipal Ctr Dis Control & Prevent, Microbiol Lab, Shanghai, Peoples R China; [Wang, Chuanxian] Shanghai Entry Exit Inspect AND Quarantine Bur, Tech Ctr Anim & Plant & Food Inspect, Shanghai, Peoples R China; [Wang, Chun] Shanghai Childrens Hosp, Clin Lab, Shanghai 200040, Peoples R China; [Ghildyal, Reena] Univ Canberra, Fac Sci Appl, Ctr Res Therapeut Solut, Canberra, ACT 2601, Australia	Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; University of Canberra	Ghildyal, R (corresponding author), Univ Canberra, Fac Sci Appl, Ctr Res Therapeut Solut, Canberra, ACT 2601, Australia.	Reena.Ghildyal@canberra.edu.au		Ghildyal, Reena/0000-0002-3147-4976	Shanghai Municipal Health Bureau [12GWZX0801]; Youth Scientific Research Project of Shanghai Health Bureau [20124y184]; Scientific Leaders of Shanghai Public Health Project from Shanghai Municipal Health Bureau Talents Development Foundation [GWDTR201201]	Shanghai Municipal Health Bureau; Youth Scientific Research Project of Shanghai Health Bureau; Scientific Leaders of Shanghai Public Health Project from Shanghai Municipal Health Bureau Talents Development Foundation	This work was supported by the grant from Shanghai Municipal Health Bureau (No. 12GWZX0801), Youth Scientific Research Project of Shanghai Health Bureau (No. 20124y184) and The Scientific Leaders of Shanghai Public Health Project from Shanghai Municipal Health Bureau Talents Development Foundation (Grant No. GWDTR201201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rousan HO, 2011, SINGAP MED J, V52, P365; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arnold JC, 2010, PEDIATR INFECT DIS J, V29, P557, DOI 10.1097/INF.0b013e3181e0747d; Christensen A, 2010, J CLIN VIROL, V49, P158, DOI 10.1016/j.jcv.2010.07.016; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Don M, 2010, PEDIATR PULM, V45, P120, DOI 10.1002/ppul.21151; DURHAM PJK, 1985, RES VET SCI, V38, P209, DOI 10.1016/S0034-5288(18)31828-9; Edner N, 2012, J CLIN MICROBIOL, V50, P531, DOI 10.1128/JCM.05706-11; Garcia-Garcia ML, 2010, PEDIATR PULM, V45, P585, DOI 10.1002/ppul.21225; Guido M, 2012, CLIN MICROBIOL INFEC, V18, pE74, DOI 10.1111/j.1469-0691.2011.03756.x; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Jin Y, 2011, J CLIN VIROL, V52, P251, DOI 10.1016/j.jcv.2011.07.012; Kantola K, 2010, J CLIN MICROBIOL, V48, P4044, DOI 10.1128/JCM.00686-10; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Khamrin P, 2012, J MED VIROL, V84, P901, DOI 10.1002/jmv.23274; Kim JS, 2011, KOREAN J LAB MED, V31, P179, DOI 10.3343/kjlm.2011.31.3.179; Korner RW, 2011, EMERG INFECT DIS, V17, P2303, DOI 10.3201/eid1712.110574; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Moriyama Y, 2010, EUR J PEDIATR, V169, P1087, DOI 10.1007/s00431-010-1183-x; Proenca-Modena JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021083; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; Wang K, 2010, J CLIN VIROL, V47, P148, DOI 10.1016/j.jcv.2009.11.015; Wang Y, 2011, EUR J CLIN MICROBIOL, V30, P799, DOI 10.1007/s10096-011-1159-4; Zeng M, 2010, WORLD J PEDIATR, V6, P65, DOI 10.1007/s12519-010-0009-2; Zhu Li-hua, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P271	26	46	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62318	10.1371/journal.pone.0062318	http://dx.doi.org/10.1371/journal.pone.0062318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638038	Green Submitted, gold, Green Published			2022-12-25	WOS:000319077300041
J	Manish, M; Rahi, A; Kaur, M; Bhatnagar, R; Singh, S				Manish, Manish; Rahi, Amit; Kaur, Manpreet; Bhatnagar, Rakesh; Singh, Samer			A Single-Dose PLGA Encapsulated Protective Antigen Domain 4 Nanoformulation Protects Mice against Bacillus anthracis Spore Challenge	PLOS ONE			English	Article							IMMUNE-RESPONSES; INHALATIONAL ANTHRAX; VACCINE; DELIVERY; MUCOSAL; NANOPARTICLES; INDUCTION; INFECTION; ADJUVANTS; BINDING	Bacillus anthracis, the etiological agent of anthrax, is a major bioterror agent. Vaccination is the most effective prophylactic measure available against anthrax. Currently available anthrax vaccines have issues of the multiple booster dose requirement, adjuvant-associated side effects and stability. Use of biocompatible and biodegradable nanoparticles to deliver the antigens to immune cells could solve the issues associated with anthrax vaccines. We hypothesized that the delivery of a stable immunogenic domain 4 of protective antigen (PAD4) of Bacillus anthracis encapsulated in a poly (lactide-co-glycolide) (PLGA) - an FDA approved biocompatible and biodegradable material, may alleviate the problems of booster dose, adjuvant toxicity and stability associated with anthrax vaccines. We made a PLGA based protective antigen domain 4 nanoparticle (PAD4-NP) formulation using water/oil/water solvent evaporation method. Nanoparticles were characterized for antigen content, morphology, size, polydispersity and zeta potential. The immune correlates and protective efficacy of the nanoparticle formulation was evaluated in Swiss Webster outbred mice. Mice were immunized with single dose of PAD4-NP or recombinant PAD4. The PAD4-NP elicited a robust IgG response with mixed IgG1 and IgG2a subtypes, whereas the control PAD4 immunized mice elicited low IgG response with predominant IgG1 subtype. The PAD4-NP generated mixed Th1/Th2 response, whereas PAD4 elicited predominantly Th2 response. When we compared the efficacy of this single-dose vaccine nanoformulation PAD4-NP with that of the recombinant PAD4 in providing protective immunity against a lethal challenge with Bacillus anthracis spores, the median survival of PAD4-NP immunized mice was 6 days as compared to 1 day for PAD4 immunized mice (p<0.001). Thus, we demonstrate, for the first time, the possibility of the development of a single-dose and adjuvant-free protective antigen based anthrax vaccine in the form of PAD4-NP. Further work in this direction may produce a better and safer candidate anthrax vaccine.	[Singh, Samer] Jawaharlal Nehru Univ, Special Ctr Nano Sci, New Delhi 110067, India; [Manish, Manish; Rahi, Amit; Kaur, Manpreet; Bhatnagar, Rakesh] Jawaharlal Nehru Univ, Sch Biotechnol, Lab Mol Biol & Genet Engn, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Singh, S (corresponding author), Jawaharlal Nehru Univ, Special Ctr Nano Sci, New Delhi 110067, India.	samersingh@gmail.com	Singh, Samer/H-8468-2013; Manish, Manish/AAP-9469-2021	Singh, Samer/0000-0002-0921-1686; 	Department of Biotechnology (DBT), India; Department of Science and Technology (DST), India; DBT, India; Utrecht University Short Stay Fellowship; Fulbright fellowship; SBRI-India GID fellowship (NIH Research Grant) [D43 TW000924]; Fogarty International Center; FOGARTY INTERNATIONAL CENTER [D43TW000924] Funding Source: NIH RePORTER	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), India(Department of Science & Technology (India)); DBT, India(Department of Biotechnology (DBT) India); Utrecht University Short Stay Fellowship; Fulbright fellowship; SBRI-India GID fellowship (NIH Research Grant); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was supported in part by funding from the Department of Biotechnology (DBT) and Department of Science and Technology (DST), India. SS is a Ramalingaswami Fellow supported by DBT, India. MM is the recipient of Utrecht University Short Stay Fellowship, Fulbright fellowship and SBRI-India GID fellowship (NIH Research Grant number D43 TW000924 funded by the Fogarty International Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Akagi T, 2012, ADV POLYM SCI, V247, P31, DOI 10.1007/12_2011_150; Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; Baillie LW, 2009, HUM VACCINES, V5, P806, DOI 10.4161/hv.9777; Bielinska AU, 2007, INFECT IMMUN, V75, P4020, DOI 10.1128/IAI.00070-07; Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; Brey RN, 2005, ADV DRUG DELIVER REV, V57, P1266, DOI 10.1016/j.addr.2005.01.028; Brodzik R, 2005, BIOCHEM BIOPH RES CO, V338, P717, DOI 10.1016/j.bbrc.2005.09.196; Cote CK, 2005, MICROB PATHOGENESIS, V38, P209, DOI 10.1016/j.micpath.2005.02.001; Demento SL, 2012, BIOMATERIALS, V33, P4957, DOI 10.1016/j.biomaterials.2012.03.041; Flick-Smith HC, 2005, MICROB PATHOGENESIS, V38, P33, DOI 10.1016/j.micpath.2004.10.007; Flick-Smith HC, 2002, INFECT IMMUN, V70, P1653, DOI 10.1128/IAI.70.3.1653-1656.2002; Flick-Smith HC, 2002, INFECT IMMUN, V70, P2022, DOI 10.1128/IAI.70.4.2022-2028.2002; Franz DR, 2009, MOL ASPECTS MED, V30, P503, DOI 10.1016/j.mam.2009.07.002; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; Friedlander AM, 2009, VACCINE, V27, pD28, DOI 10.1016/j.vaccine.2009.08.102; Ganesan A, 2012, EUR J PHARM BIOPHARM, V82, P475, DOI 10.1016/j.ejpb.2012.05.019; Gorantala J, 2011, VACCINE, V29, P4521, DOI 10.1016/j.vaccine.2011.03.082; Hu L, 2012, J PHARM SCI-US, V101, P4118, DOI 10.1002/jps.23294; Jiang G, 2006, J PHARM SCI-US, V95, P80, DOI 10.1002/jps.20484; Kaur Manpreet, 2011, Recent Pat Biotechnol, V5, P148; Kaur M, 2009, MOL IMMUNOL, V46, P2107, DOI 10.1016/j.molimm.2008.12.031; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Langley WA, 2010, J VIROL, V84, P8300, DOI 10.1128/JVI.00183-10; Lee Young-Ran, 2011, Immune Netw, V11, P163, DOI 10.4110/in.2011.11.3.163; Leggett HC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002512; Leppla SH, 2002, J CLIN INVEST, V110, P141, DOI [10.1172/JCI200216204, 10.1172/JCI0216204]; Li XR, 2011, EUR J PHARM BIOPHARM, V78, P107, DOI 10.1016/j.ejpb.2010.12.017; Lutsiak MEC, 2006, J PHARM PHARMACOL, V58, P739, DOI 10.1211/jpp.58.6.0004; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; McBride B, 1998, VACCINE, V16, P810, DOI 10.1016/S0264-410X(97)00268-5; Merkel TJ, 2010, P NATL ACAD SCI USA, V107, P18091, DOI 10.1073/pnas.1013083107; Moon JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031472; Mourez M, 2005, REV PHYSIOL BIOCH P, V152, P135, DOI 10.1007/s10254-004-0028-2; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI 10.1586/ERV.10.89; Plaut RD, 2012, INFECT IMMUN, V80, P3189, DOI 10.1128/IAI.00515-12; Quinn CP, 2012, CLIN VACCINE IMMUNOL, V19, P1730, DOI 10.1128/CVI.00324-12; Radha C, 1996, J BIOTECHNOL, V50, P235, DOI 10.1016/0168-1656(96)01569-6; Ribeiro S, 2007, INT J PHARMACEUT, V331, P228, DOI 10.1016/j.ijpharm.2006.11.063; Santos Diego M, 2012, Int J Nanomedicine, V7, P2115, DOI 10.2147/IJN.S30093; Singh S, 2002, BIOCHEM BIOPH RES CO, V296, P1058, DOI 10.1016/S0006-291X(02)02049-1; Smith ME, 2006, VIROLOGY, V353, P344, DOI 10.1016/j.virol.2006.05.010; Tournier JN, 2009, EXPERT REV ANTI-INFE, V7, P219, DOI 10.1586/14787210.7.2.219; Wagner L, 2012, CLIN VACCINE IMMUNOL, V19, P1465, DOI 10.1128/CVI.00174-12; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Williams AS, 2009, PROTEIN SCI, V18, P2277, DOI 10.1002/pro.238; Zomber G, 2005, J BIOL CHEM, V280, P39897, DOI 10.1074/jbc.M508569200	49	65	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61885	10.1371/journal.pone.0061885	http://dx.doi.org/10.1371/journal.pone.0061885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637922	gold, Green Submitted, Green Published			2022-12-25	WOS:000321662800015
J	Stuckenholz, C; Lu, LL; Thakur, PC; Choi, TY; Shin, D; Bahary, N				Stuckenholz, Carsten; Lu, Lili; Thakur, Prakash C.; Choi, Tae-Young; Shin, Donghun; Bahary, Nathan			Sfrp5 Modulates Both Wnt and BMP Signaling and Regulates Gastrointestinal Organogensis in the Zebrafish, Danio rerio	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; PLANAR CELL POLARITY; WNT/BETA-CATENIN; TUMOR-SUPPRESSOR; EXPRESSION; LIVER; GENES; CHORDIN; ANTAGONIST; GASTRULATION	Sfrp5 belongs to the family of secreted frizzled related proteins (Sfrp), secreted inhibitors of Wingless-MMTV Integration Site (Wnt) signaling, which play an important role in cancer and development. We selected sfrp5 because of its compelling expression profile in the developing endoderm in zebrafish, Danio rerio. In this study, overexpression of sfrp5 in embryos results in defects in both convergent extension (CE) by inhibition of non-canonical Wnt signaling and defects in dorsoventral patterning by inhibition of Tolloid-mediated proteolysis of the BMP inhibitor Chordin. From 25 hours post fertilization (hpf) to 3 days post fertilization (dpf), both overexpression and knockdown of Sfrp5 decrease the size of the endoderm, significantly reducing liver cell number. At 3 dpf, insulin-positive endodermal cells fail to coalesce into a single pancreatic islet. We show that Sfrp5 inhibits both canonical and non-canonical Wnt signaling during embryonic and endodermal development, resulting in endodermal abnormalities.	[Stuckenholz, Carsten; Lu, Lili; Thakur, Prakash C.; Bahary, Nathan] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol,Med Ctr, Pittsburgh, PA 15213 USA; [Choi, Tae-Young; Shin, Donghun] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bahary, N (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol,Med Ctr, Pittsburgh, PA 15213 USA.	bahary@pitt.edu	Thakur, Prakash/H-7398-2012; Choi, Tae-Young/AAP-1730-2021; CHOI, TAE-YOUNG/J-1697-2015; Shin, Donghun/A-2092-2012; Choi, Tae-Young/AAO-3379-2020	Choi, Tae-Young/0000-0002-3285-0005; Choi, Tae-Young/0000-0003-1810-5292; Shin, Donghun/0000-0002-7975-9014	NIH [R21DK073177, R01HD50872]; March of Dimes [FY04-109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by NIH R21DK073177, NIH R01HD50872, March of Dimes FY04-109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2010, EVOL DEV, V12, P494, DOI 10.1111/j.1525-142X.2010.00435.x; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bhat RA, 2007, J CELL BIOCHEM, V102, P1519, DOI 10.1002/jcb.21372; Blader P, 1997, SCIENCE, V278, P1937, DOI 10.1126/science.278.5345.1937; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Chung WS, 2008, DEV CELL, V15, P738, DOI 10.1016/j.devcel.2008.08.019; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Connors SA, 2006, DEV BIOL, V293, P191, DOI 10.1016/j.ydbio.2006.01.029; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Ho CY, 1999, CURR BIOL, V9, P1131, DOI 10.1016/S0960-9822(99)80485-0; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Kawakami K, 2011, INT J CANCER, V128, P541, DOI 10.1002/ijc.25357; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kim HJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-23; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Kong WH, 2012, EVOL DEV, V14, P168, DOI 10.1111/j.1525-142X.2012.00533.x; KU M, 1993, DEVELOPMENT, V119, P1161; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lade AG, 2011, DEV DYNAM, V240, P486, DOI 10.1002/dvdy.22522; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Leaf I, 2006, GENESIS, V44, P573, DOI 10.1002/dvg.20248; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Ruiz JM, 2009, DEV NEUROBIOL, V69, P617, DOI 10.1002/dneu.20731; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Meani N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004273; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Muller M, 1996, DEV GENES EVOL, V206, P153, DOI 10.1007/s004270050041; Mullins MC, 1996, DEVELOPMENT, V123, P81; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Niu XB, 2010, SCI CHINA LIFE SCI, V53, P455, DOI 10.1007/s11427-010-0078-4; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Nusse R., 2012, COLD SPRING HARBOR P, V4; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Pei JM, 2012, PROTEIN SCI, V21, P1172, DOI 10.1002/pro.2105; Peng G, 2006, DEVELOPMENT, V133, P3191, DOI 10.1242/dev.02485; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Ploper D, 2011, DEV BIOL, V352, P317, DOI 10.1016/j.ydbio.2011.01.029; Polakis P, 2012, COLD SPRING HARBOR P, V4; Poulain M, 2011, DEVELOPMENT, V138, P3557, DOI 10.1242/dev.055921; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Sawada Y, 2012, CLIN CANCER RES, V18, P3686, DOI 10.1158/1078-0432.CCR-11-3044; Scardigli R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002471; Schepers A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007989; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Shin DH, 2012, MECH DEVELOP, V128, P525, DOI 10.1016/j.mod.2012.01.005; Shin D, 2011, DEVELOPMENT, V138, P1339, DOI 10.1242/dev.054395; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Stuckenholz C, 2009, GASTROENTEROLOGY, V137, P1321, DOI 10.1053/j.gastro.2009.06.050; Su HY, 2010, INT J CANCER, V127, P555, DOI 10.1002/ijc.25083; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Tendeng C, 2006, GENE EXPR PATTERNS, V6, P761, DOI 10.1016/j.modgep.2006.01.006; Tremblay KD, 2011, J CELL PHYSIOL, V226, P1727, DOI 10.1002/jcp.22409; Tsang M, 2000, GENESIS, V28, P47, DOI 10.1002/1526-968X(200010)28:2<47::AID-GENE20>3.0.CO;2-S; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Verkade Heather, 2008, V469, P225, DOI 10.1007/978-1-60327-469-2_17; Verzi Michael P, 2008, Organogenesis, V4, P87; Wallace KN, 2001, GENESIS, V30, P141, DOI 10.1002/gene.1050; Wang SW, 1997, BIOCHEM BIOPH RES CO, V236, P502, DOI 10.1006/bbrc.1997.6995; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	90	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62470	10.1371/journal.pone.0062470	http://dx.doi.org/10.1371/journal.pone.0062470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638093	Green Published, gold, Green Accepted			2022-12-25	WOS:000321662800048
J	van Dinther, M; Zhang, J; Weidauer, SE; Boschert, V; Muth, EM; Knappik, A; de Gorter, DJJ; van Kasteren, PB; Frisch, C; Mueller, TD; ten Dijke, P				van Dinther, Maarten; Zhang, Juan; Weidauer, Stella E.; Boschert, Verena; Muth, Eva-Maria; Knappik, Achim; de Gorter, David J. J.; van Kasteren, Puck B.; Frisch, Christian; Mueller, Thomas D.; ten Dijke, Peter			Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling	PLOS ONE			English	Article							INCREASES BONE-FORMATION; WNT; RECEPTOR; PROTEIN; DENSITY; LIGAND; GENE; BINDING; LRP6; OSTEOPOROSIS	Sclerosteosis is a rare high bone mass disease that is caused by inactivating mutations in the SOST gene. Its gene product, Sclerostin, is a key negative regulator of bone formation and might therefore serve as a target for the anabolic treatment of osteoporosis. The exact molecular mechanism by which Sclerostin exerts its antagonistic effects on Wnt signaling in bone forming osteoblasts remains unclear. Here we show that Wnt3a-induced transcriptional responses and induction of alkaline phosphatase activity, an early marker of osteoblast differentiation, require the Wnt co-receptors LRP5 and LRP6. Unlike Dickkopf1 (DKK1), Sclerostin does not inhibit Wnt-3a-induced phosphorylation of LRP5 at serine 1503 or LRP6 at serine 1490. Affinity labeling of cell surface proteins with [(125) I] Sclerostin identified LRP6 as the main specific Sclerostin receptor in multiple mesenchymal cell lines. When cells were challenged with Sclerostin fused to recombinant green fluorescent protein (GFP) this was internalized, likely via a Clathrin-dependent process, and subsequently degraded in a temperature and proteasome-dependent manner. Ectopic expression of LRP6 greatly enhanced binding and cellular uptake of Sclerostin-GFP, which was reduced by the addition of an excess of non-GFP-fused Sclerostin. Finally, an anti-Sclerostin antibody inhibited the internalization of Sclerostin-GFP and binding of Sclerostin to LRP6. Moreover, this antibody attenuated the antagonistic activity of Sclerostin on canonical Wnt-induced responses.	[van Dinther, Maarten; Zhang, Juan; de Gorter, David J. J.; van Kasteren, Puck B.; ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [van Dinther, Maarten; Zhang, Juan; de Gorter, David J. J.; van Kasteren, Puck B.; ten Dijke, Peter] Leiden Univ, Med Ctr, Ctr Biomed Genet, Leiden, Netherlands; [Weidauer, Stella E.; Boschert, Verena; Muth, Eva-Maria; Mueller, Thomas D.] Julius von Sachs Inst, Dept Mol Plant Physiol & Biophys, Wurzburg, Germany; [Knappik, Achim; Frisch, Christian] AbD Serotec, Puchheim, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; MorphoSys	ten Dijke, P (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands.	P.ten_Dijke@lumc.nl	van Kasteren, Puck/H-6203-2019; Knappik, Achim/D-3677-2011; Dijke, Peter ten/AAG-4660-2021	van Kasteren, Puck/0000-0003-4369-6055; Dijke, Peter ten/0000-0002-7234-342X; van Dinther, Maarten/0000-0002-9451-8884; Mueller, Thomas/0000-0003-1862-7357	Dutch Organization for Scientific Research Grant [NWO 918.66.606]; Centre for Biomedical Genetics; European Union	Dutch Organization for Scientific Research Grant; Centre for Biomedical Genetics; European Union(European Commission)	Funding provided by the Dutch Organization for Scientific Research Grant NWO 918.66.606 (www.nwo.nl) and the Centre for Biomedical Genetics and European Union FP7 Program TALOS (www.talosproject.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Balemans W., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P139; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Janssens K, 2002, HUM MOL GENET, V11, P2385, DOI 10.1093/hmg/11.20.2385; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kaplan FS, CYTOKINE GROWTH FACT, V20, P399; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Leupin O, 2011, J BIOL CHEM, V286, P19489, DOI 10.1074/jbc.M110.190330; Lewiecki EM, 2011, NAT REV RHEUMATOL, V7, P631, DOI 10.1038/nrrheum.2011.130; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marie PJ, 2012, CURR OSTEOPOROS REP, V10, P190, DOI 10.1007/s11914-012-0109-0; McDonald MM, 2012, J ORTHOP RES, V30, P1541, DOI 10.1002/jor.22109; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Olson BR, 2006, PRIMER METABOLIC BON, P2; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; OSTENDORP R, 2004, ANTIBODIES, P13, DOI DOI 10.1007/978-1-4419-8877-5_2; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sakane H, 2010, J CELL SCI, V123, P360, DOI 10.1242/jcs.058008; SCHLEGEL R, 1982, P NATL ACAD SCI-BIOL, V79, P2291, DOI 10.1073/pnas.79.7.2291; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Virdi AS, 2012, J BONE JOINT SURG AM, V94A, P1670, DOI 10.2106/JBJS.K.00344; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yamamoto H, 2008, WNT3A DKK1 REGULATE; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yamashita T, 1996, BONE, V19, P429, DOI 10.1016/S8756-3282(96)00255-4; Zhang J, 2012, J BONE MINER RES, V27, P2065, DOI 10.1002/jbmr.1661	57	40	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62295	10.1371/journal.pone.0062295	http://dx.doi.org/10.1371/journal.pone.0062295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638027	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800034
J	Damen, R; Haugen, M; Svejda, B; Alaimo, D; Brenna, O; Pfragner, R; Gustafsson, BI; Kidd, M				Damen, Rikard; Haugen, Martin; Svejda, Bernhard; Alaimo, Daniele; Brenna, Oystein; Pfragner, Roswitha; Gustafsson, Bjorn I.; Kidd, Mark			The Stimulatory Adenosine Receptor ADORA2B Regulates Serotonin (5-HT) Synthesis and Release in Oxygen-Depleted EC Cells in Inflammatory Bowel Disease	PLOS ONE			English	Article							ENTEROCHROMAFFIN CELLS; FUNCTIONAL-CHARACTERIZATION; INTESTINAL EPITHELIA; GUT INFLAMMATION; CHROMOGRANIN-A; TUMOR DISEASE; HYPOXIA; SECRETION; SIGNAL; IDENTIFICATION	Objective: We recently demonstrated that hypoxia, a key feature of IBD, increases enterochromaffin (EC) cell 5-HT secretion, which is also physiologically regulated by the ADORA2B mechanoreceptor. Since hypoxia is associated with increased extracellular adenosine, we wanted to examine whether this nucleotide amplifies HIF-1 alpha-mediated 5-HT secretion. Design: The effects of hypoxia were studied on IBD mucosa, isolated IBD-EC cells, isolated normal EC cells and the EC cell tumor derived cell line KRJ-1. Hypoxia (0.5% O-2) was compared to NECA (adenosine agonist), MRS1754 (ADORA2B receptor antagonist) and SCH442146 (ADORA2A antagonist) on HIF signaling and 5-HT secretion. Antisense approaches were used to mechanistically evaluate EC cells in vitro. PCR and western blot were used to analyze transcript and protein levels of HIF-1 alpha signaling and neuroendocrine cell function. An animal model of colitis was evaluated to confirm hypoxia: adenosine signaling in vivo. Results: HIF-1a is upregulated in IBD mucosa and IBD-EC cells, the majority (similar to 90%) of which express an activated phenotype in situ. Hypoxia stimulated 5-HT release maximally at 30 mins, an effect amplified by NECA and selectively inhibited by MRS1754, through phosphorylation of TPH-1 and activation of VMAT-1. Transient transfection with Renilla luciferase under hypoxia transcriptional response element (HRE) control identified that ADORA2B activated HIF-1 alpha signaling under hypoxic conditions. Additional signaling pathways associated with hypoxia: adenosine included MAP kinase and CREB. Antisense approaches mechanistically confirmed that ADORA2B signaling was linked to these pathways and 5-HT release under hypoxic conditions. Hypoxia: adenosine activation which could be reversed by 5'-ASA treatment was confirmed in a TNBS-model. Conclusion: Hypoxia induced 5-HT synthesis and secretion is amplified by ADORA2B signaling via MAPK/CREB and TPH-1 activation. Targeting ADORA2s may decrease EC cell 5-HT production and secretion in IBD.	[Damen, Rikard; Haugen, Martin; Svejda, Bernhard; Alaimo, Daniele; Kidd, Mark] Yale Univ, Sch Med, Gastrointestinal Pathobiol Res Grp, New Haven, CT 06520 USA; [Brenna, Oystein; Gustafsson, Bjorn I.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Pfragner, Roswitha] Ctr Mol Med, Inst Pathophysiol & Immunol, Graz, Austria	Yale University; Norwegian University of Science & Technology (NTNU)	Kidd, M (corresponding author), Yale Univ, Sch Med, Gastrointestinal Pathobiol Res Grp, New Haven, CT 06520 USA.	mark.kidd@yale.edu	Brenna, Øystein/AAH-2774-2020		National Institutes of Health (NIH) [R01DK080871]; Kontaktutvalget at St Olavs University Hospital; Faculty of Medicine, NTNU, Trondheim, Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080871] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kontaktutvalget at St Olavs University Hospital; Faculty of Medicine, NTNU, Trondheim, Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were funded by National Institutes of Health (NIH) R01DK080871 (Kidd) and Kontaktutvalget (Gustafsson) at St Olavs University Hospital and Faculty of Medicine, NTNU, Trondheim, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae MK, 2006, ONCOL REP, V15, P1557; BERTACCINI G, 1960, J PHYSIOL-LONDON, V153, P239, DOI 10.1113/jphysiol.1960.sp006532; Brenna O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054543; BULBRING E, 1958, J PHYSIOL-LONDON, V140, P381; Chin A, 2011, AM J PHYSIOL-GASTR L, V28, P28; Cooke HJ, 2000, ANN NY ACAD SCI, V915, P77; Damen R, 2013, PLOS ONE IN PRESS; Drozdov I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022457; Eiden LE, 2004, PFLUG ARCH EUR J PHY, V447, P636, DOI 10.1007/s00424-003-1100-5; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Garcia-Osta A, 2004, MOL BRAIN RES, V126, P181, DOI 10.1016/j.molbrainres.2004.04.006; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Granlund AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056818; Haugen M, 2012, AM J PHYSIOL-GASTR L, V303, pG1164, DOI 10.1152/ajpgi.00027.2012; Hirota SA, 2009, RECENT PATENTS INFLA, V3, P1, DOI 10.2174/187221309787158434; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; Kalhan A, 2008, ADENOSINE RECEPTOR S; Kalhan A, 2011, PURINERG SIGNAL, V27, P27; KELLUM JM, 1976, GASTROENTEROLOGY, V70, P516; Kellum JM, 1999, AM J PHYSIOL-GASTR L, V277, pG515, DOI 10.1152/ajpgi.1999.277.3.G515; Kidd M, 2007, AM J PHYSIOL-GASTR L, V292, pG191, DOI 10.1152/ajpgi.00131.2006; Kidd M, 2006, AM J PHYSIOL-GASTR L, V291, pG778, DOI 10.1152/ajpgi.00552.2005; Kidd M, 2006, ANN SURG, V243, P273, DOI 10.1097/01.sla.0000197734.28551.0f; Kidd M, 2005, CANCER-AM CANCER SOC, V103, P229, DOI 10.1002/cncr.20750; Kidd M, 2009, NEUROGASTROENT MOTIL, V21, P439, DOI 10.1111/j.1365-2982.2008.01210.x; Kidd M, 2008, AM J PHYSIOL-GASTR L, V295, pG260, DOI 10.1152/ajpgi.00056.2008; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Kidd M, 2007, CANCER-AM CANCER SOC, V109, P2420, DOI 10.1002/cncr.22725; Kidd M, 2007, J MOL ENDOCRINOL, V38, P181, DOI 10.1677/jme.1.02037; Kolachala V, 2005, CELL MOL LIFE SCI, V62, P2647, DOI 10.1007/s00018-005-5328-4; Kolachala VL, 2008, GASTROENTEROLOGY, V135, P861, DOI 10.1053/j.gastro.2008.05.049; Lauffer JM, 2001, REGUL PEPTIDES, V102, P157, DOI 10.1016/S0167-0115(01)00314-7; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Li N, 2011, AM J PATHOL, V178, P662, DOI 10.1016/j.ajpath.2010.10.028; Matheus N, 2009, BIOCHEM PHARMACOL, V78, P1198, DOI 10.1016/j.bcp.2009.06.006; Modlin IM, 2006, J CLIN ENDOCR METAB, V91, P2340, DOI 10.1210/jc.2006-0110; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Pierdomenico M, 2011, J PEDIATR GASTR NUTR, V52, P271, DOI 10.1097/MPG.0b013e3182034d08; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Raybould HE, 2003, AM J PHYSIOL-GASTR L, V284, pG367, DOI 10.1152/ajpgi.00292.2001; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Sitkovsky MV, 2008, BLOOD, V111, P5424, DOI 10.1182/blood-2008-03-143990; Strober W, 2006, SCIENCE, V313, P1052, DOI 10.1126/science.1131997; STROHMEIER GR, 1995, J BIOL CHEM, V270, P2387, DOI 10.1074/jbc.270.5.2387; Svejda B, 2011, CANCER; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Willemssen R, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004898, 10.1371/journal.pone.0006453]; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhu JX, 2001, J PHYSIOL-LONDON, V530, P431, DOI 10.1111/j.1469-7793.2001.0431k.x; Zubenko GS, 2009, AM J MED GENET B, V150B, P12, DOI 10.1002/ajmg.b.30891	56	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62607	10.1371/journal.pone.0062607	http://dx.doi.org/10.1371/journal.pone.0062607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638125	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700063
J	Gillam, EH; Chaverri, G; Montero, K; Sagot, M				Gillam, Erin H.; Chaverri, Gloriana; Montero, Karina; Sagot, Maria			Social Calls Produced within and near the Roost in Two Species of Tent-Making Bats, Dermanura watsoni and Ectophylla alba	PLOS ONE			English	Article							CONTACT CALLS; CHIROPTERA; DISCRIMINATION; PHYLLOSTOMIDAE; CONSPECIFICS; CONVERGENCE; RESPONSES; PATTERNS; ECOLOGY; CONTEXT	Social animals regularly face the problem of relocating conspecifics when separated. Communication is one of the most important mechanisms facilitating group formation and cohesion. Known as contact calls, signals exchanged between conspecifics that permit group maintenance are widespread across many taxa. Foliage-roosting bats are an excellent model system for studying the evolution of contact calling, as there are opportunities to compare closely related species that exhibit major differences in ecology and behavior. Further, foliage-roosting bats rely on relatively ephemeral roosts, which leads to major challenges in maintaining group cohesion. Here, we report findings on the communication signals produced by two tent-making bats, Dermanura watsoni and Ectophylla alba. We found that both species produced calls in the early morning near the roost that were associated with roostmate recruitment. Calling often ended once other bats arrived at the tent, suggesting that calls may be involved in roostmate recruitment and group formation. The structure and function of these calls are described and future research directions are discussed.	[Gillam, Erin H.; Montero, Karina] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Chaverri, Gloriana] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Sagot, Maria] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	North Dakota State University Fargo; Boston University; Texas Tech University System; Texas Tech University	Gillam, EH (corresponding author), N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA.	Erin.Gillam@ndsu.edu	Chaverri, Gloriana/J-4798-2012	Chaverri, Gloriana/0000-0002-1155-432X; Montero, B. Karina/0000-0003-4246-6004	National Science Foundation [HRD-0811239]; North Dakota State University Department of Biological Sciences; College of Science and Mathematics	National Science Foundation(National Science Foundation (NSF)); North Dakota State University Department of Biological Sciences; College of Science and Mathematics	This work was supported by National Science Foundation Grant # HRD-0811239 to the NDSU Advance FORWARD program (http://www.nsf.gov; http://www.ndsu.edu/forward/) and North Dakota State University Department of Biological Sciences and College of Science and Mathematics (http://www.ndsu.edu/scimath/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN SA, 1974, AM ZOOL, V14, P221; [Anonymous], 2007, NEOTROPICAL TENT ROO; Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; Balsby TJS, 2008, P ROY SOC B-BIOL SCI, V275, P2147, DOI 10.1098/rspb.2008.0517; Barta Z, 2001, BEHAV ECOL, V12, P121, DOI 10.1093/beheco/12.2.121; Behr O, 2004, BEHAV ECOL SOCIOBIOL, V56, P106, DOI 10.1007/s00265-004-0768-7; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Bohn KM, 2007, ANIM BEHAV, V73, P423, DOI 10.1016/j.anbehav.2006.09.003; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; BROOKE AP, 1990, J ZOOL, V221, P11, DOI 10.1111/j.1469-7998.1990.tb03771.x; Brumm H, 2003, BEHAVIOUR, V140, P43, DOI 10.1163/156853903763999881; Carter GG, 2009, CAN J ZOOL, V87, P604, DOI 10.1139/Z09-051; Carter GG, 2008, ANIM BEHAV, V76, P1343, DOI 10.1016/j.anbehav.2008.04.023; Carter GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038791; Chaverri G, 2006, J ZOOL, V270, P650, DOI 10.1111/j.1469-7998.2006.00171.x; Chaverri G, 2006, BIOTROPICA, V38, P77, DOI 10.1111/j.1744-7429.2005.00107.x; Chaverri G, 2007, ETHOLOGY, V113, P598, DOI 10.1111/j.1439-0310.2007.01365.x; Chaverri Gloriana, 2010, Communicative & Integrative Biology, V3, P599, DOI 10.4161/cib.3.6.13277; Chaverri G, 2010, BEHAV ECOL SOCIOBIOL, V64, P1619, DOI 10.1007/s00265-010-0975-3; Chaverri G, 2010, BIOL LETTERS, V6, P441, DOI 10.1098/rsbl.2009.0964; Chaverri G, 2008, J MAMMAL, V89, P1361, DOI 10.1644/08-MAMM-S-057.1; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Kondo N, 2012, P ROY SOC B-BIOL SCI, V279, P1937, DOI 10.1098/rspb.2011.2419; LAIR H, 1990, BEHAVIOUR, V115, P254, DOI 10.1163/156853990X00608; LaVal RK, 2002, MURCIELAGOS COSTA RI; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; MORI A, 1983, Primates, V24, P486, DOI 10.1007/BF02381682; MUMME RL, 1992, BEHAV ECOL SOCIOBIOL, V31, P319; Rodriguez-Herrera B, 2008, ACTA CHIROPTEROL, V10, P89, DOI 10.3161/150811008X331126; Rodriguez-Herrera B, 2006, ACTA CHIROPTEROL, V8, P557, DOI 10.3161/1733-5329(2006)8[557:TBBFEA]2.0.CO;2; Russ JM, 2004, ANIM BEHAV, V67, P1005, DOI 10.1016/j.anbehav.2003.09.003; Schoner CR, 2010, BEHAV ECOL SOCIOBIOL, V64, P2053, DOI 10.1007/s00265-010-1019-8; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; TIMM R M, 1982, Mammalian Species, P1, DOI 10.2307/3503942; Vonhof MJ, 2004, ANIM BEHAV, V68, P507, DOI 10.1016/j.anbehav.2003.08.025; WIEWANDT TA, 1969, COPEIA, P276; Wilkinson GS, 2003, ANIMAL SOCIAL COMPLEXITY, P322; Wilkinson GS, 1998, ANIM BEHAV, V55, P337, DOI 10.1006/anbe.1997.0557	40	11	11	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61731	10.1371/journal.pone.0061731	http://dx.doi.org/10.1371/journal.pone.0061731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637893	Green Published, gold			2022-12-25	WOS:000318340400044
J	Li, XY; Pang, LR; Chen, YG; Weng, SP; Yue, HT; Zhang, ZZ; Chen, YH; He, JG				Li, Xiao-Yun; Pang, Li-Ran; Chen, Yong-Gui; Weng, Shao-Ping; Yue, Hai-Tao; Zhang, Ze-Zhi; Chen, Yi-Hong; He, Jian-Guo			Activating Transcription Factor 4 and X Box Binding Protein 1 of Litopenaeus vannamei Transcriptional Regulated White Spot Syndrome Virus Genes Wsv023 and Wsv083	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; EXPRESSION; PHOSPHORYLATION; ENHANCER; PATHWAY; LEAD; CELL; RNA	In response to endoplasmic reticulum (ER) stress, the signaling pathway termed unfolded protein response (UPR) is activated. To investigate the role of UPR in Litopenaeus vannamei immunity, the activating transcription factor 4 (designated as LvATF4) which belonged to a branch of the UPR, the [protein kinase RNA (PKR)-like ER kinase, (PERK)]-[eukaryotic initiation factor 2 subunit alpha (eIF2 alpha)] pathway, was identified and characterized. The full-length cDNA of LvATF4 was 1972 bp long, with an open reading frame of 1299 bp long that encoded a 432 amino acid protein. LvATF4 was highly expressed in gills, intestines and stomach. For the white spot syndrome virus (WSSV) challenge, LvATF4 was upregulated in the gills after 3 hpi and increased by 1.9-fold (96 hpi) compared to the mock-treated group. The LvATF4 knock-down by RNA interference resulted in a lower cumulative mortality of L. vannamei under WSSV infection. Reporter gene assays show that LvATF4 could upregulate the expression of the WSSV gene wsv023 based on the activating transcription factor/cyclic adenosine 3', 5'-monophosphate response element (ATF/CRE). Another transcription factor of L. vannamei, X box binding protein 1 (designated as LvXBP1), has a significant function in [inositol-requiring enzyme-1(IRE1) - (XBP1)] pathway. This transcription factor upregulated the expression of the WSSV gene wsv083 based on the UPR element (UPRE). These results suggest that in L. vannamei UPR signaling pathway transcription factors are important for WSSV and might facilitate WSSV infection.	[Li, Xiao-Yun; Pang, Li-Ran; Weng, Shao-Ping; Yue, Hai-Tao; Zhang, Ze-Zhi; He, Jian-Guo] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yong-Gui; Chen, Yi-Hong; He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Chen, YH (corresponding author), Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China.	Chenyihong365@gmail.com; lsshjg@mail.sysu.edu.cn			National Natural Science Foundation of China [2012420004103030, U1131002]; China Agriculture Research System [47]; National High Technology Research and Development Program of China (973 Program) [2012CB114401]; Special Fund for Agro-scientific Research in the Public Interest [201103034]; Foundation from Administration of Ocean and Fisheries of Guangdong Province [A201101B02]; State Key Laboratory of Biocontrol [SKLBC09K04]; Foundation from Science and Technology Bureau of Guangdong Province [2011A020102002, 2009A020102002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; National High Technology Research and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest; Foundation from Administration of Ocean and Fisheries of Guangdong Province; State Key Laboratory of Biocontrol; Foundation from Science and Technology Bureau of Guangdong Province	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by National Natural Science Foundation of China under grant No. 2012420004103030; National Natural Science Foundation of China under grant No. U1131002; Supported by China Agriculture Research System (47); National High Technology Research and Development Program of China (973 Program) 2012CB114401; Special Fund for Agro-scientific Research in the Public Interest 201103034; Foundation from Administration of Ocean and Fisheries of Guangdong Province A201101B02; the Open Project of the State Key Laboratory of Biocontrol (SKLBC09K04); and Foundation from Science and Technology Bureau of Guangdong Province 2011A020102002, 2009A020102002. The nucleotide sequences of LvATF4 has been submitted to the NCBI database and GenBank under accession numbers JX908828.	Ai HS, 2008, FISH SHELLFISH IMMUN, V25, P28, DOI 10.1016/j.fsi.2007.12.002; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Briggs MM, 2005, INTRO MOVEMENT 2 PEN; Chen YH, 2012, DEV COMP IMMUNOL, V38, P66, DOI 10.1016/j.dci.2012.04.005; Chen YH, 2011, DEV COMP IMMUNOL, V35, P661, DOI 10.1016/j.dci.2011.01.010; Gething M J, 1990, Semin Cell Biol, V1, P65; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hooks KB, 2011, RNA BIOL, V8, P552, DOI 10.4161/rna.8.4.15396; Huang XD, 2010, VIROLOGY, V406, P176, DOI 10.1016/j.virol.2010.06.046; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Lan Y, 2006, ARCH VIROL, V151, P1723, DOI 10.1007/s00705-006-0751-x; LEMBO D, 1994, J GEN VIROL, V75, P1685, DOI 10.1099/0022-1317-75-7-1685; Lim DH, 2011, FEBS LETT, V585, P3079, DOI 10.1016/j.febslet.2011.08.034; Lin YR, 2011, J VIROL, V85, P3517, DOI 10.1128/JVI.01973-10; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Liu WJ, 2008, J VIROL, V82, P11362, DOI 10.1128/JVI.01244-08; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Lu HS, 2011, VIROLOGY, V419, P84, DOI 10.1016/j.virol.2011.07.021; Luan W, 2009, MOL BIOL REP, V36, P289, DOI 10.1007/s11033-007-9178-z; Luana W, 2007, COMP BIOCHEM PHYS B, V147, P482, DOI 10.1016/j.cbpb.2007.03.001; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Qian ZK, 2012, J VIROL, V86, P6712, DOI 10.1128/JVI.00200-12; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; SAMBUCETTI LC, 1989, EMBO J, V8, P4251, DOI 10.1002/j.1460-2075.1989.tb08610.x; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shinkai Y, 2010, TOXICOL SCI, V114, P378, DOI 10.1093/toxsci/kfq008; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P269, DOI 10.1080/10409230500315352; Wang KCHC, 2010, DEV COMP IMMUNOL, V34, P49, DOI 10.1016/j.dci.2009.08.003; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Zhao ZY, 2007, FISH SHELLFISH IMMUN, V22, P520, DOI 10.1016/j.fsi.2006.07.003	43	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62603	10.1371/journal.pone.0062603	http://dx.doi.org/10.1371/journal.pone.0062603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638122	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400116
J	Lin, PF; Lan, XL; Chen, FL; Yang, YZ; Jin, YP; Wang, AH				Lin, PengFei; Lan, XiangLi; Chen, FengLei; Yang, YanZhou; Jin, YaPing; Wang, Aihua			Reference Gene Selection for Real-Time Quantitative PCR Analysis of the Mouse Uterus in the Peri-Implantation Period	PLOS ONE			English	Article							HOUSEKEEPING GENES; EXPRESSION ANALYSIS; RT-PCR; IDENTIFICATION; NORMALIZATION	The study of uterine gene expression patterns is valuable for understanding the biological and molecular mechanisms that occur during embryo implantation. Real-time quantitative RT-PCR (qRT-PCR) is an extremely sensitive technique that allows for the precise quantification of mRNA abundance; however, selecting stable reference genes suitable for the normalization of qRT-PCR data is required to avoid the misinterpretation of experimental results and erroneous analyses. This study employs several mouse models, including an early pregnancy, a pseudopregnancy, a delayed implantation and activation, an artificial decidualization and a hormonal treatment model; ten candidate reference genes (PPIA, RPLP0, HPRT1, GAPDH, ACTB, TBP, B2M, 18S, UBC and TUBA) that are found in uterine tissues were assessed for their suitability as internal controls for relative qRT-PCR quantification. GeNorm(PLUS), NormFinder, and BestKeeper were used to evaluate these candidate reference genes, and all of these methods identified RPLP0 and GAPDH as the most stable candidates and B2M and 18S as the least stable candidates. However, when the different models were analyzed separately, the reference genes exhibited some variation in their expression levels.	[Lin, PengFei; Lan, XiangLi; Chen, FengLei; Yang, YanZhou; Jin, YaPing] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China; [Lin, PengFei; Lan, XiangLi; Chen, FengLei; Yang, YanZhou; Jin, YaPing; Wang, Aihua] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Wang, AH (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	pflin2001n@163.com	Chen, Fenglei/GVT-9361-2022	Yang, Yanzhou/0000-0002-1220-5164	Scientific Research Foundation for Doctor [2010BSJJ012]; Specialized Research Fund for the Doctoral Program of Higher Education [20110204120010]; Fundamental Research Funds for the Central Universities [QN2011105]	Scientific Research Foundation for Doctor; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research was granted by Scientific Research Foundation for Doctor (2010BSJJ012), Specialized Research Fund for the Doctoral Program of Higher Education (20110204120010), and Fundamental Research Funds for the Central Universities (QN2011105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bazer Fuller W, 2011, Front Biosci (Schol Ed), V3, P745, DOI 10.2741/s184; Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Kayis SA, 2011, ANIM REPROD SCI, V125, P124, DOI 10.1016/j.anireprosci.2011.02.019; Koot YEM, 2012, BBA-MOL BASIS DIS, V1822, P1943, DOI 10.1016/j.bbadis.2012.05.017; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Lee KY, 2007, TRENDS ENDOCRIN MET, V18, P234, DOI 10.1016/j.tem.2007.06.002; Liu ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045224; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Paulson RJ, 2011, FERTIL STERIL, V96, P530, DOI 10.1016/j.fertnstert.2011.07.1097; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Sadek KH, 2012, HUM REPROD, V27, P251, DOI 10.1093/humrep/der363; Sellayah D, 2008, NEUROSCI LETT, V447, P54, DOI 10.1016/j.neulet.2008.09.060; Smits Katrien, 2009, BMC Res Notes, V2, P246, DOI 10.1186/1756-0500-2-246; Sun ZG, 2009, FERTIL STERIL, V91, P2116, DOI 10.1016/j.fertnstert.2008.01.092; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker CG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-100; Wang SQ, 2011, BIOCHEM BIOPH RES CO, V408, P265, DOI 10.1016/j.bbrc.2011.04.010	25	39	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62462	10.1371/journal.pone.0062462	http://dx.doi.org/10.1371/journal.pone.0062462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638092	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400110
J	Mayeur, A; Duclos, C; Honore, A; Gauberti, M; Drouot, L; do Rego, JC; Bon-Mardion, N; Jean, L; Verin, E; Emery, E; Lemarchant, S; Vivien, D; Boyer, O; Marie, JP; Guerout, N				Mayeur, Anne; Duclos, Celia; Honore, Axel; Gauberti, Maxime; Drouot, Laurent; do Rego, Jean-Claude; Bon-Mardion, Nicolas; Jean, Laetitia; Verin, Eric; Emery, Evelyne; Lemarchant, Sighild; Vivien, Denis; Boyer, Olivier; Marie, Jean-Paul; Guerout, Nicolas			Potential of Olfactory Ensheathing Cells from Different Sources for Spinal Cord Repair	PLOS ONE			English	Article							AXON REGENERATION; SCHWANN-CELLS; STEM-CELLS; COMPLETE TRANSECTION; FUNCTIONAL RECOVERY; LOCOMOTOR RECOVERY; GENE-EXPRESSION; LAMINA-PROPRIA; NEURAL CREST; INJURY	Spinal cord injury (SCI) induces a permanent disability in patients. To this day no curative treatment can be proposed to restore lost functions. Therefore, extensive experimental studies have been conducted to induce recovery after SCI. One of the most promising therapies is based on the use of olfactory ensheathing cells (OECs). OECs can be obtained from either the olfactory bulbs (OB-OECs) or from olfactory mucosa (OM-OECs), involving a less invasive approach for autotransplantation. However the vast majority of experimental transplantations have been focusing on OB-OECs although the OM represents a more accessible source of OECs. Importantly, the ability of OM-OECs in comparison to OB-OECs to induce spinal cord recovery in the same lesion paradigm has never been described. We here present data using a multiparametric approach, based on electrophysiological, behavioral, histological and magnetic resonance imaging experiments on the repair potential of OB-OECs and OM-OECs from either primary or purified cultures after a severe model of SCI. Our data demonstrate that transplantation of OECs obtained from OB or OM induces electrophysiological and functional recovery, reduces astrocyte reactivity and glial scar formation and improves axonal regrowth. We also show that the purification step is essential for OM-OECs while not required for OB-OECs. Altogether, our study strongly indicates that transplantation of OECs from OM represents the best benefit/risk ratio according to the safety of access of OM and the results induced by transplantations of OM-OECs. Indeed, purified OM-OECs in addition to induce recovery can integrate and survive up to 60 days into the spinal cord. Therefore, our results provide strong support for these cells as a viable therapy for SCI.	[Mayeur, Anne; Duclos, Celia; Honore, Axel; Bon-Mardion, Nicolas; Verin, Eric; Marie, Jean-Paul; Guerout, Nicolas] Univ Rouen, Inst Res & Innovat Biomed, UPRES EA 3830, Rouen, Normandy, France; [Mayeur, Anne; Bon-Mardion, Nicolas; Marie, Jean-Paul] Rouen Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Rouen, Normandy, France; [Gauberti, Maxime; Emery, Evelyne; Lemarchant, Sighild; Vivien, Denis] Univ Caen Basse Normandie, GIP Cyceron, Neurovasc Unit, INSERM,UMR S 919, Caen, France; [Drouot, Laurent; Jean, Laetitia; Boyer, Olivier] Univ Rouen, INSERM, Inst Biomed Res & Innovat, U905, Rouen, Normandy, France; [do Rego, Jean-Claude] Univ Rouen, Natl Ctr Sci Res CNRS DR19, Inst Res & Innovat Biomed, Platform Behav Anal SCAC, Rouen, France; [Boyer, Olivier] Rouen Univ Hosp, Dept Immunol, Rouen, Normandy, France	Universite de Rouen Normandie; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; CHU de Rouen	Guerout, N (corresponding author), Univ Rouen, Inst Res & Innovat Biomed, UPRES EA 3830, Rouen, Normandy, France.	nicolas.guerout@ki.se	Boyer, Olivier/N-6552-2013	Boyer, Olivier/0000-0002-7591-307X; Gauberti, Maxime/0000-0003-0752-7342; VIVIEN, DENIS/0000-0002-7636-2185; Lemarchant, Sighild/0000-0001-8671-9099	ADIR (Aide a Domicile aux Insuffisants Respiratoires); Fondation de l'Avenir; IRIB (Institute for Research and Innovation in Biomedicine)	ADIR (Aide a Domicile aux Insuffisants Respiratoires); Fondation de l'Avenir; IRIB (Institute for Research and Innovation in Biomedicine)	The study was financially supported by ADIR (Aide a Domicile aux Insuffisants Respiratoires), Fondation de l'Avenir and IRIB (Institute for Research and Innovation in Biomedicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Au E, 2007, J NEUROSCI, V27, P7208, DOI 10.1523/JNEUROSCI.0509-07.2007; Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; Bianco JI, 2004, GLIA, V45, P111, DOI 10.1002/glia.10298; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; do Rego JC, 2007, NEUROPSYCHOPHARMACOL, V32, P1641, DOI 10.1038/sj.npp.1301280; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; Ghosh M, 2012, GLIA, V60, P979, DOI 10.1002/glia.22330; Guerout N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022816; Guerout N, 2010, GLIA, V58, P1570, DOI 10.1002/glia.21030; Gueye Y, 2011, GLIA, V59, P750, DOI 10.1002/glia.21146; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Honore A, 2012, GLIA, V60, P404, DOI 10.1002/glia.22274; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Jani HR, 2004, GLIA, V47, P130, DOI 10.1002/glia.20038; Kueh JLL, 2011, GLIA, V59, P1658, DOI 10.1002/glia.21213; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lakatos A, 2003, BRAIN, V126, P598, DOI 10.1093/brain/awg055; Li BC, 2012, J MOL NEUROSCI; Li Y, 2005, GLIA, V52, P245, DOI 10.1002/glia.20241; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 2005, J NEUROCYTOL, V34, P343, DOI 10.1007/s11068-005-8361-1; Lu J, 2001, BRAIN RES, V889, P344, DOI 10.1016/S0006-8993(00)03235-2; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Nash HH, 2001, GLIA, V34, P81, DOI 10.1002/glia.1043; Novikova LN, 2011, EXP NEUROL, V229, P132, DOI 10.1016/j.expneurol.2010.09.021; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pastrana E, 2007, NEUROCHEM INT, V50, P491, DOI 10.1016/j.neuint.2006.10.004; Paviot A, 2011, NEUROBIOL DIS, V41, P688, DOI 10.1016/j.nbd.2010.12.004; Perrin FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015914; Polentes J, 2004, NEUROBIOL DIS, V16, P638, DOI 10.1016/j.nbd.2004.04.009; Radtke C, 2010, XENOTRANSPLANTATION, V17, P71, DOI 10.1111/j.1399-3089.2009.00562.x; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; RAMONCUETO A, 1992, NEUROSCIENCE, V47, P213, DOI 10.1016/0306-4522(92)90134-N; Resnick DK, 2003, J NEUROTRAUM, V20, P279, DOI 10.1089/089771503321532860; Richter MW, 2005, J NEUROSCI, V25, P10700, DOI 10.1523/JNEUROSCI.3632-05.2005; Rubio MP, 2008, GLIA, V56, P539, DOI 10.1002/glia.20635; Ruitenberg MJ, 2002, GENE THER, V9, P135, DOI 10.1038/sj.gt.3301626; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stamegna JC, 2011, EXP NEUROL, V229, P120, DOI 10.1016/j.expneurol.2010.07.002; Steward O, 2006, EXP NEUROL, V198, P483, DOI 10.1016/j.expneurol.2005.12.034; Takeoka A, 2011, J NEUROSCI, V31, P4298, DOI 10.1523/JNEUROSCI.4967-10.2011; Tauchi R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-53; Toft A, 2013, GLIA; Windus LCE, 2010, CELL MOL LIFE SCI, V67, P1735, DOI 10.1007/s00018-010-0280-3; Yamamoto M, 2009, BRAIN RES, V1303, P26, DOI 10.1016/j.brainres.2009.09.073	51	33	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62860	10.1371/journal.pone.0062860	http://dx.doi.org/10.1371/journal.pone.0062860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638158	Green Submitted, gold, Green Published			2022-12-25	WOS:000318340400130
J	Bennett, RD; Pittelkow, MR; Strehler, EE				Bennett, Richard D.; Pittelkow, Mark R.; Strehler, Emanuel E.			Immunolocalization of the Tumor-Sensitive Calmodulin-Like Protein CALML3 in Normal Human Skin and Hyperproliferative Skin Disorders	PLOS ONE			English	Article							MYOSIN-X; FILOPODIA; CELLS; GENE	Background and Objective: Calmodulin-like protein CALML3 is an epithelial-specific protein regulated during keratinocyte differentiation in vitro. CALML3 expression is downregulated in breast cancers and transformed cell lines making it an attractive marker for tumor formation. The objective of this study was to survey CALML3 localization in normal epidermis and in hyperproliferative skin diseases including actinic keratosis, squamous and basal cell carcinoma as well as verruca and psoriasis and to compare CALML3 immunoreactivity with the proliferation marker Ki-67. Methods: Paraffin-embedded tissue sections from normal human skin and hyperproliferative skin disorders were examined by immunohistochemistry and analyzed for localization and expression of CALML3 and Ki-67. Results: CALML3 was strongly expressed in differentiating layers of normal skin, staining the periphery in suprabasal cells and exhibiting nuclear localization in the stratum granulosum. CALML3 nuclear localization was inversely correlated to Ki-67 staining in each disease, indicating that CALML3 nuclear presence is related to terminal cell differentiation and postmitotic state. Conclusions: Increased CALML3 expression in suprabasal layers is characteristic for differentiating keratinocytes in normal epidermis, and nuclear expression of CALML3 inversely correlates with expression of the proliferation marker Ki-67. This suggests that CALML3 is a useful marker for normal and benign hyperplastic epidermal development, whereas the loss of nuclear CALML3 indicates progression to a proliferative and potentially malignant phenotype.	[Bennett, Richard D.; Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Bennett, Richard D.] Mayo Clin, Coll Med, Dept Cell Biol, Rochester, MN USA; [Bennett, Richard D.] Mayo Clin, Coll Med, Genet Program, Grad Sch, Rochester, MN USA; [Pittelkow, Mark R.] Mayo Clin, Coll Med, Dept Dermatol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Strehler, EE (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	strehler.emanuel@mayo.edu		Strehler, Emanuel/0000-0001-5998-7055	Mayo Graduate School; Biospecimens Accessioning and Processing and the Pathology Research Cores of the Mayo Clinic Cancer Center	Mayo Graduate School; Biospecimens Accessioning and Processing and the Pathology Research Cores of the Mayo Clinic Cancer Center	This work was supported in part by the Mayo Graduate School and the Biospecimens Accessioning and Processing and the Pathology Research Cores of the Mayo Clinic Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett RD, 2008, FEBS LETT, V582, P2377, DOI 10.1016/j.febslet.2008.05.051; Bennett RD, 2007, J BIOL CHEM, V282, P3205, DOI 10.1074/jbc.M607174200; Bennett RD, 2009, J INVEST DERMATOL, V129, P765, DOI 10.1038/jid.2008.288; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Bordbar A, 2007, APPL IMMUNOHISTO M M, V15, P229, DOI 10.1097/01.pai.0000209867.20581.c7; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; de Rie Menno A, 2004, Dermatol Ther, V17, P341, DOI 10.1111/j.1396-0296.2004.04037.x; Divito M.M., 2008, MYOS SUP MOL MOT; Lebwohl M, 2003, BRIT J DERMATOL, V149, P31, DOI 10.1046/j.0366-077X.2003.05621.x; Rogers Michael S., 1999, Neoplasia (New York), V1, P220, DOI 10.1038/sj.neo.7900029; Rogers MS, 2001, EXP CELL RES, V267, P216, DOI 10.1006/excr.2001.5254; Rogers MS, 2001, J BIOL CHEM, V276, P12182, DOI 10.1074/jbc.M010056200; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; YASWEN P, 1992, CELL GROWTH DIFFER, V3, P335; YASWEN P, 1990, P NATL ACAD SCI USA, V87, P7360, DOI 10.1073/pnas.87.19.7360; Yonezawa S, 2003, DEV GROWTH DIFFER, V45, P175	16	13	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62347	10.1371/journal.pone.0062347	http://dx.doi.org/10.1371/journal.pone.0062347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23638045	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700082
J	de'Donato, FK; Leone, M; Noce, D; Davoli, M; Michelozzi, P				de'Donato, Francesca K.; Leone, Michela; Noce, Damia; Davoli, Marina; Michelozzi, Paola			The Impact of the February 2012 Cold Spell on Health in Italy Using Surveillance Data	PLOS ONE			English	Article							HEAT WAVES; EMERGENCY-DEPARTMENTS; MORTALITY; TEMPERATURE; WEATHER; WALES; INFLUENZA; ENGLAND; CITIES	In February 2012 Italy was hit by an exceptional cold spell with extremely low temperatures and heavy snowfall. The aim of this work is to estimate the impact of the cold spell on health in the Italian cities using data from the rapid surveillance systems. In Italy, a national mortality surveillance system has been operational since 2004 in 34 cities for the rapid monitoring of daily mortality. Data from this system were used to evaluate the impact of the February 2012 cold spell on mortality shortly after the occurrence of the event. Furthermore, a cause-specific analysis was conducted in Roma using the Regional Mortality Registry and the emergency visits (ER) surveillance system. Cold spell episodes were defined as days when mean temperatures were below the 10th percentile of February distribution for more than three days. To estimate the impact of the cold spell, excess mortality was calculated as the difference between observed and daily expected values. An overall 1578 (+25%) excess deaths among the 75+ age group was recorded in the 14 cities that registered a cold spell in February 2012. A statistically significant excess in mortality was observed in several cities ranging from +22% in Bologna to +58% in Torino. Cause-specific analysis conducted in Roma showed a statistically significant excess in mortality among the 75+ age group for respiratory disease (+64%), COPD (+57%), cardiovascular disease +20% ischemic heart disease (14%) and other heart disease (+33%). Similar results were observed for ER visits. Surveillance systems need to become are a key component of prevention plans as they can help improve public health response and are a valid data source to rapidly quantify the impact on health. Cold-related mortality is still an important issue and should not be underestimated by public health Authorities.	[de'Donato, Francesca K.; Leone, Michela; Noce, Damia; Davoli, Marina; Michelozzi, Paola] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [de'Donato, Francesca K.; Leone, Michela; Noce, Damia; Davoli, Marina; Michelozzi, Paola] Natl Ctr Prevent Heat Hlth Effects, Dept Civil Protect, Rome, Italy		de'Donato, FK (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.	f.dedonato@deplazio.it	Michelozzi, Paola/J-8608-2016; Davoli, Marina/K-1975-2016	Michelozzi, Paola/0000-0002-1646-2555; Davoli, Marina/0000-0003-4521-032X; de'Donato, Francesca K./0000-0002-2225-9457	Italian Ministry of Health; EU [EAHC 20101103]	Italian Ministry of Health(Ministry of Health, Italy); EU(European Commission)	This work was carried out within the National Program for the Prevention of Heat Health Effects funded by the Italian Ministry of Health and the EU project "Public Health Adaptation Strategies to Extreme weather events - PHASE'' (contract number EAHC 20101103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Bargagli AM, 2012, EPIDEMIOL PREV S5, V36, P69; Barnett AG, 2012, ENVIRON RES, V112, P218, DOI 10.1016/j.envres.2011.12.010; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; Chan TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011626; Claessens YE, 2006, CRIT CARE, V10, DOI 10.1186/cc5092; Cox B, 2010, INT J PUBLIC HEALTH, V55, P251, DOI 10.1007/s00038-010-0135-6; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Diaz J, 2005, INT J BIOMETEOROL, V49, P179, DOI 10.1007/s00484-004-0224-4; Donaldson GC, 2003, J EPIDEMIOL COMMUN H, V57, P790, DOI 10.1136/jech.57.10.790; Donaldson GC, 1997, J EPIDEMIOL COMMUN H, V51, P643, DOI 10.1136/jech.51.6.643; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Galli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022719; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Johnson Helen, 2005, Health Stat Q, P6; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Keatinge W R, 2002, Int J Circumpolar Health, V61, P292; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Kysely J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-19; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; Meier CR, 1999, BIOMED PHARMACOTHER, V53, P397, DOI 10.1016/S0753-3322(99)80118-8; Michelozzi P, 2010, BMJ-BRIT MED J, V10, P341; Michelozzi P, 2010, INT J ENV RES PUB HE, V7, P2256, DOI 10.3390/ijerph7052256; Muscatello DJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-141; Pin SP, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.005; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rete Italiana Sorveglianza Influenze, 2012, STAG INFL 2011 2012, P1; Rhea S, 2012, J COMMUN HEALTH, V37, P495, DOI 10.1007/s10900-011-9469-0; Rocklov J, 2009, EUR RESPIR J, V33, P245, DOI 10.1183/09031936.00037808; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Stafoggia M, 2009, EPIDEMIOLOGY, V20, P575, DOI 10.1097/EDE.0b013e31819ecdf0; von Klot S, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-74; Wang YC, 2012, SCI TOTAL ENVIRON, V416, P97, DOI 10.1016/j.scitotenv.2011.11.073; WMO, 2012, COLD SPELL EUR AS LA; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]	39	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61720	10.1371/journal.pone.0061720	http://dx.doi.org/10.1371/journal.pone.0061720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637892	gold, Green Submitted, Green Published			2022-12-25	WOS:000317908700056
J	Barcelona, PF; Jaldin-Fincati, JR; Sanchez, MC; Chiabrando, GA				Barcelona, Pablo F.; Jaldin-Fincati, Javier R.; Sanchez, Maria C.; Chiabrando, Gustavo A.			Activated alpha(2)-macroglobulin induces Muller glial cell migration by regulating MT1-MMP activity through LRP1	FASEB JOURNAL			English	Article						endocytosis; intracellular traffic; proteases; retina; retinopathies	RECEPTOR-RELATED PROTEIN-1; TYPE-1 MATRIX-METALLOPROTEINASE; FIBRILLARY ACIDIC PROTEIN; PREGNANCY ZONE PROTEIN; NERVE GROWTH-FACTOR; PROLIFERATIVE DIABETIC-RETINOPATHY; RETINAL-DETACHMENT; IN-VITRO; 1-MATRIX METALLOPROTEINASE; PERICELLULAR PROTEOLYSIS	In retinal proliferative diseases, Muller glial cells (MGCs) acquire migratory abilities. However, the mechanisms that regulate this migration remain poorly understood. In addition, proliferative disorders associated with enhanced activities of matrix metalloprotease 2 (MMP-2) and MMP-9 also present increased levels of the protease inhibitor (2)-macroglobulin (M-2) and its receptor, the low-density lipoprotein receptor-related protein 1 (LRP1). In the present work, we investigated whether the protease activated form of M-2, M-2*, and LRP1 are involved with the MGC migratory process. By performing wound-scratch migration and zymography assays, we demonstrated that M-2* induced cell migration and proMMP-2 activation in the human Muller glial cell line, MIO-M1. This induction was blocked when LRP1 and MT1-MMP were knocked down with siRNA techniques. Using fluorescence microscopy and biochemical procedures, we found that M-2* induced an increase in LRP1 and MT1-MMP accumulation in early endosomes, followed by endocytic recycling and intracellular distribution of MT1-MMP toward cellular protrusions. Moreover, Rab11-dominant negative mutant abrogated MT1-MMP recycling pathway, cell migration, and proMMP-2 activation induced by M-2*. In conclusion, M-2*, through its receptor LRP1, induces cellular migration of Muller glial cells by a mechanism that involves MT1-MMP intracellular traffic to the plasma membrane by a Rab11-dependent recycling pathway.	[Barcelona, Pablo F.; Jaldin-Fincati, Javier R.; Sanchez, Maria C.; Chiabrando, Gustavo A.] Univ Nacl Cordoba, Dept Bioquim Clin, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol Consejo Nacl In, RA-5000 Cordoba, Argentina	National University of Cordoba	Chiabrando, GA (corresponding author), Univ Nacl Cordoba, Dept Bioquim Clin, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol Consejo Nacl In, Ciudad Univ, RA-5000 Cordoba, Argentina.	csanchez@fcq.unc.edu.ar; gustavo@fcq.unc.edu.ar	Barcelona, Pablo Federico/AAJ-8440-2020	Barcelona, Pablo/0000-0001-8248-2282; Jaldin-Fincati, Javier Roberto/0000-0002-9490-4785	Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyTUNC) [214/10, 26/1169/08]; Fondo para la Investigacion Cientifica y Tecnologica (FONCyT): Prestamo BID Proyecto de Investigacion en Ciencia y Tecnolog a (PICT) [06-01207]; Proyecto de Investigacion en Ciencia y Tecnolog a Orientados (PICTO)-Glaxo [2012-0084]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Proyecto de Investigacion Plurianual (PIP) [112-200801-02067]	Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyTUNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT): Prestamo BID Proyecto de Investigacion en Ciencia y Tecnolog a (PICT); Proyecto de Investigacion en Ciencia y Tecnolog a Orientados (PICTO)-Glaxo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Proyecto de Investigacion Plurianual (PIP)	This work was supported in part by Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyTUNC) grants 214/10 and 26/1169/08, Fondo para la Investigacion Cientifica y Tecnologica (FONCyT): Prestamo BID Proyecto de Investigacion en Ciencia y Tecnolog a (PICT) grant 06-01207, Proyecto de Investigacion en Ciencia y Tecnolog a Orientados (PICTO)-Glaxo grant 2012-0084, and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Proyecto de Investigacion Plurianual (PIP) grant 112-200801-02067. P. B. and J.J-F. are doctoral fellows of CONICET. M. C. S. and G. A. C. are members of the Research Career of CONICET. The authors thank Dr. Paul D. Hobson, native speaker, for revising the manuscript.	Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Bai YJ, 2011, INVEST OPHTH VIS SCI, V52, P5260, DOI 10.1167/iovs.10-6691; Barcelona PF, 2010, EXP EYE RES, V91, P264, DOI 10.1016/j.exer.2010.05.017; Barcelona PF, 2011, INVEST OPHTH VIS SCI, V52, P778, DOI 10.1167/iovs.10-5759; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonacci GR, 2007, ARCH BIOCHEM BIOPHYS, V460, P100, DOI 10.1016/j.abb.2007.01.004; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bull ND, 2008, INVEST OPHTH VIS SCI, V49, P3449, DOI 10.1167/iovs.08-1770; Caceres LC, 2010, J CELL BIOCHEM, V111, P607, DOI 10.1002/jcb.22737; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Chiabrando G, 1997, PROTEIN EXPRES PURIF, V9, P399, DOI 10.1006/prep.1996.0680; Chiabrando GA, 2002, J NEUROSCI RES, V70, P57, DOI 10.1002/jnr.10369; CHU CT, 1994, LAB INVEST, V71, P792; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Gonias SL, 2000, J BIOL CHEM, V275, P5826, DOI 10.1074/jbc.275.8.5826; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Guidry C, 2005, PROG RETIN EYE RES, V24, P75, DOI 10.1016/j.preteyeres.2004.07.001; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hollborn MR, 2004, LAB INVEST, V84, P963, DOI 10.1038/labinvest.3700121; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Kim IB, 1998, EXP BRAIN RES, V121, P419, DOI 10.1007/s002210050476; Kimura H, 1999, INVEST OPHTH VIS SCI, V40, P524; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Laatsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029385; Lehti K, 2009, J CELL SCI, V122, P126, DOI 10.1242/jcs.035279; Lewis G, 1999, AM J OPHTHALMOL, V128, P165, DOI 10.1016/S0002-9394(99)00103-8; LEWIS GP, 1995, INVEST OPHTH VIS SCI, V36, P2404; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Limb GA, 2002, AM J PATHOL, V160, P1847, DOI 10.1016/S0002-9440(10)61131-5; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P1905, DOI 10.1161/01.ATV.0000035391.46201.9A; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Noda K, 2003, INVEST OPHTH VIS SCI, V44, P2163, DOI 10.1167/iovs.02-0662; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Romo P, 2011, ACTA OPHTHALMOL, V89, pe263, DOI 10.1111/j.1755-3768.2010.01968.x; Sanchez MC, 2007, EXP EYE RES, V85, P644, DOI 10.1016/j.exer.2007.07.018; Sanchez MC, 2006, EXP EYE RES, V83, P1378, DOI 10.1016/j.exer.2006.07.016; Sanchez MC, 2001, ARCH BIOCHEM BIOPHYS, V389, P218, DOI 10.1006/abbi.2001.2329; Schram K, 2011, ENDOCRINOLOGY, V152, P2037, DOI 10.1210/en.2010-1166; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Sethi CS, 2005, INVEST OPHTH VIS SCI, V46, P329, DOI 10.1167/iovs.03-0518; Shi Y, 2011, J NEUROSCI RES, V89, P544, DOI 10.1002/jnr.22576; Shi ZH, 2008, J BIOL CHEM, V283, P29156, DOI 10.1074/jbc.M802365200; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Tackenberg MA, 2009, MOL VIS, V15, P1886; Tang BL, 2009, CELL MOTIL CYTOSKEL, V66, P365, DOI 10.1002/cm.20376; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Wang Y, 2002, CURR EYE RES, V24, P305, DOI 10.1076/ceyr.24.4.305.8408; Wickramasinghe RD, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-58; Williams KC, 2011, J BIOL CHEM, V286, P43405, DOI 10.1074/jbc.M111.297069; Xue LP, 2006, NEUROSCIENCE, V139, P723, DOI 10.1016/j.neuroscience.2005.12.032; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387	65	28	29	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3181	3197		10.1096/fj.12-221598	http://dx.doi.org/10.1096/fj.12-221598			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23640058				2022-12-25	WOS:000329877600024
J	Madsen, K; Reddy, RN; Price, SR; Williams, CR; Gooch, JL				Madsen, Kirsten; Reddy, Ramesh N.; Price, S. Russ; Williams, Clintoria R.; Gooch, Jennifer L.			Nutritional Intervention Restores Muscle but Not Kidney Phenotypes in Adult Calcineurin A alpha Null Mice	PLOS ONE			English	Article							BETA; RESTRICTION; ISOFORM; RAT	Mice lacking the alpha isoform of the catalytic subunit of calcineurin (CnA alpha) were first reported in 1996 and have been an important model to understand the role of calcineurin in the brain, immune system, bones, muscle, and kidney. Research using the mice has been limited, however, by failure to thrive and early lethality of most null pups. Work in our laboratory led to the rescue of CnA alpha-/- mice by supplemental feeding to compensate for a defect in salivary enzyme secretion. The data revealed that, without intervention, knockout mice suffer from severe caloric restriction. Since nutritional deprivation is known to significantly alter development, it is imperative that previous conclusions based on CnA alpha-/- mice are revisited to determine which aspects of the phenotype were attributable to caloric restriction versus a direct role for CnA alpha. In this study, we find that defects in renal development and function persist in adult CnA alpha-/- mice including a significant decrease in glomerular filtration rate and an increase in blood urea nitrogen levels. These data indicate that impaired renal development we previously reported was not due to caloric restriction but rather a specific role for CnA alpha in renal development and function. In contrast, we find that rather than being hypoglycemic, rescued mice are mildly hyperglycemic and insulin resistant. Examination of muscle fiber types shows that previously reported reductions in type I muscle fibers are no longer evident in rescued null mice. Rather, loss of CnA alpha likely alters insulin response due to a reduction in insulin receptor substrate-2 (IRS2) expression and signaling in muscle. This study illustrates the importance of re-examining the phenotypes of CnA alpha-/- mice and the advances that are now possible with the use of adult, rescued knockout animals.	[Williams, Clintoria R.; Gooch, Jennifer L.] Atlanta Vet Adm Med Ctr, Decatur, GA USA; [Madsen, Kirsten; Reddy, Ramesh N.; Price, S. Russ; Williams, Clintoria R.; Gooch, Jennifer L.] Emory Univ, Sch Med, Dept Med, Div Nephrol, Atlanta, GA USA; [Madsen, Kirsten] Univ Southern Denmark, Dept Cardiovasc & Renal Res, Odense, Denmark	Emory University; University of Southern Denmark	Gooch, JL (corresponding author), Atlanta Vet Adm Med Ctr, Decatur, GA USA.	jgooch@emory.edu			Department of Veterans Affairs; Presidential Early Career Award for Scientists and Engineers; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK50740, DK95610]; Danish Heart Foundation; Lundbeck Foundation; Hoerslev Foundation; Danish Medical Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095610, T32DK007656, R01DK050740] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001456] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF13OC0006215] Funding Source: researchfish	Department of Veterans Affairs(US Department of Veterans Affairs); Presidential Early Career Award for Scientists and Engineers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Danish Heart Foundation; Lundbeck Foundation(Lundbeckfonden); Hoerslev Foundation; Danish Medical Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding for this research was provided by the Department of Veterans Affairs, Presidential Early Career Award for Scientists and Engineers (JLG), and National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases DK50740 and DK95610 (SRP). In addition, the authors thank the Danish Heart Foundation, the Lundbeck Foundation, the Hoerslev Foundation and the Danish Medical Foundation for financial support (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JL, 2006, J AM SOC NEPHROL, V17, P1388, DOI 10.1681/ASN.2004100842; Bailey JL, 1996, J CLIN INVEST, V97, P1447, DOI 10.1172/JCI118566; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; BUTTINI M, 1993, N-S ARCH PHARMACOL, V348, P679, DOI 10.1007/BF00167247; Gooch JL, 2007, TRANSPLANTATION, V83, P439, DOI 10.1097/01.tp.0000251423.78124.51; Gooch JL, 2006, J CELL SCI, V119, P2468, DOI 10.1242/jcs.02971; Gooch JL, 2004, AM J PATHOL, V165, P1755, DOI 10.1016/S0002-9440(10)63430-X; Gooch JL, 2006, AM J PHYSIOL-RENAL, V290, pF769, DOI 10.1152/ajprenal.00281.2005; Gooch JL, 2003, AM J PHYSIOL-RENAL, V284, pF144, DOI 10.1152/ajprenal.00158.2002; Kayyali US, 1997, J NEUROCHEM, V68, P1668; Kelly FM, 2009, AM J PHYSIOL-RENAL, V296, pF512, DOI 10.1152/ajprenal.90629.2008; Kim M, 2010, EXP DERMATOL, V19, P501, DOI 10.1111/j.1600-0625.2009.00941.x; Komhoff M, 2000, KIDNEY INT, V57, P414; Norwood VF, 2000, KIDNEY INT, V58, P2291, DOI 10.1046/j.1523-1755.2000.00413.x; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Pena JA, 2009, J INVEST DERMATOL; Pena JA, 2010, J INVEST DERMATOL, V130, P135, DOI 10.1038/jid.2009.222; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Reddy RN, 2011, AM J PATHOL, V178, P1605, DOI 10.1016/j.ajpath.2010.12.054; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Ryder JW, 2003, J BIOL CHEM, V278, P44298, DOI 10.1074/jbc.M304510200; Satoh S, 2008, NEUROPHARMACOLOGY, V55, P71, DOI 10.1016/j.neuropharm.2008.04.015; Schreuder MF, 2006, AM J PHYSIOL-RENAL, V291, pF1104, DOI 10.1152/ajprenal.00158.2006; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Sun L, 2007, ANN NY ACAD SCI, V1116, P216, DOI 10.1196/annals.1402.050; Wlodek ME, 2008, KIDNEY INT, V74, P187, DOI 10.1038/ki.2008.153; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62503	10.1371/journal.pone.0062503	http://dx.doi.org/10.1371/journal.pone.0062503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638102	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300071
J	Ambroggio, EE; Sillibourne, J; Antonny, B; Manneville, JB; Goud, B				Ambroggio, Ernesto E.; Sillibourne, James; Antonny, Bruno; Manneville, Jean-Baptiste; Goud, Bruno			Arf1 and Membrane Curvature Cooperate to Recruit Arfaptin2 to Liposomes	PLOS ONE			English	Article							BIN/AMPHIPHYSIN/RVS BAR DOMAIN; ADP-RIBOSYLATION FACTORS; RAC1-INTERACTING PROTEIN; AMPHIPATHIC HELICES; MYRISTOYLATED ARF1; STRUCTURAL BASIS; ARL1; BINDING	Arfaptin2 contains a Bin/Amphiphysin/Rvs (BAR) domain and directly interacts with proteins of the Arf/Arl family in their active GTP-bound state. It has been proposed that BAR domains are able to sense membrane curvature and to induce membrane tubulation. We report here that active Arf1 is required for the recruitment of Arfaptin2 to artificial liposomes mimicking the Golgi apparatus lipid composition. The Arf1-dependent recruitment of Arfaptin2 increases with membrane curvature, while the recruitment of Arf1 itself is not sensitive to curvature. At high protein concentrations, the binding of Arfaptin2 induces membrane tubulation. Finally, membrane-bound Arfaptin2 is released from the liposome when ArfGAP1 catalyzes the hydrolysis of GTP to GDP in Arf1. These results show that both Arf1 activation and high membrane curvature are required for efficient recruitment of Arfaptin2 to membranes.	[Ambroggio, Ernesto E.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, Lab Biofis Biomembranas, Dept Quim Biol,Fac Ciencias Quim,UNC CONICET, RA-5000 Cordoba, Argentina; [Sillibourne, James; Manneville, Jean-Baptiste; Goud, Bruno] Inst Curie, CNRS, UMR 144, Lab Mecanismes Mol Transport Intracellulaire, F-75231 Paris, France; [Antonny, Bruno] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Valbonne, France; [Antonny, Bruno] CNRS, F-06560 Valbonne, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Ambroggio, EE (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, Lab Biofis Biomembranas, Dept Quim Biol,Fac Ciencias Quim,UNC CONICET, RA-5000 Cordoba, Argentina.	ambroggioernesto@yahoo.com; Jean-Baptiste.Manneville@curie.fr; Bruno.Goud@curie.fr	Goud, Bruno/GWC-4807-2022; Manneville, Jean-Baptiste/L-5914-2019; Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; Sillibourne, James/0000-0001-6755-3644; Manneville, Jean-Baptiste/0000-0002-8670-3940	Centre National de la Recherche Scientifique (CNRS); Institut Curie; Agence Nationale de la Recherche [ANR-05-BLAN-0095]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Institut Curie, and a grant from the Agence Nationale de la Recherche (ANR-05-BLAN-0095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio E, 2010, EMBO J, V29, P292, DOI 10.1038/emboj.2009.341; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Campelo F, 2010, FEBS LETT, V584, P1830, DOI 10.1016/j.febslet.2009.10.023; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Lu L, 2001, J CELL SCI, V114, P4543; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Manneville JB, 2008, P NATL ACAD SCI USA, V105, P16946, DOI 10.1073/pnas.0807102105; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Peters PJ, 2002, NAT CELL BIOL, V4, P240, DOI 10.1038/ncb761; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Stachowiak JC, 2012, NAT CELL BIOL; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Thoresen T, 2008, BIOCHEMISTRY-US, V47, P9514, DOI 10.1021/bi800747e; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x	27	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62963	10.1371/journal.pone.0062963	http://dx.doi.org/10.1371/journal.pone.0062963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638170	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800069
J	Fracasso, A; Targher, S; Zampini, M; Melcher, D				Fracasso, Alessio; Targher, Stefano; Zampini, Massimiliano; Melcher, David			Fooling the Eyes: The Influence of a Sound-Induced Visual Motion Illusion on Eye Movements	PLOS ONE			English	Article							MULLER-LYER-ILLUSION; PERCEPTION; DISSOCIATION	The question of whether perceptual illusions influence eye movements is critical for the long-standing debate regarding the separation between action and perception. To test the role of auditory context on a visual illusion and on eye movements, we took advantage of the fact that the presence of an auditory cue can successfully modulate illusory motion perception of an otherwise static flickering object (sound-induced visual motion effect). We found that illusory motion perception modulated by an auditory context consistently affected saccadic eye movements. Specifically, the landing positions of saccades performed towards flickering static bars in the periphery were biased in the direction of illusory motion. Moreover, the magnitude of this bias was strongly correlated with the effect size of the perceptual illusion. These results show that both an audio-visual and a purely visual illusion can significantly affect visuo-motor behavior. Our findings are consistent with arguments for a tight link between perception and action in localization tasks.	[Fracasso, Alessio] Univ Utrecht, Utrecht, Netherlands; [Targher, Stefano; Zampini, Massimiliano; Melcher, David] Univ Trento, Ctr Mind Brain Studies, Rovereto, Italy; [Targher, Stefano; Zampini, Massimiliano; Melcher, David] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, Italy	Utrecht University; University of Trento; University of Trento	Fracasso, A (corresponding author), Univ Utrecht, Utrecht, Netherlands.	alessio.fracasso@gmail.com	Melcher, David/D-1775-2010; Zampini, Massimiliano/AAR-1311-2020; Fracasso, Alessio/AAC-4830-2022	Melcher, David/0000-0003-0926-585X; Zampini, Massimiliano/0000-0001-5950-7365; Fracasso, Alessio/0000-0002-4542-112X	Provincia Autonoma di Trento; Fondazione Cassa di Risparmio di Trento e Rovereto	Provincia Autonoma di Trento(Autonomous Province of Trento); Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro)	This work has been realized thanks to the support from the Provincia Autonoma di Trento and the Fondazione Cassa di Risparmio di Trento e Rovereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Brenner E, 1996, EXP BRAIN RES, V111, P473; Bruno N, 2008, NEUROSCI BIOBEHAV R, V32, P423, DOI 10.1016/j.neubiorev.2007.08.006; Bruno N, 2010, VISION RES, V50, P2671, DOI 10.1016/j.visres.2010.09.016; Bruno N, 2009, NEUROPSYCHOLOGIA, V47, P1421, DOI 10.1016/j.neuropsychologia.2008.10.031; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Burr DC, 2001, CURR BIOL, V11, P798, DOI 10.1016/S0960-9822(01)00183-X; Craighero L, 2004, CURR BIOL, V14, P331, DOI 10.1016/j.cub.2004.01.054; de Grave DDJ, 2010, EXP BRAIN RES, V203, P671, DOI 10.1007/s00221-010-2275-6; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Franz VH, 2000, PSYCHOL SCI, V11, P20, DOI 10.1111/1467-9280.00209; Franz VH, 2001, J EXP PSYCHOL HUMAN, V27, P1124, DOI 10.1037//0096-1523.27.5.1124; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Ganel T, 2008, CURR BIOL, V18, pR599, DOI 10.1016/j.cub.2008.04.052; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Hidaka S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-44; Hidaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008188; Jancke D, 2004, J PHYSIOL-LONDON, V556, P971, DOI 10.1113/jphysiol.2003.058941; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Kerzel D, 2005, EXP BRAIN RES, V162, P191, DOI 10.1007/s00221-004-2139-z; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Maij F, 2009, J NEUROPHYSIOL, V102, P490, DOI 10.1152/jn.91253.2008; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Pavani F, 1999, EXP BRAIN RES, V127, P95, DOI 10.1007/s002210050777; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Schenk T, 2012, J NEUROSCI, V32, P2013, DOI 10.1523/JNEUROSCI.3413-11.2012; Schenk T, 2011, VISION RES, V51, P812, DOI 10.1016/j.visres.2011.02.003; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; SHELIGA BM, 1995, NEUROREPORT, V6, P585, DOI 10.1097/00001756-199502000-00044; SMEETS JBJ, 1995, J EXP PSYCHOL HUMAN, V21, P19, DOI 10.1037/0096-1523.21.1.19; Smeets JBJ, 2008, CURR BIOL, V18, pR1089, DOI 10.1016/j.cub.2008.10.008; Westwood DA, 2011, VISION RES, V51, P804, DOI 10.1016/j.visres.2010.10.014	32	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62131	10.1371/journal.pone.0062131	http://dx.doi.org/10.1371/journal.pone.0062131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637981	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700034
J	Robinson, JW; Dando, SJ; Nitsos, I; Newnham, J; Polglase, GR; Kallapur, SG; Pillow, JJ; Kramer, BW; Jobe, AH; Payton, D; Knox, CL				Robinson, James W.; Dando, Samantha J.; Nitsos, Ilias; Newnham, John; Polglase, Graeme R.; Kallapur, Suhas G.; Pillow, J. Jane; Kramer, Boris W.; Jobe, Alan H.; Payton, Diane; Knox, Christine L.			Ureaplasma parvum Serovar 3 Multiple Banded Antigen Size Variation after Chronic Intra-Amniotic Infection/Colonization	PLOS ONE			English	Article							INTRAUTERINE INFECTION; ANTIBODY-PRODUCTION; PHASE VARIATION; MB ANTIGEN; KAPPA-B; UREALYTICUM; MYCOPLASMAS; DISEASE; IDENTIFICATION; AMMONIA	Ureaplasma species are the microorganisms most frequently associated with adverse pregnancy outcomes. The multiple banded antigen (MBA), a surface-exposed lipoprotein, is a key virulence factor of ureaplasmas. The MBA demonstrates size variation, which we have shown previously to be correlated with the severity of chorioamnion inflammation. We aimed to investigate U. parvum serovar 3 pathogenesis in vivo, using a sheep model, by investigating: MBA variation after long term (chronic) and short term (acute) durations of in utero ureaplasma infections, and the severity of chorioamnionitis and inflammation in other fetal tissues. Inocula of 2x10(7) colony-forming-units (CFU) of U. parvum serovar 3 (Up) or media controls (C) were injected intra-amniotically into pregnant ewes at one of three time points: day 55 (69d Up, n = 8; C69, n = 4); day 117 (7d Up, n = 8; C7, n = 2); and day 121 (3d Up, n = 8; C3, n = 2) of gestation (term = 145-150d). At day 124, preterm fetuses were delivered surgically. Samples of chorioamnion, fetal lung, and umbilical cord were: (i) snap frozen for subsequent ureaplasma culture, and (ii) fixed, embedded, sectioned and stained by haematoxylin and eosin stain for histological analysis. Selected fetal lung clinical ureaplasma isolates were cloned and filtered to obtain cultures from a single CFU. Passage 1 and clone 2 ureaplasma cultures were tested by western blot to demonstrate MBA variation. In acute durations of ureaplasma infection no MBA variants (3d Up) or very few MBA variants (7d Up) were present when compared to the original inoculum. However, numerous MBA size variants were generated in vivo (alike within contiguous tissues, amniotic fluid and fetal lung, but different variants were present within chorioamnion), during chronic, 69d exposure to ureaplasma infection. For the first time we have shown that the degree of ureaplasma MBA variation in vivo increased with the duration of gestation.	[Robinson, James W.; Dando, Samantha J.; Knox, Christine L.] Queensland Univ Technol, Fac Hlth, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Nitsos, Ilias; Newnham, John; Polglase, Graeme R.; Kallapur, Suhas G.; Jobe, Alan H.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Neonatol & Pulm Biol, Cincinnati, OH USA; [Pillow, J. Jane] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Kramer, Boris W.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol, Dept Pediat, Maastricht, Netherlands; [Payton, Diane] Royal Brisbane & Womens Hosp, Herston, Qld, Australia	Queensland University of Technology (QUT); University of Western Australia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia; Maastricht University; Royal Brisbane & Women's Hospital	Knox, CL (corresponding author), Queensland Univ Technol, Fac Hlth, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	c.knox@qut.edu.au	Pillow, Jane/A-3335-2009; Kramer, Boris/AAO-3183-2021	Pillow, Jane/0000-0002-6500-0138; Knox, Christine/0000-0003-3997-6812; Polglase, Graeme/0000-0002-8906-614X; Newnham, John/0000-0001-9983-7457; Dando, Samantha/0000-0002-5119-1711	National Health and Medical Research Council of Australia [303261, 458577]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia Grant numbers 303261 & 458577 (http://www.nhmrc.gov.au/grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE CT, 1963, J EXP MED, V117, P1075, DOI 10.1084/jem.117.6.1075; BLANCHARD A, 1991, FEMS MICROBIOL LETT, V81, P37, DOI 10.1016/0378-1097(91)90467-O; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Cheah FC, 2005, PEDIATR RES, V57, P616, DOI 10.1203/01.PDR.0000156209.37627.82; Dando SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029856; delaHoz RE, 1996, AM J IND MED, V29, P209, DOI 10.1002/(SICI)1097-0274(199602)29:2<209::AID-AJIM12>3.3.CO;2-E; Denison AM, 2005, INFECT IMMUN, V73, P2033, DOI 10.1128/IAI.73.4.2033-2039.2005; Dessi D, 2006, FRONT BIOSCI-LANDMRK, V11, P2028, DOI 10.2741/1944; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; GRAY DJ, 1992, PRENATAL DIAG, V12, P111, DOI 10.1002/pd.1970120206; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Issley S, 2011, AMMONIA TOXICITY DIF; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; KENNY GE, 1993, CLIN INFECT DIS, V17, pS215, DOI 10.1093/clinids/17.Supplement_1.S215; KENNY GE, 1977, J BACTERIOL, V132, P144, DOI 10.1128/JB.132.1.144-150.1977; Knox CL, 2010, BIOL REPROD, V83, P415, DOI 10.1095/biolreprod.109.083121; Knox CL, 2003, FERTIL STERIL, V80, P921, DOI 10.1016/S0015-0282(03)01125-7; Knox CL, 1997, AUST NZ J OBSTET GYN, V37, P45, DOI 10.1111/j.1479-828X.1997.tb02216.x; Knox CL, 1998, J CLIN MICROBIOL, V36, P3032, DOI 10.1128/JCM.36.10.3032-3039.1998; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LHOPITAL S, 1993, J CLIN MICROBIOL, V31, P1537, DOI 10.1128/JCM.31.6.1537-1540.1993; Makarovsky I, 2008, ISR MED ASSOC J, V10, P537; MASOVER GK, 1977, J BACTERIOL, V130, P292, DOI 10.1128/JB.130.1.292-296.1977; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Moss TJM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.065; Moss TJM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.044; Moss TJM, 2005, AM J OBSTET GYNECOL, V192, P1179, DOI 10.1016/j.ajog.2004.11.063; PYLE LE, 1988, NUCLEIC ACIDS RES, V16, P6015, DOI 10.1093/nar/16.13.6015; RAZIN S, 1985, MICROBIOL REV, V49, P419, DOI 10.1128/MMBR.49.4.419-455.1985; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Relman DA, 1998, EMERG INFECT DIS, V4, P382, DOI 10.3201/eid0403.980310; Reyes L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-9; Schelonka RL, 2007, SEMIN PERINATOL, V31, P2, DOI 10.1053/j.semperi.2007.01.001; SHEPARD MC, 1978, J CLIN MICROBIOL, V8, P566; SHEPARD MC, 1976, J CLIN MICROBIOL, V3, P613; Shimizu T, 2008, MICROBIOL-SGM, V154, P1318, DOI 10.1099/mic.0.2007/016212-0; SIMECKA JW, 1993, CLIN INFECT DIS, V17, pS176, DOI 10.1093/clinids/17.Supplement_1.S176; TENG LJ, 1994, J CLIN MICROBIOL, V32, P1464, DOI 10.1128/JCM.32.6.1464-1469.1994; Tully J.G., 1983, METHODS MYCOPLASMOLO, P173; Viscardi RM, 2009, PEDIATR RES, V65, p84R, DOI 10.1203/PDR.0b013e31819dc2f9; Volgmann Thorsten, 2005, Archives of Gynecology and Obstetrics, V273, P133, DOI 10.1007/s00404-005-0030-1; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; WATSON HL, 1990, INFECT IMMUN, V58, P3679, DOI 10.1128/IAI.58.11.3679-3688.1990; Westover AJ, 2012, CLIN EXP PHARMACOL P, V39, P824, DOI 10.1111/j.1440-1681.2012.05742.x; ZHENG X, 1992, INFECT IMMUN, V60, P3472, DOI 10.1128/IAI.60.8.3472-3474.1992; ZHENG XT, 1995, INFECT IMMUN, V63, P891, DOI 10.1128/IAI.63.3.891-898.1995	49	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62746	10.1371/journal.pone.0062746	http://dx.doi.org/10.1371/journal.pone.0062746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638142	Green Published, gold			2022-12-25	WOS:000318343700070
J	Dargahi, D; Baillie, D; Pio, F				Dargahi, Daryanaz; Baillie, David; Pio, Frederic			Bioinformatics Analysis Identify Novel OB Fold Protein Coding Genes in C. elegans	PLOS ONE			English	Article							STRAND; HOMOLOGY; IDENTIFICATION; SERVER; GENERATION; PROTECTION; SEQUENCES; REPAIR; MODES; BLAST	Background: The C. elegans genome has been extensively annotated by the WormBase consortium that uses state of the art bioinformatics pipelines, functional genomics and manual curation approaches. As a result, the identification of novel genes in silico in this model organism is becoming more challenging requiring new approaches. The Oligonucleotide-oligosaccharide binding (OB) fold is a highly divergent protein family, in which protein sequences, in spite of having the same fold, share very little sequence identity (5-25%). Therefore, evidence from sequence-based annotation may not be sufficient to identify all the members of this family. In C. elegans, the number of OB-fold proteins reported is remarkably low (n = 46) compared to other evolutionary-related eukaryotes, such as yeast S. cerevisiae (n = 344) or fruit fly D. melanogaster (n = 84). Gene loss during evolution or differences in the level of annotation for this protein family, may explain these discrepancies. Methodology/Principal Findings: This study examines the possibility that novel OB-fold coding genes exist in the worm. We developed a bioinformatics approach that uses the most sensitive sequence-sequence, sequence-profile and profile-profile similarity search methods followed by 3D-structure prediction as a filtering step to eliminate false positive candidate sequences. We have predicted 18 coding genes containing the OB-fold that have remarkably partially been characterized in C. elegans. Conclusions/Significance: This study raises the possibility that the annotation of highly divergent protein fold families can be improved in C. elegans. Similar strategies could be implemented for large scale analysis by the WormBase consortium when novel versions of the genome sequence of C. elegans, or other evolutionary related species are being released. This approach is of general interest to the scientific community since it can be used to annotate any genome.	[Dargahi, Daryanaz; Baillie, David; Pio, Frederic] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Pio, F (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	fpio@sfu.ca		pio, frederic/0000-0003-2050-847X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andachi Y, 2008, RNA, V14, P2440, DOI 10.1261/rna.1139508; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Boerckel J, 2007, GENETICS, V176, P703, DOI 10.1534/genetics.106.070201; Bujnicki JM, 2001, BIOINFORMATICS, V17, P750, DOI 10.1093/bioinformatics/17.8.750; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; DOOLITTLE RF, 1981, SCIENCE, V214, P149, DOI 10.1126/science.7280687; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gallo CM, 2008, DEV BIOL, V323, P76, DOI 10.1016/j.ydbio.2008.07.008; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devcel.2007.11.016; Grundy WN, 1997, COMPUT APPL BIOSCI, V13, P397; Harris J, 2006, GENETICS, V174, P601, DOI 10.1534/genetics.106.058701; Hawkins T, 2006, PROTEIN SCI, V15, P1550, DOI 10.1110/ps.062153506; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ko E, 2008, MOL CELLS, V26, P590; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Lemmens BBLG, 2011, CHROMOSOMA, V120, P1, DOI 10.1007/s00412-010-0296-3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li WZ, 2000, BIOINFORMATICS, V16, P1105, DOI 10.1093/bioinformatics/16.12.1105; Lowden MR, 2008, GENETICS, V180, P741, DOI 10.1534/genetics.108.089920; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; McJunkin K, 2011, P NATL ACAD SCI USA, V108, P7113, DOI 10.1073/pnas.1104097108; Meier B, 2009, EMBO J, V28, P3549, DOI 10.1038/emboj.2009.278; Min J, 2007, BIOCHEM BIOPH RES CO, V362, P958, DOI 10.1016/j.bbrc.2007.08.083; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; Petalcorin MIR, 2006, J MOL BIOL, V361, P231, DOI 10.1016/j.jmb.2006.06.020; Pispa J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-51; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sadreyev RI, 2007, NUCLEIC ACIDS RES, V35, pW653, DOI 10.1093/nar/gkm293; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Soding J, 2011, CURR OPIN STRUC BIOL, V21, P404, DOI 10.1016/j.sbi.2011.03.005; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Theobald DL, 2003, STRUCTURE, V11, P1049, DOI 10.1016/S0969-2126(03)00183-7; van Haaften G, 2006, CURR BIOL, V16, P1344, DOI 10.1016/j.cub.2006.05.047; Ward JD, 2007, EMBO J, V26, P3384, DOI 10.1038/sj.emboj.7601766; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Youds JL, 2008, MOL CELL BIOL, V28, P1470, DOI 10.1128/MCB.01641-07; Youds JL, 2009, MUTAT RES-FUND MOL M, V668, P103, DOI 10.1016/j.mrfmmm.2008.11.007; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	57	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62204	10.1371/journal.pone.0062204	http://dx.doi.org/10.1371/journal.pone.0062204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638006	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400044
J	Perez-Brumer, AG; Konda, KA; Salvatierra, HJ; Segura, ER; Hall, ER; Montano, SM; Coates, TJ; Klausner, JD; Caceres, CF; Clark, JL				Perez-Brumer, Amaya G.; Konda, Kelika A.; Javier Salvatierra, H.; Segura, Eddy R.; Hall, Eric R.; Montano, Silvia M.; Coates, Thomas J.; Klausner, Jeff D.; Caceres, Carlos F.; Clark, Jesse L.			Prevalence of HIV, STIs, and Risk Behaviors in a Cross-Sectional Community- and Clinic-Based Sample of Men Who Have Sex with Men (MSM) in Lima, Peru	PLOS ONE			English	Article							VIRUS TYPE-2 INFECTION; EPIDEMIOLOGY; POPULATIONS; SYPHILIS; WOMEN	Background: Further research is necessary to understand the factors contributing to the high prevalence of HIV/STIs among men who have sex with men (MSM) in Peru. We compared HIV/STI prevalence and risk factors between two non-probability samples of MSM, one passively enrolled from an STI clinic and the other actively enrolled from community venues surrounding the clinic in Lima, Peru. Methods: A total of 560 self-identified MSM were enrolled between May-December, 2007. 438 subjects enrolled from a municipal STI clinic and 122 subjects enrolled during community outreach visits. All participants underwent screening for HIV, syphilis, HSV-2, gonorrhoea, and chlamydia and completed a survey assessing their history of HIV/STIs, prior HIV testing, and sexual behavior. Results: HIV prevalence was significantly higher among MSM enrolled from the clinic, with previously undiagnosed HIV identified in 9.1% compared with 2.6% of community participants. 15.4 % of all MSM screened were infected with <= 1 curable STI, 7.4% with early syphilis (RPR >= 1:16) and 5.5% with urethral gonorrhoea and/or chlamydia. No significant differences between populations were reported in prevalence of STIs, number of male sex partners, history of unprotected anal intercourse, or alcohol and/or drug use prior to sex. Exchange of sex for money or goods was reported by 33.5% of MSM enrolled from the clinic and 21.2% of MSM from the community (p = 0.01). Conclusions: Our data demonstrate that the prevalence of HIV and STIs, including syphilis, gonorrhoea, and chlamydia are extremely high among MSM enrolled from both clinic and community venues in urban Peru. New strategies are needed to address differences in HIV/STI epidemiology between clinic-and community-enrolled samples of MSM.	[Perez-Brumer, Amaya G.; Konda, Kelika A.; Segura, Eddy R.; Coates, Thomas J.; Klausner, Jeff D.; Clark, Jesse L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Perez-Brumer, Amaya G.; Konda, Kelika A.; Segura, Eddy R.; Coates, Thomas J.; Klausner, Jeff D.; Clark, Jesse L.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr World Hlth, Los Angeles, CA 90095 USA; [Javier Salvatierra, H.; Caceres, Carlos F.] Univ Peruana Cayetano Heredia, Unidad Salud Sexual & Derechos Humanos, Lima, Peru; [Hall, Eric R.; Montano, Silvia M.] US Naval Med Res Unit 6, Lima, Peru	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad Peruana Cayetano Heredia; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6)	Perez-Brumer, AG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA.	aperezbr@hsph.harvard.edu		Clark, Jesse/0000-0001-5862-6530; Caceres, Carlos F./0000-0002-8101-0790; Perez-Brumer, Amaya/0000-0003-2441-4358; Segura, Eddy R/0000-0003-3580-7712	National Institutes of Health (NIH) [T32 MH080634, K23 MH084611, MH58107, P30AI028697, UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U10MH061536, P30MH058107, T32MH080634, K23MH084611] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by National Institutes of Health (NIH) grants T32 MH080634, K23 MH084611, MH58107, P30AI028697, and UL1TR000124. The content is solely the responsibility of the authors and does not necessarily represent the views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista CT, 2004, SEX TRANSM INFECT, V80, P498, DOI 10.1136/sti.2004.013094; Clark JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000778; Dodds JP, 2004, SEX TRANSM INFECT, V80, P236, DOI 10.1136/sti.2003.007286; Dougan S, 2007, SEX TRANSM INFECT, V83, P120, DOI 10.1136/sti.2006.021428; Ellen JA, 2003, JAIDS-J ACQ IMM DEF, V32, P388, DOI 10.1097/00126334-200304010-00007; Klausner JD, 2001, J INFECT DIS, V183, P1087, DOI 10.1086/319276; Konda KA, 2005, SEX TRANSM DIS, V32, P534, DOI 10.1097/01.olq.0000175413.89733.ae; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; McCarthy MC, 1996, AIDS, V10, P1141, DOI 10.1097/00002030-199609000-00013; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Snowden JM, 2010, SEX TRANSM DIS, V37, P75, DOI 10.1097/OLQ.0b013e3181c03434; Weinhardt LS, 2004, JAIDS-J ACQ IMM DEF, V36, P1057, DOI 10.1097/00126334-200408150-00009	13	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e59072	10.1371/journal.pone.0059072	http://dx.doi.org/10.1371/journal.pone.0059072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634201	Green Submitted, gold, Green Published			2022-12-25	WOS:000318341400003
J	Todd, GK; Boosalis, CA; Burzycki, AA; Steinman, MQ; Hester, LD; Shuster, PW; Patterson, RL				Todd, George K.; Boosalis, Casey A.; Burzycki, Aaron A.; Steinman, Michael Q.; Hester, Lynda D.; Shuster, Pete W.; Patterson, Randen L.			Towards Neuronal Organoids: A Method for Long-Term Culturing of High-Density Hippocampal Neurons	PLOS ONE			English	Article							DENDRITIC SPINES; CA2+ ENTRY; S-NITROSYLATION; ASTROCYTES; GLUTAMATE; GLIA; SYNAPSES; SYNAPTOGENESIS; NEUROGENESIS; ACTIVATION	One of the goals in neuroscience is to obtain tractable laboratory cultures that closely recapitulate in vivo systems while still providing ease of use in the lab. Because neurons can exist in the body over a lifetime, long-term culture systems are necessary so as to closely mimic the physiological conditions under laboratory culture conditions. Ideally, such a neuronal organoid culture would contain multiple cell types, be highly differentiated, and have a high density of interconnected cells. However, before these types of cultures can be created, certain problems associated with long-term neuronal culturing must be addressed. We sought to develop a new protocol which may further prolong the duration and integrity of E18 rat hippocampal cultures. We have developed a protocol that allows for culturing of E18 hippocampal neurons at high densities for more than 120 days. These cultured hippocampal neurons are (i) well differentiated with high numbers of synapses, (ii) anchored securely to their substrate, (iii) have high levels of functional connectivity, and (iv) form dense multilayered cellular networks. We propose that our culture methodology is likely to be effective for multiple neuronal subtypes-particularly those that can be grown in Neurobasal/B27 media. This methodology presents new avenues for long-term functional studies in neurons.	[Todd, George K.; Boosalis, Casey A.; Burzycki, Aaron A.; Patterson, Randen L.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Todd, George K.; Boosalis, Casey A.; Burzycki, Aaron A.; Patterson, Randen L.] Univ Calif Davis, Sch Med, Dept Biochem, Davis, CA 95616 USA; [Todd, George K.; Boosalis, Casey A.; Burzycki, Aaron A.; Patterson, Randen L.] Univ Calif Davis, Ctr Translat Biosci & Comp, Davis, CA 95616 USA; [Todd, George K.; Boosalis, Casey A.; Steinman, Michael Q.] Univ Calif Davis, Mol Cellular & Integrat Physiol Grad Grp, Davis, CA 95616 USA; [Steinman, Michael Q.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Hester, Lynda D.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Shuster, Pete W.] Neuromics, Edina, MN USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Johns Hopkins University	Patterson, RL (corresponding author), Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA.	randen100@gmail.com			Searle Young Investigators Award; UC Davis; National Science Foundation [428-15 691M]; National Institutes of Health [R01 GM087410-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087410] Funding Source: NIH RePORTER	Searle Young Investigators Award; UC Davis; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Searle Young Investigators Award and start-up money from UC Davis (RLP), The National Science Foundation 428-15 691M (RLP), and The National Institutes of Health R01 GM087410-01 (RLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bergles DE, 1998, J NEUROSCI, V18, P7709; Bertrand SJ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-38; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Brewer GJ, 2005, EXP GERONTOL, V40, P426, DOI 10.1016/j.exger.2005.03.007; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chalisova N I, 2001, Dokl Biol Sci, V380, P424, DOI 10.1023/A:1012350700252; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Favre CJ, 1998, J BIOL CHEM, V273, P30855, DOI 10.1074/jbc.273.47.30855; Feldt S, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046004; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Holowacz T, 2011, EUR J NEUROSCI, V33, P1366, DOI 10.1111/j.1460-9568.2011.07632.x; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; LoTurco JJ, 2000, P NATL ACAD SCI USA, V97, P8196, DOI 10.1073/pnas.97.15.8196; Majd Shohreh, 2008, Iran Biomed J, V12, P101; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Qu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029641; Schipke CG, 2004, GLIA, V47, P226, DOI 10.1002/glia.20029; Slezak M, 2003, TRENDS NEUROSCI, V26, P531, DOI 10.1016/j.tins.2003.08.005; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Verbich D, 2012, GLIA, V60, P1067, DOI 10.1002/glia.22335; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; ZIMMERMANN B, 1993, ANAT EMBRYOL, V187, P67	36	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e58996	10.1371/journal.pone.0058996	http://dx.doi.org/10.1371/journal.pone.0058996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634200	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400002
J	Valente, V; Serafim, RB; de Oliveira, LC; Adorni, FS; Torrieri, R; Tirapelli, DPD; Espreafico, EM; Oba-Shinjo, SM; Marie, SKN; Paco-Larson, ML; Carlotti, CG				Valente, Valeria; Serafim, Rodolfo Bortolozo; de Oliveira, Leonardo Cesar; Adorni, Fernando Soares; Torrieri, Raul; da Cunha Tirapelli, Daniela Pretti; Espreafico, Enilza Maria; Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue; Paco-Larson, Maria Luisa; Carlotti, Carlos Gilberto, Jr.			Modulation of HJURP (Holliday Junction-Recognizing Protein) Levels Is Correlated with Glioblastoma Cells Survival	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; CENP-A; BREAST-CANCER; BRAIN-TUMORS; SUBTYPES; GLIOMAS; SENSITIVITY; MULTIFORME; MUTATIONS; IDH1	Background: Diffuse astrocytomas are the most common type of primary brain cancer in adults. They present a wide variation in differentiation and aggressiveness, being classified into three grades: low-grade diffuse astrocytoma (grade II), anaplastic astrocytoma (grade III) and glioblastoma multiforme (grade IV), the most frequent and the major lethal type. Recent studies have highlighted the molecular heterogeneity of astrocytomas and demonstrated that large-scale analysis of gene expression could help in their classification and treatment. In this context, we previously demonstrated that HJURP, a novel protein involved in the repair of DNA double-strand breaks, is highly overexpressed in glioblastoma. Methodology/Principal Findings: Here we show that HJURP is remarkably overexpressed in a cohort composed of 40 patients with different grade astrocytomas. We also observed that tumors presenting the higher expression levels of HJURP are associated with poor survival prognosis, indicating HJURP overexpression as an independent prognostic factor of death risk for astrocytoma patients. More importantly, we found that HJURP knockdown strongly affects the maintenance of glioblastoma cells in a selective manner. Glioblastoma cells showed remarkable cell cycle arrest and premature senescence that culminated in elevated levels of cell death, differently from non-tumoral cells that were minimally affected. Conclusions: These data suggest that HJURP has an important role in the maintenance of extremely proliferative cells of high-grade gliomas and point to HJURP as a potential therapeutic target for the development of novel treatments for glioma patients.	[Valente, Valeria; Serafim, Rodolfo Bortolozo; de Oliveira, Leonardo Cesar; Adorni, Fernando Soares] Univ Sao Paulo State UNESP, Fac Pharmaceut Sci Araraquara, Dept Clin Anal, Araraquara, Brazil; [Valente, Valeria; Carlotti, Carlos Gilberto, Jr.] NAP USP, Ctr Integrat Syst Biol CISBi, Ribeirao Preto, Brazil; [Torrieri, Raul] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil; [da Cunha Tirapelli, Daniela Pretti; Carlotti, Carlos Gilberto, Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surg & Anat, Ribeirao Preto, Brazil; [Espreafico, Enilza Maria; Paco-Larson, Maria Luisa] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cellular & Mol Biol, Ribeirao Preto, Brazil; [Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue] Univ Sao Paulo, Fac Med, Dept Neurol, Ribeirao Preto, Brazil	Universidade Estadual Paulista; Hospital de Cancer de Barretos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Valente, V (corresponding author), Univ Sao Paulo State UNESP, Fac Pharmaceut Sci Araraquara, Dept Clin Anal, Araraquara, Brazil.	valenteval@gmail.com	Carlotti, Carlos G/C-1608-2012; Espreafico, Enilza/AAW-4658-2021; Oba-Shinjo, Sueli M./C-4017-2012; Espreafico, Enilza/O-3053-2016; Valente, Valeria/F-1301-2014; Paço-Larson, Maria L/I-8613-2012; Marie, Suely Kazue Nagahashi/D-1870-2012; Tirapelli, Daniela PC/F-9230-2012	Carlotti, Carlos G/0000-0002-7055-0564; Espreafico, Enilza/0000-0002-7552-4234; Oba-Shinjo, Sueli M./0000-0002-1650-5973; Espreafico, Enilza/0000-0002-7552-4234; Valente, Valeria/0000-0002-3942-7744; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Tirapelli, Daniela PC/0000-0002-1886-4988; Serafim, Rodolfo/0000-0002-8884-2303	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2004/12133-6, 2006/57602-9, 2011/05674-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [485342/2006-5, 154707/2006-6, 19347/2011]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA) do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA) do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was funded by the Brazilian governmental agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, #2004/12133-6), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, #485342/2006-5) and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA) do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto. This work has also been supported by fellowships from FAPESP (#2006/57602-9; #2011/05674-4), CNPq (#154707/2006-6; #19347/2011), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). EME, SMOS, SKNM, MLPL and CGC are CNPq fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; COX DR, 1982, BIOMETRICS, V38, P541, DOI 10.2307/2530040; de Tayrac M, 2011, CLIN CANCER RES, V17, P317, DOI 10.1158/1078-0432.CCR-10-1126; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Galante PAF, 2011, NUCLEIC ACIDS RES, V39, P6056, DOI 10.1093/nar/gkr221; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Heo JI, 2013, J GERONTOLOGY A; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09; Mishra PK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002303; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Petalidis LP, 2008, MOL CANCER THER, V7, P1013, DOI 10.1158/1535-7163.MCT-07-0177; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Roy K, 2006, BIOCHEM BIOPH RES CO, V344, P821, DOI 10.1016/j.bbrc.2006.03.222; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	31	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62200	10.1371/journal.pone.0062200	http://dx.doi.org/10.1371/journal.pone.0062200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638004	gold, Green Published, Green Submitted			2022-12-25	WOS:000318341400043
J	Cardenas-Mondragon, MG; Carreon-Talavera, R; Camorlinga-Ponce, M; Gomez-Delgado, A; Torres, J; Fuentes-Panana, EM				Cardenas-Mondragon, Maria G.; Carreon-Talavera, Ricardo; Camorlinga-Ponce, Margarita; Gomez-Delgado, Alejandro; Torres, Javier; Fuentes-Panana, Ezequiel M.			Epstein Barr Virus and Helicobacter pylori Co-Infection Are Positively Associated with Severe Gastritis in Pediatric Patients	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; INFECTIOUS-MONONUCLEOSIS; CAGA; DIAGNOSIS; MUCOSA; PATHOGENESIS; INFLAMMATION; ANTIBODIES; LYMPHOMA; CHILDREN	Background: H. pylori infection is acquired during childhood and causes a chronic inflammatory response in the gastric mucosa, which is considered the main risk factor to acquire gastric cancer (GC) later in life. More recently, infection by Epstein-Barr virus (EBV) have also been associated with GC. The role of EBV in early inflammatory responses and its relationship with H. pylori infection remains poorly studied. Here, we assessed whether EBV infection in children correlated with the stage of gastritis and whether co-infection with H. pylori affected the severity of inflammation. Methodology/Principal Findings: 333 pediatric patients with chronic abdominal pain were studied. From them, gastric biopsies were taken and inflammation graded according to the Sydney system; peripheral blood was drawn and antibodies against EBV (IgG and IgM anti-VCA) and H. pylori (IgG anti-whole bacteria and anti-CagA) were measured in sera. We found that children infected only by EBV presented mild mononuclear (MN) and none polymorphonuclear (PMN) cell infiltration, while those infected by H. pylori presented moderate MN and mild PMN. In contrast, patients co-infected with both pathogens were significantly associated with severe gastritis. Importantly, co-infection of H. pylori CagA+/EBV+ had a stronger association with severe MN (PR 3.0) and PMN (PR 7.2) cells than cases with single H. pylori CagA+ infection. Conclusions/Significance: Co-infection with EBV and H. pylori in pediatric patients is associated with severe gastritis. Even single infections with H. pylori CagA+ strains are associated with mild to moderate infiltration arguing for a cooperative effect of H. pylori and EBV in the gastric mucosa and revealing a critical role for EBV previously un-appreciated. This study points out the need to study both pathogens to understand the mechanism behind severe damage of the gastric mucosa, which could identified children with increased risk to present more serious lesions later in life.	[Cardenas-Mondragon, Maria G.; Carreon-Talavera, Ricardo; Camorlinga-Ponce, Margarita; Gomez-Delgado, Alejandro; Torres, Javier; Fuentes-Panana, Ezequiel M.] IMSS, CMN Siglo 21, Hosp Pediat, UIMEIP, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social	Fuentes-Panana, EM (corresponding author), IMSS, CMN Siglo 21, Hosp Pediat, UIMEIP, Mexico City, DF, Mexico.	empanana@yahoo.com	Fuentes-Pananá, Ezequiel/AAI-2856-2020	MARIA GUADALUPE, CARDENAS MONDRAGON/0000-0002-4089-6441; Fuentes-Panana, Ezequiel M./0000-0003-2872-0459	Fondo de Investigacion en Salud (FIS)-IMSS [FIS/IMSS/PROT/G2011/941]; CONACYT [178199, 69450]	Fondo de Investigacion en Salud (FIS)-IMSS; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was partially supported by grant FIS/IMSS/PROT/G2011/941 (to M.G. Cardenas-Mondragon) from the Fondo de Investigacion en Salud (FIS)-IMSS, and grants 178199 (to MGC-M) and 69450 (to J. Torres) from CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba S, 2008, CANCER SCI, V99, P195, DOI 10.1111/j.1349-7006.2007.00674.x; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Baumann M, 1998, J VIROL, V72, P8105, DOI 10.1128/JVI.72.10.8105-8114.1998; Brandt S, 2009, CELL MOTIL CYTOSKEL, V66, P874, DOI 10.1002/cm.20373; Camargo MC, 2011, BRIT J CANCER, V105, P38, DOI 10.1038/bjc.2011.215; Camorlinga-Ponce M, 2003, HELICOBACTER, V8, P554, DOI 10.1046/j.1523-5378.2003.00176.x; Camorlinga-Ponce M, 1998, AM J GASTROENTEROL, V93, P1264, DOI 10.1111/j.1572-0241.1998.00407.x; Camorlinga-Ponce M, 2008, CANCER EPIDEM BIOMAR, V17, P2498, DOI 10.1158/1055-9965.EPI-08-0289; Chang Mee Soo, 2005, Cancer Res Treat, V37, P257, DOI 10.4143/crt.2005.37.5.257; Chen LC, 2012, EMBO MOL MED, V4, P1276, DOI 10.1002/emmm.201201569; Chen ZME, 2007, AM J SURG PATHOL, V31, P1446, DOI 10.1097/PAS.0b013e318050072f; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fachiroh J, 2006, J CLIN MICROBIOL, V44, P1459, DOI 10.1128/JCM.44.4.1459-1467.2006; Faulkner GC, 1999, J VIROL, V73, P1555, DOI 10.1128/JVI.73.2.1555-1564.1999; Gu AD, 2008, J GEN VIROL, V89, P1152, DOI 10.1099/vir.0.83686-0; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Hirano Atsuyoshi, 2003, Int J Gastrointest Cancer, V34, P87, DOI 10.1385/IJGC:34:2-3:087; Hisamatsu A, 2010, INTERNAL MED, V49, P2101, DOI 10.2169/internalmedicine.49.3789; Kabir S, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2010.00812.x; Kitayama Y, 2000, GASTROINTEST ENDOSC, V52, P290, DOI 10.1067/mge.2000.107715; Lee HH, 2008, J GEN VIROL, V89, P878, DOI 10.1099/vir.0.83533-0; Li S, 2010, CHINESE MED J-PEKING, V123, P1201, DOI 10.3760/cma.j.issn.0366-6999.2010.09.018; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Owens SR, 2008, INT J SURG PATHOL; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; RecavarrenArce S, 1997, CLIN INFECT DIS, V25, P1006, DOI 10.1086/516080; Ryan JL, 2012, DIGEST DIS SCI, V57, P1887, DOI 10.1007/s10620-012-2116-5; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Sagaert X, 2010, NAT REV GASTRO HEPAT, V7, P336, DOI 10.1038/nrgastro.2010.58; SHIBATA D, 1992, AM J PATHOL, V140, P769; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Torres J, 1998, J INFECT DIS, V178, P1089, DOI 10.1086/515663; Yamamoto I, 1995, J CLIN GASTROENTEROL, V21, pS164; Zhang Q. B., 1998, Inflammopharmacology, V6, P109, DOI 10.1007/s10787-998-0028-y; Zhang YL, 2003, ARCH PATHOL LAB MED, V127, P478	38	60	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62850	10.1371/journal.pone.0062850	http://dx.doi.org/10.1371/journal.pone.0062850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638154	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400128
J	Gou, HF; Li, X; Qiu, M; Cheng, K; Li, LH; Dong, H; Chen, Y; Tang, Y; Gao, F; Zhao, F; Men, HT; Ge, J; Su, JM; Xu, F; Bi, F; Gao, JJ; Liu, JY				Gou, Hong-Feng; Li, Xiang; Qiu, Meng; Cheng, Ke; Li, Long-Hao; Dong, Hang; Chen, Ye; Tang, Yuan; Gao, Feng; Zhao, Feng; Men, Hai-Tao; Ge, Jun; Su, Jing-Mei; Xu, Feng; Bi, Feng; Gao, Jian-Jun; Liu, Ji-Yan			Epidermal Growth Factor Receptor (EGFR)-RAS Signaling Pathway in Penile Squamous Cell Carcinoma	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; TUMOR-SUPPRESSOR; PROMOTER METHYLATION; MUTATION STATUS; LUNG-CANCER; BRAF GENE; RASSF1A; HEAD; NECK; CETUXIMAB	Penile Squamous Cell Carcinoma (SCC) is a rare cancer with poor prognosis and limited response to conventional chemotherapy. The genetic and epigenetic alterations of Epidermal Growth Factor Receptor (EGFR)-RAS-RAF signaling in penile SCC are unclear. This study aims to investigate four key members of this pathway in penile SCC. We examined the expression of EGFR and RAS-association domain family 1 A (RASSF1A) as well as the mutation status of K-RAS and BRAF in 150 cases of penile SCC. EGFR and RASSF1A expression was evaluated by immunohistochemistry. KRAS mutations at codons 12 and 13, and the BRAF mutation at codon 600 were analyzed on DNA isolated from formalin fixed paraffin embedded tissues by direct genomic sequencing. EGFR expression was positive in all specimens, and its over-expression rate was 92%. RASSF1A expression rate was only 3.42%. Significant correlation was not found between the expression of EGFR or RASSF1A and tumor grade, pT stage or lymph node metastases. The detection of KRAS and BRAF mutations analysis was performed in 94 and 83 tumor tissues, respectively. We found KRAS mutation in only one sample and found no BRAF V600E point mutation. In summary, we found over-expression of EGFR in the majority cases of penile SCC, but only rare expression of RASSF1A, rare KRAS mutation, and no BRAF mutation in penile SCC. These data suggest that anti-EGFR agents may be potentially considered as therapeutic options in penile SCC.	[Gou, Hong-Feng; Qiu, Meng; Cheng, Ke; Li, Long-Hao; Dong, Hang; Chen, Ye; Gao, Feng; Zhao, Feng; Men, Hai-Tao; Ge, Jun; Su, Jing-Mei; Xu, Feng; Bi, Feng; Liu, Ji-Yan] Sichuan Univ, West China Hosp, West China Med Sch, State Key Lab Biotherapy,Canc Ctr,Dept Med Oncol, Chengdu 610064, Peoples R China; [Li, Xiang] Sichuan Univ, West China Hosp, West China Med Sch, Dept Urol, Chengdu 610064, Peoples R China; [Tang, Yuan] Sichuan Univ, West China Hosp, West China Med Sch, Dept Pathol, Chengdu 610064, Peoples R China; [Gao, Jian-Jun] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	Sichuan University; Sichuan University; Sichuan University; University of Texas System; UTMD Anderson Cancer Center	Gao, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	JGao1@mdanderson.org; liujiyan1972@163.com			National Natural Science Foundation of China [31070801, 81272457]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported partly by the National Natural Science Foundation of China (31070801 and 81272457). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2008, J UROLOGY, V179, P2030, DOI 10.1016/j.juro.2007.12.040; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Basavaraj C, 2010, CANCER BIOL THER, V10, P673, DOI 10.4161/cbt.10.7.12793; Borgermann C, 2009, UROLOGE, V48, P1483, DOI 10.1007/s00120-009-2101-6; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Carthon BC, 2010, ASCO M; Chen HX, 2009, CURR PROB CANCER, V33, P245, DOI 10.1016/j.currproblcancer.2009.10.002; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Culkin DJ, 2003, J UROLOGY, V170, P359, DOI 10.1097/01.ju.0000062829.43654.5e; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2001, ONCOGENE, V20, P3563, DOI 10.1038/sj.onc.1204469; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Lorenzo G, 2011, EUR UROL, V60, P1280, DOI 10.1016/j.eururo.2011.08.028; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; FRISCH M, 1995, BRIT MED J, V311, P1471, DOI 10.1136/bmj.311.7018.1471; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Goerner M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-8; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Kim DH, 2003, CANCER RES, V63, P6206; Kuzmin I, 2003, CANCER RES, V63, P1888; Kwong J, 2002, CLIN CANCER RES, V8, P131; Lavens N, 2010, CURR ONCOL, V17, P8; Le LH, 2005, AM J CLIN PATHOL, V124, P20, DOI 10.1309/X4UADHVN317V2XMW; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Peters I, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-49; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van Engeland M, 2002, ONCOGENE, V21, P3792, DOI 10.1038/sj.onc.1205466; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Weber A, 2003, ONCOGENE, V22, P4757, DOI 10.1038/sj.onc.1206705; Yanagawa N, 2008, PATHOL INT, V58, P477, DOI 10.1111/j.1440-1827.2008.02259.x	34	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62175	10.1371/journal.pone.0062175	http://dx.doi.org/10.1371/journal.pone.0062175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637996	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400081
J	Yan, W; Zhang, LL; Yan, L; Zhang, F; Yin, NB; Lin, HB; Huang, CY; Wang, L; Yu, J; Wang, DM; Zhao, ZM				Yan, Wei; Zhang, Li-Li; Yan, Li; Zhang, Feng; Yin, Ning-Bei; Lin, Hong-Bin; Huang, Chen-Yu; Wang, Lei; Yu, Jun; Wang, Duen-Mei; Zhao, Zhen-Min			Transcriptome Analysis of Skin Photoaging in Chinese Females Reveals the Involvement of Skin Homeostasis and Metabolic Changes	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-VIVO; MITOCHONDRIAL-DNA; BETA/SMAD PATHWAY; GENE-EXPRESSION; MECHANISMS; SYSTEM; MODULATION; RADIATION; COLLAGEN	Background: Photoaging is cumulative damage to skin, caused by chronic, repeated solar radiation exposure. Its molecular mechanisms are poorly understood at the level of global gene expression. Objective: This study set out to uncover genes and functional modules involved in photoaging at the level of transcription, with the use of skin samples from Chinese women. Methods: Using the Illumina microarray platform, we compared the genome-wide expression profiles of 21 pairs of sun-exposed pre-auricular and sun-protected post-auricular skin samples from northern Chinese women. Results: With microarray analysis, 1,621 significantly regulated genes due to photoaging were identified from skin samples. These genes were subjected to functional enrichment analyses with both the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) annotation databases. As revealed by the functional analyses, the up-regulated functional modules in sun-exposed pre-auricular skin were related to various cellular activities in regulation of the skin homeostasis (e. g., the KEGG pathways TGF-beta signaling pathway and ECM-receptor interaction), whereas the down-regulated functional modules were mostly metabolic-related. Additionally, five selected genes (HOXA5, LEPR, CLDN5, LAMC3, and CGA) identified as differentially-expressed were further confirmed by quantitative real-time PCR (Q-RT-PCR). Conclusion: Our findings suggest that disruption of skin homeostasis and down-regulation of skin metabolism may play important roles in the process of photoaging.	[Yan, Wei; Yan, Li; Yin, Ning-Bei; Zhao, Zhen-Min] Chinese Acad Med Sci, Plast Surg Hosp, Beijing 100730, Peoples R China; [Yan, Wei; Yan, Li; Yin, Ning-Bei; Zhao, Zhen-Min] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Li-Li; Zhang, Feng; Lin, Hong-Bin; Wang, Lei; Yu, Jun; Wang, Duen-Mei] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhang, Li-Li] Univ Chinese Acad Sci, Beijing, Peoples R China; [Huang, Chen-Yu] China Meitan Gen Hosp, Beijing, Peoples R China; [Zhao, Zhen-Min] Peoples Hosp Jincheng City, Jincheng, Shanxi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, DM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China.	dmwang@usa.net; zhenminzhao123@126.com	Huang, Chenyu/I-4410-2018; HUANG, CHENYU/GVT-7299-2022	Huang, Chenyu/0000-0001-9521-5650; 	100 Talents Program of the Chinese Academy of Sciences	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by 100 Talents Program of the Chinese Academy of Sciences to DMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berneburg M, 2005, J INVEST DERMATOL, V125, P213, DOI 10.1111/j.0022-202X.2005.23806.x; Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Chung JH, 2002, J INVEST DERMATOL, V119, P507, DOI 10.1046/j.1523-1747.2002.01844.x; Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Han KH, 2005, MECH AGEING DEV, V126, P560, DOI 10.1016/j.mad.2004.11.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacobson EL, 2001, J PHOTOCH PHOTOBIO B, V63, P141, DOI 10.1016/S1011-1344(01)00211-1; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Jungersted JM, 2008, CONTACT DERMATITIS, V58, P255, DOI 10.1111/j.1600-0536.2008.01320.x; Kambayashi H, 2001, J DERMATOL SCI, V27, pS19; Kim EJ, 2010, J DERMATOL SCI, V57, P19, DOI 10.1016/j.jdermsci.2009.10.008; Knott A, 2009, BIOGERONTOLOGY, V10, P181, DOI 10.1007/s10522-008-9165-3; Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Puizina-Ivic N, 2008, ACTA DERMATOVEN ALP, V17, P47; Quan T, 2002, J INVEST DERMATOL, V119, P499, DOI 10.1046/j.1523-1747.2002.01834.x; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; Quan TH, 2001, J BIOL CHEM, V276, P26349, DOI 10.1074/jbc.M010835200; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Robinson MK, 2009, J DRUGS DERMATOL, V8, pS8; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; Slominski A., 2008, DRUG DISCOV TODAY DI, V5, pe137; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, pvii, Patent No. 22894052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Urschitz J, 2002, J INVEST DERMATOL, V119, P3, DOI 10.1046/j.1523-1747.2002.01829.x; Wilson MMG, 2003, J APPL PHYSIOL, V95, P1728, DOI 10.1152/japplphysiol.00313.2003; Yaar M, 1998, J Investig Dermatol Symp Proc, V3, P47; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	42	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61946	10.1371/journal.pone.0061946	http://dx.doi.org/10.1371/journal.pone.0061946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637934	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400059
J	Loureiro, J; Sandoval, P; del Peso, G; Gonzalez-Mateo, G; Fernandez-Millara, V; Santamaria, B; Bajo, MA; Sanchez-Tomero, JA; Guerra-Azcona, G; Selgas, R; Lopez-Cabrera, M; Aguilera, AI				Loureiro, Jesus; Sandoval, Pilar; del Peso, Gloria; Gonzalez-Mateo, Guadalupe; Fernandez-Millara, Vanessa; Santamaria, Beatriz; Auxiliadora Bajo, Maria; Antonio Sanchez-Tomero, Jose; Guerra-Azcona, Gonzalo; Selgas, Rafael; Lopez-Cabrera, Manuel; Aguilera, Abelardo I.			Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis	PLOS ONE			English	Article							SCLEROSING ENCAPSULATING PERITONITIS; IN-VITRO; MYOFIBROBLASTIC CONVERSION; CELLS; ESTROGEN; MECHANISMS; PROTECTS; FAILURE; INTACT; MICE	Mesothelial-to-mesenchymal transition (MMT) is an auto-regulated physiological process of tissue repair that in uncontrolled conditions such as peritoneal dialysis (PD) can lead to peritoneal fibrosis. The maximum expression of peritoneal fibrosis induced by PD fluids and other peritoneal processes is the encapsulating peritoneal sclerosis (EPS) for which no specific treatment exists. Tamoxifen, a synthetic estrogen, has successfully been used to treat retroperitoneal fibrosis and EPS associated with PD. Hence, we used in vitro and animal model approaches to evaluate the efficacy of Tamoxifen to inhibit the MMT as a trigger of peritoneal fibrosis. In vitro studies were carried out using omentum-derived mesothelial cells (MCs) and effluent-derived MCs. Tamoxifen blocked the MMT induced by transforming growth factor (TGF)-beta 1, as it preserved the expression of E-cadherin and reduced the expression of mesenchymal-associated molecules such as snail, fibronectin, collagen-I, alpha-smooth muscle actin, and matrix metalloproteinse-2. Tamoxifen-treatment preserved the fibrinolytic capacity of MCs treated with TGF-beta 1 and decreased their migration capacity. Tamoxifen did not reverse the MMT of non-epitheliod MCs from effluents, but it reduced the expression of some mesenchymal molecules. In mice PD model, we demonstrated that MMT progressed in parallel with peritoneal membrane thickness. In addition, we observed that Tamoxifen significantly reduced peritoneal thickness, angiogenesis, invasion of the compact zone by mesenchymal MCs and improved peritoneal function. Tamoxifen also reduced the effluent levels of vascular endothelial growth factor and leptin. These results demonstrate that Tamoxifen is a therapeutic option to treat peritoneal fibrosis, and that its protective effect is mediated via modulation of the MMT process.	[Loureiro, Jesus; Sandoval, Pilar; Lopez-Cabrera, Manuel] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [del Peso, Gloria; Gonzalez-Mateo, Guadalupe; Fernandez-Millara, Vanessa; Auxiliadora Bajo, Maria; Selgas, Rafael] Hosp Univ La Paz, Inst Invest Sanitaria La Paz IdiPAZ, Serv Nefrol, Madrid, Spain; [Santamaria, Beatriz] Fdn Jimenez Diaz, Unidad Dialisis, E-28040 Madrid, Spain; [Santamaria, Beatriz] Fdn Jimenez Diaz, Lab Invest Renal & Vasc, E-28040 Madrid, Spain; [Antonio Sanchez-Tomero, Jose; Aguilera, Abelardo I.] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IP, Unidad Biol Mol, Madrid, Spain; [Antonio Sanchez-Tomero, Jose; Aguilera, Abelardo I.] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IP, Serv Nefrol, Madrid, Spain; [Guerra-Azcona, Gonzalo] Hosp Quiron San Camilo, Serv Cirugia, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario La Paz	Aguilera, AI (corresponding author), Hosp Univ Princesa, Inst Invest Sanitaria Princesa IP, Unidad Biol Mol, Madrid, Spain.	abelardo.aguilera@salud.madrid.org	González-Mateo, Guadalupe T/G-2551-2016; Santamaria, Beatriz/B-3469-2015; Sandoval, Pilar/GVS-6463-2022; Cabrera, Manuel López/AAA-5463-2019; González-Mateo, Guadalupe Tirma/AAS-5509-2021; SANCHEZ TOMERO, JOSE ANTONIO/Q-9346-2017; Bajo, Maria A/ABF-6991-2020	González-Mateo, Guadalupe T/0000-0002-8144-904X; Santamaria, Beatriz/0000-0002-1990-2106; Sandoval, Pilar/0000-0002-5893-7037; González-Mateo, Guadalupe Tirma/0000-0002-8144-904X; Bajo, Maria A/0000-0001-7364-557X; Lopez Cabrera, Manuel/0000-0002-0976-9719; Loureiro, Jesus/0000-0003-4307-1303	"Ministerio de Economia y Competitividad" [SAF2010-21249]; "Comunidad Autonoma de Madrid" [S2010/BMD-2321]; "Fondo de Investigaciones Sanitarias" [PI 09/0776]; REDinREN, Fondos FEDER, EU [RETICS 06/0016]	"Ministerio de Economia y Competitividad"(Spanish Government); "Comunidad Autonoma de Madrid"(Comunidad de Madrid); "Fondo de Investigaciones Sanitarias"(Instituto de Salud Carlos III); REDinREN, Fondos FEDER, EU	This work was supported by grant SAF2010-21249 from the "Ministerio de Economia y Competitividad" to MLC and by grant S2010/BMD-2321 from "Comunidad Autonoma de Madrid" to MLC and RS. This work was also partially supported by grants PI 09/0776 from "Fondo de Investigaciones Sanitarias" to AA, and RETICS 06/0016 (REDinREN, Fondos FEDER, EU) to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera Abelardo, 2005, Curr Opin Investig Drugs, V6, P262; Allaria PM, 1999, J NEPHROL, V12, P395; Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Balasubramaniam G, 2009, NEPHROL DIAL TRANSPL, V24, P3209, DOI 10.1093/ndt/gfp008; Blackwell KL, 2000, CLIN CANCER RES, V6, P4359; Cakmak A, 2005, AM J OBSTET GYNECOL, V193, P347, DOI 10.1016/j.ajog.2005.01.023; Christodoulakos GE, 2006, ANN NY ACAD SCI, V1092, P374, DOI 10.1196/annals.1365.034; CLARK CP, 1991, SURGERY, V109, P502; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; del Peso Gloria, 2003, Adv Perit Dial, V19, P32; Delle H, 2012, J AM SOC NEPHROL, V23, P37, DOI 10.1681/ASN.2011010046; Devuyst O, 2010, J AM SOC NEPHROL, V21, P1077, DOI 10.1681/ASN.2009070694; Dhandapani KM, 2003, ENDOCRINE, V21, P59, DOI 10.1385/ENDO:21:1:59; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Hashimoto M, 1997, BIOCHEM BIOPH RES CO, V240, P464, DOI 10.1006/bbrc.1997.7681; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hozumi Y, 2005, GYNECOL OBSTET INVES, V59, P70, DOI 10.1159/000082111; Huang JW, 2011, BLOOD PURIFICAT, V31, P252, DOI 10.1159/000322255; ISSANDOU M, 1990, CANCER RES, V50, P5845; Justo P, 2003, J AM SOC NEPHROL, V14, P3072, DOI 10.1097/01.ASN.0000099383.57934.0E; Kawanishi H, 2005, INT J ARTIF ORGANS, V28, P150, DOI 10.1177/039139880502800211; Korte MR, 2011, NEPHROL DIAL TRANSPL, V26, P691, DOI 10.1093/ndt/gfq362; Krediet RT, 2000, PERITON DIALYSIS INT, V20, pS19; Leung JCK, 2006, KIDNEY INT, V69, P2078, DOI 10.1038/sj.ki.5000409; Lopez-Cabrera M, 2006, PERITON DIALYSIS INT, V26, P26; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Mele T, 2010, BREAST CANCER RES TR, V123, P795, DOI 10.1007/s10549-010-1063-0; Nomoto Y, 1996, AM J KIDNEY DIS, V28, P420, DOI 10.1016/S0272-6386(96)90501-6; Park WC, 2002, TRENDS MOL MED, V8, P82, DOI 10.1016/S1471-4914(02)02282-7; Reckless J, 1997, CIRCULATION, V95, P1542; Sandoval P, 2010, LAB INVEST, V90, P1517, DOI 10.1038/labinvest.2010.111; Selgas R, 2000, PERITON DIALYSIS INT, V20, P595; Shao ZM, 2000, CANCER LETT, V157, P133, DOI 10.1016/S0304-3835(00)00466-3; Sourla A, 1997, ENDOCRINOLOGY, V138, P5605, DOI 10.1210/en.138.12.5605; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Tanos V, 2002, EUR J OBSTET GYN R B, V102, P188, DOI 10.1016/S0301-2115(01)00582-6; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Yang AH, 2007, NEPHROL DIAL TRANSPL, V22, P756, DOI 10.1093/ndt/gfl715; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433	43	44	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61165	10.1371/journal.pone.0061165	http://dx.doi.org/10.1371/journal.pone.0061165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637793	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400028
J	Khayatt, BI; Overmars, L; Siezen, RJ; Francke, C				Khayatt, Barzan I.; Overmars, Lex; Siezen, Roland J.; Francke, Christof			Classification of the Adenylation and Acyl-Transferase Activity of NRPS and PKS Systems Using Ensembles of Substrate Specific Hidden Markov Models	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; POLYKETIDE SYNTHASES; NATURAL-PRODUCTS; BIOSYNTHESIS; PREDICTION; SEQUENCE; ANTIBIOTICS; ORGANIZATION; RECOGNITION; MECHANISMS	There is a growing interest in the Non-ribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs) of microbes, fungi and plants because they can produce bioactive peptides such as antibiotics. The ability to identify the substrate specificity of the enzyme's adenylation (A) and acyl-transferase (AT) domains is essential to rationally deduce or engineer new products. We here report on a Hidden Markov Model (HMM)-based ensemble method to predict the substrate specificity at high quality. We collected a new reference set of experimentally validated sequences. An initial classification based on alignment and Neighbor Joining was performed in line with most of the previously published prediction methods. We then created and tested single substrate specific HMMs and found that their use improved the correct identification significantly for A as well as for AT domains. A major advantage of the use of HMMs is that it abolishes the dependency on multiple sequence alignment and residue selection that is hampering the alignment-based clustering methods. Using our models we obtained a high prediction quality for the substrate specificity of the A domains similar to two recently published tools that make use of HMMs or Support Vector Machines (NRPSsp and NRPS predictor2, respectively). Moreover, replacement of the single substrate specific HMMs by ensembles of models caused a clear increase in prediction quality. We argue that the superiority of the ensemble over the single model is caused by the way substrate specificity evolves for the studied systems. It is likely that this also holds true for other protein domains. The ensemble predictor has been implemented in a simple web-based tool that is available at http://www.cmbi.ru.nl/NRPS-PKS-substrate-predictor/.	[Khayatt, Barzan I.; Overmars, Lex; Siezen, Roland J.; Francke, Christof] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Overmars, Lex; Siezen, Roland J.; Francke, Christof] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [Siezen, Roland J.; Francke, Christof] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Siezen, Roland J.; Francke, Christof] TI Food & Nutr, Wageningen, Netherlands	Radboud University Nijmegen; Top Institute Food & Nutrition	Francke, C (corresponding author), Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	c.francke@cmbi.ru.nl	Francke, C/AAW-2402-2021; Siezen, Roland J/P-5745-2015		City Nijmegen-The Netherlands (Gemeente Nijmegen)	City Nijmegen-The Netherlands (Gemeente Nijmegen)	This work was supported by the City Nijmegen-The Netherlands (Gemeente Nijmegen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Baker DD, 2007, NAT PROD REP, V24, P1225, DOI 10.1039/b602241n; Barbier J, 2012, ANGEW CHEM INT EDIT, V51, P1256, DOI 10.1002/anie.201106435; Behnken S, 2012, APPL MICROBIOL BIOT, V96, P61, DOI 10.1007/s00253-012-4285-8; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; COSMINA P, 1993, MOL MICROBIOL, V8, P821, DOI 10.1111/j.1365-2958.1993.tb01629.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; deCrecyLagard V, 1997, ANTIMICROB AGENTS CH, V41, P1904, DOI 10.1128/AAC.41.9.1904; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eustaquio AS, 2009, P NATL ACAD SCI USA, V106, P12295, DOI 10.1073/pnas.0901237106; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Galm U, 2009, MOL BIOSYST, V5, P77, DOI 10.1039/b814075h; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Husi H, 1997, FEBS LETT, V414, P532, DOI 10.1016/S0014-5793(97)01064-8; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Khosla C, 2009, J ORG CHEM, V74, P6416, DOI 10.1021/jo9012089; Kopp M, 2011, MOL BIOSYST, V7, P1549, DOI 10.1039/c0mb00240b; Lautru S, 2004, MICROBIOL-SGM, V150, P1629, DOI 10.1099/mic.0.26837-0; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; Llewellyn NM, 2007, NATURE, V448, P755, DOI 10.1038/448755a; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099; Prieto C, 2012, BIOINFORMATICS, V28, P426, DOI 10.1093/bioinformatics/btr659; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Ridley CP, 2008, P NATL ACAD SCI USA, V105, P4595, DOI 10.1073/pnas.0710107105; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Siezen RJ, 2008, MICROB BIOTECHNOL, V1, P275, DOI 10.1111/j.1751-7915.2008.00044.x; Sprote P, 2008, MOL MICROBIOL, V70, P445, DOI 10.1111/j.1365-2958.2008.06422.x; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Steller S, 1999, CHEM BIOL, V6, P31, DOI 10.1016/S1074-5521(99)80018-0; Tae H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-327; TURGAY K, 1992, MOL MICROBIOL, V6, P2743, DOI 10.1111/j.1365-2958.1992.tb01451.x; Valerio E, 2010, TOXINS, V2, P2359, DOI 10.3390/toxins2102359; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Wakimoto T, 2011, J AM CHEM SOC, V133, P4746, DOI 10.1021/ja2006737; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020; Wong FT, 2012, CURR OPIN CHEM BIOL, V16, P117, DOI 10.1016/j.cbpa.2012.01.018; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8	57	58	59	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62136	10.1371/journal.pone.0062136	http://dx.doi.org/10.1371/journal.pone.0062136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637983	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700079
J	Condello, S; Cao, LY; Matei, D				Condello, Salvatore; Cao, Liyun; Matei, Daniela			Tissue transglutaminase regulates beta-catenin signaling through a c-Src-dependent mechanism	FASEB JOURNAL			English	Article						EMT; Wnt signaling; beta-integrin; fibronectin	BREAST-CANCER CELLS; FACTOR-KAPPA-B; OVARIAN-CANCER; WNT/BETA-CATENIN; STEM-CELLS; TYROSINE PHOSPHORYLATION; COLORECTAL-CANCER; INDUCED APOPTOSIS; GENE-EXPRESSION; ACTIVATION	Tissue transglutaminase (TG2) is a multifunctional enzyme involved in protein cross-linking and cell adhesion to fibronectin (FN). In cancer, TG2 induces an epithelial to mesenchymal transition, contributing to metastasis. Because cadherins bind -catenin at cell-cell junctions, disruption of adherens junctions destabilizes cadherin-catenin complexes. The goal of the present study was to analyze whether and how TG2 interacts with and regulates -catenin signaling in ovarian cancer (OC) cells. We observed a significant correlation between TG2 and -catenin expression levels in OC cells and tumors. TG2 augmented Wnt/-catenin signaling, as evidenced by enhanced -catenin transcriptional activity, inducing transcription of target genes cyclin D1 and c-Myc. By promoting integrin-mediated cell adhesion to FN, TG2 physically associates with and recruits c-Src, which in turn phosphorylates -catenin at Tyr(654), releasing it from E-cadherin and rendering it available for transcriptional regulation. By interacting with FN and enhancing -catenin signaling, complexed TG2 stimulates OC cell proliferation. In summary, our data demonstrate that TG2 regulates -catenin expression and function in OC cells and define the c-Src-dependent mechanism through which this occurs.	[Condello, Salvatore; Cao, Liyun; Matei, Daniela] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ Sch Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ Sch Med, Vet Affairs Roudebush Hosp, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Matei, D (corresponding author), Indiana Univ Simon Canc Ctr, 535 Barnhill Dr,RT 473, Indianapolis, IN 46202 USA.	salvcond@iupui.edu; dmatei@iupui.edu	Condello, Salvatore/ABB-6743-2021	Matei, Daniela/0000-0003-2169-5035; Condello, Salvatore/0000-0003-4979-3681	U.S. Department of Veterans Affairs; American Cancer Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Janusz Tucholski (University of Alabama, Birmingham, AL, USA), Dr. Harikrishna Nakshatri (Indiana University School of Medicine, Indianapolis, IN, USA), and Dr. Alexey M. Belkin (University of Maryland, Baltimore, MD, USA) for reagents; Dr. Susan Perkins for assistance with statistical analyses; and Dr. David Donner for helpful comments. This work was supported by the U.S. Department of Veterans Affairs through a merit award and the American Cancer Society through a research scholar grant (to D.M.).	Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Antonyak MA, 2004, J BIOL CHEM, V279, P41461, DOI 10.1074/jbc.M404976200; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Chau WK, 2012, ONCOGENE, DOI 10.1038/onc.2012.290; Chen SH, 1996, J BIOL CHEM, V271, P32385, DOI 10.1074/jbc.271.50.32385; Chen X, 2010, ONCOTARGET, V1, P210, DOI 10.18632/oncotarget.127; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Karni R, 2005, MOL CELL BIOL, V25, P5031, DOI 10.1128/MCB.25.12.5031-5039.2005; KASUGAI S, 1990, JPN J PHARMACOL, V52, P95, DOI 10.1254/jjp.52.95; Kumar A, 2011, PLOS ONE, V6; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; PINCUS JH, 1968, ARCH BIOCHEM BIOPHYS, V126, P44, DOI 10.1016/0003-9861(68)90557-2; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Schmid S, 2011, INT J GYNECOL CANCER, V21, P975, DOI 10.1097/IGC.0b013e31821caa6f; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Shedden KA, 2005, CLIN CANCER RES, V11, P2123, DOI 10.1158/1078-0432.CCR-04-2061; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6; Usongo M, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-17; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Verma A, 2007, CURR CANCER DRUG TAR, V7, P559, DOI 10.2174/156800907781662275; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wu R, 2001, CANCER RES, V61, P8247; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177; Zhang XL, 2010, NEOPLASMA, V57, P545, DOI 10.4149/neo_2010_06_545	51	33	34	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3100	3112		10.1096/fj.12-222620	http://dx.doi.org/10.1096/fj.12-222620			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23640056	Green Published			2022-12-25	WOS:000329877600017
J	Hawkins, BE; Krishnamurthy, S; Castillo-Carranza, DL; Sengupta, U; Prough, DS; Jackson, GR; DeWitt, DS; Kayed, R				Hawkins, Bridget E.; Krishnamurthy, Shashirekha; Castillo-Carranza, Diana L.; Sengupta, Urmi; Prough, Donald S.; Jackson, George R.; DeWitt, Douglas S.; Kayed, Rakez			Rapid Accumulation of Endogenous Tau Oligomers in a Rat Model of Traumatic Brain Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; POSTTRAUMATIC EPILEPSY; PHOSPHORYLATION SITES; NEURONAL LOSS; MOUSE MODEL; HEAD-INJURY; IN-VITRO; TAUOPATHY	Traumatic brain injury (TBI) is a serious problem that affects millions of people in the United States alone. Multiple concussions or even a single moderate to severe TBI can also predispose individuals to develop a pathologically distinct form of tauopathy- related dementia at an early age. No effective treatments are currently available for TBI or TBI-related dementia; moreover, only recently has insight been gained regarding the mechanisms behind their connection. Here, we used antibodies to detect oligomeric and phosphorylated Tau proteins in a non-transgenic rodent model of parasagittal fluid percussion injury. Oligomeric and phosphorylated Tau proteins were detected 4 and 24 h and 2 weeks post-TBI in injured, but not sham control rats. These findings suggest that diagnostic tools and therapeutics that target only toxic forms of Tau may provide earlier detection and safe, more effective treatments for tauopathies associated with repetitive neurotrauma.	[Hawkins, Bridget E.; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Hawkins, Bridget E.; Prough, Donald S.; DeWitt, Douglas S.] Univ Texas Med Branch, Moody Ctr Traumat Brain & Spinal Cord Injury Res, Galveston, TX 77555 USA; [Hawkins, Bridget E.; Prough, Donald S.; DeWitt, Douglas S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Krishnamurthy, Shashirekha; Castillo-Carranza, Diana L.; Sengupta, Urmi; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Krishnamurthy, Shashirekha; Castillo-Carranza, Diana L.; Sengupta, Urmi; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Krishnamurthy, Shashirekha; Castillo-Carranza, Diana L.; Sengupta, Urmi; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, George & Cynthia Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kayed, R (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	rakayed@utmb.edu	Prough, Donald S/G-5793-2013; Hawkins, Bridget/H-4933-2015	Prough, Donald S/0000-0001-7994-532X; Hawkins, Bridget/0000-0002-1887-3657; Castillo-Carranza, Diana/0000-0003-2511-949X	Cullen Family Trust for Health Care, the Mitchell Center for Neurodegenerative Diseases; Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect	Cullen Family Trust for Health Care, the Mitchell Center for Neurodegenerative Diseases; Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect	This work was supported by the Cullen Family Trust for Health Care, the Mitchell Center for Neurodegenerative Diseases, and the Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect. R.K. has patent applications on the compositions and methods related to Tau oligomers and antibodies.	Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Castillo-Carranza D. L., 2010, SOC NEUROSCI; Castillo-Carranza Diana L, 2013, Front Biosci (Schol Ed), V5, P426; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOLDSTEIN LE, 2012, SCI TRANSL MED, V4; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hall GF, 2012, PRION, V6, P223, DOI 10.4161/pri.19912; Haroutunian V, 2007, NEUROBIOL AGING, V28, P1, DOI 10.1016/j.neurobiolaging.2005.11.001; Hawkins BE, 2012, BRAIN RES, V1432, P28, DOI 10.1016/j.brainres.2011.11.009; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Henkins KM, 2012, BRAIN PATHOL, V22, P826, DOI 10.1111/j.1750-3639.2012.00598.x; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kril JJ, 2002, ACTA NEUROPATHOL, V103, P370, DOI 10.1007/s00401-001-0477-5; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Le Meghan N, 2012, Am J Neurodegener Dis, V1, P316; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Schneider A, 2008, NEUROTHERAPEUTICS, V5, P443, DOI 10.1016/j.nurt.2008.05.006; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Ubhi K, 2011, EXP NEUROL, V230, P157, DOI 10.1016/j.expneurol.2010.10.007; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528	63	99	102	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					17042	17050		10.1074/jbc.M113.472746	http://dx.doi.org/10.1074/jbc.M113.472746			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23632019	Green Published, hybrid			2022-12-25	WOS:000320378900075
J	Akinyemiju, TF; Soliman, AS; Copeland, G; Banerjee, M; Schwartz, K; Merajver, SD				Akinyemiju, Tomi F.; Soliman, Amr S.; Copeland, Glenn; Banerjee, Mousumi; Schwartz, Kendra; Merajver, Sofia D.			Trends in Breast Cancer Stage and Mortality in Michigan (1992-2009) by Race, Socioeconomic Status, and Area Healthcare Resources	PLOS ONE			English	Article							ETHNIC DISPARITIES; RACIAL DISPARITIES; UNITED-STATES; RISK-FACTORS; FOLLOW-UP; WOMEN; BLACK; SURVIVAL; DIAGNOSIS; ACCESS	The long-term effect of socioeconomic status (SES) and healthcare resources availability (HCA) on breast cancer stage of presentation and mortality rates among patients in Michigan is unclear. Using data from the Michigan Department of Community Health (MDCH) between 1992 and 2009, we calculated annual proportions of late-stage diagnosis and age-adjusted breast cancer mortality rates by race and zip code in Michigan. SES and HCA were defined at the zip-code level. Joinpoint regression was used to compare the Average Annual Percent Change (AAPC) in the median zip-code level percent late stage diagnosis and mortality rate for blacks and whites and for each level of SES and HCA. Between 1992 and 2009, the proportion of late stage diagnosis increased among white women [AAPC = 1.0 (0.4, 1.6)], but was statistically unchanged among black women [AAPC = -0.5 (-1.9, 0.8)]. The breast cancer mortality rate declined among whites [AAPC = -1.3% (-1.8,-0.8)], but remained statistically unchanged among blacks [AAPC = -0.3% (-0.3, 1.0)]. In all SES and HCA area types, disparities in percent late stage between blacks and whites appeared to narrow over time, while the differences in breast cancer mortality rates between blacks and whites appeared to increase over time.	[Akinyemiju, Tomi F.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Soliman, Amr S.] Univ Nebraska, Sch Publ Hlth, Dept Epidemiol, Omaha, NE 68182 USA; [Copeland, Glenn] Michigan Dept Community Hlth, Michigan Canc Surveillance Program, Lansing, MI USA; [Banerjee, Mousumi] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Schwartz, Kendra] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Schwartz, Kendra] Wayne State Univ, Sch Med, Barbara Ann Karmanos Inst, Detroit, MI USA; [Merajver, Sofia D.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Merajver, Sofia D.] Univ Michigan, Ctr Global Hlth, Ann Arbor, MI 48109 USA	Columbia University; University of Nebraska System; MDHHS - Michigan Department of Health & Human Services; University of Michigan System; University of Michigan; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Akinyemiju, TF (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	ofa2107@columbia.edu			University of Michigan Graduate School; University of Michigan Department of Epidemiology block grant	University of Michigan Graduate School; University of Michigan Department of Epidemiology block grant	Funding for this research was provided by the University of Michigan Graduate School and the University of Michigan Department of Epidemiology block grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2008, PATIENT EDUC COUNS, V72, P283, DOI 10.1016/j.pec.2008.03.024; Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Ansell D, 2009, CANCER CAUSE CONTROL, V20, P1681, DOI 10.1007/s10552-009-9419-7; Banerjee M, 2007, CANCER-AM CANCER SOC, V110, P2169, DOI 10.1002/cncr.23026; Baquet CR, 2008, J NATL MED ASSOC, V100, P480, DOI 10.1016/S0027-9684(15)31294-3; Benjamins MR, 2004, PREV MED, V39, P704, DOI 10.1016/j.ypmed.2004.02.039; Bickell NA, 2006, J CLIN ONCOL, V24, P1357, DOI 10.1200/JCO.2005.04.5799; Bradley CJ, 2008, INQUIRY-J HEALTH CAR, V45, P323, DOI 10.5034/inquiryjrnl_45.03.323; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Celaya MO, 2010, RURAL REMOTE HEALTH, V10; Chu KC, 1996, JNCI-J NATL CANCER I, V88, P1571, DOI 10.1093/jnci/88.21.1571; Coburn N, 2008, BREAST J, V14, P128, DOI 10.1111/j.1524-4741.2007.00542.x; Coughlin SS, 2008, SOC SCI MED, V66, P260, DOI 10.1016/j.socscimed.2007.09.009; Coughlin Steven S, 2009, Open Health Serv Policy J, V2, P45; Dai DJ, 2010, HEALTH PLACE, V16, P1038, DOI 10.1016/j.healthplace.2010.06.012; DeLancey JOL, 2008, CANCER EPIDEM BIOMAR, V17, P2908, DOI 10.1158/1055-9965.EPI-08-0131; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Du XL, 2011, CANCER, V117, P3242; Dunn BK, 2010, BREAST CANCER RES TR, V121, P281, DOI 10.1007/s10549-010-0827-x; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Farmer D, 2007, ONCOL NURS FORUM, V34, P117, DOI 10.1188/07.ONF.117-123; Farmer MM, 2005, SOC SCI MED, V60, P191, DOI 10.1016/j.socscimed.2004.04.026; Harper S, 2009, CANCER EPIDEM BIOMAR, V18, P121, DOI 10.1158/1055-9965.EPI-08-0679; Hirschman J, 2007, CANCER CAUSE CONTROL, V18, P323, DOI 10.1007/s10552-006-0102-y; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; KANG SH, 1993, J NATL CANCER I, V85, P737, DOI 10.1093/jnci/85.9.737; Keegan THM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-603; Kim SH, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-26; Krieger N, 2005, CANCER CAUSE CONTROL, V16, P5, DOI 10.1007/s10552-004-1251-5; Krieger N, 2006, CANCER CAUSE CONTROL, V17, P217, DOI 10.1007/s10552-005-0408-1; Krieger N, 2012, CANCER CAUSE CONTROL, V23, P297, DOI 10.1007/s10552-011-9879-4; Krieger N, 2010, AM J PUBLIC HEALTH, V100, pS132, DOI 10.2105/AJPH.2009.181628; Masi CM, 2005, MED CLIN N AM, V89, P753, DOI 10.1016/j.mcna.2005.02.004; McKenzie F, 2010, CANCER EPIDEMIOL, V34, P702, DOI 10.1016/j.canep.2010.07.007; Meliker JR, 2009, CANCER-AM CANCER SOC, V115, P2212, DOI 10.1002/cncr.24251; Menashe I, 2009, J NATL CANCER I, V101, P993, DOI 10.1093/jnci/djp176; Michigan Public Health Institute and Michigan Department of Community Health, 2011, CANC BURD MICH SEL S; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pisu M, 2010, J HEALTH CARE POOR U, V21, P961, DOI 10.1353/hpu.0.0346; Ricciardi R, 2011, DIS COLON RECTUM, V54, P207, DOI 10.1007/DCR.0b013e3181fb8903; Robert SA, 2004, EPIDEMIOLOGY, V15, P442, DOI 10.1097/01.ede.0000129512.61698.03; Robert SA, 2006, J GERONTOL B-PSYCHOL, V61, pS203, DOI 10.1093/geronb/61.4.S203; Schootman M, 2010, BREAST CANCER RES TR, V122, P533, DOI 10.1007/s10549-009-0729-y; Schootman M, 2010, CANCER EPIDEM BIOMAR, V19, P1122, DOI 10.1158/1055-9965.EPI-09-0966; Schootman M, 2009, AM J EPIDEMIOL, V169, P554, DOI 10.1093/aje/kwn369; Smigal C, 2006, CA-CANCER J CLIN, V56, P168, DOI 10.3322/canjclin.56.3.168; Sprague Brian L, 2011, Cancer, V117, P1542, DOI 10.1002/cncr.25589; SUAREZ L, 1994, J NATL CANCER I, V86, P775, DOI 10.1093/jnci/86.10.775; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Nguyen TUN, 2008, HEALTH PROMOT PRACT, V9, P356, DOI 10.1177/1524839906290251; U. S. Cancer Statistics Working Group, 2010, US CANC STAT 1999 20; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Whitman S, 2011, J COMMUN HEALTH, V36, P588, DOI 10.1007/s10900-010-9346-2	56	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61879	10.1371/journal.pone.0061879	http://dx.doi.org/10.1371/journal.pone.0061879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	181JC	23637921	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800014
J	Hu, EA; Toledo, E; Diez-Espino, J; Estruch, R; Corella, D; Salas-Salvado, J; Vinyoles, E; Gomez-Gracia, E; Aros, F; Fiol, M; Lapetra, J; Serra-Majem, L; Pinto, X; Portillo, MP; Lamuela-Raventos, RM; Ros, E; Sorli, JV; Martinez-Gonzalez, MA				Hu, Emily A.; Toledo, Estefania; Diez-Espino, Javier; Estruch, Ramon; Corella, Dolores; Salas-Salvado, Jordi; Vinyoles, Ernest; Gomez-Gracia, Enrique; Aros, Fernando; Fiol, Miquel; Lapetra, Jose; Serra-Majem, Lluis; Pinto, Xavier; Puy Portillo, Maria; Lamuela-Raventos, Rosa M.; Ros, Emilio; Sorli, Jose V.; Martinez-Gonzalez, Miguel A.			Lifestyles and Risk Factors Associated with Adherence to the Mediterranean Diet: A Baseline Assessment of the PREDIMED Trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; TYPE-2 DIABETES-MELLITUS; SEGUIMIENTO UNIVERSIDAD; WEIGHT CHANGE; PATTERNS; HEALTH; POPULATION; OBESITY; HABITS; PREVALENCE	Background: The traditional Mediterranean dietary pattern (MedDiet) is associated with longevity and low rates of cardiovascular disease (CVD). However, there is little information on who is more likely to follow this food pattern. Aim: To evaluate how different factors are associated with lower MedDiet adherence in older Spanish subjects. Methods: We included 7305 participants (men aged 55-80 y, women 60-80 y) at high-risk of CVD recruited into the PREDIMED trial (ISRCTN35739639). Socioeconomic, anthropometric, lifestyle characteristics and CVD risk factors were recorded. A validated 14-item questionnaire was used to evaluate MedDiet adherence at baseline. Multivariate models were used to estimate odds ratios (OR) and 95% confidence intervals for lower adherence to the MedDiet (<9 points out of 14) and ascertain factors independently associated with it. Results: Former smoking (OR = 0.87; 95% CI, 0.78-0.98), physical activity (OR for the 3rd vs. the 1st tertile: 0.69; 0.62-0.78), and higher educational level (OR for university vs. less than primary school: 0.54; 0.38-0.77) were associated with higher MedDiet adherence. Conversely, having a larger waist-to-height ratio (OR for 0.1 units, 1.35; 1.22-1.49), being diabetic (OR = 1.13; 1.03-1.24), being single (OR = 1.27; 1.01-1.61) or divorced or separated (OR = 1.44; 1.09-1.89), and current smoking (OR = 1.28; 1.11-1.47) were associated with lower adherence. Conclusions: Participants with little education, a larger waist-to-height ratio, or diabetes and those who were less physically active, single, divorced or separated, or smokers were less likely to adhere to the MedDiet, an ideal model for food choices. Stronger efforts of health promotion are needed in these groups to foster adoption of the MedDiet.	[Hu, Emily A.; Toledo, Estefania] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Toledo, Estefania; Diez-Espino, Javier; Martinez-Gonzalez, Miguel A.] Univ Navarra, Sch Med Clin, Dept Prevent Med & Publ Hlth, Navarra, Spain; [Toledo, Estefania; Diez-Espino, Javier; Gomez-Gracia, Enrique; Aros, Fernando; Fiol, Miquel; Lapetra, Jose; Serra-Majem, Lluis; Pinto, Xavier; Puy Portillo, Maria; Lamuela-Raventos, Rosa M.; Martinez-Gonzalez, Miguel A.] Spanish Govt, Inst Salud Carlos 3, RETIC RD06 0045, Madrid, Spain; [Toledo, Estefania; Estruch, Ramon; Corella, Dolores; Salas-Salvado, Jordi; Vinyoles, Ernest; Gomez-Gracia, Enrique; Aros, Fernando; Fiol, Miquel; Lapetra, Jose; Serra-Majem, Lluis; Pinto, Xavier; Puy Portillo, Maria; Lamuela-Raventos, Rosa M.; Ros, Emilio; Sorli, Jose V.; Martinez-Gonzalez, Miguel A.] Spanish Govt, Inst Salud Carlos 3, CIBER Fisiopatol Obesidad & Nutr CIBER Obn, Madrid, Spain; [Diez-Espino, Javier] Primary Hlth Care Ctr Tafalla Osasunbidea, Navarra, Spain; [Estruch, Ramon] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi Sunyer IDIBAPS, Dept Internal Med, Barcelona, Spain; [Corella, Dolores; Sorli, Jose V.] Univ Valencia, Dept Prevent Med, Valencia, Spain; [Salas-Salvado, Jordi] Univ Rovira & Virgili, Dept Human Nutr, IISPV, E-43201 Reus, Spain; [Vinyoles, Ernest] Univ Barcelona, La Mina Primary Care Ctr, E-08007 Barcelona, Spain; [Vinyoles, Ernest] IDIAP JordiGol, Barcelona, Spain; [Gomez-Gracia, Enrique] Univ Malaga, Dept Prevent Med, E-29071 Malaga, Spain; [Aros, Fernando] Univ Hosp Alava, Dept Cardiol, Vitoria, Spain; [Fiol, Miquel] Univ Balearic Isl, Inst Hlth Sci IUNICS, Palma De Mallorca, Spain; [Fiol, Miquel] Hosp Son Espases, Palma De Mallorca, Spain; [Lapetra, Jose] San Pablo Hlth Ctr, Primary Care Div Sevilla, Dept Family Med, Seville, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Pinto, Xavier] Hosp Univ Bellvitge, Lipids & Vasc Risk Unit, Barcelona, Spain; [Puy Portillo, Maria] Univ Basque Cty UPV EHU, Sch Pharm, Dept Nutr & Food Sci, Vitoria, Spain; [Lamuela-Raventos, Rosa M.] Univ Barcelona, INSA, XaRTA, Dept Nutr & Food Sci,Sch Pharm, Barcelona, Spain; [Ros, Emilio] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi Sunyer IDIBAPS, Lipid Clin,Dept Endocrinol & Nutr, Barcelona, Spain	Harvard University; Harvard T.H. Chan School of Public Health; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Valencia; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Barcelona; Universidad de Malaga; Universitat de les Illes Balears; Hospital Universitari Son Espases; Universidad de Las Palmas de Gran Canaria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Basque Country; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Toledo, E (corresponding author), Univ Navarra, Sch Med Clin, Dept Prevent Med & Publ Hlth, Navarra, Spain.	etoledo@unav.es	Lapetra, Jose/F-2552-2015; Salas-Salvado, Jordi/C-7229-2017; Fiol, Miguel/F-6793-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Sorlí, José V/L-8758-2014; Vinyoles, Ernest/GRX-4615-2022; IBIS, ATENCION PRIMARIA/I-3524-2016; Toledo, Estefania/H-6211-2014; Estruch, Ramon/AAZ-3723-2020; Pintó, Xavier/AGI-4297-2022; Portillo, Maria Puy/ABH-2374-2020; Serra-Majem, Lluis/I-6708-2019; Lamuela-Raventos, Rosa M/F-3986-2016; Stefanadis, Christodoulos/ABH-2232-2020	Salas-Salvado, Jordi/0000-0003-2700-7459; Fiol, Miguel/0000-0002-5370-1391; Sorlí, José V/0000-0002-0130-2006; Toledo, Estefania/0000-0002-6263-4434; Pintó, Xavier/0000-0002-2216-2444; Portillo, Maria Puy/0000-0003-0210-6549; Serra-Majem, Lluis/0000-0002-9658-9061; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Ros, Emilio/0000-0002-2573-1294; PORTILLO BAQUEDANO, MARIA PUY/0000-0003-2290-592X; Vinyoles, Ernest/0000-0002-8725-9431; Stefanadis, Christodoulos/0000-0001-5974-6454	official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII) [RTIC G03/140, RTIC RD 06/0045]; official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII) through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]); Centro Nacional de Investigaciones Cardiovasculares [CNIC 06/2007]; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional [PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI10/02658, PI11/01647, P11/02505]; Ministerio de Ciencia e Innovacion [AGL-2009- 13906-C02, AGL2010-22319-C03, SAF2009-12304]; Fundacion Mapfre; Consejeria de Salud de la Junta de Andalucia [PI0105/2007]; Public Health Division of the Department of Health of the Autonomous Government of Catalonia; Generalitat Valenciana [COMP06109, GVACOMP2010-181, CS2010- AP-111, CS2011-AP-042, BEST11-263, BEST/2011/261, GVACOMP2011-151, ACOMP/2011/145, ACOMP/2012/190]; Regional Government of Navarra [P27/2011]; Rio Hortega post-residency fellowship of ISCIII, Ministry of Economy and Competitiveness, Spanish Government; Fundacion Mutua Madrilena	official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII); official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII) through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]); Centro Nacional de Investigaciones Cardiovasculares; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mapfre; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Public Health Division of the Department of Health of the Autonomous Government of Catalonia; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Regional Government of Navarra; Rio Hortega post-residency fellowship of ISCIII, Ministry of Economy and Competitiveness, Spanish Government; Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	Supported by the official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII), through grants provided to research networks specifically developed for the trial (RTIC G03/140, to Dr. Estruch; RTIC RD 06/0045, to Dr. Martinez-Gonzalez and through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]), and by grants from Centro Nacional de Investigaciones Cardiovasculares (CNIC 06/2007), Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI10/02658, PI11/01647, and P11/02505), Ministerio de Ciencia e Innovacion (AGL-2009- 13906-C02, AGL2010-22319-C03 and SAF2009-12304), Fundacion Mapfre 2010, Consejeria de Salud de la Junta de Andalucia (PI0105/2007), Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana (ACOMP06109, GVACOMP2010-181, GVACOMP2011-151, CS2010- AP-111, CS2011-AP-042, BEST11-263, BEST/2011/261, GVACOMP2011-151, ACOMP/2011/145 and ACOMP/2012/190), and Regional Government of Navarra (P27/2011). Dr. Toledo is supported by a Rio Hortega post-residency fellowship of ISCIII, Ministry of Economy and Competitiveness, Spanish Government and by the Fundacion Mutua Madrilena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043134; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S1368980011002515; Boyle RG, 2000, PREV MED, V31, P177, DOI 10.1006/pmed.2000.0699; Buckland G, 2009, AM J EPIDEMIOL, V170, P1518, DOI 10.1093/aje/kwp282; Bullo M, 2011, PREV MED, V53, P155, DOI 10.1016/j.ypmed.2011.06.008; Costacou T, 2003, EUR J CLIN NUTR, V57, P1378, DOI 10.1038/sj.ejcn.1601699; Couto E, 2011, BRIT J CANCER, V104, P1493, DOI 10.1038/bjc.2011.106; Dallongeville J, 1998, J NUTR, V128, P1450; Diez-Espino J, 2011, ANN NUTR METAB, V58, P74, DOI 10.1159/000324718; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Esposito K, 2009, ANN INTERN MED, V151, P306, DOI 10.7326/0003-4819-151-5-200909010-00004; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Filippidis FT, 2011, PUBLIC HEALTH, V125, P436, DOI 10.1016/j.puhe.2011.03.009; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; González C.A., 2002, Gac Sanit, V16, P214; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043275; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Basterra-Gortari FJ, 2011, REV ESP CARDIOL, V64, P424, DOI [10.1016/j.recesp.2010.06.010, 10.1016/j.rec.2010.06.015]; Beunza JJ, 2010, AM J CLIN NUTR, V92, P1484, DOI 10.3945/ajcn.2010.29764; Jurado D, 2012, J ACAD NUTR DIET, V112, P887, DOI 10.1016/j.jand.2012.02.026; Katsarou A, 2010, PUBLIC HEALTH NUTR, V13, P1614, DOI 10.1017/S1368980010000479; Majem LS, 2001, MED CLIN-BARCELONA, V116, P129, DOI 10.1016/S0025-7753(01)71747-2; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Martinez-Gonzalez MA, 2011, NUTR METAB CARDIOVAS, V21, P237, DOI 10.1016/j.numecd.2009.10.005; Mendez MA, 2006, J NUTR, V136, P2934, DOI 10.1093/jn/136.11.2934; Morabia A, 1999, EUR J CLIN NUTR, V53, P239, DOI 10.1038/sj.ejcn.1600710; MORABIA A, 1990, AM J CLIN NUTR, V52, P933, DOI 10.1093/ajcn/52.5.933; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Panagiotakos DB, 2006, NUTRITION, V22, P449, DOI 10.1016/j.nut.2005.11.004; Panagiotakos DB, 2007, J AM COLL NUTR, V26, P32, DOI 10.1080/07315724.2007.10719583; Romaguera D, 2010, AM J CLIN NUTR, V92, P912, DOI 10.3945/ajcn.2010.29482; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Sanchez-Benito JL, 2009, NUTR HOSP, V24, P77; Sanchez-Tainta A, 2008, EUR J CARDIOV PREV R, V15, P589, DOI 10.1097/HJR.0b013e328308ba61; Sanchez-Villegas A, 2003, EUR J CLIN NUTR, V57, P285, DOI 10.1038/sj.ejcn.1601528; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Serra-Majem L, 2009, BRIT J NUTR, V101, pS21, DOI 10.1017/S0007114509990559; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; Tur JA, 2004, BRIT J NUTR, V92, P341, DOI 10.1079/BJN20041209; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Zazpe I, 2010, EUR J NUTR, V49, P91, DOI 10.1007/s00394-009-0053-7	49	69	70	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e60166	10.1371/journal.pone.0060166	http://dx.doi.org/10.1371/journal.pone.0060166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637743	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800004
J	Zhang, Z; Hsieh, B; Poe, A; Anderson, J; Ocorr, K; Gibson, G; Bodmer, R				Zhang, Zhi; Hsieh, Benjamin; Poe, Amy; Anderson, Julie; Ocorr, Karen; Gibson, Greg; Bodmer, Rolf			Complex Genetic Architecture of Cardiac Disease in a Wild Type Inbred Strain of Drosophila melanogaster	PLOS ONE			English	Article							HEART FUNCTION; MUTATIONS; VARIANTS; SUSCEPTIBILITY; IDENTIFICATION; ARRHYTHMIAS; DYSFUNCTION; DEFICIENCY; PATTERNS; COMMON	Natural populations of the fruit fly, Drosophila melanogaster, segregate genetic variation that leads to cardiac disease phenotypes. One nearly isogenic line from a North Carolina peach orchard, WE70, is shown to harbor two genetically distinct heart phenotypes: elevated incidence of arrhythmias, and a dramatically constricted heart diameter in both diastole and systole, with resemblance to restrictive cardiomyopathy in humans. Assuming the source to be rare variants of large effect, we performed Bulked Segregant Analysis using genomic DNA hybridization to Affymetrix chips to detect single feature polymorphisms, but found that the mutant phenotypes are more likely to have a polygenic basis. Further mapping efforts revealed a complex architecture wherein the constricted cardiomyopathy phenotype was observed in individual whole chromosome substitution lines, implying that variants on both major autosomes are sufficient to produce the phenotype. A panel of 170 Recombinant Inbred Lines (RIL) was generated, and a small subset of mutant lines selected, but these each complemented both whole chromosome substitutions, implying a non-additive (epistatic) contribution to the "disease'' phenotype. Low coverage whole genome sequencing was also used to attempt to map chromosomal regions contributing to both the cardiomyopathy and arrhythmia, but a polygenic architecture had to be again inferred to be most likely. These results show that an apparently simple rare phenotype can have a complex genetic basis that would be refractory to mapping by deep sequencing in pedigrees. We present this as a cautionary tale regarding assumptions related to attempts to map new disease mutations on the assumption that probands carry a single causal mutation.	[Zhang, Zhi; Anderson, Julie; Ocorr, Karen; Bodmer, Rolf] Sanford Burnham Med Res Inst, Dev & Aging Program, Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA USA; [Hsieh, Benjamin; Poe, Amy; Gibson, Greg] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Sanford Burnham Prebys Medical Discovery Institute; University System of Georgia; Georgia Institute of Technology	Gibson, G (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	greg.gibson@biology.gatech.edu; rolf@sbmri.org			National Institutes of Health [(R01-HL085481)424, R01-HL54732]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085481, R01HL054732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was 423 supported by funds provided by the National Institutes of Health to RB and GG (R01-HL085481)424 and to RB (R01-HL54732. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Bloemink MJ, 2011, J BIOL CHEM, V286, P28435, DOI 10.1074/jbc.M111.258228; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Creemers EE, 2011, NAT REV GENET, V12, P357, DOI 10.1038/nrg2983; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; John RM, 2012, LANCET, V380, P1520, DOI 10.1016/S0140-6736(12)61413-5; Logan CV, 2011, NAT GENET, V43, P1189, DOI 10.1038/ng.995; Mery A, 2008, J EXP BIOL, V211, P15, DOI 10.1242/jeb.012435; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Need AC, 2012, AM J HUM GENET, V91, P303, DOI 10.1016/j.ajhg.2012.06.018; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Ocorr K, 2009, JOVE-J VIS EXP; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Ocorr KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000601; Prins BP, 2012, ATHEROSCLEROSIS, V225, P1, DOI 10.1016/j.atherosclerosis.2012.05.015; Qian L, 2009, HUM MOL GENET, V18, P3153, DOI 10.1093/hmg/ddp254; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Slatkin M, 2008, AM J HUM GENET, V83, P120, DOI 10.1016/j.ajhg.2008.06.011; Su SY, 2010, TWIN RES HUM GENET, V13, P1, DOI 10.1375/twin.13.1.1; Taghli-Lamallem O, 2008, AGING CELL, V7, P237, DOI 10.1111/j.1474-9726.2008.00367.x; Team RC, 2012, R LANG ENV STAT COMP; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131	39	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62909	10.1371/journal.pone.0062909	http://dx.doi.org/10.1371/journal.pone.0062909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638165	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800068
J	Bertolini, G; Tarnutzer, AA; Olasagasti, I; Khojasteh, E; Weber, KP; Bockisch, CJ; Straumann, D; Marti, S				Bertolini, Giovanni; Tarnutzer, Alexander A.; Olasagasti, Itsaso; Khojasteh, Elham; Weber, Konrad P.; Bockisch, Christopher J.; Straumann, Dominik; Marti, Sarah			Gaze Holding in Healthy Subjects	PLOS ONE			English	Article							HEAD-MOUNTED CAMERA; EYE-MOVEMENTS; REBOUND NYSTAGMUS; CEREBELLAR DISEASE; ENDPOINT NYSTAGMUS; NEURAL INTEGRATOR; EVOKED NYSTAGMUS; NONLINEAR MODEL; POSITION; STABILITY	Eccentric gaze in darkness evokes minor centripetal eye drifts in healthy subjects, as cerebellar control sufficiently compensates for the inherent deficiencies of the brainstem gaze-holding network. This behavior is commonly described using a leaky integrator model, which assumes that eye velocity grows linearly with gaze eccentricity. Results from previous studies in patients and healthy subjects suggest caution when this assumption is applied to eye eccentricities larger than 20 degrees. To obtain a detailed characterization of the centripetal gaze-evoked drift, we recorded horizontal eye position in 20 healthy subjects. With their head fixed, they were asked to fixate a flashing dot (50 ms every 2 s) that was quasi-stationary displacing(0.5 deg/s) between +/- 40 deg horizontally in otherwise complete darkness. Drift velocity was weak at all angles tested. Linearity was assessed by dividing the range of gaze eccentricity in four bins of 20 deg each, and comparing the slopes of a linear function fitted to the horizontal velocity in each bin. The slopes of single subjects for gaze eccentricities of +/- 0-20 deg were, in median, 0.41 times the slopes obtained for gaze eccentricities of +/- 20-40 deg. By smoothing the individual subjects' eye velocity as a function of gaze eccentricity, we derived a population of position-velocity curves. We show that a tangent function provides a better fit to the mean of these curves when large eccentricities are considered. This implies that the quasi-linear behavior within the typical ocular motor range is the result of a tuning procedure, which is optimized in the most commonly used range of gaze. We hypothesize that the observed non-linearity at eccentric gaze results from a saturation of the input that each neuron in the integrating network receives from the others. As a consequence, gaze-holding performance declines more rapidly at large eccentricities.	[Bertolini, Giovanni; Tarnutzer, Alexander A.; Olasagasti, Itsaso; Weber, Konrad P.; Bockisch, Christopher J.; Straumann, Dominik; Marti, Sarah] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Khojasteh, Elham; Bockisch, Christopher J.] Univ Zurich Hosp, Dept Otorhinolaryngol, CH-8091 Zurich, Switzerland; [Khojasteh, Elham; Bockisch, Christopher J.] Univ Zurich Hosp, Dept Head & Neck Surg, CH-8091 Zurich, Switzerland; [Weber, Konrad P.; Bockisch, Christopher J.] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Bertolini, G (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	bertoweb@gmail.com	Bertolini, Giovanni/H-3510-2016; Weber, Konrad P/A-1941-2013; Tarnutzer, Alexander/H-3236-2019; Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Weber, Konrad P/0000-0003-2526-4582; Tarnutzer, Alexander/0000-0002-6984-6958; Bertolini, Giovanni/0000-0003-2428-9454; Olasagasti, Itsaso/0000-0002-5172-5373; Bockisch, Christopher/0000-0003-1054-2578	Swiss National Science Foundation [32003B_130163/1]; Koetser Foundation for Brain Research, Zurich; Bonizzi Theler Foundation, Zurich; Center for Integrative Human Physiology, University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Koetser Foundation for Brain Research, Zurich; Bonizzi Theler Foundation, Zurich; Center for Integrative Human Physiology, University of Zurich	This study was supported by Swiss National Science Foundation (32003B_130163/1), Koetser Foundation for Brain Research, Zurich; Bonizzi Theler Foundation, Zurich; and Center for Integrative Human Physiology, University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL LA, 1978, IEEE T BIO-MED ENG, V25, P71, DOI 10.1109/TBME.1978.326380; ABEL LA, 1978, INVEST OPHTH VIS SCI, V17, P539; Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; ASCHAN G, 1975, ACTA OTO-LARYNGOL, P15; BECKER W, 1973, VISION RES, V13, P1021, DOI 10.1016/0042-6989(73)90141-7; BONDAR RL, 1984, ANN NEUROL, V15, P474, DOI 10.1002/ana.410150512; Booker JL, 2001, SCI JUSTICE, V41, P113, DOI 10.1016/S1355-0306(01)71862-X; Chan WWP, 2007, P ANN INT IEEE EMBS, P1156, DOI 10.1109/IEMBS.2007.4352501; Chan WWP, 2005, J NEUROPHYSIOL, V93, P3709, DOI 10.1152/jn.00814.2004; Citek Karl, 2003, Optometry, V74, P695; Citek K, 2011, J FORENSIC SCI, V56, P1170, DOI 10.1111/j.1556-4029.2011.01813.x; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dera T, 2006, IEEE SYS MAN CYBERN, P5191; EIZENMAN M, 1990, VISION RES, V30, P863, DOI 10.1016/0042-6989(90)90055-P; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P679, DOI 10.1162/neco.1994.6.4.679; GALIANA HL, 1995, ACTA OTO-LARYNGOL, V115, P585, DOI 10.3109/00016489509139372; Glasauer S, 2003, ANN NY ACAD SCI, V1004, P206, DOI 10.1196/annals.1303.018; Goldman M.S., 2009, ENCYCL NEUROSCI, V6, P165, DOI DOI 10.1016/B978-008045046-9.01434-0; GORDON S E, 1986, Investigative Ophthalmology and Visual Science, V27, P158; Grinsted A, 2008, QUANTREG M QUANTILE; HOOD JD, 1973, BRAIN, V96, P507, DOI 10.1093/brain/96.3.507; Khojasteh E, 2006, IEEE T BIO-MED ENG, V53, P986, DOI 10.1109/TBME.2006.873545; Khojasteh E, 2013, EUR J NEUROSCI, V37, P141, DOI 10.1111/ejn.12030; Khojasteh E, 2009, EXP BRAIN RES, V198, P1, DOI 10.1007/s00221-009-1930-2; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; LEECH J, 1977, BRIT J OPHTHALMOL, V61, P774, DOI 10.1136/bjo.61.12.774; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; LOPEZBARNEO J, 1982, J NEUROPHYSIOL, V47, P329, DOI 10.1152/jn.1982.47.2.329; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; Nakamagoe K, 2000, SCIENCE, V288, P857, DOI 10.1126/science.288.5467.857; OPTICAN LM, 1984, BIOL CYBERN, V50, P119, DOI 10.1007/BF00337159; ROBINSON DA, 1973, KYBERNETIK, V14, P71, DOI 10.1007/BF00288906; ROBINSON DA, 1974, BRAIN RES, V71, P195, DOI 10.1016/0006-8993(74)90961-5; Rubenzer SJ, 2010, J FORENSIC SCI, V55, P394, DOI 10.1111/j.1556-4029.2009.01289.x; Schneider E, 2005, IEEE SYS MAN CYBERN, P2437; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SHALLOHOFFMANN J, 1990, INVEST OPHTH VIS SCI, V31, P388; TRUJILLOORTIZ AR, 2006, RMAOV33 3 WAY ANAL V; Wang XJ, 1999, J NEUROSCI, V19, P9587; WESTHEIMER G, 1973, INVEST OPHTH VISUAL, V12, P618; Whyte CA, 2010, INVEST OPHTH VIS SCI, V51, P2476, DOI 10.1167/iovs.08-3241; Wild F, 1991, OPHTHALMOLOGY, V88, P73; Wilson E, 2005, ANN NY ACAD SCI, V1039, P593, DOI 10.1196/annals.1325.075; ZEE DS, 1980, ANN NEUROL, V7, P37, DOI 10.1002/ana.410070108; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878	47	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61389	10.1371/journal.pone.0061389	http://dx.doi.org/10.1371/journal.pone.0061389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637824	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700011
J	Boult, JKR; Terkelsen, J; Walker-Samuel, S; Bradley, DP; Robinson, SP				Boult, Jessica K. R.; Terkelsen, Jennifer; Walker-Samuel, Simon; Bradley, Daniel P.; Robinson, Simon P.			A Multi-Parametric Imaging Investigation of the Response of C6 Glioma Xenografts to MLN0518 (Tandutinib) Treatment	PLOS ONE			English	Article							GROWTH-FACTOR; IN-VIVO; PDGF-B; PERICYTE RECRUITMENT; SUSCEPTIBILITY MRI; MESSENGER-RNA; ANGIOGENESIS; THERAPY; CANCER; TUMORS	Angiogenesis, the development of new blood vessels, is essential for tumour growth; this process is stimulated by the secretion of numerous growth factors including platelet derived growth factor (PDGF). PDGF signalling, through its receptor platelet derived growth factor receptor (PDGFR), is involved in vessel maturation, stimulation of angiogenesis and upregulation of other angiogenic factors, including vascular endothelial growth factor (VEGF). PDGFR is a promising target for anti-cancer therapy because it is expressed on both tumour cells and stromal cells associated with the vasculature. MLN0518 (tandutinib) is a potent inhibitor of type III receptor tyrosine kinases that demonstrates activity against PDGFR alpha/beta, FLT3 and c-KIT. In this study a multi-parametric MRI and histopathological approach was used to interrogate changes in vascular haemodynamics, structural response and hypoxia in C6 glioma xenografts in response to treatment with MLN0518. The doubling time of tumours in mice treated with MLN0518 was significantly longer than tumours in vehicle treated mice. The perfused vessel area, number of alpha smooth muscle actin positive vessels and hypoxic area in MLN0518 treated tumours were also significantly lower after 10 days treatment. These changes were not accompanied by alterations in vessel calibre or fractional blood volume as assessed using susceptibility contrast MRI. Histological assessment of vessel size and total perfused area did not demonstrate any change with treatment. Intrinsic susceptibility MRI did not reveal any difference in baseline R-2* or carbogen-induced change in R-2*. Dynamic contrast-enhanced MRI revealed anti-vascular effects of MLN0518 following 3 days treatment. Hypoxia confers chemo- and radio-resistance, and alongside PDGF, is implicated in evasive resistance to agents targeted against VEGF signalling. PDGFR antagonists may improve potency and efficacy of other therapeutics in combination. This study highlights the challenges of identifying appropriate quantitative imaging response biomarkers in heterogeneous models, particularly considering the multifaceted roles of angiogenic growth factors.	[Boult, Jessica K. R.; Walker-Samuel, Simon; Robinson, Simon P.] Inst Canc Res, Div Radiotherapy & Imaging, Sutton, Surrey, England; [Boult, Jessica K. R.; Walker-Samuel, Simon; Robinson, Simon P.] Royal Marsden NHS Trust, Sutton, Surrey, England; [Terkelsen, Jennifer; Bradley, Daniel P.] Millennium Takeda Oncol Co, Biomed Imaging Grp, Cambridge, MA USA	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Takeda Oncology	Boult, JKR (corresponding author), Inst Canc Res, Div Radiotherapy & Imaging, Sutton, Surrey, England.	Jessica.Boult@icr.ac.uk		Robinson, Simon/0000-0003-4101-7274	NHS; Royal Society;  [C1060/A10334]; Cancer Research UK [16464] Funding Source: researchfish	NHS; Royal Society(Royal Society of London); ; Cancer Research UK(Cancer Research UK)	The authors acknowledge the support received for The Institute of Cancer Research CR-UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) (grant C1060/A10334) and NHS funding to the NIHR Biomedical Research Centre. SPR was the recipient of a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Barrios CH, 2006, J CLIN ONCOL, V24, P11518; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Boult JKR, 2012, BRIT J CANCER, V106, P1960, DOI 10.1038/bjc.2012.208; Boult JKR, 2011, J PATHOL, V225, P344, DOI 10.1002/path.2904; Bradley DP, 2009, MAGN RESON IMAGING, V27, P377, DOI 10.1016/j.mri.2008.07.021; Calzolari F, 2010, BRAIN PATHOL, V20, P527, DOI 10.1111/j.1750-3639.2009.00335.x; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; Guo P, 2003, AM J PATHOL, V162, P1083, DOI 10.1016/S0002-9440(10)63905-3; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; HERMANSON M, 1992, CANCER RES, V52, P3213; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Howe FA, 2008, INT J RADIAT ONCOL, V71, P1470, DOI 10.1016/j.ijrobp.2008.04.027; Kelly LM, 2002, CANCER CELL, V1, P421, DOI 10.1016/S1535-6108(02)00070-3; Kohne CH, 2009, ONCOLOGIST, V14, P478, DOI 10.1634/theoncologist.2008-0202; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; OIKAWA T, 1994, BIOL PHARM BULL, V17, P1686; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Robinson SP, 2008, INT J CANCER, V122, P1548, DOI 10.1002/ijc.23279; Robinson SP, 2007, INT J RADIAT ONCOL, V69, P872, DOI 10.1016/j.ijrobp.2007.06.061; Robinson SP, 2003, J MAGN RESON IMAGING, V17, P445, DOI 10.1002/jmri.10274; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Tropres I, 2004, MAGN RESON MED, V51, P533, DOI 10.1002/mrm.20017; Tuettenberg J, 2006, CRIT REV ONCOL HEMAT, V59, P181, DOI 10.1016/j.critrevonc.2006.01.004; Walker-Samuel S, 2012, INT J CANCER, V130, P1284, DOI 10.1002/ijc.26112; Walker-Samuel S, 2010, MAGN RESON MED, V64, P914, DOI 10.1002/mrm.22478; Walker-Samuel S, 2009, MAGN RESON MED, V62, P420, DOI 10.1002/mrm.22014; Waterton JC, 2012, EUR J CANCER, V48, P409, DOI 10.1016/j.ejca.2011.11.037; Wilkinson S, 2009, GENE DEV, V23, P1283, DOI 10.1101/gad.521709; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wysocki PJ, 2008, CURR OPIN INVEST DR, V9, P570; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yu XF, 2006, LEUKEMIA, V20, P1, DOI 10.1038/sj.leu.2404021; YUAN F, 1994, CANCER RES, V54, P4564	43	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e63024	10.1371/journal.pone.0063024	http://dx.doi.org/10.1371/journal.pone.0063024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638177	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700086
J	Liu, N; Wang, LH; Guo, LL; Wang, GQ; Zhou, XP; Jiang, Y; Shang, J; Murao, K; Chen, JW; Fu, WQ; Zhang, GX				Liu, Nan; Wang, Lin-Hui; Guo, Ling-Ling; Wang, Guo-Qing; Zhou, Xi-Ping; Jiang, Yan; Shang, Jing; Murao, Koji; Chen, Jing-Wei; Fu, Wen-Qing; Zhang, Guo-Xing			Chronic Restraint Stress Inhibits Hair Growth via Substance P Mediated by Reactive Oxygen Species in Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; IMMOBILIZATION STRESS; MAST-CELLS; CATAGEN DEVELOPMENT; TELOGEN STAGE; TISSUE-DAMAGE; SKIN-DISEASE; MOUSE MODEL; FOLLICLE	Backgrounds: Solid evidence has demonstrated that psychoemotional stress induced alteration of hair cycle through neuropeptide substance P (SP) mediated immune response, the role of reactive oxygen species (ROS) in brain-skin-axis regulation system remains unknown. Objectives: The present study aims to investigate possible mechanisms of ROS in regulation of SP-mast cell signal pathway in chronic restraint stress (CRS, a model of chronic psychoemotional stress) which induced abnormal of hair cycle. Methods and Results: Our results have demonstrated that CRS actually altered hair cycle by inhibiting hair follicle growth in vivo, prolonging the telogen stage and delaying subsequent anagen and catagen stage. Up-regulation of SP protein expression in cutaneous peripheral nerve fibers and activation of mast cell were observed accompanied with increase of lipid peroxidation levels and reduction of the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in CRS mice skin. In addition, SP receptor antagonist (RP67580) reduced mast cell activations and lipid peroxidation levels as well as increased GSH-Px activity and normalized hair cycle. Furthermore, antioxidant Tempol (a free radical scavenger) also restored hair cycle, reduced SP protein expression and mast cell activation. Conclusions: Our study provides the first solid evidence for how ROS play a role in regulation of psychoemotional stress induced SP-Mast cell pathway which may provide a convincing rationale for antioxidant application in clinical treatment with psychological stress induced hair loss.	[Liu, Nan; Fu, Wen-Qing] Soochow Univ, Coll Med, Dept Clin Psychol, Suzhou, Peoples R China; [Wang, Lin-Hui; Wang, Guo-Qing; Zhou, Xi-Ping; Jiang, Yan; Zhang, Guo-Xing] Soochow Univ, Coll Med, Dept Physiol, Suzhou, Peoples R China; [Guo, Ling-Ling] Soochow Univ, Coll Med, Dept Pathol, Suzhou, Peoples R China; [Shang, Jing] China Pharmaceut Univ, New Drug Screening Ctr, Nanjing 210009, Peoples R China; [Murao, Koji] Kagawa Univ, Fac Med, Dept Clin Lab, Kagawa, Japan; [Chen, Jing-Wei] Suzhou Chinese Tradit Med Hosp, Dept Internal Med, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; China Pharmaceutical University; Kagawa University	Fu, WQ (corresponding author), Soochow Univ, Coll Med, Dept Clin Psychol, Suzhou, Peoples R China.	fuwenqing@suda.edu.cn; zhangguoxing@suda.edu.cn	wang, lili/HDL-7210-2022; wang, lin/GSE-3040-2022; wang, lin/HHM-2225-2022		National Natural Science Foundation of China [30900464, 81270316]; Research Program of Soochow University [Q413400111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Program of Soochow University	This work was supported by the National Natural Science Foundation of China (30900464, 81270316), the Research Program of Soochow University (Q413400111). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar A, 2002, J DERMATOL SCI, V29, P85, DOI 10.1016/S0923-1811(02)00015-4; Ansel JC, 1996, J INVEST DERMATOL, V106, P198, DOI 10.1111/1523-1747.ep12330326; Ansel JC, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P23, DOI 10.1038/jidsymp.1997.6; Aoki E, 2003, EXP DERMATOL, V12, P371, DOI 10.1034/j.1600-0625.2002.120403.x; Arck PC, 2005, J MOL MED, V83, P386, DOI 10.1007/s00109-004-0627-z; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Arck PC, 2001, FASEB J, V15, P2536, DOI 10.1096/fj.00-0699fje; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; BEAUJOUAN JC, 1993, BRIT J PHARMACOL, V108, P793, DOI 10.1111/j.1476-5381.1993.tb12880.x; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bowers SL, 2008, BRAIN BEHAV IMMUN, V22, P105, DOI 10.1016/j.bbi.2007.07.012; Cotsarelis G, 2001, TRENDS MOL MED, V7, P293, DOI 10.1016/S1471-4914(01)02027-5; Fontella F, 2005, NEUROCHEM RES, V30, P105, DOI 10.1007/s11064-004-9691-6; Frossi B, 2003, EUR J IMMUNOL, V33, P2168, DOI 10.1002/eji.200323995; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; HAHN SM, 1992, CANCER RES, V52, P1750; Hendrix S, 2008, EXP DERMATOL, V17, P214, DOI 10.1111/j.1600-0625.2007.00653.x; Ito T, 2010, J DERMATOL SCI, V60, P67, DOI 10.1016/j.jdermsci.2010.09.006; Jiang WY, 1998, INT J DERMATOL, V37, P572, DOI 10.1046/j.1365-4362.1998.00533.x; Joachim RA, 2004, PSYCHOSOM MED, V66, P564, DOI 10.1097/01.psy.0000132878.08780.93; Kamanh A, 2004, CELL BIOCHEM FUNCT, V22, P53, DOI 10.1002/cbf.1055; Katayama M, 2007, EXP DERMATOL, V16, P553, DOI 10.1111/j.1600-0625.2007.00558.x; Kawana S, 2006, J DERMATOL SCI, V42, P47, DOI 10.1016/j.jdermsci.2005.12.004; Kennedy PGE, 1997, P NATL ACAD SCI USA, V94, P4167, DOI 10.1073/pnas.94.8.4167; Kohen R, 1999, BIOMED PHARMACOTHER, V53, P181, DOI 10.1016/S0753-3322(99)80087-0; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Linley JE, 2012, P NATL ACAD SCI USA, V109, pE1578, DOI 10.1073/pnas.1201544109; Liu JK, 1996, FASEB J, V10, P1532, DOI 10.1096/fasebj.10.13.8940299; Maurer M, 1997, AM J PATHOL, V150, P1433; Miyata K, 2005, J AM SOC NEPHROL, V16, P2906, DOI 10.1681/ASN.2005040390; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Naziroglu M, 2000, CELL BIOCHEM FUNCT, V18, P169; Naziroglu M, 2004, TOXICOLOGY, V195, P221, DOI 10.1016/j.tox.2003.10.012; Okayama Yoshimichi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P517, DOI 10.2174/1568010054526386; Patacchini R, 2004, HANDB EXP PHARM, V164, P173; PAUS R, 1994, J INVEST DERMATOL, V103, P143, DOI 10.1111/1523-1747.ep12392542; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Peters EMJ, 2006, EXP DERMATOL, V15, P1, DOI 10.1111/j.0906-6705.2005.00372.x; Peters EMJ, 2007, AM J PATHOL, V171, P1872, DOI 10.2353/ajpath.2007.061206; Sahin E, 2007, COMP BIOCHEM PHYS C, V144, P342, DOI 10.1016/j.cbpc.2006.10.009; Sander CS, 2004, INT J DERMATOL, V43, P326, DOI 10.1111/j.1365-4632.2004.02222.x; Schnackenberg CG, 1999, HYPERTENSION, V33, P424, DOI 10.1161/01.HYP.33.1.424; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Singh LK, 1999, BRAIN BEHAV IMMUN, V13, P225, DOI 10.1006/brbi.1998.0541; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Stucchi AF, 2000, AM J PHYSIOL-GASTR L, V279, pG1298, DOI 10.1152/ajpgi.2000.279.6.G1298; Suzuki Y, 2005, CHEM IMMUNOL ALLERGY, V87, P32, DOI 10.1159/000087569; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175; Trueb Ralph M, 2005, J Cosmet Dermatol, V4, P60, DOI 10.1111/j.1473-2165.2005.40203.x; Trueb Ralph M, 2009, Int J Trichology, V1, P6, DOI 10.4103/0974-7753.51923; Wang KX, 2009, J IMMUNOL, V182, P2485, DOI 10.4049/jimmunol.0803023; Wang L, 2007, EVID-BASED COMPL ALT, V4, P195, DOI 10.1093/ecam/nel080; Williamson D, 2001, J EUR ACAD DERMATOL, V15, P137, DOI 10.1046/j.1468-3083.2001.00229.x; Wolfreys K, 1997, EUR J IMMUNOL, V27, P297, DOI 10.1002/eji.1830270143; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; Zafir A, 2009, INDIAN J BIOCHEM BIO, V46, P53; Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013; Zhang GX, 2004, HYPERTENSION, V43, P117, DOI 10.1161/01.HYP.0000105110.12667.F8	62	44	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61574	10.1371/journal.pone.0061574	http://dx.doi.org/10.1371/journal.pone.0061574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637859	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700015
J	Buschiazzo, J; Ialy-Radio, C; Auer, J; Wolf, JP; Serres, C; Lefevre, B; Ziyyat, A				Buschiazzo, Jorgelina; Ialy-Radio, Come; Auer, Jana; Wolf, Jean-Philippe; Serres, Catherine; Lefevre, Brigitte; Ziyyat, Ahmed			Cholesterol Depletion Disorganizes Oocyte Membrane Rafts Altering Mouse Fertilization	PLOS ONE			English	Article							SRC FAMILY KINASE; TETRASPANIN-ENRICHED MICRODOMAINS; DOMAIN-MEDIATED ACTIVATION; METHYL-BETA-CYCLODEXTRIN; LIPID RAFTS; TYROSINE KINASE; PLASMA-MEMBRANE; CA2+ RELEASE; FUSION PEPTIDE; CELL-CYCLE	Drastic membrane reorganization occurs when mammalian sperm binds to and fuses with the oocyte membrane. Two oocyte protein families are essential for fertilization, tetraspanins and glycosylphosphatidylinositol-anchored proteins. The firsts are associated to tetraspanin-enriched microdomains and the seconds to lipid rafts. Here we report membrane raft involvement in mouse fertilization assessed by cholesterol modulation using methyl-beta-cyclodextrin. Cholesterol removal induced: (1) a decrease of the fertilization rate and index; and (2) a delay in the extrusion of the second polar body. Cholesterol repletion recovered the fertilization ability of cholesterol-depleted oocytes, indicating reversibility of these effects. In vivo time-lapse analyses using fluorescent cholesterol permitted to identify the time-point at which the probe is mainly located at the plasma membrane enabling the estimation of the extent of the cholesterol depletion. We confirmed that the mouse oocyte is rich in rafts according to the presence of the raft marker lipid, ganglioside GM1 on the membrane of living oocytes and we identified the coexistence of two types of microdomains, planar rafts and caveolae-like structures, by terms of two differential rafts markers, flotillin-2 and caveolin-1, respectively. Moreover, this is the first report that shows characteristic caveolae-like invaginations in the mouse oocyte identified by electron microscopy. Raft disruption by cholesterol depletion disturbed the subcellular localization of the signal molecule c-Src and the inhibition of Src kinase proteins prevented second polar body extrusion, consistent with a role of Src-related kinases in fertilization via signaling complexes. Our data highlight the functional importance of intact membrane rafts for mouse fertilization and its dependence on cholesterol.	[Buschiazzo, Jorgelina; Ialy-Radio, Come; Auer, Jana; Wolf, Jean-Philippe; Serres, Catherine; Lefevre, Brigitte; Ziyyat, Ahmed] Univ Paris 05, Inst Cochin, INSERM U1016, F-75014 Paris, France; [Buschiazzo, Jorgelina] UNS CONICET, Inst Invest Bioquim Bahi Blanca, Bahia Blanca, Buenos Aires, Argentina; [Wolf, Jean-Philippe] Hop Cochin, AP HP, Serv Histol Embryol Biol Reprod, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Lefevre, B (corresponding author), Univ Paris 05, Inst Cochin, INSERM U1016, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	brigitte.lefevre@parisdescartes.fr	ZIYYAT, Ahmed/ABB-1861-2021; ZIYYAT, Ahmed/F-7617-2019	ZIYYAT, Ahmed/0000-0001-9724-3831; ZIYYAT, Ahmed/0000-0001-9724-3831	Ministry of Education of Argentina	Ministry of Education of Argentina	Jorgelina Buschiazzo thanks Ministry of Education of Argentina for the fellowship granted to support her stay in France.	Alfieri JA, 2003, J CELL SCI, V116, P2149, DOI 10.1242/jcs.00430; Asano A, 2009, J CELL PHYSIOL, V218, P537, DOI 10.1002/jcp.21623; Balkrishna S, 2010, AM J PHYSIOL-CELL PH, V299, pC1047, DOI 10.1152/ajpcell.00209.2010; Breusegem SY, 2005, AM J PHYSIOL-RENAL, V289, pF154, DOI 10.1152/ajprenal.00331.2004; Bromfield EG, 2013, REPRODUCTION, V145, pR31, DOI 10.1530/REP-12-0316; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Buschiazzo J, 2008, BBA-BIOMEMBRANES, V1778, P1398, DOI 10.1016/j.bbamem.2008.03.004; Buschiazzo J, 2011, BIOL REPROD, V85, P808, DOI 10.1095/biolreprod.110.090365; Carroll J, 2001, SEMIN CELL DEV BIOL, V12, P37, DOI 10.1006/scdb.2000.0215; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Castano S, 2005, BBA-BIOMEMBRANES, V1715, P81, DOI 10.1016/j.bbamem.2005.07.008; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; Christian AE, 1997, J LIPID RES, V38, P2264; Comiskey M, 2007, DEV BIOL, V303, P727, DOI 10.1016/j.ydbio.2006.12.009; Coonrod S, 1999, MOL HUM REPROD, V5, P1027, DOI 10.1093/molehr/5.11.1027; Coonrod SA, 1999, DEV BIOL, V207, P334, DOI 10.1006/dbio.1998.9161; EVANS JP, 2011, ANN REV PHYSL; FUJIMOTO T, 2011, COLD SPRING HARB PER, P3; Hasan AKMM, 2007, GENES CELLS, V12, P251, DOI 10.1111/j.1365-2443.2007.01048.x; Hehlgans S, 2011, AM J CANCER RES, V1, P521; Hernandez-Bello R, 2008, INT J PARASITOL, V38, P189, DOI 10.1016/j.ijpara.2007.07.009; Hogue IB, 2011, J VIROL, V85, P9749, DOI 10.1128/JVI.00743-11; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Ivankin A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238103; Izmailyan R, 2012, J VIROL, V86, P6677, DOI 10.1128/JVI.06860-11; Jegou A, 2011, P NATL ACAD SCI USA, V108, P10946, DOI 10.1073/pnas.1017400108; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Katoh SY, 2009, EXP CELL RES, V315, P2818, DOI 10.1016/j.yexcr.2009.07.008; Kawakami Y, 2002, J BIOL CHEM, V277, P34349, DOI 10.1074/jbc.M200771200; Kawano N, 2011, J LIPIDS, V2011, DOI 10.1155/2011/264706; Kurokawa M, 2004, REPRODUCTION, V127, P441, DOI 10.1530/rep.1.00128; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Lefevre B, 2010, BIOESSAYS, V32, P143, DOI 10.1002/bies.200900159; Levi M, 2011, REPROD FERT DEVELOP, V23, P846, DOI 10.1071/RD11033; Lupianez DG, 2012, J EXP ZOOL PART B, V318B, P170, DOI 10.1002/jez.b.22000; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; McGinnis LK, 2007, DEV BIOL, V306, P241, DOI 10.1016/j.ydbio.2007.03.024; McGinnis LK, 2011, MOL REPROD DEV, V78, P831, DOI 10.1002/mrd.21326; Mehlmann LM, 2005, REPRODUCTION, V129, P557, DOI 10.1530/rep.1.00638; Mehlmann LM, 1998, DEV BIOL, V203, P221, DOI 10.1006/dbio.1998.9051; Miranda PV, 2009, BIOL REPROD, V80, P897, DOI 10.1095/biolreprod.108.075242; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Motoyama K, 2009, EUR J PHARM SCI, V38, P249, DOI 10.1016/j.ejps.2009.07.010; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Nixon B, 2011, J CELL PHYSIOL, V226, P2651, DOI 10.1002/jcp.22615; Ono A, 2010, BIOL CELL, V102, P335, DOI 10.1042/BC20090165; Pang H, 2004, J CELL SCI, V117, P1421, DOI 10.1242/jcs.01009; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Qiang W, 2009, BIOCHEMISTRY-US, V48, P289, DOI 10.1021/bi8015668; Rana S, 2011, INT J BIOCHEM CELL B, V43, P106, DOI 10.1016/j.biocel.2010.10.002; Rocha-Perugini V, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-111; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Sakakibara K, 2005, J BIOL CHEM, V280, P15029, DOI 10.1074/jbc.M410538200; Salani B, 2009, BIOCHEM BIOPH RES CO, V380, P489, DOI 10.1016/j.bbrc.2009.01.102; Sasseville M, 2009, MOL ENDOCRINOL, V23, P700, DOI 10.1210/me.2008-0320; Sathananthan A H, 1997, Hum Cell, V10, P21; Sato B, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-22; Sato K, 2002, DEVELOPMENT, V129, P885; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Sato Ken-ichi, 2006, V322, P395; Sato M, 2008, J CELL SCI, V121, P3177, DOI 10.1242/jcs.034678; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Stricker SA, 2010, INT J DEV BIOL, V54, P787, DOI 10.1387/ijdb.092918ss; Stuermer CAO, 2010, TRENDS CELL BIOL, V20, P6, DOI 10.1016/j.tcb.2009.10.003; Sturmey RG, 2006, REPRODUCTION, V132, P829, DOI 10.1530/REP-06-0073; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Talmor A, 1998, DEV BIOL, V194, P38, DOI 10.1006/dbio.1997.8816; Talmor-Cohen A, 2004, REPRODUCTION, V127, P455, DOI 10.1530/rep.1.00104; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Townley IK, 2009, DEV BIOL, V327, P465, DOI 10.1016/j.ydbio.2008.12.032; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Wright MD, 2004, TISSUE ANTIGENS, V64, P533, DOI 10.1111/j.1399-0039.2004.00321.x; Xu CF, 2009, FASEB J, V23, P3273, DOI 10.1096/fj.08-123414; Yang X, 2010, REPROD FERT DEVELOP, V22, P1262, DOI 10.1071/RD10091; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479; Zhou XF, 2011, ADV EXP MED BIOL, V713, P33, DOI 10.1007/978-94-007-0763-4_4; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	83	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62919	10.1371/journal.pone.0062919	http://dx.doi.org/10.1371/journal.pone.0062919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638166	gold, Green Published			2022-12-25	WOS:000318341400074
J	Breed, AC; Meers, J; Sendow, I; Bossart, KN; Barr, JA; Smith, I; Wacharapluesadee, S; Wang, LF; Field, HE				Breed, Andrew C.; Meers, Joanne; Sendow, Indrawati; Bossart, Katharine N.; Barr, Jennifer A.; Smith, Ina; Wacharapluesadee, Supaporn; Wang, Linfa; Field, Hume E.			The Distribution of Henipaviruses in Southeast Asia and Australasia: Is Wallace's Line a Barrier to Nipah Virus?	PLOS ONE			English	Article							PTEROPUS-VAMPYRUS BATS; HENDRA VIRUS; FLYING FOXES; RT-PCR; INFECTION; ANTIBODIES; ASSAYS	Nipah virus (NiV) (Genus Henipavirus) is a recently emerged zoonotic virus that causes severe disease in humans and has been found in bats of the genus Pteropus. Whilst NiV has not been detected in Australia, evidence for NiV-infection has been found in pteropid bats in some of Australia's closest neighbours. The aim of this study was to determine the occurrence of henipaviruses in fruit bat (Family Pteropodidae) populations to the north of Australia. In particular we tested the hypothesis that Nipah virus is restricted to west of Wallace's Line. Fruit bats from Australia, Papua New Guinea, East Timor and Indonesia were tested for the presence of antibodies to Hendra virus (HeV) and Nipah virus, and tested for the presence of HeV, NiV or henipavirus RNA by PCR. Evidence was found for the presence of Nipah virus in both Pteropus vampyrus and Rousettus amplexicaudatus populations from East Timor. Serology and PCR also suggested the presence of a henipavirus that was neither HeV nor NiV in Pteropus alecto and Acerodon celebensis. The results demonstrate the presence of NiV in the fruit bat populations on the eastern side of Wallace's Line and within 500 km of Australia. They indicate the presence of non-NiV, non-HeV henipaviruses in fruit bat populations of Sulawesi and Sumba and possibly in Papua New Guinea. It appears that NiV is present where P. vampyrus occurs, such as in the fruit bat populations of Timor, but where this bat species is absent other henipaviruses may be present, as on Sulawesi and Sumba. Evidence was obtained for the presence henipaviruses in the non-Pteropid species R. amplexicaudatus and in A. celebensis. The findings of this work fill some gaps in knowledge in geographical and species distribution of henipaviruses in Australasia which will contribute to planning of risk management and surveillance activities.	[Breed, Andrew C.] Anim Hlth & Vet Labs Agcy, Surveillance & Risk Grp, Addlestone, Surrey, England; [Breed, Andrew C.; Meers, Joanne] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Sendow, Indrawati] Balai Besar Penelitian Vet, Bogor, West Java, Indonesia; [Bossart, Katharine N.; Barr, Jennifer A.; Smith, Ina; Wang, Linfa] CSIRO Livestock Ind, Australian Anim Hlth Lab, East Geelong, Vic, Australia; [Wacharapluesadee, Supaporn] Chulalongkorn Univ, Fac Med, Neurosci Ctr Res & Dev, Bangkok 10330, Thailand; [Field, Hume E.] Biosecur Queensland, Dept Employment Econ Dev & Innovat, Brisbane, Qld, Australia	Veterinary Laboratories Agency; University of Queensland; Central Veterinary Research Lab - Indonesia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chulalongkorn University; Queensland Department of Agriculture & Fisheries	Breed, AC (corresponding author), Anim Hlth & Vet Labs Agcy, Surveillance & Risk Grp, Addlestone, Surrey, England.	andrew.breed@ahvla.gsi.gov.uk	Barr, Jennifer A/H-9254-2013; Breed, Andrew C/A-5682-2011; Smith, Ina/H-7225-2013; Meers, Joanne/B-4141-2011; wang, lin/GSE-3040-2022	Breed, Andrew C/0000-0002-3439-9510; Smith, Ina/0000-0001-5807-3737; Meers, Joanne/0000-0001-9305-0469; Barr, Jennifer/0000-0001-5266-9142; Wang, Lin-Fa/0000-0003-2752-0535; Wacharapluesadee, Supaporn/0000-0001-7636-1900; Bossart, Katharine/0000-0001-6886-6896	Australian Biosecurity CRC for Emerging Infectious Disease; Henipavirus Ecology Research Group (HERG); National Institutes of Health/National Science Foundation from the John E. Fogarty International Center [R01-TW05869]; European Commission Seventh Framework Programme under ANTIGONE [278976]; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER	Australian Biosecurity CRC for Emerging Infectious Disease(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Henipavirus Ecology Research Group (HERG); National Institutes of Health/National Science Foundation from the John E. Fogarty International Center; European Commission Seventh Framework Programme under ANTIGONE; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors acknowledge support from the Australian Biosecurity CRC for Emerging Infectious Disease; the Henipavirus Ecology Research Group (HERG), funded in part by an National Institutes of Health/National Science Foundation "Ecology of Infectious Diseases" award from the John E. Fogarty International Center R01-TW05869; and the European Commission Seventh Framework Programme under ANTIGONE with project number 278976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Breed AC, 2006, BIOL CONSERV, V131, P211, DOI 10.1016/j.biocon.2006.04.007; Breed AC, 2010, EMERG INFECT DIS, V16, P1997, DOI 10.3201/eid1612.100879; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Council NHaMR, 2004, AUSTR COD PRACT CAR; Daniels P, 2001, MICROBES INFECT, V3, P289, DOI 10.1016/S1286-4579(01)01382-X; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Epstein J, 2008, J APPL ECOL IN PRESS; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Epstein Jonathan H, 2006, Curr Infect Dis Rep, V8, P59, DOI 10.1007/s11908-006-0036-2; Feldman KS, 2009, J VIROL METHODS, V161, P52, DOI 10.1016/j.jviromet.2009.05.014; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field H, 2012, CURR TOP MICROBIOL I; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; Hall L. S., 2004, SARAWAK MUS J, V80, P191; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K., 2000, GENETIC STUDIES HEND; Hanna JN, 2006, MED J AUSTRALIA, V185, P562, DOI 10.5694/j.1326-5377.2006.tb00692.x; Hasebe F, 2012, EMERG INFECT DIS, V18, P536, DOI 10.3201/eid1803.111121; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Mackenzie JS, 2003, J APPL MICROBIOL, V94, p59S; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; McCallum HI, 2008, ECOL SOC, V13; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; *OIE, 2010, HENDR NIP VIR DIS MA, P1; Olival KJ, 2008, POPULATION GENETIC S; Peel AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030346; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Sendow I, 2006, EMERG INFECT DIS, V12, P711, DOI 10.3201/eid1204.051181; Sendow I, 2010, ZOONOSES PUBLIC HLTH, V57, P499, DOI 10.1111/j.1863-2378.2009.01252.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons N.B., 2005, MAMMAL SPECIES WORLD; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Smith I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025275; Sohayati AR, 2011, EPIDEMIOL INFECT, V139, P1570, DOI 10.1017/S0950268811000550; van Oosterzee P., 1997, WORLDS COLLIDE WALLA; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wacharapluesadee S, 2007, J VIROL METHODS, V141, P97, DOI 10.1016/j.jviromet.2006.11.023; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105	51	31	33	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61316	10.1371/journal.pone.0061316	http://dx.doi.org/10.1371/journal.pone.0061316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637812	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400015
J	Eloe-Fadrosh, EA; McArthur, MA; Seekatz, AM; Drabek, EF; Rasko, DA; Sztein, MB; Fraser, CM				Eloe-Fadrosh, Emiley A.; McArthur, Monica A.; Seekatz, Anna M.; Drabek, Elliott F.; Rasko, David A.; Sztein, Marcelo B.; Fraser, Claire M.			Impact of Oral Typhoid Vaccination on the Human Gut Microbiota and Correlations with S. Typhi-Specific Immunological Responses	PLOS ONE			English	Article							T-CELLS; VACCINES; FEVER; GREENGENES; EFFECTOR; BACTERIA; TAXONOMY; ARB	The resident microbial consortia of the human gastrointestinal tract play an integral role in modulating immune responses both locally and systemically. However, detailed information regarding the effector immune responses after vaccine administration in relation to the gastrointestinal microbiota is absent. In this study, the licensed oral live-attenuated typhoid vaccine Ty21a was administered in a clinical study to investigate whether oral immunization resulted in alterations of the microbiota and to identify whether a given microbiota composition, or subsets of the community, are associated with defined S. Typhi-specific immunological responses. The fecal microbiota composition and temporal dynamics were characterized using bacterial 16S rRNA pyrosequencing from individuals who were either immunized with the Ty21a typhoid vaccine (n = 13) or served as unvaccinated controls (n = 4). The analysis revealed considerable inter- and intra-individual variability, yet no discernible perturbations of the bacterial assemblage related to vaccine administration were observed. S. Typhi-specific cell mediated immune (CMI) responses were evaluated by measurement of intracellular cytokine production using multiparametric flow cytometry, and humoral responses were evaluated by measurement of serum anti-LPS IgA and IgG titers. Volunteers were categorized according to the kinetics and magnitude of their responses. While differences in microbial composition, diversity, or temporal stability were not observed among individuals able to mount a positive humoral response, individuals displaying multiphasic CMI responses harbored more diverse, complex communities. In line with this preliminary observation, over two hundred operational taxonomic units (OTUs) were found to differentiate multiphasic and late CMI responders, the vast majority of which classified within the order Clostridiales. These results provide an unprecedented view into the dramatic temporal heterogeneity of both the gut microbiota and host immune responses.	[Eloe-Fadrosh, Emiley A.; Seekatz, Anna M.; Drabek, Elliott F.; Rasko, David A.; Fraser, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [McArthur, Monica A.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Fraser, Claire M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fraser, CM (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	cmfraser@som.umaryland.edu	McArthur, Monica/AAD-9682-2019; Eloe-Fadrosh, Emiley/AAP-8019-2021	Eloe-Fadrosh, Emiley/0000-0002-8162-1276; David, Rasko/0000-0002-7337-7154; Fraser, Claire/0000-0003-1462-2428	NIAID; NIH; DHHS [R01-AI036525, U19-AI082655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036525, U19AI082655] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This paper includes work funded, in part, by NIAID, NIH, DHHS grants R01-AI036525 (to MBS) and U19-AI082655 (Cooperative Center for Translational Research in Human Immunology and Biodefense; CCHI) to MBS and CMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Benyacoub J, 2008, J NUTR, V138, P123, DOI 10.1093/jn/138.1.123; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duong T, 2008, COMPUT STAT DATA AN, V52, P4225, DOI 10.1016/j.csda.2008.02.035; Fang H, 2000, FEMS IMMUNOL MED MIC, V29, P47, DOI 10.1111/j.1574-695X.2000.tb01504.x; Ferreira RBR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001190; Gill N, 2011, NAT REV IMMUNOL, V11, P636, DOI 10.1038/nri3061; Guzman CA, 2006, VACCINE, V24, P3804, DOI 10.1016/j.vaccine.2005.07.111; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Levine MM, 2001, MICROBES INFECT, V3, P1271, DOI 10.1016/S1286-4579(01)01487-3; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McArthur MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038408; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Oksanen J., 2016, R PACKAG; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Salerno-Goncalves R, 2002, J IMMUNOL, V169, P2196, DOI 10.4049/jimmunol.169.4.2196; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Salerno-Goncalves R, 2010, CLIN VACCINE IMMUNOL, V17, P1305, DOI 10.1128/CVI.00234-10; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Sztein MB, 2007, CLIN INFECT DIS, V45, pS15, DOI 10.1086/518140; Thompson CL, 2013, MUCOSAL IMMUNOL, V6, P200, DOI 10.1038/mi.2012.91; Wahid R, 2008, MUCOSAL IMMUNOL, V1, P389, DOI 10.1038/mi.2008.30; Wahid R, 2012, CLIN VACCINE IMMUNOL, V19, P825, DOI 10.1128/CVI.00058-12; Wahid R, 2011, CLIN IMMUNOL, V138, P187, DOI 10.1016/j.clim.2010.11.006; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitaker JA, 2009, J TRAVEL MED, V16, P46, DOI 10.1111/j.1708-8305.2008.00273.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x	39	67	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62026	10.1371/journal.pone.0062026	http://dx.doi.org/10.1371/journal.pone.0062026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637957	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400072
J	Municio, C; Alvarez, Y; Montero, O; Hugo, E; Rodriguez, M; Domingo, E; Alonso, S; Fernandez, N; Crespo, MS				Municio, Cristina; Alvarez, Yolanda; Montero, Olimpio; Hugo, Etzel; Rodriguez, Mario; Domingo, Esther; Alonso, Sara; Fernandez, Nieves; Sanchez Crespo, Mariano			The Response of Human Macrophages to beta-Glucans Depends on the Inflammatory Milieu	PLOS ONE			English	Article							ARACHIDONIC-ACID; BINDING PROTEIN; SYK KINASE; DECTIN-1; ACTIVATION; INDUCTION; RECEPTOR; PROSTAGLANDIN; ZYMOSAN; GAMMA	Background: beta-glucans are fungal cell wall components that bind to the C-type lectin-like receptor dectin-1. Polymorphisms of dectin-1 gene are associated with susceptibility to invasive fungal infection and medically refractory ulcerative colitis. The purpose of this study has been addressing the response of human macrophages to b-glucans under different conditions mimicking the composition of the inflammatory milieu in view of the wide plasticity and large range of phenotypical changes showed by these cells, and the relevant role of dectin-1 in several pathophysiological conditions. Principal Findings: Serum-differentiated macrophages stimulated with beta-glucans showed a low production of TNF alpha and IL-1 beta, a high production of IL-6 and IL-23, and a delayed induction of cyclooxygenase-2 and PGE(2) biosynthesis that resembled the responses elicited by crystals and those produced when phagosomal degradation of the phagocytic cargo increases ligand access to intracellular pattern recognition receptors. Priming with a low concentration of LPS produced a rapid induction of cyclooxygenase-2 and a synergistic release of PGE(2). When the differentiation of the macrophages was carried out in the presence of M-CSF, an increased expression of dectin-1 B isoform was observed. In addition, this treatment made the cells capable to release arachidonic acid in response to beta-glucan. Conclusions: These results indicate that the macrophage response to fungal beta-glucans is strongly influenced by cytokines and microbial-derived factors that are usual components of the inflammatory milieu. These responses can be sorted into three main patterns i) an elementary response dependent on phagosomal processing of pathogen-associated molecular patterns and/or receptor-independent, direct membrane binding linked to the immunoreceptor tyrosine-based activation motif-bearing transmembrane adaptor DNAX-activating protein 12, ii) a response primed by TLR4-dependent signals, and iii) a response dependent on M-CSF and dectin-1 B isoform expression that mainly signals through the dectin-1 B/spleen tyrosine kinase/cytosolic phospholipase A(2) route.	[Municio, Cristina; Alvarez, Yolanda; Hugo, Etzel; Domingo, Esther; Alonso, Sara; Sanchez Crespo, Mariano] CSIC, Inst Biol & Genet Mol, Valladolid, Spain; [Montero, Olimpio] CSIC, Ctr Desarrollo Biotecnol, Valladolid, Spain; [Rodriguez, Mario; Fernandez, Nieves] Univ Valladolid, Dept Bioquim & Biol Mol & Fisiol, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Crespo, MS (corresponding author), CSIC, Inst Biol & Genet Mol, Valladolid, Spain.	mscres@ibgm.uva.es	Montero, Olimpio/L-8263-2014; Rodríguez, Mario/AAE-9602-2020; Alvarez, Yolanda/AAD-4964-2021; Fernández, Nieves/N-5426-2018; Municio, Cristina/D-2916-2019	Montero, Olimpio/0000-0002-0241-8756; Rodríguez, Mario/0000-0002-4587-3863; Fernández, Nieves/0000-0002-9141-3956; Municio, Cristina/0000-0002-8552-8183; Sanchez Crespo, Mariano/0000-0002-6149-154X; Alvarez, Yolanda/0000-0002-4851-8277	Plan Nacional de Salud y Farmacia [SAF2007-60446, SAF2010-15070]; Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon [CSI003A11-2]	Plan Nacional de Salud y Farmacia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Plan Nacional de Salud y Farmacia (grants SAF2007-60446 and SAF2010-15070), Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular, and Junta de Castilla y Leon (grant CSI003A11-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2011, J BIOL CHEM, V286, P16583, DOI 10.1074/jbc.M111.222158; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; CEBON J, 1994, BRIT J HAEMATOL, V86, P265, DOI 10.1111/j.1365-2141.1994.tb04725.x; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Faro-Trindade I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035675; Fernandez N, 2003, J BIOL CHEM, V278, P52179, DOI 10.1074/jbc.M310905200; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Leea S, 2011, BIOMATERIALS, DOI [10.1016/j.biomaterials.2011.08.042, DOI 10.1016/J.BI0MATERIALS.2011.08.042]; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; McDonald JU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045781; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; O'Reilly KMA, 2005, AM J PHYSIOL-LUNG C, V288, pL1010, DOI 10.1152/ajplung.00024.2004; Parry GCN, 1997, J IMMUNOL, V159, P5450; Parti RP, 2010, AM J RESP CELL MOL, V42, P415, DOI 10.1165/rcmb.2009-0110OC; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rosenzweig HL, 2011, INFLAMM RES, V60, P705, DOI 10.1007/s00011-011-0324-7; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Wolf AJ, 2011, J IMMUNOL, V187, P6002, DOI 10.4049/jimmunol.1100232; Wright KL, 2004, BRIT J PHARMACOL, V141, P1091, DOI 10.1038/sj.bjp.0705719; Xia Y, 1999, J IMMUNOL, V162, P2281	43	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62016	10.1371/journal.pone.0062016	http://dx.doi.org/10.1371/journal.pone.0062016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637950	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400069
J	Xu, YF; Kreth, J				Xu, Yifan; Kreth, Jens			Role of LytF and AtlS in eDNA Release by Streptococcus gordonii	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; EXTRACELLULAR-DNA; BIOFILM FORMATION; MUREIN HYDROLASE; CELL-DEATH; COMPETENCE; PNEUMONIAE; STRESS; MUTANS; EXPRESSION	Extracellular DNA (eDNA) is an important component of the biofilm matrix produced by many bacteria. In general, the release of eDNA is associated with the activity of muralytic enzymes leading to obvious cell lysis. In the Gram-positive oral commensal Streptococcus gordonii, eDNA release is dependent on pyruvate oxidase generated hydrogen peroxide (H2O2). Addition of H2O2 to cells grown under conditions non-permissive for H2O2 production causes eDNA release. Furthermore, eDNA release is maximal under aerobic growth conditions known to induce pyruvate oxidase gene expression and H2O2 production. Obvious cell lysis, however, does not occur. Two enzymes have been recently associated with eDNA release in S. gordonii. The autolysin AtlS and the competence regulated murein hydrolase LytF. In the present report, we investigated the role of both proteins in the H2O2 dependent eDNA release process. Single and double mutants in the respective genes for LytF and AtlS released less eDNA under normal growth conditions, but the AtlS mutant was still inducible for eDNA release by external H2O2. Moreover, we showed that the AtlS mutation interfered with the ability of S. gordonii to produce eDNA release inducing amounts of H2O2. Our data support a role of LytF in the H2O2 eDNA dependent release of S. gordonii as part of the competence stress pathway responding to oxidative stress.	[Xu, Yifan; Kreth, Jens] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Kreth, Jens] Univ Oklahoma, Hlth Sci Ctr, Coll Dent, Oklahoma City, OK 73190 USA; [Xu, Yifan] China Med Univ, Hosp 1, Dept Surg Oncol, Shenyang, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; China Medical University	Kreth, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	JKreth@ouhsc.edu	Kreth, Jens/AAU-7833-2021	Kreth, Jens/0000-0002-8599-8310	National Institutes of Health/National Institute of Dental and Craniofacial Research [R00 DE018400, R03 DE022601]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE022601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018400] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding came from R00 DE018400 & R03 DE022601 from National Institutes of Health/National Institute of Dental and Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-187; Ahn SJ, 2010, MICROBIOL-SGM, V156, P3136, DOI 10.1099/mic.0.039586-0; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Barnes AMT, 2012, MBIO, V3, DOI 10.1128/mBio.00193-12; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Berg KH, 2012, J BACTERIOL, V194, P627, DOI 10.1128/JB.06273-11; Bose JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042244; Carlsson J, 1987, Oral Microbiol Immunol, V2, P15, DOI 10.1111/j.1399-302X.1987.tb00264.x; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Dominiak DM, 2011, ENVIRON MICROBIOL, V13, P710, DOI 10.1111/j.1462-2920.2010.02375.x; Eldholm V, 2009, MICROBIOL-SGM, V155, P2223, DOI 10.1099/mic.0.026328-0; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Itzek A, 2011, J BACTERIOL, V193, P6912, DOI 10.1128/JB.05791-11; Kaplan JB, 2011, RES MICROBIOL, V162, P535, DOI 10.1016/j.resmic.2011.03.008; Kausmally L, 2005, J BACTERIOL, V187, P4338, DOI 10.1128/JB.187.13.4338-4345.2005; Klein MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013478; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Liu JX, 1999, GENE, V237, P153, DOI 10.1016/S0378-1119(99)00314-5; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; MARTIN B, 1987, PLASMID, V18, P250, DOI 10.1016/0147-619X(87)90068-0; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Srikantha T, 1996, J BACTERIOL, V178, P121, DOI 10.1128/jb.178.1.121-129.1996; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; SUNDQVIST G, 1988, ORAL MICROBIOL IMMUN, V3, P103, DOI 10.1111/j.1399-302X.1988.tb00093.x; Tannous BA, 2011, BIOTECHNOL ADV, V29, P997, DOI 10.1016/j.biotechadv.2011.08.021; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zafra O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048716; Zheng LY, 2011, APPL ENVIRON MICROB, V77, P4318, DOI 10.1128/AEM.00309-11; Zheng LY, 2011, J BACTERIOL, V193, P516, DOI 10.1128/JB.01131-10; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843	44	10	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62339	10.1371/journal.pone.0062339	http://dx.doi.org/10.1371/journal.pone.0062339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638042	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400098
J	Jasik, J; Boggetti, B; Baluska, F; Volkmann, D; Gensch, T; Rutten, T; Altmann, T; Schmelzer, E				Jasik, Jan; Boggetti, Barbara; Baluska, Frantisek; Volkmann, Dieter; Gensch, Thomas; Rutten, Twan; Altmann, Thomas; Schmelzer, Elmon			PIN2 Turnover in Arabidopsis Root Epidermal Cells Explored by the Photoconvertible Protein Dendra2	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; FLUORESCENT PROTEINS; INTRACELLULAR TRAFFICKING; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; EFFLUX CARRIER; PLANT-CELLS; GRAVITROPISM; ENDOCYTOSIS	The steady state level of integral membrane proteins is dependent on a strictly controlled delivery and removal. Here we show that Dendra2, a green-to-red photoconvertible fluorescent protein, is a suitable tool to study protein turnover in plants. We characterized the fluorescence properties of Dendra2 expressed either as a free protein or as a tag in Arabidopsis thaliana roots and optimized photoconversion settings to study protein turnover. Dendra2 was fused to the PIN2 protein, an auxin transporter in the root tip, and by time-lapse imaging and assessment of red and green signal intensities in the membrane after photoconversion we quantified directly and simultaneously the rate of PIN2 delivery of the newly synthesized protein into the plasma membrane as well as the disappearance of the protein from the plasma membrane due to degradation. Additionally we have verified several factors which are expected to affect PIN2 protein turnover and therefore potentially regulate root growth.	[Jasik, Jan; Schmelzer, Elmon] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Boggetti, Barbara] Ctr Mol Med Cologne, Dept Dermatol, Cologne, Germany; [Jasik, Jan; Baluska, Frantisek; Volkmann, Dieter] Univ Bonn, Inst Cellular & Mol Bot, Bonn, Germany; [Gensch, Thomas] Res Ctr Juelich, Inst Complex Syst 4, Julich, Germany; [Jasik, Jan; Rutten, Twan; Altmann, Thomas] Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany; [Jasik, Jan] Comenius Univ, Fac Nat Sci, Bratislava, Slovakia	Max Planck Society; University of Cologne; University of Bonn; Helmholtz Association; Research Center Julich; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Comenius University Bratislava	Jasik, J (corresponding author), Max Planck Inst Plant Breeding Res, Cologne, Germany.	jan.jasik@yahoo.com	Baluska, Frantisek/AAQ-1358-2021; Jásik, Ján/AAA-3935-2019	Rutten, Twan/0000-0001-5891-6503; Altmann, Thomas/0000-0002-3759-360X; Jasik, Jan/0000-0001-8522-932X	ESA MAP Project "Perception of gravity, signal transduction and graviresponse in higher plants - application of innovative genomic technologies"; Leibniz Institute of Plant Genetics and Crop Plant Research, Gatersleben	ESA MAP Project "Perception of gravity, signal transduction and graviresponse in higher plants - application of innovative genomic technologies"; Leibniz Institute of Plant Genetics and Crop Plant Research, Gatersleben	This work was partially supported by the ESA MAP Project "Perception of gravity, signal transduction and graviresponse in higher plants - application of innovative genomic technologies (2005-2009)" and by a shot term fellowship from The Leibniz Institute of Plant Genetics and Crop Plant Research, Gatersleben, to JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Adam V, 2009, BIOCHEMISTRY-US, V48, P4905, DOI 10.1021/bi900383a; Baker SM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-15; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Brown SC, 2010, PLANT J, V63, P696, DOI 10.1111/j.1365-313X.2010.04272.x; Caneparo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020230; Cho M, 2012, PLANT PHYSIOL, V159, P642, DOI 10.1104/pp.112.196139; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Chudakov DM, 2007, BIOTECHNIQUES, V42, P553, DOI 10.2144/000112470; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Claydon AJ, 2011, METHODS MOL BIOL, V759, P179, DOI 10.1007/978-1-61779-173-4_11; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Craggs TD, 2009, CHEM SOC REV, V38, P2865, DOI 10.1039/b903641p; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Dempsey WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032888; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Dovas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016485; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Friml J, 2010, EUR J CELL BIOL, V89, P231, DOI 10.1016/j.ejcb.2009.11.003; Grunewald W, 2010, EMBO J, V29, P2700, DOI 10.1038/emboj.2010.181; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hamer G, 2010, NAT METHODS, V7, P473, DOI [10.1038/nmeth.1460, 10.1038/NMETH.1460]; Held MA, 2008, PLANT PHYSIOL, V147, P1469, DOI 10.1104/pp.108.120147; Hinkson IV, 2011, TRENDS CELL BIOL, V21, P293, DOI 10.1016/j.tcb.2011.02.002; Ihara S, 2011, NAT CELL BIOL, V13, P641, DOI 10.1038/ncb2233; Jasik J, 2011, PLANT PHYSIOL, V157, P563, DOI 10.1104/pp.111.180760; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Koncz C, 1994, PLANT MOL BIOL MANUA, VB2, P1, DOI DOI 10.1007/978-94-011-0511-8_4; Kuzmenko A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00195; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Leitner J, 2012, P NATL ACAD SCI USA, V109, P8322, DOI 10.1073/pnas.1200824109; Li L, 2005, PLANT CELL, V17, P2738, DOI 10.1105/tpc.105.034397; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Mathur J, 2010, PLANT PHYSIOL, V154, P1573, DOI 10.1104/pp.110.165431; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nagawa S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001299; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Piatkevich KD, 2010, CURR OPIN CHEM BIOL, V14, P23, DOI 10.1016/j.cbpa.2009.10.011; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Rahman A, 2010, PLANT CELL, V22, P1762, DOI 10.1105/tpc.110.075317; Schattat MH, 2012, PLANT CELL, V24, P1465, DOI 10.1105/tpc.111.095398; Schenkel M, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-21; Shibasaki K, 2009, PLANT CELL, V21, P3823, DOI 10.1105/tpc.109.069906; Stepanenko OV, 2011, BIOTECHNIQUES, V51, P313, DOI 10.2144/000113765; Sun FF, 2008, PLANT PHYSIOL, V146, P178, DOI 10.1104/pp.107.109413; Sun JQ, 2011, NEW PHYTOL, V191, P360, DOI 10.1111/j.1469-8137.2011.03713.x; Sun P, 2010, J EXP BOT, V61, P347, DOI 10.1093/jxb/erp306; Wan YL, 2012, PLANT CELL, V24, P551, DOI 10.1105/tpc.111.094284; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Willige BC, 2011, PLANT CELL, V23, P2184, DOI 10.1105/tpc.111.086355; Wu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027536; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zhang LJ, 2007, BIOTECHNIQUES, V42, P446, DOI 10.2144/000112453	60	29	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61403	10.1371/journal.pone.0061403	http://dx.doi.org/10.1371/journal.pone.0061403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637828	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700030
J	Tan, GKX; Ng, JKW; Tan, KW; Angeli, V; Moochhala, S; Ooi, EE; Alonso, S				Tan, Grace Kai Xin; Ng, Jowin Kai Wei; Tan, Kar Wai; Angeli, Veronique; Moochhala, Shabbir; Ooi, Eng Eong; Alonso, Sylvie			Hypertonic Saline Reduces Vascular Leakage in a Mouse Model of Severe Dengue	PLOS ONE			English	Article							SMALL-VOLUME RESUSCITATION; VIRUS; INFECTION; REPLICATION; ENDOTHELIUM; STRAIN; MICE	Dengue (DEN) is a mosquito-borne viral disease and represents a serious public health threat and an economical burden throughout the tropics. Dengue clinical manifestations range from mild acute febrile illness to severe DEN hemorrhagic fever/DEN shock syndrome (DHF/DSS). Currently, resuscitation with large volumes of isotonic fluid remains the gold standard of care for DEN patients who develop vascular leakage and shock. Here, we investigated the ability of small volume of hypertonic saline (HTS) suspensions to control vascular permeability in a mouse model of severe DEN associated with vascular leakage. Several HTS treatment regimens were considered and our results indicated that a single bolus of 7.5% NaCl at 4 mL per kg of body weight administered at the onset of detectable vascular leakage rapidly and significantly reduced vascular leak for several days after injection. This transient reduction of vascular leakage correlated with reduced intestine and liver damage with restoration of the hepatic functions, and resulted in delayed death of the infected animals. Mechanistically, we showed that HTS did not directly impact on the viral titers but resulted in lower immune cells counts and decreased systemic levels of soluble mediators involved in vascular permeability. In addition, we demonstrated that neutrophils do not play a critical role in DEN-associated vascular leakage and that the therapeutic effect of HTS is not mediated by its impact on the neutrophil counts. Together our data indicate that HTS treatment can transiently but rapidly reduce dengue-associated vascular leakage, and support the findings of a recent clinical trial which evaluated the efficacy of a hypertonic suspension to impact on vascular permeability in DSS children.	[Tan, Grace Kai Xin; Ng, Jowin Kai Wei; Tan, Kar Wai; Angeli, Veronique; Alonso, Sylvie] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Microbiol,Immunol Programme, Singapore 117595, Singapore; [Moochhala, Shabbir; Ooi, Eng Eong] DSO Natl Labs, Singapore, Singapore; [Ooi, Eng Eong] Duke NUS Grad Med Sch, Progamme Emerging Infect Dis, Singapore, Singapore	National University of Singapore; National University of Singapore	Alonso, S (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Microbiol,Immunol Programme, Singapore 117595, Singapore.	micas@nus.edu.sg		Ooi, Eng Eong/0000-0002-0520-1544; MOOCHHALA, SHABBIR/0000-0003-4521-3192	National Medical Research Council under the TCR grant "STOP Dengue''	National Medical Research Council under the TCR grant "STOP Dengue''	This work was funded by the National Medical Research Council under the TCR grant "STOP Dengue''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; COIMBRA R, 1995, SHOCK, V4, P45, DOI 10.1097/00024382-199507000-00007; Grant D, 2011, J VIROL, V85, P7775, DOI 10.1128/JVI.00665-11; Whitehorn J, 2011, CLIN MED, V11, P483, DOI 10.7861/clinmedicine.11-5-483; Junger WG, 1997, J TRAUMA, V42, P437, DOI 10.1097/00005373-199703000-00011; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lee L, 2011, J SURG RES; McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Somasetia DH, 2011, MKB BANDUNG MED J, V42, p23S; Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6; Srikiatkhachorn A, 2009, THROMB HAEMOSTASIS, V102, P1042, DOI 10.1160/TH09-03-0208; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Tan GKX, 2011, ANN ACAD MED SINGAP, V40, P523; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Trung DT, 2010, CURR TOP MICROBIOL, V338, P57, DOI 10.1007/978-3-642-02215-9_5; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754; World Health Organization (WHO), GUID DENG	31	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61621	10.1371/journal.pone.0061621	http://dx.doi.org/10.1371/journal.pone.0061621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637867	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700048
J	Cacioppo, S; Bianchi-Demicheli, F; Bischof, P; DeZiegler, D; Michel, CM; Landis, T				Cacioppo, Stephanie; Bianchi-Demicheli, Francesco; Bischof, Paul; DeZiegler, Dominique; Michel, Christoph M.; Landis, Theodor			Hemispheric Specialization Varies with EEG Brain Resting States and Phase of Menstrual Cycle	PLOS ONE			English	Article							FUNCTIONAL CEREBRAL ASYMMETRIES; ACTIVATION PATTERNS; FLUCTUATIONS; ABILITIES; DEPEND	A growing body of behavioral studies has demonstrated that women's hemispheric specialization varies as a function of their menstrual cycle, with hemispheric specialization enhanced during their menstruation period. Our recent high-density electroencephalogram (EEG) study with lateralized emotional versus neutral words extended these behavioral results by showing that hemispheric specialization in men, but not in women under birth-control, depends upon specific EEG resting brain states at stimulus arrival, suggesting that hemispheric specialization may be pre-determined at the moment of the stimulus onset. To investigate whether EEG brain resting state for hemispheric specialization could vary as a function of the menstrual phase, we tested 12 right-handed healthy women over different phases of their menstrual cycle combining high-density EEG recordings and the same lateralized lexical decision paradigm with emotional versus neutral words. Results showed the presence of specific EEG resting brain states, associated with hemispheric specialization for emotional words, at the moment of the stimulus onset during the menstruation period only. These results suggest that the pre-stimulus EEG pattern influencing hemispheric specialization is modulated by the hormonal state.	[Cacioppo, Stephanie] Univ Chicago, Dept Psychol, High Performance Elect NeuroImaging HPEN Lab, CCSN, Chicago, IL 60637 USA; [Bianchi-Demicheli, Francesco; Bischof, Paul] Univ Hosp Geneva, Dept Gynecol & Obstet, Geneva, Switzerland; [Bianchi-Demicheli, Francesco; Bischof, Paul; Michel, Christoph M.; Landis, Theodor] Med Fac Geneva, Geneva, Switzerland; [DeZiegler, Dominique] Hop Cochin St Vincent de Paul, Dept Obstet & Gynecol 2, Paris, France; [Michel, Christoph M.; Landis, Theodor] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland	University of Chicago; University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Geneva	Cacioppo, S (corresponding author), Univ Chicago, Dept Psychol, High Performance Elect NeuroImaging HPEN Lab, CCSN, 5848 S Univ Ave, Chicago, IL 60637 USA.	cacioppos@uchicago.edu; theodor.landis@unige.ch		Michel, Christoph/0000-0003-3426-5739	Swiss National Science Foundation [31-65096.01, 320030_132967, FNS_PP00_1_128599/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Swiss National Science Foundation to TL (#31-65096.01 and 320030_132967). SC received a professorship by the Swiss National Science Foundation (#FNS_PP00_1_128599/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer U, 2008, NEUROPSYCHOLOGIA, V46, P2415, DOI 10.1016/j.neuropsychologia.2008.02.028; BIBAWI D, 1995, NEUROPSYCHOLOGIA, V33, P131, DOI 10.1016/0028-3932(94)00103-V; Britz J, 2008, CEREBRAL CORTEX; Britz J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00370; Britz J, 2010, NEUROIMAGE, V49, P2774, DOI 10.1016/j.neuroimage.2009.10.033; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Choi JC, 2006, ANESTHESIOLOGY, V105, P120, DOI 10.1097/00000542-200607000-00021; Dietrich T, 2001, NEUROIMAGE, V13, P425, DOI 10.1006/nimg.2001.0703; Fernandez G, 2003, J NEUROSCI, V23, P3790; GRAVES R, 1981, NEUROPSYCHOLOGIA, V19, P95, DOI 10.1016/0028-3932(81)90049-X; HAMPSON E, 1990, BRAIN COGNITION, V14, P26, DOI 10.1016/0278-2626(90)90058-V; Hausmann M, 2006, CLIN NEUROPHYSIOL, V117, P26, DOI 10.1016/j.clinph.2005.08.022; Hausmann M, 2000, BEHAV NEUROSCI, V114, P1245, DOI 10.1037/0735-7044.114.6.1245; Hausmann M, 2002, NEUROPSYCHOLOGIA, V40, P808, DOI 10.1016/S0028-3932(01)00179-8; Hausmann M, 2000, NEUROPSYCHOLOGIA, V38, P1362, DOI 10.1016/S0028-3932(00)00045-2; KONDAKOR I, 1995, J MED ENG TECHNOL, V19, P66, DOI 10.3109/03091909509030277; Kondakor I, 1997, PRESTIMULUS EEG MICR; Lehmann D, 1971, Nervenarzt, V42, P257; Lehmann D, 1998, INT J PSYCHOPHYSIOL, V29, P1, DOI 10.1016/S0167-8760(97)00098-6; Lehmann D, 1994, Int J Neurosci, V74, P239; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mead LA, 1996, SEX DIFFERENCE TURNI; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Mihm M, 2011, ANIM REPROD SCI, V124, P229, DOI 10.1016/j.anireprosci.2010.08.030; Mohr C, 2005, BRAIN STATE DEPENDEN; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ortigue S, 2004, NEUROIMAGE, V21, P1242, DOI 10.1016/j.neuroimage.2003.11.007; RODE C, 1995, NEUROPSYCHOLOGIA, V33, P855, DOI 10.1016/0028-3932(95)00015-U; Weis S, 2011, HUM BRAIN MAPP, V32, P1544, DOI 10.1002/hbm.21126; Weis S, 2010, NEUROSCIENTIST, V16, P132, DOI 10.1177/1073858409341481; Weis S, 2008, J NEUROSCI, V28, P13401, DOI 10.1523/JNEUROSCI.4392-08.2008	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63196	10.1371/journal.pone.0063196	http://dx.doi.org/10.1371/journal.pone.0063196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638185	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300150
J	Karl, I; Stoks, R; Bauerfeind, SS; Dierks, A; Franke, K; Fischer, K				Karl, Isabell; Stoks, Robby; Bauerfeind, Stephanie S.; Dierks, Anneke; Franke, Kristin; Fischer, Klaus			No Trade-Off between Growth Rate and Temperature Stress Resistance in Four Insect Species	PLOS ONE			English	Article							LIFE-HISTORY; COMPENSATORY GROWTH; IMMUNE FUNCTION; DROSOPHILA-MELANOGASTER; PHENOTYPIC PLASTICITY; PHYSIOLOGICAL COSTS; COLD TOLERANCE; RAPID GROWTH; SELECTION; TIME	Although fast growth seems to be generally favored by natural selection, growth rates are rarely maximized in nature. Consequently, fast growth is predicted to carry costs resulting in intrinsic trade-offs. Disentangling such trade-offs is of great ecological importance in order to fully understand the prospects and limitations of growth rate variation. A recent study provided evidence for a hitherto unknown cost of fast growth, namely reduced cold stress resistance. Such relationships could be especially important under climate change. Against this background we here investigate the relationships between individual larval growth rate and adult heat as well as cold stress resistance, using eleven data sets from four different insect species (three butterfly species: Bicyclus anynana, Lycaena tityrus, Pieris napi; one Dipteran species: Protophormia terraenovae). Despite using different species (and partly different populations within species) and an array of experimental manipulations (e.g. different temperatures, photoperiods, feeding regimes, inbreeding levels), we were not able to provide any consistent evidence for trade-offs between fast growth and temperature stress resistance in these four insect species.	[Karl, Isabell; Bauerfeind, Stephanie S.; Dierks, Anneke; Franke, Kristin; Fischer, Klaus] Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany; [Stoks, Robby] Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Louvain, Belgium	Ernst Moritz Arndt Universitat Greifswald; KU Leuven	Fischer, K (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany.	Klaus.fischer@uni-greifswald.de	Stoks, Robby/AAK-1227-2020	Stoks, Robby/0000-0003-4130-0459	German Research Foundation (DFG) [Fi 846/6-1]; Greifswald University; Fund for Scientific Research-Flanders (FWO); KU Leuven research fund	German Research Foundation (DFG)(German Research Foundation (DFG)); Greifswald University; Fund for Scientific Research-Flanders (FWO)(FWO); KU Leuven research fund(KU Leuven)	IK was funded by the German Research Foundation (DFG grant Fi 846/6-1 to KF) while preparing this manuscript. The authors acknowledge financial support from Greifswald University to KF and from the Fund for Scientific Research-Flanders (FWO) and the KU Leuven research fund to RS. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2005, CAN J FISH AQUAT SCI, V62, P2169, DOI 10.1139/F05-130; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Auer SK, 2010, ECOL LETT, V13, P998, DOI 10.1111/j.1461-0248.2010.01491.x; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Blanckenhorn WU, 2004, EVOL ECOL, V18, P385, DOI 10.1007/s10682-004-2680-z; Brodin T, 2004, ECOLOGY, V85, P2927, DOI 10.1890/03-3120; Byrd JH., 2001, FORENSIC ENTOMOLOGY; Castaneda LE, 2005, J INSECT PHYSIOL, V51, P1346, DOI 10.1016/j.jinsphys.2005.08.005; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Collinge JE, 2006, J EVOLUTION BIOL, V19, P473, DOI 10.1111/j.1420-9101.2005.01016.x; Cotter SC, 2008, J EVOLUTION BIOL, V21, P1744, DOI 10.1111/j.1420-9101.2008.01587.x; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; De Block M, 2008, P ROY SOC B-BIOL SCI, V275, P781, DOI 10.1098/rspb.2007.1515; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dierks A, 2012, J EVOLUTION BIOL, V25, P1650, DOI 10.1111/j.1420-9101.2012.02547.x; Dierks A, 2012, EVOLUTION, V66, P2384, DOI 10.1111/j.1558-5646.2012.01604.x; Dierks A, 2012, POPUL ECOL, V54, P83, DOI 10.1007/s10144-011-0291-4; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; EBERT G., 1991, SCHMETTERLINGE BADEN, V2; Ebert G, 1993, SCHMETTERLINGE BADEN; Fischer K, 2004, EVOL ECOL, V18, P343, DOI 10.1007/s10682-004-2004-3; Fischer K, 2012, EVOL ECOL, V26, P1067, DOI 10.1007/s10682-011-9547-x; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Franke K, 2013, J EVOLUTION BIOL, V26, P517, DOI 10.1111/jeb.12064; Franke K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-235; Gotthard K, 2001, EXPTL BIOL REV, P287; GOTTHARD K, 1994, OECOLOGIA, V99, P281, DOI 10.1007/BF00627740; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Inness CLW, 2008, P ROY SOC B-BIOL SCI, V275, P1703, DOI 10.1098/rspb.2008.0357; Karl I, 2008, FUNCT ECOL, V22, P887, DOI 10.1111/j.1365-2435.2008.01438.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Karl I, 2011, GLOBAL CHANGE BIOL, V17, P676, DOI 10.1111/j.1365-2486.2010.02277.x; Larsen T. B., 1991, BUTTERFLIES KENYA; Lee DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026172; Lee WS, 2010, J EXP BIOL, V213, P3289, DOI 10.1242/jeb.043083; Mangel M, 2005, AM NAT, V166, pE155, DOI 10.1086/444439; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Morgan IJ, 2001, P ROY SOC B-BIOL SCI, V268, P295, DOI 10.1098/rspb.2000.1365; Munch SB, 2003, EVOLUTION, V57, P2119, DOI 10.1554/02-711; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Rantala MJ, 2005, FUNCT ECOL, V19, P323, DOI 10.1111/j.1365-2435.2005.00979.x; Roff Derek A., 1992; Rolff J, 2004, AM NAT, V164, P559, DOI 10.1086/423715; Sinclair BJ, 2003, TRENDS ECOL EVOL, V18, P257, DOI 10.1016/S0169-5347(03)00014-4; Stearns S.C., 1992, pi; Stoks R, 2005, J ANIM ECOL, V74, P708, DOI 10.1111/j.1365-2656.2005.00969.x; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Stoks R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016935; van der Most PJ, 2011, FUNCT ECOL, V25, P74, DOI 10.1111/j.1365-2435.2010.01800.x; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Willmer P., 2000, ENV PHYSL ANIMALS; Zeilstra I, 2005, PHYSIOL ENTOMOL, V30, P92, DOI 10.1111/j.0307-6962.2005.00430.x; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	60	5	5	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62434	10.1371/journal.pone.0062434	http://dx.doi.org/10.1371/journal.pone.0062434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638084	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300058
J	Leung, CK; Wang, Y; Malany, S; Deonarine, A; Nguyen, K; Vasile, S; Choe, KP				Leung, Chi K.; Wang, Ying; Malany, Siobhan; Deonarine, Andrew; Nguyen, Kevin; Vasile, Stefan; Choe, Keith P.			An Ultra High-Throughput, Whole-Animal Screen for Small Molecule Modulators of a Specific Genetic Pathway in Caenorhabditis elegans	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; OXIDATIVE-STRESS-RESPONSE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; MODEL SYSTEMS; FACTOR SKN-1; ADMET RULES; NEMATODE; DISCOVERY; LONGEVITY	High-throughput screening (HTS) is a powerful approach to drug discovery, but many lead compounds are found to be unsuitable for use in vivo after initial screening. Screening in small animals like C. elegans can help avoid these problems, but this system has been limited to screens with low-throughput or no specific molecular target. We report the first in vivo 1536-well plate assay for a specific genetic pathway in C. elegans. Our assay measures induction of a gene regulated by SKN-1, a master regulator of detoxification genes. SKN-1 inhibitors will be used to study and potentially reverse multidrug resistance in parasitic nematodes. Screens of two small commercial libraries and the full Molecular Libraries Small Molecule Repository (MLSMR) of similar to 364,000 compounds validate our platform for ultra HTS. Our platform overcomes current limitations of many whole-animal screens and can be widely adopted for other inducible genetic pathways in nematodes and humans.	[Leung, Chi K.; Wang, Ying; Deonarine, Andrew; Choe, Keith P.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Leung, Chi K.; Wang, Ying; Deonarine, Andrew; Choe, Keith P.] Univ Florida, Genet Inst, Gainesville, FL USA; [Malany, Siobhan; Nguyen, Kevin; Vasile, Stefan] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute	Choe, KP (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	kchoe@ufl.edu			National Institutes of Health (NIH) [1R21NS067678]; National Science Foundation (NSF) [IOS-1120130]; Division Of Integrative Organismal Systems [1120130] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067678] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (NIH) grant 1R21NS067678 (http://www.nih.gov/) and National Science Foundation (NSF) grant IOS-1120130 (http://www.nsf.gov/) to KPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478; Aithal BK, 2011, J PHARM SCI-US, V100, P3517, DOI 10.1002/jps.22573; Aithal BK, 2009, CELL BIOL INT, V33, P1039, DOI 10.1016/j.cellbi.2009.06.018; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Anastassopoulou CG, 2011, CURR PHARM DESIGN, V17, P1225, DOI 10.2174/138161211795703753; Antoshechkin I, 2007, NAT REV GENET, V8, P518, DOI 10.1038/nrg2105; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Bass Alan S., 2009, Journal of Pharmacological and Toxicological Methods, V60, P69, DOI 10.1016/j.vascn.2009.04.194; Basu A, 2010, THESCIENTIFICWORLDJO, V10, P2272, DOI 10.1100/tsw.2010.214; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2010, NAT CHEM BIOL; Calliste CA, 2001, ANTICANCER RES, V21, P3949; Carroll PM, 2003, PHARMACOL THERAPEUT, V99, P183, DOI 10.1016/S0163-7258(03)00059-7; Castoreno AB, 2011, ACS CHEM BIOL, V6, P86, DOI 10.1021/cb1002976; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Choe KP, 2007, AM J PHYSIOL-CELL PH, V293, pC915, DOI 10.1152/ajpcell.00126.2007; Choe KP, 2012, DRUG METAB REV, V44, P209, DOI 10.3109/03602532.2012.684799; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Collins JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000230; Ellerbrock BR, 2004, J BIOMOL SCREEN, V9, P147, DOI 10.1177/1087057103261038; Fox JT, 2012, ONCOTARGET, V3, P581; Geary TG, 2001, VET PARASITOL, V101, P371, DOI 10.1016/S0304-4017(01)00562-3; Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q; Gleeson P, 2009, BIOORGAN MED CHEM, V17, P5906, DOI 10.1016/j.bmc.2009.07.002; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Harrington AJ, 2010, DEV DYNAM, V239, P1282, DOI 10.1002/dvdy.22231; Hasegawa K, 2004, TOXICOL LETT, V152, P183, DOI 10.1016/j.toxlet.2004.04.037; Hasegawa K, 2008, TOXICOL SCI, V101, P215, DOI 10.1093/toxsci/kfm276; Hasegawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011194; Hobert O, 2006, METHOD BIOCHEM ANAL, V47, P203; Holden-Dye L, 2012, INVERTEBR NEUROSCI, V12, P29, DOI 10.1007/s10158-012-0133-x; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Hotez P, 2009, HEALTH AFFAIR, V28, P1720, DOI 10.1377/hlthaff.28.6.1720; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; James CE, 2007, PARASITOL RES, V101, P975, DOI 10.1007/s00436-007-0572-1; Jasmer DP, 2003, ANNU REV PHYTOPATHOL, V41, P245, DOI 10.1146/annurev.phyto.41.052102.104023; Johnston PA, 2009, ASSAY DRUG DEV TECHN, V7, P250, DOI 10.1089/adt.2008.186; Jones AK, 2005, NAT REV DRUG DISCOV, V4, P321, DOI 10.1038/nrd1692; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kalive M, 2010, MOL REPROD DEV, V77, P95, DOI 10.1002/mrd.21112; Katiki LM, 2011, VET PARASITOL, V182, P264, DOI 10.1016/j.vetpar.2011.05.020; Kotze AC, 2004, AM J TROP MED HYG, V71, P608, DOI 10.4269/ajtmh.2004.71.608; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leung CK, 2012, FREE RADICAL BIO MED, V52, P937, DOI 10.1016/j.freeradbiomed.2011.12.009; Leung CK, 2011, JOVE-J VIS EXP, pe2754; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Liu QA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-37; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Ma XD, 2012, CANCER CHEMOTH PHARM, V69, P485, DOI 10.1007/s00280-011-1722-9; Marvanova M, 2007, J MOL NEUROSCI, V31, P127, DOI 10.1385/JMN/31:02:127; Mathiesen L, 1997, FREE RADICAL BIO MED, V22, P307, DOI 10.1016/S0891-5849(96)00277-8; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Moye-Rowley WS, 2003, PROG NUCLEIC ACID RE, V73, P251, DOI 10.1016/S0079-6603(03)01008-0; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Oresajo Christian, 2008, J Cosmet Dermatol, V7, P290, DOI 10.1111/j.1473-2165.2008.00408.x; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Persidis A, 1999, NAT BIOTECHNOL, V17, P94, DOI 10.1038/5289; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Praitis V, 2011, METHOD CELL BIOL, V106, P161, DOI 10.1016/B978-0-12-544172-8.00006-2; Prasad R, 2005, INT REV CYTOL, V242, P215; Prasad R, 2002, ADV MICROB PHYSIOL, V46, P155, DOI 10.1016/S0065-2911(02)46004-3; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Rezk BM, 2002, BIOCHEM BIOPH RES CO, V295, P9, DOI 10.1016/S0006-291X(02)00618-6; Roberts SA, 2001, XENOBIOTICA, V31, P557, DOI 10.1080/00498250110060978; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; SIMPKIN KG, 1981, J CHEM TECHNOL BIOT, V31, P66, DOI 10.1002/jctb.280310110; Sipos G, 2006, CURR DRUG TARGETS, V7, P471, DOI 10.2174/138945006776359403; Smout MJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000885; Solis GM, 2011, JOVE-J VIS EXP, DOI 10.3791/2496; Strange K, 2003, PHYSIOL REV, V83, P377, DOI 10.1152/physrev.00025.2002; Sumantran VN, 2011, METHODS MOL BIOL, V731, P219, DOI 10.1007/978-1-61779-080-5_19; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Walker GA, 2003, FASEB J, V17, P1960, DOI 10.1096/fj.03-0164fje; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang Z, 2011, METHOD CELL BIOL, V106, P113, DOI 10.1016/B978-0-12-544172-8.00005-0; Weyermann J, 2005, INT J PHARMACEUT, V288, P369, DOI 10.1016/j.ijpharm.2004.09.018; Williams RG, 2006, METHOD ENZYMOL, V414, P364, DOI 10.1016/S0076-6879(06)14021-5; Wright DA, 2007, ENVIRON TECHNOL, V28, P1091, DOI 10.1080/09593332808618873; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954	86	46	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62166	10.1371/journal.pone.0062166	http://dx.doi.org/10.1371/journal.pone.0062166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637990	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800030
J	Martinez, IA; Campoy, S; Tort, M; Llagostera, M; Petrov, D				Martinez, Ignacio A.; Campoy, Susana; Tort, Meritxell; Llagostera, Montserrat; Petrov, Dmitri			A Simple Technique Based on a Single Optical Trap for the Determination of Bacterial Swimming Pattern	PLOS ONE			English	Article							ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; FLAGELLAR MOTOR; CHEMOTAXIS; MOTILITY; GENES; MANIPULATION; REGULATOR; MECHANISM; VIRULENCE	Bacterial motility is associated to a wide range of biological processes and it plays a key role in the virulence of many pathogens. Here we describe a method to distinguish the dynamic properties of bacteria by analyzing the statistical functions derived from the trajectories of a bacterium trapped by a single optical beam. The approach is based on the model of the rotation of a solid optically trapped sphere. The technique is easily implemented in a biological laboratory, since with only a small number of optical and electronic components a simple biological microscope can be converted into the required analyzer. To illustrate the functionality of this method, we probed several Salmonella enterica serovar Typhimurium mutants that differed from the wild-type with respect to their swimming patterns. In a further application, the motility dynamics of the S: Typhimurium cheV mutant were characterized.	[Martinez, Ignacio A.; Petrov, Dmitri] ICFO Inst Ciencies Foton, Castelldefels, Spain; [Campoy, Susana; Tort, Meritxell; Llagostera, Montserrat] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain; [Petrov, Dmitri] ICREA Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Autonomous University of Barcelona; ICREA	Campoy, S (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain.	Susana.Campoy@uab.cat	Martinez, Ignacio A A/C-2024-2015; campoy, susana/E-4346-2010; Campoy, Susana/C-7335-2008; Llagostera, Montserrat/K-5325-2014	Martinez, Ignacio A A/0000-0002-0208-7790; campoy, susana/0000-0003-1369-0197; Campoy, Susana/0000-0003-1369-0197; Llagostera, Montserrat/0000-0001-8177-8321	Fundacio Privada Cellex Barcelona; Spanish Ministry of Science and Innovation [MICINN FIS2008-00114, FIS2011-24409, BFU2011-23478]; Generalitat de Catalunya [2009SGR-1106]; ICREA Funding Source: Custom	Fundacio Privada Cellex Barcelona(Foundation CELLEX); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	The authors acknowledge financial support from the Fundacio Privada Cellex Barcelona, the Spanish Ministry of Science and Innovation (MICINN FIS2008-00114, FIS2011-24409 and BFU2011-23478), and the Generalitat de Catalunya (2009SGR-1106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1967, J GEN MICROBIOL, V46, P175, DOI 10.1099/00221287-46-2-175; ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x; Alexander RP, 2010, TRENDS MICROBIOL, V18, P494, DOI 10.1016/j.tim.2010.07.004; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Altindal T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018231; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1995, P NATL ACAD SCI USA, V92, P477, DOI 10.1073/pnas.92.2.477; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Berry RM, 1997, P NATL ACAD SCI USA, V94, P14433, DOI 10.1073/pnas.94.26.14433; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; Campoy S, 2002, INFECT IMMUN, V70, P4721, DOI 10.1128/IAI.70.8.4721-4725.2002; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; DEAN GE, 1983, J BACTERIOL, V154, P84, DOI 10.1128/JB.154.1.84-91.1983; DEFRANCO AL, 1979, J BACTERIOL, V139, P107, DOI 10.1128/JB.139.1.107-114.1979; Evans MR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-58; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; JONES BD, 1992, INFECT IMMUN, V60, P2475, DOI 10.1128/IAI.60.6.2475-2480.1992; Jurica MS, 1998, STRUCT FOLD DES, V6, P809, DOI 10.1016/S0969-2126(98)00082-3; Koch M, 2012, NAT PHOTONICS, V6, P680, DOI [10.1038/nphoton.2012.232, 10.1038/NPHOTON.2012.232]; Landry MP, 2009, BIOPHYS J, V97, P2128, DOI 10.1016/j.bpj.2009.07.048; Ling L, 2010, J APPL PHYS, V108, DOI 10.1063/1.3484045; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MACNAB RM, 1977, P NATL ACAD SCI USA, V74, P221, DOI 10.1073/pnas.74.1.221; MACNAB RM, 1976, J CLIN MICROBIOL, V4, P258; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Min TL, 2009, NAT METHODS, V6, P831, DOI [10.1038/NMETH.1380, 10.1038/nmeth.1380]; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Parkinson JS, 2005, CURR OPIN MICROBIOL, V8, P116, DOI 10.1016/j.mib.2005.02.008; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Sambrook J, 2001, MOL CLONING LAB MANU; Sano G, 2007, J BACTERIOL, V189, P8224, DOI 10.1128/JB.00898-07; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Staropoli JF, 2000, BIOPHYS J, V78, P513, DOI 10.1016/S0006-3495(00)76613-6; Stock JB, 1996, CELLULAR MOL BIOL; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; TSUICOLLINS AL, 1976, J BACTERIOL, V128, P754, DOI 10.1128/JB.128.3.754-765.1976; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Volpe G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.210603; WARRICK HM, 1977, J BACTERIOL, V130, P223, DOI 10.1128/JB.130.1.223-231.1977; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335	53	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61630	10.1371/journal.pone.0061630	http://dx.doi.org/10.1371/journal.pone.0061630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637869	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800010
J	Mathews, V; George, B; Viswabandya, A; Abraham, A; Ahmed, R; Ganapule, A; Sindhuvi, E; Lakshmi, KM; Srivastava, A				Mathews, Vikram; George, Biju; Viswabandya, Auro; Abraham, Aby; Ahmed, Rayaz; Ganapule, Abhijeet; Sindhuvi, Eunice; Lakshmi, Kavitha M.; Srivastava, Alok			Improved Clinical Outcomes of High Risk beta Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; VENOOCCLUSIVE-DISEASE; BUSULFAN; CHILDREN	Improving clinical outcomes among high risk Class III beta thalassemia major patients (Class IIIHR) receiving an allogeneic SCT remains a challenge. From October, 2009 a treosulfan based regimen (TreoFluT) was used for all consecutive Class III patients (n = 50). The clinical outcomes were compared with the historical conventional busulfan (BuCy) based regimen (n = 139). Use of TreoFluT was associated with a significantly reduced incidence of sinusoidal obstruction syndrome (SOS) among Class IIIHR cases (78% to 30%; P = 0.000) and early TRM (46% to 13%; p = 0.005). There was also a trend towards better engraftment in the Class IIIHR subset (P = 0.055). However, the use of bone marrow (BM) as source of stem cells along with the TreoFluT regimen was associated with 50% early mixed chimerism which reduced to 8.5% with the use of a peripheral blood stem cell graft (PBSC). Use of a PBSC graft was not associated with a significant increase in the incidence of acute or chronic graft versus host disease (GVHD). The overall and event free survival was significantly better among the Class IIIHR subset with the use of TreoFluT Vs. BuCy (86.6 +/- 7.3 Vs. 39.4 +/- 6.8%; P = 0.002 and 77.8 +/- 8.8 Vs. 32.4 +/- 6.5%; P = 0.003 respectively). A TreoFluT conditioning regimen with a PBSC graft can significantly improve clinical outcomes of Class IIIHR patients.	[Mathews, Vikram; George, Biju; Viswabandya, Auro; Abraham, Aby; Ahmed, Rayaz; Ganapule, Abhijeet; Sindhuvi, Eunice; Lakshmi, Kavitha M.; Srivastava, Alok] Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Mathews, V (corresponding author), Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India.	vikram@cmcvellore.ac.in	ahmed, rayaz/ABG-1228-2020	Mathews, Vikram/0000-0001-9417-2353; Abraham, Aby/0000-0002-2596-4434				Bernardo ME, 2008, BRIT J HAEMATOL, V143, P548, DOI 10.1111/j.1365-2141.2008.07385.x; Bernardo ME, 2012, BLOOD; Chandy M, 2005, BONE MARROW TRANSPL, V36, P839, DOI 10.1038/sj.bmt.1705151; Chiesa R, 2010, BIOL BLOOD MARROW TR, V16, P622, DOI 10.1016/j.bbmt.2009.11.024; Danylesko I, 2012, BONE MARROW TRANSPL, V47, P5, DOI 10.1038/bmt.2011.88; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; JONES RJ, 1987, TRANSPLANTATION, V44, P778, DOI 10.1097/00007890-198712000-00011; Lawson SE, 2003, BRIT J HAEMATOL, V120, P289, DOI 10.1046/j.1365-2141.2003.04065.x; Li CF, 2012, BLOOD, V120, P3875, DOI 10.1182/blood-2012-03-417998; LUCARELLI G, 1985, LANCET, V1, P1355; Lucarelli G, 1996, BLOOD, V87, P2082, DOI 10.1182/blood.V87.5.2082.bloodjournal8752082; LUCARELLI G, 1990, NEW ENGL J MED, V322, P417, DOI 10.1056/NEJM199002153220701; Lucarelli G, 2002, BLOOD REV, V16, P81, DOI 10.1054/blre.2002.0192; LUCARELLI G, 1992, BLOOD, V80, P1603; Mathews V, 2007, BIOL BLOOD MARROW TR, V13, P889, DOI 10.1016/j.bbmt.2007.05.004; Rajasekar R, 2009, BIOL BLOOD MARROW TR, V15, P597, DOI 10.1016/j.bbmt.2009.01.016; Sabloff M, 2011, BLOOD, V117, P1745, DOI 10.1182/blood-2010-09-306829; Sellathamby S, 2006, BONE MARROW TRANSPL, V37, P751, DOI 10.1038/sj.bmt.1705317; Sodani P, 2004, BLOOD, V104, P1201, DOI 10.1182/blood-2003-08-2800; Srivastava A, 2004, BLOOD, V104, P1574, DOI 10.1182/blood-2003-11-3778; THOMAS ED, 1982, LANCET, V2, P227	21	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61637	10.1371/journal.pone.0061637	http://dx.doi.org/10.1371/journal.pone.0061637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637873	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700017
J	Kanda, S; Akazome, Y; Mitani, Y; Okubo, K; Oka, Y				Kanda, Shinji; Akazome, Yasuhisa; Mitani, Yuta; Okubo, Kataaki; Oka, Yoshitaka			Neuroanatomical Evidence That Kisspeptin Directly Regulates Isotocin and Vasotocin Neurons	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; SOCIAL-BEHAVIOR; EVOLUTIONARY INSIGHTS; ARGININE VASOTOCIN; SEXUAL-BEHAVIOR; BRAIN; ACTIVATION; GOLDFISH; SYSTEM; GPR54	Neuropeptide kisspeptin has been suggested to be an essential central regulator of reproduction in response to changes in serum gonadal steroid concentrations. However, in spite of wide kisspeptin receptor distribution in the brain, especially in the preoptic area and hypothalamus, the research focus has mostly been confined to the kisspeptin regulation on GnRH neurons. Here, by using medaka whose kisspeptin (kiss1) neurons have been clearly demonstrated to be regulated by sex steroids, we analyzed the anatomical distribution of kisspeptin receptors Gpr54-1 and Gpr54-2. Because the both receptors were shown to be activated by kisspeptins (Kiss1 and Kiss2), we analyzed the anatomical distribution of the both receptors by in situ hybridization. They were mainly expressed in the ventral telencephalon, preoptic area, and hypothalamus, which have been suggested to be involved in homeostatic functions including reproduction. First, we found gpr54-2 mRNA expression in nucleus preopticus pars magnocellularis and demonstrated that vasotocin and isotocin (Vasopressin and Oxytocin ortholog, respectively) neurons express gpr54-2 by dual in situ hybridization. Given that kisspeptin administration increases serum oxytocin and vasopressin concentration in mammals, the present finding are likely to be vertebrate-wide phenomenon, although direct regulation has not yet been demonstrated in mammals. We then analyzed co-expression of kisspeptin receptors in three types of GnRH neurons. It was clearly demonstrated that gpr54-expressing cells were located adjacent to GnRH1 neurons, although they were not GnRH1 neurons themselves. In contrast, there was no gpr54-expressing cell in the vicinities of neuromodulatory GnRH2 or GnRH3 neurons. From these results, we suggest that medaka kisspeptin neurons directly regulate some behavioral and neuroendocrine functions via vasotocin/isotocin neurons, whereas they do not regulate hypophysiotropic GnRH1 neurons at least in a direct manner. Thus, direct kisspeptin regulation of GnRH1 neurons proposed in mammals may not be the universal feature of vertebrate kisspeptin system in general.	[Kanda, Shinji; Akazome, Yasuhisa; Mitani, Yuta; Oka, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Okubo, Kataaki] Univ Tokyo, Grad Sch Sci, Dept Aquat Biosci, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Oka, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	okay@biol.s.u-tokyo.ac.jp	Oka, Yoshitaka/C-9670-2010; Oka, Yoshitaka/G-4952-2014	Oka, Yoshitaka/0000-0002-3482-3051; Oka, Yoshitaka/0000-0002-3482-3051; Kanda, Shinji/0000-0001-7556-1433	Japan Society for the Promotion of Science (JSPS) [20-10112, 20247005]; Ministry of Education, Culture, Sports, Science, and Technology [20021012]; Program for Promotion of Basic Research Activities for Innovative Biosciences Project from Bio-oriented Technology Research Advancement Institution of Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic Research Activities for Innovative Biosciences Project from Bio-oriented Technology Research Advancement Institution of Japan	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS) (20-10112) to SK, JSPS (20247005), Ministry of Education, Culture, Sports, Science, and Technology (20021012), and the Program for Promotion of Basic Research Activities for Innovative Biosciences Project from Bio-oriented Technology Research Advancement Institution of Japan to YO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazome Y, 2010, J FISH BIOL, V76, P161, DOI 10.1111/j.1095-8649.2009.02496.x; Biran J, 2008, BIOL REPROD, V79, P776, DOI 10.1095/biolreprod.107.066266; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dumalska I, 2008, J NEUROSCI, V28, P8003, DOI 10.1523/JNEUROSCI.1225-08.2008; Felip A, 2008, MOL CELL ENDOCRINOL; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Godwin J, 2012, HORM BEHAV, V61, P230, DOI 10.1016/j.yhbeh.2011.12.016; Goodson JL, 2010, CURR OPIN NEUROBIOL, V20, P784, DOI 10.1016/j.conb.2010.08.020; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Greenwood AK, 2008, P ROY SOC B-BIOL SCI, V275, P2393, DOI 10.1098/rspb.2008.0622; Grone BP, 2010, GEN COMP ENDOCR, V169, P98, DOI 10.1016/j.ygcen.2010.07.018; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Kanda S, 2012, J NEUROENDOCRINOL, V24, P897, DOI 10.1111/j.1365-2826.2012.02296.x; Kanda S, 2009, KISSPEPTIN NEURONS A; Kanda S, 2008, ENDOCRINOLOGY, V149, P2467, DOI 10.1210/en.2007-1503; Kanda Shinji, 2012, Front Endocrinol (Lausanne), V3, P28, DOI 10.3389/fendo.2012.00028; Kanda S, 2011, GEN COMP ENDOCR, V173, P253, DOI 10.1016/j.ygcen.2011.05.015; Kanda S, 2010, ENDOCRINOLOGY, V151, P695, DOI 10.1210/en.2009-0842; Karigo T, 2012, ENDOCRINOLOGY, V153, P3394, DOI 10.1210/en.2011-2022; Kauffman AS, 2006, ENDOCRINOLOGY, V147, P5069, DOI 10.1210/en.2006-0615; Kauffman AS, 2004, J NEUROENDOCRINOL, V16, P794, DOI 10.1111/j.1365-2826.2004.01229.x; Kauffman AS, 2004, ENDOCRINOLOGY, V145, P3639, DOI 10.1210/en.2004-0148; Kawabata Y, 2012, NEUROSCIENCE; Kim DK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00003; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; KOYAMA Y, 1984, BEHAV NEURAL BIOL, V40, P70, DOI 10.1016/S0163-1047(84)90182-1; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Li SS, 2009, J ENDOCRINOL, V201, P407, DOI 10.1677/JOE-09-0016; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Maruska KP, 2007, COMP BIOCHEM PHYS A, V147, P129, DOI 10.1016/j.cbpa.2006.12.019; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ogawa S, 2012, ENDOCRINOLOGY, V153, P2398, DOI 10.1210/en.2012-1062; Oka Y, 2009, J NEUROENDOCRINOL, V21, P334, DOI 10.1111/j.1365-2826.2009.01850.x; Okubo K, 2008, ACTA PHYSIOL, V193, P3, DOI 10.1111/j.1748-1716.2008.01832.x; Oldfield RG, 2011, PHYSIOL BEHAV, V102, P296, DOI 10.1016/j.physbeh.2010.11.022; Pielecka-Fortuna J, 2008, ENDOCRINOLOGY, V149, P1979, DOI 10.1210/en.2007-1365; Pielecka-Fortuna J, 2010, ENDOCRINOLOGY, V151, P291, DOI 10.1210/en.2009-0692; SATOU M, 1984, PHYSIOL BEHAV, V33, P441, DOI 10.1016/0031-9384(84)90167-7; Scott V, 2011, ENDOCRINOLOGY, V152, P3862, DOI 10.1210/en.2011-1181; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Ten SC, 2010, ENDOCR RES, V35, P128, DOI 10.3109/07435801003769995; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; WIRSIG CR, 1987, BRAIN RES, V417, P293, DOI 10.1016/0006-8993(87)90454-9; Zhang CG, 2008, J NEUROSCI, V28, P4423, DOI 10.1523/JNEUROSCI.5352-07.2008; Zhao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037909; Zmora N, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097667	52	68	68	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62776	10.1371/journal.pone.0062776	http://dx.doi.org/10.1371/journal.pone.0062776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638144	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400067
J	Manzo, N; Di Luccia, B; Isticato, R; D'Apuzzo, E; De Felice, M; Ricca, E				Manzo, Nicola; Di Luccia, Blanda; Isticato, Rachele; D'Apuzzo, Enrica; De Felice, Maurilio; Ricca, Ezio			Pigmentation and Sporulation Are Alternative Cell Fates in Bacillus pumilus SF214	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; MASTER REGULATOR; SUBTILIS; CAROTENOIDS; PROTEIN; COAT; LOCALIZATION; BISTABILITY; RESISTANCE	Bacillus pumilus SF214 is a spore forming bacterium, isolated from a marine sample, able to produce a matrix and a orange-red, water soluble pigment. Pigmentation is strictly regulated and high pigment production was observed during the late stationary growth phase in a minimal medium and at growth temperatures lower than the optimum. Only a subpopulation of stationary phase cells produced the pigment, indicating that the stationary culture contains a heterogeneous cell population and that pigment synthesis is a bimodal phenomenon. The fraction of cells producing the pigment varied in the different growth conditions and occured only in cells not devoted to sporulation. Only some of the pigmented cells were also able to produce a matrix. Pigment and matrix production in SF214 appear then as two developmental fates both alternative to sporulation. Since the pigment had an essential role in the cell resistance to oxidative stress conditions, we propose that within the heterogeneous population different survival strategies can be followed by the different cells.	[Manzo, Nicola; Di Luccia, Blanda; Isticato, Rachele; D'Apuzzo, Enrica; De Felice, Maurilio; Ricca, Ezio] Univ Naples Federico II, Dept Biol, Naples, Italy	University of Naples Federico II	Ricca, E (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	ericca@unina.it	Ricca, Ezio/AAG-2998-2020; Isticato, Rachele/J-3476-2012; ISTICATO, Rachele/AAX-9972-2021	Ricca, Ezio/0000-0002-7355-0332; ISTICATO, Rachele/0000-0001-9141-4038	EU grant from the EU 7th Framework [KBBE-2007-207948]	EU grant from the EU 7th Framework	This research was supported by a EU grant (KBBE-2007-207948) from the EU 7th Framework to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2010, MBIO, V1, DOI 10.1128/mBio.00035-10; An GH, 2000, BIOTECHNOL LETT, V22, P1031, DOI 10.1023/A:1005614010003; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bosak T, 2008, P NATL ACAD SCI USA, V105, P6725, DOI 10.1073/pnas.0800199105; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chai YR, 2011, EMBO J, V30, P1402, DOI 10.1038/emboj.2011.36; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Cremades O, 2001, J AGR FOOD CHEM, V49, P5468, DOI 10.1021/jf0104174; Cutting S., 1990, MOL BIOL METHODS BAC; Cutting SM, 2009, INT REV IMMUNOL, V28, P487, DOI 10.3109/08830180903215605; Duc LH, 2006, FEMS MICROBIOL LETT, V255, P215, DOI 10.1111/j.1574-6968.2005.00091.x; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Hong HA, 2009, RES MICROBIOL, V160, P375, DOI 10.1016/j.resmic.2009.06.006; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Isticato R, 2010, J BACTERIOL, V192, P949, DOI 10.1128/JB.01408-09; Khaneja R, 2010, J APPL MICROBIOL, V108, P1889, DOI 10.1111/j.1365-2672.2009.04590.x; Kleinegris DMM, 2010, J APPL PHYCOL, V22, P645, DOI 10.1007/s10811-010-9505-y; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Lopez D, 2009, GENE DEV, V23, P1631, DOI 10.1101/gad.1813709; Manzo N, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-198; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; POGLIANO K, 1995, MOL MICROBIOL, V18, P459, DOI 10.1111/j.1365-2958.1995.mmi_18030459.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Serrano M, 1999, J BACTERIOL, V181, P3632, DOI 10.1128/JB.181.12.3632-3643.1999; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Steiger S, 2012, J APPL MICROBIOL, V113, P888, DOI 10.1111/j.1365-2672.2012.05377.x; Stover AG, 1999, J BACTERIOL, V181, P1664; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; ZHENG LB, 1988, GENE DEV, V2, P1047, DOI 10.1101/gad.2.8.1047	37	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62093	10.1371/journal.pone.0062093	http://dx.doi.org/10.1371/journal.pone.0062093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634224	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400035
J	Pettitt, SJ; Rehman, FL; Bajrami, I; Brough, R; Wallberg, F; Kozarewa, I; Fenwick, K; Assiotis, I; Chen, LN; Campbell, J; Lord, CJ; Ashworth, A				Pettitt, Stephen J.; Rehman, Farah L.; Bajrami, Ilirjana; Brough, Rachel; Wallberg, Fredrik; Kozarewa, Iwanka; Fenwick, Kerry; Assiotis, Ioannis; Chen, Lina; Campbell, James; Lord, Christopher J.; Ashworth, Alan			A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies Parp1 as a Mediator of Olaparib Toxicity	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; POLY(ADP-RIBOSE) POLYMERASE; GENOME-WIDE; ES CELLS; REPAIR; MUTAGENESIS; LEUKEMIA; INHIBITORS; DERIVATION; MUTATION	Genetic perturbation screens have the potential to dissect a wide range of cellular phenotypes. Such screens have historically been difficult in diploid mammalian cells. The recent derivation of haploid embryonic stem cells provides an opportunity to cause loss of function mutants with a random mutagen in a mammalian cell with a normal genetic background. We describe an approach to genetic screens that exploits the highly active piggyBac transposon in haploid mammalian cells. As an example of haploid transposon (HTP) screening, we apply this approach to identifying determinants of cancer drug toxicity and resistance. In a screen for 6-thioguanine resistance we recovered components of the DNA mismatch repair pathway, a known requirement for toxicity. In a further screen for resistance to the clinical poly(ADP-ribose) polymerase (PARP) inhibitor olaparib we recovered multiple Parp1 mutants. Our results show that olaparib toxicity to normal cells is mediated predominantly via Parp1, and suggest that the clinical side effects of olaparib may be on target. The transposon mutant libraries are stable and can be readily reused to screen other drugs. The screening protocol described has several advantages over other methods such as RNA interference: it is rapid and low cost, and mutations can be easily reverted to establish causality.	[Pettitt, Stephen J.; Rehman, Farah L.; Bajrami, Ilirjana; Brough, Rachel; Wallberg, Fredrik; Campbell, James; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Pettitt, Stephen J.; Bajrami, Ilirjana; Brough, Rachel; Campbell, James; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, CRUK Gene Funct Lab, London SW3 6JB, England; [Kozarewa, Iwanka; Fenwick, Kerry; Assiotis, Ioannis; Chen, Lina; Campbell, James] Inst Canc Res, Tumour Profiling Unit, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Lord, CJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	Chris.Lord@icr.ac.uk; Alan.Ashworth@icr.ac.uk	Lord, Christopher J/B-3295-2012; Lord, Christopher/AAX-7130-2021	Lord, Christopher J/0000-0002-3226-0515; Pettitt, Stephen/0000-0003-3313-3857; Campbell, James/0000-0001-6756-8766	Breakthrough Breast Cancer; Cancer Research UK (CRUK); American Association for Cancer Research (AACR) as part of the Stand Up to Cancer Breast Cancer Dream Team initiative; Avon Breast Cancer Crusade; Cancer Research UK [14276] Funding Source: researchfish	Breakthrough Breast Cancer; Cancer Research UK (CRUK)(Cancer Research UK); American Association for Cancer Research (AACR) as part of the Stand Up to Cancer Breast Cancer Dream Team initiative; Avon Breast Cancer Crusade; Cancer Research UK(Cancer Research UK)	This work was supported by Breakthrough Breast Cancer, Cancer Research UK (CRUK) and American Association for Cancer Research (AACR) as part of the Stand Up to Cancer Breast Cancer Dream Team initiative. FR is a Breakthrough Breast Cancer Avon Clinical Fellow and is funded as part of the Avon Breast Cancer Crusade. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Huang Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr908; Kong J, 2008, BIOINFORMATICS, V24, P2923, DOI 10.1093/bioinformatics/btn541; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MA, 2013, MOL CELLULAR BIOL; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li MA, 2010, METHOD ENZYMOL, V477, P217, DOI 10.1016/S0076-6879(10)77012-9; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; Liu XS, 2009, MOL CANCER RES, V7, P1686, DOI 10.1158/1541-7786.MCR-09-0299; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Vora A, 2006, LANCET, V368, P1339, DOI 10.1016/S0140-6736(06)69558-5; Wang W, 2009, GENOME RES, V19, P667, DOI 10.1101/gr.085621.108; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	29	126	130	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61520	10.1371/journal.pone.0061520	http://dx.doi.org/10.1371/journal.pone.0061520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634208	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400011
J	Barron, L; Smith, AM; El Kasmi, KC; Qualls, JE; Huang, XZ; Cheever, A; Borthwick, LA; Wilson, MS; Murray, PJ; Wynn, TA				Barron, Luke; Smith, Amber M.; El Kasmi, Karim C.; Qualls, Joseph E.; Huang, Xiaozhu; Cheever, Allen; Borthwick, Lee A.; Wilson, Mark S.; Murray, Peter J.; Wynn, Thomas A.			Role of Arginase 1 from Myeloid Cells in Th2-Dominated Lung Inflammation	PLOS ONE			English	Article							MANSONI ANTIGENS MODULATE; NITRIC-OXIDE SYNTHASE; L-ARGININE METABOLISM; ALLERGIC-ASTHMA; SCHISTOSOMA-MANSONI; AIRWAY HYPERRESPONSIVENESS; IMMUNE-RESPONSE; MURINE MODEL; MOUSE MODEL; T-CELLS	Th2-driven lung inflammation increases Arginase 1 (Arg1) expression in alternatively-activated macrophages (AAMs). AAMs modulate T cell and wound healing responses and Arg1 might contribute to asthma pathogenesis by inhibiting nitric oxide production, regulating fibrosis, modulating arginine metabolism and restricting T cell proliferation. We used mice lacking Arg1 in myeloid cells to investigate the contribution of Arg1 to lung inflammation and pathophysiology. In six model systems encompassing acute and chronic Th2-mediated lung inflammation we observed neither a pathogenic nor protective role for myeloid-expressed Arg1. The number and composition of inflammatory cells in the airways and lungs, mucus secretion, collagen deposition, airway hyper-responsiveness, and T cell cytokine production were not altered if AAMs were deficient in Arg1 or simultaneously in both Arg1 and NOS2. Our results argue that Arg1 is a general feature of alternative activation but only selectively regulates Th2 responses. Therefore, attempts to experimentally or therapeutically inhibit arginase activity in the lung should be examined with caution.	[Barron, Luke; Wynn, Thomas A.] NIAID, Program Barrier Immun & Repair, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Smith, Amber M.; El Kasmi, Karim C.; Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Smith, Amber M.; El Kasmi, Karim C.; Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Huang, Xiaozhu] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA USA; [Cheever, Allen] Biomed Res Inst, Rockville, MD 20852 USA; [Borthwick, Lee A.] Newcastle Univ, Sch Med, Inst Cellular Med, Tissue Fibrosis & Repair Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wilson, Mark S.] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of California System; University of California San Francisco; Newcastle University - UK; MRC National Institute for Medical Research	Barron, L (corresponding author), NIAID, Program Barrier Immun & Repair, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	BarronL@niaid.nih.gov	Murray, Peter J/K-4725-2018; Wynn, Thomas A/AAO-3523-2021	Murray, Peter J/0000-0001-6329-9802; Wynn, Thomas A/0000-0002-7244-8731; Borthwick, Lee/0000-0003-2885-3382; Qualls, Joseph/0000-0002-0113-2166	Sandler Program for Asthma Research; NIH [AI062921]; CORE [P30 CA21765]; American Lebanese Syrian Associated Charities; NIAID intramural research program; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062921, ZIAAI000829] Funding Source: NIH RePORTER; MRC [MC_UP_A253_1028] Funding Source: UKRI; Medical Research Council [MC_UP_A253_1028] Funding Source: researchfish	Sandler Program for Asthma Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CORE(Luxembourg National Research Fund); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NIAID intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Sandler Program for Asthma Research (PJM), NIH grant AI062921 (PJM), CORE grant P30 CA21765, the American Lebanese Syrian Associated Charities, and the NIAID intramural research program (TAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Cardoso LS, 2010, CLIN EXP IMMUNOL, V160, P266, DOI 10.1111/j.1365-2249.2009.04084.x; Coomes SM, 2011, IMMUNOL RES, V50, P78, DOI 10.1007/s12026-010-8200-z; Di Costanzo L, 2005, P NATL ACAD SCI USA, V102, P13058, DOI 10.1073/pnas.0504027102; Di Costanzo L, 2010, ARCH BIOCHEM BIOPHYS, V496, P101, DOI 10.1016/j.abb.2010.02.004; Dowling DP, 2008, CELL MOL LIFE SCI, V65, P2039, DOI 10.1007/s00018-008-7554-z; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; El-Gayar S, 2003, J IMMUNOL, V171, P4561, DOI 10.4049/jimmunol.171.9.4561; Gordon ED, 2012, CLIN EXP ALLERGY, V42, P144, DOI 10.1111/j.1365-2222.2011.03840.x; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Ilies M, 2011, J MED CHEM, V54, P5432, DOI 10.1021/jm200443b; Jacobsen LC, 2007, BLOOD, V109, P3084, DOI 10.1182/blood-2006-06-032599; Kim JO, 2004, J ALLERGY CLIN IMMUN, V114, P1332, DOI 10.1016/j.jaci.2004.09.004; Lewis F, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1901s28; Maarsingh H, 2011, EUR RESPIR J, V38, P318, DOI 10.1183/09031936.00057710; Maarsingh H, 2008, AM J RESP CRIT CARE, V178, P565, DOI 10.1164/rccm.200710-1588OC; Maarsingh H, 2008, EUR J PHARMACOL, V585, P375, DOI 10.1016/j.ejphar.2008.02.096; Maarsingh H, 2009, BRIT J PHARMACOL, V158, P652, DOI 10.1111/j.1476-5381.2009.00374.x; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nguyen THT, 2011, IMMUNOL REV, V242, P258, DOI 10.1111/j.1600-065X.2011.01034.x; Niese KA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-33; Nieuwenhuizen NE, 2012, J ALLERGY CLIN IMMUN, V130, P743, DOI 10.1016/j.jaci.2012.03.011; North ML, 2009, AM J PHYSIOL-LUNG C, V296, pL911, DOI 10.1152/ajplung.00025.2009; Pacifico LGG, 2009, INFECT IMMUN, V77, P98, DOI 10.1128/IAI.00783-07; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Ramalingam TR, 2005, CURR OPIN ALLERGY CL, V5, P392, DOI 10.1097/01.all.0000182542.30100.6f; Rothenberg ME, 2006, P NATL ACAD SCI USA, V103, P14895, DOI 10.1073/pnas.0605478103; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Takahashi N, 2010, AM J PHYSIOL-LUNG C, V299, pL17, DOI 10.1152/ajplung.00216.2009; Taylor J, 2006, ANTIOCH REV, V64, P176; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; WYNN TA, 1994, J EXP MED, V179, P1551, DOI 10.1084/jem.179.5.1551; WYNN TA, 2011, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1422S93; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yang M, 2006, J IMMUNOL, V177, P5595, DOI 10.4049/jimmunol.177.8.5595; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	51	59	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61961	10.1371/journal.pone.0061961	http://dx.doi.org/10.1371/journal.pone.0061961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637937	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400061
J	Fan, Y; Xing, YY; Zhang, ZY; Ai, HS; Ouyang, ZX; Ouyang, J; Yang, M; Li, PH; Chen, YJ; Gao, J; Li, L; Huang, LS; Ren, J				Fan, Yin; Xing, Yuyun; Zhang, Zhiyan; Ai, Huashui; Ouyang, Zixuan; Ouyang, Jing; Yang, Ming; Li, Pinghua; Chen, Yijie; Gao, Jun; Li, Lin; Huang, Lusheng; Ren, Jun			A Further Look at Porcine Chromosome 7 Reveals VRTN Variants Associated with Vertebral Number in Chinese and Western Pigs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RESOURCE POPULATION; CARCASS TRAITS; MEAT QUALITY; DOMESTIC PIG; GENOME; CROSS	The number of vertebrae is an economically important trait that affects carcass length and meat production in pigs. A major quantitative trait locus (QTL) for thoracic vertebral number has been repeatedly identified on pig chromosome (SSC) 7. To dissect the genetic basis of the major locus, we herein genotyped a large sample of animals from 3 experimental populations of Chinese and Western origins using 60K DNA chips. Genome-wide association studies consistently identified the locus across the 3 populations and mapped the locus to a 947-Kb region on SSC7. An identical-by-descent sharing assay refined the locus to a 100-Kb segment that harbors only two genes including VRTN and SYNDIG1L. Of them, VRNT has been proposed as a strong candidate of the major locus in Western modern breeds. Further, we resequenced the VRTN gene using DNA samples of 35 parental animals with known QTL genotypes by progeny testing. Concordance tests revealed 4 candidate causal variants as their genotypes showed the perfect segregation with QTL genotypes of the tested animals. An integrative analysis of evolutional constraints and functional elements supported two VRTN variants in a complete linkage disequilibrium phase as the most likely causal mutations. The promising variants significantly affect the number of thoracic vertebrae (one vertebra) in large scale outbred animals, and are segregating at rather high frequencies in Western pigs and at relatively low frequencies in a number of Chinese breeds. Altogether, we show that VRTN variants are significantly associated with the number of thoracic vertebrae in both Chinese and Western pigs. The finding advances our understanding of the genetic architecture of the vertebral number in pigs. Furthermore, our finding is of economical importance as it provides a robust breeding tool for the improvement of vertebral number and meat production in both Chinese indigenous pigs and Western present-day commercial pigs.	[Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	lushenghuang@hotmail.com; renjunjxau@hotmail.com	Li, Ping/GYV-4914-2022; Chen, Yijie/AAE-8964-2019; Ren, Jun/H-9793-2019		Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]; National Natural Science Foundation of China [31000999]; Program for Innovative Research Team in Jiangxi Province	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Jiangxi Province	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT1136), National Natural Science Foundation of China (31000999), and Program for Innovative Research Team in Jiangxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bao WB, 2011, J GENET, V90, P315, DOI 10.1007/s12041-011-0059-9; BERGE S, 1948, J ANIM SCI, V7, P233, DOI 10.2527/jas1948.72233x; Borchers N, 2004, J ANIM BREED GENET, V121, P392, DOI 10.1111/j.1439-0388.2004.00482.x; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; de Chaldee M, 2006, GENOMICS, V87, P200, DOI 10.1016/j.ygeno.2005.10.009; Edwards DB, 2008, J ANIM SCI, V86, P254, DOI 10.2527/jas.2006-626; Elnitski Laura, 2010, Curr Protoc Bioinformatics, VChapter 10, DOI [10.1002/0471250953.bi1004s9, 10.1002/0471250953.bi1004s30]; FREDEEN H. T., 1962, CANADIAN JOUR ANIMAL SCI, V42, P240; Galis F, 1999, J EXP ZOOL, V285, P19, DOI 10.1002/(SICI)1097-010X(19990415)285:1<19::AID-JEZ3>3.0.CO;2-Z; Giuffra E, 2000, GENETICS, V154, P1785; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x; Jones GF, 1998, GENETICS OF THE PIG, P17; KING J. W. B., 1960, Animal Prod., V2, P59; Mikawa S, 2005, J ANIM SCI, V83, P2247; Mikawa S, 2007, GENOME RES, V17, P586, DOI 10.1101/gr.6085507; Mikawa S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-5; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Nezer C, 2003, GENETICS, V165, P277; Ren DR, 2012, ANIM GENET, V43, P545, DOI 10.1111/j.1365-2052.2011.02313.x; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sato S, 2003, J ANIM SCI, V81, P2938; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Uemoto Y, 2008, J ANIM SCI, V86, P2833, DOI 10.2527/jas.2007-0293; Wada Y, 2000, ANIM GENET, V31, P376, DOI 10.1046/j.1365-2052.2000.00696.x; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; ZHANG Z, 1986, PIG BREEDS CHINA	28	51	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62534	10.1371/journal.pone.0062534	http://dx.doi.org/10.1371/journal.pone.0062534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638110	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400113
J	Kanter, U; Heller, W; Durner, J; Winkler, JB; Engel, M; Behrendt, H; Holzinger, A; Braun, P; Hauser, M; Ferreira, F; Mayer, K; Pfeifer, M; Ernst, D				Kanter, Ulrike; Heller, Werner; Durner, Joerg; Winkler, J. Barbro; Engel, Marion; Behrendt, Heidrun; Holzinger, Andreas; Braun, Paula; Hauser, Michael; Ferreira, Fatima; Mayer, Klaus; Pfeifer, Matthias; Ernst, Dieter			Molecular and Immunological Characterization of Ragweed (Ambrosia artemisiifolia L.) Pollen after Exposure of the Plants to Elevated Ozone over a Whole Growing Season	PLOS ONE			English	Article							ATMOSPHERIC CO2; ABIOTIC STRESS; BIRCH POLLEN; ALLERGEN; RELEASE; EXPRESSION; RESPONSES; PECTIN; BIOSYNTHESIS; SENSITIVITY	Climate change and air pollution, including ozone is known to affect plants and might also influence the ragweed pollen, known to carry strong allergens. We compared the transcriptome of ragweed pollen produced under ambient and elevated ozone by 454-sequencing. An enzyme-linked immunosorbent assay (ELISA) was carried out for the major ragweed allergen Amb a 1. Pollen surface was examined by scanning electron microscopy and attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), and phenolics were analysed by high-performance liquid chromatography. Elevated ozone had no influence on the pollen size, shape, surface structure or amount of phenolics. ATR-FTIR indicated increased pectin-like material in the exine. Transcriptomic analyses showed changes in expressed-sequence tags (ESTs), including allergens. However, ELISA indicated no significantly increased amounts of Amb a 1 under elevated ozone concentrations. The data highlight a direct influence of ozone on the exine components and transcript level of allergens. As the total protein amount of Amb a 1 was not altered, a direct correlation to an increased risk to human health could not be derived. Additional, the 454-sequencing contributes to the identification of stress-related transcripts in mature pollen that could be grouped into distinct gene ontology terms.	[Kanter, Ulrike; Heller, Werner; Durner, Joerg; Ernst, Dieter] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Neuherberg, Germany; [Winkler, J. Barbro] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Environm Simulat, Neuherberg, Germany; [Engel, Marion] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Soil Ecol, Neuherberg, Germany; [Behrendt, Heidrun] Tech Univ, Ctr Allergy & Environm Munchen, Neuherberg, Germany; [Behrendt, Heidrun] Helmholtz Zentrum Munchen, Neuherberg, Germany; [Holzinger, Andreas] Leopold Franzens Univ Innsbruck, Inst Bot, Innsbruck, Austria; [Braun, Paula] Univ Appl Sci, Hsch Munchen, Dept Nat Sci & Mechatron, Munich, Germany; [Hauser, Michael; Ferreira, Fatima] Salzburg Univ, Div Allergy & Immunol, Dept Mol Biol, A-5020 Salzburg, Austria; [Mayer, Klaus; Pfeifer, Matthias] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Innsbruck; Salzburg University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kanter, U (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Neuherberg, Germany.	ulrike.kanter@helmholtz-muenchen.de	Holzinger, Andreas/A-6396-2008; Pfeifer, Matthias/GRJ-4579-2022; Holzinger, Andreas/Z-2659-2019; Ferreira, Fatima/E-4889-2011; Hauser, Michael/P-6148-2017; Winkler, Jana Barbro/M-9850-2014; Mayer, Klaus FX/M-7941-2015; Frank, Ulrike/M-9859-2014; Ferreira, Fatima/AAB-4321-2019; Ernst, Dieter/M-7336-2014	Holzinger, Andreas/0000-0002-7745-3978; Holzinger, Andreas/0000-0002-7745-3978; Ferreira, Fatima/0000-0003-0989-2335; Hauser, Michael/0000-0001-6558-755X; Winkler, Jana Barbro/0000-0002-7092-9742; Mayer, Klaus FX/0000-0001-6484-1077; Frank, Ulrike/0000-0001-8544-0651; Ferreira, Fatima/0000-0003-0989-2335; Ernst, Dieter/0000-0003-0503-0228	Christine Kuhne Center for Allergy Research and Education [3/09 CK-Care]	Christine Kuhne Center for Allergy Research and Education	This work was supported by the grant 3/09 CK-Care, Christine Kuhne Center for Allergy Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qsous S, 2004, PLANTA, V219, P369, DOI 10.1007/s00425-004-1246-1; Behrendt H, 2001, CURR OPIN IMMUNOL, V13, P709, DOI 10.1016/S0952-7915(01)00283-7; Berrens L, 1997, LIFE SCI, V60, P1497, DOI 10.1016/S0024-3205(97)00101-X; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Breton MC, 2006, SCI TOTAL ENVIRON, V370, P39, DOI 10.1016/j.scitotenv.2006.05.022; Bryce M, 2010, INT ARCH ALLERGY IMM, V151, P46, DOI 10.1159/000232570; Buters JTM, 2008, INT ARCH ALLERGY IMM, V145, P122, DOI 10.1159/000108137; Cecchi L, 2010, AEROBIOLOGIA, V26, P351, DOI 10.1007/s10453-010-9164-0; Chehregani A, 2004, ECOTOX ENVIRON SAFE, V58, P267, DOI 10.1016/j.ecoenv.2003.12.004; Cho SK, 2006, FEBS LETT, V580, P3136, DOI 10.1016/j.febslet.2006.04.062; Cortegano I, 2004, ALLERGY, V59, P485, DOI 10.1046/j.1398-9995.2003.00363.x; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; DeWitt AM, 2006, CLIN EXP ALLERGY, V36, P77, DOI 10.1111/j.1365-2222.2006.02399.x; ECKEYKALTENBACH H, 1993, PHYTOCHEMISTRY, V34, P687, DOI 10.1016/0031-9422(93)85340-W; Eckl-Dorna J, 2010, J ALLERGY CLIN IMMUN, V126, P1315, DOI 10.1016/j.jaci.2010.06.012; Elwell AL, 2011, PLANT CELL ENVIRON, V34, P291, DOI 10.1111/j.1365-3040.2010.02243.x; Filippov M.P., 1972, J APPL SPECTROSC+, V17, P1052, DOI [10.1007/BF00635158, DOI 10.1007/BF00635158]; Flenley JR, 2011, J BIOGEOGR, V38, P809, DOI 10.1111/j.1365-2699.2011.02480.x; Gadermaier G, 2008, ALLERGY, V63, P1543, DOI 10.1111/j.1398-9995.2008.01780.x; Galler K, 2003, EINFLUSS OZON ALLERG; Ghiani A, 2012, ALLERGY, V67, P887, DOI 10.1111/j.1398-9995.2012.02846.x; Ghirardo A, 2012, PLANT CELL ENV; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; GunthardtGoerg MS, 1996, J PLANT PHYSIOL, V148, P207, DOI 10.1016/S0176-1617(96)80316-6; Haerizadeh F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-25; He XY, 2006, BOT STUD, V47, P409; Holzinger A, 2009, MICRON, V40, P831, DOI 10.1016/j.micron.2009.06.008; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Jakob-Grun S, 2012, PHOTOSYNTH RES, V111, P139, DOI 10.1007/s11120-012-9727-8; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; KANGASJARVI J, 1994, PLANT CELL ENVIRON, V17, P783, DOI 10.1111/j.1365-3040.1994.tb00173.x; Koistinen KM, 2005, PHYTOCHEMISTRY, V66, P2524, DOI 10.1016/j.phytochem.2005.09.007; LANGEBARTELS C, 1991, PLANT PHYSIOL, V95, P882, DOI 10.1104/pp.95.3.882; Leisner CP, 2012, GLOBAL CHANGE BIOL, V18, P606, DOI 10.1111/j.1365-2486.2011.02535.x; LI YQ, 1994, SEX PLANT REPROD, V7, P145; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; LUTZ C, 1990, ENVIRON POLLUT, V64, P313, DOI 10.1016/0269-7491(90)90053-F; Masuch G, 1997, ALLERGY, V52, P874, DOI 10.1111/j.1398-9995.1997.tb02163.x; Matyssek R, 2008, ENVIRON POLLUT, V156, P567, DOI 10.1016/j.envpol.2008.04.017; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motta AC, 2006, INT ARCH ALLERGY IMM, V139, P294, DOI 10.1159/000091600; Olbrich M, 2009, PLANT SOIL, V323, P61, DOI 10.1007/s11104-009-0129-4; Pasqualini S, 2011, ENVIRON POLLUT, V159, P2823, DOI 10.1016/j.envpol.2011.05.003; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Rezanejad F, 2009, GRANA, V48, P205, DOI 10.1080/00173130902949417; Ring J, 2001, CURR OPIN IMMUNOL, V13, P701, DOI 10.1016/S0952-7915(01)00282-5; Rogerieux F, 2007, INT ARCH ALLERGY IMM, V143, P127, DOI 10.1159/000099079; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Romano MLG, 1996, MOL IMMUNOL, V33, P1287, DOI 10.1016/S0161-5890(96)00106-X; ROWLANDBAMFORD AJ, 1989, ENVIRON POLLUT, V61, P95, DOI 10.1016/0269-7491(89)90030-4; Sandermann H, 2008, BIOCHEM BIOPH RES CO, V366, P271, DOI 10.1016/j.bbrc.2007.12.018; Shirley BW, 1996, TRENDS PLANT SCI, V1, P377, DOI 10.1016/1360-1385(96)10040-6; Singer BD, 2005, FUNCT PLANT BIOL, V32, P667, DOI 10.1071/FP05039; Synytsya A, 2003, CARBOHYD POLYM, V54, P97, DOI 10.1016/S0144-8617(03)00158-9; Thiel S, 1996, J PLANT PHYSIOL, V148, P456, DOI 10.1016/S0176-1617(96)80279-3; Traidl-Hoffmann C, 2003, INT ARCH ALLERGY IMM, V131, P1, DOI 10.1159/000070428; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Wi SG, 2005, ANN BOT-LONDON, V95, P863, DOI 10.1093/aob/mci092; Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188; Yoon MS, 2006, MOL PHARMACOL, V70, P1033, DOI 10.1124/mol.106.024547; Zimmermann B, 2010, APPL SPECTROSC, V64, P1364, DOI 10.1366/000370210793561664; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108; Ziska LH, 2008, MITIG ADAPT STRAT GL, V13, P607, DOI 10.1007/s11027-007-9134-1; Ziska LH, 2002, FUNCT PLANT BIOL, V29, P1365, DOI 10.1071/FP02039	65	46	47	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61518	10.1371/journal.pone.0061518	http://dx.doi.org/10.1371/journal.pone.0061518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637846	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700041
J	Reithinger, JH; Kim, JEH; Kim, H				Reithinger, Johannes H.; Kim, Ji Eun Hani; Kim, Hyun			Sec62 Protein Mediates Membrane Insertion and Orientation of Moderately Hydrophobic Signal Anchor Proteins in the Endoplasmic Reticulum (ER)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREPRO-ALPHA-FACTOR; SEQUENCE ORIENTATION; TARGETING PATHWAY; MOLECULAR CODE; YEAST; TRANSPORT; COMPLEX; TRANSLOCATION; RECOGNITION; DOMAIN	Nascent chains are known to be targeted to the endoplasmic reticulum membrane either by a signal recognition particle (SRP)-dependent co-translational or by an SRP-independent post-translational translocation route depending on signal sequences. Using a set of model and cellular proteins carrying an N-terminal signal anchor sequence of controlled hydrophobicity and yeast mutant strains defective in SRP or Sec62 function, the hydrophobicity-dependent targeting efficiency and targeting pathway preference were systematically evaluated. Our results suggest that an SRP-dependent co-translational and an SRP-independent post-translational translocation are not mutually exclusive for signal anchor proteins and that moderately hydrophobic ones require both SRP and Sec62 for proper targeting and translocation to the endoplasmic reticulum. Further, defect in Sec62 selectively reduced signal sequences inserted in an N-in-C-out (type II) membrane topology, implying an undiscovered role of Sec62 in regulating the orientation of the signal sequence in an early stage of translocation.	[Reithinger, Johannes H.; Kim, Ji Eun Hani; Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Reithinger, Johannes H.] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden	Seoul National University (SNU); Stockholm University	Kim, H (corresponding author), Seoul Natl Univ, Sch Biol Sci, Bldg 504-421, Seoul 151747, South Korea.	joy@snu.ac.kr			National Research Foundation of Korea [2012-0001935, C00048]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Basic Research Grant 2012-0001935 and Global Research Network Grant C00048 from the National Research Foundation of Korea (to H. K.).	Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Eusebio A, 1998, EXP CELL RES, V241, P181, DOI 10.1006/excr.1998.4042; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Kocik L, 2012, J MOL BIOL, V424, P368, DOI 10.1016/j.jmb.2012.10.010; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; Lee H, 2012, BIOCHEM BIOPH RES CO, V427, P780, DOI 10.1016/j.bbrc.2012.09.138; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; SPIESS M, 1995, FEBS LETT, V369, P76, DOI 10.1016/0014-5793(95)00551-J; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859	35	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18058	18067		10.1074/jbc.M113.473009	http://dx.doi.org/10.1074/jbc.M113.473009			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23632075	hybrid, Green Published			2022-12-25	WOS:000320721900012
J	Chai, L; Romero, D; Kayatekin, C; Akabayov, B; Vlamakis, H; Losick, R; Kolter, R				Chai, Liraz; Romero, Diego; Kayatekin, Can; Akabayov, Barak; Vlamakis, Hera; Losick, Richard; Kolter, Roberto			Isolation, Characterization, and Aggregation of a Structured Bacterial Matrix Precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS BIOFILMS; AMYLOID FIBERS; IN-VITRO; PROTEIN; BIOGENESIS; OLIGOMERS; SURFACE; PSEUDOMONAS; MONOLAYERS; DIVERSITY	Biofilms are surface-associated groups of microbial cells that are embedded in an extracellular matrix (ECM). The ECM is a network of biopolymers, mainly polysaccharides, proteins, and nucleic acids. ECM proteins serve a variety of structural roles and often form amyloid-like fibers. Despite the extensive study of the formation of amyloid fibers from their constituent subunits in humans, much less is known about the assembly of bacterial functional amyloid-like precursors into fibers. Using dynamic light scattering, atomic force microscopy, circular dichroism, and infrared spectroscopy, we show that our unique purification method of a Bacillus subtilis major matrix protein component results in stable oligomers that retain their native alpha-helical structure. The stability of these oligomers enabled us to control the external conditions that triggered their aggregation. In particular, we show that stretched fibers are formed on a hydrophobic surface, whereas plaque-like aggregates are formed in solution under acidic pH conditions. TasA is also shown to change conformation upon aggregation and gain some beta-sheet structure. Our studies of the aggregation of a bacterial matrix protein from its subunits shed new light on assembly processes of the ECM within bacterial biofilms.	[Chai, Liraz; Romero, Diego; Vlamakis, Hera; Kolter, Roberto] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Kayatekin, Can] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Akabayov, Barak] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Harvard University	Kolter, R (corresponding author), 77 Louis Pasteur Ave, Boston, MA 02115 USA.	rkolter@hms.harvard.edu	Akabayov, Barak/Y-5786-2019; Kayatekin, Can/B-6618-2009; Romero, Diego/D-3849-2013	Akabayov, Barak/0000-0002-3882-2742; Romero, Diego/0000-0002-2052-6515; Kayatekin, Can/0000-0002-4367-9645	National Institutes of Health [GM58213, GM18546]; BASF (Badische Anilin- und Soda-Fabrik) Advanced Research Initiative at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568, R01GM058213, F31GM018546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF (Badische Anilin- und Soda-Fabrik) Advanced Research Initiative at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58213 (to R. K.) and GM18546 (to R. L.). This work was also supported by grants from the BASF (Badische Anilin- und Soda-Fabrik) Advanced Research Initiative at Harvard University (to R. L. and R. K.).	Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Flory P. J, 1953, PRINCIPLES POLYM CHE; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Keller A, 2011, ACS NANO, V5, P2770, DOI 10.1021/nn1031998; Kobayashi K, 2012, MOL MICROBIOL, V85, P51, DOI 10.1111/j.1365-2958.2012.08094.x; Magdassi S., 1996, SURFACE ACTIVITIES P; MAOZ R, 1988, J CHIM PHYS PCB, V85, P1059, DOI 10.1051/jcp/1988851059; McGlinchey RP, 2011, J BIOL CHEM, V286, P8385, DOI 10.1074/jbc.M110.197152; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; PARRISH JR, 1972, BIOPOLYMERS, V11, P1001, DOI 10.1002/bip.1972.360110506; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rubinstein SM, 2012, MOL MICROBIOL, V86, P426, DOI 10.1111/j.1365-2958.2012.08201.x; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shahnawaz M, 2012, J BIOL CHEM, V287, P11665, DOI 10.1074/jbc.M111.282533; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; SINGH BR, 2000, ACS S SERIES, V750; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Stover AG, 1999, J BACTERIOL, V181, P1664; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035; Wilking JN, 2011, MRS BULL, V36, P385, DOI 10.1557/mrs.2011.71; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; YAMADA M, 1987, J NEUROL, V234, P371, DOI 10.1007/BF00314080; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858	47	50	50	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17559	17568		10.1074/jbc.M113.453605	http://dx.doi.org/10.1074/jbc.M113.453605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632024	hybrid, Green Published			2022-12-25	WOS:000320380600047
J	Kovalenko, OV; Olland, A; Piche-Nicholas, N; Godbole, A; King, D; Svenson, K; Calabro, V; Muller, MR; Barelle, CJ; Somers, W; Gill, DS; Mosyak, L; Tchistiakova, L				Kovalenko, Oleg V.; Olland, Andrea; Piche-Nicholas, Nicole; Godbole, Adarsh; King, Daniel; Svenson, Kristine; Calabro, Valerie; Mueller, Mischa R.; Barelle, Caroline J.; Somers, William; Gill, Davinder S.; Mosyak, Lidia; Tchistiakova, Lioudmila			Atypical Antigen Recognition Mode of a Shark Immunoglobulin New Antigen Receptor (IgNAR) Variable Domain Characterized by Humanization and Structural Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEINS; ANTIBODIES; COMPLEX; MATURATION; SELECTION; DESIGN; SYSTEM; ENZYME; VHH	The immunoglobulin new antigen receptors (IgNARs) are a class of Ig-like molecules of the shark immune system that exist as heavy chain-only homodimers and bind antigens by their single domain variable regions (V-NARs). Following shark immunization and/or in vitro selection, V-NARs can be generated as soluble, stable, and specific high affinity monomeric binding proteins of similar to 12 kDa. We have previously isolated a V-NAR from an immunized spiny dogfish shark, named E06, that binds specifically and with high affinity to human, mouse, and rat serum albumins. Humanization of E06 was carried out by converting over 60% of non-complementarity-determining region residues to those of a human germ line V kappa 1 sequence, DPK9. The resulting huE06 molecules have largely retained the specificity and affinity of antigen binding of the parental V-NAR. Crystal structures of the shark E06 and its humanized variant (huE06 v1.1) in complex with human serum albumin (HSA) were determined at 3- and 2.3-angstrom resolution, respectively. The huE06 v1.1 molecule retained all but one amino acid residues involved in the binding site for HSA. Structural analysis of these V-NARs has revealed an unusual variable domain-antigen interaction. E06 interacts with HSA in an atypical mode that utilizes extensive framework contacts in addition to complementarity-determining regions that has not been seen previously in V-NARs. On the basis of the structure, the roles of various elements of the molecule are described with respect to antigen binding and V-NAR stability. This information broadens the general understanding of antigen recognition and provides a framework for further design and humanization of shark IgNARs.	[Kovalenko, Oleg V.; Olland, Andrea; Piche-Nicholas, Nicole; Godbole, Adarsh; King, Daniel; Svenson, Kristine; Calabro, Valerie; Somers, William; Gill, Davinder S.; Mosyak, Lidia; Tchistiakova, Lioudmila] Pfizer Res & Dev, Global Biotherapeut Technol, Cambridge, MA 02140 USA; [Mueller, Mischa R.] Pfizer, Aberdeen AB25 2ZS, Scotland; [Barelle, Caroline J.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	Pfizer; Pfizer; University of Aberdeen	Kovalenko, OV (corresponding author), Pfizer Inc, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	oleg.kovalenko@pfizer.com	Piche-Nicholas, Nicole/AAH-5536-2021	Piche-Nicholas, Nicole/0000-0003-0695-7965				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barelle C, 2009, ADV EXP MED BIOL, V655, P49, DOI 10.1007/978-1-4419-1132-2_6; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bricogne G, 2009, BUSTER VERSION 2 8 0; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dooley H, 2003, MOL IMMUNOL, V40, P25, DOI 10.1016/S0161-5890(03)00084-1; Dooley H, 2006, P NATL ACAD SCI USA, V103, P1846, DOI 10.1073/pnas.0508341103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Fennell BJ, 2010, J MOL BIOL, V400, P155, DOI 10.1016/j.jmb.2010.04.061; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Hwang WYK, 2005, METHODS, V36, P35, DOI 10.1016/j.ymeth.2005.01.004; JANIN J, 1990, J BIOL CHEM, V265, P16027; Koide A, 2002, P NATL ACAD SCI USA, V99, P1253, DOI 10.1073/pnas.032665299; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Liu JL, 2007, MOL IMMUNOL, V44, P1775, DOI 10.1016/j.molimm.2006.07.299; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller MR, 2012, MABS-AUSTIN, V4, P673, DOI 10.4161/mabs.22242; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Roux KH, 1998, P NATL ACAD SCI USA, V95, P11804, DOI 10.1073/pnas.95.20.11804; Simmons DP, 2006, J IMMUNOL METHODS, V315, P171, DOI 10.1016/j.jim.2006.07.019; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Stanfield RL, 2007, J MOL BIOL, V367, P358, DOI 10.1016/j.jmb.2006.12.045; Streltsov VA, 2004, P NATL ACAD SCI USA, V101, P12444, DOI 10.1073/pnas.0403509101; Transue TR, 1998, PROTEINS, V32, P515, DOI 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E; Tsurushita N, 2005, METHODS, V36, P69, DOI 10.1016/j.ymeth.2005.01.007; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	37	52	67	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17408	17419		10.1074/jbc.M112.435289	http://dx.doi.org/10.1074/jbc.M112.435289			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632026	Green Published, hybrid			2022-12-25	WOS:000320380600033
J	Ding, FY; Qian, BJ; Zhao, X; Shen, SQ; Deng, Y; Wang, DF; Zhang, F; Sui, ZQ; Jing, P				Ding, Fengyun; Qian, Bingjun; Zhao, Xin; Shen, Shanqi; Deng, Yun; Wang, Danfeng; Zhang, Feng; Sui, Zhongquan; Jing, Pu			VPPIPP and IPPVPP: Two Hexapeptides Innovated to Exert Antihypertensive Activity	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; BLOOD-PRESSURE; INHIBITORY PEPTIDES; STRUCTURAL-ANALYSIS; SOUR MILK; PROTEIN; ACE	In this study, two hexapeptides of IPPVPP and VPPIPP were innovated by using two commercial antihypertensive peptides IPP and VPP as two domains cis-linked and trans-linked, respectively. The IPPVPP and VPPIPP were chemically synthesized and evaluated for the antihypertensive activity in vitro/vivo. The in vitro ACE-inhibitory study showed that VPPIPP (34.71 +/- 4.38%) has a significantly stronger activity than that of IPPVPP (13.17 +/- 0.25%) at a treatment concentration of 10 mu mol/L, but it was weaker than the commercial IPP (56.97 +/- 2.40%) (P<0.05). However, VPPIPP, IPPVPP, and IPP lowered the systolic blood pressure by 21 +/- 0.9%, 17.4 +/- 1.3% and 17.5 +/- 0.9%, respectively, in rats at 1.5 mg/kg body weight dosage. The result was consistent with the mRNA level of sarcoplasmic reticulum Ca2+, Mg2+-ATPase Gene (SERCA 2a) in rat hearts. Additionally, VPPIPP and IPPVPP showed no negative impact on blood glycometabolism. The results suggested that the two hexapeptides could be potent bioactive peptides in functional foods for people with high blood pressure.	[Ding, Fengyun; Qian, Bingjun; Zhao, Xin; Shen, Shanqi; Deng, Yun; Wang, Danfeng; Zhang, Feng; Sui, Zhongquan; Jing, Pu] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Food Sci & Engn, Shanghai 200030, Peoples R China; [Ding, Fengyun] Yancheng Inst Hlth Sci, Yancheng, Jiangsu, Peoples R China; [Qian, Bingjun; Shen, Shanqi; Deng, Yun; Sui, Zhongquan; Jing, Pu] Shanghai Jiao Tong Univ, Bor Luh Food Safety Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Qian, BJ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Food Sci & Engn, Shanghai 200030, Peoples R China.	bjqianfd@sjtu.edu.cn; pjcolumbus@gmail.com	Jing, Pu/AAG-7020-2021; Jing, Pu/V-2258-2019	Jing, Pu/0000-0001-8204-7475	Shanghai Municipal Natural Science Foundation [11ZR1416200]; National Natural Science Foundation of China [31071530]; Youth Foundation of the School of Agriculture and Biology of Shanghai Jiao Tong University [NQN201001]	Shanghai Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of the School of Agriculture and Biology of Shanghai Jiao Tong University	This research was jointly supported by the Shanghai Municipal Natural Science Foundation (grant no. 11ZR1416200), the National Natural Science Foundation of China (grant no. 31071530), and the Youth Foundation of the School of Agriculture and Biology of Shanghai Jiao Tong University (NQN201001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 1998, J DAIRY SCI, V81, P3131, DOI 10.3168/jds.S0022-0302(98)75878-3; ASANO K, 1993, HEART FAIL REV, V3, P199; Braga FC, 2007, FITOTERAPIA, V78, P353, DOI [10.1016/j.fitote.2007.02.007, 10.1016/J.fitote.2007.02.007]; CHEUNG HS, 1980, J BIOL CHEM, V255, P401; Cui ZQ, 1999, CHINESE J BIOCH MOL, V15, P284; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; Fang H, 2008, PEPTIDES, V29, P1062, DOI 10.1016/j.peptides.2008.02.005; FitzGerald RJ, 2004, J NUTR, V134, p980S, DOI 10.1093/jn/134.4.980S; Fujita H, 2000, J FOOD SCI, V65, P564, DOI 10.1111/j.1365-2621.2000.tb16049.x; JARRETT RJ, 1978, INT J EPIDEMIOL, V7, P15, DOI 10.1093/ije/7.1.15; Kajimoto O., 2001, J NUTR FOOD, V4, P51; Loizzo MR, 2007, PHYTOTHER RES, V21, P32, DOI 10.1002/ptr.2008; Maeno M, 1996, J DAIRY SCI, V79, P1316, DOI 10.3168/jds.S0022-0302(96)76487-1; Martinez-Maqueda D, 2012, FOOD FUNCT, V3, P350, DOI 10.1039/c2fo10192k; McGrowder Donovan, 2003, Diabetologia Croatica, V32, P125; Miguel M, 2009, FOOD CHEM, V112, P211, DOI 10.1016/j.foodchem.2008.05.041; Mizushima S, 2004, AM J HYPERTENS, V17, P701, DOI 10.1016/j.amjhyper.2004.03.674; Motoi H, 2003, NAHRUNG, V47, P354, DOI 10.1002/food.200390081; Murakami M, 2004, J DAIRY SCI, V87, P1967, DOI 10.3168/jds.S0022-0302(04)70013-2; Murray BA, 2007, CURR PHARM DESIGN, V13, P773, DOI 10.2174/138161207780363068; Nagai T, 2006, FOOD SCI TECHNOL INT, V12, P335, DOI 10.1177/1082013206067933; NAKAMURA Y, 1995, J DAIRY SCI, V78, P1253, DOI 10.3168/jds.S0022-0302(95)76745-5; NAKAMURA Y, 1995, J DAIRY SCI, V78, P777, DOI 10.3168/jds.S0022-0302(95)76689-9; Nakashima Y, 2002, J FOOD SCI, V67, P434, DOI 10.1111/j.1365-2621.2002.tb11424.x; Nurminen ML, 2000, LIFE SCI, V66, P1535, DOI 10.1016/S0024-3205(00)00471-9; Ojeda D, 2010, J ETHNOPHARMACOL, V127, P7, DOI 10.1016/j.jep.2009.09.059; Ottaviani JI, 2006, BIOCHIMIE, V88, P359, DOI 10.1016/j.biochi.2005.10.001; ROBERT WP, 2000, AM J HEALTH-SYST PH, V1, pS3; Seppo L, 2003, AM J CLIN NUTR, V77, P326, DOI 10.1093/ajcn/77.2.326; SKEGGS LT, 1956, J EXP MED, V103, P295, DOI 10.1084/jem.103.3.295; Stewart BH, 1996, LIFE SCI, V58, P971, DOI 10.1016/0024-3205(96)00045-8; Takano T, 1998, INT DAIRY J, V8, P375, DOI 10.1016/S0958-6946(98)00060-0; Talha J, 2011, INT RES J PHARM, V2, P26; Tong XY, 2010, CURR OPIN PHARMACOL, V10, P133, DOI 10.1016/j.coph.2009.11.008; *WHO WORLD HLTH ST, 2012, WHO WORLD HLTH STAT; Wu JP, 2002, FOOD RES INT, V35, P367, DOI 10.1016/S0963-9969(01)00131-4; Zhang H, 2010, PLANT CELL, V22, P672, DOI 10.1105/tpc.109.073668; Ziv E, 2000, MICROSC RES TECHNIQ, V49, P346, DOI 10.1002/(SICI)1097-0029(20000515)49:4<346::AID-JEMT3>3.3.CO;2-2	38	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62384	10.1371/journal.pone.0062384	http://dx.doi.org/10.1371/journal.pone.0062384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638059	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300049
J	Li, Q; Zhou, XM; Shi, YQ; Li, JG; Zheng, LH; Cui, LN; Zhang, J; Wang, L; Han, ZY; Han, Y; Fan, DM				Li, Qiang; Zhou, Xinmin; Shi, Yongquan; Li, Jinge; Zheng, Linhua; Cui, Lina; Zhang, Jun; Wang, Lu; Han, Zheyi; Han, Ying; Fan, Daiming			In Vivo Tracking and Comparison of the Therapeutic Effects of MSCs and HSCs for Liver Injury	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW-CELLS; HEPATIC STELLATE CELLS; HEPATOCYTE DIFFERENTIATION; STEM/PROGENITOR CELLS; TISSUE-REPAIR; MOUSE-LIVER; RAT-LIVER; FIBROSIS; TRANSPLANTATION	Background: Mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs) have been studied for damaged liver repair; however, the conclusions drawn regarding their homing capacity to the injured liver are conflicting. Besides, the relative utility and synergistic effects of these two cell types on the injured liver remain unclear. Methodology/Principal Findings: MSCs, HSCs and the combination of both cells were obtained from the bone marrow of male mice expressing enhanced green uorescent protein(EGFP) and injected into the female mice with or without liver fibrosis. The distribution of the stem cells, survival rates, liver function, hepatocyte regeneration, growth factors and cytokines of the recipient mice were analyzed. We found that the liver content of the EGFP-donor cells was significantly higher in the MSCs group than in the HSCs or MSCs+HSCs group. The survival rate for the MSCs group was significantly higher than that of the HSCs or MSCs+HSCs group; all surpassed the control group. After MSC-transplantation, the injured livers were maximally restored, with less collagen than the controls. The fibrotic areas had decreased to a lesser extent in the mice transplanted with HSCs or MSCs+HSCs. Compared with mice in the HSCs group, the mice that received MSCs had better improved liver function. MSCs exhibited more remarkable paracrine effects and immunomodulatory properties on hepatic stellate cells and native hepatocytes in the treatment of the liver pathology. Synergistic actions of MSCs and HSCs were most likely not observed because the stem cells in liver were detected mostly as single cells, and single MSCs are insufficient to provide a beneficial niche for HSCs. Conclusions/Significance: MSCs exhibited a greater homing capability for the injured liver and modulated fibrosis and inflammation more effectively than did HSCs. Synergistic effects of MSCs and HSCs were not observed in liver injury.	[Li, Qiang; Zhou, Xinmin; Shi, Yongquan; Li, Jinge; Zheng, Linhua; Cui, Lina; Zhang, Jun; Wang, Lu; Han, Zheyi; Han, Ying; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University	Han, Y (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Shaanxi Provinc, Peoples R China.	hanying1@fmmu.edu.cn	Shi, Yongquan/AAE-3954-2020; 金华, 郑/GWM-7529-2022; huijuan, Cao/A-2427-2014		National Natural Science Foundation of China [81070326]; "863'' Program of China [2011AA020111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863'' Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (No. 81070326) and "863'' Program of China (2011AA020111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x; Cho KA, 2009, CELL BIOL INT, V33, P772, DOI 10.1016/j.cellbi.2009.04.023; Ciulla MM, 2007, MICRON, V38, P321, DOI 10.1016/j.micron.2006.08.007; Di Bonzo LV, 2008, GUT, V57, P223, DOI 10.1136/gut.2006.111617; Esch JSA, 2005, STEM CELLS, V23, P463, DOI 10.1634/stemcells.2004-0283; Ezquer M, 2011, J HEPATOL, V55, P1112, DOI 10.1016/j.jhep.2011.02.020; Fang BJ, 2004, TRANSPLANTATION, V78, P83, DOI 10.1097/01.TP.0000128326.95294.14; Fassett J, 2006, MOL BIOL CELL, V17, P345, DOI 10.1091/mbc.E05-09-0871; Herrera MB, 2004, INT J MOL MED, V14, P1035; Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Ichim Thomas E, 2010, Int Arch Med, V3, P5, DOI 10.1186/1755-7682-3-5; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Kawai K, 2012, CELL TRANSPLANT, V21, P453, DOI 10.3727/096368911X605367; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Li CY, 2009, J HEPATOL, V50, P1174, DOI 10.1016/j.jhep.2009.01.028; Li LR, 2012, J CLIN ENDOCR METAB, V97, P1729, DOI 10.1210/jc.2011-2188; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Mendt M, 2012, STEM CELLS DEV, V21, P2142, DOI 10.1089/scd.2011.0565; Miyata E, 2008, BLOOD, V111, P2427, DOI 10.1182/blood-2007-07-101261; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Newsome PN, 2003, GASTROENTEROLOGY, V124, P1891, DOI 10.1016/S0016-5085(03)00401-3; Orlic D, 2003, ANN NY ACAD SCI, V996, P152, DOI 10.1111/j.1749-6632.2003.tb03243.x; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Parekkadan B, 2007, BIOCHEM BIOPH RES CO, V363, P247, DOI 10.1016/j.bbrc.2007.05.150; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Pulavendran S, 2010, INT IMMUNOPHARMACOL, V10, P513, DOI 10.1016/j.intimp.2010.01.014; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sassoli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037512; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184; Seebach C, 2007, CALCIFIED TISSUE INT, V80, P294, DOI 10.1007/s00223-007-9020-6; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Trak-Smayra V, 2004, TRANSPLANTATION, V77, P1755, DOI 10.1097/01.TP.0000131172.75294.A9; Urban VS, 2008, STEM CELLS, V26, P244, DOI 10.1634/stemcells.2007-0267; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang JB, 2010, CYTOTHERAPY, V12, P1022, DOI 10.3109/14653249.2010.515578; Wang XY, 2008, BLOOD, V111, P2436, DOI 10.1182/blood-2007-07-099333; Weil BR, 2009, SURGERY, V146, P190, DOI 10.1016/j.surg.2009.03.031; Yannaki E, 2006, EXP HEMATOL, V34, P1583, DOI 10.1016/j.exphem.2006.06.012; Zhao DC, 2005, WORLD J GASTROENTERO, V11, P3431, DOI 10.3748/wjg.v11.i22.3431; Zhao QJ, 2009, BIOL CELL, V101, P557, DOI 10.1042/BC20080105; Zhao W, 2012, WORLD J GASTROENTERO, V18, P1048, DOI 10.3748/wjg.v18.i10.1048	52	53	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62363	10.1371/journal.pone.0062363	http://dx.doi.org/10.1371/journal.pone.0062363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638052	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300046
J	Singh, A; Kanwar, P; Pandey, A; Tyagi, AK; Sopory, SK; Kapoor, S; Pandey, GK				Singh, Amarjeet; Kanwar, Poonam; Pandey, Amita; Tyagi, Akhilesh K.; Sopory, Sudhir K.; Kapoor, Sanjay; Pandey, Girdhar K.			Comprehensive Genomic Analysis and Expression Profiling of Phospholipase C Gene Family during Abiotic Stresses and Development in Rice	PLOS ONE			English	Article							ABSCISIC-ACID; PLASMA-MEMBRANE; ORYZA-SATIVA; DROUGHT TOLERANCE; ARABIDOPSIS; PROTEIN; IDENTIFICATION; KINASE; CELLS; NPC4	Background: Phospholipase C (PLC) is one of the major lipid hydrolysing enzymes, implicated in lipid mediated signaling. PLCs have been found to play a significant role in abiotic stress triggered signaling and developmental processes in various plant species. Genome wide identification and expression analysis have been carried out for this gene family in Arabidopsis, yet not much has been accomplished in crop plant rice. Methodology/Principal Findings: An exhaustive in-silico exploration of rice genome using various online databases and tools resulted in the identification of nine PLC encoding genes. Based on sequence, motif and phylogenetic analysis rice PLC gene family could be divided into phosphatidylinositol-specific PLCs (PI-PLCs) and phosphatidylcholine- PLCs (PC-PLC or NPC) classes with four and five members, respectively. A comparative analysis revealed that PLCs are conserved in Arabidopsis (dicots) and rice (monocot) at gene structure and protein level but they might have evolved through a separate evolutionary path. Transcript profiling using gene chip microarray and quantitative RT-PCR showed that most of the PLC members expressed significantly and differentially under abiotic stresses (salt, cold and drought) and during various developmental stages with condition/stage specific and overlapping expression. This finding suggested an important role of different rice PLC members in abiotic stress triggered signaling and plant development, which was also supported by the presence of relevant cis-regulatory elements in their promoters. Sub-cellular localization of few selected PLC members in Nicotiana benthamiana and onion epidermal cells has provided a clue about their site of action and functional behaviour. Conclusion/Significance: The genome wide identification, structural and expression analysis and knowledge of sub-cellular localization of PLC gene family envisage the functional characterization of these genes in crop plants in near future.	[Singh, Amarjeet; Kanwar, Poonam; Pandey, Amita; Tyagi, Akhilesh K.; Kapoor, Sanjay; Pandey, Girdhar K.] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Tyagi, Akhilesh K.] Natl Inst Plant Genome Res, New Delhi, India; [Sopory, Sudhir K.] Jawaharlal Nehru Univ, New Delhi 110067, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Jawaharlal Nehru University, New Delhi	Pandey, GK (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi, India.	gkpandey@south.du.ac.in		Pandey, Amita/0000-0001-8717-3227; Kapoor, Sanjay/0000-0002-0283-1137; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Kanwar, Poonam/0000-0002-9328-9274	Department of Biotechnology (DBT); Department of Science and Technology (DST); Council for Scientific and Industrial Research (CSIR), INDIA	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR), INDIA(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge Department of Biotechnology (DBT), Department of Science and Technology (DST) and Council for Scientific and Industrial Research (CSIR), INDIA for funding the research in GKP's lab. AS and PK acknowledge senior research fellowship from CSIR, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; Boss WF, 2008, ANNU PLANT REV, V33, P202, DOI 10.1111/b.9781405160025.2008.00008.x; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chen GQ, 2011, CRIT REV PLANT SCI, V30, P239, DOI 10.1080/07352689.2011.572033; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Das R, 2010, CURR GENOMICS, V11, P2, DOI 10.2174/138920210790217981; Gaude N, 2008, PLANT J, V56, P28, DOI 10.1111/j.1365-313X.2008.03582.x; Georges F, 2009, PLANT CELL ENVIRON, V32, P1664, DOI 10.1111/j.1365-3040.2009.02027.x; HUANG CH, 1995, PLANT J, V8, P257, DOI 10.1046/j.1365-313X.1995.08020257.x; Hunt L, 2004, NEW PHYTOL, V162, P643, DOI 10.1111/j.1469-8137.2004.01069.x; Jiang C, 1996, PLANT MOL BIOL, V30, P679, DOI 10.1007/BF00049344; KIM SY, 1990, NUCLEIC ACIDS RES, V18, P6845, DOI 10.1093/nar/18.23.6845; Kim YJ, 2004, FEBS LETT, V556, P127, DOI 10.1016/S0014-5793(03)01388-7; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kocourkova D, 2011, J EXP BOT, V62, P3753, DOI 10.1093/jxb/err039; Kopka J, 1998, PLANT PHYSIOL, V116, P239, DOI 10.1104/pp.116.1.239; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li G, 2007, CELL RES, V17, P881, DOI 10.1038/cr.2007.77; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Mikami K, 2004, J EXP BOT, V55, P1437, DOI 10.1093/jxb/erh140; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Pandey Girdhar K., 2008, Physiology and Molecular Biology of Plants, V14, P51, DOI 10.1007/s12298-008-0005-3; Perera IK, 2001, PLANT PHYSIOL, V125, P1499, DOI 10.1104/pp.125.3.1499; Peters C, 2010, PLANT CELL, V22, P2642, DOI 10.1105/tpc.109.071720; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Rupwate SD, 2012, PLANT MOL BIOL, V78, P247, DOI 10.1007/s11103-011-9862-1; Sanchez JP, 2001, PLANT CELL, V13, P1143, DOI 10.1105/tpc.13.5.1143; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SHI JR, 1995, PLANT J, V8, P381, DOI 10.1046/j.1365-313X.1995.08030381.x; Singh A, 2012, PLANT SIGNAL BEHAV, V7, P847, DOI 10.4161/psb.20385; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; TAKAIWA F, 1991, PLANT MOL BIOL, V16, P49, DOI 10.1007/BF00017916; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tasma IM, 2008, PLANT PHYSIOL BIOCH, V46, P627, DOI 10.1016/j.plaphy.2008.04.015; Tripathy MK, 2012, PLANT MOL BIOL REP, V30, P488, DOI 10.1007/s11105-011-0360-z; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; van Leeuwen W, 2007, PLANT J, V52, P1014, DOI 10.1111/j.1365-313X.2007.03292.x; van Schooten B, 2006, BBA-MOL CELL BIOL L, V1761, P151, DOI 10.1016/j.bbalip.2005.12.010; Venkataraman G, 2004, MOL GENET GENOMICS, V270, P378, DOI 10.1007/s00438-003-0925-0; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Vossen JH, 2010, PLANT J, V62, P224, DOI 10.1111/j.1365-313X.2010.04136.x; Waadt R., 2008, COLD SPRING HARBOR P, V2008; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang CR, 2008, PLANTA, V227, P1127, DOI 10.1007/s00425-007-0686-9; Wang XM, 2001, ANNU REV PLANT PHYS, V52, P211, DOI 10.1146/annurev.arplant.52.1.211; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Wimalasekera R, 2010, MOL PLANT, V3, P610, DOI 10.1093/mp/ssq005; Xia HJ, 2003, PLANT CELL, V15, P449, DOI 10.1105/tpc.006676; Xue H, 2007, CURR OPIN PLANT BIOL, V10, P483, DOI 10.1016/j.pbi.2007.07.003; YOTSUSHIMA K, 1993, PLANT PHYSIOL, V102, P165, DOI 10.1104/pp.102.1.165; Zonia Laura, 2006, V39, P207	58	53	67	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62494	10.1371/journal.pone.0062494	http://dx.doi.org/10.1371/journal.pone.0062494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638098	Green Submitted, gold, Green Published			2022-12-25	WOS:000319077300068
J	Yang, L; Cai, XY; Liu, J; Jia, Z; Jiao, JJ; Zhang, JC; Li, CL; Li, J; Tang, XD				Yang, Liang; Cai, Xiangyu; Liu, Jie; Jia, Zhe; Jiao, Jinjin; Zhang, Jincai; Li, Changlin; Li, Jing; Tang, Xiang D.			CpG-ODN Attenuates Pathological Cardiac Hypertrophy and Heart Failure by Activation of PI3K alpha-Akt Signaling	PLOS ONE			English	Article							NF-KAPPA-B; ISCHEMIA/REPERFUSION INJURY; THERAPEUTIC STRATEGIES; EXERCISE; PATHWAY; TOLL-LIKE-RECEPTOR-9; CARDIOMYOPATHY; CONTRACTILITY; MECHANISM; CHANNELS	Phosphoinositide-3-kinase alpha (PI3K alpha) represents a potential novel drug target for pathological cardiac hypertrophy (PCH) and heart failure. Oligodeoxynucleotides containing CpG motifs (CpG-ODN) are classic agonists of Toll-like receptor 9 (TLR9), which typically activates PI3K-Akt signaling in immune cells; however, the role of the nucleotide TLR9 agonists in cardiac myocytes is largely unknown. Here we report that CpG-ODN C274 could both attenuate PCH and improve cardiac dysfunction by activating PI3K alpha-Akt signaling cascade. In vitro studies indicated that C274 could blunt reactivation of fetal cardiac genes and cell enlargement induced by a hypertrophic agent, isoproterenol. The anti-hypertrophic effect of C274 was suppressed by a pan-PI3K inhibitor, LY294002, or a small interfering RNA targeting PI3K alpha. In vivo studies demonstrated that PCH, as marked by increased heart weight (HW) and cardiac ANF mRNA, was normalized by pre-administration with C274. In addition, Doppler echocardiography detected cardiac ventricular dilation, and contractile dysfunction in isoproterenol-treated animals, consistent with massive replacement fibrosis, reflecting cardiac cell death. As expected, pre-treatment of mice with C274 could prevent cardiac dysfunction associated with diminished cardiac cell death and fibrosis. In conclusion, CpG-ODNs are novel cardioprotective agents possessing antihypertrophic and anti-cell death activity afforded by engagement of the PI3K alpha-Akt signaling. CpG-ODNs may have clinical use curbing the progression of PCH and preventing heart failure.	[Yang, Liang; Cai, Xiangyu; Liu, Jie; Jia, Zhe; Jiao, Jinjin; Zhang, Jincai; Li, Changlin; Li, Jing; Tang, Xiang D.] Nankai Univ, Dept Pharmacol, Sch Med, Tianjin 300071, Peoples R China; [Tang, Xiang D.] Nankai Univ, Sch Med, Chinese Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Li, J (corresponding author), Nankai Univ, Dept Pharmacol, Sch Med, Tianjin 300071, Peoples R China.	stellarli@nankai.edu.cn; stang@nankai.edu.cn			National Nature Scientific Foundation of China [81102436, 81072629]; Tianjin Natural Science Foundation [12JCQNJC08300, 10JCYBJC14800]; National Basic Research Program of China (973) [2010CB945001]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); National Basic Research Program of China (973)(National Basic Research Program of China)	This work was supported by the National Nature Scientific Foundation of China (81102436 to L.Y., 81072629 to J.L.) and Tianjin Natural Science Foundation (12JCQNJC08300 to L.Y., 10JCYBJC14800 to J. L.). National Basic Research Program of China (973) (2010CB945001 to X.D.T. and J. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorisio R, 2006, HEART FAIL REV, V11, P109, DOI 10.1007/s10741-006-9482-z; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Cao ZJ, 2013, BBA-MOL BASIS DIS, V1832, P96, DOI 10.1016/j.bbadis.2012.08.008; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Davies EJ, 2010, EUR J HEART FAIL, V12, P706, DOI 10.1093/eurjhf/hfq056; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Ha TZ, 2010, CARDIOVASC RES, V87, P694, DOI 10.1093/cvr/cvq116; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Leenen FHH, 2001, AM J PHYSIOL-HEART C, V281, pH2410, DOI 10.1152/ajpheart.2001.281.6.H2410; Li CL, 2011, J BIOL CHEM, V286, P40782, DOI 10.1074/jbc.M111.263046; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; Mann DL, 2010, EUR J HEART FAIL, V12, P789, DOI 10.1093/eurjhf/hfq113; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Zhang KR, 2007, APOPTOSIS, V12, P1579, DOI 10.1007/s10495-007-0090-8; Zhang X, 2012, SHOCK	31	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62373	10.1371/journal.pone.0062373	http://dx.doi.org/10.1371/journal.pone.0062373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638055	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300048
J	Cho, CP; Lin, SC; Chou, MY; Hsu, HT; Chang, KY				Cho, Che-Pei; Lin, Szu-Chieh; Chou, Ming-Yuan; Hsu, Hsiu-Ting; Chang, Kung-Yao			Regulation of Programmed Ribosomal Frameshifting by Co-Translational Refolding RNA Hairpins	PLOS ONE			English	Article							MESSENGER-RNA; E-SITE; PSEUDOKNOT STIMULATOR; READING FRAME; P-SITE; YEAST; TRANSCRIPTION; SIGNALS; SYSTEM	RNA structures are unwound for decoding. In the process, they can pause the elongating ribosome for regulation. An example is the stimulation of -1 programmed ribosomal frameshifting, leading to 39 direction slippage of the reading-frame during elongation, by specific pseudoknot stimulators downstream of the frameshifting site. By investigating a recently identified regulatory element upstream of the SARS coronavirus (SARS-CoV) 21 frameshifting site, it is shown that a minimal functional element with hairpin forming potential is sufficient to down-regulate-1 frameshifting activity. Mutagenesis to disrupt or restore base pairs in the potential hairpin stem reveals that base-pair formation is required for-1 frameshifting attenuation in vitro and in 293T cells. The attenuation efficiency of a hairpin is determined by its stability and proximity to the frameshifting site; however, it is insensitive to E site sequence variation. Additionally, using a dual luciferase assay, it can be shown that a hairpin stimulated +1 frameshifting when placed upstream of a+1 shifty site in yeast. The investigations indicate that the hairpin is indeed a cis-acting programmed reading-frame switch modulator. This result provides insight into mechanisms governing-1 frameshifting stimulation and attenuation. Since the upstream hairpin is unwound (by a marching ribosome) before the downstream stimulator, this study's findings suggest a new mode of translational regulation that is mediated by the reformed stem of a ribosomal unwound RNA hairpin during elongation.	[Cho, Che-Pei; Lin, Szu-Chieh; Chou, Ming-Yuan; Hsu, Hsiu-Ting; Chang, Kung-Yao] Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan	National Chung Hsing University	Chang, KY (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan.	kychang@dragon.nchu.edu.tw		Chang, Kung Yao/0000-0002-4469-0387	National Science Council of Taiwan [NSC 99-2311-B-005-004-MY3, NSC 99-2627-M-005-002, NSC 101-2627-M-005-007]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by Grants NSC 99-2311-B-005-004-MY3, NSC 99-2627-M-005-002 and NSC 101-2627-M-005-007 from the National Science Council of Taiwan (to K.-Y. Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; BELCOURT MF, 1990, CELL, V62, P339, DOI 10.1016/0092-8674(90)90371-K; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; CHAMORRO M, 1992, P NATL ACAD SCI USA, V89, P713, DOI 10.1073/pnas.89.2.713; Chou MY, 2010, NUCLEIC ACIDS RES, V38, P1676, DOI 10.1093/nar/gkp1107; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; FRUGIER M, 1994, NUCLEIC ACIDS RES, V22, P2784, DOI 10.1093/nar/22.14.2784; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Grentzmann G, 1998, RNA, V4, P479; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Hung M, 1998, J VIROL, V72, P4819, DOI 10.1128/JVI.72.6.4819-4824.1998; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kim YG, 2001, NUCLEIC ACIDS RES, V29, P1125, DOI 10.1093/nar/29.5.1125; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Passos DO, 2009, MOL BIOL CELL, V20, P3025, DOI 10.1091/mbc.E09-01-0028; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; Plant EP, 2010, J VIROL, V84, P4330, DOI 10.1128/JVI.02480-09; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Stahl G, 2002, TRENDS BIOCHEM SCI, V27, P178, DOI 10.1016/S0968-0004(02)02064-9; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; Su MC, 2005, NUCLEIC ACIDS RES, V33, P4265, DOI 10.1093/nar/gki731; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62283	10.1371/journal.pone.0062283	http://dx.doi.org/10.1371/journal.pone.0062283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638024	Green Submitted, Green Published, gold			2022-12-25	WOS:000321662800033
J	Bai, XY; Feldman, NE; Chmura, K; Ovrutsky, AR; Su, WL; Griffin, L; Pyeon, D; McGibney, MT; Strand, MJ; Numata, M; Murakami, S; Gaido, L; Honda, JR; Kinney, WH; Oberley-Deegan, RE; Voelker, DR; Ordway, DJ; Chan, ED				Bai, Xiyuan; Feldman, Nicole E.; Chmura, Kathryn; Ovrutsky, Alida R.; Su, Wen-Lin; Griffin, Laura; Pyeon, Dohun; McGibney, Mischa T.; Strand, Matthew J.; Numata, Mari; Murakami, Seiji; Gaido, Loretta; Honda, Jennifer R.; Kinney, William H.; Oberley-Deegan, Rebecca E.; Voelker, Dennis R.; Ordway, Diane J.; Chan, Edward D.			Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DRUG-RESISTANT TUBERCULOSIS; TOLL-LIKE RECEPTORS; NITRIC-OXIDE; TRANSCRIPTION FACTOR; HOST-DEFENSE; TNF-ALPHA; ALVEOLAR MACROPHAGES; MURINE MACROPHAGES; INTERLEUKIN-8 GENE	Nuclear factor-kappa B (NF kappa B) is a ubiquitous transcription factor that mediates pro-inflammatory responses required for host control of many microbial pathogens; on the other hand, NF kappa B has been implicated in the pathogenesis of other inflammatory and infectious diseases. Mice with genetic disruption of the p50 subunit of NF kappa B are more likely to succumb to Mycobacterium tuberculosis (MTB). However, the role of NF kappa B in host defense in humans is not fully understood. We sought to examine the role of NFkB activation in the immune response of human macrophages to MTB. Targeted pharmacologic inhibition of NF kappa B activation using BAY 11-7082 (BAY, an inhibitor of I kappa B alpha kinase) or an adenovirus construct with a dominant-negative IkBa significantly decreased the number of viable intracellular mycobacteria recovered from THP-1 macrophages four and eight days after infection. The results with BAY were confirmed in primary human monocyte-derived macrophages and alveolar macrophages. NF kappa B inhibition was associated with increased macrophage apoptosis and autophagy, which are well-established killing mechanisms of intracellular MTB. Inhibition of the executioner protease caspase-3 or of the autophagic pathway significantly abrogated the effects of BAY. We conclude that NF kappa B inhibition decreases viability of intracellular MTB in human macrophages via induction of apoptosis and autophagy.	[Bai, Xiyuan; Chan, Edward D.] Denver Vet Affairs Med Ctr, Dept Med, Denver, CO USA; [Bai, Xiyuan; Feldman, Nicole E.; Chmura, Kathryn; Ovrutsky, Alida R.; McGibney, Mischa T.; Strand, Matthew J.; Numata, Mari; Murakami, Seiji; Honda, Jennifer R.; Kinney, William H.; Oberley-Deegan, Rebecca E.; Voelker, Dennis R.; Chan, Edward D.] Natl Jewish Hlth, Dept Med & Acad Affairs, Denver, CO USA; [Bai, Xiyuan; Chmura, Kathryn; Ovrutsky, Alida R.; Honda, Jennifer R.; Kinney, William H.; Chan, Edward D.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Gaido, Loretta] Denver Hlth Med Ctr, Denver, CO USA; [Griffin, Laura; Pyeon, Dohun] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA; [Su, Wen-Lin] Natl Def Med Ctr, Dept Med, Tri Serv Gen Hosp, Taipei, Taiwan; [Ordway, Diane J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; National Defense Medical Center; Tri-Service General Hospital; Colorado State University	Bai, XY (corresponding author), Denver Vet Affairs Med Ctr, Dept Med, Denver, CO USA.	baix@njhealth.org; chane@njhealth.org	Strand, Matt/AAU-3762-2021; Ordway, Diane/H-9732-2017	Strand, Matt/0000-0002-9083-5989; Ordway, Diane/0000-0003-0003-326X; Pyeon, Dohun/0000-0003-1970-844X	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development [1 I01 BX001028-01A2]; National Institutes of Health (NIH) [PHL073907]; General Clinical Research Center Program Grant [M01-RR00051]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091968] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Center Program Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development 1 I01 BX001028-01A2 (to EDC), National Institutes of Health (NIH) PHL073907 (to DRV), and General Clinical Research Center Program Grant No. M01-RR00051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bai XY, 2010, J IMMUNOL, V184, P3830, DOI 10.4049/jimmunol.0901913; Bai XY, 2004, TUBERCULOSIS, V84, P375, DOI 10.1016/j.tube.2004.05.001; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bernardo J, 1998, INFECT IMMUN, V66, P28, DOI 10.1128/IAI.66.1.28-35.1998; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6; Changsen C, 2003, ANTIMICROB AGENTS CH, V47, P3682, DOI 10.1128/AAC.47.12.3682-3687.2003; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chiang CY, 2009, INT J TUBERC LUNG D, V13, P304; Cota-Gomez A, 2002, J BIOL CHEM, V277, P14390, DOI 10.1074/jbc.M108591200; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Dhiman R, 2007, BBA-GEN SUBJECTS, V1770, P649, DOI 10.1016/j.bbagen.2006.11.016; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foryst-Ludwig A, 2000, J BIOL CHEM, V275, P39779, DOI 10.1074/jbc.M007617200; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jobin C, 1998, J IMMUNOL, V160, P410; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kwon J, 1996, J BIOL CHEM, V271, P22383, DOI 10.1074/jbc.271.37.22383; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; LURIE MB, 1964, RESISTANCE TUBERCULO; Macdonald SHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038488; Madariaga MG, 2008, AM J MED, V121, P835, DOI 10.1016/j.amjmed.2008.04.015; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Means TK, 1999, J IMMUNOL, V163, P3920; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morris KR, 2003, INFECT IMMUN, V71, P1442, DOI 10.1128/IAI.71.3.1442-1452.2003; Morris KR, 2009, TUBERCULOSIS, V89, P294, DOI 10.1016/j.tube.2009.03.004; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; Patel NR, 2009, J LEUKOCYTE BIOL, V86, P53, DOI [10.1189/JLB.0908574, 10.1189/jlb.0908574]; Peng H, 2011, J BIOL CHEM, V286, P24508, DOI 10.1074/jbc.M111.234062; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rojas M, 1997, J IMMUNOL, V159, P1352; Rojas M, 1999, J IMMUNOL, V162, P6122; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Yamada H, 2001, INFECT IMMUN, V69, P7100, DOI 10.1128/IAI.69.11.7100-7105.2001; Yuk JM, 2012, EXP MOL MED, V44, P99, DOI 10.3858/emm.2012.44.2.032; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zingarelli B, 2003, CRIT CARE MED, V31, pS105, DOI 10.1097/00003246-200301001-00015	75	57	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61925	10.1371/journal.pone.0061925	http://dx.doi.org/10.1371/journal.pone.0061925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634218	Green Submitted, Green Published, gold			2022-12-25	WOS:000318341400027
J	Teodoro, D; Lovis, C				Teodoro, Douglas; Lovis, Christian			Empirical Mode Decomposition and k-Nearest Embedding Vectors for Timely Analyses of Antibiotic Resistance Trends	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; EPIDEMICS; FREQUENCY; MANAGEMENT; DYNAMICS; OUTBREAK; FATIGUE	Background: Antibiotic resistance is a major worldwide public health concern. In clinical settings, timely antibiotic resistance information is key for care providers as it allows appropriate targeted treatment or improved empirical treatment when the specific results of the patient are not yet available. Objective: To improve antibiotic resistance trend analysis algorithms by building a novel, fully data-driven forecasting method from the combination of trend extraction and machine learning models for enhanced biosurveillance systems. Methods: We investigate a robust model for extraction and forecasting of antibiotic resistance trends using a decade of microbiology data. Our method consists of breaking down the resistance time series into independent oscillatory components via the empirical mode decomposition technique. The resulting waveforms describing intrinsic resistance trends serve as the input for the forecasting algorithm. The algorithm applies the delay coordinate embedding theorem together with the k-nearest neighbor framework to project mappings from past events into the future dimension and estimate the resistance levels. Results: The algorithms that decompose the resistance time series and filter out high frequency components showed statistically significant performance improvements in comparison with a benchmark random walk model. We present further qualitative use-cases of antibiotic resistance trend extraction, where empirical mode decomposition was applied to highlight the specificities of the resistance trends. Conclusion: The decomposition of the raw signal was found not only to yield valuable insight into the resistance evolution, but also to produce novel models of resistance forecasters with boosted prediction performance, which could be utilized as a complementary method in the analysis of antibiotic resistance trends.	[Teodoro, Douglas; Lovis, Christian] Univ Hosp Geneva, Div Med Informat Sci, Geneva, Switzerland	University of Geneva	Teodoro, D (corresponding author), Univ Hosp Geneva, Div Med Informat Sci, Geneva, Switzerland.	douglas.teodoro@unige.ch	Teodoro, Douglas H/H-5122-2012; Teodoro, Douglas/AAN-8343-2020; Lovis, Christian/D-2634-2012; Lovis, Christian/T-5364-2019	Teodoro, Douglas H/0000-0001-6238-4503; Teodoro, Douglas/0000-0001-6238-4503; Lovis, Christian/0000-0002-2681-8076; Lovis, Christian/0000-0002-2681-8076	DebugIT project of the European Union Seventh Framework Programme [ICT-2007.5.2-217139]	DebugIT project of the European Union Seventh Framework Programme	This work is funded by the DebugIT project of the European Union Seventh Framework Programme grant agreement ICT-2007.5.2-217139. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Chakrabarti D., 2002, Proceedings of the Eleventh International Conference on Information and Knowledge Management. CIKM 2002, P2, DOI 10.1145/584792.584797; Cook AR, 2007, P NATL ACAD SCI USA, V104, P20392, DOI 10.1073/pnas.0706461104; Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647; Crone SF, 2011, INT J FORECASTING, V27, P635, DOI 10.1016/j.ijforecast.2011.04.001; D'Agata EMC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004036; Diekema DJ, 2004, CLIN INFECT DIS, V38, P78, DOI 10.1086/380457; Felmingham D, 2002, J ANTIMICROB CHEMOTH, V50, P1, DOI 10.1093/jac/dkf807; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Haber M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-254; Hegger R, 2000, PHYS REV LETT, V84, P3197, DOI 10.1103/PhysRevLett.84.3197; Hu M, 2012, COMPUT INTEL NEUROSC, V2012, DOI 10.1155/2012/275073; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jaecklin T, 2006, EUR J PEDIATR, V165, P3, DOI 10.1007/s00431-005-1737-5; Kiffer CRV, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-17; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li K, 2012, MED ENG PHYS, V34, P832, DOI 10.1016/j.medengphy.2011.09.025; Lovis C, 2008, STUD HEALTH TECHNOL, V136, P641; McBryde ES, 2007, J R SOC INTERFACE, V4, P745, DOI 10.1098/rsif.2007.0224; Murphy SP, 2008, J AM MED INFORM ASSN, V15, P77, DOI 10.1197/jamia.M2587; Muthuswamy J, 1999, IEEE T BIO-MED ENG, V46, P92, DOI 10.1109/10.736762; Nielsen EI, 2007, ANTIMICROB AGENTS CH, V51, P128, DOI 10.1128/AAC.00604-06; O'Brien TF, 2011, CLIN MICROBIOL REV, V24, P281, DOI 10.1128/CMR.00021-10; Pasche E, 2009, STUD HEALTH TECHNOL, V150, P569, DOI 10.3233/978-1-60750-044-5-569; Reynolds R, 2009, J ANTIMICROB CHEMOTH, V64, P19, DOI 10.1093/jac/dkp257; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Sintchenko V, 2008, CURR OPIN INFECT DIS, V21, P573, DOI 10.1097/QCO.0b013e3283118932; Takens F, 1981, LECT NOTES MATH, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Teodoro D, 2012, J MED INTERNET RES, V14, P332, DOI 10.2196/jmir.2043; Teodoro D, 2011, STUD HEALTH TECHNOL, V169, P185, DOI 10.3233/978-1-60750-806-9-185; Teodoro D, 2009, STUD HEALTH TECHNOL, V150, P175, DOI 10.3233/978-1-60750-044-5-175; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Webb GF, 2005, P NATL ACAD SCI USA, V102, P13343, DOI 10.1073/pnas.0504053102; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Xie HB, 2006, COMPUT METH PROG BIO, V82, P114, DOI 10.1016/j.cmpb.2006.02.009; Yang AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014612; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	38	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61180	10.1371/journal.pone.0061180	http://dx.doi.org/10.1371/journal.pone.0061180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637796	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400009
J	Kuryatov, A; Mukherjee, J; Lindstrom, J				Kuryatov, Alexander; Mukherjee, Jayanta; Lindstrom, Jon			Chemical Chaperones Exceed the Chaperone Effects of RIC-3 in Promoting Assembly of Functional alpha 7 AChRs	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; PHARMACOLOGICAL-PROPERTIES; CELL-LINE; STABLE EXPRESSION; MAMMALIAN-CELLS; XENOPUS-OOCYTES; UP-REGULATION; SUBUNIT; MATURATION; POTENTIATION	Functional alpha 7 nicotinic acetylcholine receptors (AChRs) do not assemble efficiently in cells transfected with alpha 7 subunits unless the cells are also transfected with the chaperone protein RIC-3. Despite the presence of RIC-3, large amounts of these subunits remain improperly assembled. Thus, additional chaperone proteins are probably required for efficient assembly of alpha 7 AChRs. Cholinergic ligands can act as pharmacological chaperones to promote assembly of mature AChRs and upregulate the amount of functional AChRs. In addition, we have found that the chemical chaperones 4-phenylbutyric acid (PBA) and valproic acid (VPA) greatly increase the amount of functional alpha 7 AChRs produced in a cell line expressing both alpha 7 and RIC-3. Increased alpha 7 AChR expression allows assay of drug action using a membrane potential-sensitive fluorescent indicator. Both PBA and VPA also increase alpha 7 expression in the SH-SY5Y neuroblastoma cell line that endogenously expresses alpha 7 AChRs. VPA increases expression of endogenous alpha 7 AChRs in hippocampal neurons but PBA does not. RIC-3 is insufficient for optimal assembly of alpha 7 AChRs, but provides assay conditions for detecting additional chaperones. Chemical chaperones are a useful pragmatic approach to express high levels of human alpha 7 AChRs for drug selection and characterization and possibly to increase alpha 7 expression in vivo.	[Kuryatov, Alexander; Mukherjee, Jayanta; Lindstrom, Jon] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Lindstrom, J (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	JSLKK@mail.med.upenn.edu			National Institutes of Health [NS11323]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant NS11323 from the National Institutes of Health to J. Lindstrom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmaca A, 2004, J CLIN ONCOL, V22, P3169; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Castillo M, 2009, J NEUROCHEM, V108, P1399, DOI 10.1111/j.1471-4159.2009.05924.x; Conroy WG, 2003, MOL PHARMACOL, V63, P419, DOI 10.1124/mol.63.2.419; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; Cooper ST, 1997, J NEUROCHEM, V68, P2140; Craig PJ, 2004, EUR J PHARMACOL, V502, P31, DOI 10.1016/j.ejphar.2004.08.042; Dunlop J, 2007, BIOCHEM PHARMACOL, V74, P1172, DOI 10.1016/j.bcp.2007.07.006; Faghih R, 2008, J MED CHEM, V51, P701, DOI 10.1021/jm070256g; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Gao BX, 2010, PAIN, V149, P33, DOI 10.1016/j.pain.2010.01.007; GOPALAKRISHNAN M, 1995, EUR J PHARM-MOLEC PH, V290, P237, DOI 10.1016/0922-4106(95)00083-6; GREEN WN, 1991, P NATL ACAD SCI USA, V88, P854, DOI 10.1073/pnas.88.3.854; Kassner PD, 1997, J NEUROBIOL, V33, P968, DOI 10.1002/(SICI)1097-4695(199712)33:7<968::AID-NEU8>3.0.CO;2-6; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Luo J, 2009, J NEUROSCI, V29, P13898, DOI 10.1523/JNEUROSCI.2833-09.2009; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Malysz J, 2009, J PHARMACOL EXP THER, V330, P257, DOI 10.1124/jpet.109.151886; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Mukherjee J, 2009, J NEUROCHEM, V110, P1885, DOI 10.1111/j.1471-4159.2009.06285.x; Papke RL, 2010, J PHARMACOL EXP THER, V333, P501, DOI 10.1124/jpet.109.164566; Peng JH, 1999, BRAIN RES, V825, P172, DOI 10.1016/S0006-8993(99)01066-5; PENG X, 1994, MOL PHARMACOL, V45, P546; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Roncarati R, 2008, ASSAY DRUG DEV TECHN, V6, P181, DOI 10.1089/adt.2007.120; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Tietje KR, 2008, CNS NEUROSCI THER, V14, P65, DOI 10.1111/j.1527-3458.2008.00037.x; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Valles AS, 2008, ACTA PHARMACOL SIN, V6, P818; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Xiao YX, 2009, ACTA PHARMACOL SIN, V30, P842, DOI 10.1038/aps.2009.69; Yamauchi JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016519; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhao LK, 2003, J PHARMACOL EXP THER, V305, P1132, DOI 10.1124/jpet.103.048777	42	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62246	10.1371/journal.pone.0062246	http://dx.doi.org/10.1371/journal.pone.0062246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638015	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400088
J	Kyrchanova, O; Leman, D; Parshikov, A; Fedotova, A; Studitsky, V; Maksimenko, O; Georgiev, P				Kyrchanova, Olga; Leman, Dmitry; Parshikov, Alexander; Fedotova, Anna; Studitsky, Vasily; Maksimenko, Oksana; Georgiev, Pavel			New Properties of Drosophila scs and scs' Insulators	PLOS ONE			English	Article							ENHANCER-PROMOTER COMMUNICATION; SITE-SPECIFIC RECOMBINATION; MATRIX ATTACHMENT REGIONS; BOUNDARY-ELEMENT; REGULATORY ELEMENTS; WHITE GENE; CHROMATIN INTERACTIONS; FUNCTIONAL ELEMENTS; CHROMOSOMAL DOMAINS; BITHORAX COMPLEX	Insulators are defined as a class of regulatory elements that delimit independent transcriptional domains within eukaryotic genomes. The first insulators to be identified were scs and scs', which flank the domain including two heat shock 70 genes. Zw5 and BEAF bind to scs and scs', respectively, and are responsible for the interaction between these insulators. Using the regulatory regions of yellow and white reporter genes, we have found that the interaction between scs and scs' improves the enhancer-blocking activity of the weak scs' insulator. The sequences of scs and scs' insulators include the promoters of genes that are strongly active in S2 cells but not in the eyes, in which the enhancer-blocking activity of these insulators has been extensively examined. Only the promoter of the Cad87A gene located at the end of the scs insulator drives white expression in the eyes, and the white enhancer can slightly stimulate this promoter. The scs insulator contains polyadenylation signals that may be important for preventing transcription through the insulator. As shown previously, scs and scs' can insulate transcription of the white transgene from the enhancing effects of the surrounding genome, a phenomenon known as the chromosomal position effect (CPE). After analyzing many independent transgenic lines, we have concluded that transgenes carrying the scs insulator are rarely inserted into genomic regions that stimulate the white reporter expression in the eyes.	[Kyrchanova, Olga; Fedotova, Anna] Russian Acad Sci, Inst Gene Biol, Grp Transcript Regulat, Moscow, Russia; [Leman, Dmitry; Parshikov, Alexander; Maksimenko, Oksana; Georgiev, Pavel] Russian Acad Sci, Inst Gene Biol, Dept Control Genet Proc, Moscow, Russia; [Studitsky, Vasily] Moscow MV Lomonosov State Univ, Sch Biol, Moscow, Russia; [Studitsky, Vasily] UMDNJ Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Georgiev, P (corresponding author), Russian Acad Sci, Inst Gene Biol, Dept Control Genet Proc, Moscow, Russia.	georgiev_p@mail.ru	Kyrchanova, Olga/ABD-7925-2021; Maksimenko, Oksana/I-1582-2013; Fedotova, Anna/L-8301-2017; Studitsky, Vasily/A-9382-2014; Kyrchanova, Olga/C-1163-2014	Kyrchanova, Olga/0000-0002-6249-0418; Maksimenko, Oksana/0000-0003-3502-0303; Fedotova, Anna/0000-0003-4420-0883; Georgiev, Pavel/0000-0002-6509-3194	Russian Foundation for Basic Research [12-04-92423-EMBL-a]; Molecular and Cellular Biology Program of the Russian Academy of Sciences; Ministry of Science and Education of the Russian Federation [8103, 16.552.11.7067]; Government of the Russian Federation [220]; President's Stipendy [SP-1960.2012.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cellular Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation); Government of the Russian Federation; President's Stipendy	This study was supported by the Russian Foundation for Basic Research (project no. 12-04-92423-EMBL-a) and grants from the Molecular and Cellular Biology Program of the Russian Academy of Sciences (to OK), the Ministry of Science and Education of the Russian Federation (Project no. 8103), the Government of the Russian Federation (order #220) (to VS), and the President's Stipendy (no. SP-1960.2012.4) (to OM). Experiments were performed using the equipment of IGB RAS facilities supported by the Ministry of Science and Education of the Russian Federation (grant no. 16.552.11.7067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avramova Z, 1999, TRENDS GENET, V15, P138, DOI 10.1016/S0168-9525(99)01712-6; Belozerov VE, 2003, EMBO J, V22, P3113, DOI 10.1093/emboj/cdg297; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; Brasset E, 2005, HEREDITY, V94, P571, DOI 10.1038/sj.hdy.6800669; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Chetverina D, 2008, NUCLEIC ACIDS RES, V36, P929, DOI 10.1093/nar/gkm992; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; Cuvier O, 1998, MOL CELL BIOL, V18, P7478, DOI 10.1128/MCB.18.12.7478; Dean A, 2011, BRIEF FUNCT GENOMICS, V10, P3, DOI 10.1093/bfgp/elq033; Erokhin M, 2011, DEVELOPMENT, V138, P4097, DOI 10.1242/dev.062836; Gaszner M, 1999, GENE DEV, V13, P2098, DOI 10.1101/gad.13.16.2098; GEYER PK, 1987, GENE DEV, V1, P996, DOI 10.1101/gad.1.9.996; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Gohl D, 2011, GENETICS, V187, P731, DOI 10.1534/genetics.110.123752; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hart CM, 1997, MOL CELL BIOL, V17, P999, DOI 10.1128/MCB.17.2.999; Hernandez G, 2004, RNA, V10, P1783, DOI 10.1261/rna.7154104; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hogga I, 2002, DEVELOPMENT, V129, P4915; HOLDRIDGE C, 1991, MOL CELL BIOL, V11, P1894, DOI 10.1128/MCB.11.4.1894; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Kuhn EJ, 2004, MOL CELL BIOL, V24, P1470, DOI 10.1128/MCB.24.4.1470-1480.2004; Kuhn EJ, 2003, EMBO J, V22, P2463, DOI 10.1093/emboj/cdg241; Kuhn EJ, 2003, CURR OPIN CELL BIOL, V15, P259, DOI 10.1016/S0955-0674(03)00039-5; Kyrchanova O, 2007, MOL CELL BIOL, V27, P3035, DOI 10.1128/MCB.02203-06; Kyrchanova O, 2008, NUCLEIC ACIDS RES, V36, P7019, DOI 10.1093/nar/gkn781; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; Maeda RK, 2007, CURR OPIN GENET DEV, V17, P394, DOI 10.1016/j.gde.2007.08.002; Majumder P, 2003, P NATL ACAD SCI USA, V100, P5223, DOI 10.1073/pnas.0830190100; Majumder P, 2009, NUCLEIC ACIDS RES, V37, P4227, DOI 10.1093/nar/gkp362; Maksimenko OG, 2006, RUSS J GENET+, V42, P845, DOI 10.1134/S1022795406080023; Mallin DR, 1998, GENETICS, V148, P331; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P19919, DOI 10.1073/pnas.1103845108; Namciu SJ, 2004, MOL CELL BIOL, V24, P10236, DOI 10.1128/MCB.24.23.10236-10245.2004; Namciu SJ, 1998, MOL CELL BIOL, V18, P2382, DOI 10.1128/MCB.18.4.2382; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Parnell TJ, 2000, EMBO J, V19, P5864, DOI 10.1093/emboj/19.21.5864; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; Pirrotta V, 1988, Biotechnology, V10, P437; QIAN S, 1992, GENETICS, V131, P79; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; ROSEMAN RR, 1995, GENETICS, V141, P1061; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Siegal ML, 2000, METH MOL B, V136, P487; Sigrist CJA, 1997, GENETICS, V147, P209; Silicheva M, 2010, NUCLEIC ACIDS RES, V38, P39, DOI 10.1093/nar/gkp877; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; van Steensel B, 2011, EMBO J, V30, P1885, DOI 10.1038/emboj.2011.135; VAZQUEZ J, 1994, EMBO J, V13, P5984, DOI 10.1002/j.1460-2075.1994.tb06944.x; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	62	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62690	10.1371/journal.pone.0062690	http://dx.doi.org/10.1371/journal.pone.0062690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638134	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400121
J	Peshavariya, HM; Taylor, CJ; Goh, C; Liu, GS; Jiang, F; Chan, EC; Dusting, GJ				Peshavariya, Hitesh M.; Taylor, Caroline J.; Goh, Celeste; Liu, Guei-Sheung; Jiang, Fan; Chan, Elsa C.; Dusting, Gregory J.			Annexin Peptide Ac2-26 Suppresses TNF alpha-Induced Inflammatory Responses via Inhibition of Rac1-Dependent NADPH Oxidase in Human Endothelial Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; KAPPA-B ACTIVATION; LIPOCORTIN 1; ADHESION MOLECULE-1; GENE-EXPRESSION; NAD(P)H OXIDASE; NEUTROPHIL; SUPEROXIDE; NOX4; RECEPTOR	The anti-inflammatory peptide annexin-1 binds to formyl peptide receptors (FPR) but little is known about its mechanism of action in the vasculature. Here we investigate the effect of annexin peptide Ac2-26 on NADPH oxidase activity induced by tumour necrosis factor alpha (TNF alpha) in human endothelial cells. Superoxide release and intracellular reactive oxygen species (ROS) production from NADPH oxidase was measured with lucigenin-enhanced chemiluminescence and 2',7'-dichlorodihydrofluorescein diacetate, respectively. Expression of NADPH oxidase subunits and intracellular cell adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM-1) were determined by real-time PCR and Western blot analysis. Promoter activity of nuclear factor kappa B (NF kappa B) was measured by luciferase activity assay. TNF alpha stimulated NADPH-dependent superoxide release, total ROS formation and expression of ICAM-1 and VCAM-1. Pre-treatment with N-terminal peptide of annexin-1 (Ac2-26, 0.5-1.5 mu M) reduced all these effects, and the inhibition was blocked by the FPRL-1 antagonist WRW4. Furthermore, TNF alpha-induced NF kappa B promoter activity was attenuated by both Ac2-26 and NADPH oxidase inhibitor diphenyliodonium (DPI). Surprisingly, Nox4 gene expression was reduced by TNF alpha whilst expression of Nox2, p22phox and p67phox remained unchanged. Inhibition of NADPH oxidase activity by either dominant negative Rac1 (N17Rac1) or DPI significantly attenuated TNF alpha-induced ICAM-1 and VCAM-1 expression. Ac2-26 failed to suppress further TNF alpha-induced expression of ICAM-1 and VCAM-1 in N17Rac1-transfected cells. Thus, Ac2-26 peptide inhibits TNF alpha-activated, Rac1-dependent NADPH oxidase derived ROS formation, attenuates NF kappa B pathways and ICAM-1 and VCAM-1 expression in endothelial cells. This suggests that Ac2-26 peptide blocks NADPH oxidase activity and has anti-inflammatory properties in the vasculature which contributes to modulate in reperfusion injury inflammation and vascular disease.	[Peshavariya, Hitesh M.; Taylor, Caroline J.; Goh, Celeste; Liu, Guei-Sheung; Jiang, Fan; Chan, Elsa C.; Dusting, Gregory J.] Univ Melbourne, OBrien Inst, Fitzroy, Vic 3065, Australia; [Peshavariya, Hitesh M.; Liu, Guei-Sheung; Chan, Elsa C.; Dusting, Gregory J.] Univ Melbourne, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Jiang, Fan] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Jiang, Fan] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China	University of Melbourne; Centre for Eye Research Australia; University of Melbourne; Shandong University; Shandong University	Peshavariya, HM (corresponding author), Univ Melbourne, OBrien Inst, Fitzroy, Vic 3065, Australia.	hitesh.peshavariya@unimelb.edu.au; dusting@unimelb.edu.au	Liu, Guei-Sheung/Q-6472-2018; Jiang, Fan/B-7753-2013	Liu, Guei-Sheung/0000-0003-3379-724X; Jiang, Fan/0000-0001-9466-2192; Yergin, Celeste Goh/0000-0002-0070-3924; Taylor, Caroline/0000-0003-2151-8709	National Health and Medical Research Council (NHMRC) of Australia; National Heart Foundation of Australia; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grants from the National Health and Medical Research Council (NHMRC) of Australia and Grants-in-Aid from the National Heart Foundation of Australia. GJD also receives a Principal Research Fellowship from NHMRC. The O'Brien Institute and Center for Eye Research Australia acknowledges the Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Alom-Ruiz SP, 2008, ANTIOXID REDOX SIGNA; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Ayoub SS, 2008, BRIT J PHARMACOL, V154, P1135, DOI 10.1038/bjp.2008.166; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BelAiba RS, 2007, FREE RADICAL BIO MED, V42, P446, DOI 10.1016/j.freeradbiomed.2006.10.054; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chan EC, 2007, CARDIOVASC RES, V75, P710, DOI 10.1016/j.cardiores.2007.06.005; Chen XL, 2004, AM J PHYSIOL-HEART C, V286, pH1001, DOI 10.1152/ajpheart.00716.2003; Chen XL, 2003, J PHARMACOL EXP THER, V305, P573, DOI 10.1124/jpet.102.047894; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; Fan J, 2002, J BIOL CHEM, V277, P3404, DOI 10.1074/jbc.M110054200; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Getting SJ, 1997, BRIT J PHARMACOL, V120, P1075, DOI 10.1038/sj.bjp.0701029; Karlsson J, 2005, J LEUKOCYTE BIOL, V78, P762, DOI 10.1189/jlb.0305153; KIM KM, 1994, FEBS LETT, V343, P251, DOI 10.1016/0014-5793(94)80566-0; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Lim LHK, 1998, P NATL ACAD SCI USA, V95, P14535, DOI 10.1073/pnas.95.24.14535; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Lin SJ, 2005, ARTERIOSCL THROM VAS, V25, P334, DOI 10.1161/01.ATV.0000152114.00114.d8; Liu JH, 2003, ARTERIOSCL THROM VAS, V23, P776, DOI 10.1161/01.ATV.0000066684.37829.16; MCPHAIL LC, 1993, EUR J HAEMATOL, V51, P294; Min JK, 2005, J IMMUNOL, V175, P531, DOI 10.4049/jimmunol.175.1.531; Moe KT, 2006, J CELL MOL MED, V10, P231, DOI 10.1111/j.1582-4934.2006.tb00304.x; Montezano AC, 2010, CIRC RES, V106, P1363, DOI 10.1161/CIRCRESAHA.109.216036; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; PERRETTI M, 1995, BIOCHEM PHARMACOL, V50, P1037, DOI 10.1016/0006-2952(95)00238-U; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Peshavariya H, 2009, ANTIOXID REDOX SIGN, V11, P2399, DOI [10.1089/ars.2009.2579, 10.1089/ARS.2009.2579]; Peshavariya H, 2009, FREE RADICAL RES, V43, P772, DOI 10.1080/10715760903045304; Rahman A, 1998, AM J PHYSIOL-LUNG C, V275, pL533, DOI 10.1152/ajplung.1998.275.3.L533; Rajashekhar G, 2006, J VASC RES, V43, P193, DOI 10.1159/000090949; Ritchie RH, 2005, BRIT J PHARMACOL, V145, P495, DOI 10.1038/sj.bjp.0706211; ROMISCH J, 1992, BLOOD COAGUL FIBRIN, V3, P11; Solito E, 2000, J IMMUNOL, V165, P1573, DOI 10.4049/jimmunol.165.3.1573; True AL, 2000, AM J PHYSIOL-LUNG C, V279, pL302, DOI 10.1152/ajplung.2000.279.2.L302; Tummala PE, 2000, J MOL CELL CARDIOL, V32, P1499, DOI 10.1006/jmcc.2000.1183; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Vendrov AE, 2007, ARTERIOSCL THROM VAS, V27, P2714, DOI 10.1161/ATVBAHA.107.152629; Vergnolle N, 1997, AM J PHYSIOL-REG I, V273, pR623, DOI 10.1152/ajpregu.1997.273.2.R623; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Williams SL, 2010, J IMMUNOL, V185, P3057, DOI 10.4049/jimmunol.1000119; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Xu H, 2008, FREE RADICAL BIO MED, V44, P1656, DOI 10.1016/j.freeradbiomed.2008.01.023; Yin H, 2010, HYPERTENSION, V56, P260, DOI 10.1161/HYPERTENSIONAHA.110.152330	56	32	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e60790	10.1371/journal.pone.0060790	http://dx.doi.org/10.1371/journal.pone.0060790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637767	gold, Green Published			2022-12-25	WOS:000318340400009
J	Shahabi, S; He, SQ; Kopf, M; Mariani, M; Petrini, J; Scambia, G; Ferlini, C				Shahabi, Shohreh; He, Shiquan; Kopf, Michael; Mariani, Marisa; Petrini, Joann; Scambia, Giovanni; Ferlini, Cristiano			Free Testosterone Drives Cancer Aggressiveness: Evidence from US Population Studies	PLOS ONE			English	Article							SEX DISPARITIES; STAGING SYSTEM; WHITE MEN; AGE; SURVIVAL; EXPRESSION; BLACK; GENE	Cancer incidence and mortality are higher in males than in females, suggesting that some gender-related factors are behind such a difference. To analyze this phenomenon the most recent Surveillance, Epidemiology and End Results (SEER) database served to access cancer survival data for the US population. Patients with gender-specific cancer and with limited information were excluded and this fact limited the sample size to 1,194,490 patients. NHANES III provided the distribution of physiologic variables in US population (n = 29,314). Cox model and Kaplan-Meier method were used to test the impact of gender on survival across age, and to calculate the gender-specific hazard ratio of dying from cancer five years following diagnosis. The distribution of the hazard ratio across age was then compared with the distribution of 65 physiological variables assessed in NHANES III. Spearman and Kolmogorov-Smirnov test assessed the homology. Cancer survival was lower in males than in females in the age range 17 to 61 years. The risk of death from cancer in males was about 30% higher than that of females of the same age. This effect was present only in sarcomas and epithelial solid tumors with distant disease and the effect was more prominent in African-Americans than Caucasians. When compared to the variables assessed in the NHANES III study, the hazard ratio almost exactly matched the distribution of free testosterone in males; none of the other analyzed variables exhibited a similar homology. Our findings suggest that male sex hormones give rise to cancer aggressiveness in patients younger than 61 years.	[Shahabi, Shohreh; He, Shiquan; Kopf, Michael; Mariani, Marisa; Petrini, Joann; Ferlini, Cristiano] Danbury Hosp, Res Inst, Dept Obstet & Gynecol, Danbury, CT USA; [Mariani, Marisa; Scambia, Giovanni] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, I-00168 Rome, Italy; [Scambia, Giovanni; Ferlini, Cristiano] Jean Paul II Res Fdn, Dept Oncol, Campobasso, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ferlini, C (corresponding author), Danbury Hosp, Res Inst, Dept Obstet & Gynecol, Danbury, CT USA.	Cristiano.ferlini@danhosp.org	Ferlini, Cristiano/K-1339-2013	Ferlini, Cristiano/0000-0003-3886-9134	Ruth C. Donovan Cancer Research Program; Associazione Italiana Ricerca sul Cancro [IG11975]	Ruth C. Donovan Cancer Research Program; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by the Ruth C. Donovan Cancer Research Program and by a generous donation from Mr. and Mrs. Ruggles and by a grant from Associazione Italiana Ricerca sul Cancro (IG11975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1990, JAMA-J AM MED ASSOC, V263, P2189, DOI 10.1001/jama.263.16.2189; Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1; Chumlea WC, 2003, PEDIATRICS, V111, P110, DOI 10.1542/peds.111.1.110; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Cook MB, 2009, CANCER EPIDEM BIOMAR, V18, P1174, DOI 10.1158/1055-9965.EPI-08-1118; EFRON B, 1981, J AM STAT ASSOC, V76, P312, DOI 10.2307/2287832; Ellis KJ, 1997, AM J CLIN NUTR, V66, P1323, DOI 10.1093/ajcn/66.6.1323; Faddy MJ, 1996, HUM REPROD, V11, P1484; Hale GE, 2007, J CLIN ENDOCR METAB, V92, P3060, DOI 10.1210/jc.2007-0066; HENSON DE, 1992, SEMIN SURG ONCOL, V8, P57, DOI 10.1002/ssu.2980080203; Litman HJ, 2006, J CLIN ENDOCR METAB, V91, P4326, DOI 10.1210/jc.2006-0037; Mariani M, 2012, CLIN CANC RES; Micheli A, 2009, EUR J CANCER, V45, P1017, DOI 10.1016/j.ejca.2008.11.008; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Raspaglio G, 2008, GENE, V409, P100, DOI 10.1016/j.gene.2007.11.015; Raspaglio G, 2010, CANCER RES, V70, P5891, DOI 10.1158/0008-5472.CAN-09-4656; Rohrmann S, 2007, J CLIN ENDOCR METAB, V92, P2519, DOI 10.1210/jc.2007-0028; SEMPOS CT, 1993, JAMA-J AM MED ASSOC, V269, P3009, DOI 10.1001/jama.269.23.3009; Utriainen P, 2012, J CLIN ENDOCRINOL ME; Zmuda JM, 2001, J BONE MINER RES, V16, P911, DOI 10.1359/jbmr.2001.16.5.911	20	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61955	10.1371/journal.pone.0061955	http://dx.doi.org/10.1371/journal.pone.0061955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637935	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400060
J	Swaminathan, B; Cuapio, A; Alloza, I; Matesanz, F; Alcina, A; Garcia-Barcina, M; Fedetz, M; Fernandez, O; Lucas, M; Orpez, T; Pinto-Medel, MJ; Otaegui, D; Olascoaga, J; Urcelay, E; Ortiz, MA; Arroyo, R; Oksenberg, JR; Antiguedad, A; Tolosa, E; Vandenbroeck, K				Swaminathan, Bhairavi; Cuapio, Angelica; Alloza, Iraide; Matesanz, Fuencisla; Alcina, Antonio; Garcia-Barcina, Maria; Fedetz, Maria; Fernandez, Oscar; Lucas, Miguel; Orpez, Teresa; Jesus Pinto-Medel, Ma; Otaegui, David; Olascoaga, Javier; Urcelay, Elena; Ortiz, Miguel A.; Arroyo, Rafael; Oksenberg, Jorge R.; Antigueedad, Alfredo; Tolosa, Eva; Vandenbroeck, Koen			Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6	PLOS ONE			English	Article							ANTI-CD6 MONOCLONAL-ANTIBODY; T-CELL-ACTIVATION; HELPER 17 CELLS; INTERLEUKIN-7 RECEPTOR; DIAGNOSTIC-CRITERIA; EXPRESSION; ASSOCIATION; ANTIGEN; GUIDELINES; VARIANTS	CD6 has recently been identified and validated as risk gene for multiple sclerosis (MS), based on the association of a single nucleotide polymorphism (SNP), rs17824933, located in intron 1. CD6 is a cell surface scavenger receptor involved in T-cell activation and proliferation, as well as in thymocyte differentiation. In this study, we performed a haptag SNP screen of the CD6 gene locus using a total of thirteen tagging SNPs, of which three were non-synonymous SNPs, and replicated the recently reported GWAS SNP rs650258 in a Spanish-Basque collection of 814 controls and 823 cases. Validation of the six most strongly associated SNPs was performed in an independent collection of 2265 MS patients and 2600 healthy controls. We identified association of haplotypes composed of two non-synonymous SNPs [rs11230563 (R225W) and rs2074225 (A257V)] in the 2nd SRCR domain with susceptibility to MS (P-max(T) (permutation) = 1 x 10(-4)). The effect of these haplotypes on CD6 surface expression and cytokine secretion was also tested. The analysis showed significantly different CD6 expression patterns in the distinct cell subsets, i.e. -CD4(+) naive cells, P = 0.0001; CD8(+) naive cells, P < 0.0001; CD4(+) and CD8(+) central memory cells, P = 0.01 and 0.05, respectively; and natural killer T (NKT) cells, P = 0.02; with the protective haplotype (RA) showing higher expression of CD6. However, no significant changes were observed in natural killer (NK) cells, effector memory and terminally differentiated effector memory T cells. Our findings reveal that this new MS-associated CD6 risk haplotype significantly modifies expression of CD6 on CD4(+) and CD8(+) T cells.	[Swaminathan, Bhairavi; Alloza, Iraide; Vandenbroeck, Koen] Univ Basque Country UPV EHU, Neurogenomiks Lab, Leioa, Spain; [Cuapio, Angelica; Tolosa, Eva] Univ Med Ctr Hamburg Eppendorf, Dept Immunol, Hamburg, Germany; [Matesanz, Fuencisla; Alcina, Antonio; Fedetz, Maria] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Garcia-Barcina, Maria] Hosp Basurto, Serv Genet, Bilbao, Spain; [Fernandez, Oscar] Hosp Reg Univ Carlos Haya, Inst Clin Neurosci, Dept Neurol, Malaga, Spain; [Lucas, Miguel] Hosp Virgen Macarena, Unidad Esclerosis Multiple, Seville, Spain; [Orpez, Teresa; Jesus Pinto-Medel, Ma] Hosp Reg Univ Carlos Haya, Inst Clin Neurosci, Res Lab, Malaga, Spain; [Otaegui, David] Inst Invest Sanitaria Biodonostia, Area Neurociencias, San Sebastian, Spain; [Olascoaga, Javier] Hosp Donostia, Unidad Esclerosis Multiple, Serv Neurol, San Sebastian, Spain; [Urcelay, Elena; Ortiz, Miguel A.] Inst Invest Sanitaria S Carlos IdISSC, Immunol Dept H Clin S Carlos, Madrid, Spain; [Arroyo, Rafael] Inst Invest Sanitaria S Carlos IdISSC, Neurol Dept H Clin S Carlos, Multiple Sclerosis Unit, Madrid, Spain; [Oksenberg, Jorge R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Antigueedad, Alfredo] Hosp Basurto, Serv Neurol, Bilbao, Spain; [Vandenbroeck, Koen] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	University of Basque Country; University of Hamburg; University Medical Center Hamburg-Eppendorf; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Basurto Hospital; Hospital Carlos Haya; Hospital Universitario Virgen Macarena; Hospital Carlos Haya; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of California System; University of California San Francisco; Basurto Hospital; Basque Foundation for Science	Vandenbroeck, K (corresponding author), Univ Basque Country UPV EHU, Neurogenomiks Lab, Leioa, Spain.	k.vandenbroeck@ikerbasque.org	Matesanz, Fuencisla/F-3715-2016; Tolosa, Eva/S-3454-2016; Alcina, Antonio/T-1893-2017; Vandenbroeck, Koen/D-6845-2012; Otaegui, David/H-4390-2013	Matesanz, Fuencisla/0000-0002-9429-1819; Alcina, Antonio/0000-0001-7294-0948; Vandenbroeck, Koen/0000-0002-6967-6485; Otaegui, David/0000-0002-6625-5976; Cuapio, Angelica/0000-0002-9451-1914; Urcelay, Elena/0000-0001-8470-8396; Alloza, Iraide/0000-0002-8949-7732	European Community [212877]; Gobierno Vasco (Grupos de Investigacion del Sistema Universitario Vasco) [IT512-10]; Ministerio de Ciencia e Innovacion - FEDER [SAF2009-11491]; FIS_FEDER [CP10/00526]; Junta de Andalucia-FEDER [P07-CVI-02551]	European Community(European Commission); Gobierno Vasco (Grupos de Investigacion del Sistema Universitario Vasco); Ministerio de Ciencia e Innovacion - FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FIS_FEDER(Instituto de Salud Carlos IIIEuropean Commission); Junta de Andalucia-FEDER(Junta de AndaluciaEuropean Commission)	This work was supported by grants to K. V. from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement no. 212877 (UEPHA*MS; www.reem.es/uepha-ms/) and from the Gobierno Vasco (Grupos de Investigacion del Sistema Universitario Vasco; ref. IT512-10). B. S. and A. C. are early-stage researchers of UEPHA*MS (No 2121877). Grants to A. A. and F. M. were provided by Ministerio de Ciencia e Innovacion - FEDER (SAF2009-11491) and FIS_FEDER (CP10/00526), Junta de Andalucia-FEDER (P07-CVI-02551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1991, J EXP MED, V174, P949, DOI 10.1084/jem.174.4.949; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOTT CM, 1993, INT IMMUNOL, V5, P783, DOI 10.1093/intimm/5.7.783; Bowen MA, 1997, J IMMUNOL, V158, P1149; Braun M, 2011, J INNATE IMMUN, V3, P420, DOI 10.1159/000322720; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Castro MAA, 2007, J IMMUNOL, V178, P4351, DOI 10.4049/jimmunol.178.7.4351; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GANGEMI RMR, 1989, J IMMUNOL, V143, P2439; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hassan NJ, 2004, EUR J IMMUNOL, V34, P930, DOI 10.1002/eji.200424856; Heap GA, 2009, HUM MOL GENET, V18, pR101, DOI [10.1093/hmg/ddp001, 10.1093/hmg/ddp473]; Ibanez A, 2006, J IMMUNOL, V177, P1152, DOI 10.4049/jimmunol.177.2.1152; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; LANIER LL, 1986, J IMMUNOL, V136, P4480; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MAYER B, 1990, J NEUROIMMUNOL, V29, P193, DOI 10.1016/0165-5728(90)90162-G; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MORIMOTO C, 1988, J IMMUNOL, V140, P2165; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Oksenberg JR, 2010, NAT REV NEUROL, V6, P429, DOI 10.1038/nrneurol.2010.91; Oliveira MI, 2012, EUR J IMMUNOL, V42, P195, DOI 10.1002/eji.201040528; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez-Ezpeleta N, 2010, HUM GENET, V128, P113, DOI 10.1007/s00439-010-0833-4; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Singer NG, 2002, INT IMMUNOL, V14, P585, DOI 10.1093/intimm/dxf025; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Swaminathan B, 2010, J NEUROIMMUNOL, V223, P100, DOI 10.1016/j.jneuroim.2010.03.020; Vandenbroeck K, 2012, GENES IMMUN, V13, P21, DOI 10.1038/gene.2011.44; Vandenbroeck K, 2011, J INTERFERON CYTOKIN, V32, P139; Vila J. M., 2000, Inmunologia, V19, P105; Waite JC, 2012, INT J INFLAM, V2012, P10; Zuvich RL, 2010, HUM GENET, V127, P525, DOI 10.1007/s00439-010-0789-4; Zuvich RL, 2011, HUM MOL GENET, P1	54	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62376	10.1371/journal.pone.0062376	http://dx.doi.org/10.1371/journal.pone.0062376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638056	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400101
J	Cui, AL; Xu, CP; Tan, XJ; Zhang, Y; Zhu, Z; Mao, NY; Lu, YY; Xu, WB				Cui, Aili; Xu, Changping; Tan, Xiaojuan; Zhang, Yan; Zhu, Zhen; Mao, Naiying; Lu, Yiyu; Xu, Wenbo			The Development and Application of the Two Real-Time RT-PCR Assays to Detect the Pathogen of HFMD	PLOS ONE			English	Article							CLINICAL SPECIMENS; ENTEROVIRUS 71; SEROTYPE; VP1; IDENTIFICATION; OUTBREAK; TAIWAN; FOOT; HAND	Large-scale Hand, Foot, and Mouth Disease (HFMD) outbreaks have frequently occurred in China since 2008, affecting more than one million children and causing several hundred children deaths every year. The pathogens of HFMD are mainly human enteroviruses (HEVs). Among them, human enterovirus 71 (HEV71) and coxsackievirus A16 (CVA16) are the most common pathogens of HFMD. However, other HEVs could also cause HFMD. To rapidly detect HEV71 and CVA16, and ensure detection of all HEVs causing HFMD, two real-time hybridization probe-based RT-PCR assays were developed in this study. One is a multiplex real-time RT-PCR assay, which was developed to detect and differentiate HEV71 specifically from CVA16 directly from clinical specimens within 1-2 h, and the other is a broad-spectrum real-time RT-PCR assay, which targeted almost all HEVs. The experiments confirmed that the two assays have high sensitivity and specificity, and the sensitivity was up to 0.1 TCID50/ml for detection of HEVs, HEV71, and CVA16, respectively. A total of 213 clinical specimens were simultaneously detected by three kinds of assays, including the two real-time RT-PCR assays, direct conventional RT-PCR assay, and virus isolation assay on human rhabdomyosarcoma cells (RD cells). The total positive rate of both HEV71 and CVA16 was 69.48% with real-time RT-PCR assay, 47.42% with RT-PCR assay, and 34.58% with virus isolation assay. One HFMD clinical specimen was positive for HEV, but negative for HEV71 or CVA16, which was identified as Echovirus 11 (Echo11) by virus isolation, RT-PCR, and sequencing for the VP1 gene. The two real-time RT-PCR assays had been applied in 31 provincial HFMD labs to detect the pathogens of HFMD, which has contributed to the rapid identification of the pathogens in the early stages of HFMD outbreaks, and helped to clarify the etiologic agents of HFMD in China.	[Cui, Aili; Tan, Xiaojuan; Zhang, Yan; Zhu, Zhen; Mao, Naiying; Xu, Wenbo] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xu, Changping; Lu, Yiyu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention	Lu, YY (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	luyiyuzjh@yahoo.com.cn; wenbo_xu1@yahoo.com.cn			National Basic Research Program of China (973 Program) [2011CB504902]; Projects of the National Natural Science Foundation of China [30901259]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Projects of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of National Ministry of Science	This study was supported by the National Basic Research Program of China (973 Program), (Grant No. 2011CB504902); Projects of the National Natural Science Foundation of China (Grant No. 30901259); and Key Technologies R&D Program of National Ministry of Science (Grant No. 2013ZX10004-202; 2012ZX10004201-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendig JWA, 2001, J CLIN MICROBIOL, V39, P3690, DOI 10.1128/JCM.39.10.3690-3692.2001; Brown BA, 2000, J CLIN VIROL, V16, P107, DOI 10.1016/S1386-6532(00)00065-2; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; LIM KA, 1960, J IMMUNOL, V84, P309; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Melnick J, 1996, FIELDS VIROLOGY, P655; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Singh S, 2002, J CLIN MICROBIOL, V40, P2823, DOI 10.1128/JCM.40.8.2823-2827.2002; Tsao KC, 2002, J VIROL METHODS, V102, P9, DOI 10.1016/S0166-0934(01)00376-7; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	15	37	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61451	10.1371/journal.pone.0061451	http://dx.doi.org/10.1371/journal.pone.0061451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637836	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700035
J	Herwig, A; de Vries, EM; Bolborea, M; Wilson, D; Mercer, JG; Ebling, FJP; Morgan, PJ; Barrett, P				Herwig, Annika; de Vries, Emmely M.; Bolborea, Matei; Wilson, Dana; Mercer, Julian G.; Ebling, Francis J. P.; Morgan, Peter J.; Barrett, Perry			Hypothalamic Ventricular Ependymal Thyroid Hormone Deiodinases Are an Important Element of Circannual Timing in the Siberian Hamster (Phodopus sungorus)	PLOS ONE			English	Article							MELATONIN-RELATED RECEPTOR; INACTIVATING ENZYME GENES; DJUNGARIAN HAMSTER; PHOTOPERIODIC REGULATION; BODY-WEIGHT; SIGNAL-TRANSDUCTION; PINEAL-GLAND; F344 RATS; EXPRESSION; REPRODUCTION	Exposure to short days (SD) induces profound changes in the physiology and behaviour of Siberian hamsters, including gonadal regression and up to 30% loss in body weight. In a continuous SD environment after approximately 20 weeks, Siberian hamsters spontaneously revert to a long day (LD) phenotype, a phenomenon referred to as the photorefractory response. Previously we have identified a number of genes that are regulated by short photoperiod in the neuropil and ventricular ependymal (VE) cells of the hypothalamus, although their importance and contribution to photoperiod induced physiology is unclear. In this refractory model we hypothesised that the return to LD physiology involves reversal of SD expression levels of key hypothalamic genes to their LD values and thereby implicate genes required for LD physiology. Male Siberian hamsters were kept in either LD or SD for up to 39 weeks during which time SD hamster body weight decreased before increasing, after more than 20 weeks, back to LD values. Brain tissue was collected between 14 and 39 weeks for in situ hybridization to determine hypothalamic gene expression. In VE cells lining the third ventricle, expression of nestin, vimentin, Crbp1 and Gpr50 were down-regulated at 18 weeks in SD photoperiod, but expression was not restored to the LD level in photorefractory hamsters. Dio2, Mct8 and Tsh-r expression were altered by SD photoperiod and were fully restored, or even exceeded values found in LD hamsters in the refractory state. In hypothalamic nuclei, expression of Srif and Mc3r mRNAs was altered at 18 weeks in SD, but were similar to LD expression values in photorefractory hamsters. We conclude that in refractory hamsters not all VE cell functions are required to establish LD physiology. However, thyroid hormone signalling from ependymal cells and reversal of neuronal gene expression appear to be essential for the SD refractory response.	[Herwig, Annika; de Vries, Emmely M.; Bolborea, Matei; Wilson, Dana; Mercer, Julian G.; Morgan, Peter J.; Barrett, Perry] Univ Aberdeen, Rowett Inst Nutr & Hlth, Bucksburn, Aberdeen, Scotland; [Bolborea, Matei; Ebling, Francis J. P.] Univ Nottingham, Sch Med, Queen Med Ctr, Sch Biomed Sci, Nottingham, England	University of Aberdeen; University of Nottingham	Barrett, P (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Bucksburn, Aberdeen, Scotland.	P.Barrett@abdn.ac.uk	Ebling, Francis/Q-6193-2019; Mercer, Julian/AAD-2030-2022	Ebling, Francis/0000-0002-7316-9582; Barrett, Perry/0000-0003-3604-2950; Herwig, Annika/0000-0003-3048-0618; Bolborea, Matei/0000-0003-2313-2770; Morgan, Peter/0000-0002-5071-6512	Marie Curie individual fellowship [PIEF-GA-2009-235106]; Dutch brain fund de Nederlandse Hersenstichting; BBSRC (Biotechnology and Biological Sciences Research Council) [BB/E020437/1]; Scottish Government; BBSRC [BB/E020437/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020437/1] Funding Source: researchfish	Marie Curie individual fellowship(European Commission); Dutch brain fund de Nederlandse Hersenstichting; BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by PIEF-GA-2009-235106 Marie Curie individual fellowship to Annika Herwig, travel grant from the Dutch brain fund de Nederlandse Hersenstichting to Emmely de Vries, BBSRC (Biotechnology and Biological Sciences Research Council) project grant (BB/E020437/1) and the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2000, ENDOCRINOLOGY, V141, P4349, DOI 10.1210/en.141.12.4349; Adams VL, 2006, ENDOCRINOLOGY, V147, P4843, DOI 10.1210/en.2006-0408; Barrett P, 2009, ENDOCRINOLOGY, V150, P3655, DOI 10.1210/en.2008-1620; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Barrett P, 2006, J ENDOCRINOL, V191, P687, DOI 10.1677/joe.1.06929; Bechtold DA, 2012, CURR BIOL, V22, P70, DOI 10.1016/j.cub.2011.11.043; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bockers TM, 1997, ENDOCRINOLOGY, V138, P4101, DOI 10.1210/en.138.10.4101; Bolborea M, 2011, ENDOCRINOLOGY, V152, P3871, DOI 10.1210/en.2011-1039; DAVIS DE, 1976, Q REV BIOL, V51, P477, DOI 10.1086/409594; Dawson A, 2007, GEN COMP ENDOCR, V153, P378, DOI 10.1016/j.ygcen.2007.01.043; Drew JE, 1998, J NEUROENDOCRINOL, V10, P651, DOI 10.1046/j.1365-2826.1998.00229.x; Dupre SM, 2007, CURR BIOL, V17, pR216, DOI 10.1016/j.cub.2007.01.042; FIGALA J, 1973, OECOLOGIA, V12, P89, DOI 10.1007/BF00345511; Freeman DA, 2001, P NATL ACAD SCI USA, V98, P6447, DOI 10.1073/pnas.111140398; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Helfer G, 2012, ENDOCRINOLOGY, V153, P815, DOI 10.1210/en.2011-1792; Herwig A, 2012, J NEUROENDOCRINOL, V24, P991, DOI 10.1111/j.1365-2826.2012.02324.x; Herwig A, 2009, AM J PHYSIOL-REG I, V296, pR1307, DOI 10.1152/ajpregu.90755.2008; Kauffman AS, 2003, J NEUROENDOCRINOL, V15, P191, DOI 10.1046/j.1365-2826.2003.00966.x; Murphy M, 2012, ENDOCRINOLOGY, V153, P101, DOI 10.1210/en.2011-1249; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; NICHOLLS TJ, 1988, PHYSIOL REV, V68, P133, DOI 10.1152/physrev.1988.68.1.133; NIKLOWITZ P, 1992, J PINEAL RES, V12, P64, DOI 10.1111/j.1600-079X.1992.tb00028.x; Nilaweera KN, 2009, J NEUROENDOCRINOL, V21, P123, DOI 10.1111/j.1365-2826.2008.01810.x; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; PEVET P, 1988, REPROD NUTR DEV, V28, P443, DOI 10.1051/rnd:19880310; Prendergast BJ, 2002, P NATL ACAD SCI USA, V99, P16291, DOI 10.1073/pnas.232490799; REITER RJ, 1972, ANAT REC, V173, P365, DOI 10.1002/ar.1091730311; Reppert SM, 1996, FEBS LETT, V386, P219, DOI 10.1016/0014-5793(96)00437-1; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Ross AW, 2009, J NEUROENDOCRINOL, V21, P610, DOI 10.1111/j.1365-2826.2009.01878.x; Ross AW, 2005, ENDOCRINOLOGY, V146, P1940, DOI 10.1210/en.2004-1538; Ross AW, 2004, ENDOCRINOLOGY, V145, P13, DOI 10.1210/en.2003-0838; Saenz de Miera C, 2013, J NEUROENDOCRINOL, V25, P412, DOI 10.1111/jne.12013; SCHLATT S, 1995, BIOL REPROD, V53, P1169, DOI 10.1095/biolreprod53.5.1169; STEINLECHNER S, 1982, INT J BIOMETEOROL, V26, P329, DOI 10.1007/BF02219503; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593; Watanabe T, 2007, AM J PHYSIOL-REG I, V292, pR568, DOI 10.1152/ajpregu.00521.2006; WEAVER DR, 1991, ENDOCRINOLOGY, V128, P1086, DOI 10.1210/endo-128-2-1086; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	42	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62003	10.1371/journal.pone.0062003	http://dx.doi.org/10.1371/journal.pone.0062003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637944	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700072
J	Lian, ZJ; Chai, W; Shi, LL; Chen, C; Liu, JY; Wang, Y				Lian, Zijian; Chai, Wei; Shi, Lewis L.; Chen, Chao; Liu, Jingyi; Wang, Yan			Analysis of PPARGC1B, RUNX3 and TBKBP1 Polymorphisms in Chinese Han Patients with Ankylosing Spondylitis: A Case-Control Study	PLOS ONE			English	Article							COACTIVATOR PGC-1; MITOCHONDRIAL BIOGENESIS; RADIOGRAPHIC PROGRESSION; HEPATIC GLUCONEOGENESIS; DISEASE-ACTIVITY; BREAST-CANCER; HYPERMETHYLATION; EXPRESSION; DISORDERS; VARIANTS	Background: Susceptibility to and severity of ankylosing spondylitis (AS) are largely genetically determined. PPARGC1B, RUNX3 and TBKBP1 have recently been found to be associated with AS in patients of western European descent. Our purpose is to examine the influence of PPARGC1B, RUNX3 and TBKBP1 polymorphisms on the susceptibility to and the severity of ankylosing spondylitis in Chinese ethnic majority Han population. Methods: Blood samples are drawn from 396 AS patients and 404 unrelated healthy controls. All the patients and the controls are Han Chinese and the patients are HLA-B27 positive. The AS patients are classified based on the severity of the disease. Twelve tag single nucleotide polymorphisms (tagSNPs) in PPARGC1B, RUNX3 and TBKBP1 are selected and genotyped. Frequencies of different genotypes and alleles are analyzed among the different severity AS patients and the controls. Results: After Bonferroni correction, the rs7379457 SNP in PPARGC1B shows significant difference when comparing all AS patients to controls (p = 0.005). This SNP also shows significant difference when comparing normal AS patients to controls (p = 0.002). The rs1395621 SNP in RUNX3 shows significant difference when comparing severe AS patients to controls (p = 0.007). The rs9438876 SNP in RUNX3 shows significant difference when comparing normal AS patients to controls (p = 0.007). The rs8070463 SNP in TBKBP1 shows significant difference in genotype distribution when comparing severe AS patients to controls (p = 0.003). Conclusions: The rs7379457 SNP in PPARGC1B is related to susceptibility to AS in Chinese Han population. The rs7379457 SNP in PPARGC1B, the rs1395621 and rs9438876 SNPs in RUNX3, and the rs8070463 SNP in TBKBP1 are related to the severity of AS in Chinese Han population.	[Lian, Zijian; Chai, Wei; Chen, Chao; Wang, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing, Peoples R China; [Lian, Zijian; Liu, Jingyi; Wang, Yan] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Lian, Zijian; Chen, Chao] Tianjin Hosp, Dept Orthopaed, Tianjin, Peoples R China; [Shi, Lewis L.] Univ Chicago Hosp, Dept Orthopaed, Chicago, IL 60637 USA	Chinese People's Liberation Army General Hospital; Nankai University; University of Chicago; University of Illinois System	Wang, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing, Peoples R China.	wangyaneasy@163.com			Nature science founding of Beijing [7102146]	Nature science founding of Beijing	Nature science founding of Beijing supports this research. The number is 7102146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Riquelme ME, 2004, ARTHRITIS RES THER, V6, P169, DOI 10.1186/ar1203; AMOR B, 1994, J RHEUMATOL, V21, P1883; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Braun J, 2002, ANN RHEUM DIS     S3, V61, piii9; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Brown MA, 2002, CLIN EXP RHEUMATOL, V20, pS43; CALIN A, 1994, J RHEUMATOL, V21, P2281; CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186, DOI 10.1002/art.1780260210; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Goel A, 2004, INT J CANCER, V112, P754, DOI 10.1002/ijc.20472; Gran JT, 1997, BRIT J RHEUMATOL, V36, P766; Hamersma J, 2001, IS DIS SEVERITY ANKY; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Kiaer T, 2010, EUR SPINE J, V19, P57, DOI 10.1007/s00586-009-1104-8; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lehne B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020133; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Li QL, 2005, CANCER RES, V65, P7743; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reveille JD, 2001, CURR OPIN RHEUMATOL, V13, P265, DOI 10.1097/00002281-200107000-00004; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Taylor AL, 1998, ARTHRITIS RHEUM, V41, P1119, DOI 10.1002/1529-0131(199806)41:6<1119::AID-ART20>3.0.CO;2-0; The Australo-Anglo-American Spondyloarthritis Consortium (TASC) & the Wellcome Trust Case Control Consortium (WTCCC), 2011, NATURE GENETICS, V43; Tost J, 2005, CLIN BIOCHEM, V38, P335, DOI 10.1016/j.clinbiochem.2004.12.005; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Wanders A, 2004, ANN RHEUM DIS, V63, P1601, DOI 10.1136/ard.2004.022038; Wirtenberger M, 2006, CARCINOGENESIS, V27, P2201, DOI 10.1093/carcin/bgl067; Wu YF, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3257; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	46	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61527	10.1371/journal.pone.0061527	http://dx.doi.org/10.1371/journal.pone.0061527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637848	gold, Green Published, Green Submitted			2022-12-25	WOS:000317908700043
J	Bittar, C; Shrivastava, S; Chowdhury, JB; Rahal, P; Ray, RB				Bittar, Cintia; Shrivastava, Shubham; Chowdhury, Joydip Bhanja; Rahal, Paula; Ray, Ratna B.			Hepatitis C Virus NS2 Protein Inhibits DNA Damage Pathway by Sequestering p53 to the Cytoplasm	PLOS ONE			English	Article							CYCLIN-E; HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; LIVER-CANCER; CHECKPOINT; EXPRESSION; ACTIVATION; INTERACTS; GENE	Chronic hepatitis C virus (HCV) infection is an important cause of morbidity and mortality globally, and often leads to end-stage liver disease. The DNA damage checkpoint pathway induces cell cycle arrest for repairing DNA in response to DNA damage. HCV infection has been involved in this pathway. In this study, we assess the effects of HCV NS2 on DNA damage checkpoint pathway. We have observed that HCV NS2 induces ataxia-telangiectasia mutated checkpoint pathway by inducing Chk2, however, fails to activate the subsequent downstream pathway. Further study suggested that p53 is retained in the cytoplasm of HCV NS2 expressing cells, and p21 expression is not enhanced. We further observed that HCV NS2 expressing cells induce cyclin E expression and promote cell growth. Together these results suggested that HCV NS2 inhibits DNA damage response by altering the localization of p53, and may play a role in the pathogenesis of HCV infection.	[Bittar, Cintia; Shrivastava, Shubham; Chowdhury, Joydip Bhanja; Ray, Ratna B.] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA; [Bittar, Cintia; Rahal, Paula] Sao Paulo State Univ, UNESP, Deaprtment Biol, Sao Paulo, Brazil	Saint Louis University; Universidade Estadual Paulista	Ray, RB (corresponding author), St Louis Univ, Dept Pathol, St Louis, MO 63103 USA.	rayrb@slu.edu	Rahal, Paula/D-3871-2012; Bittar, Cintia/A-5042-2015	Rahal, Paula/0000-0001-5693-6148; Bittar, Cintia/0000-0002-2048-4589; Shrivastava, Shubham/0000-0002-5980-8536	National Institutes of Health [DK081817]; FAPESP; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK081817 (R.B.R) from the National Institutes of Health. The authors also acknowledge FAPESP for financial support (C.B and P.R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariumi Y, 2008, J VIROL, V82, P9639, DOI 10.1128/JVI.00351-08; Banerjee A, 2010, VIRUSES-BASEL, V2, P2108, DOI 10.3390/v2092108; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Beckerman R, 2010, COLD SPRING HARB PER, V28; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Chehab NH, 2000, GENE DEV, V14, P278; Cho JW, 2001, LIVER, V21, P137, DOI 10.1034/j.1600-0676.2001.021002137.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Deng L, 2006, J GEN VIROL, V87, P1703, DOI 10.1099/vir.0.81735-0; Gaspar M, 2006, P NATL ACAD SCI USA, V103, P2821, DOI 10.1073/pnas.0511148103; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Ishido S, 1998, FEBS LETT, V438, P258, DOI 10.1016/S0014-5793(98)01312-X; Jin DY, 2007, FRONT BIOSCI-LANDMRK, V12, P222, DOI 10.2741/2060; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Koike K, 2007, J GASTROEN HEPATOL, V22, pS108, DOI 10.1111/j.1440-1746.2006.04669.x; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Loden M, 2002, ONCOGENE, V21, P4680, DOI 10.1038/sj.onc.1205578; Ma YH, 2011, J VIROL, V85, P86, DOI 10.1128/JVI.01070-10; Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Nurse P, 1997, CELL, V91, P865, DOI 10.1016/S0092-8674(00)80476-6; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Ray A, 2009, MOL CELL BIOL, V29, P986, DOI 10.1128/MCB.00898-08; SANTOLINI E, 1995, J VIROL, V69, P7461, DOI 10.1128/JVI.69.12.7461-7471.1995; Schregel V, 2009, P NATL ACAD SCI USA, V106, P5342, DOI 10.1073/pnas.0810950106; SHAULSKY G, 1991, ONCOGENE, V6, P2055; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Weitzman MD, 2004, DNA REPAIR, V3, P1165, DOI 10.1016/j.dnarep.2004.03.018; Wu Z, 1998, TRENDS BIOCHEM SCI, V23, P92, DOI 10.1016/S0968-0004(98)01180-3; Yamaga AK, 2002, J BIOL CHEM, V277, P33228, DOI 10.1074/jbc.M202304200; Zannini L, 2003, J BIOL CHEM, V278, P42346, DOI 10.1074/jbc.M303304200; Zein NN, 1996, ANN INTERN MED, V125, P634, DOI 10.7326/0003-4819-125-8-199610150-00002	43	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62581	10.1371/journal.pone.0062581	http://dx.doi.org/10.1371/journal.pone.0062581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638118	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300077
J	Fan, CM; Wang, X; Wang, YW; Hu, RB; Zhang, XM; Chen, JX; Fu, YF				Fan, Cheng-Ming; Wang, Xu; Wang, Yan-Wei; Hu, Rui-Bo; Zhang, Xiao-Mei; Chen, Jian-Xin; Fu, Yong-Fu			Genome-Wide Expression Analysis of Soybean MADS Genes Showing Potential Function in the Seed Development	PLOS ONE			English	Article							BOX GENES; TRANSCRIPTION FACTOR; FLOWER DEVELOPMENT; PHYLOGENETIC ANALYSES; ENDOSPERM DEVELOPMENT; FEMALE GAMETOPHYTE; EMBRYO DEVELOPMENT; HOMEOTIC GENES; FLORAL ORGAN; ARABIDOPSIS	The MADS family is an ancient and best-studied transcription factor and plays fundamental roles in almost every developmental process in plants. In the plant evolutionary history, the whole genome duplication (WGD) events are important not only to the plant species evolution, but to expansion of members of the gene families. Soybean as a model legume crop has experience three rounds of WGD events. Members of some MIKCC subfamilies, such as SOC, AGL6, SQUA, SVP, AGL17 and DEF/GLO, were expanded after soybean three rounds of WGD events. And some MIKCC subfamilies, MIKC* and type I MADS families had experienced faster birth-and-death evolution and their traces before the Glycine WGD event were not found. Transposed duplication played important roles in tandem arrangements among the members of different subfamilies. According to the expression profiles of type I and MIKC paralog pair genes, the fates of MIKC paralog gene pairs were subfunctionalization, and the fates of type I MADS paralog gene pairs were nonfunctionalization. 137 out of 163 MADS genes were close to 186 loci within 2 Mb genomic regions associated with seed-relative QTLs, among which 115 genes expressed during the seed development. Although MIKCC genes kept the important and conserved functions of the flower development, most MIKCC genes showed potentially essential roles in the seed development as well as the type I MADS.	[Fan, Cheng-Ming; Wang, Xu; Zhang, Xiao-Mei; Fu, Yong-Fu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Wang, Yan-Wei; Chen, Jian-Xin] Henan Agr Univ, Coll Life Sci, Zhengzhou, Henan, Peoples R China; [Hu, Rui-Bo] Chinese Acad Sci, CAS Key Lab Biofuels, Shandong Prov Key Lab Energy Genet, Qingdao Inst BioEnergy & BioProc Technol, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Henan Agricultural University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Chen, JX (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou, Henan, Peoples R China.	xinjian1@yahoo.com; fuyf@caas.cn	Hu, Ruibo/P-3471-2018	Hu, Ruibo/0000-0001-6299-5320; Fan, Chengming/0000-0002-1352-8301	National High Technology Research and Development Program '863' [2013AA102602]; Transgenic program [2009ZX08009-133B]; Chinese National Key Basic Research Program'973' [2010CB125906]; National Natural Science Foundings [31000680, 31000681]	National High Technology Research and Development Program '863'(National High Technology Research and Development Program of China); Transgenic program; Chinese National Key Basic Research Program'973'(National Basic Research Program of China); National Natural Science Foundings	This work was partly supported by National High Technology Research and Development Program '863' (2013AA102602), Transgenic program (2009ZX08009-133B), the Chinese National Key Basic Research Program'973' (2010CB125906), and the National Natural Science Foundings (31000680 and 31000681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bemer M, 2010, PLANT PHYSIOL, V154, P287, DOI 10.1104/pp.110.160770; Buggs RJA, 2010, NEW PHYTOL, V186, P175, DOI 10.1111/j.1469-8137.2010.03205.x; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Colombo M, 2008, PLANT J, V54, P1037, DOI 10.1111/j.1365-313X.2008.03485.x; Cusack BP, 2007, MOL BIOL EVOL, V24, P679, DOI 10.1093/molbev/msl199; De Bodt S, 2003, J MOL EVOL, V56, P573, DOI 10.1007/s00239-002-2426-x; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Diaz-Riquelme J, 2009, PLANT PHYSIOL, V149, P354, DOI 10.1104/pp.108.131052; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Du JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-113; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Geuten K, 2010, PLANT CELL, V22, P2562, DOI 10.1105/tpc.110.076026; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; HECK GR, 1995, PLANT CELL, V7, P1271, DOI 10.1105/tpc.7.8.1271; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Hileman LC, 2006, MOL BIOL EVOL, V23, P2245, DOI 10.1093/molbev/msl095; Hu LF, 2012, GENOME, V55, P245, DOI [10.1139/G2012-009, 10.1139/g2012-009]; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Immink RGH, 2003, MOL GENET GENOMICS, V268, P598, DOI 10.1007/s00438-002-0781-3; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kang IH, 2008, PLANT CELL, V20, P635, DOI 10.1105/tpc.107.055137; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kofuji R, 2003, MOL BIOL EVOL, V20, P1963, DOI 10.1093/molbev/msg216; Kwantes M, 2012, MOL BIOL EVOL, V29, P293, DOI 10.1093/molbev/msr200; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Lehti-Shiu MD, 2005, PLANT MOL BIOL, V58, P89, DOI 10.1007/s11103-005-4546-3; Leseberg CH, 2006, GENE, V378, P84, DOI 10.1016/j.gene.2006.05.022; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Masiero S, 2011, PLANT CELL, V23, P865, DOI 10.1105/tpc.110.081737; Mizzotti C, 2012, PLANT J, V70, P409, DOI 10.1111/j.1365-313X.2011.04878.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; PASSMORE S, 1988, J MOL BIOL, V204, P593, DOI 10.1016/0022-2836(88)90358-0; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Perry SE, 1996, PLANT CELL, V8, P1977, DOI 10.1105/tpc.8.11.1977; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Roulin A, 2012, PLANT J; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; Severin AJ, 2011, PLANT CELL, V23, P3129, DOI 10.1105/tpc.111.089573; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teeri TH, 2006, J EXP BOT, V57, P3445, DOI 10.1093/jxb/erl181; Thakare D, 2008, PLANT PHYSIOL, V146, P1663, DOI 10.1104/pp.108.115832; Theissen G, 2004, CRIT REV PLANT SCI, V23, P129, DOI 10.1080/07352680490433240; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Theissen G, 2007, ANN BOT-LONDON, V100, P603, DOI 10.1093/aob/mcm143; Vandenbussche M, 2003, NUCLEIC ACIDS RES, V31, P4401, DOI 10.1093/nar/gkg642; Vekemans D, 2012, MOL BIOL EVOL; Verelst W, 2007, PLANT PHYSIOL, V143, P447, DOI 10.1104/pp.106.089805; Verelst W, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r249; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028150; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Woodhouse MR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000949; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yoshida H, 2011, J EXP BOT, V62, P4719, DOI 10.1093/jxb/err272; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhao Y, 2011, PLANT CELL TISS ORG, V105, P159, DOI 10.1007/s11240-010-9848-8	76	29	31	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62288	10.1371/journal.pone.0062288	http://dx.doi.org/10.1371/journal.pone.0062288			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638026	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300037
J	Tan, R; Wang, WJ; Wang, SC; Wang, Z; Sun, LX; He, W; Fan, R; Zhou, YH; Xu, XH; Hong, WJ; Wang, TL				Tan, Ran; Wang, Weijie; Wang, Shicong; Wang, Zhen; Sun, Lixiang; He, Wei; Fan, Rong; Zhou, Yunhe; Xu, Xiaohui; Hong, Wanjin; Wang, Tuanlao			Small GTPase Rab40c Associates with Lipid Droplets and Modulates the Biogenesis of Lipid Droplets	PLOS ONE			English	Article							GOLGI INTERMEDIATE COMPARTMENT; EARLY ENDOSOMES; PROTEINS; ADIPOCYTES; PERILIPIN; TIP47; LOCALIZATION; LIPOLYSIS; MEMBRANE; CELL	The subcellular location and cell biological function of small GTPase Rab40c in mammalian cells have not been investigated in detail. In this study, we demonstrated that the exogenously expressed GFP-Rab40c associates with lipid droplets marked by neutral lipid specific dye Oil red or Nile red, but not with the Golgi or endosomal markers. Further examination demonstrated that Rab40c is also associated with ERGIC-53 containing structures, especially under the serum starvation condition. Rab40c is increasingly recruited to the surface of lipid droplets during lipid droplets formation and maturation in HepG2 cells. Rab40c knockdown moderately decreases the size of lipid droplets, suggesting that Rab40c is involved in the biogenesis of lipid droplets. Stimulation for adipocyte differentiation increases the expression of Rab40c in 3T3-L1 cells. Rab40c interacts with TIP47, and is appositionally associated with TIP47-labeled lipid droplets. In addition, over-expression of Rab40c causes the clustering of lipid droplets independent of its GTPase activity, but completely dependent of the intact SOCS box domain of Rab40c. In addition, Rab40c displayed self-interaction as well as interaction with TIP47 and the SOCS box is essential for its ability to induce clustering of lipid droplets. Our results suggest that Rab40c is a novel Rab protein associated with lipid droplets, and is likely involved in modulating the biogenesis of lipid droplets.	[Tan, Ran; Wang, Weijie; Wang, Shicong; Wang, Zhen; Sun, Lixiang; He, Wei; Fan, Rong; Zhou, Yunhe; Xu, Xiaohui; Hong, Wanjin; Wang, Tuanlao] Xiamen Univ, Sch Pharmaceut Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Hong, Wanjin] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	Xiamen University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Wang, TL (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	xmuibrwtl@xmu.edu.cn			National Natural Science Foundation of China [30971442, 31071176, 30928011]; National 973 prophase grant [2010CB535004]; Natural Science Foundation of Fujian Province of China [2010J01234]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 prophase grant; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by National Natural Science Foundation of China (No. 30971442, No. 31071176 and No. 30928011), National 973 prophase grant (No. 2010CB535004), and the Natural Science Foundation of Fujian Province of China(Grant 2010J01234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; CUSHMAN SW, 1970, J CELL BIOL, V46, P326, DOI 10.1083/jcb.46.2.326; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Ho PC, 2011, CELL SIGNAL, V23, P1396, DOI 10.1016/j.cellsig.2011.03.023; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Klumperman J, 1998, J CELL SCI, V111, P3411; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Linossi EM, 2012, IUBMB LIFE, V64, P316, DOI 10.1002/iub.1011; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; LONDOS C, 1995, BIOCHEM SOC T, V23, P611, DOI 10.1042/bst0230611; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; NOVIKOFF AB, 1980, J CELL BIOL, V87, P180, DOI 10.1083/jcb.87.1.180; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Pulido MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022931; Qin SY, 2012, GLYCOBIOLOGY, V22, P1709, DOI 10.1093/glycob/cws114; Rodriguez-Gabin AG, 2004, J NEUROSCI RES, V76, P758, DOI 10.1002/jnr.20121; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Sturmey RG, 2006, REPRODUCTION, V132, P829, DOI 10.1530/REP-06-0073; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang TL, 2004, MOL BIOL CELL, V15, P815, DOI 10.1091/mbc.E03-06-0413; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Xie Y, 2006, DIABETES OBES METAB, V8, P83, DOI 10.1111/j.1463-1326.2005.00472.x; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	44	26	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63213	10.1371/journal.pone.0063213	http://dx.doi.org/10.1371/journal.pone.0063213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638186	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300157
J	Chen, YC; Liu, TL; Yu, CH; Chiang, TY; Hwang, CC				Chen, Yen-Chun; Liu, Tsunglin; Yu, Chun-Hui; Chiang, Tzen-Yuh; Hwang, Chi-Chuan			Effects of GC Bias in Next-Generation-Sequencing Data on De Novo Genome Assembly	PLOS ONE			English	Article							READ DATA SETS; LIBRARY PREPARATION; PCR AMPLIFICATION; DNA-SEQUENCES; TECHNOLOGIES; ALGORITHMS; CHALLENGES; EFFICIENT; ALLPATHS; REPEATS	Next-generation-sequencing (NGS) has revolutionized the field of genome assembly because of its much higher data throughput and much lower cost compared with traditional Sanger sequencing. However, NGS poses new computational challenges to de novo genome assembly. Among the challenges, GC bias in NGS data is known to aggravate genome assembly. However, it is not clear to what extent GC bias affects genome assembly in general. In this work, we conduct a systematic analysis on the effects of GC bias on genome assembly. Our analyses reveal that GC bias only lowers assembly completeness when the degree of GC bias is above a threshold. At a strong GC bias, the assembly fragmentation due to GC bias can be explained by the low coverage of reads in the GC-poor or GC-rich regions of a genome. This effect is observed for all the assemblers under study. Increasing the total amount of NGS data thus rescues the assembly fragmentation because of GC bias. However, the amount of data needed for a full rescue depends on the distribution of GC contents. Both low and high coverage depths due to GC bias lower the accuracy of assembly. These pieces of information provide guidance toward a better de novo genome assembly in the presence of GC bias.	[Chen, Yen-Chun; Yu, Chun-Hui; Hwang, Chi-Chuan] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan; [Liu, Tsunglin] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Chiang, Tzen-Yuh] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Hwang, Chi-Chuan] Natl Cheng Kung Univ, Supercomp Res Ctr, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Hwang, CC (corresponding author), Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan.	chchwang@mail.ncku.edu.tw	Chiang, Tzen-Yuh/F-7383-2014; Hwang, Chi-Chuan/A-8237-2010		International Research-Intensive Centers of Excellence (I-RICE) of NSC in Taiwan [103-2911-I-006-301]	International Research-Intensive Centers of Excellence (I-RICE) of NSC in Taiwan	study was funded by International Research-Intensive Centers of Excellence (I-RICE; https://irice.stpi.narl.org.tw/index_en.jsp) of NSC in Taiwan (NSC 103-2911-I-006-301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Golovko G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-166; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hube F, 2005, MOL BIOTECHNOL, V31, P81, DOI 10.1385/MB:31:1:081; Koboldt DC, 2010, BRIEF BIOINFORM, V11, P484, DOI 10.1093/bib/bbq016; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Mamedov TG, 2008, COMPUT BIOL CHEM, V32, P452, DOI 10.1016/j.compbiolchem.2008.07.021; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nagarajan N, 2010, METHODS MOL BIOL, V673, P1, DOI 10.1007/978-1-60761-842-3_1; Narzisi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019175; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Salzberg SL, 2011, GENOME RES; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schmidt B, 2009, BIOINFORMATICS, V25, P2279, DOI 10.1093/bioinformatics/btp374; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Shintani M, 2011, MICROBIOL-SGM, V157, P3405, DOI 10.1099/mic.0.053280-0; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	42	122	128	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62856	10.1371/journal.pone.0062856	http://dx.doi.org/10.1371/journal.pone.0062856			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638157	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800065
J	Azim, HA; Singhal, S; Ignatiadis, M; Desmedt, C; Fumagalli, D; Veys, I; Larsimont, D; Piccart, M; Michiels, S; Sotiriou, C				Azim, Hatem A., Jr.; Singhal, Sandeep; Ignatiadis, Michail; Desmedt, Christine; Fumagalli, Debora; Veys, Isabelle; Larsimont, Denis; Piccart, Martine; Michiels, Stefan; Sotiriou, Christos			Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis	PLOS ONE			English	Article							ALBUMIN-BOUND PACLITAXEL; EXTRACELLULAR-MATRIX; NAB-PACLITAXEL; PREDICTOR; SIGNATURE; SUBTYPES; TUMORS; CELLS; TRIAL	Introduction: SPARC is an important regulator of the extracellular matrix and has been suggested to improve delivery of albumin-bound cytotoxics. However, little is known regarding its role in breast cancer (BC). Methods: We conducted a pooled analysis of publically available datasets, in which BC patients who received no systemic therapy or received neoadjuvant chemotherapy were eligible. Patients were assigned to molecular subtypes using PAM-50. We computed a SPARC module (SPARC7), composed of genes with an absolute correlation with SPARC >0.7. In the systemically untreated cohort, we evaluated 1) expression of SPARC/SPARC7 according to breast cancer subtype, 2) association between SPARC/SPARC7 and biological processes related to proliferation, immune and stroma, and 3) association between SPARC/SPARC7 and relapse-free survival in a Cox model in all patients and in the different molecular subtypes adjusted for tumor size, nodal status, histological grade, and age. In the neoadjuvant cohort, we evaluated the association between SPARC and pCR in a logistic regression model, adjusted for the same clinicopathologic factors. Results: 948 (10 datasets), and 791 (8 datasets) patients were included in the systemically untreated and neoadjuvant cohorts, respectively. High SPARC expression was associated with small tumor size, low histological grade and luminal-A tumors (all p<0.0001). There was a positive correlation between SPARC and stroma-related modules but negative correlation with proliferation modules. High SPARC expression was associated with poor prognosis in patients with basal and HER2+ breast cancer even after adjusting for clinicopathologic parameters. In the neoadjuvant cohort, a subgroup analysis suggested that high SPARC is associated with low rates of pCR in the HER2 subtype. Same results were observed on replacing SPARC by SPARC7. Conclusion: This analysis suggests a potential role of SPARC in determining prognosis and response to primary chemotherapy in early BC. This information could guide further development of albumin-bound cytotoxics in BC.	[Azim, Hatem A., Jr.; Singhal, Sandeep; Ignatiadis, Michail; Desmedt, Christine; Fumagalli, Debora; Michiels, Stefan; Sotiriou, Christos] Univ Libre Brussels, Breast Canc Translat Res Lab, JC Heuson, Inst Jules Bordet, Brussels, Belgium; [Ignatiadis, Michail; Piccart, Martine; Sotiriou, Christos] Univ Libre Brussels, Dept Med Oncol, Inst Jules Bordet, Brussels, Belgium; [Veys, Isabelle] Inst Jules Bordet, Dept Breast & Gynecol Surg, B-1000 Brussels, Belgium; [Larsimont, Denis] Inst Jules Bordet, Dept Pathol, B-1000 Brussels, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles; Institut Jules Bordet; Institut Jules Bordet; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Sotiriou, C (corresponding author), Univ Libre Brussels, Breast Canc Translat Res Lab, JC Heuson, Inst Jules Bordet, Brussels, Belgium.	christos.sotiriou@bordet.be	Desmedt, Christine/P-7438-2017; Michiels, Stefan/L-1516-2013	Desmedt, Christine/0000-0002-5223-5579; Michiels, Stefan/0000-0002-6963-2968	Celgene; European Society for Medical Oncology (ESMO)	Celgene(Bristol-Myers SquibbCelgene Corporation); European Society for Medical Oncology (ESMO)	Celgene provided financial support for this analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Hatem A. Azim Jr. acknowledges a translational research fellowship from the European Society for Medical Oncology (ESMO). The authors would like to thank all the patients who have generously donated their tumor tissue for research purposes	Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bornstein P, 2002, METHOD CELL BIOL, V69, P7, DOI 10.1016/S0091-679X(02)69003-X; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Criscitiello C, 2012, ANN ONCOL, V23, P13, DOI 10.1093/annonc/mds188; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Desai N, 2009, TRANSL ONCOL, V2, P59, DOI 10.1593/tlo.09109; Desai NP, 2008, ANTI-CANCER DRUG, V19, P899, DOI 10.1097/CAD.0b013e32830f9046; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Guarneri V, 2012, EXPERT OPIN PHARMACO, V13, P395, DOI 10.1517/14656566.2012.651127; Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555; Hsiao YH, 2010, BREAST J, V16, P305, DOI 10.1111/j.1524-4741.2009.00899.x; Ignatiadis M, 2012, J CLIN ONCOL, V30, P1996, DOI 10.1200/JCO.2011.39.5624; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Sage EH, 2001, J CLIN INVEST, V107, P781, DOI 10.1172/JCI12683; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	34	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62451	10.1371/journal.pone.0062451	http://dx.doi.org/10.1371/journal.pone.0062451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638089	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700058
J	Dossinger, G; Bunse, M; Bet, J; Albrecht, J; Paszkiewicz, PJ; Weissbrich, B; Schiedewitz, I; Henkel, L; Schiemann, M; Neuenhahn, M; Uckert, W; Busch, DH				Doessinger, Georg; Bunse, Mario; Bet, Jeannette; Albrecht, Julia; Paszkiewicz, Paulina J.; Weissbrich, Bianca; Schiedewitz, Isabell; Henkel, Lynette; Schiemann, Matthias; Neuenhahn, Michael; Uckert, Wolfgang; Busch, Dirk H.			MHC Multimer-Guided and Cell Culture-Independent Isolation of Functional T Cell Receptors from Single Cells Facilitates TCR Identification for Immunotherapy	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CANCER REGRESSION; HIGH-AVIDITY; ANTIGEN; LYMPHOCYTES; REPERTOIRE; EXPRESSION; SELECTION; LEVEL; EXPANSIONS	Adoptive therapy using T cells redirected to target tumor- or infection-associated antigens is a promising strategy that has curative potential and broad applicability. In order to accelerate the screening process for suitable antigen-specific T cell receptors (TCRs), we developed a new approach circumventing conventional in vitro expansion-based strategies. Direct isolation of paired full-length TCR sequences from non-expanded antigen-specific T cells was achieved by the establishment of a highly sensitive PCR-based T cell receptor single cell analysis method (TCR-SCAN). Using MHC multimer-labeled and single cell-sorted HCMV-specific T cells we demonstrate a high efficacy (approximately 25%) and target specificity of TCR-SCAN receptor identification. In combination with MHC-multimer based pre-enrichment steps, we were able to isolate TCRs specific for the oncogenes Her2/neu and WT1 even from very small populations (original precursor frequencies of down to 0.00005% of CD3(+) T cells) without any cell culture step involved. Genetic re-expression of isolated receptors demonstrates their functionality and target specificity. We believe that this new strategy of TCR identification may provide broad access to specific TCRs for therapeutically relevant T cell epitopes.	[Doessinger, Georg; Bet, Jeannette; Paszkiewicz, Paulina J.; Weissbrich, Bianca; Henkel, Lynette; Schiemann, Matthias; Neuenhahn, Michael; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Bet, Jeannette; Paszkiewicz, Paulina J.; Weissbrich, Bianca; Busch, Dirk H.] Tech Univ Munich, Inst Adv Study, Focus Grp Clin Cell Proc & Purificat, D-80290 Munich, Germany; [Albrecht, Julia; Schiedewitz, Isabell; Schiemann, Matthias; Neuenhahn, Michael; Busch, Dirk H.] Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Antigen Specif Immunotherapy, Munich, Germany; [Albrecht, Julia; Schiedewitz, Isabell; Schiemann, Matthias; Neuenhahn, Michael; Busch, Dirk H.] Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Immune Monitoring, Munich, Germany; [Albrecht, Julia; Schiedewitz, Isabell; Schiemann, Matthias; Neuenhahn, Michael; Busch, Dirk H.] Tech Univ Munich, D-80290 Munich, Germany; [Busch, Dirk H.] DZIF Natl Ctr Infect Res, Munich, Germany; [Bunse, Mario; Uckert, Wolfgang] Max Delbruck Ctr Mol Med, Berlin, Germany; [Uckert, Wolfgang] Humboldt Univ, D-10099 Berlin, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; German Center for Infection Research; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin	Busch, DH (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany.	dirk.busch@mikrobio.med.tum.de		Bunse, Mario/0000-0002-7554-2520	SFB (Sonderforschungsbereich/Collaborative Research Centre) TR36 [TP-B10/13, TP-Z1]; Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer	SFB (Sonderforschungsbereich/Collaborative Research Centre) TR36; Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer	This work was supported by the SFB (Sonderforschungsbereich/Collaborative Research Centre) TR36 (TP-B10/13, TP-Z1) and the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Dietrich PY, 1997, INT IMMUNOL, V9, P1073, DOI 10.1093/intimm/9.8.1073; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Hawiger D, 2010, NAT IMMUNOL, V11, P962, DOI 10.1038/ni.1929; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Junker A, 2007, BRAIN, V130, P2789, DOI 10.1093/brain/awm214; Kawase T, 2009, BLOOD, V113, P2851, DOI 10.1182/blood-2008-08-171934; Khan N, 2010, IMMUNOLOGY, V131, P537, DOI 10.1111/j.1365-2567.2010.03326.x; Kim SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037338; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Moris A, 2001, J IMMUNOL, V166, P4818, DOI 10.4049/jimmunol.166.8.4818; Munz C, 1999, J IMMUNOL, V162, P25; Obst R, 1998, EUR J IMMUNOL, V28, P2432, DOI 10.1002/(SICI)1521-4141(199808)28:08<2432::AID-IMMU2432>3.0.CO;2-0; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; Pilch H, 2002, CLIN DIAGN LAB IMMUN, V9, P267, DOI 10.1128/CDLI.9.2.267-278.2002; PORTER DL, 1994, NEW ENGL J MED, V330, P100, DOI 10.1056/NEJM199401133300204; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Savage P, 2004, BLOOD, V103, P4613, DOI 10.1182/blood-2003-11-3903; Sun XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040386; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Zhou D, 2006, LAB INVEST, V86, P314, DOI 10.1038/labinvest.3700381	30	33	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61384	10.1371/journal.pone.0061384	http://dx.doi.org/10.1371/journal.pone.0061384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637823	Green Published, Green Accepted, gold			2022-12-25	WOS:000318343700010
J	Ueno, H; Okita, H; Akimoto, S; Kobayashi, K; Nakabayashi, K; Hata, K; Fujimoto, J; Hata, J; Fukuzawa, M; Kiyokawa, N				Ueno, Hitomi; Okita, Hajime; Akimoto, Shingo; Kobayashi, Kenichiro; Nakabayashi, Kazuhiko; Hata, Kenichiro; Fujimoto, Junichiro; Hata, Jun-ichi; Fukuzawa, Masahiro; Kiyokawa, Nobutaka			DNA Methylation Profile Distinguishes Clear Cell Sarcoma of the Kidney from Other Pediatric Renal Tumors	PLOS ONE			English	Article							THROMBOSPONDIN-1 GENE; WILMS-TUMORS; CANCER; HYPERMETHYLATION; EXPRESSION; ANGIOGENESIS; METHYLTRANSFERASE; INHIBITORS; MUTATIONS; DENSITY	A number of specific, distinct neoplastic entities occur in the pediatric kidney, including Wilms' tumor, clear cell sarcoma of the kidney (CCSK), congenital mesoblastic nephroma (CMN), rhabdoid tumor of the kidney (RTK), and the Ewing's sarcoma family of tumors (ESFT). By employing DNA methylation profiling using Illumina Infinium HumanMethylation27, we analyzed the epigenetic characteristics of the sarcomas including CCSK, RTK, and ESFT in comparison with those of the nonneoplastic kidney (NK), and these tumors exhibited distinct DNA methylation profiles in a tumor-type-specific manner. CCSK is the most frequently hypermethylated, but least frequently hypomethylated, at CpG sites among these sarcomas, and exhibited 490 hypermethylated and 46 hypomethylated CpG sites in compared with NK. We further validated the results by MassARRAY, and revealed that a combination of four genes was sufficient for the DNA methylation profile-based differentiation of these tumors by clustering analysis. Furthermore, THBS1 CpG sites were found to be specifically hypermethylated in CCSK and, thus, the DNA methylation status of these THBS1 sites alone was sufficient for the distinction of CCSK from other pediatric renal tumors, including Wilms' tumor and CMN. Moreover, combined bisulfite restriction analysis could be applied for the detection of hypermethylation of a THBS1 CpG site. Besides the biological significance in the pathogenesis, the DNA methylation profile should be useful for the differential diagnosis of pediatric renal tumors.	[Ueno, Hitomi; Okita, Hajime; Akimoto, Shingo; Kobayashi, Kenichiro; Kiyokawa, Nobutaka] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Setagaya Ku, Tokyo, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan; [Fujimoto, Junichiro] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Setagaya Ku, Tokyo, Japan; [Hata, Jun-ichi] Tokiwa Univ, Coll Human Sci, Mito, Ibaraki, Japan; [Fukuzawa, Masahiro] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Izumi Ku, Osaka, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Okita, H (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Setagaya Ku, Tokyo, Japan.	okita-h@ncchd.go.jp			Health and Labour Sciences Research Grants (the 3rd-term comprehensive 10-year strategy for cancer control) [H22-011]; National Center for Child Health and Development [22A-5, 24-4]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) [10-41, 10-42, 10-43, 10-44, 10-45];  [23390405]	Health and Labour Sciences Research Grants (the 3rd-term comprehensive 10-year strategy for cancer control); National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); 	This work was supported by Health and Labour Sciences Research Grants (the 3rd-term comprehensive 10-year strategy for cancer control H22-011), Grant-in-Aid for Scientific Research (B)(23390405, Grant of National Center for Child Health and Development (22A-5, 24-4), and Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO, 10-41, -42, -43, -44, -45). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Argani P, 2000, AM J SURG PATHOL, V24, P4, DOI 10.1097/00000478-200001000-00002; Baylin SB, 2000, J NATL CANCER I, V92, P1460, DOI 10.1093/jnci/92.18.1460; Beckwith J. Bruce, 1994, P1741; Biegel JA, 2002, CLIN CANCER RES, V8, P3461; Chilukamarri L, 2007, NEOPLASIA, V9, P970, DOI 10.1593/neo.07661; Eble JN, 2004, WHO CLASSIFICATION T, P48; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esteller M, 2004, ONCOGENE, V23, P1, DOI 10.1038/sj.onc.1207316; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Goto Y, 2009, CANCER RES, V69, P9073, DOI 10.1158/0008-5472.CAN-09-1595; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Guerrero D, 2008, BJU INT, V102, P747, DOI 10.1111/j.1464-410X.2008.07603.x; Guo W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721485; Haruta M, 2008, MOL CARCINOGEN, V47, P660, DOI 10.1002/mc.20412; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Imbalzano AN, 2005, CANCER CELL, V7, P294, DOI 10.1016/j.ccr.2005.04.001; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lawler J, 2001, AM J PATHOL, V159, P1949, DOI 10.1016/S0002-9440(10)63042-8; Mahoney SE, 2012, EPIGENETICS-US, V7, P400, DOI 10.4161/epi.19463; O'Meara E, 2012, J PATHOL, V227, P72, DOI 10.1002/path.3985; Rubin BP, 1998, AM J PATHOL, V153, P1451, DOI 10.1016/S0002-9440(10)65732-X; Schuster AE, 2003, LAB INVEST, V83, P1293, DOI 10.1097/01.LAB.0000087850.69363.59; Sund M, 2005, P NATL ACAD SCI USA, V102, P2934, DOI 10.1073/pnas.0500180102; Szemes M, 2013, HUM MOL GENET, V22, P74, DOI 10.1093/hmg/dds403; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Yu J, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-29	29	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62233	10.1371/journal.pone.0062233	http://dx.doi.org/10.1371/journal.pone.0062233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638012	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700041
J	Ding, C; Wilding, JPH; Bing, C				Ding, Cherlyn; Wilding, John P. H.; Bing, Chen			1,25-dihydroxyvitamin D-3 Protects against Macrophage-Induced Activation of NF kappa B and MAPK Signalling and Chemokine Release in Human Adipocytes	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; SUBCUTANEOUS ADIPOSE-TISSUE; BLOOD MONONUCLEAR-CELLS; INSULIN-RESISTANCE; GLUCOSE-HOMEOSTASIS; CYTOKINE PRODUCTION; OBESITY; RECRUITMENT; SECRETION	Increased accumulation of macrophages in adipose tissue in obesity is linked to low-grade chronic inflammation, and associated with features of metabolic syndrome. Vitamin D-3 may have immunoregulatory effects and reduce adipose tissue inflammation, although the molecular mechanisms remain to be established. This study investigated the effects of vitamin D-3 on macrophage-elicited inflammatory responses in cultured human adipocytes, particularly the signalling pathways involved. Macrophage-conditioned (MC) medium (25% with adipocyte maintenance media) markedly inhibited protein expression of the nuclear factor-kappa B (NF kappa B) subunit inhibitor kappa B alpha (I kappa B alpha) (71%, P<0.001) and increased NF kappa B p65 (1.5-fold, P=0.026) compared with controls. Treatment with 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) abolished macrophage-induced activation of NF kappa B signalling by increasing I kappa Ba expression (2.7-fold, P=0.005) and reducing NF kappa B p65 phosphorylation (68%; P<0.001). The mitogen-activated protein kinase (MAPK) signalling was activated by MC medium, which was also blunted by 1,25(OH)(2)D-3 with a downregulation of phosphorylated p38 MAPK (32%, P = 0.005) and phosphorylated Erk1/2 (49%, P=0.001). Furthermore, MC medium (12.5% or 25%) dose-dependently upregulated secretion of key proinflammatory chemokines/cytokines (22-368-fold; all P<0.001) and this was significantly decreased by 1,25(OH)(2)D-3: IL-8 (61% and 31%, P<0.001), MCP-1 (37%, P<0.001 and 36%, P=0.002), RANTES (78% and 62%, P<0.001) and IL-6 (29%, P<0.001 and 34%, P=0.019). Monocyte migration-elicited by adipocytes treated with 1,25(OH)(2)D-3 was also reduced (up to 25%, P<0.001). In conclusion, vitamin D-3 could be anti-inflammatory in adipose tissue, decreasing macrophage-induced release of chemokines and cytokines by adipocytes and the chemotaxis of monocytes. Our data suggests these effects are mediated by inhibition of the NF kappa B and MAPK signalling pathways.	[Ding, Cherlyn; Wilding, John P. H.; Bing, Chen] Univ Liverpool, Inst Ageing & Chron Dis, Dept Obes & Endocrinol, Obes Biol Res Unit, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Bing, C (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Obes & Endocrinol, Obes Biol Res Unit, Liverpool L69 3BX, Merseyside, England.	bing@liverpool.ac.uk	Ding, Cherlyn/S-5007-2018; Wilding, John/ABB-6443-2020; Wilding, John PH/A-7106-2008	Ding, Cherlyn/0000-0002-5255-8677; Wilding, John/0000-0003-2839-8404; Wilding, John PH/0000-0003-2839-8404	University of Liverpool, UK Medical Research Council [G0801226]	University of Liverpool, UK Medical Research Council	The work was supported by University of Liverpool, UK Medical Research Council (G0801226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HY, 2011, STROKE, V42, P65, DOI 10.1161/STROKEAHA.110.590323; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85; Bashan N, 2007, ENDOCRINOLOGY, V148, P2955, DOI 10.1210/en.2006-1369; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Blum M, 2008, ENDOCRINE, V33, P90, DOI 10.1007/s12020-008-9051-4; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bourlier V, 2009, DIABETES METAB, V35, P251, DOI 10.1016/j.diabet.2009.05.001; Brock K, 2010, J STEROID BIOCHEM, V121, P462, DOI 10.1016/j.jsbmb.2010.03.091; Bruun JM, 2004, AM J PHYSIOL-ENDOC M, V286, pE8, DOI 10.1152/ajpendo.00269.2003; Carlberg C, 2003, RECENT RESULTS CANC, V164, P29; Ching S, 2011, J CELL BIOCHEM, V112, P3393, DOI 10.1002/jcb.23273; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Cohen-Lahav M, 2007, J STEROID BIOCHEM, V103, P558, DOI 10.1016/j.jsbmb.2006.12.093; Demay MB, 2006, ANN NY ACAD SCI, V1068, P204, DOI 10.1196/annals.1346.026; Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285; DUSSO AS, 1991, J CLIN ENDOCR METAB, V72, P157, DOI 10.1210/jcem-72-1-157; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Fain JN, 2005, INT J OBESITY, V29, P1299, DOI 10.1038/sj.ijo.0803032; Fish E, 2010, J SURG RES, V164, P198, DOI 10.1016/j.jss.2010.06.029; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Gao D, 2010, MOL CELL ENDOCRINOL, V325, P135, DOI 10.1016/j.mce.2010.05.020; Gao D, 2012, INT J OBES LOND; Gao D, 2011, J CELL PHYSIOL, V226, P2869, DOI 10.1002/jcp.22630; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Goldner WS, 2008, OBES SURG, V18, P145, DOI 10.1007/s11695-007-9315-8; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Kos K, 2009, DIABETES, V58, P1780, DOI 10.2337/db09-0211; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Kull M, 2009, INTERN MED J, V39, P256, DOI 10.1111/j.1445-5994.2009.01900.x; Lira FS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-37; Lolmede K, 2011, DIABETES METAB, V37, P283, DOI 10.1016/j.diabet.2011.03.002; Lorente-Cebrian S, 2012, EUR J NUTR, V51, P335, DOI 10.1007/s00394-011-0218-z; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marcotorchino J, 2012, MOL NUTR FOOD RES; Martinesi M, 2008, INFLAMM BOWEL DIS, V14, P597, DOI 10.1002/ibd.20354; Matter CM, 2007, CIRCULATION, V115, P946, DOI 10.1161/CIRCULATIONAHA.106.685230; MELLANBY E, 1976, NUTR REV, V34, P338; Mellanby E, 1919, LANCET, V1, P407; Mutt SJ, 2012, FASEB J, V26, P4400, DOI 10.1096/fj.12-210880; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Nimitphong H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052171; Olson ML, 2012, J CLIN ENDOCR METAB, V97, P279, DOI 10.1210/jc.2011-1507; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Stio M, 2007, J STEROID BIOCHEM, V103, P51, DOI 10.1016/j.jsbmb.2006.07.008; Sun XC, 2008, J NUTR BIOCHEM, V19, P392, DOI 10.1016/j.jnutbio.2007.05.013; Sun XZ, 2012, BREAST CANCER RES TR, V131, P1003, DOI 10.1007/s10549-011-1789-3; Suzuki Y, 2009, J STEROID BIOCHEM, V113, P134, DOI 10.1016/j.jsbmb.2008.12.004; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wamberg L, 2012, INT J OBES LOND; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zhang Y, 2010, J AM SOC NEPHROL, V21, P966, DOI 10.1681/ASN.2009080872; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	65	81	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61707	10.1371/journal.pone.0061707	http://dx.doi.org/10.1371/journal.pone.0061707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637889	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400043
J	Janssen, IJI; Krucken, J; Demeler, J; Basiaga, M; Kornas, S; von Samson-Himmelstjerna, G				Janssen, I. Jana I.; Kruecken, Juergen; Demeler, Janina; Basiaga, Marta; Kornas, Slawomir; von Samson-Himmelstjerna, Georg			Genetic Variants and Increased Expression of Parascaris equorum P-glycoprotein-11 in Populations with Decreased Ivermectin Susceptibility	PLOS ONE			English	Article							P-GLYCOPROTEIN GENE; MACROCYCLIC LACTONE RESISTANCE; BEST-FIT MODELS; FECAL EGG COUNT; HAEMONCHUS-CONTORTUS; ANTHELMINTIC RESISTANCE; CAENORHABDITIS-ELEGANS; MULTIDRUG-RESISTANCE; ONCHOCERCA-VOLVULUS; ABC TRANSPORTERS	Macrocyclic lactones (MLs) represent the major drug class for control of parasitic infections in humans and animals. However, recently reports of treatment failures became more frequent. In addition to human and ruminant parasitic nematodes this also is the case for the horse-nematode Parascaris equorum. Nevertheless, to date the molecular basis of ML resistance is still not understood. Unspecific resistance mechanisms involving transporters such as P-glycoproteins (Pgps) are expected to contribute to ML resistance in nematodes. Here, complete sequences of two P. equorum Pgps were cloned and identified as orthologs of Caenorhabditis elegans Ppg-11 and an unnamed Caenorhabditis briggsae Pgp designated as Pgp-16 using phylogenetic analysis. Quantitative real-time PCR was used to compare expression between tissues. Significantly higher PeqPgp-11 expression was found in the gut for both genders, whereas for PeqPgp-16 the body wall was identified as predominant expression site. Furthermore, Pgps were analyzed regarding their participation in resistance development. Using SeqDoC analyses, Pgp-sequences of P. equorum populations with different ML susceptibility were compared. This approach revealed three single nucleotide polymorphisms (SNPs) causing missense mutations in the PeqPgp-11 sequence which correlated with decreased ML susceptibility. However, no resistance associated differences in mRNA expression levels were detected between embryonated eggs of these populations. In contrast, comparison of two pre-adult groups with different ivermectin (IVM) susceptibility revealed the presence of the three SNPs and in addition statistically significant PeqPgp-11 overexpression in the group of worms with reduced susceptibility. These results indicate that Pgp-11 might be involved in IVM resistance in P. equorum as it shows increased expression in an IVM exposed life-cycle stage of an IVM resistant population as well as occurrence of putatively resistance associated SNPs in populations with reduced IVM susceptibility. These SNPs are promising diagnostic candidates for detection of ML resistance with potential also for other parasitic nematode species.	[Janssen, I. Jana I.; Kruecken, Juergen; Demeler, Janina; von Samson-Himmelstjerna, Georg] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Basiaga, Marta; Kornas, Slawomir] Agr Univ Krakow, Dept Zool & Ecol, Krakow, Poland	Free University of Berlin; Agricultural University Krakow	von Samson-Himmelstjerna, G (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.	gvsamson@fu-berlin.de	Krücken, Jürgen/CAF-6903-2022; Krücken, Jürgen/AAE-3133-2021; von Samson, Georg/R-1123-2016; Basiaga, Marta/U-8151-2019; McKay-Demeler, Janina/AAO-4336-2020; Krücken, Jürgen/B-6794-2009; Demeler, Janina/A-1727-2014	Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Basiaga, Marta/0000-0001-7698-1253; Krücken, Jürgen/0000-0002-2842-8100; 	Deutsche Forschungsgemeinschaft (DFG) [SA973/3-1]; Freie Universitat Berlin	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Freie Universitat Berlin	This work was supported by a research grant from the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) (SA973/3-1) and by funding from the Freie Universitat Berlin (http://www.fu-berlin.de) for interim employment of IJIJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Ardelli BF, 2010, PARASITOLOGY, V137, P1195, DOI 10.1017/S0031182010000120; Ardelli BF, 2005, MOL BIOCHEM PARASIT, V143, P58, DOI 10.1016/j.molbiopara.2005.05.006; Beech RN, 2011, PARASITOLOGY, V138, P160, DOI 10.1017/S0031182010001198; Beech RN, 2010, TRENDS PARASITOL, V26, P334, DOI 10.1016/j.pt.2010.04.003; Blackhall WJ, 2008, VET PARASITOL, V152, P101, DOI 10.1016/j.vetpar.2007.12.001; Blackhall WJ, 1998, MOL BIOCHEM PARASIT, V95, P193, DOI 10.1016/S0166-6851(98)00087-5; Bourguinat C, 2011, VET PARASITOL, V181, P388, DOI 10.1016/j.vetpar.2011.04.012; Bourguinat C, 2011, VET PARASITOL, V176, P374, DOI 10.1016/j.vetpar.2011.01.024; BROEKS A, 1995, EMBO J, V14, P1858, DOI 10.1002/j.1460-2075.1995.tb07178.x; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell WC, 2012, CURR PHARM BIOTECHNO, V13, P853; CLAYTON HM, 1979, INT J PARASITOL, V9, P285, DOI 10.1016/0020-7519(79)90076-6; Crowe ML, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-133; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Diawara A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000397; Dicker AJ, 2011, INT J PARASITOL, V41, P935, DOI 10.1016/j.ijpara.2011.03.015; Drogemuller M, 2004, J PARASITOL, V90, P998, DOI 10.1645/GE-3312; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hejmadi MV, 2000, PARASITOLOGY, V120, P535, DOI 10.1017/S0031182099005843; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huang YJ, 1999, MOL BIOCHEM PARASIT, V102, P273, DOI 10.1016/S0166-6851(99)00104-8; James CE, 2009, INT J PARASITOL, V39, P213, DOI 10.1016/j.ijpara.2008.06.009; Kerboeuf D, 2003, INT J ANTIMICROB AG, V22, P332, DOI 10.1016/S0924-8579(03)00221-8; Kerboeuf D, 2003, PARASITOL RES, V91, P79, DOI 10.1007/s00436-003-0942-2; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Kwa MSG, 1998, INT J PARASITOL, V28, P1235, DOI 10.1016/S0020-7519(98)00071-X; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P58, DOI 10.1016/j.ijpddr.2011.10.001; LINCKE CR, 1992, J MOL BIOL, V228, P701, DOI 10.1016/0022-2836(92)90855-E; Lustigman S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000076; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Menez C, 2011, BIOCHEM PHARMACOL, V83, P269; Miller CM, 2006, NEW ZEAL VET J, V54, P323, DOI 10.1080/00480169.2006.36718; Nielsen MK, 2010, VET PARASITOL, V174, P77, DOI 10.1016/j.vetpar.2010.08.007; Njue AI, 2004, J NEUROCHEM, V89, P1137, DOI 10.1111/j.1471-4159.2004.02379.x; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Prichard RK, 2007, PARASITOLOGY, V134, P1123, DOI 10.1017/S0031182007000091; Reinemeyer CR, 2012, VET PARASITOL, V185, P9, DOI 10.1016/j.vetpar.2011.10.009; Reinemeyer CR, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S2-S8; ROHRER SP, 1994, J PARASITOL, V80, P493, DOI 10.2307/3283426; Sangster NC, 1999, PARASITOL TODAY, V15, P141, DOI 10.1016/S0169-4758(99)01413-1; Sangster NC, 1999, EXP PARASITOL, V91, P250, DOI 10.1006/expr.1998.4373; von Samson-Himmelstjerna G, 2009, PARASITOLOGY, V136, P349, DOI 10.1017/S003118200800543X; von Samson-Himmelstjerna G, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S2-S3; WEISBLAT DA, 1976, J COMP PHYSIOL, V107, P293, DOI 10.1007/BF00656739; Williamson SM, 2011, MOL BIOCHEM PARASIT, V180, P99, DOI 10.1016/j.molbiopara.2011.09.003; Williamson SM, 2011, J HELMINTHOL, V1, P1; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Xu M, 1998, MOL BIOCHEM PARASIT, V91, P327, DOI 10.1016/S0166-6851(97)00215-6; Yan RF, 2012, VET PARASITOL, V190, P519, DOI 10.1016/j.vetpar.2012.06.038; Zhao ZY, 2004, J MOL BIOL, V344, P409, DOI 10.1016/j.jmb.2004.09.052	57	44	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61635	10.1371/journal.pone.0061635	http://dx.doi.org/10.1371/journal.pone.0061635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637871	gold, Green Submitted, Green Published			2022-12-25	WOS:000318340400036
J	Keramati, M; Gutkin, B				Keramati, Mehdi; Gutkin, Boris			Imbalanced Decision Hierarchy in Addicts Emerging from Drug-Hijacked Dopamine Spiraling Circuit	PLOS ONE			English	Article							BASAL GANGLIA; COGNITIVE CONTROL; DORSAL STRIATUM; COCAINE; REINFORCEMENT; BEHAVIOR; PARALLEL; HABITS; STIMULUS; LINKING	Despite explicitly wanting to quit, long-term addicts find themselves powerless to resist drugs, despite knowing that drug-taking may be a harmful course of action. Such inconsistency between the explicit knowledge of negative consequences and the compulsive behavioral patterns represents a cognitive/behavioral conflict that is a central characteristic of addiction. Neurobiologically, differential cue-induced activity in distinct striatal subregions, as well as the dopamine connectivity spiraling from ventral striatal regions to the dorsal regions, play critical roles in compulsive drug seeking. However, the functional mechanism that integrates these neuropharmacological observations with the above-mentioned cognitive/behavioral conflict is unknown. Here we provide a formal computational explanation for the drug-induced cognitive inconsistency that is apparent in the addicts' "self-described mistake". We show that addictive drugs gradually produce a motivational bias toward drug-seeking at low-level habitual decision processes, despite the low abstract cognitive valuation of this behavior. This pathology emerges within the hierarchical reinforcement learning framework when chronic exposure to the drug pharmacologically produces pathologicaly persistent phasic dopamine signals. Thereby the drug hijacks the dopaminergic spirals that cascade the reinforcement signals down the ventro-dorsal cortico-striatal hierarchy. Neurobiologically, our theory accounts for rapid development of drug cue-elicited dopamine efflux in the ventral striatum and a delayed response in the dorsal striatum. Our theory also shows how this response pattern depends critically on the dopamine spiraling circuitry. Behaviorally, our framework explains gradual insensitivity of drug-seeking to drug-associated punishments, the blocking phenomenon for drug outcomes, and the persistent preference for drugs over natural rewards by addicts. The model suggests testable predictions and beyond that, sets the stage for a view of addiction as a pathology of hierarchical decision-making processes. This view is complementary to the traditional interpretation of addiction as interaction between habitual and goal-directed decision systems.	[Keramati, Mehdi; Gutkin, Boris] Ecole Normale Super, Grp Neural Theory, INSERM U960, Dept Etud Cognit, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Keramati, M (corresponding author), Ecole Normale Super, Grp Neural Theory, INSERM U960, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France.	Mr.Mehdi.Keramati@gmail.com	Gutkin, Boris/ABC-5754-2020; Gutkin, Boris/A-7420-2014	Gutkin, Boris/0000-0001-6409-979X; 	Frontiers du Vivant; French MESR; CNRS; INSERM; ANR; ENP; NERF	Frontiers du Vivant; French MESR; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); ENP; NERF	This study was supported by fundings from Frontiers du Vivant, the French MESR, CNRS, INSERM, ANR, ENP and NERF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Badre D, 2009, NAT NEUROSCI, V12, P515, DOI 10.1038/nn.2277; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2009, PHARMACOPSYCHIATRY, V42, pS56, DOI 10.1055/s-0028-1124107; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dezfouli A, 2012, EUR J NEUROSCI, V35, P1036, DOI 10.1111/j.1460-9568.2012.08050.x; Dezfouli A, 2009, NEURAL COMPUT, V21, P2869, DOI 10.1162/neco.2009.10-08-882; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Frank MJ, 2009, J MOL CELL BIOL, V1, P15, DOI 10.1093/jmcb/mjp010; Goldstein Avram, 2001, ADDICTION BIOL DRUG; Goldstein RZ, 2010, J PSYCHOPHARMACOL, V24, P257, DOI 10.1177/0269881108096982; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haruno M, 2006, NEURAL NETWORKS, V19, P1242, DOI 10.1016/j.neunet.2006.06.007; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koob GF, 2005, NEUROBIOLOGY ADDICTI; LAMB RJ, 1991, J PHARMACOL EXP THER, V259, P1165; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Panlilio LV, 2007, PHARMACOL BIOCHEM BE, V86, P774, DOI 10.1016/j.pbb.2007.03.005; Piray P, 2010, NEURAL COMPUT, V22, P2334, DOI 10.1162/NECO_a_00009; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Stacy AW, 2010, ANNU REV CLIN PSYCHO, V6, P551, DOI 10.1146/annurev.clinpsy.121208.131444; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Takahashi Y, 2008, FRONT NEUROSCI-SWITZ, V2, P86, DOI 10.3389/neuro.01.014.2008; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Willuhn I, 2012, P NATL ACAD SCI USA, V109, P20703, DOI 10.1073/pnas.1213460109	41	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61489	10.1371/journal.pone.0061489	http://dx.doi.org/10.1371/journal.pone.0061489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637842	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000318340400024
J	Lehman, J; Stanley, KO				Lehman, Joel; Stanley, Kenneth O.			Evolvability Is Inevitable: Increasing Evolvability without the Pressure to Adapt	PLOS ONE			English	Article							EVOLUTION	Why evolvability appears to have increased over evolutionary time is an important unresolved biological question. Unlike most candidate explanations, this paper proposes that increasing evolvability can result without any pressure to adapt. The insight is that if evolvability is heritable, then an unbiased drifting process across genotypes can still create a distribution of phenotypes biased towards evolvability, because evolvable organisms diffuse more quickly through the space of possible phenotypes. Furthermore, because phenotypic divergence often correlates with founding niches, niche founders may on average be more evolvable, which through population growth provides a genotypic bias towards evolvability. Interestingly, the combination of these two mechanisms can lead to increasing evolvability without any pressure to out-compete other organisms, as demonstrated through experiments with a series of simulated models. Thus rather than from pressure to adapt, evolvability may inevitably result from any drift through genotypic space combined with evolution's passive tendency to accumulate niches.	[Lehman, Joel] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Stanley, Kenneth O.] Univ Cent Florida, Dept Elect Engn & Comp Sci, Orlando, FL 32816 USA	University of Texas System; University of Texas Austin; State University System of Florida; University of Central Florida	Lehman, J (corresponding author), Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA.	joel@cs.utexas.edu	Lehman, Joel/AAH-9977-2019	Lehman, Joel/0000-0002-9535-1123	Defense Advanced Research Projects Agency (DARPA); Army Research Office through DARPA [N11AP20003]; United States Army Research Office [W911NF-11-1-0489]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office through DARPA; United States Army Research Office	This research was supported by Defense Advanced Research Projects Agency (DARPA) and Army Research Office through DARPA grant N11AP20003 (Computer Science Study Group Phase 3), and United States Army Research Office grant Award No. W911NF-11-1-0489. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Brookfield JFY, 2001, CURR BIOL, V11, pR106, DOI 10.1016/S0960-9822(01)00041-0; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; Dawkins Richard, 2003, P239, DOI 10.1016/B978-012428765-5/50046-3; Dichtel-Danjoy ML, 2004, TRENDS GENET, V20, P268, DOI 10.1016/j.tig.2004.03.010; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lehman J, 2011, IEEE C EVOL COMPUTAT, P2693; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Lenski R, 2003, NATURE; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Risi S., 2010, ADAPTIVE BEHAV; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x	18	46	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62186	10.1371/journal.pone.0062186	http://dx.doi.org/10.1371/journal.pone.0062186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637999	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400084
J	Li, YJ; Fang, Y; Fu, YR; Huang, JG; Wu, CA; Zheng, CC				Li, Yan-Jie; Fang, Yi; Fu, Ya-Ru; Huang, Jin-Guang; Wu, Chang-Ai; Zheng, Cheng-Chao			NFYA1 Is Involved in Regulation of Postgermination Growth Arrest Under Salt Stress in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; TRANSCRIPTION FACTOR; NF-Y; LEAFY COTYLEDON1; LATE EMBRYOGENESIS; PROTEIN; GENE; ABI5; GERMINATION; EXPRESSION	The nuclear factor Y (NF-Y), which is a ubiquitous transcription factor found in eukaryotes, is composed of three distinct subunits, namely, NF-YA, NF-YB, and NF-YC. Here, we firstly characterized the detailed function of the Arabidopsis NFYA1 factor. It is found that the 35S::AtNFYA1-overexpressed lines were hypersensitive to salt stress and Abscisic acid (ABA) during the early-postgermination growth stages. The transgenic lines exhibited a severe postgermination growth arrest compared with the wild-type (WT) under salt stress and ABA treatment. Interestingly, sodium tungstate, which is an ABA synthesis inhibitor, restored the salt-sensitive phenotype of the 35S::AtNFYA1 lines. Results of the qRT-PCR analysis showed that the mRNA levels of ABI3 and ABI5, as well as their downstream genes AtEM1 and AtEM6, were more greatly upregulated under salt stress during seed germination in the transgenic lines compared with those in WT. On the other hand, the NFYA1-RNAi lines were found to be insensitive to salt stress and exhibited decreased levels of ABI3, ABI5, EM1, and EM6 transcripts. Our results provide clear evidence supporting a role of AtNFYA1 in regulating postgermination growth arrest under salt stress.	[Li, Yan-Jie; Fang, Yi; Fu, Ya-Ru; Huang, Jin-Guang; Wu, Chang-Ai; Zheng, Cheng-Chao] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wu, CA (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	cawu@sdau.edu.cn; cczheng@sdau.edu.cn	Wu, Changai/AFF-1493-2022	Wu, Changai/0000-0003-4053-8262	National Natural Science Foundation [31000121]; National Basic Research Program [2012CB114200]; Genetically modified organisms breeding major projects of China [2011ZX08009-003-002]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Genetically modified organisms breeding major projects of China	Funding was provided by National Natural Science Foundation (Grant No. 31000121), http://www.nsfc.gov.cn/Portal0/default166.htm; National Basic Research Program (Grant No. 2012CB114200), http://www.973.gov.cn/English/Index.aspx; and Genetically modified organisms breeding major projects of China (Grant No. 2011ZX08009-003-002), http://www.nmp.gov.cn/zxjs/zjy/201012/t20101208_2129.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensmihen S, 2002, PLANT CELL, V14, P1391, DOI 10.1105/tpc.000869; Bies-Etheve N, 1999, PLANT MOL BIOL, V40, P1045, DOI 10.1023/A:1006252512202; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Frontini M, 2004, CELL CYCLE, V3, P217; Gao GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019406; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Hansen H, 2000, PLANT PHYSIOL, V124, P1437, DOI 10.1104/pp.124.3.1437; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Hu XL, 2006, PLANT CELL PHYSIOL, V47, P1484, DOI 10.1093/pcp/pcl014; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kinoshita N, 2010, PLANT CELL PHYSIOL, V51, P239, DOI 10.1093/pcp/pcp183; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Lopez-Molina L, 2000, PLANT CELL PHYSIOL, V41, P541, DOI 10.1093/pcp/41.5.541; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Lu C, 2002, P NATL ACAD SCI USA, V99, P15812, DOI 10.1073/pnas.242607499; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Manfre AJ, 2006, PLANT PHYSIOL, V140, P140, DOI 10.1104/pp.105.072967; Mu JY, 2013, MOL PLANT, V6, P188, DOI 10.1093/mp/sss061; Nambara E, 2003, TRENDS PLANT SCI, V8, P213, DOI 10.1016/S1360-1385(03)00060-8; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Toh S, 2008, PLANT PHYSIOL, V146, P1368, DOI 10.1104/pp.107.113738; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Ye NH, 2011, PLANT CELL PHYSIOL, V52, P689, DOI 10.1093/pcp/pcr028	38	25	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61289	10.1371/journal.pone.0061289	http://dx.doi.org/10.1371/journal.pone.0061289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637805	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400014
J	Osada, K; Kurihara, K; Izumi, H; Kashiwayanagi, M				Osada, Kazumi; Kurihara, Kenzo; Izumi, Hiroshi; Kashiwayanagi, Makoto			Pyrazine Analogues Are Active Components of Wolf Urine That Induce Avoidance and Freezing Behaviours in Mice	PLOS ONE			English	Article							REDUCE FEEDING DAMAGE; HOUSE MOUSE MUS; PREDATOR ODOR; FOX ODOR; VOLATILE CONSTITUENTS; CROSS-LINKING; FEAR; SCENT; IDENTIFICATION; HERBIVORES	Background: The common grey wolf (Canis lupus) is found throughout the entire Northern hemisphere and preys on many kinds of mammals. The urine of the wolf contains a number of volatile constituents that can potentially be used for predator-prey chemosignalling. Although wolf urine is put to practical use to keep rabbits, rodents, deer and so on at bay, we are unaware of any prior behavioural studies or chemical analyses regarding the fear-inducing impact of wolf urine on laboratory mice. Methodology/Principal Findings: Three wolf urine samples harvested at different times were used in this study. All of them induced stereotypical fear-associated behaviors (i.e., avoidance and freezing) in female mice. The levels of certain urinary volatiles varied widely among the samples. To identify the volatiles that provoked avoidance and freezing, behavioural, chemical, and immunohistochemical analyses were performed. One of the urine samples (sample C) had higher levels of 2,6-dimethylpyrazine (DMP), trimethylpyrazine (TMP), and 3-ethyl-2,5-dimethyl pyrazine (EDMP) compared with the other two urine samples (samples A and B). In addition, sample C induced avoidance and freezing behaviours more effectively than samples A and B. Moreover, only sample C led to pronounced expression of Fos-immunoreactive cells in the accessory olfactory bulb (AOB) of female mice. Freezing behaviour and Fos immunoreactivity were markedly enhanced when the mice were confronted with a mixture of purified DMP, TMP, and EDMP vs. any one pyrazine alone. Conclusions/Significance: The current results suggest that wolf urinary volatiles can engender aversive and fear-related responses in mice. Pyrazine analogues were identified as the predominant active components among these volatiles to induce avoidance and freezing behaviours via stimulation of the murine AOB.	[Osada, Kazumi; Izumi, Hiroshi] Hlth Sci Univ Hokkaido, Div Physiol, Dept Oral Biol, Sch Dent, Ishikari, Hokkaido 06102, Japan; [Kurihara, Kenzo] Aomori Univ, Kobata, Aomori, Japan; [Kashiwayanagi, Makoto] Asahikawa Med Coll, Dept Sensory Physiol, Asahikawa, Hokkaido 078, Japan	Health Sciences University of Hokkaido; Asahikawa Medical College	Osada, K (corresponding author), Hlth Sci Univ Hokkaido, Div Physiol, Dept Oral Biol, Sch Dent, Ishikari, Hokkaido 06102, Japan.	osadak@hoku-iryo-u.ac.jp			Health Sciences University of Hokkaido	Health Sciences University of Hokkaido	This study was supported by the Health Sciences University of Hokkaido. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 2008, J AGR FOOD CHEM, V56, P2147, DOI 10.1021/jf0726785; ANDREOLINI F, 1987, EXPERIENTIA, V43, P998, DOI 10.1007/BF01952217; ASA CS, 1990, HORM BEHAV, V24, P497, DOI 10.1016/0018-506X(90)90038-Y; Bauchart C, 2007, J NUTR, V137, P589, DOI 10.1093/jn/137.3.589; BEAUCHAMP GK, 1976, NATURE, V263, P587, DOI 10.1038/263587a0; Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Buron G, 2007, BEHAV NEUROSCI, V121, P1063, DOI 10.1037/0735-7044.121.5.1063; Endres T, 2009, J EXP BIOL, V212, P2324, DOI 10.1242/jeb.028498; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Fendt M, 2008, NEUROSCI BIOBEHAV R, V32, P1259, DOI 10.1016/j.neubiorev.2008.05.010; Fendt M, 2006, J CHEM ECOL, V32, P2617, DOI 10.1007/s10886-006-9186-9; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Fox M, 1977, ANIMALS COMMUNICATE; FU MX, 1992, DIABETES, V41, P42, DOI 10.2337/diab.41.2.S42; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Hebb ALO, 2002, NEUROPSYCHOPHARMACOL, V27, P744, DOI 10.1016/S0893-133X(02)00354-8; HOLLAND M, 1983, LIFE SCI, V32, P787, DOI 10.1016/0024-3205(83)90314-4; Iwai K, 2005, J AGR FOOD CHEM, V53, P6531, DOI 10.1021/jf050206p; Janitzky K, 2009, BEHAV BRAIN RES, V202, P218, DOI 10.1016/j.bbr.2009.03.038; JORGENSON JW, 1978, SCIENCE, V199, P796, DOI 10.1126/science.199.4330.796; Kluever BM, 2009, BEHAV PROCESS, V81, P85, DOI 10.1016/j.beproc.2009.02.004; Kwak J, 2011, CHEM SENSES, V36, P443, DOI 10.1093/chemse/bjr015; Kwak J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003591; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Lindgren PMF., 1995, 24 U NEBR NAT WILDL, P217; Lu CY, 2005, J AGR FOOD CHEM, V53, P6443, DOI 10.1021/jf050534p; Matsumura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008819; MCPHERSON JD, 1988, BIOCHEMISTRY-US, V27, P1901, DOI 10.1021/bi00406a016; Nolte Dale L., 2001, Western Journal of Applied Forestry, V16, P182; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; NOVOTNY M, 1986, SCIENCE, V231, P722, DOI 10.1126/science.3945805; Novotny MV, 2007, J CHEM ECOL, V33, P417, DOI 10.1007/s10886-006-9230-9; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Osada K, 2008, CHEM SENSES, V33, P815, DOI 10.1093/chemse/bjn045; Osada K, 2011, CHEM SENSES, V36, P137, DOI 10.1093/chemse/bjq104; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Parsons MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010403; PETERS RP, 1975, AM SCI, V63, P628; RAYMER J, 1984, EXPERIENTIA, V40, P707, DOI 10.1007/BF01949734; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Severud William J., 2011, Human-Wildlife Interactions, V5, P296; Singer AG, 1997, P NATL ACAD SCI USA, V94, P2210, DOI 10.1073/pnas.94.6.2210; Staples LG, 2008, NEUROSCIENCE, V151, P937, DOI 10.1016/j.neuroscience.2007.11.039; SULLIVAN TP, 1985, J CHEM ECOL, V11, P903, DOI 10.1007/BF01012077; SULLIVAN TP, 1985, J CHEM ECOL, V11, P921, DOI 10.1007/BF01012078; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Takahashi LK, 2008, NEUROSCI BIOBEHAV R, V32, P1218, DOI 10.1016/j.neubiorev.2008.06.001; Takahashi LK, 2007, BEHAV NEUROSCI, V121, P100, DOI 10.1037/0735-7044.121.1.100; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; Wallace KJ, 2000, BEHAV NEUROSCI, V114, P912, DOI 10.1037//0735-7044.114.5.912; WILSON SR, 1978, J ORG CHEM, V43, P4675, DOI 10.1021/jo00418a038; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; Zhang JX, 2007, CHEM SENSES, V32, P293, DOI 10.1093/chemse/bjl058	54	32	34	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61753	10.1371/journal.pone.0061753	http://dx.doi.org/10.1371/journal.pone.0061753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637901	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400047
J	Wang, SQ; Li, XJ; Zhou, SB; Sun, DX; Wang, H; Cheng, PF; Ma, XR; Liu, L; Liu, JX; Wang, FF; Liang, YF; Wu, JM				Wang, Shu-Qiu; Li, Xiao-Jie; Zhou, Shaobo; Sun, Di-Xiang; Wang, Hui; Cheng, Peng-Fei; Ma, Xiao-Ru; Liu, Lei; Liu, Jun-Xing; Wang, Fang-Fang; Liang, Yan-Feng; Wu, Jia-Mei			Intervention Effects of Ganoderma Lucidum Spores on Epileptiform Discharge Hippocampal Neurons and Expression of Neurotrophin-4 and N-Cadherin	PLOS ONE			English	Article							IN-VIVO; BDNF; NT-4; RECEPTORS; NGF; REORGANIZATION; EPILEPSY; CORTEX; DEATH	Epilepsy can cause cerebral transient dysfunctions. Ganoderma lucidum spores (GLS), a traditional Chinese medicinal herb, has shown some antiepileptic effects in our previous studies. This was the first study of the effects of GLS on cultured primary hippocampal neurons, treated with Mg2+ free medium. This in vitro model of epileptiform discharge hippocampal neurons allowed us to investigate the anti-epileptic effects and mechanism of GLS activity. Primary hippocampal neurons from <1 day old rats were cultured and their morphologies observed under fluorescence microscope. Neurons were confirmed by immunofluorescent staining of neuron specific enolase (NSE). Sterile method for GLS generation was investigated and serial dilutions of GLS were used to test the maximum non-toxic concentration of GLS on hippocampal neurons. The optimized concentration of GLS of 0.122 mg/ml was identified and used for subsequent analysis. Using the in vitro model, hippocampal neurons were divided into 4 groups for subsequent treatment i) control, ii) model (incubated with Mg2+ free medium for 3 hours), iii) GLS group I (incubated with Mg2+ free medium containing GLS for 3 hours and replaced with normal medium and incubated for 6 hours) and iv) GLS group II (neurons incubated with Mg2+ free medium for 3 hours then replaced with a normal medium containing GLS for 6 hours). Neurotrophin-4 and N-Cadherin protein expression were detected using Western blot. The results showed that the number of normal hippocampal neurons increased and the morphologies of hippocampal neurons were well preserved after GLS treatment. Furthermore, the expression of neurotrophin-4 was significantly increased while the expression of N-Cadherin was decreased in the GLS treated group compared with the model group. This data indicates that GLS may protect hippocampal neurons by promoting neurotrophin-4 expression and inhibiting N-Cadherin expression.	[Wang, Shu-Qiu; Zhou, Shaobo; Sun, Di-Xiang; Wang, Hui; Cheng, Peng-Fei; Ma, Xiao-Ru; Liu, Lei; Liu, Jun-Xing; Wang, Fang-Fang; Liang, Yan-Feng; Wu, Jia-Mei] Jiamusi Univ, Sch Basic Med Sci, Dept Pathophysiol, Jiamusi, Heilongjiang Pr, Peoples R China; [Li, Xiao-Jie] Jiamusi Univ, Sch Rehabil Med Sci, Jiamusi, Heilongjiang Pr, Peoples R China; [Wang, Shu-Qiu; Li, Xiao-Jie] Jiamusi Univ, Children Neural Rehabil Lab, Jiamusi, Heilongjiang Pr, Peoples R China; [Zhou, Shaobo] Univ Bedfordshire, Inst Biomed & Environm Sci & Technol, Dept Life Sci, Luton, Beds, England	Jiamusi University; Jiamusi University; Jiamusi University; University of Bedfordshire	Wang, SQ (corresponding author), Jiamusi Univ, Sch Basic Med Sci, Dept Pathophysiol, Jiamusi, Heilongjiang Pr, Peoples R China.		Zhou, Shaobo/I-1536-2019	Zhou, Shaobo/0000-0001-5214-2973	National Natural Science Foundation, Beijing, P.R. China [81241112]; Innovation Scientific Research Foundation for Postgraduates in Heilongjiang Province [YJSC2011-375HLJ]	National Natural Science Foundation, Beijing, P.R. China(National Natural Science Foundation of China (NSFC)); Innovation Scientific Research Foundation for Postgraduates in Heilongjiang Province	This work was supported by the National Natural Science Foundation, Beijing, P.R. China(No. 81241112) and Innovation Scientific Research Foundation for Postgraduates in Heilongjiang Province (No. YJSC2011-375HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANCET, V380, P1121, DOI 10.1016/S0140-6736(12)61646-8; ARDELT AA, 1994, BRAIN RES, V647, P340, DOI 10.1016/0006-8993(94)91333-1; BANDOPADHYAY R, 1991, NEUROPEPTIDES, V18, P159, DOI 10.1016/0143-4179(91)90108-U; Buckmaster PS, 1999, J NEUROPHYSIOL, V81, P712, DOI 10.1152/jn.1999.81.2.712; Cavazos JE, 2004, NEUROSCIENCE, V126, P677, DOI 10.1016/j.neuroscience.2004.04.014; Chen MW, 2006, FOREIGN MED SCI, V33, P401; Chen YH, 2000, J KUNMING MED COLL, V21, P8; CHENG B, 1994, BRAIN RES, V650, P331, DOI 10.1016/0006-8993(94)91801-5; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; Engelhardt M, 2007, EUR J NEUROSCI, V25, P529, DOI 10.1111/j.1460-9568.2006.05301.x; Fujita M, 2001, NEUROSCI LETT, V297, P13, DOI 10.1016/S0304-3940(00)01635-9; GOBBI G, 1992, LANCET, V340, P439; HYMAN C, 1994, J NEUROSCI, V14, P335; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Leite JP, 2005, EPILEPSIA, V46, P134, DOI 10.1111/j.1528-1167.2005.01021.x; [李晶 LI Jing], 2009, [中国病理生理杂志, Chinese Journal of Pathophysiology], V25, P386; Lin Zhi-bin, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P541; Liu J, 2007, FOOD CHEM, V100, P1691, DOI 10.1016/j.foodchem.2006.01.003; Liu Y, 2009, BRAIN RES, V1278, P27, DOI 10.1016/j.brainres.2009.04.043; Lobner D, 2002, BRAIN RES, V954, P42, DOI 10.1016/S0006-8993(02)03337-1; Mikati MA, 2003, EPILEPSIA, V44, P282, DOI 10.1046/j.1528-1157.2003.22502.x; O'Mahony R, 2005, J MICROBIOL METH, V61, P105, DOI 10.1016/j.mimet.2004.11.020; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sakuma K, 2001, BRAIN RES, V907, P1, DOI 10.1016/S0006-8993(01)02288-0; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Sliva D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047873; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706, DOI 10.1152/jn.1995.73.4.1706; Somjen GG, 2000, BRAIN RES, V885, P102, DOI 10.1016/S0006-8993(00)02948-6; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Treubert-Zimmermann U, 2002, J NEUROSCI, V22, P7617; VONBARTHELD CS, 1995, J NEUROSCI, V15, P2225, DOI 10.1523/JNEUROSCI.15-03-02225.1995; Wang H, 2005, CHIN J CLIN REHABIT, V9, P71; Wang Q, 2003, MED ENG PHYS, V25, P887, DOI 10.1016/S1350-4533(03)00114-0; Wang WQ, 2005, HEILONGJIANG MED PHA, P48; Wasterlain CG, 2002, PROG BRAIN RES, V135, P335; Yun TK, 1999, ANN NY ACAD SCI, V889, P157, DOI 10.1111/j.1749-6632.1999.tb08734.x; Zhang HT, 2007, J HISTOCHEM CYTOCHEM, V55, P1, DOI 10.1369/jhc.6A6952.2006; [赵爽 ZHAO Shuang], 2007, [中国病理生理杂志, Chinese Journal of Pathophysiology], V23, P1153	39	14	18	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61687	10.1371/journal.pone.0061687	http://dx.doi.org/10.1371/journal.pone.0061687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637882	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400039
J	Yue, XJ; Xu, LB; Zhu, MS; Zhang, R; Liu, C				Yue, Xiu-jing; Xu, Lei-bo; Zhu, Man-sheng; Zhang, Rui; Liu, Chao			Over-Expression of Nerve Growth Factor-beta in Human Cholangiocarcinoma QBC939 Cells Promote Tumor Progression	PLOS ONE			English	Article							LYMPHANGIOGENESIS; ANGIOGENESIS	Aims: It has been shown that nerve growth factor-beta (NGF-beta) promoted the initiation and progression of many tumors, and we have previously demonstrated that the expression of NGF-beta was associated with tumor stage, nerve infiltration and lymph node metastasis in human hilar cholangiocarcinoma. However, whether NGF-beta promotes tumor progression in human cholangiocarcinoma requires further investigation. Therefore, we aimed to determine the effects of NGF-beta on the progression of human cholangiocarcinoma. Methods: Human cholangiocarcinoma QBC939 stable cell lines with over-expressed or silenced NGF-beta genes were generated with pEGFP-N1-NGF-beta and pGPU6/GFP/Neo-NGF-beta-shRNA recombinant plasmids. Cell proliferation assay, colony formation assay, cell cycle analysis, apoptosis assay and tumorigenicity assay were performed to evaluate the role of NGF-beta in the progression of human cholangiocarcinoma. In addition, human lymphatic endothelial cells were co-cultured with QBC939 culture supernatants, and the cell proliferation and migration abilities of the lymphatic endothelial cells were evaluated. Results: Forced expression of NGF-beta in QBC939 cell lines promoted proliferation, colony formation and tumorigenicity in these cells and inhibited the apoptosis. However, down-regulation of NGF-beta inhibited proliferation, colony formation and tumorigenicity, and increased the apoptotic rate of QBC939 cells. In addition, the NGF-beta gain-of-function induced a high expression of vascular endothelial growth factor C and enhanced the proliferation and migration of lymphatic endothelial cells, while NGF-beta loss-of-function showed opposite effects. Conclusions: We concluded that NGF-beta promoted tumor progression in human cholangiocarcinoma QBC939 cells. Our results provided a new concept to understand the role of NGF-beta in cholangiocarcinoma progression, and might provide important information for the development of new targeted therapies in human cholangiocarcinoma.	[Yue, Xiu-jing; Xu, Lei-bo; Zhu, Man-sheng; Zhang, Rui; Liu, Chao] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepato Pancreato Biliary Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Liu, C (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepato Pancreato Biliary Surg, Guangzhou 510275, Guangdong, Peoples R China.	mdliuchao@hotmail.com			Special Research Foundation of the National Nature Science Foundation of China [81172068]	Special Research Foundation of the National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The Special Research Foundation of the National Nature Science Foundation of China (81172068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Aishima S, 2008, MODERN PATHOL, V21, P256, DOI 10.1038/modpathol.3800985; Blechacz BRA, 2008, CLIN LIVER DIS, V12, P131, DOI 10.1016/j.cld.2007.11.003; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Choi SB, 2009, ANN SURG ONCOL, V16, P3048, DOI 10.1245/s10434-009-0631-1; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Gigliozzi A, 2004, GASTROENTEROLOGY, V127, P1198, DOI 10.1053/j.gastro.2004.06.023; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Kitagawa Y, 2001, ANN SURG, V233, P385, DOI 10.1097/00000658-200103000-00013; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Murakami Y, 2007, WORLD J SURG, V31, P337, DOI 10.1007/s00268-006-0224-0; Park BK, 2006, AM J CLIN ONCOL-CANC, V29, P138, DOI 10.1097/01.coc.0000204402.29830.08; Patel T, 2011, NAT REV GASTRO HEPAT, V8, P189, DOI 10.1038/nrgastro.2011.20; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Sigala S, 2008, MOL CELL ENDOCRINOL, V284, P11, DOI 10.1016/j.mce.2007.12.015; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; Xu LB, 2010, WORLD J SURG, V34, P1039, DOI 10.1007/s00268-010-0417-4; Ye Y, 2011, MOL CANCER THER, V10, P1667, DOI 10.1158/1535-7163.MCT-11-0123	22	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62024	10.1371/journal.pone.0062024	http://dx.doi.org/10.1371/journal.pone.0062024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637956	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400071
J	Dadzie, I; Xu, SG; Ni, B; Zhang, XL; Zhang, HF; Sheng, XM; Xu, HX; Huang, XX				Dadzie, Isaac; Xu, Shungao; Ni, Bin; Zhang, Xiaolei; Zhang, Haifang; Sheng, Xiumei; Xu, Huaxi; Huang, Xinxiang			Identification and Characterization of a Cis-Encoded Antisense RNA Associated with the Replication Process of Salmonella enterica Serovar Typhi	PLOS ONE			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; REGULATORY SYSTEMS; INITIATOR DNAA; EXPRESSION; TRANSCRIPTION; MECHANISMS; ACTIVATOR; BINDING; STRESS	Antisense RNAs that originate from the complementary strand of protein coding genes are involved in the regulation of gene expression in all domains of life. In bacteria, some of these antisense RNAs are transcriptional noise whiles others play a vital role to adapt the cell to changing environmental conditions. By deep sequencing analysis of transcriptome of Salmonella enterica serovar Typhi, a partial RNA sequence encoded in-cis to the dnaA gene was revealed. Northern blot and RACE analysis confirmed the transcription of this antisense RNA which was expressed mostly in the stationary phase of the bacterial growth and also under iron limitation and osmotic stress. Pulse expression analysis showed that overexpression of the antisense RNA resulted in a significant increase in the mRNA levels of dnaA, which will ultimately enhance their translation. Our findings have revealed that antisense RNA of dnaA is indeed transcribed not merely as a by-product of the cell's transcription machinery but plays a vital role as far as stability of dnaA mRNA is concerned.	[Dadzie, Isaac; Xu, Shungao; Ni, Bin; Zhang, Xiaolei; Zhang, Haifang; Sheng, Xiumei; Xu, Huaxi; Huang, Xinxiang] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Biochem & Mol Biol, Zhenjiang, Jiangsu, Peoples R China; [Dadzie, Isaac] Univ Cape Coast, Dept Lab Technol, Cape Coast, Ghana	Jiangsu University; University of Cape Coast	Huang, XX (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Dept Biochem & Mol Biol, Zhenjiang, Jiangsu, Peoples R China.	huxinx@ujs.edu.cn	Dadzie, Isaac/AAA-6026-2019	Dadzie, Isaac/0000-0002-2146-6796	National Special Scientific Program of China [2008ZX10004-009]; National Natural Science Foundation of China [30870095]	National Special Scientific Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Special Scientific Program of China (2008ZX10004-009) and National Natural Science Foundation of China (30870095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiso T, 2011, GENES CELLS, V16, P670, DOI 10.1111/j.1365-2443.2011.01516.x; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Breier AM, 2009, J BACTERIOL, V191, P486, DOI 10.1128/JB.01294-08; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Chinni SV, 2010, NUCLEIC ACIDS RES, V38, P5893, DOI 10.1093/nar/gkq281; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Du H, 2011, CURR MICROBIOL, V62, P1483, DOI 10.1007/s00284-011-9890-8; Frohlich KS, 2012, NUCLEIC ACIDS RES, V40, P3623, DOI 10.1093/nar/gkr1156; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Huang XX, 2004, FEMS MICROBIOL LETT, V234, P239, DOI 10.1016/j.femsle.2004.03.030; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Messer W, 2001, BIOCHIMIE, V83, P5, DOI 10.1016/S0300-9084(00)01216-5; Messer W, 2003, MOL MICROBIOL, V24, P1; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Mutalik VK, 2009, J BACTERIOL, V191, P7279, DOI 10.1128/JB.01047-09; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Raghavan R, 2012, MBIO, V3, DOI 10.1128/mBio.00156-12; Regnier P, 2000, BIOESSAYS, V22, P235; SCHAPER S, 1995, J BIOL CHEM, V270, P17622, DOI 10.1074/jbc.270.29.17622; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Viegas SC, 2007, NUCLEIC ACIDS RES, V35, P7651, DOI 10.1093/nar/gkm916; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	38	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61308	10.1371/journal.pone.0061308	http://dx.doi.org/10.1371/journal.pone.0061308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637809	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400034
J	Blaber, EA; Dvorochkin, N; Lee, C; Alwood, JS; Yousuf, R; Pianetta, P; Globus, RK; Burns, BP; Almeida, EAC				Blaber, Elizabeth A.; Dvorochkin, Natalya; Lee, Chialing; Alwood, Joshua S.; Yousuf, Rukhsana; Pianetta, Piero; Globus, Ruth K.; Burns, Brendan P.; Almeida, Eduardo A. C.			Microgravity Induces Pelvic Bone Loss through Osteoclastic Activity, Osteocytic Osteolysis, and Osteoblastic Cell Cycle Inhibition by CDKN1a/p21	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES MMPS; SKELETAL-MUSCLE; GENE-EXPRESSION; TRABECULAR BONE; SPACE-FLIGHT; SIMULATED MICROGRAVITY; GROWING RATS; BED-REST; TGF-BETA; IN-VITRO	Bone is a dynamically remodeled tissue that requires gravity-mediated mechanical stimulation for maintenance of mineral content and structure. Homeostasis in bone occurs through a balance in the activities and signaling of osteoclasts, osteoblasts, and osteocytes, as well as proliferation and differentiation of their stem cell progenitors. Microgravity and unloading are known to cause osteoclast-mediated bone resorption; however, we hypothesize that osteocytic osteolysis, and cell cycle arrest during osteogenesis may also contribute to bone loss in space. To test this possibility, we exposed 16-week-old female C57BL/6J mice (n = 8) to microgravity for 15-days on the STS-131 space shuttle mission. Analysis of the pelvis by mu CT shows decreases in bone volume fraction (BV/TV) of 6.29%, and bone thickness of 11.91%. TRAP-positive osteoclast-covered trabecular bone surfaces also increased in microgravity by 170% (p = 0.004), indicating osteoclastic bone degeneration. High-resolution X-ray nanoCT studies revealed signs of lacunar osteolysis, including increases in cross-sectional area (+17%, p = 0.022), perimeter (+14%, p = 0.008), and canalicular diameter (+6%, p = 0.037). Expression of matrix metalloproteinases (MMP) 1, 3, and 10 in bone, as measured by RT-qPCR, was also up-regulated in microgravity (+12.94, +2.98 and +16.85 fold respectively, p<0.01), with MMP10 localized to osteocytes, and consistent with induction of osteocytic osteolysis. Furthermore, expression of CDKN1a/p21 in bone increased 3.31 fold (p<0.01), and was localized to osteoblasts, possibly inhibiting the cell cycle during tissue regeneration as well as conferring apoptosis resistance to these cells. Finally the apoptosis inducer Trp53 was down-regulated by -1.54 fold (p<0.01), possibly associated with the quiescent survival-promoting function of CDKN1a/p21. In conclusion, our findings identify the pelvic and femoral region of the mouse skeleton as an active site of rapid bone loss in microgravity, and indicate that this loss is not limited to osteoclastic degradation. Therefore, this study offers new evidence for microgravity-induced osteocytic osteolysis, and CDKN1a/p21-mediated osteogenic cell cycle arrest.	[Blaber, Elizabeth A.; Dvorochkin, Natalya; Lee, Chialing; Alwood, Joshua S.; Yousuf, Rukhsana; Globus, Ruth K.; Almeida, Eduardo A. C.] NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA; [Blaber, Elizabeth A.; Burns, Brendan P.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Pianetta, Piero] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of New South Wales Sydney; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Almeida, EAC (corresponding author), NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA.	e.almeida@nasa.gov	Pianetta, Piero/GLS-9094-2022	Pianetta, Piero/0000-0002-4834-6014; BURNS, BRENDAN/0000-0002-2962-2597	 [NASA-NNH08ZTT003]		This work was supported by NASA-NNH08ZTT003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Aubert AE, 2005, ACTA CARDIOL, V60, P129, DOI 10.2143/AC.60.2.2005024; Baecker N, 2003, J APPL PHYSIOL, V95, P977, DOI 10.1152/japplphysiol.00264.2003; Bajotto G, 2006, J NUTR SCI VITAMINOL, V52, P233, DOI 10.3177/jnsv.52.233; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; BONEWALD LF, 1990, CLIN ORTHOP RELAT R, P261; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Bucaro MA, 2007, J CELL BIOCHEM, V102, P483, DOI 10.1002/jcb.21310; CAIOZZO VJ, 1994, J APPL PHYSIOL, V76, P1764, DOI 10.1152/jappl.1994.76.4.1764; Carmeliet G, 1999, FASEB J, V13, pS129, DOI 10.1096/fasebj.13.9001.s129; Cavolina JM, 1997, ENDOCRINOLOGY, V138, P1567, DOI 10.1210/en.138.4.1567; Chang SF, 2009, MOL ENDOCRINOL, V23, P1827, DOI 10.1210/me.2009-0143; Convertino Victor A, 2005, Gravit Space Biol Bull, V18, P59; Cooke WH, 2005, CURR PHARM BIOTECHNO, V6, P285, DOI 10.2174/1389201054553671; Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; Ferrando AA, 2002, NUTRITION, V18, P837, DOI 10.1016/S0899-9007(02)00930-9; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Fitts RH, 2001, J EXP BIOL, V204, P3201; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; GIUS D, 1990, MOL CELL BIOL, V10, P4243, DOI 10.1128/MCB.10.8.4243; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Heber-Katz E, 2004, PHILOS T ROY SOC B, V359, P785, DOI 10.1098/rstb.2004.1468; Hill P A, 1998, Br J Orthod, V25, P101; HILL PA, 1994, J CELL SCI, V107, P3055; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; HughesFulford M, 1996, EXP CELL RES, V224, P103, DOI 10.1006/excr.1996.0116; Iagodovskii V S, 1977, Kosm Biol Aviakosm Med, V11, P14; JEE WSS, 1983, AM J PHYSIOL, V244, pR310, DOI 10.1152/ajpregu.1983.244.3.R310; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Liu HJ, 2010, J CELL BIOCHEM, V111, P529, DOI 10.1002/jcb.22749; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; MUNDY GR, 1991, CIBA F SYMP, V157, P137; Mundy GR, 1991, CIBA F SYMP, V157, P137; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036; Nakano Y, 2004, J HISTOCHEM CYTOCHEM, V52, P1475, DOI 10.1369/jhc.4A6378.2004; Norsk P, 2005, CURR PHARM BIOTECHNO, V6, P325, DOI 10.2174/1389201054553734; Ohshima Hiroshi, 2006, Clin Calcium, V16, P81; Okada S, 2002, MICROSC MICROANAL, V8, P104, DOI 10.1017/S1431927601020037; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Qing H, 2009, INT J ORAL SCI, V1, P59, DOI 10.4248/ijos.09019; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rizzo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032361; Sakai A, 2002, J BONE MINER RES, V17, P119, DOI 10.1359/jbmr.2002.17.1.119; Schoenfeld MP, 2011, MED HYPOTHESES, V76, P117, DOI 10.1016/j.mehy.2010.08.046; Schutz H, 2009, J MORPHOL, V270, P834, DOI 10.1002/jmor.10723; Shiloh Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.296pe73; Siu PM, 2006, J APPL PHYSIOL, V100, P907, DOI 10.1152/japplphysiol.01012.2005; Smith SM, 2002, NUTRITION, V18, P849, DOI 10.1016/S0899-9007(02)00895-X; Srivastava S, 1998, J CLIN INVEST, V102, P1850, DOI 10.1172/JCI4561; Stein TP, 2002, NUTRITION, V18, P867, DOI 10.1016/S0899-9007(02)00938-3; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179; Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; VICO L, 1987, BONE MINER, V2, P383; Vico L, 2001, CALCIFIED TISSUE INT, V68, P1, DOI 10.1007/BF02684996; VICO L, 1991, AVIAT SPACE ENVIR MD, V62, P26; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; WESTERLIND KC, 1995, J BONE MINER RES, V10, P843; WRONSKI TJ, 1983, AM J PHYSIOL, V244, pR305, DOI 10.1152/ajpregu.1983.244.3.R305; Yoshihara Y, 2000, ANN RHEUM DIS, V59, P455, DOI 10.1136/ard.59.6.455; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6; Zerath E, 1998, ADV SPACE RES, V21, P1049, DOI 10.1016/S0273-1177(98)00026-X; Zhang R, 2012, J PHYSIOL BIOCHEM, V68, P99, DOI 10.1007/s13105-011-0123-1	75	122	135	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61372	10.1371/journal.pone.0061372	http://dx.doi.org/10.1371/journal.pone.0061372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637819	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700027
J	Carvalho, M; Bockmann, FA; de Carvalho, MR				Carvalho, Murilo; Bockmann, Flavio Alicino; de Carvalho, Marcelo Rodrigues			Homology of the Fifth Epibranchial and Accessory Elements of the Ceratobranchials among Gnathostomes: Insights from the Development of Ostariophysans	PLOS ONE			English	Article							GILL-ARCHES; TELEOSTEAN FISHES; SKELETAL ANATOMY; HEAD SKELETON; SHEDS LIGHT; PAIRED FINS; OSTEOLOGY; MORPHOLOGY; INTERRELATIONSHIPS; CHONDROCRANIUM	Epibranchials are among the main dorsal elements of the gill basket in jawed vertebrates (Gnathostomata). Among extant fishes, chondrichthyans most resemble the putative ancestral condition as all branchial arches possess every serially homologous piece. In osteichthyans, a primitive rod-like epibranchial 5, articulated to ceratobranchial 5, is absent. Instead, epibranchial 5 of many actinopterygians is here identified as an accessory element attached to ceratobranchial 4. Differences in shape and attachment of epibranchial 5 in chondrichthyans and actinopterygians raised suspicions about their homology, prompting us to conduct a detailed study of the morphology and development of the branchial basket of three ostariophysans (Prochilodus argenteus, Characiformes; Lophiosilurus alexandri and Pseudoplatystoma corruscans, Siluriformes). Results were interpreted within a phylogenetic context of major gnathostome lineages. Developmental series strongly suggest that the so-called epibranchial 5 of actinopterygians does not belong to the epal series because it shares the same chondroblastic layer with ceratobranchial 4 and its ontogenetic emergence is considerably late. This neomorphic structure is called accessory element of ceratobranchial 4. Its distribution among gnathostomes indicates it is a teleost synapomorphy, occurring homoplastically in Polypteriformes, whereas the loss of the true epibranchial 5 is an osteichthyan synapomorphy. The origin of the accessory element of ceratobranchial 4 appears to have occurred twice in osteichthyans, but it may have a single origin; in this case, the accessory element of ceratobranchial 4 would represent a remnant of a series of elements distally attached to ceratobranchials 1-4, a condition totally or partially retained in basal actinopterygians. Situations wherein a structure is lost while a similar neomorphic element is present may lead to erroneous homology assessments; these can be avoided by detailed morphological and ontogenetic investigations interpreted in the light of well-supported phylogenetic hypotheses.	[Carvalho, Murilo; Bockmann, Flavio Alicino] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, PPG Biol Comparada,LIRP, Ribeirao Preto, SP, Brazil; [Carvalho, Murilo; de Carvalho, Marcelo Rodrigues] Univ Sao Paulo, Inst Biociencias, Dept Zool, Lab Ictiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Carvalho, M (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, PPG Biol Comparada,LIRP, Ribeirao Preto, SP, Brazil.	mcarvalho79@gmail.com	Carvalho, Murilo/B-7950-2012; Bockmann, Flavio A./L-4998-2017	Carvalho, Murilo/0000-0001-6881-5271; 	Conselho Nacional de Desenvolvimento iientifico e Tecnologico (CNPq) [140415/2006-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/05152-0]; CNPq [309752/2010-8, 303061/2008-1, 304615/2011-0]; FAPESP [2004/09219-6, 2009/54931-0, 2012/21159-5, 2010/51193-5, 2012/02349-8, 2012/09877-0, 2012/05391-5]	Conselho Nacional de Desenvolvimento iientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	MC is supported by the Conselho Nacional de Desenvolvimento iientifico e Tecnologico (CNPq, 140415/2006-8) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2012/05152-0); FAB by CNPq (309752/2010-8) and FAPESP (2004/09219-6, 2009/54931-0, 2012/21159-5); MRC by CNPq (303061/2008-1, 304615/2011-0) and FAPESP (2010/51193-5, 2012/02349-8, 2012/09877-0, 2012/05391-5). Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens D, 1997, J FISH BIOL, V50, P1221; Agar WE., 1906, T ROY SOC EDINBURGH, V45, P49, DOI 10.1017/S0080456800011637; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; ALBERCH P, 1985, J EMBRYOL EXP MORPH, V88, P71; Allis E. P., 1897, Journal of Morphology, Vxii, P487; Allis EP, 1922, J ANAT, V56, P189; Arratia Gloria, 1999, P265; Arratia G, 2010, SER TELEOST FISH BIO, P73; Baldwin Carole C., 1996, P355, DOI 10.1016/B978-012670950-6/50015-1; BAUCHOT R, 1993, ENVIRON BIOL FISH, V37, P307, DOI 10.1007/BF00004638; BEGLE DP, 1992, COPEIA, P350, DOI 10.2307/1446196; Bemis WE, 1997, ENVIRON BIOL FISH, V48, P25, DOI 10.1023/A:1007370213924; BEMIS WE, 1984, PALEOBIOLOGY, V10, P293, DOI 10.1017/S0094837300008277; Bertmar G., 1969, INT REV GEN EXP ZOOL, V4, P1; BERTMAR GUNNAR, 1959, ACTA ZOOL [STOCKHOLM], V40, P203; Bischoff TLW, 1840, ANN SCI NATURELLE, V14, P116; Block AJ, 2012, J FISH BIOL, V81, P54, DOI 10.1111/j.1095-8649.2012.03307.x; Bockmann FA, 2008, ZOOTAXA, P1; Bockmann Flávio A., 2004, Neotrop. ichthyol., V2, P61, DOI 10.1590/S1679-62252004000200003; Bockmann Flavio A., 2004, Ichthyological Exploration of Freshwaters, V15, P225; Brazeau MD, 2012, PALAEONTOLOGY, V55, P355, DOI 10.1111/j.1475-4983.2012.01130.x; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; BRIDGE TW, 1898, T ZOOL SOC LONDON, V14, P325; Britto MR, 2003, THESIS U SAO PAULO S; Britz R, 2003, ZOOL J LINN SOC-LOND, V138, P495, DOI 10.1046/j.1096-3642.2003.t01-1-00067.x; Britz R, 2009, J MORPHOL, V270, P389, DOI 10.1002/jmor.10698; Britz Ralf, 2007, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V83, P3, DOI 10.1002/mmnz.200600016; Burrow CJ, 2012, HIST BIOL, V24, P349, DOI 10.1080/08912963.2012.660150; BYSTROW A. P., 1938, ACTA ZOOLOGICA, V19, P209; Campos-da-Paz R., 1997, THESIS U SAO PAULO S; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA., 2012, GAINING GROUND ORIGI; Claeson KM, 2007, J MORPHOL, V268, P1021, DOI 10.1002/jmor.10567; Cloutier R., 2004, RECENT ADV ORIGIN EA, P217; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Coates MI, 1998, ZOOL J LINN SOC-LOND, V122, P27; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Compagno L.J.V., 1973, Zoological J Linn Soc, V53, P15; Conway KW, 2008, ZOOTAXA, P1; Conway KW, 2007, COPEIA, P267, DOI 10.1643/0045-8511(2007)7[267:TGAOPO]2.0.CO;2; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Daget J., 1959, Bull Inst franY Afr noire, V21A, P1275; DAGET J., 1964, MEM MUS NAT HIST NATUR NOUV SERIE SERIE A ZOOL, V31, P163; Daniel J. F., 1934, ELASMOBRANCH FISHES; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; de Carvalho Marcelo R., 1996, P35, DOI 10.1016/B978-012670950-6/50004-7; De Carvalho MR, 2004, B AM MUS NAT HIST, P1; de Pinna M. C. C., 1993, THESIS CITY U NEW YO; de Pinna Mario, 2010, P251; de Santana, 2002, THESIS U FEDERAL PER; Dean B., 1909, AM MUSEUM NATURAL HI, V9, P209; Dean MN, 2012, J MORPHOL, V273, P461, DOI 10.1002/jmor.11035; DEBEER G, 1985, DEV VERTEBRATE SKULL; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Di Dario F, 2004, THESIS U SAO PAULO S, VI; DICK J R F, 1978, Transactions of the Royal Society of Edinburgh, V70, P63; Didier DA, 1995, AM MUS NOVIT, V3119, P1; EDGEWORTH F. H., 1926, TRANS ROY SOC EDINBURGH, V54, P719; Edgeworth FH, 1935, CRANIAL MUSCLES VERT; ELTOUBI MR, 1949, J MORPHOL, V84, P227, DOI 10.1002/jmor.1050840204; ELTOUBI MR, 1952, J MORPHOL, V90, P33, DOI 10.1002/jmor.1050900103; Engeman JM, 2009, J MORPHOL, V270, P291, DOI 10.1002/jmor.10688; Findeis EK, 1997, ENVIRON BIOL FISH, V48, P73, DOI 10.1023/A:1007372832213; Fink S. V., 1996, INTERRELATIONSHIPS F, P209, DOI DOI 10.1111/J.1096-3642.1981.TB01575.X; Fink W.L., 1982, B MUS COMP ZOOL HARV, V150, P31; Fink W.L, 1985, MISC PUBL MUS ZOOL, V171, P1; Forey P.L., 1998, HIST COELACANTH FISH; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gardiner BG, 2005, ZOOL J LINN SOC-LOND, V144, P511, DOI 10.1111/j.1096-3642.2005.00181.x; GARDINER BG, 1989, ZOOL J LINN SOC-LOND, V97, P135, DOI 10.1111/j.1096-3642.1989.tb00550.x; Geerinckx T, 2005, J MORPHOL, V208, P4627; Gillis JA, 2012, J APPL ICHTHYOL, V28, P341, DOI 10.1111/j.1439-0426.2012.01976.x; Gillis JA, 2011, P NATL ACAD SCI USA, V108, P1507, DOI 10.1073/pnas.1012968108; Gillis JA, 2009, J MORPHOL, V270, P628, DOI 10.1002/jmor.10710; Goujet D, 2001, SYST ASSOC SPEC VOL, V61, P209; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Grande L., 2005, 4 INT M MES FISH SYS, P119; Grande L., 1991, J VERTEBR PALEONTOL, V11, P1, DOI [DOI 10.1080/02724634.1991.10011424, 10.1080/02724634.1991.10011424]; Grande L, 2010, COPEIA, P1; Grande T, 2010, SER TELEOST FISH BIO, P1, DOI 10.1201/b10194-2; Greenwood P.H, 1971, American Mus Novit, VNo. 2473, P1; Greenwood PH, 1966, B AM MUS NAT HIST, V131, P340; Grogan ED, 2012, CRC MAR BIOL SER, P3; Gross W., 1963, Notizblatt des Hessischen Landesamtes fuer Bodenforschung zu Wiesbaden, V91, P36; Gunther A., 1871, PHILOS T ROYAL SOC L, V161, P511, DOI DOI 10.1098/RSTL.1871.0020; Haines WR, 1934, Q J MICROSC SCI, V77, P77; Hall B.K., 2015, BONES CARTILAGE DEV; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Hamdy AR, 1961, PUBLICATIONS MARINE, V11, P207; Hanke G.F., 2004, RECENT ADV ORIGIN EA, P703; Harold Antony S., 1996, P333, DOI 10.1016/B978-012670950-6/50014-X; Hilton EJ, 2003, ZOOL J LINN SOC-LOND, V137, P1, DOI 10.1046/j.1096-3642.2003.00032.x; Hilton Eric J., 2002, Fieldiana Zoology, V100, P1; Hilton Eric J., 2011, Fieldiana-Life and Earth Sciences, V3, P1; Hilton EJ, 2010, COPEIA, P312, DOI 10.1643/CI-09-118; Hilton EL, 2007, P ACAD NAT SCI PHILA, V156, P1, DOI 10.1635/0097-3157(2007)156[1:ROOTBG]2.0.CO;2; Howes G.J., 1985, Bulletin of the British Museum (Natural History) Zoology, V49, P273; Huysentruyt F, 2008, J MORPHOL, V269, P522, DOI 10.1002/jmor.10603; Janvier P., 1996, EARLY VERTEBRATES; Janvier P, 2008, ZOOL SCI, V25, P1045, DOI 10.2108/zsj.25.1045; JARVIK E, 1972, Meddelelser om Gronland, V187, P1; Jarvik E., 1977, PROBLEMS VERTEBRATE, P199; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; JARVIK ERIK, 1954, K SVENSKA VETENSKAPSAKAD HANDL, V5, P1; Johanson Z, 1997, T ROY SOC EDIN-EARTH, V88, P39, DOI 10.1017/S0263593300002303; Johnson G.D., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P464; Johnson GD, 2012, P ROY SOC B-BIOL SCI, V279, P934, DOI 10.1098/rspb.2011.1289; Johnson G. David, 1996, P251; JOHNSON GD, 1992, COPEIA, P8; Johnson GD, 1997, S AFR J SCI, V93, P594; Jollie M., 1984, Gegenbaurs Morphologisches Jahrbuch, V130, P315; JOLLIE M, 1984, COPEIA, P476, DOI 10.2307/1445204; JOLLIE M, 1980, COPEIA, P226, DOI 10.2307/1444000; JOLLIE M, 1984, J ZOOL, V204, P469; JOLLIE M, 1975, J MORPHOL, V147, P61, DOI 10.1002/jmor.1051470106; Kleinteich T, 2011, J MORPHOL, V272, P598, DOI 10.1002/jmor.10940; LAUDER G V, 1983, Bulletin of the Museum of Comparative Zoology, V150, P95; Lecointre G., 1996, P193, DOI 10.1016/B978-012670950-6/50011-4; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; Lecointre Guillaume, 1995, Geobios Memoire Special (Villeurbanne), V19, P205; Lehn C., 1918, Zs angew Anat Konst Berlin, V2, P349; Liem KF., 2001, FUNCTIONAL ANATOMY V; Long JA, 2001, J VERTEBR PALEONTOL, V21, P815, DOI 10.1671/0272-4634(2001)021[0815:OTROPA]2.0.CO;2; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; Lundberg J.G., 1986, NOTULAE NATURAE PHIL, V463, P1; Mabee PM, 1996, J MORPHOL, V227, P249, DOI 10.1002/(SICI)1097-4687(199603)227:3<249::AID-JMOR1>3.0.CO;2-1; Maddison WP, 2011, MESQUITE MODULAR SYS; Maisey, 1982, AM MUS NOVIT, V2724, P1; Maisey, 1989, AM MUS NOVIT, V2931, P1; Maisey J.G., 1989, Journal of Vertebrate Paleontology, V9, P174; Maisey J.G., 1984, Journal of Vertebrate Paleontology, V4, P359; Maisey JG, 1997, NATURE, V385, P779, DOI 10.1038/385779a0; MAISEY JG, 2004, MESOZOIC FISHES, V3, P17; Matsuoka M, 1997, ICHTHYOL RES, V44, P275, DOI 10.1007/BF02678707; Mehta RS, 2008, J MORPHOL, V269, P604, DOI 10.1002/jmor.10612; MENIN E, 1991, Revista Ceres, V38, P229; Miles R. S., 1968, P109; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; Miles RS., 1973, B BR MUS NAT HIS G, V24, P111; Millot J., 1958, ANATOMIE LATIMERIA C; Mok H.-K., 1983, Taiwan Museum Special Publication Series, P1; Monod T., 1949, Bull inst franc Afrique noire, V11, P36; Monod T, 1963, MELANGES ICHTHYLOGIQ, V66, P255; Moy-Thomas JA, 1933, Q J MICROSC SCI, V76, P209; Nakae M, 2011, J MORPHOL, V272, P503, DOI 10.1002/jmor.10930; Nelson G., 1989, P60; Nelson G. J., 1968, P129; NELSON GJ, 1967, J ZOOL, V153, P71; NELSON GJ, 1967, COPEIA, P389; NELSON GJ, 1967, J NAT HIST, V1, P289, DOI 10.1080/00222936700770231; NELSON GJ, 1966, PAC SCI, V20, P391; Nelson GJ, 1969, B AM MUS NAT HIST, V141, P476; Nelson JS, 1984, FISHES WORLD; NIELSEN E, 1942, MEDDELELSER GRONLAND, V138, P1; Nielsen E., 1949, PALAEOZOOLOGICA GROE, V146, P1; Olsson L, 2005, THEOR BIOSCI, V124, P145, DOI 10.1016/j.thbio.2005.06.001; Parker W.k., 1882, l c, P443; Parker WK, 1882, PHILOS T ROY SOC LON, V173, P139; Parker WN, 1907, COMP ANATOMY VERTEBR; PASHINE RG, 1977, P INDIAN ACAD SCI B, V85, P351; Pasleau F, 2010, SER TELEOST FISH BIO, P145, DOI 10.1201/b10194-6; PATTERSON C, 1982, AM ZOOL, V22, P241; Patterson Colin, 1994, Short Courses in Paleontology, V7, P57; Pollard H. B., 1892, Morphologisches Jahrbuch Anat, Vv, P387; Pollard HB, 1891, ANAT ANZEIGER, V6, P338; Reif WE, 1978, PALAEONTOLOGIE MONAT, V1, P42; Ribeiro AC, 2004, J FISH BIOL, V64, P597, DOI 10.1111/j.1095-8649.2004.00324.x; Ridewood W. G., 1894, Proceedings of the Zoological Society of London, P632; Ridewood W. G., 1905, Annals of Natural History, V(7), P361; Ridewood W.G., 1904, ZOOL J LINN SOC-LOND, V29, P188, DOI [10.1111/j.1096-3642.1904.tb00435.x, DOI 10.1111/J.1096-3642.1904.TB00435.X]; Ridewood WG, 1904, P ZOOL SOC LOND, V1904, P448; ROBERTS T R, 1984, Proceedings of the California Academy of Sciences, V43, P179; ROMER A. S., 1947, BULL MUS COMP ZOOL HARVARD UNIV, V99, P1; Rosen D.E., 1973, Zoological J Linn Soc, V53, P397; ROSEN D E, 1985, American Museum Novitates, P1; Rosen D.E., 1981, Bulletin of the American Museum of Natural History, V167, P163; Rosen D. E., 1981, AM MUS NOVIT, V2719, P1; Rosen DE, 1974, B AM MUS NAT HIST, V153, P269; Sanford CPJ, 2000, SALMONOID FISH OSTEO; SCHAEFFER B, 1981, Bulletin of the American Museum of Natural History, V169, P1; Schnell NK, 2012, COPEIA, P394, DOI 10.1643/CG-11-051; Schoch RR, 2011, ACTA ZOOL-STOCKHOLM, V92, P251, DOI 10.1111/j.1463-6395.2010.00456.x; Sewertzoff A., 1895, Bulletin Societe Moscou, P186; SHIRAI S, 1992, Bulletin of the Faculty of Fisheries Hokkaido University, V43, P24; Siebert D. J, 1987, THESIS CITY U NEW YO; Smith MM, 2003, SCIENCE, V299, P1235, DOI 10.1126/science.1079623; Springer Victor G., 2004, Bulletin of the Biological Society of Washington, V11, P1; SRINIVASACHAR H. R., 1956, PROC NATL INST SCI INDIA B BIOL SCI, V22, P335; SRINIVASACHAR HR, 1959, MORPHOLOGISCHES JB, V101, P373; Srinivasachar HR, 1959, MORPHOLOGISCHEN JB, V99, P986; Srinivasachar HR, 1956, MORPHOLOGISCHEN JB, V98, P244; STEIN DL, 1985, J FISH BIOL, V27, P215, DOI 10.1111/j.1095-8649.1985.tb04022.x; STIASSNY M L, 1986, Journal of Zoology Series B, V1, P411; Stiassny Melanie L.J., 1996, P405, DOI 10.1016/B978-012670950-6/50016-3; Stiassny MLJ, 2004, ASSEMBLING THE TREE OF LIFE, P410; Sushkin PP, 1936, AKAD NAUK SSSR T PAL, V5, P43; TAKI Y, 1987, JPN J ICHTHYOL, V34, P198, DOI 10.1007/BF02912415; TAYLOR W R, 1985, Cybium, V9, P107; Tewari S.K., 1971, Gegenbaurs Morph. Jb., V116, P491; Thomas KR, 2003, THESIS U CHICAGO ILL; Triques Mauro L., 2005, Lundiana, V6, P121; Vandewalle P, 2005, J FISH BIOL, V66, P996, DOI 10.1111/j.0022-1112.2005.00656.x; Vandewalle P, 1997, J FISH BIOL, V50, P227, DOI 10.1111/j.1095-8649.1997.tb01355.x; VANDEWALLE P, 1992, J FISH BIOL, V41, P43, DOI 10.1111/j.1095-8649.1992.tb03169.x; Vari R.P., 1989, Smithsonian Contributions to Zoology, P1; VOROBYEVA EI, 1980, ZOOL J LINN SOC-LOND, V70, P191, DOI 10.1111/j.1096-3642.1980.tb00851.x; Wacker K, 2001, ANN ANAT, V183, P37, DOI 10.1016/S0940-9602(01)80011-X; WAGNER GP, 1989, ANNU REV ECOL SYST, V20, P51, DOI 10.1146/annurev.es.20.110189.000411; Wang CH, 2003, ZOOL SCR, V32, P231, DOI 10.1046/j.1463-6409.2003.00114.x; Watson DMS, 1938, PHILOS T ROY SOC B, V228, P49; Wijhe J. W. Van., 1882, Niederlaendsches Archiv fuer Zoologie, Vv., P207; Wiley E.O., 2010, P123; Wiley EO, 2000, BIOCHEM SYST ECOL, V28, P319, DOI 10.1016/S0305-1978(99)00069-1; Xu GH, 2011, ZOOL J LINN SOC-LOND, V161, P595, DOI 10.1111/j.1096-3642.2010.00645.x; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	220	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62389	10.1371/journal.pone.0062389	http://dx.doi.org/10.1371/journal.pone.0062389			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23638061	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700084
J	Meng, JH; Wang, JF; Lawrence, GW; Dolly, JO				Meng, Jianghui; Wang, Jiafu; Lawrence, Gary W.; Dolly, J. Oliver			Molecular components required for resting and stimulated endocytosis of botulinum neurotoxins by glutamatergic and peptidergic neurons	FASEB JOURNAL			English	Article						amphiphysin; AP2; clathrin; dynamin; large dense-core vesicles; small clear synaptic vesicles	DEPENDENT BULK ENDOCYTOSIS; CLATHRIN-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLES; SYNAPTOTAGMIN-I; NERVE-TERMINALS; PROTEIN-RECEPTOR; DYNAMIN ISOFORMS; SENSORY NEURONS; HIGH-AFFINITY; TOXIN	Proteins responsible for basal and stimulated endocytosis in nerves containing small clear synaptic vesicles (SCSVs) or large dense-core vesicles (LDCVs) are revealed herein, using probes that exploit surface-exposed vesicle proteins as acceptors for internalization. Basal uptake of botulinum neurotoxins (BoNTs) by both SCSV-releasing cerebellar granule neurons (CGNs) and LDCV-enriched trigeminal ganglionic neurons (TGNs) was found to require protein acceptors and acidic compartments. In addition, dynamin, clathrin, adaptor protein complex-2 (AP2), and amphiphysin contribute to the depolarization-evoked entry. For fast recycling of SCSVs, knockdown and knockout strategies demonstrated that CGNs use predominantly dynamin 1, whereas isoform 2 and, to a smaller extent, isoform 3 support a less rapid mode of stimulated endocytosis. Accordingly, proximity ligation assay confirmed that dynamin 1 and 2 colocalize with amphiphysin 1 in CGNs, and the latter copurified with both dynamins from cell extracts. In contrast, LDCV-releasing TGNs preferentially employ dynamins 2 and 3 and amphiphysin 1 for evoked endocytosis and lack the fast phase. Hence, stimulation recruits dynamin, clathrin, AP2, and amphiphysin to augment BoNT internalization, and neurons match endocytosis mediators to the different demands for locally recycling SCSVs or replenishing distally synthesized LDCVs.	[Meng, Jianghui; Wang, Jiafu; Lawrence, Gary W.; Dolly, J. Oliver] Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland	Dublin City University	Dolly, JO (corresponding author), Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland.	oliver.dolly@dcu.ie	Wang, Jiafu/AAX-9388-2020; Dolly, Oliver/G-1532-2012; Dolly, Oliver/ABH-6677-2020; Meng, Jianghui/H-4302-2014	Wang, Jiafu/0000-0002-3654-4400; Dolly, Oliver/0000-0002-0861-5320; Dolly, Oliver/0000-0002-0861-5320; Meng, Jianghui/0000-0002-3107-4200	Science Foundation Ireland; Allergan Inc. (Irvine, CA, USA); Neuroscience Section of the Programme for Research in Third Level Institutions (PRTLI); European Regional Development Fund (ERDF) of the European Union	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Allergan Inc. (Irvine, CA, USA)(AbbVieAllergan); Neuroscience Section of the Programme for Research in Third Level Institutions (PRTLI); European Regional Development Fund (ERDF) of the European Union	This research is funded by a Principle Investigator Award (to J.O.D.) from Science Foundation Ireland, in part by Allergan Inc. (Irvine, CA, USA) and under the Neuroscience Section of the Programme for Research in Third Level Institutions (PRTLI) Cycle 4. The PRTLI is cofunded through the European Regional Development Fund (ERDF), part of the European Union Structural Funds Programme 2007-2013. The authors thank Pietro De Camilli (Yale University, New Haven, CT, USA) for providing dynamin 1 heterozygous mice and Dr. Shawn M. Ferguson (Yale University) for suggestions on breeding and genotyping. The authors are also grateful to Dr. Y. Zhu (Northwestern University, Evanston, IL, USA) for providing the SypHluorin construct.	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; BLACK JD, 1986, J CELL BIOL, V103, P521, DOI 10.1083/jcb.103.2.521; BLACK JD, 1986, J CELL BIOL, V103, P535, DOI 10.1083/jcb.103.2.535; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Cheung G, 2012, J NEUROSCI, V32, P6014, DOI 10.1523/JNEUROSCI.6305-11.2012; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Couesnon A, 2009, CELL MICROBIOL, V11, P289, DOI 10.1111/j.1462-5822.2008.01253.x; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dolly JO, 2011, FEBS J, V278, P4454, DOI 10.1111/j.1742-4658.2011.08205.x; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fischer A, 2009, P NATL ACAD SCI USA, V106, P1330, DOI 10.1073/pnas.0812839106; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Hesse S, 1995, NEUROSCI LETT, V201, P37, DOI 10.1016/0304-3940(94)12124-9; Jackson JL, 2012, JAMA-J AM MED ASSOC, V307, P1736, DOI 10.1001/jama.2012.505; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; LICHTE B, 1992, EMBO J, V11, P2521, DOI 10.1002/j.1460-2075.1992.tb05317.x; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Meng JH, 2007, J CELL SCI, V120, P2864, DOI 10.1242/jcs.012211; Meng JH, 2009, J NEUROSCI, V29, P4981, DOI 10.1523/JNEUROSCI.5490-08.2009; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; Partoens P, 1998, J CELL SCI, V111, P681; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Restani L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003087; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; SIMPSON LL, 1980, J PHARMACOL EXP THER, V212, P16; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang JF, 2008, J BIOL CHEM, V283, P16993, DOI 10.1074/jbc.M710442200; Wang JF, 2012, BIOCHEM J, V444, P59, DOI 10.1042/BJ20120100; Wang JF, 2011, J BIOL CHEM, V286, P6375, DOI 10.1074/jbc.M110.181784; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013; Yiangou Yiangos, 2011, J Pain Res, V4, P347, DOI 10.2147/JPR.S25189; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	73	15	15	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3167	3180		10.1096/fj.13-228973	http://dx.doi.org/10.1096/fj.13-228973			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23640057				2022-12-25	WOS:000329877600023
J	Euden, J; Mason, SA; Viero, C; Thomas, NL; Williams, AJ				Euden, Joanne; Mason, Sammy A.; Viero, Cedric; Thomas, N. Lowri; Williams, Alan J.			Investigations of the Contribution of a Putative Glycine Hinge to Ryanodine Receptor Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELEASE CHANNEL; TRANSMEMBRANE SEQUENCE; CA2+-RELEASE CHANNEL; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; CALCIUM-RELEASE; ACTIVATION; MUTATION; CATIONS; FAMILY	Ryanodine receptor channels (RyR) are key components of striated muscle excitation-contraction coupling, and alterations in their function underlie both inherited and acquired disease. A full understanding of the disease process will require a detailed knowledge of the mechanisms and structures involved in RyR function. Unfortunately, high-resolution structural data, such as exist for K+-selective channels, are not available for RyR. In the absence of these data, we have used modeling to identify similarities in the structural elements of K+ channel pore-forming regions and postulated equivalent regions of RyR. This has identified a sequence of residues in the cytosolic cavity-lining transmembrane helix of RyR (G(4864)LIIDA(4869) in RyR2) analogous to the glycine hinge motif present in many K+ channels. Gating in these K+ channels can be disrupted by substitution of residues for the hinge glycine. We investigated the involvement of glycine 4864 in RyR2 gating by monitoring properties of recombinant human RyR2 channels in which this glycine is replaced by residues that alter gating in K+ channels. Our data demonstrate that introducing alanine at position 4864 produces no significant change in RyR2 function. In contrast, function is altered when glycine 4864 is replaced by either valine or proline, the former preventing channel opening and the latter modifying both ion translocation and gating. Our studies reveal novel information on the structural basis of RyR gating, identifying both similarities with, and differences from, K+ channels. Glycine 4864 is not absolutely required for channel gating, but some flexibility at this point in the cavity-lining transmembrane helix is necessary for normal RyR function.	[Euden, Joanne; Mason, Sammy A.; Viero, Cedric; Thomas, N. Lowri; Williams, Alan J.] Cardiff Univ, Inst Mol & Expt Med, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Williams, AJ (corresponding author), Cardiff Univ, Inst Mol & Expt Med, Cardiff CF14 4XN, S Glam, Wales.	williamsaj9@cardiff.ac.uk		Williams, Alan/0000-0002-3770-8761; Thomas, Nia Lowri/0000-0001-8822-8576; Viero, Cedric/0000-0001-5291-1234; euden, joanne/0000-0002-2844-6878	British Heart Foundation [RG/09/009/28069]	British Heart Foundation(British Heart Foundation)	The work was supported by British Heart Foundation Programme Grant RG/09/009/28069.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; George CH, 2003, CIRC RES, V93, P531, DOI 10.1161/01.RES.0000091335.07574.86; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Mason SA, 2012, J GEN PHYSIOL, V140, P325, DOI 10.1085/jgp.201210851; Mead-Savery FC, 2009, BIOPHYS J, V96, P1374, DOI 10.1016/j.bpj.2008.10.054; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Ramachandran S, 2013, J BIOL CHEM, V288, P6154, DOI 10.1074/jbc.M112.433789; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Ranatunga KM, 2007, MOL MEMBR BIOL, V24, P185, DOI 10.1080/09687860601076522; Ranatunga KM, 2005, MOL PHARMACOL, V68, P840, DOI 10.1124/mol.105.012807; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; SITSAPESAN R, 1994, BIOPHYS J, V67, P1484, DOI 10.1016/S0006-3495(94)80622-8; Thomas LN, 2004, CARDIOVASC RES, V64, P52, DOI 10.1016/j.cardiores.2004.06.009; Thomas NL, 2012, WILEY INTERDISCIP RE, V1, P383, DOI DOI 10.1002/WMTS.34; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; Williams A. J., 1995, ION CHANNELS PRACTIC, P43; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	34	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16671	16679		10.1074/jbc.M113.465310	http://dx.doi.org/10.1074/jbc.M113.465310			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23632022	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000320378900042
J	Quinn, EM; Wang, JH; O'Callaghan, G; Redmond, HP				Quinn, Edel M.; Wang, Jiang Huai; O'Callaghan, Grace; Redmond, H. Paul			MicroRNA-146a Is Upregulated by and Negatively Regulates TLR2 Signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ENDOTOXIN TOLERANCE; C-ELEGANS; INDUCTION; SEPSIS; EXPRESSION; MECHANISMS; COMPONENTS; RESPONSES; COMPLEX	TLR signaling is a crucial component of the innate immune response to infection. MicroRNAs (miRNAs) have been shown to be upregulated during TLR signaling. Specifically, microRNA-146a (miR-146a) plays a key role in endotoxin tolerance by downregulating interleukin-1 receptor-associated kinase 1 (IRAK-1). The aim of this study was to assess the role of miR-146a in the TLR2 signaling and development of bacterial lipoprotein (BLP) self-tolerance and cross-tolerance to bacteria. Expression of miR-146a increased in a dose-and time-dependent manner in BLP-stimulated human THP-1 promonocytic cells. In BLP-tolerised cells miR-146a was even further upregulated in response to BLP re-stimulation (p < 0.001). Restimulation of BLP-tolerised cells with heat-killed gram-negative Salmonella typhimurium (S. typhimurium), but not gram-positive Staphylococcus aureus (S. aureus), led to significant overexpression of miR-146a (p < 0.05). Transfection of naive cells with a miR-146a mimic substantially suppressed TNF-alpha production (p < 0.05). Furthermore, overexpression of miR-146a resulted in strong reduction in IRAK-1 and phosphorylated I kappa B alpha expression in naive and S. typhimurium-stimulated THP-1 cells. Collectively, miR-146a is upregulated in response to BLP and bacterial stimulation in both naive and BLP-tolerised cells. Overexpression of miR-146a induces a state analogous to tolerance in BLP-stimulated cells and therefore may represent a future target for exogenous modulation of tolerance during microbial infection and sepsis.	[Quinn, Edel M.; Wang, Jiang Huai; Redmond, H. Paul] Natl Univ Ireland Univ Coll Cork, Cork Univ Hosp, Acad Dept Surg, Cork, Ireland; [O'Callaghan, Grace] Natl Univ Ireland Univ Coll Cork, Cork Univ Hosp, Dept Med, Cork, Ireland	University College Cork; University College Cork	Wang, JH (corresponding author), Natl Univ Ireland Univ Coll Cork, Cork Univ Hosp, Acad Dept Surg, Cork, Ireland.	jh.wang@ucc.ie		Quinn, Edel/0000-0001-8419-2684				Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Buckley JM, 2006, J LEUKOCYTE BIOL, V80, P731, DOI 10.1189/jlb.0506312; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cross AS, 2002, J ENDOTOXIN RES, V8, P83, DOI 10.1179/096805102125000227; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; El Gazzar M, 2011, J LEUKOCYTE BIOL, V90, P509, DOI 10.1189/jlb.0211074; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; GREISMAN SE, 1969, J IMMUNOL, V103, P1223; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Quinn EM, 2012, J LEUKOCYTE BIOL, V91, P721, DOI 10.1189/jlb.1111571; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sonkoly E, 2009, INT REV IMMUNOL, V28, P535, DOI 10.3109/08830180903208303; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wang JH, 2003, J IMMUNOL, V170, P14, DOI 10.4049/jimmunol.170.1.14; Wang JH, 2002, J BIOL CHEM, V277, P36068, DOI 10.1074/jbc.M205584200; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	34	54	58	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62232	10.1371/journal.pone.0062232	http://dx.doi.org/10.1371/journal.pone.0062232			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638011	Green Submitted, Green Published, gold			2022-12-25	WOS:000321662800031
J	Kay, CN; Ryals, RC; Aslanidi, GV; Min, SH; Ruan, Q; Sun, JF; Dyka, FM; Kasuga, D; Ayala, AE; Van Vliet, K; Agbandje-McKenna, M; Hauswirth, WW; Boye, SL; Boye, SE				Kay, Christine N.; Ryals, Renee C.; Aslanidi, George V.; Min, Seok Hong; Ruan, Qing; Sun, Jingfen; Dyka, Frank M.; Kasuga, Daniel; Ayala, Andrea E.; Van Vliet, Kim; Agbandje-McKenna, Mavis; Hauswirth, William W.; Boye, Sanford L.; Boye, Shannon E.			Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSDUCTION; LEBERS CONGENITAL AMAUROSIS; RHODOPSIN KINASE PROMOTER; INNER LIMITING MEMBRANE; ADENOASSOCIATED VIRUS; GENE-THERAPY; MOUSE RETINA; CONE PHOTORECEPTORS; SUBRETINAL DELIVERY; PRIMATE RETINA	Development of viral vectors capable of transducing photoreceptors by less invasive methods than subretinal injection would provide a major advancement in retinal gene therapy. We sought to develop novel AAV vectors optimized for photoreceptor transduction following intravitreal delivery and to develop methodology for quantifying this transduction in vivo. Surface exposed tyrosine (Y) and threonine (T) residues on the capsids of AAV2, AAV5 and AAV8 were changed to phenylalanine (F) and valine (V), respectively. Transduction efficiencies of self-complimentary, capsid-mutant and unmodified AAV vectors containing the smCBA promoter and mCherry cDNA were initially scored in vitro using a cone photoreceptor cell line. Capsid mutants exhibiting the highest transduction efficiencies relative to unmodified vectors were then injected intravitreally into transgenic mice constitutively expressing a Rhodopsin-GFP fusion protein in rod photoreceptors (Rho-GFP mice). Photoreceptor transduction was quantified by fluorescent activated cell sorting (FACS) by counting cells positive for both GFP and mCherry. To explore the utility of the capsid mutants, standard, (non-self-complementary) AAV vectors containing the human rhodopsin kinase promoter (hGRK1) were made. Vectors were intravitreally injected in wildtype mice to assess whether efficient expression exclusive to photoreceptors was achievable. To restrict off-target expression in cells of the inner and middle retina, subsequent vectors incorporated multiple target sequences for miR181, an miRNA endogenously expressed in the inner and middle retina. Results showed that AAV2 containing four Y to F mutations combined with a single T to V mutation (quadY-F+T-V) transduced photoreceptors most efficiently. Robust photoreceptor expression was mediated by AAV2(quadY-F+T-V) -hGRK1-GFP. Observed off-target expression was reduced by incorporating target sequence for a miRNA highly expressed in inner/middle retina, miR181c. Thus we have identified a novel AAV vector capable of transducing photoreceptors following intravitreal delivery to mouse. Furthermore, we describe a robust methodology for quantifying photoreceptor transduction from intravitreally delivered AAV vectors.	[Kay, Christine N.; Ryals, Renee C.; Min, Seok Hong; Ruan, Qing; Sun, Jingfen; Dyka, Frank M.; Kasuga, Daniel; Ayala, Andrea E.; Hauswirth, William W.; Boye, Sanford L.; Boye, Shannon E.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Aslanidi, George V.] Univ Florida, Coll Med, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL USA; [Van Vliet, Kim] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Boye, Shannon E.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Boye, SE (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA.	Shannon.Boye@eye.ufl.edu	Van Vliet, Kim/AAK-7368-2021; Aslanidi, George/C-5680-2019	Sun, Jingfen/0000-0001-9810-2133; Aslanidi, George/0000-0002-2726-8627; Van Vliet, Kim/0000-0001-7802-9514; Boye, Shannon/0000-0002-7312-3197; hauswirth, william/0000-0002-3244-4947	Foundation Fighting Blindness; Research to Prevent Blindness; NEI [P30EY021721]; NATIONAL EYE INSTITUTE [R24EY022012, P30EY021721, R01EY017549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082946] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Foundation Fighting Blindness (http://www.blindness.org/), Research to Prevent Blindness (http://www.rpbusa.org/rpb/) and NEI Core Grant P30EY021721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Al-Ubaidi MR, 2008, ADV EXP MED BIOL, V613, P301, DOI 10.1007/978-0-387-74904-4_35; Ali RR, 1996, HUM MOL GENET, V5, P591, DOI 10.1093/hmg/5.5.591; Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Aslanidi GV, 2012, VACCINE, V30, P3908, DOI 10.1016/j.vaccine.2012.03.079; Aslanidi GV RA, 2001, PLOS ONE IN PRESS; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bartel MA, 2012, GENE THER, V19, P694, DOI 10.1038/gt.2012.20; Beltran WA, 2010, GENE THER, V17, P1162, DOI 10.1038/gt.2010.56; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; Boye SL, 2011, INVEST OPHTH VIS SCI, V52, P7098, DOI 10.1167/iovs.11-7867; Boye SE, 2012, HUM GENE THER, V23, P1101, DOI 10.1089/hum.2012.125; Boye SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011306; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; CHAI L, 1994, CURR EYE RES, V13, P669, DOI 10.3109/02713689408999903; Cho EYP, 2002, HISTOCHEM J, V34, P589, DOI 10.1023/A:1026032005521; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Dalkara D, 2009, MOL THER, V17, P2096, DOI 10.1038/mt.2009.181; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Gabriel N, 2013, HUM GENE THER METHOD; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Karali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022166; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Khani SC, 2007, INVEST OPHTH VIS SCI, V48, P3954, DOI 10.1167/iovs.07-0257; Klimczak RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007467; Li CW, 2012, J VIROL, V86, P7752, DOI 10.1128/JVI.00675-12; Lotery AJ, 2003, HUM GENE THER, V14, P1663, DOI 10.1089/104303403322542301; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; MATSUMOTO B, 1984, INVEST OPHTH VIS SCI, V25, P71; Mussolino C, 2011, GENE THER, V18, P637, DOI 10.1038/gt.2011.3; Pang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035250; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Petersen-Jones SM, 2009, MOL VIS, V15, P1835; Petrs-Silva H, 2011, MOL THER, V19, P293, DOI 10.1038/mt.2010.234; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Pulicherla N, 2011, GENE THER, V18, P1020, DOI 10.1038/gt.2011.46; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Raupp C, 2012, J VIROL, V86, P9396, DOI 10.1128/JVI.00209-12; Ryals RC, 2011, MOL VIS, V17, P1090; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Vandenberghe LH BP, 2011, ARVO; Vandenberghe LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002103; Weber M, 2003, MOL THER, V7, P774, DOI 10.1016/S1525-0016(03)00098-4; Wensel TG, 2005, VISION RES, V45, P3445, DOI 10.1016/j.visres.2005.07.016; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yang GS, 2002, J VIROL, V76, P7651, DOI 10.1128/JVI.76.15.7651-7660.2002; Yin L, 2011, INVEST OPHTH VIS SCI, V52, P2775, DOI 10.1167/iovs.10-6250; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	56	126	149	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62097	10.1371/journal.pone.0062097	http://dx.doi.org/10.1371/journal.pone.0062097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637972	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700033
J	Bittar, C; Jardim, ACG; Yamasaki, LHT; Carareto, CMA; Pinho, JRR; Lemey, P; de Carvalho-Mello, IMVG; Rahal, P				Bittar, Cintia; Gomes Jardim, Ana Carolina; Tomonari Yamasaki, Lilian Hiromi; Aparecida Carareto, Claudia Marcia; Rebello Pinho, Joao Renato; Lemey, Philippe; Vicente Guedes de Carvalho-Mello, Isabel Maria; Rahal, Paula			On Hepatitis C Virus Evolution: The Interaction between Virus and Host towards Treatment Outcome	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; DYNAMICS IN-VIVO; GENETIC DIVERSITY; NS5A PROTEIN; INTERFERON; 1B; REPLICATION; POPULATION; MUTATIONS; ORIGIN	Background: Hepatitis C is a disease spread throughout the world. Hepatitis C virus (HCV), the etiological agent of this disease, is a single-stranded positive RNA virus. Its genome encodes a single precursor protein that yields ten proteins after processing. NS5A, one of the non-structural viral proteins, is most associated with interferon-based therapy response, the approved treatment for hepatitis C in Brazil. HCV has a high mutation rate and therefore high variability, which may be important for evading the immune system and response to therapy. The aim of this study was to analyze the evolution of NS5A quasispecies before, during, and after treatment in patients infected with HCV genotype 3a who presented different therapy responses. Methods: Viral RNA was extracted, cDNA was synthesized, the NS5A region was amplified and cloned, and 15 clones from each time-point were sequenced. The sequences were analyzed for evolutionary history, genetic diversity and selection. Results: This analysis shows that the viral population that persists after treatment for most non-responder patients is present in before-treatment samples, suggesting it is adapted to evade treatment. In contrast, the population found in before treatment samples from most end-of-treatment responder patients either are selected out or appears in low frequency after relapse, therefore changing the population structure. The exceptions illustrate the uniqueness of the evolutionary process, and therefore the treatment resistance process, in each patient. Conclusion: Although evolutionary behavior throughout treatment showed that each patient presented different population dynamics unrelated to therapy outcome, it seems that the viral population from non-responders that resists the treatment already had strains that could evade therapy before it started.	[Bittar, Cintia; Gomes Jardim, Ana Carolina; Tomonari Yamasaki, Lilian Hiromi; Aparecida Carareto, Claudia Marcia; Rahal, Paula] UNESP Sao Paulo State Univ, IBILCE Inst Biosci Language & Literature & Exact, Dept Biol, Sao Paulo, Brazil; [Rebello Pinho, Joao Renato] Univ Sao Paulo, Fac Med, Dept Gastroenterol, Lab Hepatol & Gastroenterol,Inst Trop Med, Sao Paulo, Brazil; [Rebello Pinho, Joao Renato] Albert Einstein Israeli Hosp, Dept Clin Pathol, Sao Paulo, Brazil; [Lemey, Philippe] Katholieke Univ Leuven, Lab Clin & Epidemiol Virol, Rega Inst, Louvain, Belgium; [Vicente Guedes de Carvalho-Mello, Isabel Maria] Univ Fed Sao Paulo, Escola Paulista Med, Dept Med, Disciplina Gastroenterol,Lab Hepatol Mol Aplicada, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; KU Leuven; Universidade Federal de Sao Paulo (UNIFESP)	de Carvalho-Mello, IMVG (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Med, Disciplina Gastroenterol,Lab Hepatol Mol Aplicada, Sao Paulo, Brazil.	imvgcmello@gmail.com	Lemey, Philippe/C-3755-2018; Carareto, Claudia M/D-2814-2012; Rahal, Paula/D-3871-2012; Bittar, Cintia/A-5042-2015; de carvalho-Mello, Isabel Maria V G/D-3641-2012; Yamasaki, Lilian/M-8063-2013; Jardim, Ana Carolina/H-3615-2012; Pinho, Joao R. R./G-2850-2012	Lemey, Philippe/0000-0003-2826-5353; Rahal, Paula/0000-0001-5693-6148; Bittar, Cintia/0000-0002-2048-4589; de carvalho-Mello, Isabel Maria V G/0000-0002-4448-1972; Jardim, Ana Carolina/0000-0002-6348-7923; Pinho, Joao R. R./0000-0003-3999-0489; Carareto, Claudia Marcia Aparecida/0000-0002-0298-1354	FAPESP [2008/51165-1, 2006/60012-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was financially supported by FAPESP. Grant numbers 2008/51165-1 and 2006/60012-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; Bittar C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-36; Bowen DG, 2005, J HEPATOL, V42, P408, DOI 10.1016/j.jhep.2004.12.013; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Craig S, 2003, J VIROL, V77, P4463, DOI 10.1128/JVI.77.7.4463-4467.2003; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duverlie G, 1998, J GEN VIROL, V79, P1373, DOI 10.1099/0022-1317-79-6-1373; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; Eigen M, 1988, SEQUENCE SPACE QUASI; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Jardim ACG, 2009, INFECT GENET EVOL, V9, P689, DOI 10.1016/j.meegid.2008.11.001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Ide Y, 1996, GENE, V182, P203, DOI 10.1016/S0378-1119(96)00555-0; INCHAUSPE G, 1991, P NATL ACAD SCI USA, V88, P10292, DOI 10.1073/pnas.88.22.10292; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; Le Guillou-Guillemette H, 2007, WORLD J GASTROENTERO, V13, P2416, DOI 10.3748/wjg.v13.i17.2416; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Marucci EA, 2008, GENET MOL RES, V7, P970, DOI 10.4238/vol7-3X-Meeting013; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Polyak Stephen J, 2003, Clin Liver Dis, V7, P67, DOI 10.1016/S1089-3261(02)00075-2; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Satoh S, 2000, VIROLOGY, V270, P476, DOI 10.1006/viro.2000.0287; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Togawa R, 2007, BIOMOL ELECTROPHEROG; Tong X, 2006, VIRUS RES, V115, P122, DOI 10.1016/j.virusres.2005.07.012; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62393	10.1371/journal.pone.0062393	http://dx.doi.org/10.1371/journal.pone.0062393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638063	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400053
J	Byerly, MS; Swanson, R; Wei, Z; Seldin, MM; McCulloh, PS; Wong, GW				Byerly, Mardi S.; Swanson, Roy; Wei, Zhikui; Seldin, Marcus M.; McCulloh, Patrick S.; Wong, G. William			A Central Role for C1q/TNF-Related Protein 13 (CTRP13) in Modulating Food Intake and Body Weight	PLOS ONE			English	Article							ACTIVITY-BASED ANOREXIA; AGOUTI-RELATED PROTEIN; EATING-DISORDERS; BINGE/PURGE FORM; BULIMIA-NERVOSA; ADIPOSE-TISSUE; ADIPONECTIN; MICE; EXPRESSION; FAMILY	C1q/TNF-related protein 13 (CTRP13), a hormone secreted by adipose tissue (adipokines), helps regulate glucose metabolism in peripheral tissues. We previously reported that CTRP13 expression is increased in obese and hyperphagic leptin-deficient mice, suggesting that it may modulate food intake and body weight. CTRP13 is also expressed in the brain, although its role in modulating whole-body energy balance remains unknown. Here, we show that CTRP13 is a novel anorexigenic factor in the mouse brain. Quantitative PCR demonstrated that food restriction downregulates Ctrp13 expression in mouse hypothalamus, while high-fat feeding upregulates expression. Central administration of recombinant CTRP13 suppressed food intake and reduced body weight in mice. Further, CTRP13 and the orexigenic neuropeptide agouti-related protein (AgRP) reciprocally regulate each other's expression in the hypothalamus: central delivery of CTRP13 suppressed Agrp expression, while delivery of AgRP increased Ctrp13 expression. Food restriction alone reduced Ctrp13 and increased orexigenic neuropeptide gene (Npy and Agrp) expression in the hypothalamus; in contrast, when food restriction was coupled to enhanced physical activity in an activity-based anorexia (ABA) mouse model, hypothalamic expression of both Ctrp13 and Agrp were upregulated. Taken together, these results suggest that CTRP13 and AgRP form a hypothalamic feedback loop to modulate food intake and that this neural circuit may be disrupted in an anorexic-like condition.	[Byerly, Mardi S.; Swanson, Roy; Wei, Zhikui; Seldin, Marcus M.; McCulloh, Patrick S.; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21218 USA; [Byerly, Mardi S.; Swanson, Roy; Wei, Zhikui; Seldin, Marcus M.; McCulloh, Patrick S.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21218 USA.	gwwong@jhmi.edu		Wong, G. William/0000-0002-5286-6506; Wei, Zhikui/0000-0002-2311-9800	National Institute of Health [T32DK007751, DK084171]; American Heart Association [SDG2260721]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, T32DK007751, P30DK079637] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding source for CTRP13 and food intake work: MSB is supported by a training grant from the National Institute of Health (T32DK007751). GWW is supported by grants from the National Institute of Health (DK084171) and the American Heart Association (SDG2260721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aja S, 2006, AM J PHYSIOL-REG I, V291, pR148, DOI 10.1152/ajpregu.00041.2006; Attia E, 2010, ANNU REV MED, V61, P425, DOI 10.1146/annurev.med.050208.200745; Bulik CM, 2007, ANNU REV NUTR, V27, P263, DOI 10.1146/annurev.nutr.27.061406.093713; Davis C, 1997, COMPR PSYCHIAT, V38, P321, DOI 10.1016/S0010-440X(97)90927-5; de Rijke CE, 2005, J MOL ENDOCRINOL, V35, P381, DOI 10.1677/jme.1.01808; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gelegen C, 2008, GENES BRAIN BEHAV, V7, P552, DOI 10.1111/j.1601-183X.2008.00394.x; Gelegen C, 2007, EUR NEUROPSYCHOPHARM, V17, P199, DOI 10.1016/j.euroneuro.2006.04.007; Hebebrand J, 2003, PHYSIOL BEHAV, V79, P25, DOI 10.1016/S0031-9384(03)00102-1; HEBEBRAND J, 1995, LANCET, V346, P1624, DOI 10.1016/S0140-6736(95)91955-4; Hillebrand JJG, 2005, PEPTIDES, V26, P1690, DOI 10.1016/j.peptides.2004.11.027; Hillebrand JJG, 2005, BIOL PSYCHIAT, V58, P165, DOI 10.1016/j.biopsych.2005.03.011; Housova J, 2005, J CLIN ENDOCR METAB, V90, P1366, DOI 10.1210/jc.2004-1364; Javaras KN, 2008, INT J EAT DISORDER, V41, P174, DOI 10.1002/eat.20484; Kim SF, 2012, NEUROSCIENCE, V211, P2, DOI 10.1016/j.neuroscience.2012.03.024; Klenotich SJ, 2012, NEUROPSYCHOPHARMACOL, V37, P1620, DOI 10.1038/npp.2012.7; Klenotich SJ, 2012, METHODS MOL BIOL, V829, P377, DOI 10.1007/978-1-61779-458-2_25; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Lewis DY, 2010, EUR NEUROPSYCHOPHARM, V20, P622, DOI 10.1016/j.euroneuro.2010.04.002; Lusk G, 1928, ELEMENTS SCI NUTR; Merle JV, 2011, PSYCHOL MED, V41, P2183, DOI 10.1017/S0033291711000365; Misra M, 2007, J CLIN ENDOCR METAB, V92, P2046, DOI 10.1210/jc.2006-2855; Moriya J, 2006, PSYCHONEUROENDOCRINO, V31, P1057, DOI 10.1016/j.psyneuen.2006.06.006; Nogueira JP, 2010, EUR J CLIN NUTR, V64, P840, DOI 10.1038/ejcn.2010.66; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Pjetri E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050453; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Tagami T, 2004, J CLIN ENDOCR METAB, V89, P1833, DOI 10.1210/jc.2003-031260; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Vink T, 2001, MOL PSYCHIATR, V6, P325, DOI 10.1038/sj.mp.4000854; Wade TD, 2008, PSYCHOSOM MED, V70, P239, DOI 10.1097/PSY.0b013e31815c40f1; Wei Z, 2013, J BIOL CHEM IN PRESS; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	41	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62862	10.1371/journal.pone.0062862	http://dx.doi.org/10.1371/journal.pone.0062862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638159	Green Submitted, gold, Green Published			2022-12-25	WOS:000318341400071
J	Jimenez-Solem, E; Andersen, JT; Petersen, M; Broedbaek, K; Andersen, NL; Torp-Pedersen, C; Poulsen, HE				Jimenez-Solem, Espen; Andersen, Jon Traerup; Petersen, Morten; Broedbaek, Kasper; Andersen, Nadia Lyhne; Torp-Pedersen, Christian; Poulsen, Henrik Enghusen			Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort Study	PLOS ONE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; POPULATION-BASED COHORT; PERSISTENT PULMONARY-HYPERTENSION; MAJOR CONGENITAL-MALFORMATIONS; MATERNAL USE; 1ST-TRIMESTER USE; BIRTH-DEFECTS; DRUG-USE; RISK; DEPRESSION	Aim: The aim of this study was to assess the prevalence and patterns of exposure to antidepressants before, during and after pregnancy in a cohort including all pregnant women in Denmark between 1997 and 2010. Methods: We performed a retrospective cohort study including 912 322 pregnancies. Information was retrieved from the Danish Birth Registry and The Register of Medicinal Product Statistics to identify women redeeming an antidepressant prescription during pregnancy. Exposure periods were based on standard treatment doses and dispensed pack sizes. Results: We identified 19 740 pregnancies exposed to an antidepressant at some point during pregnancy. The rate of exposure increased from 0.2% in 1997 to 3.2% in 2010. We found that the rate of exposure was halved during the first 3 months of pregnancy. In contrast, we describe a clear increase in exposure after pregnancy among pre-delivery treatment-naive women. Conclusions: In spite of uncertainty concerning antidepressants' safety during pregnancy we find a 16-fold increase in exposure rates between 1997 and 2010. The rates describe a sharp decrease in exposure during pregnancy that is probably caused by physicians' hesitation to prescribe antidepressants and women's fear of unwanted effects on the unborn child. More studies are needed to clarify the consequences of antidepressant discontinuation during pregnancy.	[Jimenez-Solem, Espen; Andersen, Jon Traerup; Petersen, Morten; Broedbaek, Kasper; Poulsen, Henrik Enghusen] Rigshosp, Lab Clin Pharmacol Q7642, DK-2100 Copenhagen, Denmark; [Jimenez-Solem, Espen; Andersen, Jon Traerup; Petersen, Morten; Broedbaek, Kasper; Poulsen, Henrik Enghusen] Bispebjerg Hosp, Dept Clin Pharmacol, DK-2400 Copenhagen, Denmark; [Broedbaek, Kasper] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Andersen, Nadia Lyhne] Copenhagen Univ Hosp, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark; [Torp-Pedersen, Christian] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [Torp-Pedersen, Christian; Poulsen, Henrik Enghusen] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Jimenez-Solem, E (corresponding author), Rigshosp, Lab Clin Pharmacol Q7642, DK-2100 Copenhagen, Denmark.	espen.jimenez.solem@regionh.dk	Jimenez-Solem, Espen/B-4207-2012	Jimenez-Solem, Espen/0000-0002-3777-147X; Poulsen, Henrik Enghusen/0000-0003-4242-9924; Andersen, Jon/0000-0003-0169-1328	Capital Region of Copenhagen; Danish Agency for Science, Technology and Innovation	Capital Region of Copenhagen; Danish Agency for Science, Technology and Innovation	The Research Project was partially sponsored by the Capital Region of Copenhagen and the Danish Agency for Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan S, 2010, J CLIN PHARMACOL; Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Andersen TF, 1999, DAN MED BULL, V46, P263; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; Bakker MK, 2008, BRIT J CLIN PHARMACO, V65, P600, DOI 10.1111/j.1365-2125.2007.03048.x; Bakker MK, 2010, BIRTH DEFECTS RES A, V88, P94, DOI 10.1002/bdra.20641; Beck CT, 2006, JOGNN-J OBST GYN NEO, V35, P735, DOI 10.1111/J.1552-6909.2006.00094.x; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Chatillon O, 2010, ENCEPHALE, V36, P443, DOI 10.1016/j.encep.2010.02.004; Chung TKH, 2001, PSYCHOSOM MED, V63, P830, DOI 10.1097/00006842-200109000-00017; Cohen L S, 2004, Arch Womens Ment Health, V7, P217, DOI 10.1007/s00737-004-0059-3; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cole JA, 2007, PHARMACOEPIDEM DR S, V16, P1075, DOI 10.1002/pds.1463; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Danish Society of Obstetrics and Gynaecology, 2012, BEH MED SER GRAV UND; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; De las Cuevas C, 2004, PHARMACOEPIDEM DR S, V13, P309; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; Einarson A, 2001, J PSYCHIATR NEUROSCI, V26, P44; Einarson A, 2009, CAN J PSYCHIAT, V54, P242, DOI 10.1177/070674370905400405; Ericson A, 1999, EUR J CLIN PHARMACOL, V55, P503, DOI 10.1007/s002280050664; FDA, 2009, FDA ADV RISK BIRTH D; Gaist D, 1997, DAN MED BULL, V44, P445; Goodman JH, 2009, BIRTH-ISS PERINAT C, V36, P60, DOI 10.1111/j.1523-536X.2008.00296.x; Grigoriadis Sophie, 2007, Ann Clin Psychiatry, V19, P247, DOI 10.1080/10401230701653294; Jimenez-Solem E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001148; Jimenez-Solem E, 2013, AM J PSYCHIAT, V170, P299, DOI 10.1176/appi.ajp.2012.11081251; Kallen B, 2006, REPROD TOXICOL, V21, P221, DOI 10.1016/j.reprotox.2005.11.006; Kallen BAJ, 2007, BIRTH DEFECTS RES A, V79, P301, DOI 10.1002/bdra.20327; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kieler H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8012; Knudsen LB, 1998, DAN MED BULL, V45, P221; Kulin NA, 1998, JAMA-J AM MED ASSOC, V279, P609, DOI 10.1001/jama.279.8.609; Lennestal R, 2007, J CLIN PSYCHOPHARM, V27, P607, DOI 10.1097/jcp.0b013e31815ac4d2; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Malm H, 2005, OBSTET GYNECOL, V106, P1289, DOI 10.1097/01.AOG.0000187302.61812.53; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; Munk-Olsen T, 2012, ACTA PSYCHIAT SCAND; O'Brien L, 2009, CAN J PSYCHIAT, V54, P399, DOI 10.1177/070674370905400607; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; PAGANINIHILL A, 1982, AM J EPIDEMIOL, V116, P114; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Ramos E, 2007, BJOG-INT J OBSTET GY, V114, P1055, DOI 10.1111/j.1471-0528.2007.01387.x; Ramos E, 2008, BRIT J PSYCHIAT, V192, P344, DOI 10.1192/bjp.bp.107.042523; Reefhuis J, 2006, NEW ENGL J MED, V354, P2188; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Schatzberg AF, 2000, J CLIN PSYCHIAT, V61, P9; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Sorensen H T, 1996, J Med Syst, V20, P57; Statistics Denmark, 2008, CONT DET STAT INF DA; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; Talati A, 2007, SOC PSYCH PSYCH EPID, V42, P962, DOI 10.1007/s00127-007-0262-4; TILLEY BC, 1985, AM J EPIDEMIOL, V121, P269, DOI 10.1093/oxfordjournals.aje.a113997; Van den Berg LTWDJ, 1999, TERATOLOGY, V60, P33; VANDENBRANDT PA, 1991, PHARM WEEKBLAD, V13, P91, DOI 10.1007/BF01974987; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Weissman MM, 2006, AM J PSYCHIAT, V163, P1001, DOI 10.1176/appi.ajp.163.6.1001; Wen SW, 2006, AM J OBSTET GYNECOL, V194, P961, DOI 10.1016/j.ajog.2006.02.019; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Wichman CL, 2008, J CLIN PSYCHOPHARM, V28, P714, DOI 10.1097/JCP.0b013e31818b53fd; Wichman CL, 2009, MAYO CLIN PROC, V84, P23, DOI 10.4065/84.1.23; Wogelius P, 2006, EPIDEMIOLOGY, V17, P701, DOI 10.1097/01.ede.0000239581.76793.ae; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627	68	87	89	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e63034	10.1371/journal.pone.0063034	http://dx.doi.org/10.1371/journal.pone.0063034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136DM	23638179	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400076
J	Kim, SY; Park, G; Han, KH; Kim, A; Koo, JW; Chang, SO; Oh, SH; Park, WY; Choi, BY				Kim, So Young; Park, Gibeom; Han, Kyu-Hee; Kim, Ahreum; Koo, Ja-Won; Chang, Sun O.; Oh, Seung Ha; Park, Woong-Yang; Choi, Byung Yoon			Prevalence of p.V37I Variant of GJB2 in Mild or Moderate Hearing Loss in a Pediatric Population and the Interpretation of Its Pathogenicity	PLOS ONE			English	Article							CONNEXIN 26 GENE; MUTATIONS; DEAFNESS; IMPAIRMENT; DFNB1; PHENOTYPE; GENOTYPE; DELETION	A p.V37I variant of GJB2 has been reported from subjects with moderate or slight hearing loss especially in East Asian populations. This study aimed to estimate the prevalence of the p.V37I variant among such subjects and prove, epidemiologically, its pathogenic potential to cause mild hearing loss. A total of 380 subjects from 201 families with hearing loss were enrolled. From them, 103 families were selected who had autosomal recessive inheritance or sporadic occurrence of hearing loss and who were younger than 15 years old. GJB2 sequencing was carried out for the probands of all 103 families. The prevalence of the p.V37I variant was compared between the subtle, mild or moderate hearing loss (group I) and the severe or profound hearing loss (group II) groups. Where possible, a targeted next generation sequencing of 82 deafness genes was performed from the p.V37I carrier to exclude the existence of other pathogenic genes. Five (4.8%) of 103 probands were found to carry p.V37I. The carrier frequency of p.V37I among group I (18.2%) was significantly higher than that of group II (1.2%) or the reported Korean normal hearing control group (1.0%). Detection of the p.V37I variant of GJB2 in 18.2% of Koreans with mild hearing loss strongly suggests its contribution to the pathogenesis of milder hearing loss, which might justify sequencing of GJB2 from these subjects in the Korean population.	[Kim, So Young; Han, Kyu-Hee; Kim, Ahreum; Chang, Sun O.; Oh, Seung Ha] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Gibeom] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Koo, Ja-Won; Choi, Byung Yoon] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea; [Koo, Ja-Won; Chang, Sun O.; Oh, Seung Ha; Choi, Byung Yoon] Seoul Natl Univ, Med Res Ctr, Sensory Organ Res Inst, Seoul, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea; Samsung Med Ctr, Samsung Genome Inst, Translat Genom Lab, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, BY (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.	choiby@snubh.org		Park, Woong-Yang/0000-0003-4234-0380	Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080588, A111377]; Seoul National University Bundang Hospital research fund [06-2011-024]	Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; Seoul National University Bundang Hospital research fund	The authors declare no conflict of interest related to funding sources, or financial holdings that might raise questions about possible sources of bias. This study was supported by the Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (No. A080588 and No. A111377) and Seoul National University Bundang Hospital research fund 06-2011-024 (to BYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Chan DK, 2011, OTOL NEUROTOL, V32, P81, DOI 10.1097/MAO.0b013e3181fc786f; Chan DK, 2010, GENET MED, V12, P174, DOI 10.1097/GIM.0b013e3181d0d42b; Cryns K, 2004, J MED GENET, V41, P147, DOI 10.1136/jmg.2003.013896; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Huculak C, 2006, AM J MED GENET A, V140A, P2394, DOI 10.1002/ajmg.a.31486; Jara O, 2012, MOL BIOL CELL; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Kim SY, 2011, INT J AUDIOL, V50, P694, DOI 10.3109/14992027.2011.563247; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; Lalayants M. R., 2011, Vestnik Otorinolaringologii, P31; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036621; Liu YH, 2002, J HUM GENET, V47, P688, DOI 10.1007/s100380200106; Oguchi T, 2005, J HUM GENET, V50, P76, DOI 10.1007/s10038-004-0223-7; Palmada M, 2006, NEUROBIOL DIS, V22, P112, DOI 10.1016/j.nbd.2005.10.005; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Schrijver I, 2006, INT J PEDIATR OTORHI, V70, P2109, DOI 10.1016/j.ijporl.2006.07.015; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; VanCamp G, 1997, AM J HUM GENET, V60, P758; Wang T, 2001, GENE CHROMOSOME CANC, V31, P91, DOI 10.1002/gcc.1110; Wu CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022314; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	30	33	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61592	10.1371/journal.pone.0061592	http://dx.doi.org/10.1371/journal.pone.0061592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637863	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400016
J	Davies, KTJ; Bates, PJJ; Maryanto, I; Cotton, JA; Rossiter, SJ				Davies, Kalina T. J.; Bates, Paul J. J.; Maryanto, Ibnu; Cotton, James A.; Rossiter, Stephen J.			The Evolution of Bat Vestibular Systems in the Face of Potential Antagonistic Selection Pressures for Flight and Echolocation	PLOS ONE			English	Article							SEMICIRCULAR CANAL SIZE; CONVERGENT EVOLUTION; MOLECULAR PHYLOGENY; TRADE-OFF; INNER-EAR; BROWN BAT; MORPHOLOGY; DIMENSIONS; EOCENE; CHIROPTERA	The vestibular system maintains the body's sense of balance and, therefore, was probably subject to strong selection during evolutionary transitions in locomotion. Among mammals, bats possess unique traits that place unusual demands on their vestibular systems. First, bats are capable of powered flight, which in birds is associated with enlarged semicircular canals. Second, many bats have enlarged cochleae associated with echolocation, and both cochleae and semicircular canals share a space within the petrosal bone. To determine how bat vestibular systems have evolved in the face of these pressures, we used micro-CT scans to compare canal morphology across species with contrasting flight and echolocation capabilities. We found no increase in canal radius in bats associated with the acquisition of powered flight, but canal radius did correlate with body mass in bat species from the suborder Yangochiroptera, and also in non-echolocating Old World fruit bats from the suborder Yinpterochiroptera. No such trend was seen in members of the Yinpterochiroptera that use laryngeal echolocation, although canal radius was associated with wing-tip roundedness in this group. We also found that the vestibular system scaled with cochlea size, although the relationship differed in species that use constant frequency echolocation. Across all bats, the shape of the anterior and lateral canals was associated with large cochlea size and small body size respectively, suggesting differential spatial constraints on each canal depending on its orientation within the skull. Thus in many echolocating bats, it seems that the combination of small body size and enlarged cochlea together act as a principal force on the vestibular system. The two main groups of echolocating bats displayed different canal morphologies, in terms of size and shape in relation to body mass and cochlear size, thus suggesting independent evolutionary pathways and offering tentative support for multiple acquisitions of echolocation.	[Davies, Kalina T. J.; Cotton, James A.; Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Davies, Kalina T. J.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Bates, Paul J. J.] Harrison Inst, Sevenoaks, Kent, England; [Maryanto, Ibnu] Indonesian Inst Sci LIPI, Cibinong, West Java, Indonesia; [Maryanto, Ibnu] Museum Bogoriense, Cibinong, West Java, Indonesia	University of London; Queen Mary University London; Natural History Museum London; Indonesian Institute of Sciences	Davies, KTJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	kalinadavies@gmail.com; s.j.rossiter@qmul.ac.uk	Bates, Paul/HDO-0192-2022; Rossiter, Stephen J/E-2111-2011; Cotton, James A/B-8806-2008	Cotton, James A/0000-0001-5475-3583; Davies, Kalina/0000-0002-4258-4775; Rossiter, Stephen/0000-0002-3881-4515	NERC studentship; Centre for Ecology and Evolution; University of London Central Research Fund	NERC studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Centre for Ecology and Evolution; University of London Central Research Fund	This work was funded by a NERC studentship awarded to KTJD with additional support from the Centre for Ecology and Evolution (http://www.ceevol.co.uk/) and the University of London Central Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Arita HT, 1997, TRENDS ECOL EVOL, V12, P53, DOI 10.1016/S0169-5347(96)10058-6; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Billet G, 2012, P ROY SOC B-BIOL SCI, V279, P3932, DOI 10.1098/rspb.2012.1212; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; Cohen B., 1974, VESTIBULAR SYSTEM 1, P477; Cox PG, 2008, J ANAT, V213, P583, DOI 10.1111/j.1469-7580.2008.00983.x; Cox PG, 2010, J ANAT, V216, P37, DOI 10.1111/j.1469-7580.2009.01172.x; David R, 2010, CR PALEVOL, V9, P397, DOI 10.1016/j.crpv.2010.07.012; Davies KTJ, 2012, HEREDITY, V108, P480, DOI 10.1038/hdy.2011.119; Dietz C, 2006, J MAMMAL, V87, P1241, DOI 10.1644/05-MAMM-A-299R2.1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUCROCQ S, 1992, PALAEONTOLOGY, V35, P373; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; Eklof J, 2003, VISION ECHOLOCATING; FENTON MB, 1984, J MAMMAL, V65, P395, DOI 10.2307/1381085; Freeman PW, 2007, J ZOOL, V273, P273, DOI 10.1111/j.1469-7998.2007.00325.x; Gatesy J, 2001, TRENDS ECOL EVOL, V16, P562, DOI 10.1016/S0169-5347(01)02236-4; GINGERICH PD, 1984, YEARB PHYS ANTHROPOL, V27, P57; Graf W, 1996, J HUM EVOL, V30, P175, DOI 10.1006/jhev.1996.0017; Gunz P, 2012, J ANAT, V220, P529, DOI 10.1111/j.1469-7580.2012.01493.x; GUSTAFSSON L, 1995, NATURE, V375, P311, DOI 10.1038/375311a0; HABERSETZER J, 1992, NATURWISSENSCHAFTEN, V79, P462, DOI 10.1007/BF01139198; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herrel A, 2009, FUNCT ECOL, V23, P119, DOI 10.1111/j.1365-2435.2008.01494.x; Hopkins MA, 1906, BIOL BULL-US, V11, P253, DOI 10.2307/1535747; Horowitz SS, 2004, J VESTIBUL RES-EQUIL, V14, P17; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; Jeffery N, 2008, J HUM EVOL, V55, P326, DOI 10.1016/j.jhevol.2008.02.010; Jeffery N, 2010, J ANAT, V216, P496, DOI 10.1111/j.1469-7580.2010.01211.x; Jennings NV, 2004, ACTA CHIROPTEROL, V6, P75, DOI 10.3161/001.006.0106; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; JONES GM, 1963, PROC R SOC SER B-BIO, V157, P403, DOI 10.1098/rspb.1963.0019; Ketten Darlene R., 1997, Bioacoustics, V8, P103; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kingston T, 2000, OECOLOGIA, V124, P332, DOI 10.1007/PL00008866; Kirkegaard M, 2001, J COMP NEUROL, V438, P433, DOI 10.1002/cne.1326; Knell RJ, 2009, ECOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-2311.2008.01022.x; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebrun R, 2010, J ANAT, V216, P368, DOI 10.1111/j.1469-7580.2009.01177.x; LINDENLAUB T, 1995, J MORPHOL, V224, P303, DOI 10.1002/jmor.1052240305; LOHMANN GP, 1983, J INT ASS MATH GEOL, V15, P659, DOI 10.1007/BF01033230; MacLeod N, 1999, PALEOBIOLOGY, V25, P107; MacLeod N, EIGENSHAPE 2 1; Macrini TE, 2010, J ANAT, V216, P600, DOI 10.1111/j.1469-7580.2010.01224.x; Malinzak MD, 2012, P NATL ACAD SCI USA, V109, P17914, DOI 10.1073/pnas.1206139109; McVean A, 1999, COMP BIOCHEM PHYS A, V123, P173, DOI 10.1016/S1095-6433(99)00047-1; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miller-Butterworth CM, 2003, NATURE, V424, P187, DOI 10.1038/nature01742; Muller M, 1999, J THEOR BIOL, V198, P405, DOI 10.1006/jtbi.1999.0922; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; NORBERG UM, 1981, PHILOS T R SOC B, V292, P359, DOI 10.1098/rstb.1981.0034; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; NUMMELA S, 1995, HEARING RES, V85, P18, DOI 10.1016/0378-5955(95)00030-8; PEDERSEN SC, 1993, J MORPHOL, V218, P85, DOI 10.1002/jmor.1052180107; RAMPRASHAD F, 1980, J COMP NEUROL, V192, P883, DOI 10.1002/cne.901920415; Riskin DK, 2009, J EXP BIOL, V212, P945, DOI 10.1242/jeb.026161; Riskin DK, 2006, J EXP BIOL, V209, P1725, DOI 10.1242/jeb.02186; Riskin DK, 2005, J EXP BIOL, V208, P1309, DOI 10.1242/jeb.01522; Rose KD, 2008, P ROY SOC B-BIOL SCI, V275, P1203, DOI 10.1098/rspb.2007.1661; Rosevear D.R, 1965, TRUSTEES BRIT MUSEUM; SCHLUTER D, 1991, P ROY SOC B-BIOL SCI, V246, P11, DOI 10.1098/rspb.1991.0118; Schmelzle Thomas, 2007, Mammal Study, V32, P83, DOI 10.3106/1348-6160(2007)32[83:VLDIDM]2.0.CO;2; Seiffert ER, 2003, NATURE, V422, P421, DOI 10.1038/nature01489; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Simmons NB, 2010, NATURE, V466, pE8, DOI 10.1038/nature09219; Sipla J. S., 2007, SEMICIRCULAR CANALS; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Storch Gerhard, 2002, Palaeontologische Zeitschrift, V76, P189; Swartz SM, 2003, BAT ECOLOGY, P257; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; TENKATE JH, 1970, J EXP BIOL, V53, P501; TURKEWITSCH B. G., 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P551, DOI 10.1007/BF02118934; Veselka N, 2010, NATURE, V463, P939, DOI 10.1038/nature08737; Warrick DR, 2002, INTEGR COMP BIOL, V42, P141, DOI 10.1093/icb/42.1.141; Welker KL, 2009, J ANAT, V215, P444, DOI 10.1111/j.1469-7580.2009.01124.x; Wiley DF, 2007, LANDMARK I DATA ANAL; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Yang AZ, 2007, J NEUROPHYSIOL, V98, P3197, DOI 10.1152/jn.00798.2007; Zhou XM, 2012, SYST BIOL, V61, P150, DOI 10.1093/sysbio/syr089; [No title captured], DOI DOI 10.1002/(SICI)1096-8644(1998)107:27+<211::AID-AJPA8>3.0.CO;2-V	89	25	25	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61998	10.1371/journal.pone.0061998	http://dx.doi.org/10.1371/journal.pone.0061998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637943	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400064
J	Hoyer, J; Burmann, I; Kieseler, ML; Vollrath, F; Hellrung, L; Arelin, K; Roggenhofer, E; Villringer, A; Sacher, J				Hoyer, Jana; Burmann, Inga; Kieseler, Marie-Luise; Vollrath, Florian; Hellrung, Lydia; Arelin, Katrin; Roggenhofer, Elisabeth; Villringer, Arno; Sacher, Julia			Menstrual Cycle Phase Modulates Emotional Conflict Processing in Women with and without Premenstrual Syndrome (PMS) - A Pilot Study	PLOS ONE			English	Article							DYSPHORIC DISORDER; TENSION SYNDROME; PANIC DISORDER; DEPRESSION; CORTISOL; SYMPTOMS; MOOD; PREVALENCE; STRESS; MEMORY	Background: Premenstrual syndrome (PMS) is characterized by a cluster of psychological and somatic symptoms during the late luteal phase of the menstrual cycle that disappear after the onset of menses. Behavioral differences in emotional and cognitive processing have been reported in women with PMS, and it is of particular interest whether PMS affects the parallel execution of emotional and cognitive processing. Related to this is the question of how the performance of women with PMS relates to stress levels compared to women without PMS. Cortisol has been shown to affect emotional processing in general and it has also been shown that women with severe PMS have a particular cortisol profile. Methods: We measured performance in an emotional conflict task and stress levels in women with PMS (n = 15) and women without PMS (n = 15) throughout their menstrual cycle. Results: We found a significant increase (p = 0.001) in the mean reaction time for resolving emotional conflict from the follicular to the luteal cycle phase in all subjects. Only women with PMS demonstrated an increase in physiological and subjective stress measures during the luteal menstrual cycle phase. Conclusions: Our findings suggest that the menstrual cycle modulates the integration of emotional and cognitive processing in all women. Preliminary data are supportive of the secondary hypothesis that stress levels are mediated by the menstrual cycle phase only in women with PMS. The presented evidence for menstrual cycle-specific differences in integrating emotional and cognitive information highlights the importance of controlling for menstrual cycle phase in studies that aim to elucidate the interplay of emotion and cognition.	[Hoyer, Jana; Burmann, Inga; Kieseler, Marie-Luise; Vollrath, Florian; Hellrung, Lydia; Arelin, Katrin; Roggenhofer, Elisabeth; Villringer, Arno; Sacher, Julia] Max Planck Inst Human Cognit & Brain Sci, Dept Cognit Neurol, Leipzig, Germany; [Arelin, Katrin; Roggenhofer, Elisabeth; Villringer, Arno; Sacher, Julia] Univ Leipzig, Univ Hosp Leipzig, Clin Cognit Neurol, D-04109 Leipzig, Germany	Max Planck Society; Leipzig University	Sacher, J (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Cognit Neurol, Leipzig, Germany.	sacher@cbs.mpg.de	Hellrung, Lydia/AAC-3062-2019; Sacher, Julia/M-7060-2016	Hellrung, Lydia/0000-0003-0317-4770; Sacher, Julia/0000-0003-0944-0558; Villringer, Arno/0000-0003-2604-2404	Alexander von Humboldt Foundation (AvH); Society in Science (SoS) Branco Weiss fellowship	Alexander von Humboldt Foundation (AvH)(Alexander von Humboldt Foundation); Society in Science (SoS) Branco Weiss fellowship	This work was supported by project and salary support from the Alexander von Humboldt Foundation (AvH) and a Society in Science (SoS) Branco Weiss fellowship to Dr. Julia Sacher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2009, PSYCHONEUROENDOCRINO, V34, P1423, DOI 10.1016/j.psyneuen.2009.06.011; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreano JM, 2008, PSYCHONEUROENDOCRINO, V33, P874, DOI 10.1016/j.psyneuen.2008.03.009; Backstrom T, 2003, CNS DRUGS, V17, P325; Banerjee N, 2000, INT J FERTIL WOMEN M, V45, P342; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bentz D, 2012, NERVENARZT, V83, P33, DOI 10.1007/s00115-010-3210-6; Chechko N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005537; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Derntl B, 2008, HORM BEHAV, V53, P90, DOI 10.1016/j.yhbeh.2007.09.006; Dickerson LM, 2003, AM FAM PHYSICIAN, V67, P1743; Ekman P., 1976, PICTURES FACIAL AFFE; Epperson CN, 2012, AM J PSYCHIAT, V169, P465, DOI 10.1176/appi.ajp.2012.11081302; Epperson CN, 2007, NEUROPSYCHOPHARMACOL, V32, P2190, DOI 10.1038/sj.npp.1301351; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, AM J PSYCHIAT, V168, P968, DOI 10.1176/appi.ajp.2011.10091290; First M. B., 2002, STRUCTURED CLIN INTE; Frey BN, 2010, MENOPAUSE, V17, P840, DOI 10.1097/gme.0b013e3181df840f; Girdler SS, 2001, BIOL PSYCHIAT, V49, P788, DOI 10.1016/S0006-3223(00)01044-1; Guapo VG, 2009, PSYCHONEUROENDOCRINO, V34, P1087, DOI 10.1016/j.psyneuen.2009.02.007; Halbreich U, 2010, J AFFECT DISORDERS, V122, P10, DOI 10.1016/j.jad.2009.05.018; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hartlage SA, 2012, ARCH GEN PSYCHIAT, V69, P300, DOI 10.1001/archgenpsychiatry.2011.1368; HASKETT RF, 1984, J AFFECT DISORDERS, V6, P191, DOI 10.1016/0165-0327(84)90024-7; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; JOHNSON SR, 1987, CLIN OBSTET GYNECOL, V30, P367, DOI 10.1097/00003081-198706000-00017; KEENAN PA, 1992, PSYCHONEUROENDOCRINO, V17, P179, DOI 10.1016/0306-4530(92)90056-D; KENDLER KS, 1992, PSYCHOL MED, V22, P85, DOI 10.1017/S0033291700032761; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nepomnaschy PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018242; Nillni YI, 2011, CLIN PSYCHOL REV, V31, P1183, DOI 10.1016/j.cpr.2011.07.006; Odber J, 1998, J PSYCHOSOM RES, V45, P557, DOI 10.1016/S0022-3999(98)00061-0; Ogebe O, 2011, J PEDIATR ADOL GYNEC, V24, P397, DOI 10.1016/j.jpag.2011.07.009; PARRY BL, 1991, NEUROPSYCHOPHARMACOL, V5, P127; Parry BL, 2000, BIOL PSYCHIAT, V48, P920, DOI 10.1016/S0006-3223(00)00876-3; PEARLSTEIN TB, 1995, AM J OBSTET GYNECOL, V173, P646, DOI 10.1016/0002-9378(95)90297-X; Pearson R, 2005, HORM BEHAV, V47, P267, DOI 10.1016/j.yhbeh.2004.11.003; Protopopescu X, 2008, J AFFECT DISORDERS, V108, P87, DOI 10.1016/j.jad.2007.09.015; RABIN DS, 1990, J CLIN ENDOCR METAB, V71, P1158, DOI 10.1210/jcem-71-5-1158; Reed SC, 2008, HORM BEHAV, V54, P185, DOI 10.1016/j.yhbeh.2008.02.018; Robinson RL, 2000, J WOMEN HEALTH GEN-B, V9, P757, DOI 10.1089/15246090050147736; Rohleder N, 2003, STRESS, V6, P207, DOI 10.1080/1025389031000153658; Rubinow DR, 2007, J AFFECT DISORDERS, V104, P37, DOI 10.1016/j.jad.2007.01.031; Rubinow DR, 2006, FRONT NEUROENDOCRIN, V27, P210, DOI 10.1016/j.yfrne.2006.02.003; Sakaki M, 2012, SOC PERSONAL PSYCHOL, V6, P1, DOI 10.1111/j.1751-9004.2011.00415.x; Schmidt PJ, 1998, NEW ENGL J MED, V338, P209, DOI 10.1056/NEJM199801223380401; STEINER M, 1984, BRIT J OBSTET GYNAEC, V91, P466, DOI 10.1111/j.1471-0528.1984.tb04785.x; Steiner M, 2003, Arch Womens Ment Health, V6, P203, DOI 10.1007/s00737-003-0018-4; Steiner M, 1997, ANNU REV MED, V48, P447, DOI 10.1146/annurev.med.48.1.447; Steiner M, 2011, ARCH WOMEN MENT HLTH, V14, P77, DOI 10.1007/s00737-010-0202-2; STOUT AL, 1986, AM J PSYCHIAT, V143, P1436; Takeda T, 2006, ARCH WOMEN MENT HLTH, V9, P209, DOI 10.1007/s00737-006-0137-9; Van Honk J, 2003, PSYCHONEUROENDOCRINO, V28, P941, DOI 10.1016/S0306-4530(02)00116-6; Walder DJ, 2012, PSYCHIAT RES, V197, P314, DOI 10.1016/j.psychres.2011.09.009; Wittchen HU, 2002, PSYCHOL MED, V32, P119, DOI 10.1017/S0033291701004925	55	34	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e59780	10.1371/journal.pone.0059780	http://dx.doi.org/10.1371/journal.pone.0059780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637739	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400003
J	Kish, L; Hotte, N; Kaplan, GG; Vincent, R; Tso, R; Ganzle, M; Rioux, KP; Thiesen, A; Barkema, HW; Wine, E; Madsen, KL				Kish, Lisa; Hotte, Naomi; Kaplan, Gilaad G.; Vincent, Renaud; Tso, Robert; Gaenzle, Michael; Rioux, Kevin P.; Thiesen, Aducio; Barkema, Herman W.; Wine, Eytan; Madsen, Karen L.			Environmental Particulate Matter Induces Murine Intestinal Inflammatory Responses and Alters the Gut Microbiome	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; DIESEL EXHAUST PARTICLES; RAT ALVEOLAR MACROPHAGES; AMBIENT AIR-POLLUTION; GENE-DEFICIENT MICE; EPITHELIAL-CELLS; BOWEL DISEASES; CROHNS-DISEASE; RIBOSOMAL-RNA; CYTOKINE PRODUCTION	Background: Particulate matter (PM) is a key pollutant in ambient air that has been associated with negative health conditions in urban environments. The aim of this study was to examine the effects of orally administered PM on the gut microbiome and immune function under normal and inflammatory conditions. Methods: Wild-type 129/SvEv mice were gavaged with Ottawa urban PM10 (EHC-93) for 7-14 days and mucosal gene expression analyzed using Ingenuity Pathways software. Intestinal permeability was measured by lactulose/mannitol excretion in urine. At sacrifice, segments of small and large intestine were cultured and cytokine secretion measured. Splenocytes were isolated and incubated with PM10 for measurement of proliferation. Long-term effects of exposure (35 days) on intestinal cytokine expression were measured in wild-type and IL-10 deficient (IL-10(-/-)) mice. Microbial composition of stool samples was assessed using terminal restriction fragment length polymorphism. Short chain fatty acids were measured in caecum. Results: Short-term treatment of wild-type mice with PM10 altered immune gene expression, enhanced pro-inflammatory cytokine secretion in the small intestine, increased gut permeability, and induced hyporesponsiveness in splenocytes. Long-term treatment of wild-type and IL-10(-/-) mice increased pro-inflammatory cytokine expression in the colon and altered short chain fatty acid concentrations and microbial composition. IL-10(-/-) mice had increased disease as evidenced by enhanced histological damage. Conclusions: Ingestion of airborne particulate matter alters the gut microbiome and induces acute and chronic inflammatory responses in the intestine.	[Kish, Lisa; Hotte, Naomi; Tso, Robert; Madsen, Karen L.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Kaplan, Gilaad G.; Rioux, Kevin P.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Vincent, Renaud] Hlth Canada, Environm Hlth Directorate, Ottawa, ON K1A 0L2, Canada; [Gaenzle, Michael] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Thiesen, Aducio] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Barkema, Herman W.] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB, Canada; [Wine, Eytan] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Alberta; University of Calgary; Health Canada; University of Alberta; University of Alberta; University of Calgary; University of Alberta	Madsen, KL (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	karen.madsen@ualberta.ca	Madsen, Karen L/H-5898-2011; Gänzle, Michael/F-1432-2017; Barkema, Herman/B-9583-2008; Kaplan, Gil/AAH-2335-2021	Gänzle, Michael/0000-0003-0972-928X; Barkema, Herman/0000-0002-9678-8378; Kaplan, Gil/0000-0003-2719-0556	Alberta IBD Consortium; Alberta Innovates; Canadian Institutes for Health Research; Crohns and Colitis Foundation of Canada	Alberta IBD Consortium; Alberta Innovates; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Crohns and Colitis Foundation of Canada	This study was funded through the Alberta IBD Consortium, Alberta Innovates, Canadian Institutes for Health Research, and Crohns and Colitis Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson IYR, 1999, TOXICOL APPL PHARM, V157, P43, DOI 10.1006/taap.1999.8658; Ananthakrishnan AN, 2011, INFLAMM BOWEL DIS, V17, P1138, DOI 10.1002/ibd.21455; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888; Beamish LA, 2011, J CROHNS COLITIS, V5, P279, DOI 10.1016/j.crohns.2011.02.017; Becker S, 1996, TOXICOL APPL PHARM, V141, P637, DOI 10.1006/taap.1996.0330; Brook RD, 2010, CURR ATHEROSCLER REP, V12, P291, DOI 10.1007/s11883-010-0122-7; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Campeau JL, 2012, INFECT IMMUN, V80, P2632, DOI 10.1128/IAI.00288-12; Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254; Chen TM, 2007, AM J MED SCI, V333, P230, DOI 10.1097/MAJ.0b013e31803b8c91; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Brouwere K, 2012, SCI TOTAL ENVIRON, V419, P25, DOI 10.1016/j.scitotenv.2011.12.049; Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujii T, 2001, AM J RESP CELL MOL, V25, P265, DOI 10.1165/ajrcmb.25.3.4445; Ghio AJ, 1998, AM J PHYSIOL-LUNG C, V274, pL396, DOI 10.1152/ajplung.1998.274.3.L396; GUBERAN E, 1992, BRIT J IND MED, V49, P337; Hall J, 2008, IMMUNITY, V29, P1; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hetland RB, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-4; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Hotte NSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037932; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kaplan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047669; Kaplan GG, 2010, AM J GASTROENTEROL, V105, P2412, DOI 10.1038/ajg.2010.252; Kaplan GG, 2009, CAN MED ASSOC J, V181, P591, DOI 10.1503/cmaj.082068; Kennedy T, 1998, AM J RESP CELL MOL, V19, P366, DOI 10.1165/ajrcmb.19.3.3042; Kitts C L, 2001, Curr Issues Intest Microbiol, V2, P17; Kooter IM, 2005, INHAL TOXICOL, V17, P53, DOI 10.1080/08958370590885717; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leblanc JC, 2005, FOOD ADDIT CONTAM A, V22, P624, DOI 10.1080/02652030500135367; LI XY, 1994, AM J RESP CRIT CARE, V149, P1518, DOI 10.1164/ajrccm.149.6.8004308; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lomer MCE, 2004, BRIT J NUTR, V92, P947, DOI 10.1079/BJN20041276; Lomer MCE, 2002, P NUTR SOC, V61, P123, DOI 10.1079/PNS2001134; Ma BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047416; Madara JL, 2000, ADV DRUG DELIVER REV, V41, P251, DOI 10.1016/S0169-409X(00)00044-2; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Madsen KL, 2002, INFLAMM BOWEL DIS, V8, P390, DOI 10.1097/00054725-200211000-00003; Madsen KL, 2000, GASTROENTEROLOGY, V118, P1094, DOI 10.1016/S0016-5085(00)70362-3; Mage D, 1996, ATMOS ENVIRON, V30, P681, DOI 10.1016/1352-2310(95)00219-7; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Meddings JB, 1998, GASTROENTEROLOGY, V114, P83, DOI 10.1016/S0016-5085(98)70636-5; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Moller W, 2004, J APPL PHYSIOL, V97, P2200, DOI 10.1152/japplphysiol.00970.2003; Mukae H, 2000, AM J PHYSIOL-LUNG C, V279, pL924, DOI 10.1152/ajplung.2000.279.5.L924; Mutlu EA, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-19; Orazzo F, 2009, ENVIRON HEALTH PERSP, V117, P1780, DOI 10.1289/ehp.0900599; Samet J M, 2000, Res Rep Health Eff Inst, V94, P5; SAMET JM, 2000, RES REP HLTH EFF I, V94, P71; Sarkar S, 2012, ENV MONIT ASSESS; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Semmler-Behnke M, 2007, ENVIRON HEALTH PERSP, V115, P728, DOI 10.1289/ehp.9685; Sepehri S, 2007, INFLAMMATORY BOWEL D; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Solano AF, 2008, FREE RADICAL RES, V42, P707, DOI 10.1080/10715760802311179; Soon IS, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-51; Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; URBANSKI SJ, 1989, MODERN PATHOL, V2, P222; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vincent R, 1997, AM J PATHOL, V151, P1563; Vincent R, 1997, FUND APPL TOXICOL, V39, P18, DOI 10.1006/faat.1997.2336; Willemsen LEM, 2003, GUT, V52, P1442, DOI 10.1136/gut.52.10.1442; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766; Zhang R, 2008, FEMS MICROBIOL ECOL, V65, P169, DOI 10.1111/j.1574-6941.2008.00493.x	73	164	172	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62220	10.1371/journal.pone.0062220	http://dx.doi.org/10.1371/journal.pone.0062220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638009	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400086
J	Liu, Y; Feng, J; Metzner, W				Liu, Ying; Feng, Jiang; Metzner, Walter			Different Auditory Feedback Control for Echolocation and Communication in Horseshoe Bats	PLOS ONE			English	Article							SOCIAL CALLS; RHINOLOPHUS-FERRUMEQUINUM; VOCAL COMMUNICATION; MOUSTACHED BAT; CONCOMITANT SHIFTS; FORAGING BEHAVIOR; MYOTIS-LUCIFUGUS; BROWN BATS; NOSED BAT; FREQUENCY	Auditory feedback from the animal's own voice is essential during bat echolocation: to optimize signal detection, bats continuously adjust various call parameters in response to changing echo signals. Auditory feedback seems also necessary for controlling many bat communication calls, although it remains unclear how auditory feedback control differs in echolocation and communication. We tackled this question by analyzing echolocation and communication in greater horseshoe bats, whose echolocation pulses are dominated by a constant frequency component that matches the frequency range they hear best. To maintain echoes within this "auditory fovea'', horseshoe bats constantly adjust their echolocation call frequency depending on the frequency of the returning echo signal. This Doppler-shift compensation (DSC) behavior represents one of the most precise forms of sensory-motor feedback known. We examined the variability of echolocation pulses emitted at rest (resting frequencies, RFs) and one type of communication signal which resembles an echolocation pulse but is much shorter (short constant frequency communication calls, SCFs) and produced only during social interactions. We found that while RFs varied from day to day, corroborating earlier studies in other constant frequency bats, SCF-frequencies remained unchanged. In addition, RFs overlapped for some bats whereas SCF-frequencies were always distinctly different. This indicates that auditory feedback during echolocation changed with varying RFs but remained constant or may have been absent during emission of SCF calls for communication. This fundamentally different feedback mechanism for echolocation and communication may have enabled these bats to use SCF calls for individual recognition whereas they adjusted RF calls to accommodate the daily shifts of their auditory fovea.	[Liu, Ying; Feng, Jiang] NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Jilin, Peoples R China; [Liu, Ying; Metzner, Walter] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Metzner, Walter] Doshisha Univ, Neurosensing & Bionav Res Ctr, Kyotanabe, Kyoto, Japan	Northeast Normal University - China; University of California System; University of California Los Angeles; Doshisha University	Feng, J (corresponding author), NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Jilin, Peoples R China.	fengj@nenu.edu.cn; metzner@ucla.edu			Natural Science Foundation of China [30900166, 31030011]; Chinese Education Ministry [MS2011DBSF023]; program for Introducing Talents to Universities [B07017]; National Institutes of Health [DC5400]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Education Ministry(Ministry of Education, China); program for Introducing Talents to Universities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by Natural Science Foundation of China to YL (Grant No.: 30900166) and JF (Grant No.: 31030011), a cooperation grant from the Chinese Education Ministry to JF and WM (Grant No.: MS2011DBSF023), the program for Introducing Talents to Universities (B07017) to JF, and National Institutes of Health to WM (DC5400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1990, J MAMMAL, V71, P242, DOI 10.2307/1382175; ALTES RA, 1976, J ACOUST SOC AM, V59, P97, DOI 10.1121/1.380831; BALCOMBE JP, 1990, ANIM BEHAV, V39, P960, DOI 10.1016/S0003-3472(05)80961-3; BARCLAY RMR, 1979, J MAMMAL, V60, P632, DOI 10.2307/1380109; Behr O, 2004, BEHAV ECOL SOCIOBIOL, V56, P106, DOI 10.1007/s00265-004-0768-7; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Bohn KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006746; Boughman JW, 2003, SPR HDB AUD, V16, P138; Boughman JW, 1998, ANIM BEHAV, V55, P1717, DOI 10.1006/anbe.1997.0721; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; BROWN P, 1976, Z TIERPSYCHOL, V41, P34; deFanis E, 1996, J ZOOL, V240, P781, DOI 10.1111/j.1469-7998.1996.tb05324.x; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; ESSER KH, 1994, NEUROREPORT, V5, P1718, DOI 10.1097/00001756-199409080-00007; Fenton M.B., 1985, COMMUNICATION CHIROP; FENTON MB, 1977, CAN J ZOOL, V55, P1151, DOI 10.1139/z77-149; Fenton MB, 1994, COMMUNICATION CHIROP; Fenzl T, 2007, BEHAV BRAIN RES, V182, P173, DOI 10.1016/j.bbr.2006.12.021; GOLDMAN LJ, 1977, BEHAV ECOL SOCIOBIOL, V2, P411, DOI 10.1007/BF00299509; GRINNELL AD, 1989, NATURE, V341, P488, DOI 10.1038/341488a0; Hage SR, 2010, HBK BEHAV NEUROSCI, V19, P339, DOI 10.1016/B978-0-12-374593-4.00032-2; Hiryu S, 2006, J COMP PHYSIOL A, V192, P807, DOI 10.1007/s00359-006-0118-5; HUFFMAN RF, 1993, J COMP PHYSIOL A, V171, P735, DOI 10.1007/BF00213070; HUFFMAN RF, 1993, J COMP PHYSIOL A, V171, P725, DOI 10.1007/BF00213069; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; JONES G, 1994, FOLIA ZOOL, V43, P347; JONES G, 1991, J ZOOL, V225, P71, DOI 10.1111/j.1469-7998.1991.tb03802.x; JONES G, 1989, BEHAV ECOL SOCIOBIOL, V25, P183, DOI 10.1007/BF00302917; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Knornschild M, 2007, ANIM BEHAV, V74, P1055, DOI 10.1016/j.anbehav.2006.12.024; Knornschild M, 2010, BIOL LETTERS, V6, P156, DOI 10.1098/rsbl.2009.0685; KOSSL M, 1994, HEARING RES, V72, P73, DOI 10.1016/0378-5955(94)90207-0; Kunz Thomas H., 2000, P415, DOI 10.1016/B978-012195670-7/50011-4; Ma J, 2006, J COMP PHYSIOL A, V192, P535, DOI 10.1007/s00359-006-0094-9; MASTERS WM, 1995, ANIM BEHAV, V50, P1243, DOI 10.1016/0003-3472(95)80041-7; MATSUMURA S, 1981, J MAMMAL, V62, P20, DOI 10.2307/1380474; Metzner W, 2002, J EXP BIOL, V205, P1607; MOHRES FP, 1953, Z VERGL PHYSIOL, V34, P547, DOI 10.1007/BF00297923; NEUWEILER G, 1987, BEHAV ECOL SOCIOBIOL, V20, P53, DOI 10.1007/BF00292166; NEUWEILER G, 1990, PHYSIOL REV, V70, P615, DOI 10.1152/physrev.1990.70.3.615; Pfalzer G, 2003, J ZOOL, V261, P21, DOI 10.1017/S0952836903003935; RUBSAMEN R, 1990, J COMP PHYSIOL A, V167, P771; Russo D, 1999, J ZOOL, V249, P476, DOI 10.1111/j.1469-7998.1999.tb01219.x; SCHERRER JA, 1993, ANIM BEHAV, V46, P847, DOI 10.1006/anbe.1993.1270; Schmidt C., 1981, Z SAUGETIERKD, V47, P143; Schnitzler HU, 2011, J COMP PHYSIOL A, V197, P541, DOI 10.1007/s00359-010-0569-6; SCHNITZLER HU, 1968, Z VERGL PHYSIOL, V57, P376, DOI 10.1007/BF00303062; SCHULLER G, 1979, J COMP PHYSIOL, V132, P47, DOI 10.1007/BF00617731; SCHULLER G, 1986, J COMP PHYSIOL A, V158, P239, DOI 10.1007/BF01338567; SCHULLER G, 1974, J COMP PHYSIOL, V89, P275, DOI 10.1007/BF00696191; Smotherman M, 2005, J NEUROPHYSIOL, V93, P1295, DOI 10.1152/jn.00653.2004; Smotherman M, 2003, J COMP PHYSIOL A, V189, P435, DOI 10.1007/s00359-003-0422-2; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; THOMSON CE, 1985, CAN J ZOOL, V63, P1982, DOI 10.1139/z85-290; Tian B, 1997, J ACOUST SOC AM, V101, P2347, DOI 10.1121/1.418272; Vater M, 2004, ECHOLOCATION BATS DO, P89; Wilkinson GS, 2003, ANIMAL SOCIAL COMPLEXITY, P322; Wilkinson GS, 1998, ANIM BEHAV, V55, P337, DOI 10.1006/anbe.1997.0557	59	14	15	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62710	10.1371/journal.pone.0062710	http://dx.doi.org/10.1371/journal.pone.0062710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638137	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400123
J	Propper, RE; McGraw, SE; Brunye, TT; Weiss, M				Propper, Ruth E.; McGraw, Sean E.; Brunye, Tad T.; Weiss, Michael			Getting a Grip on Memory: Unilateral Hand Clenching Alters Episodic Recall	PLOS ONE			English	Article							HEMISPHERIC ACTIVATION; AFFECTIVE STYLE; HANDEDNESS; CONTRACTION; ASYMMETRY; EMOTION	Unilateral hand clenching increases neuronal activity in the frontal lobe of the contralateral hemisphere. Such hand clenching is also associated with increased experiencing of a given hemisphere's "mode of processing.'' Together, these findings suggest that unilateral hand clenching can be used to test hypotheses concerning the specializations of the cerebral hemispheres during memory encoding and retrieval. We investigated this possibility by testing effects of unilateral hand clenching on episodic memory. The hemispheric Encoding/Retrieval Asymmetry (HERA) model proposes left prefrontal regions are associated with encoding, and right prefrontal regions with retrieval, of episodic memories. It was hypothesized that right hand clenching (left hemisphere activation) pre-encoding, and left hand clenching (right hemisphere activation) pre-recall, would result in superior memory. Results supported the HERA model. Also supported was that simple unilateral hand clenching can be used as a means by which the functional specializations of the cerebral hemispheres can be investigated in intact humans.	[Propper, Ruth E.; McGraw, Sean E.; Weiss, Michael] Montclair State Univ, Dept Psychol, Montclair, NJ 07043 USA; [Brunye, Tad T.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Brunye, Tad T.] USA, Natick Soldier Res, Ctr Dev & Engn, Natick, MA 01760 USA	Montclair State University; Tufts University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM)	Propper, RE (corresponding author), Montclair State Univ, Dept Psychol, Montclair, NJ 07043 USA.	propperr@mail.montclair.edu		Brunye, Tad/0000-0002-8788-8764	U.S. Army [W911QY-12-C-0046]	U.S. Army	Parts of this work were supported by U.S. Army contract #W911QY-12-C-0046 to author R.E.P. The opinions expressed herein are those of the authors and not necessarily of the US Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; GRAF P, 1984, J VERB LEARN VERB BE, V23, P553, DOI 10.1016/S0022-5371(84)90346-3; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Harmon-Jones E, 2006, PSYCHOPHYSIOLOGY, V43, P598, DOI 10.1111/j.1469-8986.2006.00465.x; Khedr EM, 2002, EUR J APPL PHYSIOL, V87, P469, DOI 10.1007/s00421-002-0652-y; Lyle KB, 2008, NEUROPSYCHOLOGY, V22, P523, DOI 10.1037/0894-4105.22.4.523; Nicholls MER, 2001, BRAIN COGNITION, V46, P219, DOI 10.1016/S0278-2626(01)80070-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peterson CK, 2008, PSYCHOPHYSIOLOGY, V45, P86, DOI 10.1111/j.1469-8986.2007.00597.x; Propper RE, 2005, MEM COGNITION, V33, P751, DOI 10.3758/BF03195341; Propper RE, 2010, J NERV MENT DIS, V198, P691, DOI 10.1097/NMD.0b013e3181ef1f35; Rogers L.J., 2013, DIVIDED BRAINS BIOL; SCHIFF BB, 1994, CORTEX, V30, P247, DOI 10.1016/S0010-9452(13)80196-7; SCHIFF BB, 1989, NEUROPSYCHOLOGIA, V27, P923, DOI 10.1016/0028-3932(89)90068-7; TOMARKEN AJ, 1992, J PERS SOC PSYCHOL, V62, P676, DOI 10.1037/0022-3514.62.4.676; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; TULVING E, 1982, J EXP PSYCHOL LEARN, V8, P336, DOI 10.1037/0278-7393.8.4.336	18	20	20	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62474	10.1371/journal.pone.0062474	http://dx.doi.org/10.1371/journal.pone.0062474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136DE	23638094	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400111
J	Song, KJ; Mize, RR; Marrero, L; Corti, M; Kirk, JM; Pincus, SH				Song, Kejing; Mize, R. Ranney; Marrero, Luis; Corti, Miriam; Kirk, Jason M.; Pincus, Seth H.			Antibody to Ricin A Chain Hinders Intracellular Routing of Toxin and Protects Cells Even after Toxin Has Been Internalized	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; DIPHTHERIA-TOXIN; IN-VITRO; ANTHRAX TOXIN; BREFELDIN-A; NEUTRALIZATION; MICE; ENDOCYTOSIS; INHIBITION; TRANSPORT	Background: Mechanisms of antibody-mediated neutralization are of much interest. For plant and bacterial A-B toxins, A chain mediates toxicity and B chain binds target cells. It is generally accepted and taught that antibody (Ab) neutralizes by preventing toxin binding to cells. Yet for some toxins, ricin included, anti-A chain Abs afford greater protection than anti-B. The mechanism(s) whereby Abs to the A chain neutralize toxins are not understood. Methodology/Principal Findings: We use quantitative confocal imaging, neutralization assays, and other techniques to study how anti-A chain Abs function to protect cells. Without Ab, ricin enters cells and penetrates to the endoplasmic reticulum within 15 min. Within 45-60 min, ricin entering and being expelled from cells reaches equilibrium. These results are consistent with previous observations, and support the validity of our novel methodology. The addition of neutralizing Ab causes ricin accumulation at the cell surface, delays internalization, and postpones retrograde transport of ricin. Ab binds ricin for >6hr as they traffic together through the cell. Ab protects cells even when administered hours after exposure. Conclusions/Key Findings: We demonstrate the dynamic nature of the interaction between the host cell and toxin, and how Ab can alter the balance in favor of the cell. Ab blocks ricin's entry into cells, hinders its intracellular routing, and can protect even after ricin is present in the target organelle, providing evidence that the major site of neutralization is intracellular. These data add toxins to the list of pathogenic agents that can be neutralized intracellularly and explain the in vivo efficacy of delayed administration of anti-toxin Abs. The results encourage the use of post-exposure passive Ab therapy, and show the importance of the A chain as a target of Abs.	[Song, Kejing; Corti, Miriam; Pincus, Seth H.] Childrens Hosp, Res Inst Children, New Orleans, LA USA; [Mize, R. Ranney] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA; [Marrero, Luis] Louisiana State Univ, Hlth Sci Ctr, Imaging Core, New Orleans, LA USA; [Pincus, Seth H.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Pincus, Seth H.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Kirk, Jason M.] Carl Zeiss Microimaging, Thornwood, NY USA	Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Carl Zeiss AG	Pincus, SH (corresponding author), Childrens Hosp, Res Inst Children, New Orleans, LA USA.	spincus@chnola-research.org			USPHS [AI 059376]; Research Institute for Children; Louisiana Vaccine Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059376] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Research Institute for Children; Louisiana Vaccine Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by USPHS grant AI 059376 and by funds from the Research Institute for Children (www.chnola-research.org) and the Louisiana Vaccine Center (www.louisianavc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 2010, INFECT IMMUN, V78, P1376, DOI 10.1128/IAI.00867-09; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; BARBIERI JT, 1992, INFECT IMMUN, V60, P5071, DOI 10.1128/IAI.60.12.5071-5077.1992; CALAFAT J, 1988, CANCER RES, V48, P3822; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Dobrucki JW, 2004, METHOD CELL BIOL, V75, P41; Feng NG, 2002, J CLIN INVEST, V109, P1203, DOI 10.1172/JCI200214397; FOXWELL BMJ, 1985, TOXICOLOGY, V34, P79, DOI 10.1016/0300-483X(85)90080-0; HANSEN SH, 1989, EXP CELL RES, V185, P373, DOI 10.1016/0014-4827(89)90307-8; Jeong KI, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-16; Joller N, 2010, P NATL ACAD SCI USA, V107, P20441, DOI 10.1073/pnas.1013827107; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; LEMLEY PV, 1994, HYBRIDOMA, V13, P417, DOI 10.1089/hyb.1994.13.417; Leppla SH, 2003, BACTERIAL PROTEIN TO, P132; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; MATSUDA M, 1992, EUR J EPIDEMIOL, V8, P1, DOI 10.1007/BF02427384; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Migone TS, 2009, NEW ENGL J MED, V361, P135, DOI 10.1056/NEJMoa0810603; Murphy K, 2008, JANEWAYS IMMUNOBIOLO, P413; NICOLSON GL, 1975, CANCER RES, V35, P144; NICOLSON GL, 1974, NATURE, V251, P628, DOI 10.1038/251628a0; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; OLSNES S, 1974, J IMMUNOL, V113, P842; PAPPENHEIMER AM, 1973, SCIENCE, V182, P353, DOI 10.1126/science.182.4110.353; PAPPENHEIMER AM, 1972, IMMUNOCHEMISTRY, V9, P891, DOI 10.1016/0019-2791(72)90163-2; Parham P, 2009, IMMUNE SYSTEM, P271; Paul WE, 2008, FUNDAMENTAL IMMUNOLO, P1195; Pincus SH, 2011, TOXINS, V3, P1163, DOI 10.3390/toxins3091163; PINCUS SH, 1991, J IMMUNOL, V146, P4315; Pincus SH, 2002, COMPARATIVE MED, V52, P530; Pratt TS, 2007, EXP LUNG RES, V33, P459, DOI 10.1080/01902140701731805; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; Radjainia M, 2010, P NATL ACAD SCI USA, V107, P14070, DOI 10.1073/pnas.1006473107; Roche JK, 2008, LAB INVEST, V88, P1178, DOI 10.1038/labinvest.2008.83; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; SANDVIG K, 1990, J BIOL CHEM, V265, P6382; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Smallshaw JE, 2002, VACCINE, V20, P3422, DOI 10.1016/S0264-410X(02)00312-2; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Staats HF, 2007, INFECT IMMUN, V75, P5443, DOI 10.1128/IAI.00529-07; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; VANDEURS B, 1988, J CELL BIOL, V106, P253, DOI 10.1083/jcb.106.2.253; VANDEURS B, 1985, EXP CELL RES, V159, P287, DOI 10.1016/S0014-4827(85)80003-3; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; Vitetta ES, 2006, P NATL ACAD SCI USA, V103, P2268, DOI 10.1073/pnas.0510893103; YAMAIZUMI M, 1978, CELL, V13, P227, DOI 10.1016/0092-8674(78)90191-5; YOULE RJ, 1987, J BIOL CHEM, V262, P4676; Zhou P, 1998, J IMMUNOL, V160, P1489; ZUCKER DR, 1984, MOL IMMUNOL, V21, P785, DOI 10.1016/0161-5890(84)90165-2	52	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62417	10.1371/journal.pone.0062417	http://dx.doi.org/10.1371/journal.pone.0062417			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638075	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400107
J	Stallings-Smith, S; Zeka, A; Goodman, P; Kabir, Z; Clancy, L				Stallings-Smith, Sericea; Zeka, Ariana; Goodman, Pat; Kabir, Zubair; Clancy, Luke			Reductions in Cardiovascular, Cerebrovascular, and Respiratory Mortality following the National Irish Smoking Ban: Interrupted Time-Series Analysis	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HOSPITAL ADMISSIONS; FREE LEGISLATION; SECONDHAND SMOKE; AIR-POLLUTION; IMPLEMENTATION; ASSOCIATION; WORKERS; STROKE; IMPACT	Background: Previous studies have shown decreases in cardiovascular mortality following the implementation of comprehensive smoking bans. It is not known whether cerebrovascular or respiratory mortality decreases post-ban. On March 29, 2004, the Republic of Ireland became the first country in the world to implement a national workplace smoking ban. The aim of this study was to assess the effect of this policy on all-cause and cause-specific, non-trauma mortality. Methods: A time-series epidemiologic assessment was conducted, utilizing Poisson regression to examine weekly age and gender-standardized rates for 215,878 non-trauma deaths in the Irish population, ages >= 35 years. The study period was from January 1, 2000, to December 31, 2007, with a post-ban follow-up of 3.75 years. All models were adjusted for time trend, season, influenza, and smoking prevalence. Results: Following ban implementation, an immediate 13% decrease in all-cause mortality (RR: 0.87; 95% CI: 0.76-0.99), a 26% reduction in ischemic heart disease (IHD) (RR: 0.74; 95% CI: 0.63-0.88), a 32% reduction in stroke (RR: 0.68; 95% CI: 0.54-0.85), and a 38% reduction in chronic obstructive pulmonary disease (COPD) (RR: 0.62; 95% CI: 0.46-0.83) mortality was observed. Post-ban reductions in IHD, stroke, and COPD mortalities were seen in ages >= 65 years, but not in ages 35-64 years. COPD mortality reductions were found only in females (RR: 0.47; 95% CI: 0.32-0.70). Post-ban annual trend reductions were not detected for any smoking-related causes of death. Unadjusted estimates indicate that 3,726 (95% CI: 2,305-4,629) smoking-related deaths were likely prevented post-ban. Mortality decreases were primarily due to reductions in passive smoking. Conclusions: The national Irish smoking ban was associated with immediate reductions in early mortality. Importantly, post-ban risk differences did not change with a longer follow-up period. This study corroborates previous evidence for cardiovascular causes, and is the first to demonstrate reductions in cerebrovascular and respiratory causes.	[Stallings-Smith, Sericea; Zeka, Ariana] Brunel Univ, Inst Environm, London, England; [Goodman, Pat] Dublin Inst Technol, Environm Hlth Sci Inst, Dublin, Ireland; [Goodman, Pat; Clancy, Luke] TobaccoFree Res Inst Ireland, Dublin, Ireland; [Kabir, Zubair] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland	Brunel University; Technological University Dublin; University College Cork	Stallings-Smith, S (corresponding author), Brunel Univ, Inst Environm, London, England.	Sericea.Smith@brunel.ac.uk; Ariana.Zeka@brunel.ac.uk	clancy, luke/ABA-1826-2020; Clancy, Luke/O-6597-2019	Clancy, Luke/0000-0003-2407-2263; Zeka, Ariana/0000-0002-9570-8831; Kabir, Zubair/0000-0003-1529-004X; Goodman, Patrick/0000-0001-9509-131X				Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Barnett R, 2009, AUST NZ J PUBL HEAL, V33, P515, DOI 10.1111/j.1753-6405.2009.00446.x; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Barone-Adesi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017419; Bartecchi C, 2006, CIRCULATION, V114, P1490, DOI 10.1161/CIRCULATIONAHA.106.615245; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Central Statistics Office Ireland, 2011, CENS INT TABL CENS 1; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Cronin EM, 2012, CLIN CARDIOL, V35, P205, DOI 10.1002/clc.21014; Currie LM, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2011-050248; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dove MS, 2010, AM J PUBLIC HEALTH, V100, P2206, DOI 10.2105/AJPH.2009.189662; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; Goodman P, 2007, AM J RESP CRIT CARE, V175, P840, DOI 10.1164/rccm.200608-1085OC; Goodman PG, 2009, J AIR WASTE MANAGE, V59, P207, DOI [10.3155/1047-3289.59.2.207, 10.3155/1047-3289.59.1.207]; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P491, DOI 10.2105/AJPH.2009.179572; Irish Health Protection Surveillance Centre, 2011, PREV INFL SEAS SURV; Irish National Tobacco Control Office, 2012, CIG SMOK TRENDS; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; Kent BD, 2012, CHEST, V142, P673, DOI 10.1378/chest.11-2757; Kurth T, 2003, STROKE, V34, P1151, DOI 10.1161/01.STR.0000065200.93070.32; Law MR, 2003, PROG CARDIOVASC DIS, V46, P31, DOI 10.1016/S0033-0620(03)00078-1; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Mackay DF, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001175; Mulcahy M, 2005, TOB CONTROL, V14, P384, DOI 10.1136/tc.2005.011635; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; Oono IP, 2011, J PUBLIC HEALTH-UK, V33, P496, DOI 10.1093/pubmed/fdr025; Ornato JP, 1996, J AM COLL CARDIOL, V28, P1684, DOI 10.1016/S0735-1097(96)00411-1; Pechacek TF, 2004, BRIT MED J, V328, P980, DOI 10.1136/bmj.328.7446.980; Pell Jill P, 2008, N Engl J Med, V359, P482, DOI 10.1056/NEJMsa0706740; Pell JP, 1999, QJM-INT J MED, V92, P689, DOI 10.1093/qjmed/92.12.689; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; SAS, 2011, PROD GLIMMIX PROC; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Vasselli S, 2008, Minerva Cardioangiol, V56, P197; Villalbi JR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000067; Villalbi JR, 2009, REV ESP CARDIOL, V62, P812, DOI 10.1016/S0300-8932(09)71695-1; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; World Health Organization, 2019, WHO REPORT GLOBAL TO; Zeka A, 2005, OCCUP ENVIRON MED, V62, P718, DOI 10.1136/oem.2004.017012	47	65	70	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62063	10.1371/journal.pone.0062063	http://dx.doi.org/10.1371/journal.pone.0062063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136DE	23637964	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400074
J	Taichman, RS; Patel, LR; Bedenis, R; Wang, JC; Weidner, S; Schumann, T; Yumoto, K; Berry, JE; Shiozawa, Y; Pienta, KJ				Taichman, Russell S.; Patel, Lalit R.; Bedenis, Rachel; Wang, Jingcheng; Weidner, Savannah; Schumann, Taibriana; Yumoto, Kenji; Berry, Janice E.; Shiozawa, Yusuke; Pienta, Kenneth J.			GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; TYROSINE KINASE AXL; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HEMATOPOIETIC STEM-CELLS; IN-VIVO; THERAPEUTIC TARGET; ENDOTHELIAL-CELLS; PROGENITOR CELLS; DISEASE-ACTIVITY; GROWTH ARREST	Disseminated tumor cells (DTCs) are believed to lie dormant in the marrow before they can be activated to form metastases. How DTCs become dormant in the marrow and how dormant DTCs escape dormancy remains unclear. Recent work has shown that prostate cancer (PCa) cell lines express the growth-arrest specific 6 (GAS6) receptors Axl, Tyro3, and Mer, and become growth arrested in response to GAS6. We therefore hypothesized that GAS6 signaling regulates the proliferative activity of DTCs in the marrow. To explore this possibility, in vivo studies were performed where it was observed that when Tyro3 expression levels exceed Axl expression, the PCa cells exhibit rapid growth. When when Axl levels predominate, PCa cells remain largely quiescent. These findings suggest that a balance between the expression of Axl and Tyro3 is associated with a molecular switch between a dormant and a proliferative phenotype in PCa metastases.	[Taichman, Russell S.; Wang, Jingcheng; Yumoto, Kenji; Berry, Janice E.; Shiozawa, Yusuke] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Patel, Lalit R.; Bedenis, Rachel; Weidner, Savannah; Schumann, Taibriana; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Patel, Lalit R.; Bedenis, Rachel; Weidner, Savannah; Schumann, Taibriana; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Pienta, Kenneth J.] Brady Urol Inst, Dept Urol, Baltimore, MD USA; [Pienta, Kenneth J.] Brady Urol Inst, Dept Oncol, Baltimore, MD USA; [Pienta, Kenneth J.] Brady Urol Inst, Dept Pharmacol, Baltimore, MD USA; [Pienta, Kenneth J.] Brady Urol Inst, Dept Mol Sci, Baltimore, MD USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Taichman, RS (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	rtaich@umich.edu; kpienta1@jhmi.edu	Forster, Rachel/AAS-2634-2021	Patel, Lalit/0000-0002-9064-5560; Taichman, Russell S./0000-0002-7890-0020	National Cancer Institute [CA163124, CA093900]; Fund for Cancer Research; Department of Defense; Prostate Cancer Foundation; National Institutes of Health SPORE in prostate cancer [P50 CA69568]; Cancer Center [P30 CA46592]; NATIONAL CANCER INSTITUTE [P50CA069568, U54CA163124, P30CA046592, P01CA093900] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fund for Cancer Research; Department of Defense(United States Department of Defense); Prostate Cancer Foundation; National Institutes of Health SPORE in prostate cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is directly supported by the National Cancer Institute (CA163124, CA093900, YS, KJP and RST), the Fund for Cancer Research (RST), the Department of Defense (KJP and RST) and the Prostate Cancer Foundation (YS, KJP and RST). KJP receives support as an American Cancer Society Clinical Research Professor, National Institutes of Health SPORE in prostate cancer grant P50 CA69568, and the Cancer Center support grant P30 CA46592. The funding sources played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2003, CANC FACTS FIG 2003, P1; Athanassiadou P, 2006, CANCER METAST REV, V25, P507, DOI 10.1007/s10555-006-9030-2; Bellido-Martin L, 2008, VITAM HORM, V78, P185, DOI 10.1016/S0083-6729(07)00009-X; Caberoy NB, 2012, J CELL PHYSIOL, V227, P401, DOI 10.1002/jcp.22955; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chitteti BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017498; Cooper CR, 2000, ANTICANCER RES, V20, P4159; Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U; Crosier PS, 1996, EXP HEMATOL, V24, P318; Darby C, 2000, EXP HEMATOL, V28, P716, DOI 10.1016/S0301-472X(00)00162-4; Dormady SP, 2000, P NATL ACAD SCI USA, V97, P12260, DOI 10.1073/pnas.97.22.12260; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Ekman C, 2011, RHEUMATOLOGY, V50, P1064, DOI 10.1093/rheumatology/keq459; Ekman C, 2010, CLIN BIOCHEM, V43, P873, DOI 10.1016/j.clinbiochem.2010.04.006; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Havens A, 2008, NEOPLASIA, V10, P371, DOI 10.1593/neo.08154; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jung YH, 2007, BLOOD, V110, P82, DOI 10.1182/blood-2006-05-021352; Jung YH, 2012, NEOPLASIA, V14, P429, DOI 10.1596/neo.111740; Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Korenchuk S, 2001, IN VIVO, V15, P163; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Loberg RD, 2004, NEOPLASIA, V6, P302, DOI 10.1593/neo.03484; Mishra A, 2012, MOL CANCER RES, V10, P703, DOI 10.1158/1541-7786.MCR-11-0569; Mollard A, 2011, ACS MED CHEM LETT, V2, P907, DOI 10.1021/ml200198x; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; NEUBAUER A, 1994, BLOOD, V84, P1931; Paccez JD, 2012, ONCOGENE, P689; Park Serk In, 2010, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1415s51; Pienta KJ, 2008, TRANSL ONCOL, V1, P158, DOI 10.1593/tlo.08178; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Sainaghi PP, 2004, J CELLULAR PHYSL, P36; Shain SA, 2004, MOL CANCER RES, V2, P653; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Suh CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3088; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Taichman RS, 2007, J CLIN INVEST, V117, P2351, DOI 10.1172/JCI31791; THALMANN GN, 1994, CANCER RES, V54, P3953; THALMANN GN, 1994, CANCER RES, V54, P2577; van Ginkel PR, 2004, CANCER RES, V64, P128, DOI 10.1158/0008-5472.CAN-03-0245; Vessella Robert L, 2007, Cancer Biol Ther, V6, P1496; Viale A, 2009, EMBO MOL MED, V1, P88, DOI 10.1002/emmm.200900019; Weinger JG, 2009, AM J PATHOL, V175, P283, DOI 10.2353/ajpath.2009.080807; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yu CY, 2012, CRIT REV EUKAR GENE, V22, P131, DOI 10.1615/CritRevEukarGeneExpr.v22.i2.50	56	91	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61873	10.1371/journal.pone.0061873	http://dx.doi.org/10.1371/journal.pone.0061873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637920	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400055
J	Valle, BL; D'Souza, T; Becker, KG; Wood, WH; Zhang, YQ; Wersto, RP; Morin, PJ				Valle, Blanca L.; D'Souza, Theresa; Becker, Kevin G.; Wood, William H., III; Zhang, Yongqing; Wersto, Robert P.; Morin, Patrice J.			Non-Steroidal Anti-inflammatory Drugs Decrease E2F1 Expression and Inhibit Cell Growth in Ovarian Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2F-1; CYCLE ARREST; GENE-EXPRESSION; CARCINOMA-CELLS; DOWN-REGULATION; NUDE-MICE; INDOMETHACIN; APOPTOSIS; ASPIRIN; TUMORS	Epidemiological studies have shown that the regular use of non-steroidal anti-inflammatory (NSAIDs) drugs is associated with a reduced risk of various cancers. In addition, in vitro and experiments in mouse models have demonstrated that NSAIDs decrease tumor initiation and/or progression of several cancers. However, there are limited preclinical studies investigating the effects of NSAIDs in ovarian cancer. Here, we have studied the effects of two NSAIDs, diclofenac and indomethacin, in ovarian cancer cell lines and in a xenograft mouse model. Diclofenac and indomethacin treatment decreased cell growth by inducing cell cycle arrest and apoptosis. In addition, diclofenac and indomethacin reduced tumor volume in a xenograft model of ovarian cancer. To identify possible molecular pathways mediating the effects of NSAID treatment in ovarian cancer, we performed microarray analysis of ovarian cancer cells treated with indomethacin or diclofenac. Interestingly, several of the genes found downregulated following diclofenac or indomethacin treatment are transcriptional target genes of E2F1. E2F1 was downregulated at the mRNA and protein level upon treatment with diclofenac and indomethacin, and overexpression of E2F1 rescued cells from the growth inhibitory effects of diclofenac and indomethacin. In conclusion, NSAIDs diclofenac and indomethacin exert an anti-proliferative effect in ovarian cancer in vitro and in vivo and the effects of NSAIDs may be mediated, in part, by downregulation of E2F1.	[Valle, Blanca L.; D'Souza, Theresa; Morin, Patrice J.] NIA, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA; [Becker, Kevin G.; Wood, William H., III; Zhang, Yongqing; Wersto, Robert P.] NIA, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Morin, Patrice J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Medicine	Morin, PJ (corresponding author), Amer Assoc Canc Res, Philadelphia, PA USA.	pat.morin@aacr.org		Becker, Kevin/0000-0002-6794-6656	Intramural Research Program of the National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZICAG000618, ZIAAG000395, ZICAG000616] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Research Program of the National Institutes of Health, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2001, BIOCHEM BIOPH RES CO, V288, P579, DOI 10.1006/bbrc.2001.5819; BAYER BM, 1979, J PHARMACOL EXP THER, V210, P106; Bock JM, 2007, MOL CARCINOGEN, V46, P857, DOI 10.1002/mc.20318; Brooks G, 2003, J PHARM PHARMACOL, V55, P519, DOI 10.1211/002235702775; Chien J, 2009, GYNECOL ONCOL, V114, P3, DOI 10.1016/j.ygyno.2009.04.002; Chirasani SR, 2013, INT J CANCER, V132, P843, DOI 10.1002/ijc.27712; Crokart N, 2005, CANCER RES, V65, P7911, DOI 10.1158/0008-5472.CAN-05-1288; Cui W, 2005, CLIN CANCER RES, V11, P8213, DOI 10.1158/1078-0432.CCR-05-1044; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Detjen KM, 2003, INT J CANCER, V107, P844, DOI 10.1002/ijc.11446; Du YF, 2008, ONCOL REP, V20, P605, DOI 10.3892/or_00000048; Ebihara Y, 2004, DIS ESOPHAGUS, V17, P150, DOI 10.1111/j.1442-2050.2004.00393.x; Fischer SM, 2011, CANCER PREV RES, V4, P1728, DOI 10.1158/1940-6207.CAPR-11-0166; Gao JC, 2004, CANCER SCI, V95, P901, DOI 10.1111/j.1349-7006.2004.tb02200.x; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; KUDO T, 1980, GANN, V71, P260; Kwon HJ, 2010, CANCER LETT, V290, P96, DOI 10.1016/j.canlet.2009.09.003; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Lau LMS, 2009, ONCOGENE, V28, P2024, DOI 10.1038/onc.2009.59; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Liu SQ, 2004, J MED CHEM, V47, P999, DOI 10.1021/jm030346v; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayorek N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012715; Moody TW, 2010, LUNG CANCER, V68, P154, DOI 10.1016/j.lungcan.2009.06.012; NAGASAWA H, 1986, BREAST CANCER RES TR, V8, P249, DOI 10.1007/BF01807338; NARISAWA T, 1981, CANCER RES, V41, P1954; Price J E, 2001, Methods Mol Med, V58, P205, DOI 10.1385/1-59259-137-X:205; Reimer D, 2007, CLIN CANCER RES, V13, P144, DOI 10.1158/1078-0432.CCR-06-0780; Rodriguez-Burford C, 2002, CLIN CANCER RES, V8, P202; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Santander S, 2012, INT J ONCOL, V40, P527, DOI 10.3892/ijo.2011.1219; SCHILDER RJ, 1990, INT J CANCER, V45, P416, DOI 10.1002/ijc.2910450306; Singh R, 2011, APOPTOSIS, V16, P889, DOI 10.1007/s10495-011-0624-y; STRATTON JA, 1983, J CLIN LAB IMMUNOL, V11, P181; Suh DS, 2008, INT J GYNECOL CANCER, V18, P492, DOI 10.1111/j.1525-1438.2007.01044.x; Wernli KJ, 2008, BRIT J CANCER, V98, P1781, DOI 10.1038/sj.bjc.6604392; Yan KH, 2010, MOL CARCINOGEN, V49, P235, DOI 10.1002/mc.20593; Youns M, 2011, EUR J PHARMACOL, V650, P170, DOI 10.1016/j.ejphar.2010.10.026; Zacharatos P, 2004, J PATHOL, V203, P744, DOI 10.1002/path.1582; Zerbini LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024285	40	42	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61836	10.1371/journal.pone.0061836	http://dx.doi.org/10.1371/journal.pone.0061836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637916	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400054
J	Pepponi, I; Stylianou, E; van Dolleweerd, C; Diogo, GR; Paul, MJ; Drake, PMW; Ma, JKC; Reljic, R				Pepponi, Ilaria; Stylianou, Elena; van Dolleweerd, Craig; Diogo, Gil Reynolds; Paul, Matthew J.; Drake, Pascal M. W.; Ma, Julian K. -C.; Reljic, Rajko			Immune-Complex Mimics as a Molecular Platform for Adjuvant-Free Vaccine Delivery	PLOS ONE			English	Article							T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS INFECTION; B SURFACE-ANTIGEN; MONOCLONAL-ANTIBODIES; CROSS-PRESENTATION; DENDRITIC CELLS; IMMUNOGLOBULIN-A; DORMANCY REGULON; IGG-ANTIBODIES; PROTEIN	Protein-based vaccine development faces the difficult challenge of finding robust yet non-toxic adjuvants suitable for humans. Here, using a molecular engineering approach, we have developed a molecular platform for generating self-adjuvanting immunogens that do not depend on exogenous adjuvants for induction of immune responses. These are based on the concept of Immune Complex Mimics (ICM), structures that are formed between an oligomeric antigen and a monoclonal antibody (mAb) to that antigen. In this way, the roles of antigens and antibodies within the structure of immune complexes are reversed, so that a single monoclonal antibody, rather than polyclonal sera or expensive mAb cocktails can be used. We tested this approach in the context of Mycobacterium tuberculosis (MTB) infection by linking the highly immunogenic and potentially protective Ag85B with the oligomeric Acr (alpha crystallin, HspX) antigen. When combined with an anti-Acr monoclonal antibody, the fusion protein formed ICM which bound to C1q component of the complement system and were readily taken up by antigen-presenting cells in vitro. ICM induced a strong Th1/Th2 mixed type antibody response, which was comparable to cholera toxin adjuvanted antigen, but only moderate levels of T cell proliferation and IFN-gamma secretion. Unfortunately, the systemic administration of ICM did not confer statistically significant protection against intranasal MTB challenge, although a small BCG-boosting effect was observed. We conclude that ICM are capable of inducing strong humoral responses to incorporated antigens and may be a suitable vaccination approach for pathogens other than MTB, where antibody-based immunity may play a more protective role.	[Pepponi, Ilaria; Stylianou, Elena; van Dolleweerd, Craig; Diogo, Gil Reynolds; Paul, Matthew J.; Drake, Pascal M. W.; Ma, Julian K. -C.; Reljic, Rajko] St Georges Univ London, Infect & Immun Res Ctr, London, England	St Georges University London	Reljic, R (corresponding author), St Georges Univ London, Infect & Immun Res Ctr, London, England.	rreljic@sgul.ac.uk	Pepponi, Ilaria/AAA-6083-2020	Pepponi, Ilaria/0000-0001-7610-738X; Drake, Pascal/0000-0002-6181-0600; Paul, Mathew/0000-0002-0852-8788; Ma, Julian/0000-0003-0767-0042; van Dolleweerd, Craig/0000-0002-1380-6930	Dunhill Medical Trust [R40/0207]	Dunhill Medical Trust(Dunhill Medical Trust)	The work was supported by Dunhill Medical Trust grant R40/0207 (www.dunhillmedical.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Motal U, 2006, J VIROL, V80, P6943, DOI 10.1128/JVI.00310-06; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Antoniou AN, 2002, EUR J IMMUNOL, V32, P530, DOI 10.1002/1521-4141(200202)32:2<530::AID-IMMU530>3.0.CO;2-X; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Berengian AR, 1999, J BIOL CHEM, V274, P6305, DOI 10.1074/jbc.274.10.6305; BOESEN H, 1995, INFECT IMMUN, V63, P1491, DOI 10.1128/IAI.63.4.1491-1497.1995; Caccamo N, 2004, EUR J IMMUNOL, V34, P2220, DOI 10.1002/eji.200425090; Cady CT, 2010, IMMUNOL LETT, V130, P57, DOI 10.1016/j.imlet.2009.12.001; CELIS E, 1984, SCIENCE, V224, P297, DOI 10.1126/science.6231724; CELIS E, 1984, P NATL ACAD SCI-BIOL, V81, P6846, DOI 10.1073/pnas.81.21.6846; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; Chargelegue D, 2005, INFECT IMMUN, V73, P5915, DOI 10.1128/IAI.73.9.5915-5922.2005; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; EISENBERG RJ, 1982, J VIROL, V41, P478, DOI 10.1128/JVI.41.2.478-488.1982; Falero-Diaz G, 2000, INT ARCH ALLERGY IMM, V122, P143, DOI 10.1159/000024370; Guyre PM, 1997, CANCER IMMUNOL IMMUN, V45, P146, DOI 10.1007/s002620050418; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HEYMAN B, 1990, IMMUNOL TODAY, V11, P310, DOI 10.1016/0167-5699(90)90126-T; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; HOUSTON WE, 1977, J INFECT DIS, V135, P600, DOI 10.1093/infdis/135.4.600; JACKETT PS, 1988, J CLIN MICROBIOL, V26, P2313, DOI 10.1128/JCM.26.11.2313-2318.1988; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; JEMMERSON R, 1986, SCIENCE, V232, P1001, DOI 10.1126/science.2422757; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; KLAUS GGB, 1978, IMMUNOLOGY, V34, P643; LAISSUE J, 1971, J IMMUNOL, V107, P822; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Li Q, 2011, SCAND J IMMUNOL, V73, P568, DOI 10.1111/j.1365-3083.2011.02531.x; MANCA F, 1988, J IMMUNOL, V140, P2893; MARUSICGALESIC S, 1992, IMMUNOLOGY, V75, P325; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; Moreno-Mendieta SA, 2010, FEMS IMMUNOL MED MIC, V58, P75, DOI 10.1111/j.1574-695X.2009.00629.x; Mustafa AS, 1998, SCAND J IMMUNOL, V48, P535; OSATO K, 1972, IMMUNOLOGY, V23, P545; Pal R, 2010, APMIS, V118, P729, DOI 10.1111/j.1600-0463.2010.02650.x; Phoolcharoen W, 2011, PLANT BIOTECHNOL J, V9, P807, DOI 10.1111/j.1467-7652.2011.00593.x; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Polyanskaya N, 2001, VIROLOGY, V279, P527, DOI 10.1006/viro.2000.0704; Raja A, 2002, CLIN DIAGN LAB IMMUN, V9, P308, DOI 10.1128/CDLI.9.2.308-312.2002; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; REID KBM, 1986, ESSAYS BIOCHEM, V22, P27; Reljic R, 2006, CLIN EXP IMMUNOL, V143, P467, DOI 10.1111/j.1365-2249.2006.03012.x; Reljic R, 2006, TUBERCULOSIS, V86, P179, DOI 10.1016/j.tube.2006.01.011; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; SCHALKE BCG, 1985, J IMMUNOL, V134, P3643; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; TERRES G, 1972, J IMMUNOL, V108, P1473; Villinger F, 2003, J VIROL, V77, P10, DOI 10.1128/JVI.77.1.10-24.2003; Wen YM, 2009, EXPERT OPIN BIOL TH, V9, P285, DOI [10.1517/14712590802715749, 10.1517/14712590802715749 ]; WIERSMA EJ, 1989, SCAND J IMMUNOL, V29, P439, DOI 10.1111/j.1365-3083.1989.tb01143.x; Wilkinson RJ, 1998, SCAND J IMMUNOL, V48, P403; Williams A, 2004, IMMUNOLOGY, V111, P328, DOI 10.1111/j.1365-2567.2004.01809.x; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996	60	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60855	10.1371/journal.pone.0060855	http://dx.doi.org/10.1371/journal.pone.0060855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637771	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000318008400016
J	Chou, YW; Zhang, L; Muniyan, S; Ahmad, H; Kumar, S; Alam, M; Lin, MF				Chou, Yu-Wei; Zhang, Li; Muniyan, Sakthivel; Ahmad, Humera; Kumar, Satyendra; Alam, Mahfuzul; Lin, Ming-Fong			Androgens Upregulate Cdc25C Protein by Inhibiting Its Proteasomal and Lysosomal Degradation Pathways	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; ACID-PHOSPHATASE-ACTIVITY; TYROSINE-PHOSPHATASE; CHECKPOINT CONTROL; G(2)/M TRANSITION; CYCLE REGULATION; CARCINOMA; PHOSPHORYLATION; EXPRESSION; GROWTH	Cdc25C is a cell cycle protein of the dual specificity phosphatase family essential for activating the cdk1/Cyclin B1 complex in cells entering into mitosis. Since altered cell cycle is a hallmark of human cancers, we investigated androgen regulation of Cdc25C protein in human prostate cancer (PCa) cells, including androgen-sensitive (AS) LNCaP C-33 cells and androgen-independent (AI) LNCaP C-81 as well as PC-3 cells. In the regular culture condition containing fetal bovine serum (FBS), Cdc25C protein levels were similar in these PCa cells. In a steroid-reduced condition, Cdc25C protein was greatly decreased in AS C-33 cells but not AI C-81 or PC-3 cells. In androgen-treated C-33 cells, the Cdc25C protein level was greatly elevated, following a dose-and a time-dependent manner, correlating with increased cell proliferation. This androgen effect was blocked by Casodex, an androgen receptor blocker. Nevertheless, epidermal growth factor (EGF), a growth stimulator of PCa cells, could only increase Cdc25C protein level by about 1.5-fold. Altered expression of Cdc25C in C-33 cells and PC-3 cells by cDNA and/or shRNA transfection is associated with the corresponding changes of cell growth and Cyclin B1 protein level. Actinomycin D and cycloheximide could only partially block androgen-induced Cdc25C protein level. Treatments with both proteasomal and lysosomal inhibitors resulted in elevated Cdc25C protein levels. Immunoprecipitation revealed that androgens reduced the ubiquitination of Cdc25C proteins. These results show for the first time that Cdc25C protein plays a role in regulating PCa cell growth, and androgen treatments, but not EGF, greatly increase Cdc25C protein levels in AS PCa cells, which is in part by decreasing its degradation. These results can lead to advanced PCa therapy via up-regulating the degradation pathways of Cdc25C protein.	[Chou, Yu-Wei; Zhang, Li; Muniyan, Sakthivel; Ahmad, Humera; Kumar, Satyendra; Alam, Mahfuzul; Lin, Ming-Fong] Univ Nebraska, Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68182 USA; [Zhang, Li] Capital Med Univ, Beijing Digest Dis Ctr, Beijing Friendship Hosp, Beijing, Peoples R China; [Lin, Ming-Fong] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Lin, Ming-Fong] Univ Nebraska, Med Ctr, Dept Urol Surg, Omaha, NE USA; [Lin, Ming-Fong] Kaohsiung Med Univ, Coll Pharm, Kaohsiung, Taiwan	University of Nebraska System; University of Nebraska Medical Center; Capital Medical University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Kaohsiung Medical University	Lin, MF (corresponding author), Univ Nebraska, Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68182 USA.	mlin@unmc.edu	Muniyan, Sakthivel/L-3868-2019	Muniyan, Sakthivel/0000-0001-9405-7857	NIH [CA88184]; DOD [PC050769, PC074289]; UNMC Eppley Cancer Center Core Grant [P30CA036727]; NATIONAL CANCER INSTITUTE [R01CA088184, P30CA036727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); UNMC Eppley Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants CA88184 (NIH), PC050769 (DOD) and PC074289 (DOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the UNMC Flow Cytometry Core facility, which is supported by UNMC Eppley Cancer Center Core Grant P30CA036727 (NIH), for technical support. We thank Dr. Tsai-der Chuang for preparing DHT- and EGF-treated cell lysate samples (Fig. 2D). We also thank Dr. William G. Chaney for critical reading and editing the manuscript.	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Busch C, 2007, INT J BIOCHEM CELL B, V39, P1707, DOI 10.1016/j.biocel.2007.04.022; Chen F, 2002, P NATL ACAD SCI USA, V99, P1990, DOI 10.1073/pnas.032428899; Chen MS, 2001, MOL CELL BIOL, V21, P3853, DOI 10.1128/MCB.21.12.3853-3861.2001; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Chou YW, 2011, CANCER LETT, V311, P177, DOI 10.1016/j.canlet.2011.07.015; Chuang TD, 2010, J BIOL CHEM, V285, P23598, DOI 10.1074/jbc.M109.098301; Clair SS, 2006, CELL CYCLE, V5, P709, DOI 10.4161/cc.5.7.2628; Dillard PR, 2008, MOL CELL ENDOCRINOL, V295, P115, DOI 10.1016/j.mce.2008.08.013; Eymin B, 2006, CELL CYCLE, V5, P759, DOI 10.4161/cc.5.7.2625; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hernandez S, 2001, LAB INVEST, V81, P465, DOI 10.1038/labinvest.3780254; Hoffmann I, 2000, PROTOPLASMA, V211, P8, DOI 10.1007/BF01279894; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kawabe T, 2002, ONCOGENE, V21, P1717, DOI 10.1038/sj.onc.1205229; Kiyokawa H, 2008, ANTI-CANCER AGENT ME, V8, P832, DOI 10.2174/187152008786847693; Korenchuk S, 2001, IN VIVO, V15, P163; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015942; Lee MS, 2004, ONCOGENE, V23, P3048, DOI 10.1038/sj.onc.1207451; Lee MS, 2004, INT J CANCER, V108, P672, DOI 10.1002/ijc.11621; LIN MF, 1986, MOL CELL BIOL, V6, P4753, DOI 10.1128/MCB.6.12.4753; Lin MF, 1998, J BIOL CHEM, V273, P5939, DOI 10.1074/jbc.273.10.5939; LIN MF, 1992, CANCER RES, V52, P4600; Lin MF, 2001, J UROLOGY, V166, P1943, DOI 10.1016/S0022-5347(05)65725-4; Lin MF, 2000, CELL BIOL INT, V24, P681, DOI 10.1006/cbir.2000.0433; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Ma ZQ, 2001, MOL CELL BIOL, V21, P8056, DOI 10.1128/MCB.21.23.8056-8067.2001; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meng TC, 2000, ONCOGENE, V19, P2664, DOI 10.1038/sj.onc.1203576; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; NAGATA A, 1991, NEW BIOL, V3, P959; Navone NM, 1997, CLIN CANCER RES, V3, P2493; Ngan ESW, 2003, ONCOGENE, V22, P734, DOI 10.1038/sj.onc.1206121; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ozen M, 2005, CLIN CANCER RES, V11, P4701, DOI 10.1158/1078-0432.CCR-04-2551; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perdiguero E, 2004, CELL CYCLE, V3, P733; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x; Tsuda H, 2003, ONCOLOGY-BASEL, V65, P159, DOI 10.1159/000072342; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; Veeramani S, 2008, ONCOGENE, V27, P5057, DOI 10.1038/onc.2008.143; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; Veeramani S, 2012, FREE RADICAL BIO MED, V53, P95, DOI 10.1016/j.freeradbiomed.2012.03.024; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wu WG, 2003, CANCER RES, V63, P6195; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	58	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61934	10.1371/journal.pone.0061934	http://dx.doi.org/10.1371/journal.pone.0061934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637932	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700067
J	Dover, N; Barash, JR; Hill, KK; Davenport, KW; Teshima, H; Xie, G; Arnon, SS				Dover, Nir; Barash, Jason R.; Hill, Karen K.; Davenport, Karen W.; Teshima, Hazuki; Xie, Gary; Arnon, Stephen S.			Clostridium botulinum Strain Af84 Contains Three Neurotoxin Gene Clusters: Bont/A2, bont/F4 and bont/F5	PLOS ONE			English	Article							INFANT BOTULISM; COMPLEX GENES; TOXIN; ALGORITHMS; DIVERSITY; PATIENT	Sanger and shotgun sequencing of Clostridium botulinum strain Af84 type Af and its botulinum neurotoxin gene (bont) clusters identified the presence of three bont gene clusters rather than the expected two. The three toxin gene clusters consisted of bont subtypes A2, F4 and F5. The bont/A2 and bont/F4 gene clusters were located within the chromosome (the latter in a novel location), while the bont/F5 toxin gene cluster was located within a large 246 kb plasmid. These findings are the first identification of a C. botulinum strain that contains three botulinum neurotoxin gene clusters.	[Dover, Nir; Barash, Jason R.; Arnon, Stephen S.] Calif Dept Publ Hlth, Infant Botulism Treatment & Prevent Program, Richmond, CA USA; [Hill, Karen K.; Davenport, Karen W.; Teshima, Hazuki; Xie, Gary] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	California Department of Public Health; United States Department of Energy (DOE); Los Alamos National Laboratory	Arnon, SS (corresponding author), Calif Dept Publ Hlth, Infant Botulism Treatment & Prevent Program, Richmond, CA USA.	Stephen.Arnon@cdph.ca.gov		xie, gary/0000-0002-9176-924X	California Department of Public Health	California Department of Public Health	These studies were supported by the California Department of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sayyed B, 2009, PEDIATR ANN, V38, P479, DOI 10.3928/00904481-20090820-01; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barash JR, 2005, J CLIN MICROBIOL, V43, P4280, DOI 10.1128/JCM.43.8.4280-4282.2005; Barash JR, 2004, J CLIN MICROBIOL, V42, P1713, DOI 10.1128/JCM.42.4.1713-1715.2004; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Centers for Disease Control and Prevention, 1998, HDB EPID CLIN LAB WO; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dover N, 2011, APPL ENVIRON MICROB, V77, P1904, DOI 10.1128/AEM.02422-10; Dover N, 2010, J CLIN MICROBIOL, V48, P1989, DOI 10.1128/JCM.00468-10; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FERNANDEZ R A, 1986, Revista Argentina de Microbiologia, V18, P29; FRANCIOSA G, 1994, J CLIN MICROBIOL, V32, P1911, DOI 10.1128/JCM.32.8.1911-1917.1994; Franciosa G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004829; GIMENEZ DF, 1978, ZBL BAKT-INT J MED M, V240, P215; GIMENEZ DF, 1970, ZENTBL BAKTERIOLOG P, V215, P212; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HALL JD, 1985, J CLIN MICROBIOL, V21, P654, DOI 10.1128/JCM.21.4.654-655.1985; Hatheway CL, 1996, ADV EXP MED BIOL, V391, P481; HATHEWAY CL, 1987, J CLIN MICROBIOL, V25, P2334, DOI 10.1128/JCM.25.12.2334-2338.1987; Hatheway CL, 1989, P 5 INT S MICR EC RE, P477; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; HOFFMAN RE, 1982, AM J DIS CHILD, V136, P270, DOI 10.1001/archpedi.1982.03970390084021; ISTRE GR, 1986, AM J DIS CHILD, V140, P1013, DOI 10.1001/archpedi.1986.02140240059027; Jacobson MJ, 2008, APPL ENVIRON MICROB, V74, P2778, DOI 10.1128/AEM.02828-07; Keet CA, 2005, PEDIATR NEUROL, V32, P193, DOI 10.1016/j.pediatrneurol.2004.09.003; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Luquez C, 2009, APPL ENVIRON MICROB, V75, P6094, DOI 10.1128/AEM.01009-09; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; PAISLEY JW, 1995, PEDIATR INFECT DIS J, V14, P912; Raphael BH, 2010, APPL ENVIRON MICROB, V76, P4805, DOI 10.1128/AEM.03109-09; SMITH GE, 1989, ARCH DIS CHILD, V64, P871, DOI 10.1136/adc.64.6.871; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	40	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61205	10.1371/journal.pone.0061205	http://dx.doi.org/10.1371/journal.pone.0061205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23637798	Green Published, Green Submitted, gold			2022-12-25	WOS:000317385300059
J	Choi, YS; Lee, JE; Nam, SJ; Park, JT; Kim, HS; Choi, KH; Kim, BS; Shin, EC				Choi, Yoon Seok; Lee, Jung Eun; Nam, Seung Joo; Park, Jung Tak; Kim, Hyon-Suk; Choi, Kyu Hun; Kim, Beom Seok; Shin, Eui-Cheol			Two Distinct Functional Patterns of Hepatitis C Virus (HCV)-Specific T Cell Responses in Seronegative, Aviremic Patients	PLOS ONE			English	Article							IMMUNE-RESPONSES; BLOOD-DONORS; DETECTABLE VIREMIA; INFECTION; HCV; EXPOSURE; LIVER; SEROCONVERSION; PERSISTENCE; CHIMPANZEES	In hepatitis C Virus (HCV) high-risk groups, HCV-specific T cell responses have been detected in seronegative, aviremic persons who have no evidence of HCV infection. Herein, we investigated functional profiles of HCV-specific T-cell responses in seronegative, aviremic patients of a HCV high-risk group. Seventy seven hemodialysis patients with chronic renal disease were analyzed by IFN-gamma ELISpot assays, and eight of 71 (11.3%) seronegative, aviremic patients displayed HCV-specific T-cell responses. Their HCV-specific memory T cells were characterized by assessing cytokine polyfunctionality, known to provide antiviral protection. By intracellular staining of IFN-gamma, TNF-alpha, IL- 2 and MIP-1 beta, we identified two distinct populations in the seronegative, aviremic patients: polyfunctional responders and TNF-alpha-predominant responders. In further analysis, occult HCV infection was excluded as a cause of the HCV-specific T cell response via secondary nested RT-PCR of HCV RNA in peripheral blood mononuclear cell samples. HCV-specific T cells targeted multiple epitopes including non-structural proteins in a single patient, implying that their T cells might have been primed by HCV proteins synthesized within the host. We conclude that HCV-specific memory T cells of seronegative, aviremic patients arise from authentic HCV replication in the host, but not from current occult HCV infection. By functional pattern of HCV-specific T cells, there are two distinct populations in these patients: polyfunctional responders and TNF-alpha-predominant responders.	[Choi, Yoon Seok; Nam, Seung Joo; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea; [Choi, Yoon Seok] Chungnam Natl Univ, Coll Med, Dept Internal Med, Taejon, South Korea; [Lee, Jung Eun; Park, Jung Tak; Choi, Kyu Hun; Kim, Beom Seok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Hyon-Suk] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, BS (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	docbsk@yuhs.ac; ecshin@kaist.ac.kr	Kim, Hyon-Suk/R-4113-2017; Shin, Eui-Cheol/C-1690-2011; Nam, Seung-Joo/AAD-2495-2022	Kim, Hyon-Suk/0000-0001-5662-7740; Shin, Eui-Cheol/0000-0002-6308-9503; Nam, Seung-Joo/0000-0002-0349-0901; Choi, Kyu Hun/0000-0003-0095-9011; LEE, JUNG EUN/0000-0003-0917-2872; Kim, Beom Seok/0000-0002-5732-2583; Park, Jung Tak/0000-0002-2325-8982	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A101923]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A101923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sherbiny M, 2005, AM J TROP MED HYG, V73, P44; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Barril G, 2008, J AM SOC NEPHROL, V19, P2288, DOI 10.1681/ASN.2008030293; Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371; Bes M, 2009, TRANSFUSION, V49, P1296, DOI 10.1111/j.1537-2995.2009.02103.x; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bronowicki JP, 1997, J INFECT DIS, V176, P518, DOI 10.1086/517279; Castillo I, 2004, J INFECT DIS, V189, P7, DOI 10.1086/380202; Castillo I, 2005, GUT, V54, P682, DOI 10.1136/gut.2004.057281; Castillo I, 2010, J MED VIROL, V82, P1554, DOI 10.1002/jmv.21866; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; DEMARIA A, 1994, J INFECT DIS, V170, P1296, DOI 10.1093/infdis/170.5.1296; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hashem M, 2011, J INFECT DIS, V203, P854, DOI 10.1093/infdis/jiq123; Hitziger T, 2009, TRANSFUSION, V49, P1306, DOI 10.1111/j.1537-2995.2009.02113.x; Koziel MJ, 1997, J INFECT DIS, V176, P859, DOI 10.1086/516546; Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; Mizukoshi E, 2008, J INFECT DIS, V198, P203, DOI 10.1086/589510; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Park SH, 2012, GASTROENTEROLOGY; Perrella A, 2009, AM J INFECT CONTROL, V37, P426, DOI 10.1016/j.ajic.2008.08.003; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Post JJ, 2004, J INFECT DIS, V189, P1846, DOI 10.1086/383279; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; QUARATINO S, 1995, P NATL ACAD SCI USA, V92, P10398, DOI 10.1073/pnas.92.22.10398; Quiroga JA, 2006, J VIROL, V80, P10972, DOI 10.1128/JVI.00852-06; Rehermann B, 2005, J EXP MED, V201, P667, DOI 10.1084/jem.20050220; Rosen HR, 2002, HEPATOLOGY, V35, P190, DOI 10.1053/jhep.2002.30293; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Scognamiglio P, 1999, J IMMUNOL, V162, P6681; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Semmo N, 2005, LANCET, V365, P327, DOI 10.1016/S0140-6736(05)17787-3; Shata MT, 2003, VIROLOGY, V314, P601, DOI 10.1016/S0042-6822(03)00461-6; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shin EC, 2005, J VIROL, V79, P13412, DOI 10.1128/JVI.79.21.13412-13420.2005; Shin EC, 2011, GASTROENTEROLOGY, V141, P686, DOI 10.1053/j.gastro.2011.05.006; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Urbani S, 2005, J EXP MED, V201, P675, DOI 10.1084/jem.20041058; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Welker MW, 2009, HEPATOLOGY, V49, P665, DOI 10.1002/hep.22706	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62319	10.1371/journal.pone.0062319	http://dx.doi.org/10.1371/journal.pone.0062319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638039	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300042
J	Yazawa, T; Kawahigashi, H; Matsumoto, T; Mizuno, H				Yazawa, Takayuki; Kawahigashi, Hiroyuki; Matsumoto, Takashi; Mizuno, Hiroshi			Simultaneous Transcriptome Analysis of Sorghum and Bipolaris sorghicola by Using RNA-seq in Combination with De Novo Transcriptome Assembly	PLOS ONE			English	Article							HYPERSENSITIVE-INDUCED REACTION; RICE WRKY45 PLAYS; DISEASE-RESISTANCE; DEFENSE RESPONSE; PLASMA-MEMBRANE; PROTEIN-KINASE; CELL-DEATH; PEROXIDASE; PATHOGEN; EXPRESSION	The recent development of RNA sequencing (RNA-seq) technology has enabled us to analyze the transcriptomes of plants and their pathogens simultaneously. However, RNA-seq often relies on aligning reads to a reference genome and is thus unsuitable for analyzing most plant pathogens, as their genomes have not been fully sequenced. Here, we analyzed the transcriptomes of Sorghum bicolor (L.) Moench and its pathogen Bipolaris sorghicola simultaneously by using RNA-seq in combination with de novo transcriptome assembly. We sequenced the mixed transcriptome of the disease-resistant sorghum cultivar SIL-05 and B. sorghicola in infected leaves in the early stages of infection (12 and 24 h post-inoculation) by using Illumina mRNA-Seq technology. Sorghum gene expression was quantified by aligning reads to the sorghum reference genome. For B. sorghicola, reads that could not be aligned to the sorghum reference genome were subjected to de novo transcriptome assembly. We identified genes of B. sorghicola for growth of this fungus in sorghum, as well as genes in sorghum for the defense response. The genes of B. sorghicola included those encoding Woronin body major protein, LysM domain-containing intracellular hyphae protein, transcriptional factors CpcA and HacA, and plant cell-wall degrading enzymes. The sorghum genes included those encoding two receptors of the simple eLRR domain protein family, transcription factors that are putative orthologs of OsWRKY45 and OsWRKY28 in rice, and a class III peroxidase that is a homolog involved in disease resistance in the Poaceae. These defense-related genes were particularly strongly induced among paralogs annotated in the sorghum genome. Thus, in the absence of genome sequences for the pathogen, simultaneous transcriptome analysis of plant and pathogen by using de novo assembly was useful for identifying putative key genes in the plant-pathogen interaction.	[Yazawa, Takayuki; Kawahigashi, Hiroyuki; Matsumoto, Takashi; Mizuno, Hiroshi] NIAS, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan; [Yazawa, Takayuki] Hitachi Govt & Publ Corp Syst Engn Ltd, Koto Ku, Tokyo, Japan	National Institute of Agrobiological Sciences - Japan	Mizuno, H (corresponding author), NIAS, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan.	hmizuno@nias.affrc.go.jp		Mizuno, Hiroshi/0000-0002-4110-4717	Genomics for Agricultural Innovation grant from the Ministry of Agriculture, Forestry and Fisheries of Japan [QTL5502, 5506]	Genomics for Agricultural Innovation grant from the Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported by Genomics for Agricultural Innovation grant (QTL5502, 5506) from the Ministry of Agriculture, Forestry and Fisheries of Japan. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Allison SD, 2004, J CHEM ECOL, V30, P1363, DOI 10.1023/B:JOEC.0000037745.66972.3e; Altpeter F, 2005, PLANT MOL BIOL, V57, P271, DOI 10.1007/s11103-004-7564-7; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campos-Soriano L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-90; CARSIOTIS M, 1974, J BACTERIOL, V119, P893, DOI 10.1128/JB.119.3.893-898.1974; Chen F, 2007, PROTEOMICS, V7, P1529, DOI 10.1002/pmic.200500765; Choi HW, 2011, MOL PLANT MICROBE IN, V24, P68, DOI 10.1094/MPMI-02-10-0030; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; Delteil A, 2012, MOL PLANT PATHOL, V13, P72, DOI 10.1111/j.1364-3703.2011.00731.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Elliott CE, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-169; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Higo K, 1998, NUCLEIC ACIDS RES, V26, P358, DOI 10.1093/nar/26.1.358; Hilaire E, 2001, MOL PLANT MICROBE IN, V14, P1411, DOI 10.1094/MPMI.2001.14.12.1411; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; HIPSKIND JD, 1997, MOL PLANTMICROBE INT, V10, P819; Hok S, 2010, MOL PLANT MICROBE IN, V23, P1253, DOI 10.1094/MPMI-04-10-0103; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jacques A, 2006, MOL PLANT MICROBE IN, V19, P747, DOI 10.1094/MPMI-19-0747; Johrde A, 2008, MOL PLANT PATHOL, V9, P687, DOI 10.1111/J.1364-3703.2008.00494.X; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kawahigashi H, 2011, THEOR APPL GENET, V123, P131, DOI 10.1007/s00122-011-1572-1; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koua D, 2009, NUCLEIC ACIDS RES, V37, pD261, DOI 10.1093/nar/gkn680; Krappmann S, 2004, MOL MICROBIOL, V52, P785, DOI 10.1111/j.1365-2958.2004.04015.x; Lalaoui F, 2000, PLANT PATHOL, V49, P727, DOI 10.1046/j.1365-3059.2000.00491.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu GS, 2005, MOL PLANT MICROBE IN, V18, P730, DOI 10.1094/MPMI-18-0730; Loukili A, 1999, PHYSIOL PLANTARUM, V105, P24, DOI 10.1034/j.1399-3054.1999.105105.x; Mall TK, 2011, PLANT MOL BIOL, V75, P467, DOI 10.1007/s11103-011-9741-9; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Mizuno H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-121; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naoumkina MA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-132; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Park YH, 2012, PLANT CELL REP, V31, P1845, DOI 10.1007/s00299-012-1298-9; Passardi F, 2004, PHYTOCHEMISTRY, V65, P1879, DOI 10.1016/j.phytochem.2004.06.023; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; REIMERS PJ, 1992, PLANT PHYSIOL, V99, P1044, DOI 10.1104/pp.99.3.1044; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Schulz M. H., 2012, BIOINF ADV ACCESS, V28, P1; Schweizer P, 2008, MOL PLANT PATHOL, V9, P45, DOI [10.1111/J.1364-3703.2007.00446.X, 10.1111/j.1364-3703.2007.00446.x]; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Shimono M, 2012, MOL PLANT PATHOL, V13, P83, DOI 10.1111/j.1364-3703.2011.00732.x; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Wally O, 2010, PLANTA, V232, P1229, DOI 10.1007/s00425-010-1252-4; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Xiang Y, 2007, PLANT PHYSIOL, V144, P1416, DOI 10.1104/pp.107.101295; Xu ZS, 2009, PLANT SCI, V176, P38, DOI 10.1016/j.plantsci.2008.09.004; YOUNG SA, 1995, PLANT PHYSIOL, V107, P1333, DOI 10.1104/pp.107.4.1333; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhou LA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-290; Zhou L, 2009, PLANT CELL ENVIRON, V32, P1804, DOI 10.1111/j.1365-3040.2009.02039.x	85	69	70	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62460	10.1371/journal.pone.0062460	http://dx.doi.org/10.1371/journal.pone.0062460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638091	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300063
J	Cortes-Campos, C; Elizondo, R; Carril, C; Martinez, F; Boric, K; Nualart, F; Garcia-Robles, MA				Cortes-Campos, Christian; Elizondo, Roberto; Carril, Claudio; Martinez, Fernando; Boric, Katica; Nualart, Francisco; Angeles Garcia-Robles, Maria			MCT2 Expression and Lactate Influx in Anorexigenic and Orexigenic Neurons of the Arcuate Nucleus	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTER MCT2; XENOPUS-LAEVIS OOCYTES; CENTRAL-NERVOUS-SYSTEM; ADULT-MOUSE BRAIN; HYPOTHALAMIC NEURONS; GLUCOSE-HOMEOSTASIS; CONFOCAL MICROSCOPY; NEUROPEPTIDE-Y; GLIAL-CELLS; FOOD-INTAKE	Hypothalamic neurons of the arcuate nucleus control food intake, releasing orexigenic and anorexigenic neuropeptides in response to changes in glucose concentration. Several studies have suggested that the glucosensing mechanism is governed by a metabolic interaction between neurons and glial cells via lactate flux through monocarboxylate transporters (MCTs). Hypothalamic glial cells (tanycytes) release lactate through MCT1 and MCT4; however, similar analyses in neuroendocrine neurons have yet to be undertaken. Using primary rat hypothalamic cell cultures and fluorimetric assays, lactate incorporation was detected. Furthermore, the expression and function of MCT2 was demonstrated in the hypothalamic neuronal cell line, GT1-7, using kinetic and inhibition assays. Moreover, MCT2 expression and localization in the Sprague Dawley rat hypothalamus was analyzed using RT-PCR, in situ hybridization and Western blot analyses. Confocal immunohistochemistry analyses revealed MCT2 localization in neuronal but not glial cells. Moreover, MCT2 was localized to similar to 90% of orexigenic and similar to 60% of anorexigenic neurons as determined by immunolocalization analysis of AgRP and POMC with MCT2-positives neurons. Thus, MCT2 distribution coupled with lactate uptake by hypothalamic neurons suggests that hypothalamic neurons control food intake using lactate to reflect changes in glucose levels.	[Cortes-Campos, Christian; Elizondo, Roberto; Carril, Claudio; Martinez, Fernando; Boric, Katica; Angeles Garcia-Robles, Maria] Univ Concepcion, Lab Biol Celular, Dept Biol Celular, Concepcion, Chile; [Nualart, Francisco] Univ Concepcion, Lab Neurobiol & Celulas Madre, Ctr Microscopia Avanzada CMA BIO BIO, Concepcion, Chile	Universidad de Concepcion; Universidad de Concepcion	Nualart, F (corresponding author), Univ Concepcion, Lab Neurobiol & Celulas Madre, Ctr Microscopia Avanzada CMA BIO BIO, Concepcion, Chile.	frnualart@udec.cl; mgarcia@udec.cl	Cortes Campos, Christian/Q-4096-2016; Garcia-Robles, Maria/F-4900-2014; Nualart, Francisco/AAB-9342-2021	Cortes Campos, Christian/0000-0002-2532-9035; Boric, Katica/0000-0003-2319-3063; Elizondo, Roberto/0000-0001-9790-0002; Garcia-Robles, Maria/0000-0001-8482-0361	FONDECYT [1100705, 1100396]; Research Centro de Microscopia Avanzada CMA BIO BIO, Universidad de Concepcion (FNS)	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Research Centro de Microscopia Avanzada CMA BIO BIO, Universidad de Concepcion (FNS)	This work was supported by FONDECYT grants, 1100705 (MAG) and 1100396, and the Research Centro de Microscopia Avanzada CMA BIO BIO, Universidad de Concepcion (FNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; AKMAYEV IG, 1977, CELL TISSUE RES, V180, P263; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Bergersen L. H., 2004, CEREB CORTEX; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Borg MA, 2003, DIABETES, V52, P663, DOI 10.2337/diabetes.52.3.663; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cortes-Campos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016411; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Eladari D, 1999, J BIOL CHEM, V274, P28420, DOI 10.1074/jbc.274.40.28420; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Garcia MD, 2003, J NEUROCHEM, V86, P709, DOI 10.1046/j.1471-4159.2003.01892.x; Garcia MDL, 2005, GLIA, V50, P32, DOI 10.1002/glia.20133; Gerhart DZ, 1998, GLIA, V22, P272; Gonzalez JA, 2009, J PHYSIOL-LONDON, V587, P41, DOI 10.1113/jphysiol.2008.163410; Hanu R, 2000, AM J PHYSIOL-CELL PH, V278, pC921, DOI 10.1152/ajpcell.2000.278.5.C921; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Kokorovic A, 2009, J CELL MOL MED, V13, P4403, DOI 10.1111/j.1582-4934.2008.00596.x; Lam CKL, 2008, AM J PHYSIOL-ENDOC M, V295, pE491, DOI 10.1152/ajpendo.90481.2008; Lam CKL, 2009, PHYSIOLOGY, V24, P159, DOI 10.1152/physiol.00003.2009; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959; LIPOSITS Z, 1991, ENDOCRINOLOGY, V129, P1575, DOI 10.1210/endo-129-3-1575; MANDERS EMM, 1992, J CELL SCI, V103, P857; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Millan C, 2010, ASN NEURO, V2, P135, DOI 10.1042/AN20090059; Muroya S, 1999, NEUROSCI LETT, V264, P113, DOI 10.1016/S0304-3940(99)00185-8; OOMURA Y, 1984, J AUTONOM NERV SYST, V10, P359, DOI 10.1016/0165-1838(84)90033-X; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pierre K, 2002, J CEREBR BLOOD F MET, V22, P586, DOI 10.1097/00004647-200205000-00010; Pierre K, 2007, J PHYSIOL-LONDON, V583, P469, DOI 10.1113/jphysiol.2007.138594; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; Thorens Bernard, 2012, Handb Exp Pharmacol, P277, DOI 10.1007/978-3-642-24716-3_12; Wang R, 2004, DIABETES, V53, P1959, DOI 10.2337/diabetes.53.8.1959; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763	46	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62532	10.1371/journal.pone.0062532	http://dx.doi.org/10.1371/journal.pone.0062532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638108	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700062
J	Capone, SH; Dufresne, M; Rechel, M; Fleury, MJ; Salsac, AV; Paullier, P; Daujat-Chavanieu, M; Legallais, C				Capone, Stephanie H.; Dufresne, Murielle; Rechel, Mathias; Fleury, Marie-Jose; Salsac, Anne-Virginie; Paullier, Patrick; Daujat-Chavanieu, Martine; Legallais, Cecile			Impact of Alginate Composition: From Bead Mechanical Properties to Encapsulated HepG2/C3A Cell Activities for In Vivo Implantation	PLOS ONE			English	Article							FLUIDIZED-BED BIOREACTOR; BIOARTIFICIAL LIVER DEVICES; FULMINANT HEPATIC-FAILURE; C3A CELLS; MICROENCAPSULATED HEPATOCYTES; EXTRACELLULAR MATRICES; RAT HEPATOCYTES; MASS TRANSFERS; GEL BEADS; MICROCAPSULES	Recently, interest has focused on hepatocytes' implantation to provide end stage liver failure patients with a temporary support until spontaneous recovery or a suitable donor becomes available. To avoid cell damage and use of an immunosuppressive treatment, hepatic cells could be implanted after encapsulation in a porous biomaterial of bead or capsule shape. The aim of this study was to compare the production and the physical properties of the beads, together with some hepatic cell functions, resulting from the use of different material combinations for cell microencapsulation: alginate alone or combined with type I collagen with or without poly-L-lysine and alginate coatings. Collagen and poly-L-lysine increased the bead mechanical resistance but lowered the mass transfer kinetics of vitamin B12. Proliferation of encapsulated HepG2/C3A cells was shown to be improved in alginate-collagen beads. Finally, when the beads were subcutaneously implanted in mice, the inflammatory response was reduced in the case of alginate mixed with collagen. This in vitro and in vivo study clearly outlines, based on a systematic comparison, the necessity of compromising between material physical properties (mechanical stability and porosity) and cell behavior (viability, proliferation, functionalities) to define optima hepatic cell microencapsulation conditions before implantation.	[Capone, Stephanie H.; Dufresne, Murielle; Rechel, Mathias; Fleury, Marie-Jose; Salsac, Anne-Virginie; Paullier, Patrick; Legallais, Cecile] Univ Technol Compiegne, Lab Biomech & Bioengn, UMR CNRS 7338, Compiegne, France; [Capone, Stephanie H.; Daujat-Chavanieu, Martine] CHU St Eloi, INSERM U1040, Inst Res Biotherapy, Montpellier, France	Picardie Universites; Universite de Technologie de Compiegne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Legallais, C (corresponding author), Univ Technol Compiegne, Lab Biomech & Bioengn, UMR CNRS 7338, Compiegne, France.	cecile.legallais@utc.fr	Daujat-Chavanieu, Martine/T-5155-2018; Daujat-Chavanieu, Martine/AAU-2908-2020	Daujat-Chavanieu, Martine/0000-0001-5560-1610; Daujat-Chavanieu, Martine/0000-0001-5560-1610; Legallais, Cecile/0000-0002-8061-906X	Research Minister of French Government; ANR TECSAN (SUPPLIVER Project)	Research Minister of French Government; ANR TECSAN (SUPPLIVER Project)(French National Research Agency (ANR))	This work was supported by Research Minister of French Government, and also by ANR TECSAN 2011 (SUPPLIVER Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2005, TRANSPLANTATION, V79, P783, DOI 10.1097/01.TP.0000156319.47645.3B; BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161; Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380; Catapano G, 1996, INT J ARTIF ORGANS, V19, P18, DOI 10.1177/039139889601900105; Chia SM, 2000, TISSUE ENG, V6, P481, DOI 10.1089/107632700750022134; Coward SM, 2009, ARTIF ORGANS, V33, P1117, DOI 10.1111/j.1525-1594.2009.00821.x; David B, 2006, INT J ARTIF ORGANS, V29, P756, DOI 10.1177/039139880602900805; David B, 2004, BIOTECHNOL PROGR, V20, P1204, DOI 10.1021/bp034301z; David B, 2004, INT J ARTIF ORGANS, V27, P284, DOI 10.1177/039139880402700404; de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Fassett JT, 2003, J BIOL CHEM, V278, P31691, DOI 10.1074/jbc.M300899200; Gao Y, 2004, WORLD J GASTROENTERO, V10, P2067, DOI 10.3748/wjg.v10.i14.2067; Gautier A, 2011, EUR CELLS MATER, V21, P94, DOI 10.22203/eCM.v021a08; Gillette BM, 2010, ADV MATER, V22, P686, DOI 10.1002/adma.200902265; GRASDALEN H, 1979, CARBOHYD RES, V68, P23, DOI 10.1016/S0008-6215(00)84051-3; Gupta S, 1997, CELL TRANSPLANT, V6, P377, DOI 10.1016/S0963-6897(97)00047-X; HALLE JP, 1992, TRANSPL P, V24, P2930; Harm S, 2009, INT J ARTIF ORGANS, V32, P769, DOI 10.1177/039139880903201102; Hertz H, 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156; Ijima H, 2010, J BIOSCI BIOENG, V109, P179, DOI 10.1016/j.jbiosc.2009.07.017; Khalil M, 2001, J HEPATOL, V34, P68, DOI 10.1016/S0168-8278(00)00080-5; Kinasiewicz A, 2008, INT J ARTIF ORGANS, V31, P340, DOI 10.1177/039139880803100411; King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276; Knaebel A, 1997, POLYM GELS NETW, V5, P107, DOI 10.1016/S0966-7822(96)00034-2; KOHN R, 1972, ACTA CHEM SCAND, V26, P2455, DOI 10.3891/acta.chem.scand.26-2455; Kulseng B, 1997, CELL TRANSPLANT, V6, P387, DOI 10.1016/S0963-6897(97)00002-X; Lee M, 2009, BIOMATERIALS, V30, P1214, DOI 10.1016/j.biomaterials.2008.11.017; Lewinska D, 2002, J MEMBRANE SCI, V209, P533, DOI 10.1016/S0376-7388(02)00370-8; Li RH, 1998, ADV DRUG DELIVER REV, V33, P87, DOI 10.1016/S0169-409X(98)00022-2; Mavri-Damelin D, 2008, BIOTECHNOL BIOENG, V99, P644, DOI 10.1002/bit.21599; Mei J, 2009, CELL TRANSPLANT, V18, P101, DOI 10.3727/096368909788237168; Ng S, 2005, BIOMATERIALS, V26, P3153, DOI 10.1016/j.biomaterials.2004.08.017; Tran NM, 2013, TISSUE ENG PT A, V19, P103, DOI [10.1089/ten.TEA.2012.0139, 10.1089/ten.tea.2012.0139]; Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7; Qiu LY, 2012, INT J ARTIF ORGANS, V35, P458, DOI 10.5301/ijao.5000092; Quek CH, 2004, BIOMATERIALS, V25, P3531, DOI 10.1016/j.biomaterials.2003.09.112; Rahman TM, 2005, TRANSPL INT, V18, P1001, DOI 10.1111/j.1432-2277.2005.00156.x; Rahman TM, 2004, ARTIF ORGANS, V28, P476, DOI 10.1111/j.1525-1594.2004.07259.x; Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011; Saudek F, 2010, TRANSPLANTATION, V90, P1602, DOI 10.1097/TP.0b013e3181ffba5e; Selden C, 1999, ANN NY ACAD SCI, V875, P353, DOI 10.1111/j.1749-6632.1999.tb08517.x; Selden C, 2004, TRANSPL IMMUNOL, V12, P273, DOI 10.1016/j.trim.2003.12.008; Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I; Shulman Maria, 2013, Methods Mol Biol, V945, P287, DOI 10.1007/978-1-62703-125-7_17; Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800; Strom S, 2003, GASTROENTEROLOGY, V124, P568, DOI 10.1053/gast.2003.50072; Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006; Teng Y, 2010, TISSUE ENG PART C-ME, V16, P1125, DOI [10.1089/ten.tec.2009.0374, 10.1089/ten.TEC.2009.0374]; VANDENBOSSCHE GMR, 1993, BIOTECHNOL BIOENG, V42, P381, DOI 10.1002/bit.260420316; Yongsunthon R, 2009, ULTRAMICROSCOPY, V109, P942, DOI 10.1016/j.ultramic.2009.03.007; Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x	52	41	41	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62032	10.1371/journal.pone.0062032	http://dx.doi.org/10.1371/journal.pone.0062032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637958	Green Published, gold			2022-12-25	WOS:000318341400030
J	Montbarbon, M; Pichavant, M; Langlois, A; Erdual, E; Maggiotto, F; Neut, C; Mallevaey, T; Dharancy, S; Dubuquoy, L; Trottein, F; Cortot, A; Desreumaux, P; Gosset, P; Bertin, B				Montbarbon, Muriel; Pichavant, Muriel; Langlois, Audrey; Erdual, Edmone; Maggiotto, Francois; Neut, Christel; Mallevaey, Thierry; Dharancy, Sebastien; Dubuquoy, Laurent; Trottein, Francois; Cortot, Antoine; Desreumaux, Pierre; Gosset, Philippe; Bertin, Benjamin			Colonic Inflammation in Mice Is Improved by Cigarette Smoke through iNKT Cells Recruitment	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; KILLER T-CELLS; EXPERIMENTAL COLITIS; BOWEL-DISEASE; NKT CELLS; ACTIVATION; NEUTROPHILS; MECHANISMS; CYTOKINES; PATHWAY	Cigarette smoke (CS) protects against intestinal inflammation during ulcerative colitis. Immunoregulatory mechanisms sustaining this effect remain unknown. The aim of this study was to assess the effects of CS on experimental colitis and to characterize the intestinal inflammatory response at the cellular and molecular levels. Using the InExpose (R) System, a smoking device accurately reproducing human smoking habit, we pre-exposed C57BL/6 mice for 2 weeks to CS, and then we induced colitis by administration of dextran sodium sulfate (DSS). This system allowed us to demonstrate that CS exposure improved colonic inflammation (significant decrease in clinical score, body weight loss and weight/length colonic ratio). This improvement was associated with a significant decrease in colonic proinflammatory Th1/Th17 cytokine expression, as compared to unexposed mice (TNF (p = 0.0169), IFN gamma (p < 0.0001), and IL-17 (p = 0.0008)). Smoke exposure also induced an increased expression of IL-10 mRNA (p = 0.0035) and a marked recruitment of iNKT (invariant Natural Killer T; CD45+ TCR beta+ CD1d tetramer+) cells in the colon of DSS-untreated mice. Demonstration of the role of iNKT cells in CS-dependent colitis improvement was performed using two different strains of NKT cells deficient mice. Indeed, in J alpha 18KO and CD1dKO animals, CS exposure failed to induce significant regulation of DSS-induced colitis both at the clinical and molecular levels. Thus, our study demonstrates that iNKT cells are pivotal actors in the CS-dependent protection of the colon. These results highlight the role of intestinal iNKT lymphocytes and their responsiveness to environmental stimuli. Targeting iNKT cells would represent a new therapeutic way for inflammatory bowel diseases.	[Montbarbon, Muriel; Pichavant, Muriel; Langlois, Audrey; Erdual, Edmone; Maggiotto, Francois; Neut, Christel; Dharancy, Sebastien; Dubuquoy, Laurent; Trottein, Francois; Cortot, Antoine; Desreumaux, Pierre; Gosset, Philippe; Bertin, Benjamin] Univ Lille Nord France, Lille, France; [Montbarbon, Muriel; Langlois, Audrey; Erdual, Edmone; Maggiotto, Francois; Neut, Christel; Dubuquoy, Laurent; Cortot, Antoine; Desreumaux, Pierre; Bertin, Benjamin] INSERM, U995, F-59045 Lille, France; [Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Inst Pasteur, Ctr Infect & Immunite Lille, Team LI3 8, F-59019 Lille, France; [Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] INSERM, U1019, F-59045 Lille, France; [Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Mallevaey, Thierry] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Dharancy, Sebastien; Cortot, Antoine; Desreumaux, Pierre] Hop Claude Huriez, CHU Lille, Serv Malad Appareil Digestif & Nutr, Lille, France; [Neut, Christel; Bertin, Benjamin] UDSL, Fac Sci Pharmaceut & Biol, Lille, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Toronto; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Bertin, B (corresponding author), Univ Lille Nord France, Lille, France.	benjamin.bertin-2@univ-lille2.fr	CORTOT, ANTOINE/I-7739-2016; Dubuquoy, Laurent/N-1623-2019; Pichavant, Muriel/B-9036-2018; Desreumaux, Pierre F/R-6877-2018; Dubuquoy, laurent/J-4978-2015; TROTTEIN, Francois/C-2405-2018; Gosset, Philippe/C-6174-2018; Neut, Christel/AAA-5153-2021; Dharancy, Sebastien/M-4357-2018; Mallevaey, Thierry/AAH-4499-2020; Neut, Christel/S-2521-2018; CORTOT, Antoine/I-5796-2015; Bertin, Benjamin/M-8300-2016	CORTOT, ANTOINE/0000-0002-1067-8996; Pichavant, Muriel/0000-0002-1315-4397; Desreumaux, Pierre F/0000-0002-6127-5281; Dubuquoy, laurent/0000-0003-3596-5497; TROTTEIN, Francois/0000-0003-3373-1814; Gosset, Philippe/0000-0002-4043-6429; Dharancy, Sebastien/0000-0002-8262-5607; Neut, Christel/0000-0002-2036-6152; Dewaeles, Edmone/0000-0001-5074-3679; Bertin, Benjamin/0000-0002-9160-3717	Inserm; Association Francois Aupetit (AFA)	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francois Aupetit (AFA)	This work was supported by Inserm and by the Association Francois Aupetit (AFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Arsenescu R, 2011, INFLAMM BOWEL DIS, V17, P1149, DOI 10.1002/ibd.21463; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benson JM, 2011, TOXICOL SCI, V120, P68, DOI 10.1093/toxsci/kfq360; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Birrenbach T, 2004, INFLAMM BOWEL DIS, V10, P848, DOI 10.1097/00054725-200411000-00019; Borgerding M, 2005, EXP TOXICOL PATHOL, V57, P43, DOI 10.1016/j.etp.2005.05.010; Cosnes J, 2004, BEST PRACT RES CL GA, V18, P481, DOI 10.1016/j.bpg.2003.12.003; De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fang K, 2011, PHYSIOL GENOMICS, V43, P43, DOI 10.1152/physiolgenomics.00138.2010; Furumatsu K, 2011, DIGEST DIS SCI, V56, P2532, DOI 10.1007/s10620-011-1643-9; Galeazzi F, 1999, GASTROENTEROLOGY, V117, P877, DOI 10.1016/S0016-5085(99)70346-X; Hegde S, 2009, J LEUKOCYTE BIOL, V86, P757, DOI 10.1189/jlb.0209059; Hogan AE, 2011, CLIN IMMUNOL, V140, P229, DOI 10.1016/j.clim.2011.01.011; Horras CJ, 2012, J IMMUNOTOXICOL; Huang Z, 2013, MOL IMMUNOL, V53, P335, DOI 10.1016/j.molimm.2012.09.007; Karban A, 2007, WORLD J GASTROENTERO, V13, P2150, DOI 10.3748/wjg.v13.i15.2150; Kasai A, 2006, CANCER RES, V66, P7143, DOI 10.1158/0008-5472.CAN-05-4541; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Ko JKS, 2005, TOXICOL SCI, V87, P285, DOI 10.1093/toxsci/kfi238; Ko JKS, 2001, J INVEST MED, V49, P21, DOI 10.2310/6650.2001.34087; LOFROTH G, 1992, B ENVIRON CONTAM TOX, V48, P789; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Middendorp S, 2009, MUCOSAL IMMUNOL, V2, P393, DOI 10.1038/mi.2009.99; Monteleone I, 2012, CURR OPIN GASTROEN, V28, P310, DOI 10.1097/MOG.0b013e328352ad69; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; MUTO H, 1989, ARCH ENVIRON HEALTH, V44, P171, DOI 10.1080/00039896.1989.9935882; Nikolaus S, 1998, GUT, V42, P470, DOI 10.1136/gut.42.4.470; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Saubermann LJ, 2000, GASTROENTEROLOGY, V119, P119, DOI 10.1053/gast.2000.9114; Shibolet O, 2004, J LEUKOCYTE BIOL, V75, P76, DOI 10.1189/jlb.0703351; Simoni Y, 2013, CLIN EXP IMMUNOL, V171, P8, DOI 10.1111/j.1365-2249.2012.04625.x; Singh NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023522; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Takamura T, 2010, IMMUNOL CELL BIOL, V88, P685, DOI 10.1038/icb.2010.35; Ueno Y, 2005, INFLAMM BOWEL DIS, V11, P35, DOI 10.1097/00054725-200501000-00005; van de Wal Y, 2003, GASTROENTEROLOGY, V124, P1420, DOI 10.1016/S0016-5085(03)00219-1; van Dieren JM, 2007, INFLAMM BOWEL DIS, V13, P1146, DOI 10.1002/ibd.20164; Verschuere S, 2012, J CROHNS COLITIS, V6, P1, DOI 10.1016/j.crohns.2011.09.006; Wallace JL, 1998, AM J PHYSIOL-GASTR L, V274, pG802, DOI 10.1152/ajpgi.1998.274.5.G802; Wingender G, 2008, AM J PHYSIOL-GASTR L, V294, pG1, DOI 10.1152/ajpgi.00437.2007; Wingender G, 2012, GASTROENTEROLOGY, V143, P418, DOI 10.1053/j.gastro.2012.04.017; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	47	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62208	10.1371/journal.pone.0062208	http://dx.doi.org/10.1371/journal.pone.0062208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638007	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400045
J	Penjor, T; Yamamoto, M; Uehara, M; Ide, M; Matsumoto, N; Matsumoto, R; Nagano, Y				Penjor, Tshering; Yamamoto, Masashi; Uehara, Miki; Ide, Manami; Matsumoto, Natsumi; Matsumoto, Ryoji; Nagano, Yukio			Phylogenetic Relationships of Citrus and Its Relatives Based on matK Gene Sequences	PLOS ONE			English	Article							CHLOROPLAST DNA; LOCAL CITRUS; MOLECULAR PHYLOGENY; LEAF ISOZYMES; RFLP ANALYSIS; RUTACEAE; AURANTIOIDEAE; DIVERSITY; SYSTEMATICS; MARKERS	The genus Citrus includes mandarin, orange, lemon, grapefruit and lime, which have high economic and nutritional value. The family Rutaceae can be divided into 7 subfamilies, including Aurantioideae. The genus Citrus belongs to the subfamily Aurantioideae. In this study, we sequenced the chloroplast matK genes of 135 accessions from 22 genera of Aurantioideae and analyzed them phylogenetically. Our study includes many accessions that have not been examined in other studies. The subfamily Aurantioideae has been classified into 2 tribes, Clauseneae and Citreae, and our current molecular analysis clearly discriminate Citreae from Clauseneae by using only 1 chloroplast DNA sequence. Our study confirms previous observations on the molecular phylogeny of Aurantioideae in many aspects. However, we have provided novel information on these genetic relationships. For example, inconsistent with the previous observation, and consistent with our preliminary study using the chloroplast rbcL genes, our analysis showed that Feroniella oblata is not nested in Citrus species and is closely related with Feronia limonia. Furthermore, we have shown that Murraya paniculata is similar to Merrillia caloxylon and is dissimilar to Murraya koenigii. We found that "true citrus fruit trees'' could be divided into 2 subclusters. One subcluster included Citrus, Fortunella, and Poncirus, while the other cluster included Microcitrus and Eremocitrus. Compared to previous studies, our current study is the most extensive phylogenetic study of Citrus species since it includes 93 accessions. The results indicate that Citrus species can be classified into 3 clusters: a citron cluster, a pummelo cluster, and a mandarin cluster. Although most mandarin accessions belonged to the mandarin cluster, we found some exceptions. We also obtained the information on the genetic background of various species of acid citrus grown in Japan. Because the genus Citrus contains many important accessions, we have comprehensively discussed the classification of this genus.	[Penjor, Tshering; Uehara, Miki; Ide, Manami; Matsumoto, Natsumi; Matsumoto, Ryoji] Saga Univ, Dept Appl Biol Sci, Honjo, Saga, Japan; [Penjor, Tshering] Renewable Nat Resources Res Ctr Wengkhar, Mongar, Bhutan; [Yamamoto, Masashi] Kagoshima Univ, Fac Agr, Korimoto, Kagoshima, Japan; [Nagano, Yukio] Saga Univ, Analyt Res Ctr Expt Sci, Honjo, Saga, Japan	Saga University; Kagoshima University; Saga University	Yamamoto, M (corresponding author), Kagoshima Univ, Fac Agr, Korimoto, Kagoshima, Japan.	yamasa@agri.kagoshima-u.ac.jp; nagano@cc.saga-u.ac.jp	Nagano, Yukio/H-8734-2019	Nagano, Yukio/0000-0001-5030-676X	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Part of this work was supported by a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkenar AA, 2004, SCI HORTIC-AMSTERDAM, V102, P233, DOI 10.1016/j.scienta.2004.01.003; Abkenar AA, 2008, GENET RESOUR CROP EV, V55, P487, DOI 10.1007/s10722-007-9253-2; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Bruni I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043256; Chase MW, 1999, AM J BOT, V86, P1191, DOI 10.2307/2656983; Cheng YJ, 2005, TREE PHYSIOL, V25, P661, DOI 10.1093/treephys/25.6.661; DA SILVA MFGF, 1988, PLANT SYST EVOL, V161, P97; de Araujo EF, 2003, ORG DIVERS EVOL, V3, P55, DOI 10.1078/1439-6092-00058; Deng ZN, 2007, SCI HORTIC-AMSTERDAM, V111, P186, DOI 10.1016/j.scienta.2006.10.004; Dianxiang Z, 2008, FLORA CHINA, P51; Federici CT, 1998, THEOR APPL GENET, V96, P812, DOI 10.1007/s001220050807; Froelicher Y, 2011, TREE GENET GENOMES, V7, P49, DOI 10.1007/s11295-010-0314-x; GREEN RM, 1986, THEOR APPL GENET, V72, P170, DOI 10.1007/BF00266989; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Gulsen O, 2001, J AM SOC HORTIC SCI, V126, P210, DOI 10.21273/JASHS.126.2.210; HANDA T, 1986, JPN J GENET, V61, P15, DOI 10.1266/jjg.61.15; HANDA T, 1985, J JPN SOC HORTIC SCI, V54, P145, DOI 10.2503/jjshs.54.145; Herrero R, 1996, THEOR APPL GENET, V93, P1327, DOI 10.1007/BF00223466; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Hilu KW, 1997, AM J BOT, V84, P830, DOI 10.2307/2445819; HIRAI M, 1987, JPN J BREED, V37, P377; HIRAI M, 1986, JPN J BREED, V36, P377; Inafuku-Teramoto Sayuri, 2010, Horticultural Research (Japan), V9, P263, DOI 10.2503/hrj.9.263; Jung YH, 2005, SCI HORTIC-AMSTERDAM, V104, P179, DOI 10.1016/j.scienta.2004.08.008; Li YZ, 2006, J HORTIC SCI BIOTECH, V81, P371, DOI 10.1080/14620316.2006.11512075; Lu ZH, 2011, AGR SCI CHINA, V10, P49, DOI 10.1016/S1671-2927(11)60306-4; Mabberley D. J., 1998, Telopea, V7, P333; Mabberley DJ, 2004, BLUMEA, V49, P481; Morton CM, 2003, AM J BOT, V90, P1463, DOI 10.3732/ajb.90.10.1463; Nalumpang S., 2002, Thai Journal of Agricultural Science, V35, P147; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Penjor T, 2010, TREE GENET GENOMES, V6, P931, DOI 10.1007/s11295-010-0302-1; Platt AR, 2007, BIOTECHNIQUES, V43, P58, DOI 10.2144/000112499; Salvo G, 2011, TAXON, V60, P513, DOI 10.1002/tax.602018; Salvo G, 2010, SYST BIOL, V59, P705, DOI 10.1093/sysbio/syq046; Samuel R, 2001, PLANT BIOLOGY, V3, P77, DOI 10.1055/s-2001-11747; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Swingle W T, 1967, CITRUS IND, P190; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANAKA T., 1969, Bulletin of the University of Osaka Prefecture. Series B. Agriculture and Biology, V21, P139; Tanaka T., 1977, STUD CITROG, V14, P1; THOMSON D, 1995, BIOTECHNIQUES, V19, P394; TORRES AM, 1978, AM J BOT, V65, P869, DOI 10.2307/2442183; Urasaki N., 2005, Japanese Journal of Tropical Agriculture, V49, P246; Uzun A, 2009, SCI HORTIC-AMSTERDAM, V121, P306, DOI 10.1016/j.scienta.2009.02.018; Yamamoto M, 2003, EUPHYTICA, V129, P267, DOI 10.1023/A:1022284908424; YAMAMOTO M, 1993, JPN J BREED, V43, P355; Yamamoto M, 1996, J JPN SOC HORTIC SCI, V65, P291, DOI 10.2503/jjshs.65.291; Yamamoto M, 2011, J JPN SOC HORTIC SCI, V80, P268, DOI 10.2503/jjshs1.80.268; Yamamoto Masashi, 2010, Horticultural Research (Japan), V9, P7, DOI 10.2503/hrj.9.7; Yingzhi L, 2007, J AM SOC HORTIC SCI, V132, P796, DOI 10.21273/JASHS.132.6.796	54	59	66	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62574	10.1371/journal.pone.0062574	http://dx.doi.org/10.1371/journal.pone.0062574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638116	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400062
J	Barbosa, RPA; Galvao, B; dos Santos, LI; Sales, PA; Marques, PE; Pereira, RVS; Cara, DC; Bruna-Romero, O; Rodrigues, MM; Gazzinelli, RT; Machado, AV				Alves Barbosa, Rafael Polidoro; Galvao Filho, Bruno; dos Santos, Luara Isabela; Sales Junior, Policarpo Ademar; Marques, Pedro Elias; Sousa Pereira, Rafaela Vaz; Cara, Denise Carmona; Bruna-Romero, Oscar; Rodrigues, Mauricio Martins; Gazzinelli, Ricardo Tostes; Machado, Alexandre Vieira			Vaccination Using Recombinants Influenza and Adenoviruses Encoding Amastigote Surface Protein-2 Are Highly Effective on Protection against Trypanosoma cruzi Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; CHAGAS-DISEASE; IMMUNE-RESPONSES; LYMPHOCYTE RESPONSES; BOOST IMMUNIZATION; TRANS-SIALIDASE; VIRUS INFECTION; IFN-GAMMA; A VIRUS; MICE	In the present study we evaluated the protection raised by immunization with recombinant influenza viruses carrying sequences coding for polypeptides corresponding to medial and carboxi-terminal moieties of Trypanosoma cruzis amastigote surface protein 2 (ASP2). Those viruses were used in sequential immunization with recombinant adenovirus (heterologous prime-boost immunization protocol) encoding the complete sequence of ASP2 (Ad-ASP2) in two mouse strains (C57BL/6 and C3H/He). The CD8 effector response elicited by this protocol was comparable to that observed in mice immunized twice with Ad-ASP2 and more robust than that observed in mice that were immunized once with Ad-ASP2. Whereas a single immunization with Ad-ASP2 sufficed to completely protect C57BL/6 mice, a higher survival rate was observed in C3H/He mice that were primed with recombinant influenza virus and boosted with Ad-ASP2 after being challenged with T. cruzi. Analyzing the phenotype of CD8+ T cells obtained from spleen of vaccinated C3H/He mice we observed that heterologous prime-boost immunization protocol elicited more CD8+ T cells specific for the immunodominant epitope as well as a higher number of CD8+ T cells producing TNF-alpha and IFN-gamma and a higher mobilization of surface marker CD107a. Taken together, our results suggest that immunodominant subpopulations of CD8+ T elicited after immunization could be directly related to degree of protection achieved by different immunization protocols using different viral vectors. Overall, these results demonstrated the usefulness of recombinant influenza viruses in immunization protocols against Chagas Disease.	[Alves Barbosa, Rafael Polidoro; Galvao Filho, Bruno; dos Santos, Luara Isabela; Gazzinelli, Ricardo Tostes] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Bruna-Romero, Oscar] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Marques, Pedro Elias; Sousa Pereira, Rafaela Vaz; Cara, Denise Carmona] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil; [Sales Junior, Policarpo Ademar; Gazzinelli, Ricardo Tostes; Machado, Alexandre Vieira] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Rodrigues, Mauricio Martins] Univ Fed Sao Paulo, Escola Paulista Med, Ctr Terapia Celular & Mol CTCMol, Sao Paulo, Brazil; [Rodrigues, Mauricio Martins] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP); University of Massachusetts System; University of Massachusetts Worcester	Machado, AV (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	amarok@cpqrr.fiocruz.br	Rodrigues, Mauricio M./B-8512-2012; Dos Santos, Luara Isabela/D-5031-2014; Polidoro, Rafael Barbosa/A-6385-2016; BRUNA-ROMERO, OSCAR/B-3918-2010; Marques, Pedro Elias/U-5740-2019; Machado, Alexandre M Vieira/G-2468-2012	Dos Santos, Luara Isabela/0000-0002-6212-2164; Polidoro, Rafael Barbosa/0000-0003-2982-0072; BRUNA-ROMERO, OSCAR/0000-0002-8855-4969; Marques, Pedro Elias/0000-0002-5613-8012; Machado, Alexandre M Vieira/0000-0003-1506-4093; Gazzinelli, Ricardo/0000-0003-2427-7699	FIOCRUZ/PDTIS-Vacinas; National Institute for Vaccine Development and Technology (CNPq/FAPEMIG) [015/2008]; CNPq/MAPA/SDA [064/2008]; Universal FAPEMIG; CNPq	FIOCRUZ/PDTIS-Vacinas; National Institute for Vaccine Development and Technology (CNPq/FAPEMIG); CNPq/MAPA/SDA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universal FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from FIOCRUZ/PDTIS-Vacinas, and National Institute for Vaccine Development and Technology (CNPq/FAPEMIG No 015/2008; http://www.cpqrr.fiocruz.br/inctv/), CNPq/MAPA/SDA No 064/2008, and Universal FAPEMIG (http://www.fapemig.br). Fellowships were provided by CNPq (http://www.cnpq.br/) to all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AFS, 2005, INFECT IMMUN, V73, P6017, DOI 10.1128/IAI.73.9.6017-6025.2005; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Bethony JM, 2011, IMMUNOL REV, V239, P237, DOI 10.1111/j.1600-065X.2010.00976.x; Boscardin SB, 2003, INFECT IMMUN, V71, P2744, DOI 10.1128/IAI.71.5.2744-2757.2003; Caetano BC, 2006, HUM GENE THER, V17, P415, DOI 10.1089/hum.2006.17.415; Camandaroba Edson L.P., 2003, Rev. Soc. Bras. Med. Trop., V36, P201, DOI 10.1590/S0037-86822003000200002; da Costa SCG, 2002, HISTOL HISTOPATHOL, V17, P837, DOI 10.14670/HH-17.837; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; Dominguez MR, 2012, VACCINE, V30, P2882, DOI 10.1016/j.vaccine.2012.02.037; Dominguez MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022011; Duan XF, 2009, VACCINE, V27, P6154, DOI 10.1016/j.vaccine.2009.08.026; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; Ferko B, 2001, J VIROL, V75, P8899, DOI 10.1128/JVI.75.19.8899-8908.2001; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Garg N, 2002, INFECT IMMUN, V70, P5547, DOI 10.1128/IAI.70.10.5547-5555.2002; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Hamada H, 2013, J IMMUNOL, V190, P296, DOI 10.4049/jimmunol.1200571; Horimoto T, 2009, CURR TOP MICROBIOL, V333, P165, DOI 10.1007/978-3-540-92165-3_8; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; KRETTLI AU, 1976, J IMMUNOL, V116, P755; Le Loup G, 2011, CURR OPIN INFECT DIS, V24, P428, DOI 10.1097/QCO.0b013e32834a667f; Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255; Low WP, 1998, J IMMUNOL, V160, P1817; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Machado AV, 2006, HUM GENE THER, V17, P898, DOI 10.1089/hum.2006.17.898; Machado AV, 2010, VACCINE, V28, P3247, DOI 10.1016/j.vaccine.2010.02.003; Machado AV, 2006, VIROLOGY, V345, P73, DOI 10.1016/j.virol.2005.09.050; Machado AV, 2003, VIROLOGY, V313, P235, DOI 10.1016/S0042-6822(03)00289-7; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Marinho CRF, 2007, SCAND J IMMUNOL, V66, P297, DOI 10.1111/j.1365-3083.2007.01958.x; Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2; Miyahira Y, 2008, PARASITOL INT, V57, P38, DOI 10.1016/j.parint.2007.07.005; Muller U, 2003, EUR J IMMUNOL, V33, P70, DOI 10.1002/immu.200390009; Nogueira RT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-127; Parodi C, 2009, MEM I OSWALDO CRUZ, V104, P288, DOI 10.1590/S0074-02762009000900038; Radosevic K, 2009, EXPERT REV VACCINES, V8, P577, DOI 10.1586/ERV.09.14; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rodrigues AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001598; Rodrigues MM, 2003, AN ACAD BRAS CIENC, V75, P443, DOI 10.1590/S0001-37652003000400005; Rodriguez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034445; Roffe E, 2012, J IMMUNOL, V188, P649, DOI 10.4049/jimmunol.1003845; Rosenberg CS, 2010, J IMMUNOL, V185, P560, DOI 10.4049/jimmunol.1000432; Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141; Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x; Silverio JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002645; Silverio JC, 2010, INT J EXP PATHOL, V91, P72, DOI 10.1111/j.1365-2613.2009.00670.x; Takayama E, 2010, INT J PARASITOL, V40, P1549, DOI 10.1016/j.ijpara.2010.05.011; Tan ACL, 2012, ANTIVIR RES, V94, P168, DOI 10.1016/j.antiviral.2012.03.009; Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006; Urbina JA, 2001, CURR OPIN INFECT DIS, V14, P733, DOI 10.1097/00001432-200112000-00012; Vasconcelos JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00358; Vasconcelos JR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002699; Vazquez-Chagoyan JC, 2011, ADV PARASIT, V75, P121, DOI 10.1016/B978-0-12-385863-4.00006-X; Wizel B, 1998, J CLIN INVEST, V102, P1062, DOI 10.1172/JCI3835; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	60	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61795	10.1371/journal.pone.0061795	http://dx.doi.org/10.1371/journal.pone.0061795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637908	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400052
J	Gagnon, H; Refaie, S; Gagnon, S; Desjardins, R; Salzet, M; Day, R				Gagnon, Hugo; Refaie, Sarah; Gagnon, Sandra; Desjardins, Roxane; Salzet, Michel; Day, Robert			Proprotein Convertase 1/3 (PC1/3) in the Rat Alveolar Macrophage Cell Line NR8383: Localization, Trafficking and Effects on Cytokine Secretion	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; PROHORMONE CONVERTASES; MESSENGER-RNA; IMMUNOCYTOCHEMICAL LOCALIZATION; CHROMOSOMAL LOCALIZATION; ENDOPLASMIC-RETICULUM; ENZYMATIC-PROPERTIES; LYSOSOME BIOGENESIS; SIGNAL-TRANSDUCTION; RECYCLING ENDOSOME	The proprotein convertase 1/3 (PC1/3) is an important post-translational processing enzyme for the activation of precursor proteins within the regulated secretory pathway. Well characterized for its role in the neural and endocrine systems, we recently reported an unconventional role of PC1/3 as a modulator of the Toll-like receptor innate immune response. There are only a few reports that have studied PC1/3 expression in macrophages, and more investigation is needed to better characterize its function. These studies would greatly benefit from model cell lines. Our study aims to identify and characterize PC1/3 in a relevant model macrophage cell line and to determine the links between PC1/3 and innate immune cellular responses. We describe the rat alveolar cell line, NR8383, as expressing PC1/3 and the most common Toll-like receptors. In NR8383 cells, PC1/3 is localized at the Trans-Golgi network and traffics to lysosome related vesicles upon lipopolysaccharide stimulation. Moreover, we report the co-localization of PC1/3 and Toll-like receptor 4 upon lipopolysaccharide stimulation. Down regulation of PC1/3 by shRNA produce a similar phenotype in NR8383 to what we previously reported in isolated peritoneal macrophages. PC1/3 shRNA induced changes in the cellular organization and expression of the specific trafficking regulator RAB GTPase. As a consequence, NR8383 down-regulated for PC1/3, present an abnormal cytokine secretion profile. We conclude that the NR8383 cell line represents a good model to study PC1/3 in macrophages and we present PC1/3 as an important regulator of vesicle trafficking and secretion in macrophages.	[Gagnon, Hugo; Refaie, Sarah; Gagnon, Sandra; Desjardins, Roxane; Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Gagnon, Hugo; Salzet, Michel] Univ Lille 1, EA 4550, Lab Spectrometrie Masse Biol Fondamentale & Appl, Univ Lille Nord France, Villeneuve Dascq, France	University of Sherbrooke; Universite de Lille - ISITE; Universite de Lille	Salzet, M (corresponding author), Univ Lille 1, EA 4550, Lab Spectrometrie Masse Biol Fondamentale & Appl, Univ Lille Nord France, Villeneuve Dascq, France.	Michel.salzet@univ-lille1.fr; Robert.day@usherbrooke.ca	Salzet, Michel/A-7675-2011	Salzet, Michel/0000-0003-4318-0817	Canadian Institutes of Health Research (CIHR); Ministere du Developpement Economique de l'Innovation et de l'Exportation (MDEIE); Fond de recherche du Quebec-Sante (FRQ-S); Ministere de L'Education Nationale, de L'Enseignement Superieur; CNRS; FQRNT; French consulate	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministere du Developpement Economique de l'Innovation et de l'Exportation (MDEIE); Fond de recherche du Quebec-Sante (FRQ-S); Ministere de L'Education Nationale, de L'Enseignement Superieur; CNRS(Centre National de la Recherche Scientifique (CNRS)); FQRNT(FQRNT); French consulate	This work was supported by the Canadian Institutes of Health Research (CIHR to Robert Day), the Ministere du Developpement Economique de l'Innovation et de l'Exportation (MDEIE to Robert Day) and the Fond de recherche du Quebec-Sante (FRQ-S to Robert day). Additional support was received from grants from Ministere de L'Education Nationale, de L'Enseignement Superieur (to Michel Salzet) and the CNRS (to Michel Salzet). Robert Day is a member of the Centre de Recherche Clinique Etienne-LeBel (Sherbrooke, Qc, Canada). Hugo Gagnon holds a bursary from CNRS and received the Frontenac mobility grant for a joint thesis (Franco-Quebec) from FQRNT and the French consulate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuffo H, 1999, CLIN EXP IMMUNOL, V117, P529; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; BAILYES EM, 1992, BIOCHEM J, V285, P391, DOI 10.1042/bj2850391; Basak A, 2001, J BIOL CHEM, V276, P32720, DOI 10.1074/jbc.M104064200; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Brechler V, 1996, J BIOL CHEM, V271, P20636, DOI 10.1074/jbc.271.34.20636; Brodeur J, 2009, TRAFFIC, V10, P1098, DOI 10.1111/j.1600-0854.2009.00933.x; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bundgaard JR, 2004, J BIOL CHEM, V279, P5488, DOI 10.1074/jbc.M310547200; CHAPMAN HA, 1991, ANN NY ACAD SCI, V624, P87, DOI 10.1111/j.1749-6632.1991.tb17009.x; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; CHEN YT, 1993, P NATL ACAD SCI USA, V90, P6508, DOI 10.1073/pnas.90.14.6508; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; D'Anjou F, 2011, TRANSL ONCOL, V4, P157, DOI 10.1593/tlo.10295; Dalm VASH, 2003, AM J PHYSIOL-ENDOC M, V285, pE344, DOI 10.1152/ajpendo.00048.2003; DAY R, 1993, NEUROSCI LETT, V149, P27, DOI 10.1016/0304-3940(93)90339-M; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Dikeakos JD, 2007, FEBS J, V274, P4094, DOI 10.1111/j.1742-4658.2007.05937.x; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DONG W, 1995, J NEUROSCI, V15, P1778, DOI 10.1523/JNEUROSCI.15-03-01778.1995; Duitman EH, 2011, EUR J CELL BIOL, V90, P476, DOI 10.1016/j.ejcb.2011.01.010; Dustin ML, 2012, J CLIN INVEST, V122, P1149, DOI 10.1172/JCI58705; Feliciangeli S, 2001, J BIOL CHEM, V276, P6140, DOI 10.1074/jbc.M009613200; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Girish V, 2004, Indian J Cancer, V41, P47; Guha M, 2012, NAT REV DRUG DISCOV, V11, P503, DOI 10.1038/nrd3775; HELMKE RJ, 1987, IN VITRO CELL DEV B, V23, P567; HELMKE RJ, 1989, IN VITRO CELL DEV B, V25, P44; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; HORNBY PJ, 1993, NEUROENDOCRINOLOGY, V58, P555, DOI 10.1159/000126590; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; KNAPP PE, 1990, J CELL SCI, V95, P433; LaMendola J, 1997, FEBS LETT, V404, P19, DOI 10.1016/S0014-5793(97)00078-1; Lanoue E, 2001, ENDOCRINOLOGY, V142, P4141, DOI 10.1210/en.142.9.4141; Lansac G, 2006, J NEUROIMMUNOL, V171, P57, DOI 10.1016/j.jneuroim.2005.09.019; Lee SN, 2004, J ENDOCRINOL, V182, P353, DOI 10.1677/joe.0.1820353; LINDBERG I, 1994, MOL CELL NEUROSCI, V5, P263, DOI 10.1006/mcne.1994.1030; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; LOLAIT SJ, 1984, J CLIN INVEST, V73, P277, DOI 10.1172/JCI111203; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; MALIDE D, 1995, J HISTOCHEM CYTOCHEM, V43, P11, DOI 10.1177/43.1.7822759; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Meng LS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3034; MERESSE S, 1995, J CELL SCI, V108, P3349; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; O'Neill LAJ, 2008, NAT IMMUNOL, V9, P459, DOI 10.1038/ni0508-459; Pan H, 2005, BIOCHEMISTRY-US, V44, P4939, DOI 10.1021/bi047852m; Ponnambalam S, 1996, J CELL SCI, V109, P675; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; RALPH P, 1977, J IMMUNOL, V119, P950; Refaie S, 2012, J BIOL CHEM, V287, P14703, DOI 10.1074/jbc.M111.323220; Ren WY, 2011, IMMUNOL LETT, V141, P94, DOI 10.1016/j.imlet.2011.07.010; Rholam M, 2009, CELL MOL LIFE SCI, V66, P2075, DOI 10.1007/s00018-009-0007-5; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rittig MG, 1999, MICROBES INFECT, V1, P727, DOI 10.1016/S1286-4579(99)80074-4; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Saravia F, 1998, NEUROPEPTIDES, V32, P351, DOI 10.1016/S0143-4179(98)90058-0; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah N G, 1992, NIDA Res Monogr, V126, P132; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Tanaka S, 1996, ARCH HISTOL CYTOL, V59, P261, DOI 10.1679/aohc.59.261; Tapper H, 1996, J LEUKOCYTE BIOL, V59, P613, DOI 10.1002/jlb.59.5.613; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VINDROLA O, 1994, NEUROPEPTIDES, V27, P235, DOI 10.1016/0143-4179(94)90004-3; Yuasa K, 2009, J BIOCHEM, V146, P407, DOI 10.1093/jb/mvp090; Zandberg WF, 2011, GLYCOBIOLOGY, V21, P1290, DOI 10.1093/glycob/cwr060; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; ZHOU Y, 1994, J BIOL CHEM, V269, P18408; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	94	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61557	10.1371/journal.pone.0061557	http://dx.doi.org/10.1371/journal.pone.0061557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637853	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400028
J	Zhang, FF; Jiang, ZG; Xu, AC; Zeng, Y; Li, CW				Zhang, Fangfang; Jiang, Zhigang; Xu, Aichun; Zeng, Yan; Li, Chunwang			Recent Geological Events and Intrinsic Behavior Influence the Population Genetic Structure of the Chiru and Tibetan Gazelle on the Tibetan Plateau	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SNAPPER LUTJANUS-CAMPECHANUS; COMPARATIVE PHYLOGEOGRAPHY; RED SNAPPER; STATISTICAL TESTS; COALESCENT; HISTORY; NEUTRALITY; MIGRATION; SEQUENCES	The extent to which a species responds to environmental changes is mediated not only by extrinsic processes such as time and space, but also by species-specific ecology. The Qinghai-Tibetan Plateau uplifted approximately 3000 m and experienced at least four major glaciations during the Pleistocene epoch in the Quaternary Period. Consequently, the area experienced concurrent changes in geomorphological structure and climate. Two species, the Tibetan antelope (Pantholops hodgsonii, chiru) and Tibetan gazelle (Procapra picticaudata), both are endemic on the Qinghai-Tibetan Plateau, where their habitats overlap, but have different migratory behaviors: the chiru is inclined to have female-biased dispersal with a breeding migration during the calving season; in contrast, Tibetan gazelles are year-round residents and never migrate distantly. By using coalescence methods we compared mitochondrial control region DNA sequences and variation at nine microsatellite loci in these two species. Coalescent simulations indicate that the chiru and Tibetan gazelle do not share concordant patterns in their genealogies. The non-migratory Tibetan gazelle, that is more vulnerable to the impact of drastic geographic changes such as the elevation of the plateau, glaciations and so on, appears to have a strong population genetic structure with complicated demographic history. Specifically, the Tibetan gazelle population appears to have experienced isolation and divergence with population fluctuations since the Middle Pleistocene (0.781 Ma). However, it showed continued decline since the Upper Pleistocene (0.126 Ma), which may be attributed to the irreversible impact of increased human activities on the plateau. In contrast, the migratory chiru appears to have simply experienced population expansion. With substantial gene flow among regional populations, this species shows no historical population isolation and divergence. Thus, this study adds to many empirical studies that show historical and contemporary extrinsic and intrinsic processes shape the recent evolutionary history and population genetic structure of species.	[Zhang, Fangfang; Jiang, Zhigang; Xu, Aichun; Zeng, Yan; Li, Chunwang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhang, Fangfang; Jiang, Zhigang; Zeng, Yan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Xu, Aichun] China Jiliang Univ, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Jiliang University	Jiang, ZG (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Zhang, Fang/HHN-2153-2022; Jiang, Zhigang/E-4598-2014; Zeng, Yan/U-5030-2019	Jiang, Zhigang/0000-0003-2154-8588; 	Chinese Academy of Sciences [KSCX2-EW-Z-4]; Science and Technology Supporting Project, Ministry of Science and Technology, China [2008BAC39B04]; State Forestry Administration	Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Supporting Project, Ministry of Science and Technology, China; State Forestry Administration	This study was supported by the Knowledge Innovation Project of Chinese Academy of Sciences (KSCX2-EW-Z-4, http://www.bio.cas.cn/xmyj/yzscxzdxm/), the Science and Technology Supporting Project, Ministry of Science and Technology, China (Monitoring of Important Biological Species and Demonstration of Key Conservation Technology Application in China, 2008BAC39B04, http://program.most.gov.cn/), and the State Forestry Administration (http://zrbhq.forestry.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboim MA, 2005, MOL ECOL, V14, P1343, DOI 10.1111/j.1365-294X.2005.02518.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; AVISE JC, 1984, EVOLUTION, V38, P931, DOI 10.1111/j.1558-5646.1984.tb00364.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P., 2004, MIGRATE DOCUMENTATIO; Bermingham E, 1998, MOL ECOL, V7, P367, DOI 10.1046/j.1365-294x.1998.00424.x; BISHOP MD, 1994, GENETICS, V136, P619; BREZINSKY L, 1993, ANIM GENET, V24, P73; Brouat C, 2003, MOL ECOL, V12, P1731, DOI 10.1046/j.1365-294X.2003.01861.x; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Carling MD, 2003, MOL ECOL NOTES, V3, P10, DOI 10.1046/j.1471-8286.2003.00334.x; Chen Y, 1984, QUATERNARY CLIMATES; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans BJ, 2003, EVOLUTION, V57, P1436; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FERRIS SD, 1983, P NATL ACAD SCI-BIOL, V80, P2290, DOI 10.1073/pnas.80.8.2290; Fort M, 1996, PALAEOGEOGR PALAEOCL, V120, P123, DOI 10.1016/0031-0182(94)00038-7; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1996, GENETICS, V143, P557; Fu YX, 1997, GENETICS, V147, P915; Gold JR, 2001, MAR BIOTECHNOL, V3, P293, DOI 10.1007/s10126-001-0004-7; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hu JH, 2012, NATURWISSENSCHAFTEN, V99, P553, DOI 10.1007/s00114-012-0933-1; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; JOSEPH L, 1995, P ROY SOC B-BIOL SCI, V260, P177, DOI 10.1098/rspb.1995.0077; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kwan H.K., 1996, PALAEOGEOGR PALAEOCL, V120, P159; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Matocq MD, 2000, EVOLUTION, V54, P1423; Meyer S, 1999, GENETICS, V152, P1103; Miller, 1999, RANGELANDS, V21, P17; MOORE SS, 1994, MAMM GENOME, V5, P84, DOI 10.1007/BF00292333; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; PALUMBI SR, 1994, MOL BIOL EVOL, V11, P426; Patterson WF, 2001, T AM FISH SOC, V130, P533, DOI 10.1577/1548-8659(2001)130<0533:MOTRSI>2.0.CO;2; Patton JL, 1996, MOL ECOL, V5, P229; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Petit E, 2001, EVOLUTION, V55, P635, DOI 10.1554/0014-3820(2001)055[0635:SBDIAM]2.0.CO;2; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Pruett C, 2005, MAR BIOL, V147, P593, DOI 10.1007/s00227-005-1615-8; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Rambaut A., 2006, FIGTREE TREE FIGURE; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruan XD, 2005, J MAMMAL, V86, P881, DOI 10.1644/1545-1542(2005)86[881:EHACPR]2.0.CO;2; Russell AL, 2005, MOL ECOL, V14, P2207, DOI 10.1111/j.1365-294X.2005.02552.x; SCHALLER GB, 1991, APPL ANIM BEHAV SCI, V29, P361, DOI 10.1016/0168-1591(91)90261-U; Schaller GB., 1998, WILDLIFE TIBETAN STE; Schaller George B., 2006, Acta Theriologica Sinica, V26, P105; Schneider CJ, 1998, MOL ECOL, V7, P487, DOI 10.1046/j.1365-294x.1998.00334.x; Schneider S., 2000, ARLEQUIN VER 2 000 S; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; SLATKIN M, 1991, GENETICS, V129, P555; STEFFEN P, 1993, ANIM GENET, V24, P121, DOI 10.1111/j.1365-2052.1993.tb00252.x; Stiller M, 2010, MOL BIOL EVOL, V27, P975, DOI 10.1093/molbev/msq083; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Templeton AR, 2001, P NATL ACAD SCI USA, V98, P5426, DOI 10.1073/pnas.091093098; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yang J, 2011, CONSERV GENET, V12, P1457, DOI 10.1007/s10592-011-0244-7; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang FF, 2006, MOL PHYLOGENET EVOL, V41, P313, DOI 10.1016/j.ympev.2006.05.024	85	11	15	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e60712	10.1371/journal.pone.0060712	http://dx.doi.org/10.1371/journal.pone.0060712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637761	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400008
J	Lei, HZ; Zou, DL; Li, Z; Luo, M; Dong, L; Wang, B; Yin, HX; Ma, YN; Liu, CZ; Wang, F; Zhang, JW; Yu, J; Li, Y				Lei, Huizi; Zou, Dongling; Li, Zheng; Luo, Min; Dong, Lei; Wang, Bin; Yin, Haixin; Ma, Yanni; Liu, Changzheng; Wang, Fang; Zhang, Junwu; Yu, Jia; Li, Yu			MicroRNA-219-2-3p Functions as a Tumor Suppressor in Gastric Cancer and Is Regulated by DNA Methylation	PLOS ONE			English	Article							PROSTATE-CANCER; MICRORNA EXPRESSION; THERAPY; HYPERMETHYLATION; GEFITINIB; CARCINOMA; SPECIMENS; HER3	Background & Aims: Gastric cancer is the most frequent gastrointestinal tumor in adults and is the most lethal form of human cancer. Despite of the improvements in treatments, the underlying mechanism of gastric carcinogenesis is not well known. To define novel modulators that regulate susceptibility to tumorgenesis, we focused on miR-219-2-3p. Methods: Quantitative RT-PCR was employed to investigate the level of miR-219-2-3p in gastric cancer (GC) tissues (n = 113) and their matched adjacent normal tissues (n = 113). In vitro cell proliferation, apoptosis assays, cell migration, and invasion assays were performed to elucidate biological effects of miR-219-2-3p. Since silencing of miRNA by promoter CpG island methylation may be an important mechanism in tumorgenesis, GC cells were treated with 5-aza-2'-deoxycytidine and trichostatin A, and expression changes of miR-219-2-3p were subsequently examined by quantitative RT-PCR. Finally, the methylation status of CpG island upstream of miR-219-2-3p was analyzed by methylation-specific PCR in GC tissues (n = 22). Results: miR-219-2-3p was down-regulated in GC and cell lines. In addition, the experiments documented the lower expression of miR-219-2-3p in GC specimens with higher grade and later stage tumors. Meanwhile, miR-219-2-3p exerted antiproliferative, proapoptotic, and antimetastatic roles and reduced levels of p-ERK1/2 in GC cells. Furthermore, 5-aza-2'-deoxycytidine and trichostatin A increased the expression (similar to 2 fold) of miR-219-2-3p in GC cells. By methylation-specific PCR, DNA methylation in the upstream region of miR-219-2-3p was detected in both adjacent normal tissues and cancer tissues. As expected, the methylation level was considerably higher in the miR-219-2-3p down-regulated group than up-regulated group. Conclusions: miR-219-2-3p is potentially involved in gastric cancer progression and metastasis by regulating ERK1/2-related signal pathways, which may provide a novel therapeutic strategy for treatment of gastric cancer. Methylation mechanism may be involved in modulating the expression level of miR-219-2-3p in gastric cancer.	[Lei, Huizi; Li, Yu] Chongqing Med Univ, Dept Pathol, Chongqing, Peoples R China; [Lei, Huizi; Zou, Dongling; Luo, Min; Dong, Lei; Wang, Bin; Yin, Haixin; Ma, Yanni; Liu, Changzheng; Wang, Fang; Zhang, Junwu; Yu, Jia] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem, Beijing 100730, Peoples R China; [Lei, Huizi; Zou, Dongling; Luo, Min; Dong, Lei; Wang, Bin; Yin, Haixin; Ma, Yanni; Liu, Changzheng; Wang, Fang; Zhang, Junwu; Yu, Jia] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zou, Dongling] Chongqing Canc Inst, Dept Gynecol Oncol, Chongqing, Peoples R China; [Li, Zheng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthoped Surg, Beijing 100021, Peoples R China	Chongqing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Yu, J (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem, Beijing 100730, Peoples R China.	j-yu@ibms.pumc.edu.cn; liyu100@163.com	Dong, Lei/AAA-9495-2020	Dong, Lei/0000-0001-9574-0148	National Natural Science Foundation of China [91129716]; Beijing Municipal Science & Technology Commission [2010B071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the National Natural Science Foundation of China [2012, 91129716, to JY] and the Beijing Municipal Science & Technology Commission [2010B071, to JY]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Andolfo I, 2012, NEURO-ONCOLOGY, V14, P596, DOI 10.1093/neuonc/nos002; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; de Faria Omar Jr., 2012, Frontiers in Genetics, V3, P46, DOI 10.3389/fgene.2012.00046; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Huang N, 2012, FEBS LETT, V586, P884, DOI 10.1016/j.febslet.2012.02.017; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CELL CYCLE, V6, P1455; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Park S, 2011, BIOCHEM BIOPH RES CO, V407, P680, DOI 10.1016/j.bbrc.2011.03.075; Pinhel IF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2719; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rojo F, 2006, J CLIN ONCOL, V24, P4309, DOI 10.1200/JCO.2005.04.2424; Sawaki A, 2012, GASTRIC CANCER, V15, P313, DOI 10.1007/s10120-011-0118-1; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041773; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Suh SO, 2011, CARCINOGENESIS, V32, P772, DOI 10.1093/carcin/bgr036; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wu JH, 2012, OPHTHALMIC RES, V47, P195, DOI 10.1159/000331992; Wurdinger T, 2007, PHARMACOGENOMICS J, V7, P297, DOI 10.1038/sj.tpj.6500429; Yasui W, 2009, PATHOL INT, V59, P121, DOI 10.1111/j.1440-1827.2009.02329.x; Zambon CF, 2004, GASTROENTEROLOGY, V126, P382, DOI 10.1053/j.gastro.2003.08.042	37	45	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60369	10.1371/journal.pone.0060369	http://dx.doi.org/10.1371/journal.pone.0060369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637748	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400005
J	Navarro-Vidal, B; Banegas, JR; Leon-Munoz, LM; Rodriguez-Artalejo, F; Graciani, A				Navarro-Vidal, Beatriz; Banegas, Jose R.; Leon-Munoz, Luz M.; Rodriguez-Artalejo, Fernando; Graciani, Auxiliadora			Achievement of Cardiometabolic Goals among Diabetic Patients in Spain. A Nationwide Population-Based Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; PRIMARY PREVENTION; CLINICAL-PRACTICE; LIFE-STYLE; MELLITUS; DISEASE; ADULTS; ASSOCIATION; ADHERENCE; NUTRITION	Background: No previous study has reported a comprehensive assessment of the attainment of cardiometabolic goals in the diabetic population of a European country. We examined the achievement of cardiometabolic goals among diabetics in Spain. Methods and Findings: A cross-sectional survey was performed in 2008-2010 among 12,077 individuals representative of the Spanish population aged >= 18 years. Information on cardiometabolic characteristics was collected at the participants' homes through structured questionnaires, physical examination, and fasting blood samples. Attainment of cardiometabolic goals was evaluated according to the most well-known guidelines. A total of 834 individuals had diabetes (fasting serum glucose >= 126 mg/dl, or glycosylated hemoglobin >= 6.5%,) or were being treated with oral antidiabetic drugs or insulin). Among diabetic patients, 661 (79.2%) were aware of their condition. Among the aware diabetic patients, only 11.4% had neither general (body mass index <25 kg/m(2)) nor abdominal obesity (waist circumference <= 102 cm in men and <= 88 cm in women), 8.6% consumed <7% of calories daily from saturated fats, and 41.1% achieved the recommendation on weekly physical activity. About 71% had glycosylated hemoglobin <7%, 22% had blood pressure <130/80 mmHg, and 36% reached the LDL-cholesterol goal of <100 mg/dl. Although a large proportion of aware diabetic individuals received lifestyle medical advice, only 38% of overweight individuals and 20% of daily smokers were offered a specific strategy for weight loss or quitting smoking, respectively. Conclusions: In a European country with universal healthcare coverage, achievement of many cardiometabolic goals, in particular lifestyle, among aware diabetic individuals is poor. This suggests a need for improvement in both clinical guidelines' implementation and patients' adherence.	[Navarro-Vidal, Beatriz; Banegas, Jose R.; Leon-Munoz, Luz M.; Rodriguez-Artalejo, Fernando; Graciani, Auxiliadora] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, IdiPAZ, CIBERESP, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Graciani, A (corresponding author), Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, IdiPAZ, CIBERESP, Madrid, Spain.	a.graciani@uam.es	León-Muñoz, Luz M/H-8275-2017; Graciani, Auxiliadora/D-8243-2013	Graciani, Auxiliadora/0000-0002-6211-587X; Leon-Munoz, Luz Maria/0000-0001-5447-5907	Sanofi-Aventis; Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular	Sanofi-Aventis(Sanofi-Aventis); Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular	Data for this work were taken from the ENRICA study, which was funded by Sanofi-Aventis. Additional funding was obtained from the 'Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular'. The ENRICA study is being run by an independent academic steering committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; [Anonymous], 1997, Int J Epidemiol, V26 Suppl 1, pS100; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P622, DOI 10.1017/S1368980010002752; Banegas JR, 2011, EUR HEART J, V32, P2143, DOI 10.1093/eurheartj/ehr080; de Leon AC, 2009, REV ESP SALUD PUBLIC, V83, P567; Centers of Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P1007; Charpentier G, 2003, DIABETES METAB, V29, P152, DOI 10.1016/S1262-3636(07)70022-8; Comaschi M, 2005, NUTR METAB CARDIOVAS, V15, P204, DOI 10.1016/j.numecd.2004.07.003; Donker GA, 2004, FAM PRACT, V21, P364, DOI 10.1093/fampra/cmh404; Dorsey R, 2011, PREV CHRONIC DIS, V8; Eko~e J. M., 2008, EPIDEMIOLOGY DIABETE; Ford ES, 2011, J DIABETES, V3, P337, DOI 10.1111/j.1753-0407.2011.00148.x; Galán Iñaki, 2004, Gac Sanit, V18, P440, DOI 10.1157/13069762; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Meyers CD, 2006, AM J CARDIOL, V98, P63, DOI 10.1016/j.amjcard.2006.01.061; Nicolucci A, 2011, DIABETES CARE, V34, pS150, DOI 10.2337/dc11-s210; Ortega-Anta RM, 2007, PROGRAMA DIAL; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pignone M, 2010, J AM COLL CARDIOL, V55, P2878, DOI 10.1016/j.jacc.2010.04.003; Pols MA, 1979, INT J EPIDEMIOL S1, V26, pS181; Prevost G, 2005, DIABETES METAB, V31, P479, DOI 10.1016/S1262-3636(07)70219-7; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; Rodriguez-Artalejo F, 2011, REV ESP CARDIOL, V64, P876, DOI 10.1016/j.recesp.2011.05.019; Rosen AB, 2006, J GEN INTERN MED, V21, P315, DOI 10.1111/j.1525-1497.2006.00351.x; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Schauer GL, 2013, J BEHAV MED, V36, P10, DOI 10.1007/s10865-011-9386-9; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD), 2007, EUR HEART J SUPPL, V9, pC3; U.S. Department of Agriculture Agricultural Research Service, 2010, NAT NUTR DAT STAND R	31	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61549	10.1371/journal.pone.0061549	http://dx.doi.org/10.1371/journal.pone.0061549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637851	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700044
J	Cavaliere, S; Malik, BR; Hodge, JJL				Cavaliere, Sonia; Malik, Bilal R.; Hodge, James J. L.			KCNQ Channels Regulate Age-Related Memory Impairment	PLOS ONE			English	Article							MUSHROOM BODY NEURONS; SLOW AFTERHYPERPOLARIZATION; POTASSIUM CHANNELS; K+ CURRENTS; TERM-MEMORY; DROSOPHILA; GENE; INHIBITION; BRAIN; SUSCEPTIBILITY	In humans KCNQ2/3 heteromeric channels form an M-current that acts as a brake on neuronal excitability, with mutations causing a form of epilepsy. The M-current has been shown to be a key regulator of neuronal plasticity underlying associative memory and ethanol response in mammals. Previous work has shown that many of the molecules and plasticity mechanisms underlying changes in alcohol behaviour and addiction are shared with those of memory. We show that the single KCNQ channel in Drosophila (dKCNQ) when mutated show decrements in associative short- and long-term memory, with KCNQ function in the mushroom body alpha/beta neurons being required for short-term memory. Ethanol disrupts memory in wildtype flies, but not in a KCNQ null mutant background suggesting KCNQ maybe a direct target of ethanol, the blockade of which interferes with the plasticity machinery required for memory formation. We show that as in humans, Drosophila display age-related memory impairment with the KCNQ mutant memory defect mimicking the effect of age on memory. Expression of KCNQ normally decreases in aging brains and KCNQ overexpression in the mushroom body neurons of KCNQ mutants restores age-related memory impairment. Therefore KCNQ is a central plasticity molecule that regulates age dependent memory impairment.	[Cavaliere, Sonia; Malik, Bilal R.; Hodge, James J. L.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol	Hodge, JJL (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	james.hodge@bristol.ac.uk		Malik, Bilal/0000-0001-5522-4990; Hodge, James/0000-0003-4741-2363	EU FP7 Marie-Curie [IRG200632]; Royal Society [2008/R1]; BBSRC [BB/G008973/1]; Wellcome PhD program [083361]; Biotechnology and Biological Sciences Research Council [BB/J017221/1, BB/G008973/1] Funding Source: researchfish; BBSRC [BB/J017221/1] Funding Source: UKRI	EU FP7 Marie-Curie(European Commission); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome PhD program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the EU FP7 Marie-Curie (IRG200632), Royal Society (2008/R1), BBSRC (BB/G008973/1), and from a Wellcome PhD program (083361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Cavaliere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050279; Cavaliere S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023898; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; COWAN TM, 1986, J NEUROGENET, V3, P187, DOI 10.3109/01677068609106849; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Gasque G, 2005, J NEUROSCI, V25, P2348, DOI 10.1523/JNEUROSCI.4384-04.2005; Gasque G, 2006, J CELL PHYSIOL, V209, P1046, DOI 10.1002/jcp.20764; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; GORCZYCA MG, 1987, J NEUROSCI, V7, P1361; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; Gu HY, 2006, J NEUROSCI, V26, P265, DOI 10.1523/JNEUROSCI.4109-05.2006; Hansen HH, 2008, J PHYSIOL-LONDON, V586, P1823, DOI 10.1113/jphysiol.2007.149450; Hodge JJL, 2006, NEURON, V51, P327, DOI 10.1016/j.neuron.2006.06.020; Huang H, 2011, NAT NEUROSCI, V14, P840, DOI 10.1038/nn.2830; Kaczorowski CC, 2009, LEARN MEMORY, V16, P362, DOI 10.1101/lm.1365609; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Koyama S, 2007, J NEUROPHYSIOL, V97, P1977, DOI 10.1152/jn.00270.2006; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Martin JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000275; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Roepke TA, 2012, AM J PHYSIOL-ENDOC M, V302, pE1399, DOI 10.1152/ajpendo.00565.2011; Rogero O, 1997, J NEUROSCI, V17, P5108; Ruiz-Canada C, 2002, J NEUROCHEM, V82, P1490, DOI 10.1046/j.1471-4159.2002.01092.x; Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Tombaugh GC, 2005, J NEUROSCI, V25, P2609, DOI 10.1523/JNEUROSCI.5023-04.2005; Tonoki A, 2012, P NATL ACAD SCI USA, V109, P6319, DOI 10.1073/pnas.1118126109; Tsydzik V, 2009, DEV NEUROBIOL, V69, P705, DOI 10.1002/dneu.20716; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Van Eyken E, 2006, HUM MUTAT, V27, P1007, DOI 10.1002/humu.20375; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang M, 2011, NATURE, V476, P210, DOI 10.1038/nature10243; Wen H, 2005, J NEUROSCI, V25, P10147, DOI 10.1523/JNEUROSCI.3086-05.2005; WRIGHT NJD, 1995, J NEUROSCI, V15, P1025; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yamazaki D, 2010, J NEUROSCI, V30, P15573, DOI 10.1523/JNEUROSCI.3229-10.2010; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yu DH, 2003, J NEUROSCI, V23, P64; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	52	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62445	10.1371/journal.pone.0062445	http://dx.doi.org/10.1371/journal.pone.0062445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638087	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300060
J	Boulanger, CA; Bruno, RD; Mack, DL; Gonzales, M; Castro, NP; Salomon, DS; Smith, GH				Boulanger, Corinne A.; Bruno, Robert D.; Mack, David L.; Gonzales, Monica; Castro, Nadia P.; Salomon, David S.; Smith, Gilbert H.			Embryonic Stem Cells Are Redirected to Non-Tumorigenic Epithelial Cell Fate by Interaction with the Mammary Microenvironment	PLOS ONE			English	Article							IN-VIVO; MOUSE; EXPRESSION; GLAND; DIFFERENTIATION; MORPHOGENESIS; PHENOTYPE; STRAIN; CANCER; GENES	Experiments were conducted to redirect mouse Embryonic Stem (ES) cells from a tumorigenic phenotype to a normal mammary epithelial phenotype in vivo. Mixing LacZ-labeled ES cells with normal mouse mammary epithelial cells at ratios of 1:5 and 1:50 in phosphate buffered saline and immediately inoculating them into epithelium-divested mammary fat pads of immune-compromised mice accomplished this. Our results indicate that tumorigenesis occurs only when normal mammary ductal growth is not achieved in the inoculated fat pads. When normal mammary gland growth occurs, we find ES cells (LacZ+) progeny interspersed with normal mammary cell progeny in the mammary epithelial structures. We demonstrate that these progeny, marked by LacZ expression, differentiate into multiple epithelial subtypes including steroid receptor positive luminal cells and myoepithelial cells indicating that the ES cells are capable of epithelial multipotency in this context but do not form teratomas. In addition, in secondary transplants, ES cell progeny proliferate, contribute apparently normal mammary progeny, maintain their multipotency and do not produce teratomas.	[Boulanger, Corinne A.; Bruno, Robert D.; Mack, David L.; Smith, Gilbert H.] NCI, Mammary Stem Cell Biol Sect, Cell & Canc Biol Branch, Bethesda, MD 20892 USA; [Gonzales, Monica; Castro, Nadia P.; Salomon, David S.] NCI, Tumor Growth Factor Sect, Mammary Biol & Tumorigenesis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smith, GH (corresponding author), NCI, Mammary Stem Cell Biol Sect, Cell & Canc Biol Branch, Bethesda, MD 20892 USA.	gs4d@nih.gov	Mack, David/AAE-5437-2022	Bruno, Robert/0000-0003-3329-9478	NATIONAL CANCER INSTITUTE [ZIABC010021] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Al Sulti F, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016309; Booth BW, 2011, ONCOGENE, V30, P679, DOI 10.1038/onc.2010.439; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Boulanger CA, 2011, STEM CELLS DEV; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Chang TC, 2011, STEM CELLS DEV, V20, P1053, DOI 10.1089/scd.2010.0372; DANIEL CW, 1965, SCIENCE, V149, P634, DOI 10.1126/science.149.3684.634; DEOME KB, 1959, CANCER RES, V19, P515; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Pierce G B, 1975, Bibl Haematol, P271; Pierce G B, 1967, Curr Top Dev Biol, V2, P223; PIERCE GB, 1971, IN VITRO CELL DEV B, V7, P140; Roche E, 2005, FASEB J, V19, P1341, DOI 10.1096/fj.04-3024fje; SAKAKURA T, 1987, DEVELOPMENT, V100, P421; SAKAKURA T, 1976, SCIENCE, V194, P1439, DOI 10.1126/science.827022; SMITH GH, 1991, J VIROL, V65, P6365, DOI 10.1128/JVI.65.11.6365-6370.1991; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Van Keymeulen A, 2012, J CELL BIOL, V197, P575, DOI 10.1083/jcb.201201041; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; Wansbury O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2928; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	27	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62019	10.1371/journal.pone.0062019	http://dx.doi.org/10.1371/journal.pone.0062019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637952	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700028
J	Dylla, L; Jedlicka, P				Dylla, Layne; Jedlicka, Paul			Growth-Promoting Role of the miR-106a similar to 363 Cluster in Ewing Sarcoma	PLOS ONE			English	Article							CHILDRENS ONCOLOGY GROUP; CELL-CYCLE ARREST; EXPRESSION PROFILE; SIGNALING PATHWAY; MICRORNA SPONGES; CANCER; FAMILY; TRANSFORMATION; MIR-16; SENSITIVITY	MicroRNAs (miRs) have been identified as potent regulators of both normal development and the hallmarks of cancer. Targeting of microRNAs has been shown to have preclinical promise, and select miR-based therapies are now in clinical trials. Ewing Sarcoma is a biologically aggressive pediatric cancer with little change in clinical outcomes despite improved chemotherapeutic regimens. There is a substantial need for new therapies to improve Ewing Sarcoma outcomes and to prevent chemotherapy-related secondary sequelae. Most Ewing Sarcoma tumors are driven by the EWS/Fli-1 fusion oncoprotein, acting as a gain-of-function transcription factor causing dysregulation of a variety of targets, including microRNAs. Our previous studies, and those of others, have identified upregulation of miRs belonging to the related miR-17 similar to 92a, miR-106b similar to 25, and miR-106a similar to 363 clusters in Ewing Sarcoma. However, the functional consequences of this have not been characterized, nor has miR blockade been explored as an anti-cancer strategy in Ewing Sarcoma. To simulate a potential therapeutic approach, we examined the effects of blockade of these clusters, and their component miRs. Using colony formation as a read-out, we find that blockade of selected individual cluster component miRs, using specific inhibitors, has little or no effect. Combinatorial inhibition using miR "sponge" methodology, on the other hand, is inhibitory to colony formation, with blockade of whole clusters generally more effective than blockade of miR families. We show that a miR-blocking sponge directed against the poorly characterized miR-106a similar to 363 cluster is a particularly potent inhibitor of clonogenic growth in a subset of Ewing Sarcoma cell lines. We further identify upregulation of miR-15a as a downstream mechanism contributing to the miR-106a similar to 363 sponge growth-inhibitory effect. Taken together, our studies provide support for a pro-oncogenic role of the miR-106a similar to 363 cluster in Ewing Sarcoma, and identify miR-106a similar to 363 blockade, as well as miR-15a replacement, as possible strategies for inhibition of Ewing Sarcoma growth.	[Dylla, Layne; Jedlicka, Paul] Univ Colorado Denver, Canc Biol Grad Program, Aurora, CO USA; [Dylla, Layne; Jedlicka, Paul] Univ Colorado Denver, Med Scientist Training Program, Aurora, CO USA; [Jedlicka, Paul] Univ Colorado Denver, Dept Pathol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Jedlicka, P (corresponding author), Univ Colorado Denver, Canc Biol Grad Program, Anschutz Med Campus, Aurora, CO USA.	paul.jedlicka@ucdenver.edu	Dylla, Layne/AAE-5952-2021	Dylla, Layne/0000-0002-5664-779X	Boettcher Foundation; University of Colorado School of Medicine and Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	Boettcher Foundation; University of Colorado School of Medicine and Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Boettcher Foundation's Webb-Waring Biomedical Research Program and funds from the University of Colorado School of Medicine and Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Ban J, 2011, ONCOGENE, V30, P2173, DOI 10.1038/onc.2010.581; Bandres E, 2005, J PEDIAT HEMATOL ONC, V27, P537, DOI 10.1097/01.mph.0000184576.38835.e2; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Borinstein SC, 2011, CANCER-AM CANCER SOC, V117, P4966, DOI 10.1002/cncr.26112; Bueno MJ, 2010, MOL CELL BIOL, V30, P2983, DOI 10.1128/MCB.01372-09; Dai LX, 2012, CELL BIOL INT, V36, P765, DOI 10.1042/CBI20110404; de Alava E, 1998, J CLIN ONCOL, V16, P1248, DOI 10.1200/JCO.1998.16.4.1248; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; De Vito C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023592; Delattre O., 2012, ONCOGENE; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Diniz MG, 2012, CELL ONCOL, V35, P285, DOI 10.1007/s13402-012-0087-3; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Frieden M, 2008, CURR PHARM DESIGN, V14, P1138, DOI 10.2174/138161208784246234; Fu X, 2012, FEBS LETT, V586, P1279, DOI 10.1016/j.febslet.2012.03.006; Gonzalez I, 2007, J MOL MED, V85, P1015, DOI 10.1007/s00109-007-0202-5; Huang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026060; Huynh C, 2011, ONCOGENE, V30, P1481, DOI 10.1038/onc.2010.523; Jiang YG, 2011, TOXICOL SCI, V119, P50, DOI 10.1093/toxsci/kfq306; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lindow M, 2012, J CELL BIOL, V199, P407, DOI 10.1083/jcb.201208082; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; Mackintosh C, 2012, ONCOGENE; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Nittner D, 2012, NAT CELL BIOL, V14, P958, DOI 10.1038/ncb2556; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pickering BF, 2011, J BIOL CHEM, V286, P44095, DOI 10.1074/jbc.M111.265439; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Pouliot LM, 2012, CANCER RES, V72, P5945, DOI 10.1158/0008-5472.CAN-12-1400; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Reichek JL, 2011, CLIN CANCER RES, V17, P1463, DOI 10.1158/1078-0432.CCR-10-0091; Riggi N, 2009, EXPERT REV ANTICANC, V9, P1025, DOI 10.1586/ERA.09.81; Sampath D, 2012, BLOOD, V119, P1162, DOI 10.1182/blood-2011-05-351510; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Subbiah Vivek, 2011, Sarcoma, V2011, P686985, DOI 10.1155/2011/686985; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Thapa DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020781; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Doorninck JA, 2010, J CLIN ONCOL, V28, P1989, DOI 10.1200/JCO.2009.24.5845; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Z., 2012, MOL CARCINOG; Young CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023205	59	39	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e63032	10.1371/journal.pone.0063032	http://dx.doi.org/10.1371/journal.pone.0063032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638178	Green Submitted, gold, Green Published			2022-12-25	WOS:000318343700088
J	Wende, E; Laudeley, R; Bleich, A; Bleich, E; Wetsel, RA; Glage, S; Klos, A				Wende, Elisabeth; Laudeley, Robert; Bleich, Andre; Bleich, Eva; Wetsel, Rick A.; Glage, Silke; Klos, Andreas			The Complement Anaphylatoxin C3a Receptor (C3aR) Contributes to the Inflammatory Response in Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BOWEL-DISEASE; ULCERATIVE-COLITIS; CROHNS-DISEASE; MATRIX METALLOPROTEINASES; MURINE COLITIS; IFN-GAMMA; RAT MODEL; T-CELLS; EXPRESSION	Inflammatory bowel diseases are a critical public health issue, and as treatment options remain limited, there is a need to unravel the underlying pathomechanisms in order to identify new therapeutic targets. Complement activation was found in patients suffering from inflammatory bowel disease, and the complement anaphylatoxin C5a and its receptor C5aR have been implicated in disease pathogenesis in animal models of bowel inflammation. To further characterize complement-related pathomechanisms in inflammatory bowel disease, we have investigated the role of the anaphylatoxin C3a receptor in acute dextran sulfate sodium-induced colitis in mice. For this, colitis was induced in C3a receptor-deficient BALB/c and C57BL/6 mice, and disease severity was evaluated by clinical and histological examination, and by measuring the mRNA expression or protein levels of inflammatory mediators in the tissue. C3a receptor deficiency was partially protective in BALB/c mice, which had significantly reduced weight loss, clinical and histological scores, colon shortening, and CXCL-1/KC mRNA, myeloperoxidase and interleukin-6 tissue levels compared to the corresponding wild type mice. In C57BL/6 mice the differences between wild type and C3a receptor-deficient animals were much smaller and reached no significance. Our data demonstrate that the contribution of C3a receptor to disease pathogenesis and severity of dextran sulfate sodium-induced colitis in mice depends on the genetic background. Further studies will be required to clarify whether targeting of C3a receptor, possibly in combination with C5a receptor, might be considered as a therapeutic strategy for inflammatory bowel disease.	[Wende, Elisabeth; Laudeley, Robert; Klos, Andreas] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany; [Bleich, Andre; Bleich, Eva; Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Wetsel, Rick A.] Univ Texas Houston, Hlth Sci Ctr, Brown Fdn Inst Mol Med, Houston, TX USA	Hannover Medical School; Hannover Medical School; University of Texas System; University of Texas Health Science Center Houston	Klos, A (corresponding author), Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany.	klos.andreas@mh-hannover.de			Deutsche Forschungsgemeinschaft through a Collaborative Research Centre Grant [SFB566/A04]; Hannover Biomedical Research School; Helmholtz International Research School for Infection Biology	Deutsche Forschungsgemeinschaft through a Collaborative Research Centre Grant; Hannover Biomedical Research School; Helmholtz International Research School for Infection Biology	This work was supported by the Deutsche Forschungsgemeinschaft through a Collaborative Research Centre Grant (SFB566/A04 "Cytokine Receptors and Cytokine-Dependent Signalling"), and by a scholarship of the Hannover Biomedical Research School and the Helmholtz International Research School for Infection Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Bleich A, 2004, MAMM GENOME, V15, P865, DOI 10.1007/s00335-004-2392-2; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Chen GJ, 2011, LAB INVEST, V91, P472, DOI 10.1038/labinvest.2010.183; COOPER HS, 1993, LAB INVEST, V69, P238; Deguchi Y, 2005, INT J MOL MED, V16, P605; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; HALSTENSEN TS, 1992, GUT, V33, P902, DOI 10.1136/gut.33.7.902; Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004; Johswich K, 2009, INFLAMM BOWEL DIS, V15, P1812, DOI 10.1002/ibd.21012; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Kobayashi K, 2006, J PATHOL, V209, P376, DOI 10.1002/path.1978; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lin F, 2004, J IMMUNOL, V172, P3836, DOI 10.4049/jimmunol.172.6.3836; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Myers KJ, 2003, J PHARMACOL EXP THER, V304, P411, DOI 10.1124/jpet.102.040329; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Nicklas W, 2010, LAB ANIMAL, V39, P43, DOI 10.1038/laban0210-43; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Perrier C, 2011, IMMUNOTHERAPY-UK, V3, P1341, DOI [10.2217/imt.11.122, 10.2217/IMT.11.122]; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Sandborn WJ, 2004, GUT, V53, P1366, DOI 10.1136/gut.2003.025452; Scheinin T, 1999, HUM PATHOL, V30, P1427, DOI 10.1016/S0046-8177(99)90163-6; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Ueki T, 1996, CLIN EXP IMMUNOL, V104, P286, DOI 10.1046/j.1365-2249.1996.17721.x; von Lampe B, 2000, GUT, V47, P63, DOI 10.1136/gut.47.1.63; Woodruff TM, 2005, J PHARMACOL EXP THER, V314, P811, DOI 10.1124/jpet.105.086835; Woodruff TM, 2003, J IMMUNOL, V171, P5514, DOI 10.4049/jimmunol.171.10.5514; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002	38	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62257	10.1371/journal.pone.0062257	http://dx.doi.org/10.1371/journal.pone.0062257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638016	Green Submitted, Green Published, gold			2022-12-25	WOS:000318343700043
J	Dhital, S; Lin, AHM; Hamaker, BR; Gidley, MJ; Muniandy, A				Dhital, Sushil; Lin, Amy Hui-Mei; Hamaker, Bruce R.; Gidley, Michael J.; Muniandy, Anbuhkani			Mammalian Mucosal alpha-Glucosidases Coordinate with alpha-Amylase in the Initial Starch Hydrolysis Stage to Have a Role in Starch Digestion beyond Glucogenesis	PLOS ONE			English	Article							HUMAN INTESTINAL DISACCHARIDASES; ISOMALTASE; SUCRASE	Starch digestion in the human body is typically viewed in a sequential manner beginning with alpha-amylase and followed by alpha-glucosidase to produce glucose. This report indicates that the two enzyme types can act synergistically to digest granular starch structure. The aim of this study was to investigate how the mucosal alpha-glucosidases act with alpha-amylase to digest granular starch. Two types of enzyme extracts, pancreatic and intestinal extracts, were applied. The pancreatic extract containing predominantly alpha-amylase, and intestinal extract containing a combination of alpha-amylase and mucosal alpha-glucosidase activities, were applied to three granular maize starches with different amylose contents in an in vitro system. Relative glucogenesis, released maltooligosaccharide amounts, and structural changes of degraded residues were examined. Pancreatic extract-treated starches showed a hydrolysis limit over the 12 h incubation period with residues having a higher gelatinization temperature than the native starch. alpha-Amylase combined with the mucosal alpha-glucosidases in the intestinal extract showed higher glucogenesis as expected, but also higher maltooligosaccharide amounts indicating an overall greater degree of granular starch breakdown. Starch residues after intestinal extract digestion showed more starch fragmentation, higher gelatinization temperature, higher crystallinity (without any change in polymorph), and an increase of intermediate-sized or small-sized fractions of starch molecules, but did not show preferential hydrolysis of either amylose or amylopectin. Direct digestion of granular starch by mammalian recombinant mucosal alpha-glucosidases was observed which shows that these enzymes may work either independently or together with alpha-amylase to digest starch. Thus, mucosal alpha-glucosidases can have a synergistic effect with alpha-amylase on granular starch digestion, consistent with a role in overall starch digestion beyond their primary glucogenesis function.	[Dhital, Sushil; Lin, Amy Hui-Mei; Hamaker, Bruce R.; Muniandy, Anbuhkani] Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [Dhital, Sushil; Gidley, Michael J.] Univ Queensland, Ctr Nutr & Food Sci, Brisbane, Qld, Australia; [Dhital, Sushil; Gidley, Michael J.] Univ Queensland, Australian Res Council Ctr Excellence Plant Cell, Brisbane, Qld, Australia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Queensland; University of Queensland	Lin, AHM (corresponding author), Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, Smith Hall, W Lafayette, IN 47907 USA.	amylin@purdue.edu	Gidley, Mike/AAT-9543-2021; Dhital, Sushil/A-7918-2011	Dhital, Sushil/0000-0001-9405-1244	Graduate School Research Travel Grant of the University of Queensland (Brisbane, Australia); Whistler Center for Carbohydrate Research	Graduate School Research Travel Grant of the University of Queensland (Brisbane, Australia); Whistler Center for Carbohydrate Research	The Graduate School Research Travel Grant of the University of Queensland (Brisbane, Australia) funded SD to study at the Whistler Center for Carbohydrate Research at Purdue University (West Lafayette, Indiana, United States of America) for three months. This study was also supported internally by the Whistler Center for Carbohydrate Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao Z, 2007, FEBS LETT, V581, P2381, DOI 10.1016/j.febslet.2007.04.035; AURICCHIO S, 1972, PEDIATR RES, V6, P832, DOI 10.1203/00006450-197211000-00004; Brown H. T., 1879, P ROY SOC LONDON, V30, P393; Cave RA, 2009, BIOMACROMOLECULES, V10, P2245, DOI 10.1021/bm900426n; DAHLQVIST A, 1969, BIOCHEM J, V111, P139, DOI 10.1042/bj1110139; DAHLQVIST A, 1963, J CLIN INVEST, V42, P556, DOI 10.1172/JCI104744; DAHLQVIST A, 1962, J CLIN INVEST, V41, P463, DOI 10.1172/JCI104499; Dhital S, 2011, CARBOHYD POLYM, V84, P1133, DOI 10.1016/j.carbpol.2011.01.002; FANNON JE, 1993, CEREAL CHEM, V70, P611; FANNON JE, 1992, CEREAL CHEM, V69, P284; Henry FZ, 1964, METHODS CARBOHYDRATE; HEYMANN H, 1994, BIOL CHEM H-S, V375, P451, DOI 10.1515/bchm3.1994.375.7.451; Hizukuri S., 1996, CARBOHYDRATES FOOD, P347; Hokari S, 2003, COMP BIOCHEM PHYS B, V135, P63, DOI 10.1016/S1096-4959(03)00047-2; Htoon A, 2009, CARBOHYD POLYM, V75, P236, DOI 10.1016/j.carbpol.2008.06.016; Lin AH-M, 2012, FASEB J, V26; Lin AHM, 2011, FASEB J, V25; Lin AHM, 2012, J PEDIATR GASTR NUTR, V55, pS43, DOI 10.1097/01.mpg.0000421414.95751.be; Lin AHM, 2012, J BIOL CHEM, V287, P36917, DOI 10.1074/jbc.M112.378331; Lin AHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035473; Megazyme, 2008, RES STARCH ASS PROC; Nelson N, 1944, J BIOL CHEM, V153, P375; Nichols BL, 1998, J BIOL CHEM, V273, P3076, DOI 10.1074/jbc.273.5.3076; Pan DD, 2000, BIOMACROMOLECULES, V1, P126, DOI 10.1021/bm990016l; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; VANBEERS EH, 1995, CRIT REV BIOCHEM MOL, V30, P197, DOI 10.3109/10409239509085143; Vilaplana F, 2010, MACROMOLECULES, V43, P7321, DOI 10.1021/ma101349t; Zobel H.F., 1964, METHODS CARBOHYDR CH, P109	29	29	29	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62546	10.1371/journal.pone.0062546	http://dx.doi.org/10.1371/journal.pone.0062546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638112	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400059
J	Iseli, TJ; Turner, N; Zeng, XY; Cooney, GJ; Kraegen, EW; Yao, S; Ye, Y; James, DE; Ye, JM				Iseli, Tristan J.; Turner, Nigel; Zeng, Xiao-Yi; Cooney, Gregory J.; Kraegen, Edward W.; Yao, Sheng; Ye, Yang; James, David E.; Ye, Ji-Ming			Activation of AMPK by Bitter Melon Triterpenoids Involves CaMKK beta	PLOS ONE			English	Article							KINASE KINASE-BETA; DEPENDENT PROTEIN-KINASE; MOMORDICA-CHARANTIA; METABOLIC SYNDROME; COMPLEX; BERBERINE; MECHANISM; RECEPTOR; IDENTIFICATION; LOCALIZATION	We recently showed that bitter melon-derived triterpenoids (BMTs) activate AMPK and increase GLUT4 translocation to the plasma membrane in vitro, and improve glucose disposal in insulin resistant models in vivo. Here we interrogated the mechanism by which these novel compounds activate AMPK, a leading anti-diabetic drug target. BMTs did not activate AMPK directly in an allosteric manner as AMP or the Abbott compound (A-769662) does, nor did they activate AMPK by inhibiting cellular respiration like many commonly used anti-diabetic medications. BMTs increased AMPK activity in both L6 myotubes and LKB1-deficient HeLa cells by 20-35%. Incubation with the CaMKK beta inhibitor, STO-609, completely attenuated this effect suggesting a key role for CaMKK beta in this activation. Incubation of L6 myotubes with the calcium chelator EGTA-AM did not alter this activation suggesting that the BMT-dependent activation was Ca2+-independent. We therefore propose that CaMKK beta is a key upstream kinase for BMT-induced activation of AMPK.	[Iseli, Tristan J.; Turner, Nigel; Zeng, Xiao-Yi; Cooney, Gregory J.; Kraegen, Edward W.; James, David E.; Ye, Ji-Ming] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia; [Zeng, Xiao-Yi; Ye, Ji-Ming] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia; [Zeng, Xiao-Yi; Ye, Ji-Ming] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Yao, Sheng; Ye, Yang; Ye, Ji-Ming] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Garvan Institute of Medical Research; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Ye, JM (corresponding author), Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia.	jiming.ye@rmit.edu.au	Turner, Nigel/H-7176-2013	Turner, Nigel/0000-0002-0119-9328; James, David/0000-0001-5946-5257; Zeng, Xiaoyi/0000-0002-0102-0367	National Health and Medical Research Council of Australia (NHMRC) [535930]; Australia-China Special Fund [CH0812110]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australia-China Special Fund	This work was supported by funding from a Project Grant [grant number 535930 to JMY and YY] of the National Health and Medical Research Council of Australia (NHMRC) and Australia-China Special Fund [grant number CH0812110 to DEJ, JMY and EWK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chaturvedi P, 2010, J MED FOOD, V13, P520, DOI 10.1089/jmf.2009.0151; Chen XS, 2011, EXP DIABETES RES, DOI 10.1155/2011/853501; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; DAY C, 1990, PLANTA MED, V56, P426, DOI 10.1055/s-2006-961003; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Fuangchan A, 2011, J ETHNOPHARMACOL, V134, P422, DOI 10.1016/j.jep.2010.12.045; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Green MF, 2011, CELL SIGNAL, V23, P2005, DOI 10.1016/j.cellsig.2011.07.014; Green MF, 2011, J BIOL CHEM, V286, P28066, DOI 10.1074/jbc.M111.251504; Hardie DG, 1999, BIOCHEM SOC SYMP, P13; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hsu C, 2011, J AGR FOOD CHEM, V59, P4553, DOI 10.1021/jf200418g; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwang YP, 2011, TOXICOL APPL PHARM, V257, P48, DOI 10.1016/j.taap.2011.08.017; Iglesias MA, 2004, DIABETES, V53, P1649, DOI 10.2337/diabetes.53.7.1649; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Iseli TJ, 2008, J BIOL CHEM, V283, P4799, DOI 10.1074/jbc.M708298200; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P1064, DOI 10.1016/j.jnutbio.2010.09.004; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Zeng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042115; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zhu YJ, 2007, J TOXICOL ENV HEAL A, V70, P895, DOI 10.1080/15287390701285956; Zini R, 1999, DRUG EXP CLIN RES, V25, P87	46	44	47	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62309	10.1371/journal.pone.0062309	http://dx.doi.org/10.1371/journal.pone.0062309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638033	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400049
J	Bleier, BS; Kohman, RE; Feldman, RE; Ramanlal, S; Han, X				Bleier, Benjamin S.; Kohman, Richie E.; Feldman, Rachel E.; Ramanlal, Shreshtha; Han, Xue			Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; DOUBLE-BLIND; MODEL; FLUORESCEIN; GDNF	Utilization of neuropharmaceuticals for central nervous system(CNS) disease is highly limited due to the blood-brain barrier(BBB) which restricts molecules larger than 500Da from reaching the CNS. The development of a reliable method to bypass the BBB would represent an enormous advance in neuropharmacology enabling the use of many potential disease modifying therapies. Previous attempts such as transcranial catheter implantation have proven to be temporary and associated with multiple complications. Here we describe a novel method of creating a semipermeable window in the BBB using purely autologous tissues to allow for high molecular weight(HMW) drug delivery to the CNS. This approach is inspired by recent advances in human endoscopic transnasal skull base surgical techniques and involves engrafting semipermeable nasal mucosa within a surgical defect in the BBB. The mucosal graft thereby creates a permanent transmucosal conduit for drugs to access the CNS. The main objective of this study was to develop a murine model of this technique and use it to evaluate transmucosal permeability for the purpose of direct drug delivery to the brain. Using this model we demonstrate that mucosal grafts allow for the transport of molecules up to 500 kDa directly to the brain in both a time and molecular weight dependent fashion. Markers up to 40 kDa were found within the striatum suggesting a potential role for this technique in the treatment of Parkinson's disease. This proof of principle study demonstrates that mucosal engrafting represents the first permanent and stable method of bypassing the BBB thereby providing a pathway for HMW therapeutics directly into the CNS.	[Bleier, Benjamin S.; Feldman, Rachel E.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Kohman, Richie E.; Ramanlal, Shreshtha; Han, Xue] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Boston University	Bleier, BS (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA.	benjamin_bleier@meei.harvard.edu	Bleier, Benjamin S/H-6726-2019; Kohman, Richie/P-8395-2019	Bleier, Benjamin S/0000-0003-0783-8861; 	Michael J. Fox Foundation for Parkinson's Research 2011 Rapid Response Innovations Awards Program	Michael J. Fox Foundation for Parkinson's Research 2011 Rapid Response Innovations Awards Program	This study was funded by the Michael J. Fox Foundation for Parkinson's Research 2011 Rapid Response Innovations Awards Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Bagger MA, 2004, EUR J PHARM SCI, V21, P235, DOI 10.1016/j.ejps.2003.10.012; Bernal-Sprekelsen M, 2005, RHINOLOGY, V43, P277; Bleier BS, 2007, OTOLARYNG HEAD NECK, V137, P810, DOI 10.1016/j.otohns.2007.05.060; Bleier BS, 2011, INT FORUM ALLERGY RH, V1, P361, DOI 10.1002/alr.20041; Bleier BS, 2011, AM J RHINOL ALLERGY, V25, P186, DOI 10.2500/ajra.2011.25.3587; Bleier BS, 2010, AM J RHINOL ALLERGY, V24, P129, DOI 10.2500/ajra.2010.24.3439; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Dewey RB, 1998, MOVEMENT DISORD, V13, P782, DOI 10.1002/mds.870130505; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Dietz GPH, 2006, BRAIN RES, V1082, P61, DOI 10.1016/j.brainres.2006.01.083; FISHER AN, 1992, J PHARM PHARMACOL, V44, P550, DOI 10.1111/j.2042-7158.1992.tb05462.x; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; Merkus Frans W H M, 2007, Drugs R D, V8, P133, DOI 10.2165/00126839-200708030-00001; Modi G, 2010, ANN NY ACAD SCI, V1184, P154, DOI 10.1111/j.1749-6632.2009.05108.x; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Ngwuluka N, 2010, EXPERT OPIN DRUG DEL, V7, P203, DOI 10.1517/17425240903483166; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Shoichet MS, 2000, ADV DRUG DELIVER REV, V42, P81, DOI 10.1016/S0169-409X(00)00055-7; Zhao Hong-mei, 2004, Chinese Medical Sciences Journal, V19, P257	22	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61694	10.1371/journal.pone.0061694	http://dx.doi.org/10.1371/journal.pone.0061694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637885	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400041
J	Cardena, MMSG; Ribeiro-dos-Santos, A; Santos, S; Mansur, AJ; Pereira, AC; Fridman, C				Cardena, Mari M. S. G.; Ribeiro-dos-Santos, Andrea; Santos, Sidney; Mansur, Alfredo J.; Pereira, Alexandre C.; Fridman, Cintia			Assessment of the Relationship between Self-Declared Ethnicity, Mitochondrial Haplogroups and Genomic Ancestry in Brazilian Individuals	PLOS ONE			English	Article							CONSISTENT TREATMENT; LENGTH VARIANTS; CONTROL REGION; DNA; POPULATION; SEQUENCE; GENETICS; COLOR	In populations that have a high degree of admixture, such as in Brazil, the sole use of ethnicity self-declaration information is not a good method for classifying individuals regarding their ethnicity. Here, we evaluate the relationship of self-declared ethnicities with genomic ancestry and mitochondrial haplogroups in 492 individuals from southeastern Brazil. Mitochondrial haplogroups were obtained by analyzing the hypervariable regions of the mitochondrial DNA (mtDNA), and the genomic ancestry was obtained using 48 autosomal insertion-deletion ancestry informative markers (AIM). Of the 492 individuals, 74.6% self-declared as White, 13.8% as Brown and 10.4% as Black. Classification of the mtDNA haplogroups showed that 46.3% had African mtDNA, and the genomic ancestry analysis showed that the main contribution was European (57.4%). When we looked at the distribution of mtDNA and genomic ancestry according to the self-declared ethnicities from 367 individuals who self-declared as White, 37.6% showed African mtDNA, and they had a high contribution of European genomic ancestry (63.3%) but also a significant contribution of African ancestry (22.2%). Of the 68 individuals who self-declared as Brown, 25% showed Amerindian mtDNA and similar contribution of European and African genomic ancestries. Of the 51 subjects who self-declared as black, 80.4% had African mtDNA, and the main contribution of genomic ancestry was African (55.6%), but they also had a significant proportion of European ancestry (32.1%). The Brazilian population had a uniform degree of Amerindian genomic ancestry, and it was only with the use of genetic markers (autosomal or mitochondrial) that we were able to capture Amerindian ancestry information. Additionally, it was possible to observe a high degree of heterogeneity in the ancestry for both types of genetic markers, which shows the high genetic admixture that is present in the Brazilian population. We suggest that in epidemiological studies, the use of these methods could provide complementary information.	[Cardena, Mari M. S. G.; Fridman, Cintia] Univ Sao Paulo, Sch Med, Dept Legal Med Eth & Occupat Hlth, Sao Paulo, Brazil; [Ribeiro-dos-Santos, Andrea; Santos, Sidney] Fed Univ Para, Lab Human Genet & Med, BR-66059 Belem, Para, Brazil; [Mansur, Alfredo J.; Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Inst Heart, Dept Cardiol,Lab Genet & Mol Cardiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Para; Universidade de Sao Paulo	Fridman, C (corresponding author), Univ Sao Paulo, Sch Med, Dept Legal Med Eth & Occupat Hlth, Sao Paulo, Brazil.	cfridman@usp.br	Fridman, Cintia/G-1837-2012; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Pereira, Alexandre/HHN-1038-2022; Fridman, Cintia/E-2657-2013; Santos, Ândrea Ribeiro dos/B-6061-2013	Fridman, Cintia/0000-0003-2430-4888; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/05317-4]; HC-LIM/FMUSP	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); HC-LIM/FMUSP	This study was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-2010/05317-4) and HC-LIM/FMUSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bamshad M, 2007, CURR OPIN PEDIATR, V19, P613, DOI 10.1097/MOP.0b013e3282f163ca; Bandelt HJ, 2008, INT J LEGAL MED, V122, P11, DOI 10.1007/s00414-006-0151-5; Barnholtz-Sloan JS, 2005, CANCER EPIDEM BIOMAR, V14, P1545, DOI 10.1158/1055-9965.EPI-04-0832; Bastos João Luiz, 2008, Rev. Saúde Pública, V42, P324, DOI 10.1590/S0034-89102008005000005; Carracedo A, 2000, FORENSIC SCI INT, V110, P79, DOI 10.1016/S0379-0738(00)00161-4; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Francez PAD, 2012, FORENSIC SCI INT-GEN, V6, P132, DOI 10.1016/j.fsigen.2011.04.002; Egeland T, 2004, ANN HUM GENET, V68, P461, DOI 10.1046/j.1529-8817.2004.00109.x; Enoch Mary-Anne, 2006, J Psychopharmacol, V20, P19, DOI 10.1177/1359786806066041; Giolo SR, 2012, EUR J HUM GENET, V20, P111, DOI 10.1038/ejhg.2011.144; Guimaraes Antonio Sergio, 1999, RACISMO ANTIRACISMO, P34; IBGE-Instituto Brasileiro de Geografia e Estatistica, SINT IND SOC AN COND; Kimura L, 2013, AM J HUM BIOL, V25, P35, DOI 10.1002/ajhb.22335; Lee Chih, 2011, BMC Proc, V5 Suppl 2, pS11, DOI 10.1186/1753-6561-5-S2-S11; Lee H, 2006, INT J LEGAL MED, V120, P5, DOI 10.1007/s00414-005-0005-6; Leite TKM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027162; Lins TC, 2011, J EPIDEMIOL, V21, P240, DOI 10.2188/jea.JE20100164; Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena Sérgio D. J., 2005, Hist. cienc. saude-Manguinhos, V12, P321, DOI 10.1590/S0104-59702005000200006; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Ribeiro D., 1995, POVO BRASILEIRO FORM; Rohl A, 2001, INT J LEGAL MED, V115, P29, DOI 10.1007/s004140100217; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Shriver MD, 1997, AM J HUM GENET, V60, P957; Sucheston LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030950; Tarazona-Santos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016123; Telles EE, 2002, ETHNIC RACIAL STUD, V25, P415, DOI 10.1080/01419870252932133; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Wilson MR, 2002, FORENSIC SCI INT, V129, P35, DOI 10.1016/S0379-0738(02)00206-2	37	67	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62005	10.1371/journal.pone.0062005	http://dx.doi.org/10.1371/journal.pone.0062005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637946	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400065
J	Yan, C; Li, AA; Zhang, B; Ding, WX; Luo, QM; Gong, H				Yan, Cheng; Li, Anan; Zhang, Bin; Ding, Wenxiang; Luo, Qingming; Gong, Hui			Automated and Accurate Detection of Soma Location and Surface Morphology in Large-Scale 3D Neuron Images	PLOS ONE			English	Article							HIGH-RESOLUTION ATLAS; MOUSE-BRAIN; SCANNING MICROSCOPY; CELL-NUCLEI; SEGMENTATION; RECONSTRUCTION; ALGORITHMS; ZEBRAFISH; TRACKING; EDGE	Automated and accurate localization and morphometry of somas in 3D neuron images is essential for quantitative studies of neural networks in the brain. However, previous methods are limited in obtaining the location and surface morphology of somas with variable size and uneven staining in large-scale 3D neuron images. In this work, we proposed a method for automated soma locating in large-scale 3D neuron images that contain relatively sparse soma distributions. This method involves three steps: (i) deblocking the image with overlap between adjacent sub-stacks; (ii) locating the somas in each small sub-stack using multi-scale morphological close and adaptive thresholds; and (iii) fusion of the repeatedly located somas in all sub-stacks. We also describe a new method for the accurate detection of the surface morphology of somas containing hollowness; this was achieved by improving the classical Rayburst Sampling with a new gradient-based criteria. Three 3D neuron image stacks of different sizes were used to quantitatively validate our methods. For the soma localization algorithm, the average recall and precision were greater than 93% and 96%, respectively. For the soma surface detection algorithm, the overlap of the volumes created by automatic detection of soma surfaces and manually segmenting soma volumes was more than 84% for 89% of all correctly detected somas. Our method for locating somas can reveal the soma distributions in large-scale neural networks more efficiently. The method for soma surface detection will serve as a valuable tool for systematic studies of neuron types based on neuron structure.	[Yan, Cheng; Li, Anan; Zhang, Bin; Luo, Qingming; Gong, Hui] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Yan, Cheng; Li, Anan; Zhang, Bin; Ding, Wenxiang; Luo, Qingming; Gong, Hui] Huazhong Univ Sci & Technol, Dept Biomed Engn, MoE Key Lab Biomed Photon, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Gong, H (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China.	huigong@mail.hust.edu.cn		Luo, Qingming/0000-0002-6725-9311	National Natural Science Foundation of China [81127002, 81171067, 61102122]; Science Fund for Creative Research Group of China [61121004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups)	This work was supported by the National Natural Science Foundation of China (Grant No. 81127002, 81171067, 61102122) and Science Fund for Creative Research Group of China (Grant No. 61121004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi KA, 2003, IEEE T INF TECHNOL B, V7, P302, DOI 10.1109/TITB.2003.816564; Al-Kofahi KA, 2002, IEEE T INF TECHNOL B, V6, P171, DOI 10.1109/TITB.2002.1006304; Al-Kofahi Y, 2008, CYTOM PART A, V73A, P36, DOI 10.1002/cyto.a.20499; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Bashar MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035550; Bear MF, 2007, NEUROSCIENCE EXPLORI; Dobrovic B, 2011, COLLEGIUM ANTROPOL, V35, P25; Dufour A, 2005, IEEE T IMAGE PROCESS, V14, P1396, DOI 10.1109/TIP.2005.852790; He W, 2003, MICROSC MICROANAL, V9, P296, DOI 10.1017/S143192760303040X; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Li G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-40; Li G, 2007, CYTOM PART A, V71A, P835, DOI 10.1002/cyto.a.20436; Liu TM, 2008, NEUROINFORMATICS, V6, P5, DOI 10.1007/s12021-007-9005-7; Makhoul John, 1999, P DARPA BROADCAST NE, P249; Mayerich D, 2008, J MICROSC-OXFORD, V231, P134, DOI 10.1111/j.1365-2818.2008.02024.x; Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895; Olson DL, 2008, ADV DATA MINING TECH, DOI DOI 10.1007/978-3-540-76917-0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Qi X, 2012, IEEE T BIO-MED ENG, V59, P754, DOI 10.1109/TBME.2011.2179298; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Roysam B, 2005, HDB BIOL CONFOCAL MI, P316; Shah A, 2004, J NEUROSCI METH, V136, P123, DOI 10.1016/j.jneumeth.2004.01.010; Standring S, 2004, GRAYS ANATOMY ANATOM, V39th; Svoboda K, 2011, NEUROINFORMATICS, V9, P97, DOI 10.1007/s12021-011-9097-y; Vallotton P, 2007, CYTOM PART A, V71A, P889, DOI 10.1002/cyto.a.20462; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wang QD, 2012, EXP BIOL MED, V237, P1134, DOI 10.1258/ebm.2012.012142; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Weaver CM, 2003, J NEUROSCI METH, V124, P197, DOI 10.1016/S0165-0270(03)00017-7; Yu WM, 2010, CYTOM PART A, V77A, P379, DOI 10.1002/cyto.a.20876; Zhang B, 2011, J NEUROSCI METH, V197, P1, DOI 10.1016/j.jneumeth.2010.10.001	34	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62579	10.1371/journal.pone.0062579	http://dx.doi.org/10.1371/journal.pone.0062579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638117	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400115
J	D'allard, D; Gay, J; Descarpentries, C; Frisan, E; Adam, K; Verdier, F; Floquet, C; Dubreuil, P; Lacombe, C; Fontenay, M; Mayeux, P; Kosmider, O				D'allard, Diane; Gay, Julie; Descarpentries, Clotilde; Frisan, Emilie; Adam, Kevin; Verdier, Frederique; Floquet, Celia; Dubreuil, Patrice; Lacombe, Catherine; Fontenay, Michaela; Mayeux, Patrick; Kosmider, Olivier			Tyrosine Kinase Inhibitors Induce Down-Regulation of c-Kit by Targeting the ATP Pocket	PLOS ONE			English	Article							FACTOR RECEPTOR/C-KIT; ACTIVATING MUTATIONS; DOMAIN MUTATIONS; STRUCTURAL BASIS; CELL; GROWTH; CBL; INTERNALIZATION; ERYTHROPOIETIN; CLATHRIN	The stem cell factor receptor (SCF) c-Kit plays a pivotal role in regulating cell proliferation and survival in many cell types. In particular, c-Kit is required for early amplification of erythroid progenitors, while it must disappear from cell surface for the cell entering the final steps of maturation in an erythropoietin-dependent manner. We initially observed that imatinib (IM), an inhibitor targeting the tyrosine kinase activity of c-Kit concomitantly down-regulated the expression of c-Kit and accelerated the Epo-driven differentiation of erythroblasts in the absence of SCF. We investigated the mechanism by which IM or related masitinib (MA) induce c-Kit down-regulation in the human UT-7/Epo cell line. We found that the down-regulation of c-Kit in the presence of IM or MA was inhibited by a pre-incubation with methyl-beta-cyclodextrin suggesting that c-Kit was internalized in the absence of ligand. By contrast to SCF, the internalization induced by TKI was independent of the E3 ubiquitin ligase c-Cbl. Furthermore, c-Kit was degraded through lysosomal, but not proteasomal pathway. In pulse-chase experiments, IM did not modulate c-Kit synthesis or maturation. Analysis of phosphotyrosine peptides in UT-7/Epo cells treated or not with IM show that IM did not modify overall tyrosine phosphorylation in these cells. Furthermore, we showed that a T670I mutation preventing the full access of IM to the ATP binding pocket, did not allow the internalization process in the presence of IM. Altogether these data show that TKI-induced internalization of c-Kit is linked to a modification of the integrity of ATP binding pocket.	[D'allard, Diane; Gay, Julie; Descarpentries, Clotilde; Frisan, Emilie; Adam, Kevin; Verdier, Frederique; Floquet, Celia; Lacombe, Catherine; Fontenay, Michaela; Mayeux, Patrick; Kosmider, Olivier] Inst Cochin, Dept Immunol Hematol, Paris, France; [D'allard, Diane; Gay, Julie; Descarpentries, Clotilde; Frisan, Emilie; Adam, Kevin; Verdier, Frederique; Floquet, Celia; Lacombe, Catherine; Fontenay, Michaela; Mayeux, Patrick; Kosmider, Olivier] INSERM, U1016, Paris, France; [D'allard, Diane; Gay, Julie; Descarpentries, Clotilde; Frisan, Emilie; Adam, Kevin; Verdier, Frederique; Floquet, Celia; Lacombe, Catherine; Fontenay, Michaela; Mayeux, Patrick; Kosmider, Olivier] CNRS, Unite Mixte Rech 8104, Paris, France; [D'allard, Diane; Gay, Julie; Descarpentries, Clotilde; Frisan, Emilie; Adam, Kevin; Verdier, Frederique; Floquet, Celia; Lacombe, Catherine; Fontenay, Michaela; Mayeux, Patrick; Kosmider, Olivier] Univ Paris 05, Fac Med, Paris, France; [D'allard, Diane; Gay, Julie; Descarpentries, Clotilde; Frisan, Emilie; Adam, Kevin; Verdier, Frederique; Floquet, Celia; Lacombe, Catherine; Fontenay, Michaela; Mayeux, Patrick; Kosmider, Olivier] Equipe Labellisee Ligue Canc, Paris, France; [D'allard, Diane; Adam, Kevin; Verdier, Frederique; Floquet, Celia; Lacombe, Catherine; Fontenay, Michaela; Mayeux, Patrick; Kosmider, Olivier] LABEX Lab Excellence GR Ex, Paris, France; [Dubreuil, Patrice] INSERM, CRCM, U1068, Ctr Reference Mastocytoses CEREMAST, F-13258 Marseille, France; [Dubreuil, Patrice] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Dubreuil, Patrice] Aix Marseille Univ, Marseille, France; [Dubreuil, Patrice] CNRS, UMR7258, Marseille, France; [Lacombe, Catherine; Fontenay, Michaela; Kosmider, Olivier] Hop Broca Cochin Hotel Dieu, AP HP, Serv Hematol Biol Paris, Paris, France; [Mayeux, Patrick] Paris Descartes Univ 3P5, Prote Platform, Paris, France; INSERM, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kosmider, O (corresponding author), Inst Cochin, Dept Immunol Hematol, Paris, France.	olivier.kosmider@cch.aphp.fr	Dubreuil, Patrice/V-4816-2019; dubreuil, patrice/F-5346-2011; Verdier, Frédérique/P-1512-2017	Dubreuil, Patrice/0000-0003-1155-1150; dubreuil, patrice/0000-0003-1155-1150; KOSMIDER, olivier/0000-0002-6021-4057; Fontenay, Michaela/0000-0002-5492-6349; Adam, Kevin/0000-0003-0007-0634	Ligue Nationale Contre le Cancer (LNCC : Equipe labellisee); Agence Nationale de la Recherche (ANR, CAPER); Ministere de la Recherche et de l'Enseignement superieur; Association de Recherche contre le Cancer (ARC)	Ligue Nationale Contre le Cancer (LNCC : Equipe labellisee); Agence Nationale de la Recherche (ANR, CAPER)(French National Research Agency (ANR)); Ministere de la Recherche et de l'Enseignement superieur; Association de Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants from the Ligue Nationale Contre le Cancer (LNCC : Equipe labellisee) and by a grant from the Agence Nationale de la Recherche (ANR, CAPER). DD was supported by a grant from the Ministere de la Recherche et de l'Enseignement superieur. JG, CD and CF were supported by a grant from the Association de Recherche contre le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bandi SR, 2009, BLOOD, V114, P4197, DOI 10.1182/blood-2008-12-190934; Bosbach B, 2012, P NATL ACAD SCI USA, V109, pE2276, DOI 10.1073/pnas.1115240109; Broudy VC, 1999, BLOOD, V94, P1979; COLLINS MKL, 1988, J CELL PHYSIOL, V137, P293, DOI 10.1002/jcp.1041370212; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; Frisan E, 2012, BLOOD, V119, P1532, DOI 10.1182/blood-2011-03-343475; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Guo T, 2007, CLIN CANCER RES, V14, P3204; He YY, 2003, J BIOL CHEM, V278, P42457, DOI 10.1074/jbc.M303376200; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Heinrich MC, 2012, MOL CANCER THER, V11, P1770, DOI 10.1158/1535-7163.MCT-12-0223; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; KOMATSU N, 1991, CANCER RES, V51, P341; Kosmider O, 2005, CANCER CELL, V8, P467, DOI 10.1016/j.ccr.2005.11.009; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Orinska Z, 2010, BLOOD, V116, P2665, DOI 10.1182/blood-2009-06-228460; Padron D, 2007, CANCER RES, V67, P7695, DOI 10.1158/0008-5472.CAN-07-0484; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Tamborini E, 2006, ONCOGENE, V25, P6140, DOI 10.1038/sj.onc.1209639; Verdier F, 2000, J BIOL CHEM, V275, P18375, DOI 10.1074/jbc.275.24.18375; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Yang Y, 2010, BLOOD, V116, P1114, DOI 10.1182/blood-2009-06-226027; YEE NS, 1994, J BIOL CHEM, V269, P31991; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120; Zhang HL, 2012, CLIN GENITOURIN CANC, V12, P00174	38	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60961	10.1371/journal.pone.0060961	http://dx.doi.org/10.1371/journal.pone.0060961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637779	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400020
J	Liu, RR; Sun, YF; Zhao, GP; Wang, FJ; Wu, D; Zheng, MQ; Chen, JL; Zhang, L; Hu, YD; Wen, J				Liu, Ranran; Sun, Yanfa; Zhao, Guiping; Wang, Fangjie; Wu, Dan; Zheng, Maiqing; Chen, Jilan; Zhang, Lei; Hu, Yaodong; Wen, Jie			Genome-Wide Association Study Identifies Loci and Candidate Genes for Body Composition and Meat Quality Traits in Beijing-You Chickens	PLOS ONE			English	Article							X LAYER CROSS; CARCASS TRAITS; SKELETAL DEVELOPMENT; INTRAMUSCULAR-FAT; EXPRESSION; MUSCLE; GROWTH; PERFORMANCE; POPULATION; METABOLISM	Body composition and meat quality traits are important economic traits of chickens. The development of high-throughput genotyping platforms and relevant statistical methods have enabled genome-wide association studies in chickens. In order to identify molecular markers and candidate genes associated with body composition and meat quality traits, genome-wide association studies were conducted using the Illumina 60 K SNP Beadchip to genotype 724 Beijing-You chickens. For each bird, a total of 16 traits were measured, including carcass weight (CW), eviscerated weight (EW), dressing percentage, breast muscle weight (BrW) and percentage (BrP), thigh muscle weight and percentage, abdominal fat weight and percentage, dry matter and intramuscular fat contents of breast and thigh muscle, ultimate pH, and shear force of the pectoralis major muscle at 100 d of age. The SNPs that were significantly associated with the phenotypic traits were identified using both simple (GLM) and compressed mixed linear (MLM) models. For nine of ten body composition traits studied, SNPs showing genome wide significance (P<2.59E-6) have been identified. A consistent region on chicken (Gallus gallus) chromosome 4 (GGA4), including seven significant SNPs and four candidate genes (LCORL, LAP3, LDB2, TAPT1), were found to be associated with CW and EW. Another 0.65 Mb region on GGA3 for BrW and BrP was identified. After measuring the mRNA content in beast muscle for five genes located in this region, the changes in GJA1 expression were found to be consistent with that of breast muscle weight across development. It is highly possible that GJA1 is a functional gene for breast muscle development in chickens. For meat quality traits, several SNPs reaching suggestive association were identified and possible candidate genes with their functions were discussed.	[Liu, Ranran; Sun, Yanfa; Zhao, Guiping; Wang, Fangjie; Wu, Dan; Zheng, Maiqing; Chen, Jilan; Zhang, Lei; Hu, Yaodong; Wen, Jie] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Liu, Ranran; Zhao, Guiping; Wu, Dan; Zheng, Maiqing; Chen, Jilan; Zhang, Lei; Hu, Yaodong; Wen, Jie] State Key Lab Anim Nutr, Beijing, Peoples R China; [Sun, Yanfa] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Wang, Fangjie] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Yangzhou University; Anhui Agricultural University	Wen, J (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	jiewen@iascaas.net.cn		Zhao, Guiping/0000-0002-1510-6903; Wen, Jie/0000-0001-7460-4219; Zhang, Lei/0000-0002-0580-0889	National High-tech RD Program [2011AA100301]; National Nonprofit Institute Research Grant [2010jc-1]; earmarked fund for modern agro-industry technology research system [CARS-42]	National High-tech RD Program; National Nonprofit Institute Research Grant; earmarked fund for modern agro-industry technology research system	The research was supported by funds of the National High-tech R&D Program (2011AA100301); National Nonprofit Institute Research Grant (2010jc-1); the earmarked fund for modern agro-industry technology research system (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambo M, 2009, ANIM GENET, V40, P200, DOI 10.1111/j.1365-2052.2008.01824.x; Ankra-Badu GA, 2010, ANIM GENET, V41, P400, DOI 10.1111/j.1365-2052.2009.02017.x; Baziz HA, 1996, POULTRY SCI, V75, P505, DOI 10.3382/ps.0750505; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Carty CL, 2012, HUM MOL GENET, V21, P711, DOI 10.1093/hmg/ddr489; Chandra Rashmi, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P63, DOI 10.1097/MED.0b013e3280122850; Cui HX, 2012, MOL BIOL REP, V39, P3479, DOI 10.1007/s11033-011-1120-8; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; De Koning DJ, 2004, GENET RES, V83, P211, DOI 10.1017/S0016672304006846; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Horner A, 2002, DEV DYNAM, V225, P35, DOI 10.1002/dvdy.10132; Howell GR, 2007, GENETICS, V175, P699, DOI 10.1534/genetics.106.065177; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Li L, 2004, J BIOL CHEM, V279, P34107, DOI 10.1074/jbc.M312672200; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Li WJ, 2009, BRIT POULTRY SCI, V50, P188, DOI 10.1080/00071660902755409; Lindholm-Perry AK, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-103; Luo WZ, 2012, INT J BIOL SCI, V8, P580, DOI 10.7150/ijbs.3614; Morello LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029174; N'Diaye A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002298; Nones K, 2006, ANIM GENET, V37, P95, DOI 10.1111/j.1365-2052.2005.01387.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Sovio U, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000409; Stains JP, 2005, BBA-BIOMEMBRANES, V1719, P69, DOI 10.1016/j.bbamem.2005.10.012; Tai K, 2010, BRAIN RES, V1344, P13, DOI 10.1016/j.brainres.2010.04.065; Uemoto Y, 2009, POULTRY SCI, V88, P477, DOI 10.3382/ps.2008-00296; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao GP, 2007, POULTRY SCI, V86, P2309, DOI 10.1093/ps/86.11.2309; Zhao GP, 2011, POULTRY SCI, V90, P2355, DOI 10.3382/ps.2011-01432; Zheng P., 1988, BREEDS DOMESTICATED; Zheng X, 2011, MOL BIOL REP, V38, P4053, DOI 10.1007/s11033-010-0524-1	39	87	99	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61172	10.1371/journal.pone.0061172	http://dx.doi.org/10.1371/journal.pone.0061172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637794	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700015
J	Matsushita, T; Tateishi, T; Isobe, N; Yonekawa, T; Yamasaki, R; Matsuse, D; Murai, H; Kira, J				Matsushita, Takuya; Tateishi, Takahisa; Isobe, Noriko; Yonekawa, Tomomi; Yamasaki, Ryo; Matsuse, Dai; Murai, Hiroyuki; Kira, Jun-ichi			Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis	PLOS ONE			English	Article							T-HELPER TYPE-1; RHEUMATOID-ARTHRITIS; DIAGNOSTIC-CRITERIA; SYNOVIAL-FLUIDS; MESSENGER-RNA; CELLS; DISTINCT; MARKER; MS; INFLAMMATION	Background: Differences in cytokine/chemokine profiles among patients with neuromyelitis optica (NMO), relapsing remitting multiple sclerosis (RRMS), and primary progressive MS (PPMS), and the relationships of these profiles with clinical and neuroimaging features are unclear. A greater understanding of these profiles may help in differential diagnosis. Methods/Principal Findings: We measured 27 cytokines/chemokines and growth factors in CSF collected from 20 patients with NMO, 26 with RRMS, nine with PPMS, and 18 with other non-inflammatory neurological diseases (OND) by multiplexed fluorescent bead-based immunoassay. Interleukin (IL)-17A, IL-6, CXCL8 and CXCL10 levels were significantly higher in NMO patients than in OND and RRMS patients at relapse, while granulocyte-colony stimulating factor (G-CSF) and CCL4 levels were significantly higher in NMO patients than in OND patients. In NMO patients, IL-6 and CXCL8 levels were positively correlated with disability and CSF protein concentration while IL-6, CXCL8, G-CSF, granulocyte-macrophage colony-stimulating factor (GM-CSF) and IFN-gamma were positively correlated with CSF neutrophil counts at the time of sample collection. In RRMS patients, IL-6 levels were significantly higher than in OND patients at the relapse phase while CSF cell counts were negatively correlated with the levels of CCL2. Correlation coefficients of cytokines/chemokines in the relapse phase were significantly different in three combinations, IL-6 and GM-CSF, G-CSF and GM-CSF, and GM-CSF and IFN-gamma, between RRMS and NMO/NMOSD patients. In PPMS patients, CCL4 and CXCL10 levels were significantly higher than in OND patients. Conclusions: Our findings suggest distinct cytokine/chemokine alterations in CSF exist among NMO, RRMS and PPMS. In NMO, over-expression of a cluster of Th17-and Th1-related proinflammatory cytokines/chemokines is characteristic, while in PPMS, increased CCL4 and CXCL10 levels may reflect on-going low grade T cell and macrophage/microglia inflammation in the central nervous system. In RRMS, only a mild elevation of proinflammatory cytokines/chemokines was detectable at relapse.	[Matsushita, Takuya; Tateishi, Takahisa; Isobe, Noriko; Yonekawa, Tomomi; Matsuse, Dai; Murai, Hiroyuki; Kira, Jun-ichi] Kyushu Univ, Dept Neurol, Neurol Inst, Grad Sch Med Sci, Fukuoka 812, Japan; [Yamasaki, Ryo] Kyushu Univ, Grad Sch Med Sci, Dept Neurol Therapeut, Neurol Inst, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kira, J (corresponding author), Kyushu Univ, Dept Neurol, Neurol Inst, Grad Sch Med Sci, Fukuoka 812, Japan.	kira@neuro.med.kyushu-u.ac.jp	Yamasaki, Ryo/AAQ-6245-2021; Isobe, Noriko/AAJ-3043-2020	Yamasaki, Ryo/0000-0003-2071-7861; Isobe, Noriko/0000-0001-9525-4254	Ministry of Health, Labour, and Welfare, Japan [H22-Nanchi-Ippan-130, H23-Nanchi-Ippan-017]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [22390178, 23659459]	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant on Intractable Diseases (H22-Nanchi-Ippan-130 and H23-Nanchi-Ippan-017) from the Ministry of Health, Labour, and Welfare, Japan (http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo16/14.html), by a Scientific Research B Grant (No. 22390178) and a Challenging Exploratory Research Grant (No. 23659459) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antel J, 2012, ACTA NEUROPATHOL, V123, P627, DOI 10.1007/s00401-012-0953-0; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baraczka K, 2004, EUR J NEUROL, V11, P37, DOI 10.1046/j.1351-5101.2003.00706.x; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Boven LA, 2000, CLIN EXP IMMUNOL, V122, P257, DOI 10.1046/j.1365-2249.2000.01334.x; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; BRENNAN FM, 1990, EUR J IMMUNOL, V20, P2141, DOI 10.1002/eji.1830200938; Correale J, 2008, J NEUROIMMUNOL, V195, P121, DOI 10.1016/j.jneuroim.2007.12.004; Girolomoni G, 2012, BRIT J DERMATOL, V167, P717, DOI 10.1111/j.1365-2133.2012.11099.x; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Herges K, 2012, MULT SCLER J, V18, P398, DOI 10.1177/1352458512440060; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lahrtz F, 1998, J NEUROIMMUNOL, V85, P33, DOI 10.1016/S0165-5728(97)00267-1; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; Matsushita T, 2009, MULT SCLER J, V15, P834, DOI 10.1177/1352458509104595; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Narikawa K, 2004, J NEUROIMMUNOL, V149, P182, DOI 10.1016/j.jneuroim.2003.12.010; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rentzos M, 2006, J NEUROL SCI, V241, P25, DOI 10.1016/j.jns.2005.10.003; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Saikali P, 2010, J IMMUNOL, V185, P5693, DOI 10.4049/jimmunol.1002188; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Sorensen TL, 2001, EUR J NEUROL, V8, P665, DOI 10.1046/j.1468-1331.2001.00327.x; Tanaka M, 2008, NEUROLOGY, V71, P974, DOI 10.1212/01.wnl.0000326589.57128.c3; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Warabi Y, 2007, J NEUROL SCI, V252, P57, DOI 10.1016/j.jns.2006.10.008; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Yanagawa K, 2009, NEUROLOGY, V73, P1628, DOI 10.1212/WNL.0b013e3181c1deb9; Yoshimura S, J NEUROL NE IN PRESS; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	45	130	134	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61835	10.1371/journal.pone.0061835	http://dx.doi.org/10.1371/journal.pone.0061835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637915	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700062
J	Su, ZZ; Mao, LJ; Li, N; Feng, XX; Yuan, ZL; Wang, LW; Lin, FC; Zhang, CL				Su, Zhen-Zhu; Mao, Li-Juan; Li, Na; Feng, Xiao-Xiao; Yuan, Zhi-Lin; Wang, Li-Wei; Lin, Fu-Cheng; Zhang, Chu-Long			Evidence for Biotrophic Lifestyle and Biocontrol Potential of Dark Septate Endophyte Harpophora oryzae to Rice Blast Disease	PLOS ONE			English	Article							PHIALOPHORA-GRAMINICOLA; MEDIATED TRANSFORMATION; MAGNAPORTHE-GRISEA; FUNGAL ENDOPHYTES; RESISTANCE; BARLEY; ROOTS; PCR; COLONIZATION; SUPPRESSION	The mutualism pattern of the dark septate endophyte (DSE) Harpophora oryzae in rice roots and its biocontrol potential in rice blast disease caused by Magnaporthe oryzae were investigated. Fluorescent protein-expressing H. oryzae was used to monitor the colonization pattern. Hyphae invaded from the epidermis to the inner cortex, but not into the root stele. Fungal colonization increased with root tissue maturation, showing no colonization in the meristematic zone, slight colonization in the elongation zone, and heavy colonization in the differentiation zone. H. oryzae adopted a biotrophic lifestyle in roots accompanied by programmed cell death. Real-time PCR facilitated the accurate quantification of fungal growth and the respective plant response. The biocontrol potential of H. oryzae was visualized by inoculation with eGFP-tagged M. oryzae in rice. H. oryzae protected rice from M. oryzae root invasion by the accumulation of H2O2 and elevated antioxidative capacity. H. oryzae also induced systemic resistance against rice blast. This systemic resistance was mediated by the OsWRKY45-dependent salicylic acid (SA) signaling pathway, as indicated by the strongly upregulated expression of OsWRKY45. The colonization pattern of H. oryzae was consistent with the typical characteristics of DSEs. H. oryzae enhanced local resistance by reactive oxygen species (ROS) and high antioxidative level and induced OsWRKY45-dependent SA-mediated systemic resistance against rice blast.	[Su, Zhen-Zhu; Li, Na; Feng, Xiao-Xiao; Yuan, Zhi-Lin; Wang, Li-Wei; Lin, Fu-Cheng; Zhang, Chu-Long] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Mao, Li-Juan] Zhejiang Univ, Anal Ctr Agrobiol & Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yuan, Zhi-Lin] Chinese Acad Forestry, Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China; [Wang, Li-Wei] Hangzhou Normal Univ, Sch Hlth Management, Dept Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Lin, Fu-Cheng] Zhengzhou Tobacco Res Inst CNTC, China Tobacco Gene Res Ctr, Zhenzhou, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF; Hangzhou Normal University; Zhengzhou Tobacco Research Institute of CNTC	Zhang, CL (corresponding author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	clzhang@zju.edu.cn	Lin, Fucheng/ABE-7591-2021	Lin, Fucheng/0000-0002-4127-8143; Yuan, Zhilin/0000-0002-5799-8401	National Natural Science Foundation of China [30970097, 30925025]; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of the People's Republic of China [PCSIRT0943]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of the People's Republic of China	This work was financially supported by the National Natural Science Foundation of China (30970097 and 30925025) (http://www.nsfc.gov.cn/Portal0/default152.htm), and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT0943) of Ministry of Education of the People's Republic of China (http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy HD, 2005, CAN J BOT, V83, P1, DOI [10.1139/B04-171, 10.1139/b04-171]; Arnold AE, 2007, J TROP ECOL, V23, P369, DOI 10.1017/S0266467407004038; Barrow JR, 2003, MYCORRHIZA, V13, P239, DOI 10.1007/s00572-003-0222-0; BECKER K, 1994, HISTOCHEMISTRY, V102, P389, DOI 10.1007/BF00268910; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caldo RA, 2006, MOL PLANT MICROBE IN, V19, P939, DOI 10.1094/MPMI-19-0939; CHAO CCT, 1991, CAN J BOT, V69, P2130, DOI 10.1139/b91-267; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; CURRAH RS, 1986, CAN FIELD NAT, V100, P330; Deshmukh SD, 2007, J PLANT DIS PROTECT, V114, P263, DOI 10.1007/BF03356227; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Dong B, 2009, AUTOPHAGY, V5, P946, DOI 10.4161/auto.5.7.9161; EGLEY GH, 1983, PLANTA, V157, P224, DOI 10.1007/BF00405186; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Gams W, 2000, STUD MYCOL, P187; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Hamilton CE, 2012, FUNGAL DIVERS, V54, P1, DOI 10.1007/s13225-012-0158-9; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; JACOBSON ES, 1993, J BACTERIOL, V175, P7102, DOI 10.1128/jb.175.21.7102-7104.1993; KIRK JJ, 1987, PLANT SOIL, V98, P231, DOI 10.1007/BF02374826; KLAPHECK S, 1990, PLANT CELL PHYSIOL, V31, P1005; Knapp DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032570; Knorzer OC, 1996, PHYSIOL PLANTARUM, V97, P388, DOI 10.1034/j.1399-3054.1996.970225.x; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Li HaiJiao, 2012, Journal of Agricultural Biotechnology, V20, P94; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macia-Vicente JG, 2009, NEW PHYTOL, V182, P213, DOI 10.1111/j.1469-8137.2008.02743.x; Mandyam K, 2005, STUD MYCOL, P173; Marcel S, 2010, PLANT CELL, V22, P3177, DOI 10.1105/tpc.110.078048; McDowell JM, 2005, MOL PLANT MICROBE IN, V18, P1226, DOI 10.1094/MPMI-18-1226; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Newsham KK, 1999, NEW PHYTOL, V144, P517, DOI 10.1046/j.1469-8137.1999.00537.x; Ni M, 1996, PLANT CELL, V8, P1041, DOI 10.1105/tpc.8.6.1041; NORDHOFF A, 1993, BIOCHEMISTRY-US, V32, P4060, DOI 10.1021/bi00066a029; Perpetua NS, 1996, MOL PLANT MICROBE IN, V9, P323, DOI 10.1094/MPMI-9-0323; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Reininger V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042865; Reininger V, 2012, ENVIRON MICROBIOL, V14, P1064, DOI 10.1111/j.1462-2920.2011.02686.x; Rho HS, 2001, MOL CELLS, V12, P407; Rodriguez R. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P261, DOI 10.1023/B:MITI.0000029922.31110.97; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; ROTH EF, 1984, ANAL BIOCHEM, V137, P50, DOI 10.1016/0003-2697(84)90344-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Schulz B.J.E., 2006, MUTUALISTIC INTERACT, P261; Schulz Barbara J. E., 2006, V9, P1; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Sieber T. N., 2002, Plant roots: the hidden half, P887; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; STOYKE G, 1991, CAN J BOT, V69, P347, DOI 10.1139/b91-047; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Yara A, 2008, BIOCHEM BIOPH RES CO, V376, P460, DOI 10.1016/j.bbrc.2008.08.157; Yuan ZL, 2010, FEMS MICROBIOL LETT, V307, P94, DOI 10.1111/j.1574-6968.2010.01963.x	65	64	76	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61332	10.1371/journal.pone.0061332	http://dx.doi.org/10.1371/journal.pone.0061332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637814	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700025
J	Deepak, NN; Mirzabagi, E; Koski, A; Tripathi, V				Deepak, Nitya Nand; Mirzabagi, Ellie; Koski, Alissa; Tripathi, Vandana			Knowledge, Attitudes, and Practices Related to Uterotonic Drugs during Childbirth in Karnataka, India: A Qualitative Research Study	PLOS ONE			English	Article							DEVELOPMENT GOALS 4; OXYTOCIN USE; MORTALITY; LABOR; MANAGEMENT; SURVIVAL; PROGRESS; HEALTH; BIRTHS	Background and Objectives: India has the highest annual number of maternal deaths of any country. As obstetric hemorrhage is the leading cause of maternal death in India, numerous efforts are under way to promote access to skilled attendance at birth and emergency obstetric care. Current initiatives also seek to increase access to active management of the third stage of labor for postpartum hemorrhage prevention, particularly through administration of an uterotonic after delivery. However, prior research suggests widespread inappropriate use of uterotonics at facilities and in communities-for example, without adequate monitoring or referral support for complications. This qualitative study aimed to document health providers' and community members' current knowledge, attitudes, and practices regarding uterotonic use during labor and delivery in India's Karnataka state. Methods: 140 in-depth interviews were conducted from June to August 2011 in Bagalkot and Hassan districts with physicians, nurses, recently delivered women, mothers-in-law, traditional birth attendants (dais), unlicensed village doctors, and chemists (pharmacists). Results: Many respondents reported use of uterotonics, particularly oxytocin, for labor augmentation in both facility-based and home-based deliveries. The study also identified contextual factors that promote inappropriate uterotonic use, including high value placed on pain during labor; perceived pressure to provide or receive uterotonics early in labor and delivery, perhaps leading to administration of uterotonics despite awareness of risks; and lack of consistent and correct knowledge regarding safe storage, dosing, and administration of oxytocin. Conclusions: These findings have significant implications for public health programs in a context of widespread and potentially increasing availability of uterotonics. Among other responses, efforts are needed to improve communication between community members and providers regarding uterotonic use during labor and delivery and to target training and other interventions to address identified gaps in knowledge and ensure that providers and pharmacists have up-to-date information regarding proper usage of uterotonic drugs.	[Deepak, Nitya Nand] PATH, New Delhi, India; [Mirzabagi, Ellie] Johns Hopkins Bloomberg Sch Publ Hlth, Washington, DC USA; [Koski, Alissa] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Tripathi, Vandana] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; McGill University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tripathi, V (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	vtripath@jhsph.edu	Koski, Alissa/H-8079-2019	Koski, Alissa/0000-0001-5170-6693	Oxytocin Initiative Project; Bill & Melinda Gates Foundation (BMGF) [51592]	Oxytocin Initiative Project; Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	This research was supported by the Oxytocin Initiative Project and undertaken by PATH, JHSPH, RTI International, and the Social and Rural Research Institute (SRI) of IMRB International with funding from the Bill & Melinda Gates Foundation (BMGF, www.gatesfoundation.org). The BMGF grant number is 51592. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brhlikova P, 2009, J HLTH STUD, V2, P33; Chatterjee A, 2011, BJOG-INT J OBSTET GY, V118, P47, DOI 10.1111/j.1471-0528.2011.03112.x; Dhaifalah Ishraq, 2006, Biomedical Papers (Olomouc), V150, P279; Dohlie M B, 2000, J Healthc Qual, V22, P34; Flandermeyer D, 2010, INT J GYNECOL OBSTET, V108, P269, DOI 10.1016/j.ijgo.2009.12.001; Government of Karnataka, NAT RUR HLTH MISS PR; Gulmezoglu AM, 2012, LANCET, V379, P1721, DOI 10.1016/S0140-6736(12)60206-2; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; International Institute for Population Sciences, 2010, DISTR LEV HOUS FAC S; Iyengar SD, 2008, J PERINATOL, V28, pS23, DOI 10.1038/jp.2008.174; Jeffery P, 2007, REPROD HEALTH MATTER, V15, P172, DOI 10.1016/S0968-8080(07)30320-0; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lovold A, 2008, INT J GYNECOL OBSTET, V103, P276, DOI 10.1016/j.ijgo.2008.08.009; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Ministry of Health and Family Welfare Maternal Health Division, 2008, GUID OP SBA TRAIN RC; Ministry of Health and Family Welfare Maternal Health Division, 2005, GUID ANT CAR SKILL B; Ministry of Health and Family Welfare Maternal Health Division, 2010, TRAIN GUID COND TRAI; Mirzabagi E, 2013, MIDWIFERY, DOI [10.1016/j.midw.2012.11.004, DOI 10.1016/J.MIDW.2012.11.004.EPUB]; Moran AC, 2010, BJOG-INT J OBSTET GY, V117, P1608, DOI 10.1111/j.1471-0528.2010.02714.x; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; Ramanathan G, 2006, J OBSTET GYNAECOL CA, V28, P967, DOI 10.1016/S1701-2163(16)32308-8; *REG GEN IND, 2006, MAT MORT IND 1997 20; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Save the Children, PARTN DEF QUAL TOOL; Sharan M, 2005, INT J GYNECOL OBSTET, V90, P251, DOI 10.1016/j.ijgo.2005.05.008; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; *UN STAT DIV, MILL DEV GOALS IND; Van Hollen C, 2003, MED ANTHROPOL Q, V17, P49; Walraven G, 2008, BEST PRACT RES CL OB, V22, P1013, DOI 10.1016/j.bpobgyn.2008.08.002; WHO, 2010, TRENDS MAT MORT 1990; World Health Organization, 2000, MAN COMPL PREGN CHIL; World Health Organization (WHO), 2007, WHO REC PREV POSTP H	34	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62801	10.1371/journal.pone.0062801	http://dx.doi.org/10.1371/journal.pone.0062801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	181JC	23638148	Green Submitted, gold, Green Published			2022-12-25	WOS:000321662800062
J	Feltes, BC; Poloni, JD; Notari, DL; Bonatto, D				Feltes, Bruno Cesar; Poloni, Joice de Faria; Notari, Daniel Luis; Bonatto, Diego			Toxicological Effects of the Different Substances in Tobacco Smoke on Human Embryonic Development by a Systems Chemo-Biology Approach	PLOS ONE			English	Article							GENE-EXPRESSION ATLAS; LUNG INFLAMMATION; NADPH OXIDASE; NICOTINE; EXPOSURE; PROTEINS; NETWORKS; GROWTH; MECHANISMS; CYTOSCAPE	The physiological and molecular effects of tobacco smoke in adult humans and the development of cancer have been well described. In contrast, how tobacco smoke affects embryonic development remains poorly understood. Morphological studies of the fetuses of smoking pregnant women have shown various physical deformities induced by constant fetal exposure to tobacco components, especially nicotine. In addition, nicotine exposure decreases fetal body weight and bone/cartilage growth in addition to decreasing cranial diameter and tibia length. Unfortunately, the molecular pathways leading to these morphological anomalies are not completely understood. In this study, we applied interactome data mining tools and small compound interaction networks to elucidate possible molecular pathways associated with the effects of tobacco smoke components during embryonic development in pregnant female smokers. Our analysis showed a relationship between nicotine and 50 additional harmful substances involved in a variety of biological process that can cause abnormal proliferation, impaired cell differentiation, and increased oxidative stress. We also describe how nicotine can negatively affect retinoic acid signaling and cell differentiation through inhibition of retinoic acid receptors. In addition, nicotine causes a stress reaction and/or a pro-inflammatory response that inhibits the agonistic action of retinoic acid. Moreover, we show that the effect of cigarette smoke on the developing fetus could represent systemic and aggressive impacts in the short term, causing malformations during certain stages of development. Our work provides the first approach describing how different tobacco constituents affect a broad range of biological process in human embryonic development.	[Feltes, Bruno Cesar; Bonatto, Diego] Univ Fed Rio Grande do Sul, Biotechnol Ctr Fed Univ Rio Grande Sul, Dept Mol Biol & Biotechnol, Porto Alegre, RS, Brazil; [Poloni, Joice de Faria] Univ Caxias do Sul, Inst Biotechnol, Caxias Do Sul, RS, Brazil; [Notari, Daniel Luis] Univ Caxias do Sul, Computat & Informat Technol Ctr, Caxias Do Sul, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Caxias do Sul; Universidade de Caxias do Sul	Bonatto, D (corresponding author), Univ Fed Rio Grande do Sul, Biotechnol Ctr Fed Univ Rio Grande Sul, Dept Mol Biol & Biotechnol, Porto Alegre, RS, Brazil.	diegobonatto@gmail.com	de Faria Poloni, Joice/O-2654-2018; Bonatto, Diego/F-5893-2010; Feltes, Bruno César/O-9712-2016	de Faria Poloni, Joice/0000-0002-3896-6404; Bonatto, Diego/0000-0001-8679-2448; Feltes, Bruno César/0000-0002-2825-8295	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [474117/2010-3]; Programa Institutos Nacionais de Ciencia e Tecnologia (INCT de Processos Redox em Biomedicina-REDOXOMA) [573530/2008-4]; Fundacao de Amparo a Pesquisa do Rio Grande do Sul FAPERGS (PRONEM Grant) [11/2072-2]; CAPES (Cordenacao de Aperfeicoamento de Pessoal do Ensino Superior)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Institutos Nacionais de Ciencia e Tecnologia (INCT de Processos Redox em Biomedicina-REDOXOMA); Fundacao de Amparo a Pesquisa do Rio Grande do Sul FAPERGS (PRONEM Grant); CAPES (Cordenacao de Aperfeicoamento de Pessoal do Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by research grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; Grant Number 474117/2010-3), the Programa Institutos Nacionais de Ciencia e Tecnologia (INCT de Processos Redox em Biomedicina-REDOXOMA; Grant Number 573530/2008-4; http://www.cnpq.br), Fundacao de Amparo a Pesquisa do Rio Grande do Sul FAPERGS (PRONEM Grant Number 11/2072-2; http://www.fapergs.rs.gov.br) and CAPES (Cordenacao de Aperfeicoamento de Pessoal do Ensino Superior; http://www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CHEM CONSTITUENTS CI; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Board PG, 2012, BIOCH BIOPHYS ACTA; Breiling A, 2007, INT REV CYTOL, V258, P83, DOI 10.1016/S0074-7696(07)58002-2; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Castro MAA, 2009, BIOINFORMATICS, V25, P1468, DOI 10.1093/bioinformatics/btp246; Cheng CG, 2002, INT J CANCER, V99, P171; Daftary GS, 2006, ENDOCR REV, V27, P331, DOI 10.1210/er.2005-0018; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Delpretti S, 2012, DEV DYNAM, V241, P792, DOI 10.1002/dvdy.23756; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Feltes BC, 2011, BIOGERONTOLOGY, V12, P293, DOI 10.1007/s10522-011-9325-8; Florescu A, 2009, THER DRUG MONIT, V31, P14, DOI 10.1097/FTD.0b013e3181957a3b; Goggin M, 2011, CHEM RES TOXICOL, V24, P809, DOI 10.1021/tx200009b; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Han BC, 2010, J CELL PHYSIOL, V223, P471, DOI 10.1002/jcp.22056; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Jauniaux E, 2007, EARLY HUM DEV, V83, P699, DOI 10.1016/j.earlhumdev.2007.07.016; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; KAUFFMAN SL, 1969, DEV BIOL, V20, P146, DOI 10.1016/0012-1606(69)90010-4; Kawakita A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003945; Kim YJ, 2009, REPROD DOMEST ANIM, V44, P797, DOI 10.1111/j.1439-0531.2008.01082.x; Koturbash I, 2011, TOXICOL SCI, V122, P448, DOI 10.1093/toxsci/kfr133; Lantz RC, 2006, DRUG METAB REV, V38, P791, DOI 10.1080/03602530600980108; LEON Y, 1995, DEV BIOL, V167, P75, DOI 10.1006/dbio.1995.1008; Lopatina N, 2002, J CELL BIOCHEM, V84, P324, DOI 10.1002/jcb.10015; Loureiro B, 2011, AM J REPROD IMMUNOL, V65, P578, DOI 10.1111/j.1600-0897.2010.00953.x; Ma L, 2010, J BONE MINER RES, V25, P1305, DOI 10.1002/jbmr.19; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Matarazzo MR, 2007, J CELL PHYSIOL, V210, P711, DOI 10.1002/jcp.20879; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Moledina F, 2012, P NATL ACAD SCI USA, V109, P3264, DOI 10.1073/pnas.1111478109; Morris CV, 2011, EUR J NEUROSCI, V34, P1574, DOI 10.1111/j.1460-9568.2011.07884.x; Nakayama Y, 2009, J PERIODONTAL RES, V44, P657, DOI 10.1111/j.1600-0765.2008.01171.x; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Rosado JO, 2011, CURR CANCER DRUG TAR, V11, P849; Sadeu JC, 2011, FERTIL STERIL, V95, P2410, DOI 10.1016/j.fertnstert.2011.03.072; Safran M, 2010, GENECARDS VERSION 3; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Srinivas H, 2005, MOL CELL BIOL, V25, P1054, DOI 10.1128/MCB.25.3.1054-1069.2005; Tetko IV, 2002, J CHEM INF COMP SCI, V42, P1136, DOI 10.1021/ci025515j; van der Toorn M, 2009, AM J PHYSIOL-LUNG C, V297, pL109, DOI 10.1152/ajplung.90461.2008; Votavova H, 2012, NICOTINE TOB RES, V14, P1073, DOI 10.1093/ntr/ntr325; Xu Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-13; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; Yao HW, 2008, AM J PATHOL, V172, P1222, DOI 10.2353/ajpath.2008.070765; Yildiz D, 2004, TOXICON, V43, P619, DOI 10.1016/j.toxicon.2004.01.017; YLIKORKALA O, 1992, BAILLIERE CLIN OB GY, V6, P809, DOI 10.1016/S0950-3552(05)80190-7; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059	62	28	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61743	10.1371/journal.pone.0061743	http://dx.doi.org/10.1371/journal.pone.0061743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637898	Green Submitted, Green Published, gold			2022-12-25	WOS:000321662800012
J	Khan, JM; Qadeer, A; Ahmad, E; Ashraf, R; Bhushan, B; Chaturvedi, SK; Rabbani, G; Khan, RH				Khan, Javed M.; Qadeer, Atiyatul; Ahmad, Ejaz; Ashraf, Raghib; Bhushan, Bharat; Chaturvedi, Sumit K.; Rabbani, Gulam; Khan, Rizwan H.			Monomeric Banana Lectin at Acidic pH Overrules Conformational Stability of Its Native Dimeric Form	PLOS ONE			English	Article							MOLTEN GLOBULE STATE; ALPHA-LACTALBUMIN; GUANIDINE-HYDROCHLORIDE; QUATERNARY ASSOCIATION; FLUORESCENCE METHODS; SOYBEAN AGGLUTININ; PROTEIN STABILITY; CRYSTAL-STRUCTURE; LEGUME LECTINS; CONCANAVALIN-A	Banana lectin (BL) is a homodimeric protein categorized among jacalin-related family of lectins. The effect of acidic pH was examined on conformational stability of BL by using circular dichroism, intrinsic fluorescence, 1-anilino-8-napthalene sulfonate (ANS) binding, size exclusion chromatography (SEC) and dynamic light scattering (DLS). During acid denaturation of BL, the monomerization of native dimeric protein was found at pH 2.0. The elution profile from SEC showed two different peaks (59.65 ml & 87.98 ml) at pH 2.0 while single peak (61.45 ml) at pH 7.4. The hydrodynamic radii (R-h) of native BL was 2.9 nm while at pH 2.0 two species were found with R-h of 1.7 and 3.7 nm. Furthermore at, pH 2.0 the secondary structures of BL remained unaltered while tertiary structure was significantly disrupted with the exposure of hydrophobic clusters confirming the existence of molten globule like state. The unfolding of BL with different subunit status was further evaluated by urea and temperature mediated denaturation to check their stability. As inferred from high C-m and Delta G values, the monomeric form of BL offers more resistance towards chemical denaturation than the native dimeric form. Besides, dimeric BL exhibited a Tm of 77 degrees C while no loss in secondary structures was observed in monomers even up to 95 degrees C. To the best of our knowledge, this is the first report on monomeric subunit of lectins showing more stability against denaturants than its native dimeric state.	[Khan, Javed M.; Qadeer, Atiyatul; Ahmad, Ejaz; Ashraf, Raghib; Bhushan, Bharat; Chaturvedi, Sumit K.; Rabbani, Gulam; Khan, Rizwan H.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Khan, RH (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	chaturvedi, sumit k/O-6083-2019; khan, Javed Masood/AAZ-8079-2021; Chaturvedi, Sumit K/P-5052-2014; Khan, Rizwan Hasan/F-8276-2014; Khan, Rizwan/GXZ-5789-2022; Rabbani, Gulam/AAE-5629-2022; Ahmad, Ejaz/L-1506-2013	chaturvedi, sumit k/0000-0003-3600-8883; khan, Javed Masood/0000-0003-0567-5712; Chaturvedi, Sumit K/0000-0003-3600-8883; Khan, Rizwan Hasan/0000-0002-9965-8982; Rabbani, Gulam/0000-0002-5293-8231; Ahmad, Ejaz/0000-0002-5713-6713	Department of Biotechnology, New Delhi, India [BT/PR8473/BRB/10/521/2006]; DBT; CSIR, New Delhi	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance is provided by Department of Biotechnology, New Delhi, India under sanction no. BT/PR8473/BRB/10/521/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J.M.K, A.Q, E.A, S.K.C and G.R are highly thankful to DBT and CSIR, New Delhi, for financial assistance in the form of Senior Research Fellowship. I am highly thankful to Syed Arif Abdul Rehman and Dr. Samudrala Gourinath School of Life Sciences, Jawaharlal Nehru University, New Delhi, India for providing facilities of GPC.	Ahmad B, 2007, J BIOCHEM, V141, P251, DOI 10.1093/jb/mvm026; Ahmad E, 2010, BIOCHIMIE, V92, P885, DOI 10.1016/j.biochi.2010.03.023; Ahmad E, 2010, BIOSCIENCE REP, V30, P125, DOI 10.1042/BSR20090035; Ballew RM, 1996, P NATL ACAD SCI USA, V93, P5759, DOI 10.1073/pnas.93.12.5759; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; BLEWITT MG, 1985, BIOCHEMISTRY-US, V24, P5458, DOI 10.1021/bi00341a027; Boscolo B, 2009, BBA-PROTEINS PROTEOM, V1794, P1041, DOI 10.1016/j.bbapap.2009.03.003; Bose K, 2005, PROTEIN SCI, V14, P24; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Chandra NR, 1999, J MOL BIOL, V285, P1157, DOI 10.1006/jmbi.1998.2353; Chatterjee A, 2003, BBA-PROTEINS PROTEOM, V1648, P174, DOI 10.1016/S1570-9639(03)00120-1; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; Dar TA, 2007, BIOPHYS CHEM, V127, P140, DOI 10.1016/j.bpc.2007.01.006; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Eftink MR, 1997, METHOD ENZYMOL, V278, P258; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Fast JL, 2009, BIOCHEMISTRY-US, V48, P11724, DOI 10.1021/bi900853v; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; Griko YV, 2000, J MOL BIOL, V297, P1259, DOI 10.1006/jmbi.2000.3625; Gupta G, 2008, PROTEINS, V72, P754, DOI 10.1002/prot.21961; Kelkar DA, 2010, EUR BIOPHYS J BIOPHY, V39, P1453, DOI 10.1007/s00249-010-0603-1; Khan F, 2007, IUBMB LIFE, V59, P34, DOI 10.1080/15216540601178075; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; KOSHTE VL, 1990, BIOCHEM J, V272, P721, DOI 10.1042/bj2720721; Kumar R, 2004, BIOPHYS J, V87, P2656, DOI 10.1529/biophysj.104.044701; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Mitra N, 2002, BIOCHEMISTRY-US, V41, P9256, DOI 10.1021/bi020240m; Naseem F, 2005, BBA-GEN SUBJECTS, V1723, P192, DOI 10.1016/j.bbagen.2005.02.009; PACE CN, 1992, BIOCHEMISTRY-US, V31, P2728, DOI 10.1021/bi00125a013; Park SH, 2004, J BIOCHEM MOL BIOL, V37, P676; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; PRATS M, 1986, NATURE, V322, P756, DOI 10.1038/322756a0; Privalov PL, 1996, J MOL BIOL, V258, P707, DOI 10.1006/jmbi.1996.0280; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; RADFORD SE, 1995, PHILOS T ROY SOC B, V348, P17, DOI 10.1098/rstb.1995.0041; Ramboarina S, 2003, J MOL BIOL, V330, P1177, DOI 10.1016/S0022-2836(03)00639-9; Rosner HI, 2009, J MOL BIOL, V394, P351, DOI 10.1016/j.jmb.2009.09.025; Safarian S, 2006, J BIOCHEM, V139, P1025, DOI 10.1093/jb/mvj115; Santiago PS, 2010, LANGMUIR, V26, P9794, DOI 10.1021/la100060p; Sedlak E, 1999, BBA-PROTEIN STRUCT M, V1434, P347, DOI 10.1016/S0167-4838(99)00186-7; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; SHIRLEY BA, 1989, J BIOL CHEM, V264, P11621; Shukla N, 2005, FEBS J, V272, P2216, DOI 10.1111/j.1742-4658.2005.2005.04645.x; Sinha S, 2005, BIOPHYS J, V88, P4243, DOI 10.1529/biophysj.105.061309; Sinha S, 2007, BIOPHYS J, V92, P208, DOI 10.1529/biophysj.106.092668; Swanson MD, 2010, J BIOL CHEM, V285, P8646, DOI 10.1074/jbc.M109.034926; Varejao N, 2011, BIOCHEMISTRY-US, V50, P7330, DOI 10.1021/bi200320x; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yuan T, 1998, BIOCHEMISTRY-US, V37, P3187, DOI 10.1021/bi9716579	55	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62428	10.1371/journal.pone.0062428	http://dx.doi.org/10.1371/journal.pone.0062428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638080	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700055
J	Kuang, SQ; Fang, ZH; Zweidler-McKay, PA; Yang, H; Wei, Y; Gonzalez-Cervantes, EA; Boumber, Y; Garcia-Manero, G				Kuang, Shao-Qing; Fang, Zhihong; Zweidler-McKay, Patrick A.; Yang, Hui; Wei, Yue; Gonzalez-Cervantes, Emilio A.; Boumber, Yanis; Garcia-Manero, Guillermo			Epigenetic Inactivation of Notch-Hes Pathway in Human B-Cell Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ACUTE LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR FUNCTION; PROMOTER DNA METHYLATION; GROWTH; CANCER; GENES; TUMORIGENESIS; TRANSCRIPTION; MALIGNANCIES; LYMPHOMAS	The Notch pathway can have both oncogenic and tumor suppressor roles, depending on cell context. For example, Notch signaling promotes T cell differentiation and is leukemogenic in T cells, whereas it inhibits early B cell differentiation and acts as a tumor suppressor in B cell leukemia where it induces growth arrest and apoptosis. The regulatory mechanisms that contribute to these opposing roles are not understood. Aberrant promoter DNA methylation and histone modifications are associated with silencing of tumor suppressor genes and have been implicated in leukemogenesis. Using methylated CpG island amplification (MCA)/DNA promoter microarray, we identified Notch3 and Hes5 as hypermethylated in human B cell acute lymphoblastic leukemia (ALL). We investigated the methylation status of other Notch pathway genes by bisulfite pyrosequencing. Notch3, JAG1, Hes2, Hes4 and Hes5 were frequently hypermethylated in B leukemia cell lines and primary B-ALL, in contrast to T-ALL cell lines and patient samples. Aberrant methylation of Notch3 and Hes5 in B-ALL was associated with gene silencing and was accompanied by decrease of H3K4 trimethylation and H3K9 acetylation and gain of H3K9 trimethylation and H3K27 trimethylation. 5-aza-2'-deoxycytidine treatment restored Hes5 expression and decreased promoter hypermethylation in most leukemia cell lines and primary B-ALL samples. Restoration of Hes5 expression by lentiviral transduction resulted in growth arrest and apoptosis in Hes5 negative B-ALL cells but not in Hes5 expressing T-ALL cells. These data suggest that epigenetic modifications are implicated in silencing of tumor suppressor of Notch/Hes pathway in B-ALL.	[Kuang, Shao-Qing; Fang, Zhihong; Yang, Hui; Wei, Yue; Gonzalez-Cervantes, Emilio A.; Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Zweidler-McKay, Patrick A.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Kuang, Shao-Qing] Univ Texas Houston, Hlth Sci Ctr, Dept Internal Med, Houston, TX 77225 USA; [Boumber, Yanis] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Hematol Oncol Fellowship Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Garcia-Manero, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	ggarciam@mdanderson.org	Boumber, Yanis/AAP-8901-2021	Zweidler-McKay, Patrick/0000-0001-6621-523X; Boumber, Yanis/0000-0001-5003-248X	Leukemia Specialized Program of Research Excellence Career Development Award [SPORE P50 CA100632]; National Cancer Institute [CA100067, CA105771]; Leukemia and Lymphoma Society of America; Commonwealth Cancer Foundation for Research; NATIONAL CANCER INSTITUTE [R21CA105771, R21CA100067, P50CA100632, P30CA016672] Funding Source: NIH RePORTER	Leukemia Specialized Program of Research Excellence Career Development Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Commonwealth Cancer Foundation for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Leukemia Specialized Program of Research Excellence (SPORE P50 CA100632) Career Development Award to S-QK, and National Cancer Institute grants CA100067 and CA105771, the Leukemia and Lymphoma Society of America and a MD Anderson Cancer Center's Physician-Scientist Award from the Commonwealth Cancer Foundation for Research (all to GG-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Choi JH, 2008, CANCER RES, V68, P5716, DOI 10.1158/0008-5472.CAN-08-0001; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Garcia-Manero G, 2009, SEMIN HEMATOL, V46, P24, DOI 10.1053/j.seminhematol.2008.09.008; He YP, 2003, SEMIN CELL DEV BIOL, V14, P135, DOI 10.1016/S1084-9521(02)00182-9; Ivascu C, 2007, INT J BIOCHEM CELL B, V39, P1523, DOI 10.1016/j.biocel.2007.02.006; Jundt F, 2008, CURR MOL MED, V8, P51, DOI 10.2174/156652408783565540; Kapoor-Vazirani P, 2008, CANCER RES, V68, P6810, DOI 10.1158/0008-5472.CAN-08-0141; Katoh M, 2007, INT J ONCOL, V31, P461; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kuang SQ, 2008, LEUKEMIA, V22, P1529, DOI 10.1038/leu.2008.130; Kuang SQ, 2007, ONCOGENE, V26, P1439, DOI 10.1038/sj.onc.1209907; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Roman-Gomez J, 2007, LEUKEMIA LYMPHOMA, V48, P1269, DOI 10.1080/10428190701344899; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Singh N, 2000, EXP HEMATOL, V28, P527, DOI 10.1016/S0301-472X(00)00146-6; Talora C, 2006, BLOOD, V107, P3313, DOI 10.1182/blood-2005-07-2823; Walter K, 2008, BLOOD, V112, P1673, DOI 10.1182/blood-2008-02-142786; Wang ZY, 2002, BLOOD, V99, P2740, DOI 10.1182/blood.V99.8.2740; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yendamuri S, 2007, CANCER RES, V67, P7738, DOI 10.1158/0008-5472.CAN-07-1481; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355; Zweidler-McKay PA, 2008, CURR ONCOL REP, V10, P459, DOI 10.1007/s11912-008-0071-2	25	38	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61807	10.1371/journal.pone.0061807	http://dx.doi.org/10.1371/journal.pone.0061807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637910	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700022
J	Li, LM; Pan, S; Zhou, XH; Meng, X; Han, XX; Ren, YB; Yang, K; Guan, YF				Li, Liming; Pan, Shuang; Zhou, Xiaohang; Meng, Xin; Han, Xiaoxi; Ren, Yibin; Yang, Ke; Guan, Yifu			Reduction of In-Stent Restenosis Risk on Nickel-Free Stainless Steel by Regulating Cell Apoptosis and Cell Cycle	PLOS ONE			English	Article							GENE-EXPRESSION; VIVO CORROSION; VITRO; MECHANISMS; RELEASE; DEATH; CYTOTOXICITY; IMPLANTATION; AUTOPHAGY; ALLERGIES	High nitrogen nickel-free austenitic stainless steel (HNNF SS) is one of the biomaterials developed recently for circumventing the in-stent restenosis (ISR) in coronary stent applications. To understand the ISR-resistance mechanism, we have conducted a comparative study of cellular and molecular responses of human umbilical vein endothelial cells (HUVECs) to HNNF SS and 316L SS (nickel-containing austenitic 316L stainless steel) which is the stent material used currently. CCK-8 analysis and flow cytometric analysis were used to assess the cellular responses (proliferation, apoptosis, and cell cycle), and quantitative real-time PCR (qRT-PCR) was used to analyze the gene expression profile of HUVECs exposed to HNNF SS and 316L SS, respectively. Flow cytometry analysis revealed that 316L SS could activate the cellular apoptosis more efficiently and initiate an earlier entry into the S-phase of cell cycle than HNNF SS. At the molecular level, qRT-PCR results showed that the genes regulating cell apoptosis and autophagy were overexpressed on 316L SS. Further examination indicated that nickel released from 316L SS triggered the cell apoptosis via Fas-Caspase8-Caspase3 exogenous pathway. These molecular mechanisms of HUVECs present a good model for elucidating the observed cellular responses. The findings in this study furnish valuable information for understanding the mechanism of ISR-resistance on the cellular and molecular basis as well as for developing new biomedical materials for stent applications.	[Li, Liming; Pan, Shuang; Zhou, Xiaohang; Meng, Xin; Han, Xiaoxi; Guan, Yifu] China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Li, Liming] Northeastern Univ, Coll Sci, Inst Biotechnol, Shenyang, Peoples R China; [Ren, Yibin; Yang, Ke] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China	China Medical University; Northeastern University - China; Chinese Academy of Sciences; Institute of Metal Research, CAS	Guan, YF (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China.	yfguan@mail.cmu.edu.cn	ren, yibin/M-5508-2014; Ren, Yibin/M-3881-2019	ren, yibin/0000-0002-5422-761X; 	National Basic Research Program of China (973 Program) [2012CB619101]; National Natural Science Foundation of China [31070705, 31000428]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (973 Program) (No. 2012CB619101) and the National Natural Science Foundation of China (No. 31070705, 31000428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez K, 2008, J MATER SCI-MATER M, V19, P3385, DOI 10.1007/s10856-008-3458-6; Bauters C, 1998, CIRCULATION, V97, P318; Bonnesen C, 2010, CELL BIOL TOXICOL, V26, P293, DOI 10.1007/s10565-009-9142-x; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; CRAIG RG, 1990, J DENT RES, V69, P1539, DOI 10.1177/00220345900690081801; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; EVANS EJ, 1986, BIOMATERIALS, V7, P25, DOI 10.1016/0142-9612(86)90084-0; Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2; Gali-Muhtasib H, 2002, CURR CANCER DRUG TAR, V2, P309, DOI 10.2174/1568009023333809; Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007; Garg S, 2010, EXPERT REV CARDIOVAS, V8, P449, DOI [10.1586/erc.09.138, 10.1586/ERC.09.138]; Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4; Halwani DO, 2010, J INVASIVE CARDIOL, V22, P528; Herting G, 2008, J ENVIRON MONITOR, V10, P1092, DOI 10.1039/b805075a; Hillen U, 2002, CONTACT DERMATITIS, V47, P353, DOI 10.1034/j.1600-0536.2002.470607.x; Iijima R, 2005, INT J CARDIOL, V104, P319, DOI 10.1016/j.ijcard.2004.12.034; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; Kang PM, 2003, TRENDS MOL MED, V9, P177, DOI 10.1016/S1471-4914(03)00025-X; Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1; Lamberti M, 2004, TOXICOL APPL PHARM, V195, P321, DOI 10.1016/j.taap.2003.09.022; Lu XY, 2010, BIOMATERIALS, V31, P1965, DOI 10.1016/j.biomaterials.2009.12.044; Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; McLucas E, 2008, J MATER SCI-MATER M, V19, P975, DOI 10.1007/s10856-006-0087-9; Montanaro L, 2006, J MATER SCI-MATER M, V17, P267, DOI 10.1007/s10856-006-7313-3; Muto A, 2010, CIRC J, V74, P1501, DOI 10.1253/circj.CJ-10-0495; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nayab SN, 2007, BIOMATERIALS, V28, P38, DOI 10.1016/j.biomaterials.2006.08.032; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Ren L, 2012, J MATER SCI-MATER M, V23, P1235, DOI 10.1007/s10856-012-4584-8; Ren YB, 2011, J MATER SCI TECHNOL, V27, P325, DOI 10.1016/S1005-0302(11)60069-8; Saito T, 2009, CARDIOVASC REVASCULA, V10, P17, DOI 10.1016/j.carrev.2008.01.004; Sasaki M, 2012, COLLOID SURFACE B, V92, P1, DOI 10.1016/j.colsurfb.2011.10.061; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Tuleta I, 2010, CARDIOVASC PATHOL, V19, P353, DOI 10.1016/j.carpath.2009.07.006; Walczak J, 1998, BIOMATERIALS, V19, P229, DOI 10.1016/S0142-9612(97)00208-1; Wan P, 2010, MAT SCI ENG C-MATER, V30, P1183, DOI 10.1016/j.msec.2010.06.015; Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062; Xia Y, 2012, BIOMATERIALS, V33, P2462, DOI 10.1016/j.biomaterials.2011.12.001; Yang F, 2011, BIOMATERIALS, V32, P9159, DOI 10.1016/j.biomaterials.2011.08.039; Yang K, 2012, SCI CHINA TECHNOL SC, V55, P329, DOI 10.1007/s11431-011-4679-3	45	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62193	10.1371/journal.pone.0062193	http://dx.doi.org/10.1371/journal.pone.0062193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638002	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700038
J	Juknat, A; Pietr, M; Kozela, E; Rimmerman, N; Levy, R; Gao, FY; Coppola, G; Geschwind, D; Vogel, Z				Juknat, Ana; Pietr, Maciej; Kozela, Ewa; Rimmerman, Neta; Levy, Rivka; Gao, Fuying; Coppola, Giovanni; Geschwind, Daniel; Vogel, Zvi			Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells	PLOS ONE			English	Article							NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; CANNABIDIOL AFFECTS; MULTIPLE-SCLEROSIS; INDUCED APOPTOSIS; CNS DISORDERS; IMMUNE CELLS; RECEPTORS; GENE; INFLAMMATION	Cannabinoids are known to exert immunosuppressive activities. However, the mechanisms which contribute to these effects are unknown. Using lipopolysaccharide (LPS) to activate BV-2 microglial cells, we examined how Delta(9)-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, and cannabidiol (CBD) the non-psychoactive component, modulate the inflammatory response. Microarray analysis of genome-wide mRNA levels was performed using Illumina platform and the resulting expression patterns analyzed using the Ingenuity Pathway Analysis to identify functional subsets of genes, and the Ingenuity System Database to denote the gene networks regulated by CBD and THC. From the 5338 transcripts that were differentially expressed across treatments, 400 transcripts were found to be upregulated by LPS, 502 by CBD+LPS and 424 by THC+LPS, while 145 were downregulated by LPS, 297 by CBD+LPS and 149 by THC+LPS, by 2-fold or more (p <= 0.005). Results clearly link the effects of CBD and THC to inflammatory signaling pathways and identify new cannabinoid targets in the MAPK pathway (Dusp1, Dusp8, Dusp2), cell cycle related (Cdkn2b, Gadd45a) as well as JAK/STAT regulatory molecules (Socs3, Cish, Stat1). The impact of CBD on LPS-stimulated gene expression was greater than that of THC. We attribute this difference to the fact that CBD highly upregulated several genes encoding negative regulators of both NFkB and AP-1 transcriptional activities, such as Trib3 and Dusp1 known to be modulated through Nrf2 activation. The CBD-specific expression profile reflected changes associated with oxidative stress and glutathione depletion via Trib3 and expression of ATF4 target genes. Furthermore, the CBD affected genes were shown to be controlled by nuclear factors usually involved in regulation of stress response and inflammation, mainly via Nrf2/Hmox1 axis and the Nrf2/ATF4-Trib3 pathway. These observations indicate that CBD, and less so THC, induce a cellular stress response and that this response underlies their high immunosuppressant activities.	[Juknat, Ana; Kozela, Ewa; Rimmerman, Neta; Vogel, Zvi] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Dr Miriam & Sheldon G Adelson Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel; [Pietr, Maciej; Kozela, Ewa; Rimmerman, Neta; Levy, Rivka] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Gao, Fuying; Coppola, Giovanni; Geschwind, Daniel] Univ Calif Los Angeles, Dept Neurol, Program Neurogenet, Los Angeles, CA 90024 USA	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; University of California System; University of California Los Angeles	Vogel, Z (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Dr Miriam & Sheldon G Adelson Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel.	zvi.vogel@weizmann.ac.il			Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases; Israeli Ministry for Absorption in Science	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases; Israeli Ministry for Absorption in Science	This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and by the Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases. AJ is supported by the Israeli Ministry for Absorption in Science. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashton JC, 2007, CURR OPIN INVEST DR, V8, P373; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Banisor I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-7; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Booz GW, 2011, FREE RADICAL BIO MED, V51, P1054, DOI 10.1016/j.freeradbiomed.2011.01.007; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cabral GA, 2005, HANDB EXP PHARMACOL, V168, P385; Cabral GA, 1998, J NEUROIMMUNOL, V83, P116, DOI 10.1016/S0165-5728(97)00227-0; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; Di Marzo V, 2006, ANNU REV MED, V57, P553, DOI 10.1146/annurev.med.57.011205.135648; Dietrich C, 2010, CARCINOGENESIS, V31, P1319, DOI 10.1093/carcin/bgq028; Dos Santos S, 2007, ANN NY ACAD SCI, V1096, P70, DOI 10.1196/annals.1397.071; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Esposito G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028668; Fernandez-Ruiz J, 2013, BRIT J CLIN PHARMACO, V75, P323, DOI 10.1111/j.1365-2125.2012.04341.x; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Gowran A, 2011, CNS NEUROSCI THER, V17, P637, DOI 10.1111/j.1755-5949.2010.00195.x; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hill AJ, 2012, PHARMACOL THERAPEUT, V133, P79, DOI 10.1016/j.pharmthera.2011.09.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Juknat A, 2012, NEUROCHEM INT, V61, P923, DOI 10.1016/j.neuint.2011.12.002; Juknat A, 2012, BRIT J PHARMACOL, V165, P2512, DOI 10.1111/j.1476-5381.2011.01461.x; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Klein TW, 2006, J NEUROIMMUNE PHARM, V1, P50, DOI 10.1007/s11481-005-9007-x; Klein TW, 2004, J NEUROIMMUNOL, V147, P91, DOI 10.1016/j.jneuroim.2003.10.019; Kogan Natalya M, 2007, Dialogues Clin Neurosci, V9, P413; Kozela E, 2011, BRIT J PHARMACOL, V163, P1507, DOI 10.1111/j.1476-5381.2011.01379.x; Kozela E, 2010, J BIOL CHEM, V285, P1616, DOI 10.1074/jbc.M109.069294; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Lee WK, 2006, AM J PHYSIOL-CELL PH, V291, pC195, DOI 10.1152/ajpcell.00641.2005; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; Mecha M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.71; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; O'Sullivan SE, 2009, EUR J PHARMACOL, V612, P61, DOI 10.1016/j.ejphar.2009.03.010; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pazos MR, 2012, NEUROPHARMACOLOGY, V63, P776, DOI 10.1016/j.neuropharm.2012.05.034; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2002, PHARMACOL THERAPEUT, V95, P165, DOI 10.1016/S0163-7258(02)00255-3; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Puffenbarger RA, 2000, GLIA, V29, P58, DOI 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.3.CO;2-N; Rhee MH, 1997, J MED CHEM, V40, P3228, DOI 10.1021/jm970126f; Rieder SA, 2010, IMMUNOBIOLOGY, V215, P598, DOI 10.1016/j.imbio.2009.04.001; Rimmerman N, 2013, ENDOCANNABINOIDS ACT, P143; Rimmerman N, 2012, BRIT J PHARMACOL, V165, P2436, DOI 10.1111/j.1476-5381.2011.01380.x; Rimmerman N, 2011, CELL MOL NEUROBIOL, V31, P921, DOI 10.1007/s10571-011-9692-3; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Scuderi C, 2009, PHYTOTHER RES, V23, P597, DOI 10.1002/ptr.2625; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Srivastava MD, 1998, IMMUNOPHARMACOLOGY, V40, P179, DOI 10.1016/S0162-3109(98)00041-1; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Takahashi Y, 2008, J LIPID RES, V49, P880, DOI 10.1194/jlr.M700545-JLR200; Talalay P, 2003, ADV ENZYME REGUL, V43, P121, DOI 10.1016/S0065-2571(02)00038-9; Tanaka T, 2009, CANCER RES, V69, P4945, DOI 10.1158/0008-5472.CAN-08-4407; Thomas DM, 2005, FASEB J, V19, P515, DOI 10.1096/fj.05-4873fje; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Wu HY, 2012, GLIA, V60, P1182, DOI 10.1002/glia.22345; Wu M, 2003, J BIOL CHEM, V278, P27072, DOI 10.1074/jbc.M209814200	76	65	68	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61462	10.1371/journal.pone.0061462	http://dx.doi.org/10.1371/journal.pone.0061462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637839	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400023
J	McTighe, SM; Neal, SJ; Lin, Q; Hughes, ZA; Smith, DG				McTighe, Stephanie M.; Neal, Sarah J.; Lin, Qian; Hughes, Zoe A.; Smith, Daniel G.			The BTBR Mouse Model of Autism Spectrum Disorders Has Learning and Attentional Impairments and Alterations in Acetylcholine and Kynurenic Acid in Prefrontal Cortex	PLOS ONE			English	Article							T PLUS TF/J; REACTION-TIME-TASK; COMPUTER-GRAPHIC STIMULI; DEFICIT/HYPERACTIVITY DISORDER; CEREBROSPINAL-FLUID; UNUSUAL REPERTOIRE; BASAL FOREBRAIN; T+TF/J MICE; RAT; LESIONS	Autism is a complex spectrum of disorders characterized by core behavioral deficits in social interaction, communication, repetitive stereotyped behaviors and restricted interests. Autism frequently presents with additional cognitive symptoms, including attentional deficits and intellectual disability. Preclinical models are important tools for studying the behavioral domains and biological underpinnings of autism, and potential treatment targets. The inbred BTBR T+tf/J (BTBR) mouse strain has been used as an animal model of core behavioral deficits in autism. BTBR mice exhibit repetitive behaviors and deficits in sociability and communication, but other aspects of their cognitive phenotype, including attentional performance, are not well characterized. We examined the attentional abilities of BTBR mice in the 5-choice serial reaction time task (5-CSRTT) using an automated touchscreen testing apparatus. The 5-CSRTT is an analogue of the human continuous performance task of attention, and so both the task and apparatus have translational relevance to human touchscreen cognitive testing. We also measured basal extracellular levels of a panel of neurotransmitters within the medial prefrontal cortex, a brain region critically important for performing the 5-CSRTT. We found that BTBR mice have increased impulsivity, defined as an inability to withhold responding, and decreased motivation, as compared to C57Bl/6J mice. Both of these features characterize attentional deficit disorders in humans. BTBR mice also display decreased accuracy in detecting short stimuli, lower basal levels of extracellular acetylcholine and higher levels of kynurenic acid within the prefrontal cortex. Intact cholinergic transmission in prefrontal cortex is required for accurate performance of the 5-CSRTT, consequently this cholinergic deficit may underlie less accurate performance in BTBR mice. Based on our findings that BTBR mice have attentional impairments and alterations in a key neural substrate of attention, we propose that they may be valuable for studying mechanisms for treatment of cognitive dysfunction in individuals with attention deficits and autism.	[McTighe, Stephanie M.; Neal, Sarah J.; Lin, Qian; Hughes, Zoe A.; Smith, Daniel G.] Pfizer Global Res & Dev, Neurosci Res Unit, Cambridge, MA USA	Pfizer	McTighe, SM (corresponding author), Pfizer Global Res & Dev, Neurosci Res Unit, Cambridge, MA USA.	Stephanie.McTighe@pfizer.com; Daniel.Smith@autismspeaks.org	Hughes, Zoe/P-5119-2019	Hughes, Zoe/0000-0001-7174-0944	Pfizer Inc.	Pfizer Inc.(Pfizer)	SMM, SJN, QL and ZAH are current employees of Pfizer Inc., whose company funded this study. DGS was an employee of Pfizer Inc. at the time of the study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Amodeo DA, 2012, BEHAV BRAIN RES, V227, P64, DOI 10.1016/j.bbr.2011.10.032; Baio J., 2012, MORBIDITY MORTALITY, V61; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Bartko SJ, 2011, NEUROPHARMACOLOGY, V61, P1366, DOI 10.1016/j.neuropharm.2011.08.023; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Beyer CE, 2009, BRIT J PHARMACOL, V157, P307, DOI 10.1111/j.1476-5381.2009.00146.x; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; BUSSEY TJ, 1994, NEUROSCI RES COMMUN, V15, P103; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P957, DOI 10.1037/0735-7044.115.4.957; Cardinal RN, 2010, BEHAV RES METHODS, V42, P1059, DOI 10.3758/BRM.42.4.1059; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Chudasama Y, 2004, LEARN MEMORY, V11, P78, DOI 10.1101/lm.70904; Clapcote SJ, 2006, GENETICS, V173, P2407, DOI 10.1534/genetics.106.060749; Cornish K, 2012, AJIDD-AM J INTELLECT, V117, P103, DOI 10.1352/1944-7558-117.2.103; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dulawa SC, 2000, NEUROPHARMACOLOGY, V39, P2170, DOI 10.1016/S0028-3908(00)00030-7; Erhardt S, 2007, PHYSIOL BEHAV, V92, P203, DOI 10.1016/j.physbeh.2007.05.025; Ey E, 2011, AUTISM RES, V4, P5, DOI 10.1002/aur.175; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; FREEDMAN R, 1987, SCHIZOPHRENIA BULL, V13, P669, DOI 10.1093/schbul/13.4.669; Gastrell PT, 2012, NEW TOUCH SCREEN TEC; Humby Trevor, 2005, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805hs31; Knapp M, 2012, AUTISM EC IMPACT IMP; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Matson JL, 2010, DEV NEUROREHABIL, V13, P408, DOI 10.3109/17518423.2010.510819; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Muir JL, 1996, CEREB CORTEX, V6, P470, DOI 10.1093/cercor/6.3.470; MUIR JL, 1994, J NEUROSCI, V14, P2313; Murray MJ, 2010, CURR PSYCHIAT REP, V12, P382, DOI 10.1007/s11920-010-0145-3; Niklasson L, 2009, RES DEV DISABIL, V30, P763, DOI 10.1016/j.ridd.2008.10.007; Nilsson LK, 2005, SCHIZOPHR RES, V80, P315, DOI 10.1016/j.schres.2005.07.013; Onaivi ES, 2011, CURR NEUROPHARMACOL, V9, P209, DOI 10.2174/157015911795017047; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; Pearson BL, 2011, GENES BRAIN BEHAV, V10, P228, DOI 10.1111/j.1601-183X.2010.00659.x; Pobbe RLH, 2010, BEHAV BRAIN RES, V214, P443, DOI 10.1016/j.bbr.2010.06.025; Reiersen Angela M, 2008, Expert Rev Neurother, V8, P657, DOI 10.1586/14737175.8.4.657; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; ROBBINS TW, 1989, BEHAV BRAIN RES, V35, P221, DOI 10.1016/S0166-4328(89)80143-3; Robbins TW, 1998, ANN NY ACAD SCI, V846, P222, DOI 10.1111/j.1749-6632.1998.tb09740.x; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Romberg C, 2011, J NEUROSCI, V31, P3500, DOI 10.1523/JNEUROSCI.5242-10.2011; Rutz HLH, 2012, BEHAV BRAIN RES, V234, P33, DOI 10.1016/j.bbr.2012.05.048; Sanchez-Roige S, 2012, PSYCHOPHARMACOLOGY, V219, P253, DOI 10.1007/s00213-011-2560-5; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Scharfman HE, 2000, AMINO ACIDS, V19, P283, DOI 10.1007/s007260070060; Schechter LE, 2008, NEUROPSYCHOPHARMACOL, V33, P1323, DOI 10.1038/sj.npp.1301503; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Silverman JL, 2010, NEUROSCIENCE, V171, P1197, DOI 10.1016/j.neuroscience.2010.09.059; Silverman JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003501; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Smith KRM, 2010, RES DEV DISABIL, V31, P743, DOI 10.1016/j.ridd.2010.01.016; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Tuchman R, 2009, BRAIN DEV-JPN, V31, P95, DOI 10.1016/j.braindev.2008.09.009; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Yang M, 2012, PHYSL BEHAV; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Yerys BE, 2009, AUTISM RES, V2, P322, DOI 10.1002/aur.103; Zhang YH, 2011, J CHROMATOGR B, V879, P2023, DOI 10.1016/j.jchromb.2011.05.030	72	74	81	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62189	10.1371/journal.pone.0062189	http://dx.doi.org/10.1371/journal.pone.0062189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638000	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400085
J	Fregnani, JHTG; Carvalho, AL; Eluf-Neto, J; Ribeiro, KDB; Kuil, LD; da Silva, TA; Rodrigues, SL; Mauad, EC; Longatto, A; Villa, LL				Tavares Guerreiro Fregnani, Jose Humberto; Carvalho, Andre Lopes; Eluf-Neto, Jose; Braga Ribeiro, Karina de Cassia; Kuil, Larissa de Melo; da Silva, Tauana Arcadepani; Rodrigues, Silvia Lapola; Mauad, Edmundo Carvalho; Longatto-Filho, Adhemar; Villa, Luisa Lina			A School-Based Human Papillomavirus Vaccination Program in Barretos, Brazil: Final Results of a Demonstrative Study	PLOS ONE			English	Article							HPV VACCINATION; QUADRIVALENT VACCINE; PARTICLE VACCINE; COVERAGE; EFFICACY; ADOLESCENT; AUSTRALIA	Introduction: The implementation of a public HPV vaccination program in several developing countries, especially in Latin America, is a great challenge for health care specialists. Aim: To evaluate the uptake and the three-dose completion rates of a school-based HPV vaccination program in Barretos (Brazil). Methods: The study included girls who were enrolled in public and private schools and who regularly attended the sixth and seventh grades of elementary school (mean age: 11.9 years). A meeting with the parents or guardians occurred approximately one week before the vaccination in order to explain the project and clarify the doubts. The quadrivalent vaccine was administered using the same schedule as in the product package (0-2-6 months). The school visits for regular vaccination occurred on previously scheduled dates. The vaccine was also made available at Barretos Cancer Hospital for the girls who could not be vaccinated on the day when the team visited the school. Results: Among the potential candidates for vaccination (n = 1,574), the parents or guardians of 1,513 girls (96.1%) responded to the invitation to participate in the study. A total of 1,389 parents or guardians agreed to participate in the program (acceptance rate = 91.8%). The main reason for refusing to participate in the vaccination program was fear of adverse events. The vaccine uptake rates for the first, second, and third doses were 87.5%, 86.3% and 85.0%, respectively. The three-dose completion rate was 97.2%. Conclusions: This demonstrative study achieved high rates of vaccination uptake and completion of three vaccine doses in children 10-16 years old from Brazil. The feasibility and success of an HPV vaccination program for adolescents in a developing country may depend on the integration between the public health and schooling systems.	[Tavares Guerreiro Fregnani, Jose Humberto; Carvalho, Andre Lopes; Kuil, Larissa de Melo; da Silva, Tauana Arcadepani; Rodrigues, Silvia Lapola; Mauad, Edmundo Carvalho; Longatto-Filho, Adhemar] Barretos Canc Hosp IEP HCB, Res & Teaching Inst, Barretos, Brazil; [Tavares Guerreiro Fregnani, Jose Humberto; Eluf-Neto, Jose; Braga Ribeiro, Karina de Cassia; Longatto-Filho, Adhemar; Villa, Luisa Lina] Santa Casa Sao Paulo Med Sch FCMSCSP, Natl Inst Sci & Technol Dis Associated Papillomav, Sao Paulo, Brazil; [Eluf-Neto, Jose] Univ Sao Paulo, Fac Med, Dept Prevent Med, BR-09500900 Sao Paulo, Brazil; [Braga Ribeiro, Karina de Cassia] Santa Casa Sao Paulo Med Sch FCMSCSP, Dept Social Med, Sao Paulo, Brazil; [Longatto-Filho, Adhemar] Univ Sao Paulo, Sch Med, Med Res Lab 14, BR-09500900 Sao Paulo, Brazil	Hospital de Cancer de Barretos; Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade de Sao Paulo; Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade de Sao Paulo	Fregnani, JHTG (corresponding author), Barretos Canc Hosp IEP HCB, Res & Teaching Inst, Barretos, Brazil.	mdfregnani@terra.com.br	Carvalho, Andre Lopes/S-7053-2016; Longatto-Filho, Adhemar/N-3397-2019; Eluf-Neto, Jose/B-2522-2009; USP, Oncologia/F-9053-2014; Papilomavirus, Inct/I-2406-2013; longatto-filho, adhemar/D-7039-2013; Fregnani, José H/H-4238-2012; VILLA, LUISA/AAH-4761-2019; Filho, Adhemar Longatto/A-2889-2016	Carvalho, Andre Lopes/0000-0001-7214-6402; Longatto-Filho, Adhemar/0000-0002-5779-9752; Eluf-Neto, Jose/0000-0001-7504-2115; longatto-filho, adhemar/0000-0002-5779-9752; Fregnani, José H/0000-0002-5235-6469; VILLA, LUISA/0000-0003-4074-2335; INCT de Optica Basica e Aplicada as Ciencias da Vida (CNPq), CePOF (FAPESP)/0000-0002-6403-4037; Ribeiro, Karina/0000-0002-8095-5979	CNPq [573799/2008-3]; FAPESP [2008/57889-1]; MISP (Merck Investigator Studies Program); Merck Co., Inc.	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MISP (Merck Investigator Studies Program); Merck Co., Inc.(Merck & Company)	MISP (Merck Investigator Studies Program) donated vaccines and U.S. $100,000. Luisa Lina Villa received financial support from CNPq 573799/2008-3 and FAPESP 2008/57889-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by Merck & Co., Inc. Merck & Co., Inc. provided the vaccine by Merck Investigator Studies Program (MISP) to the first author (Jose Humberto Fregnani, on behalf of Barretos Cancer Hospital). Luisa Lina Villa participated in several clinical trials that validated the safety and efficacy of the quadrivalent vaccine and is a member of the study advisory committee of Merck & Co., Inc. She never received any grant from the company to support her research activities. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P118; [Anonymous], 2010, NAT STAT LOC AR VACC, P1018; Arrossi S, 2012, VACCINE, V30, P2467, DOI 10.1016/j.vaccine.2012.01.032; Brazil, 2011, SI PNI SIST INF PROG; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Chadenier GMC, 2011, VACCINE, V29, P4405, DOI 10.1016/j.vaccine.2011.04.007; Dorell Christina, 2012, Morbidity and Mortality Weekly Report, V61, P671; Fagot JP, 2011, VACCINE, V29, P3610, DOI 10.1016/j.vaccine.2011.02.064; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Ferlay J, 2011, IARC CANCERBASE; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2011, PREV MED, V53, pS29, DOI 10.1016/j.ypmed.2011.08.015; Goldie SJ, 2007, VACCINE, V25, P6257, DOI 10.1016/j.vaccine.2007.05.058; Immunise Australia Program. Human Papillomavirus (HPV), 2011, HUM PAP HPV INF NAT; Instituto Brasileiro de Geografia e Estatistica, 2010, CENS 2010; Ladner J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-370; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Limia A, 2011, EURO SURVEILL, V16; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Rondy M, 2010, VACCINE, V28, P2070, DOI 10.1016/j.vaccine.2009.12.042; Rouzier R, 2010, J ADOLESCENT HEALTH, V47, P237, DOI 10.1016/j.jadohealth.2010.04.006; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Simoens C, 2009, EUROSURVEILLANCE, V14, P21; Singh Y, 2010, ASIAN PAC J CANCER P, V11, P615; Stokley S, 2011, PEDIATRICS, V128, P1078, DOI 10.1542/peds.2011-1048; Vanni T, 2012, VACCINE, V30, P4866, DOI 10.1016/j.vaccine.2012.04.087; Vicari Andrea S., 2011, Morbidity and Mortality Weekly Report, V60, P1382; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Villa LL, 2011, CANCER LETT, V305, P106, DOI 10.1016/j.canlet.2010.12.002; Watson M, 2009, AUST NZ J PUBL HEAL, V33, P365, DOI 10.1111/j.1753-6405.2009.00409.x; Watson-Jones D, 2012, J INFECT DIS, V206, P678, DOI 10.1093/infdis/jis407; WHO, 2012, IMM SUMM STAT REF CO, P198; WHO, 2011, IN VACC RES IVR VIR; Widgren K, 2011, VACCINE, V29, P9663, DOI 10.1016/j.vaccine.2011.10.021	40	32	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62647	10.1371/journal.pone.0062647	http://dx.doi.org/10.1371/journal.pone.0062647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638130	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400119
J	Du, LQ; Pang, H; Wang, ZL; Lu, J; Wei, YT; Huang, RB				Du, Liqin; Pang, Hao; Wang, Zilong; Lu, Jian; Wei, Yutuo; Huang, Ribo			Characterization of an Invertase with pH Tolerance and Truncation of Its N-Terminal to Shift Optimum Activity toward Neutral pH	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; BETA-FRUCTOFURANOSIDASE; YEAST INVERTASE; SUCROSE; PURIFICATION; ENZYME; BIOSENSORS; CATALYSIS; SITE	Most invertases identified to date have optimal activity at acidic pH, and are intolerant to neutral or alkaline environments. Here, an acid invertase named uninv2 is described. Uninv2 contained 586 amino acids, with a 100 amino acids N-terminal domain, a catalytic domain and a C-terminal domain. With sucrose as the substrate, uninv2 activity was optimal at pH 4.5 and at 45 degrees C. Removal of N-terminal domain of uninv2 has shifted the optimum pH to 6.0 while retaining its optimum temperaure at 45 degrees C. Both uninv2 and the truncated enzyme retained highly stable at neutral pH at 37 degrees C, and they were stable at their optimum pH at 4 degrees C for as long as 30 days. These characteristics make them far superior to invertase from Saccharomyces cerevisiae, which is mostly used as industrial enzyme.	[Du, Liqin; Wang, Zilong; Lu, Jian; Wei, Yutuo; Huang, Ribo] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi, Peoples R China; [Pang, Hao; Huang, Ribo] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China	Guangxi University	Huang, RB (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi, Peoples R China.	rbhuang@gxas.ac.cn	Wang, Zhiquan/HHS-6768-2022		National Natural Science Foundation of China [31060125]; Chinese National Programs for Fundamental Research and Development [2010CB736209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Programs for Fundamental Research and Development	This work was supported by the National Natural Science Foundation of China (31060125) and the Chinese National Programs for Fundamental Research and Development (2010CB736209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgol S, 2001, FOOD CHEM, V74, P281, DOI 10.1016/S0308-8146(01)00150-9; Alvaro-Benito M, 2007, J BIOTECHNOL, V132, P75, DOI 10.1016/j.jbiotec.2007.07.939; Amine A, 2006, BIOSENS BIOELECTRON, V21, P1405, DOI 10.1016/j.bios.2005.07.012; Arica MY, 2006, J MOL CATAL B-ENZYM, V38, P131, DOI 10.1016/j.molcatb.2005.12.006; Bagal-Kestwal D, 2008, BIOSENS BIOELECTRON, V24, P657, DOI 10.1016/j.bios.2008.06.027; Bucke C, 1990, ENZYME TECHNOLOGY, pxvi; Du LQ, 2010, WORLD J MICROB BIOT, V26, P419, DOI 10.1007/s11274-009-0184-2; ETTALIBI M, 1987, APPL MICROBIOL BIOT, V26, P13, DOI 10.1007/BF00282143; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Gallagher JA, 1998, J EXP BOT, V49, P789, DOI 10.1093/jexbot/49.322.789; Goetz M, 1999, PLANT J, V20, P707, DOI 10.1046/j.1365-313X.1999.00628.x; Goosen C, 2007, EUKARYOT CELL, V6, P674, DOI 10.1128/EC.00361-06; Joshi MD, 2000, J MOL BIOL, V299, P255, DOI 10.1006/jmbi.2000.3722; KARUPPIAH N, 1989, PLANT PHYSIOL, V91, P993, DOI 10.1104/pp.91.3.993; Kim D, 2011, J AGR FOOD CHEM, V59, P11228, DOI 10.1021/jf201057c; Kim SH, 2008, J MOL CATAL B-ENZYM, V55, P130, DOI 10.1016/j.molcatb.2008.02.006; Kotwal SM, 2009, BIOTECHNOL ADV, V27, P311, DOI 10.1016/j.biotechadv.2009.01.009; Liebl W, 1998, APPL MICROBIOL BIOT, V50, P55, DOI 10.1007/s002530051256; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Omori T, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-9; Reddy A, 1996, J BIOL CHEM, V271, P13953, DOI 10.1074/jbc.271.24.13953; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Ross HA, 1996, PLANT PHYSIOL, V111, P329, DOI 10.1104/pp.111.1.329; Rubio MC, 2002, PHYTOCHEMISTRY, V61, P605, DOI 10.1016/S0031-9422(02)00336-9; Sanjay G, 2006, FOOD CHEM, V94, P573, DOI 10.1016/j.foodchem.2004.12.043; SCHULKE N, 1988, J BIOL CHEM, V263, P8827; SILVIUS JE, 1979, PLANT PHYSIOL, V64, P1070, DOI 10.1104/pp.64.6.1070; Sturm A, 1999, PHYSIOL PLANTARUM, V107, P159, DOI 10.1034/j.1399-3054.1999.100202.x; TAKESHIGE K, 1995, J FERMENT BIOENG, V79, P513, DOI 10.1016/0922-338X(95)91274-9; Vujcic Z, 2011, FOOD CHEM, V126, P236, DOI 10.1016/j.foodchem.2010.11.010; Warchol M, 2002, LETT APPL MICROBIOL, V35, P462, DOI 10.1046/j.1472-765X.2002.01224.x; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; Xiang Y, 2011, NAT CHEM, V3, P697, DOI [10.1038/NCHEM.1092, 10.1038/nchem.1092]	33	15	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62306	10.1371/journal.pone.0062306	http://dx.doi.org/10.1371/journal.pone.0062306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23638032	Green Submitted, gold, Green Published			2022-12-25	WOS:000317909500101
J	Amantana, A; Chen, YL; Tyavanagimatt, SR; Jones, KF; Jordan, R; Chinsangaram, J; Bolken, TC; Leeds, JM; Hruby, DE				Amantana, Adams; Chen, Yali; Tyavanagimatt, Shanthakumar R.; Jones, Kevin F.; Jordan, Robert; Chinsangaram, Jarasvech; Bolken, Tove C.; Leeds, Janet M.; Hruby, Dennis E.			Pharmacokinetics and Interspecies Allometric Scaling of ST-246, an Oral Antiviral Therapeutic for Treatment of Orthopoxvirus Infection	PLOS ONE			English	Article							ANTIPOXVIRUS COMPOUND ST-246; DRUG DEVELOPMENT; PARAMETERS; CLEARANCE; PREDICTION; EFFICACY; HUMANS; SELECTION; ANIMALS; VIRUS	Plasma pharmacokinetics of ST-246, smallpox therapeutic, was evaluated in mice, rabbits, monkeys and dogs following repeat oral administrations by gavage. The dog showed the lowest T-max of 0.83 h and the monkey, the highest value of 3.25 h. A 2- to 4-fold greater dose-normalized C-max was observed for the dog compared to the other species. The mouse showed the highest dose-normalized AUC, which was 2-fold greater than that for the rabbit and monkey both of which by approximation, recorded the lowest value. The Cl/F increased across species from 0.05 L/h for mouse to 42.52 L/h for dog. The mouse showed the lowest V-D/F of 0.41 L and the monkey, the highest V-D/F of 392.95 L. The calculated extraction ratios were 0.104, 0.363, 0.231 and 0.591 for mouse, rabbit, monkey and dog, respectively. The dog showed the lowest terminal half-life of 3.10 h and the monkey, the highest value of 9.94 h. The simple allometric human V-D/F and MLP-corrected Cl/F were 2311.51 L and 51.35 L/h, respectively, with calculated human extraction ratio of 0.153 and terminal half-life of 31.20 h. Overall, a species-specific difference was observed for Cl/F with this parameter increasing across species from mouse to dog. The human MLP-corrected Cl/F, terminal half-life, extraction ratios were in close proximity to the observed estimates. In addition, the first-in-humans (FIH) dose of 485 mg, determined from the MLP-corrected allometry Cl/F, was well within the dose range of 400 mg and 600 mg administered in healthy adult human volunteers.	[Amantana, Adams; Chen, Yali; Tyavanagimatt, Shanthakumar R.; Jones, Kevin F.; Chinsangaram, Jarasvech; Bolken, Tove C.; Leeds, Janet M.; Hruby, Dennis E.] SIGA Technol Inc, Corvallis, OR USA; [Jordan, Robert] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Amantana, A (corresponding author), SIGA Technol Inc, Corvallis, OR USA.	aamantana@siga.com			NDA-Enabling Development for ST-246: A Smallpox Antiviral Drug [HHSN266200600014C]; ADB [N01-AI-60014]	NDA-Enabling Development for ST-246: A Smallpox Antiviral Drug; ADB	This work was supported by Contract Title: NDA-Enabling Development for ST-246: A Smallpox Antiviral Drug; Contract Number: HHSN266200600014C; ADB Contract Number: N01-AI-60014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN K, 1989, J APPL TOXICOL, V9, P331, DOI 10.1002/jat.2550090509; BISCHOFF KB, 1975, CANCER CHEMOTH REP 1, V59, P777; BOXENBAUM H, 1995, J CLIN PHARMACOL, V35, P957, DOI 10.1002/j.1552-4604.1995.tb04011.x; BOXENBAUM H, 1980, J PHARMACOKINET BIOP, V8, P165, DOI 10.1007/BF01065191; BOXENBAUM H, 1982, J PHARMACOKINET BIOP, V10, P201, DOI 10.1007/BF01062336; Chen YL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-44; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; DIMASI JA, 1994, REGUL TOXICOL PHARM, V19, P228, DOI 10.1006/rtph.1994.1021; Duraffour S, 2007, ANTIVIR THER, V12, P1205; FDA, 2005, EST MAX SAF START DO; Hu TM, 2001, AAPS PHARMSCI, V3; Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09; INGS RMJ, 1990, XENOBIOTICA, V20, P1201, DOI 10.3109/00498259009046839; Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08; KING FG, 1986, J PHARMACOKINET BIOP, V14, P131, DOI 10.1007/BF01065258; Kuhlmann J, 1997, INT J CLIN PHARM TH, V35, P541; Lave T, 1999, CLIN PHARMACOKINET, V36, P211; LIN JH, 1982, J PHARMACOKINET BIOP, V10, P649, DOI 10.1007/BF01062546; Mahmood, 2005, INTERSPECIES PHARMAC, P39; Mahmood I, 1996, XENOBIOTICA, V26, P887, DOI 10.3109/00498259609052491; Mahmood I, 1996, J PHARM SCI, V85, P411, DOI 10.1021/js950400y; Mahmood I, 1996, LIFE SCI, V59, P579, DOI 10.1016/0024-3205(96)00339-6; Mahmood I, 1999, CLIN PHARMACOKINET, V36, P1, DOI 10.2165/00003088-199936010-00001; Mahmood I, 2003, J CLIN PHARMACOL, V43, P692, DOI 10.1177/0091270003254631; Nalca A, 2008, ANTIVIR RES, V79, P121, DOI 10.1016/j.antiviral.2008.03.005; Obach RS, 1997, J PHARMACOL EXP THER, V283, P46; Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P689, DOI 10.1128/AAC.00879-06; RITSCHEL WA, 1992, COMP BIOCHEM PHYS C, V103, P249, DOI 10.1016/0742-8413(92)90003-P; Sacher G.A., 2008, CIBA FDN S LIFESPAN, V5, P115, DOI DOI 10.1002/9780470715253.CH9; Sbrana E, 2007, AM J TROP MED HYG, V76, P768, DOI 10.4269/ajtmh.2007.76.768; SUGITA O, 1982, J PHARMACOKINET BIOP, V10, P297, DOI 10.1007/BF01059263; US Department of Health and Human Services, 2001, GUID IND BIOAN METH; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005	33	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61514	10.1371/journal.pone.0061514	http://dx.doi.org/10.1371/journal.pone.0061514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637845	Green Submitted, gold, Green Published			2022-12-25	WOS:000317908700040
J	Hua, N; Piersma, T; Ma, ZJ				Hua, Ning; Piersma, Theunis; Ma, Zhijun			Three-Phase Fuel Deposition in a Long-Distance Migrant, the Red Knot (Calidris canutus piersmai), before the Flight to High Arctic Breeding Grounds	PLOS ONE			English	Article							BASAL METABOLIC-RATE; MIGRATORY STOPOVER; BODY-COMPOSITION; PREY QUALITY; ANNUAL CYCLE; ORGAN SIZE; MASS GAIN; BEHAVIOR; STORES; SITE	Refuelling by migratory birds before take-off on long flights is generally considered a two-phase process, with protein accumulation preceding rapid fat deposition. The first phase expresses the demands for a large digestive system for nutrient storage after shrinkage during previous flights, the second phase the demands for fat stores to fuel the subsequent flight. At the last staging site in northward migration, this process may include expression of selection pressures both en route to and after arrival at the breeding grounds, which remains unascertained. Here we investigated changes in body composition during refuelling of High Arctic breeding red knots (Calidris canutus piersmai) in the northern Yellow Sea, before their flight to the tundra. These red knots followed a three-phase fuel deposition pattern, with protein being stored in the first and last phases, and fat being deposited mainly in the second phase. Thus, they did not shrink nutritional organs before take-off, and even showed hypertrophy of the nutritional organs. These suggest the build up of strategic protein stores before departure to cope with a protein shortage upon arrival on the breeding grounds. Further comparative studies are warranted to examine the degree to which the deposition of stores by migrant birds generally reflects a balance between concurrent and upcoming environmental selection pressures.	[Hua, Ning; Ma, Zhijun] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200433, Peoples R China; [Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Piersma, Theunis] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands	Fudan University; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Ma, ZJ (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200433, Peoples R China.	zhijunm@fudan.edu.cn	Ma, Zhijun/B-4650-2011; Piersma, Theunis/D-1871-2012	Piersma, Theunis/0000-0001-9668-466X	National Basic Research Program of China [2013CB430404]; National Natural Science Foundation of China [31071939]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (2013CB430404) and the National Natural Science Foundation of China (31071939). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PW, 2007, J APPL ECOL, V44, P885, DOI 10.1111/j.1365-2664.2007.01308.x; Battley PF, 2005, J AVIAN BIOL, V36, P494, DOI 10.1111/j.0908-8857.2005.03730.x; Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; Battley PF, 2001, CONDOR, V103, P838, DOI 10.1650/0010-5422(2001)103[0838:BMRDDL]2.0.CO;2; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CARPENTER FL, 1993, ECOLOGY, V74, P1173, DOI 10.2307/1940487; Choi CY, 2009, ARDEA, V97, P61, DOI 10.5253/078.097.0108; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; GUDMUNDSSON GA, 1991, IBIS, V133, P140, DOI 10.1111/j.1474-919X.1991.tb04825.x; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hassell Chris, 2011, BirdingASIA, V16, P89; Jehl JR, 1997, J AVIAN BIOL, V28, P132, DOI 10.2307/3677306; Klaassen M, 2003, AVIAN MIGRATION, P237; Klaassen M, 2006, ARDEA, V94, P371; Landys-Ciannelli MM, 2003, FUNCT ECOL, V17, P151, DOI 10.1046/j.1365-2435.2003.00715.x; Lindstrom A, 1999, FUNCT ECOL, V13, P352, DOI 10.1046/j.1365-2435.1999.00320.x; LINDSTROM A, 1993, IBIS, V135, P70, DOI 10.1111/j.1474-919X.1993.tb02811.x; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Morrison RIG, 2005, CONDOR, V107, P449, DOI 10.1650/7614; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pennycuick CJ., 1999, MEASURING BIRDS WING, V2; Piersma T, 1997, TRENDS ECOL EVOL, V12, P134, DOI 10.1016/S0169-5347(97)01003-3; Piersma T, 2002, P ROY SOC B-BIOL SCI, V269, P1101, DOI 10.1098/rspb.2002.1990; Piersma T, 1999, PHYSIOL BIOCHEM ZOOL, V72, P405, DOI 10.1086/316680; Piersma T, 1998, J AVIAN BIOL, V29, P511, DOI 10.2307/3677170; PIERSMA T, 1987, Limosa, V60, P185; Piersma T., 2011, FLEXIBLE PHENOTYPE B; Piersma Theunis, 2005, P262; Piersma Theunis, 1999, Acta Ornithologica (Warsaw), V34, P175; Rogers DI, 2010, EMU, V110, P307, DOI 10.1071/MU10024; Schmutz JA, 2006, ARDEA, V94, P385; Sherrod P. H., 2010, NONLINEAR REGRESSION; Skagen SK, 2006, AUK, V123, P313, DOI 10.1642/0004-8038(2006)123[313:MSATCO]2.0.CO;2; Tomkovich Pavel S., 2001, Bulletin of the British Ornithologists' Club, V121, P257; Tulp I, 2009, POLAR BIOL, V32, P481, DOI 10.1007/s00300-008-0543-8; van Gils JA, 2005, P ROY SOC B-BIOL SCI, V272, P2609, DOI 10.1098/rspb.2005.3245; VANDERMEER J, 1994, PHYSIOL ZOOL, V67, P305, DOI 10.1086/physzool.67.2.30163851; Vezina F, 2012, FUNCT ECOL, V26, P500, DOI 10.1111/j.1365-2435.2011.01955.x; Wang N, 2009, MOL ECOL RESOUR, V9, P186, DOI 10.1111/j.1755-0998.2008.02177.x	41	33	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62551	10.1371/journal.pone.0062551	http://dx.doi.org/10.1371/journal.pone.0062551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638114	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300075
J	Kalfa, N; Philibert, P; Werner, R; Audran, F; Bashamboo, A; Lehors, H; Haddad, M; Guys, JM; Reynaud, R; Alessandrini, P; Wagner, K; Kurzenne, JY; Bastiani, F; Breaud, J; Valla, JS; Lacombe, GM; Orsini, M; Daures, JP; Hiort, O; Paris, F; McElreavey, K; Sultan, C				Kalfa, Nicolas; Philibert, Pascal; Werner, Ralf; Audran, Francoise; Bashamboo, Anu; Lehors, Helene; Haddad, Myriam; Guys, Jean Michel; Reynaud, Rachel; Alessandrini, Pierre; Wagner, Kathy; Kurzenne, Jean Yves; Bastiani, Florence; Breaud, Jean; Valla, Jean Stephane; Lacombe, Gerard Morisson; Orsini, Mattea; Daures, Jean-Pierre; Hiort, Olaf; Paris, Francoise; McElreavey, Kenneth; Sultan, Charles			Minor Hypospadias: The "Tip of the Iceberg'' of the Partial Androgen Insensitivity Syndrome	PLOS ONE			English	Article							RECEPTOR GENE-MUTATIONS; STRUCTURE PREDICTION; CANDIDATE GENES; RISK; POLYMORPHISMS; FERTILE; DOMAIN; BOYS; SEX; MEN	Background: Androgens are critical in male external genital development. Alterations in the androgen sensitivity pathway have been identified in severely undermasculinized boys, and mutations of the androgen receptor gene (AR) are usually found in partial or complete androgen insensitivity syndrome (AIS). Objective: The aim of this study was to determine whether even the most minor forms of isolated hypospadias are associated with AR mutations and thus whether all types of hypospadias warrant molecular analysis of the AR. Materials and Methods: Two hundred and ninety-two Caucasian children presenting with isolated hypospadias without micropenis or cryptorchidism and 345 controls were included prospectively. Mutational analysis of the AR through direct sequencing (exons 1-8) was performed. In silico and luciferase functional assays were performed for unreported variants. Results: Five missense mutations of the AR were identified in 9 patients with glandular or penile anterior (n = 5), penile midshaft (n = 2) and penile posterior (n = 2) hypospadias, i.e., 3%: p.Q58L (c.173A > T), 4 cases of p.P392S (c.1174C > T), 2 cases of p.A475V (c.1424C > T), p.D551H (c.1651G > C) and p.Q799E (c.2395C > G). None of these mutations was present in the control group. One mutation has never been reported to date (p.D551H). It was predicted to be damaging based on 6 in silico models, and in vitro functional studies confirmed the lowered transactivation function of the mutated protein. Three mutations have never been reported in patients with genital malformation but only in isolated infertility: p.Q58L, p.P392S, and p.A475V. It is notable that micropenis, a cardinal sign of AIS, was not present in any patient. Conclusion: AR mutations may play a role in the cause of isolated hypospadias, even in the most minor forms. Identification of this underlying genetic alteration may be important for proper diagnosis and longer follow-up is necessary to find out if the mutations cause differences in sexual function and fertility later in life.	[Kalfa, Nicolas; Paris, Francoise] CHU Montpellier, Hop Lapeyronie, Serv Chirurg Viscerale & Urol Pediat, Montpellier, France; [Kalfa, Nicolas; Philibert, Pascal; Audran, Francoise; Paris, Francoise; Sultan, Charles] Univ Montpellier I, Montpellier, France; [Kalfa, Nicolas; Philibert, Pascal; Audran, Francoise; Paris, Francoise; Sultan, Charles] CHU Montpellier, Hop Lapeyronie, Serv Hormonol, Montpellier, France; [Werner, Ralf; Hiort, Olaf] Univ Lubeck, Div Pediat Endocrinol & Diabet, Dept Pediat, Lubeck, Germany; [Bashamboo, Anu; McElreavey, Kenneth] Inst Pasteur, Human Dev Genet Unit, Paris, France; [Lehors, Helene; Haddad, Myriam; Guys, Jean Michel] Hop Enfants La Timone, APHM, Serv Chirurg Pediat, Marseille, France; [Reynaud, Rachel] Hop Enfants La Timone, APHM, Unite Endocrinol & Diabetol Pediat, Marseille, France; [Alessandrini, Pierre] Hop Nord Marseille, APHM, Serv Chirurg Pediat, Marseille, France; [Wagner, Kathy] CHU Nice, Hop Lenval, Serv Pediat, Nice, France; [Kurzenne, Jean Yves; Bastiani, Florence; Breaud, Jean; Valla, Jean Stephane] CHU Nice, Hop Lenval, Serv Chirurg Pediat, Nice, France; [Lacombe, Gerard Morisson] Hop St Jospeh, Serv Chirurg Pediat, Marseille, France; [Orsini, Mattea; Daures, Jean-Pierre] Univ Montpellier I, Inst Univ Rech Clin, Lab Biostat & Epidemiol, Montpellier, France; [Sultan, Charles] CHU Montpellier, Hop Arnaud de Villeneuve, Serv Pediat, Unite Endocrinol & Gynecol Pediat, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Lubeck; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Nice; CHU Nice; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Sultan, C (corresponding author), CHU Montpellier, Hop Lapeyronie, Serv Hormonol, Montpellier, France.	c-sultan@chu-montpellier.fr	Paris, Francoise/AAC-6553-2019; Kalfa, Nicolas/AAZ-8096-2021; reynaud, rachel/AAC-2167-2019; Philibert, Pascal/C-6728-2008; Kalfa, Nicolas/AAC-9287-2020	Philibert, Pascal/0000-0001-6384-521X; Kalfa, Nicolas/0000-0001-5472-4096; Werner, Ralf/0000-0003-3718-3595	Programme Hospitalier de Recherche Clinique Inter-Regional (PHRC) [UF 8270]; Fondation pour la Recherche Medicale [FRM110309]	Programme Hospitalier de Recherche Clinique Inter-Regional (PHRC); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This study was funded by a Programme Hospitalier de Recherche Clinique Inter-Regional (PHRC number UF 8270) provided by the CHU de Montpellier and by a grant from the Fondation pour la Recherche Medicale FRM110309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho MO, 2000, EUR UROL, V37, P95, DOI 10.1159/000020107; Asklund C, 2010, INT J ANDROL, V33, P80, DOI 10.1111/j.1365-2605.2009.00957.x; Audi L, 2010, J CLIN ENDOCR METAB, V95, P1876, DOI 10.1210/jc.2009-2146; Bevan CL, 1996, HUM MOL GENET, V5, P265, DOI 10.1093/hmg/5.2.265; Bhangoo A, 2010, ASIAN J ANDROL, V12, P561, DOI 10.1038/aja.2010.6; BRACKA A, 1989, BRIT J PLAST SURG, V42, P251, DOI 10.1016/0007-1226(89)90140-9; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dean A, 2012, INT J ANDROL, V35, P330, DOI 10.1111/j.1365-2605.2011.01236.x; Deeb A, 2005, CLIN ENDOCRINOL, V63, P56, DOI 10.1111/j.1365-2265.2005.02298.x; Ferlin A, 2006, CLIN ENDOCRINOL, V65, P606, DOI 10.1111/j.1365-2265.2006.02635.x; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Hiort O, 2000, J CLIN ENDOCR METAB, V85, P2810, DOI 10.1210/jc.85.8.2810; Jugenburg I, 1988, Acta Chir Plast, V30, P86; Kalfa N, 2011, J PEDIATR UROL, V7, P585, DOI 10.1016/j.jpurol.2011.09.005; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leung AKC, 2007, ASIAN J ANDROL, V9, P16, DOI 10.1111/j.1745-7262.2007.00243.x; Lund A, 2003, FERTIL STERIL, V79, P1647, DOI 10.1016/S0015-0282(03)00256-5; Maimoun L, 2011, J CLIN ENDOCR METAB, V96, P296, DOI 10.1210/jc.2010-1024; Manson JM, 2003, BIRTH DEFECTS RES A, V67, P825, DOI 10.1002/bdra.10084; MIEUSSET R, 1995, HUM REPROD, V10, P613, DOI 10.1093/oxfordjournals.humrep.a135998; Mouriquand P. D., 2007, DIALOGUE PEDIAT UROL, V28, P1; Muroya K, 2001, MOL HUM REPROD, V7, P409, DOI 10.1093/molehr/7.5.409; Nordenskjold A, 1999, UROL RES, V27, P49, DOI 10.1007/s002400050088; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Philibert P, 2010, FERTIL STERIL, V94, P472, DOI 10.1016/j.fertnstert.2009.03.057; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rey RA, 2005, J CLIN ENDOCR METAB, V90, P6035, DOI 10.1210/jc.2005-1306; Silver RI, 1999, J UROLOGY, V162, P1142, DOI 10.1016/S0022-5347(01)68102-3; Slama R, 2002, HUM REPROD, V17, P503, DOI 10.1093/humrep/17.2.503; Sultan C, 2001, HUM REPROD UPDATE, V7, P314, DOI 10.1093/humupd/7.3.314; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thonneau PE, 2003, J ANDROL, V24, P155; Vottero A, 2011, J CLIN ENDOCR METAB, V96, pE1953, DOI 10.1210/jc.2011-0511; Wang YP, 2004, EUR J HUM GENET, V12, P706, DOI 10.1038/sj.ejhg.5201232; Zuccarello D, 2008, CLIN ENDOCRINOL, V68, P580, DOI 10.1111/j.1365-2265.2007.03069.x	40	32	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61824	10.1371/journal.pone.0061824	http://dx.doi.org/10.1371/journal.pone.0061824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23637914	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300017
J	Dolt, KS; Lawrence, ML; Miller-Hodges, E; Slight, J; Thornburn, A; Devenney, PS; Hohenstein, P				Dolt, Karamjit Singh; Lawrence, Melanie L.; Miller-Hodges, Eve; Slight, Joan; Thornburn, Anna; Devenney, Paul S.; Hohenstein, Peter			A Universal Vector for High-Efficiency Multi-Fragment Recombineering of BACs and Knock-In Constructs	PLOS ONE			English	Article							KIDNEY DEVELOPMENT; DNA CLONING; STEM-CELLS; SIX2; NUCLEASES; RENEWAL; GATEWAY; PROTEIN; NANOG; MICE	There is an increasing need for more efficient generation of transgenic constructs. Here we present a universal multi-site Gateway vector for use in recombineering reactions. Using transgenic mouse models, we show its use for the generation of BAC transgenics and targeting vectors. The modular nature of the vector allows for rapid modification of constructs to generate different versions of the same construct. As such it will help streamline the generation of series of related transgenic models.	[Dolt, Karamjit Singh; Lawrence, Melanie L.; Miller-Hodges, Eve; Slight, Joan; Thornburn, Anna; Devenney, Paul S.; Hohenstein, Peter] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Dolt, Karamjit Singh; Hohenstein, Peter] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Hohenstein, P (corresponding author), Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	peter.hohenstein@roslin.ed.ac.uk	Hohenstein, Peter/Y-2428-2018	Hohenstein, Peter/0000-0001-8548-4734; Dolt, Karamjit Singh/0000-0002-0584-7505	Kidney Research UK [RP23/2009]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221658] Funding Source: researchfish; BBSRC [BBS/E/D/20221658] Funding Source: UKRI	Kidney Research UK(Kidney Research UK (KRUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	KSD was supported by Kidney Research UK (RP23/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hohenstein Peter, 2008, Pathogenetics, V1, P3, DOI 10.1186/1755-8417-1-3; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Nern A, 2011, P NATL ACAD SCI USA, V108, P14198, DOI 10.1073/pnas.1111704108; Park JS, 2012, DEV CELL, V23, P637, DOI 10.1016/j.devcel.2012.07.008; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62054	10.1371/journal.pone.0062054	http://dx.doi.org/10.1371/journal.pone.0062054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637962	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800022
J	Ehsani, A; Alluin, JV; Rossi, JJ				Ehsani, Ali; Alluin, Jessica V.; Rossi, John J.			Cell Cycle Abnormalities Associated with Differential Perturbations of the Human U5 snRNP Associated U5-200kD RNA Helicase	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; U4/U6-CENTER-DOT-U5 TRI-SNRNP; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; SPLICING FACTOR; MUTATIONS; GENES; PROTEIN; IDENTIFICATION; PROGRESSION	Splicing of pre-messenger RNAs into functional messages requires a concerted assembly of proteins and small RNAs that identify the splice junctions and facilitate cleavage of exon-intron boundaries and ligation of exons. One of the key steps in the splicing reaction is the recruitment of a tri-snRNP harboring the U5/U4/U6 snRNPs. The U5 snRNP is also required for both steps of splicing and exon-exon joining. One of the key components of the tri-snRNP is the U5 200kd helicase. The human U5-200kD gene isolated from Hela cells encodes a 200 kDa protein with putative RNA helicase function. Surprisingly, little is known about the functional role of this protein in humans. Therefore, we have investigated the role of the U5-200kD RNA helicase in mammalian cell culture. We created and expressed a dominant negative domain I mutant of the RNA helicase in HEK293 cells and used RNAi to downregulate expression of the endogenous protein. Transient and stable expression of the domain I mutant U5-200kD protein using an ecdysone-inducible system and transient expression of an anti-U5-200kD short hairpin RNA (shRNA) resulted in differential splicing and growth defects in the 293/EcR cells. Cell cycle analysis of the dominant negative clones revealed delayed exit from the G2/M phase of the cell cycle due to a mild splicing defect. In contrast to the domain I dominant negative mutant expressing cells, transient expression of an anti-U5-200kD shRNA resulted in a pronounced S phase arrest and a minute splicing defect. Collectively, this work demonstrates for the first time establishment of differential human cell culture splicing and cell cycle defect models due to perturbed levels of an essential core splicing factor.	[Rossi, John J.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Rossi, JJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA.	jrossi@coh.org			National Institutes of Health (NIH) [AI 29329]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029329, R01AI029329, R01AI042552] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health (NIH) grant AI 29329 to John Rossi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaglio P, 2011, HUM MUTAT, V32, pE2246, DOI 10.1002/humu.21485; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Biggins S, 2001, GENETICS, V159, P453; Burns CG, 2002, MOL CELL BIOL, V22, P801, DOI 10.1128/MCB.22.3.801-815.2002; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Chawla G, 2003, NUCLEIC ACIDS RES, V31, P2333, DOI 10.1093/nar/gkg333; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Dahan O, 2004, NUCLEIC ACIDS RES, V32, P2529, DOI 10.1093/nar/gkh574; Dahan O, 2002, NUCLEIC ACIDS RES, V30, P4361, DOI 10.1093/nar/gkf563; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Lauber J, 1996, EMBO J, V15, P4001, DOI 10.1002/j.1460-2075.1996.tb00774.x; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Li MJ, 2005, METHOD ENZYMOL, V392, P218, DOI 10.1016/S0076-6879(04)92013-7; Li MJ, 2003, MOL THER, V8, P196, DOI 10.1016/S1525-0016(03)00165-5; Lin J, 1996, RNA, V2, P835; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Noble SM, 1996, GENETICS, V143, P67; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Xu DM, 1996, NATURE, V381, P709, DOI 10.1038/381709a0; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020	28	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62125	10.1371/journal.pone.0062125	http://dx.doi.org/10.1371/journal.pone.0062125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637979	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800027
J	Weide, B; Faller, C; Buttner, P; Pflugfelder, A; Leiter, U; Eigentler, TK; Bauer, J; Forschner, A; Meier, F; Garbe, C				Weide, Benjamin; Faller, Christine; Buettner, Petra; Pflugfelder, Annette; Leiter, Ulrike; Eigentler, Thomas Kurt; Bauer, Juergen; Forschner, Andrea; Meier, Friedegund; Garbe, Claus			Prognostic Factors of Melanoma Patients with Satellite or In-Transit Metastasis at the Time of Stage III Diagnosis	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; DISTANT RECURRENCE; SURVIVAL; TRIAL; INTERFERON-ALPHA-2B	Background: Prognosis of patients with loco-regional skin metastases has not been analyzed in detail and the presence or absence of concurrent lymph node metastasis represents the only established prognostic factor thus far. Most studies were limited to patients already presenting with skin lesions at the time of initial diagnosis. We aimed to analyze the impact of a broad penal of prognostic factors in patients with skin metastases at the time of first metastatic spread, including patients with synchronous lesions already present at the time of initial diagnosis, stage I/II patients with loco-regional recurrence and patients initially presenting with skin metastasis but unknown primary melanoma. Patients and Methods: We investigated disease-specific survival of 380 patients treated at our department between 1996 and 2010 using Kaplan Meier survival probabilities and Cox-proportional hazard analysis. Results: Five-year survival probability was 60.1% for patients with skin metastases only and 36.3% for those with synchronous nodal metastases. The number of involved nodes and a tumor thickness of at least 3 mm had independent negative impact on prognosis. A strong relationship was identified between the risk of death and the number of involved nodes. Neither ulceration nor the timing of the first occurrence of metastases as either in stage I/II patients, at the time of excision of the primary melanoma or initially in patients with unknown primary tumor, had additional effects on survival. Conclusion: Lymph node involvement was confirmed as the most important prognostic factor for melanoma patients with loco-regional skin metastasis including those with unknown primary tumor and stage I/II patients with skin recurrence. Consideration of the tumor thickness and of the number of involved lymph nodes instead of the exclusive differentiation into presence vs. absence of nodal disease may allow a more accurate prediction of prognosis for patients with satellite or in-transit metastases.	[Weide, Benjamin; Faller, Christine; Pflugfelder, Annette; Leiter, Ulrike; Eigentler, Thomas Kurt; Bauer, Juergen; Forschner, Andrea; Meier, Friedegund; Garbe, Claus] Univ Med Ctr, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany; [Buettner, Petra; Garbe, Claus] James Cook Univ, Skin Canc Res Grp, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; James Cook University	Weide, B (corresponding author), Univ Med Ctr, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany.	benjamin.weide@med.uni-tuebingen.de	Garbe, Claus/ABH-2128-2021; Weide, Benjamin/N-3698-2013; Eigentler, Thomas/K-8570-2015; Pflugfelder, Annette/Q-2659-2016; Bauer, Jurgen/B-4656-2008	Garbe, Claus/0000-0001-8530-780X; Eigentler, Thomas/0000-0003-0019-2770; Bauer, Jurgen/0000-0001-8789-1536; Leiter, Ulrike/0000-0002-8019-1577				Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Essner R, 2004, ARCH SURG-CHICAGO, V139, P961, DOI 10.1001/archsurg.139.9.961; Francken AB, 2008, ANN SURG ONCOL, V15, P1476, DOI 10.1245/s10434-007-9717-9; Garbe C, 2008, ANN ONCOL, V19, P1195, DOI 10.1093/annonc/mdn001; KARAKOUSIS CP, 1983, CANCER-AM CANCER SOC, V52, P575, DOI 10.1002/1097-0142(19830801)52:3<575::AID-CNCR2820520333>3.0.CO;2-6; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Kretschmer L, 2000, MELANOMA RES, V10, P483, DOI 10.1097/00008390-200010000-00011; Lasithiotakis KG, 2007, CANCER-AM CANCER SOC, V109, P1174, DOI 10.1002/cncr.22511; Lee CC, 2008, J CLIN ONCOL, V26, P535, DOI 10.1200/JCO.2007.14.0285; Messeguer F, 2012, J EUR ACAD DERMATOL; Prens SP, 2011, ANN SURG ONCOL; ROSES DF, 1991, SURG GYNECOL OBSTET, V172, P262; Saleh FH, 2001, INT J CANCER, V94, P551, DOI 10.1002/ijc.1491; SINGLETARY SE, 1988, CANCER, V61, P1437; Soong SJ, 1998, J SURG ONCOL, V67, P228, DOI 10.1002/(SICI)1096-9098(199804)67:4<228::AID-JSO4>3.0.CO;2-A; SUTHERLAND CM, 1987, SURG GYNECOL OBSTET, V164, P111; Weide B, 2012, BRIT J CANCER, V107, P422, DOI 10.1038/bjc.2012.306	20	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63137	10.1371/journal.pone.0063137	http://dx.doi.org/10.1371/journal.pone.0063137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638183	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000321662800078
J	Dogsa, I; Brloznik, M; Stopar, D; Mandic-Mulec, I				Dogsa, Iztok; Brloznik, Mojca; Stopar, David; Mandic-Mulec, Ines			Exopolymer Diversity and the Role of Levan in Bacillus subtilis Biofilms	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; PSEUDOMONAS-SYRINGAE; AMYLOID FIBERS; MATRIX; PROTEIN; GENES; LEVANSUCRASE; EXTRACTION; EPS; EXOPOLYSACCHARIDE	Exopolymeric substances (EPS) are important for biofilm formation and their chemical composition may influence biofilm properties. To explore these relationships the chemical composition of EPS from Bacillus subtilis NCIB 3610 biofilms grown in sucrose-rich (SYM) and sucrose-poor (MSgg and Czapek) media was studied. We observed marked differences in composition of EPS polymers isolated from all three biofilms or from spent media below the biofilms. The polysaccharide levan dominated the EPS of SYM grown biofilms, while EPS from biofilms grown in sucrose-poor media contained significant amounts of proteins and DNA in addition to polysaccharides. The EPS polymers differed also in size with very large polymers (Mw>2000 kDa) found only in biofilms, while small polymers (Mw<200 kD) dominated in the EPS isolated from spent media. Biofilms of the eps knockout were significantly thinner than those of the tasA knockout in all media. The biofilm defective phenotypes of tasA and eps mutants were, however, partially compensated in the sucrose-rich SYM medium. Sucrose supplementation of Czapek and MSgg media increased the thickness and stability of biofilms compared to non-supplemented controls. Since sucrose is essential for synthesis of levan and the presence of levan was confirmed in all biofilms grown in media containing sucrose, this study for the first time shows that levan, although not essential for biofilm formation, can be a structural and possibly stabilizing component of B. subtilis floating biofilms. In addition, we propose that this polysaccharide, when incorporated into the biofilm EPS, may also serve as a nutritional reserve.	[Dogsa, Iztok; Brloznik, Mojca; Stopar, David; Mandic-Mulec, Ines] Univ Ljubljana, Dept Food Sci & Technol, Biotech Fac, Ljubljana, Slovenia	University of Ljubljana	Mandic-Mulec, I (corresponding author), Univ Ljubljana, Dept Food Sci & Technol, Biotech Fac, Ljubljana, Slovenia.	ines.mandic@bf.uni-lj.si		Dogsa, Iztok/0000-0002-3953-702X	ARRS [J4-3631, JP4-116]	ARRS(Slovenian Research Agency - Slovenia)	IM-M was supported by an ARRS grant J4-3631. ARRS program grant JP4-116 (www.arrs.si). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2008, J HAZARD MATER, V154, P1120, DOI 10.1016/j.jhazmat.2007.11.058; Arvidson SA, 2006, CARBOHYD POLYM, V65, P144, DOI 10.1016/j.carbpol.2005.12.039; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; BAKKE R, 1986, J MICROBIOL METH, V5, P93, DOI 10.1016/0167-7012(86)90005-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Burne RA, 1996, J DENT RES, V75, P1572, DOI 10.1177/00220345960750080801; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chai YR, 2012, MBIO, V3, DOI 10.1128/mBio.00184-12; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; Chen Y, 2012, MOL MICROBIOL, V85, P418, DOI 10.1111/j.1365-2958.2012.08109.x; Conn HI, 1930, J INFECT DIS, V46, P339; Cuesta G, 2003, J MICROBIOL METH, V52, P69, DOI 10.1016/S0167-7012(02)00151-3; DEBARBOUILLE M, 1991, RES MICROBIOL, V142, P757, DOI 10.1016/0923-2508(91)90052-C; Dogsa I, 2005, BIOPHYS J, V89, P2711, DOI 10.1529/biophysj.105.061648; Driks A, 2011, MOL MICROBIOL, V80, P1133, DOI 10.1111/j.1365-2958.2011.07666.x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; HAGEMAN JH, 1984, J BACTERIOL, V160, P438, DOI 10.1128/JB.160.1.438-441.1984; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Hess D, 1985, AZOSPIRILLUM, P147; JONES RW, 1967, CEREAL CHEM, V44, P447; Kang Soon Ah, 2009, P145; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07; Kobayashi K, 2012, MOL MICROBIOL, V85, P51, DOI 10.1111/j.1365-2958.2012.08094.x; Kovacs AT, 2012, MOL MICROBIOL, V85, P8, DOI 10.1111/j.1365-2958.2012.08101.x; Lasa I, 2006, INT MICROBIOL, V9, P21; Laue H, 2006, MICROBIOL-SGM, V152, P2909, DOI 10.1099/mic.0.28875-0; LEPESANT JA, 1972, MOL GEN GENET, V118, P135, DOI 10.1007/BF00267084; LEPESANT JA, 1976, MICROBIOLOGY 1976, P58; Liu H, 2002, J BIOTECHNOL, V95, P249, DOI 10.1016/S0168-1656(02)00025-1; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Manandhar S, 2009, CARBOHYD POLYM, V78, P794, DOI 10.1016/j.carbpol.2009.06.023; Mandic-Mulec I, 2011, SOIL BIOL, V27, P31, DOI 10.1007/978-3-642-19577-8_2; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MARTINVERSTRAETE I, 1995, J BACTERIOL, V177, P6919, DOI 10.1128/jb.177.23.6919-6927.1995; Marvasi M, 2010, FEMS MICROBIOL LETT, V313, P1, DOI 10.1111/j.1574-6968.2010.02085.x; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Model MA, 2001, CYTOMETRY, V44, P309, DOI 10.1002/1097-0320(20010801)44:4<309::AID-CYTO1122>3.0.CO;2-3; Morikawa M, 2006, MICROBIOL-SGM, V152, P2801, DOI 10.1099/mic.0.29060-0; Morita N, 1982, B U OSAKA PREFECT B, V34, P57; Morita N., 1979, B U OSAKA PREFECT B, V31, P27; Muro AC, 1999, FOLIA MICROBIOL, V44, P647, DOI 10.1007/BF02825655; Oliveira R, 1999, BIOTECHNOL TECH, V13, P391, DOI 10.1023/A:1008954301470; Omoike A, 2004, BIOMACROMOLECULES, V5, P1219, DOI 10.1021/bm034461z; Ostrowski A, 2011, J BACTERIOL, V193, P4821, DOI 10.1128/JB.00223-11; Pan XL, 2010, WATER SA, V36, P111; Pereira Y, 2001, MICROBIOL-SGM, V147, P3413, DOI 10.1099/00221287-147-12-3413; Purama RK, 2009, CARBOHYD POLYM, V76, P30, DOI 10.1016/j.carbpol.2008.09.018; Rhee S. K., 2005, BIOPOLYMERS ONLINE; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Seviour T, 2012, WATER RES, V46, P4803, DOI 10.1016/j.watres.2012.06.018; Seviour T, 2010, ENVIRON SCI TECHNOL, V44, P8964, DOI 10.1021/es102658s; Shida T, 2002, BIOSCI BIOTECH BIOCH, V66, P1555, DOI 10.1271/bbb.66.1555; Shih IL, 2005, J AGR FOOD CHEM, V53, P8211, DOI 10.1021/jf058084o; Shih IL, 2010, CARBOHYD POLYM, V82, P111, DOI 10.1016/j.carbpol.2010.04.030; SHIMOTSU H, 1986, J BACTERIOL, V168, P380, DOI 10.1128/jb.168.1.380-388.1986; SO LL, 1969, CARBOHYD RES, V10, P231, DOI 10.1016/S0008-6215(00)80465-6; Stanley NR, 2005, MOL MICROBIOL, V57, P1143, DOI 10.1111/j.1365-2958.2005.04746.x; Stefanic P, 2012, ENVIRON MICROBIOL, V14, P1378, DOI 10.1111/j.1462-2920.2012.02717.x; Stefanic P, 2009, J BACTERIOL, V191, P1756, DOI 10.1128/JB.01290-08; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Stover AG, 1999, J BACTERIOL, V181, P1664; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Vijayabaskar P., 2011, ADV BIOL RES, V5, P71; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WHITE GW, 1970, MICROSCOPE, V18, P51	75	79	80	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62044	10.1371/journal.pone.0062044	http://dx.doi.org/10.1371/journal.pone.0062044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637960	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700029
J	Nantasenamat, C; Prachayasittikul, V; Bulow, L				Nantasenamat, Chanin; Prachayasittikul, Virapong; Bulow, Leif			Molecular Modeling of the Human Hemoglobin-Haptoglobin Complex Sheds Light on the Protective Mechanisms of Haptoglobin	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; AMINO-AROMATIC INTERACTIONS; CATION-PI INTERACTIONS; BINDING-SITE; ALPHA-CHAIN; HOT-SPOTS; RESIDUES; DOCKING; RECOGNITION; PLASMA	Hemoglobin (Hb) plays a critical role in human physiological function by transporting O-2. Hb is safe and inert within the confinement of the red blood cell but becomes reactive and toxic upon hemolysis. Haptoglobin (Hp) is an acute-phase serum protein that scavenges Hb and the resulting Hb-Hp complex is subjected to CD163-mediated endocytosis by macrophages. The interaction between Hb and Hp is extraordinarily strong and largely irreversible. As the structural details of the human Hb-Hp complex are not yet available, this study reports for the first time on insights of the binding modalities and molecular details of the human Hb-Hp interaction by means of protein-protein docking. Furthermore, residues that are pertinent for complex formation were identified by computational alanine scanning mutagenesis. Results revealed that the surface of the binding interface of Hb-Hp is not flat and protrudes into each binding partner. It was also observed that the secondary structures at the Hb-Hp interface are oriented as coils and alpha-helices. When dissecting the interface in more detail, it is obvious that several tyrosine residues of Hb, particularly beta 145Tyr, alpha 42Tyr and alpha 140Tyr, are buried in the complex and protected from further oxidative reactions. Such finding opens up new avenues for the design of Hp mimics which may be used as alternative clinical Hb scavengers.	[Nantasenamat, Chanin] Mahidol Univ, Fac Med Technol, Ctr Data Min & Biomed Informat, Bangkok 10700, Thailand; [Nantasenamat, Chanin; Prachayasittikul, Virapong] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand; [Bulow, Leif] Lund Univ, Dept Chem, Lund, Sweden	Mahidol University; Mahidol University; Lund University	Bulow, L (corresponding author), Lund Univ, Dept Chem, Lund, Sweden.	Leif.Bulow@tbiokem.lth.se	Nantasenamat, Chanin/AAD-1032-2019	Nantasenamat, Chanin/0000-0003-1040-663X; Prachayasittikul, Virapong/0000-0001-7942-1083	Office of the Higher Education Commission, Mahidol University under the National Research Universities' Initiative; Swedish Research Foundation (VR); Swedish Research Links	Office of the Higher Education Commission, Mahidol University under the National Research Universities' Initiative; Swedish Research Foundation (VR)(Swedish Research Council); Swedish Research Links	The following research funding agencies are gratefully acknowledged for supporting the research performed: the Office of the Higher Education Commission, Mahidol University under the National Research Universities' Initiative, Swedish Research Foundation (VR) and Swedish Research Links. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayash AI, 2011, CLIN CHIM ACTA, V412, P493, DOI 10.1016/j.cca.2010.12.011; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; BARKER JA, 1973, MOL PHYS, V26, P789, DOI 10.1080/00268977300102101; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Chatake T, 2007, J AM CHEM SOC, V129, P14840, DOI 10.1021/ja0749441; CHIAO MT, 1972, BIOCHIM BIOPHYS ACTA, V263, P60, DOI 10.1016/0005-2795(72)90159-6; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HWANG PK, 1979, J BIOL CHEM, V254, P2265; Isarankura-Na-Ayudhya C, 2009, EUR J SCI RES, V26, P577; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; KAZIM AL, 1981, BIOCHEM J, V197, P507, DOI 10.1042/bj1970507; Kovalevsky AY, 2010, J MOL BIOL, V398, P276, DOI 10.1016/j.jmb.2010.03.016; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krissinel E, 2005, PISA PROTEIN INTERFA; Lauria A, 2010, CURR MED CHEM, V17, P3142, DOI 10.2174/092986710792232021; LUSTBADER JW, 1983, J BIOL CHEM, V258, P1227; MCCORMICK DJ, 1990, J PROTEIN CHEM, V9, P735, DOI 10.1007/BF01024768; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Mishra Seema, 2012, BMC Res Notes, V5, P495, DOI 10.1186/1756-0500-5-495; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Olsson MG, 2012, ANTIOXID REDOX SIGN, V17, P813, DOI 10.1089/ars.2011.4282; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pieraccini S, 2011, CHEM PHYS LETT, V517, P217, DOI 10.1016/j.cplett.2011.10.044; Polonovski M, 1938, CR SOC BIOL, V129, P457; Polticelli F, 2008, FEBS J, V275, P5648, DOI 10.1111/j.1742-4658.2008.06690.x; Prasad VR, 2009, PROTOPLASMA, V238, P11, DOI 10.1007/s00709-009-0066-3; Przybylska M, 1999, ACTA CRYSTALLOGR D, V55, P883, DOI 10.1107/S0907444998015789; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sansom C, 1998, NAT BIOTECHNOL, V16, P917, DOI 10.1038/nbt1098-917; Saxena A, 2009, METHOD ENZYMOL, V467, P307, DOI 10.1016/S0076-6879(09)67012-9; Scrutton NS, 1996, BIOCHEM J, V319, P1; Suvannang N, 2011, MOLECULES, V16, P3597, DOI 10.3390/molecules16053597; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; URUSHIBARA N, 1992, J BIOL CHEM, V267, P13413; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; W DeLano, 2002, PYMOL RELEASE 0 99; WEJMAN JC, 1984, J MOL BIOL, V174, P319, DOI 10.1016/0022-2836(84)90341-3; Wicher KB, 2006, P NATL ACAD SCI USA, V103, P4168, DOI 10.1073/pnas.0508723103; Wu T, 2010, INT J MULTISCALE COM, V8, P237, DOI 10.1615/IntJMultCompEng.v8.i2.80; Yadavalli V, 2011, MOL BIOSYST, V7, P3143, DOI 10.1039/c1mb05218g; YOSHIOKA N, 1986, BIOCHEM J, V234, P453, DOI 10.1042/bj2340453; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8	60	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62996	10.1371/journal.pone.0062996	http://dx.doi.org/10.1371/journal.pone.0062996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638175	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700084
J	Plowright, RK; Manlove, K; Cassirer, EF; Cross, PC; Besser, TE; Hudson, PJ				Plowright, Raina K.; Manlove, Kezia; Cassirer, E. Frances; Cross, Paul C.; Besser, Thomas E.; Hudson, Peter J.			Use of Exposure History to Identify Patterns of Immunity to Pneumonia in Bighorn Sheep (Ovis canadensis)	PLOS ONE			English	Article							HOST-PARASITE SYSTEM; TRICHOSTRONGYLUS-TENUIS; UNITED-STATES; RED GROUSE; DISEASE; DYNAMICS; POPULATION; EPIDEMIOLOGY; STABILITY; INFECTION	Individual host immune responses to infectious agents drive epidemic behavior and are therefore central to understanding and controlling infectious diseases. However, important features of individual immune responses, such as the strength and longevity of immunity, can be challenging to characterize, particularly if they cannot be replicated or controlled in captive environments. Our research on bighorn sheep pneumonia elucidates how individual bighorn sheep respond to infection with pneumonia pathogens by examining the relationship between exposure history and survival in situ. Pneumonia is a poorly understood disease that has impeded the recovery of bighorn sheep (Ovis canadensis) following their widespread extirpation in the 1900s. We analyzed the effects of pneumonia-exposure history on survival of 388 radio-collared adults and 753 ewe-lamb pairs. Results from Cox proportional hazards models suggested that surviving ewes develop protective immunity after exposure, but previous exposure in ewes does not protect their lambs during pneumonia outbreaks. Paradoxically, multiple exposures of ewes to pneumonia were associated with diminished survival of their offspring during pneumonia outbreaks. Although there was support for waning and boosting immunity in ewes, models with consistent immunizing exposure were similarly supported. Translocated animals that had not previously been exposed were more likely to die of pneumonia than residents. These results suggest that pneumonia in bighorn sheep can lead to aging populations of immune adults with limited recruitment. Recovery is unlikely to be enhanced by translocating naive healthy animals into or near populations infected with pneumonia pathogens.	[Plowright, Raina K.; Manlove, Kezia; Hudson, Peter J.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Cassirer, E. Frances] Idaho Dept Fish & Game, St Lewiston, ID USA; [Cross, Paul C.] Northern Rocky Mt Sci Ctr, Bozeman, MT USA; [Besser, Thomas E.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Hudson, Peter J.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Plowright, RK (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	rplowright@gmail.com	Cross, Paul/K-6987-2012; Hudson, Peter/AAB-8080-2020	Cross, Paul/0000-0001-8045-5213; Hudson, Peter/0000-0003-0468-3403; Manlove, Kezia/0000-0002-7200-5236	Morris Animal Foundation; New York Community Trust; EcoHealth Alliance; Cedar Tree Foundation; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health; Idaho Department of Fish and Game; Oregon Department of Fish and Wildlife; Washington Department of Fish and Wildlife; Bureau of Land Management; United States Forest Service; Wild Sheep Foundation National; Shikar-Safari Club International; Oregon Hunters Association; Wildlife Forever; Cabela's; Federal Aid to Wildlife Restoration Project [W-160-R]	Morris Animal Foundation; New York Community Trust; EcoHealth Alliance; Cedar Tree Foundation; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health; Idaho Department of Fish and Game; Oregon Department of Fish and Wildlife; Washington Department of Fish and Wildlife; Bureau of Land Management; United States Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Wild Sheep Foundation National; Shikar-Safari Club International; Oregon Hunters Association; Wildlife Forever; Cabela's; Federal Aid to Wildlife Restoration Project	The Morris Animal Foundation, New York Community Trust, EcoHealth Alliance and Pamela M. Thye supported this work. RKP was supported by the Cedar Tree Foundation through a Smith Fellowship, PJH was supported by the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health. Funding for field research was provided by Idaho Department of Fish and Game, Oregon Department of Fish and Wildlife, Washington Department of Fish and Wildlife, Bureau of Land Management, United States Forest Service, Wild Sheep Foundation National, chapters and affiliates, Shikar-Safari Club International, Oregon Hunters Association, Wildlife Forever, Cabela's, and Federal Aid to Wildlife Restoration Project W-160-R administered through the Idaho Department of Fish and Game. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Aune K.A., 1998, P BIEN S N WILD SHEE, V11, P46; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Besser TE, 2012, J WILDLIFE DIS, V48; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Black S, 1997, PEDIATR INFECT DIS J, V16, pS85, DOI 10.1097/00006454-199704001-00003; Bleich VC, 1997, WILDLIFE MONOGR, P1; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; Buechner H. K., 1960, Wildlife Monographs.; Cassirer E.F., 1996, BIENN S NO WILD SHEE, V10, P78; Cassirer EF, 2007, J WILDLIFE MANAGE, V71, P1080, DOI 10.2193/2006-002; Cassirer EF, 2013, J ANIMAL ECOLOGY, DOI 101111/1365-265612031; Coggins, 1988, P 6 BIENN S NO WILD, V6, P57; Dimmick RW, 1994, RES MANAGEMENT TECHN, P189; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; Enk TA, 2001, NORTHWEST SCI, V75, P280; Festa-Bianchet M, 1988, P 6 BIENN S NO WILD, V6, P66; Festa-Bianchet M, 2007, ECOSCIENCE, V14, P318, DOI 10.2980/1195-6860(2007)14[318:AREIBS]2.0.CO;2; FESTABIANCHET M, 1991, ANIM BEHAV, V42, P71, DOI 10.1016/S0003-3472(05)80607-4; Fieberg J, 2009, ECOLOGY, V90, P1687, DOI 10.1890/08-0724.1; FOREYT W. J., 1990, BIENN S NO WILD SHEE, V7, P92; Foster C. L., 2004, P BIENN S NO WILD SH, V14, P211; GEIST V, 1966, J WILDLIFE MANAGE, V30, P634, DOI 10.2307/3798763; Gilbert A, ECOHEALTH IN PRESS; Grenfell BT, 1998, ECOL LETT, V1, P63; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Hougaard P, 1995, Lifetime Data Anal, V1, P255; Hudson P., 2002, ECOLOGY WILDLIFE DIS; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; Jorgenson JT, 1997, ECOLOGY, V78, P1019, DOI 10.1890/0012-9658(1997)078[1019:EOASDA]2.0.CO;2; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Marcotte H, 1998, MICROBIOL MOL BIOL R, V62, P71, DOI 10.1128/MMBR.62.1.71-109.1998; MILLER MW, 1991, J WILDLIFE DIS, V27, P534, DOI 10.7589/0090-3558-27.4.534; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; R Development Core Team, 2009, R FDN STAT COMP; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Singer FJ, 2001, CONSERV BIOL, V15, P1347, DOI 10.1046/j.1523-1739.2001.99488.x; Therneau T, 2015, MIXED EFFECTS COX MO; Therneau T, 2010, MODELING SURVIVAL DA; Therneau T. M., 2011, PACKAGE SURVIVAL ANA; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Ward A. C. S., 1992, BIENNIAL S NO WILD S, V8, P164; [No title captured]	50	25	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61919	10.1371/journal.pone.0061919	http://dx.doi.org/10.1371/journal.pone.0061919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637929	gold, Green Submitted, Green Published			2022-12-25	WOS:000318343700024
J	Ding, BS; James, D; Iyer, R; Falciatori, I; Hambardzumyan, D; Wang, S; Butler, JM; Rabbany, SY; Hormigo, AL				Ding, Bi-Sen; James, Daylon; Iyer, Rajiv; Falciatori, Ilaria; Hambardzumyan, Dolores; Wang, Su; Butler, Jason M.; Rabbany, Sina Y.; Hormigo, Adilia			Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma	PLOS ONE			English	Article							NEURAL STEM-CELLS; PLASMA-MEMBRANE PROTRUSIONS; ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE; VASCULAR NICHE; HEMATOPOIETIC STEM; EPITHELIAL-CELLS; TUMOR-GROWTH; GLIOBLASTOMA; IDENTIFICATION	In glioblastoma high expression of the CD133 gene, also called Prominin1, is associated with poor prognosis. The PDGF-driven proneural group represents a subset of glioblastoma in which CD133 is not overexpressed. Interestingly, this particular subset shows a relatively good prognosis. As with many other tumors, gliobastoma is believed to arise and be maintained by a restricted population of stem-like cancer cells that express the CD133 transmembrane protein. The significance of CD133(+) cells for gliomagenesis is controversial because of conflicting supporting evidence. Contributing to this inconsistency is the fact that the isolation of CD133(+) cells has largely relied on the use of antibodies against ill-defined glycosylated epitopes of CD133. To overcome this problem, we used a knock-in lacZ reporter mouse, Prom1(lacZ/+), to track Prom1(+) cells in the brain. We found that Prom1 (prominin1, murine CD133 homologue) is expressed by cells that express markers characteristic of the neuronal, glial or vascular lineages. In proneural tumors derived from injection of RCAS-PDGF into the brains of tv-a;Ink4a-Arf(-/-) Prom1(lacZ/+) mice, Prom1(+) cells expressed markers for astrocytes or endothelial cells. Mice co-transplanted with proneural tumor sphere cells and Prom1(+) endothelium had a significantly increased tumor burden and more vascular proliferation (angiogenesis) than those co-transplanted with Prom1(-) endothelium. We also identified specific genes in Prom1(+) endothelium that code for endothelial signaling modulators that were not overexpressed in Prom1(-) endothelium. These factors may support proneural tumor progression and could be potential targets for anti-angiogenic therapy.	[Ding, Bi-Sen; James, Daylon; Iyer, Rajiv; Falciatori, Ilaria; Butler, Jason M.; Rabbany, Sina Y.; Hormigo, Adilia] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY USA; [Ding, Bi-Sen; James, Daylon; Iyer, Rajiv; Falciatori, Ilaria; Butler, Jason M.; Rabbany, Sina Y.; Hormigo, Adilia] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Iyer, Rajiv; Hambardzumyan, Dolores; Hormigo, Adilia] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Hambardzumyan, Dolores] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Wang, Su; Hormigo, Adilia] Univ Rochester, Med Ctr, Dept Neurol, Ctr Translat Neuromed Oncol & Neurosurg, New York, NY USA; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Rochester; Hofstra University	Hormigo, AL (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY USA.	Adilia_Hormigo@URMC.Rochester.edu			Brain Tumor Center, Memorial Sloan-Kettering Cancer Center	Brain Tumor Center, Memorial Sloan-Kettering Cancer Center	This work was supported by Brain Tumor Center, Memorial Sloan-Kettering Cancer Center (to AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Corbeil D, 1999, J CELL SCI, V112, P1023; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hormigo A, 2011, P NATL ACAD SCI USA, V108, P4271, DOI 10.1073/pnas.1019656108; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Meens MJPMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010917; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Smith ER, 2008, CLIN CANCER RES, V14, P2378, DOI 10.1158/1078-0432.CCR-07-1253; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009	43	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62150	10.1371/journal.pone.0062150	http://dx.doi.org/10.1371/journal.pone.0062150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637986	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400039
J	Surdu, S; Fitzgerald, EF; Bloom, MS; Boscoe, FP; Carpenter, DO; Haase, RF; Gurzau, E; Rudnai, P; Koppova, K; Fevotte, J; Leonardi, G; Vahter, M; Goessler, W; Kumar, R; Fletcher, T				Surdu, Simona; Fitzgerald, Edward F.; Bloom, Michael S.; Boscoe, Francis P.; Carpenter, David O.; Haase, Richard F.; Gurzau, Eugen; Rudnai, Peter; Koppova, Kvetoslava; Fevotte, Joelle; Leonardi, Giovanni; Vahter, Marie; Goessler, Walter; Kumar, Rajiv; Fletcher, Tony			Occupational Exposure to Ultraviolet Radiation and Risk of Non-Melanoma Skin Cancer in a Multinational European Study	PLOS ONE			English	Article							CELL CARCINOMA; VITAMIN-D; EPIDEMIOLOGY; SUNLIGHT; BREAST; LIGHT; SUN	Background: Studies suggest that ambient sunlight plays an important role in the pathogenesis of non-melanoma skin cancers (NMSC). However, there is ongoing controversy regarding the relevance of occupational exposure to natural and artificial ultraviolet radiation (UV) radiation. Objectives: We investigated potential associations between natural and artificial UV radiation exposure at work with NMSC in a case-control study conducted in Hungary, Romania, and Slovakia. Methods: Occupational exposures were classified by expert assessment for 527 controls and 618 NMSC cases (515 basal cell carcinoma, BCC). Covariate information was collected via interview and multiple logistic regression models were used to assess associations between UV exposure and NMSC. Results: Lifetime prevalence of occupational exposure in the participants was 13% for natural UV radiation and 7% for artificial UV radiation. Significant negative associations between occupational exposure to natural UV radiation and NMSC were detected for all who had ever been exposed (odds ratio (OR) 0.47, 95% confidence interval (CI) 0.27-0.80); similar results were detected using a semi-quantitative metric of cumulative exposure. The effects were modified by skin complexion, with significantly decreased risks of BCC among participants with light skin complexion. No associations were observed in relation to occupational artificial UV radiation exposure. Conclusions: The protective effect of occupational exposure to natural UV radiation was unexpected, but limited to light-skinned people, suggesting adequate sun-protection behaviors. Further investigations focusing on variations in the individual genetic susceptibility and potential interactions with environmental and other relevant factors are planned.	[Surdu, Simona; Fitzgerald, Edward F.; Bloom, Michael S.; Carpenter, David O.] SUNY Albany, Sch Publ Hlth, Dept Environm Hlth Sci, Rensselaer, NY USA; [Surdu, Simona; Fitzgerald, Edward F.; Bloom, Michael S.; Boscoe, Francis P.] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Rensselaer, NY USA; [Surdu, Simona; Bloom, Michael S.; Carpenter, David O.; Haase, Richard F.] SUNY Albany, Inst Hlth & Environm, Rensselaer, NY USA; [Boscoe, Francis P.] New York State Dept Hlth, New York State Canc Registry, Albany, NY USA; [Haase, Richard F.] SUNY Albany, Sch Educ, Dept Educ & Counseling Psychol, Albany, NY 12222 USA; [Gurzau, Eugen] Univ Babes Bolyai, Ctr Environm Hlth, Dept Hlth, R-3400 Cluj Napoca, Romania; [Rudnai, Peter] Natl Inst Environm Hlth, Dept Environm Epidemiol, Budapest, Hungary; [Koppova, Kvetoslava] Reg Author Publ Hlth, Dept Environm Hlth, Banska Bystrica, Slovakia; [Fevotte, Joelle] Univ Lyon, UMRESTTE, Dept Epidemiol Res & Survey Transport Work & Envi, Lyon, France; [Leonardi, Giovanni; Fletcher, Tony] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Leonardi, Giovanni] Hlth Protect Agcy, Ctr Radiat Chem & Environm Hazards, Chilton, England; [Vahter, Marie] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Goessler, Walter] Karl Franzens Univ Graz, Inst Chem Analyt Chem, Graz, Austria; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Babes Bolyai University from Cluj; Regional Authority of Public Health Banska Bystrica; University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; Karolinska Institutet; University of Graz; Helmholtz Association; German Cancer Research Center (DKFZ)	Surdu, S (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Environm Hlth Sci, Rensselaer, NY USA.	ssurdu@albany.edu	Fletcher, Tony/D-2394-2011; Bloom, Michael S/A-5743-2010; Kumar, Rajiv/H-6431-2019; Leonardi, Giovanni/AAS-7603-2020; Goessler, Walter/A-1084-2016; Leonardi, Giovanni S/E-5700-2015; Vahter, Marie/HGB-1674-2022	Fletcher, Tony/0000-0003-3385-200X; Kumar, Rajiv/0000-0002-6093-0395; Goessler, Walter/0000-0002-0142-9373; Leonardi, Giovanni S./0000-0001-7477-1762; Gurzau, Eugen/0000-0002-8688-6118; Bloom, Michael/0000-0002-0028-5494	European Commission [QLK4-CT-2001-00264]	European Commission(European CommissionEuropean Commission Joint Research Centre)	Financial support provided by European Commission project QLK4-CT-2001-00264 (Arsenic Health Risk Assessment and Molecular Epidemiology (ASHRAM) Study) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almahroos Mona, 2004, Skinmed, V3, P132; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Bauer A, 2011, BRIT J DERMATOL, V165, P612, DOI 10.1111/j.1365-2133.2011.10425.x; Boffetta P, 2008, INT J EPIDEMIOL, V37, P1080, DOI 10.1093/ije/dyn092; Boscoe FP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-264; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Eurostat, 1996, STAT CLASS EC ACT EU, V1; Fartasch M, 2012, DTSCH ARZTEBL INT, V109, P715, DOI 10.3238/arztebl.2012.0715; Franceschi S, 1996, INT J CANCER, V67, P24, DOI 10.1002/(SICI)1097-0215(19960703)67:1<24::AID-IJC6>3.0.CO;2-1; Freedman DM, 2002, OCCUP ENVIRON MED, V59, P257, DOI 10.1136/oem.59.4.257; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Gallagher RP, 2010, CHRONIC DIS CAN, V29, P51; Gawkrodger DJ, 2004, OCCUP MED-OXFORD, V54, P458, DOI 10.1093/occmed/kqh098; Gilaberte Y, 2011, ACTAS DERMO-SIFILOGR, V102, P572, DOI 10.1016/j.ad.2011.03.015; Glanz K, 2007, ENV HLTH, V22; Guenel P, 2001, CANCER CAUSE CONTROL, V12, P451, DOI 10.1023/A:1011271420974; Hannuksela-Svahn A, 1999, ARCH DERMATOL, V135, P781, DOI 10.1001/archderm.135.7.781; Hayes DP, 2010, MED HYPOTHESES, V75, P378, DOI 10.1016/j.mehy.2010.04.001; HSE, 2012, BURD OCC CANC GREAT; IARC, 2006, EXP ART UV RAD SKIN; IARC, 2002, CANC INCIDENCE 5 CON, VVIII; IARC, 2012, ARSENIC METALS FIBRE, V100C; IARC, 2008, VIT D CANC; ILO, 1981, INT STAND CLASS OCC; International Agency for Research on Cancer (IARC), 1992, IARC MON EV CARC RIS; Karami S, 2010, CANCER-AM CANCER SOC, V116, P2001, DOI 10.1002/cncr.24939; Kasparian NA, 2009, J BEHAV MED, V32, P406, DOI 10.1007/s10865-009-9219-2; Kenborg L, 2010, CANCER CAUSE CONTROL, V21, P1347, DOI 10.1007/s10552-010-9562-1; Knight JA, 2007, CANCER EPIDEM BIOMAR, V16, P422, DOI 10.1158/1055-9965.EPI-06-0865; Kutting B, 2010, INT ARCH OCC ENV HEA, V83, P843, DOI 10.1007/s00420-010-0532-4; Leonardi G, 2012, ENVIRON HEALTH PERSP, V120, P721, DOI 10.1289/ehp.1103534; Lucas R., 2006, SOLAR ULTRAVIOLET RA; Lucas RM, 2008, INT J EPIDEMIOL, V37, P654, DOI 10.1093/ije/dyn017; McGuire V, 1998, ANNU REV PUBL HEALTH, V19, P35, DOI 10.1146/annurev.publhealth.19.1.35; Neville JA, 2007, NAT CLIN PRACT ONCOL, V4, P462, DOI 10.1038/ncponc0883; Schmitt J, 2011, BRIT J DERMATOL, V164, P291, DOI 10.1111/j.1365-2133.2010.10118.x; Schmitt J, 2010, J DTSCH DERMATOL GES, V8, P250, DOI 10.1111/j.1610-0387.2009.07260.x; Siemiatycki J, 2004, ENVIRON HEALTH PERSP, V112, P1447, DOI 10.1289/ehp.7047; Stern RS, 1999, ARCH DERMATOL, V135, P843, DOI 10.1001/archderm.135.7.843; Tchounwou PB, 2003, TOXICOL PATHOL, V31, P575, DOI 10.1080/01926230390242007; Teschke K, 2002, OCCUP ENVIRON MED, V59, P575, DOI 10.1136/oem.59.9.575; Trakatelli M, 2007, BRIT J DERMATOL, V156, P1, DOI 10.1111/j.1365-2133.2007.07861.x; Vecchia Paolo, 2007, PROTECTING WORKERS U; World Health Organization, 2003, INTERSUN GLOB UV PRO; Yoshinaga S, 2004, RADIOLOGY, V233, P313, DOI 10.1148/radiol.2332031119	46	37	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62359	10.1371/journal.pone.0062359	http://dx.doi.org/10.1371/journal.pone.0062359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638051	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000318340400099
J	Dorjgochoo, T; Xiang, YB; Long, JR; Shi, JJ; Deming, S; Xu, WH; Cai, H; Cheng, JR; Cai, QY; Zheng, W; Shu, XO				Dorjgochoo, Tsogzolmaa; Xiang, Yong-Bing; Long, Jirong; Shi, Jiajun; Deming, Sandra; Xu, Wang-Hong; Cai, Hui; Cheng, Jiarong; Cai, Qiuyin; Zheng, Wei; Shu, Xiao-Ou			Association of Genetic Markers in the BCL-2 Family of Apoptosis-Related Genes with Endometrial Cancer Risk in a Chinese Population	PLOS ONE			English	Article							SHANGHAI BREAST-CANCER; REPRODUCTIVE FACTORS; UTERINE ENDOMETRIUM; MENSTRUAL-CYCLE; EXPRESSION; BAX; CARCINOMA; POLYMORPHISMS; P53; PROTEIN	Background: In vitro studies have demonstrated the role of the BCL-2 family of genes in endometrial carcinogenesis. The role of genetic variants in BCL-2 genes and their interactions with non-genetic factors in the development of endometrial cancer has not been investigated in epidemiological studies. Patients and Methods: We examined the relationship between BCL-2 gene family variants and endometrial cancer risk among 1,028 patients and 1,922 age-matched community controls from Shanghai, China. We also investigated possible interactions between genetic variants and established risk factors (demographic, lifestyle and clinical). Individuals were genotyped for 86 tagging single nucleotide polymorphisms (SNPs) in the BCL2, BAX, BAD and BAK1 genes. Results: Significant associations with endometrial cancer risk were found for 9 SNPs in the BCL2 gene (P trend <0.05 for all). For SNPs rs17759659 and rs7243091 (minor allele for both: G), the associations were independent. The odds ratio was 1.27 (95% CI: 1.04-1.53) for women with AG genotype for the SNP rs17759659 and 1.82 (95% CI: 1.21-2.73) for women with the GG genotype for the SNP rs7243091. No interaction between these two SNPs and established non-genetic risk factors of endometrial cancer was noticed. Conclusion: Genetic polymorphisms in the BCL2 gene may be associated with the risk of endometrial cancer in Chinese women.	[Dorjgochoo, Tsogzolmaa; Long, Jirong; Shi, Jiajun; Deming, Sandra; Cai, Hui; Cai, Qiuyin; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med, Nashville, TN 37212 USA; [Dorjgochoo, Tsogzolmaa; Long, Jirong; Shi, Jiajun; Deming, Sandra; Cai, Hui; Cai, Qiuyin; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Xiang, Yong-Bing; Xu, Wang-Hong; Cheng, Jiarong] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	Vanderbilt University; Vanderbilt University; Shanghai Jiao Tong University	Shu, XO (corresponding author), Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med, Nashville, TN 37212 USA.	xiao-ou.shu@vanderbilt.edu	Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; Long, Jirong/0000-0002-7433-9766; xu, wanghong/0000-0003-2045-2218	National Cancer Institute at the National Institutes of Health [R01 CA064277, R01 CA092585, P30 CA68485]; NATIONAL CANCER INSTITUTE [R01CA092585, R01CA064277, P30CA068485] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute at the National Institutes of Health [R01 CA064277, R01 CA092585, and in part P30 CA68485] (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bozdogan O, 2002, INT J GYNECOL PATHOL, V21, P375, DOI 10.1097/01.PGP.0000035807.01856.93; Bukholm IK, 2000, VIRCHOWS ARCH, V436, P224, DOI 10.1007/s004280050034; Cai H, 2011, AM J EPIDEMIOL, V173, P1263, DOI 10.1093/aje/kwr002; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen KX, 2007, CARCINOGENESIS, V28, P2008, DOI 10.1093/carcin/bgm172; Critchley HO, 1996, J REPROD FERTIL, V115, P389; Dorjgochoo T, 2008, BREAST CANCER RES TR, V111, P269, DOI 10.1007/s10549-007-9772-8; Fernandez Y, 2002, INT J CANCER, V101, P317, DOI 10.1002/ijc.10628; Gao YT, 2000, INT J CANCER, V87, P295, DOI 10.1002/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7; Geisler JP, 1998, GYNECOL ONCOL, V71, P305, DOI 10.1006/gyno.1998.5192; GOMPEL A, 1994, AM J PATHOL, V144, P1195; Green DR, 1998, NATURE, V396, P629, DOI 10.1038/25248; Hirata H, 2009, J UROLOGY, V181, P1907, DOI 10.1016/j.juro.2008.11.093; Jain M, 2007, CANCER DETECT PREV, V31, P225, DOI 10.1016/j.cdp.2007.04.005; Kokawa K, 2001, HUM REPROD, V16, P2211, DOI 10.1093/humrep/16.10.2211; Lindemann K, 2008, BRIT J CANCER, V98, P1582, DOI 10.1038/sj.bjc.6604313; Linjawi A, 2004, J AM COLL SURGEONS, V198, P83, DOI 10.1016/j.jamcollsurg.2003.08.008; Loerbroks A, 2007, CANCER CAUSE CONTROL, V18, P551, DOI 10.1007/s10552-007-0127-x; Maruo T, 2001, HUM REPROD, V16, P2103, DOI 10.1093/humrep/16.10.2103; Moon JH, 2010, LEUKEMIA RES, V34, P166, DOI 10.1016/j.leukres.2009.05.009; Mozzetti S, 2000, CANCER DETECT PREV, V24, P536; Niemann TH, 1996, GYNECOL ONCOL, V63, P318, DOI 10.1006/gyno.1996.0329; OTSUKI Y, 1994, LANCET, V344, P28; Pappa G, 2006, MUTAT RES-FUND MOL M, V599, P76, DOI 10.1016/j.mrfmmm.2006.01.007; PARAZZINI F, 1995, NUTR CANCER, V23, P55, DOI 10.1080/01635589509514361; Parazzini F, 1998, INT J CANCER, V76, P784, DOI 10.1002/(SICI)1097-0215(19980610)76:6<784::AID-IJC2>3.0.CO;2-U; Peiro G, 2001, INT J GYNECOL PATHOL, V20, P359, DOI 10.1097/00004347-200110000-00008; Porichi O, 2009, ANTICANCER RES, V29, P3977; Potischman N, 1996, J NATL CANCER I, V88, P1127, DOI 10.1093/jnci/88.16.1127; Saegusa M, 1997, J CANCER RES CLIN, V123, P429, DOI 10.1007/BF01372546; Soda G, 1999, J EXP CLIN CANC RES, V18, P363; Vaskivuo TE, 2002, CANCER-AM CANCER SOC, V95, P1463, DOI 10.1002/cncr.10876; Xu HL, 2009, CANCER EPIDEM BIOMAR, V18, P2114, DOI 10.1158/1055-9965.EPI-09-0152; Xu WH, 2007, CANCER EPIDEM BIOMAR, V16, P281, DOI 10.1158/1055-9965.EPI-06-0798	36	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60915	10.1371/journal.pone.0060915	http://dx.doi.org/10.1371/journal.pone.0060915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637776	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400019
J	Takahashi-Nakaguchi, A; Matsumoto, Y; Yamamoto, M; Iwabuchi, K; Totsuka, Y; Sugimura, T; Wakabayashi, K				Takahashi-Nakaguchi, Azusa; Matsumoto, Yasuko; Yamamoto, Masafumi; Iwabuchi, Kikuo; Totsuka, Yukari; Sugimura, Takashi; Wakabayashi, Keiji			Demonstration of Cytotoxicity against Wasps by Pierisin-1: A Possible Defense Factor in the Cabbage White Butterfly	PLOS ONE			English	Article							APOPTOSIS-INDUCING PROTEIN; PROPHENOLOXIDASE-ACTIVATING SYSTEM; ADP-RIBOSYLATING TOXIN; BOMBYX-MORI PHAGOCYTES; CELLULAR RECOGNITION; NEGATIVE REGULATION; FOREIGN MATERIALS; COTESIA-RUBECULA; HOST; DROSOPHILA	The cabbage white butterfly, Pieris rapae, produces pierisin-1, a protein inducing apoptosis of mammalian cells. In the present study, the biological activity of pierisin-1 as a protective agent against parasitic wasps for P. rapae was examined. Pierisin-1 caused detrimental effects on eggs and larvae of non-habitual parasitoids for P. rapae, Glyptapanteles pallipes, Cotesia kariyai and Cotesia plutellae at 1-100 mu g/ml, levels essentially equivalent to those found in P. rapae larvae. In contrast, eggs and larvae of the natural parasitoid of P. rapae, Cotesia glomerata proved resistant to the toxicity of pierisin-1 through inhibition of pierisin-1 penetration of the surface layer. The expression level of pierisin-1 mRNA in the larvae of P. rapae was increased by parasitization by C. plutellae, whereas it was decreased by C. glomerata. In addition, C. plutellae was associated with elevation of activated pierisin-1 in the hemolymph. From these observations, it is suggested that pierisin-1 could contribute as a defense factor against parasitization by some type of wasps in P. rapae.	[Takahashi-Nakaguchi, Azusa; Matsumoto, Yasuko; Yamamoto, Masafumi; Totsuka, Yukari; Sugimura, Takashi; Wakabayashi, Keiji] Natl Canc Ctr, Canc Prevent Basic Res Project, Tokyo, Japan; [Takahashi-Nakaguchi, Azusa] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Matsumoto, Yasuko] RIKEN, Ctr Mol Imaging Sci, Drug Discovery Imaging Platform Unit, Kobe, Hyogo, Japan; [Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Fac Agr, Tokyo, Japan; [Wakabayashi, Keiji] Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan	National Cancer Center - Japan; Chiba University; RIKEN; Tokyo University of Agriculture & Technology; University of Shizuoka	Takahashi-Nakaguchi, A (corresponding author), Natl Canc Ctr, Canc Prevent Basic Res Project, Tokyo, Japan.	azusan_takahashi@faculty.chiba-u.jp	Iwabuchi, Kikuo/I-7530-2012		Ministry of Health, Labour and Welfare, Japan; Foundation for Promotion of Cancer Research (Japan)	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Foundation for Promotion of Cancer Research (Japan)	Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare, Japan. Azusa Takahashi-Nakaguchi was an awardee of Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan) for the Third-Term Comprehensive 10-Year Strategy for Cancer Control during the performance of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; ASGARI S, 1994, J INSECT PHYSIOL, V40, P789, DOI 10.1016/0022-1910(94)90008-6; Asgari S, 1996, J GEN VIROL, V77, P2653, DOI 10.1099/0022-1317-77-10-2653; Asgari S, 2003, INSECT BIOCHEM MOLEC, V33, P1017, DOI 10.1016/S0965-1748(03)00116-4; Asgari S, 1998, P NATL ACAD SCI USA, V95, P3690, DOI 10.1073/pnas.95.7.3690; Baton LA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-257; Carpusca I, 2006, MOL MICROBIOL, V62, P621, DOI 10.1111/j.1365-2958.2006.05401.x; Carton Y, 2001, IMMUNOGENETICS, V52, P157; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; COUDRON TA, 1991, ACS SYM SER, V449, P41; Glatz R, 2003, J BIOL CHEM, V278, P19743, DOI 10.1074/jbc.M301396200; HAGVAR EB, 1988, ENTOMOL EXP APPL, V47, P275, DOI 10.1007/BF00352214; Hayakawa Yoichi, 1994, Insect Molecular Biology, V3, P97, DOI 10.1111/j.1365-2583.1994.tb00156.x; Jang IH, 2008, BMB REP, V41, P102, DOI 10.5483/BMBRep.2008.41.2.102; Kaeslin M, 2006, J INSECT PHYSIOL, V52, P269, DOI 10.1016/j.jinsphys.2005.11.006; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; KAYA HK, 1970, SCIENCE, V168, P251, DOI 10.1126/science.168.3928.251; Kinuthia W, 1999, J INSECT PHYSIOL, V45, P501, DOI 10.1016/S0022-1910(98)00164-4; KITANO H, 1986, J INSECT PHYSIOL, V32, P369, DOI 10.1016/0022-1910(86)90050-8; KITANO H, 1978, J INSECT PHYSIOL, V24, P261, DOI 10.1016/0022-1910(78)90044-6; Koyama K, 1996, JPN J CANCER RES, V87, P1259, DOI 10.1111/j.1349-7006.1996.tb03141.x; Matsumoto Y, 2008, P NATL ACAD SCI USA, V105, P2516, DOI 10.1073/pnas.0712221105; Matsushima-Hibiya Y, 2000, EUR J BIOCHEM, V267, P5742, DOI 10.1046/j.1432-1327.2000.01640.x; Matsushima-Hibiya Y, 2003, J BIOL CHEM, V278, P9972, DOI 10.1074/jbc.M212114200; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Natori S, 1999, DEV COMP IMMUNOL, V23, P317, DOI 10.1016/S0145-305X(99)00014-2; Okuno S, 2002, INSECT BIOCHEM MOLEC, V32, P559, DOI 10.1016/S0965-1748(01)00135-7; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; QUICKE DLJ, 1997, PARASITIC WASPS, P470; Russo J, 1996, PARASITOLOGY, V112, P135, DOI 10.1017/S0031182000065173; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; STRAND MR, 1984, ANN ENTOMOL SOC AM, V77, P679, DOI 10.1093/aesa/77.6.679; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 2001, ADV EXP MED BIOL, V484, P289; SUGUMARAN M, 1993, PARASITES PATHOGENS, V1, P317; Takamura-Enya T, 2001, P NATL ACAD SCI USA, V98, P12414, DOI 10.1073/pnas.221444598; Tanaka K, 2002, EUR J BIOCHEM, V269, P2557, DOI 10.1046/j.1432-1033.2002.02922.x; Teramoto T, 2004, J INSECT PHYSIOL, V50, P1103, DOI 10.1016/j.jinsphys.2004.08.005; Uka D, 2006, J INSECT PHYSIOL, V52, P1137, DOI 10.1016/j.jinsphys.2006.08.002; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; WAGO H, 1983, DEV COMP IMMUNOL, V7, P199, DOI 10.1016/0145-305X(83)90001-0; WAGO H, 1980, CELL IMMUNOL, V54, P155, DOI 10.1016/0008-8749(80)90198-7; WAGO H, 1982, DEV COMP IMMUNOL, V6, P591; Watanabe M, 1999, P NATL ACAD SCI USA, V96, P10608, DOI 10.1073/pnas.96.19.10608; Watanabe M, 2004, COMP BIOCHEM PHYS A, V139, P125, DOI 10.1016/j.cbpb.2004.07.010; Watanabe M, 2004, J BIOCHEM, V135, P471, DOI 10.1093/jb/mvh062; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Yamamoto M, 2011, GENETICA, V139, P1251, DOI 10.1007/s10709-011-9626-5; Yamamoto M, 2009, COMP BIOCHEM PHYS B, V154, P326, DOI 10.1016/j.cbpb.2009.07.007; Zhang GM, 2004, INSECT BIOCHEM MOLEC, V34, P477, DOI 10.1016/j.ibmb.2004.02.009; Zhang GM, 2006, DEV COMP IMMUNOL, V30, P756, DOI 10.1016/j.dci.2005.11.001	57	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60539	10.1371/journal.pone.0060539	http://dx.doi.org/10.1371/journal.pone.0060539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637752	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400006
J	Mahoney, WM; Gunaje, J; Daum, G; Dong, XR; Majesky, MW				Mahoney, William M., Jr.; Gunaje, Jagadambika; Daum, Guenter; Dong, Xiu Rong; Majesky, Mark W.			Regulator of G-Protein Signaling-5 (RGS5) Is a Novel Repressor of Hedgehog Signaling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HETEROTRIMERIC G-PROTEINS; SMALL-MOLECULE INHIBITORS; SONIC-HEDGEHOG; PRIMARY CILIUM; HEPATOCELLULAR-CARCINOMA; COUPLED RECEPTORS; DRUG DISCOVERY; BREAST-CANCER; G-ALPHA	Hedgehog (Hh) signaling plays fundamental roles in morphogenesis, tissue repair, and human disease. Initiation of Hh signaling is controlled by the interaction of two multipass membrane proteins, patched (Ptc) and smoothened (Smo). Recent studies identify Smo as a G-protein coupled receptor (GPCR)-like protein that signals through large G-protein complexes which contain the G alpha(i) subunit. We hypothesize Regulator of G-Protein Signaling (RGS) proteins, and specifically RGS5, are endogenous repressors of Hh signaling via their ability to act as GTPase activating proteins (GAPs) for GTP-bound G alpha(i), downstream of Smo. In support of this hypothesis, we demonstrate that RGS5 over-expression inhibits sonic hedgehog (Shh)-mediated signaling and osteogenesis in C3H10T1/2 cells. Conversely, signaling is potentiated by siRNA-mediated knock-down of RGS5 expression, but not RGS4 expression. Furthermore, using immuohistochemical analysis and co-immunoprecipitation (Co-IP), we demonstrate that RGS5 is present with Smo in primary cilia. This organelle is required for canonical Hh signaling in mammalian cells, and RGS5 is found in a physical complex with Smo in these cells. We therefore conclude that RGS5 is an endogenous regulator of Hh-mediated signaling and that RGS proteins are potential targets for novel therapeutics in Hh-mediated diseases.	[Mahoney, William M., Jr.; Gunaje, Jagadambika; Majesky, Mark W.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Daum, Guenter] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Majesky, Mark W.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mahoney, William M., Jr.; Gunaje, Jagadambika; Daum, Guenter; Majesky, Mark W.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Mahoney, William M., Jr.; Majesky, Mark W.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Dong, Xiu Rong; Majesky, Mark W.] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Mahoney, WM (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	wmahoney@uw.edu; mwm84@uw.edu	Mahoney, William/GQB-0802-2022	Majesky, Mark/0000-0003-4267-6220	National Institutes of Health [HL087513, HL094374, HL088374, HL019242, HL093594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093594, P01HL019242, P01HL094374, R01HL088374, R00HL087513, K99HL087513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants HL087513 and HL094374 (to WMM Jr), HL088374 (to GD) and HL019242 and HL093594 (to MWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Actis M, 2011, BIOPOLYMERS, V95, P24, DOI 10.1002/bip.21544; Adams LD, 2000, CIRC RES, V87, P623, DOI 10.1161/01.RES.87.7.623; Adams LD, 2006, ARTERIOSCL THROM VAS, V26, P319, DOI 10.1161/01.ATV.0000196647.45718.d6; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Barzi M, 2011, J BIOL CHEM, V286, P8067, DOI 10.1074/jbc.M110.178772; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Bijlsma MF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002798; Bilger A, 2004, GENETICS, V167, P859, DOI 10.1534/genetics.103.024521; Blazer LL, 2011, BIOCHEMISTRY-US, V50, P3181, DOI 10.1021/bi1019622; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Boss CN, 2007, CLIN CANCER RES, V13, P3347, DOI 10.1158/1078-0432.CCR-06-2156; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen X, 2004, MODERN PATHOL, V17, P1198, DOI 10.1038/modpathol.3800167; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chen XL, 2010, ARCH MED RES, V41, P315, DOI 10.1016/j.arcmed.2010.06.003; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cui W, 2010, CANCER SCI, V101, P927, DOI 10.1111/j.1349-7006.2010.01495.x; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Douglas AE, 2011, J BIOL CHEM, V286, P30714, DOI 10.1074/jbc.M111.219279; Goetz SC, 2009, METHOD CELL BIOL, V94, P199, DOI 10.1016/S0091-679X(08)94010-3; Gunaje JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC478, DOI 10.1152/ajpcell.00348.2010; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; Han SB, 2008, MOL CELL BIOL; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Hurst JH, 2009, CELL MOL BIOL LETT, V14, P153, DOI 10.2478/s11658-008-0040-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; Kim Y, 2007, CANCER RES, V67, P3583, DOI 10.1158/0008-5472.CAN-06-3040; Kimple AJ, 2007, BBA-PROTEINS PROTEOM, V1774, P1213, DOI 10.1016/j.bbapap.2007.06.002; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lavine KJ, 2008, DEVELOPMENT, V135, P3161, DOI 10.1242/dev.019919; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Li J, 2004, J VASC SURG, V40, P519, DOI 10.1016/j.jvs.2004.06.021; Liang YB, 2005, FEBS J, V272, P791, DOI 10.1111/j.1742-4658.2004.04516.x; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Majesky MW, 2012, CELLS TISSUES ORGANS, V195, P73, DOI 10.1159/000331413; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; Martemyanov KA, 2009, PROG MOL BIOL TRANSL, V86, P205, DOI 10.1016/S1877-1173(09)86007-9; Martemyanov KA, 2008, P NATL ACAD SCI USA, V105, P20988, DOI 10.1073/pnas.0808941106; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Mitchell TS, 2008, ANGIOGENESIS, V11, P141, DOI 10.1007/s10456-007-9085-x; Morrow D, 2007, AM J PHYSIOL-CELL PH, V292, pC488, DOI 10.1152/ajpcell.00337.2005; Morrow D, 2009, ARTERIOSCL THROM VAS, V29, P1112, DOI 10.1161/ATVBAHA.109.186890; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Nagase T, 2005, GENES CELLS, V10, P595, DOI 10.1111/j.1365-2443.2005.00861.x; Nielsen CM, 2010, DEV BIOL, V340, P430, DOI 10.1016/j.ydbio.2010.01.032; Nisancioglu MH, 2008, MOL CELL BIOL, V28, P2324, DOI 10.1128/MCB.01252-07; Nybakken K, 2002, CURR OPIN GENET DEV, V12, P503, DOI 10.1016/S0959-437X(02)00333-7; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Omenetti A, 2008, AM J PHYSIOL-GASTR L, V294, pG595, DOI 10.1152/ajpgi.00543.2007; Osmond RI, 2010, CURR OPIN MOL THER, V12, P305; Palladino M, 2011, MOL THER, V19, P658, DOI 10.1038/mt.2010.292; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Roudaut H, 2011, MOL PHARMACOL, V79, P453, DOI 10.1124/mol.110.069708; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Ruiz-Gomez A, 2007, BBA-BIOMEMBRANES, V1768, P901, DOI 10.1016/j.bbamem.2006.09.020; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Toro-Castillo C, 2007, AM J PHYSIOL-CELL PH, V292, pC573, DOI 10.1152/ajpcell.00219.2006; Wang X, 2008, J MOL CELL CARDIOL, V44, P539, DOI 10.1016/j.yjmcc.2007.11.019; Wang YR, 2004, METHOD ENZYMOL, V390, P31; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; Williams KP, 1999, J CELL SCI, V112, P4405; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yuasa T, 2002, J CELL PHYSIOL, V193, P225, DOI 10.1002/jcp.10166; Zacharias WJ, 2010, GASTROENTEROLOGY, V138, P2368, DOI 10.1053/j.gastro.2010.02.057; Zehentner BK, 2000, DNA CELL BIOL, V19, P275, DOI 10.1089/10445490050021186; Zhang HJ, 2012, FASEB J, V26, P181, DOI 10.1096/fj.11-185454; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3; Zhou J, 2001, LIFE SCI, V68, P1457, DOI 10.1016/S0024-3205(01)00939-0	107	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61421	10.1371/journal.pone.0061421	http://dx.doi.org/10.1371/journal.pone.0061421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637832	gold, Green Submitted, Green Published			2022-12-25	WOS:000317908700033
J	Palermo, T; Rawat, R; Weiser, SD; Kadiyala, S				Palermo, Tia; Rawat, Rahul; Weiser, Sheri D.; Kadiyala, Suneetha			Food Access and Diet Quality Are Associated with Quality of Life Outcomes among HIV-Infected Individuals in Uganda	PLOS ONE			English	Article							MEDICAL OUTCOMES; SOCIOECONOMIC DIFFERENTIALS; ANTIRETROVIRAL TREATMENT; HEALTH; INSECURITY; MORTALITY; NUTRITION; WOMEN; RELIABILITY; HIV/AIDS	Background: Food insecurity is associated with poor nutritional and clinical outcomes among people living with HIV/AIDS. Few studies investigate the link between food insecurity, dietary diversity and health-related quality of life among people living with HIV/AIDS. Objective: We investigated whether household food access and individual dietary diversity are associated with health-related quality of life among people living with HIV/AIDS in Uganda. Methods: We surveyed 902 people living with HIV/AIDS and their households from two clinics in Northern Uganda. Health-related quality of life outcomes were assessed using the Medical Outcomes Study (MOS)-HIV Survey. We performed multivariate regressions to investigate the relationship between health-related quality of life, household food insecurity and individual dietary diversity. Results: People living with HIV/AIDS from severe food insecurity households have mean mental health status scores that are 1.7 points lower (p<.001) and physical health status scores that are 1.5 points lower (p<.01). Individuals with high dietary diversity have mean mental health status scores that were 3.6 points higher (p<.001) and physical health status scores that were 2.8 points higher (p<.05). Conclusions: Food access and diet quality are associated with health-related quality of life and may be considered as part of comprehensive interventions designed to mitigate psychosocial consequences of HIV.	[Palermo, Tia] SUNY Stony Brook, Dept Prevent Med, Program Publ Hlth, Stony Brook, NY 11794 USA; [Rawat, Rahul; Kadiyala, Suneetha] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Weiser, Sheri D.] UCSF, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; CGIAR; International Food Policy Research Institute (IFPRI); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Kadiyala, S (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.	s.kadiyala@cgiar.org	Palermo, Tia/ABI-8328-2020; Harding, Richard/G-9729-2012	Kadiyala, Suneetha/0000-0002-9101-1471	Regional Network on AIDS, Livelihoods and Food Security (RENEWAL); Kerry Group; Irish Aid; Swedish International Development Cooperation Agency (SIDA)	Regional Network on AIDS, Livelihoods and Food Security (RENEWAL); Kerry Group; Irish Aid(CGIAR); Swedish International Development Cooperation Agency (SIDA)	This study was funded by the Regional Network on AIDS, Livelihoods and Food Security (RENEWAL) facilitated by the International Food Policy Research Institute (IFPRI), and through an IFPRI-Concern Worldwide research partnership funded by the Kerry Group. RENEWAL is grateful for support from Irish Aid and the Swedish International Development Cooperation Agency (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2008, INT J PSYCHIAT MED, V38, P43, DOI 10.2190/PM.38.1.d; Amarantos E, 2001, J GERONTOL A-BIOL, V56, P54, DOI 10.1093/gerona/56.suppl_2.54; Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Boffito M, 2005, ANTIVIR THER, V10, P375; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Dowd JB, 2012, HEALTH PSYCHOL, V31, P5, DOI 10.1037/a0025337; Dowd JB, 2008, AM J EPIDEMIOL, V167, P112, DOI 10.1093/aje/kwm247; Dowd JB, 2009, EPIDEMIOLOGY, V20, P902, DOI 10.1097/EDE.0b013e3181bb5302; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Food and Agriculture Organization of the United Nations, 2008, INTR BAS CONC FOOD S; Gibson K, 2011, AIDS PATIENT CARE ST, V25, P371, DOI 10.1089/apc.2010.0165; Gillespie S, 2008, IS POVERTY WEALTH DR; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P3, DOI 10.1016/j.bbi.2004.06.003; Hadley C, 2008, AM J PHYS ANTHROPOL, V135, P225, DOI 10.1002/ajpa.20724; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Hughes J, 2004, DISABIL REHABIL, V26, P371, DOI 10.1080/09638280410001662932; Jelsma J, 2005, AIDS CARE, V17, P579, DOI 10.1080/09540120412331319714; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Kadiyala S, 2010, SOCIOECONOMIC DIMENS, P74; Kadiyala S, 2012, PUBLIC HEALTH NUTR, V16, P164; Kalichman SC, 2010, J URBAN HEALTH, V87, P631, DOI 10.1007/s11524-010-9446-4; KANT AK, 1993, AM J CLIN NUTR, V57, P434, DOI 10.1093/ajcn/57.3.434; Kirkpatrick SI, 2008, J NUTR, V138, P604, DOI 10.1093/jn/138.3.604; Klesges LM, 2001, AM J PUBLIC HEALTH, V91, P68, DOI 10.2105/AJPH.91.1.68; Lee JS, 2001, J NUTR, V131, P1503, DOI 10.1093/jn/131.5.1503; Lis CG, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-27; Louwagie GM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-244; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; Maddigan SL, 2006, J INFORM, V96; Mast TC, 2004, AIDS CARE, V16, P81, DOI 10.1080/09540120310001633994; Murri R, 2003, AIDS CARE, V15, P581, DOI 10.1080/0954012031000134818; Normen L, 2005, J NUTR, V135, P820, DOI 10.1093/jn/135.4.820; O'Leary JF, 1998, J ACQ IMMUN DEF SYND, V17, P433, DOI 10.1097/00042560-199804150-00008; OKeefe EA, 1996, QUAL LIFE RES, V5, P275, DOI 10.1007/BF00434749; Oketch JA, 2011, HEALTH POLICY, V99, P267, DOI 10.1016/j.healthpol.2010.08.018; Piazza JR, 2010, J GERONTOL B-PSYCHOL, V65, P513, DOI 10.1093/geronb/gbq049; Rawat R, 2013, JAIDS-J ACQ IMM DEF, V62, P246, DOI 10.1097/QAI.0b013e3182797363; Revicki DA, 1998, MED CARE, V36, P126, DOI 10.1097/00005650-199802000-00003; Rueda S, 2011, AIDS CARE, V23, P435, DOI 10.1080/09540121.2010.507952; Perez IR, 2009, AIDS CARE, V21, P943, DOI 10.1080/09540120802612840; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Sekar V, 2007, J CLIN PHARMACOL, V47, P479, DOI 10.1177/0091270006298603; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Semba RD, 2005, ARCH INTERN MED, V165, P2229, DOI 10.1001/archinte.165.19.2229; Semba RD, 1999, BRIT J NUTR, V81, P181, DOI 10.1017/S0007114599000379; Smith MY, 1996, QUAL LIFE RES, V5, P47, DOI 10.1007/BF00435968; Stangl AL, 2011, QUALITY LIFE RES; Steptoe A, 2007, HEART, V2006; Stuff JE, 2004, J NUTR, V134, P2330, DOI 10.1093/jn/134.9.2330; Suttajit M, 2007, ASIA PAC J CLIN NUTR, V16, P318; Tang Alice M, 2003, AIDS Read, V13, pS23; The World Bank, 2007, HIV AIDS NUTR FOOD S; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03; Wanden-Berghe C, 2009, J HUM NUTR DIET, V22, P219, DOI 10.1111/j.1365-277X.2009.00957.x; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; World Food Programme, 2010, WFP HIV AIDS POL; Wu AW, 1997, QUAL LIFE RES, V6, P531, DOI 10.1023/A:1018460132567; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; Wu AW., 1999, MOS HIV HLTH SURVEY; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0; Zajacova A, 2009, J GERONTOL A-BIOL, V64, P272, DOI 10.1093/gerona/gln012	71	36	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62353	10.1371/journal.pone.0062353	http://dx.doi.org/10.1371/journal.pone.0062353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130IU	23638049	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000317908700083
J	Wu, XJ; Huang, AY; Xu, ML; Wang, C; Jia, ZJ; Wang, GC; Niu, JF				Wu, Xiaojie; Huang, Aiyou; Xu, Meiling; Wang, Chao; Jia, Zhaojun; Wang, Guangce; Niu, Jianfeng			Variation of Expression Levels of Seven Housekeeping Genes at Different Life-History Stages in Porphyra yezoensis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR NORMALIZATION; REAL-TIME PCR; MESSENGER-RNA; RIBOSOMAL-RNA; QUANTIFICATION; RHODOPHYTA; VALIDATION; BANGIALES; SELECTION	In order to identify the optimal internal control for relative real-time PCR when studying target gene expression in the red alga Porphyra yezoensis, we quantified the expression of seven housekeeping genes (18S ribosomal RNA, 30S ribosomal protein S8, Polyubiquitin-2, Glyceraldehyde-3-phosphate dehydrogenase, Elongation factor 1-alpha, Beta-tubulin and Actin 3) at different life-history stages. Absolute quantification was done by normalization to total RNA quantity and by normalization to genomic DNA quantity. We used these two normalization approaches, comparing the differences of expression levels of all candidate housekeeping genes between any two generations and across three life-history stages (filamentous sporophytes, leafy gametophytes and conchospores). We found GAPDH had the best stability in all cases and we recommend that GAPDH be considered as a potential internal control for gene expression studies at different life-history stages in P. yezoensis.	[Wu, Xiaojie; Xu, Meiling; Jia, Zhaojun; Wang, Guangce] Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin, Peoples R China; [Huang, Aiyou; Wang, Chao; Wang, Guangce; Niu, Jianfeng] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Huang, Aiyou; Wang, Chao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Tianjin University Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, GC (corresponding author), Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin, Peoples R China.	gcwang@ms.qdio.ac.cn			National Natural Science Foundation of China [B49082401, 30830015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (B49082401; 30830015)(http://www.nsfc.gov.cn/Portal0/default124.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2004, AZ QUANT PCR; Asamizu E, 2003, J PHYCOL, V39, P923, DOI 10.1046/j.1529-8817.2003.03003.x; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Daggett TL, 2005, AQUACULTURE, V244, P263, DOI 10.1016/j.aquaculture.2004.11.030; de la Coba F, 2009, J DERMATOL SCI, V55, P161, DOI 10.1016/j.jdermsci.2009.06.004; *FAO, 2006, STAT WORLD AQ 2006; Fleurence J, 1999, TRENDS FOOD SCI TECH, V10, P25, DOI 10.1016/S0924-2244(99)00015-1; Fukuda S, 2003, J APPL PHYCOL, V15, P81, DOI 10.1023/A:1022954312498; Fukuda S, 2008, PLANT SCI, V174, P329, DOI 10.1016/j.plantsci.2007.12.006; Giricz O, 2008, ANAL BIOCHEM, V380, P137, DOI 10.1016/j.ab.2008.05.024; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Huang T, 2005, SCIENCE, V309, P1694, DOI 10.1126/science.1117768; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Kitade Y, 2002, J APPL PHYCOL, V14, P135, DOI 10.1023/A:1019584723331; Kitade Y, 1999, FISH GENET BREED SCI, V28, P27; Kitade Yukihiro, 1998, Phycological Research, V46, P17, DOI 10.1111/j.1440-1835.1998.tb00092.x; Loncar J, 2010, COMP BIOCHEM PHYS C, V151, P209, DOI 10.1016/j.cbpc.2009.10.009; MacArtain P, 2007, NUTR REV, V65, P535, DOI [10.1301/nr.2007.dec.535-543, 10.1111/j.1753-4887.2007.tb00278.x]; Marelli SP, 2010, ANIM BIOTECHNOL, V21, P140, DOI 10.1080/10495391003608621; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ransbotyn V, 2006, LIMNOL OCEANOGR-METH, V4, P367, DOI 10.4319/lom.2006.4.367; REED RH, 1980, J EXP BOT, V31, P1539, DOI 10.1093/jxb/31.6.1539; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sahoo D, 2002, CURR SCI INDIA, V83, P1313; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; SHEATH RG, 1977, PHYCOLOGIA, V16, P265, DOI 10.2216/i0031-8884-16-3-265.1; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; SIDIRELLIWOLFF M, 1992, BOT MAR, V35, P251, DOI 10.1515/botm.1992.35.3.251; Stordeur P, 2002, J IMMUNOL METHODS, V259, P55, DOI 10.1016/S0022-1759(01)00489-6; Tichopad A, 2003, MOL CELL PROBE, V17, P5, DOI 10.1016/S0890-8508(02)00114-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; WIENCKE C, 1980, PLANTA, V150, P303, DOI 10.1007/BF00384660; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yamazaki A, 1998, J PHYCOL, V34, P1082, DOI 10.1046/j.1529-8817.1998.341082.x; Yoshida T, 1997, NAT HIST RES, V3, P5; Zhang BY, 2010, J PHYCOL, V46, P290, DOI 10.1111/j.1529-8817.2009.00801.x	46	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e60740	10.1371/journal.pone.0060740	http://dx.doi.org/10.1371/journal.pone.0060740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637763	gold, Green Published, Green Submitted			2022-12-25	WOS:000317908700006
J	Hu, ZY; Hua, W; Zhang, L; Deng, LB; Wang, XF; Liu, GH; Hao, WJ; Wang, HZ				Hu, Zhi-Yong; Hua, Wei; Zhang, Liang; Deng, Lin-Bin; Wang, Xin-Fa; Liu, Gui-Hua; Hao, Wan-Jun; Wang, Han-Zhong			Seed Structure Characteristics to Form Ultrahigh Oil Content in Rapeseed	PLOS ONE			English	Article							PROTEIN; BODIES; ACCUMULATION; OILBODIES; OLEOSINS; QTL	Background: Rapeseed (Brassica napus L.) is an important oil crop in the world, and increasing its oil content is a major breeding goal. The studies on seed structure and characteristics of different oil content rapeseed could help us to understand the biological mechanism of lipid accumulation, and be helpful for rapeseed breeding. Methodology/Principal Findings: Here we report on the seed ultrastructure of an ultrahigh oil content rapeseed line YN171, whose oil content is 64.8%, and compared with other high and low oil content rapeseed lines. The results indicated that the cytoplasms of cotyledon, radicle, and aleuronic cells were completely filled with oil and protein bodies, and YN171 had a high oil body organelle to cell area ratio for all cell types. In the cotyledon cells, oil body organelles comprised 81% of the total cell area in YN171, but only 53 to 58% in three high oil content lines and 33 to 38% in three low oil content lines. The high oil body organelle to cotyledon cell area ratio and the cotyledon ratio in seed were the main reasons for the ultrahigh oil content of YN171. The correlation analysis indicated that oil content is significantly negatively correlated with protein content, but is not correlated with fatty acid composition. Conclusions/Significance: Our results indicate that the oil content of YN171 could be enhanced by increasing the oil body organelle to cell ratio for some cell types. The oil body organelle to seed ratio significantly highly positively correlates with oil content, and could be used to predict seed oil content. Based on the structural analysis of different oil content rapeseed lines, we estimate the maximum of rapeseed oil content could reach 75%. Our results will help us to screen and identify high oil content lines in rapeseed breeding.	[Hu, Zhi-Yong; Hua, Wei; Zhang, Liang; Deng, Lin-Bin; Wang, Xin-Fa; Liu, Gui-Hua; Hao, Wan-Jun; Wang, Han-Zhong] Chinese Acad Agr Sci, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wang, HZ (corresponding author), Chinese Acad Agr Sci, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	wanghz@oilcrops.cn			National High Technology Research and Development Program of China [2013AA102602, 2012AA101107]; National Natural Science Foundation of China [31201241]; National Key Basic Research Program of China [2011CB109300]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National High Technology Research and Development Program of China (2013AA102602 and 2012AA101107), the National Natural Science Foundation of China (31201241) and the National Key Basic Research Program of China (2011CB109300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; Chung J, 2003, CROP SCI, V43, P1053, DOI 10.2135/cropsci2003.1053; Cober ER, 2000, CROP SCI, V40, P39, DOI 10.2135/cropsci2000.40139x; Hu ZY, 2009, PLANT CELL REP, V28, P541, DOI 10.1007/s00299-008-0654-2; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Katavic V, 2006, PROTEOMICS, V6, P4586, DOI 10.1002/pmic.200600020; Kuang A, 2000, ANN BOT-LONDON, V85, P851, DOI 10.1006/anbo.2000.1153; Li AM, 2009, EUPHYTICA, V170, P289, DOI 10.1007/s10681-009-9979-3; [李殿荣 Li Dianrong], 2011, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V20, P83; Mantese AI, 2006, ANN BOT-LONDON, V97, P999, DOI 10.1093/aob/mcl046; Murphy DJ, 1996, TRENDS BIOTECHNOL, V14, P206, DOI 10.1016/0167-7799(96)10028-7; Ohto M., 2007, Seed development, dormancy and germination, P1; Pinzi S, 2009, ENERG FUEL, V23, P2325, DOI 10.1021/ef801098a; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; RASHID A, 1995, P 9 INT RAP C CAMBR, P1144; Robbelen G., 1980, Brassica crops and wild allies. [II]., P285; Roscoe TJ, 2005, EUR J LIPID SCI TECH, V107, P256, DOI 10.1002/ejlt.200590023; Sarmiento C, 1997, PLANT J, V11, P783, DOI 10.1046/j.1365-313X.1997.11040783.x; [沈金雄 SHEN Jinxiong], 2007, [华中农业大学学报, Journal of Huazhong Agricultural University], V26, P894; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Tang ZL, 1997, PLANT BREEDING, V116, P471, DOI 10.1111/j.1439-0523.1997.tb01033.x; TOPFER R, 1995, SCIENCE, V268, P681, DOI 10.1126/science.268.5211.681; TURNHAM E, 1983, BIOCHEM J, V212, P223, DOI 10.1042/bj2120223; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; [王汉中 Wang Hanzhong], 2010, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V32, P300; Wang XF, 2011, THESIS CHINESE ACAD, P2; Wei CunXu, 2009, Acta Agronomica Sinica, V35, P1139, DOI 10.3724/SP.J.1006.2009.01139; Yang QY, 2012, THEOR APPL GENET, V125, P715, DOI 10.1007/s00122-012-1863-1; 王汉中, 2004, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V26, P98; [No title captured]	30	59	65	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62099	10.1371/journal.pone.0062099	http://dx.doi.org/10.1371/journal.pone.0062099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637973	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800025
J	Swei, A; Russell, BJ; Naccache, SN; Kabre, B; Veeraraghavan, N; Pilgard, MA; Johnson, BJB; Chiu, CY				Swei, Andrea; Russell, Brandy J.; Naccache, Samia N.; Kabre, Beniwende; Veeraraghavan, Narayanan; Pilgard, Mark A.; Johnson, Barbara J. B.; Chiu, Charles Y.			The Genome Sequence of Lone Star Virus, a Highly Divergent Bunyavirus Found in the Amblyomma americanum Tick	PLOS ONE			English	Article							ERYTHEMA MIGRANS; UNITED-STATES; BHANJA VIRUS; SEARCH TOOL; DISEASE; MISSOURI; ILLNESS; FEVER; ALIGNMENT; AGENT	Viruses in the family Bunyaviridae infect a wide range of plant, insect, and animal hosts. Tick-borne bunyaviruses in the Phlebovirus genus, including Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) in China, Heartland virus (HRTV) in the United States, and Bhanja virus in Eurasia and Africa have been associated with acute febrile illness in humans. Here we sought to characterize the growth characteristics and genome of Lone Star virus (LSV), an unclassified bunyavirus originally isolated from the lone star tick Amblyomma americanum. LSV was able to infect both human (HeLa) and monkey (Vero) cells. Cytopathic effects were seen within 72 h in both cell lines; vacuolization was observed in infected Vero, but not HeLa, cells. Viral culture supernatants were examined by unbiased deep sequencing and analysis using an in-house developed rapid computational pipeline for viral discovery, which definitively identified LSV as a phlebovirus. De novo assembly of the full genome revealed that LSV is highly divergent, sharing <61% overall amino acid identity with any other bunyavirus. Despite this sequence diversity, LSV was found by phylogenetic analysis to be part of a well-supported clade that includes members of the Bhanja group viruses, which are most closely related to SFSTV/HRTV. The genome sequencing of LSV is a critical first step in developing diagnostic tools to determine the risk of arbovirus transmission by A. americanum, a tick of growing importance given its expanding geographic range and competence as a disease vector. This study also underscores the power of deep sequencing analysis in rapidly identifying and sequencing the genomes of viruses of potential clinical and public health significance.	[Swei, Andrea; Naccache, Samia N.; Kabre, Beniwende; Veeraraghavan, Narayanan; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Swei, Andrea; Naccache, Samia N.; Kabre, Beniwende; Veeraraghavan, Narayanan; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA; [Russell, Brandy J.; Pilgard, Mark A.; Johnson, Barbara J. B.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Swei, Andrea] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; California State University System; San Francisco State University	Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	charles.chiu@ucsf.edu	Swei, Andrea/AAD-9649-2021	Chiu, Charles/0000-0003-2915-2094	National Institutes of Health (NIH) [R56-AI089532, R01-HL105704]; Abbott Viral Discovery Award; QB3 Swartz Foundation Lyme Disease Grant; National Research Fund for Tick-borne Diseases; UCSF Microbial Pathogenesis training grant; Centers for Disease Control and Prevention; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089532] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Viral Discovery Award; QB3 Swartz Foundation Lyme Disease Grant; National Research Fund for Tick-borne Diseases; UCSF Microbial Pathogenesis training grant; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health (NIH) grants R56-AI089532 and R01-HL105704 (C.Y.C.), an Abbott Viral Discovery Award (C.Y.C.), a QB3 Swartz Foundation Lyme Disease Grant (C.Y.C.), and a tick-borne research grant from the National Research Fund for Tick-borne Diseases (C.Y.C.). The authors also acknowledge support from a UCSF Microbial Pathogenesis training grant (A.S.) and funding from the Centers for Disease Control and Prevention in support of pathogen discovery efforts in STARI (B.J.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; CALISHER CH, 1975, AM J TROP MED HYG, V24, P1040, DOI 10.4269/ajtmh.1975.24.1040; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Dilcher M, 2012, VIRUS GENES, V45, P311, DOI 10.1007/s11262-012-0785-y; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Elbeaino T, 2009, J GEN VIROL, V90, P1281, DOI 10.1099/vir.0.008649-0; Ergonul O, 2012, CURR OPIN VIROL, V2, P215, DOI 10.1016/j.coviro.2012.03.001; Goddard J, 2009, VET PARASITOL, V160, P1, DOI 10.1016/j.vetpar.2008.10.089; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Guu TSY, 2012, ADV EXP MED BIOL, V726, P245, DOI 10.1007/978-1-4614-0980-9_11; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkland KB, 1997, ARCH INTERN MED, V157, P2635, DOI 10.1001/archinte.157.22.2635; KOKERNOT RH, 1969, AM J TROP MED HYG, V18, P789, DOI 10.4269/ajtmh.1969.18.789; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Marklewitz M, 2011, J VIROL, V85, P9227, DOI 10.1128/JVI.00230-11; Masters EJ, 2008, INFECT DIS CLIN N AM, V22, P361, DOI 10.1016/j.idc.2007.12.010; Matsuno K, 2013, J VIROL; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Paddock CD, 2007, CURR TOP MICROBIOL, V315, P289; Palacios G, 2013, J VIROL; Punda V, 1980, ZENTRALBLATT BAKTERI, P297; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruby JG, 2013, UCSF DERISI LAB WEBS; Vesenjak-Hirjan J, 1980, ZENTRALBLATT BAKTERI, P297; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Wormser GP, 2005, CLIN INFECT DIS, V40, P423, DOI 10.1086/427289; Wormser GP, 2005, CLIN INFECT DIS, V41, P958, DOI 10.1086/432935; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zaharia M, 2011, ARXIV11115572V1; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804	38	38	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62083	10.1371/journal.pone.0062083	http://dx.doi.org/10.1371/journal.pone.0062083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637969	Green Submitted, Green Published, gold			2022-12-25	WOS:000321662800023
J	Oh, YJ; Yang, SH; Kim, DK; Kang, SW; Kim, YS				Oh, Yun Jung; Yang, Seung Hee; Kim, Dong Ki; Kang, Shin-Wook; Kim, Yon Su			Autoantibodies against Phospholipase A(2) Receptor in Korean Patients with Membranous Nephropathy	PLOS ONE			English	Article							EXPERIMENTAL GLOMERULONEPHRITIS; STRONG ASSOCIATION; NEPHROTIC SYNDROME; ANTIBODIES; DISEASE; CYCLOPHOSPHAMIDE; CYCLOSPORINE; HLA-DR2; ENOLASE; KIDNEY	The data were presented in abstract form at the 45th meeting of the American Society of Nephrology, October 30-November 04 2012, San Diego, CA, USA. Circulating autoantibodies against M-type phospholipase A(2) receptor (PLA(2)R) are important pathogenic antibodies of idiopathic membranous nephropathy (MN) in adults. However, previous studies on the clinical impact of anti-PLA(2)R antibodies demonstrated several limitations, including insufficient numbers of study subjects and different time points and methods for anti-PLA(2)R antibody measurement. To verify the clinical significance of anti-PLA(2)R antibodies in Korean patients with MN, we measured autoantibodies in serum samples obtained at the time of biopsy from a total of 100 patients with idiopathic MN who had not yet received immunosuppressive treatment. We detected anti-PLA(2)R antibody in 69 patients, and we observed that autoantibody reactivity reflected the severity of disease activity. Proteinuria and hypoalbuminemia were more severe in patients with anti-PLA(2)R than in those without the autoantibodies (2.95 g/g vs. 6.85 g/g, P = 0.003; 3.1 g/dL vs. 2.5 g/dL, P = 0.004, respectively). Additionally, the clinical severities worsened proportionally as the levels of anti-PLA(2)R antibodies increased (P = 0.015 and P for trend <0.001 for proteinuria and hypoalbuminemia, respectively). However, neither the levels nor the presence or absence of anti-PLA(2)R antibody showed a significant correlation with clinical outcomes, such as remission rate and time to remission. In conclusion, we observed that anti-PLA(2)R antibodies are highly prevalent in Korean patients with idiopathic MN and that they reflect the clinical disease activity before the administration of immunosuppressive treatment. However, the levels of anti-PLA(2)R antibody at the time of kidney biopsy may not predict the clinical outcomes in current clinical practice.	[Oh, Yun Jung; Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Oh, Yun Jung; Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Yang, Seung Hee; Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University	Kim, YS (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	kswkidney@yumc.yonsei.ac.kr	Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852	Korean Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea [A110717]	Korean Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea	This work was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea (A110717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ABE S, 1986, J CLIN PATHOL, V39, P1193, DOI 10.1136/jcp.39.11.1193; Alexopoulos E, 2006, NEPHROL DIAL TRANSPL, V21, P3127, DOI 10.1093/ndt/gfl360; Beck Jr LH, 2011, J AM SOC NEPHROL; Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bruschi M, 2011, J PROTEOMICS, V74, P2008, DOI 10.1016/j.jprot.2011.05.021; Cattran D, 2005, J AM SOC NEPHROL, V16, P1188, DOI 10.1681/ASN.2005010028; Cattran DC, 2001, KIDNEY INT, V59, P1484, DOI 10.1046/j.1523-1755.2001.0590041484.x; Cattran DC, 1997, KIDNEY INT, V51, P901, DOI 10.1038/ki.1997.127; COUSER WG, 1978, J CLIN INVEST, V62, P1275, DOI 10.1172/JCI109248; DOI T, 1984, CLIN EXP IMMUNOL, V58, P57; Gitlits VM, 2001, J INVEST MED, V49, P138, DOI 10.2310/6650.2001.34040; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; HIKI Y, 1984, KIDNEY INT, V25, P953, DOI 10.1038/ki.1984.116; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2012, KIDNEY INT; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Oliveira DBG, 1998, LANCET, V351, P670, DOI 10.1016/S0140-6736(97)04122-6; PEI Y, 1992, KIDNEY INT, V42, P960, DOI 10.1038/ki.1992.374; Ponticelli C, 1998, J AM SOC NEPHROL, V9, P444; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Reichert LJM, 1998, AM J KIDNEY DIS, V31, P1, DOI 10.1053/ajkd.1998.v31.pm9428445; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; TOMURA S, 1984, NEPHRON, V36, P242, DOI 10.1159/000183162; VANDAMME BJC, 1978, LAB INVEST, V38, P502; Wakui H, 1999, CLIN EXP IMMUNOL, V118, P445; Wasserstein AG, 1997, J AM SOC NEPHROL, V8, P664	32	87	107	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62151	10.1371/journal.pone.0062151	http://dx.doi.org/10.1371/journal.pone.0062151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637987	gold, Green Published, Green Submitted			2022-12-25	WOS:000318343700035
J	Addo, J; Crichton, S; Bhalla, A; Rudd, AG; Wolfe, CDA; McKevitt, C				Addo, Juliet; Crichton, Siobhan; Bhalla, Ajay; Rudd, Anthony G.; Wolfe, Charles D. A.; McKevitt, Christopher			Impact of Implementing Evidence-Based Acute Stroke Interventions on Survival: The South London Stroke Register	PLOS ONE			English	Article							UNIT CARE; FOLLOW-UP; NATURAL HABITAT; REHABILITATION; MANAGEMENT; OUTCOMES; WARDS	Background: Studies examining the impact of organised acute stroke care interventions on survival in subgroups of stroke patients remain limited. Aims: This study examined the effects of a range of evidence-based interventions of acute stroke care on one year survival post-stroke and determined the size of the effect across different socio-demographic and clinical subgroups of patients. Methods: Data on 4026 patients with a first-ever stroke recruited to the population-based South London Stroke Register between 1995 and 2010 were used. In uni-variable analyses, one year cumulative survival rates in socio-demographic groups and by care received was determined. Survival functions were compared using Log-rank tests. Multivariable Cox models were used to test for interactions between components of care and age group, sex, ethnic group, social class, stroke subtype and level of consciousness. Results: 1949 (56.4%) patients were admitted to a stroke unit. Patients managed on a stroke unit, those with deficits receiving specific rehabilitation therapies and those with ischaemic stroke subtype receiving aspirin in the acute phase had better one year survival compared to those who did not receive these interventions. The greatest reduction in the hazards of death among patients treated on a stroke unit were in the youngest patients aged,65 years, (HR 0.39; 95% CI: 0.25-0.62), and those with reduced levels of consciousness, GCS,9, (HR: 0.44; CI: 0.33-0.58). Conclusions: There was evidence of better one year survival in patients receiving specific acute interventions after stroke with a significantly greater effect in stroke subgroups, suggesting the possibility of re-organising stroke services to ensure that the most appropriate care is made accessible to patients likely to derive the most benefits from such interventions.	[Addo, Juliet; Crichton, Siobhan; Rudd, Anthony G.; Wolfe, Charles D. A.; McKevitt, Christopher] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Bhalla, Ajay; Rudd, Anthony G.] St Thomas Hosp, Dept Ageing & Hlth, Guys & St Thomas NHS Fdn Trust, London, England; [Addo, Juliet; Wolfe, Charles D. A.] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Addo, J (corresponding author), Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England.	Juliet.Addo@lshtm.ac.uk	mckevitt, christopher/AAN-7271-2021	MCKEVITT, CHRISTOPHER/0000-0002-5290-4613; Crichton, Siobhan/0000-0001-9962-083X; Wolfe, Charles/0000-0001-8264-0981	Guy's and St Thomas' Hospital Charity; Stroke Association, Department of Health HQIP, UK; National Institute for Health [RP-PG-0407-10184]; Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre; National Institute for Health Research (NIHR) [RP-PG-0407-10184]; National Institute for Health Research [RP-PG-0407-10184] Funding Source: researchfish	Guy's and St Thomas' Hospital Charity; Stroke Association, Department of Health HQIP, UK; National Institute for Health; Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by Guy's and St Thomas' Hospital Charity, The Stroke Association, Department of Health HQIP grants, UK, National Institute for Health Research Programme Grant (RP-PG-0407-10184). Dr. Christopher McKevitt acknowledges financial support from the Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and the NIHR Research for Patient Benefit Programme award (PB-PG-0407-13228). Professor Charles D. A. Wolfe is an NIHR Senior Investigator. Professor Anthony Rudd is funded by the Guy's & St Thomas' NHS Trust AHSC PA Scheme. Disclosures: All authors had financial support from Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. This article presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10184). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Addo J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d744; Candelise L, 2007, LANCET, V369, P299, DOI 10.1016/S0140-6736(07)60152-4; DEPIPPO KL, 1992, ARCH NEUROL-CHICAGO, V49, P1259, DOI 10.1001/archneur.1992.00530360057018; Drummond AER, 2005, BMJ-BRIT MED J, V331, P491, DOI 10.1136/bmj.38537.679479.E0; Evans A, 2001, LANCET, V358, P1586, DOI 10.1016/S0140-6736(01)06652-1; Glader EL, 2001, STROKE, V32, P2124, DOI 10.1161/hs0901.095724; Govan L, 2008, STROKE, V39, P2402, DOI 10.1161/STROKEAHA.108.515510; Govan L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub2; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Indredavik B, 1999, STROKE, V30, P1524, DOI 10.1161/01.STR.30.8.1524; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Indredavik B, 1998, STROKE, V29, P895, DOI 10.1161/01.STR.29.5.895; Indredavik B, 1997, STROKE, V28, P1861, DOI 10.1161/01.STR.28.10.1861; Jorgensen HS, 1999, STROKE, V30, P930, DOI 10.1161/01.STR.30.5.930; Kalra L, 2005, HEALTH TECHNOL ASSES, V9, P1; Kjellstrom T, 2007, CEREBROVASC DIS, V23, P231; Langhorne P, 2010, J NEUROL NEUROSUR PS, V81, P1301, DOI 10.1136/jnnp.2009.195131; McKevitt C, 2005, STROKE, V36, P315, DOI 10.1161/01.STR.0000152332.32267.19; Ronning OM, 1998, STROKE, V29, P58, DOI 10.1161/01.STR.29.1.58; Seenan P, 2007, STROKE, V38, P1886, DOI 10.1161/STROKEAHA.106.480871; Stegmayr B, 1999, STROKE, V30, P709, DOI 10.1161/01.STR.30.4.709; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Terent A, 2009, J NEUROL NEUROSUR PS, V80, P881, DOI 10.1136/jnnp.2008.169102; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; WOLFE CDA, 1991, STROKE, V22, P1242, DOI 10.1161/01.STR.22.10.1242	26	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61581	10.1371/journal.pone.0061581	http://dx.doi.org/10.1371/journal.pone.0061581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634211	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000318341400015
J	Govender, P; Romero, F; Shah, D; Paez, J; Ding, SY; Liu, LB; Gower, A; Baez, E; Aly, SS; Pilch, P; Summer, R				Govender, Praveen; Romero, Freddy; Shah, Dilip; Paez, Jesus; Ding, Shi-Ying; Liu, Libin; Gower, Adam; Baez, Elizabeth; Aly, Sherif Shawky; Pilch, Paul; Summer, Ross			Cavin1; a Regulator of Lung Function and Macrophage Phenotype	PLOS ONE			English	Article							SHOW EVIDENCE; GENECHIP DATA; CAVEOLAE; EXPRESSION; MICE; PROTEIN; DYSFUNCTION; PTRF; ATHEROSCLEROSIS; RECRUITMENT	Caveolae are cell membrane invaginations that are highly abundant in adipose tissue, endothelial cells and the lung. The formation of caveolae is dependent on the expression of various structural proteins that serve as scaffolding for these membrane invaginations. Cavin1 is a newly identified structural protein whose deficiency in mice leads to loss of caveolae formation and to development of a lipodystrophic phenotype. In this study, we sought to investigate the functional role of Cavin1 in the lung. Cavin1 deficient mice possessed dramatically altered distal lung morphology and exhibited significant physiological alterations, notably, increased lung elastance. The changes in distal lung architecture were associated with hypercellularity and the accumulation of lung macrophages. The increases in lung macrophages occurred without changes to circulating numbers of mononuclear cells and without evidence for increased proliferation. However, the increases in lung macrophages were associated with higher levels of macrophage chemotactic factors CXCL2 and CCL2 in BAL fluid from Cavin1-/- mice suggesting a possible mechanism by which these cells accumulate. In addition, lung macrophages from Cavin1-/- mice were larger and displayed measurable differences in gene expression when compared to macrophages from wild-type mice. Interestingly, macrophages were also increased in adipose tissue but not in liver, kidney or skeletal muscle from Cavin1-/- mice, and similar tissue specificity for macrophage accumulation was observed in lungs and adipose tissue from Caveolin1-/- mice. In conclusion, this study demonstrates an important role for Cavin1 in lung homeostasis and suggests that caveolae structural proteins are necessary for regulating macrophage number and phenotype in the lung.	[Govender, Praveen; Paez, Jesus; Gower, Adam; Baez, Elizabeth; Aly, Sherif Shawky] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Romero, Freddy; Shah, Dilip; Summer, Ross] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Romero, Freddy; Shah, Dilip; Summer, Ross] Thomas Jefferson Univ, Div Pulm & Crit Care Med, Philadelphia, PA 19107 USA; [Ding, Shi-Ying; Liu, Libin; Pilch, Paul] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Jefferson University; Jefferson University; Boston University	Summer, R (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA.	Ross.summer@jefferson.edu	Liu, Libin/ABH-6019-2020	Govender, Praveen/0000-0001-8813-5628; Pilch, Paul/0000-0003-1997-0499; Liu, Libin/0000-0001-5056-1517; Shah, Dilip/0000-0002-4248-5611; Gower, Adam/0000-0002-6122-7511	National Institutes of Health (NIH) [R01HL105490]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105490] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) R01HL105490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerszten RE, 2012, NEW ENGL J MED, V366, P1734, DOI 10.1056/NEJMcibr1200164; GIL J, 1983, FED PROC, V42, P2414; Gosens R, 2008, CURR MOL MED, V8, P741, DOI 10.2174/156652408786733720; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Huffman JA, 1996, J CLIN INVEST, V97, P649, DOI 10.1172/JCI118461; INSELMAN LS, 1987, AM REV RESPIR DIS, V135, P613; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J BIOL CHEM, V276, P38121; Sharifi BG, 2006, ARTERIOSCL THROM VAS, V26, P1273, DOI 10.1161/01.ATV.0000222017.05085.8e; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Summer R, 2009, AM J PHYSIOL-LUNG C, V297, pL432, DOI 10.1152/ajplung.90599.2008; Torres VA, 2006, J CELL SCI, V119, P1812, DOI 10.1242/jcs.02894; Uchida K, 2007, NEW ENGL J MED, V356, P567, DOI 10.1056/NEJMoa062505; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Vinten J, 2001, CELL TISSUE RES, V305, P99, DOI 10.1007/s004410100389; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; Voldstedlund M, 2001, CELL TISSUE RES, V306, P265, DOI 10.1007/s004410100439; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Yang ZF, 2004, J IMMUNOL, V173, P2507, DOI 10.4049/jimmunol.173.4.2507	45	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62045	10.1371/journal.pone.0062045	http://dx.doi.org/10.1371/journal.pone.0062045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634221	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400032
J	Kuehn, JS; Gorden, PJ; Munro, D; Rong, RC; Dong, QF; Plummer, PJ; Wang, C; Phillips, GJ				Kuehn, Joanna S.; Gorden, Patrick J.; Munro, Daniel; Rong, Ruichen; Dong, Qunfeng; Plummer, Paul J.; Wang, Chong; Phillips, Gregory J.			Bacterial Community Profiling of Milk Samples as a Means to Understand Culture-Negative Bovine Clinical Mastitis	PLOS ONE			English	Article							BULK TANK MILK; NOSOCOMIAL INFECTIOUS ORGANISM; MYCOPLASMA-BOVIS; RIBOSOMAL-RNA; SPHINGOMONAS-PAUCIMOBILIS; RALSTONIA-PICKETTII; ANTIMICROBIAL SUSCEPTIBILITY; BURKHOLDERIA-PSEUDOMALLEI; PSEUDOMONAS-AERUGINOSA; MICROBIAL COMMUNITIES	Inflammation and infection of bovine mammary glands, commonly known as mastitis, imposes significant losses each year in the dairy industry worldwide. While several different bacterial species have been identified as causative agents of mastitis, many clinical mastitis cases remain culture negative, even after enrichment for bacterial growth. To understand the basis for this increasingly common phenomenon, the composition of bacterial communities from milk samples was analyzed using culture independent pyrosequencing of amplicons of 16S ribosomal RNA genes (16S rDNA). Comparisons were made of the microbial community composition of culture negative milk samples from mastitic quarters with that of non-mastitic quarters from the same animals. Genomic DNA from culture-negative clinical and healthy quarter sample pairs was isolated, and amplicon libraries were prepared using indexed primers specific to the V1-V2 region of bacterial 16S rRNA genes and sequenced using the Roche 454 GS FLX with titanium chemistry. Evaluation of the taxonomic composition of these samples revealed significant differences in the microbiota in milk from mastitic and healthy quarters. Statistical analysis identified seven bacterial genera that may be mainly responsible for the observed microbial community differences between mastitic and healthy quarters. Collectively, these results provide evidence that cases of culture negative mastitis can be associated with bacterial species that may be present below culture detection thresholds used here. The application of culture-independent bacterial community profiling represents a powerful approach to understand long-standing questions in animal health and disease.	[Kuehn, Joanna S.; Plummer, Paul J.; Phillips, Gregory J.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Gorden, Patrick J.; Plummer, Paul J.; Wang, Chong] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Munro, Daniel; Rong, Ruichen; Dong, Qunfeng] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA	Iowa State University; Iowa State University; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Phillips, GJ (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	gregory@iastate.edu	Wang, Chong/AAI-3796-2020; Gorden, Patrick/AAT-4403-2021	Wang, Chong/0000-0003-4489-4344; Gorden, Patrick/0000-0002-6096-0965; Munro, Daniel/0000-0002-0724-218X	Healthy Livestock Institute of the State of Iowa; Plant Sciences Institute of Iowa State University; Boehringer Ingelheim Vetmedica; Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program; NIH [1RC2HG005806-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005806] Funding Source: NIH RePORTER	Healthy Livestock Institute of the State of Iowa; Plant Sciences Institute of Iowa State University; Boehringer Ingelheim Vetmedica(Boehringer Ingelheim); Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding for this study was provided by the Healthy Livestock Institute of the State of Iowa, the Plant Sciences Institute of Iowa State University and a postdoctoral fellowship from Boehringer Ingelheim Vetmedica, and a grant to the University of North Texas from the Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program as well as NIH grant 1RC2HG005806-01 for high performance computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink FC, 2001, NEW ENGL J MED, V344, P1171, DOI 10.1056/NEJM200104123441516; Aebi M, 2012, VET MICROBIOL, V157, P363, DOI 10.1016/j.vetmic.2012.01.006; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Berriatua E, 2001, J CLIN MICROBIOL, V39, P990, DOI 10.1128/JCM.39.3.990-994.2001; Biddick R, 2003, FEMS MICROBIOL LETT, V228, P57, DOI 10.1016/S0378-1097(03)00724-9; Blum S, 2010, J VET DIAGN INVEST, V22, P995, DOI 10.1177/104063871002200627; Bore E, 2005, J APPL MICROBIOL, V98, P96, DOI 10.1111/j.1365-2672.2004.02436.x; Bowman JP, 1997, SYST APPL MICROBIOL, V20, P209, DOI 10.1016/S0723-2020(97)80067-7; Cha E, 2011, J DAIRY SCI, V94, P4476, DOI 10.3168/jds.2010-4123; Cheong HS, 2008, INFECT CONT HOSP EP, V29, P990, DOI 10.1086/591091; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Council NM, 1999, LAB HDB BOVINE MASTI; Daxboeck F, 2003, CLIN MICROBIOL INFEC, V9, P263, DOI 10.1046/j.1469-0691.2003.00590.x; Delbes C, 2007, APPL ENVIRON MICROB, V73, P1882, DOI 10.1128/AEM.01716-06; Delpin MW, 2011, ENV MICROBIOL, DOI 10111/j1462-2920201102614x; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Dogan B, 2003, APPL ENVIRON MICROB, V69, P130, DOI 10.1128/AEM.69.1.130-138.2003; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Fox LK, 2005, J VET MED B, V52, P153, DOI 10.1111/j.1439-0450.2005.00845.x; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Gonzalez RN, 2003, VET CLIN N AM-FOOD A, V19, P199, DOI 10.1016/S0749-0720(02)00076-2; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hantsis-Zacharov E, 2007, APPL ENVIRON MICROB, V73, P7162, DOI 10.1128/AEM.00866-07; HARMON RJ, 1994, J DAIRY SCI, V77, P2103, DOI 10.3168/jds.S0022-0302(94)77153-8; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; JASPER DE, 1981, INT J SYST BACTERIOL, V31, P339, DOI 10.1099/00207713-31-3-339; Jones G.M., 2009, UNDERSTANDING BASICS, V404, P1; Zumarraga MJ, 2012, FOODBORNE PATHOG DIS, V9, P132, DOI 10.1089/fpd.2011.0963; Justice-Allen A, 2011, J DAIRY SCI, V94, P3411, DOI 10.3168/jds.2010-3940; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; KIRK JH, 1984, J AM VET MED ASSOC, V184, P671; Kromker V, 2009, VET MICROBIOL, V134, P100, DOI 10.1016/j.vetmic.2008.09.002; KRZIWON C, 1995, INFECT IMMUN, V63, P2899, DOI 10.1128/IAI.63.8.2899-2905.1995; Kulakov LA, 2002, APPL ENVIRON MICROB, V68, P1548, DOI 10.1128/AEM.68.4.1548-1555.2002; LLOYDPURYEAR M, 1991, J CLIN MICROBIOL, V29, P2041, DOI 10.1128/JCM.29.9.2041-2042.1991; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MACKIE DP, 1986, VET REC, V119, P350, DOI 10.1136/vr.119.14.350; Makovec JA, 2003, J DAIRY SCI, V86, P3466, DOI 10.3168/jds.S0022-0302(03)73951-4; McDonald WL, 2009, NEW ZEAL VET J, V57, P44, DOI 10.1080/00480169.2009.36867; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mena KD, 2009, REV ENVIRON CONTAM T, V201, P71, DOI 10.1007/978-1-4419-0032-6_3; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; Nam HM, 2009, J DAIRY SCI, V92, P2020, DOI 10.3168/jds.2008-1739; Nicholas RAJ, 2003, RES VET SCI, V74, P105, DOI 10.1016/S0034-5288(02)00155-8; NISHIYAMA M, 1992, FEMS MICROBIOL ECOL, V101, P145, DOI 10.1111/j.1574-6968.1992.tb05770.x; NMC, 2017, LAB HDB BOVINE MASTI; Ohnishi M, 2012, LETT APPL MICROBIOL, V54, P572, DOI 10.1111/j.1472-765X.2012.03246.x; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pfister CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010518; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Development Core Team, 2008, R LANG ENV STAT COMP; Ralph A, 2004, PEDIATR INFECT DIS J, V23, P1169, DOI 10.1097/01.inf.0000145548.79395.da; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Romanenko LA, 2002, INT J SYST EVOL MICR, V52, P1291, DOI [10.1099/ijs.0.02087-0, 10.1099/00207713-52-4-1291]; Ryan MP, 2007, J APPL MICROBIOL, V103, P754, DOI 10.1111/j.1365-2672.2007.03361.x; Ryan MP, 2010, J HOSP INFECT, V75, P153, DOI 10.1016/j.jhin.2010.03.007; Ryan MP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-194; Ryan MP, 2006, J HOSP INFECT, V62, P278, DOI 10.1016/j.jhin.2005.08.015; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Soehnlen MK, 2011, J DAIRY SCI, V94, P1893, DOI 10.3168/jds.2010-3967; Sundquist A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-108; Vacheyrou M, 2011, INT J FOOD MICROBIOL, V146, P253, DOI 10.1016/j.ijfoodmicro.2011.02.033; Verdier-Metz I, 2012, APPL ENVIRON MICROB, V78, P326, DOI 10.1128/AEM.06229-11; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wenz JR, 2006, JAVMA-J AM VET MED A, V229, P259, DOI 10.2460/javma.229.2.259; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Yamamura S, 2002, BIOCHEM BIOPH RES CO, V294, P1138, DOI 10.1016/S0006-291X(02)00580-6; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	77	97	103	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61959	10.1371/journal.pone.0061959	http://dx.doi.org/10.1371/journal.pone.0061959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634219	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400028
J	Gong, YP; Xiao, HY; Li, CL; Bai, J; Cheng, XL; Jin, MM; Sun, BR; Lu, YH; Shao, YH; Tian, H				Gong, Yanping; Xiao, Haiying; Li, Chunlin; Bai, Jie; Cheng, Xiaoling; Jin, Mengmeng; Sun, Boruo; Lu, Yanhui; Shao, Yinghong; Tian, Hui			Elevated T/E-2 Ratio Is Associated with an Increased Risk of Cerebrovascular Disease in Elderly Men	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; CARDIOVASCULAR-DISEASE; SERUM TESTOSTERONE; OLDER MEN; MORTALITY; HYPOGONADISM; HYSTERECTOMY; POPULATION; ESTRADIOL; IMBALANCE	Objective: To investigate the relationship between sex hormones and the risk of vascular disease in elderly men and to evaluate the advantages and disadvantages of testosterone replacement. Methods: A total of 337 men, aged 60 to 91 years, were enrolled in this single-center, cross-sectional study, and their sex hormone levels were assessed. Linear and logistic regression analyses were utilized to compare the sex hormone levels between patients with and without vascular disease. The nonparametric K-sample test was used for inter-group comparisons. Results: Aging and abnormal metabolism were both significantly associated with an increased risk of vascular diseases and changes in sex hormone levels. Primary linear and logistic regression analyses showed no significant differences in sex hormone concentrations between patients with and without vascular diseases after adjusting for age. Logistic regression with abnormal metabolism as categorical variable showed that free testosterone (FT) and free estradiol (FE2) had significant relationships with CEVD risk (P<0.05). In further regression with all metabolic continuous variables included, the testosterone/estradiol (T/E-2) ratio replaced FT and FE2 (P<0.05). Trend line analyses showed that T/E-2 actually had a binomial linear correlation with the risk of cerebrovascular disease; its best protective effect occurred at values of 0.13-0.15, with an OR value extremely close to those of FT and FE2 (0.23 vs. 0.24-0.25). Conclusion: T/E-2 balance plays a key role in the relationship between sex hormones and the risk of cerebrovascular disease. The balance between T and E-2 may be more important than their absolute quantities. Extremely low T/E2 and inappropriately high T/E-2 ratio can both harm the brain blood vessels. Careful consideration should be given before beginning testosterone replacement treatment, and supplementing with estrogen seems to be a good way to protect blood vessels of the brain in elderly men.	[Gong, Yanping; Xiao, Haiying; Li, Chunlin; Cheng, Xiaoling; Jin, Mengmeng; Sun, Boruo; Lu, Yanhui; Shao, Yinghong; Tian, Hui] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Endocrinol, Beijing, Peoples R China; [Bai, Jie] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Clin Lab, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Li, CL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Endocrinol, Beijing, Peoples R China.	lcl301@sina.cn		Li, Chun-Lin/0000-0003-3723-5703	National Natural Science Foundation of China (NFSC) [81173625]; MiaoPu Foundation [12KMM33]	National Natural Science Foundation of China (NFSC)(National Natural Science Foundation of China (NSFC)); MiaoPu Foundation	This work was supported by the grants from the National Natural Science Foundation of China (NFSC, No. 81173625, http://www.nsfc.gov.cn/ Portal0/default152.htm) and MiaoPu Foundation (No. 12KMM33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Brett KM, 2005, CIRCULATION, V111, P1456, DOI 10.1161/01.CIR.0000161141.92300.F3; Dai W, 2012, CARDIOLOGY, V121, P249, DOI 10.1159/000337274; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Francomano Davide, 2010, Acta Biomed, V81 Suppl 1, P101; Gardner JD, 2010, AM J PHYSIOL-HEART C, V298, pH497, DOI 10.1152/ajpheart.00336.2009; Gierach GL, 2006, J AM COLL CARDIOL, V47, p50S, DOI 10.1016/j.jacc.2005.02.099; Gong YP, 2013, AGING MALE, V16, P8, DOI 10.3109/13685538.2013.765402; Grossmann M, 2010, ASIAN J ANDROL, V12, P783, DOI 10.1038/aja.2010.107; Jankowska EA, 2009, JAMA-J AM MED ASSOC, V301, P1892, DOI 10.1001/jama.2009.639; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Menke A, 2010, AM J EPIDEMIOL, V171, P583, DOI 10.1093/aje/kwp415; Naessen T, 2012, MENOPAUSE; Rinaldi S, 2002, CANCER EPIDEM BIOMAR, V11, P1065; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Sher L, 2012, AUST NZ J PSYCHIAT; Svartberg J, 2006, J INTERN MED, V259, P576, DOI 10.1111/j.1365-2796.2006.01637.x; Vlachopoulos C, 2013, AM J HYPERTENS, V26, P373, DOI 10.1093/ajh/hps056; Wenner MM, 2012, J PHYSL; Wittnich C, 2013, PFLUGERS ARCH; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101; Yang XP, 2011, CURR OPIN NEPHROL HY, V20, P133, DOI 10.1097/MNH.0b013e3283431921; Zheng HY, 2012, BIO-MED MATER ENG, V22, P179, DOI 10.3233/BME-2012-0705	25	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61598	10.1371/journal.pone.0061598	http://dx.doi.org/10.1371/journal.pone.0061598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637864	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400032
J	Prince, A; Pfaffinger, PJ				Prince, Alison; Pfaffinger, Paul J.			Conserved N-Terminal Negative Charges Support Optimally Efficient N-type Inactivation of Kv1 Channels	PLOS ONE			English	Article							GATED POTASSIUM CHANNEL; APLYSIA K+ CHANNEL; ALIGNMENT EDITOR; EXPRESSION; MECHANISM; MODEL; ENVIRONMENT; DROSOPHILA; PEPTIDES; DYNAMICS	N-type inactivation is produced by the binding of a potassium channel's N-terminus within the open pore, blocking conductance. Previous studies have found that introduction of negative charges into N-terminal inactivation domains disrupts inactivation; however, the Aplysia AKv1 N-type inactivation domain contains two negatively charged residues, E2 and E9. Rather than being unusual, sequence analysis shows that this N-terminal motif is highly conserved among Kv1 sequences across many phyla. Conservation analysis shows some tolerance at position 9 for other charged residues, like D9 and K9, whereas position 2 is highly conserved as E2. To examine the functional importance of these residues, site directed mutagenesis was performed and effects on inactivation were recorded by two electrode voltage clamp in Xenopus oocytes. We find that inclusion of charged residues at positions 2 and 9 prevents interactions with non-polar sites along the inactivation pathway increasing the efficiency of pore block. In addition, E2 appears to have additional specific electrostatic interactions that stabilize the inactivated state likely explaining its high level of conservation. One possible explanation for E2's unique importance, consistent with our data, is that E2 interacts electrostatically with a positive charge on the N-terminal amino group to stabilize the inactivation domain at the block site deep within the pore. Simple electrostatic modeling suggests that due to the non-polar environment in the pore in the blocked state, even a 1 angstrom larger separation between these charges, produced by the E2D substitution, would be sufficient to explain the 65 x reduced affinity of the E2D N-terminus for the pore. Finally, our studies support a multi-step, multi-site N-type inactivation model where the N-terminus interacts deep within the pore in an extended like structure placing the most N-terminal residues 35% of the way across the electric field in the pore blocked state.	[Prince, Alison; Pfaffinger, Paul J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Pfaffinger, PJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	paulp@bcm.edu			United States National Institutes of Health [P01NS37444, R01GM090029, T32GM008507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008507, R01GM090029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by United States National Institutes of Health Grants P01NS37444, R01GM090029 and T32GM008507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich RW, 2001, NATURE, V411, P643, DOI 10.1038/35079705; Antz C, 1999, NAT STRUCT BIOL, V6, P146; Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CROARKIN C, 2008, NIST SEMATECH E HDB; Decher N, 2008, EMBO J, V27, P3164, DOI 10.1038/emboj.2008.231; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Encinar JA, 1998, BIOCHEM J, V331, P497, DOI 10.1042/bj3310497; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Furukawa Y, 1997, ZOOL SCI, V14, P397, DOI 10.2108/zsj.14.397; FURUKAWA Y, 1995, J NEUROPHYSIOL, V74, P1248, DOI 10.1152/jn.1995.74.3.1248; Giese KP, 2001, PHYSIOL BEHAV, V73, P803, DOI 10.1016/S0031-9384(01)00517-0; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hille, 2001, ION CHANNELS EXCITAB; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kim M, 1998, RECEPTOR CHANNEL, V5, P291; Kondoh S, 1997, J BIOL CHEM, V272, P19333, DOI 10.1074/jbc.272.31.19333; Kurata HT, 2006, PROG BIOPHYS MOL BIO, V92, P185, DOI 10.1016/j.pbiomolbio.2005.10.001; Lee TE, 1996, J MEMBR BIOL, V151, P225; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Molina ML, 2008, J BIOL CHEM, V283, P18076, DOI 10.1074/jbc.M710132200; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Ono F, 1999, J NEUROSCI, V19, P6874, DOI 10.1523/JNEUROSCI.19-16-06874.1999; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; Prince-Carter A, 2009, J GEN PHYSIOL, V134, P15, DOI 10.1085/jgp.200910219; SCHWARZ TL, 1988, NATURE, V332, P740, DOI 10.1038/332740a0; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wissmann R, 2003, J BIOL CHEM, V278, P16142, DOI 10.1074/jbc.M210191200; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62695	10.1371/journal.pone.0062695	http://dx.doi.org/10.1371/journal.pone.0062695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638135	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400122
J	Schulte, FA; Ruffoni, D; Lambers, FM; Christen, D; Webster, DJ; Kuhn, G; Muller, R				Schulte, Friederike A.; Ruffoni, Davide; Lambers, Floor M.; Christen, David; Webster, Duncan J.; Kuhn, Gisela; Mueller, Ralph			Local Mechanical Stimuli Regulate Bone Formation and Resorption in Mice at the Tissue Level	PLOS ONE			English	Article							SURFACE REMODELING SIMULATION; ESTROGEN-RECEPTOR-ALPHA; IN-VIVO MODEL; OSTEOGENIC RESPONSE; CANCELLOUS BONE; TAIL VERTEBRAE; STRAIN; ADAPTATION; INCREASES; MASS	Bone is able to react to changing mechanical demands by adapting its internal microstructure through bone forming and resorbing cells. This process is called bone modeling and remodeling. It is evident that changes in mechanical demands at the organ level must be interpreted at the tissue level where bone (re) modeling takes place. Although assumed for a long time, the relationship between the locations of bone formation and resorption and the local mechanical environment is still under debate. The lack of suitable imaging modalities for measuring bone formation and resorption in vivo has made it difficult to assess the mechanoregulation of bone three-dimensionally by experiment. Using in vivo micro-computed tomography and high resolution finite element analysis in living mice, we show that bone formation most likely occurs at sites of high local mechanical strain (p<0.0001) and resorption at sites of low local mechanical strain (p<0.0001). Furthermore, the probability of bone resorption decreases exponentially with increasing mechanical stimulus (R-2 = 0.99) whereas the probability of bone formation follows an exponential growth function to a maximum value (R-2 = 0.99). Moreover, resorption is more strictly controlled than formation in loaded animals, and ovariectomy increases the amount of non-targeted resorption. Our experimental assessment of mechanoregulation at the tissue level does not show any evidence of a lazy zone and suggests that around 80% of all (re) modeling can be linked to the mechanical microenvironment. These findings disclose how mechanical stimuli at the tissue level contribute to the regulation of bone adaptation at the organ level.	[Schulte, Friederike A.; Ruffoni, Davide; Lambers, Floor M.; Christen, David; Webster, Duncan J.; Kuhn, Gisela; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Muller, R (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	ram@ethz.ch	Ruffoni, Davide/GQP-0042-2022; Müller, Ralph/A-1198-2008	Müller, Ralph/0000-0002-5811-7725; Christen, David/0000-0002-1562-310X; Ruffoni, Davide/0000-0003-3714-7594; Webster, Duncan/0000-0001-5028-9218	European Union for the osteoporotic virtual physiological human project (VPHOP) [FP7-ICT2008-223865]	European Union for the osteoporotic virtual physiological human project (VPHOP)	Funding from the European Union for the osteoporotic virtual physiological human project (VPHOP FP7-ICT2008-223865) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2001, J BIOMECH ENG-T ASME, V123, P403, DOI 10.1115/1.1392315; Arbenz P, 2008, INT J NUMER METH ENG, V73, P927, DOI 10.1002/nme.2101; Basso N, 2005, BONE, V37, P370, DOI 10.1016/j.bone.2005.04.033; BEAUPRE GS, 1990, J ORTHOP RES, V8, P651, DOI 10.1002/jor.1100080506; Bikle Daniel D, 2003, Gravit Space Biol Bull, V16, P45; Bonnelye E, 2002, ENDOCRINOLOGY, V143, P3658, DOI 10.1210/en.2002-220095; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Buie HR, 2008, J BONE MINER RES, V23, P2048, DOI 10.1359/JBMR.080808; CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6; Christen P, 2012, BIOMECH MODEL MECHAN, V11, P483, DOI 10.1007/s10237-011-0327-x; Cullen DM, 2000, J APPL PHYSIOL, V88, P1943, DOI 10.1152/jappl.2000.88.6.1943; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dunlop JWC, 2009, CALCIFIED TISSUE INT, V85, P45, DOI 10.1007/s00223-009-9242-x; Ellman R, 2013, J BONE MINER RES, V28, P875, DOI 10.1002/jbmr.1814; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; FROST HM, 1987, BONE MINER, V2, P73; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Gross TS, 2002, J BONE MINER RES, V17, P493, DOI 10.1359/jbmr.2002.17.3.493; Gross TS, 1997, J BONE MINER RES, V12, P982, DOI 10.1359/jbmr.1997.12.6.982; Hsieh YF, 2001, J BONE MINER RES, V16, P2291, DOI 10.1359/jbmr.2001.16.12.2291; Huiskes R, 2000, J ANAT, V197, P145, DOI 10.1046/j.1469-7580.2000.19720145.x; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Kim CH, 2003, J BONE MINER RES, V18, P2116, DOI 10.1359/jbmr.2003.18.12.2116; Lambers FM, 2012, CALCIFIED TISSUE INT, V90, P108, DOI 10.1007/s00223-011-9553-6; Lambers FM, 2011, BONE, V49, P1340, DOI 10.1016/j.bone.2011.08.035; Lambers FM, 2012, J BIOMECH, V45, pS89; LANYON LE, 1992, J BONE MINER RES, V7, pS369, DOI 10.1002/jbmr.5650071403; LANYON LE, 1973, J BIOMECH, V6, P41, DOI 10.1016/0021-9290(73)90036-5; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; R Development Core Team, 2007, R LANG ENV STAT COMP; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Roux W, 1881, KAMPF THEILE ORGANIS; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Ruimerman R, 2005, J BIOMECH, V38, P931, DOI 10.1016/j.jbiomech.2004.03.037; Schulte FA, 2012, COMPUT METHODS BIOME; Schulte FA, 2013, BONE, V52, P485, DOI 10.1016/j.bone.2012.09.008; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tsubota K, 2002, J BIOMECH, V35, P1541, DOI 10.1016/S0021-9290(02)00173-2; TURNER CH, 1994, J BONE MINER RES, V9, P87; TURNER CH, 1991, BONE, V12, P73, DOI 10.1016/8756-3282(91)90003-2; Webster D, 2010, BIOMECH MODEL MECHAN, V9, P737, DOI 10.1007/s10237-010-0210-1; Webster DJ, 2008, COMPUT METHOD BIOMEC, V11, P435, DOI 10.1080/10255840802078014; Weinkamer R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228102; Willinghamm MD, 2010, CALCIFIED TISSUE INT, V86, P470, DOI 10.1007/s00223-010-9359-y; Windahl SH, 2013, J BONE MINER RES, V28, P291, DOI 10.1002/jbmr.1754; Wolff J, 1892, GESETZ TRANSFORMATIO; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504	51	143	147	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62172	10.1371/journal.pone.0062172	http://dx.doi.org/10.1371/journal.pone.0062172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637993	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400079
J	Tilsen, S				Tilsen, Sam			A Dynamical Model of Hierarchical Selection and Coordination in Speech Planning	PLOS ONE			English	Article							SYLLABLE FREQUENCY; WORKING-MEMORY; BASAL GANGLIA; ORGANIZATION; STRESS; THETA; ARTICULATION; OSCILLATIONS; PERFORMANCE; HYPOTHESIS	Studies of the control of complex sequential movements have dissociated two aspects of movement planning: control over the sequential selection of movement plans, and control over the precise timing of movement execution. This distinction is particularly relevant in the production of speech: utterances contain sequentially ordered words and syllables, but articulatory movements are often executed in a non-sequential, overlapping manner with precisely coordinated relative timing. This study presents a hybrid dynamical model in which competitive activation controls selection of movement plans and coupled oscillatory systems govern coordination. The model departs from previous approaches by ascribing an important role to competitive selection of articulatory plans within a syllable. Numerical simulations show that the model reproduces a variety of speech production phenomena, such as effects of preparation and utterance composition on reaction time, and asymmetries in patterns of articulatory timing associated with onsets and codas. The model furthermore provides a unified understanding of a diverse group of phonetic and phonological phenomena which have not previously been related.	Cornell Univ, Dept Linguist, Ithaca, NY 14850 USA	Cornell University	Tilsen, S (corresponding author), Cornell Univ, Dept Linguist, Ithaca, NY 14850 USA.	tilsen@cornell.edu	Tilsen, Sam/AAF-4876-2021	Tilsen, Sam/0000-0003-0865-5119				Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; BALOTA DA, 1985, J MEM LANG, V24, P89, DOI 10.1016/0749-596X(85)90017-8; Bohland JW, 2010, J COGNITIVE NEUROSCI, V22, P1504, DOI 10.1162/jocn.2009.21306; Browman C., 2000, B COMMUNICATION PARL, V5, P25; Browman C., 1989, PHONOLOGY, V6, P201, DOI [10.1017/S0952675700001019, DOI 10.1017/S0952675700001019]; BROWMAN CP, 1990, J PHONETICS, V18, P299, DOI 10.1016/S0095-4470(19)30376-6; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; BROWMAN CP, 1988, PHONETICA, V45, P140, DOI 10.1159/000261823; Bullock D, 2002, CAS CNS TECH REP SER, V3, P1; Byrd D, 2003, J PHONETICS, V31, P149, DOI 10.1016/S0095-4470(02)00085-2; Chitoran I., 2006, P 10 C LAB PHONOLOGY, P69; Cholin J, 2006, COGNITION, V99, P205, DOI 10.1016/j.cognition.2005.01.009; Cholin J, 2009, LANG COGNITIVE PROC, V24, P662, DOI 10.1080/01690960802348852; CRYSTAL TH, 1990, J ACOUST SOC AM, V88, P101, DOI 10.1121/1.399955; Cummins F, 1998, J PHONETICS, V26, P145, DOI 10.1006/jpho.1998.0070; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; DeLong MR, 2011, MOTOR FUNCTIONS BASA, P1017; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; Feldman AG, 2009, ADV EXP MED BIOL, V629, P699, DOI 10.1007/978-0-387-77064-2_38; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; FROMKIN VA, 1971, LANGUAGE, V47, P27, DOI 10.2307/412187; Fukai T, 1999, NEURAL NETWORKS, V12, P975, DOI 10.1016/S0893-6080(99)00057-X; Gao M., 2009, CHINESE J PHONETICS, V2, P43; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Goldstein L, 2012, CONSONANT CLUSTERS S, V26, P205; Goldstein L.M., 2007, P 16 INT C PHONETIC; Goldstein L, 2006, ACTION TO LANGUAGE VIA THE MIRROR NEURON SYSTEM, P215, DOI 10.1017/CBO9780511541599.008; Gordon M., 2002, STUD LANG, V25, P423, DOI DOI 10.1075/SL.25.3.03G0R; GORDON MATTHEW, 2006, SYLLABLE WEIGHT PHON; Grossberg S., 1978, PROG THEOR BIOL, V5, P233, DOI 10.1016/b978-0-12-543105-7.50013-0; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Hazy TE, 2007, PHILOS T R SOC B, V362, P1601, DOI 10.1098/rstb.2007.2055; HENRY FM, 1960, RES QUART, V31, P448, DOI 10.1080/10671188.1960.10762052; Hermes A., 2008, PAPERS 8 INT SEMINAR, P433; Hermes A., 2011, P 9 INT SEMINAR SPEE, P401; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Honorof D.N., 1995, P 13 INT C PHONETIC, P552; Hoole P., 1999, COARTICULATION THEOR, P260, DOI [10.1017/CBO9780511486395.013, DOI 10.1017/CBO9780511486395.013]; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Hyman L. M., 1985, THEORY PHONOLOGICAL; Hyman LM, 2007, PHONOL PHONET, V12-1, P1; Jantzen K. J., 2007, UNDERST COMPLEX SYST, P421; Kavitskaya Darya, 2002, COMPENSATORY LENGTHE; Kawamoto AH, 1999, J EXP PSYCHOL HUMAN, V25, P361, DOI 10.1037/0096-1523.25.2.361; Kawamoto AH, 2008, J MEM LANG, V58, P347, DOI 10.1016/j.jml.2007.06.002; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; KEELE SW, 1987, PSYCHOL LEARN MOTIV, V21, P183; Klapp ST, 2003, J MOTOR BEHAV, V35, P135, DOI 10.1080/00222890309602129; Kuhnert B., 2006, P 7 INT SEMINAR SPEE, P327; Kuramoto Y., 1975, International Symposium on Mathematical Problems in Theoretical Physics, P420, DOI 10.1007/BFb0013365; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; LEVELT WJM, 1994, COGNITION, V50, P239, DOI 10.1016/0010-0277(94)90030-2; Marin S, 2010, MOTOR CONTROL, V14, P380, DOI 10.1123/mcj.14.3.380; MARTIN JG, 1972, PSYCHOL REV, V79, P487, DOI 10.1037/h0033467; McCarthy JJ, 1986, 32 RUTG U COGN SCI; Mooshammer C, 2012, J PHONETICS, V40, P374, DOI 10.1016/j.wocn.2012.02.002; Nam H., 2003, P 15 INT C PHONETIC, P2253; ODell M. L., 1999, P 14 INT C PHONETIC, V2, P1075; OHMAN SEG, 1967, J ACOUST SOC AM, V41, P310; Ostry DJ, 2003, EXP BRAIN RES, V153, P275, DOI 10.1007/s00221-003-1624-0; PETERSON GE, 1960, J ACOUST SOC AM, V32, P693, DOI 10.1121/1.1908183; Popivanov D, 1999, NEUROSCI LETT, V267, P5, DOI 10.1016/S0304-3940(99)00271-2; Port RF, 2003, J PHONETICS, V31, P599, DOI 10.1016/j.wocn.2003.08.001; Pouplier M., 2011, J LAB PHONOLOGY, V2, P243, DOI DOI 10.1515/LABPHON.2011.009; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; Saltzman E., 2008, P SPEECH PROSODY 200, P175; Shattuck-Hufnagel S., 1979, SENTENCE PROCESSING, P295; Shaw JA, 2011, PHONOLOGY, V28, P455, DOI 10.1017/S0952675711000224; Stemberger J.P., 1985, PROGR PSYCHOL LANGUA, P143; STERNBERG S, 1988, PHONETICA, V45, P175, DOI 10.1159/000261825; Sternberg S., 1978, INFORMATION PROCESSI, P117, DOI DOI 10.1016/B978-0-12-665960-3.50011-6; Stetson R. H., 1951, MOTOR PHONETICS STUD; SUMMERS JJ, 1977, J MOTOR BEHAV, V9, P49, DOI 10.1080/00222895.1977.10735094; Tian X, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00166; Tilsen S, 2009, DYNAMICAL INTERPRETA, P462; Tilsen S, 2011, J PHONETICS, V39, P642, DOI 10.1016/j.wocn.2011.04.002; Tilsen S, 2009, COGNITIVE SCI, V33, P839, DOI 10.1111/j.1551-6709.2009.01037.x; Tilsen Sam., 2011, LAB PHONOLOGY, V2, P185, DOI [DOI 10.1515/LABPHON.2011.006, 10.1515/labphon.2011.006]; Tuller B, 1990, ATTENTION PERFORMANC, V13; Wheeldon L, 1997, J MEM LANG, V37, P356, DOI 10.1006/jmla.1997.2517; Zec D, 2007, CAMBRIDGE HANDBOOK OF PHONOLOGY, P161	87	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62800	10.1371/journal.pone.0062800	http://dx.doi.org/10.1371/journal.pone.0062800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	136DE	23638147	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400126
J	Arrouss, I; Nemati, F; Roncal, F; Wislez, M; Dorgham, K; Vallerand, D; Rabbe, N; Karboul, N; Carlotti, F; Bravo, J; Mazier, D; Decaudin, D; Rebollo, A				Arrouss, Issam; Nemati, Fariba; Roncal, Fernando; Wislez, Marie; Dorgham, Karim; Vallerand, David; Rabbe, Nathalie; Karboul, Narjesse; Carlotti, Francoise; Bravo, Jeronimo; Mazier, Dominique; Decaudin, Didier; Rebollo, Angelita			Specific Targeting of Caspase-9/PP2A Interaction as Potential New Anti-Cancer Therapy	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; DEPRIVATION-INDUCED APOPTOSIS; PENETRATING PEPTIDES; CANCER CELLS; IN-VIVO; BREAST; IDENTIFICATION; INHIBITION; EXPRESSION; PATHWAY	Purpose: PP2A is a serine/threonine phosphatase critical to physiological processes, including apoptosis. Cell penetrating peptides are molecules that can translocate into cells without causing membrane damage. Our goal was to develop cell-penetrating fusion peptides specifically designed to disrupt the caspase-9/PP2A interaction and evaluate their therapeutic potential in vitro and in vivo. Experimental Design: We generated a peptide containing a penetrating sequence associated to the interaction motif between human caspase-9 and PP2A (DPT-C9h), in order to target their association. Using tumour cell lines, primary human cells and primary human breast cancer (BC) xenografts, we investigated the capacity of DPT-C9h to provoke apoptosis in vitro and inhibition of tumour growth (TGI) in vivo. DPT-C9h was intraperitonealy administered at doses from 1 to 25 mg/kg/day for 5 weeks. Relative Tumour Volume (RTV) was calculated. Results: We demonstrated that DPT-C9h specifically target caspase-9/PP2A interaction in vitro and in vivo and induced caspase-9-dependent apoptosis in cancer cell lines. DPT-C9h also induced significant TGI in BC xenografts models. The mouse-specific peptide DPT-C9 also induced TGI in lung (K-Ras model) and breast cancer (PyMT) models. DPT-C9h has a specific effect on transformed B cells isolated from chronic lymphocytic leukemia patients without any effect on primary healthy cells. Finally, neither toxicity nor immunogenic responses were observed. Conclusion: Using the cell-penetrating peptides blocking caspase-9/PP2A interactions, we have demonstrated that DPT-C9h had a strong therapeutic effect in vitro and in vivo in mouse models of tumour progression.	[Arrouss, Issam; Dorgham, Karim; Mazier, Dominique; Rebollo, Angelita] Univ Paris 06, Hop Pitie Salpetriere, INSERM, UMR 945, Paris, France; [Nemati, Fariba; Vallerand, David; Karboul, Narjesse; Decaudin, Didier] Inst Curie, Translat Res Dept, Lab Preclin Investigat, Paris, France; [Roncal, Fernando] Univ Autonoma Madrid, Ctr Nacl Biotecnol, Madrid, Spain; [Wislez, Marie; Rabbe, Nathalie] Hop Tenon, URF Pierre & Marie Curie, F-75970 Paris, France; [Carlotti, Francoise] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Bravo, Jeronimo] CSIC, Inst Biomed Valencia, Valencia, Spain; [Decaudin, Didier] Inst Curie, Dept Med Oncol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Decaudin, D (corresponding author), Inst Curie, Translat Res Dept, Lab Preclin Investigat, Paris, France.	didier.decaudin@curie.net; angelita.rebollo@upmc.fr	Bravo, Jeronimo/K-9103-2014; Dorgham, karim/A-2241-2016; Carlotti, Françoise/H-1060-2014; Carlotti, Françoise/AAN-5018-2021; Rebollo, Angelita/P-2118-2017	Bravo, Jeronimo/0000-0001-6695-2846; Dorgham, karim/0000-0001-9539-3203; Carlotti, Françoise/0000-0001-7929-8468; Carlotti, Françoise/0000-0001-7929-8468; Rebollo, Angelita/0000-0002-1293-9686; wislez, marie/0000-0001-7518-7859	Inserm; Institut Curie	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie	The authors thank the Inserm and Institut Curie for the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackler S, 2008, MOL CANCER THER, V7, P3265, DOI 10.1158/1535-7163.MCT-08-0268; Ayllon V, 2002, EUR J IMMUNOL, V32, P1847, DOI 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7; Ayllon V, 2001, J IMMUNOL, V166, P7345, DOI 10.4049/jimmunol.166.12.7345; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Bitler BG, 2010, RECENT PAT ANTI-CANC, V5, P99, DOI 10.2174/157489210790936252; de Plater L, 2010, BRIT J CANCER, V103, P1192, DOI 10.1038/sj.bjc.6605900; Dessauge F, 2006, J IMMUNOL, V177, P2441, DOI 10.4049/jimmunol.177.4.2441; Dorgham K, 2005, AIDS RES HUM RETROV, V21, P82, DOI 10.1089/aid.2005.21.82; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Ducret Francis, 2005, Nephrol Ther, V1, P52, DOI 10.1016/j.nephro.2005.01.008; Edwards MJ, 2000, J INVEST DERMATOL, V115, P88, DOI 10.1046/j.1523-1747.2000.00026.x; Guergnon J, 2006, MOL PHARMACOL, V69, P1115, DOI 10.1124/mol.105.019364; Guergnon J, 2006, APOPTOSIS, V11, P1263, DOI 10.1007/s10495-006-7702-6; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Jan G, 2007, BIOCHEM J, V401, P711, DOI 10.1042/BJ20061324; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Johansson HJ, 2009, METHOD MOL BIOL, V683, P233; Johnson RM, 2009, METHOD MOL BIOL, V683, P535; Jones S, 2009, METHOD MOL BIOL, V683, P291; Kang HS, 2001, CELL IMMUNOL, V213, P34, DOI 10.1006/cimm.2001.1861; Keen JC, 2005, J BIOL CHEM, V280, P29519, DOI 10.1074/jbc.M505317200; Kim SS, 2009, CANCER RES, V69, P9291, DOI 10.1158/0008-5472.CAN-09-2418; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Leduc AM, 2003, P NATL ACAD SCI USA, V100, P11273, DOI 10.1073/pnas.1934759100; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Lyon MA, 2002, NAT REV DRUG DISCOV, V1, P961, DOI 10.1038/nrd963; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Massodi I, 2009, CLIN EXP METASTAS, V26, P251, DOI 10.1007/s10585-009-9237-z; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Modak C, 2008, BIOCHEM BIOPH RES CO, V368, P801, DOI 10.1016/j.bbrc.2008.02.001; Nemati F, 2010, CLIN CANCER RES, V16, P2352, DOI 10.1158/1078-0432.CCR-09-3066; Obeid M, 2009, MOL CANCER THER, V8, P2693, DOI 10.1158/1535-7163.MCT-09-0228; Prochiantz Alain, 2000, Journal de la Societe de Biologie, V194, P119; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Rubin E, 2001, ONCOGENE, V20, P3776, DOI 10.1038/sj.onc.1204518; Signorile A, 2002, FEBS LETT, V512, P91, DOI 10.1016/S0014-5793(02)02226-3; Singh K, 2000, BASIC RES CARDIOL, V95, P389, DOI 10.1007/s003950070038; Switzer CH, 2009, ONCOGENE, V28, P3837, DOI 10.1038/onc.2009.244; Tan M, 2006, CANCER RES, V66, P3764, DOI 10.1158/0008-5472.CAN-05-2747; Tappan E, 2008, CHEM BIOL, V15, P167, DOI 10.1016/j.chembiol.2008.01.005; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wislez M, 2006, CANCER RES, V66, P4198, DOI 10.1158/0008-5472.CAN-05-3842; Wong LL, 2010, EXP CELL RES, V316, P3387, DOI 10.1016/j.yexcr.2010.06.007; YAMANO H, 1994, EMBO J, V13, P5310, DOI 10.1002/j.1460-2075.1994.tb06865.x	50	23	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60816	10.1371/journal.pone.0060816	http://dx.doi.org/10.1371/journal.pone.0060816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637769	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400013
J	Malecki, A; Potdevin, G; Biernath, T; Eggl, E; Garcia, EG; Baum, T; Noel, PB; Bauer, JS; Pfeiffer, F				Malecki, Andreas; Potdevin, Guillaume; Biernath, Thomas; Eggl, Elena; Garcia, Eduardo Grande; Baum, Thomas; Noel, Peter B.; Bauer, Jan S.; Pfeiffer, Franz			Coherent Superposition in Grating-Based Directional Dark-Field Imaging	PLOS ONE			English	Article							RAY; CONTRAST; RADIOGRAPHY; TOMOGRAPHY	X-ray dark-field scatter imaging allows to gain information on the average local direction and anisotropy of micro-structural features in a sample well below the actual detector resolution. For thin samples the morphological interpretation of the signal is straight forward, provided that only one average orientation of sub-pixel features is present in the specimen. For thick samples, however, where the x-ray beam may pass structures of many different orientations and dimensions, this simple assumption in general does not hold and a quantitative description of the resulting directional dark-field signal is required to draw deductions on the morphology. Here we present a description of the signal formation for thick samples with many overlying structures and show its validity in experiment. In contrast to existing experimental work this description follows from theoretical predictions of a numerical study using a Fourier optics approach. One can easily extend this description and perform a quantitative structural analysis of clinical or materials science samples with directional dark-field imaging or even direction-dependent dark-field CT.	[Malecki, Andreas; Potdevin, Guillaume; Biernath, Thomas; Eggl, Elena; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Garching, Bavaria, Germany; [Malecki, Andreas; Potdevin, Guillaume; Biernath, Thomas; Eggl, Elena; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, Garching, Bavaria, Germany; [Garcia, Eduardo Grande; Baum, Thomas; Noel, Peter B.; Bauer, Jan S.] Tech Univ Munich, Klinikum Rechts Isar, Inst Radiol, D-80290 Munich, Bavaria, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Malecki, A (corresponding author), Tech Univ Munich, Dept Phys, Garching, Bavaria, Germany.	Andreas.Malecki@ph.tum.de; franz.pfeiffer@tum.de	Kirschke, Jan/E-2550-2012; Baum, Thomas/M-6522-2014; TUM, Forschung Neurorad/C-1202-2014	Kirschke, Jan/0000-0002-7557-0003; Baum, Thomas/0000-0002-4574-5212; Noel, Peter/0000-0002-9671-6171	Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Munich-Centre for Advanced Photonics; DFG Gottfried Wilhelm Leibniz program; DFG [BA 4085/1-2]; European Research Council (FP7) [StG 240142]; Karlsruhe Nano Micro Facility, a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology; Technische Universitat Munchen Graduate School	Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Munich-Centre for Advanced Photonics(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); European Research Council (FP7); Karlsruhe Nano Micro Facility, a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology; Technische Universitat Munchen Graduate School	The authors acknowledge financial support through the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Munich-Centre for Advanced Photonics, the DFG Gottfried Wilhelm Leibniz program, the DFG grant BA 4085/1-2, and the European Research Council (FP7, StG 240142). This work was carried out with the support of the Karlsruhe Nano Micro Facility (www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology. AM acknowledges the Technische Universitat Munchen Graduate School for the support of his studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als-Nielsen J., 2001, ELEMENTS MODERN XRAY; Bandyopadhyay P, 2009, MUCAL 1 3; Bech M, 2010, PHYS MED BIOL, V55, P5529, DOI 10.1088/0031-9155/55/18/017; Chabior M, 2011, J APPL PHYS, V110, DOI 10.1063/1.3630051; Chen GH, 2010, OPT EXPRESS, V18, P12960, DOI 10.1364/OE.18.012960; Goodman J.W., 2017, INTRO FOURIER OPTICS; Jensen TH, 2010, PHYS MED BIOL, V55, P3317, DOI 10.1088/0031-9155/55/12/004; Jensen TH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214103; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lynch SK, 2011, APPL OPTICS, V50, P4310, DOI 10.1364/AO.50.004310; Malecki A, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/48001; Modregger P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.048101; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Potdevin G, 2012, PHYS MED BIOL, V57, P3451, DOI 10.1088/0031-9155/57/11/3451; Revol V, 2012, J APPL PHYS, V112, DOI 10.1063/1.4768525; Schmidt J. D., 2010, NUMERICAL SIMULATION; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Weitkamp T, 2006, PROC SPIE, V6318, DOI 10.1117/12.683851; Wen H, 2009, RADIOLOGY, V251, P910, DOI 10.1148/radiol.2521081903; Yashiro W, 2010, OPT EXPRESS, V18, P16890, DOI 10.1364/OE.18.016890; Yashiro W, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094106	23	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61268	10.1371/journal.pone.0061268	http://dx.doi.org/10.1371/journal.pone.0061268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637802	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400031
J	Shim, YM; Burnette, A; Lucas, S; Herring, RC; Weltman, J; Patrie, JT; Weltman, AL; Platts-Mills, TA				Shim, Yun M.; Burnette, Autumn; Lucas, Sean; Herring, Richard C.; Weltman, Judith; Patrie, James T.; Weltman, Arthur L.; Platts-Mills, Thomas A.			Physical Deconditioning as a Cause of Breathlessness among Obese Adolescents with a Diagnosis of Asthma	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; SAGITTAL ABDOMINAL DIAMETER; BODY-MASS INDEX; AIRWAY-OBSTRUCTION; HYPERTONIC SALINE; CHILDREN; EXERCISE; RISK; INFLAMMATION; METHACHOLINE	Background: Obese children frequently complain of breathlessness. Asthma and obesity can both contribute to the symptoms during exercise, and this symptom can contribute to a diagnosis of asthma in these children. Despite the high prevalence of obesity few studies have investigated the cardiopulmonary physiology of breathlessness in obese children with a diagnosis of asthma. Methods: In this case-control study, thirty adolescents between age 12 and 19 were studied with baseline spirometry and a cardiopulmonary exercise test. Ten adolescents were normal controls, ten had obesity without a diagnosis of asthma, and ten had obesity with a history of physician-diagnosed asthma. Results: Baseline characteristics including complete blood count and spirometry were comparable between obese adolescents with and without a diagnosis of asthma. During exercise, obese asthmatic and obese non-asthmatic adolescents had significantly reduced physical fitness compared to healthy controls as evidenced by decreased peak oxygen uptake after adjusting for actual body weight (21.7 +/- 4.5 vs. 21.4 +/- 5.4 vs. 35.3 +/- 5.8 ml/kg/min, respectively). However, pulmonary capacity at the peak of exercise was comparable among all three groups as evidenced by similar pulmonary reserve. Conclusion: In this study, breathlessness was primarily due to cardiopulmonary deconditioning in the majority of obese adolescents with or without a diagnosis of asthma.	[Shim, Yun M.; Burnette, Autumn; Lucas, Sean; Herring, Richard C.; Weltman, Judith; Weltman, Arthur L.; Platts-Mills, Thomas A.] Univ Virginia, Dept Med, Charlottesville, VA 22903 USA; [Patrie, James T.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Weltman, Arthur L.] Univ Virginia, Dept Human Serv, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Shim, YM (corresponding author), Univ Virginia, Dept Med, Charlottesville, VA 22903 USA.	yss6n@virginia.edu	Shim, Yun Michael/N-2049-2017	Shim, Yun Michael/0000-0002-3780-3371; Platts-Mills, Thomas/0000-0002-1263-329X; Weltman, Arthur/0000-0002-0125-3769	Flight Attendant Medical Research Institute (FAMRI YCSA); Virginia Thoracic Society; National Institutes of Health (NIH) [K08HL91127, AI20565, U19AI070364]; NIH [RR00847]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000847] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020565, R01AI020565, U19AI070364] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute (FAMRI YCSA); Virginia Thoracic Society; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Flight Attendant Medical Research Institute (FAMRI YCSA to YMS), by the Virginia Thoracic Society (VTS biomedical research grant to YMS), by the National Institutes of Health (NIH) (K08HL91127 to YMS, AI20565 and U19AI070364 to TAP) and by a NIH grant to the General Clinical Research Center RR00847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Berg CM, 2011, CHEST, V139, P1109, DOI 10.1378/chest.10-1299; Carlsten C, 2007, CHEST, V131, P1339, DOI 10.1378/chest.06-2299; Chen Y, 2006, CHEST, V130, P890, DOI 10.1378/chest.130.3.890; Chinn S, 2001, THORAX, V56, P845, DOI 10.1136/thorax.56.11.845; Cornmins SP, 2012, AM J RESP CRIT CARE, V185, P723, DOI 10.1164/rccm.201111-2017OC; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Crater DD, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e97; Crater Scott E., 1998, Current Opinion in Pediatrics, V10, P594; Crater SE, 1999, AM J RESP CRIT CARE, V159, P806, DOI 10.1164/ajrccm.159.3.9805103; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fredberg JJ, 1998, EUR RESPIR J, V12, P1252, DOI 10.1183/09031936.98.12061252; Gilliland FD, 2003, AM J EPIDEMIOL, V158, P406, DOI 10.1093/aje/kwg175; Hallstrand TS, 2000, CHEST, V118, P1460, DOI 10.1378/chest.118.5.1460; Hanson P., 1984, SPORTS MED, P13; Hark WT, 2005, ANN ALLERG ASTHMA IM, V94, P247, DOI 10.1016/S1081-1206(10)61303-8; Holbrook JT, 2012, JAMA-J AM MED ASSOC, V307, P373, DOI 10.1001/jama.2011.2035; Iribarren C, 2006, AM J EPIDEMIOL, V164, P1150, DOI 10.1093/aje/kwj341; Johnson BD, 1999, CHEST, V116, P488, DOI 10.1378/chest.116.2.488; Joyner BL, 2006, J ASTHMA, V43, P675, DOI 10.1080/02770900600925460; Mannino DM, 2006, INT J OBESITY, V30, P6, DOI 10.1038/sj.ijo.0803145; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Perez-de-Llano LA, 2010, EUR RESPIR J, V35, P1221, DOI 10.1183/09031936.00118809; Peters EJ, 2003, ANN ALLERG ASTHMA IM, V90, P316, DOI 10.1016/S1081-1206(10)61800-5; Petersson H, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-10; Platts-Mills TAE, 2011, IMMUNOL REV, V242, P51, DOI 10.1111/j.1600-065X.2011.01021.x; PlattsMills TAE, 1997, CIBA F SYMP, V206, P173; Puckett JL, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-47; Rastogi D, 2011, CHEST; Rodriguez MA, 2002, ARCH PEDIAT ADOL MED, V156, P269, DOI 10.1001/archpedi.156.3.269; Rosi E, 2006, LUNG, V184, P251, DOI 10.1007/s00408-005-2590-z; Sakai T, 2010, PEDIATR INT, V52, P801, DOI 10.1111/j.1442-200X.2010.03168.x; Samee S, 2003, J ALLERGY CLIN IMMUN, V111, P1205, DOI 10.1067/mai.2003.1544; Schachter LM, 2001, THORAX, V56, P4, DOI 10.1136/thorax.56.1.4; Scott S, 2012, CHEST, V141, P616, DOI 10.1378/chest.11-0948; SONT JK, 1995, AM J RESP CRIT CARE, V152, P38, DOI 10.1164/ajrccm.152.1.7599850; Teodorescu M, 2010, CHEST, V138, P543, DOI 10.1378/chest.09-3066; Tilles SA, 2010, ANN ALLERG ASTHMA IM, V104, P361, DOI 10.1016/j.anai.2009.12.008; Utter AC, 2002, MED SCI SPORT EXER, V34, P139, DOI 10.1097/00005768-200201000-00021; WASSERMAN K, 1975, AM REV RESPIR DIS, V112, P219; Wasserman K., 1999, PRINCIPLES EXERCISE, P10; Weston AT, 1997, MED SCI SPORT EXER, V29, P138, DOI 10.1097/00005768-199701000-00020	44	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61022	10.1371/journal.pone.0061022	http://dx.doi.org/10.1371/journal.pone.0061022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637784	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400022
J	Fang, SZ; Liu, D; Tian, Y; Deng, SP; Shang, XL				Fang, Shengzuo; Liu, Dong; Tian, Ye; Deng, Shiping; Shang, Xulan			Tree Species Composition Influences Enzyme Activities and Microbial Biomass in the Rhizosphere: A Rhizobox Approach	PLOS ONE			English	Article							COMMUNITY COMPOSITION; POPLAR PLANTATIONS; FUMIGATION-EXTRACTION; FUNCTIONAL DIVERSITY; SOIL ENZYMES; PLANT; GRASSLAND; ECOSYSTEM; MANAGEMENT; IDENTITY	Monoculture causes nutrient losses and leads to declines in soil fertility and biomass production over successive cultivation. The rhizosphere, a zone of usually high microbial activities and clearly distinct from bulk soil, is defined as the volume of soil around living roots and influenced by root activities. Here we investigated enzyme activities and microbial biomass in the rhizosphere under different tree compositions. Six treatments with poplar, willow, and alder mono- or mixed seedlings were grown in rhizoboxes. Enzyme activities associated with nitrogen cycling and microbial biomass were measured in all rhizosphere and bulk soils. Both enzyme activities and microbial biomass in the rhizosphere differed significantly tree compositions. Microbial biomass contents were more sensitive to the changes of the rhizosphere environment than enzyme activities. Tree species coexistence did not consistently increase tested enzyme activities and microbial biomass, but varied depending on the complementarities of species traits. In general, impacts of tree species and coexistence were more pronounced on microbial composition than total biomass, evidenced by differences in microbial biomass C/N ratios stratified across the rhizosphere soils. Compared to poplar clone monoculture, other tree species addition obviously increased rhizosphere urease activity, but greatly reduced rhizosphere L-asparaginase activity. Poplar growth was enhanced only when coexisted with alder. Our results suggested that a highly productive or keystone plant species in a community had greater influence over soil functions than the contribution of diversity.	[Fang, Shengzuo; Liu, Dong; Tian, Ye; Deng, Shiping; Shang, Xulan] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Deng, Shiping] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA	Nanjing Forestry University; Oklahoma State University System; Oklahoma State University - Stillwater	Fang, SZ (corresponding author), Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China.	fangsz@njfu.edu.cn	Fang, Shengzuo/H-5546-2011		National Basic Research Program of China (973 program) [2012CB416904]; Knowledge Innovation Group Programs of Jiangsu Province; Doctorate Fellowship Foundation of Nanjing Forestry University	National Basic Research Program of China (973 program)(National Basic Research Program of China); Knowledge Innovation Group Programs of Jiangsu Province; Doctorate Fellowship Foundation of Nanjing Forestry University	This work was supported by the National Basic Research Program of China (973 program, 2012CB416904) and the Knowledge Innovation Group Programs of Jiangsu Province, as well as the Doctorate Fellowship Foundation of Nanjing Forestry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviani I, 2006, PLANT SOIL, V279, P327, DOI 10.1007/s11104-005-2189-4; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bashan Y, 1997, CAN J MICROBIOL, V43, P103, DOI 10.1139/m97-015; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bezemer TM, 2006, J ECOL, V94, P893, DOI 10.1111/j.1365-2745.2006.01158.x; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; Broughton LC, 2000, OECOLOGIA, V125, P420, DOI 10.1007/s004420000456; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Chen Xin, 2002, Journal of Zhejiang University (Science), V3, P355, DOI 10.1631/jzus.2002.0355; de Neergaard A, 2001, EUR J SOIL SCI, V52, P377, DOI 10.1046/j.1365-2389.2001.00393.x; Fang S, 2007, J ENVIRON MANAGE, V85, P672, DOI 10.1016/j.jenvman.2006.09.014; Fang SZ, 2010, SOIL SCI PLANT NUTR, V56, P483, DOI 10.1111/j.1747-0765.2010.00480.x; Forrester DI, 2006, FOREST ECOL MANAG, V233, P211, DOI 10.1016/j.foreco.2006.05.012; FRANKENBERGER WT, 1991, BIOL FERT SOILS, V11, P6, DOI 10.1007/BF00335826; Gao Y, 2010, J ENVIRON SCI-CHINA, V22, P1040, DOI 10.1016/S1001-0742(09)60215-1; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; INUBUSHI K, 1991, SOIL BIOL BIOCHEM, V23, P737, DOI 10.1016/0038-0717(91)90143-8; JOERGENSEN RG, 1990, SOIL BIOL BIOCHEM, V22, P1023, DOI 10.1016/0038-0717(90)90027-W; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Jones DL, 2003, PLANT SOIL, V248, P31, DOI 10.1023/A:1022304332313; Jungk A, 1997, ADV AGRON, V61, P53, DOI 10.1016/S0065-2113(08)60662-8; Kandeler E, 2002, PLANT SOIL, V238, P301, DOI 10.1023/A:1014479220689; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; Kielak A, 2008, FEMS MICROBIOL ECOL, V63, P372, DOI 10.1111/j.1574-6941.2007.00428.x; Ladygina N, 2010, SOIL BIOL BIOCHEM, V42, P162, DOI 10.1016/j.soilbio.2009.10.009; Leps J, 2001, OIKOS, V92, P123, DOI 10.1034/j.1600-0706.2001.920115.x; Liu D, 2012, APPL SOIL ECOL, V59, P1, DOI 10.1016/j.apsoil.2012.03.014; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Luster J, 2009, PLANT SOIL, V321, P457, DOI 10.1007/s11104-008-9781-3; Mao R, 2010, EUR J SOIL BIOL, V46, P325, DOI 10.1016/j.ejsobi.2010.05.005; Marilley L, 1999, APPL SOIL ECOL, V13, P127, DOI 10.1016/S0929-1393(99)00028-1; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; MARTENS DA, 1992, SOIL SCI, V153, P53, DOI 10.1097/00010694-199201000-00008; NAIM MS, 1965, ARCH MIKROBIOL, V50, P321, DOI 10.1007/BF00509573; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Nunan N, 2005, APPL ENVIRON MICROB, V71, P6784, DOI 10.1128/AEM.71.11.6784-6792.2005; Okur N, 2009, TURK J AGRIC FOR, V33, P413, DOI 10.3906/tar-0806-23; Prieto LH, 2011, GEODERMA, V162, P281, DOI 10.1016/j.geoderma.2011.02.011; Rothe A, 2001, CAN J FOREST RES, V31, P1855, DOI 10.1139/cjfr-31-11-1855; Singh BK, 2007, APPL SOIL ECOL, V36, P147, DOI 10.1016/j.apsoil.2007.01.004; Sinha S, 2009, SOIL BIOL BIOCHEM, V41, P1824, DOI 10.1016/j.soilbio.2008.11.022; Stark C, 2007, BIOL FERT SOILS, V43, P531, DOI 10.1007/s00374-006-0132-3; Steer J, 2000, SOIL BIOL BIOCHEM, V32, P869, DOI 10.1016/S0038-0717(99)00219-9; Stephan A, 2000, J ECOL, V88, P988, DOI 10.1046/j.1365-2745.2000.00510.x; Sylvia D., 2005, PRINCIPLES APPL SOIL, Vsecond; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Ushio M, 2008, SOIL BIOL BIOCHEM, V40, P2699, DOI 10.1016/j.soilbio.2008.06.023; Ushio M, 2010, PEDOBIOLOGIA, V53, P227, DOI 10.1016/j.pedobi.2009.12.003; Wardle DA, 2003, OIKOS, V102, P45, DOI 10.1034/j.1600-0706.2003.12481.x; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Yanai RD, 2003, PLANT SOIL, V257, P133, DOI 10.1023/A:1026257508033; Yang RY, 2007, APPL SOIL ECOL, V37, P240, DOI 10.1016/j.apsoil.2007.07.004; YEATES G, 1991, SOIL BIOL BIOCHEM, V23, P963, DOI 10.1016/0038-0717(91)90177-L; Zhang C, 2011, GEODERMA, V161, P115, DOI 10.1016/j.geoderma.2010.12.003	56	23	25	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61461	10.1371/journal.pone.0061461	http://dx.doi.org/10.1371/journal.pone.0061461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637838	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700037
J	Gao, L; Hidalgo-Figueroa, M; Escudero, LM; Diaz-Martin, J; Lopez-Barneo, J; Pascual, A				Gao, Lin; Hidalgo-Figueroa, Maria; Escudero, Luis M.; Diaz-Martin, Juan; Lopez-Barneo, Jose; Pascual, Alberto			Age-Mediated Transcriptomic Changes in Adult Mouse Substantia Nigra	PLOS ONE			English	Article							HYDROXYLASE MESSENGER-RNA; GENE-EXPRESSION PROFILE; DOPAMINERGIC-NEURONS; BRAIN; DECREASES; MELATONIN; MIDBRAIN; DENSITY; MODELS; SYSTEM	Substantia nigra pars compacta (SNpc) is highly sensitive to normal aging and selectively degenerates in Parkinson's disease (PD). Until now, molecular mechanisms behind SNpc aging have not been fully investigated using high throughput techniques. Here, we show early signs of aging in SNpc, which are more evident than in ventral tegmental area (VTA), a region adjacent to SNpc but less affected in PD. Aging-associated early changes in transcriptome were investigated comparing late middle-aged (18 months old) to young (2 months old) mice in both SNpc and VTA. A meta-analysis of published microarray studies allowed us to generate a common "transcriptional signature" of the aged (>= 24 months old) mouse brain. SNpc of late-middle aged mice shared characteristics with the transcriptional signature, suggesting an accelerated aging in SNpc. Age-dependent changes in gene expression specific to SNpc were also observed, which were related to neuronal functions and inflammation. Future studies could greatly help determine the contribution of these changes to SNpc aging. These data help understand the processes underlying SNpc aging and their potential contribution to age-related disorders like PD.	[Gao, Lin; Hidalgo-Figueroa, Maria; Escudero, Luis M.; Diaz-Martin, Juan; Lopez-Barneo, Jose; Pascual, Alberto] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain; [Gao, Lin; Hidalgo-Figueroa, Maria; Escudero, Luis M.; Diaz-Martin, Juan; Lopez-Barneo, Jose; Pascual, Alberto] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBERNED	Gao, L (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain.	lgao-ibis@us.es; apascual-ibis@us.es	Pascual, Alberto/L-2014-2019; Diaz-Martin, Juan/F-4765-2015; Hidalgo-Figueroa, Maria/AAA-9529-2019; Diaz-Martin, Juan/AAU-1685-2021; Diaz-Martin, Juan/GSI-9230-2022; Gao, Lin/C-8318-2015; IBIS, NEURONAL/O-9910-2015; IBIS, NEUROBIOLOGIA/O-9922-2015; IBIS, SARCOMAS/O-1893-2015; Pascual, Alberto P/E-9609-2015	Pascual, Alberto/0000-0001-5459-6207; Diaz-Martin, Juan/0000-0002-3985-6434; Hidalgo-Figueroa, Maria/0000-0001-5241-0931; Diaz-Martin, Juan/0000-0002-3985-6434; Gao, Lin/0000-0002-1781-4671; Pascual, Alberto P/0000-0001-5459-6207; Escudero, Luis M./0000-0001-8030-1820	Spanish Ministry of Science and Education; Andalusian Government; "Marcelino Botin" Foundation; Spanish "Carlos III" Institute of Health; Spanish Ministry of Science and Education for MHF ("FPI" predoctoral fellowship)	Spanish Ministry of Science and Education(Spanish Government); Andalusian Government; "Marcelino Botin" Foundation; Spanish "Carlos III" Institute of Health; Spanish Ministry of Science and Education for MHF ("FPI" predoctoral fellowship)(German Research Foundation (DFG))	This work was funded by Spanish Ministry of Science and Education, Andalusian Government, and "Marcelino Botin" Foundation. "CIBERNED" (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas) was funded by the Spanish "Carlos III" Institute of Health. LME was supported by the Spanish "Carlos III" Institute of Health. Support from the Spanish Ministry of Science and Education for MHF ("FPI" predoctoral fellowship) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNON MJ, 1992, P NATL ACAD SCI USA, V89, P7095, DOI 10.1073/pnas.89.15.7095; Bannon MJ, 1997, NEUROLOGY, V48, P969, DOI 10.1212/WNL.48.4.969; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bordner KA, 2011, EXP GERONTOL, V46, P643, DOI 10.1016/j.exger.2011.03.003; CASTEL MN, 1994, BIOCHEM PHARMACOL, V47, P53, DOI 10.1016/0006-2952(94)90437-5; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Chen HL, 2003, BRAIN RES, V994, P81, DOI 10.1016/j.brainres.2003.09.020; Chu YP, 2002, J COMP NEUROL, V450, P203, DOI 10.1002/cne.10261; Dickerson JW, 2009, NEUROSCIENCE, V163, P482, DOI 10.1016/j.neuroscience.2009.06.008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hidalgo-Figueroa M, J NEUROSCIENCE, V32, P864; HIMI T, 1995, J GERONTOL A-BIOL, V50, pB193, DOI 10.1093/gerona/50A.4.B193; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jucker M, 1997, BEHAV BRAIN RES, V85, P1, DOI 10.1016/S0166-4328(96)02243-7; Kedmi M, 2011, AGE, V33, P1, DOI 10.1007/s11357-010-9155-7; Korotkova TM, 2005, EUR J NEUROSCI, V22, P1287, DOI 10.1111/j.1460-9568.2005.04327.x; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Perreau VM, 2007, J NEUROIMMUNOL, V182, P22, DOI 10.1016/j.jneuroim.2006.09.005; Rollo CD, 2009, NEUROCHEM RES, V34, P601, DOI 10.1007/s11064-008-9858-7; Ross GW, 2004, ANN NEUROL, V56, P532, DOI 10.1002/ana.20226; Rudow G, 2008, ACTA NEUROPATHOL, V115, P461, DOI 10.1007/s00401-008-0352-8; Salvatore MF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008466; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SCHULIGOI R, 1993, MOL BRAIN RES, V19, P333, DOI 10.1016/0169-328X(93)90135-C; Sharman EH, 2007, NEUROCHEM INT, V50, P336, DOI 10.1016/j.neuint.2006.09.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stark AK, 2004, CELL TISSUE RES, V318, P81, DOI 10.1007/s00441-004-0972-9; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Terao A, 2002, J NEUROIMMUNOL, V132, P99, DOI 10.1016/S0165-5728(02)00317-X; Villar-Cheda B, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.006; Villar-Cheda B, 2009, J CEREBR BLOOD F MET, V29, P230, DOI 10.1038/jcbfm.2008.127; Xu X, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r234; Zecca L, 2004, P NATL ACAD SCI USA, V101, P9843, DOI 10.1073/pnas.0403495101	52	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62456	10.1371/journal.pone.0062456	http://dx.doi.org/10.1371/journal.pone.0062456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638090	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300062
J	Behnert, A; Fritzler, MJ; Teng, BN; Zhang, MF; Bollig, F; Haller, H; Skoberne, A; Mahler, M; Schiffer, M				Behnert, Astrid; Fritzler, Marvin J.; Teng, Beina; Zhang, Meifeng; Bollig, Frank; Haller, Hermann; Skoberne, Andrej; Mahler, Michael; Schiffer, Mario			An Anti-Phospholipase A(2) Receptor Quantitative Immunoassay and Epitope Analysis in Membranous Nephropathy Reveals Different Antigenic Domains of the Receptor	PLOS ONE			English	Article							ANTIBODIES; AUTOANTIBODIES; GLOMERULONEPHRITIS; AUTOANTIGENS; DISEASES; RECURRENT; TARGET; SM	The phospholipase A(2) receptor (PLA(2)R) was recently discovered as a target autoantigen in patients with idiopathic membranous nephropathy (IMN). Published evidence suggests that the autoantibodies directed towards a conformation dependent epitope are currently effectively detected by a cell based assay (CBA) utilizing indirect immunofluorescence (IIF) on tissue culture cells transfected with the PLA(2)R cDNA. Limitations of such IIF-CBA assays include observer dependent subjective evaluation of semi-quantitative test results and the protocols are not amenable to high throughput diagnostic testing. We developed a quantitative, observer independent, high throughput capture immunoassay for detecting PLA(2)R autoantibodies on an addressable laser bead immunoassay (ALBIA) platform. Since reactive domains of PLA(2)R (i.e. epitopes) could be used to improve diagnostic tests by using small peptides in various high throughput diagnostic platforms, we identified PLA(2)R epitopes that bound autoantibodies of IMN patients. These studies confirmed that inter-molecular epitope spreading occurs in IMN but use of the cognate synthetic peptides in immunoassays was unable to conclusively distinguish between IMN patients and normal controls. However, combinations of these peptides were able to effectively absorb anti-PLA(2)R reactivity in IIF-CBA and an immunoassay that employed a lysate derived from HEK cells tranfected with and overexpressing PLA(2)R. While we provide evidence of intermolecular epitope spreading, our data indicates that in addition to conformational epitopes, human anti-PLA(2)R reactivity in a commercially available CBA and an addressable laser bead immunoassay is significantly absorbed by peptides representing epitopes of PLA(2)R.	[Behnert, Astrid; Teng, Beina; Bollig, Frank; Haller, Hermann; Skoberne, Andrej; Schiffer, Mario] Hannover Med Sch, Div Nephrol, Hannover, Germany; [Fritzler, Marvin J.; Zhang, Meifeng] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada; [Mahler, Michael] INOVA Diagnost INC, San Diego, CA USA	Hannover Medical School; University of Calgary; Inova Diagnostics, Inc.	Schiffer, M (corresponding author), Hannover Med Sch, Div Nephrol, Hannover, Germany.	schiffer.mario@mh-hannover.de	Schiffer, Mario/U-7050-2019	Schiffer, Mario/0000-0002-8414-1470; Wintering, Astrid/0000-0002-3731-6928	German Academic Exchange Service (DAAD); Biomedical Sciences Exchange Program (BMEP); StrucMed, Medical School Hanover; DFG [SCHI587/4-6]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Biomedical Sciences Exchange Program (BMEP); StrucMed, Medical School Hanover; DFG(German Research Foundation (DFG))	A.B. has been supported by the German Academic Exchange Service (DAAD), the Biomedical Sciences Exchange Program (BMEP) and StrucMed, Medical School Hanover. M.S. is supported by DFG grants (SCHI587/4-6). M.J.F. holds the Arthritis Research Chair at the University of Calgary and this work was supported by funds derived from that endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; BINDON CI, 1988, J EXP MED, V168, P127, DOI 10.1084/jem.168.1.127; Bruschi M, 2011, J PROTEOMICS, V74, P2008, DOI 10.1016/j.jprot.2011.05.021; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; de Laat B, 2011, ARTHRITIS RHEUM-US, V63, P3960, DOI 10.1002/art.30633; Debiec H, 2011, AM J TRANSPLANT, V11, P2144, DOI 10.1111/j.1600-6143.2011.03643.x; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Debiec H, 2011, NAT REV NEPHROL, V7, P496, DOI 10.1038/nrneph.2011.106; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Hanasaki K, 2004, BIOL PHARM BULL, V27, P1165, DOI 10.1248/bpb.27.1165; Hanko JB, 2009, NEPHROL DIAL TRANSPL, V24, P3050, DOI 10.1093/ndt/gfp254; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Hofstra JM, 2012, NETH J MED, V70, P109; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Jia XY, 2012, NEPHROLOGY, V17, P160, DOI 10.1111/j.1440-1797.2011.01511.x; Kanigicherla D, 2013, KIDNEY INT; Kessenbrock K, 2007, CURR MED CHEM, V14, P2831, DOI 10.2174/092986707782360150; Kuroki A, 2002, INTERNAL MED, V41, P936, DOI 10.2169/internalmedicine.41.936; Mahler M, 2000, J MOL MED-JMM, V78, P460, DOI 10.1007/s001090000128; Mahler M, 2005, ARTHRITIS RES THER, V7, pR19, DOI 10.1186/ar1455; Mahler M, 2003, CLIN IMMUNOL, V107, P65, DOI 10.1016/S1521-6616(03)00037-8; Mahler M, 2001, J MOL MED, V79, P722, DOI 10.1007/s001090100258; MATTIOLI M, 1973, J IMMUNOL, V110, P1318; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Northway JD, 1972, DIFFERENTIATION ANTI, P140; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Stahl R, 2010, NEW ENGL J MED, V363, P496, DOI 10.1056/NEJMc1003066; Stinton LM, 2011, CLIN EXP IMMUNOL, V163, P147, DOI 10.1111/j.1365-2249.2010.04288.x; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724	34	37	47	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61669	10.1371/journal.pone.0061669	http://dx.doi.org/10.1371/journal.pone.0061669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637879	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800011
J	Sun, HX; Choo-Wing, R; Sureshbabu, A; Fan, J; Leng, L; Yu, S; Jiang, DH; Noble, P; Homer, RJ; Bucala, R; Bhandari, V				Sun, Huanxing; Choo-Wing, Rayman; Sureshbabu, Angara; Fan, Juan; Leng, Lin; Yu, Shuang; Jiang, Dianhua; Noble, Paul; Homer, Robert J.; Bucala, Richard; Bhandari, Vineet			A Critical Regulatory Role for Macrophage Migration Inhibitory Factor in Hyperoxia- Induced Injury in the Developing Murine Lung	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ANGIOGENIC FACTORS; BRONCHOPULMONARY DYSPLASIA; DEVELOPMENTAL DIFFERENCES; MATURATIONAL DIFFERENCES; TRANSGENIC MICE; NEWBORN RATS; NITRIC-OXIDE; FACTOR MIF; NULL MICE	Background: The role and mechanism of action of MIF in hyperoxia-induced acute lung injury (HALI) in the newborn lung are not known. We hypothesized that MIF is a critical regulatory molecule in HALI in the developing lung. Methodology: We studied newborn wild type (WT), MIF knockout (MIFKO), and MIF lung transgenic (MIFTG) mice in room air and hyperoxia exposure for 7 postnatal (PN) days. Lung morphometry was performed and mRNA and protein expression of vascular mediators were analyzed. Results: MIF mRNA and protein expression were significantly increased in WT lungs at PN7 of hyperoxia exposure. The pattern of expression of Angiopoietin 2 protein (in MIFKO>WT>MIFTG) was similar to the mortality pattern (MIFKO>WT>MIFTG) in hyperoxia at PN7. In room air, MIFKO and MIFTG had modest but significant increases in chord length, compared to WT. This was associated with decreased expression of Angiopoietin 1 and Tie 2 proteins in the MIFKO and MIFTG, as compared to the WT control lungs in room air. However, on hyperoxia exposure, while the chord length was increased from their respective room air controls, there were no differences between the 3 genotypes. Conclusion: These data point to the potential roles of Angiopoietins 1, 2 and their receptor Tie2 in the MIF-regulated response in room air and upon hyperoxia exposure in the neonatal lung.	[Sun, Huanxing; Choo-Wing, Rayman; Sureshbabu, Angara; Bhandari, Vineet] Yale Univ, Dept Pediat, New Haven, CT 06520 USA; [Fan, Juan; Leng, Lin; Yu, Shuang; Bucala, Richard] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Jiang, Dianhua; Noble, Paul] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Homer, Robert J.] Yale Univ, Dept Pathol, New Haven, CT USA	Yale University; Yale University; Duke University; Yale University	Bhandari, V (corresponding author), Yale Univ, Dept Pediat, New Haven, CT 06520 USA.	vineet.bhandari@yale.edu	Jiang, Dianhua/B-1421-2009; Bhandari, Vineet/AAS-3365-2020; homer, robert/P-3884-2019	Jiang, Dianhua/0000-0002-4508-3829; homer, robert/0000-0002-2055-5885; Leng, Lin/0000-0002-0605-358X	American Heart Association [0755843T]; American Thoracic Society [ATS-07-005]; National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [HL-74195, HL-085103]; National Institute of Allergy and Infectious Diseases (NIAID) of the NIH [AI042310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074195, R01HL085103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042310] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Thoracic Society; National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases (NIAID) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by grants 0755843T (VB) from the American Heart Association, ATS-07-005 (VB) from the American Thoracic Society; HL-74195 (VB), HL-085103 (VB) from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI), and AI042310 (RB) from the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghai ZH, 2008, J PERINATOL, V28, P149, DOI 10.1038/sj.jp.7211886; Bhandari V, 2002, FRONT BIOSCI-LANDMRK, V7, pD1624, DOI 10.2741/bhan; Bhandari V, 2008, AM J RESP CELL MOL, V39, P420, DOI 10.1165/rcmb.2007-0024OC; Bhandari V, 2008, FRONT BIOSCI-LANDMRK, V13, P6653, DOI 10.2741/3179; Bhandari V, 2007, J IMMUNOL, V178, P4993, DOI 10.4049/jimmunol.178.8.4993; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Bhandari V, 2006, P NATL ACAD SCI USA, V103, P11021, DOI 10.1073/pnas.0601057103; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; Bhandari V, 2012, AM J RESP CELL MOL, V46, P668, DOI 10.1165/rcmb.2011-0074OC; Bondza PK, 2008, FERTIL STERIL, V90, P1433, DOI 10.1016/j.fertnstert.2007.08.046; Patrick KBA, 2008, J REPROD IMMUNOL, V77, P142, DOI 10.1016/j.jri.2007.07.004; Choo-Wing R, 2007, AM J PHYSIOL-LUNG C, V293, pL142, DOI 10.1152/ajplung.00434.2006; Cohen JC, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-21; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dani C, 2011, RESPIRATION, V82, P369, DOI 10.1159/000328928; de Visser YP, 2012, AM J PHYSIOL-LUNG C, V302, pL56, DOI 10.1152/ajplung.00041.2011; DICOSMO BF, 1994, J CLIN INVEST, V94, P2028, DOI 10.1172/JCI117556; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Frenz DA, AM J MED GENET A, V152A, P2947; Harijith A, 2011, AM J RESP CELL MOL, V44, P621, DOI 10.1165/rcmb.2010-0058OC; Hato T, 2009, BIOCHEM BIOPH RES CO, V381, P218, DOI 10.1016/j.bbrc.2009.02.030; James ML, 2010, PEDIATR RES, V67, P591, DOI 10.1203/PDR.0b013e3181dbac3d; Jorgensen WL, 2010, BIOORG MED CHEM LETT, V20, P7033, DOI 10.1016/j.bmcl.2010.09.118; Kevill KA, 2008, J IMMUNOL, V180, P601, DOI 10.4049/jimmunol.180.1.601; Kim HR, 2007, J RHEUMATOL, V34, P927; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; MITCHELL R, 1995, J IMMUNOL, V154, P3863; Munaut C, 2002, NEUROPATH APPL NEURO, V28, P452, DOI 10.1046/j.1365-2990.2002.00416.x; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Ren Y, 2005, ANN SURG, V242, P55, DOI 10.1097/01.sla.0000168555.97710.bb; Ren Y, 2004, ONCOGENE, V23, P4146, DOI 10.1038/sj.onc.1207490; Ren Y, 2003, INT J CANCER, V107, P22, DOI 10.1002/ijc.11287; Rogers LK, 2009, PEDIATR RES, V65, P33, DOI 10.1203/PDR.0b013e31818a1d0a; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Tang FG, 2005, PEDIATR PULM, V40, P437, DOI 10.1002/ppul.20299; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Veillat V, 2010, J CLIN ENDOCR METAB, V95, pE403, DOI 10.1210/jc.2010-0417; White CW, 2001, AM J RESP CELL MOL, V25, P51, DOI 10.1165/ajrcmb.25.1.4296; White ES, 2003, CLIN CANCER RES, V9, P853; Xu XD, 2008, CANCER LETT, V261, P147, DOI 10.1016/j.canlet.2007.11.028; Yang G, 2004, J CLIN INVEST, V114, P669, DOI 10.1172/JCI200419300; Yang G, 2000, AM J PHYSIOL-LUNG C, V278, pL393, DOI 10.1152/ajplung.2000.278.2.L393; You K, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-36	45	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e60560	10.1371/journal.pone.0060560	http://dx.doi.org/10.1371/journal.pone.0060560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637753	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800005
J	Zhang, YQ; Xu, L; Zhang, L; Yang, H; Wang, YX; Jonas, JB				Zhang, Yaqin; Xu, Liang; Zhang, Li; Yang, Hua; Wang, Ya Xing; Jonas, Jost B.			Ophthalmoscopic Assessment of the Retinal Nerve Fiber Layer. The Beijing Eye Study	PLOS ONE			English	Article							OPTIC DISK; GLAUCOMA; DEFECTS; HYPERTENSION; PREVALENCE; SIZE	Purpose: To examine the retinal nerve fiber layer (RNFL) ophthalmoscopically, to search for localized RNFL defects, and to assess factors associated with RNFL visibility in a population-based setting. Methods: The population-based cross-sectional Beijing Eye Study 2006 included 3251 subjects. Using color fundus photographs, RNFL visibility was assessed in grades from 0 to 8 in 8 fundus sectors. Localized RNFL defects were defined as wedge-shaped defects running towards the optic disc. Results: After exclusion of subjects with optic media opacities, 2602 subjects (mean age:58.1 +/- 9.0 years) were included. RNFL visibility score was highest (P<0.001) in the temporal inferior region, followed by the temporal superior region, nasal superior region, and nasal inferior region. In multivariate analysis, higher RNFL visibility score was associated with younger age (P<0.001;standardized coefficient beta:-0.44;regression coefficient B: -0.22; 95%CI: -0.24, -0.20), female gender (P<0.001;beta:0.11;B:1.00;95%CI:0.67,1.32), higher blood concentration of low-density lipoproteins (P = 0.002;beta:0.07;B:0.34;95%CI:0.13,0.56), absence of dyslipidemia (P = 0.001;beta: -0.07;B: -0.58;95%CI: -0.93, -0.24), lower blood glucose concentration (P = 0.006;beta: -0.05;B: -0.14;95%CI: -0.24, -0.04), hyperopic refractive error (P<0.001;beta:0.15;B:0.45;95%CI:0.34,0.56), smaller optic disc size (P<0.001;beta: -0.08; B:-0.72;95% CI:-1.04, -0.40), absence of glaucomatous optic neuropathy (P<0.001;beta: -0.06;B: -2.69;95%CI:-4.18, -1.21) and absence of non-glaucomatous optic nerve damage (P = 0.001;beta: -0.06;B: -4.80;95%CI:0. -7.64, -1.96). Localized RNFL defects were detected in 96 subjects (prevalence:3.7 +/- 0.45% (95% confidence interval(CI):3.0,4.4). In multivariate analysis, prevalence of localized RNFL defects was associated with higher blood pressure (P<0.001; odds ratio (OR):1.07;95%CI:1.03,1.10), higher concentration of low-density lipoproteins (P = 0.01;OR:1.42;95%CI:1.08,1.85), higher prevalence of glaucomatous optic neuropathy (P<0.001;OR:46.8;95%CI:19.4,113) and diabetic retinopathy (P = 0.002;OR:3.20;95%CI:1.53,6.67), and lower total RNFL visibility (P<0.001;OR:0.92;95%CI:0.88,0.96). Conclusions: In Chinese aged 45+ years, a decreased RNFL visibility was associated with older age, male gender, dyslipidemia, hyperglycemia, myopia, larger optic disc, and glaucomatous or non-glaucomatous optic neuropathy. Localized RNFL defects (prevalence:3.7 +/- 0.45%) were correlated mainly with higher blood pressure, higher concentration of low-density lipoproteins, glaucomatous optic neuropathy and diabetic retinopathy. These data are helpful for the routine ophthalmoscopic examination of the RNFL.	[Zhang, Yaqin; Xu, Liang; Zhang, Li; Yang, Hua; Wang, Ya Xing; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@gmail.com; Jost.Jonas@augen.ma.uni-heidelberg.de	wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing Government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing Government	This work was supported by the State Natural Sciences Fund (81041018); Natural Sciences Fund of Beijing Government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1984, AM J OPHTHALMOL, V98, P566, DOI 10.1016/0002-9394(84)90242-3; AIRAKSINEN PJ, 1981, ACTA OPHTHALMOL, V59, P627, DOI 10.1111/j.1755-3768.1981.tb08728.x; CAPRIOLI J, 1990, OPHTHALMOLOGY, V97, P358; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; HITCHINGS RA, 1987, EYE, V1, P621, DOI 10.1038/eye.1987.96; HOYT WF, 1972, BRIT J OPHTHALMOL, V56, P577, DOI 10.1136/bjo.56.8.577; JONAS JB, 1989, OPHTHALMOLOGY, V96, P627; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P401; Jonas JB, 1996, SURV OPHTHALMOL, V40, P369, DOI 10.1016/S0039-6257(96)80065-8; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; JONAS JB, 1994, GRAEF ARCH CLIN EXP, V232, P759, DOI 10.1007/BF00184280; Jonas JB, 1993, GRAEFES ARCH CLIN EX, V31, P207; Li YB, 2006, AM J OPHTHALMOL, V142, P788, DOI 10.1016/j.ajo.2006.06.001; SOMMER A, 1977, ARCH OPHTHALMOL-CHIC, V95, P2149; Vogt A, 1913, GRAEFES ARHIV OPHTHA, V84, P293; Xu L, 2013, AM J HYPERTENS, V26, P511, DOI 10.1093/ajh/hps081; Xu L, 2009, OPHTHALMOLOGY, V116, P732, DOI 10.1016/j.ophtha.2008.11.003	18	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62022	10.1371/journal.pone.0062022	http://dx.doi.org/10.1371/journal.pone.0062022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637954	Green Published, Green Submitted, gold			2022-12-25	WOS:000321662800019
J	Casella, CR; Mitchell, TC				Casella, Carolyn R.; Mitchell, Thomas C.			Inefficient TLR4/MD-2 Heterotetramerization by Monophosphoryl Lipid A	PLOS ONE			English	Article							IFN-REGULATORY FACTOR-3; TOLL-LIKE RECEPTOR-4; HEPATITIS-B-VACCINE; NF-KAPPA-B; SIGNALING PATHWAY; CUTTING EDGE; TLR4-MD-2 COMPLEX; ADJUVANT SYSTEM; DENDRITIC CELLS; T-CELLS	Synthetic forms of E. coli monophosphoryl lipid A (sMLA) weakly activate the MyD88 (myeloid differentiation primary response protein) branch of the bifurcated TLR4 (Toll-like receptor 4) signaling pathway, in contrast to diphosphoryl lipid A (sDLA), which is a strong activator of both branches of TLR4. sMLA's weak MyD88 signaling activity is apparent downstream of TLR4/MyD88 signaling as we show that sMLA, unlike sDLA, is unable to efficiently recruit the TNF receptor-associated factor 6 (TRAF6) to the Interleukin-1 receptor-associated kinase 1 (IRAK1). This reduced recruitment of TRAF6 explains MLA's lower MAPK (Mitogen Activated Protein Kinase) and NF-kappa B activity. As further tests of sMLA's ability to activate TLR4/Myeloid differentiation factor 2 (MD-2), we used the antibody MTS510 as an indicator for TLR4/MD-2 heterotetramer formation. Staining patterns with this antibody indicated that sMLA does not effectively drive heterotetramerization of TLR4/MD-2 when compared to sDLA. However, a F126A mutant of MD-2, which allows lipid A binding but interferes with TLR4/MD-2 heterotetramerization, revealed that while sMLA is unable to efficiently form TLR4/MD-2 heterotetramers, it still needs heterotetramer formation for the full extent of signaling it is able to achieve. Monophosphoryl lipid A's weak ability to form TLR4/MD-2 heterotetramers was not restricted to synthetic E. coli type because cells exposed to a biological preparation of S. minnesota monophosphoryl lipid A (MPLA) also showed reduced TLR4/MD-2 heterotetramer formation. The low potency with which sMLA and MPLA drive heterotetramerization of TLR4/MD-2 contributes to their weak MyD88 signaling activities.	[Casella, Carolyn R.; Mitchell, Thomas C.] Univ Louisville, Sch Med, Inst Cellular Therapeut, Louisville, KY 40292 USA; [Mitchell, Thomas C.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Mitchell, TC (corresponding author), Univ Louisville, Sch Med, Inst Cellular Therapeut, Louisville, KY 40292 USA.	tom.mitchell@louisville.edu	Mitchell, Thomas C/B-4193-2013		National Institutes of Health [AI071047]; Commonwealth of Kentucky Research Challenge Trust; W. M. Keck Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Kentucky Research Challenge Trust; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (Grant AI071047), the Commonwealth of Kentucky Research Challenge Trust (http://www.uky.edu/Development/dcs/rctf.htm), and the W. M. Keck Foundation (http://www.wmkeck.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Bowen WS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001963; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cekic C, 2011, J IMMUNOL, V186, P3858, DOI 10.4049/jimmunol.1001034; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Embry CA, 2011, SCI SIGNAL, V4, P20, DOI 10.1126/scisignal.2001486; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Gangloff M, 2012, TRENDS BIOCHEM SCI, V37, P92, DOI 10.1016/j.tibs.2011.11.003; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hagen SR, 1997, J CHROMATOGR A, V767, P53, DOI 10.1016/S0021-9673(97)00041-1; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Ismaili J, 2002, J IMMUNOL, V168, P926, DOI 10.4049/jimmunol.168.2.926; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meng J, 2011, SCI CHINA PHYS CHEM, V54, P187, DOI 10.1007/s11433-010-4225-5; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; RIBI E, 1979, CANCER IMMUNOL IMMUN, V7, P43, DOI 10.1007/BF00205409; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Salkowski CA, 1997, INFECT IMMUN, V65, P3239, DOI 10.1128/IAI.65.8.3239-3247.1997; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; Thoelen S, 2001, VACCINE, V19, P2400, DOI 10.1016/S0264-410X(00)00462-X; Thoelen S, 1998, VACCINE, V16, P708, DOI 10.1016/S0264-410X(97)00254-5; Thompson BS, 2005, J LEUKOCYTE BIOL, V78, P1273, DOI 10.1189/jlb.0305172; Tsukamoto H, 2010, INT IMMUNOL, V22, P271, DOI 10.1093/intimm/dxq005; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamakawa N, 2013, INT IMMUNOL, V25, P45, DOI 10.1093/intimm/dxs084; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yu LP, 2012, J BIOL CHEM, V287, P16346, DOI 10.1074/jbc.M112.343467; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	56	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62622	10.1371/journal.pone.0062622	http://dx.doi.org/10.1371/journal.pone.0062622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638128	gold, Green Submitted, Green Published			2022-12-25	WOS:000318343700064
J	Luo, RY; Ye, L; Tao, CY; Wang, KK				Luo, Ruoyu; Ye, Lin; Tao, Chenyang; Wang, Kankan			Simulation of E-coli Gene Regulation including Overlapping Cell Cycles, Growth, Division, Time Delays and Noise	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; FLUX-BALANCE ANALYSIS; SYSTEMS; EXPRESSION; DYNAMICS; REPLICATION; CHROMOSOME; FEEDBACK; FLUCTUATIONS; SEGREGATION	Due to the complexity of biological systems, simulation of biological networks is necessary but sometimes complicated. The classic stochastic simulation algorithm (SSA) by Gillespie and its modified versions are widely used to simulate the stochastic dynamics of biochemical reaction systems. However, it has remained a challenge to implement accurate and efficient simulation algorithms for general reaction schemes in growing cells. Here, we present a modeling and simulation tool, called 'GeneCircuits', which is specifically developed to simulate gene-regulation in exponentially growing bacterial cells (such as E. coli) with overlapping cell cycles. Our tool integrates three specific features of these cells that are not generally included in SSA tools: 1) the time delay between the regulation and synthesis of proteins that is due to transcription and translation processes; 2) cell cycle-dependent periodic changes of gene dosage; and 3) variations in the propensities of chemical reactions that have time-dependent reaction rates as a consequence of volume expansion and cell division. We give three biologically relevant examples to illustrate the use of our simulation tool in quantitative studies of systems biology and synthetic biology.	[Luo, Ruoyu; Ye, Lin; Tao, Chenyang] Fudan Univ, Sch Life Sci, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Luo, Ruoyu; Wang, Kankan] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Luo, Ruoyu; Ye, Lin] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences	Luo, RY (corresponding author), Fudan Univ, Sch Life Sci, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	ruoyuluocs@fudan.edu.cn; kankanwang@shsmu.edu.cn			European Research Council (ERC); National Natural Science Foundation of China [31171275, 31171257]; Ministry of Science and Technology of China [2009CB825607, 2011CB910202]	European Research Council (ERC)(European Research Council (ERC)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the European Research Council (ERC); the National Natural Science Foundation of China (31171275 and 31171257); and Ministry of Science and Technology of China Grants (2009CB825607 and 2011CB910202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cao Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2745299; Cookson NA, 2010, NUCLEIC ACIDS RES, V38, P2676, DOI 10.1093/nar/gkp1069; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; De Cock K, 2004, J CHEM PHYS, V121, P3347, DOI 10.1063/1.1763573; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Elf J, 2003, BIOPHYS J, V84, P154, DOI 10.1016/S0006-3495(03)74839-5; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1977, ABSTR PAP AM CHEM S, V173, P128; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gronlund A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1422; Gronlund A, 2010, P NATL ACAD SCI USA, V107, P8171, DOI 10.1073/pnas.0913317107; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; HELMSTETTER CE, 1968, BIOPHYS J, V8, pA178; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Loew LM, 2001, TRENDS BIOTECHNOL, V19, P401, DOI 10.1016/S0167-7799(01)01740-1; Lu T, 2004, SYSTEMS BIOL, V1, P121, DOI 10.1049/sb:20045016; Luo RY, 2009, P NATL ACAD SCI USA, V106, P847, DOI 10.1073/pnas.0810731105; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; Nielsen HJ, 2007, J BACTERIOL, V189, P8660, DOI 10.1128/JB.01212-07; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramakrishna R, 2001, AM J PHYSIOL-REG I, V280, pR695, DOI 10.1152/ajpregu.2001.280.3.R695; Ramsey Stephen, 2005, J Bioinform Comput Biol, V3, P437, DOI 10.1142/S0219720005001144; Rathinam M, 2003, J CHEM PHYS, V119, P12784, DOI 10.1063/1.1627296; Ribeiro AS, 2007, BIOINFORMATICS, V23, P3409, DOI 10.1093/bioinformatics/btm491; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Salis H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1835951; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tsimring LS, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.250602; Walden M, 2011, CURR OPIN BIOTECH, V22, P81, DOI 10.1016/j.copbio.2010.10.004; Wang XD, 2011, P NATL ACAD SCI USA, V108, pE243, DOI 10.1073/pnas.1100874108; WARD CB, 1970, P NATL ACAD SCI USA, V66, P365, DOI 10.1073/pnas.66.2.365; You LC, 2003, BIOINFORMATICS, V19, P435, DOI 10.1093/bioinformatics/btg009	56	4	4	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62380	10.1371/journal.pone.0062380	http://dx.doi.org/10.1371/journal.pone.0062380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638057	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700052
J	Campanella, S; Peigneux, P; Petit, G; Lallemand, F; Saeremans, M; Noel, X; Metens, T; Nouali, M; De Tiege, X; De Witte, P; Ward, R; Verbanck, P				Campanella, Salvatore; Peigneux, Philippe; Petit, Geraldine; Lallemand, Frederic; Saeremans, Melanie; Noel, Xavier; Metens, Thierry; Nouali, Mustapha; De Tiege, Xavier; De Witte, Philippe; Ward, Roberta; Verbanck, Paul			Increased Cortical Activity in Binge Drinkers during Working Memory Task: A Preliminary Assessment through a Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; PREFRONTAL CORTEX; BRAIN IMPAIRMENT; EPISODIC MEMORY; YOUNG ADULTHOOD; FRONTAL-CORTEX; DRINKING; ATTENTION; ACTIVATION; DEPENDENCE	Background: Cerebral dysfunction is a common feature of both chronic alcohol abusers and binge drinkers. Here, we aimed to study whether, at equated behavioral performance levels, binge drinkers exhibited increased neural activity while performing simple cognitive tasks. Methods: Thirty-two participants (16 binge drinkers and 16 matched controls) were scanned using functional magnetic resonance imaging (fMRI) while performing an n-back working memory task. In the control zero-back (N0) condition, subjects were required to press a button with the right hand when the number "2" was displayed. In the two-back (N2) condition, subjects had to press a button when the displayed number was identical to the number shown two trials before. Results: fMRI analyses revealed higher bilateral activity in the pre-supplementary motor area in binge drinkers than matched controls, even though behavioral performances were similar. Moreover, binge drinkers showed specific positive correlations between the number of alcohol doses consumed per occasion and higher activity in the dorsomedial prefrontal cortex, as well as between the number of drinking occasions per week and higher activity in cerebellum, thalamus and insula while performing the N2 memory task. Conclusions: Binge alcohol consumption leads to possible compensatory cerebral changes in binge drinkers that facilitate normal behavioral performance. These changes in cerebral responses may be considered as vulnerability factors for developing adult substance use disorders.	[Campanella, Salvatore; Petit, Geraldine; Lallemand, Frederic; Saeremans, Melanie; Noel, Xavier; Verbanck, Paul] Univ Libre Bruxelles, Lab Psychol Med & Addictol, Brussels, Belgium; [Campanella, Salvatore; Peigneux, Philippe; Petit, Geraldine; Lallemand, Frederic; Saeremans, Melanie; Noel, Xavier; De Tiege, Xavier; Verbanck, Paul] ULB Neurosci Inst, Brussels, Belgium; [Peigneux, Philippe] Univ Libre Bruxelles, Ctr Rech Cognit & Neurosci, Neuropsychol & Funct Neuroimaging Res Unit, Brussels, Belgium; [Lallemand, Frederic; De Witte, Philippe; Ward, Roberta] Catholic Univ Louvain, B-1348 Louvain, Belgium; [Metens, Thierry; Nouali, Mustapha] Univ Libre Bruxelles, Hop Erasme, Dept Radiol, Brussels, Belgium; [De Tiege, Xavier] Univ Libre Bruxelles, Lab Cartog Fonct Cerveau, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles	Campanella, S (corresponding author), Univ Libre Bruxelles, Lab Psychol Med & Addictol, Brussels, Belgium.	salvatore.campanella@chu-brugmann.be	Metens, Thierry/AAF-8100-2020	De Tiege, Xavier/0000-0003-0127-089X; Metens, Thierry/0000-0002-3404-7224; Peigneux, Philippe/0000-0003-4745-1434	F.R.S.-F.N.R.S; ERAB (The European Foundation for Alcohol Research) [EA 10 30]	F.R.S.-F.N.R.S(Fonds de la Recherche Scientifique - FNRS); ERAB (The European Foundation for Alcohol Research)	Salvatore Campanella and Xavier Noel are Research Associate at the Belgian Fund of Scientific Research (F.R.S.-F.N.R.S.). Geraldine Petit is Research Fellow at F.R.S.-F.N.R.S. Xavier De Tiege is "Clinicien Chercheur Specialiste" at F.R.S.-F.N.R.S. This study was financially supported by F.R.S.-F.N.R.S and by ERAB (The European Foundation for Alcohol Research - ref. EA 10 30: "Binge drinking: cognitive and brain impairment and their association with immune response"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, NIAAA RES MONOGRAPH; Barclay SM, 2010, THESIS MASSEY U WELL; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beck AT., 1996, BECK DEPRESSION INVE; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; CAMPBELL AM, 1971, LANCET, V2, P1219; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Courtney KE, 2010, INT J ENV RES PUB HE, V7, P2325, DOI 10.3390/ijerph7052325; Crego A, 2012, ALCOHOL, V46, P415, DOI 10.1016/j.alcohol.2011.10.002; Crego A, 2010, DRUG ALCOHOL DEPEN, V109, P45, DOI 10.1016/j.drugalcdep.2009.11.020; Crews FT, 2005, ALCOHOL CLIN EXP RES, V29, P1504, DOI 10.1097/01.alc.0000175013.50644.61; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Enoch MA, 2006, ANN NY ACAD SCI, V1094, P193, DOI 10.1196/annals.1376.019; Friston K.J., 2003, HUMAN BRAIN FUNCTION; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; HALL GH, 1970, BRIT J PHARMACOL, V38, P271, DOI 10.1111/j.1476-5381.1970.tb08516.x; Haller M, 2010, DEV PSYCHOPATHOL, V22, P899, DOI 10.1017/S0954579410000532; Harford TC, 2005, ALCOHOL CLIN EXP RES, V29, P810, DOI 10.1097/01.ALC.0000164381.67723.76; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; Hermens DF, 2013, CORTEX, V49, P3, DOI 10.1016/j.cortex.2012.05.021; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Jennison KM, 2004, AM J DRUG ALCOHOL AB, V30, P659, DOI 10.1081/ADA-200032331; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Keller S, 2007, ADDICT BEHAV, V32, P505, DOI 10.1016/j.addbeh.2006.05.017; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Kuntsche E, 2004, SOC SCI MED, V59, P113, DOI 10.1016/j.socscimed.2003.10.009; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Li TK, 2007, ALCOHOL ALCOHOLISM, V42, P57, DOI 10.1093/alcalc/agl125; Littel M, 2011, PLOS ONE, V6; Lopez-Caneda E, 2012, ADDICTION, V107, P1796, DOI 10.1111/j.1360-0443.2012.03908.x; Maurage P, 2012, CLIN NEUROPHYSIOL, V123, P892, DOI 10.1016/j.clinph.2011.09.018; Maurage P, 2013, CORTEX IN PRESS; Maurage P, 2009, J PSYCHIATR NEUROSCI, V34, P111; McKenzie M, 2011, MED J AUSTRALIA, V195, pS27; Meyerhoff DJ, 2004, ALCOHOL CLIN EXP RES, V28, P650, DOI 10.1097/01.ALC.0000121805.12350.CA; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093/alcalc/36.5.357; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Nicolas JM, 1997, ANN NEUROL, V41, P590, DOI 10.1002/ana.410410507; Noel X, 2013, CURRENT OPI IN PRESS; Norberg MM, 2011, ADDICT BEHAV, V36, P821, DOI 10.1016/j.addbeh.2011.03.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Penny W., 2003, HUMAN BRAIN FUNCTION; Petit G, 2012, CLIN NEUROPHYSIOL, V123, P925, DOI 10.1016/j.clinph.2011.10.042; Pfefferbaum A, 2001, NEUROIMAGE, V14, P7, DOI 10.1006/nimg.2001.0785; Presley CA, 2006, J STUD ALCOHOL, V67, P324, DOI 10.15288/jsa.2006.67.324; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schweinsburg AD, 2010, ALCOHOL, V44, P111, DOI 10.1016/j.alcohol.2009.09.032; Schweinsburg AD, 2011, ADDICTION, V106, P564, DOI 10.1111/j.1360-0443.2010.03197.x; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Squeglia LM, 2011, ALCOHOL CLIN EXP RES, V35, P1831, DOI 10.1111/j.1530-0277.2011.01527.x; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Tucker JS, 2003, HEALTH PSYCHOL, V22, P79, DOI 10.1037/0278-6133.22.1.79; Walter M, 2009, HUM BRAIN MAPP, V30, P312, DOI 10.1002/hbm.20506; WATSON D, 1969, J CONSULT CLIN PSYCH, V33, P448, DOI 10.1037/h0027806; Xiao L, 2013, PSYCHOL ADD IN PRESS; Xing Y, 2006, J ADOLESCENT HEALTH, V39, P495, DOI 10.1016/j.jadohealth.2006.03.014	67	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62260	10.1371/journal.pone.0062260	http://dx.doi.org/10.1371/journal.pone.0062260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638017	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400046
J	Chen, YR; Huang, HB; Lo, CJ; Wang, CC; Ho, LK; Liu, HT; Shiao, MS; Lin, TH; Chen, YC				Chen, Yi-Ru; Huang, Hsien-bin; Lo, Chi-Jen; Wang, Chih-Ching; Ho, Li-Kang; Liu, Hsin-Tzu; Shiao, Ming-Shi; Lin, Ta-Hsien; Chen, Yi-Cheng			Effect of Alanine Replacement of L17 and F19 on the Aggregation and Neurotoxicity of Arctic-Type A beta(40)	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; PROTEIN SECONDARY STRUCTURE; FIBRIL-FORMING PROTEINS; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; CEREBRAL-HEMORRHAGE; SH-SY5Y CELLS; MUTATION; DEMENTIA; ANGIOPATHY	Alzheimer's disease is the most common form of neurodegenerative disease. Beta-amyloid peptides (A beta) are responsible for neuronal death both in vitro and in vivo. Previously, L17 and F19 residues were identified as playing key roles in the stabilization of the A beta(40) conformation and in the reduction of its neurotoxicity. In this study, the effects of L17A/F19A mutations on the neurotoxicity of Aneurodegenerative genetic mutant Arctic-type A beta(40)(E22G) were tested. The results showed that compared to A beta(40)(E22G), A beta(40)(L17A/F19A/E22G) reduced the rate of conformation conversion, aggregation, and cytotoxicity, suggesting that L17 and F19 are critical residues responsible for conformational changes which may trigger the neurotoxic cascade of A beta. A beta(40)(L17A/F19A/E22G) also had decreased damage due to reactive oxygen species. The results are consistent with the discordant helix hypothesis, and confirm that residues 17-25 are in the discordant helix region. Compared to A beta(40)(L17A/F19A), reduction in aggregation of A beta(40)(L17A/F19A/E22G) was less significantly decreased. This observation provides an explanation based on the discordant helix hypothesis that the mutation of E22 to G22 of A beta(40)(E22G) alters the propensity of the discordant helix. Arctic-type A beta(40)(E22G) aggregates more severely than wild-type A beta(40), with a consequential increase in toxicity.	[Chen, Yi-Ru; Lo, Chi-Jen; Wang, Chih-Ching; Lin, Ta-Hsien] Natl Yang Ming Univ, Struct Biol Program, Taipei 112, Taiwan; [Chen, Yi-Ru; Ho, Li-Kang] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Huang, Hsien-bin] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Huang, Hsien-bin] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan; [Lo, Chi-Jen; Lin, Ta-Hsien] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Lo, Chi-Jen; Wang, Chih-Ching; Lin, Ta-Hsien] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Liu, Hsin-Tzu] Buddhist Tzu Chi Gen Hosp, Res Dept, Voiding Dysfunct Therapeut Ctr, Hualien, Taiwan; [Shiao, Ming-Shi] Chang Gung Univ, Dept Life Sci, Kwei Shan Tao Yuan, Taiwan; [Chen, Yi-Cheng] MacKay Med Coll, Dept Med, New Taipei City, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Chung Cheng University; National Chung Cheng University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Chang Gung University; Mackay Medical College	Lin, TH (corresponding author), Natl Yang Ming Univ, Struct Biol Program, Taipei 112, Taiwan.	thlin@vghtpe.gov.tw; chen15@mmc.edu.tw			National Science Council of Taiwan, ROC [NSC96-2311-B-010-010-MY3, NSC100-2113-M-010-001, NSC100-2627-M-715-001, NSC101-2627-M-715-001]; Taipei Veterans General Hospital, Taiwan, Republic of China [V96C1-022, V96S4-002]; Ministry of Education, Aiming for the Top University Plan; National Synchrotron Radiation Center [04B1]	National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan, Republic of China(Taipei Veterans General Hospital); Ministry of Education, Aiming for the Top University Plan; National Synchrotron Radiation Center	This work was supported by grants from National Science Council of Taiwan, ROC (NSC96-2311-B-010-010-MY3 and NSC100-2113-M-010-001 to T. H. L. and NSC100-2627-M-715-001 and NSC101-2627-M-715-001 to Y.C.C.), Taipei Veterans General Hospital, Taiwan, Republic of China (V96C1-022, V96S4-002 to T. H. L.) and a grant from Ministry of Education, Aiming for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the support from National Synchrotron Radiation Center for providing the SRCD spectroscopy (04B1).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; BEHROUZ N, 1991, J GERONTOL, V46, pB209, DOI 10.1093/geronj/46.6.B209; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Benseny-Cases Nuria, 2012, Subcell Biochem, V65, P53, DOI 10.1007/978-94-007-5416-4_3; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen YR, 2011, BIOCHEM BIOPH RES CO, V405, P91, DOI 10.1016/j.bbrc.2010.12.133; CHUI HC, 1985, NEUROLOGY, V35, P1544, DOI 10.1212/WNL.35.11.1544; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Fawzi NL, 2008, BIOPHYS J, V94, P2007, DOI 10.1529/biophysj.107.121467; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Hatip FFB, 2009, BRIT J PHARMACOL, V158, P1165, DOI 10.1111/j.1476-5381.2009.00384.x; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HOLTZMAN DM, 1991, TRENDS BIOCHEM SCI, V16, P140, DOI 10.1016/0968-0004(91)90056-2; Ito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030510; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Lee EK, 2005, PROTEIN EXPRES PURIF, V40, P183, DOI 10.1016/j.pep.2004.12.014; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Liu RT, 2004, J NEUROSCI RES, V75, P162, DOI 10.1002/jnr.10859; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Mei ZR, 2012, NEUROCHEM RES, V37, P622, DOI 10.1007/s11064-011-0652-6; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Natte R, 2001, ANN NEUROL, V50, P765, DOI 10.1002/ana.10040; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Norlin N, 2012, J STRUCT BIOL, V180, P174, DOI 10.1016/j.jsb.2012.06.010; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; SELKOE DJ, 1991, SCI AM, V265, P40, DOI 10.1038/scientificamerican1191-68; STANDAERT DG, 1991, AM J PATHOL, V139, P681; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang C, 2012, J PSYCHOEDUC ASSESS, V30, P160, DOI 10.1177/0734282911412543; Wang HQ, 2009, BRAIN RES, V1283, P139, DOI 10.1016/j.brainres.2009.05.101; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200	45	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61874	10.1371/journal.pone.0061874	http://dx.doi.org/10.1371/journal.pone.0061874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634215	Green Submitted, Green Published, gold			2022-12-25	WOS:000318341400023
J	Ono, M; Yamada, K; Endo, A; Avolio, F; Lamond, AI				Ono, Motoharu; Yamada, Kayo; Endo, Akinori; Avolio, Fabio; Lamond, Angus I.			Analysis of Human Protein Replacement Stable Cell Lines Established using snoMEN-PR Vector	PLOS ONE			English	Article							RNA-POLYMERASE-I; SMALL NUCLEOLAR RNAS; TRANSCRIPTION; GENE; CHROMATIN; REVEALS; COMPLEX; SMN; UBF; RIBONUCLEOPROTEINS	The study of the function of many human proteins is often hampered by technical limitations, such as cytotoxicity and phenotypes that result from overexpression of the protein of interest together with the endogenous version. Here we present the snoMEN (snoRNA Modulator of gene ExpressioN) vector technology for generating stable cell lines where expression of the endogenous protein can be reduced and replaced by an exogenous protein, such as a fluorescent protein (FP)-tagged version. SnoMEN are snoRNAs engineered to contain complementary sequences that can promote knock-down of targeted RNAs. We have established and characterised two such partial protein replacement human cell lines (snoMENPR). Quantitative mass spectrometry was used to analyse the specificity of knock-down and replacement at the protein level and also showed an increased pull-down efficiency of protein complexes containing exogenous, tagged proteins in the protein replacement cell lines, as compared with conventional co-expression strategies. The snoMEN approach facilitates the study of mammalian proteins, particularly those that have so far been difficult to investigate by exogenous expression and has wide applications in basic and applied gene-expression research.	[Ono, Motoharu; Yamada, Kayo; Endo, Akinori; Avolio, Fabio; Lamond, Angus I.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland	University of Dundee	Lamond, AI (corresponding author), Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland.	angus@lifesci.dundee.ac.uk		Avolio, Fabio/0000-0003-2067-5315; Lamond, Angus/0000-0001-6204-6045; Tran, Nham/0000-0001-7747-2530	Wellcome Trust [073980/Z/03/Z]; Medical Research Council [G0801738]; Japan Society for the Promotion of Science; MRC [G0801738] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this research was provided by a Wellcome Trust Programme Grant to AIL (Ref: 073980/Z/03/Z) and by a Medical Research Council Milstein Award to AIL (Ref: G0801738). AE was supported by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranat L, 2008, P NATL ACAD SCI USA, V105, P5028, DOI 10.1073/pnas.0710576105; Ahlenstiel CL, 2011, NUCL ACIDS RES; Ahmad Y, 2011, MOL CELL PROTEOMICS; Almeida F, 1998, J CELL BIOL, V142, P899, DOI 10.1083/jcb.142.4.899; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Baserga R, 2007, CELL CYCLE, V6, P814, DOI 10.4161/cc.6.7.4049; Boisvert FM, 2011, MOL CELL PROTEOMICS; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Boulon S, 2010, MOL CELL PROTEOMICS, V9, P861, DOI 10.1074/mcp.M900517-MCP200; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; De Paula D, 2007, RNA, V13, P431, DOI 10.1261/rna.459807; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Lam YW, 2005, J CELL SCI, V118, P1335, DOI 10.1242/jcs.01736; Larance M, 2012, MOL CELLULAR PROTEOM; Leung AKL, 2002, J CELL BIOL, V157, P615, DOI 10.1083/jcb.200201120; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Liu J, 2011, NUCL ACIDS RES; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Nguyen thi M, 2008, NEUROLOGY, V71, P1757; Ono M, 2010, MOL BIOL CELL, V21, P1569, DOI 10.1091/mbc.E10-01-0078; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Sleeman JE, 2003, J CELL SCI, V116, P2039, DOI 10.1242/jcs.00400; Terns MP, 2001, CURR BIOL, V11, pR862, DOI 10.1016/S0960-9822(01)00517-6; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Voit R, 1999, EMBO J, V18, P1891, DOI 10.1093/emboj/18.7.1891; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002; Westman BJ, 2010, MOL CELL, V39, P618, DOI 10.1016/j.molcel.2010.07.025; Yamada K, 2013, MOL CELL	49	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62305	10.1371/journal.pone.0062305	http://dx.doi.org/10.1371/journal.pone.0062305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638031	gold, Green Published, Green Submitted			2022-12-25	WOS:000318341400048
J	Tran, L; Ouisse, LH; Richard-Fiardo, P; Franken, PR; Darcourt, J; Cornilleau, G; Benihoud, K; Vassaux, G				Tran, Lucile; Ouisse, Laure-Helene; Richard-Fiardo, Peggy; Franken, Philippe R.; Darcourt, Jacques; Cornilleau, Gaetan; Benihoud, Karim; Vassaux, Georges			Adrenal Gland Infection by Serotype 5 Adenovirus Requires Coagulation Factors	PLOS ONE			English	Article							SELECTIVE ONCOLYTIC ADENOVIRUSES; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; GENE-TRANSFER; NA/I SYMPORTER; BETA-GALACTOSIDASE; BINDING ABLATION; DESMOID TUMORS; REPORTER GENE; RECEPTOR CAR	Recombinant, replication-deficient serotype 5 adenovirus infects the liver upon in vivo, systemic injection in rodents. This infection requires the binding of factor X to the capsid of this adenovirus. Another organ, the adrenal gland is also infected upon systemic administration of Ad, however, whether this infection is dependent on the cocksackie adenovirus receptor (CAR) or depends on the binding of factor X to the viral capsid remained to be determined. In the present work, we have used a pharmacological agent (warfarin) as well as recombinant adenoviruses lacking the binding site of Factor X to elucidate this mechanism in mice. We demonstrate that, as observed in the liver, adenovirus infection of the adrenal glands in vivo requires Factor X. Considering that the level of transduction of the adrenal glands is well-below that of the liver and that capsid-modified adenoviruses are unlikely to selectively infect the adrenal glands, we have used single-photon emission computed tomography (SPECT) imaging of gene expression to determine whether local virus administration (direct injection in the kidney) could increase gene transfer to the adrenal glands. We demonstrate that direct injection of the virus in the kidney increases gene transfer in the adrenal gland but liver transduction remains important. These observations strongly suggest that serotype 5 adenovirus uses a similar mechanism to infect liver and adrenal gland and that selective transgene expression in the latter is more likely to be achieved through transcriptional targeting.	[Tran, Lucile; Ouisse, Laure-Helene] INSERM U948, Nantes, France; [Richard-Fiardo, Peggy; Franken, Philippe R.; Darcourt, Jacques; Vassaux, Georges] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Richard-Fiardo, Peggy; Franken, Philippe R.; Darcourt, Jacques; Vassaux, Georges] CEA, UMRE4320, Nice, France; [Cornilleau, Gaetan; Benihoud, Karim] Univ Paris 11, Inst Gustave Roussy, UMR 8203, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Vassaux, G (corresponding author), Univ Nice Sophia Antipolis, Fac Med, Nice, France.	georges.vassaux@inserm.fr	, BENIHOUD/O-4334-2019; Vassaux, Georges/N-9724-2016	Vassaux, Georges/0000-0002-1149-7716	INSERM; la Ligue Nationale Contre le Cancer; Canceropole "Grand Ouest"; Vaincre la Mucoviscidose; Centre National de la Recherche Scientifique (CNRS); INCa; PRES Univer Sud	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Canceropole "Grand Ouest"; Vaincre la Mucoviscidose; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INCa(Institut National du Cancer (INCA) France); PRES Univer Sud	This work is supported by grants from INSERM, la Ligue Nationale Contre le Cancer, Canceropole "Grand Ouest", Vaincre la Mucoviscidose. KB wants to acknowledge for their support the Centre National de la Recherche Scientifique (CNRS), the INCa and the PRES Univer Sud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Alesci S, 2002, P NATL ACAD SCI USA, V99, P7484, DOI 10.1073/pnas.062170099; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Barton KN, 2011, MOL THER, V19, P1353, DOI 10.1038/mt.2011.89; Barzon L, 2004, ENDOCR REV, V25, P1, DOI 10.1210/er.2002-0035; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Cany J, 2007, J HEPATOL, V47, P396, DOI 10.1016/j.jhep.2007.03.018; Chao J, 1998, HUM GENE THER, V9, P21, DOI 10.1089/hum.1998.9.1-21; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coughlan L, 2009, J VIROL, V83, P6416, DOI 10.1128/JVI.00445-09; Descamps D, 2009, CURR GENE THER, V9, P115, DOI 10.2174/156652309787909544; Faivre J, 2004, CANCER RES, V64, P8045, DOI 10.1158/0008-5472.CAN-04-0893; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; Groot-Wassink T, 2004, CANCER RES, V64, P4906, DOI 10.1158/0008-5472.CAN-04-0426; Groot-Wassink T, 2004, MOL THER, V9, P436, DOI 10.1016/j.ymthe.2003.12.001; Groot-Wassink T, 2002, HUM GENE THER, V13, P1723, DOI 10.1089/104303402760293565; Haddad D, 2012, J NUCL MED, V53, P1933, DOI 10.2967/jnumed.112.105056; Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08; Jouret F, 2010, AM J PHYSIOL-RENAL, V298, pF454, DOI 10.1152/ajprenal.00413.2009; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Koski A, 2009, J GENE MED, V11, P966, DOI 10.1002/jgm.1373; Li LH, 2009, AM J PHYSIOL-HEART C, V297, pH1504, DOI 10.1152/ajpheart.00194.2009; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Lymperopoulos A, 2008, MOL THER, V16, P302, DOI 10.1038/sj.mt.6300371; Martinico SCM, 2006, CANCER RES, V66, P8233, DOI 10.1158/0008-5472.CAN-06-1209; Matkovic U, 2009, J CELL PHYSIOL, V220, P45, DOI 10.1002/jcp.21727; Merron A, 2007, GENE THER, V14, P1731, DOI 10.1038/sj.gt.3303043; Merron A, 2010, EUR J NUCL MED MOL I, V37, P1377, DOI 10.1007/s00259-009-1379-3; Mirza M, 2006, EXP CELL RES, V312, P817, DOI 10.1016/j.yexcr.2005.11.030; Mizuguchi H, 2002, GENE THER, V9, P769, DOI 10.1038/sj.gt.3301701; Morley SD, 1996, ENDOCR RES, V22, P631, DOI 10.1080/07435809609043757; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Peerlinck I, 2008, CLIN CANCER RES, V14, P6187, DOI 10.1158/1078-0432.CCR-08-0410; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Richard-Fiardo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034086; Tajima T, 1999, GENE THER, V6, P1898, DOI 10.1038/sj.gt.3301018; Themis M, 1999, GENE THER, V6, P1239, DOI 10.1038/sj.gt.3300970; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang Y, 2003, EUR J CLIN INVEST, V33, P794, DOI 10.1046/j.1365-2362.2003.01216.x; Wang YH, 2005, CLIN CANCER RES, V11, P351; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Willhauck M, 2008, GENE THER, V15, P214, DOI 10.1038/sj.gt.3303057; Yun CO, 2005, HUM GENE THER, V16, P248, DOI 10.1089/hum.2005.16.248	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62191	10.1371/journal.pone.0062191	http://dx.doi.org/10.1371/journal.pone.0062191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638001	gold, Green Submitted, Green Published			2022-12-25	WOS:000318341400042
J	Williamson, DA; Roberts, SA; Ritchie, SR; Coombs, GW; Fraser, JD; Heffernan, H				Williamson, Deborah A.; Roberts, Sally A.; Ritchie, Stephen R.; Coombs, Geoffrey W.; Fraser, John D.; Heffernan, Helen			Clinical and Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in New Zealand: Rapid Emergence of Sequence Type 5 (ST5)-SCCmec-IV as the Dominant Community-Associated MRSA Clone	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; UNITED-STATES; HOSPITALS; SKIN; POPULATIONS	The predominant community-associated MRSA strains vary between geographic settings, with ST8-IV USA300 being the commonest clone in North America, and the ST30-IV Southwest Pacific clone established as the dominant clone in New Zealand for the past two decades. Moreover, distinct epidemiological risk factors have been described for colonisation and/or infection with CA-MRSA strains, although these associations have not previously been characterized in New Zealand. Based on data from the annual New Zealand MRSA survey, we sought to describe the clinical and molecular epidemiology of MRSA in New Zealand. All non-duplicate clinical MRSA isolates from New Zealand diagnostic laboratories collected as part of the annual MRSA survey were included. Demographic data was collected for all patients, including age, gender, ethnicity, social deprivation index and hospitalization history. MRSA was isolated from clinical specimens from 3,323 patients during the 2005 to 2011 annual surveys. There were marked ethnic differences, with MRSA isolation rates significantly higher in Maori and Pacific Peoples. Over the study period, there was a significant increase in CA-MRSA, and a previously unidentified PVL-negative ST5-IV spa t002 clone replaced the PVL-positive ST30-IV Southwest Pacific clone as the dominant CA-MRSA clone. Of particular concern was the finding of several successful and virulent MRSA clones from other geographic settings, including ST93-IV (Queensland CA-MRSA), ST8-IV (USA300) and ST772-V (Bengal Bay MRSA). Ongoing molecular surveillance is essential to prevent these MRSA strains becoming endemic in the New Zealand healthcare setting.	[Williamson, Deborah A.; Ritchie, Stephen R.; Fraser, John D.] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Williamson, Deborah A.; Roberts, Sally A.] Auckland Dist Hlth Board, Dept Clin Microbiol, Auckland, New Zealand; [Williamson, Deborah A.; Heffernan, Helen] Inst Environm Sci & Res, Wellington, New Zealand; [Coombs, Geoffrey W.] PathWest Lab Med, Perth, WA, Australia; [Coombs, Geoffrey W.] Curtin Univ Technol, Perth, WA, Australia	University of Auckland; Auckland District Health Board; Institute of Environmental Science & Research (ESR) - New Zealand; University of Western Australia; Curtin University	Williamson, DA (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand.	dwilliamson@adhb.govt.nz		Ritchie, Stephen/0000-0001-5001-8899; Williamson, Deborah/0000-0001-7363-6665; Coombs, Geoffrey/0000-0003-1635-6506	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	Dr. Williamson is supported by a Clinical Research Training Fellowship from the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2002, J ANTIMICROB CHEMOTH, V50, P825, DOI 10.1093/jac/dkf242; Baker MG, 2012, LANCET, V379, P1112, DOI 10.1016/S0140-6736(11)61780-7; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Brennan GI, 2012, J CLIN MICROBIOL, V50, P841, DOI 10.1128/JCM.06354-11; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chua K, 2011, CLIN INFECT DIS, V52, P99, DOI 10.1093/cid/ciq067; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Frei CR, 2010, J PEDIATR SURG, V45, P1967, DOI 10.1016/j.jpedsurg.2010.05.009; Goering RV, 2004, MOL MICROBIOLOGY DIA, P185; Heffernan H BS, 2011, ANN SURVEY METHICILL; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; MARTIN DR, 1989, NEW ZEAL MED J, V102, P367; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Muttaiyah S, 2010, J CLIN MICROBIOL, V48, P3470, DOI 10.1128/JCM.00911-10; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; O'Sullivan CE, 2011, EPIDEMIOL INFECT, V139, P1794, DOI 10.1017/S0950268810002761; Ritchie SR, 2011, NEW ZEAL MED J, V124, P21; Roberts SA, 2012, NEW ZEAL MED J, V125, P75; Salmond C, 1998, AUST NZ J PUBL HEAL, V22, P835, DOI 10.1111/j.1467-842X.1998.tb01505.x; Smith JMB, 2005, EPIDEMIOL INFECT, V133, P899, DOI 10.1017/S0950268805004024; Statistics New Zealand, 2006, 2006 CENS POP DEWLL; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11; Tong SYC, 2008, CLIN INFECT DIS, V46, P1871, DOI 10.1086/588301; WHO, 2010, INT STAT CLASS DIS R; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	32	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62020	10.1371/journal.pone.0062020	http://dx.doi.org/10.1371/journal.pone.0062020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23637953	Green Published, gold			2022-12-25	WOS:000318341400029
J	Guerra-Silveira, F; Abad-Franch, F				Guerra-Silveira, Felipe; Abad-Franch, Fernando			Sex Bias in Infectious Disease Epidemiology: Patterns and Processes	PLOS ONE			English	Article							AMERICAN CUTANEOUS LEISHMANIASIS; SCHISTOSOMA-MANSONI INFECTION; INFANTUM-CHAGASI INFECTION; WATER CONTACT PATTERNS; SKIN-TEST POSITIVITY; A VIRUS-INFECTION; RIO-DE-JANEIRO; NEISSERIA-MENINGITIDIS; RISK-FACTORS; HEPATITIS-A	Background: Infectious disease incidence is often male-biased. Two main hypotheses have been proposed to explain this observation. The physiological hypothesis (PH) emphasizes differences in sex hormones and genetic architecture, while the behavioral hypothesis (BH) stresses gender-related differences in exposure. Surprisingly, the population-level predictions of these hypotheses are yet to be thoroughly tested in humans. Methods and Findings: For ten major pathogens, we tested PH and BH predictions about incidence and exposure-prevalence patterns. Compulsory-notification records (Brazil, 2006-2009) were used to estimate age-stratified male:female incidence rate ratios for the general population and across selected sociological contrasts. Exposure-prevalence odds ratios were derived from 82 published surveys. We estimated summary effect-size measures using random-effects models; our analyses encompass similar to 0.5 million cases of disease or exposure. We found that, after puberty, disease incidence is male-biased in cutaneous and visceral leishmaniasis, schistosomiasis, pulmonary tuberculosis, leptospirosis, meningococcal meningitis, and hepatitis A. Severe dengue is female-biased, and no clear pattern is evident for typhoid fever. In leprosy, milder tuberculoid forms are female-biased, whereas more severe lepromatous forms are male-biased. For most diseases, male bias emerges also during infancy, when behavior is unbiased but sex steroid levels transiently rise. Behavioral factors likely modulate male-female differences in some diseases (the leishmaniases, tuberculosis, leptospirosis, or schistosomiasis) and age classes; however, average exposure-prevalence is significantly sex-biased only for Schistosoma and Leptospira. Conclusions: Our results closely match some key PH predictions and contradict some crucial BH predictions, suggesting that gender-specific behavior plays an overall secondary role in generating sex bias. Physiological differences, including the crosstalk between sex hormones and immune effectors, thus emerge as the main candidate drivers of gender differences in infectious disease susceptibility.	[Guerra-Silveira, Felipe; Abad-Franch, Fernando] Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil; [Guerra-Silveira, Felipe] Univ Estado Amazonas, Sch Med, Manaus, Amazonas, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Amazonas	Abad-Franch, F (corresponding author), Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil.	fernando@amazonia.fiocruz.br	Abad-Franch, Fernando/AAG-2432-2020; Abad-Franch, Fernando/AAB-6729-2021; Abad-Franch, Fernando/L-4741-2013	Abad-Franch, Fernando/0000-0002-7715-0328; 	Fiocruz-Fapeam agreement, Brazil	Fiocruz-Fapeam agreement, Brazil	Fiocruz-Fapeam agreement, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Soto R, 2000, AM J GASTROENTEROL, V95, P1277, DOI 10.1111/j.1572-0241.2000.01525.x; Agrela IF, 2009, B MALARIOL SALUD AMB, V49, P107; Aguiar DM, 2007, BRAZ J MICROBIOL, V38, P93, DOI 10.1590/S1517-83822007000100019; Bakir M, 2001, EUR J EPIDEMIOL, V17, P1015, DOI 10.1023/A:1020021109462; Barao SC, 2007, AM J TROP MED HYG, V77, P1051, DOI 10.4269/ajtmh.2007.77.1051; BARRETO ML, 1991, B WORLD HEALTH ORGAN, V69, P93; BLACKWELL CC, 1990, EPIDEMIOL INFECT, V104, P203, DOI 10.1017/S0950268800059367; Blaser MJ, 2011, NEW ENGL J MED, V365, P1835, DOI 10.1056/NEJMe1110896; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; BRABIN L, 1992, ADV PARASIT, V31, P1, DOI 10.1016/S0065-308X(08)60020-2; Brandao SP, 1999, T ROY SOC TROP MED H, V93, P488, DOI 10.1016/S0035-9203(99)90346-2; Brasil MTLRF, 1998, HANSEN INT, V23, P35; Brei B, 2003, SCIENCE, V300, p55A, DOI 10.1126/science.1079746; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Cailleaux-Cezar M, 2009, INT J TUBERC LUNG D, V13, P190; Calado Karla Lucena Sampaio, 2005, An. Bras. Dermatol., V80, pS301, DOI 10.1590/S0365-05962005001000007; Camargo-Neves VLF, 1998, MEM I OSWALDO CRUZ, V93, P273, DOI 10.1590/S0074-02761998000700053; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; de Lima VLC, 2007, CAD SAUDE PUBLICA, V23, P669, DOI 10.1590/S0102-311X2007000300025; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Chung GE, 2011, GUT LIVER, V5, P88, DOI 10.5009/gnl.2011.5.1.88; Clemens S A, 2000, Rev Soc Bras Med Trop, V33, P1, DOI 10.1590/S0037-86822000000100001; de Andrade ARC, 2008, REV SOC BRAS MED TRO, V41, P56, DOI 10.1590/S0037-86822008000700012; Coelho KR, 2010, THESIS U FEDERAL MIN; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Coimbra CEA, 1996, ACTA TROP, V61, P201, DOI 10.1016/0001-706X(95)00145-5; COSTA MFFLE, 1991, REV I MED TROP, V33, P58, DOI 10.1590/S0036-46651991000100011; Coura-Filho P, 1995, Cad Saude Publica, V11, P254, DOI 10.1590/S0102-311X1995000200009; Crabtree TD, 1999, JAMA-J AM MED ASSOC, V282, P2143, DOI 10.1001/jama.282.22.2143; Crescente JAB, 2009, T ROY SOC TROP MED H, V103, P1250, DOI 10.1016/j.trstmh.2009.06.010; da Cunha R V, 1997, Rev Soc Bras Med Trop, V30, P379, DOI 10.1590/S0037-86821997000500005; Ximenes RAD, 2008, INT J EPIDEMIOL, V37, P852, DOI 10.1093/ije/dyn114; Grossi MAD, 2008, REV SOC BRAS MED TRO, V41, P39, DOI 10.1590/S0037-86822008000700009; de Oliveira ALL, 2008, CAD SAUDE PUBLICA, V24, P2827, DOI 10.1590/S0102-311X2008001200011; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diza E, 2008, EUR J CLIN MICROBIOL, V27, P997, DOI 10.1007/s10096-008-0538-y; DOUGHERTY TF, 1952, PHYSIOL REV, V32, P379, DOI 10.1152/physrev.1952.32.4.379; Drevenstedt GL, 2008, P NATL ACAD SCI USA, V105, P5016, DOI 10.1073/pnas.0800221105; Fakhar M, 2008, ANN TROP MED PARASIT, V102, P577, DOI 10.1179/136485908X337526; Falqueto A, 2009, AM J TROP MED HYG, V80, P559, DOI 10.4269/ajtmh.2009.80.559; Faye B, 2011, T ROY SOC TROP MED H, V105, P333, DOI 10.1016/j.trstmh.2011.02.009; Firmo JOA, 1996, INT J EPIDEMIOL, V25, P1292, DOI 10.1093/ije/25.6.1292; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Fitzpatrick PE, 2000, EMERG INFECT DIS, V6, P65, DOI 10.3201/eid0606.0006; Fix AD, 2002, AM J TROP MED HYG, V66, P628, DOI 10.4269/ajtmh.2002.66.628; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Garcia Rojas A, 2000, Rev Esp Salud Publica, V74, P419, DOI 10.1590/S1135-57272000000400014; GARENNE M, 1994, INT J EPIDEMIOL, V23, P632, DOI 10.1093/ije/23.3.632; Garrote JI, 2004, AM J TROP MED HYG, V71, P403, DOI 10.4269/ajtmh.2004.71.403; Gazi H, 2004, ANN ACAD MED SINGAP, V33, P758; Gilmore A, 1999, EPIDEMIOL INFECT, V123, P185, DOI 10.1017/S0950268899002794; GOMES AD, 1992, REV INST MED TROP SP, V34, P149; Gouvea MV, 2007, ACTA TROP, V104, P99, DOI 10.1016/j.actatropica.2007.07.010; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Guimaraes ICS, 2006, REV SOC BRAS MED TRO, V39, P451, DOI 10.1590/S0037-86822006000500006; Gupta A, 2006, INT J INFECT DIS, V10, P309, DOI 10.1016/j.ijid.2005.06.005; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Hillyer GV, 1999, AM J TROP MED HYG, V60, P827, DOI 10.4269/ajtmh.1999.60.827; Hillyer GV, 1999, AM J TROP MED HYG, V60, P313, DOI 10.4269/ajtmh.1999.60.313; Ibekwe AC, 2008, SCI RES ESSAYS, V3, P425; IMREY PB, 1995, J CLIN MICROBIOL, V33, P3133, DOI 10.1128/JCM.33.12.3133-3137.1995; Jackson LA, 1996, PEDIATR INFECT DIS J, V15, P992, DOI 10.1097/00006454-199611000-00012; KARLBERG J, 1987, STAT MED, V6, P185, DOI 10.1002/sim.4780060210; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Klein SL, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P1, DOI 10.1007/978-3-642-02155-8; Korenchevsky V, 1932, BIOCHEM J, V26, P1306, DOI 10.1042/bj0261306; Kozlowski AG, 2007, MEM I OSWALDO CRUZ, V102, P121, DOI 10.1590/S0074-02762007000100021; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Labrie F, 2009, J STEROID BIOCHEM, V113, P52, DOI 10.1016/j.jsbmb.2008.11.004; Lacerda HG, 2008, T ROY SOC TROP MED H, V102, P1233, DOI 10.1016/j.trstmh.2008.05.010; Lima VLC, 1998, MEM I OSWALDO CRUZ, V93, P283, DOI 10.1590/S0074-02761998000700055; Machado A, 2009, INT J TUBERC LUNG D, V13, P446; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Pessanha JEM, 2010, REV PANAM SALUD PUBL, V27, P252, DOI 10.1590/S1020-49892010000400003; Meller FD, 2011, CIENC SAUDE COLETIVA, V16, P3829, DOI 10.1590/S1413-81232011001000018; Braga WSM, 2009, REV SOC BRAS MED TRO, V42, P277, DOI 10.1590/S0037-86822009000300008; Modlin RL, 2010, CURR OPIN IMMUNOL, V22, P48, DOI 10.1016/j.coi.2009.12.001; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Moreno EC, 2005, REV SOC BRAS MED TRO, V38, P456, DOI 10.1590/S0037-86822005000600002; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Muñoz Gerardo, 2006, Biomed., V26, P131; Naiff RD, 1988, B OFIC SANIT PANAM, V140, P35; Nascimento Maria do Desterro Soares Brandão, 2005, Cad. Saúde Pública, V21, P1801, DOI 10.1590/S0102-311X2005000600028; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Oliveira CCG, 2004, ACTA TROP, V90, P155, DOI 10.1016/j.actatropica.2003.11.011; OLSEN SF, 1991, EPIDEMIOL INFECT, V106, P445, DOI 10.1017/S0950268800067492; Orr HJ, 2003, EMERG INFECT DIS, V9, P1314, DOI 10.3201/eid0910.030344; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; Parodi V, 1998, REV MED URUG, V14, P221; Patrick DM, 2003, CLIN INFECT DIS, V37, P1183, DOI 10.1086/378743; Pavlopoulou ID, 2004, CLIN MICROBIOL INFEC, V10, P137, DOI 10.1111/j.1469-0691.2004.00750.x; PEREIRA MM, 1990, MEM I OSWALDO CRUZ, V85, P47, DOI 10.1590/S0074-02761990000100007; Rabahi MF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-148; Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228; Restif O, 2010, P ROY SOC B-BIOL SCI, V277, P2247, DOI 10.1098/rspb.2010.0188; Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rodrigues Rogeria Nobre, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P81, DOI 10.1590/S0036-46651995000100013; Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335; Scarlata F, 2008, T ROY SOC TROP MED H, V102, P394, DOI 10.1016/j.trstmh.2008.01.011; Sen G., 2007, UNEQUAL UNFAIR INEFF; Sheridan LAD, 2000, OIKOS, V88, P327, DOI 10.1034/j.1600-0706.2000.880211.x; Silva Antonio Augusto Moura Da, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P91, DOI 10.1590/S0036-46651997000200005; Silveira FT, 2009, PARASITOL RES, V104, P559, DOI 10.1007/s00436-008-1230-y; Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646; Taghavi SA, 2011, HEPAT MON, V11, P258; Tayal SC, 1997, J INFECTION, V34, P101, DOI 10.1016/S0163-4453(97)92357-4; Teixeira EG, 2005, INT J TUBERC LUNG D, V9, P841; Tolhurst R., 2002, J HLTH MANAGE, V4, P135, DOI [10.1177/097206340200400204, DOI 10.1177/097206340200400204]; Travassos Cláudia, 2002, Rev Panam Salud Publica, V11, P365, DOI 10.1590/S1020-49892002000500011; Varkevisser CM, 2009, LEPROSY REV, V80, P65; Vasconcelos P F, 2000, Rev Soc Bras Med Trop, V33, P61; Vasconcelos P F, 1999, Rev Soc Bras Med Trop, V32, P171; Vasconcelos Pedro Fernando Da Costa, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P141, DOI 10.1590/S0036-46651993000200005; Verhoef L, 2011, EPIDEMIOL INFECT, V139, P1172, DOI 10.1017/S0950268810003043; Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007; Walker SL, 2006, BRIT MED BULL, V77-78, P103, DOI 10.1093/bmb/ldl010; Wizeman T.M., 2001, EXPLORING BIOL CONTR; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, 2007, ADDR SEX GEND EP PRO; Zacharias F, 2002, MEM I OSWALDO CRUZ, V97, P19, DOI 10.1590/S0074-02762002000900005; Zago-Gomes MP, 2005, REV SOC BRAS MED TRO, V38, P285, DOI 10.1590/S0037-86822005000400001; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI 10.1016/S0020-7519(96)80001-4	128	169	176	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62390	10.1371/journal.pone.0062390	http://dx.doi.org/10.1371/journal.pone.0062390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638062	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400103
J	Thimgan, MS; Gottschalk, L; Toedebusch, C; McLeland, J; Rechtschaffen, A; Gilliland-Roberts, M; Duntley, SP; Shaw, PJ				Thimgan, Matthew S.; Gottschalk, Laura; Toedebusch, Cristina; McLeland, Jennifer; Rechtschaffen, Allan; Gilliland-Roberts, Marcia; Duntley, Stephen P.; Shaw, Paul J.			Cross-Translational Studies in Human and Drosophila Identify Markers of Sleep Loss	PLOS ONE			English	Article							GENE-EXPRESSION; DEPRIVATION; INTERLEUKIN-6; PERFORMANCE; MODEL; RAT; IDENTIFICATION; CONSEQUENCES; RESTRICTION; DIAGNOSTICS	Inadequate sleep has become endemic, which imposes a substantial burden for public health and safety. At present, there are no objective tests to determine if an individual has gone without sleep for an extended period of time. Here we describe a novel approach that takes advantage of the evolutionary conservation of sleep to identify markers of sleep loss. To begin, we demonstrate that IL-6 is increased in rats following chronic total sleep deprivation and in humans following 30 h of waking. Discovery experiments were then conducted on saliva taken from sleep-deprived human subjects to identify candidate markers. Given the relationship between sleep and immunity, we used Human Inflammation Low Density Arrays to screen saliva for novel markers of sleep deprivation. Integrin alpha M (ITGAM) and Anaxin A3 (AnxA3) were significantly elevated following 30 h of sleep loss. To confirm these results, we used QPCR to evaluate ITGAM and AnxA3 in independent samples collected after 24 h of waking; both transcripts were increased. The behavior of these markers was then evaluated further using the power of Drosophila genetics as a cost-effective means to determine whether the marker is associated with vulnerability to sleep loss or other confounding factors (e. g., stress). Transcript profiling in flies indicated that the Drosophila homologues of ITGAM were not predictive of sleep loss. Thus, we examined transcript levels of additional members of the integrin family in flies. Only transcript levels of scab, the Drosophila homologue of Integrin alpha 5 (ITGA5), were associated with vulnerability to extended waking. Since ITGA5 was not included on the Low Density Array, we returned to human samples and found that ITGA5 transcript levels were increased following sleep deprivation. These cross-translational data indicate that fly and human discovery experiments are mutually reinforcing and can be used interchangeably to identify candidate biomarkers of sleep loss.	[Thimgan, Matthew S.; Gottschalk, Laura; Shaw, Paul J.] Washington Univ, Sch Med, Dept Anat & Physiol, St Louis, MO 63130 USA; [Toedebusch, Cristina; McLeland, Jennifer; Duntley, Stephen P.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Rechtschaffen, Allan; Gilliland-Roberts, Marcia] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA	Washington University (WUSTL); Washington University (WUSTL); University of Chicago	Shaw, PJ (corresponding author), Washington Univ, Sch Med, Dept Anat & Physiol, St Louis, MO 63130 USA.	shawp@pcg.wustl.edu			National Institute of Health, Heart, Lung, and Blood Institute [HL092731]; National Institute of Neurological Disease and Stroke [NS051305]; W.M. Keck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051305] Funding Source: NIH RePORTER	National Institute of Health, Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health, Heart, Lung, and Blood Institute (HL092731) and Neurological Disease and Stroke (NS051305) both to PJS. Additional funding came from the W.M. Keck Foundation Postdoctoral Fellowship (MST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2003, J INTERN MED, V254, P6, DOI 10.1046/j.1365-2796.2003.01195.x; Akerstedt T, 2005, J SLEEP RES, V14, P17, DOI 10.1111/j.1365-2869.2004.00437.x; Allebrandt KV, 2013, MOL PSYCHIATR, V18, P122, DOI 10.1038/mp.2011.142; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bachmann V, 2012, CEREB CORTEX, V22, P962, DOI 10.1093/cercor/bhr173; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Baum B J, 2011, Adv Dent Res, V23, P360, DOI 10.1177/0022034511420433; BERGMANN BM, 1989, SLEEP, V12, P5, DOI 10.1093/sleep/12.1.5; Born J, 1997, J IMMUNOL, V158, P4454; Burgos I, 2006, BRAIN BEHAV IMMUN, V20, P246, DOI 10.1016/j.bbi.2005.06.007; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Czeisler CA, 2011, J CLIN SLEEP MED, V7, pS6, DOI 10.5664/JCSM.1340; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Donlea J, 2012, P NATL ACAD SCI USA, V109, P2613, DOI 10.1073/pnas.1112623109; Everson CA, 2000, AM J PHYSIOL-REG I, V278, pR905, DOI 10.1152/ajpregu.2000.278.4.R905; Everson CA, 2005, AM J PHYSIOL-REG I, V289, pR1054, DOI 10.1152/ajpregu.00021.2005; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; Freeman A, 2012, CURR BIOL, V22, P1142, DOI 10.1016/j.cub.2012.04.027; Friedman EM, 2005, P NATL ACAD SCI USA, V102, P18757, DOI 10.1073/pnas.0509281102; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hong S, 2005, BRAIN BEHAV IMMUN, V19, P165, DOI 10.1016/j.bbi.2004.07.008; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Irwin MR, 2008, BIOL PSYCHIAT, V64, P538, DOI 10.1016/j.biopsych.2008.05.004; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Izawa S, 2013, BRAIN BEHAV IMMUN, V27, P38, DOI 10.1016/j.bbi.2012.07.001; Keppel G., 1982, DESIGN ANAL RES HDB; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Quan SF, 2011, J CLIN SLEEP MED, V7, pS4, DOI 10.5664/JCSM.1338; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Seugnet L, 2006, P NATL ACAD SCI USA, V103, P19913, DOI 10.1073/pnas.0609463104; Seugnet L, 2011, CURR BIOL, V21, P835, DOI 10.1016/j.cub.2011.04.001; Seugnet L, 2009, J NEUROSCI, V29, P7148, DOI 10.1523/JNEUROSCI.5629-08.2009; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Shaw PJ, 1997, AM J PHYSIOL-REG I, V272, pR682, DOI 10.1152/ajpregu.1997.272.2.R682; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Thimgan MS, 2011, J CLIN SLEEP MED, V7, pS26, DOI 10.5664/JCSM.1352; Thimgan MS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000466; Van Dongen HPA, 2004, SLEEP, V27, P423; Vgontzas AN, 2003, J CLIN ENDOCR METAB, V88, P2087, DOI 10.1210/jc.2002-021176; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Vgontzas AN, 2002, METABOLISM, V51, P887, DOI 10.1053/meta.2002.33357; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Williams JA, 2007, SLEEP, V30, P389, DOI 10.1093/sleep/30.4.389; Wong DT, 2006, J AM DENT ASSOC, V137, P313, DOI 10.14219/jada.archive.2006.0180	58	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61016	10.1371/journal.pone.0061016	http://dx.doi.org/10.1371/journal.pone.0061016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637783	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400011
J	Van Sickle, D; Magzamen, S; Maenner, MJ; Crane, J; Corden, TE				Van Sickle, David; Magzamen, Sheryl; Maenner, Matthew J.; Crane, Julian; Corden, Timothy E.			Variability in the Labeling of Asthma among Pediatricians	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; QUESTIONNAIRE; PREVALENCE; DIAGNOSIS; CHILDREN; WHEEZE; PARENTS	Objective: Few studies have examined variability among physicians in the perception and interpretation of asthma symptoms. We report the results of a pilot study to investigate the variability of symptom description and diagnostic labeling and nomenclature among a group of clinicians using standardized audiovisual presentations of asthma. Methods: Practicing pediatricians in Wisconsin recruited from an electronic mailing list were shown the International Study of Asthma and Allergies in Childhood (ISAAC) video questionnaire online, and asked to describe the symptoms and signs they observed and suggest possible diagnostic labels for each presentation. Results: A total of 113 pediatricians (mean age = 43 years; 56% female) responded to >= 1 of the 5 video scenes. The number of practitioners who described the principal symptom(s) of asthma depicted in the 5 sequences ranged from 5.5% for Scene 5 (featuring both dyspnea and wheeze), to 100% for Scene 4 (featuring cough). The number who suggested label of 'asthma' as a possible cause of the presentations ranged from 69.7% for Scene 3 (featuring nocturnal wheeze), to 92.7% for Scene 2 (featuring exercise induced wheeze). Conclusion: There is important unexplained variation in the perceptions and labeling of asthma symptoms among pediatricians. These differences may influence the likelihood of diagnosis and the apparent prevalence of asthma. Many participants suggested that the ISAAC video be used in the education and training of pediatricians.	[Van Sickle, David; Magzamen, Sheryl; Maenner, Matthew J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Crane, Julian] Univ Otago, Dept Med, Wellington, New Zealand; [Corden, Timothy E.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; University of Otago; Medical College of Wisconsin	Van Sickle, D (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA.	dvansickle@gmail.com		Van Sickle, David/0000-0002-3703-2060	Robert Wood Johnson Foundation Health and Society Scholars Program	Robert Wood Johnson Foundation Health and Society Scholars Program(Robert Wood Johnson Foundation (RWJF))	This study was funded entirely by the Robert Wood Johnson Foundation Health and Society Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; [Anonymous], 2008, LANCET, V372, P1009, DOI 10.1016/S0140-6736(08)61414-2; [Anonymous], 2006, LANCET, V368, P705; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bai Y, 2007, J HEALTH CARE POOR U, V18, P54, DOI 10.1353/hpu.2007.0001; Baker KM, 2003, CHEST, V124, P2156, DOI 10.1378/chest.124.6.2156; BRITTON J, 1992, BRIT MED J, V304, P857, DOI 10.1136/bmj.304.6831.857; Cane RS, 2001, ARCH DIS CHILD, V84, P31, DOI 10.1136/adc.84.1.31; DODGE RR, 1980, AM REV RESPIR DIS, V122, P567; DOLOVICH J, 1986, AM REV RESPIR DIS, V134, P1102, DOI 10.1164/arrd.1986.134.5.1102a; Fernandes RM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-112; Flores G, 2009, J ASTHMA, V46, P392, DOI 10.1080/02770900802712971; GERGEN PJ, 1992, AM REV RESPIR DIS, V146, P823, DOI 10.1164/ajrccm/146.4.823; HILL R, 1989, BRIT MED J, V299, P898, DOI 10.1136/bmj.299.6704.898; Kelly YJ, 1996, ARCH DIS CHILD, V75, P489, DOI 10.1136/adc.75.6.489; Li JTC, 1996, ANN ALLERG ASTHMA IM, V76, P1, DOI 10.1016/S1081-1206(10)63400-X; Magnus P, 1997, BRIT MED J, V314, P1795, DOI 10.1136/bmj.314.7097.1795; Michel G, 2006, EUR RESPIR J, V28, P1124, DOI 10.1183/09031936.06.00008406; National Center for Health Statistics, 2011, NAT HLTH INT SURV; National Center for Health Statistics, 2010, BEH RISK FACT SURV S; National Center for Health Statistics. Centers for Disease Control and Prevention, 2010, NAT HLTH NUTR EX SUR; PASTERKAMP H, 1987, CHEST, V92, P346, DOI 10.1378/chest.92.2.346; Pearce N, 1998, ASTHMA EPIDEMIOLOGY, P266; Shalowitz MU, 2007, AMBUL PEDIATR, V7, P271, DOI 10.1016/j.ambp.2007.03.004; SHAW RA, 1992, CLIN EXP ALLERGY, V22, P561, DOI 10.1111/j.1365-2222.1992.tb00166.x; SHAW RA, 1992, MED J AUSTRALIA, V157, P311, DOI 10.5694/j.1326-5377.1992.tb137182.x; Sistek D, 2001, EUR RESPIR J, V17, P214, DOI 10.1183/09031936.01.17202140; SPITERI MA, 1988, LANCET, V1, P873; Yeatts K, 2003, PEDIATRICS, V111, P1046, DOI 10.1542/peds.111.5.1046	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62398	10.1371/journal.pone.0062398	http://dx.doi.org/10.1371/journal.pone.0062398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638066	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400106
J	Zhang, Y; Zhu, JP; Li, YT; Bradley, KC; Cao, JY; Chen, HC; Jin, ML; Zhou, HB				Zhang, Yan; Zhu, Jiping; Li, Yongtao; Bradley, Konrad C.; Cao, Jiyue; Chen, Huanchun; Jin, Meilin; Zhou, Hongbo			Glycosylation on Hemagglutinin Affects the Virulence and Pathogenicity of Pandemic H1N1/2009 Influenza A Virus in Mice	PLOS ONE			English	Article							N-LINKED GLYCOSYLATION; RECEPTOR-BINDING; CLEAVAGE; GLYCOPROTEINS; SITE; H5N1	The two glycosylation sites (Asn142 and Asn177) were observed in the HA of most human seasonal influenza A/H1N1 viruses, while none in pandemic H1N1/2009 influenza A (pH1N1) viruses. We investigated the effect of the two glycosylation sites on viral virulence and pathogenicity in mice using recombinant pH1N1. The H1N1/144 and H1N1/177 mutants which gained potential glycosylation sites Asn142 and Asn177 on HA respectively were generated from A/Mexico/4486/2009(H1N1) by site-directed mutagenesis and reverse genetics, the same as the H1N1/144+177 gained both glycosylation sites Asn142 and Asn177. The biological characteristics and antigenicity of the mutants were compared with wild-type pH1N1. The virulence and pathogenicity of recombinants were also detected in mice. Our results showed that HA antigenicity and viral affinity for receptor may change with introduction of the glycosylation sites. Compared with wild-type pH1N1, the mutant H1N1/177 displayed an equivalent virus titer in chicken embryos and mice, and increased virulence and pathogenicity in mice. The H1N1/144 displayed the highest virus titer in mice lung. However, the H1N1/144+177 displayed the most serious alveolar inflammation and pathogenicity in infected mice. The introduction of the glycosylation sites Asn144 and Asn177 resulted in the enhancement on virulence and pathogenicity of pH1N1 in mice, and was also associated with the change of HA antigenicity and the viral affinity for receptor.	[Zhang, Yan; Zhu, Jiping; Li, Yongtao; Cao, Jiyue; Chen, Huanchun; Jin, Meilin; Zhou, Hongbo] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Bradley, Konrad C.] Emory Univ, Sch Med, Dept Microbiol & Immunol, O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA	Huazhong Agricultural University; Emory University	Zhou, HB (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	hbzhou@mail.hzau.edu.cn	zhu, ji/HDM-1538-2022	Bradley, Konrad/0000-0001-8761-6219	China National Basic Research Program (China "973" Program) [2011CB505004]; National Natural Science Foundation of China [31072154]; Fundamental Research Funds for the Central Universities [2011PY126]	China National Basic Research Program (China "973" Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded by China National Basic Research Program (China "973" Program 2011CB505004), National Natural Science Foundation of China (No. 31072154) and Fundamental Research Funds for the Central Universities (2011PY126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; MUNK K, 1992, GLYCOBIOLOGY, V2, P233, DOI 10.1093/glycob/2.3.233; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OHUCHI M, 1989, VIROLOGY, V168, P274, DOI 10.1016/0042-6822(89)90267-5; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Sun SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032119; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295; Tate MD, 2011, VIROLOGY, V413, P84, DOI 10.1016/j.virol.2011.01.036; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Tsuchiya E, 2001, J GEN VIROL, V82, P2475, DOI 10.1099/0022-1317-82-10-2475; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang W, 2010, J VIROL, V00221, P1; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277	39	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61397	10.1371/journal.pone.0061397	http://dx.doi.org/10.1371/journal.pone.0061397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637827	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400020
J	Farke, AA; Sertich, JJW				Farke, Andrew A.; Sertich, Joseph J. W.			An Abelisauroid Theropod Dinosaur from the Turonian of Madagascar	PLOS ONE			English	Article							MAJUNGASAURUS-CRENATISSIMUS THEROPODA; PHYLOGENY; BIOGEOGRAPHY; PATAGONIA	Geophysical evidence strongly supports the complete isolation of India and Madagascar (Indo-Madagascar) by similar to 100 million years ago, though sparse terrestrial fossil records from these regions prior to similar to 70 million years ago have limited insights into their biogeographic history during the Cretaceous. A new theropod dinosaur, Dahalokely tokana, from Turonian-aged (similar to 90 million years old) strata of northernmost Madagascar is represented by a partial axial column. Autapomorphies include a prominently convex prezygoepipophyseal lamina on cervical vertebrae and a divided infraprezygapophyseal fossa through the mid-dorsal region, among others. Phylogenetic analysis definitively recovers the species as an abelisauroid theropod and weakly as a noasaurid. Dahalokely is the only known dinosaur from the interval during which Indo-Madagascar likely existed as a distinct landmass, but more complete material is needed to evaluate whether or not it is more closely related to later abelisauroids of Indo-Madagascar or those known elsewhere in Gondwana.	[Farke, Andrew A.] Raymond M Alf Museum Paleontol, Claremont, CA USA; [Sertich, Joseph J. W.] Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO USA		Farke, AA (corresponding author), Raymond M Alf Museum Paleontol, Claremont, CA USA.	afarke@webb.org		Farke, Andrew/0000-0002-6930-2002	Jurassic Foundation; National Science Foundation [EAR-0446488, EAR-1123642]; Sigma Xi; Raymond M. Alf Museum of Paleontology; Division Of Earth Sciences [1123642] Funding Source: National Science Foundation	Jurassic Foundation; National Science Foundation(National Science Foundation (NSF)); Sigma Xi; Raymond M. Alf Museum of Paleontology; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by the Jurassic Foundation (to Mark Loewen; http://jurassicfoundation.org/), National Science Foundation EAR-0446488 and EAR-1123642 (to David Krause; http://www.nsf.gov/), Sigma Xi (http://www.sigmaxi.org), and the Raymond M. Alf Museum of Paleontology (http://www.alfmuseum.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Ali JR, 2009, J BIOGEOGR, V36, P1778, DOI 10.1111/j.1365-2699.2009.02105.x; Allain R, 2007, J VERTEBR PALEONTOL, V27, P610, DOI 10.1671/0272-4634(2007)27[610:AADTFT]2.0.CO;2; Babinot J.-F., 2009, CARNETS GEOLOGIE, V2009/01; Bandopadhyay S, 2010, NEW ASPECTS MESOZOIC, P45; Besairie H., 1972, ANN GEOL MADAGASCAR, V35, P1; Bonaparte J.F., 1985, Ameghiniana, V21, P259; Bonaparte J.F., 1991, Historical Biology, V5, P1; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; Burch SH, 2012, J VERTEBR PALEONTOL, V32, P1, DOI 10.1080/02724634.2012.622027; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Carrano Matthew T., 2011, Smithsonian Contributions to Paleobiology, P1; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Case Judd A., 2002, Journal of Vertebrate Paleontology, V22, p42A; Collignon M, 1972, B ACAD MALGACHE, V49, P153; Coria Rodolfo A., 2000, Gaia (Lisboa), V15, P89; Curry K. A., 1997, Journal of Vertebrate Paleontology, V17, p40A; Ezcurra MD, 2010, ZOOTAXA, P1; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hardenbol J., 1998, MESOZOIC CENOZOIC SE, V60, P3; Hay WW, 1999, GEOL S AM S, P1; HERNGREEN GFW, 1982, MICROPALEONTOLOGY, V28, P97, DOI 10.2307/1485364; Khosla Ashu, 2003, Journal of the Palaeontological Society of India, V48, P115; Krause DW, 2007, J VERTEBR PALEONTOL, V27, P1, DOI 10.1671/0272-4634(2007)27[1:OOTHOD]2.0.CO;2; Krause DW, 2006, ANN MO BOT GARD, V93, P178, DOI 10.3417/0026-6493(2006)93[178:LCTVFM]2.0.CO;2; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mendez A, 2012, ACTA PALAEONTOLOGICA; Novas Fernando E., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P67; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; Ogg J.G., 2012, TSCREATOR VISUALIZAT; Pol D, 2012, P ROY SOC B-BIOL SCI, V279, P3170, DOI 10.1098/rspb.2012.0660; Rage JC, 2003, ACTA PALAEONTOL POL, V48, P661; Randrianasolo A, 1989, GEOBIOS, V22, P119; Randrianasolo A, 1979, ANN U MADAGASCAR SNM, V16, P169; Rauhut OWM, 2012, P GEOLOGIST ASSOC, V123, P779, DOI 10.1016/j.pgeola.2012.05.008; Rogers RR, 2007, J VERTEBR PALEONTOL, V27, P21, DOI 10.1671/0272-4634(2007)27[21:PAPOMC]2.0.CO;2; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Torsvik TH, 2000, TERRA NOVA, V12, P220, DOI 10.1046/j.1365-3121.2000.00300.x; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wilkinson M, 2001, TAXEQ3 SOFTWARE DOCU; Wilson Jeffrey A., 2003, Contributions from the Museum of Paleontology University of Michigan, V31, P1	49	39	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e62047	10.1371/journal.pone.0062047	http://dx.doi.org/10.1371/journal.pone.0062047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637961	Green Submitted, gold, Green Published			2022-12-25	WOS:000317908700073
J	Johnston, JM; Jiang, M; Guo, ZH; Baker, EN				Johnston, Jodie M.; Jiang, Ming; Guo, Zhihong; Baker, Edward N.			Crystal Structures of E. coli Native MenH and Two Active Site Mutants	PLOS ONE			English	Article							ALPHA/BETA-HYDROLASE FOLD; MENAQUINONE BIOSYNTHESIS; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR-REPLACEMENT; PROTEIN-PRODUCTION; IDENTIFICATION; REFINEMENT; MECHANISMS; RESIDUES	Recent revision of the biosynthetic pathway for menaquinone has led to the discovery of a previously unrecognized enzyme 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase, also known as MenH. This enzyme has an alpha/beta hydrolase fold with a catalytic triad comprising Ser86, His232, and Asp210. Mutational studies identified a number of conserved residues of importance to activity, and modeling further implicated the side chains of Tyr85 and Trp147 in formation of a non-standard oxyanion hole. We have solved the structure of E. coli MenH (EcMenH) at 2.75 angstrom resolution, together with the structures of the active site mutant proteins Tyr85Phe and Arg124Ala, both at 2.5 angstrom resolution. EcMenH has the predicted alpha/beta hydrolase fold with its core alpha/beta domain capped by a helical lid. The active site, a long groove beneath the cap, contains a number of conserved basic residues and is found to bind exogeneous anions, modeled as sulfate and chloride, in all three crystal structures. Docking studies with the MenH substrate and a transition state model indicate that the bound anions mark the binding sites for anionic groups on the substrate. The docking studies, and careful consideration of the active site geometry, further suggest that the oxyanion hole is of a conventional nature, involving peptide NH groups, rather than the proposed site involving Tyr85 and Trp147. This is in accord with conclusions from the structure of S. aureus MenH. Comparisons with the latter do, however, indicate differences in the periphery of the active site that could be of relevance to selective inhibition of MenH enzymes.	[Johnston, Jodie M.; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr, Auckland 1, New Zealand; [Johnston, Jodie M.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Jiang, Ming; Guo, Zhihong] HKUST, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Jiang, Ming; Guo, Zhihong] HKUST, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	University of Auckland; University of Auckland; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Baker, EN (corresponding author), Univ Auckland, Maurice Wilkins Ctr, Auckland 1, New Zealand.	ted.baker@auckland.ac.nz		Baker, Edward/0000-0003-2456-7661; Guo, Zhihong/0000-0003-0374-8412	Ministry of Science and Innovation of New Zealand through the New Economy Research Fund [UOAX1005]; Research Grants Council of the HKSAR government [GRF601209, RPC11SC16]	Ministry of Science and Innovation of New Zealand through the New Economy Research Fund; Research Grants Council of the HKSAR government(Hong Kong Research Grants Council)	This work was supported by the Ministry of Science and Innovation of New Zealand through the New Economy Research Fund (grant UOAX1005 to ENB), and by the Research Grants Council of the HKSAR government (grants GRF601209 and RPC11SC16 to ZG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPH SYST; Bricogne G., 2011, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dairi T, 2011, NAT PROD REP, V28, P1054, DOI 10.1039/c0np00047g; Dawson A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-19; Debnath J, 2012, J MED CHEM, V55, P3739, DOI 10.1021/jm201608g; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhiman RK, 2009, MOL MICROBIOL, V72, P85, DOI 10.1111/j.1365-2958.2009.06625.x; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Johnston JM, 2010, ACTA CRYSTALLOGR D, V66, P909, DOI 10.1107/S0907444910025771; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meganathan R, 2001, VITAM HORM, V61, P173; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sharma P, 2012, FEBS J, V279, P3364, DOI 10.1111/j.1742-4658.2012.08608.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61325	10.1371/journal.pone.0061325	http://dx.doi.org/10.1371/journal.pone.0061325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637813	Green Submitted, Green Published, gold			2022-12-25	WOS:000317908700024
J	Kelly, CD; Tawes, BR				Kelly, Clint D.; Tawes, Brittany R.			Sex-Specific Effect of Juvenile Diet on Adult Disease Resistance in a Field Cricket	PLOS ONE			English	Article							INDUCED IMMUNE-RESPONSE; LIFE-SPAN; REPRODUCTIVE EFFORT; BATEMANS PRINCIPLE; TRADE-OFFS; BODY-SIZE; FEMALE; DROSOPHILA; COSTS; QUALITY	Food limitation is expected to reduce an individual's body condition (body mass scaled to body size) and cause a trade-off between growth and other fitness-related traits, such as immunity. We tested the condition-dependence of growth and disease resistance in male and female Gryllus texensis field crickets by manipulating diet quality via nutrient content for their entire life and then subjecting individuals to a host resistance test using the live bacterium Serratia marcescens. As predicted, crickets on a high-quality diet eclosed more quickly, and at a larger body size and mass. Crickets on a high-quality diet were not in better condition at the time of eclosion, but they were in better condition 7-11 days after eclosion, with females also being in better condition than males. Despite being in better condition, however, females provided with a high-quality diet had significantly poorer disease resistance than females on a low-quality diet and in poor condition. Similarly, males on low-and high-quality diets did not differ in their disease resistance, despite differing in their body condition. A sex difference in disease resistance under diet-restriction suggests that females might allocate resources toward immunity during development if they expect harsh environmental conditions as an adult or it might suggest that females allocate resources toward other life history activities (i.e. reproduction) when food availability increases. We do not know what immune effectors were altered under diet-restriction to increase disease resistance, but our findings suggest that increased immune function might provide an explanation for the sexually-dimorphic increase in longevity generally observed in diet-restricted animals.	[Kelly, Clint D.; Tawes, Brittany R.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA	Iowa State University	Kelly, CD (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	cdkelly@iastate.edu	Kelly, Clint D./A-2311-2008	Kelly, Clint D./0000-0002-0693-7211	Iowa State University Faculty Start-up Award	Iowa State University Faculty Start-up Award	Funding provided by Iowa State University Faculty Start-up Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Auer SK, 2010, AM NAT, V176, P818, DOI 10.1086/657061; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Brown AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004490; Campero M, 2008, J ANIM ECOL, V77, P66, DOI 10.1111/j.1365-2656.2007.01308.x; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; De Block M, 2008, ECOL ENTOMOL, V33, P796, DOI 10.1111/j.1365-2311.2008.01024.x; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Fellous S, 2010, MOL ECOL, V19, P1462, DOI 10.1111/j.1365-294X.2010.04567.x; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Gershman SN, 2008, BEHAV ECOL, V19, P810, DOI 10.1093/beheco/arn040; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jacot A, 2005, J EVOLUTION BIOL, V18, P1060, DOI 10.1111/j.1420-9101.2005.00899.x; Jacot A, 2004, EVOLUTION, V58, P2280; Jacot A, 2005, P ROY SOC B-BIOL SCI, V272, P63, DOI 10.1098/rspb.2004.2919; Judge KA, 2008, EVOLUTION, V62, P868, DOI 10.1111/j.1558-5646.2008.00318.x; Kelly CD, 2011, BIOL J LINN SOC, V104, P38, DOI 10.1111/j.1095-8312.2011.01714.x; Kelly CD, 2009, PHYSIOL ENTOMOL, V34, P174, DOI 10.1111/j.1365-3032.2009.00671.x; Kerr AM, 2010, BEHAV ECOL, V21, P647, DOI 10.1093/beheco/arq035; Klemola N, 2007, ENTOMOL EXP APPL, V123, P167, DOI 10.1111/j.1570-7458.2007.00533.x; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lyn J, 2012, EVOL BIOL, V39, P371, DOI 10.1007/s11692-012-9160-0; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; McKean KA, 2005, EVOLUTION, V59, P1510; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Molleman F, 2008, ENTOMOL EXP APPL, V129, P54, DOI 10.1111/j.1570-7458.2008.00752.x; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; PARTRIDGE L, 1981, NATURE, V294, P580, DOI 10.1038/294580a0; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Podolsky RD, 2006, INTEGR COMP BIOL, V46, P577, DOI 10.1093/icb/icl026; Povey S, 2009, J ANIM ECOL, V78, P437, DOI 10.1111/j.1365-2656.2008.01499.x; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Rolff J, 2004, AM NAT, V164, P559, DOI 10.1086/423715; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Simmons LW, 2012, BEHAV ECOL, V23, P168, DOI 10.1093/beheco/arr170; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Stoehr AM, 2007, ECOL ENTOMOL, V32, P188, DOI 10.1111/j.1365-2311.2007.00855.x; Stoehr AM, 2006, BEHAV ECOL, V17, P751, DOI 10.1093/beheco/ark018; Suwanchaichinda C, 1998, J MED ENTOMOL, V35, P157, DOI 10.1093/jmedent/35.2.157; Team RDC, R LANG ENV STAT COMP; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zajitschek F, 2009, FUNCT ECOL, V23, P602, DOI 10.1111/j.1365-2435.2008.01520.x; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	65	22	22	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61301	10.1371/journal.pone.0061301	http://dx.doi.org/10.1371/journal.pone.0061301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637808	Green Submitted, gold, Green Published			2022-12-25	WOS:000317908700021
J	Navarro, G; Moreno, E; Bonaventura, J; Brugarolas, M; Farre, D; Aguinaga, D; Mallol, J; Cortes, A; Casado, V; Lluis, C; Ferre, S; Franco, R; Canela, E; McCormick, PJ				Navarro, Gemma; Moreno, Estefania; Bonaventura, Jordi; Brugarolas, Marc; Farre, Daniel; Aguinaga, David; Mallol, Josefa; Cortes, Antoni; Casado, Vicent; Lluis, Carmen; Ferre, Sergi; Franco, Rafael; Canela, Enric; McCormick, Peter J.			Cocaine Inhibits Dopamine D-2 Receptor Signaling via Sigma-1-D-2 Receptor Heteromers	PLOS ONE			English	Article							SIGMA-RECEPTORS; GENE-EXPRESSION; STRIATOPALLIDAL NEURONS; BETA-ARRESTINS; D2 RECEPTORS; D1 RECEPTOR; IN-VIVO; MICE; TRANSPORTER; ADDICTION	Under normal conditions the brain maintains a delicate balance between inputs of reward seeking controlled by neurons containing the D-1-like family of dopamine receptors and inputs of aversion coming from neurons containing the D-2-like family of dopamine receptors. Cocaine is able to subvert these balanced inputs by altering the cell signaling of these two pathways such that D-1 reward seeking pathway dominates. Here, we provide an explanation at the cellular and biochemical level how cocaine may achieve this. Exploring the effect of cocaine on dopamine D-2 receptors function, we present evidence of sigma(1) receptor molecular and functional interaction with dopamine D-2 receptors. Using biophysical, biochemical, and cell biology approaches, we discovered that D-2 receptors (the long isoform of the D-2 receptor) can complex with sigma(1) receptors, a result that is specific to D-2 receptors, as D-3 and D-4 receptors did not form heteromers. We demonstrate that the sigma(1)-D-2 receptor heteromers consist of higher order oligomers, are found in mouse striatum and that cocaine, by binding to sigma(1)-D-2 receptor heteromers, inhibits downstream signaling in both cultured cells and in mouse striatum. In contrast, in striatum from sigma(1) knockout animals these complexes are not found and this inhibition is not seen. Taken together, these data illuminate the mechanism by which the initial exposure to cocaine can inhibit signaling via D-2 receptor containing neurons, destabilizing the delicate signaling balance influencing drug seeking that emanates from the D-1 and D-2 receptor containing neurons in the brain.	[Navarro, Gemma; Moreno, Estefania; Bonaventura, Jordi; Brugarolas, Marc; Farre, Daniel; Aguinaga, David; Mallol, Josefa; Cortes, Antoni; Casado, Vicent; Lluis, Carmen; Canela, Enric; McCormick, Peter J.] CIBERNED, Barcelona, Spain; [Navarro, Gemma; Moreno, Estefania; Bonaventura, Jordi; Brugarolas, Marc; Farre, Daniel; Aguinaga, David; Mallol, Josefa; Cortes, Antoni; Casado, Vicent; Lluis, Carmen; Canela, Enric; McCormick, Peter J.] IBUB, Barcelona, Spain; [Navarro, Gemma; Moreno, Estefania; Bonaventura, Jordi; Brugarolas, Marc; Farre, Daniel; Aguinaga, David; Mallol, Josefa; Cortes, Antoni; Casado, Vicent; Lluis, Carmen; Canela, Enric; McCormick, Peter J.] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain; [Ferre, Sergi] NIDA, Intramural Res Program, NIH, Dept Hlth & Human Serv, Baltimore, MD USA; [Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, E-31080 Pamplona, Spain	CIBERNED; University of Barcelona; University of Barcelona; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University of Navarra	McCormick, PJ (corresponding author), CIBERNED, Barcelona, Spain.	pmccormick@ub.edu	Casadó, Vicent/K-1660-2014; Canela, Enric I./M-8726-2013; Navarro, Gemma/AAO-7866-2021; Ferre, Sergi/K-6115-2014; Franco, Rafael/C-3694-2015; Mallol, Josefa/I-4194-2015; Guillén, Estefanía Moreno/ABE-4371-2020; Bonaventura, Jordi/A-5229-2019; McCormick, Peter/E-7387-2012	Casadó, Vicent/0000-0002-1764-3825; Canela, Enric I./0000-0003-4992-7440; Navarro, Gemma/0000-0003-4654-0873; Ferre, Sergi/0000-0002-1747-1779; Franco, Rafael/0000-0003-2549-4919; Mallol, Josefa/0000-0002-2479-4162; Bonaventura, Jordi/0000-0002-4745-0151; Aguinaga Andres, David/0000-0003-2506-7204; Brugarolas, Marc/0000-0002-2277-1266; Moreno, Estefania/0000-0002-2491-5753; McCormick, Peter/0000-0002-2225-5181	Spanish Ministerio de Ciencia y Tecnologia [SAF2009-07276, SAF2010-18472, SAF2011-23813]; Intramural Funds of the National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Intramural Funds of the National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (SAF2009-07276, SAF2010-18472, SAF2011-23813), and by Intramural Funds of the National Institute on Drug Abuse to SF. PJM is a Ramon y Cajal Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2000, NEUROSCIENCE, V97, P155, DOI 10.1016/S0306-4522(00)00014-2; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Callen L, 2012, J BIOL CHEM, V287, P20851, DOI 10.1074/jbc.M111.335273; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Durieux PF, 2012, EMBO J, V31, P640, DOI 10.1038/emboj.2011.400; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Ferragud A, 2009, PSYCHOPHARMACOLOGY, V207, P281, DOI 10.1007/s00213-009-1653-x; Ferraro L, 2012, NEUROPSYCHOPHARMACOL, V37, P1856, DOI 10.1038/npp.2012.33; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gonzalez S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001347; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hayashi T., 2005, Current Neuropharmacology, V3, P267, DOI 10.2174/157015905774322516; Hiranita T, 2013, NEUROPSYCHOPHARMACOL, V38, P605, DOI 10.1038/npp.2012.224; Hiranita T, 2011, J PHARMACOL EXP THER, V339, P662, DOI 10.1124/jpet.111.185025; Hiranita T, 2010, J PHARMACOL EXP THER, V332, P515, DOI 10.1124/jpet.109.159236; Hoffmann HM, 2012, ADDICT BIOL, V17, P565, DOI 10.1111/j.1369-1600.2011.00353.x; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Katz JL, 2011, PHARMACEUTICALS, V4, P880, DOI 10.3390/ph4060880; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Koob GF, 2006, ADDICTION, V101, P23, DOI 10.1111/j.1360-0443.2006.01586.x; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Krawczyk M, 2011, J NEUROSCI, V31, P8928, DOI 10.1523/JNEUROSCI.0377-11.2011; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Luo ZC, 2011, J NEUROSCI, V31, P13180, DOI 10.1523/JNEUROSCI.2369-11.2011; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Matsumoto RR, 2003, EUR J PHARMACOL, V469, P1, DOI 10.1016/S0014-2999(03)01723-0; Matsumoto RR, 2002, NEUROPHARMACOLOGY, V42, P1043, DOI 10.1016/S0028-3908(02)00056-4; Matsumoto RR, 2001, EUR J PHARMACOL, V419, P163, DOI 10.1016/S0014-2999(01)00968-2; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Moreno E, 2011, J BIOL CHEM, V286, P5846, DOI 10.1074/jbc.M110.161489; Moreno E, 2011, J NEUROSCI, V31, P7412, DOI 10.1523/JNEUROSCI.0191-11.2011; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Ng GYK, 1996, BIOCHEM BIOPH RES CO, V227, P200, DOI 10.1006/bbrc.1996.1489; PETTIT HO, 1990, J NEUROCHEM, V55, P798, DOI 10.1111/j.1471-4159.1990.tb04562.x; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; SCHIFFMANN SN, 1993, J NEUROSCI, V13, P1080; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; SHARKEY J, 1988, EUR J PHARMACOL, V149, P171, DOI 10.1016/0014-2999(88)90058-1; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Thompson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011038; Valjent E, 2000, J NEUROSCI, V20, P8701; Welter M, 2007, P NATL ACAD SCI USA, V104, P6840, DOI 10.1073/pnas.0610790104; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Xu YT, 2012, PHARMACOL BIOCHEM BE, V101, P174, DOI 10.1016/j.pbb.2011.12.016; Zhang DS, 2005, NEUROPSYCHOPHARMACOL, V30, P1443, DOI 10.1038/sj.npp.1300680	62	103	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61245	10.1371/journal.pone.0061245	http://dx.doi.org/10.1371/journal.pone.0061245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637801	Green Published, gold			2022-12-25	WOS:000317908700018
J	Piedimonte, G; Walton, C; Samsell, L				Piedimonte, Giovanni; Walton, Cheryl; Samsell, Lennie			Vertical Transmission of Respiratory Syncytial Virus Modulates Pre- and Postnatal Innervation and Reactivity of Rat Airways	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; INFLAMMATION; NEUROTROPHINS; INFECTION; INFANTS; CELLS; MECHANISMS; EXPRESSION; PREVENTION; ALLERGY	Background: Environmental exposure to respiratory syncytial virus (RSV) is a leading cause of respiratory infections in infants, but it remains unknown whether this infection is transmitted transplacentally from the lungs of infected mothers to the offspring. We sought to test the hypothesis that RSV travels from the respiratory tract during pregnancy, crosses the placenta to the fetus, persists in the lung tissues of the offspring, and modulates pre- and postnatal expression of growth factors, thereby predisposing to airway hyperreactivity. Methodology: Pregnant rats were inoculated intratracheally at midterm using recombinant RSV expressing red fluorescent protein (RFP). Viral RNA was amplified by RT-PCR and confirmed by sequencing. RFP expression was analyzed by flow cytometry and viral culture. Developmental and pathophysiologic implications of prenatal infection were determined by analyzing the expression of genes encoding critical growth factors, particularly neurotrophic factors and receptors. We also measured the expression of key neurotransmitters and postnatal bronchial reactivity in vertically infected lungs, and assessed their dependence on neurotrophic signaling using selective biological or chemical inhibition. Principal Findings: RSV genome was found in 30% of fetuses, as well as in the lungs of 40% of newborns and 25% of adults. RFP expression was also shown by flow cytometry and replicating virus was cultured from exposed fetuses. Nerve growth factor and its TrkA receptor were upregulated in RSV-infected fetal lungs and co-localized with increased cholinergic innervation. Acetylcholine expression and smooth muscle response to cholinergic stimulation increased in lungs exposed to RSV in utero and reinfected after birth, and blocking TrkA signaling inhibited both effects. Conclusions/Significance: Our data show transplacental transmission of RSV from mother to offspring and persistence of vertically transmitted virus in lungs after birth. Exposure to RSV in utero is followed by dysregulation of neurotrophic pathways predisposing to postnatal airway hyperreactivity upon reinfection with the virus.	[Piedimonte, Giovanni] Cleveland Clin, Inst Pediat, Cleveland, OH 44106 USA; [Piedimonte, Giovanni] Cleveland Clin, Childrens Hosp, Cleveland, OH 44106 USA; [Walton, Cheryl; Samsell, Lennie] W Virginia Univ, Dept Pediat, Morgantown, WV 26506 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; West Virginia University	Piedimonte, G (corresponding author), Cleveland Clin, Inst Pediat, Cleveland, OH 44106 USA.	piedimg@ccf.org		Tripp, Ralph/0000-0002-2924-9956	U.S. National Institutes of Health [RO1 HL-61007, P30-GM103488, P30-RR032138]; WVU Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WVU Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded in part by the U.S. National Institutes of Health (nih.gov) grants RO1 HL-61007, P30-GM103488, and P30-RR032138, and by funds from the WVU Foundation (wvu.edu) to Dr. Giovanni Piedimonte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonini S, 1996, P NATL ACAD SCI USA, V93, P10955, DOI 10.1073/pnas.93.20.10955; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Boukhvalova MS, 2010, CURR PROTOC CELL BIO; Braun A, 1999, INT ARCH ALLERGY IMM, V118, P163, DOI 10.1159/000024056; Buck H, 1996, J NEUROCHEM, V67, P345; Burnet FM, 1949, PRODUCTION ANTIBODIE; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Eisenhut M, 2006, CRIT CARE, V10, DOI 10.1186/cc4984; Fatemi SH, 2009, EUR NEUROPSYCHOPHARM, V19, P648, DOI 10.1016/j.euroneuro.2009.03.004; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Kernie SG, 2000, ARCH NEUROL-CHICAGO, V57, P654, DOI 10.1001/archneur.57.5.654; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Liu XM, 2007, KIDNEY INT, V71, P388, DOI 10.1038/sj.ki.5002030; MIMS CA, 1981, MICROBIOL REV, V45, P267, DOI 10.1128/MMBR.45.2.267-286.1981; Mohtasham L, 2007, PEDIATR PULM, V42, P496, DOI 10.1002/ppul.20607; O'Donnell DR, 1998, J PEDIATR-US, V133, P272, DOI 10.1016/S0022-3476(98)70234-3; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; OHMICHI M, 1992, BIOCHEMISTRY-US, V31, P4034, DOI 10.1021/bi00131a019; Othumpangat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030030; Othumpangat S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006444; Piedimonte G, 2002, RESP RES, V3, DOI 10.1186/rr185; Piedimonte G, 2001, AM J RESP CRIT CARE, V163, pS18, DOI 10.1164/ajrccm.163.supplement_1.2011113; Rezaee F, 2011, AM J RESP CELL MOL, V45, P277, DOI 10.1165/rcmb.2010-0121OC; Rohwedder A, 1998, J MED VIROL, V54, P320, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;320::AID-JMV13&gt;3.0.CO;2-J; RUBIN JS, 1981, J NEUROSCI RES, V6, P451, DOI 10.1002/jnr.490060403; Sasser JM, 2008, AM J PHYSIOL-RENAL, V294, pF1342, DOI 10.1152/ajprenal.00067.2008; Scuri Mario, 2010, Inflammation & Allergy Drug Targets, V9, P173; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Swasdipan S, 2002, MICROB PATHOGENESIS, V32, P49, DOI 10.1006/mpat.2001.0480; Team R. D. C, 2011, R LANG ENV STAT COMP; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Verbeke G, 2009, SPRINGER SER STAT, P1; Wilfong ER, 2004, AM J RESP CELL MOL, V30, P793, DOI 10.1165/rcmb.2003-0303OC; Wright M, 2011, PEDIATR PULM, V46, P324, DOI 10.1002/ppul.21377; YANKEVICH OD, 1975, VOP VIRUSOL+, P455; Zhu YH, 2012, AM J PHYSIOL-GASTR L, V302, pG176, DOI 10.1152/ajpgi.00053.2011	40	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61309	10.1371/journal.pone.0061309	http://dx.doi.org/10.1371/journal.pone.0061309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637810	gold, Green Submitted, Green Published			2022-12-25	WOS:000317908700022
J	Tropeano, M; Ahn, JW; Dobson, RJB; Breen, G; Rucker, J; Dixit, A; Pal, DK; McGuffin, P; Farmer, A; White, PS; Andrieux, J; Vassos, E; Ogilvie, CM; Curran, S; Collier, DA				Tropeano, Maria; Ahn, Joo Wook; Dobson, Richard J. B.; Breen, Gerome; Rucker, James; Dixit, Abhishek; Pal, Deb K.; McGuffin, Peter; Farmer, Anne; White, Peter S.; Andrieux, Joris; Vassos, Evangelos; Ogilvie, Caroline Mackie; Curran, Sarah; Collier, David A.			Male-Biased Autosomal Effect of 16p13.11 Copy Number Variation in Neurodevelopmental Disorders	PLOS ONE			English	Article							RARE CHROMOSOMAL DELETIONS; END RULE PATHWAY; HUMAN GENOME; DE-NOVO; DEVELOPMENTAL DELAY; RECURRENT MICRODELETIONS; GENERALIZED EPILEPSIES; GENETIC ARCHITECTURE; SPECTRUM DISORDERS; BIPOLAR DISORDER	Copy number variants (CNVs) at chromosome 16p13.11 have been associated with a range of neurodevelopmental disorders including autism, ADHD, intellectual disability and schizophrenia. Significant sex differences in prevalence, course and severity have been described for a number of these conditions but the biological and environmental factors underlying such sex-specific features remain unclear. We tested the burden and the possible sex-biased effect of CNVs at 16p13.11 in a sample of 10,397 individuals with a range of neurodevelopmental conditions, clinically referred for array comparative genomic hybridisation (aCGH); cases were compared with 11,277 controls. In order to identify candidate phenotype-associated genes, we performed an interval-based analysis and investigated the presence of ohnologs at 16p13.11; finally, we searched the DECIPHER database for previously identified 16p13.11 copy number variants. In the clinical referral series, we identified 46 cases with CNVs of variable size at 16p13.11, including 28 duplications and 18 deletions. Patients were referred for various phenotypes, including developmental delay, autism, speech delay, learning difficulties, behavioural problems, epilepsy, microcephaly and physical dysmorphisms. CNVs at 16p13.11 were also present in 17 controls. Association analysis revealed an excess of CNVs in cases compared with controls (OR = 2.59; p = 0.0005), and a sex-biased effect, with a significant enrichment of CNVs only in the male subgroup of cases (OR = 5.62; p = 0.0002), but not in females (OR = 1.19, p = 0.673). The same pattern of results was also observed in the DECIPHER sample. Interval-based analysis showed a significant enrichment of case CNVs containing interval II (OR = 2.59; p = 0.0005), located in the 0.83 Mb genomic region between 15.49-16.32 Mb, and encompassing the four ohnologs NDE1, MYH11, ABCC1 and ABCC6. Our data confirm that duplications and deletions at 16p13.11 represent incompletely penetrant pathogenic mutations that predispose to a range of neurodevelopmental disorders, and suggest a sex-limited effect on the penetrance of the pathological phenotypes at the 16p13.11 locus.	[Tropeano, Maria; Dobson, Richard J. B.; Breen, Gerome; Rucker, James; Dixit, Abhishek; McGuffin, Peter; Farmer, Anne; Vassos, Evangelos; Curran, Sarah; Collier, David A.] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Ahn, Joo Wook; Ogilvie, Caroline Mackie] Guys & St Thomas NHS Fdn Trust, Dept Cytogenet, London, England; [Pal, Deb K.] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London WC2R 2LS, England; [White, Peter S.] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [White, Peter S.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Andrieux, Joris] CHRU Lille, Inst Genet Med, Lille, France; [Collier, David A.] Eli Lilly & Co Ltd, Discovery Neurosci Res, Lilly Res Labs, Windlesham, Surrey, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Universite de Lille - ISITE; CHU Lille; Eli Lilly	Tropeano, M (corresponding author), Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	maria.tropeano@kcl.ac.uk; collier_david_andrew@lilly.com	Ahn, Joo Wook/AAM-9454-2020; Dobson, Richard j/C-9269-2011; Breen, Gerome/Y-2706-2019; Tropeano, Maria/E-7611-2011; Ogilve, Caroline/AAW-3793-2021; Vassos, Evangelos/F-9825-2013; McGuffin, Peter/A-1565-2012; curran, sarah/D-1027-2009; Collier, David A/D-1649-2011; Rucker, James/H-6374-2019	Ahn, Joo Wook/0000-0002-5628-2321; Dobson, Richard j/0000-0003-4224-9245; Breen, Gerome/0000-0003-2053-1792; Tropeano, Maria/0000-0002-5156-7539; Vassos, Evangelos/0000-0001-6363-0438; McGuffin, Peter/0000-0002-9888-2907; Collier, David A/0000-0003-4087-1559; Rucker, James/0000-0003-4647-8088; Dixit, Abhishek/0000-0001-9543-5901	South London and Maudsley Trust NIHR specialist Biomedical Research Centre; Guys and St Thomas Trust NIHR comprehensive Biomedical Research Centre; European Commission Seventh Framework project PsychCNVs [HEALTH-2007-2.2.1-10-223423]; Wellcome Trust (Wellcome Trust Case control consortium; WTCCC2)	South London and Maudsley Trust NIHR specialist Biomedical Research Centre; Guys and St Thomas Trust NIHR comprehensive Biomedical Research Centre; European Commission Seventh Framework project PsychCNVs; Wellcome Trust (Wellcome Trust Case control consortium; WTCCC2)	This project and the BBGRE database (BBGRE.org) was funded through a strategic partnership of the South London and Maudsley Trust NIHR specialist Biomedical Research Centre and the Guys and St Thomas Trust NIHR comprehensive Biomedical Research Centre. DAC is funded by the European Commission Seventh Framework project PsychCNVs (http://www.psych-cnv.eu/; Grant agreement number HEALTH-2007-2.2.1-10-223423). This work was supported by the Wellcome Trust (Wellcome Trust Case control consortium; WTCCC2) (DAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JW, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-9; Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Ayhan Y, 2011, MOL PSYCHIATR, V16, P293, DOI 10.1038/mp.2009.144; Bakircioglu M, 2011, AM J HUM GENET, V88, P523, DOI 10.1016/j.ajhg.2011.03.019; Balogh SA, 2000, LEARN MEMORY, V7, P279, DOI 10.1101/lm.33500; Balogh SA, 2001, BRAIN RES, V892, P336, DOI 10.1016/S0006-8993(00)03268-6; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Bradshaw NJ, 2011, J NEUROSCI, V31, P9043, DOI 10.1523/JNEUROSCI.5410-10.2011; Bradshaw NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1091, DOI 10.1016/j.bbrc.2008.10.120; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; Constantino JN, 2012, J AM ACAD CHILD PSY, V51, P756, DOI 10.1016/j.jaac.2012.05.017; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Hennah W, 2005, MOL PSYCHIATR, V10, P1097, DOI 10.1038/sj.mp.4001731; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hennah W, 2007, HUM MOL GENET, V16, P453, DOI 10.1093/hmg/ddl462; Hills A, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-19; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; James WH, 2008, DEV MED CHILD NEUROL, V50, P15, DOI 10.1111/j.1469-8749.2007.02001.x; Jessen HM, 2011, EPIGENETICS-US, V6, P857, DOI 10.4161/epi.6.7.16517; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Kuang SQ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002118; Kubicki M, 2008, SCHIZOPHR RES, V106, P125, DOI 10.1016/j.schres.2008.08.027; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Leu C, 2012, EPILEPSIA, V53, P308, DOI 10.1111/j.1528-1167.2011.03379.x; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Liu JYW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034813; Makino T, 2010, P NATL ACAD SCI USA, V107, P9270, DOI 10.1073/pnas.0914697107; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; MCGUFFIN P, 1986, PSYCHOL MED, V16, P461, DOI 10.1017/S0033291700009302; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Nagamani SCS, 2011, EUR J HUM GENET, V19, P280, DOI 10.1038/ejhg.2010.184; O'Donovan MC, 2008, NAT GENET, V40, P1392, DOI 10.1038/ng1208-1392; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Palo OM, 2007, HUM MOL GENET, V16, P2517, DOI 10.1093/hmg/ddm207; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Rucker JJH, 2013, MOL PSYCHIATR, V18, P183, DOI 10.1038/mp.2011.144; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shimojima K, 2010, AM J MED GENET A, V152A, P2820, DOI 10.1002/ajmg.a.33658; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Thomson PA, 2005, MOL PSYCHIATR, V10, P657, DOI 10.1038/sj.mp.4001669; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Vaags AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/j.ajhg.2011.11.025; Vassos E, 2010, HUM MOL GENET, V19, P3477, DOI 10.1093/hmg/ddq259; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Whiteley P., 2010, AUTISM INSIGHTS, V2010, P17, DOI DOI 10.4137/AUI.S3938; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	77	85	89	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61365	10.1371/journal.pone.0061365	http://dx.doi.org/10.1371/journal.pone.0061365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637818	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700026
J	Drevinge, C; Karlsson, LO; Stahlman, M; Larsson, T; Sundelin, JP; Grip, L; Andersson, L; Boren, J; Levin, MC				Drevinge, Christina; Karlsson, Lars O.; Stahlman, Marcus; Larsson, Thomas; Sundelin, Jeanna Perman; Grip, Lars; Andersson, Linda; Boren, Jan; Levin, Malin C.			Cholesteryl Esters Accumulate in the Heart in a Porcine Model of Ischemia and Reperfusion	PLOS ONE			English	Article							APOPTOSIS; STRESS; LIPOTOXICITY; CERAMIDE	Myocardial ischemia is associated with intracellular accumulation of lipids and increased depots of myocardial lipids are linked to decreased heart function. Despite investigations in cell culture and animal models, there is little data available on where in the heart the lipids accumulate after myocardial ischemia and which lipid species that accumulate. The aim of this study was to investigate derangements of lipid metabolism that are associated with myocardial ischemia in a porcine model of ischemia and reperfusion. The large pig heart enables the separation of the infarct area with irreversible injury from the area at risk with reversible injury and the unaffected control area. The surviving myocardium bordering the infarct is exposed to mild ischemia and is stressed, but remains viable. We found that cholesteryl esters accumulated in the infarct area as well as in the bordering myocardium. In addition, we found that expression of the low density lipoprotein receptor (LDLr) and the low density lipoprotein receptor-related protein 1 (LRP1) was up-regulated, suggesting that choleteryl ester uptake is mediated via these receptors. Furthermore, we found increased ceramide accumulation, inflammation and endoplasmatic reticulum (ER) stress in the infarcted area of the pig heart. In addition, we found increased levels of inflammation and ER stress in the myocardium bordering the infarct area. Our results indicate that lipid accumulation in the heart is one of the metabolic derangements remaining after ischemia, even in the myocardium bordering the infarct area. Normalizing lipid levels in the myocardium after ischemia would likely improve myocardial function and should therefore be considered as a target for treatment.	[Drevinge, Christina; Stahlman, Marcus; Larsson, Thomas; Sundelin, Jeanna Perman; Andersson, Linda; Boren, Jan; Levin, Malin C.] Sahlgrens Univ Hosp, Wallenberg Lab, Gothenburg, Sweden; [Drevinge, Christina; Karlsson, Lars O.; Stahlman, Marcus; Larsson, Thomas; Sundelin, Jeanna Perman; Grip, Lars; Andersson, Linda; Boren, Jan; Levin, Malin C.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg	Levin, MC (corresponding author), Sahlgrens Univ Hosp, Wallenberg Lab, Gothenburg, Sweden.	malin.levin@wlab.gu.se	StÃhlman, Marcus/M-4597-2019	Andersson, Linda/0000-0003-3230-5397; Karlsson, Lars/0000-0003-4852-3065; Henricsson, Marcus/0000-0002-4202-0339; Levin, Malin/0000-0003-1069-5275	Swedish Research Council; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Sahlgrenska University Hospital ALF; Novo Nordisk Fonden [NNF13OC0004973] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sahlgrenska University Hospital ALF; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, Knut and Alice Wallenberg Foundation, and the Sahlgrenska University Hospital ALF research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski M, 2011, ADV EXP MED BIOL, V721, P41, DOI 10.1007/978-1-4614-0650-1_3; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Cal R, 2012, CARDIOVASC RES, V94, P469, DOI 10.1093/cvr/cvs136; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haudek SB, 2007, J CLIN INVEST, V117, P2692, DOI 10.1172/JCI29134; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Huang Y, 2004, CIRCULATION, V109, P97, DOI 10.1161/01.CIR.0000109213.10461.F6; HUGHES HC, 1986, LAB ANIM SCI, V36, P348; Karlsson LO, 2011, EUR J PHARMACOL, V651, P146, DOI 10.1016/j.ejphar.2010.10.069; Karlsson LO, 2010, J CARDIOVASC PHARM T, V15, P182, DOI 10.1177/1074248410362074; Levin MC, 2011, CIRC RES, V109, P1210, DOI 10.1161/CIRCRESAHA.111.246702; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; MAXWELL MP, 1987, CARDIOVASC RES, V21, P737, DOI 10.1093/cvr/21.10.737; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Nojiri H, 2006, J BIOL CHEM, V281, P33789, DOI 10.1074/jbc.M602118200; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Osipov RM, 2009, CIRCULATION, V120, pS22, DOI 10.1161/CIRCULATIONAHA.108.842724; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Park TS, 2007, CURR OPIN LIPIDOL, V18, P277, DOI 10.1097/MOL.0b013e32814a57db; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Stahlman M, 2012, DIABETOLOGIA, V55, P1156, DOI 10.1007/s00125-011-2444-6; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Torffvit O, 2000, J DIABETES COMPLICAT, V14, P301, DOI 10.1016/S1056-8727(00)00117-3	29	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61942	10.1371/journal.pone.0061942	http://dx.doi.org/10.1371/journal.pone.0061942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637933	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700025
J	Tyystjarvi, T; Huokko, T; Rantamaki, S; Tyystjarvi, E				Tyystjarvi, Taina; Huokko, Tuomas; Rantamaki, Susanne; Tyystjarvi, Esa			Impact of Different Group 2 Sigma Factors on Light Use Efficiency and High Salt Stress in the Cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							SP STRAIN PCC-6803; GENE-EXPRESSION; PHOTOSYSTEM-II; INDUCIBLE POLYPEPTIDES; INACTIVATION STRAINS; CAROTENOID PROTEIN; STATE TRANSITIONS; ACCLIMATION; GLUCOSYLGLYCEROL; PCC6803	Sigma factors of RNA polymerase recognize promoters and have a central role in controlling transcription initiation and acclimation to changing environmental conditions. The cyanobacterium Synechocystis sp. PCC 6803 encodes four non-essential group 2 sigma factors, SigB, SigC, SigD and SigE that closely resemble the essential SigA factor. Three out of four group 2 sigma factors were simultaneously inactivated and acclimation responses of the triple inactivation strains were studied. All triple inactivation strains grew slowly in low light, and our analysis suggests that the reason is a reduced capacity to adjust the perception of light. Simultaneous inactivation of SigB and SigD hampered growth also in high light. SigB is the most important group 2 sigma factor for salt acclimation, and elimination of all the other group 2 sigma factors slightly improved the salt tolerance of Synechocystis. Presence of only SigE allowed full salt acclimation including up-regulation of hspA and ggpS genes, but more slowly than SigB. Cells with only SigD acclimated to high salt but the acclimation processes differed from those of the control strain. Presence of only SigC prevented salt acclimation.	[Tyystjarvi, Taina; Huokko, Tuomas; Rantamaki, Susanne; Tyystjarvi, Esa] Univ Turku, Dept Biochem & Food Chem, Turku, Finland	University of Turku	Tyystjarvi, T (corresponding author), Univ Turku, Dept Biochem & Food Chem, Turku, Finland.	taityy@utu.fi	Tyystjärvi, Esa/B-2360-2015	Tyystjärvi, Esa/0000-0001-6808-7470; Huokko, Tuomas/0000-0003-4409-3651; Tyystjarvi, Taina/0000-0003-0591-8630	Academy of Finland	Academy of Finland(Academy of Finland)	The Academy of Finland is acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; Asadulghani, 2004, ARCH MICROBIOL, V182, P487, DOI 10.1007/s00203-004-0733-x; BLUMWALD E, 1983, PLANT PHYSIOL, V73, P377, DOI 10.1104/pp.73.2.377; Elanskaya IV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P432, DOI 10.1023/A:1015281906254; Emlyn-Jones D, 1999, MOL MICROBIOL, V33, P1050, DOI 10.1046/j.1365-2958.1999.01547.x; Ferjani A, 2003, PLANT PHYSIOL, V131, P1628, DOI 10.1104/pp.102.017277; Fulda S, 2006, PROTEOMICS, V6, P2733, DOI 10.1002/pmic.200500538; Gunnelius L, 2010, MICROBIOL-SGM, V156, P220, DOI 10.1099/mic.0.032565-0; HAGEMANN M, 1994, CURR MICROBIOL, V28, P201, DOI 10.1007/BF01575962; HAGEMANN M, 1994, MICROBIOL-SGM, V140, P1427, DOI 10.1099/00221287-140-6-1427; Hagemann M, 1996, ARCH MICROBIOL, V166, P83, DOI 10.1007/s002030050360; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Imamura S, 2003, FEBS LETT, V554, P357, DOI 10.1016/S0014-5793(03)01188-8; Imamura S, 2003, J MOL BIOL, V325, P857, DOI 10.1016/S0022-2836(02)01242-1; Kaneko T, 1996, DNA Res, V3, P109; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; Kirilovsky D, 2012, BBA-BIOENERGETICS, V1817, P158, DOI 10.1016/j.bbabio.2011.04.013; Marin K, 2004, PLANT PHYSIOL, V136, P3290, DOI 10.1104/pp.104.045047; Marin K, 1998, J BACTERIOL, V180, P4843, DOI 10.1128/JB.180.18.4843-4849.1998; Mikkat S, 1996, MICROBIOL-SGM, V142, P1725, DOI 10.1099/13500872-142-7-1725; Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064; Muramatsu M, 2012, J PLANT RES, V125, P11, DOI 10.1007/s10265-011-0454-6; Nikkinen HL, 2012, PLANT PHYSIOL, V158, P514, DOI 10.1104/pp.111.190058; Osanai T, 2005, J BIOL CHEM, V280, P30653, DOI 10.1074/jbc.M505043200; Osanai T, 2011, J BIOL CHEM, V286, P30962, DOI 10.1074/jbc.M111.231183; Pollari M, 2008, PLANT PHYSIOL, V147, P1994, DOI 10.1104/pp.108.122713; Pollari M, 2011, J BACTERIOL, V193, P265, DOI 10.1128/JB.01045-10; Pollari M, 2009, J BACTERIOL, V191, P3992, DOI 10.1128/JB.00132-09; REED RH, 1985, FEMS MICROBIOL LETT, V28, P225, DOI 10.1016/0378-1097(85)90086-2; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schafer L, 2006, PLANT CELL ENVIRON, V29, P1349, DOI 10.1111/j.1365-3040.2006.01515.x; Singh AK, 2006, ARCH MICROBIOL, V186, P273, DOI 10.1007/s00203-006-0138-0; Summerfield TC, 2007, J BACTERIOL, V189, P7829, DOI 10.1128/JB.01036-07; Tsunekawa K, 2009, J BIOL CHEM, V284, P16513, DOI 10.1074/jbc.M109.001875; Tuominen I, 2006, FEBS LETT, V580, P319, DOI 10.1016/j.febslet.2005.11.082; Tuominen I, 2003, J BACTERIOL, V185, P1116, DOI 10.1128/JB.185.3.1116-1119.2003; Tuominen I, 2008, FEBS LETT, V582, P346, DOI 10.1016/j.febslet.2007.12.030; Tyystjarvi E, 2013, INT REV CEL MOL BIO, V300, P243, DOI 10.1016/B978-0-12-405210-9.00007-2; Tyystjarvi T, 2001, MOL MICROBIOL, V40, P476, DOI 10.1046/j.1365-2958.2001.02402.x; van Thor JJ, 1998, BOT ACTA, V111, P430, DOI 10.1111/j.1438-8677.1998.tb00731.x; Waditee R, 2002, P NATL ACAD SCI USA, V99, P4109, DOI 10.1073/pnas.052576899; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Zhang PP, 2012, PLANT CELL, V24, P1952, DOI 10.1105/tpc.111.094417; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331	48	12	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e63020	10.1371/journal.pone.0063020	http://dx.doi.org/10.1371/journal.pone.0063020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638176	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700085
J	Brusentsov, II; Katokhin, AV; Brusentsova, IV; Shekhovtsov, SV; Borovikov, SN; Goncharenko, GG; Lider, LA; Romashov, BV; Rusinek, OT; Shibitov, SK; Suleymanov, MM; Yevtushenko, AV; Mordvinov, VA				Brusentsov, Ilja I.; Katokhin, Alexey V.; Brusentsova, Irina V.; Shekhovtsov, Sergei V.; Borovikov, Sergei N.; Goncharenko, Grigoriy G.; Lider, Lyudmila A.; Romashov, Boris V.; Rusinek, Olga T.; Shibitov, Samat K.; Suleymanov, Marat M.; Yevtushenko, Andrey V.; Mordvinov, Viatcheslav A.			Low Genetic Diversity in Wide-Spread Eurasian Liver Fluke Opisthorchis felineus Suggests Special Demographic History of This Trematode Species	PLOS ONE			English	Article							SCHISTOSOMA-MANSONI POPULATION; COMPLEX LIFE-CYCLE; PONTO-CASPIAN REFUGIA; FOXES VULPES-VULPES; MITOCHONDRIAL-DNA; FASCIOLA-HEPATICA; PRAZIQUANTEL TREATMENT; NORTHERN EURASIA; SINGLE-WORM; SEQUENCE	Opisthorchis felineus or Siberian liver fluke is a trematode parasite (Opisthorchiidae) that infects the hepato-biliary system of humans and other mammals. Despite its public health significance, this wide-spread Eurasian species is one of the most poorly studied human liver flukes and nothing is known about its population genetic structure and demographic history. In this paper, we attempt to fill this gap for the first time and to explore the genetic diversity in O. felineus populations from Eastern Europe (Ukraine, European part of Russia), Northern Asia (Siberia) and Central Asia (Northern Kazakhstan). Analysis of marker DNA fragments from O. felineus mitochondrial cytochrome c oxidase subunit 1 and 3 (cox1, cox3) and nuclear rDNA internal transcribed spacer 1 (ITS1) sequences revealed that genetic diversity is very low across the large geographic range of this species. Microevolutionary processes in populations of trematodes may well be influenced by their peculiar biology. Nevertheless, we suggest that lack of population genetics structure observed in O. felineus can be primarily explained by the Pleistocene glacial events and subsequent sudden population growth from a very limited group of founders. Rapid range expansion of O. felineus through Asian and European territories after severe bottleneck points to a high dispersal potential of this trematode species.	[Brusentsov, Ilja I.; Katokhin, Alexey V.; Brusentsova, Irina V.; Suleymanov, Marat M.; Mordvinov, Viatcheslav A.] Russian Acad Sci, Lab Mol Mech Pathol Proc, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia; [Shekhovtsov, Sergei V.] Russian Acad Sci, Mol Biotechnol Lab, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia; [Shekhovtsov, Sergei V.] S Seifullin Kazakh Agrotech Univ, Dept Anim Biotechnol, Astana, Kazakhstan; [Goncharenko, Grigoriy G.] Francisk Skorina Gomel State Univ, Fac Biol, Gomel, BELARUS; [Lider, Lyudmila A.] S Seifullin Kazakh Agrotech Univ, Dept Vet Med, Astana, Kazakhstan; [Romashov, Boris V.] Voronezh State Biosphere Reserve, Dept Sci, Voronezh, Russia; [Rusinek, Olga T.] Russian Acad Sci, Dept Parasitol, Baikal Museum, Irkutsk Sci Ctr,Siberian Branch, Irkutsk 664003, Russia; [Shibitov, Samat K.] All Russian KI Skryabin Inst Helminthol, Dept Epizootol Problems, Moscow, Russia; [Yevtushenko, Andrey V.] Natl Sci Ctr Inst Expt & Clin Vet Med, Dept Parasitol Ichthyopathol & Arachnol, Kharkov, Ukraine	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Saken Seifullin Kazakh Agrotechnical University; Francisk Skorina Gomel State University; Saken Seifullin Kazakh Agrotechnical University; Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Baikal Museum of the Irkutsk Scientific Center SB RAS; Federal Scientific Centre VIEV; National Academy of Agrarian Sciences of Ukraine; National Scientific Center "Institute of Experimental & Clinical Veterinary Medicine"	Brusentsov, II (corresponding author), Russian Acad Sci, Lab Mol Mech Pathol Proc, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia.	brusentsovi@gmail.com	Shekhovtsov, Sergei/AAZ-5347-2020; Rusinek, Olga/AAD-3966-2022; Mordvinov, Viatcheslav A/S-8277-2017; Brusentsov, Ilja/T-9679-2017; Goncharenko, Grigori G./ABD-5708-2020; Shibitov, Samat/E-7946-2016; Katokhin, Alexey/AAH-4230-2020; Borovikov, Sergey/AAE-7841-2022; Shekhovtsov, Sergei/B-1832-2014	Mordvinov, Viatcheslav A/0000-0002-6173-0774; Goncharenko, Grigori G./0000-0003-1408-8843; Shibitov, Samat/0000-0002-7995-9673; Borovikov, Sergey/0000-0002-9721-9732; Romashov, Boris/0000-0002-7559-1445; Lider, Lyudmila/0000-0001-5842-0751	Rosnauka State [16.512.11.2129, 16.522.12.2006]; RFBR [11-04-90490-Ukr_f_a]	Rosnauka State; RFBR(Russian Foundation for Basic Research (RFBR))	The work was supported by the Rosnauka State contracts 16.512.11.2129 and 16.522.12.2006 and the RFBR grant 11-04-90490-Ukr_f_a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipov SA, 1997, GEOL GEOFIZ, V38, P1027; Armignacco O, 2008, EMERG INFECT DIS, V14, P1902, DOI 10.3201/eid1412.080782; Attwood SW, 2007, PARASITOLOGY, V134, P2009, DOI 10.1017/S0031182007003411; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Beer S, 2000, T I PARASITOLOGY RAS, P5; Beer SA., 2005, BIOL OPISTHORCHIASIS; BERNHARD K, 1985, Angewandte Parasitologie, V26, P223; Blank WA, 2009, J PARASITOL, V95, P881, DOI 10.1645/GE-1895.1; Blanton RE, 2011, INT J PARASITOL, V41, P1093, DOI 10.1016/j.ijpara.2011.06.002; Braconi C, 2010, INFECT DIS CLIN N AM, V24, P871, DOI 10.1016/j.idc.2010.07.006; Bray RA, 2008, KEYS TREMATODA, V3; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Choi BI, 2004, CLIN MICROBIOL REV, V17, P540, DOI 10.1128/CMR.17.3.540-552.2004; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; Criscione CD, 2004, EVOLUTION, V58, P198, DOI 10.1111/j.0014-3820.2004.tb01587.x; Culling MA, 2006, MOL ECOL, V15, P173, DOI 10.1111/j.1365-294X.2005.02790.X; De Liberato C, 2011, VET PARASITOL, V177, P67, DOI 10.1016/j.vetpar.2010.11.042; Depaulis F, 2003, J MOL EVOL, V57, pS190, DOI 10.1007/s00239-003-0027-y; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Despres L, 1992, MOL PHYLOGENET EVOL, V1, P295, DOI 10.1016/1055-7903(92)90005-2; Dybdahl MF, 1996, EVOLUTION, V50, P2264, DOI [10.1111/j.1558-5646.1996.tb03615.x, 10.2307/2410696]; Erhardt A, 1962, OPISTHORCHIASIS HERV; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferreri M, 2011, AFR J BIOTECHNOL, V10, P12799; Filimonova L, 2000, ACTUAL PROBLEMS GEN; Fotiev S, 2009, EARTHS CRYOSPH, V13, P3; FRIED B, 1988, INT J PARASITOL, V18, P179, DOI 10.1016/0020-7519(88)90058-6; FRIED B, 1971, J PARASITOL, V57, P866, DOI 10.2307/3277817; Fried B, 2011, CANCER LETT, V305, P239, DOI 10.1016/j.canlet.2010.07.008; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Glemin S, 2012, METHODS MOL BIOL, V855, P311, DOI 10.1007/978-1-61779-582-4_11; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HAYASHI JI, 1985, EXP CELL RES, V160, P387, DOI 10.1016/0014-4827(85)90185-5; Hering-Hagenbeck S., 1996, Applied Parasitology, V37, P260; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hubberten HW, 2004, QUATERNARY SCI REV, V23, P1333, DOI 10.1016/j.quascirev.2003.12.012; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1992, GENETICS, V132, P583; Hwang Ui-Wook, 1999, Korean Journal of Parasitology, V37, P215, DOI 10.3347/kjp.1999.37.4.215; Iwagami M, 2000, J HELMINTHOL, V74, P315; Keeney DB, 2007, INT J PARASITOL, V37, P351, DOI 10.1016/j.ijpara.2006.11.004; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Kotlik P, 2008, MOL ECOL, V17, P1076, DOI 10.1111/j.1365-294X.2007.03638.x; Kralova-Hromadova I, 2011, INT J PARASITOL, V41, P373, DOI 10.1016/j.ijpara.2010.10.010; Kuminova A, 1957, NEWS EB AS USSR, V2, P104; Kunitsa M, 1991, PALEONTOLOGICAL COLL, P27; Laoprom N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001906; Laoprom N, 2010, INFECT GENET EVOL, V10, P146, DOI 10.1016/j.meegid.2009.11.005; Lee Soo-Ung, 2004, Korean Journal of Parasitology, V42, P145, DOI 10.3347/kjp.2004.42.3.145; Liu GH, 2012, J HELMINTHOL, V86, P479, DOI 10.1017/S0022149X11000757; Loktieva IM, 1997, OPISTHORCHIASIS EPID, P146; Louhi KR, 2010, INFECT GENET EVOL, V10, P1271, DOI 10.1016/j.meegid.2010.08.013; Lu JH, 2010, J ALZHEIMERS DIS, V21, P141, DOI 10.3233/JAD-2010-100123; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Maksimova G, 2012, MED ACAD J; Mangerud J, 2004, QUATERNARY SCI REV, V23, P1313, DOI 10.1016/j.quascirev.2003.12.009; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Morgan JAT, 2005, MOL ECOL, V14, P3889, DOI 10.1111/j.1365-294X.2005.02709.x; NADLER SA, 1995, J PARASITOL, V81, P395, DOI 10.2307/3283821; Nakao M, 2009, PARASITOL INT, V58, P384, DOI 10.1016/j.parint.2009.07.010; Nei M., 1987, MOL EVOLUTIONARY GEN; Nolan MJ, 2005, ADV PARASIT, V60, P101, DOI 10.1016/S0065-308X(05)60002-4; NOLLEN PM, 1983, PARASITOLOGY, V86, P99, DOI 10.1017/S0031182000050861; Norton AJ, 2010, AM J TROP MED HYG, V83, P951, DOI 10.4269/ajtmh.2010.10-0283; Oliveira P, 2005, ARQ BRAS MED VET ZOO, V57, P556, DOI 10.1590/S0102-09352005000400020; Olson PD, 2005, ADV PARASIT, V60, P165, DOI 10.1016/S0065-308X(05)60003-6; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Perezhogin Y, 2008, B OSU, V85, P130; Posokhov P.S., 2004, CLONORCHIASIS AMUR R; Prugnolle F, 2005, MOL ECOL, V14, P1355, DOI 10.1111/j.1365-294X.2005.02541.x; Prugnolle F, 2005, INT J PARASITOL, V35, P255, DOI 10.1016/j.ijpara.2004.10.027; Rauch G, 2005, J EVOLUTION BIOL, V18, P1069, DOI 10.1111/j.1420-9101.2005.00895.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saijuntha W, 2008, PARASITOLOGY, V135, P1479, DOI 10.1017/S0031182008005015; Saijuntha W, 2007, INT J PARASITOL, V37, P695, DOI 10.1016/j.ijpara.2006.12.008; Saijuntha W, 2011, PARASITOL RES, V108, P751, DOI 10.1007/s00436-010-2180-8; Saijuntha W, 2011, INFECT GENET EVOL, V11, P375, DOI 10.1016/j.meegid.2010.11.009; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanger R, 1991, 1 GERM C INF TROP ME; Schuster R, 2003, PARASITOL RES, V90, P400, DOI 10.1007/s00436-003-0868-8; Schuster R, 1999, PARASITOL RES, V85, P142, DOI 10.1007/s004360050523; Semenov I, 1984, ALL UN C NAT FOC DIS, P144; Semyenova SK, 2006, J PARASITOL, V92, P525, DOI 10.1645/GE-673R.1; Shalaby I, 2011, TROP BIOMED, V28, P90; Shrivastava J, 2005, MOL ECOL, V14, P839, DOI 10.1111/j.1365-294X.2005.02443.x; Sidorov EG, 1983, NATURAL FOCALITY OPI; SKRIPOVA L V, 1991, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P37; Skryabin C, 1950, TREMATODES ANIMALS H; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Standley CJ, 2010, PARASITOLOGY, V137, P1937, DOI 10.1017/S0031182010000788; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stohler RA, 2004, INT J PARASITOL, V34, P595, DOI 10.1016/j.ijpara.2003.11.026; TAJIMA F, 1989, GENETICS, V123, P585; Tatonova YV, 2012, PARASITOL INT, V61, P664, DOI 10.1016/j.parint.2012.07.005; Teofanova D, 2011, INFECT GENET EVOL, V11, P109, DOI 10.1016/j.meegid.2010.10.002; Thaenkham U, 2010, PARASITOL INT, V59, P242, DOI 10.1016/j.parint.2010.02.009; Traverso A, 2012, EUR J CLIN MICROBIOL, V31, P1089, DOI 10.1007/s10096-011-1411-y; Trouve S, 2003, PARASITOL RES, V89, P81, DOI 10.1007/s00436-002-0638-z; Tselepatiotis E, 2003, INFECTION, V31, P430, DOI 10.1007/s15010-003-3225-z; van Herwerden L, 1999, INT J PARASITOL, V29, P1477, DOI 10.1016/S0020-7519(99)00072-7; Vara-Del Rio MP, 2007, PARASITOL RES, V101, P1003, DOI 10.1007/s00436-007-0574-z; Vondeling Ariel M, 2012, Ned Tijdschr Geneeskd, V156, pA3873; Walker SM, 2007, PARASITOL RES, V101, P117, DOI 10.1007/s00436-006-0440-4; Walker SM, 2011, PARASITOLOGY, V138, P215, DOI 10.1017/S0031182010001149; Webster JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-91; Wright S., 1978, EVOLUTION GENETICS P; Zarowlecki MZ, 2007, INT J PARASITOL, V37, P1401, DOI 10.1016/j.ijpara.2007.04.014; Zhao GH, 2009, INFECT GENET EVOL, V9, P903, DOI 10.1016/j.meegid.2009.06.006; Zhao QP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001503; Zykin V, 1991, CLIMATE CHANGE LATE, P5; Zykin V.S, 2003, ARCHAEOL ETHNOL ANTH, V4, P2	119	26	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62453	10.1371/journal.pone.0062453	http://dx.doi.org/10.1371/journal.pone.0062453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6GZ	23634228	Green Submitted, gold, Green Published			2022-12-25	WOS:000336230000001
J	Zorn, M; Ihling, CH; Golbik, R; Sawers, RG; Sinz, A				Zorn, Michael; Ihling, Christian H.; Golbik, Ralph; Sawers, R. Gary; Sinz, Andrea			Selective selC-Independent Selenocysteine Incorporation into Formate Dehydrogenases	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; ESCHERICHIA-COLI; NITRATE REDUCTASE; AMINO-ACID; SELENIUM; PROTEINS; OPERON; IDENTIFICATION; BIOSYNTHESIS; EXPRESSION	The formate dehydrogenases (Fdh) Fdh-O, Fdh-N, and Fdh-H, are the only proteins in Escherichia coli that incorporate selenocysteine at a specific position by decoding a UGA codon. However, an excess of selenium can lead to toxicity through misincorporation of selenocysteine into proteins. To determine whether selenocysteine substitutes for cysteine, we grew Escherichia coli in the presence of excess sodium selenite. The respiratory Fdh-N and Fdh-O enzymes, along with nitrate reductase (Nar) were co-purified from wild type strain MC4100 after anaerobic growth with nitrate and either 2 mu M or 100 mu M selenite. Mass spectrometric analysis of the catalytic subunits of both Fdhs identified the UGA-specified selenocysteine residue and revealed incorporation of additional, 'non-specific' selenocysteinyl residues, which always replaced particular cysteinyl residues. Although variable, their incorporation was not random and was independent of the selenite concentration used. Notably, these cysteines are likely to be non-essential for catalysis and they do not coordinate the iron-sulfur cluster. The remaining cysteinyl residues that could be identified were never substituted by selenocysteine. Selenomethionine was never observed in our analyses. Non-random substitution of particular cysteinyl residues was also noted in the electron-transferring subunit of both Fdhs as well as in the subunits of the Nar enzyme. Nar isolated from an E. coli selC mutant also showed a similar selenocysteine incorporation pattern to the wild-type indicating that non-specific selenocysteine incorporation was independent of the specific selenocysteine pathway. Thus, selenide replaces sulfide in the biosynthesis of cysteine and misacylated selenocysteyl-tRNA(Cys) decodes either UGU or UGC codons, which usually specify cysteine. Nevertheless, not every UGU or UGC codon was decoded as selenocysteine. Together, our results suggest that a degree of misincorporation of selenocysteine into enzymes through replacement of particular, non-essential cysteines, is tolerated and this might act as a buffering system to cope with excessive intracellular selenium.	[Zorn, Michael; Ihling, Christian H.; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06108 Halle, Saale, Germany; [Sawers, R. Gary] Univ Halle Wittenberg, Inst Microbiol, D-06108 Halle, Saale, Germany; [Golbik, Ralph] Univ Halle Wittenberg, Inst Biochem, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Sawers, RG (corresponding author), Univ Halle Wittenberg, Inst Microbiol, D-06108 Halle, Saale, Germany.	gary.sawers@mikrobiologie.uni-halle.de; andrea.sinz@pharmazie.uni-halle.de			Deutsche Forschungsgemeinschaft (DFG); Land Sachsen-Anhalt; DFG [1026]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Land Sachsen-Anhalt; DFG(German Research Foundation (DFG))	MZ is supported by the DFG-funded Graduiertenkolleg 1026 "Conformational Transitions in Macromolecular Interactions" at the Martin-Luther University Halle-Wittenberg. AS acknowledges financial support from the Deutsche Forschungsgemeinschaft (DFG) and the Land Sachsen-Anhalt. RGS acknowledges financial support from the Land Sachsen-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAIBOU H, 1995, J BACTERIOL, V177, P7141, DOI 10.1128/jb.177.24.7141-7149.1995; AXLEY MJ, 1991, P NATL ACAD SCI USA, V88, P8450, DOI 10.1073/pnas.88.19.8450; BEGG YA, 1977, FEMS MICROBIOL LETT, V2, P47, DOI 10.1111/j.1574-6968.1977.tb00905.x; BERG BL, 1991, J BIOL CHEM, V266, P22380; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; BLASCO F, 1990, MOL GEN GENET, V222, P104, DOI 10.1007/BF00283030; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; BROWN TA, 1982, CAN J MICROBIOL, V28, P307, DOI 10.1139/m82-045; COLE ST, 1989, MOL MICROBIOL, V3, P715, DOI 10.1111/j.1365-2958.1989.tb00220.x; COWIE DB, 1957, BIOCHIM BIOPHYS ACTA, V26, P252, DOI 10.1016/0006-3002(57)90003-3; ENOCH HG, 1975, J BIOL CHEM, V250, P6693; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1245, DOI 10.1021/bi00574a020; FIMMEL AL, 1977, J GEN MICROBIOL, V103, P37, DOI 10.1099/00221287-103-1-37; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; LEINFELDER W, 1988, J BACTERIOL, V170, P540, DOI 10.1128/jb.170.2.540-546.1988; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Ma S, 2003, J AM SOC MASS SPECTR, V14, P593, DOI 10.1016/S1044-0305(03)00141-7; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; MULLER S, 1994, BIOCHEMISTRY-US, V33, P3404, DOI 10.1021/bi00177a034; Muller S, 1997, ARCH MICROBIOL, V168, P421, DOI 10.1007/s002030050517; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; PINSENT J, 1954, BIOCHEM J, V57, P10, DOI 10.1042/bj0570010; Richardson D, 2002, SCIENCE, V295, P1842, DOI 10.1126/science.1070366; SAWERS G, 1991, J BACTERIOL, V173, P4983, DOI 10.1128/jb.173.16.4983-4993.1991; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; Sawers RG, 2004, ECOSAL ESCHERICHIA C; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soboh B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-173; STADTMAN T C, 1989, Biofactors, V2, P35; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; YOUNG PA, 1975, ARCH BIOCHEM BIOPHYS, V171, P483, DOI 10.1016/0003-9861(75)90057-0; Zhang CM, 2003, J MOL BIOL, V327, P911, DOI 10.1016/S0022-2836(03)00241-9	35	12	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e61913	10.1371/journal.pone.0061913	http://dx.doi.org/10.1371/journal.pone.0061913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634217	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400026
J	Dong, ZY; Wang, HY; Dong, YZ; Wang, YM; Liu, W; Miao, GJ; Lin, XY; Wang, DQ; Liu, B				Dong, Zhenying; Wang, Hongyan; Dong, Yuzhu; Wang, Yongming; Liu, Wei; Miao, Gaojian; Lin, Xiuyun; Wang, Daqing; Liu, Bao			Extensive Microsatellite Variation in Rice Induced by Introgression from Wild Rice (Zizania latifolia Griseb.)	PLOS ONE			English	Article							DNA-MISMATCH-REPAIR; SIMPLE SEQUENCE REPEATS; GENE-EXPRESSION; WIDE HYBRIDIZATION; ESCHERICHIA-COLI; GENOME EVOLUTION; PLANT SPECIATION; FOREIGN DNA; SSR MARKERS; METHYLATION	Background: It is widely accepted that interspecific hybridization may induce genomic instability in the resultant hybrids. However, few studies have been performed on the genomic analysis of homoploid hybrids and introgression lines. We have reported previously that by introgressive hybridization, a set of introgression lines between rice (Oryza sativa L.) and wild rice (Zizania latifolia Griseb.) was successfully generated, and which have led to the release of several cultivars. Methodology: Using 96 microsatellite markers located in the nuclear and organelle genomes of rice, we investigated microsatellite stability in three typical introgression lines. Expression of a set of mismatch repair (MMR) genes and microsatellite-containing genes was also analyzed. Results/Conclusions: Compared with the recipient rice cultivar (Matsumae), 55 of the 96 microsatellite loci revealed variation in one or more of the introgression lines, and 58.2% of the altered alleles were shared by at least two lines, indicating that most of the alterations had occurred in the early stages of introgression before their further differentiation. 73.9% of the non-shared variations were detected only in one introgression line, i.e. RZ2. Sequence alignment showed that the variations included substitutions and indels that occurred both within the repeat tracts and in the flanking regions. Interestingly, expression of a set of MMR genes altered dramatically in the introgression lines relative to their rice parent, suggesting participation of the MMR system in the generation of microsatellite variants. Some of the altered microsatellite loci are concordant with changed expression of the genes harboring them, suggesting their possible cis-regulatory roles in controlling gene expression. Because these genes bear meaningful homology to known-functional proteins, we conclude that the introgression-induced extensive variation of microsatellites may have contributed to the novel phenotypes in the introgression lines.	[Dong, Zhenying; Wang, Yongming; Liu, Wei; Miao, Gaojian; Lin, Xiuyun; Wang, Daqing; Liu, Bao] NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China; [Dong, Zhenying; Wang, Yongming; Liu, Wei; Miao, Gaojian; Lin, Xiuyun; Wang, Daqing; Liu, Bao] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Dong, Zhenying] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosomal Engn, Beijing, Peoples R China; [Wang, Hongyan] Liaoning Univ, Fac Life Sci, Shenyang 110036, Peoples R China; [Dong, Yuzhu] Changchun Normal Univ, Sch Life Sci, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Liaoning University; Changchun Normal University	Dong, ZY (corresponding author), NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China.	zhydong@genetics.ac.cn; baoliu@nenu.edu.cn		zakaria, seyed moein/0000-0002-0086-1279; Liu, Bao/0000-0001-5481-1675	National Natural Science Foundation of China [30990243, 31170208]; Programme for Introducing Talents to Universities [B07017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programme for Introducing Talents to Universities	This work was supported by the National Natural Science Foundation of China (No. 30990243 and 31170208), and the Programme for Introducing Talents to Universities (B07017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Anderson E., 1949, INTROGRESSIVE HYBRID; BATES LS, 1973, ECON BOT, V27, P401, DOI 10.1007/BF02860693; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Burke JM, 2004, GENETICS, V167, P449, DOI 10.1534/genetics.167.1.449; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Depeiges A, 2005, PLANT SCI, V168, P939, DOI 10.1016/j.plantsci.2004.11.006; Dettman JR, 2004, GENETICS, V168, P1231, DOI 10.1534/genetics.104.029322; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2002, TRENDS GENET, V18, P25, DOI 10.1016/S0168-9525(01)02553-7; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; GARZA JC, 1995, MOL BIOL EVOL, V12, P594; Grover A, 2007, MOL GENET GENOMICS, V277, P469, DOI 10.1007/s00438-006-0204-y; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hashimoto Z, 2004, THEOR APPL GENET, V109, P1586, DOI 10.1007/s00122-004-1794-6; Hawk JD, 2005, P NATL ACAD SCI USA, V102, P8639, DOI 10.1073/pnas.0503415102; HELLER H, 1995, P NATL ACAD SCI USA, V92, P5515, DOI 10.1073/pnas.92.12.5515; Hoffman PD, 2004, GENE DEV, V18, P2676, DOI 10.1101/gad.1217204; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Leonard JM, 2003, PLANT PHYSIOL, V133, P328, DOI 10.1104/pp.103.023952; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liu B., 1999, Journal of Genetics and Breeding, V53, P279; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Meloni R, 1998, HUM MOL GENET, V7, P423, DOI 10.1093/hmg/7.3.423; Metzgar D, 2001, MOL MICROBIOL, V39, P183, DOI 10.1046/j.1365-2958.2001.02245.x; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; Muller K, 2001, J BIOL CHEM, V276, P14271; Nishikawa T, 2005, THEOR APPL GENET, V110, P696, DOI 10.1007/s00122-004-1895-2; Oliveira EJ, 2006, GENET MOL BIOL, V29, P294, DOI 10.1590/S1415-47572006000200018; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PROUD CG, 1994, MOL BIOL REP, V19, P161, DOI 10.1007/BF00986958; Remus R, 1999, J VIROL, V73, P1010, DOI 10.1128/JVI.73.2.1010-1022.1999; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RIESEBERG LH, 1995, NATURE, V375, P313, DOI 10.1038/375313a0; Rieseberg LH, 2000, PLANT MOL BIOL, V42, P205, DOI 10.1023/A:1006340407546; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rohlf F.J., 2002, NTSYS PC NUMERICAL T; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Shan XH, 2005, MOL BIOL EVOL, V22, P976, DOI 10.1093/molbev/msi082; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang NN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-190; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wu SY, 2003, NUCLEIC ACIDS RES, V31, P6027, DOI 10.1093/nar/gkg780; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]	68	5	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62317	10.1371/journal.pone.0062317	http://dx.doi.org/10.1371/journal.pone.0062317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638037	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400095
J	Subirana, JA; Messeguer, X				Subirana, Juan A.; Messeguer, Xavier			A Satellite Explosion in the Genome of Holocentric Nematodes	PLOS ONE			English	Article							DNA; HETEROCHROMATIN; CENTROMERE; SEQUENCES; CHROMATIN; ORDER	Centromere sequences in the genome are associated with the formation of kinetochores, where spindle microtubules grow in mitosis. Centromere sequences usually have long tandem repeats (satellites). In holocentric nematodes it is not clear how kinetochores are formed during mitosis; they are distributed throughout the chromosomes. For this reason it appeared of interest to study the satellites in nematodes in order to determine if they offer any clue on how kinetochores are assembled in these species. We have studied the satellites in the genome of six nematode species. We found that the presence of satellites depends on whether the nematode chromosomes are holocentric or monocentric. It turns out that holocentric nematodes are unique because they have a large number of satellites scattered throughout their genome. Their number, length and composition are different in each species: they apparently have very little evolutionary conservation. In contrast, no scattered satellites are found in the monocentric nematode Trichinella spiralis. It appears that the absence/presence of scattered satellites in the genome distinguishes monocentric from holocentric nematodes. We conclude that the presence of satellites is related to the holocentric nature of the chromosomes of most nematodes. Satellites may stabilize a higher order structure of chromatin and facilitate the formation of kinetochores. We also present a new program, SATFIND, which is suited to find satellite sequences.	[Subirana, Juan A.] Univ Politecn Cataluna, Dept Engn Quim, Barcelona, Spain; [Messeguer, Xavier] Univ Politecn Cataluna, Dept Llenguatges & Sistemes Informat, Barcelona, Spain	Universitat Politecnica de Catalunya; Universitat Politecnica de Catalunya	Subirana, JA (corresponding author), Univ Politecn Cataluna, Dept Engn Quim, Barcelona, Spain.	juan.a.subirana@upc.edu	Subirana, juan/L-7192-2014	Subirana, juan/0000-0002-1706-9341	Ministerio de Innovacion y Ciencia, Spain [BFU2009-10380, TIN2010-21062-C02-01]	Ministerio de Innovacion y Ciencia, Spain	This work was supported in part by grants BFU2009-10380 and TIN2010-21062-C02-01 from the Ministerio de Innovacion y Ciencia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; ALBERTSON DG, 1982, CHROMOSOMA, V86, P409, DOI 10.1007/BF00292267; Buscaino A, 2010, CURR OPIN GENET DEV, V20, P118, DOI 10.1016/j.gde.2010.01.006; Bussiek M, 2009, J STRUCT BIOL, V167, P36, DOI 10.1016/j.jsb.2009.03.010; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Castagnone-Sereno P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-598; Coghlan Avril, 2005, P1; Gassmann R, 2012, NATURE, V484, P534, DOI 10.1038/nature10973; Gilbert N, 2001, P NATL ACAD SCI USA, V98, P11949, DOI 10.1073/pnas.211322798; Hall AE, 2004, CURR OPIN PLANT BIOL, V7, P108, DOI 10.1016/j.pbi.2004.01.008; Hayden KE, 2012, CHROMOSOME RES, V20, P621, DOI 10.1007/s10577-012-9295-y; Heckmann S, 2013, PLANT J, V73, P555, DOI 10.1111/tpj.12054; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; LOHE AR, 1993, GENETICS, V134, P1149; Maddox PS, 2012, CURR OPIN GENET DEV, V22, P139, DOI 10.1016/j.gde.2011.11.005; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; MCEACHERN MJ, 1994, P NATL ACAD SCI USA, V91, P3453, DOI 10.1073/pnas.91.8.3453; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; MUTAFOVA T, 1982, Z PARASITENKD, V67, P115, DOI 10.1007/BF00929519; Roset R, 2003, BIOINFORMATICS, V19, P2475, DOI 10.1093/bioinformatics/btg326; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Subirana JA, 2010, NUCLEIC ACIDS RES, V38, P1172, DOI 10.1093/nar/gkp1094; SULSTON JE, 1974, GENETICS, V77, P95; Wasmuth J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000258; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0	28	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62221	10.1371/journal.pone.0062221	http://dx.doi.org/10.1371/journal.pone.0062221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638010	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400087
J	Wang, LJ; Xu, M; Liu, CY; Wang, JF; Xi, HF; Wu, BH; Loescher, W; Duan, W; Fan, PG; Li, SH				Wang, Lijun; Xu, Man; Liu, Chunyan; Wang, Junfang; Xi, Huifen; Wu, Benhong; Loescher, Wayne; Duan, Wei; Fan, Peige; Li, Shaohua			Resveratrols in Grape Berry Skins and Leaves in Vitis Germplasm	PLOS ONE			English	Article							TRANS-RESVERATROL; RED; METABOLISM; VITACEAE; VINIFERA; DISEASE; PLANTS; WINE	Background: Resveratrol is an important stilbene that benefits human health. However, it is only distributed in a few species including grape and is very expensive. At present, grape has been an important source resveratrol. However, the details are scarce on resveratrol distribution in different Vitis species or cultivars. Methodology/Principal Finding: The composition and content of resveratrols were investigated by HPLC for assessing genotypic variation in berry skins and leaves of 75 grape cultivars, belonging to 3 species and 7 interspecific hybrids. Trans-resveratrol, cis-piceid and trans-piceid were detected in berry skins and leaves, but cis-resveratrol was not. Resveratrol content largely varied with genetic background as well as usage. In most cultivars, total resveratrol including the above three compounds was higher in berry skins than leaves. In berry skins of most cultivars and leaves of almost all cultivars, cis-piceid was the most abundant resveratrol; trans-resveratrol and trans-piceid were minor components. Some specific cultivars were found with extremely high levels of trans-resveratrol, cis-piceid, trans-piceid or total resveratrols in berry skins or leaves. In skins and leaves, rootstock cultivars had a higher content of total resveratrols, and the cultivated European type cultivars and their hybrids with V. labrusca had relatively low totals. There were no significant correlations of the amounts of total resveratrols or any individual resveratrol between berry skins and leaves. All 75 cultivars can be divided into four groups based on the composition of resveratrols and their concentration by principal component analysis. Conclusion: Resveratrol content of grape berries and leaves varied largely with their genetic background and usage. Rootstock cultivars had a higher content of total resveratrols than the other germplasm. Total resveratrols were lower in leaves than berry skins in most cultivars. Cis-piceid was the most abundant resveratrol in most cultivars, and trans-res and trans-pd were minor components.	[Wang, Lijun; Xu, Man; Liu, Chunyan; Wang, Junfang; Xi, Huifen; Wu, Benhong; Duan, Wei; Fan, Peige; Li, Shaohua] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Wang, Lijun; Xu, Man; Liu, Chunyan; Wang, Junfang; Xi, Huifen; Wu, Benhong; Duan, Wei; Fan, Peige; Li, Shaohua] Chinese Acad Sci, Inst Bot, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China; [Xu, Man; Wang, Junfang; Xi, Huifen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Loescher, Wayne] Michigan State Univ, Coll Agr & Nat Resources, E Lansing, MI 48824 USA; [Li, Shaohua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Michigan State University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Li, SH (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	shhli@wbgcas.cn	Wu, Benhong/Q-5328-2016	Wu, Benhong/0000-0002-6798-5903	National Natural Science Foundation of China [31171918]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the grants from National Natural Science Foundation of China (Grant number 31171918). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER RA, 1998, NEW S LANGUAGE PROGR, P307; Chong JL, 2009, PLANT SCI, V177, P143, DOI 10.1016/j.plantsci.2009.05.012; Gatto P, 2008, J AGR FOOD CHEM, V56, P11773, DOI 10.1021/jf8017707; Gerogiannaki-Christopoulou M, 2006, FOOD CONTROL, V17, P700, DOI 10.1016/j.foodcont.2005.04.006; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Jeandet P, 2002, J AGR FOOD CHEM, V50, P2731, DOI 10.1021/jf011429s; Jeandet P, 1995, J AGR FOOD CHEM, V43, P313; Kalantari H, 2010, BIOFACTORS, V36, P401, DOI 10.1002/biof.100; Kimura Y, 2000, J PHARM PHARMACOL, V52, P1287, DOI 10.1211/0022357001777270; LANGCAKE P, 1976, PHYSIOL PLANT PATHOL, V9, P77, DOI 10.1016/0048-4059(76)90077-1; Li XD, 2006, J AGR FOOD CHEM, V54, P8804, DOI 10.1021/jf061722y; Liu CY, 2013, FOOD CHEM, V136, P643, DOI 10.1016/j.foodchem.2012.08.017; Morales M, 1998, PLANT CELL TISS ORG, V53, P179, DOI 10.1023/A:1006027410575; Moreno A, 2008, EUR FOOD RES TECHNOL, V227, P667, DOI 10.1007/s00217-007-0770-1; Park HJ, 2009, J PLANT BIOL, V52, P319, DOI 10.1007/s12374-009-9041-y; Stervbo U, 2007, FOOD CHEM, V101, P449, DOI 10.1016/j.foodchem.2006.01.047; Takaoka M., 1940, J FS HOKKAIDO IMPERI, V3, DOI DOI 10.1246/NIKKASHI1921.60.1261; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com	18	20	22	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61642	10.1371/journal.pone.0061642	http://dx.doi.org/10.1371/journal.pone.0061642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637874	Green Submitted, Green Published, gold			2022-12-25	WOS:000318340400038
J	Li, HWR; Lee, VCY; Lau, EYL; Yeung, WSB; Ho, PC; Ng, EHY				Li, Hang Wun Raymond; Lee, Vivian Chi Yan; Lau, Estella Yee Lan; Yeung, William Shu Biu; Ho, Pak Chung; Ng, Ernest Hung Yu			Role of Baseline Antral Follicle Count and Anti-Mullerian Hormone in Prediction of Cumulative Live Birth in the First In Vitro Fertilisation Cycle: A Retrospective Cohort Analysis	PLOS ONE			English	Article							CONTROLLED OVARIAN HYPERSTIMULATION; ANTIMULLERIAN HORMONE; OOCYTE; FSH; PREGNANCY; DYNAMICS; RESERVE	Objective: This retrospective study determined for the first time the role of baseline antral follicle count (AFC) and serum anti-Mullerian hormone (AMH) level in the first in-vitro fertilisation (IVF) cycle in predicting cumulative live birth from one stimulation cycle. Methods: We studied 1,156 women (median age 35 years) undergoing the first IVF cycle. Baseline AFC and AMH level on the day before ovarian stimulation were analysed. The main outcome measure was cumulative live birth in the fresh plus all the frozen embryo transfers after the same stimulation cycle. Results: Serum AMH was significantly correlated with AFC. Both AMH and AFC showed significant correlation with age and ovarian response in the stimulated cycle and total number of transferrable embryos. Baseline AFC and serum AMH were significantly higher in subjects attaining a live birth than those who did not in the fresh stimulated cycle, as well as those attaining cumulative live birth. There was a significant trend of higher cumulative live birth rate in women with higher AMH or AFC. However, logistic regression revealed that both AMH and AFC were not significant predictors of cumulative live birth after adjusting for age and number of embryos available for transfer. Considering only one single predictor, the areas under the ROC curves for AMH (0.646, 95% CI 0.616-0.675) and age (0.648, 95% CI 0.618-0.677) were slightly higher than that for AFC (0.617, 95% CI 0.587-0.647) in predicting cumulative live birth. However, a model combining AMH (with or without AFC) and age of the women only classified an addition of less than 2% of subjects correctly compared to the model with age alone. Conclusion: Baseline AFC and serum AMH have only modest predictive performance on the occurrence of cumulative live birth, and may not give additional value on top of the women's age.	[Li, Hang Wun Raymond; Lee, Vivian Chi Yan; Lau, Estella Yee Lan; Yeung, William Shu Biu; Ho, Pak Chung; Ng, Ernest Hung Yu] Univ Hong Kong, Queen Mary Hosp, Ctr Assisted Reprod & Embryol, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Li, HWR (corresponding author), Univ Hong Kong, Queen Mary Hosp, Ctr Assisted Reprod & Embryol, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	raymondli@hku.hk	Li, H.W. Raymond/H-4442-2012	Li, H.W. Raymond/0000-0002-7957-7798; Ng, Ernest/0000-0002-7688-4557; Yeung, Shu Biu William/0000-0003-0670-0879	Small Project Funding [200607176062]; University of Hong Kong	Small Project Funding; University of Hong Kong(University of Hong Kong)	The study was supported by Small Project Funding (200607176062), The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2012, MATURITAS, V71, P28, DOI 10.1016/j.maturitas.2011.11.008; Borini A, 2008, ANN NY ACAD SCI, V1127, P49, DOI 10.1196/annals.1434.012; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034; Broer SL, 2010, CURR OPIN OBSTET GYN, V22, P193, DOI 10.1097/GCO.0b013e3283384911; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Cai QF, 2011, HUM REPROD, V26, P2532, DOI 10.1093/humrep/der228; Fanchin R, 2003, HUM REPROD, V18, P328, DOI 10.1093/humrep/deg043; Fong SL, 2008, REPROD BIOMED ONLINE, V16, P664, DOI 10.1016/S1472-6483(10)60480-4; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Kini S, 2010, J ASSIST REPROD GEN, V27, P449, DOI 10.1007/s10815-010-9427-2; Kline JK, 2011, HUM REPROD, V26, P1537, DOI 10.1093/humrep/der091; La Marca A, 2004, HUM REPROD, V19, P2738, DOI 10.1093/humrep/deh508; Lee JR, 2010, HUM REPROD, V25, P2597, DOI 10.1093/humrep/deq204; Lee MM, 1996, J CLIN ENDOCR METAB, V81, P571, DOI 10.1210/jc.81.2.571; Mitwally MFM, 2006, FERTIL STERIL, V86, P588, DOI 10.1016/j.fertnstert.2006.02.086; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nelson SM, 2012, HUM REPROD, V27, P631, DOI 10.1093/humrep/der446; Ng EHY, 2009, GYNECOL ENDOCRINOL, V25, P2, DOI 10.1080/09513590802296237; Plante BJ, 2010, J ASSIST REPROD GEN, V27, P409, DOI 10.1007/s10815-010-9433-4; Sunkara SK, 2011, HUM REPROD, V26, P1768, DOI 10.1093/humrep/der106; van Disseldorp J, 2010, HUM REPROD, V25, P221, DOI 10.1093/humrep/dep366; Veeck LL., 1999, ATLAS HUMAN GAMETES; Yeung William S. B., 2009, Hong Kong Medical Journal, V15, P420	24	76	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61095	10.1371/journal.pone.0061095	http://dx.doi.org/10.1371/journal.pone.0061095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637787	gold, Green Published			2022-12-25	WOS:000318008400025
J	Gammon, L; Biddle, A; Heywood, HK; Johannessen, AC; Mackenzie, IC				Gammon, Luke; Biddle, Adrian; Heywood, Hannah K.; Johannessen, Anne C.; Mackenzie, Ian C.			Sub-Sets of Cancer Stem Cells Differ Intrinsically in Their Patterns of Oxygen Metabolism	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; FACTOR-I; CARCINOMA; HEAD; IDENTIFICATION; HIF-1; ADAPTATION; RESISTANCE; DRUGS	The glycolytic response of hypoxic cells is primarily mediated by the hypoxia inducible factor alpha (HIF-1 alpha) but even in the presence of abundant oxygen tumours typically show high rates of glycolysis. Higher levels of HIF-1 alpha in tumours are associated with a poorer prognosis and up-regulation of markers of epithelial mesenchymal transition (EMT) due to HIF-1 alpha actions. We have recently shown that EMT occurs within the CD44(high) cancer stem cell (CSC) fraction and that epithelial and EMT CSCs are distinguished by high and low ESA expression, respectively. We here show that hypoxia induces a marked shift of the CSC fraction towards EMT leading to altered cell morphology, an increased proportion of CD44(high)/ESA(low) cells, patterns of gene expression typical of EMT, and enhanced sphere-forming ability. The size of EMT fractions returned to control levels in normoxia indicating a reversible process. Surprisingly, however, even under normoxic conditions a fraction of EMT CSCs was present and maintained high levels of HIF-1 alpha, apparently due to actions of cytokines such as TNF alpha. Functionally, this EMT CSC fraction showed decreased mitochondrial mass and membrane potential, consumed far less oxygen per cell, and produced markedly reduced levels of reactive oxygen species (ROS). These differences in the patterns of oxygen metabolism of sub-fractions of tumour cells provide an explanation for the general therapeutic resistance of CSCs and for the even greater resistance of EMT CSCs. They also identify potential mechanisms for manipulation of CSCs.	[Gammon, Luke; Biddle, Adrian; Mackenzie, Ian C.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Gammon, Luke; Johannessen, Anne C.] Univ Bergen, Haukeland Univ Hosp, Gade Inst, Bergen, Norway; [Heywood, Hannah K.] Queen Mary Univ London, Sch Engn & Mat Sci, London, England	University of London; Queen Mary University London; University of Bergen; Haukeland University Hospital; University of London; Queen Mary University London	Mackenzie, IC (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.	I.C.Mackenzie@qmul.ac.uk	Johannessen, Anne Christine/B-8929-2017	Johannessen, Anne Christine/0000-0001-5403-2380; Biddle, Adrian/0000-0003-4371-9720	Fanconi Anemia Research Foundation, NC3Rs, Barts; London Charity; Norwegian Medical Research Council; National Centre for the Replacement [NC/K500495/1, G0900799/1] Funding Source: researchfish	Fanconi Anemia Research Foundation, NC3Rs, Barts; London Charity; Norwegian Medical Research Council; National Centre for the Replacement	This work was supported by grants from the Fanconi Anemia Research Foundation, NC3Rs, Barts and The London Charity, and the Norwegian Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ayrapetov MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026064; BIDDLE A, 2011, CANC RES; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4; CHEN C, PLOS ONE, V6; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Harper LJ, 2007, J ORAL PATHOL MED, V36, P594, DOI 10.1111/j.1600-0714.2007.00617.x; Harper LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-166; Heywood HK, 2006, J CELL PHYSIOL, V206, P402, DOI 10.1002/jcp.20491; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008531; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PRIME SS, 1990, J PATHOL, V160, P259, DOI 10.1002/path.1711600313; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Sutphin PD, 2007, DEV CELL, V12, P845, DOI 10.1016/j.devcel.2007.05.006; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056664; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhong H, 1999, CANCER RES, V59, P5830	40	60	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62493	10.1371/journal.pone.0062493	http://dx.doi.org/10.1371/journal.pone.0062493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638097	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300067
J	Horsfield, MA; Jara, JL; Saeed, NP; Panerai, RB; Robinson, TG				Horsfield, Mark A.; Jara, Jose L.; Saeed, Nazia P.; Panerai, Ronney B.; Robinson, Thompson G.			Regional Differences in Dynamic Cerebral Autoregulation in the Healthy Brain Assessed by Magnetic Resonance Imaging	PLOS ONE			English	Article							BLOOD-FLOW; TRANSCRANIAL DOPPLER; HUMANS; FMRI; PRESSURE; VELOCITY; ARTERIES; SYSTEM; VOLUME	A novel method is described for mapping dynamic cerebral blood flow autoregulation to assess autoregulatory efficiency throughout the brain, using magnetic resonance imaging (MRI). Global abnormalities in autoregulation occur in clinical conditions, including stroke and head injury, and are of prognostic significance. However, there is limited information about regional variations. A gradient-echo echo-planar pulse sequence was used to scan the brains of healthy subjects at a rate of 1 scan/second during a transient decrease in arterial blood pressure provoked by a sudden release of pressure in bilateral inflated thigh cuffs. The signal decrease and subsequent recovery were analyzed to provide an index of autoregulatory efficiency (MRARI). MRI time-series were successfully acquired and analyzed in eleven subjects. Autoregulatory efficiency was not uniform throughout the brain: white matter exhibited faster recovery than gray (MRARI = 0.702 vs. 0.672, p = 0.009) and the cerebral cortex exhibited faster recovery than the cerebellum (MRARI = 0.669 vs. 0.645, p = 0.016). However, there was no evidence for differences between different cortical regions. Differences in autoregulatory efficiency between white matter, gray matter and the cerebellum may be a result of differences in vessel density and vasodilation. The techniques described may have practical importance in detecting regional changes in autoregulation consequent to disease.	[Horsfield, Mark A.; Saeed, Nazia P.; Panerai, Ronney B.; Robinson, Thompson G.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Jara, Jose L.] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile; [Panerai, Ronney B.; Robinson, Thompson G.] Glenfield Gen Hosp, NIHR Biomed Res Unit Cardiovasc Sci, Leicester LE3 9QP, Leics, England	University of Leicester; Universidad de Santiago de Chile; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Robinson, TG (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	tgr2@le.ac.uk	Jara, Jose/GQB-5331-2022; Jara, José Luis/J-7254-2015; Horsfield, Mark A/C-6569-2013	Jara, José Luis/0000-0002-3348-7017; Horsfield, Mark A/0000-0002-0815-6697; Robinson, Thompson/0000-0003-2144-2468	Stroke Association of the United Kingdom; NIHR BRU for Cardiovascular Sciences; University of Santiago de Chile; Becas Chile; Stroke Association [TSA2008/06] Funding Source: researchfish	Stroke Association of the United Kingdom; NIHR BRU for Cardiovascular Sciences; University of Santiago de Chile; Becas Chile; Stroke Association	This study was supported by The Stroke Association of the United Kingdom. NPS also received funding from the NIHR BRU for Cardiovascular Sciences. JLJ was partially funded by the University of Santiago de Chile and Becas Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Binks AP, 2008, J APPL PHYSIOL, V104, P212, DOI 10.1152/japplphysiol.00069.2007; Christen T, 2011, NMR BIOMED, V24, P393, DOI 10.1002/nbm.1603; Duong TQ, 2003, MAGN RESON MED, V49, P1019, DOI 10.1002/mrm.10472; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gommer ED, 2008, PHYSIOL MEAS, V29, P1293, DOI 10.1088/0967-3334/29/11/005; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Ito H, 2005, J CEREBR BLOOD F MET, V25, P852, DOI 10.1038/sj.jcbfm.9600076; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162, DOI 10.1152/ajpheart.2001.280.5.H2162; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Pula JH, 2008, CURR OPIN OPHTHALMOL, V19, P479, DOI 10.1097/ICU.0b013e3283129746; Reinhard M, 2012, STROKE, V43, P987, DOI 10.1161/STROKEAHA.111.644674; Saeed NP, 2011, J CEREBR BLOOD F MET, V31, P1302, DOI 10.1038/jcbfm.2010.225; ThorinTrescases N, 1997, STROKE, V28, P2486, DOI 10.1161/01.STR.28.12.2486; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259	25	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62588	10.1371/journal.pone.0062588	http://dx.doi.org/10.1371/journal.pone.0062588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638121	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300080
J	Kletke, O; Gisselmann, G; May, A; Hatt, H; Sergeeva, OA				Kletke, Olaf; Gisselmann, Guenter; May, Andrea; Hatt, Hanns; Sergeeva, Olga A.			Partial Agonism of Taurine at Gamma-Containing Native and Recombinant GABA(A) Receptors	PLOS ONE			English	Article							LONG-LASTING ENHANCEMENT; ALPHA-SUBUNITS; AMINO-ACIDS; 2 DISTINCT; RAT; MICE; EXPRESSION; SUBTYPES; BINDING; IDENTIFICATION	Taurine is a semi-essential sulfonic acid found at high concentrations in plasma and mammalian tissues which regulates osmolarity, ion channel activity and glucose homeostasis. The structural requirements of GABA(A)-receptors (GABA(A)R) gated by taurine are not yet known. We determined taurine potency and efficacy relative to GABA at different types of recombinant GABA(A)R occurring in central histaminergic neurons of the mouse hypothalamic tuberomamillary nucleus (TMN) which controls arousal. At binary alpha(1/2)beta(1/3) receptors taurine was as efficient as GABA, whereas incorporation of the gamma(1/2) subunit reduced taurine efficacy to 60-90% of GABA. The mutation gamma(2F771), which abolishes zolpidem potentiation, significantly reduced taurine efficacy at recombinant and native receptors compared to the wild type controls. As taurine was a full-or super-agonist at recombinant alpha(x)beta(1)delta-GABA(A)R, we generated a chimeric gamma(2) subunit carrying the d subunit motif around F77 (MTVFLH). At alpha(1/2)beta(1)gamma(2(MTVFLH)) receptors taurine became a super-agonist, similar to delta-containing ternary receptors, but remained a partial agonist at beta(3)-containing receptors. In conclusion, using site-directed mutagenesis we found structural determinants of taurine's partial agonism at gamma-containing GABAA receptors. Our study sheds new light on the beta(1) subunit conferring the widest range of taurine-efficacies modifying GABA(A)R function under (patho) physiological conditions.	[Kletke, Olaf; Gisselmann, Guenter; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Kletke, Olaf; May, Andrea; Sergeeva, Olga A.] Univ Dusseldorf, Fac Med, Dept Neurophysiol, D-40225 Dusseldorf, Germany	Ruhr University Bochum; Heinrich Heine University Dusseldorf	Sergeeva, OA (corresponding author), Univ Dusseldorf, Fac Med, Dept Neurophysiol, D-40225 Dusseldorf, Germany.	olga.sergeeva@uni-duesseldorf.de	Sergeeva, Olga/AAE-1869-2019	Kletke, Olaf/0000-0002-7825-1278	Deutsche Forschungsgemeinschaft [SFB 575/TP C8]; Heisenberg stipend [SE 1767]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg stipend	Supported by Deutsche Forschungsgemeinschaft SFB 575/TP C8 and a Heisenberg stipend to OAS (SE 1767). URL: http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2005, NEUROCHEM RES, V30, P1615, DOI 10.1007/s11064-005-8986-6; Bailey SJ, 2007, DIABETES, V56, P320, DOI 10.2337/db06-0712; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baur R, 2010, J BIOL CHEM, V285, P17398, DOI 10.1074/jbc.M110.108670; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; Bracamontes JR, 2008, J BIOL CHEM, V283, P26128, DOI 10.1074/jbc.M801292200; Chepkova AN, 2006, NEUROBIOL DIS, V23, P512, DOI 10.1016/j.nbd.2006.04.006; Chepkova AN, 2002, EUR J NEUROSCI, V16, P1523, DOI 10.1046/j.1460-9568.2002.02223.x; Cope DW, 2005, EUR J NEUROSCI, V21, P3002, DOI 10.1111/j.1460-9568.2005.04127.x; DominguezPerrot C, 1996, J PHYSIOL-LONDON, V497, P145, DOI 10.1113/jphysiol.1996.sp021756; Downing SS, 2005, BRIT J PHARMACOL, V145, P894, DOI 10.1038/sj.bjp.0706251; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gundersen V, 1998, J NEUROSCI, V18, P6059; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Hadley SH, 2007, J PHYSIOL-LONDON, V581, P1001, DOI 10.1113/jphysiol.2007.132886; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Jia F, 2008, J NEUROSCI, V28, P106, DOI 10.1523/JNEUROSCI.3996-07.2008; Ju YH, 2009, J NEUROSCI RES, V87, P1737, DOI 10.1002/jnr.21991; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; KONTRO P, 1980, BRAIN RES, V184, P129, DOI 10.1016/0006-8993(80)90592-2; KREIENKAMP HJ, 1995, NEURON, V14, P635, DOI 10.1016/0896-6273(95)90320-8; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Molchanova S, 2004, AMINO ACIDS, V27, P261, DOI 10.1007/s00726-004-0139-8; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nagaya N, 2001, J PHYSIOL-LONDON, V532, P17, DOI 10.1111/j.1469-7793.2001.0017g.x; Nutt D, 2006, J CLIN SLEEP MED, V2, pS7; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Ribeiro RA, 2009, DIABETES-METAB RES, V25, P370, DOI 10.1002/dmrr.959; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; Schubring SR, 2012, NEUROSCI LETT, V506, P322, DOI 10.1016/j.neulet.2011.11.036; Sergeeva OA, 2007, J PHYSIOL-LONDON, V585, P539, DOI 10.1113/jphysiol.2007.141432; Sergeeva OA, 2005, J NEUROSCI, V25, P88, DOI 10.1523/JNEUROSCI.3209-04.2005; Sergeeva OA, 2003, J PHYSIOL-LONDON, V550, P911, DOI 10.1113/jphysiol.2003.045864; Sergeeva OA, 2002, EUR J NEUROSCI, V16, P1472, DOI 10.1046/j.1460-9568.2002.02221.x; Sergeeva OA, 2001, NEUROSCIENCE, V104, P1043, DOI 10.1016/S0306-4522(01)00130-0; Sergeeva OA, 2010, J BIOL CHEM, V285, P23985, DOI 10.1074/jbc.M110.103309; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Taylor PM, 2000, J NEUROSCI, V20, P1297; Thompson SA, 2002, MOL PHARMACOL, V61, P861, DOI 10.1124/mol.61.4.861; Wagner DA, 2004, J NEUROSCI, V24, P2733, DOI 10.1523/JNEUROSCI.4316-03.2004; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Yanovsky Y., 2011, PFLUGERS ARCH, V463, P187	49	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61733	10.1371/journal.pone.0061733	http://dx.doi.org/10.1371/journal.pone.0061733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23637894	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300014
J	Portron, S; Merceron, C; Gauthier, O; Lesoeur, J; Sourice, S; Masson, M; Fellah, BH; Geffroy, O; Lallemand, E; Weiss, P; Guicheux, J; Vinatier, C				Portron, Sophie; Merceron, Christophe; Gauthier, Olivier; Lesoeur, Julie; Sourice, Sophie; Masson, Martial; Fellah, Borhane Hakim; Geffroy, Olivier; Lallemand, Elodie; Weiss, Pierre; Guicheux, Jerome; Vinatier, Claire			Effects of In Vitro Low Oxygen Tension Preconditioning of Adipose Stromal Cells on Their In Vivo Chondrogenic Potential: Application in Cartilage Tissue Repair	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HYDROXYPROPYL METHYLCELLULOSE HYDROGEL; AUTOLOGOUS CHONDROCYTE IMPLANTATION; FULL-THICKNESS DEFECTS; ARTICULAR-CARTILAGE; PROGENITOR CELLS; NASAL CHONDROCYTES; FOLLOW-UP; DIFFERENTIATION; HYPOXIA	Purpose: Multipotent stromal cell (MSC)-based regenerative strategy has shown promise for the repair of cartilage, an avascular tissue in which cells experience hypoxia. Hypoxia is known to promote the early chondrogenic differentiation of MSC. The aim of our study was therefore to determine whether low oxygen tension could be used to enhance the regenerative potential of MSC for cartilage repair. Methods: MSC from rabbit or human adipose stromal cells (ASC) were preconditioned in vitro in control or chondrogenic (ITS and TGF-beta) medium and in 21 or 5% O-2. Chondrogenic commitment was monitored by measuring COL2A1 and ACAN expression (real-time PCR). Preconditioned rabbit and human ASC were then incorporated into an Si-HPMC hydrogel and injected (i) into rabbit articular cartilage defects for 18 weeks or (ii) subcutaneously into nude mice for five weeks. The newly formed tissue was qualitatively and quantitatively evaluated by cartilage-specific immunohistological staining and scoring. The phenotype of ASC cultured in a monolayer or within Si-HPMC in control or chondrogenic medium and in 21 or 5% O-2 was finally evaluated using real-time PCR. Results/Conclusions: 5% O-2 increased the in vitro expression of chondrogenic markers in ASC cultured in induction medium. Cells implanted within Si-HPMC hydrogel and preconditioned in chondrogenic medium formed a cartilaginous tissue, regardless of the level of oxygen. In addition, the 3D in vitro culture of ASC within Si-HPMC hydrogel was found to reinforce the pro-chondrogenic effects of the induction medium and 5% O-2. These data together indicate that although 5% O-2 enhances the in vitro chondrogenic differentiation of ASC, it does not enhance their in vivo chondrogenesis. These results also highlight the in vivo chondrogenic potential of ASC and their potential value in cartilage repair.	[Portron, Sophie; Merceron, Christophe; Gauthier, Olivier; Lesoeur, Julie; Sourice, Sophie; Masson, Martial; Geffroy, Olivier; Weiss, Pierre; Guicheux, Jerome; Vinatier, Claire] INSERM, U791, Ctr Osteoarticular & Dent Tissue Engn, Grp STEP Skeletal Tissue Engn & Physiopathol, Nantes, France; [Portron, Sophie; Merceron, Christophe; Gauthier, Olivier; Lesoeur, Julie; Sourice, Sophie; Masson, Martial; Geffroy, Olivier; Weiss, Pierre; Guicheux, Jerome; Vinatier, Claire] Univ Nantes, UFR Odontol, Nantes, France; [Gauthier, Olivier; Fellah, Borhane Hakim] ONIRIS Nantes Atlantic Coll Vet Med Food Sci & En, Ctr Preclin Res & Invest, Nantes, France; [Geffroy, Olivier; Lallemand, Elodie] Coll Vet Med Nantes ONIRIS, Dept Equine Surg, Nantes, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Guicheux, J (corresponding author), INSERM, U791, Ctr Osteoarticular & Dent Tissue Engn, Grp STEP Skeletal Tissue Engn & Physiopathol, Nantes, France.	jerome.guicheux@univ-nantes.fr	guicheux, Jerome/F-7767-2013; WEISS, Pierre/AAE-9260-2020; Geffroy, Olivier/P-6384-2014; GEFFROY, olivier/A-9109-2015; Gauthier, Olivier/A-4639-2015; Vinatier, Claire S/P-1686-2014; Weiss, Pierre/P-1372-2014; FELLAH, Borhane/L-6266-2015	guicheux, Jerome/0000-0003-2754-3024; WEISS, Pierre/0000-0002-6159-8590; Vinatier, Claire S/0000-0002-6063-9901; Weiss, Pierre/0000-0002-6159-8590; Lallemand, Elodie/0000-0001-5910-4611; merceron, christophe/0000-0003-1085-7182	Courtin Arthritis Foundation; "Societe Francaise de Rhumatologie", ANR; young researchers "Scartifold" project; ANR Tecsan "Chondrograft" project; "Fondation de l'Avenir pour la Recherche Medicale Appliquee" FRM "Veillissement Osteoarticulaire" [ET7-451, ET9-491]; Haras Nationaux; Graftys S.A.; INSERM [U791]; Region des Pays de la Loire, Bioregos I and II program	Courtin Arthritis Foundation; "Societe Francaise de Rhumatologie", ANR(French National Research Agency (ANR)); young researchers "Scartifold" project; ANR Tecsan "Chondrograft" project(French National Research Agency (ANR)); "Fondation de l'Avenir pour la Recherche Medicale Appliquee" FRM "Veillissement Osteoarticulaire"; Haras Nationaux; Graftys S.A.; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region des Pays de la Loire, Bioregos I and II program(Region Pays de la Loire)	This study was financed by grants from the "Courtin Arthritis Foundation ", the "Societe Francaise de Rhumatologie", ANR, the young researchers "Scartifold" project, the ANR Tecsan "Chondrograft" project, the "Fondation de l'Avenir pour la Recherche Medicale Appliquee" FRM "Veillissement Osteoarticulaire" (ET7-451 and ET9-491), les Haras Nationaux, Graftys S.A. and the INSERM U791. CM and SP received a fellowship from the "Region des Pays de la Loire, Bioregos I and II program. Those funding had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jerome Guicheux is a PLOS ONE Editorial Board member and the authors received funding from Graftys S.A.. However, this does not alter the authors' adherence to all PLOS ONE policies on the sharing of data and materials.	Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872; Bian LM, 2012, TISSUE ENG PT A, V18, P715, DOI [10.1089/ten.tea.2011.0455, 10.1089/ten.TEA.2011.0455]; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J; Cao L, 2011, BIOMATERIALS, V32, P3910, DOI 10.1016/j.biomaterials.2011.02.014; Chen JT, 2012, EUR J MECH B-FLUID, V32, P32, DOI 10.1016/j.euromechflu.2011.09.007; Coluet J, 2009, DRUG DISCOV TODAY, V14, P913, DOI 10.1016/j.drudis.2009.07.012; Daher SR, 2008, STEM CELLS, V26, P2664, DOI 10.1634/stemcells.2008-0927; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673; Diekman BO, 2013, CURR OPIN RHEUMATOL, V25, P119, DOI 10.1097/BOR.0b013e32835aa28d; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035; Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.tea.2011.0657, 10.1089/ten.TEA.2011.0657]; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; HASELGROVE JC, 1993, AM J PHYSIOL, V265, pC497, DOI 10.1152/ajpcell.1993.265.2.C497; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Karlsson C, 2009, J ANAT, V215, P355, DOI 10.1111/j.1469-7580.2009.01115.x; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; Marquass B, 2011, AM J SPORT MED, V39, P1401, DOI 10.1177/0363546511398646; Maumus M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt55; Merceron C, 2012, STEM CELLS; Merceron C, 2011, CELL TRANSPLANT, V20, P1575, DOI 10.3727/096368910X557191; Merceron C, 2010, AM J PHYSIOL-CELL PH, V298, pC355, DOI 10.1152/ajpcell.00398.2009; Moseley JB, 2010, AM J SPORT MED, V38, P238, DOI 10.1177/0363546509348000; Nelson L, 2010, EXPERT OPIN BIOL TH, V10, P43, DOI 10.1517/14712590903321470; Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x; ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017; Owen JR, 2006, BIOMECH MODEL MECHAN, V5, P102, DOI 10.1007/s10237-006-0022-5; Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Seol D, 2012, ARTHRITIS RHEUM-US, V64, P3626, DOI 10.1002/art.34613; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009; Sheehy EJ, 2011, BIOCH BIOPHYS RES CO; Shirazi R, 2008, J BIOMECH, V41, P3340, DOI 10.1016/j.jbiomech.2008.09.033; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033; Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722; Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P258, DOI [10.1089/ten.TEB.2011.0440, 10.1089/ten.teb.2011.0440]; Tyyni A, 2000, SCAND J MED SCI SPOR, V10, P249, DOI 10.1034/j.1600-0838.2000.010005249.x; Vinardell T, 2012, TISSUE ENG PT A, V18, P1161, DOI [10.1089/ten.tea.2011.0544, 10.1089/ten.TEA.2011.0544]; Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867; Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057; Vinatier C, 2009, BIOTECHNOL BIOENG, V102, P1259, DOI 10.1002/bit.22137; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013; Yang R, 2003, Eur Cell Mater, V6, P57; YANG R, 2003, EUR CELLS MATER, V6, P71; Zhou SD, 2004, ARTHRITIS RHEUM-US, V50, P3915, DOI 10.1002/art.20675; Zscharnack M, 2010, AM J SPORT MED, V38, P1857, DOI 10.1177/0363546510365296; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	62	51	57	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62368	10.1371/journal.pone.0062368	http://dx.doi.org/10.1371/journal.pone.0062368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638053	Green Submitted, Green Published, gold			2022-12-25	WOS:000319077300047
J	Fang, H; Tan, M; Xia, M; Wang, LH; Jiang, X				Fang, Hao; Tan, Ming; Xia, Ming; Wang, Leyi; Jiang, Xi			Norovirus P Particle Efficiently Elicits Innate, Humoral and Cellular Immunity	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; GROUP ANTIGEN RECEPTORS; CAPSID PROTEIN FORMS; BLOOD GROUP ANTIGENS; NORWALK VIRUS; DENDRITIC CELLS; STRUCTURAL BASIS; HOST INTERACTION; VACCINE; IMMUNOGENICITY	Norovirus (NoV) P domain complexes, the 24 mer P particles and the P dimers, induced effective humoral immunity, but their role in the cellular immune responses remained unclear. We reported here a study on cellular immune responses of the two P domain complexes in comparison with the virus-like particle (VLP) of a GII.4 NoV (VA387) in mice. The P domain complexes induced significant central memory CD4(+) T cell phenotypes (CD4(+) CD44(+) CD62L(+) CCR7(+)) and activated polyclonal CD4(+) T cells as shown by production of Interleukin (IL)-2, Interferon (IFN)-gamma, and Tumor Necrosis Factor (TNF)-alpha. Most importantly, VA387-specific CD4(+) T cell epitope induced a production of IFN-gamma, indicating an antigen-specific CD4(+) T cell response in P domain complex-immunized mice. Furthermore, P domain complexes efficiently induced bone marrow-derived dendritic cell (BMDC) maturation, evidenced by up-regulation of co-stimulatory and MHC class II molecules, as well as production of IL-12 and IL-1 beta. Finally, P domain complex-induced mature dendritic cells (DCs) elicited proliferation of specific CD4(+) T cells targeting VA387 P domain. Overall, we conclude that the NoV P domain complexes are efficiently presented by DCs to elicit not only humoral but also cellular immune responses against NoVs. Since the P particle is highly effective for both humoral and cellular immune responses and easily produced in Escherichia coli (E. coli), it is a good choice of vaccine against NoVs and a vaccine platform against other diseases.	[Fang, Hao; Tan, Ming; Xia, Ming; Wang, Leyi; Jiang, Xi] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Tan, Ming; Jiang, Xi] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Jiang, X (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	jason.jiang@cchmc.org	Wang, Leyi/G-9448-2014; Wang, Leyi/AAB-4248-2019; Xia, Ming/AAY-7154-2021	Wang, Leyi/0000-0001-5813-9505; Wang, Leyi/0000-0001-5813-9505; 	National Institutes of Health, the National Institute of Allergy and Infectious Diseases [R01 AI37093, R01 AI055649]; National Institute of Child Health [P01 HD13021, R21AI092434-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092434, R01AI037093, R01AI055649, R01AI089634] Funding Source: NIH RePORTER	National Institutes of Health, the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health, the National Institute of Allergy and Infectious Diseases (R01 AI37093 and R01 AI055649) and National Institute of Child Health (P01 HD13021) to X.J. and R21AI092434-01A1 to M.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers JD, 2010, BLOOD, V115, P1678, DOI 10.1182/blood-2009-06-227546; Aosai F, 2006, CELL STRESS CHAPERON, V11, P13, DOI 10.1379/CSC-138R.1; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Bereszczak JZ, 2012, J STRUCT BIOL, V177, P273, DOI 10.1016/j.jsb.2012.01.005; Bertolotti-Ciarlet A, 2002, J VIROL, V76, P4044, DOI 10.1128/JVI.76.8.4044-4055.2002; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; El-Kamary SS, 2010, J INFECT DIS, V202, P1649, DOI 10.1086/657087; Fang H, 2010, FEMS IMMUNOL MED MIC, V59, P71, DOI 10.1111/j.1574-695X.2010.00663.x; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; GREENBERG HB, 1981, J VIROL, V37, P994, DOI 10.1128/JVI.37.3.994-999.1981; HARDY ME, 1995, J VIROL, V69, P1693, DOI 10.1128/JVI.69.3.1693-1698.1995; Herbst-Kralovetz M, 2010, EXPERT REV VACCINES, V9, P299, DOI [10.1586/erv.09.163, 10.1586/ERV.09.163]; Inaba K, 2009, CURR PROTOC IMMUNOL, V3; Kubota T, 2012, J VIROL, V86, P11138, DOI 10.1128/JVI.00278-12; Lees JR, 2010, IMMUNOLOGY, V130, P463, DOI 10.1111/j.1365-2567.2010.03288.x; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; LoBue AD, 2010, J VIROL, V84, P8530, DOI 10.1128/JVI.00727-10; Lobue AD, 2009, J VIROL, V83, P3212, DOI 10.1128/JVI.01650-08; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; Parra GI, 2012, VACCINE, V30, P3580, DOI 10.1016/j.vaccine.2012.03.050; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Tamminen K, 2012, IMMUNOLOGY, V135, P89, DOI 10.1111/j.1365-2567.2011.03516.x; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2012, NANOMEDICINE, V7, P1; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2006, J VIROL, V80, P7322, DOI 10.1128/JVI.00233-06; Tan M, 2012, IMMUNOLOGY, V136, P28, DOI 10.1111/j.1365-2567.2012.03555.x; Tan M, 2011, PROCEDIA VACCINOL, V4, DOI 10.1016/j.provac.2011.07.004; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tan M, 2011, VIROLOGY, V410, P345, DOI 10.1016/j.virol.2010.11.017; Tan M, 2011, J VIROL, V85, P753, DOI 10.1128/JVI.01835-10; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Tan M, 2010, CALICIVIRUSES: MOLECULAR AND CELLULAR VIROLOGY, P111; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Xia M, 2011, VACCINE, V29, P7670, DOI 10.1016/j.vaccine.2011.07.139; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09	47	55	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63269	10.1371/journal.pone.0063269	http://dx.doi.org/10.1371/journal.pone.0063269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638188	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800079
J	Heitger, MH; Goble, DJ; Dhollander, T; Dupont, P; Caeyenberghs, K; Leemans, A; Sunaert, S; Swinnen, SP				Heitger, Marcus H.; Goble, Daniel J.; Dhollander, Thijs; Dupont, Patrick; Caeyenberghs, Karen; Leemans, Alexander; Sunaert, Stefan; Swinnen, Stephan P.			Bimanual Motor Coordination in Older Adults Is Associated with Increased Functional Brain Connectivity - A Graph-Theoretical Analysis	PLOS ONE			English	Article							AGE-RELATED-CHANGES; NETWORK; MEMORY; MODULATION; ANISOTROPY; COGNITION; DECLINE; SYSTEMS; STATE	In bimanual coordination, older and younger adults activate a common cerebral network but the elderly also have additional activation in a secondary network of brain areas to master task performance. It remains unclear whether the functional connectivity within these primary and secondary motor networks differs between the old and the young and whether task difficulty modulates connectivity. We applied graph-theoretical network analysis (GTNA) to task-driven fMRI data in 16 elderly and 16 young participants using a bimanual coordination task including in-phase and anti-phase flexion/extension wrist movements. Network nodes for the GTNA comprised task-relevant brain areas as defined by fMRI activation foci. The elderly matched the motor performance of the young but showed an increased functional connectivity in both networks across a wide range of connectivity metrics, i.e., higher mean connectivity degree, connection strength, network density and efficiency, together with shorter mean communication path length between the network nodes and also a lower betweenness centrality. More difficult movements showed an increased connectivity in both groups. The network connectivity of both groups had "small world'' character. The present findings indicate (a) that bimanual coordination in the aging brain is associated with a higher functional connectivity even between areas also activated in young adults, independently from task difficulty, and (b) that adequate motor coordination in the context of task-driven bimanual control in older adults may not be solely due to additional neural recruitment but also to aging-related changes of functional relationships between brain regions.	[Heitger, Marcus H.; Goble, Daniel J.; Caeyenberghs, Karen; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Res Ctr Movement Control & Neuroplast, Motor Control Lab, Louvain, Belgium; [Dhollander, Thijs] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Med Imaging Res Ctr, Louvain, Belgium; [Dupont, Patrick] Katholieke Univ Leuven, Grp Biomed Sci, Dept Neurosci, Lab Cognit Neurol, Louvain, Belgium; [Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Sunaert, Stefan] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Med Imaging Res Ctr, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; Utrecht University; Utrecht University Medical Center; KU Leuven; University Hospital Leuven	Heitger, MH (corresponding author), Katholieke Univ Leuven, Grp Biomed Sci, Res Ctr Movement Control & Neuroplast, Motor Control Lab, Louvain, Belgium.	marcus.heitger@gmail.com	Leemans, Alexander/A-1784-2011; Dupont, Patrick/B-8044-2009; Goble, Daniel/A-1317-2007; Sunaert, Stefan/E-8031-2011	Leemans, Alexander/0000-0002-9306-6126; Dupont, Patrick/0000-0003-1980-2540; Goble, Daniel/0000-0002-8027-6722; Dhollander, Thijs/0000-0003-3088-3636; Caeyenberghs, Karen/0000-0001-7009-6843; Sunaert, Stefan/0000-0002-1177-4680	Research Fund K.U. Leuven [OT/11/071, LHR-C1131-F+/09/022]; Flanders Fund for Scientific Research [G.0483.10, G.0721.12]; Interuniversity Attraction Poles program of the Belgian federal government [P6/29]; Research Foundation Flanders [GP.004.10N]; Federaal Wetenschapsbeleid Belspo [IUAP P6/29]; IWT-TBM [080658]	Research Fund K.U. Leuven(KU Leuven); Flanders Fund for Scientific Research(FWO); Interuniversity Attraction Poles program of the Belgian federal government(Belgian Federal Science Policy Office); Research Foundation Flanders(FWO); Federaal Wetenschapsbeleid Belspo; IWT-TBM(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Research Fund K.U. Leuven (OT/11/071); the Flanders Fund for Scientific Research (G.0483.10 and G.0721.12); the Interuniversity Attraction Poles program of the Belgian federal government (grant P6/29) (covered costs: salaries, MRI costs, operating budget). Marcus Heitger was funded by a Visiting Postdoctoral Fellowship of the Research Foundation Flanders (GP.004.10N) and an F+ Fellowship from the Research Fund K.U. Leuven (LHR-C1131-F+/09/022). Patrick Dupont is supported by Federaal Wetenschapsbeleid Belspo IUAP P6/29 and IWT-TBM 080658. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bangert AS, 2010, NEUROPSYCHOLOGIA, V48, P1165, DOI 10.1016/j.neuropsychologia.2009.11.013; Bigler ED, 2003, NEUROPSYCHOLOGY, V17, P339, DOI 10.1037/0894-4105.17.3.339; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Calautti C, 2001, STROKE, V32, P139, DOI 10.1161/01.STR.32.1.139; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Fling BW, 2011, J COGNITIVE NEUROSCI, V23, P2171, DOI 10.1162/jocn.2010.21600; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fronczak A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056110; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Goble DJ, 2010, HUM BRAIN MAPP, V31, P1281, DOI 10.1002/hbm.20943; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Hutchinson S, 2002, NEUROIMAGE, V17, P1720, DOI 10.1006/nimg.2002.1309; Langan J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00017; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Madden DJ, 2010, NEUROIMAGE, V52, P643, DOI 10.1016/j.neuroimage.2010.04.249; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park CH, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.003; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Roses AD, 1997, NEUROBIOL DIS, V4, P170, DOI 10.1006/nbdi.1997.0161; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sonty SP, 2007, J NEUROSCI, V27, P1334, DOI 10.1523/JNEUROSCI.4127-06.2007; Spirduso WW, 1990, HDB PSYCHOL AGING, P183; Spirduso WW, 1982, AGING MOTOR SYSTEM, P120; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; St Jacques PL, 2009, PSYCHOL SCI, V20, P74, DOI 10.1111/j.1467-9280.2008.02258.x; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Summers JJ, 2010, HUM MOVEMENT SCI, V29, P820, DOI 10.1016/j.humov.2009.10.003; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Van Impe A, NEUROBIOL A IN PRESS, DOI DOI 10.1016/J.NEUR0BI0LA-GING.2011.06.013; Van Impe A, 2009, NEUROIMAGE, V47, P1854, DOI 10.1016/j.neuroimage.2009.06.027; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Ward NS, 2008, NEUROBIOL AGING, V29, P1434, DOI 10.1016/j.neurobiolaging.2007.04.017; Ward NS, 2006, AGEING RES REV, V5, P239, DOI 10.1016/j.arr.2006.04.003; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu T, 2005, J PHYSIOL-LONDON, V562, P605, DOI 10.1113/jphysiol.2004.076042; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Wu T, 2007, NEUROSCI LETT, V423, P189, DOI 10.1016/j.neulet.2007.06.057	61	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62133	10.1371/journal.pone.0062133	http://dx.doi.org/10.1371/journal.pone.0062133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637982	Green Published, gold			2022-12-25	WOS:000321662800028
J	Blasiak, T; Zawadzki, A; Lewandowski, MH				Blasiak, Tomasz; Zawadzki, Artur; Lewandowski, Marian Henryk			Infra-Slow Oscillation (ISO) of the Pupil Size of Urethane-Anaesthetised Rats	PLOS ONE			English	Article							RESTING-STATE NETWORKS; LESS-THAN-0.1 HZ OSCILLATIONS; BRAIN POTENTIAL FLUCTUATIONS; LATERAL GENICULATE-NUCLEUS; OLIVARY PRETECTAL NUCLEUS; INTERGENICULATE LEAFLET; SUPRACHIASMATIC NUCLEUS; LIGHT REFLEX; RECRUITMENT THRESHOLD; CHOLINERGIC AFFERENTS	Multiplicity of oscillatory phenomena in a range of infra-slow frequencies (<0.01 Hz) has been described in mammalian brains at different levels of organisation. The significance and manifestation in physiology and/or behaviour of many brain infra-slow oscillations (ISO) remain unknown. Examples of this phenomenon are two types of ISO observed in the brains of urethane-anaesthetised rats: infra-slow, rhythmic changes in the rate of action potential firing in a few nuclei of the subcortical visual system and a sleep-like cycle of activation/deactivation visible in the EEG signal. Because both of these rhythmic phenomena involve brain networks that can influence autonomic nervous system activity, we hypothesised that these two brain ISOs can be reflected by rhythmic changes of pupil size. Thus, in the present study, we used simultaneous pupillography and ECoG recording to verify the hypothesised existence of infra-slow oscillations in the pupil size of urethane-anaesthetised rats. The obtained results showed rhythmic changes in the size of the pupils and rhythmic eyeball movements in urethane-anaesthetised rats. The observed rhythms were characterised by two different dominant components in a range of infra-slow frequencies. First, the long component had a period of approximate to 29 minutes and was present in both the irises and the eyeball movements. Second, the short component had a period of approximate to 2 minutes and was observed only in the rhythmic constrictions and dilations of the pupils. Both ISOs were simultaneously present in both eyes, and they were synchronised between the left and right eye. The long ISO component was synchronised with the cyclic alternations of the brain state, as revealed by rhythmic changes in the pattern of the ECoG signal. Based on the obtained results, we propose a model of interference of ISO present in different brain systems involved in the control of pupil size.	[Blasiak, Tomasz; Zawadzki, Artur; Lewandowski, Marian Henryk] Jagiellonian Univ, Inst Zool, Dept Neurophysiol & Chronobiol, PL-30060 Krakow, Poland; [Zawadzki, Artur] AGH Univ Sci & Technol, Dept Automat & Biomed Engn, Krakow, Poland	Jagiellonian University; AGH University of Science & Technology	Blasiak, T (corresponding author), Jagiellonian Univ, Inst Zool, Dept Neurophysiol & Chronobiol, PL-30060 Krakow, Poland.	tomasz.blasiak@uj.edu.pl	Blasiak, Tomasz/K-1319-2012	Blasiak, Tomasz/0000-0002-3772-5879				ALADJALOVA NA, 1957, NATURE, V179, P957, DOI 10.1038/179957a0; Amerasinghe N, 2008, PROG BRAIN RES, V173, P31, DOI 10.1016/S0079-6123(08)01104-7; Blasiak T, 2004, BRAIN RES, V1009, P82, DOI 10.1016/j.brainres.2004.02.045; Blasiak T, 2013, NEUROSCIENCE, V228, P315, DOI 10.1016/j.neuroscience.2012.10.044; Blasiak T, 2010, J NEUROSCI METH, V185, P199, DOI 10.1016/j.jneumeth.2009.09.022; CARPENTER MB, 1992, J HIRNFORSCH, V33, P151; Carrascal L, 2010, NEUROSCIENCE, V171, P613, DOI 10.1016/j.neuroscience.2010.09.001; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Filippov IV, 2007, BRAIN RES, V1133, P78, DOI 10.1016/j.brainres.2006.11.038; Filippov IV, 2005, BRAIN RES, V1066, P179, DOI 10.1016/j.brainres.2005.10.061; Filippov IV, 2005, NEUROSCI LETT, V373, P51, DOI 10.1016/j.neulet.2004.09.056; FORT P, 1989, J COMP NEUROL, V283, P285, DOI 10.1002/cne.902830209; FORT P, 1990, J COMP NEUROL, V301, P262, DOI 10.1002/cne.903010209; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gamlin PDR, 2006, PROG BRAIN RES, V151, P379, DOI 10.1016/S0079-6123(05)51012-4; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Horowitz SS, 2004, J COMP NEUROL, V474, P227, DOI 10.1002/cne.20125; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; Hughes SW, 2011, PROG BRAIN RES, V193, P145, DOI 10.1016/B978-0-444-53839-0.00010-7; ICHIKAWA T, 1990, J HIRNFORSCH, V31, P251; Kardon RH, 1997, WALSH HOYTS CLIN NEU, V1, P847; KLOOSTER J, 1995, BRAIN RES, V688, P34, DOI 10.1016/0006-8993(95)00497-E; Klooster J, 1998, ANAT EMBRYOL, V198, P123, DOI 10.1007/s004290050170; Lall GS, 2010, NEURON, V66, P417, DOI 10.1016/j.neuron.2010.04.037; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lewandowski MH, 2004, ACTA NEUROBIOL EXP, V64, P277; Lewandowski MH, 2000, NEUROREPORT, V11, P317, DOI 10.1097/00001756-200002070-00019; Li DJ, 2011, J GLAUCOMA, V20, P331, DOI 10.1097/IJG.0b013e3181eda73a; LIU JHK, 1990, INVEST OPHTH VIS SCI, V31, P1332; Lorincz ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004447; LOWENSTEIN O, 1963, INVEST OPHTH VISUAL, V2, P138; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; MILLER JD, 1992, AM J PHYSIOL, V263, pR51, DOI 10.1152/ajpregu.1992.263.1.R51; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Morin LP, 1998, J COMP NEUROL, V396, P288; Nieto-Gonzalez JL, 2009, J NEUROPHYSIOL, V101, P100, DOI 10.1152/jn.90239.2008; Nongpiur ME, 2011, CURR OPIN OPHTHALMOL, V22, P96, DOI 10.1097/ICU.0b013e32834372b9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pickard GE, 2002, J NEUROSCI, V22, P2701, DOI 10.1523/JNEUROSCI.22-07-02701.2002; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Reuss S, 1987, PINEAL RES REV, V5, P153; Silver DM, 2004, J GLAUCOMA, V13, P100, DOI 10.1097/00061198-200404000-00004; Simpson J I, 1988, Rev Oculomot Res, V2, P335; Szkudlarek HJ, 2008, EUR J NEUROSCI, V27, P2657, DOI 10.1111/j.1460-9568.2008.06225.x; Travers JB, 2005, J COMP NEUROL, V488, P28, DOI 10.1002/cne.20604; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wilhelm B, 1999, PUPILLOGRAPHY PRINCI, P27; YOUNG MJ, 1994, NEUROSCIENCE, V62, P481, DOI 10.1016/0306-4522(94)90381-6	56	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62430	10.1371/journal.pone.0062430	http://dx.doi.org/10.1371/journal.pone.0062430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638082	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700056
J	Miranda, IA; Faria, ACD; Lopes, AJ; Jansen, JM; de Melo, PL				Miranda, Ingrid Almeida; Dias Faria, Alvaro Camilo; Lopes, Agnaldo Jose; Jansen, Jose Manoel; de Melo, Pedro Lopes			On the Respiratory Mechanics Measured by Forced Oscillation Technique in Patients with Systemic Sclerosis	PLOS ONE			English	Article							EXPIRATORY FLOW LIMITATION; INTERSTITIAL LUNG-DISEASE; PULMONARY-FUNCTION; AIRWAY-OBSTRUCTION; INCREASING DEGREES; INPUT IMPEDANCE; INVOLVEMENT; RESISTANCE; REACTANCE; SPIROMETRY	Background: Pulmonary complications are the most common cause of death and morbidity in systemic sclerosis (SSc). The forced oscillation technique (FOT) offers a simple and detailed approach to investigate the mechanical properties of the respiratory system. We hypothesized that SSc may introduce changes in the resistive and reactive properties of the respiratory system, and that FOT may help the diagnosis of these abnormalities. Methodology/Principal Findings: We tested these hypotheses in controls (n = 30) and patients with abnormalities classified using spirometry (n = 52) and pulmonary volumes (n = 29). Resistive data were interpreted with the zerointercept resistance (Ri) and the slope of the resistance (S) as a function of frequency. Reactance changes were evaluated by the mean reactance between 4 and 32 Hz (Xm) and the dynamic compliance (Crs, dyn). The mechanical load was evaluated using the absolute value of the impedance in 4 Hz (Z4Hz). A compartmental model was used to obtain central (R) and peripheral (Rp) resistances, and alveolar compliance (C). The clinical usefulness was evaluated by investigating the area under the receiver operating characteristic curve (AUC). The presence of expiratory flow limitation (EFL) was also evaluated. For the groups classified using spirometry, SSc resulted in increased values in Ri, R, Rp and Z4Hz (p<0.003) and reductions in Crs, dyn, C and Xm (p<0.004). Z4Hz, C and Crs, dyn exhibited a high diagnostic accuracy (AUC<0.90). In groups classified by pulmonary volume, SSc resulted in reductions in S, Xm, C and Crs, dyn (p<0.01). Xm, C and Crs, dyn exhibited adequate diagnostic accuracy (AUC>0.80). It was also observed that EFL is not common in patients with SSc. Conclusions/Significance: This study provides evidence that the respiratory resistance and reactance are changed in SSc. This analysis provides a useful description that is of particular significance for understanding respiratory pathophysiology and to ease the diagnosis of respiratory abnormalities in these patients.	[Miranda, Ingrid Almeida; Dias Faria, Alvaro Camilo; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil; [Miranda, Ingrid Almeida; Dias Faria, Alvaro Camilo; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil; [Lopes, Agnaldo Jose; Jansen, Jose Manoel] Univ Estado Rio De Janeiro, Fac Med Sci, Discipline Pneumol, Lab Pulm Funct Testing, Rio De Janeiro, Brazil; [de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal de Juiz de Fora; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil.	plopeslib@gmail.com	Lopes, Agnaldo J/B-6430-2016; Camilo, Alvaro/T-3470-2019; Melo, Pedro/E-8440-2011; Lopes, Agnaldo José/AAB-5944-2019	Melo, Pedro/0000-0002-2081-6619; Lopes, Agnaldo José/0000-0001-8598-4878	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	The present study was funded by the Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq) and the Rio de Janeiro Research Foundation (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanore Y, 2008, JOINT BONE SPINE, V75, P650, DOI 10.1016/j.jbspin.2008.07.003; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Bates JHT, 2011, COMPR PHYSIOL, V1, P1233, DOI 10.1002/cphy.c100058; Baydur A, 1997, CHEST, V112, P1017, DOI 10.1378/chest.112.4.1017; BLOMBULOW B, 1985, EUR J RESPIR DIS, V66, P1; Boros PW, 2004, RESPIRATION, V71, P374, DOI 10.1159/000079642; Bouros D, 2002, AM J RESP CRIT CARE, V165, P1581, DOI 10.1164/rccm.2106012; Cavalcanti JV, 2006, RESP MED, V100, P2207, DOI 10.1016/j.rmed.2006.03.009; Silva KKD, 2011, CLINICS, V66, P2085, DOI 10.1590/S1807-59322011001200014; Dawson B, 2001, BASIC CLIN BIOSTATIS, V3rd; Dellaca RL, 2007, EUR RESPIR J, V29, P363, DOI 10.1183/09031936.00038006; Dellaca RL, 2009, EUR RESPIR J, V33, P1329, DOI 10.1183/09031936.00139608; Dellaca RL, 2004, EUR RESPIR J, V23, P232, DOI 10.1183/09031936.04.00046804; Di Mango AMGT, 2006, RESP MED, V100, P399, DOI 10.1016/j.rmed.2005.07.005; Diong B, 2007, IEEE ENG MED BIOL, V26, P48, DOI 10.1109/MEMB.2007.289121; Diot E, 1998, CHEST, V114, P1623, DOI 10.1378/chest.114.6.1623; du Bois Roland M, 2007, Proc Am Thorac Soc, V4, P434, DOI 10.1513/pats.200608-152MS; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; Faria ACD, 2012, BIOMEDICAL ENG TECHN; Faria ACD, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-22; Faria ACD, 2009, RESPIRATION, V78, P93, DOI 10.1159/000213756; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Golpe R, 1999, SLEEP, V22, P932; GREENWALD GI, 1987, AM J MED, V83, P83, DOI 10.1016/0002-9343(87)90501-8; GULERIA J S, 1970, British Journal of Diseases of the Chest, V64, P150, DOI 10.1016/S0007-0971(70)80003-1; Gupta D, 2001, Indian J Chest Dis Allied Sci, V43, P97; GUTTADAURIA M, 1977, ARTHRITIS RHEUM, V20, P1071, DOI 10.1002/art.1780200506; HARRISON NK, 1991, AM REV RESPIR DIS, V144, P706, DOI 10.1164/ajrccm/144.3_Pt_1.706; Hyatt RE, 1997, INTERPRETATION PULMO, P76; Ioannidis JPA, 2005, AM J MED, V118, P2, DOI 10.1016/j.amjmed.2004.04.031; Janssens JP, 2001, RESP MED, V95, P415, DOI 10.1053/rmed.2001.1062; Kaczka David W., 2011, Critical Reviews in Biomedical Engineering, V39, P337, DOI 10.1615/CritRevBiomedEng.v39.i4.60; Katsumoto TR, 2011, ANNU REV PATHOL-MECH, V6, P509, DOI 10.1146/annurev-pathol-011110-130312; King GG, 2011, RESPIROLOGY, V16, P883, DOI 10.1111/j.1440-1843.2011.02013.x; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; KOSTOPOULOS C, 1992, CHEST, V102, P875, DOI 10.1378/chest.102.3.875; Lamblin C, 2001, EUR RESPIR J, V18, p69S; LANDSER FJ, 1982, CHEST, V81, P586, DOI 10.1378/chest.81.5.586; Levitzky M., 2003, PULMONARY PHYSL; Lorino AM, 1997, EUR RESPIR J, V10, P150, DOI 10.1183/09031936.97.10010150; LUTCHEN KR, 1987, J APPL PHYSIOL, V62, P403, DOI 10.1152/jappl.1987.62.2.403; LUTCHEN KR, 1986, IEEE T BIO-MED ENG, V33, P1000, DOI 10.1109/TBME.1986.325866; MacLeod D, 2001, MED BIOL ENG COMPUT, V39, P505, DOI 10.1007/BF02345140; McNearney TA, 2007, ARTHRIT RHEUM-ARTHR, V57, P318, DOI 10.1002/art.22532; Milic-Emili J, 1993, Monaldi Arch Chest Dis, V48, P80; Minai OA, 1998, CLIN CHEST MED, V19, P713, DOI 10.1016/S0272-5231(05)70112-X; Morelli S, 1997, J RHEUMATOL, V24, P81; NAGELS J, 1980, J APPL PHYSIOL, V49, P408, DOI 10.1152/jappl.1980.49.3.408; Ooi GC, 2003, ACTA RADIOL, V44, P258, DOI 10.1034/j.1600-0455.2003.00058.x; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Ostojic P, 2007, LUNG, V185, P211, DOI 10.1007/s00408-007-9012-3; OWENS GR, 1983, CHEST, V84, P546, DOI 10.1378/chest.84.5.546; Pasker HG, 1996, EUR RESPIR J, V9, P131, DOI 10.1183/09031936.96.09010132; Pereira CAC, 1992, J PNEUMOL, V18, P10; Peslin R, 1991, EUR RESPIR REV, V1, P140; Peslin R., 1986, HDB PHYSL 3, VIII, P145, DOI [10.1002/cphy.cp030311, DOI 10.1002/CPHY.CP030311]; Plastiras SC, 2006, ARTHRIT RHEUM-ARTHR, V55, P598, DOI 10.1002/art.22099; PRIDE NB, 1992, THORAX, V47, P317, DOI 10.1136/thx.47.4.317; REMYJARDIN M, 1993, RADIOLOGY, V188, P499, DOI 10.1148/radiology.188.2.8327704; Rotger M., 1991, EUR RESPIR REV, V1, P178; Sociedade Brasileira de Pneumologia e Tisiologia - SBPT, 2009, J PNEUMOL S3, V38; Sociedade Brasileira de Pneumologia e Tisiologia - SBPT, 1996, J PNEUMOL, V22; Steen V, 2003, ANN RHEUM DIS, V62, P97, DOI 10.1136/ard.62.2.97; STEEN VD, 1985, ARTHRITIS RHEUM-US, V28, P759, DOI 10.1002/art.1780280706; STEEN VD, 1994, ARTHRITIS RHEUM, V37, P1283, DOI 10.1002/art.1780370903; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TASHKIN DP, 1994, CHEST, V105, P489, DOI 10.1378/chest.105.2.489; Timmins SC, 2013, PHYSIOL MEAS, V34, P67, DOI 10.1088/0967-3334/34/1/67; Tomalak W, 2000, RESP PHYSIOL, V123, P101, DOI 10.1016/S0034-5687(00)00171-7; VANNOORD JA, 1991, EUR RESPIR J, V4, P945; VANNOORD JA, 1989, EUR RESPIR J, V2, P846; Veiga J, 2009, CLINICS, V64, P649, DOI 10.1590/S1807-59322009000700008; YING Y, 1990, EUR RESPIR J, V3, P1186; ZERAH F, 1995, CHEST, V108, P41, DOI 10.1378/chest.108.1.41	76	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61657	10.1371/journal.pone.0061657	http://dx.doi.org/10.1371/journal.pone.0061657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23637877	gold, Green Published, Green Submitted			2022-12-25	WOS:000318343700019
J	Bapst, DW				Bapst, David W.			When Can Clades Be Potentially Resolved with Morphology?	PLOS ONE			English	Article							FOSSIL RECORD; STRATIGRAPHIC RANGES; TAXA; EVOLUTION; DIVERSITY; ANCESTORS; ACCURACY; MODEL; INVERTEBRATES; PRESERVATION	Morphology-based phylogenetic analyses are the only option for reconstructing relationships among extinct lineages, but often find support for conflicting hypotheses of relationships. The resulting lack of phylogenetic resolution is generally explained in terms of data quality and methodological issues, such as character selection. A previous suggestion is that sampling ancestral morphotaxa or sampling multiple taxa descended from a long-lived, unchanging lineage can also yield clades which have no opportunity to share synapomorphies. This lack of character information leads to a lack of 'intrinsic' resolution, an issue that cannot be solved with additional morphological data. It is unclear how often we should expect clades to be intrinsically resolvable in realistic circumstances, as intrinsic resolution must increase as taxonomic sampling decreases. Using branching simulations, I quantify intrinsic resolution across several models of morphological differentiation and taxonomic sampling. Intrinsically unresolvable clades are found to be relatively frequent in simulations of both extinct and living taxa under realistic sampling scenarios, implying that intrinsic resolution is an issue for morphology-based analyses of phylogeny. Simulations which vary the rates of sampling and differentiation were tested for their agreement to observed distributions of durations from well-sampled fossil records and also having high intrinsic resolution. This combination only occurs in those datasets when differentiation and sampling rates are both unrealistically high relative to branching and extinction rates. Thus, the poor phylogenetic resolution occasionally observed in morphological phylogenetics may result from a lack of intrinsic resolvability within groups.	Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Bapst, DW (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	dwbapst@uchicago.edu	Bapst, David/HDM-3654-2022	Bapst, David/0000-0002-9087-1103				ALROY J, 1995, SYST BIOL, V44, P152, DOI 10.2307/2413704; Bapst DW, 2012, METHODS ECOL EVOL, V3, P803, DOI 10.1111/j.2041-210X.2012.00223.x; Bell MA, 2012, HIST BIOL, P1; Cobbett A, 2007, SYST BIOL, V56, P753, DOI 10.1080/10635150701627296; Colless D.H., 1980, Systematic Zoology, V29, P288, DOI 10.2307/2412663; Coyne JA, 2004, SPECIATION, V37; ELDREDGE N, 1971, EVOLUTION, V25, P156, DOI 10.1111/j.1558-5646.1971.tb01868.x; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Fisher D. C., 1991, ANAL PALEOBIOLOGY, P103; FISHER DC, 1994, INTERPRETING HIERARC, P133; Foote M, 1997, PALEOBIOLOGY, V23, P181, DOI 10.1017/S009483730001678X; Foote M, 1996, PALEOBIOLOGY, V22, P121, DOI 10.1017/S0094837300016134; Foote M, 1996, PALEOBIOLOGY, V22, P141, DOI 10.1017/S0094837300016146; Foote M, 1999, NATURE, V398, P415, DOI 10.1038/18872; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Forey Peter, 2007, Palaeontology Newsletter, V64, P28; Holland SM, 1999, GEOLOGY, V27, P491, DOI 10.1130/0091-7613(1999)027<0491:MFSTFR>2.3.CO;2; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Kiessling W, 2010, SCIENCE, V327, P196, DOI 10.1126/science.1182241; Lamboy WF, 1996, SYST BOT, V21, P243; Lavoue S, 2011, P ROY SOC B-BIOL SCI, V278, P1003, DOI 10.1098/rspb.2010.1639; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; Liow LH, 2004, AM NAT, V164, P431, DOI 10.1086/423673; MADDISON W, 1989, CLADISTICS, V5, P365, DOI 10.1111/j.1096-0031.1989.tb00569.x; MILLER AI, 1995, GEOLOGY, V23, P305, DOI 10.1130/0091-7613(1995)023<0305:AOOAWT>2.3.CO;2; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Norell Mark A., 1992, P89; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patzkowsky ME, 1995, PALEOBIOLOGY, V21, P440, DOI 10.1017/S0094837300013476; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; PLATNICK NI, 1977, SYST ZOOL, V26, P438, DOI 10.2307/2412799; PROTHERO DR, 1980, SYST ZOOL, V29, P119, DOI 10.2307/2412642; R Core Team, 2012, R LANG ENV STAT COMP; Rieppel O, 2002, BIOL J LINN SOC, V75, P59, DOI 10.1046/j.1095-8312.2002.00006.x; ROHLF FJ, 1990, EVOLUTION, V44, P1671, DOI 10.1111/j.1558-5646.1990.tb03855.x; Scotland RW, 2003, SYST BIOL, V52, P539, DOI 10.1080/10635150390223613; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; SMITH AB, 1994, SYSTEMATICS FOSSIL R; Solow AR, 1997, PALEOBIOLOGY, V23, P271, DOI 10.1017/S0094837300019680; Stanley S. M., 1979, MACROEVOLUTION PATTE; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wagner Peter J., 1995, P87; Wagner PJ, 2012, BIOL LETTERS, V8, P143, DOI 10.1098/rsbl.2011.0523; Wagner PJ, 1996, PALEOBIOLOGY, V22, P456, DOI 10.1017/S0094837300016407; WAGNER PJ, 1995, PALEOBIOLOGY, V21, P153, DOI 10.1017/S009483730001318X; Wagner PJ, 2000, SYST BIOL, V49, P65, DOI 10.1080/10635150050207393; Wagner PJ, 2010, SHORT COURSE QUANTIT; Wiens JJ, 2003, J VERTEBR PALEONTOL, V23, P297, DOI 10.1671/0272-4634(2003)023[0297:ITICAP]2.0.CO;2	51	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62312	10.1371/journal.pone.0062312	http://dx.doi.org/10.1371/journal.pone.0062312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638034	Green Published, gold			2022-12-25	WOS:000318341400050
J	Ferraro, JV; Plummer, TW; Pobiner, BL; Oliver, JS; Bishop, LC; Braun, DR; Ditchfield, PW; Seaman, JW; Binetti, KM; Seaman, JW; Hertel, F; Potts, R				Ferraro, Joseph V.; Plummer, Thomas W.; Pobiner, Briana L.; Oliver, James S.; Bishop, Laura C.; Braun, David R.; Ditchfield, Peter W.; Seaman, John W., III; Binetti, Katie M.; Seaman, John W., Jr.; Hertel, Fritz; Potts, Richard			Earliest Archaeological Evidence of Persistent Hominin Carnivory	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; OLDUVAI-GORGE; FLK ZINJANTHROPUS; CARCASS TRANSPORT; HUMAN-EVOLUTION; KANJERA SOUTH; TOOTH-MARK; ARCHAEOFAUNAL ASSEMBLAGES; PLIOPLEISTOCENE HOMINIDS; SURFACE MODIFICATION	The emergence of lithic technology by similar to 2.6 million years ago (Ma) is often interpreted as a correlate of increasingly recurrent hominin acquisition and consumption of animal remains. Associated faunal evidence, however, is poorly preserved prior to similar to 1.8 Ma, limiting our understanding of early archaeological (Oldowan) hominin carnivory. Here, we detail three large well-preserved zooarchaeological assemblages from Kanjera South, Kenya. The assemblages date to similar to 2.0 Ma, pre-dating all previously published archaeofaunas of appreciable size. At Kanjera, there is clear evidence that Oldowan hominins acquired and processed numerous, relatively complete, small ungulate carcasses. Moreover, they had at least occasional access to the fleshed remains of larger, wildebeest-sized animals. The overall record of hominin activities is consistent through the stratified sequence - spanning hundreds to thousands of years - and provides the earliest archaeological evidence of sustained hominin involvement with fleshed animal remains (i.e., persistent carnivory), a foraging adaptation central to many models of hominin evolution.	[Ferraro, Joseph V.; Binetti, Katie M.] Baylor Univ, Dept Anthropol, Waco, TX 76798 USA; [Ferraro, Joseph V.; Binetti, Katie M.] Baylor Univ, Inst Archaeol, Waco, TX 76798 USA; [Plummer, Thomas W.] Queens Coll, Dept Anthropol, Flushing, NY USA; [Plummer, Thomas W.] NYCEP, Flushing, NY USA; [Pobiner, Briana L.; Potts, Richard] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; [Oliver, James S.] Illinois State Museum, Dept Anthropol, Springfield, IL USA; [Oliver, James S.; Bishop, Laura C.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England; [Braun, David R.] George Washington Univ, Dept Anthropol, Washington, DC USA; [Ditchfield, Peter W.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Seaman, John W., III; Seaman, John W., Jr.] Baylor Univ, Dept Stat Sci, Waco, TX 76798 USA; [Hertel, Fritz] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Potts, Richard] Natl Museums Kenya, Dept Earth Sci, Palaeontol Sect, Nairobi, Kenya	Baylor University; Baylor University; City University of New York (CUNY) System; Queens College NY (CUNY); Smithsonian Institution; Smithsonian National Museum of Natural History; Liverpool John Moores University; George Washington University; University of Oxford; Baylor University; California State University System; California State University Northridge	Ferraro, JV (corresponding author), Baylor Univ, Dept Anthropol, Waco, TX 76798 USA.	joseph_ferraro@baylor.edu		Bishop, Laura C/0000-0002-4216-8667; Pobiner, Briana/0000-0001-5051-9175; Braun, David/0000-0002-7300-2635	National Science Foundation; Leakey Foundation; Wenner-Gren Foundation; National Geographic Society; Leverhulme Trust; University of California; Baylor University; City University of New York	National Science Foundation(National Science Foundation (NSF)); Leakey Foundation; Wenner-Gren Foundation; National Geographic Society(National Geographic Society); Leverhulme Trust(Leverhulme Trust); University of California(University of California System); Baylor University; City University of New York	This research was supported by funding from the National Science Foundation, Leakey Foundation, Wenner-Gren Foundation, National Geographic Society, The Leverhulme Trust, University of California, Baylor University, and the City University of New York. Additional logistical support was provided by the Smithsonian Institution's Human Origins Program and the Peter Buck Fund for Human Origins Research, the British Institute in Eastern Africa, and the National Museums of Kenya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LC, 2002, AM J HUM BIOL, V14, P551, DOI 10.1002/ajhb.10069; Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Binford L.R., 1981, BONES ANCIENT MEN MO; Bishop L.C., 2006, AFR ARCHAEOL REV, V23, P31, DOI [DOI 10.1007/S10437-006-9006-1, 10.1007/s10437-006-9006-1]; Blumenschine R.J., 1993, BONES BEHAV, DOI 10.1016/j.jhevol.2017.08.004; BLUMENSCHINE RJ, 1989, J HUM EVOL, V18, P345, DOI 10.1016/0047-2484(89)90036-5; BLUMENSCHINE RJ, 1986, J HUM EVOL, V15, P639, DOI 10.1016/S0047-2484(86)80002-1; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; BLUMENSCHINE RJ, 1987, CURR ANTHROPOL, V28, P383, DOI 10.1086/203544; BLUMENSCHINE RJ, 1993, J ARCHAEOL SCI, V20, P555, DOI 10.1006/jasc.1993.1034; Braun DR, 2008, J ARCHAEOL SCI, V35, P2329, DOI 10.1016/j.jas.2008.03.004; Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; Braun DR, 2009, J ARCHAEOL SCI, V36, P1605, DOI 10.1016/j.jas.2009.03.025; Braun DR, 2006, THESIS RUTGERS U NEW; Bunn H.T., 1986, THESIS U CALIFORNIA; Bunn HT, 2010, QUATERNARY RES, V74, P395, DOI 10.1016/j.yqres.2010.07.012; BUNN HT, 1993, J ARCHAEOL SCI, V20, P365, DOI 10.1006/jasc.1993.1023; BUNN HT, 1991, ANNU REV ANTHROPOL, V20, P433; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; Capaldo S.D., 1995, THESIS RUTGERS U NEW; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; CAPALDO SD, 1995, J ARCHAEOL SCI, V22, P385, DOI 10.1006/jasc.1995.0039; Capaldo SD, 1998, J ARCHAEOL SCI, V25, P311, DOI 10.1006/jasc.1997.0238; Cordain L, 2001, WORLD REV NUTR DIET, V90, P144; de Heinzelin J, 1999, SCIENCE, V284, P625; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Dominguez-Rodrigo M, 2010, QUATERNARY RES, V74, P315, DOI 10.1016/j.yqres.2010.07.003; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Dominguez-Rodrigo M, 2009, J HUM EVOL, V57, P260, DOI 10.1016/j.jhevol.2009.04.006; Dominguez-Rodrigo M, 2002, J WORLD PREHIST, V16, P1, DOI 10.1023/A:1014507129795; Dominguez-Rodrigo M, 1999, LIFESTYLES SURVIVAL, P89; Dominguez-Rodrigo M, 2010, P NATL ACAD SCI USA, V107, P20929, DOI 10.1073/pnas.1013711107; Dominguez-Solera SD, 2009, INT J OSTEOARCHAEOL, V19, P345, DOI 10.1002/oa.987; DominguezRodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Egeland CP, 2008, J HUM EVOL, V55, P1031, DOI 10.1016/j.jhevol.2008.05.021; Faith JT, 2007, J ARCHAEOL SCI, V34, P872, DOI 10.1016/j.jas.2006.08.007; Faith JT, 2006, J ARCHAEOL SCI, V33, P1718, DOI 10.1016/j.jas.2006.03.004; Faith JT, 2009, J HUM EVOL, V56, P247, DOI 10.1016/j.jhevol.2008.12.008; Ferraro JV, 2007, THESIS U CALIFORNIA; Foley Robert, 2001, P305; Humphrey LT, 2010, SEMIN CELL DEV BIOL, V21, P453, DOI 10.1016/j.semcdb.2009.11.003; ISAAC GL, 1978, J ANTHROPOL RES, V34, P311; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; KIBUNJIA M, 1994, J HUM EVOL, V27, P159, DOI 10.1006/jhev.1994.1040; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Lam YM, 1999, AM ANTIQUITY, V64, P343, DOI 10.2307/2694283; Leonard WR, 2007, ANNU REV NUTR, V27, P311, DOI 10.1146/annurev.nutr.27.061406.093659; LEONARD WR, 1992, AM J HUM BIOL, V4, P179, DOI 10.1002/ajhb.1310040204; Lupo KD, 1998, J ARCHAEOL SCI, V25, P657, DOI 10.1006/jasc.1997.0261; Lupo KD, 2002, J ARCHAEOL SCI, V29, P85, DOI 10.1006/jasc.2001.0690; Lyman RL., 1994, VERTEBRATE TAPHONOMY, DOI [DOI 10.1017/CBO9781139878302, 10.1017/CBO9781139878302]; Madrigal TC, 2000, J ARCHAEOL SCI, V27, P739, DOI 10.1006/jasc.1999.0497; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Marean Curtis W., 2003, Journal of Taphonomy, V1, P15; MAREAN CW, 1992, J ARCHAEOL SCI, V19, P101, DOI 10.1016/0305-4403(92)90009-R; MAREAN CW, 1991, AM ANTIQUITY, V56, P645, DOI 10.2307/281542; Marean CW, 2000, J HUM EVOL, V38, P197, DOI 10.1006/jhev.1999.0356; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; METCALFE D, 1988, AM ANTIQUITY, V53, P486, DOI 10.2307/281213; Milligan LA, 2008, J HUM EVOL, V55, P1086, DOI 10.1016/j.jhevol.2008.07.010; Milton K, 2003, J NUTR, V133, p3886S, DOI 10.1093/jn/133.11.3886S; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Monahan CM, 1998, J ARCHAEOL SCI, V25, P405, DOI 10.1006/jasc.1997.0241; Monahan CM, 1996, J HUM EVOL, V31, P93, DOI 10.1006/jhev.1996.0053; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; O'Connell JF, 2002, J HUM EVOL, V43, P831, DOI 10.1006/jhev.2002.0604; O'Connell JF, 1999, J HUM EVOL, V36, P461, DOI 10.1006/jhev.1998.0285; OLIVER JS, 1994, J HUM EVOL, V27, P267, DOI 10.1006/jhev.1994.1046; OLSEN SL, 1988, J ARCHAEOL SCI, V15, P535, DOI 10.1016/0305-4403(88)90081-7; Pante MC, 2012, J HUM EVOL, V63, P395, DOI 10.1016/j.jhevol.2011.09.002; Pickering TR, 2008, J ANTHROPOL ARCHAEOL, V27, P30, DOI 10.1016/j.jaa.2007.07.002; Plummer T, 1999, J HUM EVOL, V36, P151, DOI 10.1006/jhev.1998.0256; Plummer T, 2004, YEARB PHYS ANTHROPOL, V47, P118, DOI 10.1002/ajpa.20157; Plummer TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007199; Plummer TW, 2009, VERTEBR PALEOBIOL PA, P149, DOI 10.1007/978-1-4020-9060-8_12; Pobiner BL, 2008, J HUM EVOL, V55, P103, DOI 10.1016/j.jhevol.2008.02.001; Potts R, 1988, EARLY HOMININ ACTIVI; Psouni E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032452; REEVE HK, 1993, Q REV BIOL, V68, P1, DOI 10.1086/417909; SCHALLER GB, 1969, SOUTHWEST J ANTHROP, V25, P307, DOI 10.1086/soutjanth.25.4.3629426; Seaman III JW, 2010, THESIS BAYLOR U WACO; SELVAGGIO MM, 1994, J HUM EVOL, V27, P215, DOI 10.1006/jhev.1994.1043; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; SHIPMAN P, 1989, J HUM EVOL, V18, P373, DOI 10.1016/0047-2484(89)90037-7; Speth JD, 2010, INTERD CONTRIB ARCH, P1, DOI 10.1007/978-1-4419-6733-6; SPETH JD, 1989, J HUM EVOL, V18, P329, DOI 10.1016/0047-2484(89)90035-3; Swedell L, 2012, INT J PRIMATOL, V33, P1165, DOI 10.1007/s10764-012-9600-9; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083	94	133	137	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62174	10.1371/journal.pone.0062174	http://dx.doi.org/10.1371/journal.pone.0062174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	136DM	23637995	Green Published, gold			2022-12-25	WOS:000318341400041
J	Furu, K; Klungland, A				Furu, Kari; Klungland, Arne			Tzfp Represses the Androgen Receptor in Mouse Testis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; AURORA-C KINASE; SERTOLI-CELLS; PROMYELOCYTIC-LEUKEMIA; HISTONE DEACETYLASE; GENE-EXPRESSION; GERM-CELLS; DIFFERENTIATION; PROTEIN; PLZF	The testis zinc finger protein (Tzfp), also known as Repressor of GATA, belongs to the BTB/POZ zinc finger family of transcription factors and is thought to play a role in spermatogenesis due to its remarkably high expression in testis. Despite many attempts to find the in vivo role of the protein, the molecular function is still largely unknown. Here, we address this issue using a novel mouse model with a disrupted Tzfp gene. Homozygous Tzfp null mice are born at reduced frequency but appear viable and fertile. Sertoli cells in testes lacking Tzfp display an increase in Androgen Receptor (AR) signaling, and several genes in the testis, including Gata1, Aie1 and Fanc, show increased expression. Our results indicate that Tzfp function as a transcriptional regulator and that loss of the protein leads to alterations in AR signaling and reduced number of apoptotic cells in the testicular tubules.	[Furu, Kari; Klungland, Arne] Oslo Univ Hosp, Dept Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway; [Klungland, Arne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; University of Oslo	Klungland, A (corresponding author), Oslo Univ Hosp, Dept Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway.	arne.klungland@medisin.uio.no	Klungland, Arne/X-1233-2019	Klungland, Arne/0000-0001-7274-3661	Norwegian Research Council; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Norwegian Research Council and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cumming RC, 2001, NAT MED, V7, P814, DOI 10.1038/89937; Dai MS, 2002, J BIOL CHEM, V277, P26327, DOI 10.1074/jbc.M201834200; De GK, 2004, P NATL ACAD SCI USA, V101, P1327; DJAKIEW D, 1988, BIOL REPROD, V39, P1193, DOI 10.1095/biolreprod39.5.1193; Eder IE, 2003, MOL CARCINOGEN, V37, P181, DOI 10.1002/mc.10136; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hoatlin ME, 1999, BLOOD, V94, P3737, DOI 10.1182/blood.V94.11.3737.423k39_3737_3747; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; HOOVER F, 1992, EXP EYE RES, V54, P561, DOI 10.1016/0014-4835(92)90135-F; Ikeda R, 2007, J CELL BIOCHEM, V101, P147, DOI 10.1002/jcb.21165; Jeong BC, 2004, MOL ENDOCRINOL, V18, P13, DOI 10.1210/me.2003-0065; Jiang F, 2003, ENDOCRINOLOGY, V144, P1257, DOI 10.1210/en.2002-220718; Kang BY, 2005, MOL CELL BIOL, V25, P554, DOI 10.1128/MCB.25.2.554-562.2005; Kaufmann S, 2010, J GEN VIROL, V91, P1494, DOI 10.1099/vir.0.014241-0; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Ketola I, 1999, ENDOCRINOLOGY, V140, P1470, DOI 10.1210/en.140.3.1470; Ketola I, 2002, EUR J ENDOCRINOL, V147, P397, DOI 10.1530/eje.0.1470397; Khan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026512; KIMURA N, 1993, J HISTOCHEM CYTOCHEM, V41, P671, DOI 10.1177/41.5.8468448; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Lin WC, 1999, BIOCHEM BIOPH RES CO, V264, P789, DOI 10.1006/bbrc.1999.1594; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nordstrand LM, 2012, NUCL ACIDS RES; Omori M, 2003, IMMUNITY, V19, P281, DOI 10.1016/S1074-7613(03)00210-3; ONODA M, 1991, IN VITRO CELL DEV B, V27, P215; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Piazza F, 2004, MOL CELL BIOL, V24, P10456, DOI 10.1128/MCB.24.23.10456-10469.2004; Qamar I, 2009, J BIOL CHEM, V284, P18021, DOI 10.1074/jbc.M900896200; RUSSELL LB, 1990, PROG CLIN BIOL RES, V340, P101; RUSSELL LD, 1977, ANAT RECORD, V187, P347, DOI 10.1002/ar.1091870307; Shu SK, 2010, J BIOL CHEM, V285, P33045, DOI 10.1074/jbc.M110.121129; Syed V, 1999, ENDOCRINOLOGY, V140, P5754, DOI 10.1210/en.140.12.5754; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036; Tang CJC, 2001, J BIOL CHEM, V276, P19631, DOI 10.1074/jbc.M100170200; Tsuzuki S, 2002, BLOOD, V99, P3404, DOI 10.1182/blood.V99.9.3404; VERHOEVEN G, 1992, BAILLIERE CLIN ENDOC, V6, P313, DOI 10.1016/S0950-351X(05)80152-1; Viger RS, 2004, J ANDROL, V25, P441; Watamoto K, 2003, ONCOGENE, V22, P9176, DOI 10.1038/sj.onc.1206902; Wong CW, 1998, MOL CELL BIOL, V18, P5500, DOI 10.1128/MCB.18.9.5500; Yamamoto M, 1997, GENES CELLS, V2, P107, DOI 10.1046/j.1365-2443.1997.1080305.x; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Yoon HS, 2012, J IMMUNOL	58	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62314	10.1371/journal.pone.0062314	http://dx.doi.org/10.1371/journal.pone.0062314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634227	gold, Green Submitted, Green Published			2022-12-25	WOS:000318341400051
J	Toledo, A; Zolessi, FR; Arruti, C				Toledo, Andrea; Zolessi, Flavio R.; Arruti, Cristina			A Novel Effect of MARCKS Phosphorylation by Activated PKC: The Dephosphorylation of Its Serine 25 in Chick Neuroblasts	PLOS ONE			English	Article							PROTEIN-KINASE-C; SUBSTRATE MARCKS; MEMBRANE ASSOCIATION; NEURAL RETINA; MONOCLONAL-ANTIBODY; FAMILY; CELLS; DIFFERENTIATION; EXPRESSION; BRAIN	MARCKS (Myristoylated Alanine-Rich C Kinase Substrate) is a peripheral membrane protein, especially abundant in the nervous system, and functionally related to actin organization and Ca-calmodulin regulation depending on its phosphorylation by PKC. However, MARCKS is susceptible to be phosphorylated by several different kinases and the possible interactions between these phosphorylations have not been fully studied in intact cells. In differentiating neuroblasts, as well as some neurons, there is at least one cell-type specific phosphorylation site: serine 25 (S25) in the chick. We demonstrate here that S25 is included in a highly conserved protein sequence which is a Cdk phosphorylatable region, located far away from the PKC phosphorylation domain. S25 phosphorylation was inhibited by olomoucine and roscovitine in neuroblasts undergoing various states of cell differentiation in vitro. These results, considered in the known context of Cdks activity in neuroblasts, suggest that Cdk5 is the enzyme responsible for this phosphorylation. We find that the phosphorylation by PKC at the effector domain does not occur in the same molecules that are phosphorylated at serine 25. The in situ analysis of the subcellular distribution of these two phosphorylated MARCKS variants revealed that they are also segregated in different protein clusters. In addition, we find that a sustained stimulation of PKC by phorbol-12-myristate-13-acetate (PMA) provokes the progressive disappearance of phosphorylation at serine 25. Cells treated with PMA, but in the presence of several Ser/Thr phosphatase (PP1, PP2A and PP2B) inhibitors indicated that this dephosphorylation is achieved via a phosphatase 2A (PP2A) form. These results provide new evidence regarding the existence of a novel consequence of PKC stimulation upon the phosphorylated state of MARCKS in neural cells, and propose a link between PKC and PP2A activity on MARCKS.	[Toledo, Andrea; Zolessi, Flavio R.; Arruti, Cristina] Univ Republica, Fac Ciencias, Dept Cellular & Mol Biol, Sec Biol Celular,Lab Cultivo Tejidos, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Arruti, C (corresponding author), Univ Republica, Fac Ciencias, Dept Cellular & Mol Biol, Sec Biol Celular,Lab Cultivo Tejidos, Montevideo, Uruguay.	arruti@fcien.edu.uy		Zolessi, Flavio/0000-0003-2405-994X; Toledo, Andrea/0000-0002-8310-8636	PEDECIBA (Uruguay); ANII (Uruguay); CSIC/UDELAR [C610]	PEDECIBA (Uruguay); ANII (Uruguay); CSIC/UDELAR	AT was the recipient of PEDECIBA (Uruguay) and ANII (Uruguay) fellowships. This work was partially supported by CSIC/UDELAR (Grant C610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ahn JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026292; AIGNER L, 1993, J CELL BIOL, V123, P417, DOI 10.1083/jcb.123.2.417; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BHAT NR, 1991, J NEUROSCI RES, V30, P447, DOI 10.1002/jnr.490300222; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; CLARKE PR, 1993, FEBS LETT, V336, P37, DOI 10.1016/0014-5793(93)81604-X; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Espanel X, 1997, INT J DEV BIOL, V41, P469; GEORGE DJ, 1992, J BIOL CHEM, V267, P24879; GRAFF JM, 1989, MOL ENDOCRINOL, V3, P1903, DOI 10.1210/mend-3-11-1903; Hamada H, 2003, CHILD NERV SYST, V19, P152, DOI 10.1007/s00381-002-0713-x; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Kakiya N, 2012, J BIOL CHEM, V287, P29362, DOI 10.1074/jbc.M112.340372; Kastner A, 1998, CELL GROWTH DIFFER, V9, P857; Kim HS, 1998, DEV BIOL, V200, P146, DOI 10.1006/dbio.1998.8952; Kim SS, 2002, J CELL SCI, V115, P2465; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; LI JX, 1992, CELL, V70, P791, DOI 10.1016/0092-8674(92)90312-Z; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Manenti S, 1999, BIOCHEM J, V340, P775, DOI 10.1042/0264-6021:3400775; MCLOON SC, 1989, J NEUROSCI, V9, P1424; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; RODRIGUEZPENA A, 1986, BIOCHEM BIOPH RES CO, V140, P379, DOI 10.1016/0006-291X(86)91101-0; Rombouts K, 2012, AM J PHYSL CELL PHYS; Scarlett CO, 2003, DEV BRAIN RES, V144, P25, DOI 10.1016/S0165-3806(03)00155-x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schonwasser DC, 1996, FEBS LETT, V395, P1; SEKI K, 1995, ARCH BIOCHEM BIOPHYS, V316, P673, DOI 10.1006/abbi.1995.1090; Strack S., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/398751; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Swierczynski SL, 1996, J BIOL CHEM, V271, P23424, DOI 10.1074/jbc.271.38.23424; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; Tanabe A, 2012, J CELL PHYSIOL, V227, P618, DOI 10.1002/jcp.22763; TANIGUCHI H, 1994, J BIOL CHEM, V269, P18299; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Toledo A, 2009, BIOCHEM BIOPH RES CO, V383, P353, DOI 10.1016/j.bbrc.2009.04.029; WU WCS, 1982, P NATL ACAD SCI-BIOL, V79, P5249, DOI 10.1073/pnas.79.17.5249; YAMAMOTO H, 1995, J NEUROCHEM, V65, P802; Zolessi FR, 2004, DEV NEUROSCI-BASEL, V26, P371, DOI 10.1159/000082279; Zolessi FR, 2004, J PROTEOME RES, V3, P84, DOI 10.1021/pr034066f; Zolessi FR, 1999, BIOCHEM BIOPH RES CO, V257, P480, DOI 10.1006/bbrc.1999.0490; Zolessi FR, 2001, DEV BRAIN RES, V130, P257, DOI 10.1016/S0165-3806(01)00251-6; Zolessi FR, 2003, THESIS U REPUBLICA M	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62863	10.1371/journal.pone.0062863	http://dx.doi.org/10.1371/journal.pone.0062863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23634231	Green Published, gold, Green Submitted			2022-12-25	WOS:000318341400072
J	Yang, D; James, S; de Faire, U; Alfredsson, L; Jernberg, T; Moradi, T				Yang, Dong; James, Stefan; de Faire, Ulf; Alfredsson, Lars; Jernberg, Tomas; Moradi, Tahereh			Likelihood of Treatment in a Coronary Care Unit for a First-Time Myocardial Infarction in Relation to Sex, Country of Birth and Socioeconomic Position in Sweden	PLOS ONE			English	Article							ETHNIC-DIFFERENCES; RACIAL-DIFFERENCES; THROMBOLYTIC ERA; MEDICAL-CARE; REGISTER; MANAGEMENT; KNOWLEDGE; SYMPTOMS; SURVIVAL; DISEASE	Objective: To examine the relationship between sex, country of birth, level of education as an indicator of socioeconomic position, and the likelihood of treatment in a coronary care unit (CCU) for a first-time myocardial infarction. Design: Nationwide register based study. Setting: Sweden. Patients: 199 906 patients (114 387 men and 85,519 women) of all ages who were admitted to hospital for first-time myocardial infarction between 2001 and 2009. Main outcome measures: Admission to a coronary care unit due to myocardial infarction. Results: Despite the observed increasing access to coronary care units over time, the proportion of women treated in a coronary care unit was 13% less than for men. As compared with men, the multivariable adjusted odds ratio among women was 0.80 (95% confidence interval 0.77 to 0.82). This lower proportion of women treated in a CCU varied by age and year of diagnosis and country of birth. Overall, there was no evidence of a difference in likelihood of treatment in a coronary care unit between Sweden-born and foreign-born patients. As compared with patients with high education, the adjusted odds ratio among patients with a low level of education was 0.93 (95% confidence interval 0.89 to 0.96). Conclusions: Foreign-born and Sweden-born first-time myocardial infarction patients had equal opportunity of being treated in a coronary care unit in Sweden; this is in contrast to the situation in many other countries with large immigrant populations. However, the apparent lower rate of coronary care unit admission after first-time myocardial infarction among women and patients with low socioeconomic position warrants further investigation.	[Yang, Dong; de Faire, Ulf; Alfredsson, Lars; Moradi, Tahereh] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [James, Stefan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Jernberg, Tomas] Karolinska Inst, Dept Med, Cardiol Sect, Stockholm, Sweden; [Moradi, Tahereh] Stockholm Cty Council, Hlth Care Serv, Ctr Epidemiol & Social Med, Stockholm, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; Stockholm County Council	Moradi, T (corresponding author), Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden.	tahereh.moradi@ki.se	James, Stefan K/J-4554-2014; Alfredsson, Lars/AAC-9007-2019	Alfredsson, Lars/0000-0003-1688-6697; Jernberg, Tomas/0000-0003-1695-379X	Swedish Council for Working Life and Social Research [FAS 2008-1128]; Karolinska Institutet Doctoral funds	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet Doctoral funds	This work was supported by research grants from the Swedish Council for Working Life and Social Research [grant number FAS 2008-1128] and Karolinska Institutet Doctoral funds. (http://www.fas.se/) (http://ki.se/ki/jsp/polopoly.jsp?d = 13467&l = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson Joakim, 2009, Acute Card Care, V11, P173, DOI 10.1080/17482940903215190; Ancona C, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-34; Bjorck L, 2010, ARCH INTERN MED, V170, P1375, DOI 10.1001/archinternmed.2010.203; Chen J, 2001, NEW ENGL J MED, V344, P1443, DOI 10.1056/NEJM200105103441906; Cohen MG, 2010, CIRCULATION, V121, P2294, DOI 10.1161/CIRCULATIONAHA.109.922286; Coventry LL, 2011, HEART LUNG, V40, P477, DOI 10.1016/j.hrtlng.2011.05.001; Elo SL, 2009, PUBLIC HEALTH, V123, P52, DOI 10.1016/j.puhe.2008.07.010; Feder G, 2002, BRIT MED J, V324, P511, DOI 10.1136/bmj.324.7336.511; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Groarke J D, 2010, Ir Med J, V103, P308; Henriksson C, 2011, INT J CARDIOL, V147, P224, DOI 10.1016/j.ijcard.2009.08.019; Herlitz J, 2002, INT J CARDIOL, V82, P279, DOI 10.1016/S0167-5273(02)00009-8; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800; Jones Ian, 2008, Intensive Crit Care Nurs, V24, P286, DOI 10.1016/j.iccn.2008.01.005; King KM, 2009, AM J CARDIOL, V103, P1368, DOI 10.1016/j.amjcard.2009.01.344; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McSweeney JC, 2003, CIRCULATION, V108, P2619, DOI 10.1161/01.CIR.0000097116.29625.7C; Rasmussen JN, 2007, CARDIOVASC DRUG THER, V21, P449, DOI 10.1007/s10557-007-6058-7; Ravn-Fischer A, 2012, INT J CARDIOL, V156, P139, DOI 10.1016/j.ijcard.2010.10.023; RIKS-HIA Sc, 2005, RIKS HIA REP; Rosvall M, 2010, SCAND J PUBLIC HEALT, V38, P533, DOI 10.1177/1403494810365109; Rotstein Z, 1999, EUR HEART J, V20, P813, DOI 10.1053/euhj.1998.1452; Socialstyrelsen, 2013, NAT PAT REG; socialstyrelsen, 2000, VARD DIAGN AK HJART; Stenestrand U, 2005, AM HEART J, V149, P82, DOI 10.1016/j.ahj.2004.07.018; Stenestrand Ulf, 2007, Lakartidningen, V104, P1580; Ting HH, 2010, ARCH INTERN MED, V170, P1834, DOI 10.1001/archinternmed.2010.385; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Yang D, 2011, EUR J CARDIOVASC PRE	31	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2013	8	4							e62316	10.1371/journal.pone.0062316	http://dx.doi.org/10.1371/journal.pone.0062316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DM	23638036	Green Published, Green Submitted, gold			2022-12-25	WOS:000318341400052
J	Gericke, J; Ittensohn, J; Mihaly, J; Alvarez, S; Alvarez, R; Torocsik, D; de Lera, AR; Ruhl, R				Gericke, Janine; Ittensohn, Jan; Mihaly, Johanna; Alvarez, Susana; Alvarez, Rosana; Toeroecsik, Daniel; de Lera, Angel R.; Ruehl, Ralph			Regulation of Retinoid-Mediated Signaling Involved in Skin Homeostasis by RAR and RXR Agonists/Antagonists in Mouse Skin	PLOS ONE			English	Article							VITAMIN-A; ACID RECEPTORS; BINDING-PROTEINS; MESSENGER-RNA; X-RECEPTOR; KERATINOCYTE PROLIFERATION; DIFFERENTIAL EXPRESSION; DERMAL FIBROBLASTS; BARRIER FUNCTION; GENE-EXPRESSION	Endogenous retinoids like all-trans retinoic acid (ATRA) play important roles in skin homeostasis and skin-based immune responses. Moreover, retinoid signaling was found to be dysregulated in various skin diseases. The present study used topical application of selective agonists and antagonists for retinoic acid receptors (RARs) alpha and gamma and retinoid-X receptors (RXRs) for two weeks on mouse skin in order to determine the role of retinoid receptor subtypes in the gene regulation in skin. We observed pronounced epidermal hyperproliferation upon application of ATRA and synthetic agonists for RAR gamma and RXR. ATRA and the RAR gamma agonist further increased retinoid target gene expression (Rbp1, Crabp2, Krt4, Cyp26a1, Cyp26b1) and the chemokines Ccl17 and Ccl22. In contrast, a RAR alpha agonist strongly decreased the expression of ATRA-synthesis enzymes, of retinoid target genes, markers of skin homeostasis, and various cytokines in the skin, thereby markedly resembling the expression profile induced by RXR and RAR antagonists. Our results indicate that RAR alpha and RAR gamma subtypes possess different roles in the skin and may be of relevance for the auto-regulation of endogenous retinoid signaling in skin. We suggest that dysregulated retinoid signaling in the skin mediated by RXR, RAR alpha and/or RAR gamma may promote skin-based inflammation and dysregulation of skin barrier properties.	[Gericke, Janine; Ittensohn, Jan; Mihaly, Johanna; Ruehl, Ralph] Univ Debrecen, Dept Biochem & Mol Biol, Debrecen, Hungary; [Mihaly, Johanna; Ruehl, Ralph] Paprika Bioanalyt BT, Debrecen, Hungary; [Alvarez, Susana; Alvarez, Rosana; de Lera, Angel R.] Univ Vigo, Dept Quim Organ, Vigo 36310, Spain; [Toeroecsik, Daniel] Univ Debrecen, Dept Dermatol, Debrecen, Hungary; [Ruehl, Ralph] Hungarian Acad Sci, Apoptosis & Genom Res Grp, Debrecen, Hungary	University of Debrecen; Universidade de Vigo; University of Debrecen; Hungarian Academy of Sciences	Ruhl, R (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Debrecen, Hungary.	ralphruehl@web.de	Rodríguez, Rosana Alvarez/AAA-1998-2019; alvarez, susana/L-9941-2015	Rodríguez, Rosana Alvarez/0000-0001-5608-7561; alvarez, susana/0000-0003-2420-4721; Rodriguez de Lera, Angel/0000-0001-6896-9078; Torocsik, Daniel/0000-0002-6094-6266	European Social fund; DEOEC BMC Korea [4/2011]	European Social fund(European Social Fund (ESF)); DEOEC BMC Korea	The project is implemented through the New Hungary Development Plan, co-financed by the European Social fund. RR is member of the COST actions BM0903 "SkinBAD-skin barrier and atopic diseases'' and BM1007 "Mast Cells and Basophils - Targets for Innovative Therapies''. DT is supported by the DEOEC BMC Korea 4/2011 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2011, DERM-ENDOCRINOL, V3, P107, DOI 10.4161/derm.3.2.15136; ALLENBY G, 1994, J BIOL CHEM, V269, P16689; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Alvarez S, 2009, BIOORGAN MED CHEM, V17, P4345, DOI 10.1016/j.bmc.2009.05.035; Attar PS, 1997, MOL ENDOCRINOL, V11, P792, DOI 10.1210/me.11.6.792; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bourguet W, 2010, METHOD ENZYMOL, V485, P161, DOI [10.1016/S0076-6879(10)85010-4, 10.1016/B978-0-12-381296-4.00010-5]; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Calleja C, 2006, GENE DEV, V20, P1525, DOI 10.1101/gad.368706; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chai XY, 1997, J BIOL CHEM, V272, P33125, DOI 10.1074/jbc.272.52.33125; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Cheepala SB, 2007, MOL CARCINOGEN, V46, P634, DOI 10.1002/mc.20346; Dawson HD, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-16; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; DOLLE P, 1990, DEVELOPMENT, V110, P1133; Dulkys Y, 2001, J INVEST DERMATOL, V116, P498, DOI 10.1046/j.1523-1747.2001.01299.x; ELDER JT, 1991, J INVEST DERMATOL, V96, P425, DOI 10.1111/1523-1747.ep12469889; ELDER JT, 1992, J INVEST DERMATOL, V98, pS36, DOI 10.1111/1523-1747.ep12462180; ELIAS P M, 1987, Dermatologica (Basel), V175, P28; ELIAS PM, 1981, LAB INVEST, V44, P531; Everts HB, 2004, J INVEST DERMATOL, V123, P258, DOI 10.1111/j.0022-202X.2004.23223.x; Everts HB, 2007, J INVEST DERMATOL, V127, P1593, DOI 10.1038/sj.jid.5700753; Feng X, 1997, GENE DEV, V11, P59, DOI 10.1101/gad.11.1.59; FISHER GJ, 1994, J BIOL CHEM, V269, P20629; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Fullerton A, 1997, BRIT J DERMATOL, V137, P234, DOI 10.1046/j.1365-2133.1997.18111911.x; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; GOODMAN DS, 1984, J NATL CANCER I, V73, P1375; Goyette P, 2000, J BIOL CHEM, V275, P16497, DOI 10.1074/jbc.M909382199; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Harris IR, 1997, J INVEST DERMATOL, V109, P783, DOI 10.1111/1523-1747.ep12340962; Holleran WM, 2006, FEBS LETT, V580, P5456, DOI 10.1016/j.febslet.2006.08.039; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Lee DD, 2009, J CELL PHYSIOL, V220, P427, DOI 10.1002/jcp.21784; Li M, 2001, DEVELOPMENT, V128, P675; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mao CG, 2003, J BIOL CHEM, V278, P31184, DOI 10.1074/jbc.M303875200; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Mevorah B, 1996, J AM ACAD DERMATOL, V34, P379, DOI 10.1016/S0190-9622(07)80013-2; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Mihaly J, 2011, EXP DERMATOL, V20, P326, DOI 10.1111/j.1600-0625.2010.01225.x; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Perez E, 2012, BBA-MOL CELL BIOL L, V1821, P57, DOI 10.1016/j.bbalip.2011.04.003; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; REDFERN CPF, 1992, J CELL SCI, V102, P113; Roelandt T., 2009, International Journal of Cosmetic Science, V31, P247, DOI 10.1111/j.1468-2494.2009.00516.x; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Roos TC, 1998, PHARMACOL REV, V50, P315; Ruhl R, 2007, P NUTR SOC, V66, P458, DOI 10.1017/S002966510600509X; Ruhl R, 2007, MOL NUTR FOOD RES, V51, P1173, DOI 10.1002/mnfr.200600277; Ruhl R, 2004, INT J VITAM NUTR RES, V74, P279, DOI 10.1024/0300-9831.74.4.279; Ruhl R, 2006, RAPID COMMUN MASS SP, V20, P2497, DOI 10.1002/rcm.2621; Sabroe I, 1999, J IMMUNOL, V162, P2946; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Saurat JH, 1999, J AM ACAD DERMATOL, V41, pS2, DOI 10.1016/S0190-9622(99)70358-0; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Starrett JE, 1996, US patents, Patent No. [US5559248, 5559248]; Starrett JE, 1998, US patents, Patent No. [US5849923, 5849923]; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Stucker M, 2002, SKIN RES TECHNOL, V8, P133, DOI 10.1034/j.1600-0846.2002.00330.x; Swann RT, 1996, Eur Pat Appl EP, Patent No. 747347; Tan NS, 2005, J STEROID BIOCHEM, V93, P99, DOI 10.1016/j.jsbmb.2004.12.025; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tsang KY, 2005, Disubstituted chalcone oximes having RARgamma retinoid receptor antagonist activity, Patent No. [US 2005/0165095, 20050165095]; Tsang KY, 2007, Patent No. [US 7,253,319 B2, 7253319]; Virtanen M, 2000, J INVEST DERMATOL, V114, P487, DOI 10.1046/j.1523-1747.2000.00901.x; Volakakis N, 2009, BIOCHEM BIOPH RES CO, V390, P1186, DOI 10.1016/j.bbrc.2009.10.116; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; Yoshimura K, 2003, EXP DERMATOL, V12, P28, DOI 10.1034/j.1600-0625.12.s2.5.x; Zusi F. C., 1998, patent, Patent No. [WO9847861, 9847861]	81	38	41	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62643	10.1371/journal.pone.0062643	http://dx.doi.org/10.1371/journal.pone.0062643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638129	Green Published, gold, Green Accepted			2022-12-25	WOS:000318340400118
J	Gomoiu, I; Chatzitheodoridis, E; Vadrucci, S; Walther, I				Gomoiu, Ioana; Chatzitheodoridis, Elias; Vadrucci, Sonia; Walther, Isabelle			The Effect of Spaceflight on Growth of Ulocladium chartarum Colonies on the International Space Station	PLOS ONE			English	Article							ESCHERICHIA-COLI; SIMULATED MICROGRAVITY; CANDIDA-ALBICANS; FILAMENTOUS GROWTH; GENE-EXPRESSION; SURVIVAL; GRAVITY; STRESS; HYPHAE	The objectives of this 14 days experiment were to investigate the effect of spaceflight on the growth of Ulocladium chartarum, to study the viability of the aerial and submerged mycelium and to put in evidence changes at the cellular level. U. chartarum was chosen for the spaceflight experiment because it is well known to be involved in biodeterioration of organic and inorganic substrates covered with organic deposits and expected to be a possible contaminant in Spaceships. Colonies grown on the International Space Station (ISS) and on Earth were analysed post-flight. This study clearly indicates that U. chartarum is able to grow under spaceflight conditions developing, as a response, a complex colony morphotype never mentioned previously. We observed that spaceflight reduced the rate of growth of aerial mycelium, but stimulated the growth of submerged mycelium and of new microcolonies. In Spaceships and Space Stations U. chartarum and other fungal species could find a favourable environment to grow invasively unnoticed in the depth of surfaces containing very small amount of substrate, posing a risk factor for biodegradation of structural components, as well as a direct threat for crew health. The colony growth cycle of U. chartarum provides a useful eukaryotic system for the study of fungal growth under spaceflight conditions.	[Gomoiu, Ioana] Romanian Acad Sci, Inst Biol Bucharest, Bucharest, Romania; [Chatzitheodoridis, Elias] Natl Tech Univ Athens, Sch Min & Met Engn, Athens, Greece; [Vadrucci, Sonia; Walther, Isabelle] Swiss Fed Inst Technol, Space Biol Grp, Zurich, Switzerland	Romanian Academy of Sciences; National Technical University of Athens; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gomoiu, I (corresponding author), Romanian Acad Sci, Inst Biol Bucharest, Bucharest, Romania.	ioana.gomoiu@ibiol.ro			European Commission; Specific Programme "Structuring ERA"; ESA (European Space Agency) project "the International Space Station: a Unique REsearch Infrastructure" (SURE) [SURE-AO2006-022A-RITA 026069/PECS, 98047]	European Commission(European CommissionEuropean Commission Joint Research Centre); Specific Programme "Structuring ERA"; ESA (European Space Agency) project "the International Space Station: a Unique REsearch Infrastructure" (SURE)	This work was supported by the European Commission within the sixth framework programme for RTD activities (2002-2006), Specific Programme "Structuring ERA" support to Research Infrastructures and the ESA (European Space Agency) project "the International Space Station: a Unique REsearch Infrastructure" (SURE) (SURE-AO2006-022A-RITA 026069/PECS Arrangement No. 98047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg Sara D., 2008, Genomics Proteomics & Bioinformatics, V6, P42, DOI 10.1016/S1672-0229(08)60019-4; Andersen B, 2008, INT J FOOD MICROBIOL, V126, P172, DOI 10.1016/j.ijfoodmicro.2008.05.036; [Anonymous], IMAGE J; Benoit MR, 2006, APPL MICROBIOL BIOT, V70, P403, DOI 10.1007/s00253-005-0098-3; Block I, 1986, Adv Space Res, V6, P143, DOI 10.1016/0273-1177(86)90078-5; BOULOC P, 1991, J GEN MICROBIOL, V137, P2839, DOI 10.1099/00221287-137-12-2839; Brown RB, 2002, MICROGRAVITY SCI TEC, V13, P24, DOI 10.1007/BF02881678; BUCHEN B, 1991, PROTOPLASMA, V165, P121, DOI 10.1007/BF01322282; Cartwright JHE, 2009, HFSP J, V3, P77, DOI 10.2976/1.3043738; Ceccato-Antonini SR, 2004, BRAZ J MICROBIOL, V35, P173, DOI 10.1590/S1517-83822004000200001; Collinage AJ, 1974, T BRIT MYCOLOGY SOC, V71, P107; COLOTELO N, 1978, CAN J MICROBIOL, V24, P1173, DOI 10.1139/m78-191; Fang A, 1997, APPL ENVIRON MICROB, V63, P4090, DOI 10.1128/AEM.63.10.4090-4092.1997; GASSET G, 1994, RES MICROBIOL, V145, P111, DOI 10.1016/0923-2508(94)90004-3; Gorbushina AA, 2003, CAN J BOT, V81, P131, DOI 10.1139/B03-011; Gorovits R, 2000, FUNGAL GENET BIOL, V30, P63, DOI 10.1006/fgbi.2000.1198; Granek JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000823; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Holler U, 1999, EUR J ORG CHEM, V1999, P2949; Horneck G, 1996, J BIOTECHNOL, V47, P99, DOI 10.1016/0168-1656(96)01382-X; Horneck G, 2007, ADV SPACE RES, V40, P445, DOI 10.1016/j.asr.2006.12.049; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Juergensmeyer MA, 1999, MICROGRAVITY SCI TEC, V12, P41; Kacena MA, 1997, AVIAT SPACE ENVIR MD, V68, P1104; Kawamura C, 1999, MOL PLANT MICROBE IN, V12, P59, DOI 10.1094/MPMI.1999.12.1.59; Kawano CY, 2005, J BASIC MICROB, V45, P199, DOI 10.1002/jobm.200410496; KERN VD, 1995, ADV SPACE RES, V17, P183; Klaus DM, 1998, TRENDS BIOTECHNOL, V16, P369, DOI 10.1016/S0167-7799(98)01197-4; Lawal A, 2010, ASTROBIOLOGY, V10, P881, DOI 10.1089/ast.2010.0493; Leys N, 2009, ANTON LEEUW INT J G, V96, P227, DOI 10.1007/s10482-009-9360-5; Liang Y, 2010, J PROTEOME RES, V9, P3290, DOI 10.1021/pr900942w; Liu HZ, 2008, APPL MICROBIOL BIOT, V81, P543, DOI 10.1007/s00253-008-1692-y; Makimura K, 2001, MICROBIOL IMMUNOL, V45, P357, DOI 10.1111/j.1348-0421.2001.tb02631.x; Matia I, 2010, J PLANT PHYSIOL, V167, P184, DOI 10.1016/j.jplph.2009.08.012; MCPHEE WJ, 1977, CAN J BOT, V55, P358, DOI 10.1139/b77-045; Miyazaki Y, 2010, FEMS MICROBIOL LETT, V307, P72, DOI 10.1111/j.1574-6968.2010.01966.x; Moore D, 1996, MYCOL RES, V100, P257, DOI 10.1016/S0953-7562(96)80152-3; Novikova N, 2006, RES MICROBIOL, V157, P5, DOI 10.1016/j.resmic.2005.07.010; Novikova ND, 2004, MICROB ECOL, V47, P127, DOI 10.1007/s00248-003-1055-2; Onofri S, 2008, STUD MYCOL, P99, DOI 10.3114/sim.2008.61.10; Ott CM, 2004, MICROBIAL ECOL, V47, P133, DOI 10.1007/s00248-003-1038-3; Purevdorj-Gage B, 2006, APPL ENVIRON MICROB, V72, P4569, DOI 10.1128/AEM.03050-05; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Robson GD, 2006, MED MYCOL, V44, pS109, DOI 10.1080/13693780600835765; Ryba-White M, 2001, PLANT CELL PHYSIOL, V42, P657, DOI 10.1093/pcp/pce082; Samson R. A., 1988, Introduction to food-borne fungi.; Sarantopoulou E, 2011, PLANET SPACE SCI, V59, P63, DOI 10.1016/j.pss.2010.11.002; Satoh K, 2011, MICROBIOL IMMUNOL, V55, P823, DOI 10.1111/j.1348-0421.2011.00386.x; Sviridov SI, 1991, HIM PRIR SOEDIN, V5, P642; Van Mulders SE, 2011, ASTROBIOLOGY, V11, P45, DOI 10.1089/ast.2010.0518; Vesper SJ, 2008, RES MICROBIOL, V159, P432, DOI 10.1016/j.resmic.2008.06.001; Walker SK, 2006, FUNGAL GENET BIOL, V43, P357, DOI 10.1016/j.fgb.2006.01.004; Walther I, 1996, J BIOTECHNOL, V47, P113, DOI 10.1016/0168-1656(96)01375-2; Warenda AJ, 2003, INFECT IMMUN, V71, P4045, DOI 10.1128/IAI.71.7.4045-4051.2003; Watters MK, 2011, FUNGAL BIOL-UK, V115, P296, DOI 10.1016/j.funbio.2010.12.015; Woolley C.M., 2010, GRAVIT SPACE BIOL, V23, P93; Yamazaki T, 2012, MICROBIOL IMMUNOL, V56, P441, DOI 10.1111/j.1348-0421.2012.00471.x	58	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62130	10.1371/journal.pone.0062130	http://dx.doi.org/10.1371/journal.pone.0062130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637980	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400076
J	Chen, XS; Yin, YP; Liu, GG; Wei, WH; Wang, HC; Yu, YL; Mabey, DC; Peeling, RW				Chen, Xiang-Sheng; Yin, Yue-Ping; Liu, Guo-Gu; Wei, Wan-Hui; Wang, Hong-Chun; Yu, Yuan-Lin; Mabey, David C.; Peeling, Rosanna W.			Outreach Syphilis Testing Services by Different Health Providers to Female Sex Workers in Southern China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS	Health providers have played important roles on delivering prevention and care services to control syphilis in China. The current study was aimed to evaluate the performance of different health providers in providing outreach syphilis testing services to female sex workers (FSWs). The current study carried out during April to August 2009 in Liuzhou was aimed to investigate the services delivered by two different types of clinics in China. A total of 1,808 FSWs recruited from sex work venues were included in the study. Prevalence of positive syphilis test (6.4%) among FSWs accessed by the local center for disease control outreach teams (CDC teams) was significantly lower than that (9.3%) among FSWs accessed by the local reproductive health hospital outreach teams (RHH teams). As compared with CDC teams, RHH teams had more FSWs to be successfully referred to the designated STD clinics for further syphilis confirmation and intervention (85.7% vs. 26.7%, P< 0.001). These findings indicate that RHH teams may be more efficient than CDC teams to provide outreach-based services to FSWs. Participation of the reproductive health providers or other medical facilities in outreach services to FSWs should be considered in developing intervention programs in China.	[Chen, Xiang-Sheng; Yin, Yue-Ping; Wei, Wan-Hui; Wang, Hong-Chun] China Ctr Dis Control, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China; [Chen, Xiang-Sheng; Yin, Yue-Ping; Wei, Wan-Hui; Wang, Hong-Chun] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Liu, Guo-Gu; Yu, Yuan-Lin] Hlth Bur Liuzhou City, Liuzhou, Peoples R China; [Mabey, David C.; Peeling, Rosanna W.] London Sch Hyg & Trop Med, London WC1, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; University of London; London School of Hygiene & Tropical Medicine	Chen, XS (corresponding author), China Ctr Dis Control, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China.	chenxs@ncstdlc.org		Mabey, David/0000-0002-0031-8276	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases; Bill and Melinda Gates Foundation [A70577]	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by the Rapid Syphilis Test Introduction Project (UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases A70577 through a grant from the Bill and Melinda Gates Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-111; Chen XS, 2012, NAT C STD CONTR MAY; Minichiello SN, 2011, 2011 INT C FAM PLANN; Sopheab H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-167; State Council of PR China, 2001, CHIN ACT PLAN RED PR; Wang BX, 2012, J INFECT DIS, V206, P907, DOI 10.1093/infdis/jis466; Wang Y, 2011, AIDS BEHAV, V15, P702, DOI 10.1007/s10461-010-9703-2; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5	8	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60626	10.1371/journal.pone.0060626	http://dx.doi.org/10.1371/journal.pone.0060626			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637755	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000318008400007
J	Duning, T; Deppe, M; Brand, E; Stypmann, J; Becht, C; Heidbreder, A; Young, P				Duning, Thomas; Deppe, Michael; Brand, Eva; Stypmann, Joerg; Becht, Charlotte; Heidbreder, Anna; Young, Peter			Brainstem Involvement as a Cause of Central Sleep Apnea: Pattern of Microstructural Cerebral Damage in Patients with Cerebral Microangiopathy	PLOS ONE			English	Article							ANDERSON-FABRY-DISEASE; CHEYNE-STOKES RESPIRATION; ALZHEIMERS-DISEASE; HEART-FAILURE; ONDINES CURSE; DIFFUSION; STROKE; MRI; MANIFESTATIONS; PREVALENCE	Background: The exact underlying pathomechanism of central sleep apnea with Cheyne-Stokes respiration (CSA-CSR) is still unclear. Recent studies have demonstrated an association between cerebral white matter changes and CSA. A dysfunction of central respiratory control centers in the brainstem was suggested by some authors. Novel MR-imaging analysis tools now allow far more subtle assessment of microstructural cerebral changes. The aim of this study was to investigate whether and what severity of subtle structural cerebral changes could lead to CSA-CSR, and whether there is a specific pattern of neurodegenerative changes that cause CSR. Therefore, we examined patients with Fabry disease (FD), an inherited, lysosomal storage disease. White matter lesions are early and frequent findings in FD. Thus, FD can serve as a "model disease" of cerebral microangiopathy to study in more detail the impact of cerebral lesions on central sleep apnea. Patients and Methods: Genetically proven FD patients (n = 23) and age-matched healthy controls (n = 44) underwent a cardio-respiratory polysomnography and brain MRI at 3.0 Tesla. We applied different MR-imaging techniques, ranging from semiquantitative measurement of white matter lesion (WML) volumes and automated calculation of brain tissue volumes to VBM of gray matter and voxel-based diffusion tensor imaging (DTI) analysis. Results: In 5 of 23 Fabry patients (22%) CSA-CSR was detected. Voxel-based DTI analysis revealed widespread structural changes in FD patients when compared to the healthy controls. When calculated as a separate group, DTI changes of CSA-CSR patients were most prominent in the brainstem. Voxel-based regression analysis revealed a significant association between CSR severity and microstructural DTI changes within the brainstem. Conclusion: Subtle microstructural changes in the brainstem might be a neuroanatomical correlate of CSA-CSR in patients at risk of WML. DTI is more sensitive and specific than conventional structural MRI and other advanced MR analyses tools in demonstrating these abnormalities.	[Duning, Thomas; Deppe, Michael; Becht, Charlotte; Heidbreder, Anna; Young, Peter] Univ Hosp Muenster, Dept Neurol, Munster, Germany; [Brand, Eva] Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany; [Stypmann, Joerg] Univ Hosp Muenster, Dept Cardiovasc Med, Div Cardiol, Munster, Germany; [Heidbreder, Anna; Young, Peter] Univ Hosp Muenster, Dept Neurol, Sect Sleepmed, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Duning, T (corresponding author), Univ Hosp Muenster, Dept Neurol, Munster, Germany.	thomas.duning@ukmuenster.de	Deppe, Michael/C-5780-2017	Deppe, Michael/0000-0002-8372-9678; Heidbreder, Anna/0000-0002-9552-7619	Heisenberg professorship [BR 1589/8-2]	Heisenberg professorship(German Research Foundation (DFG))	Parts of the retrospective analysis of clinical data were supported by Genzyme. Eva Brand was supported by a Heisenberg professorship (BR 1589/8-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlDabal L, 2010, LUNG, V188, P5, DOI 10.1007/s00408-009-9200-4; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Aurora RN, 2012, SLEEP, V35, P17, DOI 10.5665/sleep.1580; Bitter T, 2009, EUR J HEART FAIL, V11, P602, DOI 10.1093/eurjhf/hfp057; Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Buechner S, 2008, J NEUROL NEUROSUR PS, V79, P1249, DOI 10.1136/jnnp.2008.143693; Cabrera-Salazar MA, 2005, J PEDIATR-US, V147, P102, DOI 10.1016/j.jpeds.2005.03.004; Charlton RA, 2010, J NEUROL NEUROSUR PS, V81, P13, DOI 10.1136/jnnp.2008.167288; Chen JT, 2004, NEUROIMAGE, V23, P1168, DOI 10.1016/j.neuroimage.2004.07.046; Chen X, 2007, ACTA NEUROCHIR, V149, P1117, DOI 10.1007/s00701-007-1282-2; Cheyne J, 1818, DUBLIN HOSP REP, V12, p[216, 317]; DEBACKER WA, 1995, EUR RESPIR J, V8, P1372, DOI 10.1183/09031936.95.08081372; Deppe M, 2008, NEUROLOGY, V71, P1981, DOI 10.1212/01.wnl.0000336969.98241.17; Deppe M, 2007, INVEST RADIOL, V42, P338, DOI 10.1097/01.rli.0000261935.41188.39; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Dijkhuizen RM, 2012, TRANSL STROKE RES, V3, P36, DOI 10.1007/s12975-011-0143-8; Ding JZ, 2004, SLEEP, V27, P474, DOI 10.1093/sleep/27.3.474; Duning T, 2009, CASE REP NEUROL, V1, P33, DOI 10.1159/000226792; Eckert DJ, 2007, CHEST, V131, P595, DOI 10.1378/chest.06.2287; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007/s10545-007-0521-2; Fein G, 2006, NEUROIMAGE, V30, P1187, DOI 10.1016/j.neuroimage.2005.10.054; Fellgiebel A, 2006, LANCET NEUROL, V5, P791, DOI 10.1016/S1474-4422(06)70548-8; Ferrier K, 2005, CHEST, V128, P2116, DOI 10.1378/chest.128.4.2116; Flemons WW, 2003, CHEST, V124, P1535, DOI 10.1378/chest.124.4.1535; Gascon-Bayarri J, 2010, ACTA NEUROL BELG, V110, P113; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Habek M, 2009, NEUROLOGY, V73, P1923, DOI 10.1212/WNL.0b013e3181c3fd85; Henderson LA, 2006, RESP PHYSIOL NEUROBI, V150, P87, DOI 10.1016/j.resp.2005.08.007; Hermann DM, 2008, STROKE, V39, P62, DOI 10.1161/STROKEAHA.107.494955; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kagitani-Shimono Kuriko, 2009, No To Hattatsu, V41, P349; Keller SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046791; Kitamura K, 2008, NEURORADIOLOGY, V50, P285, DOI 10.1007/s00234-007-0351-9; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; Mared L, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-14; Marin-Sanabria EA, 2006, J CLIN NEUROSCI, V13, P370, DOI 10.1016/j.jocn.2005.03.038; Mohammadi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036851; Nakano K, 2000, BRAIN DEV-JPN, V22, pS5; Nogues MA, 2008, NEUROLOGIST, V14, P273, DOI 10.1097/NRL.0b013e318173e830; Nopmaneejumruslers C, 2005, AM J RESP CRIT CARE, V171, P1048, DOI 10.1164/rccm.200411-1591OC; Oku Y, 2008, RESPIROLOGY, V13, P608, DOI 10.1111/j.1440-1843.2008.01267.x; Oldenburg O, 2007, DEUT MED WOCHENSCHR, V132, P661, DOI 10.1055/s-2007-973599; Olson LG, 1998, J SLEEP RES, V7, P248, DOI 10.1046/j.1365-2869.1998.00123.x; Parenti A, 2005, CLIN NEUROPATHOL, V24, P239; Patel MR, 2005, J AM COLL CARDIOL, V46, P1606, DOI 10.1016/j.jacc.2005.08.030; Pedroso JL, 2009, NEUROL INDIA, V57, P206, DOI 10.4103/0028-3886.51298; Pierre-Louis B, 2009, CARDIOL REV, V17, P31, DOI 10.1097/CRD.0b013e31818adc50; Robbins J, 2005, J CLIN SLEEP MED, V1, P159; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Scheltens P, 1998, EUR NEUROL, V39, P80, DOI 10.1159/000007921; Siccoli MM, 2008, J NEUROL, V255, P1687, DOI 10.1007/s00415-008-0981-9; Sims K, 2009, STROKE, V40, P788, DOI 10.1161/STROKEAHA.108.526293; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Solin P, 2000, AM J RESP CRIT CARE, V162, P2194, DOI 10.1164/ajrccm.162.6.2002024; Stebbins GT, 2009, BEHAV NEUROL, V21, P39, DOI [10.3233/BEN-2009-0234, 10.1155/2009/915041]; van Bruggen T, 2012, PSYCHIAT RES; Van Camp N, 2012, NEUROBIOL AGING, V33, P945, DOI 10.1016/j.neurobiolaging.2010.07.001; Vazir A, 2007, EUR J HEART FAIL, V9, P243, DOI 10.1016/j.ejheart.2006.08.001; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; XIE AL, 1995, AM J RESP CRIT CARE, V152, P1950, DOI 10.1164/ajrccm.152.6.8520761; Yumino Dai, 2008, Proc Am Thorac Soc, V5, P226, DOI 10.1513/pats.200708-129MG	68	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60304	10.1371/journal.pone.0060304	http://dx.doi.org/10.1371/journal.pone.0060304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637744	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400002
J	Mummert, A; Weiss, H; Long, LP; Amigo, JM; Wan, XF				Mummert, Anna; Weiss, Howard; Long, Li-Ping; Amigo, Jose M.; Wan, Xiu-Feng			A Perspective on Multiple Waves of Influenza Pandemics	PLOS ONE			English	Article							H1N1 2009 VIRUS; A H1N1; RECEPTOR SPECIFICITY; HEMAGGLUTININ; MUTATION; TRANSMISSION; INFECTION; VIRULENCE; PROGRAM; CLOSURE	Background: A striking characteristic of the past four influenza pandemic outbreaks in the United States has been the multiple waves of infections. However, the mechanisms responsible for the multiple waves of influenza or other acute infectious diseases are uncertain. Understanding these mechanisms could provide knowledge for health authorities to develop and implement prevention and control strategies. Materials and Methods: We exhibit five distinct mechanisms, each of which can generate two waves of infections for an acute infectious disease. The first two mechanisms capture changes in virus transmissibility and behavioral changes. The third mechanism involves population heterogeneity (e.g., demography, geography), where each wave spreads through one sub-population. The fourth mechanism is virus mutation which causes delayed susceptibility of individuals. The fifth mechanism is waning immunity. Each mechanism is incorporated into separate mathematical models, and outbreaks are then simulated. We use the models to examine the effects of the initial number of infected individuals (e.g., border control at the beginning of the outbreak) and the timing of and amount of available vaccinations. Results: Four models, individually or in any combination, reproduce the two waves of the 2009 H1N1 pandemic in the United States, both qualitatively and quantitatively. One model reproduces the two waves only qualitatively. All models indicate that significantly reducing or delaying the initial numbers of infected individuals would have little impact on the attack rate. Instead, this reduction or delay results in a single wave as opposed to two waves. Furthermore, four of these models also indicate that a vaccination program started earlier than October 2009 (when the H1N1 vaccine was initially distributed) could have eliminated the second wave of infection, while more vaccine available starting in October would not have eliminated the second wave.	[Mummert, Anna] Marshall Univ, Dept Math, Huntington, WV USA; [Weiss, Howard] Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA; [Long, Li-Ping; Wan, Xiu-Feng] Mississippi State Univ, Dept Basic Sci, Mississippi State, MS 39762 USA; [Amigo, Jose M.] Univ Miguel Hernandez, Ctr Invest Operat, Elche, Spain	Marshall University; University System of Georgia; Georgia Institute of Technology; Mississippi State University; Universidad Miguel Hernandez de Elche	Wan, XF (corresponding author), Mississippi State Univ, Dept Basic Sci, Mississippi State, MS 39762 USA.	wan@cvm.msstate.edu	Amigo, Jose/B-2217-2008	Amigo, Jose/0000-0002-1642-1171	United States Department of Justice [2010-DD-BX-0596]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086830] Funding Source: NIH RePORTER	United States Department of Justice; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	L.P. Long and X.-F. Wan were supported by 2010-DD-BX-0596 from the United States Department of Justice to X.-F. Wan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2011, J INFECT DIS, V204, P1008, DOI 10.1093/infdis/jir483; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; CDC, 2010, 2009 H1N1 VACC DOS A; CDC, 2009, UPD CDC EST 2009 H1N; CDC, 2010, 2009 H1N1 FLU; Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Chutinimitkul S, 2010, J VIROL; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Dietz K, 1976, MATH MODELS MED, P1; Drews SJ, 2011, CLIN MICROBIOL INFEC, V17, P582, DOI 10.1111/j.1469-0691.2010.03341.x; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hadeler KP, 2011, MATH BIOSCI, V229, P185, DOI 10.1016/j.mbs.2010.12.004; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jackson C, 2010, AM J EPIDEMIOL, V171, P465, DOI 10.1093/aje/kwp394; Kilander A, 2010, EUROSURVEILLANCE, V4, P15; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Long Li-Ping, 2011, In Silico Biology, V11, P225, DOI 10.3233/ISB-2012-0457; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; MILLER RR, 2010, EURO SURVEILL, V15; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Mummert A, 2013, J MATH BIOL, V67, P483, DOI 10.1007/s00285-012-0558-1; Nei M., 2000, MOL EVOLUTION PHYLOG; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Pollicott M., 2009, ARXIV09073529; Puzelli S, 2010, EMERG INFECT DIS, V16, P863, DOI [10.3201/eid1605.091858, 10.3201/eid1605.091815]; Towers S, 2009, EUROSURVEILLANCE, V14, P6; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Valli MB, 2011, EMERG INFECT DIS, V17, P749, DOI [10.3201/eid1706.100784, 10.3201/eid1704.100784]; Wan YF, 2007, AVIAN DIS, V51, P434, DOI 10.1637/7625-042706R1.1; Wang B, 2011, J CLIN VIROL, V52, P304, DOI 10.1016/j.jcv.2011.08.023; Wang W, 2010, VIROLOGY, V407, P374, DOI 10.1016/j.virol.2010.08.027; Wood JG, 2007, EMERG INFECT DIS, V13, P1038, DOI 10.3201/eid1307.060740; Zheng BJ, 2010, EXP BIOL MED, V235, P981, DOI 10.1258/ebm.2010.010071; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	47	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60343	10.1371/journal.pone.0060343	http://dx.doi.org/10.1371/journal.pone.0060343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637746	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400003
J	Fan, P; Chen, ZX; Tian, P; Liu, W; Jiao, Y; Xue, Y; Bhattacharya, A; Wu, JM; Lu, MF; Guo, YQ; Cui, Y; Gu, WK; Gu, WW; Yue, JM				Fan, Pei; Chen, Zixuan; Tian, Peng; Liu, Wen; Jiao, Yan; Xue, Yi; Bhattacharya, Anindya; Wu, Jianmin; Lu, Meifen; Guo, Yuqi; Cui, Yan; Gu, Weikuan; Gu, Weiwang; Yue, Junming			miRNA Biogenesis Enzyme Drosha Is Required for Vascular Smooth Muscle Cell Survival	PLOS ONE			English	Article							MICRORNA BIOGENESIS; MAMMALIAN MICRORNAS; COMPLEX; MIR-143; DGCR8; PHENOTYPE; PATHWAY	miRNA biogenesis enzyme Drosha cleaves double-stranded primary miRNA by interacting with double-stranded RNA binding protein DGCR8 and processes primary miRNA into precursor miRNA to participate in the miRNA biogenesis pathway. The role of Drosha in vascular smooth muscle cells (VSMCs) has not been well addressed. We generated Drosha conditional knockout (cKO) mice by crossing VSMC-specific Cre mice, SM22-Cre, with Drosha (loxp/loxp) mice. Disruption of Drosha in VSMCs resulted in embryonic lethality at E14.5 with severe liver hemorrhage in mutant embryos. No obvious developmental delay was observed in Drosha cKO embryos. The vascular structure was absent in the yolk sac of Drosha homozygotes at E14.5. Loss of Drosha reduced VSMC proliferation in vitro and in vivo. The VSMC differentiation marker genes, including alpha SMA, SM22, and CNN1, and endothelial cell marker CD31 were significantly downregulated in Drosha cKO mice compared to controls. ERK1/2 mitogen-activated protein kinase and the phosphatidylinositol 3-kinase/AKT were attenuated in VSMCs in vitro and in vivo. Disruption of Drosha in VSMCs of mice leads to the dysregulation of miRNA expression. Using bioinformatics approach, the interactions between dysregulated miRNAs and their target genes were analyzed. Our data demonstrated that Drosha is required for VSMC survival by targeting multiple signaling pathways.	[Fan, Pei; Chen, Zixuan; Tian, Peng; Liu, Wen; Wu, Jianmin; Lu, Meifen; Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA; [Fan, Pei; Chen, Zixuan; Tian, Peng; Liu, Wen; Wu, Jianmin; Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Jiao, Yan; Gu, Weikuan] Univ Tennessee, Ctr Hlth Sci, Dept Orthopaed Surg, Campbell Clin, Memphis, TN 38163 USA; [Xue, Yi] Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA; [Fan, Pei; Chen, Zixuan; Liu, Wen; Gu, Weiwang] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Tian, Peng; Guo, Yuqi] Zhengzhou Univ, Affiliated Hosp 3, Zhengzhou, Henan, Peoples R China; [Bhattacharya, Anindya; Cui, Yan] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Wu, Jianmin] Vet Res Inst, Nanning, Guangxi, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Southern Medical University - China; Zhengzhou University; University of Tennessee System; University of Tennessee Health Science Center	Gu, WW (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.	guww100@163.com; jyue@uthsc.edu	Bhattacharya, Anindya/K-3740-2016	Cui, Yan/0000-0002-7577-6845	NHLBI [HL095957, HD061420]; Eunice Kennedy Shriver National Institute of Child Health & Human Development; UTHSC startup funding; Chinese government [S2012ZR0233, 1021010200004, 2010A011200003, 2012B040304010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061420] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095957] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UTHSC startup funding; Chinese government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by awards HL095957 and HD061420 to J. Yue from NHLBI, the Eunice Kennedy Shriver National Institute of Child Health & Human Development, and by UTHSC startup funding as well as by awards S2012ZR0233,1021010200004, 2010A011200003 and 2012B040304010 to W. Gu from Chinese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen ZX, 2012, J BIOL CHEM, V287, P19018, DOI 10.1074/jbc.M112.351791; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Havens MA, 2012, NUCLEIC ACIDS RES, V40, P4626, DOI 10.1093/nar/gks026; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; Pan YQ, 2011, BIOCHEM BIOPH RES CO, V408, P369, DOI 10.1016/j.bbrc.2011.02.119; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Sibley CR, 2012, NUCLEIC ACIDS RES, V40, P438, DOI 10.1093/nar/gkr722; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yue JM, 2011, ADV DRUG DELIVER REV, V63, P616, DOI 10.1016/j.addr.2011.01.001	31	31	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e60888	10.1371/journal.pone.0060888	http://dx.doi.org/10.1371/journal.pone.0060888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637774	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700009
J	Podell, S; Ugalde, JA; Narasingarao, P; Banfield, JF; Heidelberg, KB; Allen, EE				Podell, Sheila; Ugalde, Juan A.; Narasingarao, Priya; Banfield, Jillian F.; Heidelberg, Karla B.; Allen, Eric E.			Assembly- Driven Community Genomics of a Hypersaline Microbial Ecosystem	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; DIVERSITY; RECONSTRUCTION; PROKARYOTES; SEQUENCES; ARCHAEON; ABUNDANT; WATER; LIFE; TREE	Microbial populations inhabiting a natural hypersaline lake ecosystem in Lake Tyrrell, Victoria, Australia, have been characterized using deep metagenomic sampling, iterative de novo assembly, and multidimensional phylogenetic binning. Composite genomes representing habitat-specific microbial populations were reconstructed for eleven different archaea and one bacterium, comprising between 0.6 and 14.1% of the planktonic community. Eight of the eleven archaeal genomes were from microbial species without previously cultured representatives. These new genomes provide habitat-specific reference sequences enabling detailed, lineage-specific compartmentalization of predicted functional capabilities and cellular properties associated with both dominant and less abundant community members, including organisms previously known only by their 16S rRNA sequences. Together, these data provide a comprehensive, culture-independent genomic blueprint for ecosystem-wide analysis of protein functions, population structure, and lifestyles of co-existing, co-evolving microbial groups within the same natural habitat. The "assembly-driven'' community genomic approach demonstrated in this study advances our ability to push beyond single gene investigations, and promotes genome-scale reconstructions as a tangible goal in the quest to define the metabolic, ecological, and evolutionary dynamics that underpin environmental microbial diversity.	[Podell, Sheila; Ugalde, Juan A.; Narasingarao, Priya; Allen, Eric E.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Heidelberg, Karla B.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Allen, Eric E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Southern California; University of California System; University of California San Diego	Allen, EE (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	eallen@ucsd.edu	Ugalde, Juan Antonio/GLV-2034-2022; Ugalde, Juan/E-7070-2010; Heidelberg, Karla B./L-2096-2017	Ugalde, Juan Antonio/0000-0001-6638-0817; Ugalde, Juan/0000-0001-6638-0817; Heidelberg, Karla B./0000-0002-2645-8269; Banfield, Jill/0000-0001-8203-8771	NSF [0626526]; NIH [R21HG005107-02]; Fulbright- Conicyt fellowship; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005107] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright- Conicyt fellowship; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding for this work was provided by NSF award number 0626526 (JFB, KBH, EEA) and NIH award R21HG005107-02 (EEA). JAU was supported by a Fulbright- Conicyt fellowship. Work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EE, 2005, NAT REV MICROBIOL, V3, P489, DOI 10.1038/nrmicro1157; Andrei AS, 2012, FEMS MICROBIOL LETT, V330, P1, DOI 10.1111/j.1574-6968.2012.02526.x; Atanasova NS, 2011, ENV MICROBIOL; Bastian M., 2009, 3 INT AAAI C WEBLOGS; Bettarel Y, 2011, FEMS MICROBIOL ECOL, V76, P360, DOI 10.1111/j.1574-6941.2011.01054.x; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Bolhuis H, 2004, ENVIRON MICROBIOL, V6, P1287, DOI 10.1111/j.1462-2920.2004.00692.x; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Burns DG, 2010, INT J SYST EVOL MICR, V60, P1196, DOI 10.1099/ijs.0.010017-0; Casanueva A, 2008, EXTREMOPHILES, V12, P651, DOI 10.1007/s00792-008-0170-x; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dyall-Smith ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020968; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Emerson JB, 2012, APPL ENVIRON MICROB, V78, P6309, DOI 10.1128/AEM.01212-12; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Garcia-Heredia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033802; Ghai R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00135; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Holler T, 2011, ISME J, V5, P1946, DOI 10.1038/ismej.2011.77; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kashyap S, 1998, BIOTECHNOL BIOENG, V60, P636, DOI 10.1002/(SICI)1097-0290(19981205)60:5<636::AID-BIT14>3.0.CO;2-A; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Legault BA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-171; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mesbah NM, 2007, MICROB ECOL, V54, P598, DOI 10.1007/s00248-006-9193-y; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Oh D, 2010, EXTREMOPHILES, V14, P161, DOI 10.1007/s00792-009-0295-6; OREN A, 1995, INT J SYST BACTERIOL, V45, P747, DOI 10.1099/00207713-45-4-747; Oren A., 2002, HALOPHILIC MICROORGA; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Pena A, 2010, ISME J, V4, P882, DOI 10.1038/ismej.2010.6; Podell S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r16; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; R Development Core Team, 2008, LANG ENV STAT COMP; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Santos F, 2010, ENVIRON MICROBIOL, V12, P2965, DOI 10.1111/j.1462-2920.2010.02273.x; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharon I, 2012, GENOME RES; Sime-Ngando T, 2010, ENV MICROBIOL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	56	66	67	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61692	10.1371/journal.pone.0061692	http://dx.doi.org/10.1371/journal.pone.0061692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637883	gold, Green Submitted, Green Published			2022-12-25	WOS:000317908700051
J	Diaz-Coranguez, M; Segovia, J; Lopez-Ornelas, A; Puerta-Guardo, H; Ludert, J; Chavez, B; Meraz-Cruz, N; Gonzalez-Mariscal, L				Diaz-Coranguez, Monica; Segovia, Jose; Lopez-Ornelas, Adolfo; Puerta-Guardo, Henry; Ludert, Juan; Chavez, Bibiana; Meraz-Cruz, Noemi; Gonzalez-Mariscal, Lorenza			Transmigration of Neural Stem Cells across the Blood Brain Barrier Induced by Glioma Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR GENE; PRECURSOR CELLS; ENDOTHELIAL-CELLS; GLIOBLASTOMA CELLS; TIGHT JUNCTIONS; IN-VITRO; EXPRESSION; MIGRATION; IDENTIFICATION	Transit of human neural stem cells, ReNcell CX, through the blood brain barrier (BBB) was evaluated in an in vitro model of BBB and in nude mice. The BBB model was based on rat brain microvascular endothelial cells (RBMECs) cultured on Millicell inserts bathed from the basolateral side with conditioned media (CM) from astrocytes or glioma C6 cells. Glioma C6 CM induced a significant transendothelial migration of ReNcells CX in comparison to astrocyte CM. The presence in glioma C6 CM of high amounts of HGF, VEGF, zonulin and PGE(2), together with the low abundance of EGF, promoted ReNcells CX transmigration. In contrast cytokines IFN-alpha, TNF-alpha, IL-12p70, IL-1 beta, IL-6, IL-8 and IL-10, as well as metalloproteinases -2 and -9 were present in equal amounts in glioma C6 and astrocyte CMs. ReNcells expressed the tight junction proteins occludin and claudins 1, 3 and 4, and the cell adhesion molecule CRTAM, while RBMECs expressed occludin, claudins 1 and 5 and CRTAM. Competing CRTAM mediated adhesion with soluble CRTAM, inhibited ReNcells CX transmigration, and at the sites of transmigration, the expression of occludin and claudin-5 diminished in RBMECs. In nude mice we found that ReNcells CX injected into systemic circulation passed the BBB and reached intracranial gliomas, which overexpressed HGF, VEGF and zonulin/prehaptoglobin 2.	[Diaz-Coranguez, Monica; Segovia, Jose; Gonzalez-Mariscal, Lorenza] CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City 14000, DF, Mexico; [Lopez-Ornelas, Adolfo] CINVESTAV, Dept Pharmacol, Mexico City 14000, DF, Mexico; [Puerta-Guardo, Henry; Ludert, Juan; Chavez, Bibiana] CINVESTAV, Dept Infect & Mol Pathogenesis, Mexico City 14000, DF, Mexico; [Diaz-Coranguez, Monica; Meraz-Cruz, Noemi] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico; [Meraz-Cruz, Noemi] Natl Inst Genom Med, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica	Gonzalez-Mariscal, L (corresponding author), CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City 14000, DF, Mexico.	lorenza@fisio.cinvestav.mx	Ludert, Juan E./H-5658-2019; Segovia, Jose V/C-9277-2011; Puerta-Guardo, Henry Nelson/CAG-7706-2022	Segovia, Jose V/0000-0001-8215-4772; Gonzalez-Mariscal, Lorenza/0000-0003-4914-7671; Ludert, Juan Ernesto/0000-0003-4790-7681; Diaz Coranguez, Monica/0000-0002-4485-023X	Mexican Council of Science and Technology; CONACYT (Consejo Nacional de Ciencia y Technologia) [98448, 127357]; CINVESTAV (Centro de Investigaciony de Estudios Avanzados del Instituto Politecnico Nacional); CONACYT [267383, 206882, 225017]	Mexican Council of Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT (Consejo Nacional de Ciencia y Technologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CINVESTAV (Centro de Investigaciony de Estudios Avanzados del Instituto Politecnico Nacional); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Mexican Council of Science and Technology, CONACYT (Consejo Nacional de Ciencia y Technologia) (URL: http://www.conacyt.mx), grants98448 (LGM) and 127357 (JS) and by a multidisciplinary grant from CINVESTAV (Centro de Investigaciony de Estudios Avanzados del Instituto Politecnico Nacional) (URL: http://www.cinvestav.mx). Monica Diaz Coranguez, Adolfo Lopez -Ornelas and Henry Puerta were recipients of doctoral fellowships from CONACYT (267383, 206882 and 225017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; da Silveira FDA, 2012, J CANCER RES CLIN, V138, P1347, DOI 10.1007/s00432-012-1203-5; Ahmed AU, 2010, CURR OPIN MOL THER, V12, P546; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Bexell D, 2012, CANC TREAT REV; Bhowmick DA, 2004, CANCER RES, V64, P1220, DOI 10.1158/0008-5472.CAN-03-3137; BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97; Chirasani SR, 2010, BRAIN, V133, P1961, DOI 10.1093/brain/awq128; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Fazakas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020758; Flores-Benitez D, 2009, AM J PHYSIOL-CELL PH, V297, pC611, DOI 10.1152/ajpcell.00622.2008; Frederick L, 2000, CANCER RES, V60, P1383; Fries G, 1996, J NEUROSURG, V85, P642, DOI 10.3171/jns.1996.85.4.0642; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Garay E, 2010, J CELL BIOCHEM, V111, P111, DOI 10.1002/jcb.22673; Ghosh AK, 2000, J PHARMACOL EXP THER, V295, P802; Gonzalez-Mariscal L, 2012, CURRENT FRONTIERS PE, V1, P3; Gonzalez-Mariscal L, 2011, METHODS MOL BIOL, V762, P213, DOI 10.1007/978-1-61779-185-7_15; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Karyekar CS, 2003, J PHARM SCI-US, V92, P414, DOI 10.1002/jps.10310; Kendall SE, 2008, STEM CELLS, V26, P1575, DOI 10.1634/stemcells.2007-0887; Lara E, 2012, EXP NEUROL, V237, P134, DOI 10.1016/j.expneurol.2012.06.022; Lechuga S, 2010, EXP CELL RES, V316, P3124, DOI 10.1016/j.yexcr.2010.09.008; Li SY, 2007, CANCER LETT, V251, P220, DOI 10.1016/j.canlet.2006.11.024; Lu R, 2000, J NEUROCHEM, V74, P320, DOI 10.1046/j.1471-4159.2000.0740320.x; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Masui K, 2012, NEUROPATH APPL NEURO, V38, P271, DOI 10.1111/j.1365-2990.2011.01238.x; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; Skardelly M, 2009, TRANSL ONCOL, V2, P117, DOI 10.1593/tlo.09115; Smith B.E., 2012, SCIENCE; STECK PA, 1988, CANCER RES, V48, P5433; Stock K, 2012, NAT MED, V18, P1232, DOI 10.1038/nm.2827; Synowitz Michael, 2006, Clin Neurosurg, V53, P336; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Takeuchi H, 2007, NEUROSCI LETT, V426, P69, DOI 10.1016/j.neulet.2007.08.048; TAMIYA T, 1995, GENE THER, V2, P531; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; von Wedel-Parlow M, 2011, BRAIN RES, V1367, P62, DOI 10.1016/j.brainres.2010.09.076; Walzlein JH, 2008, STEM CELLS, V26, P2945, DOI 10.1634/stemcells.2008-0307; Wang CQF, 2007, J CELL BIOL, V178, P549, DOI 10.1083/jcb.200704061; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Wolburg Hartwig, 2006, P175; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; YAMAZAKI H, 1988, MOL CELL BIOL, V8, P1816, DOI 10.1128/MCB.8.4.1816	52	39	39	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60655	10.1371/journal.pone.0060655	http://dx.doi.org/10.1371/journal.pone.0060655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23637756	Green Published, gold, Green Submitted			2022-12-25	WOS:000319109800080
J	Chen, MF; Lin, PY; Wu, CF; Chen, WC; Wu, CT				Chen, Miao-Fen; Lin, Paul-Yang; Wu, Ching-Fang; Chen, Wen-Cheng; Wu, Chun-Te			IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer	PLOS ONE			English	Article							DNA METHYLTRANSFERASE 1; RECEPTOR INHIBITOR; SIGNALING PATHWAYS; PHARYNGEAL CANCER; CELL-MIGRATION; GROWTH-FACTOR; TUMOR-GROWTH; KAPPA-B; INTERLEUKIN-6; INFLAMMATION	Identification of potential tumor markers will help stratify and identify a tumor's malignant potential and its response to specific therapies. IL-6 has been reported to be a predictor in various cancers. Therefore, the present study was performed to highlight the role of IL-6 in improving treatment and determining prognosis of bladder cancer. The human bladder cancer cell lines HT1376 and HT1197 were selected for cell and animal experiments, in which biological changes after experimental manipulation of IL-6 were explored, including tumor behavior and related signaling in bladder cancer. In addition, clinical specimens from 85 patients with muscle-invasive, and 50 with non-muscle invasive bladder cancers were selected for immunohistochemical staining to evaluate the predictive capacity of IL-6 in relation to clinical outcome. The data revealed that IL-6 was overexpressed in the bladder cancer specimens compared with non-malignant tissues at both mRNA and protein levels. Positive staining of IL-6 was significantly correlated with higher clinical stage, higher recurrence rate after curative treatment, and reduced survival rate. Tumor growth and invasive capability were attenuated when IL-6 was blocked. The underlying changes included decreased cell proliferation, less epithelial-mesenchymal transition (EMT), decreased DNA methyltransferase 1 expression and attenuated angiogenesis. In conclusion, our findings showed that IL-6 could be a significant predictor for clinical stage and prognosis of bladder cancer. Moreover, targeting IL-6 may be a promising strategy for treating bladder cancer.	[Chen, Miao-Fen; Chen, Wen-Cheng] Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Chen, Miao-Fen; Lin, Paul-Yang; Wu, Ching-Fang; Chen, Wen-Cheng; Wu, Chun-Te] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Lin, Paul-Yang] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan; [Wu, Ching-Fang] Chang Gung Mem Hosp, Dept Urol, Chiayi, Taiwan; [Wu, Chun-Te] Chang Gung Mem Hosp, Dept Urol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wu, CT (corresponding author), Chang Gung Univ, Coll Med, Tao Yuan, Taiwan.	wucgmh@gmail.com			Chang Gung Memorial Hospital, Taiwan [CMRPG690332-3]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	The work was supported by Chang Gung Memorial Hospital, Taiwan, grant CMRPG690332-3. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MMM, 2009, CURR OPIN PHARMACOL, V9, P396, DOI 10.1016/j.coph.2009.06.010; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Andrews B, 2002, J UROLOGY, V167, P1475, DOI 10.1016/S0022-5347(05)65348-7; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Chen CC, 2011, HEAD NECK-J SCI SPEC, V33, P1132, DOI 10.1002/hed.21586; Chen CC, 2010, INT J RADIAT ONCOL, V76, P1214, DOI 10.1016/j.ijrobp.2009.09.059; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; George DJ, 2005, CLIN CANCER RES, V11, P1815, DOI 10.1158/1078-0432.CCR-04-1560; Gonda TA, 2009, CELL CYCLE, V8, P2005, DOI 10.4161/cc.8.13.8985; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kozin SV, 2012, JNCI-J NATL CANCER I, V104, P899, DOI 10.1093/jnci/djs239; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee SJ, 2008, ONCOL REP, V19, P1007; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin JZ, 2010, CLIN CANCER RES, V16, P77, DOI 10.1158/1078-0432.CCR-08-2362; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Mian BM, 2003, CLIN CANCER RES, V9, P3167; Nakanishi R, 2009, UROL INT, V83, P98, DOI 10.1159/000224877; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-18; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; SCAMBIA G, 1995, BRIT J CANCER, V71, P354, DOI 10.1038/bjc.1995.71; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; SEGUCHI T, 1992, J UROLOGY, V148, P791, DOI 10.1016/S0022-5347(17)36721-6; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wu CT, 2011, CANCER-AM CANCER SOC, V117, P5221, DOI 10.1002/cncr.26150; Zhu ZW, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/528690	36	86	90	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61901	10.1371/journal.pone.0061901	http://dx.doi.org/10.1371/journal.pone.0061901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23637926	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300019
J	Du, W; Yi, Y; Zhang, HB; Bergholz, J; Wu, JF; Ying, HQ; Zhang, YJ; Xiao, ZXJ				Du, Wei; Yi, Yong; Zhang, Haibo; Bergholz, Johann; Wu, Junfeng; Ying, Haoqiang; Zhang, Yujun; Xiao, Zhi-Xiong Jim			Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; HUMAN TUMOR-CELLS; RETINOBLASTOMA PROTEIN; TRANSLATION INITIATION; INDUCED APOPTOSIS; UBIQUITINATION; PATHWAY; P53; DEGRADATION; MECHANISM	The Murine Double Minute 2 (MDM2) protein is a key regulator of cell proliferation and apoptosis that acts primarily by inhibiting the p53 tumor suppressor. Similarly, the PI3-Kinase (PI3K)/AKT pathway is critical for growth factor-mediated cell survival. Additionally, it has been reported that AKT can directly phosphorylate and activate MDM2. In this study, we show that IGF-1 up-regulates MDM2 protein levels in a PI3K/AKT-dependent manner. Inhibition of mTOR by rapamycin or expression of a dominant negative eukaryotic initiation factor 4E binding protein 1 (4EBP1) mutant protein, as well as ablation of eukaryotic initiation factor 4E (eIF4E), efficiently abolishes IGF-1-mediated up-regulation of MDM2. In addition, we show that rapamycin effectively inhibits MDM2 expression and sensitizes cancer cells to chemotherapy. Taken together, this study reveals a novel mechanism by which IGF-1 activates MDM2 via the mTOR pathway, and that pharmacologic inhibition of mTOR combined with chemotherapy may be more effective in treatment of a subset of cancers harboring increased MDM2 activation.	[Du, Wei; Bergholz, Johann; Wu, Junfeng; Xiao, Zhi-Xiong Jim] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Yi, Yong; Zhang, Haibo; Bergholz, Johann; Zhang, Yujun; Xiao, Zhi-Xiong Jim] Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Chengdu 610064, Peoples R China; [Yi, Yong; Zhang, Haibo; Bergholz, Johann; Zhang, Yujun; Xiao, Zhi-Xiong Jim] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Ying, Haoqiang] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Boston University; Sichuan University; Sichuan University; University of Texas System; UTMD Anderson Cancer Center	Xiao, ZXJ (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	jimzx@scu.edu.cn	zhang, haibo/K-5146-2019; Ying, Haoqiang/AAK-4325-2020	Yi, Yong/0000-0003-4664-9692	National Institutes of Health (NIH) [CA79804]; National Key Basic Research Program (973 Program) of China [2012CB910700]; United States Department of Defense Congressionally Directed Medical Research Programs grant [W81XWH-10-1-0161]; NATIONAL CANCER INSTITUTE [R01CA079804] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Basic Research Program (973 Program) of China(National Basic Research Program of China); United States Department of Defense Congressionally Directed Medical Research Programs grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants (CA79804) and by the National Key Basic Research Program (973 Program) of China (2012CB910700) to ZX, and United States Department of Defense Congressionally Directed Medical Research Programs grant (W81XWH-10-1-0161) to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bouska A, 2009, TRENDS BIOCH SCI; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dobbelstein M, 1999, ONCOGENE, V18, P2101, DOI 10.1038/sj.onc.1202512; Du W, 2009, J BIOL CHEM, V284, P26315, DOI 10.1074/jbc.M109.046904; FENG J, 2004, J BIOL CHEM; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gu L, 2003, FEBS LETT, V544, P218, DOI 10.1016/S0014-5793(03)00502-7; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Landers JE, 1997, CANCER RES, V57, P3562; LANDERS JE, 1994, ONCOGENE, V9, P2745; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mills RE, 2008, J IMMUNOL, V181, P3974, DOI 10.4049/jimmunol.181.6.3974; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Moumen A, 2007, DEVELOPMENT, V134, P1443, DOI 10.1242/dev.02820; Murray SA, 2003, ONCOGENE, V22, P1703, DOI 10.1038/sj.onc.1206327; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Ogawara Y, 2002, J BIOL CHEM, V28, P28; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; SHI YF, 1995, CANCER RES, V55, P1982; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Stromberg T, 2004, BLOOD, V103, P3138, DOI 10.1182/blood-2003-05-1543; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wan XL, 2006, NEOPLASIA, V8, P394, DOI 10.1593/neo.05820; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xiong L, 2007, J CELL BIOL, V178, P995, DOI 10.1083/jcb.200703044; Yan HJ, 2006, CANCER RES, V66, P2305, DOI 10.1158/0008-5472.CAN-05-2447; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	44	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63179	10.1371/journal.pone.0063179	http://dx.doi.org/10.1371/journal.pone.0063179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23638184	gold, Green Published, Green Submitted			2022-12-25	WOS:000319077300149
J	Southon, GE; Field, C; Caporn, SJM; Britton, AJ; Power, SA				Southon, Georgina E.; Field, Christopher; Caporn, Simon J. M.; Britton, Andrea J.; Power, Sally A.			Nitrogen Deposition Reduces Plant Diversity and Alters Ecosystem Functioning: Field-Scale Evidence from a Nationwide Survey of UK Heathlands	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN; CALLUNA-VULGARIS; SPECIES RICHNESS; REGIONAL TRENDS; PHOSPHORUS; IMPACTS; BIODIVERSITY; GRASSLANDS; VEGETATION; INDICATORS	Findings from nitrogen (N) manipulation studies have provided strong evidence of the detrimental impacts of elevated N deposition on the structure and functioning of heathland ecosystems. Few studies, however, have sought to establish whether experimentally observed responses are also apparent under natural, field conditions. This paper presents the findings of a nationwide field-scale evaluation of British heathlands, across broad geographical, climatic and pollution gradients. Fifty two heathlands were selected across an N deposition gradient of 5.9 to 32.4 kg ha(-1) yr(-1). The diversity and abundance of higher and lower plants and a suite of biogeochemical measures were evaluated in relation to climate and N deposition indices. Plant species richness declined with increasing temperature and N deposition, and the abundance of nitrophilous species increased with increasing N. Relationships were broadly similar between upland and lowland sites, with the biggest reductions in species number associated with increasing N inputs at the low end of the deposition range. Both oxidised and reduced forms of N were associated with species declines, although reduced N appears to be a stronger driver of species loss at the functional group level. Plant and soil biochemical indices were related to temperature, rainfall and N deposition. Litter C: N ratios and enzyme (phenol-oxidase and phosphomonoesterase) activities had the strongest relationships with site N inputs and appear to represent reliable field indicators of N deposition. This study provides strong, field-scale evidence of links between N deposition - in both oxidised and reduced forms - and widespread changes in the composition, diversity and functioning of British heathlands. The similarity of relationships between upland and lowland environments, across broad spatial and climatic gradients, highlights the ubiquity of relationships with N, and suggests that N deposition is contributing to biodiversity loss and changes in ecosystem functioning across European heathlands.	[Southon, Georgina E.; Power, Sally A.] Imperial Coll London, Div Biol, Ascot, Berks, England; [Field, Christopher; Caporn, Simon J. M.] Manchester Metropolitan Univ, Div Biol & Conservat Ecol, Manchester M15 6BH, Lancs, England; [Britton, Andrea J.] James Hutton Inst, Aberdeen, Scotland; [Power, Sally A.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia	Imperial College London; Manchester Metropolitan University; James Hutton Institute; Western Sydney University	Power, SA (corresponding author), Imperial Coll London, Div Biol, Ascot, Berks, England.	s.power@uws.edu.au	Power, Sally/I-2923-2012; Britton, Andrea J/E-7568-2013	Power, Sally/0000-0002-2723-8671; Britton, Andrea J/0000-0002-0603-7432	UK Department for Environment, Food and Rural Affairs, under the UKREATE programme; Natural Environment Research Council [NE/G002363/1] Funding Source: researchfish; NERC [NE/G002363/1] Funding Source: UKRI	UK Department for Environment, Food and Rural Affairs, under the UKREATE programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the UK Department for Environment, Food and Rural Affairs, under the UKREATE programme (http://ukreate.defra.gov.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby Bent, 1994, P284; AERTS R, 1990, OIKOS, V57, P310, DOI 10.2307/3565959; BADDELEY JA, 1994, ENVIRON POLLUT, V84, P189, DOI 10.1016/0269-7491(94)90102-3; Barker C, 2001, THESIS IMPERIAL COLL; Barker CG, 2004, BIOL CONSERV, V120, P41, DOI 10.1016/j.biocon.2004.01.024; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bobbink R., 1993, Heathlands: patterns and processes in a changing environment., P25; Britton AJ, 2007, J APPL ECOL, V44, P125, DOI 10.1111/j.1365-2664.2006.01251.x; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Carroll JA, 2003, ENVIRON POLLUT, V121, P363, DOI 10.1016/S0269-7491(02)00241-5; Carroll JA, 1999, NEW PHYTOL, V141, P423, DOI 10.1046/j.1469-8137.1999.00358.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Crawley MJ., 2007, R BOOK; Criquet S, 2004, SOIL BIOL BIOCHEM, V36, P1111, DOI 10.1016/j.soilbio.2004.02.021; Dahlman L, 2003, PLANTA, V217, P41, DOI 10.1007/s00425-003-0977-8; Dupre C, 2001, THESIS ACTA U UPSALI; Edmondson JL, 2010, SCI TOTAL ENVIRON, V408, P6202, DOI 10.1016/j.scitotenv.2010.08.060; Fenn ME, 2008, ENVIRON POLLUT, V155, P492, DOI 10.1016/j.envpol.2008.03.019; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Giller K. E., 2005, Biological diversity and function in soils, P295, DOI 10.1017/CBO9780511541926.017; Gilliam F.S., 2003, HERBACEOUS LAYER FOR, P48; GIMINGHAM C H, 1972, P266; Godefroid S, 2003, LANDSCAPE URBAN PLAN, V65, P169, DOI 10.1016/S0169-2046(03)00013-6; Gordon C, 2001, NEW PHYTOL, V149, P461, DOI 10.1046/j.1469-8137.2001.00053.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Green ER, 2013, SOIL BIOL BIOCHEM, V57, P775, DOI 10.1016/j.soilbio.2012.08.025; HALLINGBACK T, 1992, BIOL CONSERV, V59, P163, DOI 10.1016/0006-3207(92)90577-A; Hauck M, 2010, ENVIRON POLLUT, V158, P1127, DOI 10.1016/j.envpol.2009.12.036; Heil G. W., 1993, Heathlands: Patterns and processes in a changing environment., P201; Hill MO., 2007, BRYOATT ATTRIBUTES B; Hogan EJ, 2010, NEW PHYTOL, V186, P911, DOI 10.1111/j.1469-8137.2010.03222.x; Hyvarinen M, 1998, NEW PHYTOL, V140, P519, DOI 10.1111/j.1469-8137.1998.00292.x; Jamieson N, 1998, BIOL FERT SOILS, V27, P267, DOI 10.1007/s003740050432; Johnson D, 1998, ENVIRON POLLUT, V103, P239, DOI 10.1016/S0269-7491(98)00115-8; Jones AG, 2012, J ECOL, V100, P331, DOI 10.1111/j.1365-2745.2011.01911.x; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Kleijn D, 2008, J APPL ECOL, V45, P680, DOI 10.1111/j.1365-2664.2007.01444.x; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Matejko M, 2009, ENVIRON SCI POLICY, V12, P882, DOI 10.1016/j.envsci.2009.08.005; MORECROFT MD, 1992, J ECOL, V80, P49, DOI 10.2307/2261062; Nordin A, 2009, ECOSYSTEMS, V12, P1204, DOI 10.1007/s10021-009-9287-8; O'Sullivan OS, 2011, GLOBAL CHANGE BIOL, V17, P2615, DOI 10.1111/j.1365-2486.2011.02403.x; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Phoenix GK, 2003, GLOBAL CHANGE BIOL, V9, P1309, DOI 10.1046/j.1365-2486.2003.00660.x; Phoenix GK., 2004, WATER AIR SOIL POLL, V4, P159, DOI [10.1007/s11267-004-3026-0, DOI 10.1007/S11267-004-3026-0]; Pilkington MG, 2007, ENVIRON POLLUT, V148, P191, DOI 10.1016/j.envpol.2006.10.034; Pilkington MG, 2005, ENVIRON POLLUT, V138, P473, DOI 10.1016/j.envpol.2005.04.011; Pitcairn C, 2006, ENVIRON POLLUT, V144, P941, DOI 10.1016/j.envpol.2006.01.049; Power S. A., 2001, TheScientificWorldJOURNAL, V1, P714, DOI 10.1100/tsw.2001.379; Power SA, 2010, ATMOS ENVIRON, V44, P1772, DOI 10.1016/j.atmosenv.2010.01.034; Power SA, 1998, ENVIRON POLLUT, V102, P27, DOI 10.1016/S0269-7491(98)80011-0; Power SA, 1998, NEW PHYTOL, V138, P663, DOI 10.1046/j.1469-8137.1998.00160.x; Power SA, 2006, GLOBAL CHANGE BIOL, V12, P1241, DOI 10.1111/j.1365-2486.2006.01161.x; Remke E, 2009, ENVIRON POLLUT, V157, P792, DOI 10.1016/j.envpol.2008.11.020; RoTAP, 2012, REV TRANSB AIR POLL; Rowe EC, 2008, ENVIRON POLLUT, V155, P201, DOI 10.1016/j.envpol.2007.12.008; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schimel J. P., 2005, Biological diversity and function in soils, P171, DOI 10.1017/CBO9780511541926.011; Sheppard LJ, 2004, PLANT ECOPH, V3, P65; Sheppard LJ, 2009, WATER AIR SOIL POLL, V4, P197; Siebel H.N., 2005, BUXBAUMIELLA, V73, P26; Sinsabaugh RL, 2002, BOOK SOIL P, P249; Smart SM, 2003, J ENVIRON MANAGE, V67, P239, DOI 10.1016/S0301-4797(02)00177-9; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Southon GE, 2012, GLOBAL CHANGE BIOL, V18, P2824, DOI 10.1111/j.1365-2486.2012.02732.x; Stevens CJ, 2009, BIOL CONSERV, V142, P2069, DOI 10.1016/j.biocon.2009.04.002; Stevens CJ, 2006, GLOBAL CHANGE BIOL, V12, P1823, DOI 10.1111/j.1365-2486.2006.01217.x; Stevens CJ, 2011, ENVIRON POLLUT, V159, P665, DOI 10.1016/j.envpol.2010.12.008; Stevens CJ, 2010, ENVIRON POLLUT, V158, P2940, DOI 10.1016/j.envpol.2010.06.006; Stevens CJ, 2009, ENVIRON POLLUT, V157, P313, DOI 10.1016/j.envpol.2008.06.033; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Strengbom JA, 2001, FUNCTIONAL ECOLOGY, V15, P454; Sutton MA., 2004, 356 JNCC; van Vuuren DP, 2006, ECOL SOC, V11; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Watson RT, 1995, CLIMATE CHANGE 1995; Wells ED, 1997, SCAND J FOREST RES, V12, P138, DOI 10.1080/02827589709355395	80	56	57	4	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e59031	10.1371/journal.pone.0059031	http://dx.doi.org/10.1371/journal.pone.0059031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23637736	gold, Green Published, Green Submitted			2022-12-25	WOS:000321662800001
J	Atanu, FO; Oviedo-Orta, E; Watson, KA				Atanu, Francis O.; Oviedo-Orta, Ernesto; Watson, Kimberly A.			A Novel Transport Mechanism for MOMP in Chlamydophila pneumoniae and Its Putative Role in Immune-Therapy	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; I BINDING PEPTIDES; CHLAMYDIA-PNEUMONIAE; ALIGNMENT ALGORITHM; FLEXIBLE DOCKING; PREDICTION; EXPRESSION; INFECTION; QUALITY; RISK	Major outer membrane proteins (MOMPs) of Gram negative bacteria are one of the most intensively studied membrane proteins. MOMPs are essential for maintaining the structural integrity of bacterial outer membranes and in adaptation of parasites to their hosts. There is evidence to suggest a role for purified MOMP from Chlamydophila pneumoniae and corresponding MOMP-derived peptides in immune-modulation, leading to a reduced atherosclerotic phenotype in apoE(-/-) mice via a characteristic dampening of MHC class II activity. The work reported herein tests this hypothesis by employing a combination of homology modelling and docking to examine the detailed molecular interactions that may be responsible. A three-dimensional homology model of the C. pneumoniae MOMP was constructed based on the 14 transmembrane beta-barrel crystal structure of the fatty acid transporter from Escherichia coli, which provides a plausible transport mechanism for MOMP. Ligand docking experiments were used to provide details of the possible molecular interactions driving the binding of MOMP-derived peptides to MHC class II alleles known to be strongly associated with inflammation. The docking experiments were corroborated by predictions from conventional immuno-informatic algorithms. This work supports further the use of MOMP in C. pneumoniae as a possible vaccine target and the role of MOMP-derived peptides as vaccine candidates for immune-therapy in chronic inflammation that can result in cardiovascular events.	[Atanu, Francis O.; Watson, Kimberly A.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Oviedo-Orta, Ernesto] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Reading; University of Surrey	Watson, KA (corresponding author), Univ Reading, Sch Biol Sci, Whiteknights Campus, Reading, Berks, England.	k.a.watson@reading.ac.uk	OVIEDO-ORTA, Ernesto/L-4846-2018; Atanu, Francis/GPK-1716-2022; Watson, Kimberly/AAL-7548-2020	OVIEDO-ORTA, Ernesto/0000-0003-1323-3316; Atanu, Francis/0000-0002-0817-0106; Watson, Kimberly/0000-0002-9987-8539	Tertiary Education Trust Fund of Nigeria	Tertiary Education Trust Fund of Nigeria	FO Atanu received funding from the Tertiary Education Trust Fund of Nigeria for a PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BAEHR W, 1988, P NATL ACAD SCI USA, V85, P4000, DOI 10.1073/pnas.85.11.4000; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bermudex-Fajardo A, 2011, IMMUNOBIOLOGY, V216, P152, DOI 10.1016/j.imbio.2010.06.004; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; CAMPBELL LA, 1990, INFECT IMMUN, V58, P93, DOI 10.1128/IAI.58.1.93-97.1990; Cherian SM, 2006, INDIAN J THORAC CARD, V22, P126, DOI 10.1007/s12055-006-0020-3; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DASCHER C, 1993, MICROB PATHOGENESIS, V15, P455, DOI 10.1006/mpat.1993.1094; de Almeida DE, 2011, FEBS LETT, V585, P3619, DOI 10.1016/j.febslet.2011.03.035; Deniset JF, 2010, FUND CLIN PHARMACOL, V24, P607, DOI 10.1111/j.1472-8206.2010.00863.x; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Donnes P, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-25; El Kadri R, 2010, ATHEROSCLEROSIS, V213, pE6, DOI 10.1016/j.atherosclerosis.2010.08.003; El Kadri R, 2010, ATHEROSCLEROSIS, V213, pE13, DOI 10.1016/j.atherosclerosis.2010.08.026; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Findlay HE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-5; Freeman TC, 2011, BIOPHYS J, V100, P319; Freeman TC, 2011, BBA-BIOMEMBRANES, V1808, P287, DOI 10.1016/j.bbamem.2010.09.008; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Guan XG, 2010, IUBMB LIFE, V62, P222, DOI 10.1002/iub.311; Hauer AD, 2006, CARDIOVASC RES, V69, P280, DOI 10.1016/j.cardiores.2005.07.011; Heinz E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-634; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hughes ES, 2001, INFECT IMMUN, V69, P1671, DOI 10.1128/IAI.69.3.1671-1678.2001; ILBACK NG, 1990, AM J PATHOL, V136, P159; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klein M, 2003, J CLIN MICROBIOL, V41, P1957, DOI 10.1128/JCM.41.5.1957-1962.2003; Kumar S, 2007, CLIN INFECT DIS, V44, P568, DOI 10.1086/511076; LABANOWSKI J, 1986, QUANT STRUCT-ACT REL, V5, P138, DOI 10.1002/qsar.19860050403; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lata Sneh, 2007, V409, P201, DOI 10.1007/978-1-60327-118-9_14; Leinonen M, 2000, J INFECT DIS, V181, pS414, DOI 10.1086/315624; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MELGOSA MP, 1991, INFECT IMMUN, V59, P2195, DOI 10.1128/IAI.59.6.2195-2199.1991; Menconi F, 2010, P NATL ACAD SCI USA, V107, P16899, DOI 10.1073/pnas.1009511107; Mundkur LA, 2012, EXP CLIN CARDIOL, V17, P63; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Nuccitelli A, 2011, P NATL ACAD SCI USA, V108, P10278, DOI 10.1073/pnas.1106590108; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Penttila T, 2000, VACCINE, V19, P1256, DOI 10.1016/S0264-410X(00)00237-1; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Puolakkainen M, 1999, CR ACAD SCI III-VIE, V322, P973, DOI 10.1016/S0764-4469(00)87195-4; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; Roche DB, 2011, NUCLEIC ACIDS RES, V39, pW171, DOI 10.1093/nar/gkr184; ROSENFELD R, 1995, ANNU REV BIOPH BIOM, V24, P677, DOI 10.1146/annurev.bb.24.060195.003333; Rosenfeld R, 1995, GENET ANAL-BIOMOL E, V12, P1, DOI 10.1016/1050-3862(95)00107-7; Schrodinger L., 2020, PYMOL; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Stark A, 2010, ATHEROSCLEROSIS, V213, pE10, DOI 10.1016/j.atherosclerosis.2010.08.018; Streblow DN, 2001, J NUTR, V131, p2798S, DOI 10.1093/jn/131.10.2798S; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Sukumaran S, 2005, FEBS LETT, V579, P2546, DOI 10.1016/j.febslet.2005.03.059; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomlinson SM, 2009, ANTIVIR RES, V82, P110, DOI 10.1016/j.antiviral.2009.02.190; Valassina M, 2001, J MED MICROBIOL, V50, P228, DOI 10.1099/0022-1317-50-3-228; van den Berg B, 2010, CHEMBIOCHEM, V11, P1339, DOI 10.1002/cbic.201000105; Vehmaan-Kreula P, 2001, ARTERIOSCL THROM VAS, V21, pE1, DOI 10.1161/01.ATV.21.1.e1; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang Y, 2006, PROTEIN SCI, V15, P122, DOI 10.1110/ps.051616206; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou QA, 2003, HUM IMMUNOL, V64, P857, DOI 10.1016/S0198-8859(03)00143-5	72	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61139	10.1371/journal.pone.0061139	http://dx.doi.org/10.1371/journal.pone.0061139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637791	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400012
J	Mou, XZ; Lu, XX; Jacob, J; Sun, SL; Heath, R				Mou, Xiaozhen; Lu, Xinxin; Jacob, Jisha; Sun, Shulei; Heath, Robert			Metagenomic Identification of Bacterioplankton Taxa and Pathways Involved in Microcystin Degradation in Lake Erie	PLOS ONE			English	Article							BACTERIAL-DEGRADATION; MICROBIAL COMMUNITY; TOXIC CYANOBACTERIA; ENZYMATIC PATHWAY; WATER; GENE; COASTAL; CARBON; LR; BIODEGRADATION	Cyanobacterial harmful blooms (CyanoHABs) that produce microcystins are appearing in an increasing number of freshwater ecosystems worldwide, damaging quality of water for use by human and aquatic life. Heterotrophic bacteria assemblages are thought to be important in transforming and detoxifying microcystins in natural environments. However, little is known about their taxonomic composition or pathways involved in the process. To address this knowledge gap, we compared the metagenomes of Lake Erie free-living bacterioplankton assemblages in laboratory microcosms amended with microcystins relative to unamended controls. A diverse array of bacterial phyla were responsive to elevated supply of microcystins, including Acidobacteria, Actinobacteria, Bacteroidetes, Planctomycetes, Proteobacteria of the alpha, beta, gamma, delta and epsilon subdivisions and Verrucomicrobia. At more detailed taxonomic levels, Methylophilales (mainly in genus Methylotenera) and Burkholderiales (mainly in genera Bordetella, Burkholderia, Cupriavidus, Polaromonas, Ralstonia, Polynucleobacter and Variovorax) of Betaproteobacteria were suggested to be more important in microcystin degradation than Sphingomonadales of Alphaproteobacteria. The latter taxa were previously thought to be major microcystin degraders. Homologs to known microcystin-degrading genes (mlr) were not overrepresented in microcystin-amended metagenomes, indicating that Lake Erie bacterioplankton might employ alternative genes and/or pathways in microcystin degradation. Genes for xenobiotic metabolism were overrepresented in microcystin-amended microcosms, suggesting they are important in bacterial degradation of microcystin, a phenomenon that has been identified previously only in eukaryotic systems.	[Mou, Xiaozhen; Lu, Xinxin; Jacob, Jisha; Heath, Robert] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Sun, Shulei] Univ Calif San Diego, Ctr Res Biol Syst, CAMERA Project, San Diego, CA 92103 USA; [Sun, Shulei] Univ Calif San Diego, Calif Inst Telecommun & Informat Technol, San Diego, CA 92103 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of California System; University of California San Diego; University of California System; University of California San Diego	Mou, XZ (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	xmou@kent.edu	Mou, Xiaozhen/AAG-2806-2020	Jacob, Jisha/0000-0002-6594-4673	Lake Erie Protection Fund [SG374-09]; KSU Farris Family Innovation Research Fellowship	Lake Erie Protection Fund; KSU Farris Family Innovation Research Fellowship	This study was supported by Lake Erie Protection Fund SG374-09 and KSU Farris Family Innovation Research Fellowship to XM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008; Bourne DG, 1996, APPL ENVIRON MICROB, V62, P4086, DOI 10.1128/AEM.62.11.4086-4094.1996; Bourne DG, 2001, ENVIRON TOXICOL, V16, P523, DOI 10.1002/tox.10013; Bridgewater L.L., 2017, STANDARD METHODS EXA, V23rd; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Carlson CA, 1999, AQUAT MICROB ECOL, V19, P229, DOI 10.3354/ame019229; Carmichael W, 2008, ADV EXP MED BIOL, V619, P105, DOI 10.1007/978-0-387-75865-7_4; Chen C, 2011, PROCEDIA ENGINEER, V18, DOI 10.1016/j.proeng.2011.11.054; Chen W, 2008, WATER RES, V42, P763, DOI 10.1016/j.watres.2007.08.007; CHRISTIAN JR, 1994, J GEOPHYS RES-OCEANS, V99, P14269, DOI 10.1029/94JC00681; Christoffersen K, 2002, AQUAT MICROB ECOL, V27, P125, DOI 10.3354/ame027125; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dziallas C, 2011, ENVIRON MICROBIOL, V13, P1632, DOI 10.1111/j.1462-2920.2011.02479.x; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Eleuterio L, 2010, TOXICON, V55, P1434, DOI 10.1016/j.toxicon.2010.02.020; Elliott ET, 1986, PERSPECTIVES MICROBI, P472; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Ho L, 2007, WATER RES, V41, P4685, DOI 10.1016/j.watres.2007.06.057; Ho LN, 2007, TOXICON, V50, P438, DOI 10.1016/j.toxicon.2007.03.021; Ho L, 2010, J HAZARD MATER, V180, P628, DOI [10.1016/j.hazmat.2010.04.081, 10.1016/j.jhazmat.2010.04.081]; Hoefel D, 2009, APPL ENVIRON MICROB, V75, P5167, DOI 10.1128/AEM.00036-09; Hu LB, 2009, NEW BIOTECHNOL, V26, P205, DOI 10.1016/j.nbt.2009.09.001; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hwang SJ, 1999, J PLANKTON RES, V21, P699, DOI 10.1093/plankt/21.4.699; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; Jimbo Yusuke, 2010, Journal of Water and Environmental Technology, V8, P193, DOI 10.2965/jwet.2010.193; Lavrentyev PJ, 2004, MICROB ECOL, V48, P567, DOI 10.1007/s00248-004-0250-0; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P1725; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Lemes GAF, 2008, ECOTOX ENVIRON SAFE, V69, P358, DOI 10.1016/j.ecoenv.2007.03.013; Li N, 2011, CHIN J OCEANOL LIMN, V29, P505, DOI 10.1007/s00343-011-0056-0; Manage PM, 2009, APPL ENVIRON MICROB, V75, P6924, DOI 10.1128/AEM.01928-09; Manage PM, 2010, INTERDISCIPLINARY ST, V3, P97; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Mou X, 2013, J GREAT LAK IN PRESS; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Mou XZ, 2005, APPL ENVIRON MICROB, V71, P1405, DOI 10.1128/AEM.71.3.1405-1416.2005; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Philosof A, 2009, ENVIRON MICROBIOL, V11, P3189, DOI 10.1111/j.1462-2920.2009.02024.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rinta-Kanto JM, 2006, APPL ENVIRON MICROB, V72, P5083, DOI 10.1128/AEM.00312-06; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Saito T, 2003, FEMS MICROBIOL LETT, V229, P271, DOI 10.1016/S0378-1097(03)00847-4; Shimizu K, 2012, J BIOSCI BIOENG, V114, P630, DOI 10.1016/j.jbiosc.2012.07.004; Troussellier M, 1997, AQUAT MICROB ECOL, V13, P113, DOI 10.3354/ame013113; Vuilleumier S, 1997, J BACTERIOL, V179, P1431, DOI 10.1128/jb.179.5.1431-1441.1997; Wilhelm SW, 2011, HARMFUL ALGAE, V10, P207, DOI 10.1016/j.hal.2010.10.001; Wilhelm SW, 2000, CAN J FISH AQUAT SCI, V57, P317, DOI 10.1139/cjfas-57-2-317	52	79	85	4	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61890	10.1371/journal.pone.0061890	http://dx.doi.org/10.1371/journal.pone.0061890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637924	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400057
J	Rebelo, M; Sousa, C; Shapiro, HM; Mota, MM; Grobusch, MP; Hanscheid, T				Rebelo, Maria; Sousa, Claudia; Shapiro, Howard M.; Mota, Maria M.; Grobusch, Martin P.; Haenscheid, Thomas			A Novel Flow Cytometric Hemozoin Detection Assay for Real-Time Sensitivity Testing of Plasmodium falciparum	PLOS ONE			English	Article							SYBR GREEN I; ANTIMALARIAL-DRUG EFFICACY; RICH PROTEIN-II; MALARIA DIAGNOSIS; RESISTANT MALARIA; PHARMACODYNAMIC PROPERTIES; HEMATOLOGY ANALYZER; VITRO; ARTEMISININ; HAEMOZOIN	Resistance of Plasmodium falciparum to almost all antimalarial drugs, including the first-line treatment with artemisinins, has been described, representing an obvious threat to malaria control. In vitro antimalarial sensitivity testing is crucial to detect and monitor drug resistance. Current assays have been successfully used to detect drug effects on parasites. However, they have some limitations, such as the use of radioactive or expensive reagents or long incubation times. Here we describe a novel assay to detect antimalarial drug effects, based on flow cytometric detection of hemozoin (Hz), which is rapid and does not require any additional reagents. Hz is an optimal parasite maturation indicator since its amount increases as the parasite matures. Due to its physical property of birefringence, Hz depolarizes light, hence it can be detected using optical methods such as flow cytometry. A common flow cytometer was adapted to detect light depolarization caused by Hz. Synchronized in vitro cultures of P. falciparum were incubated for 48 hours with several antimalarial drugs. Analysis of depolarizing events, corresponding to parasitized red blood cells containing Hz, allowed the detection of parasite maturation. Moreover, chloroquine resistance and the inhibitory effect of all antimalarial drugs tested, except for pyrimethamine, could be determined as early as 18 to 24 hours of incubation. At 24 hours incubation, 50% inhibitory concentrations (IC50) were comparable to previously reported values. These results indicate that the reagent-free, real-time Hz detection assay could become a novel assay for the detection of drug effects on Plasmodium falciparum.	[Rebelo, Maria; Sousa, Claudia; Mota, Maria M.; Haenscheid, Thomas] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal; [Rebelo, Maria; Grobusch, Martin P.; Haenscheid, Thomas] Albert Schweitzer Hosp, Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Shapiro, Howard M.] Ctr Microbial Cytometry, West Newton, MA USA; [Grobusch, Martin P.] Amsterdam Med Ctr, Ctr Trop & Travel Med, Dept Infect Dis, Amsterdam, Netherlands; [Grobusch, Martin P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany	Universidade de Lisboa; University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen	Hanscheid, T (corresponding author), Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.	t.hanscheid@fm.ul.pt	Mota, Maria/AAF-2048-2019; Hanscheid, Thomas/AAT-3639-2021	Hanscheid, Thomas/0000-0001-6353-9132; Mota, Maria Manuel/0000-0002-2858-1041; Rebelo, Maria/0000-0003-2715-7182	Luso-American Foundation (FLAD-LACR grant) [B-A.V-109-09/07]	Luso-American Foundation (FLAD-LACR grant)	This work was supported by the Luso-American Foundation (FLAD-LACR grant: B-A.V-109-09/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun OO, 2010, PARASITOL RES, V106, P933, DOI 10.1007/s00436-010-1743-z; Aunpad R, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-19; Bacon DJ, 2007, ANTIMICROB AGENTS CH, V51, P1172, DOI 10.1128/AAC.01313-06; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Basco LK., 2007, FIELD APPL IN VITRO; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Bloland PB., 2001, DRUG RESISTANCE MALA; Corbett Y, 2004, AM J TROP MED HYG, V70, P119, DOI 10.4269/ajtmh.2004.70.119; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duraisingh MT, 1999, PARASITOLOGY, V119, P435, DOI 10.1017/S0031182099004953; Frita R, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-74; GLUZMAN IY, 1987, ANTIMICROB AGENTS CH, V31, P32, DOI 10.1128/AAC.31.1.32; GRITZMACHER CA, 1984, J BACTERIOL, V160, P1165, DOI 10.1128/JB.160.3.1165-1167.1984; Grobusch MP, 2003, CYTOM PART B-CLIN CY, V55B, P46, DOI 10.1002/cyto.b.10039; Grooth BG, 1987, CYTOMETRY, V8, P539; Hanscheid T, 2007, LANCET INFECT DIS, V7, P675, DOI 10.1016/S1473-3099(07)70238-4; Hanscheid T, 2000, PARASITOL TODAY, V16, P549, DOI 10.1016/S0169-4758(00)01742-7; Hanscheid T, 2000, CLIN LAB HAEMATOL, V22, P259, DOI 10.1046/j.1365-2257.2000.00327.x; Held J, 2011, INT J ANTIMICROB AG, V37, P485, DOI 10.1016/j.ijantimicag.2010.12.022; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Ikpa T. F., 2010, African Journal of Clinical and Experimental Microbiology, V11, P111; JAMJOOM GA, 1983, J CLIN MICROBIOL, V17, P717, DOI 10.1128/JCM.17.5.717-721.1983; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Karl S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-294; Kramer B, 2001, CYTOMETRY, V45, P133, DOI 10.1002/1097-0320(20011001)45:2<133::AID-CYTO1155>3.0.CO;2-K; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lawrence C, 1996, AM J CLIN PATHOL, V96, P360; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; Lim P, 2010, ANTIMICROB AGENTS CH, V54, P2135, DOI 10.1128/AAC.01304-09; Maerki S, 2006, J ANTIMICROB CHEMOTH, V58, P52, DOI 10.1093/jac/dkl209; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Mendelow BV, 1999, BRIT J HAEMATOL, V104, P499, DOI 10.1046/j.1365-2141.1999.01199.x; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; Mphande F, 2008, METHODS MALARIA RES, V5th, P1; Noedl H, 2002, ANTIMICROB AGENTS CH, V46, P1658, DOI 10.1128/AAC.46.6.1658-1664.2002; Noedl H, 2003, TRENDS PARASITOL, V19, P175, DOI 10.1016/S1471-4922(03)00028-X; Rebelo M, 2012, ACTA TROP, V123, P58, DOI 10.1016/j.actatropica.2012.03.005; RIECKMANN KH, 1978, LANCET, V1, P22; RIECKMANN KH, 1982, LANCET, V1, P1333; Sanz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030949; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P355, DOI 10.1128/CMR.15.3.355-364.2002; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Shapiro HM, 2010, CYTOM PART A, V77A, P500, DOI 10.1002/cyto.a.20903; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Suh IB, 2003, TROP MED INT HEALTH, V8, P1074, DOI 10.1046/j.1360-2276.2003.01135.x; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Thomas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041006; Men TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-272; Tucker MS, 2012, ANTIMICROB AGENTS CH, V56, P302, DOI 10.1128/AAC.05540-11; Vossen MG, 2010, AM J TROP MED HYG, V82, P398, DOI 10.4269/ajtmh.2010.09-0417; WARHURST DC, 1974, ANN TROP MED PARASIT, V68, P265, DOI 10.1080/00034983.1974.11686949; Wein S, 2010, J CLIN MICROBIOL, V48, P1651, DOI 10.1128/JCM.02250-09; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2011, GLOB PALN ART RES CO	58	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61606	10.1371/journal.pone.0061606	http://dx.doi.org/10.1371/journal.pone.0061606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637865	gold, Green Published, Green Submitted			2022-12-25	WOS:000318340400033
J	Yang, WL; Feng, YL; Zhang, YY; Yan, J; Fu, Y; Chen, SD				Yang, Wanlin; Feng, Yulan; Zhang, Yunyun; Yan, Jing; Fu, Yi; Chen, Shengdi			Volume Quantification of Acute Infratentorial Hemorrhage with Computed Tomography: Validation of the Formula 1/2ABC and 2/3SH	PLOS ONE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; PRIMARY PONTINE HEMORRHAGE; ASSISTED PLANIMETRIC ANALYSIS; ABC/2 ESTIMATION TECHNIQUE; CEREBELLAR HEMORRHAGE; 30-DAY MORTALITY; HEMATOMA GROWTH; PREDICTORS; MANAGEMENT; WARFARIN	Objective: To compare the accuracy of formula 1/2ABC with 2/3SH on volume estimation for hypertensive infratentorial hematoma. Methods: One hundred and forty-seven CT scans diagnosed as hypertensive infratentorial hemorrhage were reviewed. Based on the shape, hematomas were categorized as regular or irregular. Multilobular was defined as a special shape of irregular. Hematoma volume was calculated employing computer-assisted volumetric analysis (CAVA), 1/2ABC and 2/3SH, respectively. Results: The correlation coefficients between 1/2ABC (or 2/3SH) and CAVA were greater than 0.900 in all subgroups. There were neither significant differences in absolute values of volume deviation nor percentage deviation between 1/2ABC and 2/3SH for regular hemorrhage (P>0.05). While for cerebellar, brainstem and irregular hemorrhages, the absolute values of volume deviation and percentage deviation by formula 1/2ABC were greater than 2/3SH (P<0.05). 1/2ABC and 2/3SH underestimated hematoma volume each by 10% and 5% for cerebellar hemorrhage, 14% and 9% for brainstem hemorrhage, 19% and 16% for regular hemorrhage, 9% and 3% for irregular hemorrhage, respectively. In addition, for the multilobular hemorrhage, 1/2ABC underestimated the volume by 9% while 2/3SH overestimated it by 2%. Conclusions: For regular hemorrhage volume calculation, the accuracy of 2/3SH is similar to 1/2ABC. While for cerebellar, brainstem or irregular hemorrhages (including multilobular), 2/3SH is more accurate than 1/2ABC.	[Yang, Wanlin; Yan, Jing; Fu, Yi; Chen, Shengdi] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China; [Yang, Wanlin; Yan, Jing; Fu, Yi; Chen, Shengdi] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Inst Neurol, Shanghai 200030, Peoples R China; [Feng, Yulan] Minhang Cent Hosp, Dept Neurol, Shanghai, Peoples R China; [Zhang, Yunyun] Tradit Med Univ, Yueyang Hosp, Dept Neurol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fu, Y (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China.	fuyiki@sina.com						AUER LM, 1986, ACTA NEUROCHIR, V79, P74, DOI 10.1007/BF01407448; Balci K, 2005, CLIN NEUROL NEUROSUR, V108, P36, DOI 10.1016/j.clineuro.2005.02.007; Barras CD, 2009, STROKE, V40, P1325, DOI 10.1161/STROKEAHA.108.536888; Beslow LA, 2010, STROKE, V41, P313, DOI 10.1161/STROKEAHA.109.568071; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; BRODERICK JP, 1990, J NEUROSURG, V72, P195, DOI 10.3171/jns.1990.72.2.0195; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Cohen ZR, 2002, CEREBROVASC DIS, V14, P207, DOI 10.1159/000065666; Da Pian R, 1984, Neurol Res, V6, P145; Dammann P, 2011, NEUROSURG REV, V34, P77, DOI 10.1007/s10143-010-0279-0; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Delcourt C, 2012, NEUROLOGY, V79, P314, DOI 10.1212/WNL.0b013e318260cbba; Divani AA, 2011, STROKE, V42, P1569, DOI 10.1161/STROKEAHA.110.607861; Ferroli P, 2005, NEUROSURGERY, V56, P1203, DOI 10.1227/01.NEU.0000159644.04757.45; Flaherty ML, 2005, STROKE, V36, P934, DOI 10.1161/01.STR.0000160756.72109.95; Freeman WD, 2008, NEUROCRIT CARE, V9, P307, DOI 10.1007/s12028-008-9089-4; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Godoy DA, 2006, STROKE, V37, P1038, DOI 10.1161/01.STR.0000206441.79646.49; Hara T, 2001, NEUROL SURG TOKYO, V29, P823; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Jang JH, 2011, J KOREAN MED SCI, V26, P100, DOI 10.3346/jkms.2011.26.1.100; Jeong JH, 2002, STROKE, V33, P925, DOI 10.1161/01.STR.0000013563.73522.CB; Jordan LC, 2009, STROKE, V40, P1666, DOI 10.1161/STROKEAHA.108.541383; Jung DS, 2007, J KOREAN NEUROSURG S, V41, P82; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; Kleinman JT, 2011, DEV MED CHILD NEUROL, V53, P281, DOI 10.1111/j.1469-8749.2010.03798.x; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; KWAK R, 1983, STROKE, V14, P493, DOI 10.1161/01.STR.14.4.493; Lim JK, 2008, SURG NEUROL, V69, P40, DOI 10.1016/j.surneu.2007.07.025; Ruiz-Sandoval JL, 2007, STROKE, V38, P1641, DOI 10.1161/STROKEAHA.106.478222; Sheth KN, 2010, NEUROCRIT CARE, V12, P30, DOI 10.1007/s12028-009-9296-7; Wang CW, 2009, ACTA RADIOL, V50, P306, DOI 10.1080/02841850802647039; Wu YT, 2010, CEREBELLUM, V9, P259, DOI 10.1007/s12311-010-0181-x; Zhao KJ, 2010, NEUROL RES, V32, P910, DOI 10.1179/016164110X12681290831441; Zhao KJ, 2009, NEUROL RES, V31, P1031, DOI 10.1179/174313209X385662	36	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62286	10.1371/journal.pone.0062286	http://dx.doi.org/10.1371/journal.pone.0062286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23638025	Green Published, Green Submitted, gold			2022-12-25	WOS:000318340400093
J	Zhang, XL; Kuo, C; Moore, A; Ran, CZ				Zhang, Xueli; Kuo, Chaincy; Moore, Anna; Ran, Chongzhao			In Vivo Optical Imaging of Interscapular Brown Adipose Tissue with F-18-FDG via Cerenkov Luminescence Imaging	PLOS ONE			English	Article							POSITRON-EMITTING RADIOTRACERS; ENERGY-EXPENDITURE; ADULT HUMANS; FAT; OBESITY; MICE; THERMOGENESIS; RADIONUCLIDES; ADIPOGENESIS; TOMOGRAPHY	Objective: Brown adipose tissue (BAT), a specialized tissue for thermogenesis, plays important roles for metabolism and energy expenditure. Recent studies validated BAT's presence in human adults, making it an important re-emerging target for various pathologies. During this validation, PET images with F-18-FDG showed significant uptake of F-18-FDG by BAT under certain conditions. Here, we demonstrated that Cerenkov luminescence imaging (CLI) using F-18-FDG could be utilized for in vivo optical imaging of BAT in mice. Methods: Mice were injected with F-18-FDG and imaged 60 minutes later with open filter and 2 minute acquisition. In vivo activation of BAT was performed by norepinephrine and cold treatment under isoflurane or ketamine anesthesia. Spectral unmixing and 3D imaging reconstruction were conducted with multiple-filter CLI images. Results: 1) It was feasible to use CLI with F-18-FDG to image interscapular BAT in mice, with the majority of the signal (>85%) at the interscapular site originating from BAT; 2) The method was reliable because excellent correlations between in vivo CLI, ex vivo CLI, and ex vivo radioactivity were observed; 3) CLI could be used for monitoring BAT activation under different conditions; 4) CLI signals from the group under short-term isoflurane anesthesia were significantly higher than that from the group under long-term anesthesia; 5) The CLI spectrum of F-18-FDG with a peak at 640 nm in BAT after spectral unmixing reflected the actual context of BAT; 6) Finally 3D reconstruction images showed excellent correlation between the source of the light signal and the location and physical shape of BAT. Conclusion: CLI with F-18-FDG is a feasible and reliable method for imaging BAT in mice. Compared to PET imaging, CLI is significantly cheaper, faster for 2D planar imaging and easier to use. We believe that this method could be used as an important tool for researchers investigating BAT.	[Zhang, Xueli; Moore, Anna; Ran, Chongzhao] Harvard Univ, Sch Med, Massachusetts Gen Hosp,Dept Radiol,Mol Imaging La, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA USA; [Zhang, Xueli] China Pharmaceut Univ, Sch Pharm, Ctr Drug Discovery, Nanjing, Jiangsu, Peoples R China; [Kuo, Chaincy] Caliper, Alameda, CA USA	Harvard University; Massachusetts General Hospital; China Pharmaceutical University	Moore, A (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp,Dept Radiol,Mol Imaging La, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA USA.	amoore@helix.mgh.harvard.edu; cran@nmr.mgh.harvard.edu	Kuo, Chaincy/G-2403-2015; Kuo, Chaincy/H-9475-2016	Kuo, Chaincy/0000-0001-7958-8764	NCRR NIH HHS [S10 RR025504] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025504] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ackerman NL, 2012, PHYS MED BIOL, V57, P771, DOI 10.1088/0031-9155/57/3/771; Basu S, 2008, NUCL MED COMMUN, V29, P931, DOI 10.1097/MNM.0b013e328310af46; Boschi F, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3663441; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen YI, 2012, OBESITY, V20, P1519, DOI 10.1038/oby.2012.22; Cherenkov P.A., 1934, DOKL AKAD NAUK SSSR, V2, P451; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dothager RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013300; Fueger BJ, 2006, J NUCL MED, V47, P999; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Holland J.P., 2012, MOL IMAGING, V11, P1; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037623; Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Lewis MA, 2010, OPT LETT, V35, P3889, DOI 10.1364/OL.35.003889; Li CQ, 2010, OPT LETT, V35, P1109, DOI 10.1364/OL.35.001109; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu HG, 2012, J NUCL MED, V53, P1579, DOI 10.2967/jnumed.111.098541; Liu HG, 2010, SMALL, V6, P1087, DOI 10.1002/smll.200902408; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Lowell BB, 1997, ANNU REV MED, V48, P307; Lucignani G, 2011, EUR J NUCL MED MOL I, V38, P592, DOI 10.1007/s00259-010-1708-6; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Mattson MP, 2010, AGEING RES REV, V9, P69, DOI 10.1016/j.arr.2009.11.004; Mitchell GS, 2011, PHILOS T R SOC A, V369, P4605, DOI 10.1098/rsta.2011.0271; Nagajyothi F, 2012, J INFECT DIS, V205, P830, DOI 10.1093/infdis/jir840; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ocloo A, 2007, AM J PHYSIOL-REG I, V293, pR1086, DOI 10.1152/ajpregu.00128.2007; Ohlson KBE, 2004, BIOCHEM PHARMACOL, V68, P463, DOI 10.1016/j.bcp.2004.03.028; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Ran CZ, 2012, MOL IMAGING BIOL, V14, P156, DOI 10.1007/s11307-011-0489-z; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; Spinelli AE, 2012, Q J NUCL MED MOL IM, V56, P280; Spinelli AE, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040506; Spinelli AE, 2011, OPT EXPRESS, V19, P12605, DOI 10.1364/OE.19.012605; Spinelli AE, 2010, PHYS MED BIOL, V55, P483, DOI 10.1088/0031-9155/55/2/010; Spinelli AE, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.020502; Stephens M, 2011, CLIN ENDOCRINOL, V74, P661, DOI 10.1111/j.1365-2265.2011.04018.x; Tatsumi M, 2004, J NUCL MED, V45, P1189; Thorek DLJ, 2012, J NUCL MED, V53, P1438, DOI 10.2967/jnumed.112.104349; Tran TT, 2010, NAT REV ENDOCRINOL, V6, P195, DOI 10.1038/nrendo.2010.20; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Wu CX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/159834; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Xu YD, 2012, J NUCL MED, V53, P312, DOI 10.2967/jnumed.111.094623; Xu YD, 2011, J NUCL MED, V52, P2009, DOI 10.2967/jnumed.111.092965; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Zhang HB, 2010, MOL CELL BIOL, V30, P4224, DOI 10.1128/MCB.00363-10; ZHONG JH, 2011, C P ANN INT C IEEE E, P6158; Zhong JH, 2012, MOL IMAGING BIOL, V14, P286, DOI 10.1007/s11307-011-0510-6; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	55	36	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e62007	10.1371/journal.pone.0062007	http://dx.doi.org/10.1371/journal.pone.0062007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	23637947	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400066
J	Feng, GZ; Jiang, QT; Xia, M; Lu, YL; Qiu, W; Zhao, D; Lu, LW; Peng, GY; Wang, YW				Feng, Ganzhu; Jiang, Qingtao; Xia, Mei; Lu, Yanlai; Qiu, Wen; Zhao, Dan; Lu, Liwei; Peng, Guangyong; Wang, Yingwei			Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection	PLOS ONE			English	Article							DENDRITIC CELLS; DELIVERY VEHICLES; MOLECULAR-WEIGHT; NANOPARTICLES; MICE; ADJUVANT; NASAL; IMMUNOGENICITY; BCG; IDENTIFICATION	Development of a novel and effective vaccine against Mycobacterium tuberculosis (M.tb) is a challenging for preventing TB infection. In this study, a novel nanoparticle-based recombinant DNA vaccine was developed, which contains Esat-6 three T cell epitopes (Esat-6/3e) and fms-like tyrosine kinase 3 ligand (FL) genes (termed Esat-6/3e-FL), and was enveloped with chitosan (CS) nanoparticles (nano-chitosan). The immunologic and protective efficacy of the nano-chitosan-based DNA vaccine (termed nano-Esat-6/3e-FL) was assessed in C57BL/6 mice after intramuscular prime vaccination with the plasmids DNA and nasal boost with the Esat-6/3e peptides. The results showed that the immunized mice remarkably elicited enhanced T cell responses and protection against M.tb H37Rv challenge. These findings indicate that the nano-chitosan can significantly elevate the immunologic and protective effects of the DNA vaccine, and the nano-Esat-6/3e-FL is a useful vaccine for preventing M.tb infection in mice.	[Feng, Ganzhu; Jiang, Qingtao; Xia, Mei; Lu, Yanlai; Qiu, Wen; Zhao, Dan; Wang, Yingwei] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Lu, Liwei] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Peng, Guangyong] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO USA	Nanjing Medical University; University of Hong Kong; Saint Louis University	Wang, YW (corresponding author), Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China.	wangyw1508@njmu.edu.cn	QIU, WENJING/GZL-9992-2022; Lu, Liwei/C-4357-2009	Lu, Liwei/0000-0002-8634-0967	Natural Scientific Fund of Jiangsu Province in China [09KJA310002, DG216D5016, 12KJB310007, 2011NJMU263, 11JC005]	Natural Scientific Fund of Jiangsu Province in China	This work was supported by funding from Natural Scientific Fund of Jiangsu Province (09KJA310002, DG216D5016, 12KJB310007, 2011NJMU263 and 11JC005) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard CS, 2009, J IMMUNOL, V183, P2659, DOI 10.4049/jimmunol.0900947; Bal SM, 2012, EUR J PHARM SCI, V45, P475, DOI 10.1016/j.ejps.2011.10.003; Begum D, 2009, IMMUNOLOGY, V128, P556, DOI 10.1111/j.1365-2567.2009.03141.x; Behrens I, 2002, PHARMACEUT RES, V19, P1185, DOI 10.1023/A:1019854327540; Bennekov T, 2006, EUR J IMMUNOL, V36, P3346, DOI 10.1002/eji.200636128; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Borsuk S, 2009, TUBERCULOSIS, V89, P423, DOI 10.1016/j.tube.2009.07.003; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Chua BY, 2012, MOL PHARMACEUT, V9, P81, DOI 10.1021/mp200264m; Cui ZR, 2001, J CONTROL RELEASE, V75, P409, DOI 10.1016/S0168-3659(01)00407-2; De Groot AS, 2005, VACCINE, V23, P2121, DOI 10.1016/j.vaccine.2005.01.059; Deng YH, 2010, SCAND J IMMUNOL, V72, P332, DOI 10.1111/j.1365-3083.2010.02444.x; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fahmy TM, 2005, BIOMATERIALS, V26, P5727, DOI 10.1016/j.biomaterials.2005.02.025; Ganguly N, 2008, IMMUNOL CELL BIOL, V86, P98, DOI 10.1038/sj.icb.7100117; Gao HF, 2009, MICROBIOL IMMUNOL, V53, P541, DOI 10.1111/j.1348-0421.2009.00157.x; Gupta UD, 2007, VACCINE, V25, P3742, DOI 10.1016/j.vaccine.2007.01.112; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Huang M, 2004, PHARM RES-DORDR, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5; Hussey G, 2007, PAEDIATR RESPIR REV, V8, P148, DOI 10.1016/j.prrv.2007.04.009; Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5; Jones GJ, 2010, INFECT IMMUN, V78, P1326, DOI 10.1128/IAI.01246-09; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Khatri K, 2008, INT J PHARMACEUT, V354, P235, DOI 10.1016/j.ijpharm.2007.11.027; Latorre I, 2012, SCAND J IMMUNOL, V75, P77; Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6; Li L, 2012, TUBERCULOSIS, V92, P63, DOI 10.1016/j.tube.2011.11.004; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; McCormick S, 2008, J IMMUNOL, V181, P2356, DOI 10.4049/jimmunol.181.4.2356; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neimert-Andersson T, 2011, VACCINE, V29, P8965, DOI 10.1016/j.vaccine.2011.09.041; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Qingtao J, 2012, J BIOM RES IN PRESS; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sette A, 2001, BIOLOGICALS, V29, P271, DOI 10.1006/biol.2001.0297; Shen HB, 2010, MICROBIOL IMMUNOL, V54, P435, DOI 10.1111/j.1348-0421.2010.00232.x; Slutter B, 2009, J CONTROL RELEASE, V138, P113, DOI 10.1016/j.jconrel.2009.05.011; Teutschbein J, 2009, MICROBIOL RES, V164, P253, DOI 10.1016/j.micres.2006.11.016; Toliver-Kinsky TE, 2003, INFECT IMMUN, V71, P3058, DOI 10.1128/IAI.71.6.3058-3067.2003; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366; Vila A, 2004, EUR J PHARM BIOPHARM, V57, P123, DOI 10.1016/j.ejpb.2003.09.006; Wang F, 2006, VACCINE, V24, P2017, DOI 10.1016/j.vaccine.2005.11.042; Xu J, 2008, VACCINE, V26, P4519, DOI 10.1016/j.vaccine.2008.06.044; Yang Y, 2007, COMP IMMUNOL MICROB, V30, P19, DOI 10.1016/j.cimid.2006.09.006; Yu FL, 2012, NANOMED-NANOTECHNOL, V8, P1337, DOI 10.1016/j.nano.2012.02.015; Zheng Y, 2006, J BIOMAT SCI-POLYM E, V17, P1389, DOI 10.1163/156856206778937217; Zhou Q, 2010, VACCINE, V28, P1357, DOI 10.1016/j.vaccine.2009.11.006	52	52	59	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61135	10.1371/journal.pone.0061135	http://dx.doi.org/10.1371/journal.pone.0061135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637790	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400027
J	Lu, SJ; Jin, B; Cowart, LA; Lu, XH				Lu, Songjian; Jin, Bo; Cowart, L. Ashley; Lu, Xinghua			From Data towards Knowledge: Revealing the Architecture of Signaling Systems by Unifying Knowledge Mining and Data Mining of Systematic Perturbation Data	PLOS ONE			English	Article							MAP KINASE PATHWAYS; GENE ONTOLOGY; YEAST; MITOCHONDRIAL; MODULES; MODELS	Genetic and pharmacological perturbation experiments, such as deleting a gene and monitoring gene expression responses, are powerful tools for studying cellular signal transduction pathways. However, it remains a challenge to automatically derive knowledge of a cellular signaling system at a conceptual level from systematic perturbation-response data. In this study, we explored a framework that unifies knowledge mining and data mining towards the goal. The framework consists of the following automated processes: 1) applying an ontology-driven knowledge mining approach to identify functional modules among the genes responding to a perturbation in order to reveal potential signals affected by the perturbation; 2) applying a graph-based data mining approach to search for perturbations that affect a common signal; and 3) revealing the architecture of a signaling system by organizing signaling units into a hierarchy based on their relationships. Applying this framework to a compendium of yeast perturbation-response data, we have successfully recovered many well-known signal transduction pathways; in addition, our analysis has led to many new hypotheses regarding the yeast signal transduction system; finally, our analysis automatically organized perturbed genes as a graph reflecting the architecture of the yeast signaling system. Importantly, this framework transformed molecular findings from a gene level to a conceptual level, which can be readily translated into computable knowledge in the form of rules regarding the yeast signaling system, such as "if genes involved in the MAPK signaling are perturbed, genes involved in pheromone responses will be differentially expressed."	[Lu, Songjian; Jin, Bo; Lu, Xinghua] Univ Pittsburth, Dept Biomed Informat, Pittsburgh, PA USA; [Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Lu, XH (corresponding author), Univ Pittsburth, Dept Biomed Informat, Pittsburgh, PA USA.	xinghua@pitt.edu			National Institutes of Health [R01LM011155, R01LM010144]; NATIONAL LIBRARY OF MEDICINE [R01LM010144, R01LM011155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was partially supported by the following National Institutes of Health grants: R01LM011155 and R01LM010144. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chen V, 2013, BMC P GLBI IN PRESS; Cheng Y, 2000, P PAC S BIOC; Erten C, 2010, BIOINFORMATICS, V26, P2594, DOI 10.1093/bioinformatics/btq473; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Huang SSC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000350; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jin B, 2010, BIOINFORMATICS, V26, P2445, DOI 10.1093/bioinformatics/btq449; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lu SJ, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-2; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; Muller Brian, 2009, BMC Res Notes, V2, P122, DOI 10.1186/1756-0500-2-122; Ourfali O, 2007, BIOINFORMATICS, V23, pI359, DOI 10.1093/bioinformatics/btm170; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; Richards AJ, 2010, BIOINFORMATICS, V26, pi79, DOI 10.1093/bioinformatics/btq203; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Thomas MC, 2006, ELEMENTS INFORM THEO; Winzeler EA, 1999, SCIENCE, V181, P3058; Yamaguchi-Iwai Y, 1996, EMBO J, V14, P1231; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61134	10.1371/journal.pone.0061134	http://dx.doi.org/10.1371/journal.pone.0061134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23637789	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400026
J	Alam, MM; Khurshid, A; Rana, MS; Shaukat, S; Sharif, S; Angez, M; Naeem, M; Zaidi, SSZ				Alam, Muhammad Masroor; Khurshid, Adnan; Rana, Muhammad Suleman; Shaukat, Shahzad; Sharif, Salmaan; Angez, Mehar; Naeem, Muhammad; Zaidi, Syed Sohail Zahoor			Serotype Diversity of Astroviruses in Rawalpindi, Pakistan during 2009-2010	PLOS ONE			English	Article							GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; INFANTILE GASTROENTERITIS; VIRAL GASTROENTERITIS; CHILDREN; INFECTIONS; AUSTRALIA; MELBOURNE; PREVALENCE; SEQUENCE	Astroviruses are globally known enteropathogens causing gastroenteritis and diarrhea, with eight well defined serotypes. Epidemiological studies have recognized serotype-1 as the most common subtype but no such data is available in Pakistan. During 2009-2010, we found astroviruses in 41 out of 535 (7%) samples collected from hospitalized children. Thirty one strains belonged to serotype-1 and clustered into two distinct lineages. Serotype-3, -4 and -6 were detected with 97-98% genetic homology to Indian and Chinese strains.	[Alam, Muhammad Masroor; Naeem, Muhammad] Quaid I Azam Univ, Dept Biotechnol, Islamabad, Pakistan; [Khurshid, Adnan; Rana, Muhammad Suleman; Shaukat, Shahzad; Sharif, Salmaan; Angez, Mehar; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan	Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	zaidis@pak.emro.who.int	Angez, Mehar/J-3792-2015; Rana, Dr. Muhammad Suleman/HCH-1540-2022; Zaidi, Syed Sohail Zahoor/F-7432-2015; Shaukat, Shahzad/HHZ-1088-2022; Naeem, Muhammad/F-4869-2011	Naeem, Muhammad/0000-0002-3894-3085				Colomba C, 2006, EUR J CLIN MICROBIOL, V25, P570, DOI 10.1007/s10096-006-0188-x; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Gabbay YB, 2007, VIRUS RES, V129, P166, DOI 10.1016/j.virusres.2007.07.006; Guix S, 2002, J CLIN MICROBIOL, V40, P133, DOI 10.1128/JCM.40.1.133-139.2002; JIANG BM, 1993, P NATL ACAD SCI USA, V90, P10539, DOI 10.1073/pnas.90.22.10539; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Kirkwood CD, 2005, J MED VIROL, V77, P96, DOI 10.1002/jmv.20419; LEWIS TL, 1995, ARCH VIROL, V140, P1127, DOI 10.1007/BF01315421; Liu MQ, 2007, J CLIN MICROBIOL, V45, P1308, DOI 10.1128/JCM.00010-07; MADELEY CR, 1975, LANCET, V2, P451; MARCZINKE B, 1994, J VIROL, V68, P5588, DOI 10.1128/JVI.68.9.5588-5595.1994; Matsui S.M., 1996, FIELDS VIROLOGY, P811; Mendez E., 2007, FIELDS VIROLOGY, V5, P981; Mendez-Toss M, 2004, J CLIN MICROBIOL, V42, P151, DOI 10.1128/JCM.42.1.151-157.2004; Mustafa H, 2000, J CLIN MICROBIOL, V38, P1058, DOI 10.1128/JCM.38.3.1058-1062.2000; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Palombo EA, 1996, J CLIN MICROBIOL, V34, P1750, DOI 10.1128/JCM.34.7.1750-1753.1996; Phan TG, 2004, J MED VIROL, V73, P256, DOI 10.1002/jmv.20084; Roman E, 2003, J MED MICROBIOL, V52, P435, DOI 10.1099/jmm.0.05079-0; Schnagl RD, 2002, J CLIN MICROBIOL, V40, P4114, DOI 10.1128/JCM.40.11.4114-4120.2002; WILLCOCKS MM, 1994, J GEN VIROL, V75, P1785, DOI 10.1099/0022-1317-75-7-1785	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61667	10.1371/journal.pone.0061667	http://dx.doi.org/10.1371/journal.pone.0061667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637878	Green Published, gold, Green Submitted			2022-12-25	WOS:000317908700049
J	Bobjer, J; Katrinaki, M; Tsatsanis, C; Giwercman, YL; Giwercman, A				Bobjer, Johannes; Katrinaki, Marianna; Tsatsanis, Christos; Giwercman, Yvonne Lundberg; Giwercman, Aleksander			Negative Association between Testosterone Concentration and Inflammatory Markers in Young Men: A Nested Cross-Sectional Study	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; CORONARY-ARTERY-DISEASE; SEX-HORMONES; METABOLIC SYNDROME; ATHEROSCLEROSIS; REPLACEMENT; MACROPHAGE; INCREASE; CELLS; IL-6	Objective: Low grade systemic inflammation (LGSI) as well as androgen deficiency has in older men been associated with several pathologies, including cardiovascular disease (CVD). We wanted to investigate whether low testosterone levels are linked to biomarkers of LGSI already in young age, before any concurrent manifestations of CVD or other systemic diseases. Design: Nested cross-sectional study. Methods: Forty subfertile biochemically hypogonadal (n = 20) or eugonadal (n = 20) men (mean age 37 years, SD = 4.3) and 20 age-matched controls were randomly selected from an ongoing study on male subfertility. Subjects comprised male partners in infertile couples in whom also subnormal sperm concentration was present. Blood sampling, interviews, and anthropometric measures were undertaken. Serum levels of testosterone, LH, estradiol, SHBG, and 21 LGSI-markers were assessed. Results: Among 21 inflammatory markers, macrophage inflammatory protein 1-alpha (MIP1a) (beta = -0.025; p = 0.028), 1-beta (MIP1B) (beta = -0.015; p = 0.049) and tumor necrosis factor alpha (TNFa) (beta = -0.015; p = 0.040) showed negative association to total testosterone (TT) levels. MIP1a (beta = -1.95; p = 0.001) and TNFa (beta = -0.95; p = 0.014) showed negative association to calculated free testosterone (cFT) levels. Compared to men with normal TT and cFT levels, TNFa levels were higher in men with subnormal levels of TT (mean ratio 1.61; p = 0.006) and cFT (mean ratio 1.58; p = 0.007). Also, MIP1a levels were higher in men with subnormal levels of TT (mean ratio 1.84; p = 0.030). Conclusions: Subnormal testosterone may already in young age associate to LGSI, which might be a part of the mechanism underlying adverse health outcomes of male hypogonadism.	[Bobjer, Johannes; Giwercman, Aleksander] Skane Univ Hosp Malmo, Reprod Med Ctr, Malmo, Sweden; [Bobjer, Johannes; Giwercman, Aleksander] Lund Univ, Reprod Med Res Grp, Dept Clin Sci Malmo, Malmo, Sweden; [Katrinaki, Marianna; Tsatsanis, Christos] Univ Crete, Sch Med, Dept Clin Chem, Iraklion, Greece; [Giwercman, Yvonne Lundberg] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; University of Crete; Lund University	Bobjer, J (corresponding author), Skane Univ Hosp Malmo, Reprod Med Ctr, Malmo, Sweden.	johannes.bobjer@med.lu.se	Tsatsanis, Christos/C-2516-2018; Tsatsanis, Christos/AAM-9362-2020	Tsatsanis, Christos/0000-0003-1214-4151; Tsatsanis, Christos/0000-0003-1214-4151	Swedish Governmental Grant (ALF); Skane county councils research and development foundation; Skane University Hospital Fonds	Swedish Governmental Grant (ALF); Skane county councils research and development foundation; Skane University Hospital Fonds	This work was supported by grants from Swedish Governmental Grant (ALF), Skane county councils research and development foundation, and Skane University Hospital Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bjorkbacka H, 2013, ATHEROSCLEROSIS, V227, P9, DOI 10.1016/j.atherosclerosis.2012.10.074; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; D'Agostino P, 1999, ANN NY ACAD SCI, V876, P426, DOI 10.1111/j.1749-6632.1999.tb07667.x; HAFFNER SM, 1993, J CLIN ENDOCR METAB, V77, P1610, DOI 10.1210/jc.77.6.1610; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Jones TH, 2009, ATHEROSCLEROSIS, V207, P318, DOI 10.1016/j.atherosclerosis.2009.04.016; Kalinchenko SY, 2010, CLIN ENDOCRINOL, V73, P602, DOI 10.1111/j.1365-2265.2010.03845.x; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1550, DOI 10.1210/jc.87.4.1550; Kupelian V, 2010, CLIN ENDOCRINOL, V72, P527, DOI 10.1111/j.1365-2265.2009.03713.x; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; LI ZG, 1993, CLIN EXP RHEUMATOL, V11, P157; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Maggio M, 2006, J CLIN ENDOCR METAB, V91, P345, DOI 10.1210/jc.2005-1097; Malkin CJ, 2004, J CLIN ENDOCR METAB, V89, P3313, DOI 10.1210/jc.2003-031069; Muller M, 2004, CIRCULATION, V109, P2074, DOI 10.1161/01.CIR.0000125854.51637.06; Nieschlag E, 2004, HUM REPROD UPDATE, V10, P409, DOI 10.1093/humupd/dmh035; PHILLIPS GB, 1994, ARTERIOSCLER THROMB, V14, P701, DOI 10.1161/01.ATV.14.5.701; Pikwer M, 2013, ANN RHEUM D IN PRESS; Rosano GMC, 2007, INT J IMPOT RES, V19, P176, DOI 10.1038/sj.ijir.3901504; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Ruige JB, 2012, J CLIN ENDOCR METAB, V97, pE1187, DOI 10.1210/jc.2011-3069; Ruige JB, 2011, HEART, V97, P870, DOI 10.1136/hrt.2010.210757; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Tracy RP, 2003, INT J CLIN PRACT, P10; Vermeulen A, 1996, J CLIN ENDOCR METAB, V81, P1821, DOI 10.1210/jc.81.5.1821; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Yialamas MA, 2007, J CLIN ENDOCR METAB, V92, P4254, DOI 10.1210/jc.2007-0454	29	106	108	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61466	10.1371/journal.pone.0061466	http://dx.doi.org/10.1371/journal.pone.0061466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637840	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700038
J	Bustamante, MF; Nurtdinov, RN; Rio, J; Montalban, X; Comabella, M				Bustamante, Marta F.; Nurtdinov, Ramil N.; Rio, Jordi; Montalban, Xavier; Comabella, Manuel			Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta	PLOS ONE			English	Article							IFN-BETA; DOUBLE-BLIND; CELLS; ALPHA; PROGRESSION; ACTIVATION; APOPTOSIS; RESPONSES; THERAPY; PATHWAY	Background: A relatively large proportion of relapsing-remitting multiple sclerosis (RRMS) patients do not respond to interferon-beta (IFNb) treatment. In previous studies with peripheral blood mononuclear cells (PBMC), we identified a subgroup of IFNb non-responders that was characterized by a baseline over-expression of type I IFN inducible genes. Additional mechanistic experiments carried out in IFNb non-responders suggested a selective alteration of the type I IFN signaling pathway in the population of blood monocytes. Here, we aimed (i) to investigate whether the type I IFN signaling pathway is up-regulated in isolated monocytes from IFNb non-responders at baseline; and (ii) to search for additional biological pathways in this cell population that may be implicated in the response to IFNb treatment. Methods: Twenty RRMS patients classified according to their clinical response to IFNb treatment and 10 healthy controls were included in the study. Monocytes were purified from PBMC obtained before treatment by cell sorting and the gene expression profiling was determined with oligonucleotide microarrays. Results and discussion: Purified monocytes from IFNb non-responders were characterized by an over-expression of type I IFN responsive genes, which confirms the type I IFN signature in monocytes suggested from previous studies. Other relevant signaling pathways that were up-regulated in IFNb non-responders were related with the mitochondrial function and processes such as protein synthesis and antigen presentation, and together with the type I IFN signaling pathway, may also be playing roles in the response to IFNb.	[Bustamante, Marta F.; Nurtdinov, Ramil N.; Rio, Jordi; Montalban, Xavier; Comabella, Manuel] Cemcat Hosp Univ Vall dHebron HUVH, Ctr Esclerosi Multiple Catalunya, Serv Neurol Neuroimmunol, Barcelona, Spain		Comabella, M (corresponding author), Cemcat Hosp Univ Vall dHebron HUVH, Ctr Esclerosi Multiple Catalunya, Serv Neurol Neuroimmunol, Barcelona, Spain.	manuel.comabella@vhir.org	Montalban, Xavier/J-5938-2016; Nurtdinov, Ramil/H-4713-2015	Montalban, Xavier/0000-0002-0098-9918; Nurtdinov, Ramil/0000-0002-9753-6287; Comabella Lopez, Manuel/0000-0002-2373-6657; Rio, Jordi/0000-0003-4546-7627	Fondo de Investigacion Sanitaria (FIS), Ministry of Science and Innovation, Spain; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Spain	Fondo de Investigacion Sanitaria (FIS), Ministry of Science and Innovation, Spain; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Spain(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	The authors thank the "Red Espanola de Esclerosis Multiple (REEM)" sponsored by the Fondo de Investigacion Sanitaria (FIS), Ministry of Science and Innovation, Spain, and the Ajuts per donar Suport als Grups de Recerca de Catalunya, sponsored by the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the "Red Espanola de Esclerosis Multiple (REEM)" sponsored by the "Fondo de Investigacion Sanitaria" (FIS), Ministry of Science and Innovation, Spain, and the "Ajuts per donar Suport als Grups de Recerca de Catalunya, sponsored by the "Agencia de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR), Generalitat de Catalunya, Spain.	ADAMS CWM, 1975, J NEUROL SCI, V25, P165, DOI 10.1016/0022-510X(75)90138-0; Brkic Z, 2012, ANN RHEUM DIS; Bustamante MF, 2011, ANN NEUROL, V70, P634, DOI 10.1002/ana.22511; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; FISHER M, 1988, INFLAMMATION, V12, P123, DOI 10.1007/BF00916395; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; IMAMURA K, 1993, ACTA NEUROL SCAND, V87, P281, DOI 10.1111/j.1600-0404.1993.tb05508.x; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jaitin DA, 2007, J INTERF CYTOK RES, V27, P653, DOI 10.1089/jir.2006.0162; Jamaluddin M, 2001, AM J PHYSIOL-LUNG C, V280, pL248, DOI 10.1152/ajplung.2001.280.2.L248; Kouwenhoven M, 2001, J NEUROIMMUNOL, V112, P197, DOI 10.1016/S0165-5728(00)00396-9; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Lattanzi L, 2011, IMMUNOBIOLOGY, V216, P537, DOI 10.1016/j.imbio.2010.10.003; Onomoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019799; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Rio J, 2002, ANN NEUROL, V52, P400, DOI 10.1002/ana.10290; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Su QZ, 2007, EMBO REP, V8, P265, DOI 10.1038/sj.embor.7400891; Ubogu EE, 2006, CELL IMMUNOL, V243, P19, DOI 10.1016/j.cellimm.2006.12.001; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Wittnebel S, 2005, EUR CYTOKINE NETW, V16, P123; Yanase N, 2000, J INTERF CYTOK RES, V20, P1121, DOI 10.1089/107999000750053799; Zhang FL, 2009, IMMUNOLOGY, V128, pe905, DOI 10.1111/j.1365-2567.2009.03104.x; Zula JA, 2011, P NATL ACAD SCI USA, V108, P19689, DOI 10.1073/pnas.1117347108	31	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e60994	10.1371/journal.pone.0060994	http://dx.doi.org/10.1371/journal.pone.0060994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637780	gold, Green Published, Green Submitted			2022-12-25	WOS:000317908700012
J	De Groote, MA; Nahid, P; Jarlsberg, L; Johnson, JL; Weiner, M; Muzanyi, G; Janjic, N; Sterling, DG; Ochsner, UA				De Groote, Mary A.; Nahid, Payam; Jarlsberg, Leah; Johnson, John L.; Weiner, Marc; Muzanyi, Grace; Janjic, Nebojsa; Sterling, David G.; Ochsner, Urs A.			Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment	PLOS ONE			English	Article							HUMAN MONOCYTIC CELLS; MYCOBACTERIUM-TUBERCULOSIS; LUNG INFLAMMATION; IN-VITRO; INFECTION; THROMBOSPONDIN-2; DISEASE; MATRIX-METALLOPROTEINASE-9; IDENTIFICATION; PLASMINOGEN	In an unbiased approach to biomarker discovery, we applied a highly multiplexed proteomic technology (SOMAscan, SomaLogic, Inc, Boulder, CO) to understand changes in proteins from paired serum samples at enrollment and after 8 weeks of TB treatment from 39 patients with pulmonary TB from Kampala, Uganda enrolled in the Center for Disease Control and Prevention's Tuberculosis Trials Consortium (TBTC) Study 29. This work represents the first large-scale proteomic analysis employing modified DNA aptamers in a study of active tuberculosis (TB). We identified multiple proteins that exhibit significant expression differences during the intensive phase of TB therapy. There was enrichment for proteins in conserved networks of biological processes and function including antimicrobial defense, tissue healing and remodeling, acute phase response, pattern recognition, protease/anti-proteases, complement and coagulation cascade, apoptosis, immunity and inflammation pathways. Members of cytokine pathways such as interferon-gamma, while present, were not as highly represented as might have been predicted. The top proteins that changed between baseline and 8 weeks of therapy were TSP4, TIMP-2, SEPR, MRC-2, Antithrombin III, SAA, CRP, NPS-PLA2, LEAP-1, and LBP. The novel proteins elucidated in this work may provide new insights for understanding TB disease, its treatment and subsequent healing processes that occur in response to effective therapy.	[De Groote, Mary A.; Janjic, Nebojsa; Sterling, David G.; Ochsner, Urs A.] SomaLogic Inc, Boulder, CO USA; [De Groote, Mary A.] Colorado State Univ Campus, Dept Microbiol Immunol & Pathol, Ft Collins, CO USA; [Nahid, Payam; Jarlsberg, Leah] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Johnson, John L.] Case Western Reserve Univ, Div Infect Dis, TB Res Unit, Cleveland, OH 44106 USA; [Weiner, Marc] Univ Texas Hlth Sci Ctr, Div Infect Dis, San Antonio, TX USA; [Muzanyi, Grace] Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda	Colorado State University; University of California System; University of California San Francisco; Case Western Reserve University; University of Texas System; University of Texas Health San Antonio; Case Western Reserve University	Ochsner, UA (corresponding author), SomaLogic Inc, Boulder, CO USA.	uochsner@somalogic.com		Nahid, Payam/0000-0003-2811-1311; Jarlsberg, Leah/0000-0001-6548-6337	SomaLogic, Inc.; United States Centers for Disease Control and Prevention	SomaLogic, Inc.; United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The entire sample analysis was funded by SomaLogic, Inc. Funding for recruitment, enrollment and clinical and laboratory follow-up of TBTC Study 29 patients was provided by the United States Centers for Disease Control and Prevention. SomaLogic had no role in study design or patient selection, but conducted the assay and data analysis. SomaLogic decided what and when to publish, and prepared the manuscript with input from the co-authors listed.; NJ, DS and UO are employees and shareholders of SomaLogic, Inc. MAD is a Consultant to SomaLogic, Inc. The entire sample analysis was funded by SomaLogic, Inc. A provisional patent has been filed by SomaLogic. The patent name is "Tuberculosis Biomarkers and Uses Thereof", and the application number is 61/623,732. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agarwal R, 2006, ANTICANCER RES, V26, P4457; Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Anand SP, 2009, CLIN IMMUNOL, V133, P126, DOI 10.1016/j.clim.2009.06.009; Aranday-Cortes E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030626; Armstrong LC, 2002, MOL BIOL CELL, V13, P1893, DOI 10.1091/mbc.E01-09-0066; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Calzada MJ, 2004, CIRC RES, V94, P462, DOI 10.1161/01.RES.0000115555.05668.93; Cardona PJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868246; Chan ED, 2007, SCAND J INFECT DIS, V39, P690, DOI 10.1080/00365540701225744; Dabney A, 2011, QVALUE Q VALUE ESTIM; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; Dorman SE, 2012, J INFECT DIS, V206, P1030, DOI 10.1093/infdis/jis461; Eickhoff M, 2007, INFECT IMMUN, V75, P2853, DOI 10.1128/IAI.01045-06; FALK AJ, 1969, CLASSIFICATION PULMO; Friedland JS, 2002, MATRIX BIOL, V21, P103, DOI 10.1016/S0945-053X(01)00175-5; Frolova EG, 2012, FASEB J OFFICIAL PUB; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hoheisel G, 1997, RESPIRATION, V64, P152; Hrabec E, 2002, INT J TUBERC LUNG D, V6, P713; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Juffermans NP, 1998, J INFECT DIS, V178, P1839, DOI 10.1086/314492; Juncker-Jensen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016954; Kent PT, 1985, GUIDE LEVEL 3 LAB; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Ma YJ, 2011, J BIOL CHEM, V286, P3405, DOI 10.1074/jbc.M110.190637; Maertzdorf J, 2012, P NATL ACAD SCI US; Maretti-Mira AC, 2011, ACTA TROP, V119, P160, DOI 10.1016/j.actatropica.2011.05.009; Marquis JF, 2008, INFECT IMMUN, V76, P78, DOI 10.1128/IAI.00369-07; Marrer E, 2010, TOXICOL APPL PHARM, V243, P167, DOI 10.1016/j.taap.2009.12.015; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Mustonen E, 2012, ANN MED; Nemeth J, 2011, CLIN IMMUNOL, V138, P50, DOI 10.1016/j.clim.2010.09.005; Odrowqz-Sypniewska G, 2007, ADV MED SCI-POLAND, V52, P246; Ostroff R, 2010, J PROTEOMICS, V73, P649, DOI 10.1016/j.jprot.2009.09.004; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Pakasi TA, 2009, EUR J CLIN NUTR, V63, P1130, DOI 10.1038/ejcn.2009.25; Paulissen G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-127; Pohjolainen V, 2012, ATHEROSCLEROSIS, V220, P66, DOI 10.1016/j.atherosclerosis.2011.10.003; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Rae JM, 2001, J PHARMACOL EXP THER, V299, P849; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Reece ST, 2010, J CLIN INVEST, V120, P3365, DOI 10.1172/JCI42796; Rivera-Marrero CA, 2000, MICROB PATHOGENESIS, V29, P231, DOI 10.1006/mpat.2000.0383; Salgame P, 2011, J CLIN INVEST, V121, P1686, DOI 10.1172/JCI57423; Sato J, 2003, AM J PATHOL, V163, P517, DOI 10.1016/S0002-9440(10)63680-2; Schroder NWJ, 2005, J ENDOTOXIN RES, V11, P237, DOI 10.1179/096805105X37420; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Sigdel TK, 2008, PEDIATR TRANSPLANT, V12, P737, DOI 10.1111/j.1399-3046.2008.01018.x; Smit van Dixhoorn MGA, 2008, MOL IMMUNOL, V45, P1573, DOI 10.1016/j.molimm.2007.10.022; Song QB, 2011, ACTA PHARMACOL SIN, V32, P1537, DOI 10.1038/aps.2011.137; Sood A, 2012, AM J RESP CRITICAL C; Sow FB, 2011, TUBERCULOSIS, V91, P314, DOI 10.1016/j.tube.2011.03.003; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tan SSH, 2005, J ENDOTOXIN RES, V11, P249, DOI 10.1179/096805105X37402; Tanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-71; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Vatansever S, 2009, CLIN INVEST MED, V32, pE293; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Weijer S, 2005, BLOOD, V106, P2761, DOI 10.1182/blood-2004-12-4623; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Wu M, 2012, SCAND J IMMUNOL, V75, P301, DOI 10.1111/j.1365-3083.2011.02668.x; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3; Zhang YM, 2011, CLIN CHIM ACTA, V412, P227, DOI 10.1016/j.cca.2010.09.036	75	76	82	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61002	10.1371/journal.pone.0061002	http://dx.doi.org/10.1371/journal.pone.0061002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637781	gold, Green Published			2022-12-25	WOS:000317908700013
J	Goh, SK; Olsen, P; Banerjee, I				Goh, Saik-Kia; Olsen, Phillip; Banerjee, Ipsita			Extracellular Matrix Aggregates from Differentiating Embryoid Bodies as a Scaffold to Support ESC Proliferation and Differentiation	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; EPITHELIAL MORPHOGENESIS; DECELLULARIZED MATRIX; AMPHIBIAN EMBRYOS; VASCULAR NICHE; IN-VITRO; LAMININ; EXPRESSION; MICROENVIRONMENTS; ACELLULARIZATION	Embryonic stem cells (ESCs) have emerged as potential cell sources for tissue engineering and regeneration owing to its virtually unlimited replicative capacity and the potential to differentiate into a variety of cell types. Current differentiation strategies primarily involve various growth factor/inducer/repressor concoctions with less emphasis on the substrate. Developing biomaterials to promote stem cell proliferation and differentiation could aid in the realization of this goal. Extracellular matrix (ECM) components are important physiological regulators, and can provide cues to direct ESC expansion and differentiation. ECM undergoes constant remodeling with surrounding cells to accommodate specific developmental event. In this study, using ESC derived aggregates called embryoid bodies (EB) as a model, we characterized the biological nature of ECM in EB after exposure to different treatments: spontaneously differentiated and retinoic acid treated (denoted as SPT and RA, respectively). Next, we extracted this treatment-specific ECM by detergent decellularization methods (Triton X-100, DOC and SDS are compared). The resulting EB ECM scaffolds were seeded with undifferentiated ESCs using a novel cell seeding strategy, and the behavior of ESCs was studied. Our results showed that the optimized protocol efficiently removes cells while retaining crucial ECM and biochemical components. Decellularized ECM from SPT EB gave rise to a more favorable microenvironment for promoting ESC attachment, proliferation, and early differentiation, compared to native EB and decellularized ECM from RA EB. These findings suggest that various treatment conditions allow the formulation of unique ESC-ECM derived scaffolds to enhance ESC bioactivities, including proliferation and differentiation for tissue regeneration applications.	[Goh, Saik-Kia; Olsen, Phillip] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Banerjee, Ipsita] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Banerjee, Ipsita] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Banerjee, I (corresponding author), Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA.	ipb1@pitt.edu			National Institutes of Health (NIH) [DP2 116520]; Oak Ridge Associated Universities (ORAU); University of Pittsburgh; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; Div Of Engineering Education and Centers [1156899] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Associated Universities (ORAU); University of Pittsburgh(University of Pittsburgh); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Div Of Engineering Education and Centers(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Institutes of Health (NIH; www.nih.gov) New Innovator Award DP2 116520, the Oak Ridge Associated Universities (ORAU; www.orau.org) Ralph Powe Award, and University of Pittsburgh internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2010, ACTA BIOMATER, V6, P4622, DOI 10.1016/j.actbio.2010.07.029; Abraham S, 2010, BIOTECHNOL PROGR, V26, P1126, DOI 10.1002/btpr.412; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; BOUCAUT JC, 1983, CELL TISSUE RES, V234, P135; BOUCAUT JC, 1984, J CELL BIOL, V99, P1822, DOI 10.1083/jcb.99.5.1822; Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410; Carpenedo RL, 2007, STEM CELLS, V25, P2224, DOI 10.1634/stemcells.2006-0523; Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Dickinson LE, 2011, MACROMOL BIOSCI, V11, P36, DOI 10.1002/mabi.201000245; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Fujiwara H, 2007, J BIOL CHEM, V282, P29701, DOI 10.1074/jbc.M611452200; Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Grauss RW, 2003, J THORAC CARDIOV SUR, V126, P2003, DOI 10.1016/S0022-5223(03)00956-5; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hieda Y, 1997, DEV GROWTH DIFFER, V39, P1; Hoshiba T, 2010, ADV MATER, V22, P3042, DOI 10.1002/adma.201000038; Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jensen T, 2012, TISSUE ENG PART C-ME, V18, P632, DOI [10.1089/ten.tec.2011.0584, 10.1089/ten.TEC.2011.0584]; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002; Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671; LEIVO I, 1980, DEV BIOL, V76, P100, DOI 10.1016/0012-1606(80)90365-6; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811; Lin H, 2012, BIOMATERIALS, V33, P4480, DOI 10.1016/j.biomaterials.2012.03.012; Lin YM, 2010, TISSUE ENG PT A, V16, P1515, DOI [10.1089/ten.tea.2009.0232, 10.1089/ten.TEA.2009.0232]; Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Nair R, 2008, J BIOMAT SCI-POLYM E, V19, P801, DOI 10.1163/156856208784522056; Nair R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042580; Nair R, 2008, J BIOMED MATER RES A, V87A, P1075, DOI 10.1002/jbm.a.31851; Ngangan AV, 2009, BIOMATERIALS, V30, P1143, DOI 10.1016/j.biomaterials.2008.11.001; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Rust WL, 2006, STEM CELLS DEV, V15, P889, DOI 10.1089/scd.2006.15.889; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHUGER L, 1995, DEV BIOL, V169, P520, DOI 10.1006/dbio.1995.1166; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Shukla S, 2010, J HISTOCHEM CYTOCHEM, V58, P345, DOI 10.1369/jhc.2009.954826; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Wong JCY, 2010, CELL ADHES MIGR, V4, P39, DOI 10.4161/cam.4.1.10627; Zwolinski CM, 2011, TISSUE ENG PART C-ME, V17, P589, DOI [10.1089/ten.TEC.2010.0619, 10.1089/ten.tec.2010.0619]	62	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61856	10.1371/journal.pone.0061856	http://dx.doi.org/10.1371/journal.pone.0061856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637919	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000317908700063
J	Gove, JM; Williams, GJ; McManus, MA; Heron, SF; Sandin, SA; Vetter, OJ; Foley, DG				Gove, Jamison M.; Williams, Gareth J.; McManus, Margaret A.; Heron, Scott F.; Sandin, Stuart A.; Vetter, Oliver J.; Foley, David G.			Quantifying Climatological Ranges and Anomalies for Pacific Coral Reef Ecosystems	PLOS ONE			English	Article							CLIMATE-CHANGE; BASE-LINES; INTERMEDIATE DISTURBANCE; INTERNAL WAVES; FLORIDA-KEYS; TEMPERATURE; SUSCEPTIBILITY; MORPHOLOGY; STRESSORS; PATTERNS	Coral reef ecosystems are exposed to a range of environmental forcings that vary on daily to decadal time scales and across spatial scales spanning from reefs to archipelagos. Environmental variability is a major determinant of reef ecosystem structure and function, including coral reef extent and growth rates, and the abundance, diversity, and morphology of reef organisms. Proper characterization of environmental forcings on coral reef ecosystems is critical if we are to understand the dynamics and implications of abiotic-biotic interactions on reef ecosystems. This study combines high-resolution bathymetric information with remotely sensed sea surface temperature, chlorophyll-a and irradiance data, and modeled wave data to quantify environmental forcings on coral reefs. We present a methodological approach to develop spatially constrained, island-and atoll-scale metrics that quantify climatological range limits and anomalous environmental forcings across U. S. Pacific coral reef ecosystems. Our results indicate considerable spatial heterogeneity in climatological ranges and anomalies across 41 islands and atolls, with emergent spatial patterns specific to each environmental forcing. For example, wave energy was greatest at northern latitudes and generally decreased with latitude. In contrast, chlorophyll-a was greatest at reef ecosystems proximate to the equator and northern-most locations, showing little synchrony with latitude. In addition, we find that the reef ecosystems with the highest chlorophyll-a concentrations; Jarvis, Howland, Baker, Palmyra and Kingman are each uninhabited and are characterized by high hard coral cover and large numbers of predatory fishes. Finally, we find that scaling environmental data to the spatial footprint of individual islands and atolls is more likely to capture local environmental forcings, as chlorophyll-a concentrations decreased at relatively short distances (>7 km) from 85% of our study locations. These metrics will help identify reef ecosystems most exposed to environmental stress as well as systems that may be more resistant or resilient to future climate change.	[Gove, Jamison M.; Vetter, Oliver J.; Foley, David G.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Gove, Jamison M.; Vetter, Oliver J.] NOAA, Coral Reef Ecosyst Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Williams, Gareth J.; Sandin, Stuart A.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [McManus, Margaret A.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Honolulu, HI USA; [Heron, Scott F.] NOAA, Natl Environm & Satellite Data & Informat Serv, Silver Spring, MD USA; [Heron, Scott F.] James Cook Univ, Sch Engn & Phys Sci, Dept Phys, Marine Geophys Lab, Townsville, Qld 4811, Australia; [Foley, David G.] NOAA, Div Environm Res, Southwest Fisheries Sci Ctr, Pacific Grove, CA USA	University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA	Gove, JM (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	jamison.gove@noaa.gov	Heron, Scott F/E-7928-2011; McManus, Margaret Anne/AAA-2604-2020	Williams, Dr Gareth J./0000-0001-7837-1619; Heron, Scott/0000-0001-5262-6978	Comparative Analysis of Marine Ecosystem Organization (CAMEO) program; NOAA's Coral Reef Conservation Program	Comparative Analysis of Marine Ecosystem Organization (CAMEO) program; NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding was provided by the Comparative Analysis of Marine Ecosystem Organization (CAMEO) program and NOAA's Coral Reef Conservation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton AD, 2005, CORAL REEFS, V24, P536, DOI 10.1007/s00338-005-0017-1; Boss E, 2003, LIMNOL OCEANOGR, V48, P346, DOI 10.4319/lo.2003.48.1_part_2.0346; BRADBURY RH, 1981, MAR ECOL PROG SER, V5, P229, DOI 10.3354/meps005229; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI 10.1016/S0065-2881(08)60224-2; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CARDER K, 2003, INSTANTANEOUS PHOTOS; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Castillo KD, 2012, NAT CLIM CHANGE, V2, P756, DOI [10.1038/nclimate1577, 10.1038/NCLIMATE1577]; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Clarke K., 2006, PRIMER E USER MANUAL; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Couce E, 2012, J BIOGEOGR, V39, P1508, DOI 10.1111/j.1365-2699.2012.02706.x; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; Done TJ, 1999, AM ZOOL, V39, P66; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Donner SD, 2011, ECOL APPL, V21, P1718, DOI 10.1890/10-0107.1; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; DOTY M. S., 1956, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V22, P33; Eakin CM, 2010, OCEANOGRAPHY, V23, P118, DOI 10.5670/oceanog.2010.10; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Freeman LA, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007099; Gove JM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003161; Grigg RW, 1983, MARINE ECOLOGY PROGR, V11, P1; HENDRY R, 1973, J FLUID MECH, V58, P97, DOI 10.1017/S0022112073002156; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2005, LIMNOL OCEANOGR, V50, P265, DOI 10.4319/lo.2005.50.1.0265; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 2011, IMPACT CLIMATE CHANG, P391, DOI DOI 10.1007/978-94-007-0114-4_22; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Karnauskas KB, 2012, NATURE CLIM CHANGE; KILAR JA, 1989, MAR ECOL PROG SER, V54, P265, DOI 10.3354/meps054265; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Kleypas JA, 1999, AM ZOOL, V39, P146; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Leichter JJ, 2007, LIMNOL OCEANOGR, V52, P1258, DOI 10.4319/lo.2007.52.3.1258; Leichter JJ, 2006, MAR ECOL PROG SER, V316, P95, DOI 10.3354/meps316095; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; Lough JM, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008199; Madin JS, 2006, CORAL REEFS, V25, P635, DOI 10.1007/s00338-006-0137-2; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; Miller J, 2008, STATE CORAL REEF ECO, V73, P354; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Obura D, 2011, CORAL REEFS, V30, P607, DOI 10.1007/s00338-011-0741-7; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Reidenbach MA, 2006, LIMNOL OCEANOGR, V51, P1134, DOI 10.4319/lo.2006.51.2.1134; ROGERS CS, 1993, CORAL REEFS, V12, P127, DOI 10.1007/BF00334471; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sheppard C, 2009, CORAL REEFS, V28, P399, DOI 10.1007/s00338-009-0476-x; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Smith JE, 2004, LIMNOL OCEANOGR, V49, P1923, DOI 10.4319/lo.2004.49.6.1923; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; Storlazzi C.D, 2001, WAW C AM SOC CIV ENG, P784; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Storlazzi CD, 2003, GEOL SOC AM BULL, V115, P1344, DOI 10.1130/B25200.1; Teneva L, 2012, CORAL REEFS, V31, P1, DOI 10.1007/s00338-011-0812-9; Visram S, 2007, J EXP MAR BIOL ECOL, V349, P35, DOI 10.1016/j.jembe.2007.04.014; Vroom PS, 2010, BIODIVERS CONSERV, V19, P797, DOI 10.1007/s10531-009-9735-y; Williams GJ, 2010, MAR POLLUT BULL, V60, P1467, DOI 10.1016/j.marpolbul.2010.05.009; Williams ID, 2011, J MARINE BIOL, V2011; WOLANSKI E, 1995, CONT SHELF RES, V15, P357, DOI 10.1016/0278-4343(93)E0004-R; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013	71	77	77	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61974	10.1371/journal.pone.0061974	http://dx.doi.org/10.1371/journal.pone.0061974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637939	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000317908700069
J	Yiu, WC; Yap, MKH; Fung, WY; Ng, PW; Yip, SP				Yiu, Wai Chi; Yap, Maurice K. H.; Fung, Wai Yan; Ng, Po Wah; Yip, Shea Ping			Genetic Susceptibility to Refractive Error: Association of Vasoactive Intestinal Peptide Receptor 2 (VIPR2) with High Myopia in Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VPAC(2) RECEPTOR; PATHOLOGICAL COMPLICATIONS; EYE GROWTH; C-FOS; LOCUS; TRANSCRIPTION; LINKAGE; RETINA; MAPS	Myopia is the most common ocular disease worldwide. We investigated the association of high myopia with the common single nucleotide polymorphisms (SNPs) of five candidate genes - early growth response 1 (EGR1), v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS), jun oncogene (JUN), vasoactive intestinal peptide (VIP), and vasoactive intestinal peptide receptor 2 (VIPR2). We recruited 1200 unrelated Chinese subjects with 600 cases (spherical equivalent <=-8.00 diopters) and 600 controls (spherical equivalent within +/- 1.00 diopter). A discovery sample set was formed from 300 cases and 300 controls, and a replication sample set from the remaining samples. Tag SNPs were genotyped for the discovery sample set, and the most significant haplotypes and their constituent SNPs were followed up with the replication sample set. The allele and haplotype frequencies in cases and controls were compared by logistic regression adjusted for sex and age to give P-a values, and multiple comparisons were corrected by permutation test to give P-aemp values. Odd ratios (OR) were calculated accordingly. In the discovery phase, EGR1, JUN and VIP did not show any significant association while FOS and VIPR2 demonstrated significant haplotype association with high myopia. In the replication phase, the haplotype association for VIPR2 was successfully replicated, but not FOS. In analysis combining both sample sets, the most significant association signals of VIPR2 were the single marker rs2071625 (P-a = 0.0008, P-aemp = 0.0046 and OR = 0.75) and the 4-SNP haplotype window rs2071623-rs2071625-rs2730220-rs885863 (omnibus test, P-a = 9.10e-10 and P-aemp = 0.0001) with one protective haplotype (GGGG: P-aemp = 0.0002 and OR = 0.52) and one high-risk haplotype (GAGA: P-aemp = 0.0027 and OR = 4.68). This 4-SNP haplotype window was the most significant in all sample sets examined. This is the first study to suggest a role of VIPR2 in the genetic susceptibility to high myopia. EGR1, JUN, FOS and VIP are unlikely to be important in predisposing humans to high myopia.	[Yiu, Wai Chi; Yap, Maurice K. H.; Ng, Po Wah] Hong Kong Polytech Univ, Ctr Myopia Res, Sch Optometry, Hong Kong, Hong Kong, Peoples R China; [Yiu, Wai Chi; Fung, Wai Yan; Ng, Po Wah; Yip, Shea Ping] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	Yip, SP (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.	shea.ping.yip@polyu.edu.hk	Yap, Maurice KH/K-4927-2016; Yip, Shea Ping/A-1185-2016	Yap, Maurice KH/0000-0003-4687-4101; Yip, Shea Ping/0000-0002-2170-8185	Hong Kong Polytechnic University [RP3C, JBB7P, G-U730, 87TP, 1.55.xx.99NE]	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work is a contribution from the Centre for Myopia Research of The Hong Kong Polytechnic University, and was supported by grants from The Hong Kong Polytechnic University (RP3C, JBB7P, G-U730, 87TP and 1.55.xx.99NE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos JF, 1987, DIAGNOSIS MANAGEMENT; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bitzer M, 2002, INVEST OPHTH VIS SCI, V43, P246; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Brand C, 2005, MOL VIS, V11, P309; Chen ZTY, 2009, OPHTHALMOLOGY, V116, P1920, DOI 10.1016/j.ophtha.2009.03.023; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; EDWARDS DR, 1992, BIOCHIM BIOPHYS ACTA, V1171, P41, DOI 10.1016/0167-4781(92)90138-P; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Guo YF, 2009, EUR J HUM GENET, V17, P785, DOI 10.1038/ejhg.2008.244; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; Hysi PG, 2010, NAT GENET, V42, P902, DOI 10.1038/ng.664; Jiang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019587; Leung KH, 2011, INVEST OPHTH VIS SCI, V52, P3893, DOI 10.1167/iovs.11-7286; Li T, 2008, MOL VIS, V14, P1309; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Li YJ, 2009, INVEST OPHTH VIS SCI, V50, P3116, DOI 10.1167/iovs.08-2781; Liu Shuang-zhen, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P456; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Mak JYY, 2012, ARCH OPHTHALMOL-CHIC, V130, P209, DOI 10.1001/archophthalmol.2011.365; Matsumura H, 1999, SURV OPHTHALMOL, V44, pS109, DOI 10.1016/S0039-6257(99)00094-6; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Metlapally R, 2009, INVEST OPHTH VIS SCI, V50, P4080, DOI 10.1167/iovs.08-3346; Mori M, 2001, INVEST OPHTH VIS SCI, V42, P1312; Naiglin L, 2002, J MED GENET, V39, P118, DOI 10.1136/jmg.39.2.118; Nickla DL, 2013, EXP EYE RES, V114, P25, DOI 10.1016/j.exer.2012.12.013; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; RAVIOLA E, 1985, NEW ENGL J MED, V312, P1609, DOI 10.1056/NEJM198506203122505; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Schippert R, 2007, INVEST OPHTH VIS SCI, V48, P11, DOI 10.1167/iovs.06-0851; Shen SB, 2000, P NATL ACAD SCI USA, V97, P11575, DOI 10.1073/pnas.97.21.11575; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; Tang WC, 2008, CLIN EXP OPTOM, V91, P4, DOI 10.1111/j.1444-0938.2007.00181.x; Tkatchenko AV, 2006, P NATL ACAD SCI USA, V103, P4681, DOI 10.1073/pnas.0600589103; WALLMAN J, 1987, SCIENCE, V237, P73, DOI 10.1126/science.3603011; Wang Ping-bao, 2008, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V33, P669; White LA, 1995, MATRIX BIOL, V14, P715, DOI 10.1016/S0945-053X(05)80014-9; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wojciechowski R, 2011, CLIN GENET, V79, P301, DOI 10.1111/j.1399-0004.2010.01592.x; Wojciechowski R, 2010, INVEST OPHTH VIS SCI, V51, P4989, DOI 10.1167/iovs.10-5474; YANGYEN HF, 1991, NEW BIOL, V3, P1206; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907; Young TL, 1998, AM J HUM GENET, V63, P1419, DOI 10.1086/302111; Zha Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P541, DOI 10.1001/archophthalmol.2008.623	50	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61805	10.1371/journal.pone.0061805	http://dx.doi.org/10.1371/journal.pone.0061805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637909	Green Published, Green Submitted, gold			2022-12-25	WOS:000317908700060
J	Ma, WJ; Kuijper, B; de Boer, JG; van de Zande, L; Beukeboom, LW; Wertheim, B; Pannebakker, BA				Ma, Wen-Juan; Kuijper, Bram; de Boer, Jetske G.; van de Zande, Louis; Beukeboom, Leo W.; Wertheim, Bregje; Pannebakker, Bart A.			Absence of Complementary Sex Determination in the Parasitoid Wasp Genus Asobara (Hymenoptera: Braconidae)	PLOS ONE			English	Article							NASONIA-VITRIPENNIS HYMENOPTERA; TABIDA NEES BRACONIDAE; DROSOPHILA-MELANOGASTER; DETERMINING MECHANISMS; INBREEDING DEPRESSION; DETERMINATION PATHWAY; DIPLOID MALES; ENCAPSULATION; ALYSIINAE; EVOLUTION	An attractive way to improve our understanding of sex determination evolution is to study the underlying mechanisms in closely related species and in a phylogenetic perspective. Hymenopterans are well suited owing to the diverse sex determination mechanisms, including different types of Complementary Sex Determination (CSD) and maternal control sex determination. We investigated different types of CSD in four species within the braconid wasp genus Asobara that exhibit diverse life-history traits. Nine to thirteen generations of inbreeding were monitored for diploid male production, brood size, offspring sex ratio, and pupal mortality as indicators for CSD. In addition, simulation models were developed to compare these observations to predicted patterns for multilocus CSD with up to ten loci. The inbreeding regime did not result in diploid male production, decreased brood sizes, substantially increased offspring sex ratios nor in increased pupal mortality. The simulations further allowed us to reject CSD with up to ten loci, which is a strong refutation of the multilocus CSD model. We discuss how the absence of CSD can be reconciled with the variation in life-history traits among Asobara species, and the ramifications for the phylogenetic distribution of sex determination mechanisms in the Hymenoptera.	[Ma, Wen-Juan; Kuijper, Bram; de Boer, Jetske G.; van de Zande, Louis; Beukeboom, Leo W.; Wertheim, Bregje; Pannebakker, Bart A.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of Groningen	Ma, WJ (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	wenjuanma84@gmail.com	Ma, Wen-Juan/AAL-9136-2020; de Boer, Jetske G/B-1081-2019; Pannebakker, Bart A./D-3823-2012; Wertheim, Bregje/B-6436-2009; Kuijper, Bram/E-9409-2013; de boer, jetske/K-6827-2012	Ma, Wen-Juan/0000-0003-2585-6406; de Boer, Jetske G/0000-0002-3182-8543; Pannebakker, Bart A./0000-0001-8503-3896; Wertheim, Bregje/0000-0001-8555-1925; Kuijper, Bram/0000-0002-7263-2846; van de Zande, Louis/0000-0001-5687-3220	Netherlands Organization for Scientific Research (NWO) [863.08.008]; JGdB [863.07.010]; BW [864.08.008]; NWO/ALW TOP grant [854.10.001]; Netherlands Genomics Initiative (NGI) [935.19.006, 935.11.041]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); JGdB; BW; NWO/ALW TOP grant; Netherlands Genomics Initiative (NGI)	This work was supported by funding from the Netherlands Organization for Scientific Research (NWO) to BAP (Veni grant no. 863.08.008), JGdB (Veni grant no. 863.07.010), BW (Vidi grant no. 864.08.008) and a NWO/ALW TOP grant (no. 854.10.001) to LWB and LvdZ. BAP was also funded by the Netherlands Genomics Initiative (NGI) (Horizon Breakthrough and Zenith grants no. 935.19.006 and 935.11.041). NWO URL: http://www.nwo.nl/. NGI URL:http://www.genomics.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Aron S, 2005, CURR BIOL, V15, P824, DOI 10.1016/j.cub.2005.03.017; Asplen MK, 2009, J EVOLUTION BIOL, V22, P1762, DOI 10.1111/j.1420-9101.2009.01774.x; Beukeboom LW, 2007, SEMIN CELL DEV BIOL, V18, P371, DOI 10.1016/j.semcdb.2006.12.015; Beukeboom LW, 2010, J GENET, V89, P333, DOI 10.1007/s12041-010-0045-7; Beukeboom LW, 2000, HEREDITY, V84, P29, DOI 10.1046/j.1365-2540.2000.00628.x; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; BULL JJ, 1985, EXPERIENTIA, V41, P1285, DOI 10.1007/BF01952071; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1993, HEREDITY, V71, P130, DOI 10.1038/hdy.1993.116; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; CROZIER RH, 1977, ANNU REV ENTOMOL, V22, P263, DOI 10.1146/annurev.en.22.010177.001403; CROZIER RH, 1971, AM NAT, V105, P399, DOI 10.1086/282733; de Boer JG, 2007, HEREDITY, V99, P288, DOI 10.1038/sj.hdy.6800995; De Boer JG, 2007, J EVOLUTION BIOL, V20, P340, DOI 10.1111/j.1420-9101.2006.01193.x; de Boer JG, 2008, GENETICS, V180, P1525, DOI 10.1534/genetics.107.083907; de Boer JG, 2012, EVOL APPL, V5, P444, DOI 10.1111/j.1752-4571.2012.00270.x; de Jong PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020870; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; HOFFMANN AA, 1988, J INSECT PHYSIOL, V34, P197, DOI 10.1016/0022-1910(88)90050-9; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kozielska M, 2008, GENET RES, V90, P157, DOI 10.1017/S001667230700907X; KRAAIJEVELD AR, 1994, PHYSIOL ENTOMOL, V19, P9, DOI 10.1111/j.1365-3032.1994.tb01068.x; Kraak SBM, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P158, DOI 10.1017/CBO9780511542053.008; Lynch M., 1998, GENETICS ANAL QUANTI; Murata Y, 2009, EUR J ENTOMOL, V106, P171, DOI 10.14411/eje.2009.020; Niyibigira EI, 2004, APPL ENTOMOL ZOOL, V39, P705, DOI 10.1303/aez.2004.705; Ohno S., 1970, EVOLUTION GENE DUPLI; Pannebakker BA, 2011, J EVOLUTION BIOL, V24, P12, DOI 10.1111/j.1420-9101.2010.02129.x; Peer K, 2005, EVOLUTION, V59, P317; Prevost G, 2005, J INSECT PHYSIOL, V51, P171, DOI 10.1016/j.jinsphys.2004.10.002; Saccone G, 2002, GENETICA, V116, P15, DOI 10.1023/A:1020903523907; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Schmieder S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1898; Schrempf A, 2006, HEREDITY, V97, P75, DOI 10.1038/sj.hdy.6800846; Seyahooei MA, 2011, BIOL J LINN SOC, V103, P45, DOI 10.1111/j.1095-8312.2011.01637.x; Snell GD, 1935, P NATL ACAD SCI USA, V21, P446, DOI 10.1073/pnas.21.7.446; Trent C, 2006, HEREDITY, V96, P368, DOI 10.1038/sj.hdy.6800810; Uller T, 2007, TRENDS ECOL EVOL, V22, P292, DOI 10.1016/j.tree.2007.03.008; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; VANALPHEN JJM, 1982, NETH J ZOOL, V32, P215, DOI 10.1163/002829682X00148; VANALPHEN JJM, 1982, NETH J ZOOL, V32, P232, DOI 10.1163/002829682X00157; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; West S., 2009, SEX ALLOCATION; Whiting PW, 1933, SCIENCE, V78, P537, DOI 10.1126/science.78.2032.537-a; Whiting PW, 1943, GENETICS, V28, P365; Wu Z, 2005, HEREDITY, V95, P228, DOI 10.1038/sj.hdy.6800720; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zayed A, 2004, HEREDITY, V93, P627, DOI 10.1038/sj.hdy.6800588; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou Y, 2006, HEREDITY, V96, P487, DOI 10.1038/sj.hdy.6800829	54	18	18	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60459	10.1371/journal.pone.0060459	http://dx.doi.org/10.1371/journal.pone.0060459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23637750	Green Submitted, Green Published, gold			2022-12-25	WOS:000317717300121
J	Wang, JH; Cui, SZ; Zhang, XL; Wu, YB; Tang, HS				Wang, Jiahong; Cui, Shuzhong; Zhang, Xiangliang; Wu, Yinbing; Tang, Hongsheng			High Expression of Heat Shock Protein 90 Is Associated with Tumor Aggressiveness and Poor Prognosis in Patients with Advanced Gastric Cancer	PLOS ONE			English	Article							HSP90; CHEMOTHERAPY; SURGERY; CELLS	The heat shock protein 90 (HSP90) is overexpressed and highly associated with poor prognosis in many malignancies. However, the role of HSP90 in gastric cancer has not been thoroughly elucidated. The aim of this study is to investigate the relationship of HSP90 expression with clinicopathological parameters and prognosis in advanced gastric cancer, and estimate the alteration of HSP90 expression after neoadjuvant chemotherapy. HSP90 and matrix metallopeptidase 9 (MMP-9) antigen expression was evaluated by immunohistochemistry in 322 advanced gastric carcinoma samples. The relationships between HSP90 and clinicopathological parameters and prognosis were analyzed. The response of HSP90 level was assessed in chemotherapeutic effect in 54 patients received 1-2 cycles of neoadjuvant chemotherapy. The positive expression of HSP90 was found to be 69.6% in 322 advanced gastric carcinoma samples. HSP90 protein expression was significantly associated with depth invasion (P < 0.001), lymph node metastasis (P < 0.001) and stage of disease (P < 0.001). The positive rates of HSP90 expression were higher in both prominent serosal invasion group (P < 0.001) and lymph node metastasis group (P < 0.001). Moreover, HSP90 was significantly correlated with MMP-9 among 322 gastric cancer tissues (P < 0.001). In univariate and multivariate analyses, HSP90 was an independent prognostic factor for both recurrence-free survival (RFS) and overall survival (OS). These results suggested that HSP90 may play an important role on tumor invasion, metastasis and prognosis, and might act as a promising target for prognostic prediction.	[Wang, Jiahong; Cui, Shuzhong; Zhang, Xiangliang; Wu, Yinbing; Tang, Hongsheng] Guangzhou Med Univ, Affiliated Oncol Hosp, Dept Abdominal Surg, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Wang, JH (corresponding author), Guangzhou Med Univ, Affiliated Oncol Hosp, Dept Abdominal Surg, Guangzhou, Guangdong, Peoples R China.	cuishuzhong@126.com		Xu, Lin/0000-0002-2710-3507; Wang, Jing/0000-0002-3075-2874; chai, anping/0000-0003-4651-7307; Wang, Liping/0000-0001-6893-3809				Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bang YJ, 2010, LANCET, V376, P1302; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chu DK, 2011, INT J CANCER, V129, P887, DOI 10.1002/ijc.25734; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dikken JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-329; Dudeja V, 2009, GUT, V58, P1000, DOI 10.1136/gut.2007.140194; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Hong J, 2012, J CLIN INVEST, V122, P2165, DOI 10.1172/JCI61380; Jego G, 2010, CANC LETT; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kang GH, 2010, HISTOPATHOLOGY, V56, P694, DOI 10.1111/j.1365-2559.2010.03550.x; Lagarrigue F, 2010, CANCER RES, V70, P6978, DOI 10.1158/0008-5472.CAN-10-0861; Lang SA, 2007, MOL CANCER THER, V6, P1123, DOI 10.1158/1535-7163.MCT-06-0628; Lee KH, 2011, CANCER SCI, V102, P1388, DOI 10.1111/j.1349-7006.2011.01944.x; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Ruiz MIG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001722; Solit DB, 2003, SEMIN ONCOL, V30, P709, DOI 10.1016/S0093-7754(03)00346-4; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; Wang RE, 2011, CURR MED CHEM, V18, P4250; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	25	189	198	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62876	10.1371/journal.pone.0062876	http://dx.doi.org/10.1371/journal.pone.0062876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638161	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700078
J	Kim, J; Yoon, JH; Kim, YC				Kim, Jiyoung; Yoon, Jee-Hyun; Kim, Yeon-Soo			HIV-1 Tat Interacts with and Regulates the Localization and Processing of Amyloid Precursor Protein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MICROTUBULE-ASSOCIATED PROTEIN-2; LIPID RAFTS; A-BETA; TRANSACTIVATOR PROTEIN; MODULATION; RECEPTOR; EXPRESSION; SECRETASE; CELLS	HIV-1 Tat protein plays various roles in virus proliferation and in the regulation of numerous host cell functions. Accumulating evidence suggests that HIV-1 Tat also plays an important role in HIV-associated neurocognitive disorders (HAND) by disrupting intracellular communication. Amyloid beta (A beta) is generated from amyloid precursor protein (APP) and accumulates in the senile plaques of Alzheimer's disease patients. This study demonstrates that Tat interacts with APP both in vitro and in vivo, and increases the level of A beta 42 by recruiting APP into lipid rafts. Co-localization of Tat with APP in the cytosol was observed in U-87 MG cells that expressed high levels of Tat, and redistribution of APP into lipid rafts, a site of increased beta- and gamma-secretase activity, was demonstrated by discontinuous sucrose density gradient ultracentrifugation in the presence of Tat. Furthermore, Tat enhanced the cleavage of APP by beta-secretase in vitro, resulting in 5.5-fold higher levels of A beta 42. This was consistent with increased levels of beta-C-terminal fragment (beta-CTF) and reduced levels of alpha-CTF. Moreover, stereotaxic injection of a lentiviral Tat expression construct into the hippocampus of APP/presenilin-1 (PS1) transgenic mice resulted in increased Tat-mediated production and processing of A beta in vivo. Increased levels of A beta 42, as well as an increase in the number and size of A beta plaques, were observed in the hippocampus following injection of Tat virus compared with mock virus. These results suggest that HIV-1 Tat may contribute to HAND by interacting with and modifying APP processing, thereby increasing A beta production.	[Kim, Jiyoung; Kim, Yeon-Soo] Inje Univ, Lndang Inst Mol Biol, Seoul, South Korea; [Yoon, Jee-Hyun; Kim, Yeon-Soo] Inje Univ, Dept Smart Foods & Drugs, Seoul, South Korea	Inje University; Inje University	Kim, YC (corresponding author), Inje Univ, Lndang Inst Mol Biol, Seoul, South Korea.	kimys@inje.ac.kr			National Research Foundation of Korea [2005-2001152]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (2005-2001152) (www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aksenov MY, 2010, NEUROSCI LETT, V475, P174, DOI 10.1016/j.neulet.2010.03.073; Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Andersen OS, 2005, J GEN PHYSIOL, V125, P1, DOI 10.1085/jgp.200409233; Andersson LM, 1999, J NEUROL SCI, V171, P92, DOI 10.1016/S0022-510X(99)00253-1; Andras IE, 2003, J NEUROSCI RES, V74, P255, DOI 10.1002/jnr.10762; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Anthony IC, 2006, ACTA NEUROPATHOL, V111, P529, DOI 10.1007/s00401-006-0037-0; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bonavia R, 2001, BIOCHEM BIOPH RES CO, V288, P301, DOI 10.1006/bbrc.2001.5743; BRADDOCK M, 1990, CELL, V62, P1123, DOI 10.1016/0092-8674(90)90389-V; Brew BJ, 2005, NEUROLOGY, V65, P1490, DOI 10.1212/01.wnl.0000183293.95787.b7; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Chen L, 2012, NEUROBIOL AGING, V33, P1579, DOI 10.1016/j.neurobiolaging.2011.06.004; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; CRAS P, 1991, ANN NEUROL, V30, P853, DOI 10.1002/ana.410300621; Crozet C, 2004, J CELL SCI, V117, P5591, DOI 10.1242/jcs.01484; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Giometto B, 1997, ANN NEUROL, V42, P34, DOI 10.1002/ana.410420108; Giunta B, 2009, INT J CLIN EXP PATHO, V2, P433; Giunta B, 2008, INT J CLIN EXP PATHO, V1, P260; Green AJE, 2000, SEX TRANSM INFECT, V76, P443, DOI 10.1136/sti.76.6.443; Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c; Harris B, 2009, BRAIN RES, V1296, P203, DOI 10.1016/j.brainres.2009.07.105; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Huigen MCDG, 2004, EUR J CLIN INVEST, V34, P57, DOI 10.1111/j.1365-2362.2004.01282.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kaniowska D, 2006, J VIROL, V80, P9288, DOI 10.1128/JVI.02138-05; Kim SY, 2002, J BIOTECHNOL, V93, P183, DOI 10.1016/S0168-1656(01)00388-1; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; Kittiworakarn J, 2006, J BIOL CHEM, V281, P3105, DOI 10.1074/jbc.M509899200; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Levy-Dweck S, 2005, J GERONTOL SOC WORK, V46, P37, DOI 10.1300/J083v46n02_04; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; LOTZ M, 1994, J CELL BIOL, V124, P365, DOI 10.1083/jcb.124.3.365; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Milani D, 1996, J BIOL CHEM, V271, P22961, DOI 10.1074/jbc.271.38.22961; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Parkin ET, 1999, BIOCHEM J, V344, P23, DOI 10.1042/0264-6021:3440023; Raja F, 1997, ACTA NEUROPATHOL, V93, P184, DOI 10.1007/s004010050601; REFOLO LM, 1991, J NEUROSCI, V11, P3888; Rempel HC, 2005, AIDS, V19, P127, DOI 10.1097/00002030-200501280-00004; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Saunders M, 2005, APOPTOSIS, V10, P1419, DOI 10.1007/s10495-005-2467-x; SENGUPTA DN, 1990, P NATL ACAD SCI USA, V87, P7492, DOI 10.1073/pnas.87.19.7492; SHIOMURA Y, 1987, J CELL BIOL, V104, P1575, DOI 10.1083/jcb.104.6.1575; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Ulich C, 1999, J VIROL, V73, P2499, DOI 10.1128/JVI.73.3.2499-2508.1999; Valvatne H, 1996, AIDS RES HUM RETROV, V12, P611, DOI 10.1089/aid.1996.12.611; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang Can, 2009, Discov Med, V8, P18	70	94	99	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e77972	10.1371/journal.pone.0077972	http://dx.doi.org/10.1371/journal.pone.0077972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	23637966	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300003
J	Yu, Y; Wang, R; Nan, YC; Zhang, LS; Zhang, YJ				Yu, Ying; Wang, Rong; Nan, Yuchen; Zhang, Linsheng; Zhang, Yanjin			Induction of STAT1 Phosphorylation at Serine 727 and Expression of Proinflammatory Cytokines by Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							MORPHOLINO OLIGOMERS; TARGETED DISRUPTION; SIGNALING PATHWAY; PRRS VIRUS; TRANSCRIPTION; PROTEIN; REPLICATION; INFECTION; INTERLEUKIN-8; MACROPHAGES	Porcine reproductive and respiratory syndrome virus (PRRSV) is a viral pathogen that causes acute respiratory illnesses in young pigs. Since 1987, PRRSV has contributed substantial economic losses to the swine industry. Elevation of proinflammatory cytokines in PRRSV-infected pigs is thought to contribute to PRRSV pathogenesis. In this study, PRRSV VR-2385, a Type 2 strain with moderate virulence, was found to induce phosphorylation of signal transducer and activator of transcription 1 (STAT1) at serine 727 (pSTAT1-S727) in MARC-145 cells. No phosphorylated STAT1 at tyrosine 701 was detected, which indicates that the pSTAT1-S727 elevation was interferon-independent. The PRRSV-induced pSTAT1-S727, however, was dose-dependent and its levels increased with infection time. IngelVac PRRS MLV strain had a minimal effect on pSTAT1-S727. Compared to MLV-infected cells, VR-2385 infection caused significantly higher level of expression of proinflammatory cytokines, including interleukin 1 beta (IL-1beta) and IL-8. The VR-2385-induced pSTAT1-S727 and cytokine expression were reduced after SB203580, an inhibitor of p38 mitogen-activated protein kinase (MAPK), or methylthioadenosine (MTA), a methyl transferase inhibitor, was added to the cells. The SB203580 and MTA-mediated inhibition suggested that the virus-induced pSTAT1-S727 was dependent on p38 MAPK pathway. In primary porcine alveolar macrophages (PAMs), VR-2385 also induced pSTAT1-S727 and expression of proinflammatory cytokines and chemokines, including IL-1beta, IL-8, chemokine ligand 2 (CCL2) and chemokine (C-X-C motif) ligand 10 (CXCL10). Similarly, SB203580 treatment of PAM cells blocked the elevation of pSTAT1-S727 and cytokine expression. Overexpression of individual viral proteins showed that non-structural protein 12 (nsp12) was able to induce elevation of pSTAT1-S727 and the expression of IL-1 beta and IL-8. These results indicated that PRRSV VR-2385 induces pSTAT1-S727 and the expression of proinflammatory cytokines, which contributes to the insight of PRRSV pathogenesis.	[Yu, Ying; Zhang, Linsheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Yu, Ying; Wang, Rong; Nan, Yuchen; Zhang, Yanjin] Univ Maryland, Mol Virol Lab, VA MD Reg Coll Vet Med, College Pk, MD 20742 USA; [Yu, Ying; Wang, Rong; Nan, Yuchen; Zhang, Yanjin] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	Northwest A&F University - China; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Zhang, LS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	linszhang@nwsuaf.edu.cn; zhangyj@umd.edu	Nan, Yuchen/ABF-3746-2021; Zhang, Yanjin/H-5035-2019; Nan, Yuchen/F-9917-2014; Schneider, Harald/B-6681-2008	Nan, Yuchen/0000-0002-4442-8004; Wang, Rong/0000-0002-9947-4307; Schneider, Harald/0000-0002-4548-7268; Zhang, Yanjin/0000-0002-5847-3260	China Scholarship Council; National Pork Board	China Scholarship Council(China Scholarship Council); National Pork Board	This study was partially supported by National Pork Board. Y. Yu, R. Wang, and Y. Nan were partially supported by China Scholarship Council. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TQ, 2011, EMERG INFECT DIS, V17, P1782, DOI 10.3201/eid1709.110411; Bautista EM, 1996, ARCH VIROL, V141, P1357, DOI 10.1007/BF01718837; Conti P, 2003, IMMUNOL LETT, V86, P123, DOI 10.1016/S0165-2478(03)00002-6; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DENBOON JA, 1995, J VIROL, V69, P4500, DOI 10.1128/JVI.69.7.4500-4505.1995; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Faaberg K.S., 2011, VIRUS TAXONOMY; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gomez-Laguna J, 2010, J COMP PATHOL, V142, P51, DOI 10.1016/j.jcpa.2009.07.004; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; Hou J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-165; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lunney JK, 2010, VIRAL IMMUNOL, V23, P127, DOI 10.1089/vim.2009.0087; Lusso P, 2000, VIROLOGY, V273, P228, DOI 10.1006/viro.2000.0443; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; Miguel JC, 2010, VET IMMUNOL IMMUNOP, V135, P314, DOI 10.1016/j.vetimm.2010.01.002; Moreno B, 2010, MULT SCLER J, V16, P1102, DOI 10.1177/1352458510375968; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nan YC, 2012, VIROLOGY, V432, P261, DOI 10.1016/j.virol.2012.05.015; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Opriessnig T, 2011, ANTIVIR RES, V91, P36, DOI 10.1016/j.antiviral.2011.04.012; Patel D, 2008, ANTIVIR RES, V77, P95, DOI 10.1016/j.antiviral.2007.09.002; Patel D, 2010, J VIROL, V84, P11045, DOI 10.1128/JVI.00655-10; Patel D, 2009, ANTIVIR THER, V14, P899, DOI 10.3851/IMP1409; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; ROSSOW KD, 1995, VET PATHOL, V32, P361, DOI 10.1177/030098589503200404; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Song S, 2013, DEV COMP IMMUNOL, V39, P265, DOI 10.1016/j.dci.2012.10.001; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; van Reeth K, 2000, VET RES, V31, P187, DOI 10.1051/vetres:2000113; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu WH, 2001, VIROLOGY, V287, P183, DOI 10.1006/viro.2001.1034; Zhang YJ, 2007, ANTIVIR RES, V73, P12, DOI 10.1016/j.antiviral.2006.05.017	39	36	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61967	10.1371/journal.pone.0061967	http://dx.doi.org/10.1371/journal.pone.0061967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	24367634	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400062
J	Bahijri, S; Borai, A; Ajabnoor, G; Khaliq, AA; AlQassas, I; Al-Shehri, D; Chrousos, G				Bahijri, Suhad; Borai, Anwar; Ajabnoor, Ghada; Khaliq, Altaf Abdul; AlQassas, Ibrahim; Al-Shehri, Dhafer; Chrousos, George			Relative Metabolic Stability, but Disrupted Circadian Cortisol Secretion during the Fasting Month of Ramadan	PLOS ONE			English	Article							SLEEP-DEPRIVATION; GENE-EXPRESSION; CONSEQUENCES; STRESS; PLASMA; DEPRESSION; RHYTHM; MODEL; ACTH	Background: Chronic feeding and sleep schedule disturbances are stressors that exert damaging effects on the organism. Practicing Muslims in Saudi Arabia go through strict Ramadan fasting from dawn till sunset for one month yearly. Modern era Ramadan practices in Saudi Arabia are associated with disturbed feeding and sleep patterns, namely abstaining from food and water and increasing daytime sleep, and staying awake and receiving food and water till dawn. Hypothesis: Strict Ramadan practices in Saudi Arabia may influence metabolism, sleep and circadian cortisol secretion. Protocol: Young, male Ramadan practitioners were evaluated before and two weeks into the Ramadan. Blood samples were collected at 9.00 am and 9.00 pm for measurements of metabolic parameters and cortisol. Saliva was collected serially during the day for cortisol determinations. Results: Ramadan practitioners had relative metabolic stability or changes expected by the pattern of feeding. However, the cortisol circadian rhythm was abolished and circulating insulin levels and HOMA index were increased during this period. Discussion: The flattening of the cortisol rhythm is typical of conditions associated with chronic stress or endogenous hypercortisolism and associated with insulin resistance. Conclusions: Modern Ramadan practices in Saudi Arabia are associated with evening hypercortisolism and increased insulin resistance. These changes might contribute to the high prevalence of chronic stress-related conditions, such as central obesity, hypertension, metabolic syndrome and diabetes mellitus type 2, and their cardiovascular sequelae observed in the Kingdom.	[Bahijri, Suhad; Ajabnoor, Ghada] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21413, Saudi Arabia; [Bahijri, Suhad; Borai, Anwar; Ajabnoor, Ghada; Khaliq, Altaf Abdul; AlQassas, Ibrahim; Al-Shehri, Dhafer; Chrousos, George] King Abdulaziz Univ, King Fahd Med Res Ctr, Saudi Diabet Study Res Grp, Jeddah 21413, Saudi Arabia; [Borai, Anwar] King Abdul Aziz Med City, King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia; [Khaliq, Altaf Abdul] Um Alqura Univ, Fac Allied Med Sci, Dept Clin Biochem, Mecca, Saudi Arabia; [Chrousos, George] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Dept Pediat, GR-11527 Athens, Greece	King Abdulaziz University; King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Jeddah; Umm Al Qura University; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Borai, A (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Saudi Diabet Study Res Grp, Jeddah 21413, Saudi Arabia.	boraiaa@ngha.med.sa	AlShehri, Dhafer A/B-5950-2015; ajabnoor, ghada M.A/H-5128-2012; Bahijri, Suhad M/AAF-4141-2020	AlShehri, Dhafer A/0000-0002-7032-5199; ajabnoor, ghada M.A/0000-0001-9096-1531; Bahijri, Suhad M/0000-0001-6674-5409; ABDULKHALIQ, ALTAF A./0000-0002-8148-1103	deanship of research at King Abdulaziz University - Jeddah-Kingdom of Saudi Arabia [HiCi/1432-6-2]	deanship of research at King Abdulaziz University - Jeddah-Kingdom of Saudi Arabia	This study was supported by the deanship of research at King Abdulaziz University - Jeddah-Kingdom of Saudi Arabia under grant number (HiCi/1432-6-2) as part of a main research project conducted by "Saudi Diabetes Study Research Group''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHADRAMY MS, 1988, EUR J CLIN NUTR, V42, P359; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Ben Salem L, 2002, ANN ENDOCRINOL-PARIS, V63, P497; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Charmandari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025612; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; CHROUSOS GP, 2001, ENDOCRINOLOGY METABO; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedman TC, 1996, ENDOCR J, V43, P645, DOI 10.1507/endocrj.43.645; Froy O, 2010, AGING-US, V2, P7, DOI 10.18632/aging.100116; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Ho Kettani, 2010, P 8 HAW INT C ARTS H; Kino T, 2011, ENDOCR DEV, V20, P116, DOI 10.1159/000321232; Kluge M, 2007, J PSYCHIATR RES, V41, P928, DOI 10.1016/j.jpsychires.2006.08.005; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Knutsson A, 1989, Scand J Soc Med Suppl, V44, P1; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Maurovich-Horvat E, 2008, Prague Med Rep, V109, P275; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Paslakis G, 2011, PSYCHONEUROENDOCRINO, V36, P691, DOI 10.1016/j.psyneuen.2010.10.002; Pervanidou P, 2012, METABOLISM, V61, P611, DOI 10.1016/j.metabol.2011.10.005; Russ SJ, 2012, PSYCHONEUROENDOCRINO, V37, P462, DOI 10.1016/j.psyneuen.2011.07.014; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Van Cauter E, 2007, HORM RES, V67, P2, DOI 10.1159/000097543	31	50	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e60917	10.1371/journal.pone.0060917	http://dx.doi.org/10.1371/journal.pone.0060917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23637777	gold, Green Published, Green Submitted			2022-12-25	WOS:000317908700010
J	Kim, J; Dotson, B; Rey, C; Lindsey, J; Bleecker, AB; Binder, BM; Patterson, SE				Kim, Joonyup; Dotson, Bradley; Rey, Camila; Lindsey, Joshua; Bleecker, Anthony B.; Binder, Brad M.; Patterson, Sara E.			New Clothes for the Jasmonic Acid Receptor COI1: Delayed Abscission, Meristem Arrest and Apical Dominance	PLOS ONE			English	Article							FLORAL ORGAN ABSCISSION; SIGNAL-TRANSDUCTION; GROWTH-RESPONSE; GENE-EXPRESSION; CROSS-TALK; ARABIDOPSIS; ETHYLENE; PATHWAYS; SEPARATION; ENCODES	In a screen for delayed floral organ abscission in Arabidopsis, we have identified a novel mutant of CORONATINE INSENSITIVE 1 (COI1), the F-box protein that has been shown to be the jasmonic acid (JA) co-receptor. While JA has been shown to have an important role in senescence, root development, pollen dehiscence and defense responses, there has been little focus on its critical role in floral organ abscission. Abscission, or the detachment of organs from the main body of a plant, is an essential process during plant development and a unique type of cell separation regulated by endogenous and exogenous signals. Previous studies have indicated that auxin and ethylene are major plant hormones regulating abscission; and here we show that regulation of floral organ abscission is also controlled by jasmonic acid in Arabidopsis thaliana. Our characterization of coi1-1 and a novel allele (coi1-37) has also revealed an essential role in apical dominance and floral meristem arrest. In this study we provide genetic evidence indicating that delayed abscission 4 (dab4-1) is allelic to coi1-1 and that meristem arrest and apical dominance appear to be evolutionarily divergent functions for COI1 that are governed in an ecotype-dependent manner. Further characterizations of ethylene and JA responses of dab4-1/coi1-37 also provide new information suggesting separate pathways for ethylene and JA that control both floral organ abscission and hypocotyl growth in young seedlings. Our study opens the door revealing new roles for JA and its interaction with other hormones during plant development.	[Kim, Joonyup; Dotson, Bradley; Rey, Camila; Lindsey, Joshua; Patterson, Sara E.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Kim, Joonyup; Binder, Brad M.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA; [Dotson, Bradley] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Rey, Camila] Pontificia Univ Catolica Chile, Dept Ecosistemas & Medio Ambiente, Santiago, Chile; [Lindsey, Joshua] Univ Washington, Seattle, WA 98195 USA; [Bleecker, Anthony B.] Univ Wisconsin, Dept Bot, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Knoxville; University of California System; University of California Berkeley; Pontificia Universidad Catolica de Chile; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison	Patterson, SE (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.	spatters@wisc.edu			USDA HATCH WISO [4409]; NSF [DBI-0077719, MCB-0918430]	USDA HATCH WISO; NSF(National Science Foundation (NSF))	Funding was provided by USDA HATCH WISO 4409 and NSF DBI-0077719 to SEP and NSF MCB-0918430 to BMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1964, PLANT PHYSIOL, V39, P169, DOI 10.1104/pp.39.6.963; Acosta Ivan F, 2010, Arabidopsis Book, V8, pe0129, DOI 10.1199/tab.0129; Addicott F.T, 1982, ABSCISSION; Agusti J, 2008, J EXP BOT, V59, P2717, DOI 10.1093/jxb/ern138; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; [Anonymous], 1901, BOT CENTRALBL BEIH; Beno-Moualem D, 2004, PLANT SCI, V167, P499, DOI 10.1016/j.plantsci.2004.04.016; Binder B, 2009, STEWART POSTHARVEST; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Brown KM, 1997, PHYSIOL PLANTARUM, V100, P567, DOI 10.1034/j.1399-3054.1997.1000319.x; Butenko MA, 2003, PLANT CELL, V15, P2296, DOI 10.1105/tpc.014365; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; CURTIS RW, 1984, J PLANT GROWTH REGUL, V3, P157, DOI 10.1007/BF02042000; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Fernandez DE, 2000, PLANT CELL, V12, P183, DOI 10.1105/tpc.12.2.183; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Gonzalez-Carranza ZH, 2007, PLANT PHYSIOL, V144, P1370, DOI 10.1104/pp.106.092288; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hartmond U, 2000, J AM SOC HORTIC SCI, V125, P547, DOI 10.21273/JASHS.125.5.547; HENSEL LL, 1994, PLANT PHYSIOL, V106, P863, DOI 10.1104/pp.106.3.863; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Jinn TL, 2000, GENE DEV, V14, P108; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim J, 2013, FEBS LETT, V587, P226, DOI 10.1016/j.febslet.2012.11.030; Kim J, 2012, PLANT PHYSIOL, V160, P1567, DOI 10.1104/pp.112.205799; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kou XH, 2012, J EXP BOT, V63, P6139, DOI 10.1093/jxb/ers266; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Laux T, 1996, DEVELOPMENT, V122, P87; Lewis MW, 2010, PLANT J, V62, P817, DOI 10.1111/j.1365-313X.2010.04194.x; Lewis MW, 2006, CURR OPIN PLANT BIOL, V9, P59, DOI 10.1016/j.pbi.2005.11.009; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Liljegren SJ, 2012, CURR OPIN PLANT BIOL, V15, P670, DOI 10.1016/j.pbi.2012.09.012; Liljegren SJ, 2009, DEVELOPMENT, V136, P1909, DOI 10.1242/dev.033605; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Patterson S, 2007, ADVANCES IN PLANT ETHYLENE RESEARCH, P271, DOI 10.1007/978-1-4020-6014-4_60; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Patterson SE, 2001, PLANT PHYSIOL, V126, P494, DOI 10.1104/pp.126.2.494; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; ROBERTS JA, 1984, PLANTA, V160, P159, DOI 10.1007/BF00392864; Rohwer CL, 2008, J HORTIC SCI BIOTECH, V83, P283, DOI 10.1080/14620316.2008.11512381; Rojo E, 1999, PLANT J, V20, P135, DOI 10.1046/j.1365-313x.1999.00570.x; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; vanDoorn WG, 1997, J EXP BOT, V48, P821, DOI 10.1093/jxb/48.4.821; Wager A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00041; WOLTERING EJ, 1988, J EXP BOT, V39, P1605, DOI 10.1093/jxb/39.11.1605; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; XU Y, 1994, PLANT CELL, V6, P1077, DOI 10.1105/tpc.6.8.1077; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yoshida Y, 2009, DEVELOPMENT, V136, P1039, DOI 10.1242/dev.030585; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	67	94	99	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60505	10.1371/journal.pone.0060505	http://dx.doi.org/10.1371/journal.pone.0060505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23637966	Green Submitted, Green Published, gold			2022-12-25	WOS:000316930900070
J	Wang, FQ; Wang, L; Xu, ZY; Liang, GL				Wang, Fuqiang; Wang, Ling; Xu, Zhiyang; Liang, Gaolin			Identification and Analysis of Multi-Protein Complexes in Placenta	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; NATIVE GEL-ELECTROPHORESIS; PLASMA-MEMBRANE; PROTEOMIC ANALYSIS; PROTEASOME; UBIQUITINATION; DEGRADATION; PREECLAMPSIA; HOMEOSTASIS; EXPRESSION	Placental malfunction induces pregnancy disorders which contribute to life-threatening complications for both the mother and the fetus. Identification and characterization of placental multi-protein complexes is an important step to integratedly understand the protein-protein interaction networks in placenta which determine placental function. In this study, blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) and Liquid chromatography-tandem mass spectrometry (LC-MS/MS) were used to screen the multi-protein complexes in placenta. 733 unique proteins and 34 known and novel heterooligomeric multi-protein complexes including mitochondrial respiratory chain complexes, integrin complexes, proteasome complexes, histone complex, and heat shock protein complexes were identified. A novel protein complex, which involves clathrin and small conductance calcium-activated potassium (SK) channel protein 2, was identified and validated by antibody based gel shift assay, co-immunoprecipitation and immunouorescence staining. These results suggest that BN/SDS-PAGE, when integrated with LC-MS/MS, is a very powerful and versatile tool for the investigation of placental protein complexes. This work paves the way for deeper functional characterization of the placental protein complexes associated with pregnancy disorders.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Xu, Zhiyang] Nanjing Med Univ, Anal Ctr, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; CARVER W, 1995, J CELL PHYSIOL, V165, P425, DOI 10.1002/jcp.1041650224; Chenette EJ, 2012, NAT CELL BIOL, V14, P566; Cox B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012526; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Ekambaram P, 2011, INDIAN J BIOCHEM BIO, V48, P243; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feikova S, 2000, NEOPLASMA, V47, P212; Garnica AD, 1996, J AM COLL NUTR, V15, P206; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Katz A, 2007, MOL CELL PROTEOMICS, V6, P1459, DOI 10.1074/mcp.M700002-MCP200; Lafond J, 2006, INT REV CYTOL, V250, P109, DOI 10.1016/S0074-7696(06)50004-X; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; LEWIS PN, 1976, CAN J BIOCHEM CELL B, V54, P641, DOI 10.1139/o76-093; Li XW, 2009, J PROTEOME RES, V8, P3475, DOI 10.1021/pr900101d; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Liu K, 2009, MOL CELL PROTEOMICS, V8, P495, DOI 10.1074/mcp.M800250-MCP200; Mari G, 2007, CLIN OBSTET GYNECOL, V50, P497, DOI 10.1097/GRF.0b013e31804c96a9; Marin R, 2008, PLACENTA, V29, P671, DOI 10.1016/j.placenta.2008.06.003; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Streicher WW, 2009, BIOCHEMISTRY-US, V48, P2788, DOI 10.1021/bi8019959; Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516; Ueki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00827; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Wang HX, 2006, J CELL PHYSIOL, V206, P616, DOI 10.1002/jcp.20508; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhang HJ, 2012, DEVELOPMENT, V139, P2071, DOI 10.1242/dev.077347; Zhang Q, 2010, PROTEOM CLIN APPL, V4, P538, DOI 10.1002/prca.200900048; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294	46	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62988	10.1371/journal.pone.0062988	http://dx.doi.org/10.1371/journal.pone.0062988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638173	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800072
J	Wang, F; Song, XX; Li, XJ; Xin, J; Wang, SX; Yang, WD; Wang, J; Wu, KC; Chen, XY; Liang, JM; Tian, J; Cao, F				Wang, Fu; Song, Xinxing; Li, Xiujuan; Xin, Jing; Wang, Shenxu; Yang, Weidong; Wang, Jing; Wu, Kaichun; Chen, Xiaoyuan; Liang, Jimin; Tian, Jie; Cao, Feng			Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System	PLOS ONE			English	Article							DRUG-RESISTANCE; MAPK PATHWAYS; CELLS; CHEMOTHERAPY; ACTIVATION	MicroRNAs (miRNAs) have been implicated to play a central role in the development of drug resistance in a variety of malignancies. However, many studies were conducted at the in vitro level and could not provide the in vivo information on the functions of miRNAs in the anticancer drug resistance. Here, we introduced a dual reporter gene imaging system for noninvasively monitoring the kinetic expression of miRNA-16 during chemoresistance in gastric cancer both in vitro and in vivo. Human sodium iodide symporter (hNIS) and firefly luciferase (Fluc) genes were linked to form hNIS/Fluc double fusion reporter gene and then generate human gastric cancer cell line NF-3xmir16 and its multidrug resistance cell line NF-3xmir16/VCR. Radioiodide uptake and Fluc luminescence signals in vitro correlated well with viable cell numbers. The luciferase activities and radioiodide uptake in NF-3xmir16 cells were remarkably repressed by exogenous or endogenous miRNA-16. The NF-3xmir16/VCR cells showed a significant increase of I-131 uptake and luminescence intensity compared to NF-3xmir16 cells. The radioactivity from in vivo Tc-99m-pertechnetate imaging and the intensity from bioluminescence imaging were also increased in NF-3xmir16/VCR compared with that in NF-3xmir16 tumor xenografts. Furthermore, using this reporter gene system, we found that etoposide (VP-16) and 5-fluorouracil (5-FU) activated miRNA-16 expression in vitro and in vivo, and the upregulation of miRNA-16 is p38MAPK dependent but NF-kappa B independent. This dual imaging reporter gene may be served as a novel tool for in vivo imaging of microRNAs in the chemoresistance of cancers, as well as for early detection and diagnosis in clinic.	[Wang, Fu; Xin, Jing; Liang, Jimin] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Yang, Weidong; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Shaanxi, Peoples R China; [Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Chinese Academy of Sciences; Institute of Automation, CAS	Liang, JM (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	jimleung@mail.xidian.edu.cn; tian@ieee.org; wind8828@gmail.com	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	Program of the National Basic Research and Development Program of China (973) [2012CB518101, 2011CB707702]; National Natural Science Foundation of China [81090272, 81090274, 81227901]; China Department of Education [2010CXTD01]; 863 Program of China [2012AA02A603]; National Key Technology Support Program [2012BAI23B06]	Program of the National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Department of Education; 863 Program of China(National High Technology Research and Development Program of China); National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the Program of the National Basic Research and Development Program of China (973) under Grant No. 2012CB518101, 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 81090272, 81090274, 81227901, Innovation Team Development Grant by China Department of Education (2010CXTD01), 863 Program of China (2012AA02A603) and the National Key Technology Support Program under Grant No. 2012BAI23B06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blasberg RG, 2002, J CELL BIOCHEM, P172, DOI 10.1002/jcb.10433; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chung JK, 2002, J NUCL MED, V43, P1188; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jo MH, 2012, BIOMATERIALS, V33, P6456, DOI 10.1016/j.biomaterials.2012.05.057; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Kang WJ, 2012, BIOMATERIALS, V33, P6430, DOI 10.1016/j.biomaterials.2012.05.056; Kim JK, 2012, BIOMATERIALS, V33, P207, DOI 10.1016/j.biomaterials.2011.09.023; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Wang F, 2011, EUR J NUCL MED MOL I, V38, P1572, DOI 10.1007/s00259-011-1786-0; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yang SY, 2011, INT J ONCOL, V38, P1695, DOI 10.3892/ijo.2011.982; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	25	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61792	10.1371/journal.pone.0061792	http://dx.doi.org/10.1371/journal.pone.0061792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23638173	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200086
J	Wang, F; Hu, CM; Hua, XT; Song, L; Xia, QY				Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou			Translationally Controlled Tumor Protein, a Dual Functional Protein Involved in the Immune Response of the Silkworm, Bombyx mori	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; DROSOPHILA-MELANOGASTER; PATHOGEN RECOGNITION; CELL-PROLIFERATION; SCAVENGER RECEPTOR; INNATE IMMUNITY; PHAGE DISPLAY; TCTP; IDENTIFICATION; INFECTION	Insect gut immunity is the first line of defense against oral infection. Although a few immune-related molecules in insect intestine has been identified by genomics or proteomics approach with comparison to well-studied tissues, such as hemolymph or fat body, our knowledge about the molecular mechanism underlying the gut immunity which would involve a variety of unidentified molecules is still limited. To uncover additional molecules that might take part in pathogen recognition, signal transduction or immune regulation in insect intestine, a T7 phage display cDNA library of the silkworm midgut is constructed. By use of different ligands for biopanning, Translationally Controlled Tumor Protein (TCTP) has been selected. BmTCTP is produced in intestinal epithelial cells and released into the gut lumen. The protein level of BmTCTP increases at the early time points during oral microbial infection and declines afterwards. In vitro binding assay confirms its activity as a multi-ligand binding molecule and it can further function as an opsonin that promotes the phagocytosis of microorganisms. Moreover, it can induce the production of anti-microbial peptide via a signaling pathway in which ERK is required and a dynamic tyrosine phosphorylation of certain cytoplasmic membrane protein. Taken together, our results characterize BmTCTP as a dual-functional protein involved in both the cellular and the humoral immune response of the silkworm, Bombyx mori.	[Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Basic Research Program of China [2012CB114600]; Natural Science Foundation of China [31201854]; Fundamental Research Funds for the Central Universities [XDJK2009B033]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grant of "National Basic Research Program of China'' (http://www.973.gov.cn/Default_3.aspx) (2012CB114600), "Natural Science Foundation of China'' (http://www.nsfc.gov.cn/Portal0/default152.htm) (31201854) and "Fundamental Research Funds for the Central Universities'' (XDJK2009B033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chen TS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-16; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu XL, 2012, MOL BIOL REP, V39, P3427, DOI 10.1007/s11033-011-1114-6; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kashiwakura JI, 2012, J CLIN INVEST, V122, P218, DOI 10.1172/JCI59072; Kim CH, 2010, J BIOL CHEM, V285, P25243, DOI 10.1074/jbc.M110.134940; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lee JM, 2004, COMP BIOCHEM PHYS B, V139, P35, DOI 10.1016/j.cbpc.2004.06.004; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Meyvis Y, 2009, INT J PARASITOL, V39, P1205, DOI 10.1016/j.ijpara.2009.02.017; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nie ZM, 2010, MOL BIOL REP, V37, P2621, DOI 10.1007/s11033-009-9787-9; Niikura M, 2004, POULTRY SCI, V83, P1117, DOI 10.1093/ps/83.7.1117; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Panrat T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033291; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Shitomi Y, 2006, J BIOCHEM, V139, P223, DOI 10.1093/jb/mvj024; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sunagar SG, 2011, J INSECT PHYSIOL, V57, P1707, DOI 10.1016/j.jinsphys.2011.09.009; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Venugopal T, 2005, COMP BIOCHEM PHYS B, V142, P8, DOI 10.1016/j.cbpc.2005.04.011; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Wang F, 2009, EUR J IMMUNOL, V39, P254, DOI 10.1002/eji.200838472; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064	55	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69284	10.1371/journal.pone.0069284	http://dx.doi.org/10.1371/journal.pone.0069284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23638173	Green Submitted, Green Published, gold			2022-12-25	WOS:000322132100052
J	Wang, FQ; Wang, L; Shi, ZH; Liang, GL				Wang, Fuqiang; Wang, Ling; Shi, Zhonghua; Liang, Gaolin			Comparative N-Glycoproteomic and Phosphoproteomic Profiling of Human Placental Plasma Membrane between Normal and Preeclampsia Pregnancies with High-Resolution Mass Spectrometry	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LATE-ONSET PREECLAMPSIA; UTERINE ARTERY DOPPLER; METASTASIS SUPPRESSOR; SIGNALING NETWORKS; QUANTITATIVE PROTEOMICS; TROPHOBLAST INVASION; IN-VITRO; EXPRESSION; KISS-1	Preeclampsia is a serious complication of pregnancy, which affects 2-8% of all pregnancies and is one of the leading causes of maternal and perinatal mortality and morbidity worldwide. To better understand the molecular mechanisms involved in pathological development of placenta in preeclampsia, we used high-resolution LC-MS/MS technologies to construct a comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane in normal and preeclamptic pregnancies. A total of 1027 N-glyco-and 2094 phospho-sites were detected in human placental plasma membrane, and 5 N-glyco-and 38 phospho-proteins, respectively, with differentially expression were definitively identified between control and preeclamptic placental plasma membrane. Further bioinformatics analysis indicated that these differentially expressed proteins correlate with several specific cellular processes occurring during pathological changes of preeclamptic placental plasma membrane.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Shi, Zhonghua] Nanjing Med Univ, State Key Lab Reprod Med, Anal Ctr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Technology Development Key Project Fund of Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Development Key Project Fund of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Danussi C, 2012, CANCER PREV RES, V5, P1131, DOI 10.1158/1940-6207.CAPR-12-0076-T; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Fleischer S, 1974, Methods Enzymol, V31, P6; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Li CF, 2012, PLACENTA, V33, P47, DOI 10.1016/j.placenta.2011.10.008; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Ping C, 2007, SCI CHINA SER C, V50, P731, DOI 10.1007/s11427-007-0103-4; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; [乔宠 Qiao Chong], 2003, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V19, P289; Qin HQ, 2013, CHEM COMMUN, V49, P5162, DOI 10.1039/c3cc41479e; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Vazquez-Alaniz F, 2011, EUR J OBSTET GYN R B, V159, P67, DOI 10.1016/j.ejogrb.2011.07.019; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	43	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80480	10.1371/journal.pone.0080480	http://dx.doi.org/10.1371/journal.pone.0080480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	23638173	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600065
J	Wang, FP; Li, L; Li, J; Wang, JY; Wang, LY; Jiang, W				Wang, Fu-ping; Li, Lei; Li, Jing; Wang, Ji-yao; Wang, Ling-yan; Jiang, Wei			RETRACTED: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							GLYCATION END-PRODUCTS; RECEPTOR 4; LIVER FIBROSIS; KAPPA-B; HMGB1; PROTEIN; RAT; EXPRESSION; APOPTOSIS; INFLAMMATION	Background: The migration of hepatic stellate cells (HSCs) is essential to the hepatic fibrotic response, and recently High-mobility group box 1 (HMGB1) has been shown up-regulated during liver fibrosis. Nevertheless, whether HMGB1 can modulate the proliferation and migration of HSCs is poorly understood, as well as the involved intracellular signaling. In this study, we examined the effect of HMGB1 on proliferation, migration, pro-fibrotic function of HSCs and investigated whether toll-like family of receptor 4 (TLR4) dependent signal pathway is involved in the intracellular signaling regulation. Methodology/Principal Findings: Modified transwell chamber system to mimic the space of Disse was used to evaluate the migration of human primary HSCs, and the protein expressions of related signal factors were evaluated by western blot. Cell proliferation was analyzed by MTT assay, the pro-fibrotic functions of HSCs by qRT-PCR and ELISA respectively. Recombinant human HMGB1 could significantly promote migration of HSCs under both haptotactic and chemotactic stimulation, especially the latter. Human TLR4 neutralizing antibody could markedly inhibit HMGB1-induced migration of HSCs. HMGB1 could enhance the phosphorylation of JNK and PI3K/Akt, and TLR4 neutralizing antibody inhibited HMGB1-enhanced phosphorylation of JNK and PI3K/Akt and activation of NF-kappa B. JNK inhibitor (SP600125) and PI3K inhibitor (LY 294002) significantly inhibited HMGB1-induced proliferation and migration of HSCs, and also reduced HMGB1-enhanced related collagen expressions and pro-fibrotic cytokines production. Conclusions/Significance: HMGB1 could significantly enhance migration of HSCs in vitro, and TLR4-dependent JNK and PI3K/Akt signal pathways are involved in the HMGB1-induced proliferation, migration and pro-fibrotic effects of HSCs, which indicates HMGB1 might be an effective target to treat liver fibrosis.	[Wang, Fu-ping; Li, Lei; Wang, Ji-yao; Jiang, Wei] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Li, Jing] Tongji Univ, Tongji Hosp, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Wang, Ling-yan] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Jiang, W (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	jiang.wei@zs-hospital.sh.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Nature Science Foundation of China [30300151, 81070341]; Shanghai Nature Science Foundation [09ZR1406000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation	This study is supported by grants from the National Nature Science Foundation of China (No. 30300151 &81070341, http://www.nsfc.gov.cn) and Shanghai Nature Science Foundation (No. 09ZR1406000, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Chen GQ, 2004, J INTERF CYTOK RES, V24, P329, DOI 10.1089/107999004323142187; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Kao YH, 2008, TRANSPL P, V40, P2704, DOI 10.1016/j.transproceed.2008.07.055; Kim CH, 2010, INT J ONCOL, V36, P117, DOI 10.3892/ijo_00000482; Kim DE, 2012, BIOCHEM BIOPH RES CO, V421, P436, DOI 10.1016/j.bbrc.2012.03.131; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Li L, 2012, LIVER INT, V32, P1093, DOI 10.1111/j.1478-3231.2012.02809.x; Lin YL, 2009, J GASTROEN HEPATOL, V24, P453, DOI 10.1111/j.1440-1746.2008.05573.x; Lohwasser C, 2009, WORLD J GASTROENTERO, V15, P5789, DOI 10.3748/wjg.15.5789; Ma JJ, 2009, LIVER INT, V29, P567, DOI 10.1111/j.1478-3231.2009.01981.x; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Nogueira-Machado JA, 2011, EXPERT OPIN THER TAR, V15, P1023, DOI 10.1517/14728222.2011.575360; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schnabl B, 2008, BIOCHEM BIOPH RES CO, V375, P210, DOI 10.1016/j.bbrc.2008.07.150; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Tang XM, 2009, BIOL PHARM BULL, V32, P963, DOI 10.1248/bpb.32.963; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Uyama N, 2012, LAB INVEST, V92, P57, DOI 10.1038/labinvest.2011.150; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Xia JR, 2008, INT J MOL SCI, V9, P638, DOI 10.3390/ijms9040638; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yang LC, 2012, LEUKEMIA LYMPHOMA, V53, P315, DOI 10.3109/10428194.2011.616962	48	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64373	10.1371/journal.pone.0064373	http://dx.doi.org/10.1371/journal.pone.0064373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23638173	Green Published, gold			2022-12-25	WOS:000319081900089
